data_2d21_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2d21 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -91.4 167.12 12.5 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.25 24.31 75.68 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 117.099 1.6 . . . . 0.0 117.099 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -148.24 157.92 43.78 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 121.145 2.472 . . . . 0.0 113.856 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.2 mt -144.95 152.19 39.8 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.346 2.258 . . . . 0.0 108.604 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -134.82 139.78 46.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 126.641 1.976 . . . . 0.0 106.97 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.2 mt -122.77 121.23 62.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.697 1.199 . . . . 0.0 108.99 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -115.95 137.08 52.44 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 mt -128.59 159.22 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -52.74 -20.35 3.1 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.17 155.13 30.22 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 104.846 -3.302 . . . . 0.0 104.846 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.89 0.57 0.38 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.261 1.424 . . . . 0.0 113.943 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -82.23 172.5 13.07 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.0 2.12 . . . . 0.0 111.885 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.61 51.01 2.97 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.062 1.791 . . . . 0.0 113.355 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -57.42 -35.98 70.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.76 1.224 . . . . 0.0 113.978 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -62.21 -38.51 89.41 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.871 0.76 . . . . 0.0 111.031 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.11 -35.72 57.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.8 tp -70.9 -32.46 69.41 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 123.119 0.568 . . . . 0.0 111.535 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.28 -48.64 71.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.298 0.639 . . . . 0.0 110.851 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -53.31 -38.47 63.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.33 -46.66 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.82 -29.42 72.61 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 124.539 1.066 . . . . 0.0 111.215 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -68.06 -43.77 77.87 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 118.851 1.326 . . . . 0.0 107.448 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -60.47 3.29 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -52.69 -54.17 37.33 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.984 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.18 -29.74 65.88 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.553 1.524 . . . . 0.0 112.292 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -28.39 58.74 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.601 -1.312 . . . . 0.0 109.83 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -91.63 -38.33 12.52 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.223 0.952 . . . . 0.0 112.05 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.5 p -102.62 -31.54 10.33 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.45 -17.35 54.69 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 121.106 -0.996 . . . . 0.0 112.206 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.3 mm -62.76 119.96 8.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.4 143.08 15.91 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 t -138.83 105.88 2.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 123.649 0.779 . . . . 0.0 109.128 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.5 m -96.96 153.45 17.89 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.82 127.28 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.88 154.79 51.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -122.58 57.29 9.22 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.08 1.752 . . . . 0.0 110.281 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.46 167.26 27.48 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.187 2.592 . . . . 0.0 112.299 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -121.71 1.78 10.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.221 1.008 . . . . 0.0 112.874 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 14.37 6.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.886 1.674 . . . . 0.0 112.117 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -58.33 -26.36 63.0 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 120.588 -1.32 . . . . 0.0 113.083 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -58.58 -27.51 64.68 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.845 1.202 . . . . 0.0 113.635 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -106.17 -24.55 12.3 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 123.66 0.784 . . . . 0.0 110.192 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.35 28.03 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.716 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -48.78 -60.06 5.23 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 117.629 -1.177 . . . . 0.0 109.403 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.28 -17.12 57.46 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.602 1.535 . . . . 0.0 114.004 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -89.03 -28.54 20.09 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.34 1.427 . . . . 0.0 111.753 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.8 -45.73 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 120.01 1.277 . . . . 0.0 109.651 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.26 -22.95 66.4 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 122.061 -0.399 . . . . 0.0 111.315 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.72 -24.31 67.61 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.23 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -103.23 4.86 37.16 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.59 1.556 . . . . 0.0 109.917 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.35 36.54 78.53 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.797 -1.189 . . . . 0.0 111.64 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -128.39 1.97 5.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.855 1.662 . . . . 0.0 112.915 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.41 -169.94 44.47 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.892 1.234 . . . . 0.0 113.693 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.36 162.24 34.41 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.189 1.926 . . . . 0.0 109.768 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -94.47 -19.2 20.77 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 124.545 1.138 . . . . 0.0 111.225 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -138.9 147.96 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tp -134.4 145.98 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.625 1.17 . . . . 0.0 108.622 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -130.55 108.94 10.3 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.714 1.606 . . . . 0.0 109.707 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -156.4 167.22 31.12 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 123.878 0.871 . . . . 0.0 109.975 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.76 155.33 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -57.29 -29.42 63.87 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -49.89 -59.06 4.21 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -66.09 -17.56 64.78 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.547 -0.721 . . . . 0.0 111.659 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -83.17 -5.11 59.0 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.497 -0.752 . . . . 0.0 110.3 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.4 -13.96 46.39 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.052 1.311 . . . . 0.0 113.591 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -125.06 -31.41 0.86 Allowed Glycine 0 CA--C 1.526 0.727 0 CA-C-N 118.827 1.314 . . . . 0.0 114.128 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -57.51 -41.74 81.41 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.017 1.408 . . . . 0.0 112.822 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.8 -40.72 79.42 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.58 1.082 . . . . 0.0 110.705 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -41.79 87.55 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.5 m -68.44 -8.12 37.85 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.079 0.952 . . . . 0.0 111.781 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.74 1.24 83.08 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 126.545 2.021 . . . . 0.0 113.016 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.38 -41.07 89.96 Favored 'General case' 0 C--N 1.338 0.067 0 CA-C-N 118.899 1.35 . . . . 0.0 113.232 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 mt -85.5 130.47 34.57 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.18 164.94 19.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.464 1.106 . . . . 0.0 112.082 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -73.8 131.34 41.44 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pp -113.99 -174.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.315 1.446 . . . . 0.0 109.191 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m 60.08 75.73 0.47 Allowed Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.502 1.121 . . . . 0.0 111.051 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.16 -23.64 15.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.021 2.481 . . . . 0.0 113.984 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -140.95 -162.67 1.4 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.518 1.927 . . . . 0.0 108.575 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -110.56 -19.92 12.74 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.793 1.237 . . . . 0.0 113.376 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.25 83.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.97 -1.081 . . . . 0.0 113.586 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -61.76 -28.28 69.33 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.862 1.265 . . . . 0.0 110.356 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -68.57 -44.51 74.29 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.294 0.952 . . . . 0.0 108.916 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.26 -21.53 66.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.228 0.467 . . . . 0.0 111.762 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -68.04 -12.04 60.08 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.526 0.603 . . . . 0.0 110.509 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -122.07 165.78 15.54 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.833 1.653 . . . . 0.0 111.211 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -77.1 155.69 82.33 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.31 -43.1 3.26 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.325 2.684 . . . . 0.0 114.295 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -57.2 -41.99 80.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.543 1.065 . . . . 0.0 112.354 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.96 -25.63 67.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.649 1.18 . . . . 0.0 111.051 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -76.26 -40.67 51.23 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -37.99 81.3 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.8 0.75 0.75 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.474 1.51 . . . . 0.0 114.002 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.04 3.91 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-N 120.487 1.494 . . . . 0.0 111.693 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.9 mtt-85 -63.08 170.46 2.79 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 123.3 1.524 . . . . 0.0 113.418 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -149.92 179.47 8.02 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 128.17 2.588 . . . . 0.0 105.868 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -68.21 99.9 0.96 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.79 -72.9 1.74 Allowed Glycine 0 CA--C 1.521 0.466 0 C-N-CA 125.012 1.291 . . . . 0.0 111.782 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 167.67 13.49 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 122.53 1.157 . . . . 0.0 112.374 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.14 154.1 22.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.266 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.3 pt -134.2 -15.08 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.9 172.55 13.84 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.084 1.311 . . . . 0.0 108.029 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.22 150.5 75.52 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 123.842 0.857 . . . . 0.0 110.829 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.94 144.63 53.67 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 124.336 3.358 . . . . 0.0 111.387 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.58 -55.53 3.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 126.105 1.762 . . . . 0.0 111.596 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.06 162.0 33.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.1 t -128.69 75.07 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 . . . . . 0 C--N 1.331 -0.229 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.73 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.5 mt . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.3 p90 . . . . . 0 CA--C 1.537 0.443 0 C-N-CA 126.553 1.941 . . . . 0.0 110.529 -179.847 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo . . . . . 0 N--CA 1.459 -0.559 0 CA-C-O 121.375 0.49 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -86.6 -26.04 24.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.913 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.9 t -170.96 161.13 6.88 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.953 1.252 . . . . 0.0 108.822 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -64.81 -29.22 70.18 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.61 -12.67 61.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.625 0.648 . . . . 0.0 112.485 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -90.38 -21.3 22.04 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.743 1.217 . . . . 0.0 109.951 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.43 -57.34 21.18 Favored Pre-proline 0 N--CA 1.456 -0.158 0 CA-C-O 117.441 -1.266 . . . . 0.0 110.762 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.75 -23.4 62.98 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 CA-C-N 120.769 1.31 . . . . 0.0 111.815 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.58 -39.83 57.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.488 0.715 . . . . 0.0 110.494 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.0 tp -79.39 -31.44 42.81 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.306 1.443 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.57 -46.84 80.53 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.617 1.167 . . . . 0.0 110.862 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -70.74 -29.42 65.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.35 0.66 . . . . 0.0 112.139 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -75.0 -41.43 59.52 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.56 -33.99 67.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -65.24 -32.91 74.82 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.22 -14.67 61.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 4.38 5.76 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.098 1.359 . . . . 0.0 111.879 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 174.08 -96.21 0.11 Allowed Glycine 0 CA--C 1.526 0.719 0 CA-C-N 119.748 1.158 . . . . 0.0 115.007 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -134.97 -173.54 3.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.145 0.973 . . . . 0.0 112.493 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.4 p -62.8 161.62 12.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.429 1.892 . . . . 0.0 112.055 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.82 -68.05 0.79 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.809 1.244 . . . . 0.0 109.375 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.4 tp -125.93 141.23 52.07 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.451 1.5 . . . . 0.0 110.577 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.6 mtp -139.43 149.1 43.65 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.739 1.616 . . . . 0.0 107.452 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -163.76 173.56 12.68 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.126 0.97 . . . . 0.0 109.766 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -75.36 80.73 2.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.207 1.803 . . . . 0.0 108.904 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mp -72.63 -16.23 61.72 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 121.031 -1.043 . . . . 0.0 110.12 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -70.05 -14.06 62.5 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -121.29 155.12 58.99 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 121.718 2.054 . . . . 0.0 114.845 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.0 -28.71 12.71 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.521 2.147 . . . . 0.0 115.619 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -56.13 -41.51 75.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -89.93 -25.31 21.0 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 119.252 -0.404 . . . . 0.0 111.387 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . 0.25 53.3 p -85.33 -13.39 49.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.011 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -61.54 -53.48 61.21 Favored Pre-proline 0 CA--C 1.532 0.258 0 O-C-N 120.605 -1.309 . . . . 0.0 111.159 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.18 -7.81 14.75 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 CA-C-N 120.574 1.241 . . . . 0.0 112.746 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.79 -67.84 0.63 Allowed 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 121.424 1.92 . . . . 0.0 107.979 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.41 -27.09 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 126.005 1.722 . . . . 0.0 115.014 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.74 -18.72 56.32 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.774 -0.579 . . . . 0.0 111.01 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.89 -47.1 75.97 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.13 -33.24 73.08 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 154.56 -9.79 0.41 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-O 117.188 -1.895 . . . . 0.0 116.756 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.02 149.28 38.47 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-N 120.242 2.021 . . . . 0.0 112.798 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -151.29 143.42 24.0 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.232 1.016 . . . . 0.0 109.285 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.46 -67.99 0.42 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.832 0.853 . . . . 0.0 112.126 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -139.0 143.53 38.52 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.476 1.11 . . . . 0.0 108.695 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -76.85 141.01 40.81 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.26 102.33 3.96 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -70.87 -174.12 0.89 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -67.02 34.43 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.449 1.899 . . . . 0.0 114.262 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 138.6 -3.51 2.93 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.47 1.986 . . . . 0.0 112.645 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.65 127.5 56.13 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.875 1.838 . . . . 0.0 106.68 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -120.82 152.2 38.67 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.894 0.746 . . . . 0.0 110.962 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.12 161.14 40.4 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 128.989 2.916 . . . . 0.0 106.093 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.73 -3.66 10.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.376 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -75.15 -30.7 60.84 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.281 0.632 . . . . 0.0 112.394 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.67 87.34 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.949 0.88 . . . . 0.0 110.606 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -105.91 110.48 31.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.756 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -81.23 28.67 2.93 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.029 1.776 . . . . 0.0 114.046 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 37.5 t -74.23 -57.13 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -80.11 57.6 2.74 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 122.183 0.992 . . . . 0.0 110.18 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -127.09 142.25 51.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -51.0 -34.56 29.73 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.417 1.087 . . . . 0.0 113.755 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.63 -38.66 96.78 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 119.474 1.034 . . . . 0.0 112.162 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.98 51.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 117.679 0.739 . . . . 0.0 109.397 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.468 ' HE3' ' OD2' ' A' ' 358' ' ' ASP . 2.6 ptmm? -62.44 -38.45 89.81 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -54.64 -53.3 56.54 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.823 1.249 . . . . 0.0 111.8 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -74.01 -29.81 62.19 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 13.0 tp -70.2 -37.23 75.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.727 1.264 . . . . 0.0 112.856 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 6.6 t -67.53 -19.1 65.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 117.397 -1.287 . . . . 0.0 110.97 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -65.65 -50.58 64.45 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.412 1.46 . . . . 0.0 107.84 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.9 tt -52.9 -49.91 64.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.273 1.429 . . . . 0.0 109.761 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.45 -27.68 42.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 124.401 1.08 . . . . 0.0 111.041 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.625 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 18.2 t0 -65.43 -31.73 72.98 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.933 1.242 . . . . 0.0 112.848 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.4 mt -76.46 -48.31 20.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 51.6 mt -59.75 -36.13 64.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.145 0.978 . . . . 0.0 109.488 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.625 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -52.18 -43.82 64.35 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.076 1.35 . . . . 0.0 110.666 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -90.77 -2.91 57.76 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.319 1.848 . . . . 0.0 112.189 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 59.22 9.8 1.49 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.887 2.475 . . . . 0.0 113.679 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -28.68 67.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.582 0.628 . . . . 0.0 109.934 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.7 tpt -90.88 154.37 19.53 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.402 0.681 . . . . 0.0 109.759 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -75.59 88.26 2.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.51 -8.08 55.82 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.28 1.032 . . . . 0.0 112.232 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -105.63 8.19 33.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.892 1.277 . . . . 0.0 113.882 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.8 m -87.12 127.61 35.13 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.524 -0.735 . . . . 0.0 109.494 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.25 -172.08 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.476 1.91 . . . . 0.0 107.412 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -51.67 60.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.893 1.277 . . . . 0.0 109.267 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -50.13 70.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.771 1.229 . . . . 0.0 111.428 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.86 -46.53 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.35 0.66 . . . . 0.0 111.506 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.38 79.05 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.463 1.105 . . . . 0.0 113.156 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -59.18 -54.77 43.15 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.084 1.353 . . . . 0.0 108.885 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.52 -55.79 25.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 124.393 1.058 . . . . 0.0 110.771 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.27 -35.39 64.96 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.719 0.69 . . . . 0.0 111.956 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -69.83 -43.04 72.79 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -58.25 -40.13 80.98 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -66.95 -21.18 65.98 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.337 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.28 12.47 63.15 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.297 0.951 . . . . 0.0 111.998 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -79.99 -49.71 11.44 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.483 1.142 . . . . 0.0 112.502 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.3 p -64.8 119.99 11.65 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.77 -17.33 62.94 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.361 0.528 . . . . 0.0 112.406 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -158.54 166.56 31.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.405 1.082 . . . . 0.0 109.151 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 2.0 t -159.06 170.81 21.21 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.453 -0.317 0 C-N-CA 126.064 1.746 . . . . 0.0 106.744 179.168 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--O 1.236 0.358 0 CA-C-O 117.73 -1.129 . . . . 0.0 108.041 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.74 156.29 65.95 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.938 2.425 . . . . 0.0 108.721 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.4 p -131.25 -173.22 3.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.15 0.98 . . . . 0.0 110.936 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -91.1 171.87 8.96 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -51.65 102.38 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.328 2.251 . . . . 0.0 110.09 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 63.85 23.63 67.59 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 117.603 -1.665 . . . . 0.0 114.726 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.8 128.41 4.74 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-N 121.291 2.546 . . . . 0.0 111.196 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.67 159.55 52.36 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.016 2.477 . . . . 0.0 111.473 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.6 m -92.3 162.88 14.1 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -150.51 91.68 4.08 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.198 1.399 . . . . 0.0 110.877 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.21 -77.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.197 2.598 . . . . 0.0 109.644 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 127.049 2.139 . . . . 0.0 106.876 179.369 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.209 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.9 165.47 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.172 0.989 . . . . 0.0 110.985 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.16 140.98 30.51 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.034 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.3 m -133.09 168.27 18.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.114 0.87 . . . . 0.0 111.356 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -139.6 147.57 41.29 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.296 1.439 . . . . 0.0 108.606 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.26 155.01 23.2 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.57 138.74 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -71.98 132.22 44.0 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.49 0.662 . . . . 0.0 109.892 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -73.67 -17.4 61.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -80.54 -18.88 47.08 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 116.954 -1.498 . . . . 0.0 114.953 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 40.8 m -55.06 154.26 10.55 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 119.577 1.08 . . . . 0.0 109.974 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -69.51 -54.64 0.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.84 1.693 . . . . 0.0 111.229 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -125.16 92.85 3.72 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.512 1.925 . . . . 0.0 110.444 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -55.62 -18.34 7.54 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.512 1.925 . . . . 0.0 112.199 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.85 -35.78 77.44 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.969 1.308 . . . . 0.0 109.807 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 95.9 mt -56.51 -44.41 80.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.989 0.813 . . . . 0.0 110.123 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.4 -48.52 60.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.175 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -38.04 81.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 123.5 0.5 . . . . 0.0 110.614 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -68.34 -53.47 23.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.491 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -49.14 -46.66 45.42 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 119.328 0.967 . . . . 0.0 111.434 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.46 -50.74 72.04 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.799 0.84 . . . . 0.0 111.105 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.262 4.8 pt-20 -95.59 26.96 3.64 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -135.31 -35.51 0.82 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 110.73 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -130.17 -39.19 1.37 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 119.454 1.025 . . . . 0.0 112.453 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 12.4 tp -62.67 -58.48 7.33 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 119.504 1.047 . . . . 0.0 110.331 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 40.0 mt -78.79 60.46 2.81 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.434 1.494 . . . . 0.0 113.059 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 43.7 p -133.98 162.31 32.41 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.21 -3.22 15.94 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.734 0.813 . . . . 0.0 111.629 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -109.28 -44.3 3.96 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.247 1.419 . . . . 0.0 109.691 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.29 -50.57 21.14 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 124.924 1.249 . . . . 0.0 110.304 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.53 -38.01 85.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.054 0.927 . . . . 0.0 109.414 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -63.05 -45.43 92.26 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 124.468 1.105 . . . . 0.0 108.521 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.78 82.66 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 123.808 0.843 . . . . 0.0 111.698 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.5 t -68.9 -38.55 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -67.55 -28.96 68.24 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.496 0.589 . . . . 0.0 111.405 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -68.12 -42.55 80.06 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.0 -32.71 73.28 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -160.03 147.06 12.41 Favored Pre-proline 0 N--CA 1.467 0.379 0 C-N-CA 125.341 1.456 . . . . 0.0 108.931 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.06 123.94 9.22 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.566 2.177 . . . . 0.0 108.681 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 32.7 mt -107.1 -4.36 18.98 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.463 1.505 . . . . 0.0 112.971 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 62.05 -153.17 42.37 Favored Glycine 0 C--N 1.335 0.498 0 CA-C-N 119.23 0.923 . . . . 0.0 111.391 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.65 159.03 7.05 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.965 0.906 . . . . 0.0 112.65 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 4.1 m -125.57 155.27 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 124.072 0.949 . . . . 0.0 109.797 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.67 -36.12 62.8 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.187 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.18 105.56 0.73 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.93 1.292 . . . . 0.0 110.43 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -53.71 -38.16 63.99 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.244 1.018 . . . . 0.0 112.547 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 21.4 m -56.1 -35.02 66.56 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.626 0.77 . . . . 0.0 112.937 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -109.28 -5.87 15.73 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.187 0.995 . . . . 0.0 110.942 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -60.94 -50.0 75.19 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -58.16 -33.35 69.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.457 1.103 . . . . 0.0 111.733 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -69.62 -49.21 56.07 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.7 0.8 . . . . 0.0 109.896 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 21.1 mt -68.82 -34.15 75.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.23 -5.3 6.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.618 1.567 . . . . 0.0 112.444 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -62.11 -21.05 64.68 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.31 0.959 . . . . 0.0 109.439 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.13 142.33 26.65 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 119.266 0.939 . . . . 0.0 109.171 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.82 -30.67 84.69 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.55 2.833 . . . . 0.0 115.038 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -58.08 -36.47 72.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.303 0.956 . . . . 0.0 110.148 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.5 mp -77.89 -61.02 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.83 -54.78 7.53 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.992 0.917 . . . . 0.0 113.222 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.94 86.04 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.252 -0.905 . . . . 0.0 112.513 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 55.6 m -68.5 -33.17 73.67 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.153 0.581 . . . . 0.0 109.482 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.0 tpt -69.27 -45.37 69.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -59.12 -35.47 73.52 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 122.709 0.404 . . . . 0.0 110.093 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -62.56 -27.63 69.31 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.713 -0.617 . . . . 0.0 111.186 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 CA-C-N 118.864 0.757 . . . . 0.0 108.977 178.121 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 CA--C 1.538 0.692 0 CA-C-O 121.818 0.674 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -129.19 24.42 5.57 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.249 1.82 . . . . 0.0 110.429 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 20.5 pt -86.04 153.08 56.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.857 1.263 . . . . 0.0 113.101 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -72.95 -21.63 20.71 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.446 2.097 . . . . 0.0 111.935 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.55 -21.99 41.9 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.36 1.864 . . . . 0.0 111.258 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 67.7 mtp -57.09 -35.1 69.0 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.814 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 10.2 t -60.04 -49.52 77.33 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.902 1.228 . . . . 0.0 109.295 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.92 92.4 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 122.544 0.338 . . . . 0.0 110.633 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -58.64 -53.58 56.8 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.514 1.126 . . . . 0.0 110.031 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -62.66 -41.69 99.2 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.142 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -65.79 -38.32 88.7 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.253 0.479 . . . . 0.0 110.849 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.78 -57.06 5.56 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.637 1.175 . . . . 0.0 113.054 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.24 -39.59 74.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 122.922 0.489 . . . . 0.0 110.261 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -53.43 28.09 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.768 0.827 . . . . 0.0 109.037 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 27.4 m -62.4 -39.66 93.98 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.441 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.75 99.68 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.008 1.276 . . . . 0.0 112.173 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.1 -48.69 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 24.4 mm -58.39 -40.48 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 118.481 0.582 . . . . 0.0 109.494 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -61.25 -44.61 96.97 Favored 'General case' 0 CA--C 1.522 -0.121 0 O-C-N 121.206 -0.933 . . . . 0.0 110.839 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.31 -43.93 69.31 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 118.25 0.477 . . . . 0.0 110.431 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.69 89.49 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.936 0.895 . . . . 0.0 111.977 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 46.6 m -83.88 -14.54 50.88 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.199 1.0 . . . . 0.0 109.587 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 74.36 17.05 79.68 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -66.9 -31.3 71.8 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.848 1.259 . . . . 0.0 110.363 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -147.73 159.67 43.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.8 m -66.64 150.14 49.48 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.3 t -57.27 -52.72 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . 0.468 ' OD2' ' HE3' ' A' ' 189' ' ' LYS . 0.8 OUTLIER -47.35 -49.98 23.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 129.411 3.084 . . . . 0.0 111.881 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.59 -35.62 58.02 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.16 77.6 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.202 -0.936 . . . . 0.0 109.66 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.1 mp -66.59 -49.44 66.35 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.552 1.941 . . . . 0.0 108.635 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -55.39 -49.73 71.55 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.464 1.105 . . . . 0.0 108.726 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -56.92 -53.1 61.77 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.977 1.311 . . . . 0.0 109.746 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.95 -47.81 83.76 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.544 1.138 . . . . 0.0 113.56 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -60.06 -37.61 80.37 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.0 m -64.19 -37.49 87.64 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -62.6 -17.17 59.65 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.447 -1.408 . . . . 0.0 112.374 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.3 mt -98.07 -20.58 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.369 1.068 . . . . 0.0 110.733 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 80.7 p -105.77 -12.19 15.98 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.807 -1.183 . . . . 0.0 112.412 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 46.3 pttt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 117.368 -1.301 . . . . 0.0 111.06 -178.77 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.48 168.2 9.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.72 1.608 . . . . 0.0 110.128 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.66 33.8 73.97 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.913 1.244 . . . . 0.0 115.072 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -145.36 172.86 12.57 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 118.372 1.086 . . . . 0.0 110.34 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.6 mt -150.56 144.77 25.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.944 2.098 . . . . 0.0 107.297 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.8 140.0 41.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.6 mt -125.12 133.0 70.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 C-N-CA 127.149 2.179 . . . . 0.0 106.558 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -122.72 136.76 54.97 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.7 mm -121.91 165.69 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.424 0.689 . . . . 0.0 110.279 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -77.98 -15.35 59.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 117.441 2.385 . . . . 0.0 117.441 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.29 -13.79 58.4 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 120.506 1.503 . . . . 0.0 116.347 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -116.92 -13.81 10.66 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.748 1.219 . . . . 0.0 111.222 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -83.81 167.87 16.68 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.845 -0.534 . . . . 0.0 110.383 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.3 72.64 2.3 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.359 1.457 . . . . 0.0 109.712 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -73.89 -28.87 61.77 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.55 -0.971 . . . . 0.0 111.664 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.12 -45.03 86.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.417 1.008 . . . . 0.0 109.2 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.43 94.88 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.8 tp -70.23 -32.56 70.49 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.638 -0.919 . . . . 0.0 110.442 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.14 80.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 117.773 -1.108 . . . . 0.0 109.41 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -59.89 -33.7 72.18 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.007 0.821 . . . . 0.0 111.456 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.4 t -68.48 -50.99 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.83 -41.9 99.68 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.232 -0.918 . . . . 0.0 114.228 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -29.69 69.37 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.42 -1.047 . . . . 0.0 110.341 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -71.03 -53.53 14.42 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -54.82 -46.55 74.58 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.699 0.227 . . . . 0.0 110.661 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.46 -28.72 70.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.92 0.888 . . . . 0.0 111.017 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -74.0 -26.61 60.54 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.446 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.25 -35.25 10.41 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 124.113 0.883 . . . . 0.0 112.176 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.5 p -101.77 -27.8 12.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.494 1.043 . . . . 0.0 113.424 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.6 -15.65 53.68 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.181 -0.949 . . . . 0.0 111.718 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.8 mm -65.74 120.6 13.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -55.9 140.34 43.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.815 0.846 . . . . 0.0 112.203 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.1 102.43 5.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.9 m -91.63 139.79 30.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.71 117.73 45.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -123.38 158.14 31.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.743 0.817 . . . . 0.0 109.337 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -124.77 67.12 50.23 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.546 1.139 . . . . 0.0 108.813 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -73.7 175.29 10.93 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.094 1.862 . . . . 0.0 108.821 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.41 -18.28 6.78 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.373 0.669 . . . . 0.0 111.063 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.34 1.33 49.31 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.731 2.012 . . . . 0.0 112.897 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.92 -23.32 2.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.126 1.37 . . . . 0.0 114.196 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -55.14 -36.1 65.41 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.439 1.096 . . . . 0.0 111.275 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -118.53 -26.33 6.22 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.578 1.551 . . . . 0.0 110.092 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -67.98 -42.88 80.14 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 117.245 -1.36 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.54 -58.5 15.17 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 120.524 1.511 . . . . 0.0 109.776 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.41 -25.99 81.71 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 121.027 1.403 . . . . 0.0 113.67 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -75.03 -54.85 6.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.631 1.105 . . . . 0.0 112.165 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.57 -40.53 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.099 0.56 . . . . 0.0 110.634 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.75 -29.45 70.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.095 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 -17.17 17.83 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.497 1.044 . . . . 0.0 113.053 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.8 t -123.26 17.5 9.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.586 0.754 . . . . 0.0 112.108 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.05 7.44 66.8 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.16 -10.68 32.41 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.193 1.496 . . . . 0.0 111.776 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.32 -177.85 34.72 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.616 1.579 . . . . 0.0 116.212 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.11 176.9 3.44 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.427 2.751 . . . . 0.0 111.084 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -108.6 -21.15 12.83 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.4 mt -136.6 148.55 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.8 tt -133.12 135.62 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.27 1.428 . . . . 0.0 108.494 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -130.15 101.06 5.64 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.651 1.58 . . . . 0.0 109.306 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -151.66 178.42 9.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.312 0.96 . . . . 0.0 109.99 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.02 154.48 39.36 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -57.77 -27.49 63.12 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.512 0.725 . . . . 0.0 109.844 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.28 -58.79 5.56 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.517 1.127 . . . . 0.0 111.556 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -69.99 -14.48 62.72 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.619 -1.301 . . . . 0.0 111.276 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.18 11.96 8.87 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.369 -0.832 . . . . 0.0 109.512 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.41 0.43 77.79 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.114 -1.381 . . . . 0.0 112.983 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.9 -27.65 0.23 Allowed Glycine 0 CA--C 1.535 1.338 0 CA-C-N 120.351 2.075 . . . . 0.0 116.576 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -56.44 -44.08 80.1 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.945 1.872 . . . . 0.0 113.401 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.71 -41.18 99.02 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.3 -0.875 . . . . 0.0 110.076 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -29.89 59.21 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.961 1.304 . . . . 0.0 110.474 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.6 m -86.62 1.05 53.21 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.702 1.201 . . . . 0.0 112.388 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.94 16.77 80.48 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.886 1.708 . . . . 0.0 110.931 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.3 mt -83.49 -11.98 56.81 Favored 'General case' 0 CA--C 1.527 0.072 0 O-C-N 121.017 -1.284 . . . . 0.0 114.018 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.7 mt -114.15 142.54 46.1 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 119.7 1.136 . . . . 0.0 111.039 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.02 -161.57 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.508 1.923 . . . . 0.0 113.316 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.3 86.43 2.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.851 1.661 . . . . 0.0 110.152 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.26 174.22 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.973 1.309 . . . . 0.0 111.933 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.9 m 61.77 82.2 0.22 Allowed Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 126.119 1.768 . . . . 0.0 110.681 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.81 -28.93 7.47 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.416 2.077 . . . . 0.0 111.377 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -139.81 165.82 26.28 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.488 1.915 . . . . 0.0 109.277 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -63.29 -34.94 78.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.638 1.175 . . . . 0.0 110.985 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.46 -43.06 44.74 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.399 1.08 . . . . 0.0 112.371 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -60.0 -33.62 72.24 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.617 -0.677 . . . . 0.0 111.483 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -69.53 -44.29 71.29 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.479 -0.763 . . . . 0.0 109.576 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -62.2 -26.38 68.32 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.418 1.087 . . . . 0.0 112.536 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -71.35 -11.52 60.95 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.042 0.937 . . . . 0.0 111.062 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 mt -126.51 164.91 20.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.202 0.91 . . . . 0.0 110.539 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -75.26 149.92 84.86 Favored Pre-proline 0 CA--C 1.544 0.742 0 O-C-N 121.514 -0.741 . . . . 0.0 110.817 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.73 -46.75 1.12 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.514 2.809 . . . . 0.0 114.789 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -61.26 -33.93 74.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.968 1.258 . . . . 0.0 111.824 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -21.81 64.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.517 0.727 . . . . 0.0 110.716 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -70.84 -37.13 73.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.317 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.44 -28.11 64.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.476 1.035 . . . . 0.0 113.141 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.72 -23.35 67.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.444 0.698 . . . . 0.0 111.787 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.1 m -120.57 6.86 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.227 1.411 . . . . 0.0 112.284 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -72.66 170.25 14.89 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.806 0.813 . . . . 0.0 108.965 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -153.26 -174.52 4.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.487 1.115 . . . . 0.0 108.048 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -73.54 107.94 6.1 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.95 -77.68 0.53 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.719 1.628 . . . . 0.0 112.835 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 174.92 2.67 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.408 1.083 . . . . 0.0 111.928 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.75 156.22 27.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.99 1.316 . . . . 0.0 109.932 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.3 pt -126.04 -17.96 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.66 178.04 4.28 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.589 1.541 . . . . 0.0 109.291 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.62 148.39 69.83 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 124.27 1.028 . . . . 0.0 110.522 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.42 148.7 38.52 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.226 3.284 . . . . 0.0 109.265 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.3 mm -130.07 -53.01 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.982 1.313 . . . . 0.0 110.898 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -130.8 156.01 45.72 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.2 t -136.11 101.86 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.3 1.04 . . . . 0.0 110.551 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 . . . . . 0 N--CA 1.465 0.317 0 O-C-N 121.117 -0.989 . . . . 0.0 109.064 179.098 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.233 0.217 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.6 p90 . . . . . 0 C--O 1.238 0.48 0 C-N-CA 124.146 0.978 . . . . 0.0 109.359 179.271 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 N--CA 1.458 -0.589 0 N-CA-C 110.384 -0.66 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -104.64 -17.23 14.75 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.6 t -166.34 160.34 15.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.393 1.451 . . . . 0.0 108.481 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -70.1 -27.86 64.93 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 121.325 -0.859 . . . . 0.0 112.156 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -70.04 -16.11 63.11 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.138 0.881 . . . . 0.0 111.226 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -88.2 -23.98 23.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 110.544 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 40.2 mm -54.34 -58.84 12.06 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.58 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.77 -21.33 38.63 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 CA-C-N 120.429 1.189 . . . . 0.0 111.581 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.98 -36.92 64.58 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.975 1.31 . . . . 0.0 111.25 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 68.4 tp -88.23 -30.04 20.0 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.338 1.455 . . . . 0.0 110.712 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.45 -45.0 85.2 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -66.65 -33.14 74.99 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.572 0.749 . . . . 0.0 112.22 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -72.35 -44.45 62.59 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.7 mt -72.93 -33.27 65.84 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.672 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -34.75 77.26 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.62 -13.02 60.6 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 0.12 7.3 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 124.815 1.246 . . . . 0.0 111.903 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.53 -90.08 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 119.231 0.923 . . . . 0.0 114.961 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 176.22 8.88 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.146 0.978 . . . . 0.0 112.231 -177.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.95 160.68 7.51 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.852 1.261 . . . . 0.0 112.811 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.89 -71.01 0.66 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.0 0.92 . . . . 0.0 109.043 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.3 tp -106.15 135.54 47.44 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.81 1.244 . . . . 0.0 109.45 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.6 ttm -147.46 104.85 3.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -126.97 163.07 24.5 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -77.89 144.92 36.53 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.6 mt -120.56 -9.82 9.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.724 0.81 . . . . 0.0 111.87 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -69.32 -16.58 63.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -113.56 124.04 32.0 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.652 1.581 . . . . 0.0 110.81 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.09 -14.06 42.68 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.347 2.031 . . . . 0.0 114.911 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -60.83 -27.93 68.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.826 1.194 . . . . 0.0 112.258 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -88.99 -36.71 15.69 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.184 0.994 . . . . 0.0 113.194 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -86.52 -21.68 26.8 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -51.65 -54.29 41.21 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -64.91 -19.32 64.0 Favored 'Trans proline' 0 C--N 1.348 0.513 0 CA-C-N 121.163 1.451 . . . . 0.0 113.883 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.58 -57.35 3.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 46.2 pt -63.04 -29.39 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 119.213 0.915 . . . . 0.0 112.131 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.66 -20.01 66.05 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.281 0.633 . . . . 0.0 111.914 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -43.16 -60.65 1.58 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.246 1.818 . . . . 0.0 113.065 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.69 -46.37 81.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.984 0.514 . . . . 0.0 111.977 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -175.52 -23.7 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.681 0 CA-C-O 116.99 -2.005 . . . . 0.0 114.497 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -37.09 123.46 0.95 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.387 1.946 . . . . 0.0 114.089 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -139.59 140.8 37.13 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.98 -59.11 2.86 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -135.8 149.67 49.19 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 125.294 1.438 . . . . 0.0 108.691 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.419 ' HE3' ' OD2' ' A' ' 180' ' ' ASP . 10.9 tppt? -76.75 145.14 38.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.886 0.85 . . . . 0.0 109.931 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -142.21 104.83 4.51 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -74.79 -171.08 1.2 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -51.25 -20.39 1.6 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.08 22.36 0.05 OUTLIER Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.92 1.724 . . . . 0.0 111.277 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -125.5 106.27 9.66 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 118.61 1.205 . . . . 0.0 107.822 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -97.14 137.08 36.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.86 147.64 28.96 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.176 1.39 . . . . 0.0 108.808 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.79 -0.31 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.944 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.06 -42.57 69.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.419 ' OD2' ' HE3' ' A' ' 170' ' ' LYS . 56.2 t0 -90.2 107.69 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.658 1.583 . . . . 0.0 109.622 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.3 t -118.37 157.73 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.25 2.22 . . . . 0.0 107.55 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -143.39 29.7 2.02 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 118.536 0.607 . . . . 0.0 114.508 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.04 -42.93 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 C-N-CA 125.049 1.34 . . . . 0.0 111.217 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -96.12 61.45 2.09 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -117.23 154.35 31.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.231 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -48.93 -38.31 22.46 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.4 -35.56 82.27 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 118.774 0.715 . . . . 0.0 112.703 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.6 -49.0 65.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.032 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.79 -42.52 99.1 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-O 118.856 -0.592 . . . . 0.0 109.446 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.25 95.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.12 0.968 . . . . 0.0 109.81 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.13 -26.41 71.49 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.859 -0.967 . . . . 0.0 112.383 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.43 -44.46 12.73 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.262 1.031 . . . . 0.0 111.77 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.4 t -55.01 -28.5 52.52 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.023 0.829 . . . . 0.0 111.86 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -60.21 -50.91 71.78 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.6 tp -59.82 -51.92 67.65 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.721 1.208 . . . . 0.0 109.832 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 56.2 t -55.55 -30.41 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 117.429 -1.272 . . . . 0.0 109.949 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.597 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 12.7 t0 -66.58 -44.52 82.03 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 120.431 1.469 . . . . 0.0 111.857 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.6 mt -66.66 -40.04 88.46 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 83.9 mt -66.01 -36.44 77.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.597 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -60.95 -46.82 89.18 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.116 1.367 . . . . 0.0 108.247 178.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -79.22 -2.32 40.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.157 0.983 . . . . 0.0 110.703 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt 55.38 1.56 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 130.126 3.37 . . . . 0.0 116.636 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -66.36 -26.94 67.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 11.1 ttt -81.64 141.39 33.71 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -79.57 77.91 6.14 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.0 -5.0 18.98 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.04 1.736 . . . . 0.0 114.176 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -94.67 -20.96 19.1 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 128.0 2.52 . . . . 0.0 111.457 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.2 m -58.14 137.2 57.17 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.061 0.945 . . . . 0.0 110.58 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -130.78 -178.82 4.97 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 127.481 2.312 . . . . 0.0 106.195 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -54.87 -44.79 74.36 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -46.74 88.6 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 123.694 0.798 . . . . 0.0 110.4 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.6 mt -67.37 -48.99 75.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.926 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.39 76.96 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.956 0.798 . . . . 0.0 110.485 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.03 -46.44 65.04 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.34 -55.19 34.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.008 0.923 . . . . 0.0 110.178 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.79 -49.93 61.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.818 2.047 . . . . 0.0 109.86 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -61.69 -38.15 86.76 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.853 -0.529 . . . . 0.0 110.524 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -63.87 -11.03 24.02 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.75 0.82 . . . . 0.0 112.167 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -111.6 -8.13 14.24 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.188 1.795 . . . . 0.0 112.128 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.01 27.79 25.1 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.457 1.027 . . . . 0.0 111.79 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -87.48 -0.35 56.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.289 1.045 . . . . 0.0 112.424 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.8 p -138.84 160.49 39.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.914 0.886 . . . . 0.0 109.274 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -117.24 -19.62 9.55 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.395 1.078 . . . . 0.0 109.544 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -159.2 164.91 34.68 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.952 0.901 . . . . 0.0 111.693 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.6 t -165.78 174.03 10.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.826 2.45 . . . . 0.0 106.975 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 41.6 mt . . . . . 0 C--O 1.236 0.376 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.716 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.2 149.73 64.53 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 60.6 p -124.28 167.49 14.26 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -73.54 153.5 40.24 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -64.82 135.0 55.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.68 -11.23 10.66 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 117.62 -1.655 . . . . 0.0 115.425 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.2 124.32 5.32 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 120.693 2.246 . . . . 0.0 113.591 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.48 146.22 34.69 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.146 2.564 . . . . 0.0 110.86 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.1 m -66.81 157.94 31.7 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -133.6 100.28 13.73 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.62 -175.76 2.74 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.73 2.287 . . . . 0.0 110.638 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 CA--C 1.541 0.616 0 C-N-CA 126.096 1.758 . . . . 0.0 108.878 178.137 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.466 0 N-CA-C 104.341 -3.504 . . . . 0.0 104.341 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 26.4 m -133.11 137.05 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 119.761 1.781 . . . . 0.0 111.213 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.49 138.32 57.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 m -124.37 148.41 47.55 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.864 0.866 . . . . 0.0 110.269 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.11 139.39 52.53 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 123.461 0.704 . . . . 0.0 109.449 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -137.16 164.16 25.31 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.59 1.09 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 61.9 mt -113.31 136.18 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -67.48 117.61 9.67 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.95 -22.23 64.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 118.475 -0.774 . . . . 0.0 112.642 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -74.62 -13.27 60.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 72.5 m -59.99 155.28 44.41 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 118.819 0.736 . . . . 0.0 109.597 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.92 -60.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.514 1.476 . . . . 0.0 110.117 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -108.9 88.43 2.72 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -54.7 -23.72 18.84 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.4 1.08 . . . . 0.0 111.169 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -64.82 -31.28 72.44 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.848 1.259 . . . . 0.0 112.235 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.76 -40.28 83.44 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.048 -1.033 . . . . 0.0 109.402 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.88 -42.94 63.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.53 -0.747 . . . . 0.0 111.407 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -34.92 79.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.718 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -70.84 -56.12 7.01 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -48.78 -49.09 40.3 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 119.18 0.9 . . . . 0.0 110.854 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.7 tt -62.31 -45.83 91.45 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.006 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -79.21 -18.54 52.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.744 -1.223 . . . . 0.0 114.148 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -90.34 -33.88 15.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 117.612 -1.185 . . . . 0.0 112.344 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -137.52 -23.24 1.1 Allowed 'General case' 0 C--N 1.347 0.457 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.01 -50.89 13.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.184 1.356 . . . . 0.0 109.09 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.47 67.27 9.28 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.63 1.572 . . . . 0.0 109.47 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.8 p -144.12 166.22 25.62 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -67.42 -41.36 84.96 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -73.42 -29.75 62.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.323 1.049 . . . . 0.0 111.092 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.79 -51.19 11.63 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.987 1.279 . . . . 0.0 110.036 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 27.8 mt -59.85 -45.28 92.92 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.64 -45.85 84.91 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.359 1.064 . . . . 0.0 109.793 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.56 -44.4 89.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.6 1.091 . . . . 0.0 112.292 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.6 t -72.59 -34.35 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.657 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -68.2 -38.02 81.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.233 1.413 . . . . 0.0 110.319 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -60.47 -43.9 96.44 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.44 1.496 . . . . 0.0 110.252 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.26 -43.88 69.62 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.482 0.313 . . . . 0.0 111.484 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -151.69 152.27 30.02 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 124.808 1.243 . . . . 0.0 108.389 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.11 137.13 73.53 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.771 2.981 . . . . 0.0 113.92 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 23.2 mt -124.0 -7.39 7.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.574 1.549 . . . . 0.0 112.958 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 65.26 -131.56 35.67 Favored Glycine 0 N--CA 1.464 0.559 0 C-N-CA 126.068 1.794 . . . . 0.0 112.186 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.62 177.41 8.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 17.9 m -135.44 153.67 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 O-C-N 120.626 -1.296 . . . . 0.0 110.434 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.27 -26.93 56.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.494 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.85 106.7 1.96 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -54.94 -31.87 60.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 57.8 m -68.59 -52.8 27.67 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.612 1.096 . . . . 0.0 111.064 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -72.14 -17.64 61.94 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.152 0.433 . . . . 0.0 110.664 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -61.7 -39.35 91.17 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -62.71 -39.83 95.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.708 0.685 . . . . 0.0 111.413 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -66.19 -49.99 65.42 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.683 1.193 . . . . 0.0 109.837 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.54 -34.45 74.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.679 -0.677 . . . . 0.0 110.135 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.13 -2.85 4.59 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.513 1.525 . . . . 0.0 112.469 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -58.13 -14.46 6.91 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.647 1.112 . . . . 0.0 110.387 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.95 145.5 52.2 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 124.914 1.286 . . . . 0.0 109.194 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.57 -17.56 43.22 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.692 2.261 . . . . 0.0 113.138 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -59.87 -48.52 81.34 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.6 mp -68.33 -57.73 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.449 1.1 . . . . 0.0 108.255 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.6 -43.38 62.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.31 -35.73 81.14 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 120.402 1.456 . . . . 0.0 112.407 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.7 m -65.43 -37.25 86.37 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 7.2 tpt -61.55 -49.5 76.44 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -61.0 -27.95 68.69 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.71 1.204 . . . . 0.0 113.464 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -76.75 -42.77 39.74 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.554 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 CA--C 1.536 0.604 0 CA-C-O 122.114 0.797 . . . . 0.0 111.391 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -78.4 65.35 3.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.553 1.941 . . . . 0.0 108.905 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.8 pt -130.35 144.18 52.22 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 120.558 -1.339 . . . . 0.0 112.247 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.86 -15.29 37.31 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.341 2.694 . . . . 0.0 114.634 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -80.22 -18.28 49.96 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.462 -0.774 . . . . 0.0 110.864 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 59.6 mmm -70.22 -34.43 72.89 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.123 -0.986 . . . . 0.0 111.565 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.3 p -66.1 -42.31 89.42 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.338 -1.476 . . . . 0.0 108.522 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.61 -46.35 88.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -51.7 -51.46 55.86 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.841 1.656 . . . . 0.0 110.254 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -59.06 -36.2 74.65 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.024 -1.047 . . . . 0.0 113.18 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -76.26 -42.17 46.55 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.172 0.51 . . . . 0.0 109.835 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.8 72.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.442 1.497 . . . . 0.0 110.903 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 44.7 t -68.53 -46.25 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 117.223 -1.37 . . . . 0.0 111.483 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -55.76 -42.55 75.61 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 121.391 1.905 . . . . 0.0 108.832 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 20.0 m -65.0 -44.88 87.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.02 0.528 . . . . 0.0 109.751 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -56.91 -37.26 71.2 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.311 -0.868 . . . . 0.0 112.193 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 71.2 t -69.27 -58.79 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.2 mm -53.45 -46.62 59.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.86 0.864 . . . . 0.0 111.47 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -51.84 -49.68 62.38 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 121.924 -0.485 . . . . 0.0 110.842 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -77.95 -37.66 47.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.25 71.24 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.189 0.904 . . . . 0.0 110.69 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.3 m -94.74 -9.22 35.34 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.442 1.097 . . . . 0.0 110.593 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.51 14.79 82.11 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 118.843 0.747 . . . . 0.0 112.695 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -64.16 -40.06 95.34 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -147.75 154.64 40.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.1 m -61.77 155.14 23.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.826 1.25 . . . . 0.0 111.449 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.97 -53.02 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.201 1.0 . . . . 0.0 109.063 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.83 -50.12 61.49 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.844 2.057 . . . . 0.0 111.549 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -70.52 -42.51 71.15 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.951 1.301 . . . . 0.0 112.166 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.18 77.12 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.566 -0.709 . . . . 0.0 110.426 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.2 mp -72.69 -43.96 62.4 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.047 0.939 . . . . 0.0 109.243 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -54.45 -48.67 71.47 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.21 -34.3 74.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.304 1.042 . . . . 0.0 111.105 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.94 -48.36 66.14 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.825 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -52.16 -39.88 60.63 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.572 0.749 . . . . 0.0 109.746 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.4 m -62.46 -24.82 67.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.461 0.704 . . . . 0.0 112.184 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -81.5 -15.48 54.81 Favored 'General case' 0 C--O 1.226 -0.145 0 O-C-N 120.603 -1.311 . . . . 0.0 111.409 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.5 mt -98.16 -31.45 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.782 1.633 . . . . 0.0 110.398 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 3.2 p -81.55 -17.99 46.5 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.879 -0.513 . . . . 0.0 111.145 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt . . . . . 0 C--O 1.251 1.178 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 177.446 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.38 162.18 14.91 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.1 41.88 99.71 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.231 0.923 . . . . 0.0 115.037 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -149.18 169.22 21.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.33 1.052 . . . . 0.0 109.844 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.0 mt -146.19 135.85 23.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.616 1.567 . . . . 0.0 108.208 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.0 t -127.21 136.84 59.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.0 mt -135.71 142.11 40.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.888 1.275 . . . . 0.0 109.393 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -120.54 154.41 35.37 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.0 mm -116.52 147.29 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.913 2.085 . . . . 0.0 106.104 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.4 118.07 5.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.502 1.121 . . . . 0.0 109.916 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.46 20.3 6.26 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.576 -1.125 . . . . 0.0 112.86 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 53.75 30.55 11.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.296 1.838 . . . . 0.0 111.155 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -58.35 172.11 0.51 Allowed 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 127.672 2.389 . . . . 0.0 114.194 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.85 50.85 1.2 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.676 2.084 . . . . 0.0 113.474 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -56.14 -30.4 62.11 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.475 1.11 . . . . 0.0 111.467 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -58.19 -30.6 66.56 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.233 1.013 . . . . 0.0 111.42 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.56 -33.96 17.78 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.6 tp -71.75 -31.18 66.39 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.257 1.423 . . . . 0.0 112.711 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.8 86.01 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.33 1.052 . . . . 0.0 109.889 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -58.89 -37.82 77.47 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.368 1.867 . . . . 0.0 110.287 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 95.0 t -70.09 -48.34 62.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.528 1.131 . . . . 0.0 109.2 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.2 -43.54 99.26 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.755 -0.591 . . . . 0.0 111.722 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -33.27 71.24 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 121.687 -0.89 . . . . 0.0 111.05 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -63.88 -53.02 57.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -56.7 -43.02 80.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.046 0.839 . . . . 0.0 110.774 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -13.42 58.61 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.698 1.199 . . . . 0.0 110.821 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HZ1' ' HA ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -101.34 -14.94 17.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.619 -1.926 . . . . 0.0 111.86 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -105.79 -10.93 16.46 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.062 0.851 . . . . 0.0 109.95 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.0 p -130.45 -35.16 1.54 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.488 1.115 . . . . 0.0 112.346 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.64 -13.31 67.45 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.384 -0.823 . . . . 0.0 111.229 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.4 mm -64.3 130.92 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.74 145.55 54.54 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.646 1.179 . . . . 0.0 110.719 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.8 t -140.27 126.7 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.5 m -114.97 141.77 47.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.074 1.35 . . . . 0.0 108.257 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.25 121.31 45.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 126.022 1.729 . . . . 0.0 106.682 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -140.35 157.77 45.04 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.702 0.683 . . . . 0.0 109.651 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -126.38 71.03 71.06 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.407 1.083 . . . . 0.0 111.748 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.68 165.75 30.85 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.463 2.775 . . . . 0.0 111.526 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.56 5.24 15.42 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.774 1.63 . . . . 0.0 110.214 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.52 2.58 7.64 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.457 1.103 . . . . 0.0 113.481 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -52.62 -24.93 9.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.419 1.009 . . . . 0.0 113.677 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.48 -24.32 65.17 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.444 1.098 . . . . 0.0 112.284 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -120.53 -22.16 6.52 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.002 1.321 . . . . 0.0 110.175 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -47.59 26.05 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 117.575 -1.202 . . . . 0.0 109.407 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -48.25 -58.21 8.62 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 120.328 1.422 . . . . 0.0 111.157 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.03 -18.2 63.97 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 121.857 1.705 . . . . 0.0 114.187 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -92.87 -1.11 57.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.909 1.284 . . . . 0.0 112.927 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 t -128.13 -37.74 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 120.287 1.403 . . . . 0.0 110.268 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.83 77.62 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.864 -0.588 . . . . 0.0 111.996 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.05 73.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.413 0.551 . . . . 0.0 110.764 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -77.11 -43.73 33.09 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.847 -0.533 . . . . 0.0 110.809 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.92 19.2 4.89 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -114.82 3.53 14.66 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.261 1.031 . . . . 0.0 111.705 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.32 -170.07 26.84 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.805 1.669 . . . . 0.0 113.82 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.15 178.15 7.31 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.822 2.348 . . . . 0.0 111.916 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -99.99 -24.36 14.65 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 120.593 -1.317 . . . . 0.0 111.526 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.2 mt -140.08 156.37 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 124.832 1.253 . . . . 0.0 107.904 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 tt -142.9 147.27 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.398 1.479 . . . . 0.0 107.863 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -140.05 107.26 5.49 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.635 1.174 . . . . 0.0 110.187 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.402 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 41.5 t-105 -153.0 -165.88 2.3 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.838 1.199 . . . . 0.0 110.576 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 62' ' ' TRP . . . -73.44 147.81 43.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.061 1.344 . . . . 0.0 110.163 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -61.04 -27.38 68.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.239 0.542 . . . . 0.0 112.116 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -58.87 -31.43 68.56 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -104.33 -6.0 21.24 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.473 0.579 . . . . 0.0 109.796 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.16 -35.57 61.6 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.434 0.694 . . . . 0.0 111.267 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.89 -4.64 59.26 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.83 -60.78 1.4 Allowed Glycine 0 C--N 1.336 0.556 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -51.85 -43.47 63.22 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.082 0.953 . . . . 0.0 113.208 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.34 85.31 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 119.211 0.914 . . . . 0.0 111.266 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -48.86 70.74 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.1 m -61.06 -14.39 23.4 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.532 1.533 . . . . 0.0 112.909 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.45 24.65 33.0 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 124.578 1.085 . . . . 0.0 112.548 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.23 6.97 44.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.3 1.05 . . . . 0.0 113.241 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.6 mt -128.88 138.64 52.14 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 120.076 -1.64 . . . . 0.0 108.345 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.5 160.16 28.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.03 101.31 0.12 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.171 2.189 . . . . 0.0 106.459 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -67.0 152.7 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 122.086 0.946 . . . . 0.0 111.77 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.3 m 56.22 93.91 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 129.889 3.276 . . . . 0.0 115.574 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.74 -41.66 10.43 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.805 1.67 . . . . 0.0 110.909 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -131.07 142.64 50.31 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.905 0.882 . . . . 0.0 112.912 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -44.76 -43.18 8.35 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 128.073 2.549 . . . . 0.0 116.994 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.01 -34.03 12.35 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.24 1.382 . . . . 0.0 114.698 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -64.55 -25.36 67.95 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.456 -0.778 . . . . 0.0 111.338 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -72.04 -44.88 62.66 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -61.85 -22.68 65.72 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.789 1.236 . . . . 0.0 112.261 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -75.4 -13.74 60.42 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.477 1.111 . . . . 0.0 112.25 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mt -124.38 154.51 40.27 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.159 0.891 . . . . 0.0 112.838 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -69.98 146.87 95.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.95 -41.39 7.74 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.173 2.582 . . . . 0.0 114.124 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -59.72 -37.21 78.29 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.138 0.881 . . . . 0.0 111.629 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -26.2 66.69 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.268 1.027 . . . . 0.0 111.56 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -73.74 -30.98 63.13 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 121.471 -0.768 . . . . 0.0 111.387 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.0 -29.33 65.19 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.208 0.913 . . . . 0.0 111.919 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.64 -16.91 63.5 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.524 1.129 . . . . 0.0 112.978 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 m -132.23 18.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.666 1.586 . . . . 0.0 112.167 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -70.65 165.54 22.67 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 122.275 1.036 . . . . 0.0 110.509 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -152.33 -177.02 5.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.419 1.488 . . . . 0.0 107.155 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -69.71 102.02 1.8 Allowed 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.21 -81.53 0.47 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.447 1.499 . . . . 0.0 112.323 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.91 170.26 4.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.393 0.596 . . . . 0.0 109.595 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.94 162.03 13.94 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.86 0.864 . . . . 0.0 109.432 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 37.7 pt -123.67 -14.58 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.182 0.993 . . . . 0.0 112.599 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.3 175.4 4.89 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.04 1.736 . . . . 0.0 107.977 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -134.3 148.29 67.14 Favored Pre-proline 0 C--O 1.242 0.684 0 C-N-CA 124.83 1.252 . . . . 0.0 111.58 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.02 143.7 26.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.301 2.668 . . . . 0.0 108.267 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.3 mm -134.42 -52.08 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 C-N-CA 125.128 1.371 . . . . 0.0 109.773 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.42 148.86 44.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.507 0.723 . . . . 0.0 111.008 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.1 t -137.82 110.37 7.04 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.116 0 C-N-CA 123.478 0.711 . . . . 0.0 110.106 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 . . . . . 0 C--O 1.238 0.45 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.054 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.1 mt . . . . . 0 C--O 1.238 0.466 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 35.9 p90 . . . . . 0 C--O 1.236 0.379 0 C-N-CA 124.342 1.057 . . . . 0.0 111.196 -178.587 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo . . . . . 0 C--O 1.238 0.498 0 N-CA-C 109.781 -0.892 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -132.27 -25.01 2.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.046 1.338 . . . . 0.0 112.091 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.6 t -147.75 152.58 37.98 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.569 1.077 . . . . 0.0 109.337 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -67.34 -15.85 63.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.28 -24.41 61.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.846 1.203 . . . . 0.0 112.329 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -86.41 -16.26 37.78 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 118.292 0.497 . . . . 0.0 110.691 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.66 -57.12 29.04 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 124.775 1.23 . . . . 0.0 107.988 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.25 -24.76 31.64 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 CA-C-N 120.804 1.323 . . . . 0.0 111.023 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.09 -52.7 38.67 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.18 -26.16 68.03 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.187 0.995 . . . . 0.0 109.838 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.37 -41.25 89.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.098 0.863 . . . . 0.0 111.25 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -75.67 -31.16 59.65 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.936 -0.477 . . . . 0.0 110.376 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -70.49 -46.75 63.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 42.2 mt -74.01 -32.44 63.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.766 -1.111 . . . . 0.0 110.294 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -67.88 -36.32 80.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 120.54 1.518 . . . . 0.0 108.707 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.69 -9.78 15.85 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.41 0.684 . . . . 0.0 112.796 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.56 11.27 2.29 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.321 1.449 . . . . 0.0 111.829 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.01 -111.95 0.32 Allowed Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -142.46 -170.25 3.15 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.488 1.915 . . . . 0.0 110.558 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 p -52.38 148.69 6.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.17 1.788 . . . . 0.0 112.802 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.09 -57.0 3.95 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.64 1.176 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.11 146.23 29.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.012 1.725 . . . . 0.0 107.604 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.7 ttm -145.88 105.76 4.0 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -138.23 163.47 31.66 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -72.18 91.81 1.31 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.273 1.429 . . . . 0.0 112.452 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -16.69 61.44 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.212 1.405 . . . . 0.0 109.188 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -75.37 -9.47 58.59 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.991 0.916 . . . . 0.0 112.358 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -119.47 123.34 28.74 Favored Pre-proline 0 C--N 1.34 0.19 0 C-N-CA 124.029 0.932 . . . . 0.0 108.728 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.01 -10.55 27.47 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.714 2.276 . . . . 0.0 115.749 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -61.07 -37.64 83.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -90.13 -23.5 21.34 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.335 0.516 . . . . 0.0 112.179 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.7 p -83.59 -25.87 30.51 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.146 0.43 . . . . 0.0 110.363 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -55.44 -55.87 35.27 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.204 -0.903 . . . . 0.0 112.608 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -62.66 -21.01 72.51 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.62 1.547 . . . . 0.0 112.071 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.2 tp -70.93 -59.48 2.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 25.3 pt -64.74 -30.8 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 117.573 -1.203 . . . . 0.0 113.793 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.68 -4.34 11.82 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 120.822 1.646 . . . . 0.0 113.883 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.35 -50.24 65.45 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.468 1.107 . . . . 0.0 113.801 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.97 -44.57 97.16 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 120.803 -1.186 . . . . 0.0 111.644 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 175.35 13.28 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.807 -0.996 . . . . 0.0 115.248 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.52 151.46 48.72 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 118.78 1.29 . . . . 0.0 111.624 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -164.25 151.34 11.69 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.31 -55.46 3.66 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -141.93 167.83 21.21 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.468 0.707 . . . . 0.0 112.038 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -101.12 155.23 18.12 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.936 0.874 . . . . 0.0 108.691 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -155.56 118.87 4.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.613 1.565 . . . . 0.0 107.574 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -92.58 67.72 4.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 33.6 47.6 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.391 2.276 . . . . 0.0 115.232 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.51 -18.91 1.67 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 126.157 1.837 . . . . 0.0 112.057 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -117.97 106.19 12.68 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.13 128.91 34.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -132.0 88.69 2.58 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-O 123.705 1.716 . . . . 0.0 109.512 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -5.2 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.306 1.443 . . . . 0.0 114.06 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -70.01 -40.39 75.29 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 120.11 1.323 . . . . 0.0 108.25 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -76.76 108.05 9.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.2 t -129.08 140.32 49.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -129.63 16.92 5.57 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 118.283 -1.287 . . . . 0.0 115.676 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -13.99 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.164 1.982 . . . . 0.0 115.341 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -119.12 10.15 12.0 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 120.841 -1.162 . . . . 0.0 111.083 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -65.38 155.75 34.4 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -49.08 -35.66 16.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.562 0.745 . . . . 0.0 112.198 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.27 -40.13 98.61 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 119.878 1.217 . . . . 0.0 114.055 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.91 -52.1 52.85 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.622 1.211 . . . . 0.0 109.189 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -63.0 -39.9 96.14 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 119.095 -0.479 . . . . 0.0 110.598 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.78 65.61 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.72 0.808 . . . . 0.0 111.92 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -94.14 -34.76 6.3 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 31.5 tp -70.72 -40.13 72.97 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.481 0.712 . . . . 0.0 111.269 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.4 t -50.55 -45.76 57.12 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 116.672 -1.633 . . . . 0.0 109.848 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -55.64 -56.75 16.71 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 120.547 1.521 . . . . 0.0 111.054 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 64.6 tp -56.04 -49.36 73.94 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.583 0.753 . . . . 0.0 110.934 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.07 -27.89 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.135 0.974 . . . . 0.0 110.895 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.12 -40.16 96.79 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.998 1.319 . . . . 0.0 110.135 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 9.7 mt -66.23 -45.52 80.38 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.28 -40.6 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.458 1.103 . . . . 0.0 108.891 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -56.62 -37.48 70.77 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.779 -1.2 . . . . 0.0 109.588 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -88.27 -4.17 58.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.767 1.627 . . . . 0.0 112.268 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 56.65 14.51 1.77 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.5 2.32 . . . . 0.0 113.758 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -83.42 -5.31 59.11 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.381 -0.825 . . . . 0.0 111.251 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.7 tpt -109.07 154.59 22.04 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.726 0.81 . . . . 0.0 111.382 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -76.18 71.09 2.89 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 108.767 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.3 -10.66 59.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.324 1.05 . . . . 0.0 112.003 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -85.85 -15.84 40.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 129.517 3.127 . . . . 0.0 115.086 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 12.4 m -67.16 127.76 33.82 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.03 1.332 . . . . 0.0 113.244 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -122.24 -178.37 3.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -62.47 -31.63 72.4 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.258 -0.901 . . . . 0.0 113.002 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 t -64.98 -48.8 72.7 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.223 1.009 . . . . 0.0 109.842 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 13.8 mm -61.39 -47.9 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.783 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.68 -52.74 59.34 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.428 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.96 -44.31 94.5 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.62 1.1 . . . . 0.0 110.164 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.81 -54.2 45.42 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.601 0.36 . . . . 0.0 110.35 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.9 79.36 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.655 0.661 . . . . 0.0 111.556 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.85 -44.72 92.29 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -59.22 -42.17 90.37 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -68.45 -27.72 66.42 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.219 -0.925 . . . . 0.0 111.717 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.68 63.48 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.57 1.557 . . . . 0.0 111.948 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.15 -60.85 2.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.442 1.497 . . . . 0.0 111.503 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.2 t -69.04 151.29 46.66 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.67 -26.92 13.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.305 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -130.29 158.66 39.19 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 3.1 t -173.23 -179.72 2.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.09 2.156 . . . . 0.0 108.424 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 63.4 mt . . . . . 0 C--O 1.235 0.321 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.335 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.65 152.77 79.99 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.324 2.016 . . . . 0.0 111.75 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 69.8 p -119.6 171.45 8.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.245 1.418 . . . . 0.0 111.033 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -84.81 158.97 20.51 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -59.11 122.94 15.04 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 120.82 -1.175 . . . . 0.0 109.762 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 71.01 7.74 63.04 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 117.712 -1.605 . . . . 0.0 114.215 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.38 127.02 6.08 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 121.269 2.535 . . . . 0.0 112.574 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.02 161.13 47.13 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.728 2.952 . . . . 0.0 113.693 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 89.4 p -83.24 139.3 33.19 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.829 0.852 . . . . 0.0 108.77 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -132.77 76.17 71.52 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.831 1.652 . . . . 0.0 107.967 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -77.01 -170.32 0.9 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.324 3.349 . . . . 0.0 112.139 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.47 0.546 0 C-N-CA 123.982 0.913 . . . . 0.0 110.869 179.535 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.533 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.37 127.18 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.83 158.7 35.04 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.1 m -131.05 140.66 50.11 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 120.917 -1.114 . . . . 0.0 110.551 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.4 128.2 40.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.967 1.707 . . . . 0.0 107.407 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.61 160.45 24.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 58.8 mt -95.16 130.11 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -77.51 133.34 38.58 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -82.46 -5.02 58.44 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -62.33 -31.05 71.62 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 49.7 m -78.5 157.15 77.79 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.156 1.782 . . . . 0.0 112.564 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.32 -59.64 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.028 3.152 . . . . 0.0 113.335 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -104.68 98.84 8.53 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -13.76 61.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.758 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -59.81 -41.04 90.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.251 1.42 . . . . 0.0 109.926 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.75 -39.49 84.96 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.3 -44.44 62.71 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.942 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -29.72 68.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.046 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -79.46 -49.92 11.56 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.94 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -55.93 -45.38 78.77 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.889 1.677 . . . . 0.0 109.726 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.36 -30.03 70.89 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.102 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -99.26 -17.4 18.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 120.337 1.426 . . . . 0.0 114.55 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -84.11 -35.9 23.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.899 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -139.23 -32.37 0.66 Allowed 'General case' 0 C--N 1.344 0.329 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -21.2 63.46 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.6 1.545 . . . . 0.0 112.002 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 57.6 mt -110.35 41.6 1.72 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.825 1.65 . . . . 0.0 109.837 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.0 p -128.47 160.08 33.43 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.4 -38.59 66.39 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -68.68 -43.79 75.36 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.33 -42.22 66.05 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.32 -43.04 92.25 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.636 1.174 . . . . 0.0 110.213 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.33 -43.53 90.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.68 -43.63 80.65 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.101 0.961 . . . . 0.0 112.323 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.7 t -71.3 -39.94 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.46 1.027 . . . . 0.0 108.341 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -62.26 -35.43 78.94 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.026 0.531 . . . . 0.0 111.215 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -60.91 -47.95 84.06 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 121.283 -0.885 . . . . 0.0 109.695 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -41.05 66.54 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -143.98 148.33 41.62 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.01 131.29 23.49 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.594 2.196 . . . . 0.0 111.809 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 24.6 mt -119.35 -17.8 8.72 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.723 0.809 . . . . 0.0 112.592 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 70.06 -150.75 49.33 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 119.629 1.104 . . . . 0.0 110.69 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -65.53 167.82 8.31 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.525 1.53 . . . . 0.0 112.206 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.03 165.43 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 124.05 1.881 . . . . 0.0 111.086 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.58 -23.11 29.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.055 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.02 107.71 6.38 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 125.177 1.391 . . . . 0.0 110.57 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -61.1 1.87 0.15 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.192 1.397 . . . . 0.0 114.676 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.7 m -95.97 -67.75 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -68.62 -22.33 64.43 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.86 0.755 . . . . 0.0 111.263 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -62.67 -32.16 73.18 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 118.955 0.798 . . . . 0.0 109.186 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.89 -34.11 77.61 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.005 1.275 . . . . 0.0 110.244 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -79.18 -42.31 26.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.771 1.228 . . . . 0.0 110.45 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 19.3 mt -68.15 -39.31 82.67 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.07 -7.85 10.04 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.78 1.232 . . . . 0.0 112.361 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -62.44 -30.27 71.12 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.188 -0.945 . . . . 0.0 108.677 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.6 142.06 25.34 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 124.238 1.015 . . . . 0.0 108.934 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.74 -25.2 46.52 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.524 2.15 . . . . 0.0 113.138 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -58.47 -49.8 76.03 Favored 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.01 -42.01 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.334 1.054 . . . . 0.0 109.05 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.66 -47.6 73.36 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.148 0.431 . . . . 0.0 110.166 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.24 91.63 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.641 -0.662 . . . . 0.0 111.503 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.6 m -61.88 -37.47 84.67 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 60.7 tpp -73.05 -42.31 63.25 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 118.584 0.629 . . . . 0.0 109.974 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -56.78 -38.96 73.21 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -57.9 -41.82 83.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.401 0.28 . . . . 0.0 110.399 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.36 0 O-C-N 121.861 -0.524 . . . . 0.0 111.125 178.718 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.461 -0.428 0 N-CA-C 111.559 -0.208 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -129.58 73.96 1.56 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 pt -129.67 153.73 80.82 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.501 1.121 . . . . 0.0 111.225 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.41 -32.73 49.43 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.33 2.687 . . . . 0.0 113.453 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -63.26 -24.24 67.78 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.106 -0.996 . . . . 0.0 111.084 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 26.3 mmm -68.64 -26.36 65.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.239 0.927 . . . . 0.0 111.102 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.5 m -62.53 -48.82 77.86 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.72 -31.03 67.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.409 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -55.92 -58.87 6.05 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.305 0.957 . . . . 0.0 109.909 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -60.55 -37.77 82.32 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.943 -0.473 . . . . 0.0 111.742 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -62.56 -44.33 96.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.403 0.681 . . . . 0.0 109.226 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.63 -50.99 67.16 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.056 1.342 . . . . 0.0 110.698 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.19 -43.76 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.069 0.395 . . . . 0.0 110.236 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -53.65 -38.55 64.23 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.684 0.794 . . . . 0.0 110.833 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 5.7 m -82.4 -50.44 8.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.522 1.055 . . . . 0.0 110.067 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.84 63.46 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.37 -49.12 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 118.051 -0.975 . . . . 0.0 109.918 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.6 mm -65.31 -35.4 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 119.836 1.198 . . . . 0.0 109.67 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -64.73 -45.97 84.25 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.143 -0.973 . . . . 0.0 109.93 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.46 65.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.701 0.8 . . . . 0.0 111.003 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.91 -36.81 84.6 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 125.328 1.451 . . . . 0.0 113.497 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 42.4 m -92.22 -2.7 56.34 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.443 0.697 . . . . 0.0 110.707 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 76.32 13.01 83.76 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 115.532 0.973 . . . . 0.0 115.532 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -66.36 -30.78 71.24 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 119.06 1.43 . . . . 0.0 109.945 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.12 156.09 43.69 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.4 m -66.99 156.23 36.53 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.69 -51.66 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.14 -50.93 65.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.362 1.465 . . . . 0.0 111.621 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.41 -39.14 74.63 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.15 89.31 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 121.463 -0.773 . . . . 0.0 109.605 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.7 mp -72.13 -43.42 64.7 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.396 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.6 tptt -53.14 -55.07 26.97 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.122 1.369 . . . . 0.0 110.228 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -53.9 -49.16 69.21 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 127.99 2.516 . . . . 0.0 112.281 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.48 -50.11 74.88 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 125.668 1.587 . . . . 0.0 111.408 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -56.44 -33.09 65.53 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.485 1.039 . . . . 0.0 110.625 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 14.0 m -62.14 -37.01 83.55 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.806 0.73 . . . . 0.0 109.873 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -65.84 -20.39 66.22 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.154 -0.966 . . . . 0.0 112.244 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 5.7 mt -88.7 -29.21 5.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.274 1.03 . . . . 0.0 109.732 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.0 p -92.55 -7.74 46.37 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.672 -0.643 . . . . 0.0 110.709 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 25.5 tptt . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.312 1.445 . . . . 0.0 110.97 -178.55 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.655 0.74 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -92.02 99.36 12.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 145.76 19.86 0.14 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-O 119.239 -0.756 . . . . 0.0 114.958 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -141.11 172.2 13.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.55 1.175 . . . . 0.0 110.933 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.1 mt -153.53 147.03 24.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 128.521 2.728 . . . . 0.0 106.314 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.8 t -142.02 136.12 29.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.6 mt -124.02 137.79 55.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 126.348 1.859 . . . . 0.0 108.82 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -128.42 149.91 50.35 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.2 pt -136.25 168.08 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -158.91 150.95 21.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 128.121 2.569 . . . . 0.0 108.933 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.74 16.3 49.17 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-O 117.432 -1.76 . . . . 0.0 115.577 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 70.12 37.64 1.64 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.728 2.011 . . . . 0.0 110.675 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -57.61 157.05 7.48 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.299 1.047 . . . . 0.0 111.345 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.96 56.89 4.58 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.788 -0.642 . . . . 0.0 114.071 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -50.54 -39.45 49.17 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -66.51 -12.37 57.2 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.86 -45.53 1.49 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.6 tp -61.45 -37.87 85.15 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.466 0.706 . . . . 0.0 111.9 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.69 -41.76 64.16 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.705 0.802 . . . . 0.0 111.92 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -62.82 -33.15 74.62 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.3 t -65.18 -47.13 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.33 -35.77 92.5 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -62.88 -45.72 91.21 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.215 -0.898 . . . . 0.0 109.083 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -58.89 -54.94 41.48 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -52.36 -48.87 65.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.996 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -66.08 -32.51 74.01 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.858 1.208 . . . . 0.0 110.721 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -68.93 -28.05 66.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 118.171 -0.919 . . . . 0.0 112.604 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.62 -0.43 20.23 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.255 0.972 . . . . 0.0 112.903 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.2 p -130.6 -38.79 1.3 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.61 1.096 . . . . 0.0 112.259 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.72 -10.91 66.57 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.832 -0.982 . . . . 0.0 113.74 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 40.0 mm -70.31 132.28 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 147.39 53.53 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.897 -0.502 . . . . 0.0 111.373 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 t -137.84 125.94 31.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.8 m -118.46 142.49 47.52 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.5 t -132.14 120.97 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -136.29 164.95 26.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.089 1.356 . . . . 0.0 110.245 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -122.4 58.22 10.14 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.126 1.37 . . . . 0.0 112.063 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.93 136.49 16.66 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.212 1.941 . . . . 0.0 110.611 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.12 -18.4 25.92 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.236 -0.915 . . . . 0.0 110.403 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.418 ' HD2' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -83.66 -2.11 55.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 128.12 2.568 . . . . 0.0 112.761 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.47 -31.6 10.28 Favored 'General case' 0 N--CA 1.461 0.085 0 C-N-CA 124.586 1.154 . . . . 0.0 113.459 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -52.6 -33.44 46.33 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.62 1.168 . . . . 0.0 113.561 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -119.14 -21.6 7.54 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 123.375 0.67 . . . . 0.0 110.967 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -72.55 -42.78 64.31 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 117.717 -1.135 . . . . 0.0 109.122 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -51.26 -60.51 5.58 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 117.558 -1.211 . . . . 0.0 109.96 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.52 -24.57 75.37 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.146 1.23 . . . . 0.0 113.142 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -69.4 -55.26 10.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.087 0.858 . . . . 0.0 111.337 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.06 -37.47 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.696 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.07 90.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.782 -0.627 . . . . 0.0 109.31 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.0 -15.4 43.85 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 118.925 -0.56 . . . . 0.0 111.979 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.8 m -102.85 -9.23 20.09 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.036 1.734 . . . . 0.0 111.825 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.88 10.06 73.05 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.897 -1.127 . . . . 0.0 112.393 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -112.21 2.09 16.48 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.109 1.364 . . . . 0.0 112.582 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.45 176.9 34.23 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.958 -1.089 . . . . 0.0 114.848 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.23 -178.41 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.97 3.113 . . . . 0.0 110.818 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.56 -22.16 12.11 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 120.982 -1.074 . . . . 0.0 112.272 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mt -139.23 148.14 23.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.8 tp -129.35 144.45 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.974 1.71 . . . . 0.0 107.573 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -132.82 102.29 5.59 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.757 1.223 . . . . 0.0 108.808 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -153.13 171.39 18.52 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.053 0.842 . . . . 0.0 111.782 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.19 161.11 31.34 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.745 -1.222 . . . . 0.0 110.984 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -54.54 -32.14 57.72 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.794 1.638 . . . . 0.0 114.736 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.12 -58.15 8.84 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.622 1.169 . . . . 0.0 111.175 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -73.52 -9.39 58.63 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 121.156 -0.965 . . . . 0.0 111.592 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -93.75 12.1 26.83 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.218 1.807 . . . . 0.0 110.035 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 -9.9 56.61 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.815 -0.991 . . . . 0.0 112.006 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.56 -31.26 1.39 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.708 1.754 . . . . 0.0 116.211 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -53.02 -53.98 42.01 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.247 2.024 . . . . 0.0 111.863 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.21 89.75 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.427 -0.796 . . . . 0.0 109.412 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -40.86 76.91 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.804 0.842 . . . . 0.0 109.292 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 m -73.98 -38.01 64.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.694 0.797 . . . . 0.0 108.877 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.07 8.73 6.46 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.97 1.272 . . . . 0.0 114.549 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.8 mt -76.94 -8.01 56.6 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 mt -108.34 139.83 42.48 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.808 1.64 . . . . 0.0 111.857 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.32 175.12 8.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.625 0.77 . . . . 0.0 112.096 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -71.04 135.62 47.87 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.922 0.889 . . . . 0.0 109.326 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 pp -125.74 161.35 30.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 123.474 0.709 . . . . 0.0 110.805 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.9 m 50.87 82.58 0.24 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 127.122 2.169 . . . . 0.0 113.971 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.6 -21.68 25.32 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.349 2.7 . . . . 0.0 113.68 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -134.79 159.63 40.73 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.067 1.303 . . . . 0.0 113.106 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -70.78 -35.81 72.76 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.139 1.376 . . . . 0.0 113.021 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.73 -35.17 60.92 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.776 1.171 . . . . 0.0 112.213 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -65.58 -32.94 74.8 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 122.12 -0.363 . . . . 0.0 111.079 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -66.2 -43.19 87.5 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.607 -0.683 . . . . 0.0 109.54 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -60.0 -27.49 66.91 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.77 1.628 . . . . 0.0 112.938 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -72.17 -2.93 20.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.987 0.915 . . . . 0.0 111.627 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mt -132.81 156.36 47.26 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.185 1.394 . . . . 0.0 110.561 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -68.38 156.47 90.26 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.26 -50.89 0.86 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.187 3.258 . . . . 0.0 114.613 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -52.45 -36.51 54.77 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.374 0.988 . . . . 0.0 112.067 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -31.13 72.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.958 0.903 . . . . 0.0 111.28 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -75.75 -42.51 50.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.813 0.733 . . . . 0.0 110.599 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.402 ' HA ' ' CG ' ' A' ' 98' ' ' ARG . 4.0 m-20 -55.19 -36.08 65.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.086 0.403 . . . . 0.0 110.02 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.47 -2.51 4.72 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 m -133.06 15.96 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 120.146 1.339 . . . . 0.0 110.17 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.402 ' CG ' ' HA ' ' A' ' 95' ' ' ASP . 10.4 mmt180 -71.26 161.65 30.74 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 123.932 0.893 . . . . 0.0 110.832 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -152.05 179.29 8.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.616 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -63.43 97.77 0.14 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.692 1.197 . . . . 0.0 109.537 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.55 -80.96 1.0 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.443 1.496 . . . . 0.0 111.029 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 170.19 13.47 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.962 -0.728 . . . . 0.0 111.06 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.8 163.97 12.76 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.769 1.227 . . . . 0.0 109.385 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.6 pt -129.04 -34.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 116.752 -1.594 . . . . 0.0 114.03 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -143.83 -179.29 6.38 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.994 1.725 . . . . 0.0 109.165 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -132.51 148.13 68.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.251 1.02 . . . . 0.0 111.303 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.66 151.88 32.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.676 2.918 . . . . 0.0 109.388 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -133.05 -55.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.695 1.198 . . . . 0.0 110.745 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.81 161.04 31.66 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.44 108.32 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.253 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 p90 . . . . . 0 N--CA 1.451 -0.388 0 O-C-N 120.834 -1.166 . . . . 0.0 110.425 -177.965 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.456 -0.725 0 CA-C-O 123.428 1.345 . . . . 0.0 114.458 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -101.29 -33.12 10.17 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.944 2.898 . . . . 0.0 114.493 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 t -161.13 152.38 18.85 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.8 0.727 . . . . 0.0 110.47 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -64.96 -28.06 69.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.761 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -67.39 -17.27 64.66 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.886 0.766 . . . . 0.0 112.97 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -94.38 -18.6 21.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.962 0.905 . . . . 0.0 109.534 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.6 mm -52.5 -56.83 18.95 Favored Pre-proline 0 C--O 1.234 0.279 0 O-C-N 121.259 -0.901 . . . . 0.0 110.391 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.44 -29.77 44.83 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 CA-C-N 120.34 1.157 . . . . 0.0 111.608 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.25 -15.08 62.42 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.793 1.637 . . . . 0.0 112.474 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 36.6 tp -104.88 -24.57 12.85 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.798 1.639 . . . . 0.0 107.225 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.69 -49.21 69.39 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -65.51 -27.4 68.44 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.14 -42.77 30.74 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.5 mt -70.85 -33.27 70.47 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.31 68.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 123.615 0.572 . . . . 0.0 111.948 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.02 0.73 16.08 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.766 1.226 . . . . 0.0 112.982 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 179.59 -97.65 0.11 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 119.203 0.911 . . . . 0.0 113.134 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -140.55 -176.19 4.55 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.152 0.981 . . . . 0.0 111.165 -177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.3 p -52.99 166.46 0.22 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.343 1.857 . . . . 0.0 115.181 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -95.45 -69.47 0.75 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.137 1.375 . . . . 0.0 109.828 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.7 tp -121.32 152.5 38.88 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.73 2.012 . . . . 0.0 110.687 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 88.0 mtp -149.76 131.51 15.03 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.741 2.416 . . . . 0.0 105.399 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -148.58 164.58 33.82 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.8 1.24 . . . . 0.0 110.639 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.66 94.43 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.885 1.274 . . . . 0.0 113.828 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.4 mt -85.07 -19.5 31.83 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.668 -1.27 . . . . 0.0 110.342 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -77.13 -0.81 26.32 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.784 0.834 . . . . 0.0 112.85 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -125.24 122.43 25.19 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.903 0.881 . . . . 0.0 109.735 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.1 -15.09 32.19 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.417 1.411 . . . . 0.0 112.395 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -48.7 -42.19 34.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.921 1.288 . . . . 0.0 113.3 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -93.77 -33.72 13.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.8 0.727 . . . . 0.0 112.354 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 82.6 p -72.28 -28.56 63.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.018 0.826 . . . . 0.0 111.914 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -47.46 -63.33 1.49 Allowed Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.137 1.775 . . . . 0.0 112.458 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -66.4 -11.86 33.26 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.737 1.624 . . . . 0.0 114.482 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.2 tp -78.89 -55.61 5.02 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.6 pt -62.48 -34.14 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.539 0.609 . . . . 0.0 111.79 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.44 -12.42 60.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.677 -1.154 . . . . 0.0 112.206 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -48.4 -54.37 14.27 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.191 1.396 . . . . 0.0 112.396 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -53.14 -49.81 65.81 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.455 0.57 . . . . 0.0 111.447 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.81 1.54 0.03 OUTLIER Glycine 0 CA--C 1.523 0.537 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.645 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -54.83 144.5 30.89 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 119.408 1.604 . . . . 0.0 110.19 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.414 ' CE1' ' HA3' ' A' ' 182' ' ' GLY . 37.6 p90 -148.83 136.71 20.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 118.568 1.184 . . . . 0.0 108.924 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.54 -67.77 0.71 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -133.91 134.31 42.5 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -75.49 124.28 26.9 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -131.71 100.78 5.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 173' ' ' ASN . 7.3 tt0 -79.57 -173.72 3.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.421 1.488 . . . . 0.0 107.724 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.408 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 32.9 m-80 -46.9 -27.59 1.3 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.822 1.649 . . . . 0.0 114.25 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.57 13.82 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 CA-C-O 118.535 -1.147 . . . . 0.0 113.848 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -122.67 132.34 54.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.684 1.742 . . . . 0.0 108.891 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.01 114.36 19.65 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -139.52 96.01 3.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 122.442 1.115 . . . . 0.0 110.428 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.59 -3.41 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 127.622 2.369 . . . . 0.0 114.789 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -76.87 -36.74 56.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.04 93.94 5.85 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.88 151.21 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 126.246 1.819 . . . . 0.0 107.623 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' ' 167' ' ' TYR . . . -148.69 31.99 1.22 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.68 1.133 . . . . 0.0 112.246 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.05 -24.04 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 121.712 -0.875 . . . . 0.0 111.48 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -112.86 18.52 18.11 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.314 1.445 . . . . 0.0 112.814 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -61.57 160.38 11.44 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.591 0.71 . . . . 0.0 109.161 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.68 -26.27 63.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.636 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -72.45 -33.38 61.3 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.132 -0.98 . . . . 0.0 112.447 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.38 43.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.182 0.993 . . . . 0.0 109.758 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -59.79 -34.56 73.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.497 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.66 -54.34 48.21 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.709 0.686 . . . . 0.0 110.562 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.92 -32.06 81.5 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.848 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.87 -44.52 63.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.234 1.017 . . . . 0.0 111.143 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 12.9 t -62.27 -29.1 70.17 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 117.427 -1.273 . . . . 0.0 110.233 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -57.49 -46.6 83.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 120.205 1.366 . . . . 0.0 108.922 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.35 -51.56 67.12 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.918 0.887 . . . . 0.0 109.683 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.67 -32.71 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.526 0.73 . . . . 0.0 110.66 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -32.23 73.68 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.974 0.91 . . . . 0.0 110.601 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.16 -45.26 57.66 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 50.5 mt -60.81 -39.79 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.173 0.989 . . . . 0.0 108.627 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -54.69 -35.79 63.98 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.049 0.94 . . . . 0.0 109.627 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -93.15 -1.97 55.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.736 2.015 . . . . 0.0 113.131 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 9.1 mptt 55.98 11.82 0.8 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.317 2.647 . . . . 0.0 115.503 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -79.91 -8.41 59.3 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.947 -1.095 . . . . 0.0 112.362 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.62 136.44 50.84 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.236 1.014 . . . . 0.0 109.766 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -76.87 79.28 3.45 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.49 77.46 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.18 -2.25 9.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.906 2.082 . . . . 0.0 114.554 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 43.4 m -63.04 126.95 29.04 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.611 1.164 . . . . 0.0 113.629 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.82 179.38 4.03 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.954 2.102 . . . . 0.0 107.097 177.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -57.05 -45.54 83.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -40.25 97.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.148 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 59.6 mt -68.4 -48.86 70.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.42 85.51 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.088 0.555 . . . . 0.0 111.907 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -77.26 -49.55 14.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.047 0.839 . . . . 0.0 111.718 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.69 -50.54 71.84 Favored 'General case' 0 C--N 1.337 0.054 0 CA-C-N 119.114 0.87 . . . . 0.0 110.737 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.34 -44.6 84.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.292 1.037 . . . . 0.0 109.761 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -60.76 -44.06 97.22 Favored 'General case' 0 CA--C 1.524 -0.053 0 C-N-CA 123.501 0.72 . . . . 0.0 109.243 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -55.78 -42.76 76.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.797 0.839 . . . . 0.0 110.05 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -74.51 -21.33 59.6 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.265 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.96 20.26 13.17 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.981 -0.899 . . . . 0.0 112.537 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -73.46 -31.71 63.94 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.513 1.656 . . . . 0.0 112.701 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.7 t -124.2 146.57 48.62 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.796 1.639 . . . . 0.0 106.743 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -106.5 -9.63 16.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.31 1.044 . . . . 0.0 112.241 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.67 153.7 41.89 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.2 t -164.84 157.53 16.43 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 0 C--O 1.234 0.261 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.625 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.541 0.622 0 CA-C-O 119.587 -0.244 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.73 153.81 68.59 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.395 1.396 . . . . 0.0 109.062 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.5 p -125.64 163.97 21.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -83.41 139.55 32.91 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 135.39 52.16 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.745 -1.222 . . . . 0.0 109.573 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 71.59 -1.61 27.93 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.182 -1.343 . . . . 0.0 113.974 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.99 105.14 2.64 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 121.283 2.542 . . . . 0.0 111.67 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.15 144.29 56.79 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.754 1.636 . . . . 0.0 110.809 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.39 146.86 46.85 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.504 1.522 . . . . 0.0 108.019 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -140.26 92.01 9.65 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.169 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -81.97 -165.07 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 125.244 3.963 . . . . 0.0 112.082 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 124.741 1.216 . . . . 0.0 109.386 178.404 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.269 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.7 149.48 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 123.217 0.607 . . . . 0.0 110.34 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.9 tt -82.69 127.63 33.59 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.4 m -111.05 159.59 17.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.851 1.261 . . . . 0.0 107.871 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -139.07 151.49 46.78 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.427 0.691 . . . . 0.0 109.849 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -147.77 164.38 28.83 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 124.739 1.274 . . . . 0.0 113.128 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 45.7 mt -103.67 133.83 46.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.309 1.444 . . . . 0.0 108.366 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -69.91 118.82 13.24 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.04 -13.27 62.35 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.619 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -73.28 -26.49 61.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.45 1.023 . . . . 0.0 112.729 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 48.8 m -62.55 161.52 26.53 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.007 0.523 . . . . 0.0 110.782 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.3 -44.79 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.541 1.494 . . . . 0.0 114.892 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -133.92 100.62 4.8 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 119.61 1.096 . . . . 0.0 109.861 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -58.01 -20.73 40.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.247 1.019 . . . . 0.0 113.092 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -60.76 -32.09 71.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.426 0.69 . . . . 0.0 111.214 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.31 -27.89 67.69 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.42 -0.8 . . . . 0.0 110.802 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -85.22 -40.21 16.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.403 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.46 83.51 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 118.888 0.767 . . . . 0.0 110.189 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -71.29 -43.89 66.26 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.03 -49.66 77.03 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.122 -0.986 . . . . 0.0 109.28 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.3 mp -59.42 -50.6 73.32 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 118.19 -0.909 . . . . 0.0 112.712 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -76.17 -21.32 56.66 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -93.7 -23.83 18.08 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 117.06 -1.448 . . . . 0.0 112.075 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -137.17 -28.18 0.94 Allowed 'General case' 0 C--N 1.346 0.424 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -83.5 -16.16 46.66 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.86 1.664 . . . . 0.0 112.442 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 67.6 mt -121.98 68.02 0.92 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.35 1.06 . . . . 0.0 109.702 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 65.6 p -139.44 154.84 47.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.959 1.704 . . . . 0.0 107.137 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.1 1.67 7.06 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.387 1.875 . . . . 0.0 112.246 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -113.21 -48.82 2.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.672 2.389 . . . . 0.0 111.058 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.52 -35.71 62.83 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.17 -42.88 99.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -60.39 -46.47 89.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 123.933 0.77 . . . . 0.0 109.545 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.84 -32.35 60.47 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 118.035 -0.984 . . . . 0.0 113.39 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 7.1 t -84.29 -24.57 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 120.406 1.457 . . . . 0.0 109.967 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -72.06 -23.85 61.43 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.285 0.948 . . . . 0.0 110.064 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -57.76 -49.9 75.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -64.67 -50.49 66.83 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 157.19 69.42 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 118.553 0.615 . . . . 0.0 112.296 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.89 101.18 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.776 2.317 . . . . 0.0 108.323 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 71.0 mt -81.27 -12.28 59.13 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 67.47 -154.04 52.93 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 120.168 1.349 . . . . 0.0 110.313 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.89 170.24 10.05 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.423 1.089 . . . . 0.0 112.639 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 18.7 m -133.64 155.84 40.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.45 1.5 . . . . 0.0 109.003 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.08 -24.37 59.48 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.659 -0.651 . . . . 0.0 109.378 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.48 102.61 0.91 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 127.57 2.348 . . . . 0.0 110.893 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -58.76 -24.13 61.19 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.2 p -64.69 -53.36 48.54 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 120.437 -1.414 . . . . 0.0 111.16 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -86.62 -19.68 28.97 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -62.12 -36.85 83.01 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.22 -10.44 23.42 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.127 0.876 . . . . 0.0 111.672 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -97.02 -45.31 6.63 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.424 1.49 . . . . 0.0 109.049 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 27.5 mt -67.51 -41.83 83.79 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.566 1.146 . . . . 0.0 109.043 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.55 0.87 0.42 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.633 1.973 . . . . 0.0 114.256 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -67.09 -18.44 65.32 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 120.244 1.384 . . . . 0.0 110.631 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -117.57 141.03 28.23 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.52 1.128 . . . . 0.0 109.486 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.97 -16.67 46.81 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.583 2.856 . . . . 0.0 116.462 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.44 -23.95 64.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 121.201 1.819 . . . . 0.0 109.581 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.2 mp -86.46 -65.43 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.01 -52.03 15.79 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.21 -22.17 66.84 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.699 -1.251 . . . . 0.0 114.088 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 41.0 m -85.11 -31.0 23.57 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.739 1.215 . . . . 0.0 108.069 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.8 tpt -71.26 -38.56 71.87 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.41 -29.93 68.1 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.539 1.136 . . . . 0.0 110.004 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -65.93 -42.56 89.93 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.278 0.631 . . . . 0.0 110.941 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.365 0 CA-C-N 118.148 0.431 . . . . 0.0 110.085 179.021 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 CA--C 1.54 0.804 0 CA-C-O 121.683 0.618 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.71 61.34 4.34 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.035 1.334 . . . . 0.0 108.526 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 44.8 pt -126.3 147.24 59.13 Favored Pre-proline 0 CA--C 1.535 0.387 0 O-C-N 121.093 -1.004 . . . . 0.0 111.288 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.36 -19.16 67.6 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.263 2.642 . . . . 0.0 114.354 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -66.95 -22.84 65.92 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.66 -0.65 . . . . 0.0 110.298 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 97.6 mmm -64.85 -27.6 68.98 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.757 0.708 . . . . 0.0 110.387 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 7.4 t -56.73 -52.22 65.83 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.561 1.144 . . . . 0.0 108.103 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.19 68.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.316 -0.849 . . . . 0.0 110.781 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -48.31 -57.7 5.63 Favored 'General case' 0 CA--C 1.524 -0.055 0 C-N-CA 123.788 0.835 . . . . 0.0 112.574 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -62.19 -50.04 73.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -61.34 -39.84 92.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.18 -57.65 6.33 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.428 1.091 . . . . 0.0 109.922 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.65 -42.97 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.816 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -53.66 -53.51 50.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.038 1.29 . . . . 0.0 108.419 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 18.8 m -60.22 -42.56 95.45 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.829 0.452 . . . . 0.0 110.833 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.11 94.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.244 0.929 . . . . 0.0 111.638 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.75 -49.81 83.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 123.7 0.8 . . . . 0.0 109.112 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.1 mm -65.84 -38.4 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.9 0.773 . . . . 0.0 109.034 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -57.77 -49.25 77.21 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.178 -0.951 . . . . 0.0 109.979 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.24 -50.58 60.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.814 0.845 . . . . 0.0 111.936 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.18 70.71 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.165 1.386 . . . . 0.0 114.235 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 49.4 m -97.71 3.12 50.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.641 0.777 . . . . 0.0 110.284 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.51 11.26 68.17 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 121.168 -0.958 . . . . 0.0 114.577 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 31.8 ttm-85 -68.13 -27.95 66.9 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 118.128 0.964 . . . . 0.0 110.014 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -149.55 156.13 41.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.8 m -71.11 155.84 40.3 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 80.0 t -52.57 -54.14 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.575 1.15 . . . . 0.0 109.346 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.71 -47.64 73.49 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.741 1.616 . . . . 0.0 112.127 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -71.6 -34.83 70.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.38 98.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 9.9 mt -72.11 -41.68 66.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.766 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -53.52 -46.18 70.01 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.724 0.81 . . . . 0.0 110.634 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.55 -48.06 83.13 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.567 1.547 . . . . 0.0 111.793 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.65 80.2 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.823 2.049 . . . . 0.0 111.959 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.68 -36.26 61.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.518 0.599 . . . . 0.0 110.898 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.83 -44.79 84.53 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.046 0.385 . . . . 0.0 111.322 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -61.02 -25.36 66.85 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.365 -0.835 . . . . 0.0 112.591 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 48.8 mt -90.46 -21.65 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.627 1.571 . . . . 0.0 113.683 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . 0.331 1.6 t -116.66 5.84 13.27 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.339 0.972 . . . . 0.0 111.731 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? . . . . . 0 C--O 1.247 0.939 0 C-N-CA 126.667 1.987 . . . . 0.0 110.312 178.593 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.78 -173.36 2.7 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.896 0.878 . . . . 0.0 109.463 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.1 27.22 68.56 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.429 -0.794 . . . . 0.0 114.184 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -144.68 168.08 21.02 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.596 1.198 . . . . 0.0 112.44 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.2 mt -151.65 149.12 28.77 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 129.516 3.127 . . . . 0.0 107.221 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -145.13 146.16 20.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 124.72 1.208 . . . . 0.0 108.627 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.1 mt -136.0 139.8 45.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 126.155 1.782 . . . . 0.0 107.958 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -123.91 155.07 38.78 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.2 mp -135.94 136.79 49.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 125.53 1.532 . . . . 0.0 109.799 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -78.4 -50.35 11.87 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.709 0.804 . . . . 0.0 108.872 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.52 177.85 39.28 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.258 1.408 . . . . 0.0 109.779 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 64.23 -1.23 0.74 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.402 2.281 . . . . 0.0 115.448 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -85.97 170.98 11.79 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.473 -1.392 . . . . 0.0 112.862 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.17 62.79 0.49 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 126.163 1.84 . . . . 0.0 109.872 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -55.68 -34.3 64.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.61 -0.709 . . . . 0.0 112.444 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -59.2 -36.76 75.96 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.854 0.752 . . . . 0.0 111.954 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.69 -39.21 10.81 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.61 -44.74 89.6 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.656 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.52 -49.38 26.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.854 0.721 . . . . 0.0 110.491 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -57.47 -31.76 66.29 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.4 -42.68 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.67 -40.96 90.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 123.729 0.681 . . . . 0.0 111.415 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -64.37 -42.41 96.2 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.79 1.295 . . . . 0.0 109.324 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -58.24 -59.66 4.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -59.28 -42.85 92.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.075 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -66.21 -27.76 68.23 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 120.776 1.625 . . . . 0.0 110.557 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.9 -28.88 55.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.421 -1.425 . . . . 0.0 110.37 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -84.39 -47.14 10.99 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.069 1.748 . . . . 0.0 111.928 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.3 p -100.39 -32.09 11.0 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.11 -12.76 68.77 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.904 -1.122 . . . . 0.0 111.36 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.9 mm -66.86 130.58 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 142.52 58.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 118.926 -0.559 . . . . 0.0 111.807 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -135.85 102.11 3.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.2 m -96.9 142.43 28.89 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.185 0.994 . . . . 0.0 108.8 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.95 129.84 58.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -137.39 164.55 28.35 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.43 1.092 . . . . 0.0 108.662 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -133.44 61.51 54.49 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.297 1.039 . . . . 0.0 109.821 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -69.64 155.13 67.15 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.161 2.574 . . . . 0.0 111.64 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -100.61 -0.04 38.35 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.72 18.43 3.55 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -55.97 -23.95 35.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 117.829 -1.081 . . . . 0.0 113.625 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -59.7 -23.71 63.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.109 1.322 . . . . 0.0 112.491 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.38 -30.15 6.66 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.929 0.871 . . . . 0.0 109.407 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -70.43 -28.06 64.75 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.191 -0.943 . . . . 0.0 109.149 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -66.67 -60.61 6.18 Favored Pre-proline 0 CA--C 1.536 0.433 0 O-C-N 119.961 -1.712 . . . . 0.0 108.448 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.06 -25.72 80.53 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.277 1.985 . . . . 0.0 114.716 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.66 -0.63 18.59 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.278 1.031 . . . . 0.0 112.758 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.2 -36.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.85 74.19 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.73 -30.74 70.3 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.893 0.477 . . . . 0.0 110.903 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.0 m -81.43 -14.41 57.12 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.564 1.946 . . . . 0.0 110.919 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.81 56.57 2.32 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.41 -172.48 2.96 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.593 2.357 . . . . 0.0 106.382 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.72 -162.61 14.76 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 120.239 -1.538 . . . . 0.0 113.9 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.53 -179.05 3.36 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.001 3.134 . . . . 0.0 110.33 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -109.29 -24.37 11.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.409 -0.807 . . . . 0.0 112.135 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.9 mt -145.41 148.87 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 tp -132.78 141.34 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -128.97 107.32 9.52 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.875 1.67 . . . . 0.0 107.776 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -152.84 -150.71 0.35 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.945 1.248 . . . . 0.0 113.47 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.15 136.52 32.98 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.589 2.356 . . . . 0.0 110.152 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -48.66 -48.82 39.49 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.441 1.496 . . . . 0.0 112.489 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.45 -5.47 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 129.272 3.029 . . . . 0.0 113.972 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -108.84 -12.18 14.94 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.532 1.133 . . . . 0.0 109.633 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -94.34 -26.01 16.74 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 124.231 1.012 . . . . 0.0 112.304 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -49.97 -41.12 36.49 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.31 -55.79 16.79 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.949 0.785 . . . . 0.0 111.621 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -53.99 -42.48 69.08 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.55 1.14 . . . . 0.0 111.663 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.65 90.3 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 122.843 0.457 . . . . 0.0 111.086 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -44.65 96.72 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.2 m -66.87 -4.38 9.22 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.433 1.493 . . . . 0.0 113.319 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.99 6.66 88.72 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.375 0.988 . . . . 0.0 112.985 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.43 -22.87 64.58 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.6 mt -95.24 133.15 39.44 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.81 155.28 40.6 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -64.35 118.91 9.38 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.8 mm -71.58 165.33 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 122.351 1.072 . . . . 0.0 111.099 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.2 m 71.29 92.85 0.05 OUTLIER Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 129.031 2.932 . . . . 0.0 108.096 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.94 -34.54 10.49 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.463 1.442 . . . . 0.0 109.744 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.57 150.46 36.43 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.501 1.12 . . . . 0.0 109.128 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -57.27 -34.1 68.3 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.472 1.109 . . . . 0.0 112.041 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.24 -27.27 63.83 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.64 1.109 . . . . 0.0 111.898 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.31 -36.64 84.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.277 0.944 . . . . 0.0 109.008 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -59.29 -38.36 79.99 Favored 'General case' 0 C--N 1.343 0.284 0 O-C-N 121.044 -1.035 . . . . 0.0 112.707 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -65.67 -17.8 64.87 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.567 0.747 . . . . 0.0 111.6 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.14 -10.25 58.75 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.53 156.36 40.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.519 1.054 . . . . 0.0 111.962 -178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -70.52 156.17 92.32 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.971 0.908 . . . . 0.0 110.705 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.16 -41.15 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.181 2.587 . . . . 0.0 113.821 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -63.81 -27.62 69.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.038 0.835 . . . . 0.0 110.87 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.05 -28.17 54.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.837 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -70.57 -39.21 74.04 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 118.717 0.69 . . . . 0.0 109.874 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.63 -27.57 68.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.36 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.57 -4.78 36.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.88 12.52 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.605 1.162 . . . . 0.0 111.773 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -65.74 165.27 13.0 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 122.449 1.119 . . . . 0.0 111.547 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -154.42 -171.04 3.72 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.09 1.756 . . . . 0.0 107.123 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -66.23 98.78 0.48 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.171 1.388 . . . . 0.0 109.047 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.49 -74.27 0.42 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.085 1.802 . . . . 0.0 113.433 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.52 166.62 22.31 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.766 0.827 . . . . 0.0 110.735 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mt -100.15 145.88 27.48 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.0 pt -110.19 -25.87 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.29 171.97 18.41 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.01 146.82 62.28 Favored Pre-proline 0 C--O 1.242 0.668 0 C-N-CA 123.529 0.732 . . . . 0.0 110.106 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.3 149.01 44.59 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.885 2.39 . . . . 0.0 110.09 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.5 mm -138.73 -52.06 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.835 2.054 . . . . 0.0 109.421 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.51 150.91 46.99 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.594 1.158 . . . . 0.0 112.671 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.3 t -126.12 118.36 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.436 1.894 . . . . 0.0 107.723 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--O 1.236 0.354 0 C-N-CA 124.371 1.068 . . . . 0.0 108.411 179.651 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.237 0.436 0 C-N-CA 126.559 1.944 . . . . 0.0 109.46 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.457 -0.619 0 CA-C-O 121.497 0.54 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -126.74 -31.88 2.64 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.827 0.851 . . . . 0.0 111.212 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.68 154.81 14.02 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.582 1.083 . . . . 0.0 109.783 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -61.79 -22.61 65.59 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 121.232 -0.917 . . . . 0.0 110.936 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -71.39 -12.41 61.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.567 1.076 . . . . 0.0 111.07 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -108.73 -17.02 14.05 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.973 2.509 . . . . 0.0 111.817 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.2 mm -58.66 -63.01 4.58 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 121.161 -0.962 . . . . 0.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.63 -18.76 37.45 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.773 1.649 . . . . 0.0 111.745 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.71 -49.61 57.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.514 1.126 . . . . 0.0 108.52 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.8 tp -72.1 -30.59 65.23 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.794 0.838 . . . . 0.0 109.781 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.38 -48.02 72.01 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.761 0.824 . . . . 0.0 111.645 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -70.17 -31.12 68.45 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.465 0.306 . . . . 0.0 111.069 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -67.83 -45.05 75.76 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.7 mt -71.32 -30.28 66.03 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.243 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -67.8 -34.51 76.89 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 119.79 1.177 . . . . 0.0 108.14 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.43 -7.69 27.21 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.323 1.049 . . . . 0.0 111.965 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 6.12 3.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.312 1.445 . . . . 0.0 111.614 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.0 -76.42 0.1 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.02 176.09 12.97 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.45 1.1 . . . . 0.0 110.175 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.65 165.1 8.66 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.902 0.858 . . . . 0.0 111.561 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -84.85 -70.09 0.6 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.289 1.436 . . . . 0.0 111.3 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.2 tp -103.22 157.72 16.81 Favored 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 125.893 1.677 . . . . 0.0 113.334 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 92.4 mtp -150.06 118.69 6.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.466 2.306 . . . . 0.0 106.093 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -142.13 155.23 45.32 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.803 0.729 . . . . 0.0 109.281 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -68.06 96.53 0.62 Allowed 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.338 -0.851 . . . . 0.0 111.79 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.51 -10.67 58.18 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.239 1.016 . . . . 0.0 110.806 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -75.79 -29.78 58.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.566 -0.73 . . . . 0.0 112.099 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -99.55 133.0 22.2 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 119.485 1.039 . . . . 0.0 109.491 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.41 -5.39 14.97 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.68 2.92 . . . . 0.0 113.719 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -66.84 -37.62 84.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.524 1.13 . . . . 0.0 110.506 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -75.74 -46.12 32.7 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 122.034 -0.416 . . . . 0.0 112.084 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.9 p -73.96 -17.2 61.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -53.68 -61.28 5.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.69 -3.8 10.98 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.324 2.016 . . . . 0.0 114.111 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.99 -59.24 2.28 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 30.5 pt -61.84 -49.41 84.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 116.977 -1.487 . . . . 0.0 111.708 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -49.36 -8.88 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.277 2.631 . . . . 0.0 115.236 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.75 85.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.399 1.08 . . . . 0.0 111.221 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -67.87 -50.13 58.14 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 177.8 11.96 0.02 OUTLIER Glycine 0 CA--C 1.534 1.265 0 O-C-N 121.251 -0.905 . . . . 0.0 115.154 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.77 131.35 10.43 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 125.869 1.699 . . . . 0.0 111.026 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -146.76 143.32 28.59 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.55 -45.73 13.21 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.23 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -148.69 126.94 12.15 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -76.01 145.88 39.9 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.859 0.754 . . . . 0.0 111.219 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -140.46 116.27 10.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -91.75 -174.81 3.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.347 1.059 . . . . 0.0 108.306 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -56.51 -9.22 0.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.513 1.925 . . . . 0.0 115.185 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -178.9 13.41 0.03 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.208 1.861 . . . . 0.0 112.85 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -132.52 106.2 7.7 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.955 1.378 . . . . 0.0 110.47 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -104.09 125.8 50.71 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.62 110.66 8.28 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -8.61 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.058 0.543 . . . . 0.0 112.446 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -77.53 -31.19 53.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.568 1.147 . . . . 0.0 110.544 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -84.18 87.71 7.18 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 74.7 t -104.57 152.82 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.884 1.674 . . . . 0.0 108.86 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -145.25 24.83 1.88 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.881 1.229 . . . . 0.0 113.766 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.09 -22.56 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 120.796 -1.414 . . . . 0.0 113.013 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -106.27 5.93 30.21 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.125 1.77 . . . . 0.0 111.807 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -59.82 157.13 12.82 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.584 -0.698 . . . . 0.0 110.38 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.92 -34.43 55.21 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.193 0.997 . . . . 0.0 110.755 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.99 -33.01 65.68 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.9 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.45 -49.87 61.74 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.579 1.69 . . . . 0.0 107.743 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -61.85 -41.05 97.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.068 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.1 -46.6 89.93 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.054 0.942 . . . . 0.0 110.216 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.72 -36.72 93.7 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 31.5 tp -75.02 -49.36 20.08 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.998 0.919 . . . . 0.0 113.164 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.7 t -52.95 -33.7 52.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.123 0.969 . . . . 0.0 112.993 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -58.93 -51.91 68.02 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.234 1.379 . . . . 0.0 109.466 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.0 tt -64.57 -46.38 83.02 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.308 1.043 . . . . 0.0 110.264 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.61 -34.45 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 123.751 0.82 . . . . 0.0 110.695 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.605 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.3 OUTLIER -63.57 -33.46 75.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.017 0.826 . . . . 0.0 111.876 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 13.8 mt -71.65 -43.92 65.23 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 44.6 mt -60.18 -41.47 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.605 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.7 OUTLIER -55.83 -30.48 61.48 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.995 -1.066 . . . . 0.0 110.346 178.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -93.3 -5.3 50.03 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.367 1.467 . . . . 0.0 112.093 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? 58.13 18.19 5.09 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.918 2.487 . . . . 0.0 113.891 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -91.2 -13.3 33.1 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 9.1 tpt -92.86 167.13 12.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.934 0.788 . . . . 0.0 111.496 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -76.25 42.69 0.27 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.906 2.882 . . . . 0.0 109.424 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.18 -33.41 75.42 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 126.059 1.744 . . . . 0.0 115.22 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.34 -9.22 57.9 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.487 1.115 . . . . 0.0 112.685 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.3 m -78.17 131.4 37.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.165 1.386 . . . . 0.0 111.036 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -119.04 179.39 4.18 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.411 1.884 . . . . 0.0 107.821 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -52.69 -46.69 67.4 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.816 0.846 . . . . 0.0 113.082 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 54.0 m -63.31 -36.94 85.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.571 0.749 . . . . 0.0 110.785 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 28.0 mm -68.64 -49.94 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 117.78 -1.105 . . . . 0.0 108.512 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.33 -47.82 82.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.999 1.272 . . . . 0.0 111.938 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -56.62 -48.62 77.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.843 0.457 . . . . 0.0 110.164 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.96 -52.39 56.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.55 0.74 . . . . 0.0 110.744 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.71 -43.12 68.76 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.841 1.657 . . . . 0.0 110.75 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -60.41 -39.5 87.58 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.23 -43.84 97.92 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -69.31 -12.09 61.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.915 1.286 . . . . 0.0 112.704 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.69 13.31 70.23 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 120.193 1.36 . . . . 0.0 111.613 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -74.51 -9.06 58.21 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 116.609 2.078 . . . . 0.0 116.609 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.03 157.04 47.96 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 120.345 1.43 . . . . 0.0 110.543 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.41 -35.12 14.56 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.217 1.007 . . . . 0.0 110.368 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -145.05 145.66 31.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.41 1.084 . . . . 0.0 110.369 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.06 155.48 47.02 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 78.2 mt . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.306 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.37 156.13 37.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.273 2.649 . . . . 0.0 110.782 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.497 HG21 ' H ' ' A' ' 255' ' ' SER . 75.3 p -99.48 176.11 5.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.682 1.193 . . . . 0.0 108.722 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -107.79 159.25 16.64 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -55.15 103.52 0.09 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.815 0.846 . . . . 0.0 111.936 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.58 -5.65 63.89 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-O 118.176 -1.347 . . . . 0.0 113.223 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.84 108.32 32.92 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 120.206 2.003 . . . . 0.0 110.48 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.17 131.79 31.72 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.643 1.562 . . . . 0.0 109.334 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.497 ' H ' HG21 ' A' ' 249' ' ' THR . 10.1 p -64.13 160.1 19.03 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.39 1.076 . . . . 0.0 109.928 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -132.75 71.68 78.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 118.348 0.522 . . . . 0.0 110.596 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.43 156.64 65.33 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.831 2.354 . . . . 0.0 111.46 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 . . . . . 0 C--O 1.238 0.48 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.41 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.828 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 11.4 m -144.69 157.15 14.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 118.561 1.181 . . . . 0.0 109.779 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.75 147.69 52.98 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.198 0.999 . . . . 0.0 108.322 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -133.01 127.31 33.85 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.606 1.094 . . . . 0.0 109.277 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -110.26 138.77 46.19 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.344 1.858 . . . . 0.0 106.959 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -145.5 141.06 9.46 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.221 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 67.4 mt -78.48 137.8 21.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -72.65 129.26 37.85 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.43 -15.93 60.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -67.19 -40.7 86.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.095 -0.955 . . . . 0.0 113.071 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.9 m -47.41 148.85 2.14 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 125.048 1.339 . . . . 0.0 113.78 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.96 -56.02 0.23 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.479 2.119 . . . . 0.0 112.479 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -113.7 102.4 10.22 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.176 1.353 . . . . 0.0 110.392 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.63 -16.82 63.45 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 122.024 -0.423 . . . . 0.0 111.794 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -64.62 -38.08 89.77 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.969 0.907 . . . . 0.0 110.017 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.74 -39.69 81.66 Favored 'General case' 0 N--CA 1.461 0.102 0 O-C-N 121.627 -0.67 . . . . 0.0 110.504 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.89 -44.8 68.99 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -32.53 72.31 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.314 -0.85 . . . . 0.0 111.348 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -74.26 -44.75 51.66 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -58.84 -39.31 80.9 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.57 -48.06 76.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.845 -0.597 . . . . 0.0 111.107 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -79.34 -18.61 52.17 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -107.07 -16.79 14.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.645 1.111 . . . . 0.0 113.932 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -136.82 -40.04 0.62 Allowed 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.235 0.925 . . . . 0.0 113.459 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.65 -36.98 65.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.262 0.937 . . . . 0.0 111.076 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 30.5 mt -107.65 63.45 0.62 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.36 1.464 . . . . 0.0 111.79 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 23.5 p -134.15 155.2 50.53 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.35 -37.8 88.68 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.93 -31.87 61.62 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -75.78 -45.81 16.02 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 65.2 mt -61.66 -43.17 99.36 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.805 0.842 . . . . 0.0 109.598 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -56.67 -41.51 77.41 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.882 0.738 . . . . 0.0 110.249 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.5 93.0 Favored 'General case' 0 C--N 1.343 0.292 0 O-C-N 121.246 -0.909 . . . . 0.0 112.463 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 4.5 t -67.14 -41.82 87.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -65.27 -27.72 68.84 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.705 0.764 . . . . 0.0 112.51 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -70.86 -35.49 72.41 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 117.232 -1.366 . . . . 0.0 109.707 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.61 -45.4 21.69 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.595 1.543 . . . . 0.0 111.791 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -138.33 152.3 71.15 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.757 1.223 . . . . 0.0 108.851 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.65 123.43 10.13 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.556 1.504 . . . . 0.0 109.641 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 20.8 mt -79.21 -30.05 43.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 119.016 -0.516 . . . . 0.0 109.703 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.4 -155.64 22.91 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 106.098 -2.801 . . . . 0.0 106.098 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -75.43 171.58 14.0 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.29 157.01 30.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 123.58 1.657 . . . . 0.0 114.163 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.76 -17.32 59.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.852 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.04 104.76 3.1 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 125.672 1.589 . . . . 0.0 109.146 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -57.48 -29.17 64.03 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 20.5 t -63.37 -66.58 0.52 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.686 1.994 . . . . 0.0 110.304 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.93 -17.5 60.55 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -63.96 -32.29 73.78 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -70.15 -11.35 60.83 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.34 -0.85 . . . . 0.0 111.19 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -98.18 -49.15 4.83 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.97 2.108 . . . . 0.0 108.991 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 64.6 mt -69.8 -31.23 69.02 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 121.865 -0.522 . . . . 0.0 110.143 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.17 -3.78 4.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.263 0.938 . . . . 0.0 112.207 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -64.07 -10.99 25.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.553 1.141 . . . . 0.0 110.88 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.23 144.13 35.62 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 126.162 1.785 . . . . 0.0 107.376 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.78 -24.89 46.48 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.344 2.696 . . . . 0.0 114.805 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 16.9 mmm-85 -62.45 -48.21 80.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.733 0.697 . . . . 0.0 109.151 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.1 mp -65.02 -50.48 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.45 -52.25 39.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 124.197 0.935 . . . . 0.0 109.736 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.8 -36.32 76.51 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.393 -0.817 . . . . 0.0 112.404 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 88.2 m -65.56 -38.52 89.81 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 49.7 tpp -76.51 -38.34 55.34 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.351 0.523 . . . . 0.0 109.818 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -58.23 -34.07 70.03 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 123.942 0.897 . . . . 0.0 109.096 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -61.8 -38.45 88.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.042 -0.411 . . . . 0.0 109.898 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.472 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo . . . . . 0 N--CA 1.454 -0.799 0 CA-C-O 122.142 0.809 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -103.07 73.18 1.22 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.5 pt -138.55 146.23 49.93 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.734 0.813 . . . . 0.0 109.076 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.78 -18.43 53.02 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.676 2.917 . . . . 0.0 114.478 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -65.43 -17.7 64.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.522 1.129 . . . . 0.0 109.84 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 85.6 mmm -61.64 -32.5 72.66 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.313 0.645 . . . . 0.0 111.381 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 70.5 m -64.89 -45.24 86.8 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.403 1.001 . . . . 0.0 109.478 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.76 80.23 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -64.79 -51.44 62.21 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.395 1.478 . . . . 0.0 109.794 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -58.6 -45.94 88.08 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.45 1.023 . . . . 0.0 110.727 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -58.91 -47.21 85.79 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -56.19 -57.08 13.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.227 1.011 . . . . 0.0 113.052 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 23.5 t -62.41 -35.59 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.217 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.407 ' NH1' ' HG1' ' A' ' 345' ' ' THR . 7.4 tmm_? -54.08 -50.07 67.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.73 1.605 . . . . 0.0 110.119 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' THR . . . . . 0.407 ' HG1' ' NH1' ' A' ' 344' ' ' ARG . 32.2 m -67.02 -40.88 87.34 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.743 -0.598 . . . . 0.0 110.516 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.77 98.99 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.578 1.081 . . . . 0.0 113.426 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.48 -46.99 95.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 33.1 mm -68.7 -37.12 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 118.544 0.611 . . . . 0.0 110.068 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -57.21 -46.94 82.44 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.245 -0.909 . . . . 0.0 108.942 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.27 -53.77 32.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.417 1.087 . . . . 0.0 110.789 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -57.61 -34.19 69.02 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.469 1.508 . . . . 0.0 114.372 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 52.1 m -97.39 0.48 47.89 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.1 0.56 . . . . 0.0 111.173 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 67.89 12.33 62.17 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.93 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -62.98 -31.49 72.63 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.557 1.179 . . . . 0.0 108.481 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -147.18 152.95 39.24 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 7.5 m -61.52 153.13 28.31 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.283 1.433 . . . . 0.0 108.674 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 11.1 t -58.81 -45.72 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 119.435 1.016 . . . . 0.0 108.386 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.26 -48.56 76.31 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.168 1.387 . . . . 0.0 111.28 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -68.42 -44.92 73.96 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.879 1.271 . . . . 0.0 111.988 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.24 -44.04 83.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.308 0.643 . . . . 0.0 110.58 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.3 mp -70.17 -39.97 74.98 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.555 0.742 . . . . 0.0 110.602 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -57.37 -47.55 81.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.1 -54.29 45.03 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.517 1.527 . . . . 0.0 108.206 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -54.33 -50.82 66.52 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.411 1.485 . . . . 0.0 112.902 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -54.71 -39.68 68.44 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 5.6 m -69.78 -22.98 63.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.162 0.585 . . . . 0.0 111.565 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -78.41 -4.74 49.81 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 120.139 -1.6 . . . . 0.0 112.135 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 5.2 mt -112.68 -29.19 2.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 124.063 0.945 . . . . 0.0 110.252 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 20.4 p -75.7 -23.95 56.2 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.595 1.089 . . . . 0.0 110.445 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 CA-C-O 117.444 -1.265 . . . . 0.0 108.989 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -74.27 115.45 13.79 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 126.411 1.884 . . . . 0.0 107.715 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.63 31.86 1.42 Allowed Glycine 0 CA--C 1.532 1.1 0 N-CA-C 115.284 0.873 . . . . 0.0 115.284 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.39 169.72 20.2 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.217 -1.167 . . . . 0.0 110.829 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.6 mt -150.7 148.92 29.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.573 2.749 . . . . 0.0 105.743 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.5 t -140.7 128.72 23.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.7 mt -108.4 137.4 40.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 125.169 1.388 . . . . 0.0 107.501 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -135.57 129.48 33.03 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.333 1.853 . . . . 0.0 106.364 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -149.05 163.94 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 126.533 1.933 . . . . 0.0 108.106 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -78.55 170.92 15.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.817 0.847 . . . . 0.0 111.727 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.14 -43.24 73.71 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 127.217 2.342 . . . . 0.0 117.006 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -68.51 -13.37 62.28 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.342 1.071 . . . . 0.0 112.631 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -70.63 160.23 32.95 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 123.563 1.649 . . . . 0.0 113.132 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.39 60.09 4.75 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 106.306 -2.718 . . . . 0.0 106.306 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -60.11 -46.69 88.76 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 124.448 1.099 . . . . 0.0 109.693 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -61.82 -49.61 75.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.3 94.79 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.6 tp -68.99 -34.68 75.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.142 0.977 . . . . 0.0 110.972 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.68 74.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.352 -0.833 . . . . 0.0 109.602 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -58.72 -34.35 71.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.381 1.072 . . . . 0.0 111.946 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 t -76.8 -45.12 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.455 1.502 . . . . 0.0 108.291 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.58 -46.83 93.48 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 124.104 0.859 . . . . 0.0 112.222 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -37.22 84.91 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 117.886 -1.054 . . . . 0.0 108.72 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -61.33 -54.27 46.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -53.73 -46.23 70.76 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.552 0.614 . . . . 0.0 110.668 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -65.34 -32.26 73.82 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.044 -1.035 . . . . 0.0 111.0 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -71.93 -28.52 63.53 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.986 0.914 . . . . 0.0 110.879 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -95.98 -16.05 21.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.667 1.187 . . . . 0.0 111.97 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -126.33 -27.87 3.15 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.25 -14.49 63.54 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 120.866 -1.146 . . . . 0.0 113.654 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 mm -70.67 130.58 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 120.078 1.939 . . . . 0.0 106.81 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.435 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -58.11 145.28 37.28 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.82 87.65 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.505 1.122 . . . . 0.0 109.215 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 m -78.35 136.44 37.69 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.26 119.88 47.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -133.34 164.17 27.69 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.016 1.326 . . . . 0.0 107.838 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -120.26 62.15 8.6 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.661 1.585 . . . . 0.0 110.8 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.18 152.13 81.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.915 1.743 . . . . 0.0 110.662 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -120.42 19.84 11.98 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.683 1.593 . . . . 0.0 109.628 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.45 12.64 0.73 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.292 2.237 . . . . 0.0 112.683 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -56.48 -27.93 58.36 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 120.315 -1.49 . . . . 0.0 112.921 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -59.07 -20.03 49.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.29 1.436 . . . . 0.0 113.532 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -120.36 -18.02 8.04 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.756 -0.59 . . . . 0.0 110.948 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -46.7 15.43 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.491 1.116 . . . . 0.0 110.917 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -46.32 -57.38 8.59 Favored Pre-proline 0 N--CA 1.468 0.444 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.628 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.15 -18.9 64.58 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.778 1.652 . . . . 0.0 114.592 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -89.07 -8.68 53.42 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 119.995 1.27 . . . . 0.0 112.987 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.1 -36.01 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 119.191 0.905 . . . . 0.0 111.105 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -28.18 67.99 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.044 -1.035 . . . . 0.0 109.848 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.75 -5.58 4.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.581 1.152 . . . . 0.0 113.248 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.0 t -131.33 7.57 4.58 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.742 2.017 . . . . 0.0 109.585 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.37 5.6 72.89 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 119.955 -1.716 . . . . 0.0 114.881 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.53 -2.48 57.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.216 1.008 . . . . 0.0 110.103 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.55 -172.28 48.38 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.401 1.953 . . . . 0.0 115.778 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -69.82 173.92 10.31 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.188 3.259 . . . . 0.0 111.907 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -108.36 -18.4 13.76 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -141.45 145.37 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.907 1.283 . . . . 0.0 107.664 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 tt -137.06 141.19 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.701 1.6 . . . . 0.0 107.408 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -130.32 113.36 14.28 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.086 1.355 . . . . 0.0 109.608 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -157.68 171.11 20.91 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.722 0.809 . . . . 0.0 109.257 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.42 162.21 25.96 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -52.25 -25.51 9.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.327 1.451 . . . . 0.0 112.2 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -50.22 -65.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.96 1.704 . . . . 0.0 113.64 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -69.55 -18.93 63.69 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 122.151 -0.343 . . . . 0.0 110.291 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -78.03 -20.96 51.46 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.65 -5.05 7.88 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 117.836 -1.535 . . . . 0.0 112.939 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.74 -17.91 0.55 Allowed Glycine 0 CA--C 1.535 1.331 0 CA-C-O 117.26 -1.855 . . . . 0.0 115.816 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -65.09 -33.89 77.11 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.027 2.414 . . . . 0.0 112.865 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.94 -36.39 75.25 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 119.411 1.005 . . . . 0.0 108.316 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -48.04 79.77 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.8 m -65.61 -5.39 8.14 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.128 1.771 . . . . 0.0 112.856 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.29 16.95 79.99 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 126.761 2.124 . . . . 0.0 113.048 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.5 mt -87.63 -18.11 30.35 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.5 mt -96.93 135.44 38.91 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.962 0.801 . . . . 0.0 109.21 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.421 ' HB3' ' HE2' ' A' ' 273' ' ' LYS . . . -81.68 161.32 23.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.274 1.029 . . . . 0.0 111.314 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -68.34 105.46 2.16 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.593 1.157 . . . . 0.0 108.058 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.83 163.67 2.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 118.753 0.706 . . . . 0.0 111.034 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.4 m 114.77 91.21 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.525 1 C-N-CA 132.668 4.387 . . . . 0.0 108.788 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.87 -54.51 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.436 2.091 . . . . 0.0 109.106 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -148.23 152.58 37.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.175 1.79 . . . . 0.0 106.83 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -62.31 -33.76 75.29 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 118.99 -0.529 . . . . 0.0 111.084 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.05 -28.5 52.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.371 0.987 . . . . 0.0 112.306 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -68.93 -30.61 69.1 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.652 0.66 . . . . 0.0 109.989 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -69.1 -41.64 77.18 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.584 1.084 . . . . 0.0 110.707 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.07 -28.37 69.03 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.969 0.908 . . . . 0.0 111.716 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -69.03 -7.71 38.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.85 0.86 . . . . 0.0 112.952 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -117.93 149.58 40.65 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.692 1.133 . . . . 0.0 113.417 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.463 ' HH ' ' HG2' ' A' ' 308' ' ' GLU . 59.5 m-85 -63.54 150.64 89.76 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.582 0.753 . . . . 0.0 110.33 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.54 -43.63 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.657 2.238 . . . . 0.0 112.95 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -61.52 -42.08 98.28 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 121.809 -0.557 . . . . 0.0 110.973 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.69 -28.93 68.1 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -49.16 66.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.84 0.856 . . . . 0.0 109.592 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -16.72 51.43 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.9 -41.83 82.11 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.755 0.707 . . . . 0.0 109.964 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.5 m -86.08 -15.38 10.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.071 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -51.74 149.54 4.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.767 1.167 . . . . 0.0 113.612 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.5 -174.48 3.13 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 126.367 1.867 . . . . 0.0 107.381 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -63.32 100.74 0.26 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.313 0.645 . . . . 0.0 109.323 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.27 -83.04 0.25 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 124.83 1.205 . . . . 0.0 111.05 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.2 173.84 2.32 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.691 1.196 . . . . 0.0 111.661 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.4 mt -106.54 169.83 8.29 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.216 1.007 . . . . 0.0 111.358 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.7 pt -143.48 -28.18 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.03 1.732 . . . . 0.0 114.232 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.1 177.76 10.97 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.659 1.572 . . . . 0.0 111.167 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -122.16 145.65 44.62 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 125.057 1.343 . . . . 0.0 110.469 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.34 149.83 45.78 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.667 2.911 . . . . 0.0 108.171 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.8 mm -125.98 -44.99 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.109 1.364 . . . . 0.0 111.797 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.1 159.34 43.41 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.368 0.531 . . . . 0.0 110.992 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.4 t -122.45 116.01 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.657 1.183 . . . . 0.0 108.018 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 CA--C 1.519 -0.25 0 C-N-CA 125.255 1.422 . . . . 0.0 107.63 178.874 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 71.3 mt . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 . . . . . 0 C--O 1.241 0.644 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.39 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 N--CA 1.452 -0.954 0 N-CA-C 110.303 -0.691 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -134.98 -30.74 1.04 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.838 1.255 . . . . 0.0 112.731 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.404 ' HA ' ' H ' ' A' ' 249' ' ' THR . 14.9 t -158.96 157.73 31.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -65.43 -22.4 66.76 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.815 1.246 . . . . 0.0 112.426 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -69.85 -27.46 64.86 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.912 1.685 . . . . 0.0 110.469 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -89.61 -22.02 22.53 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.217 1.807 . . . . 0.0 111.983 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.6 mm -54.4 -56.02 31.11 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 117.889 -1.053 . . . . 0.0 110.355 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.85 -24.47 46.53 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 CA-C-N 120.398 1.178 . . . . 0.0 112.026 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.49 -55.4 10.35 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.5 tp -64.13 -27.23 68.94 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.529 -1.357 . . . . 0.0 110.244 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.44 -43.95 95.96 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 121.782 -0.574 . . . . 0.0 109.78 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -71.87 -27.45 62.87 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 119.116 -0.469 . . . . 0.0 111.182 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -70.69 -48.24 55.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.3 -33.46 73.21 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.501 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -67.96 -36.91 80.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.12 -27.05 69.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.863 0.756 . . . . 0.0 111.656 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.9 3.22 20.37 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.923 0.889 . . . . 0.0 112.673 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.41 -102.65 0.17 Allowed Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 118.825 0.739 . . . . 0.0 111.585 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -137.5 178.54 7.02 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.397 1.079 . . . . 0.0 110.693 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 p -54.99 157.6 3.18 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.923 1.689 . . . . 0.0 114.208 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.9 -69.14 0.73 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.644 1.578 . . . . 0.0 112.31 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.2 tp -99.2 132.64 44.37 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.029 1.332 . . . . 0.0 110.218 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.2 ttm -142.47 133.26 25.53 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -161.75 172.93 15.36 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.952 1.301 . . . . 0.0 108.954 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -69.77 92.31 0.67 Allowed 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 mt -77.12 -14.66 59.76 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.219 -0.926 . . . . 0.0 110.105 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -68.74 -31.87 71.23 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.051 -1.452 . . . . 0.0 114.742 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -104.05 154.96 37.78 Favored Pre-proline 0 C--N 1.343 0.316 0 CA-C-N 121.661 2.028 . . . . 0.0 114.147 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.16 -15.05 11.76 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.212 1.941 . . . . 0.0 114.158 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -61.04 -39.62 90.49 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.771 1.623 . . . . 0.0 111.805 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -82.28 -33.45 29.1 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -81.75 -15.84 53.0 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.242 0.928 . . . . 0.0 111.319 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -46.34 -58.21 7.02 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.04 -16.94 29.01 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.591 1.527 . . . . 0.0 115.086 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.7 tp -67.4 -62.22 1.53 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 120.262 1.392 . . . . 0.0 107.393 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 6.2 pt -68.63 -24.88 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.494 1.118 . . . . 0.0 112.649 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.62 -18.21 62.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.485 -0.759 . . . . 0.0 111.127 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -56.6 -53.84 52.95 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.655 1.182 . . . . 0.0 111.229 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -61.84 -58.19 8.92 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.26 22.37 0.03 OUTLIER Glycine 0 C--N 1.333 0.376 0 CA-C-O 118.611 -1.105 . . . . 0.0 115.126 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.29 134.11 13.36 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -137.51 140.77 41.34 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.859 1.83 . . . . 0.0 114.022 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.92 81.12 4.15 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.718 2.007 . . . . 0.0 106.992 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 67.22 164.75 0.21 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 127.166 2.186 . . . . 0.0 111.061 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -127.75 138.52 52.79 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.177 0.591 . . . . 0.0 109.51 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.58 119.66 25.19 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.604 1.962 . . . . 0.0 105.77 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -96.96 41.38 1.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.932 2.093 . . . . 0.0 111.521 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 55.33 81.21 0.12 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.743 1.217 . . . . 0.0 110.974 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 101.98 -18.62 51.82 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.728 -1.04 . . . . 0.0 113.301 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -117.54 122.75 44.52 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -131.55 115.99 16.85 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 125.733 1.613 . . . . 0.0 108.431 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -124.54 93.18 3.83 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.28 -7.33 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.524 1.929 . . . . 0.0 112.894 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -75.88 -30.89 59.01 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 120.898 -1.126 . . . . 0.0 109.422 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -81.9 67.84 8.05 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.121 0.968 . . . . 0.0 109.288 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 45.3 t -80.78 156.0 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.62 40.11 1.7 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-O 118.122 -1.377 . . . . 0.0 113.53 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.0 t -95.64 -27.64 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 120.029 1.914 . . . . 0.0 112.692 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -90.72 10.7 24.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.804 1.638 . . . . 0.0 109.995 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -60.31 152.2 25.69 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.808 -1.182 . . . . 0.0 109.311 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.73 -27.22 62.79 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.972 0.509 . . . . 0.0 111.7 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.98 -40.16 44.31 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 123.566 0.603 . . . . 0.0 112.286 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.1 -51.14 70.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -60.31 -42.83 96.38 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.561 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.41 -46.51 86.3 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.836 0.744 . . . . 0.0 110.943 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -72.62 -29.54 65.48 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 119.462 -0.632 . . . . 0.0 113.944 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 18.2 tp -80.21 -39.88 28.23 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.2 t -57.83 -34.16 69.39 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.85 0.75 . . . . 0.0 109.885 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -59.46 -48.12 82.86 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.58 0.627 . . . . 0.0 109.852 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.57 -45.53 88.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.362 0.665 . . . . 0.0 109.843 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.03 -29.4 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.148 0.579 . . . . 0.0 110.26 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -62.25 -39.25 92.24 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.085 -1.009 . . . . 0.0 112.387 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.5 mt -70.92 -43.47 68.16 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 55.4 mt -64.06 -39.84 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -52.27 -46.6 65.9 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.06 -1.025 . . . . 0.0 108.849 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -80.66 -0.98 40.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.093 2.157 . . . . 0.0 113.82 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.1 mptt 57.58 4.64 0.25 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.671 2.388 . . . . 0.0 115.424 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -71.57 -31.74 67.3 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.686 -0.634 . . . . 0.0 112.097 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.5 tpt -69.01 163.31 24.93 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 118.554 0.616 . . . . 0.0 109.97 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -91.34 52.18 2.05 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.51 -11.27 1.87 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.979 2.512 . . . . 0.0 115.606 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -102.81 0.23 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.679 0.791 . . . . 0.0 111.921 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 85.9 m -74.19 124.7 26.86 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.879 1.272 . . . . 0.0 110.908 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.61 177.31 4.88 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -53.14 -45.94 68.61 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.522 0.677 . . . . 0.0 112.268 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.5 m -63.88 -29.41 70.59 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.787 2.435 . . . . 0.0 112.577 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 77.0 mt -81.35 -49.11 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.77 72.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.09 -45.8 93.22 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.699 0.681 . . . . 0.0 111.205 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.15 -55.65 31.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.55 -38.15 77.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.548 0.739 . . . . 0.0 111.761 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -61.26 -46.55 89.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -64.69 -35.76 82.08 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -68.46 -18.93 64.52 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.951 -1.093 . . . . 0.0 111.735 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.88 16.89 66.69 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -86.81 -8.13 57.61 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 35.1 p -113.33 136.97 52.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.731 1.612 . . . . 0.0 106.71 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.07 -21.39 46.83 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.288 -0.883 . . . . 0.0 111.081 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -164.99 170.05 15.65 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.592 -0.692 . . . . 0.0 109.721 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 4.4 t -162.95 -178.44 6.09 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.486 1.914 . . . . 0.0 106.498 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 C--N 1.324 -0.523 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 178.829 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--O 1.239 0.527 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.19 150.36 87.67 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.114 1.876 . . . . 0.0 110.793 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 255' ' ' SER . 57.4 p -129.51 165.57 21.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.855 2.062 . . . . 0.0 110.234 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -85.29 159.86 19.96 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.136 0.88 . . . . 0.0 109.176 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -49.81 103.54 0.05 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.284 1.434 . . . . 0.0 113.287 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.17 1.52 90.49 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 117.225 -1.875 . . . . 0.0 115.279 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.26 122.19 11.54 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 121.39 2.595 . . . . 0.0 113.437 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.95 147.83 85.24 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.149 1.9 . . . . 0.0 111.374 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.422 ' H ' HG23 ' A' ' 249' ' ' THR . 48.0 t -64.13 152.41 40.63 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.804 1.241 . . . . 0.0 109.426 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -134.21 77.68 60.3 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.365 1.466 . . . . 0.0 107.693 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -82.62 -175.37 2.43 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.298 3.332 . . . . 0.0 111.437 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 123.621 0.768 . . . . 0.0 108.957 177.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.715 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 75.4 t -135.22 112.04 13.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.582 0.706 . . . . 0.0 109.448 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.91 126.82 28.89 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 12.5 m -117.32 164.56 14.64 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.215 1.006 . . . . 0.0 110.933 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -134.27 135.54 42.95 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.693 1.597 . . . . 0.0 107.495 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -127.42 166.54 20.11 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 62.6 mt -114.19 133.35 60.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.07 122.97 23.51 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.23 -15.07 63.43 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.197 -1.382 . . . . 0.0 114.641 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -76.63 -14.02 60.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.649 1.568 . . . . 0.0 114.373 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 36.5 m -61.98 154.24 69.48 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 123.838 0.855 . . . . 0.0 109.361 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.04 -58.5 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.967 1.778 . . . . 0.0 110.914 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -118.15 100.26 7.41 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.989 1.316 . . . . 0.0 108.254 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -59.0 -15.77 14.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.787 0.435 . . . . 0.0 112.139 178.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -59.97 -34.19 72.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.391 1.476 . . . . 0.0 110.105 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.9 mt -57.69 -44.03 85.55 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.58 -37.05 63.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.139 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -35.43 79.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.026 0.83 . . . . 0.0 109.651 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -69.97 -55.19 10.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.947 -0.549 . . . . 0.0 109.727 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -52.19 -46.51 65.6 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.049 0.841 . . . . 0.0 111.58 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.4 tt -64.63 -40.82 96.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -90.11 -3.9 57.64 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -105.96 -23.68 12.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.051 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -143.24 -36.72 0.37 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.901 1.228 . . . . 0.0 114.017 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.14 -32.7 71.26 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.105 1.321 . . . . 0.0 113.678 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.57 51.31 0.94 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.333 1.853 . . . . 0.0 110.242 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 47.7 p -120.55 163.13 18.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.26 -39.26 92.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -70.97 -41.91 70.4 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.269 0.628 . . . . 0.0 111.438 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.6 67.12 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 78.9 mt -67.62 -43.16 81.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.93 -44.5 94.3 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.2 -41.57 88.84 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.343 1.057 . . . . 0.0 113.606 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 92.9 t -76.84 -36.29 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -66.82 -36.41 82.3 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -66.96 -32.91 74.48 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.729 -0.607 . . . . 0.0 111.055 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.34 -50.49 15.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.517 1.127 . . . . 0.0 110.585 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -141.79 150.94 58.47 Favored Pre-proline 0 N--CA 1.47 0.535 0 O-C-N 121.045 -1.034 . . . . 0.0 109.299 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.01 115.77 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.202 2.602 . . . . 0.0 110.777 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 14.4 mt -84.0 -31.93 25.23 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.673 -0.642 . . . . 0.0 111.54 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 93.02 -146.91 18.34 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 106.343 -2.703 . . . . 0.0 106.343 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.66 173.28 11.5 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.01 153.34 38.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 123.193 1.473 . . . . 0.0 113.475 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.97 -30.92 62.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.914 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 58.7 tp -66.29 104.93 1.3 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.43 1.892 . . . . 0.0 107.968 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -56.66 -23.05 38.91 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.662 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 40.1 m -72.38 -61.73 1.69 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.909 0.777 . . . . 0.0 110.825 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -71.5 -19.19 62.23 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.102 0.864 . . . . 0.0 112.769 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.463 ' HG2' ' HH ' ' A' ' 90' ' ' TYR . 44.6 tp10 -63.62 -31.37 72.51 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -67.95 -15.2 63.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.364 0.984 . . . . 0.0 111.264 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.471 ' HA ' ' HE3' ' A' ' 313' ' ' LYS . 29.3 mm-40 -94.71 -48.47 6.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.259 1.424 . . . . 0.0 108.264 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 7.2 mt -64.65 -41.25 96.25 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.36 -0.55 0.59 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 310' ' ' GLU . 90.6 mttt -67.58 -13.51 62.13 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.376 1.07 . . . . 0.0 111.835 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.0 151.21 68.6 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 119.756 1.162 . . . . 0.0 109.711 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.64 -23.8 63.28 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.095 2.53 . . . . 0.0 113.84 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -61.57 -27.99 69.02 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.661 0.664 . . . . 0.0 110.551 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.2 mp -91.08 -52.32 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -48.09 -50.37 28.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.905 0.753 . . . . 0.0 110.679 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.25 -32.52 71.22 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 13.6 m -68.91 -41.04 78.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.492 1.042 . . . . 0.0 108.21 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.8 tpp -69.53 -41.57 75.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.843 -0.599 . . . . 0.0 109.457 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -53.35 -43.31 67.63 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -58.68 -46.66 86.75 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.36 1.064 . . . . 0.0 109.268 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 123.424 0.69 . . . . 0.0 111.433 178.531 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 N--CA 1.462 -0.339 0 N-CA-C 113.985 0.725 . . . . 0.0 113.985 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -116.4 76.25 1.01 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.607 1.563 . . . . 0.0 108.925 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.64 147.69 49.97 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.995 1.318 . . . . 0.0 110.922 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.46 -18.67 33.55 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.497 2.131 . . . . 0.0 111.799 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -72.49 -23.02 60.97 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 120.921 -1.112 . . . . 0.0 109.09 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -40.45 83.94 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.518 1.508 . . . . 0.0 109.42 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 p -69.0 -34.25 74.98 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.383 -0.823 . . . . 0.0 109.242 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -69.63 -42.64 74.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -53.84 -54.56 36.74 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 126.557 1.943 . . . . 0.0 109.849 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -60.89 -45.66 93.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.579 0.627 . . . . 0.0 110.084 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -63.15 -26.72 68.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.99 -60.87 2.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.702 1.201 . . . . 0.0 109.41 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -24.71 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.353 -0.842 . . . . 0.0 111.795 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 26.7 ttt-85 -56.71 -27.65 59.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.356 1.062 . . . . 0.0 110.788 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 1.5 m -97.79 -37.92 9.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.48 -48.3 66.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.874 0.761 . . . . 0.0 112.66 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.09 -56.88 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 37.4 mm -58.07 -36.5 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.289 0.635 . . . . 0.0 110.265 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -56.65 -48.99 76.35 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.843 -1.161 . . . . 0.0 110.094 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.42 -42.42 59.21 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.433 -0.318 . . . . 0.0 111.337 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -59.72 -37.14 78.09 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.468 0.707 . . . . 0.0 112.079 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.0 m -86.85 -7.72 57.96 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.148 0.979 . . . . 0.0 109.64 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 75.99 17.62 79.94 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 118.905 0.775 . . . . 0.0 113.018 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -73.3 -30.71 63.57 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.151 0.981 . . . . 0.0 110.699 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -150.75 166.45 30.42 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.032 0.833 . . . . 0.0 110.519 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.9 m -71.91 152.72 42.35 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.0 t -52.37 -56.19 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.455 1.102 . . . . 0.0 108.306 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.66 -44.73 77.5 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 124.777 1.231 . . . . 0.0 113.461 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -71.97 -36.49 69.85 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.649 0.659 . . . . 0.0 111.964 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.11 -35.25 80.14 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 10.7 tp -73.07 -42.48 63.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.949 1.699 . . . . 0.0 110.673 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -58.29 -52.86 63.82 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.461 1.504 . . . . 0.0 108.095 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -49.87 -56.73 9.35 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 126.283 1.833 . . . . 0.0 108.916 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.94 -48.61 80.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.934 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -57.39 -37.04 72.07 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.9 m -62.66 -43.97 97.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.407 0.683 . . . . 0.0 110.069 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 45.4 mtt-85 -57.97 -27.7 63.68 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.445 -0.784 . . . . 0.0 111.563 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.7 mt -86.12 -39.28 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.986 0.914 . . . . 0.0 110.459 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 22.4 p -70.17 -31.1 68.42 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.518 1.054 . . . . 0.0 112.434 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.541 1.537 . . . . 0.0 110.855 -178.787 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 123.353 1.549 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -71.94 107.24 4.58 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.129 1.772 . . . . 0.0 108.647 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.62 22.64 3.01 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 116.063 1.185 . . . . 0.0 116.063 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -136.43 170.91 15.27 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 119.218 1.509 . . . . 0.0 110.19 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.0 mt -148.38 152.87 37.76 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 128.695 2.798 . . . . 0.0 107.63 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.75 149.65 16.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.3 mt -128.82 120.69 52.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 126.893 2.077 . . . . 0.0 105.95 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -119.2 114.72 22.87 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.533 1.133 . . . . 0.0 109.124 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.7 mt -122.92 164.58 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.962 1.305 . . . . 0.0 108.074 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -84.11 4.43 30.35 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.89 175.68 49.29 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 59.51 22.42 10.99 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.234 1.017 . . . . 0.0 111.359 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -125.64 166.08 17.39 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 126.655 1.982 . . . . 0.0 108.041 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.34 47.21 2.63 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 119.062 -0.855 . . . . 0.0 114.791 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -50.83 -38.86 51.36 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.036 0.934 . . . . 0.0 113.08 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -58.57 -47.23 84.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.012 0.823 . . . . 0.0 110.303 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.96 -38.02 93.77 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.37 -35.64 78.01 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.752 0.821 . . . . 0.0 111.164 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.26 -37.44 64.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.376 0.67 . . . . 0.0 110.23 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -67.33 -30.05 69.78 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.117 0.872 . . . . 0.0 111.963 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 t -69.26 -43.94 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.58 -41.17 94.21 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -60.21 -45.73 92.18 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -58.25 -55.04 40.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -52.19 -55.6 20.02 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 117.892 0.315 . . . . 0.0 110.927 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.93 -35.68 73.5 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.144 -0.973 . . . . 0.0 111.191 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -69.06 -28.34 66.44 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 120.931 -1.106 . . . . 0.0 111.285 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -98.53 -5.86 31.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.591 1.156 . . . . 0.0 111.519 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.1 p -134.96 -35.46 0.85 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.44 -11.5 63.28 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.356 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.9 mm -67.58 137.27 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.451 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -70.64 139.8 51.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 117.652 -1.166 . . . . 0.0 109.727 -179.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.0 t -135.18 121.12 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.5 m -114.14 145.15 42.04 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.831 2.052 . . . . 0.0 110.87 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -137.24 128.52 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.84 1.656 . . . . 0.0 107.319 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -140.55 160.64 39.57 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.639 0.776 . . . . 0.0 111.68 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -127.07 68.06 71.35 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.214 1.405 . . . . 0.0 112.559 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.83 168.72 20.54 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 124.812 3.675 . . . . 0.0 111.267 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -110.8 8.11 22.25 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.709 1.604 . . . . 0.0 110.758 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.67 11.79 4.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -52.07 -30.74 27.22 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -63.7 -20.45 65.73 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.874 2.07 . . . . 0.0 113.438 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -117.82 -24.32 7.2 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 123.841 0.856 . . . . 0.0 109.498 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -74.76 -46.09 39.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.795 -1.097 . . . . 0.0 110.886 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -50.73 -57.44 13.42 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 120.296 1.407 . . . . 0.0 110.199 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.46 -0.19 5.54 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 121.767 1.644 . . . . 0.0 114.558 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -112.05 -0.15 15.77 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.753 1.221 . . . . 0.0 111.561 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 t -130.59 -42.63 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.349 1.06 . . . . 0.0 108.657 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.33 73.73 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 120.995 -1.066 . . . . 0.0 108.759 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.01 -13.36 4.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.021 1.328 . . . . 0.0 113.266 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.2 p -118.95 -0.76 11.11 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.91 1.232 . . . . 0.0 111.445 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.31 15.15 64.91 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.33 0.967 . . . . 0.0 111.56 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -106.79 -6.01 18.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.649 1.224 . . . . 0.0 113.633 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.01 -173.56 32.34 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.896 1.236 . . . . 0.0 115.228 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -70.78 179.29 4.37 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 124.205 3.27 . . . . 0.0 111.435 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -105.57 -20.18 13.55 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 121.264 -0.898 . . . . 0.0 113.045 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 mt -140.92 149.85 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.5 tt -128.71 148.88 33.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 126.293 1.837 . . . . 0.0 106.695 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -138.87 99.3 3.75 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.752 1.221 . . . . 0.0 109.785 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -153.11 177.81 10.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.133 0.968 . . . . 0.0 111.667 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.52 134.33 53.16 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.781 1.632 . . . . 0.0 107.345 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -52.63 -27.84 18.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 129.01 2.924 . . . . 0.0 112.279 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.95 -26.4 65.95 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.427 0.691 . . . . 0.0 109.717 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -102.73 12.48 36.23 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 127.507 2.323 . . . . 0.0 110.852 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -108.02 -30.83 8.23 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.825 1.648 . . . . 0.0 111.227 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.8 -10.48 38.64 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.801 -1.0 . . . . 0.0 113.865 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.27 -47.59 3.26 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 119.928 1.864 . . . . 0.0 109.229 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -55.31 -46.74 76.26 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.709 1.604 . . . . 0.0 111.68 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.14 93.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.734 1.152 . . . . 0.0 109.673 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.91 1.09 4.81 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.972 1.709 . . . . 0.0 111.149 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -122.68 2.32 9.5 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.305 2.642 . . . . 0.0 109.511 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.62 -1.03 68.29 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 125.656 1.598 . . . . 0.0 112.401 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -69.04 -34.3 74.99 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.566 1.183 . . . . 0.0 112.848 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.5 mt -89.15 127.88 35.75 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.44 170.34 16.07 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.692 0.797 . . . . 0.0 112.602 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -60.11 117.31 4.97 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -70.96 166.19 2.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 m -39.58 113.96 0.9 Allowed Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.265 1.826 . . . . 0.0 110.955 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.77 -53.32 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.434 2.756 . . . . 0.0 113.364 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -62.26 116.75 5.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.427 1.108 . . . . 0.0 111.731 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -54.33 -28.59 43.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.479 1.512 . . . . 0.0 111.971 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.82 -32.5 67.66 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.861 1.209 . . . . 0.0 112.786 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -68.98 -39.44 79.39 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -66.22 -37.73 86.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.722 1.209 . . . . 0.0 110.329 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.8 -13.4 59.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.311 1.845 . . . . 0.0 112.186 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -76.97 -9.65 58.84 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.757 -1.214 . . . . 0.0 110.591 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.9 mt -118.29 157.51 26.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.529 1.932 . . . . 0.0 108.614 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.402 ' CD1' ' HG2' ' A' ' 305' ' ' LYS . 48.9 m-85 -64.93 152.71 90.28 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 119.118 0.872 . . . . 0.0 109.497 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.53 -35.72 9.94 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.763 2.308 . . . . 0.0 114.531 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -64.18 -32.82 74.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.863 0.756 . . . . 0.0 110.902 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.77 -21.77 66.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.301 1.04 . . . . 0.0 110.401 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -77.43 -32.77 54.82 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.413 -0.804 . . . . 0.0 109.827 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.81 -4.03 3.97 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.493 1.517 . . . . 0.0 111.083 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.62 -7.0 22.16 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.032 2.133 . . . . 0.0 111.995 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.48 11.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.997 1.319 . . . . 0.0 113.179 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -69.32 169.44 12.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 122.43 1.109 . . . . 0.0 112.15 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -159.7 168.1 26.77 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 127.868 2.467 . . . . 0.0 105.469 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -60.95 108.02 0.8 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.876 1.67 . . . . 0.0 111.091 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.34 -83.39 0.87 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.62 1.105 . . . . 0.0 111.366 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.1 173.43 6.58 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.84 0.856 . . . . 0.0 111.788 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.2 157.46 18.77 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.9 pt -119.53 -26.23 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.706 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.39 178.16 8.9 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.195 0.998 . . . . 0.0 109.177 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.63 148.66 70.32 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.75 0.82 . . . . 0.0 109.864 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.71 142.24 43.26 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.569 2.846 . . . . 0.0 108.917 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.0 mm -129.9 -49.09 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 124.656 1.182 . . . . 0.0 111.422 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.01 147.08 46.52 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.033 0.833 . . . . 0.0 109.614 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.24 104.82 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 102.005 -3.331 . . . . 0.0 102.005 177.659 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 CA--C 1.53 0.197 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.0 p90 . . . . . 0 C--N 1.325 -0.494 0 C-N-CA 125.483 1.513 . . . . 0.0 108.127 -179.824 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.453 -0.853 0 N-CA-C 107.575 -1.74 . . . . 0.0 107.575 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -113.57 -10.07 13.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.047 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.7 t -153.86 157.35 39.16 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.15 1.341 . . . . 0.0 110.98 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -72.98 -24.73 60.81 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.675 -0.641 . . . . 0.0 111.261 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -70.92 -17.04 62.7 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.0 0.818 . . . . 0.0 109.956 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -86.99 -24.34 24.72 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 125.513 1.525 . . . . 0.0 110.243 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 33.7 mm -52.69 -58.97 9.88 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.894 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.77 -22.32 27.61 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 CA-C-N 120.253 1.126 . . . . 0.0 112.164 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.99 -31.05 62.8 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.271 1.428 . . . . 0.0 111.834 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.6 tp -91.89 -31.37 15.7 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.184 1.393 . . . . 0.0 110.134 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -58.57 -44.17 89.64 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.671 0.748 . . . . 0.0 110.675 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.416 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 8.6 ptmm? -65.17 -30.38 71.28 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.967 0.907 . . . . 0.0 112.316 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -77.43 -42.35 36.41 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 20.3 mt -72.58 -31.67 65.39 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.534 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.89 -34.88 79.14 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.81 -13.02 61.89 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.02 -5.4 8.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.052 0.941 . . . . 0.0 112.471 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -173.31 -89.46 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 118.868 0.758 . . . . 0.0 112.885 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.409 ' HE3' ' OE2' ' A' ' 221' ' ' GLU . 62.2 mttm -146.22 -177.45 5.62 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.515 1.526 . . . . 0.0 109.082 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 p -57.78 166.97 1.25 Allowed 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.839 0.856 . . . . 0.0 111.508 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.83 -76.51 0.46 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.5 tp -90.18 133.27 35.0 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.464 1.506 . . . . 0.0 110.207 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 53.9 ttm -139.82 107.17 5.53 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.84 160.85 37.3 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.364 1.465 . . . . 0.0 109.196 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -67.93 120.09 13.64 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.106 0.962 . . . . 0.0 110.994 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.3 mt -106.97 -9.76 16.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.659 1.984 . . . . 0.0 111.909 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -77.67 -17.61 57.52 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.337 -0.852 . . . . 0.0 111.733 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -109.57 147.44 36.08 Favored Pre-proline 0 N--CA 1.469 0.486 0 C-N-CA 124.467 1.107 . . . . 0.0 109.347 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -82.07 -18.26 7.6 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.832 2.354 . . . . 0.0 114.138 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -58.94 -37.6 77.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.445 1.021 . . . . 0.0 111.974 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -71.54 -43.67 66.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.794 0.838 . . . . 0.0 112.445 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.2 p -80.9 -14.18 58.24 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.071 0.549 . . . . 0.0 112.16 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -54.99 -57.3 20.23 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.657 -1.164 . . . . 0.0 113.509 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.5 -26.38 81.81 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 121.763 1.665 . . . . 0.0 113.332 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.82 -56.02 9.33 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.4 pt -67.6 -25.71 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.144 0.884 . . . . 0.0 111.685 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.77 -4.1 25.8 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.283 -0.886 . . . . 0.0 110.912 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.6 -54.49 42.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.698 0.799 . . . . 0.0 110.534 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -55.15 -61.23 2.46 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.105 0.479 . . . . 0.0 111.121 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.26 6.41 0.03 OUTLIER Glycine 0 CA--C 1.524 0.6 0 CA-C-O 118.47 -1.183 . . . . 0.0 115.261 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -53.37 133.08 42.76 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 118.277 1.038 . . . . 0.0 112.155 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -142.66 120.41 11.89 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.131 0.967 . . . . 0.0 110.681 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.7 85.57 5.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 66.54 165.84 0.2 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.6 1.56 . . . . 0.0 108.445 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -132.54 159.25 40.01 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 120.819 -1.175 . . . . 0.0 109.258 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -149.09 104.62 3.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.284 -1.746 . . . . 0.0 106.284 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.1 -174.79 0.84 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -52.5 -35.79 53.82 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.061 -1.024 . . . . 0.0 110.986 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -145.29 6.89 1.54 Allowed Glycine 0 CA--C 1.533 1.212 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.756 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -122.43 121.48 36.73 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 120.999 2.4 . . . . 0.0 109.275 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.48 123.6 50.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -146.36 83.49 1.61 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -0.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -83.5 -25.76 30.8 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 119.67 -1.894 . . . . 0.0 107.774 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -96.0 103.78 15.68 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 127.727 2.411 . . . . 0.0 106.798 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.7 t -142.95 165.12 16.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -140.63 35.71 1.84 Allowed Glycine 0 CA--C 1.533 1.163 0 N-CA-C 115.025 0.77 . . . . 0.0 115.025 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.0 t -60.11 -17.04 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 119.436 1.618 . . . . 0.0 114.617 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.273 0.0 OUTLIER -117.86 20.49 13.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.554 1.541 . . . . 0.0 111.255 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -69.71 159.04 34.25 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 120.601 -1.312 . . . . 0.0 108.176 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.34 -30.18 62.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.549 0.74 . . . . 0.0 112.422 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.23 -41.11 94.95 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.511 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.1 -52.92 56.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.918 0.487 . . . . 0.0 109.938 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -62.64 -36.93 84.41 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 117.921 -1.038 . . . . 0.0 111.656 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.57 -49.71 76.45 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.24 0.927 . . . . 0.0 110.234 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.85 -15.12 75.91 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.308 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 44.0 tp -89.12 -50.21 6.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.195 0.998 . . . . 0.0 110.996 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.6 t -55.61 -38.63 69.71 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.824 -1.084 . . . . 0.0 111.856 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -54.6 -54.52 40.26 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.173 1.351 . . . . 0.0 111.028 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 9.9 tt -62.01 -49.73 74.9 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.687 1.195 . . . . 0.0 109.563 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.26 -29.23 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.105 0.962 . . . . 0.0 110.601 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.494 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.9 OUTLIER -67.35 -37.03 82.6 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 119.043 0.838 . . . . 0.0 111.476 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.57 -39.55 88.53 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 37.3 mt -61.95 -48.61 87.77 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -51.39 -40.18 58.73 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.731 1.612 . . . . 0.0 111.567 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -84.77 2.23 43.1 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.969 1.308 . . . . 0.0 112.745 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? 48.32 46.72 20.16 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.776 2.03 . . . . 0.0 111.396 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 -2.31 9.18 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.7 ttp -114.49 153.52 29.84 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.28 49.92 0.73 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.453 1.501 . . . . 0.0 110.671 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.63 -11.37 11.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.481 2.712 . . . . 0.0 115.046 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -91.72 -13.51 31.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.979 1.711 . . . . 0.0 110.815 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.7 m -61.31 162.14 8.14 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.524 1.929 . . . . 0.0 108.562 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.77 -174.19 4.55 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -56.17 -45.63 79.63 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.865 0.466 . . . . 0.0 111.001 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.3 m -64.39 -44.21 92.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.984 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 22.5 mm -62.34 -51.9 66.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -56.26 -59.09 5.45 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.516 1.126 . . . . 0.0 111.829 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -55.7 -40.67 72.72 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.345 0.658 . . . . 0.0 111.99 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.09 -53.82 39.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.09 -35.52 71.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.548 0.739 . . . . 0.0 111.317 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.05 -48.96 74.22 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.62 -27.75 68.88 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.075 0.55 . . . . 0.0 110.131 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -76.49 -10.97 59.79 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.719 -1.238 . . . . 0.0 111.431 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.87 24.7 73.53 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.409 ' OE2' ' HE3' ' A' ' 144' ' ' LYS . 5.4 mm-40 -93.68 -30.26 15.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 69.9 p -87.77 146.68 25.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.996 0.816 . . . . 0.0 110.386 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -85.26 -31.25 23.21 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -160.03 166.71 29.45 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.44 0.564 . . . . 0.0 112.396 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 6.3 t -147.39 161.99 39.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.081 1.352 . . . . 0.0 107.889 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.9 mt . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -179.644 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.237 0.409 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.69 146.89 80.43 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.6 1.533 . . . . 0.0 109.257 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 255' ' ' SER . 20.4 p -129.32 156.24 44.33 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.181 0.992 . . . . 0.0 108.822 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -81.33 155.26 26.09 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.103 -0.998 . . . . 0.0 108.896 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.71 119.98 7.06 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.145 -0.972 . . . . 0.0 112.523 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.39 5.52 63.33 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.667 1.603 . . . . 0.0 113.982 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -148.12 115.46 4.0 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 119.907 1.854 . . . . 0.0 114.379 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.86 141.98 15.48 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.17 2.58 . . . . 0.0 112.574 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 249' ' ' THR . 58.8 m -59.88 140.12 56.87 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 84.17 15.01 Favored Pre-proline 0 N--CA 1.466 0.329 0 O-C-N 121.802 -0.561 . . . . 0.0 109.929 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -77.05 -175.57 2.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.762 2.308 . . . . 0.0 110.259 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 . . . . . 0 C--O 1.236 0.38 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.792 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 106.355 -2.698 . . . . 0.0 106.355 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.49 176.55 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.196 0.998 . . . . 0.0 108.365 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 5.7 tt -106.42 151.62 24.68 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.7 m -140.49 169.5 17.54 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.571 0.623 . . . . 0.0 112.18 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -132.54 137.83 47.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.835 1.654 . . . . 0.0 107.082 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.35 134.97 7.46 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.092 0.87 . . . . 0.0 111.69 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 54.2 mt -75.44 136.72 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.298 1.049 . . . . 0.0 110.431 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . 0.401 HD22 ' HB3' ' A' ' 269' ' ' ALA . 23.5 t30 -71.91 123.61 23.08 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.22 -28.64 64.34 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.69 -0.671 . . . . 0.0 112.166 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . 0.401 ' HB3' HD22 ' A' ' 267' ' ' ASN . . . -69.37 -8.42 46.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 59.9 m -64.61 163.15 29.34 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.267 1.027 . . . . 0.0 108.285 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -74.16 -56.58 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.653 1.569 . . . . 0.0 110.421 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -128.86 102.47 6.55 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -17.51 16.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -59.42 -31.58 69.4 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.553 0.741 . . . . 0.0 110.721 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 98.8 mt -60.36 -43.34 96.6 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.104 -0.998 . . . . 0.0 109.777 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.38 -43.22 41.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.739 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -34.79 75.95 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.675 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -73.41 -52.75 12.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -52.55 -50.98 61.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.059 0.845 . . . . 0.0 112.826 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.6 tt -62.35 -20.12 64.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -111.88 -8.9 14.08 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -97.3 -31.95 12.15 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.937 1.244 . . . . 0.0 112.336 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -133.18 -37.86 0.97 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.048 0.84 . . . . 0.0 113.115 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.5 -25.47 67.28 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 63.3 mt -112.11 50.53 0.85 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.598 1.159 . . . . 0.0 111.2 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 50.8 p -125.37 157.89 35.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -60.49 -44.19 96.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -65.0 -38.65 91.65 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.093 0.957 . . . . 0.0 111.883 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.57 -44.84 56.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 16.2 mt -65.35 -49.87 67.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.879 0.839 . . . . 0.0 108.852 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.18 -40.26 76.98 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.824 1.25 . . . . 0.0 111.719 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.26 74.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 118.99 0.814 . . . . 0.0 112.692 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 20.5 t -79.25 -37.95 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.203 0.601 . . . . 0.0 109.846 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -63.78 -30.43 71.53 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.607 0.718 . . . . 0.0 111.904 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -64.55 -37.18 86.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.395 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.87 -42.49 39.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.43 1.013 . . . . 0.0 111.673 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 297' ' ' LYS . 8.2 mmpt? -145.52 148.1 35.79 Favored Pre-proline 0 N--CA 1.464 0.274 0 C-N-CA 123.716 0.806 . . . . 0.0 109.361 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.6 126.95 15.54 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.378 2.052 . . . . 0.0 108.778 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 70.2 mt -102.36 -9.9 19.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 77.38 -155.97 44.4 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.46 170.59 15.39 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 23.3 m -130.32 156.71 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 121.039 -1.038 . . . . 0.0 109.569 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.14 -28.71 42.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.147 0.979 . . . . 0.0 110.96 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.19 106.91 1.78 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.471 1.109 . . . . 0.0 108.624 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.402 ' HG2' ' CD1' ' A' ' 90' ' ' TYR . 18.0 mtmt -52.89 -40.8 63.78 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.391 0.676 . . . . 0.0 112.335 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 5.1 m -53.48 -29.84 37.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.076 1.75 . . . . 0.0 112.768 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -112.75 -12.26 13.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.629 0.649 . . . . 0.0 110.196 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -64.36 -42.19 96.32 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.9 -23.37 66.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.042 0.937 . . . . 0.0 112.493 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -90.35 -44.76 9.46 Favored 'General case' 0 N--CA 1.46 0.058 0 C-N-CA 124.417 1.087 . . . . 0.0 109.014 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 6.3 mt -62.86 -35.01 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.245 -0.91 . . . . 0.0 109.888 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.02 -6.54 6.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.259 1.424 . . . . 0.0 113.242 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -68.83 -14.65 63.16 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.26 1.024 . . . . 0.0 111.377 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.93 137.51 20.12 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -14.76 37.08 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.233 2.622 . . . . 0.0 110.762 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.55 -48.05 70.92 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.186 0.994 . . . . 0.0 108.608 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.9 mp -67.97 -52.63 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.58 -49.49 26.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.92 0.888 . . . . 0.0 112.349 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.02 -11.01 2.95 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 29.6 m -98.51 -40.21 8.36 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.3 tpt -69.45 -30.17 68.03 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.837 0.455 . . . . 0.0 111.676 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -62.11 -28.5 69.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.896 -0.573 . . . . 0.0 109.81 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -61.14 -46.34 90.94 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 124.892 1.277 . . . . 0.0 110.697 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.21 0 C-N-CA 122.681 0.392 . . . . 0.0 111.486 -179.414 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.458 -0.607 0 N-CA-C 110.636 -0.563 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -77.02 56.73 1.26 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.665 1.186 . . . . 0.0 111.486 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.81 147.86 49.53 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.46 1.104 . . . . 0.0 111.422 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.48 -28.89 38.15 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.144 2.563 . . . . 0.0 110.959 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -54.23 -29.04 45.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.154 0.982 . . . . 0.0 111.81 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 5.7 mmt -62.77 -35.63 80.45 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.717 1.144 . . . . 0.0 110.729 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 8.7 t -60.8 -46.2 91.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.93 -41.61 86.73 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.423 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -56.37 -53.81 52.99 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 125.142 1.377 . . . . 0.0 109.88 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -60.16 -52.57 64.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.451 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -57.21 -38.11 73.21 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.903 0.774 . . . . 0.0 111.646 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.3 -60.71 2.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.335 1.054 . . . . 0.0 111.793 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 18.2 t -62.59 -33.0 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.377 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -34.71 70.89 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 21.4 m -80.58 -43.96 19.75 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.43 -50.83 64.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.202 1.001 . . . . 0.0 112.773 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.0 -48.99 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 123.447 0.699 . . . . 0.0 109.335 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mm -65.86 -32.79 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.909 0.777 . . . . 0.0 110.019 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -62.21 -51.11 69.11 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.822 -1.174 . . . . 0.0 109.011 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.51 -48.07 76.52 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.451 0.701 . . . . 0.0 110.602 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.37 69.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.284 1.034 . . . . 0.0 113.153 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 16.4 m -92.22 -3.33 55.69 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.591 0.757 . . . . 0.0 110.148 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 68.7 16.23 69.73 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 118.955 0.798 . . . . 0.0 111.715 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -74.74 -28.89 60.97 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.495 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -147.23 158.54 43.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.836 0.744 . . . . 0.0 109.591 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.2 m -62.71 149.9 42.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.631 1.173 . . . . 0.0 108.782 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 42.1 t -60.17 -45.71 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.83 -51.23 70.9 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 123.78 0.832 . . . . 0.0 110.097 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -66.87 -27.86 67.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.42 -38.94 91.64 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 19.5 mt -78.92 -33.99 44.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.829 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -55.18 -47.5 75.11 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.34 1.056 . . . . 0.0 108.475 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -58.32 -55.94 28.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.09 1.756 . . . . 0.0 109.265 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -55.36 -50.56 69.36 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.435 1.494 . . . . 0.0 113.533 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -37.52 73.61 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 28.3 m -66.46 -48.63 69.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 117.563 -1.208 . . . . 0.0 109.166 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -58.65 -14.58 8.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.014 1.279 . . . . 0.0 113.761 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 35.7 mt -101.51 -26.2 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.755 1.622 . . . . 0.0 110.339 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 40.1 p -101.31 8.11 42.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.011 1.324 . . . . 0.0 110.678 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? . . . . . 0 C--O 1.254 1.311 0 C-N-CA 130.347 3.459 . . . . 0.0 104.54 178.34 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.58 128.35 31.88 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.73 6.57 21.09 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 126.66 2.076 . . . . 0.0 113.958 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.32 170.91 14.83 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.765 1.626 . . . . 0.0 108.502 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -145.88 147.35 31.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.464 2.306 . . . . 0.0 105.724 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.53 143.23 39.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.6 mt -128.8 127.36 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -115.2 105.77 13.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.1 mp -71.28 155.45 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -122.63 108.0 12.6 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.827 0.851 . . . . 0.0 112.541 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.67 24.32 7.44 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 49.65 41.78 22.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.899 1.35 . . . . 0.0 110.085 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -63.36 -178.04 0.23 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.67 1.988 . . . . 0.0 113.286 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.51 51.86 2.64 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.27 1.891 . . . . 0.0 110.74 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -60.09 -20.7 59.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.571 1.548 . . . . 0.0 112.777 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -58.7 -44.55 90.37 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.543 1.065 . . . . 0.0 111.013 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.24 -31.38 78.95 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.0 tp -71.83 -38.35 70.17 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.002 0.921 . . . . 0.0 110.819 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.98 -42.75 65.85 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.965 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -58.43 -34.12 70.45 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.953 0.797 . . . . 0.0 111.39 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -68.68 -45.09 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.658 1.583 . . . . 0.0 106.981 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.83 -37.82 95.51 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -66.12 -42.86 88.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 117.848 -1.072 . . . . 0.0 108.522 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -57.62 -56.5 21.16 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -54.89 -48.83 72.49 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.325 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.93 -31.78 72.12 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.891 0.768 . . . . 0.0 111.103 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -73.26 -27.13 61.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.818 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -97.25 -36.26 10.48 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.823 0.849 . . . . 0.0 112.816 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.3 p -102.18 -27.73 12.71 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.397 0.999 . . . . 0.0 113.245 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.82 -15.73 56.72 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.623 -1.098 . . . . 0.0 112.581 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.8 mm -69.07 133.11 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.443 ' HE3' ' CA ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.69 151.57 46.24 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.716 -0.615 . . . . 0.0 111.327 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.2 t -136.68 112.06 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.9 m -102.92 123.47 46.62 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.27 115.71 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 105.933 -1.876 . . . . 0.0 105.933 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -130.7 159.47 37.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.642 0.655 . . . . 0.0 109.7 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -125.23 63.39 42.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.57 1.148 . . . . 0.0 108.888 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.87 146.49 42.41 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.494 2.129 . . . . 0.0 111.807 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -101.06 24.22 9.68 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.87 0.868 . . . . 0.0 110.185 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.67 14.09 0.84 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.586 -0.696 . . . . 0.0 112.657 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.18 -27.98 56.49 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.472 -1.393 . . . . 0.0 112.491 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.89 -25.3 56.63 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.91 1.284 . . . . 0.0 112.4 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.61 -25.26 7.93 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.222 1.009 . . . . 0.0 109.428 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -45.8 65.08 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 120.263 -1.523 . . . . 0.0 109.878 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -49.75 -59.2 7.24 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 117.598 -1.191 . . . . 0.0 110.06 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.58 -18.83 65.71 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.135 1.89 . . . . 0.0 114.559 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -89.73 1.13 56.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.313 1.445 . . . . 0.0 113.147 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 t -131.27 -41.21 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 119.481 1.037 . . . . 0.0 108.388 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.09 -30.56 71.09 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 122.038 -0.414 . . . . 0.0 110.629 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.28 95.19 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.65 -41.18 79.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.431 0.692 . . . . 0.0 110.43 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.39 19.9 1.47 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.131 -1.372 . . . . 0.0 114.324 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -134.96 -160.72 1.08 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.896 1.678 . . . . 0.0 107.038 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.78 -160.54 13.39 Favored Glycine 0 C--N 1.339 0.729 0 O-C-N 120.078 -1.639 . . . . 0.0 114.262 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.51 -179.66 5.03 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.08 2.52 . . . . 0.0 109.8 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -111.87 -23.56 10.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 121.564 -0.71 . . . . 0.0 112.418 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.1 mt -145.51 142.72 22.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.119 0.968 . . . . 0.0 108.851 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.2 tt -127.38 142.43 43.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.531 1.532 . . . . 0.0 107.412 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.64 116.85 22.35 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.69 1.196 . . . . 0.0 109.866 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -158.59 170.61 21.78 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.676 0.79 . . . . 0.0 109.371 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.58 153.64 40.97 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -58.19 -23.0 54.06 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.85 -54.63 42.29 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.853 -1.154 . . . . 0.0 111.731 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -63.7 -22.65 67.02 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 119.255 -0.402 . . . . 0.0 110.828 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -77.76 -2.75 37.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.724 0.41 . . . . 0.0 111.205 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.95 -9.13 75.3 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 120.852 -1.155 . . . . 0.0 110.871 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.97 -42.23 0.38 Allowed Glycine 0 CA--C 1.533 1.156 0 N-CA-C 117.938 1.935 . . . . 0.0 117.938 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -46.28 -44.79 16.84 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.874 2.337 . . . . 0.0 115.403 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.02 -41.49 82.07 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 119.585 1.084 . . . . 0.0 110.078 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -28.45 69.63 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.237 -0.915 . . . . 0.0 109.82 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.5 m -77.58 -2.96 38.36 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.013 1.325 . . . . 0.0 111.29 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.13 42.74 23.34 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.4 mt -126.81 -2.1 6.61 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.7 mt -121.69 135.75 54.95 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.98 1.718 . . . . 0.0 110.944 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.98 162.75 22.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.295 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -75.65 104.79 6.36 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 103.555 -2.758 . . . . 0.0 103.555 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.52 168.55 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.815 1.246 . . . . 0.0 112.982 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.5 m 57.02 91.36 0.08 OUTLIER Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 127.205 2.202 . . . . 0.0 115.049 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.36 -27.81 9.12 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.177 1.918 . . . . 0.0 112.563 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -124.99 137.69 54.24 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.856 1.207 . . . . 0.0 113.012 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.411 ' HZ3' ' NE2' ' A' ' 86' ' ' GLN . 15.8 tppt? -58.1 -22.97 53.02 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.778 2.431 . . . . 0.0 115.766 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.67 70.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 120.188 1.358 . . . . 0.0 111.699 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -59.33 -31.56 69.28 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.477 0.711 . . . . 0.0 110.881 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.411 ' NE2' ' HZ3' ' A' ' 83' ' ' LYS . 15.9 mp0 -65.36 -45.02 85.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.63 0.772 . . . . 0.0 110.302 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.22 -15.53 60.17 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.302 1.041 . . . . 0.0 112.815 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -84.39 -6.41 59.38 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.239 1.016 . . . . 0.0 111.043 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mt -126.7 159.44 33.68 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.882 1.673 . . . . 0.0 108.771 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -76.99 158.19 80.51 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 121.501 -0.749 . . . . 0.0 109.215 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.83 -47.56 1.84 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.636 2.89 . . . . 0.0 113.386 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -56.71 -30.49 63.54 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.765 0.711 . . . . 0.0 111.734 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -30.8 69.42 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.275 -0.891 . . . . 0.0 110.092 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -79.23 -40.75 29.88 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.096 0.958 . . . . 0.0 110.206 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -55.72 -21.88 20.85 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.673 1.189 . . . . 0.0 112.74 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.28 3.68 55.25 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.029 2.132 . . . . 0.0 113.997 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.18 0.53 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.48 1.112 . . . . 0.0 111.336 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -68.04 155.26 39.91 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.298 -0.877 . . . . 0.0 108.685 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -136.1 169.92 16.85 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -57.83 102.6 0.1 Allowed 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.442 0.697 . . . . 0.0 111.336 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.46 -81.68 0.95 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.521 1.058 . . . . 0.0 110.911 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.66 169.69 13.86 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.904 0.852 . . . . 0.0 110.816 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.9 mt -105.06 168.92 8.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.78 1.232 . . . . 0.0 108.502 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.6 pt -138.77 -25.88 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.17 173.25 16.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.874 1.215 . . . . 0.0 109.631 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.49 149.69 74.25 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 123.659 0.784 . . . . 0.0 109.217 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.72 141.78 38.33 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.182 2.588 . . . . 0.0 109.0 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -121.55 -51.1 3.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.431 0.692 . . . . 0.0 109.331 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.51 166.85 22.23 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.085 0.402 . . . . 0.0 111.282 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -136.67 123.64 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.579 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.4 p90 . . . . . 0 C--O 1.239 0.551 0 C-N-CA 124.605 1.162 . . . . 0.0 108.754 179.48 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 N--CA 1.45 -1.03 0 N-CA-C 109.185 -1.121 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -130.66 -38.31 1.32 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.843 0.857 . . . . 0.0 109.609 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.16 150.67 47.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.802 0.335 . . . . 0.0 110.89 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -64.29 -20.52 66.13 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.994 -1.003 . . . . 0.0 111.464 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.64 -11.55 60.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.785 1.175 . . . . 0.0 110.951 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -99.02 -28.56 13.35 Favored 'General case' 0 C--O 1.222 -0.364 0 O-C-N 120.929 -1.107 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.9 mm -52.04 -56.31 22.93 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 119.657 1.117 . . . . 0.0 111.256 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -71.13 -20.12 28.92 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 CA-C-N 120.976 1.384 . . . . 0.0 112.42 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.9 -36.46 56.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.926 1.29 . . . . 0.0 110.887 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.15 -30.52 16.65 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 126.517 1.927 . . . . 0.0 112.402 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.8 -45.79 85.57 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.406 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 9.5 ptmm? -64.1 -35.66 81.5 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.581 0.752 . . . . 0.0 111.768 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.52 -43.67 69.14 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.7 mt -73.33 -30.83 63.61 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.765 -0.635 . . . . 0.0 110.182 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -67.41 -39.64 85.53 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.68 -16.23 60.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 123.764 0.665 . . . . 0.0 112.727 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.45 4.25 8.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.629 1.171 . . . . 0.0 112.208 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.84 -99.93 0.13 Allowed Glycine 0 C--N 1.337 0.629 0 CA-C-N 118.746 0.703 . . . . 0.0 114.706 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -139.5 -176.09 4.42 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.659 2.384 . . . . 0.0 109.135 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.87 163.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.73 -52.32 5.38 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.486 1.514 . . . . 0.0 109.423 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.3 tp -137.68 150.78 47.62 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 127.621 2.369 . . . . 0.0 108.244 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -156.24 128.94 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -147.88 163.79 35.68 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -67.03 110.15 3.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.121 0.963 . . . . 0.0 108.41 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.15 -13.2 22.28 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -76.79 -15.13 59.83 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -99.72 130.73 25.96 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 119.805 1.184 . . . . 0.0 111.356 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.84 -14.05 35.29 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 121.594 1.529 . . . . 0.0 110.902 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -64.63 -42.17 95.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.609 1.964 . . . . 0.0 110.109 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -86.08 -30.36 22.65 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.358 0.663 . . . . 0.0 112.687 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.7 p -84.47 -7.51 59.26 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.09 0.859 . . . . 0.0 110.625 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -55.31 -57.94 17.72 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.546 -1.346 . . . . 0.0 112.521 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.33 -25.32 56.14 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.703 1.602 . . . . 0.0 112.95 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -66.18 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.045 1.338 . . . . 0.0 108.04 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 39.4 pt -64.82 -27.13 41.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 O-C-N 121.74 -0.6 . . . . 0.0 111.938 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.38 -16.88 61.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.947 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.0 -59.46 4.51 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.973 0.909 . . . . 0.0 113.161 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -62.33 -54.42 40.72 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.39 12.09 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 CA-C-O 118.553 -1.137 . . . . 0.0 114.51 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.57 133.97 41.53 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 119.842 1.821 . . . . 0.0 109.903 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.407 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 48.9 p90 -145.56 137.46 25.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.05 -48.68 12.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -144.46 141.11 29.36 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.046 0.939 . . . . 0.0 108.951 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.407 ' HE2' ' CE1' ' A' ' 167' ' ' TYR . 10.3 tppt? -91.2 153.06 20.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -159.38 102.35 1.57 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -138.3 160.37 39.66 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 56.77 11.74 0.99 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.209 1.803 . . . . 0.0 111.334 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.84 16.29 80.18 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -114.84 110.26 19.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 126.18 1.792 . . . . 0.0 108.928 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -81.12 143.62 32.27 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -145.32 76.05 1.46 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 119.833 1.197 . . . . 0.0 113.271 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.56 -6.94 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -41.38 80.82 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.963 1.705 . . . . 0.0 108.186 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -87.78 105.3 17.3 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.34 1.056 . . . . 0.0 108.849 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 81.1 t -127.49 98.62 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -76.0 18.0 3.49 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 117.272 1.669 . . . . 0.0 117.272 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.0 t -70.2 -20.18 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.531 2.165 . . . . 0.0 112.863 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.53 2.09 25.91 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.813 0.733 . . . . 0.0 111.854 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -66.29 165.49 13.88 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.541 1.136 . . . . 0.0 111.369 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.14 -41.39 71.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.403 1.081 . . . . 0.0 111.308 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.0 -27.96 73.53 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 120.995 -1.066 . . . . 0.0 113.394 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.91 -38.09 54.14 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.417 1.109 . . . . 0.0 110.11 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -73.55 -33.19 64.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.786 -0.571 . . . . 0.0 110.988 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -54.73 -48.64 72.28 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.478 1.111 . . . . 0.0 112.457 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -75.87 -19.08 79.2 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.95 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.9 tp -77.61 -53.12 7.96 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 122.95 0.5 . . . . 0.0 112.247 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.2 t -54.78 -32.94 60.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.417 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -53.06 -53.2 53.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.359 0.981 . . . . 0.0 110.697 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 27.4 tp -63.41 -48.78 76.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.723 0.409 . . . . 0.0 110.473 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.16 -31.61 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 123.998 0.919 . . . . 0.0 110.025 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -48.18 80.14 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.895 1.278 . . . . 0.0 110.53 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.24 -39.26 93.58 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.932 -0.48 . . . . 0.0 109.863 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 73.3 mt -67.4 -38.2 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.971 0.908 . . . . 0.0 108.753 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -57.71 -47.61 81.91 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.538 -1.351 . . . . 0.0 108.015 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -80.77 -0.13 37.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.29 1.436 . . . . 0.0 112.459 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp 56.26 6.39 0.25 Allowed 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 129.829 3.252 . . . . 0.0 116.729 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -71.45 -20.6 62.07 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.922 -0.711 . . . . 0.0 112.447 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.7 tpt -82.97 159.27 22.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.287 1.035 . . . . 0.0 112.485 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -95.94 76.09 3.12 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.34 -7.36 30.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.291 1.436 . . . . 0.0 113.598 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.61 -22.69 26.06 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 130.519 3.528 . . . . 0.0 112.179 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.6 m -58.84 127.79 33.95 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -128.62 -178.43 4.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.367 1.867 . . . . 0.0 107.513 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -59.34 -39.49 83.35 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -53.51 56.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.522 1.129 . . . . 0.0 109.121 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 60.5 mt -61.98 -55.93 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.831 1.252 . . . . 0.0 110.848 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.65 94.22 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.628 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.82 -45.27 82.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.294 1.407 . . . . 0.0 110.904 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.47 -55.43 27.65 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.485 1.114 . . . . 0.0 110.403 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.92 -38.7 76.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.397 1.079 . . . . 0.0 110.16 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -62.03 -30.65 71.11 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.456 0.571 . . . . 0.0 109.581 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.57 -35.84 65.52 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 120.923 -1.11 . . . . 0.0 109.443 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -77.01 -12.38 59.93 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.574 1.149 . . . . 0.0 113.622 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.1 16.53 59.18 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-N 120.683 1.583 . . . . 0.0 111.442 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -78.99 -9.4 59.52 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.031 1.732 . . . . 0.0 114.349 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -146.62 127.1 14.09 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.082 -1.011 . . . . 0.0 108.702 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.71 -24.77 66.29 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.322 -0.862 . . . . 0.0 111.575 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -140.92 166.64 24.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.567 1.147 . . . . 0.0 111.603 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.9 t -153.15 166.65 31.85 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.279 1.831 . . . . 0.0 107.179 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.5 mt . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 179.413 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.41 144.56 62.04 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.511 1.474 . . . . 0.0 109.211 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.6 p -136.03 -161.63 1.18 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.915 0.886 . . . . 0.0 110.262 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.5 143.65 40.53 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -55.65 134.75 51.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.569 -0.707 . . . . 0.0 110.033 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 70.58 -7.81 4.75 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.42 98.47 4.26 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 119.293 1.547 . . . . 0.0 112.1 -178.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.07 158.24 55.45 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.327 1.352 . . . . 0.0 110.788 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 80.7 p -83.07 142.53 31.22 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 120.893 -1.13 . . . . 0.0 110.116 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -142.5 118.15 6.77 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.832 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -75.76 -61.89 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.731 2.287 . . . . 0.0 110.904 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 . . . . . 0 C--O 1.24 0.591 0 C-N-CA 129.613 3.165 . . . . 0.0 105.953 179.678 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.123 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.82 122.4 62.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 117.604 0.702 . . . . 0.0 112.535 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.7 tt -77.77 128.04 33.39 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.4 m -114.97 163.42 15.61 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.28 0.632 . . . . 0.0 112.179 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -139.26 139.98 37.54 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.19 0.996 . . . . 0.0 109.27 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -129.44 153.94 20.14 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.035 1.778 . . . . 0.0 108.896 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 75.9 mt -104.41 137.97 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 125.139 1.376 . . . . 0.0 107.654 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -68.05 114.46 6.6 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -63.22 -24.71 68.0 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.334 -0.854 . . . . 0.0 110.946 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -69.84 -16.72 63.31 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 118.451 -0.785 . . . . 0.0 113.079 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 44.7 m -58.3 150.42 53.69 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 118.985 0.812 . . . . 0.0 109.781 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.83 -37.24 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.195 1.93 . . . . 0.0 112.221 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -135.81 89.03 2.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -57.31 -18.57 17.52 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.622 0.369 . . . . 0.0 111.084 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.85 -42.33 84.24 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.557 1.943 . . . . 0.0 108.409 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.08 -37.84 81.12 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.905 -1.122 . . . . 0.0 110.674 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.35 -45.53 38.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -35.33 77.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.473 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -71.71 -52.63 16.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.215 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -54.89 -47.99 73.61 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 120.657 1.572 . . . . 0.0 111.167 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.31 -45.73 91.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.772 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -83.42 -7.3 59.58 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -108.17 -24.32 11.59 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 116.92 -1.514 . . . . 0.0 114.603 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -139.65 -35.67 0.53 Allowed 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.457 1.026 . . . . 0.0 112.256 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -64.82 -44.76 88.83 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.397 1.453 . . . . 0.0 108.549 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 77.7 mt -96.86 53.97 1.26 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.358 1.863 . . . . 0.0 112.834 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.1 p -131.75 157.47 43.72 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.29 -38.49 89.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -69.44 -39.1 78.02 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.71 -0.619 . . . . 0.0 110.885 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.84 -32.26 61.34 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 121.769 -0.582 . . . . 0.0 112.122 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.9 mt -74.75 -44.17 51.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.31 -45.26 84.4 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.377 1.071 . . . . 0.0 108.541 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.69 -50.42 63.35 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.435 1.094 . . . . 0.0 112.289 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 65.4 t -72.94 -34.57 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.209 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -68.92 -32.91 72.87 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.452 0.569 . . . . 0.0 111.386 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -62.63 -35.18 78.76 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -67.17 -72.44 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.57 154.51 77.6 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 124.493 1.117 . . . . 0.0 111.581 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.44 108.1 2.54 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.44 2.093 . . . . 0.0 109.868 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.22 -30.51 70.45 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.03 -116.47 5.59 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 106.49 -2.644 . . . . 0.0 106.49 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -109.9 169.13 8.92 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.993 1.396 . . . . 0.0 108.328 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 18.6 m -131.74 153.1 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 O-C-N 121.377 -0.827 . . . . 0.0 110.977 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.11 -34.34 50.12 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.974 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 15.4 tp -69.34 102.19 1.69 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.303 1.041 . . . . 0.0 108.327 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -53.2 -28.44 26.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.608 1.563 . . . . 0.0 115.217 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -62.37 1.7 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.764 1.165 . . . . 0.0 111.483 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -78.96 -14.01 59.46 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 125.246 1.418 . . . . 0.0 112.691 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -58.88 -32.23 69.3 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.66 -30.87 71.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.711 1.204 . . . . 0.0 112.601 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -82.38 -39.46 22.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.641 1.176 . . . . 0.0 110.009 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 12.6 mt -69.14 -34.82 75.6 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.33 -6.96 1.72 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.089 1.756 . . . . 0.0 113.497 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -62.05 -33.06 73.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.797 0.726 . . . . 0.0 109.913 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.14 142.81 25.17 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.04 -13.2 37.54 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.149 1.899 . . . . 0.0 113.509 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.5 mtm-85 -64.5 -45.14 88.58 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.757 -1.215 . . . . 0.0 109.384 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.3 mp -67.25 -57.68 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 124.596 1.158 . . . . 0.0 107.965 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.63 -54.97 18.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 124.176 0.923 . . . . 0.0 110.171 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.33 -30.8 71.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.694 -1.254 . . . . 0.0 113.171 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 16.7 m -66.5 -42.92 86.66 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.3 tpt -67.33 -51.42 52.63 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.807 1.643 . . . . 0.0 110.393 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -55.16 -33.05 62.61 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.217 1.007 . . . . 0.0 112.427 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -81.97 -38.34 25.3 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.813 0.845 . . . . 0.0 108.976 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.483 0 CA-C-N 118.714 0.688 . . . . 0.0 110.48 178.851 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 CA--C 1.539 0.765 0 N-CA-C 112.833 0.282 . . . . 0.0 112.833 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -148.65 46.35 1.03 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.976 0.91 . . . . 0.0 111.768 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.41 155.43 43.71 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.553 1.541 . . . . 0.0 113.063 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.39 -19.43 61.46 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.094 3.196 . . . . 0.0 115.448 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -56.35 -24.01 41.28 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.592 1.157 . . . . 0.0 111.574 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 87.4 mmm -59.28 -33.59 71.24 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.685 0.794 . . . . 0.0 111.504 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 13.1 t -58.68 -49.3 78.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.681 0.673 . . . . 0.0 110.315 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.86 82.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.751 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -56.09 -48.93 75.2 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.892 0.877 . . . . 0.0 110.035 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 21.6 m95 -56.95 -44.34 82.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.428 0.558 . . . . 0.0 111.349 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -66.93 -45.12 78.82 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.967 -0.458 . . . . 0.0 110.258 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -52.93 -56.19 17.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.136 1.774 . . . . 0.0 112.149 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 18.1 t -68.45 -40.2 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 117.616 -1.183 . . . . 0.0 109.561 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -52.28 -50.73 61.56 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.875 1.67 . . . . 0.0 109.023 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 2.1 m -67.45 -45.01 77.24 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.58 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.06 -42.1 68.89 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.878 1.217 . . . . 0.0 111.964 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 44.1 t -58.28 -57.38 11.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.354 1.062 . . . . 0.0 109.43 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.9 mm -67.09 -26.47 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 119.344 -0.36 . . . . 0.0 110.687 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -64.94 -51.39 62.12 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 119.85 -1.781 . . . . 0.0 109.088 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.52 -44.57 70.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.383 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.24 -29.02 70.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.4 m -85.71 -12.36 51.36 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.095 0.861 . . . . 0.0 109.571 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 73.33 8.73 75.99 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.416 -0.658 . . . . 0.0 111.676 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -66.78 -34.62 78.23 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.681 1.241 . . . . 0.0 108.915 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -138.99 155.86 47.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.0 t -76.11 166.47 23.43 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.8 t -55.73 -56.07 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.142 1.377 . . . . 0.0 109.901 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -51.75 -41.25 61.45 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.59 1.556 . . . . 0.0 113.478 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -77.28 -36.48 54.2 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.19 0.196 . . . . 0.0 111.099 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.61 -50.26 72.5 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.49 -0.756 . . . . 0.0 109.74 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.04 -39.18 89.96 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.108 -0.949 . . . . 0.0 111.157 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -57.55 -56.25 24.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.815 0.734 . . . . 0.0 110.395 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.95 -38.57 91.61 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 124.274 0.984 . . . . 0.0 111.012 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.59 92.61 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.682 -0.636 . . . . 0.0 110.452 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.38 -36.36 68.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.585 0.754 . . . . 0.0 109.792 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 5.8 m -59.69 -39.08 83.36 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.62 0.645 . . . . 0.0 110.398 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -65.75 -15.67 63.06 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.092 -1.005 . . . . 0.0 112.34 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 7.8 mt -102.56 -8.62 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.988 1.315 . . . . 0.0 109.974 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 19.7 p -113.36 -2.52 13.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.802 1.641 . . . . 0.0 111.874 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.106 0 C-N-CA 127.344 2.257 . . . . 0.0 106.544 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 122.216 1.007 . . . . 0.0 108.521 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.433 ' CG ' ' H ' ' A' ' 5' ' ' GLY . 4.8 tt0 -73.04 -176.03 1.97 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.812 2.445 . . . . 0.0 113.018 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.433 ' H ' ' CG ' ' A' ' 4' ' ' GLU . . . 79.94 17.27 75.17 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.106 0.86 . . . . 0.0 111.963 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.594 ' HZ3' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -147.47 163.36 36.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.173 1.389 . . . . 0.0 110.656 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.6 mt -148.99 150.28 32.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 129.237 3.015 . . . . 0.0 104.933 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.594 ' CG2' ' HZ3' ' A' ' 6' ' ' LYS . 44.5 t -139.52 134.36 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.2 mt -114.43 123.55 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -121.45 118.93 30.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -145.81 154.78 13.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.37 1.068 . . . . 0.0 110.726 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -69.52 150.8 46.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.25 -26.79 37.48 Favored Glycine 0 N--CA 1.465 0.569 0 C-N-CA 126.161 1.839 . . . . 0.0 115.034 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.82 -19.77 63.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.605 0.703 . . . . 0.0 110.554 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -73.09 164.8 26.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 122.167 0.984 . . . . 0.0 109.962 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.69 63.5 4.35 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -68.51 -45.87 71.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.326 1.05 . . . . 0.0 110.959 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -38.63 80.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.92 -38.74 22.39 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.47 -34.95 78.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.204 1.002 . . . . 0.0 110.545 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.93 -44.66 82.68 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.142 0.577 . . . . 0.0 109.567 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -56.11 -43.1 77.8 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.527 0.731 . . . . 0.0 111.635 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.1 -44.52 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.509 1.524 . . . . 0.0 107.362 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.73 -42.84 95.05 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.305 -0.872 . . . . 0.0 110.994 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -43.25 99.2 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.052 0.926 . . . . 0.0 108.724 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -62.74 -50.32 71.56 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.613 1.165 . . . . 0.0 108.942 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -56.77 -41.89 78.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.561 1.073 . . . . 0.0 110.272 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.93 -35.93 79.86 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.965 -1.084 . . . . 0.0 108.7 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -74.18 3.77 6.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.3 1.84 . . . . 0.0 111.263 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -125.4 -37.4 2.37 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.79 1.636 . . . . 0.0 112.604 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.0 p -112.29 -22.0 11.13 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.716 0.806 . . . . 0.0 113.013 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.44 53.01 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.063 -1.023 . . . . 0.0 112.954 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.77 133.06 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 119.145 1.473 . . . . 0.0 107.468 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.494 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -66.81 146.03 54.86 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.262 -0.899 . . . . 0.0 108.812 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.3 t -136.75 91.59 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.8 m -80.73 134.28 35.8 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.2 t -130.84 129.4 63.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -140.01 166.23 25.22 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -118.54 58.66 3.55 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 123.59 0.756 . . . . 0.0 111.606 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.32 159.97 51.64 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.18 1.253 . . . . 0.0 109.24 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -120.45 -23.08 6.23 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.375 0.67 . . . . 0.0 110.501 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.2 9.13 41.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.913 1.285 . . . . 0.0 110.543 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -56.86 -30.74 64.12 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 120.565 -1.334 . . . . 0.0 112.286 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.26 -23.81 64.4 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.22 1.373 . . . . 0.0 113.652 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -105.14 -28.03 11.24 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.164 0.438 . . . . 0.0 110.272 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -51.29 10.88 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 124.492 1.117 . . . . 0.0 110.647 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -41.92 -58.25 3.46 Favored Pre-proline 0 N--CA 1.457 -0.079 0 CA-C-O 116.321 -1.799 . . . . 0.0 109.883 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.99 1.37 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.27 1.98 . . . . 0.0 116.93 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.36 -52.86 2.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.802 1.183 . . . . 0.0 108.752 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.17 -40.95 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.58 -31.04 59.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.378 -0.827 . . . . 0.0 111.144 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.15 -13.44 60.81 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.033 0.533 . . . . 0.0 111.011 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 m -93.33 -82.34 0.34 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 163.36 37.77 0.02 OUTLIER Glycine 0 CA--C 1.524 0.612 0 C-N-CA 125.598 1.57 . . . . 0.0 109.291 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.79 -3.32 2.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.812 1.645 . . . . 0.0 113.292 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.9 176.27 21.66 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 116.933 1.533 . . . . 0.0 116.933 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.92 172.38 7.28 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.766 2.311 . . . . 0.0 109.584 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -107.92 -18.5 13.79 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -142.36 143.05 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.348 1.459 . . . . 0.0 108.726 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.8 tt -135.29 140.6 44.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 125.608 1.563 . . . . 0.0 108.277 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -132.45 116.32 16.64 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -154.73 179.29 9.21 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.72 0.691 . . . . 0.0 110.726 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.41 152.95 40.63 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -61.81 -25.62 67.61 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -61.52 -23.79 66.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -98.76 -4.9 32.39 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.797 -0.564 . . . . 0.0 110.78 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -92.46 20.87 5.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.004 1.322 . . . . 0.0 109.73 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.79 -14.03 51.16 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 120.667 -1.271 . . . . 0.0 111.391 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.65 -27.45 1.94 Allowed Glycine 0 C--N 1.344 0.982 0 CA-C-N 119.304 1.552 . . . . 0.0 116.498 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -53.75 -47.37 70.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.114 1.957 . . . . 0.0 111.763 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.21 -40.91 94.78 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -27.08 54.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.303 1.041 . . . . 0.0 112.223 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.0 m -96.88 3.07 52.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.353 1.461 . . . . 0.0 112.045 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.66 16.76 78.72 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.421 1.01 . . . . 0.0 112.267 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.7 mt -88.73 9.47 24.27 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.142 0.977 . . . . 0.0 113.425 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.0 mt -131.29 146.01 52.12 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 120.979 -1.076 . . . . 0.0 108.244 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.41 161.58 14.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -78.7 94.21 5.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.43 ' CD1' ' HG1' ' A' ' 80' ' ' THR . 2.6 pp -62.11 175.21 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 127.103 2.161 . . . . 0.0 112.212 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.43 ' HG1' ' CD1' ' A' ' 79' ' ' ILE . 89.4 m 66.64 95.88 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 126.777 2.031 . . . . 0.0 111.013 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.92 -48.24 1.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.339 1.359 . . . . 0.0 110.749 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.84 154.65 51.55 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.079 0.951 . . . . 0.0 110.509 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -49.34 -38.85 29.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.07 2.548 . . . . 0.0 111.768 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.98 -25.55 44.49 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.189 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -68.77 -28.64 66.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.718 1.145 . . . . 0.0 109.963 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -64.05 -36.37 83.79 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 120.76 -1.212 . . . . 0.0 110.76 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.18 -15.3 61.02 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.065 0.946 . . . . 0.0 112.286 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -70.85 -20.92 62.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.717 1.207 . . . . 0.0 111.771 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.0 mt -122.93 161.16 24.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.799 1.64 . . . . 0.0 108.541 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -72.98 157.76 88.15 Favored Pre-proline 0 N--CA 1.476 0.847 0 CA-C-N 120.23 1.377 . . . . 0.0 108.91 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.9 -46.18 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.08 2.52 . . . . 0.0 114.168 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -60.1 -30.93 69.58 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.259 0.936 . . . . 0.0 111.34 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.11 -29.46 69.21 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.233 -0.917 . . . . 0.0 110.15 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -72.88 -30.29 63.84 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.966 0.803 . . . . 0.0 110.684 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -62.99 -16.5 59.92 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.45 -5.18 59.08 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.326 0.65 . . . . 0.0 112.506 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.5 m -133.3 27.82 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.882 1.273 . . . . 0.0 112.238 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.6 mtp85 -86.37 164.11 17.24 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.199 0.999 . . . . 0.0 110.878 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -149.95 175.5 11.62 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.174 1.39 . . . . 0.0 107.603 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -66.55 101.19 0.74 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.559 0.743 . . . . 0.0 112.157 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.84 -69.95 2.8 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.099 1.333 . . . . 0.0 111.974 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.86 162.04 27.95 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.141 0.47 . . . . 0.0 110.064 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.84 155.21 17.16 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.742 1.617 . . . . 0.0 108.557 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.1 pt -123.09 -32.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.72 -178.58 7.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 119.925 1.239 . . . . 0.0 109.912 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -133.36 147.53 65.3 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 124.668 1.187 . . . . 0.0 109.431 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.93 153.8 63.4 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.651 2.9 . . . . 0.0 109.665 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.9 mm -125.84 -47.63 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 125.364 1.466 . . . . 0.0 110.979 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.26 165.7 26.7 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 117.877 0.308 . . . . 0.0 110.739 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.7 t -127.02 121.43 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 124.281 0.988 . . . . 0.0 109.399 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.88 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--O 1.242 0.68 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--O 1.237 0.396 0 C-N-CA 123.544 0.738 . . . . 0.0 109.484 179.154 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.457 -0.648 0 N-CA-C 112.748 0.249 . . . . 0.0 112.748 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.83 -12.03 3.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.068 0.547 . . . . 0.0 112.365 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.33 154.84 45.91 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.128 -0.983 . . . . 0.0 111.949 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -80.05 -22.92 41.79 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.23 -18.29 47.66 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.79 -5.13 21.5 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.264 1.025 . . . . 0.0 111.511 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.4 mm -61.05 -52.53 71.29 Favored Pre-proline 0 C--N 1.339 0.128 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.82 -23.75 54.92 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 CA-C-N 120.997 1.392 . . . . 0.0 111.503 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.43 -44.39 75.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.4 tp -80.43 -27.29 38.02 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.219 1.008 . . . . 0.0 111.928 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.9 -44.51 82.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 123.943 0.897 . . . . 0.0 110.736 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -68.41 -31.2 70.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.407 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -71.34 -46.78 59.7 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 61.0 mt -72.57 -31.48 65.28 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.402 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -71.17 -37.37 72.2 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.01 68.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.538 0.608 . . . . 0.0 111.89 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.68 6.15 16.75 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.978 0.911 . . . . 0.0 112.534 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 179.42 -104.46 0.18 Allowed Glycine 0 CA--C 1.524 0.626 0 CA-C-N 119.141 0.882 . . . . 0.0 112.792 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -136.91 178.08 7.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.134 2.174 . . . . 0.0 109.978 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.01 155.36 3.54 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.36 1.064 . . . . 0.0 113.674 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.07 -47.61 35.42 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.7 tp -125.48 155.55 40.35 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.192 1.397 . . . . 0.0 110.247 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.1 ttm -150.68 130.5 13.25 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -159.91 168.93 24.6 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.865 1.666 . . . . 0.0 115.399 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.52 83.11 0.06 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 126.766 2.026 . . . . 0.0 112.095 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.5 mt -80.83 -20.87 41.47 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 125.842 1.657 . . . . 0.0 110.724 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.3 mm-40 -78.92 -6.53 56.41 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -112.62 129.92 23.93 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 119.163 0.892 . . . . 0.0 112.105 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.64 -13.73 24.69 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.156 1.904 . . . . 0.0 112.318 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -64.6 -40.09 94.88 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.854 1.662 . . . . 0.0 113.311 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -95.13 -29.6 14.48 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.5 p -72.75 -28.43 62.62 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.336 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -56.6 -58.67 15.65 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -56.02 -16.36 16.26 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.586 2.191 . . . . 0.0 115.842 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 66.4 tp -82.11 -59.17 2.65 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.811 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.8 pt -68.21 -27.42 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 119.403 1.001 . . . . 0.0 111.768 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.25 -20.89 66.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.449 0.699 . . . . 0.0 110.917 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.61 -54.01 43.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.153 1.381 . . . . 0.0 112.244 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.21 -41.75 84.7 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.364 0.529 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 165.88 26.13 0.02 OUTLIER Glycine 0 C--N 1.34 0.778 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -88.92 131.95 10.98 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -147.27 151.44 36.64 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.115 1.457 . . . . 0.0 112.059 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.17 -63.01 1.4 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.775 1.23 . . . . 0.0 112.542 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -138.37 126.24 22.47 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.309 1.444 . . . . 0.0 108.832 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -73.38 129.37 37.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.425 1.011 . . . . 0.0 112.156 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.85 122.18 38.87 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.542 ' HG2' ' H ' ' A' ' 173' ' ' ASN . 14.9 tt0 -93.82 -163.57 1.07 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.987 1.315 . . . . 0.0 109.45 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.542 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 71.0 m-80 -56.77 -8.84 0.65 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.249 2.22 . . . . 0.0 115.731 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.36 11.62 0.02 OUTLIER Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.224 1.392 . . . . 0.0 113.861 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.6 156.7 40.5 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.808 2.443 . . . . 0.0 105.078 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -144.93 148.71 34.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -147.88 141.03 25.04 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.8 -8.67 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.664 1.186 . . . . 0.0 110.3 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -40.01 73.51 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -78.33 92.48 4.54 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.587 1.155 . . . . 0.0 111.009 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.9 t -115.96 150.29 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.885 1.674 . . . . 0.0 108.996 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -146.08 48.58 0.68 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.55 1.548 . . . . 0.0 111.629 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 80.3 t -81.3 -55.2 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 125.1 1.36 . . . . 0.0 107.937 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -87.51 67.22 9.31 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -113.03 155.95 23.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 126.317 1.847 . . . . 0.0 110.435 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.15 -39.05 66.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.992 1.317 . . . . 0.0 113.152 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.21 -45.96 76.08 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.08 -56.59 19.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -58.87 -34.49 71.69 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 117.438 -1.268 . . . . 0.0 112.768 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.05 -52.09 66.42 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.608 1.094 . . . . 0.0 109.286 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.3 -30.31 73.48 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.77 -53.72 20.12 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.332 1.066 . . . . 0.0 108.442 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.4 t -61.14 -33.66 73.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.327 0.651 . . . . 0.0 110.303 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.85 -55.07 34.38 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.6 tt -60.58 -47.89 84.22 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.445 1.498 . . . . 0.0 110.323 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 70.9 t -57.1 -36.23 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 118.18 -0.914 . . . . 0.0 109.75 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.427 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.3 OUTLIER -65.04 -35.51 81.39 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 120.033 1.288 . . . . 0.0 112.122 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.04 -41.23 99.46 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 85.7 mt -67.98 -42.76 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -57.83 -31.69 66.89 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.575 1.55 . . . . 0.0 109.841 178.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -88.69 -5.29 58.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.764 1.625 . . . . 0.0 111.246 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? 60.39 16.88 6.66 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.321 2.648 . . . . 0.0 113.755 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -86.3 -34.53 20.31 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.4 tpt -85.44 128.37 34.7 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -76.68 120.68 22.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -88.92 -3.12 58.83 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -95.72 -15.34 22.7 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.603 1.961 . . . . 0.0 115.144 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.3 m -67.55 128.43 36.4 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.957 0.903 . . . . 0.0 112.197 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -126.95 172.32 10.55 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.761 2.024 . . . . 0.0 108.114 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -47.66 -39.81 18.17 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 57.8 m -63.14 -45.91 89.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.743 1.217 . . . . 0.0 110.45 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 58.1 mt -66.9 -48.47 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 117.063 -1.446 . . . . 0.0 110.868 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.76 91.06 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.798 1.635 . . . . 0.0 112.717 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.42 -35.32 80.58 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.047 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.26 -55.9 20.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.62 -43.14 75.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.939 2.495 . . . . 0.0 112.119 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.417 ' HB2' ' HG1' ' A' ' 225' ' ' THR . 67.9 t80 -62.49 -45.68 91.91 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.986 1.266 . . . . 0.0 108.543 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -37.9 82.59 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 118.44 -0.791 . . . . 0.0 109.192 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -74.56 -23.08 58.71 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.089 1.313 . . . . 0.0 111.618 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.47 38.25 5.36 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.415 1.483 . . . . 0.0 111.081 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -93.74 -31.1 14.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.672 1.236 . . . . 0.0 113.764 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.5 t -115.15 152.01 33.35 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.612 1.165 . . . . 0.0 109.24 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -87.88 -27.95 21.88 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.781 0.832 . . . . 0.0 111.498 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -136.51 145.49 45.16 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.927 1.291 . . . . 0.0 108.224 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.417 ' HG1' ' HB2' ' A' ' 217' ' ' PHE . 23.0 m -149.4 149.72 31.28 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.666 1.186 . . . . 0.0 108.919 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 27.6 mt . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.004 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 119.136 -0.459 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.24 143.56 39.82 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.431 1.421 . . . . 0.0 110.041 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 47.8 p -135.51 -145.0 0.21 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.834 2.054 . . . . 0.0 108.231 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -124.12 141.59 51.93 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 12.0 pttp -54.02 107.1 0.23 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.279 1.031 . . . . 0.0 109.049 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.76 84.43 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.772 1.177 . . . . 0.0 114.394 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.08 93.64 43.23 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.865 1.333 . . . . 0.0 108.936 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.4 144.17 25.55 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.976 2.451 . . . . 0.0 109.433 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 37.3 p -63.33 141.41 58.78 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 121.058 -1.026 . . . . 0.0 108.804 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -116.39 88.14 22.59 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.511 1.125 . . . . 0.0 110.398 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -82.16 168.08 15.42 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.382 2.055 . . . . 0.0 112.239 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 . . . . . 0 C--O 1.237 0.422 0 C-N-CA 124.621 1.168 . . . . 0.0 108.446 178.195 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.551 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.49 136.64 54.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 118.042 0.921 . . . . 0.0 112.092 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 tp -68.86 137.48 53.92 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.1 m -121.99 158.23 29.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.494 1.043 . . . . 0.0 113.568 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -135.33 141.2 45.57 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.194 1.798 . . . . 0.0 110.004 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.78 167.46 23.22 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.441 1.496 . . . . 0.0 110.196 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 56.2 mt -119.46 132.25 69.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.508 1.523 . . . . 0.0 107.363 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -74.1 130.5 39.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -76.2 -19.48 58.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 117.797 -1.097 . . . . 0.0 113.518 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -72.94 -7.74 52.46 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.574 1.079 . . . . 0.0 113.182 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 66.8 m -63.06 154.72 76.26 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -62.29 -53.69 1.79 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 121.877 1.718 . . . . 0.0 108.052 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -132.42 125.55 31.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -16.59 60.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.718 0.807 . . . . 0.0 111.406 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -61.55 -33.78 74.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.707 0.803 . . . . 0.0 112.517 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 61.9 mt -59.3 -40.74 87.14 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.791 -0.568 . . . . 0.0 111.031 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.42 -43.63 48.88 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.771 0.429 . . . . 0.0 111.057 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -63.9 -32.95 74.65 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.768 -0.634 . . . . 0.0 111.331 -179.084 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -72.44 -48.07 44.01 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -51.47 -49.89 60.9 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.23 -54.42 47.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.4 -22.55 66.99 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -97.55 -24.6 15.48 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 117.817 -1.087 . . . . 0.0 113.55 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -138.66 -36.42 0.56 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.99 -25.29 62.63 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.468 1.031 . . . . 0.0 110.692 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 89.7 mt -105.57 24.97 11.34 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.445 1.498 . . . . 0.0 113.711 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 6.8 p -103.07 158.19 16.47 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.48 -42.81 99.75 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -71.41 -30.73 66.44 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.582 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.05 -48.89 14.34 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 63.8 mt -62.0 -43.86 97.94 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -62.23 -42.5 99.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.03 -35.14 68.93 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.823 0.738 . . . . 0.0 110.996 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 76.0 t -72.25 -42.01 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -60.01 -29.99 68.84 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.399 1.079 . . . . 0.0 112.705 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -52.56 -47.36 66.86 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 118.272 0.487 . . . . 0.0 110.708 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.91 -73.98 0.24 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -101.47 144.64 28.96 Favored Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 121.051 -1.031 . . . . 0.0 111.615 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.62 108.48 2.64 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.256 2.637 . . . . 0.0 111.556 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 66.8 mt -73.18 -31.47 64.23 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.967 0.907 . . . . 0.0 110.908 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 71.08 -103.71 1.28 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 108.244 -1.942 . . . . 0.0 108.244 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.02 168.44 10.27 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 10.8 m -140.17 153.12 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 120.869 -1.144 . . . . 0.0 110.97 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.06 -18.73 49.29 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.773 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 21.0 tp -81.36 111.83 18.08 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -56.6 -34.16 66.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 119.198 -0.429 . . . . 0.0 111.84 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -37.49 65.96 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.25 1.42 . . . . 0.0 112.186 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -101.43 -16.85 16.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.266 0.485 . . . . 0.0 109.742 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -63.76 -38.76 92.32 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.36 -23.4 62.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.138 0.881 . . . . 0.0 111.331 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -89.39 -51.37 5.59 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.614 1.166 . . . . 0.0 109.058 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 22.0 mt -61.43 -34.66 75.77 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.757 -0.59 . . . . 0.0 110.093 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.68 -3.0 5.58 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.392 1.477 . . . . 0.0 112.964 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -61.62 -28.81 69.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.386 1.448 . . . . 0.0 107.445 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -94.54 135.63 23.91 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.9 -11.99 33.27 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.483 2.122 . . . . 0.0 113.285 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -64.83 -46.29 82.54 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.56 -48.65 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 124.412 1.085 . . . . 0.0 108.531 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.77 -49.49 65.43 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 123.545 0.528 . . . . 0.0 110.684 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.8 84.77 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.775 -0.578 . . . . 0.0 111.823 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 21.0 m -61.46 -35.2 76.95 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.0 tpt -71.12 -48.07 54.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 122.857 0.463 . . . . 0.0 110.42 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -58.45 -30.63 67.09 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.54 1.136 . . . . 0.0 111.985 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -64.32 -28.74 69.92 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.2 -0.937 . . . . 0.0 110.335 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.313 0 CA-C-N 118.774 0.716 . . . . 0.0 109.979 178.106 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.451 -1.013 0 N-CA-C 108.487 -1.39 . . . . 0.0 108.487 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -101.14 29.84 4.46 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.423 2.289 . . . . 0.0 112.63 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.1 pt -130.24 154.45 81.41 Favored Pre-proline 0 N--CA 1.47 0.573 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.1 -14.15 31.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.135 3.223 . . . . 0.0 115.163 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -57.04 -16.27 6.85 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.449 1.499 . . . . 0.0 112.394 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -32.98 71.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.443 0.697 . . . . 0.0 110.141 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 37.4 p -60.85 -48.25 82.66 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 119.115 0.87 . . . . 0.0 111.405 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.54 94.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.608 0.763 . . . . 0.0 109.147 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -52.98 -53.99 41.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.459 1.104 . . . . 0.0 111.692 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -62.63 -47.22 84.7 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.804 0.729 . . . . 0.0 110.42 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -60.59 -31.33 70.48 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.782 0.433 . . . . 0.0 111.654 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.74 -57.33 5.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.4 1.48 . . . . 0.0 110.617 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.89 -38.16 75.17 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.15 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -48.83 -56.15 9.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.263 0.938 . . . . 0.0 110.994 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -45.7 85.4 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.748 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.82 -41.88 71.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.3 -53.31 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.513 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 49.3 mm -62.76 -36.54 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.014 0.824 . . . . 0.0 110.064 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.32 -50.62 73.29 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.114 0.87 . . . . 0.0 109.599 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.49 -52.24 58.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.647 0.779 . . . . 0.0 111.152 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -59.26 -29.01 67.25 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.036 1.334 . . . . 0.0 114.115 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 7.7 m -93.26 -3.9 52.83 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.581 0.752 . . . . 0.0 110.95 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 69.02 23.35 76.07 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 35.4 mtt-85 -80.73 -33.22 35.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -150.45 148.03 28.25 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 10.8 t -71.55 166.6 21.49 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.592 0.71 . . . . 0.0 109.426 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.78 -44.65 99.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.174 1.79 . . . . 0.0 110.771 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -55.4 -47.06 76.47 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.158 0.583 . . . . 0.0 111.251 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -78.47 -38.02 42.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.113 0.565 . . . . 0.0 111.262 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.13 89.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.454 -0.779 . . . . 0.0 110.825 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.0 mt -77.25 -30.06 54.29 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.26 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -58.22 -49.2 77.91 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.349 1.431 . . . . 0.0 108.645 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -51.03 -54.53 23.81 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.737 2.015 . . . . 0.0 108.638 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.84 -49.77 76.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.605 1.562 . . . . 0.0 112.879 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -54.76 -37.15 65.62 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.11 1.364 . . . . 0.0 109.412 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 20.0 m -66.4 -37.96 86.42 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.127 0.571 . . . . 0.0 110.944 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -66.11 -31.02 71.63 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.247 -0.908 . . . . 0.0 109.912 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.0 mt -80.22 -38.26 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.762 0.825 . . . . 0.0 111.292 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.5 p -73.61 -12.98 60.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.468 1.031 . . . . 0.0 110.9 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 51.3 tttm . . . . . 0 C--O 1.251 1.139 0 C-N-CA 124.689 1.196 . . . . 0.0 109.01 178.842 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -62.33 123.87 19.38 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 131.18 3.792 . . . . 0.0 109.491 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.97 39.54 93.27 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.995 1.284 . . . . 0.0 112.634 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -146.08 -179.15 6.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.468 1.107 . . . . 0.0 108.392 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.1 mt -145.6 144.64 30.59 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 128.539 2.735 . . . . 0.0 106.864 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.0 t -145.37 129.88 12.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.727 1.611 . . . . 0.0 107.222 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.59 141.59 46.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.773 0.829 . . . . 0.0 109.391 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -120.42 164.87 15.71 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.313 1.045 . . . . 0.0 111.812 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 13' ' ' GLY . 3.6 mt -136.79 136.32 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.828 1.251 . . . . 0.0 111.545 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -117.66 12.01 13.87 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.963 1.705 . . . . 0.0 110.655 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 11' ' ' ILE . . . -161.74 59.18 0.29 Allowed Glycine 0 C--N 1.339 0.724 0 O-C-N 119.974 -1.704 . . . . 0.0 115.689 -177.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 33.23 48.93 0.18 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.552 1.941 . . . . 0.0 115.019 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 168.8 10.7 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.32 64.89 3.71 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -69.74 -23.57 63.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.079 -0.962 . . . . 0.0 112.757 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -64.72 -57.28 9.4 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-N 119.428 1.013 . . . . 0.0 108.856 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.98 -40.52 73.5 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.3 tp -68.19 -35.92 78.76 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.077 0.951 . . . . 0.0 112.034 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.47 97.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.169 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.38 -35.13 73.35 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.919 0.781 . . . . 0.0 110.096 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.69 -42.61 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.39 -38.77 95.3 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -63.45 -47.03 83.55 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.729 1.265 . . . . 0.0 107.909 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -58.76 -58.38 8.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -53.1 -45.11 68.09 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.909 1.232 . . . . 0.0 112.236 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.19 -23.33 66.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.434 1.494 . . . . 0.0 110.937 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HA ' ' HZ2' ' A' ' 29' ' ' LYS . 1.1 tppm? -92.16 -17.28 25.13 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.277 -1.514 . . . . 0.0 112.437 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.73 -7.0 22.05 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 124.247 0.967 . . . . 0.0 109.551 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 59.1 p -133.47 -34.42 1.05 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.495 1.118 . . . . 0.0 113.823 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.64 -17.91 58.44 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.696 1.141 . . . . 0.0 112.808 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.9 128.01 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.33 145.79 52.89 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.8 t -138.44 83.25 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.3 m -73.62 151.25 40.9 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.3 t -139.81 118.52 11.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.541 1.537 . . . . 0.0 107.942 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -143.86 157.34 44.43 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.855 0.752 . . . . 0.0 111.247 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -117.95 54.82 1.91 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.37 1.468 . . . . 0.0 112.218 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -69.42 123.89 10.67 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.83 2.353 . . . . 0.0 111.59 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -13.64 58.99 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 127.818 2.447 . . . . 0.0 114.398 -178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.24 21.1 11.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.245 1.418 . . . . 0.0 113.727 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.37 -23.35 56.7 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.16 -26.75 61.09 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -106.72 -20.57 13.31 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.205 0.526 . . . . 0.0 110.675 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -75.92 -56.42 4.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -40.01 -57.82 2.54 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-O 116.743 -1.599 . . . . 0.0 112.354 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.96 -44.29 25.67 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.803 1.669 . . . . 0.0 114.219 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.5 mm100 -64.01 -49.13 73.64 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.472 1.109 . . . . 0.0 112.337 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 t -72.08 -39.18 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.474 0.71 . . . . 0.0 110.366 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.62 -28.61 63.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 120.949 -1.094 . . . . 0.0 113.018 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.47 -14.32 27.92 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.165 0.893 . . . . 0.0 112.813 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.9 m -118.15 4.22 12.0 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.945 1.298 . . . . 0.0 111.081 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.52 0.43 88.12 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.279 0.942 . . . . 0.0 113.71 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.23 -10.61 58.47 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.643 -1.504 . . . . 0.0 113.277 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.92 -179.05 19.84 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.69 -177.78 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 125.222 3.948 . . . . 0.0 113.45 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.53 -25.88 13.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.262 0.554 . . . . 0.0 111.057 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 mt -146.27 154.63 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 tp -137.31 146.28 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -132.2 111.9 11.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.61 1.564 . . . . 0.0 108.02 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -156.99 -167.04 2.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.161 0.892 . . . . 0.0 112.271 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.01 143.62 50.72 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.127 0.971 . . . . 0.0 110.865 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -56.8 -41.62 78.08 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.775 1.23 . . . . 0.0 109.541 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -67.84 -5.37 16.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.436 2.294 . . . . 0.0 114.101 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -111.91 -10.18 13.99 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.891 0.876 . . . . 0.0 110.301 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -86.73 4.04 42.4 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.415 1.486 . . . . 0.0 110.254 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.24 -9.6 84.84 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.369 -1.457 . . . . 0.0 109.6 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.56 -70.59 1.16 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.542 1.544 . . . . 0.0 112.191 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -46.7 -47.56 20.41 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.707 1.603 . . . . 0.0 112.966 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.36 -45.06 94.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.379 1.071 . . . . 0.0 111.343 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.53 -46.66 83.58 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.3 m -65.61 -4.86 6.8 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.256 0.623 . . . . 0.0 112.289 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.87 13.32 83.54 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.837 1.684 . . . . 0.0 112.274 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.2 mt -73.87 -17.82 61.0 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.211 1.006 . . . . 0.0 111.67 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mt -95.22 136.41 35.59 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 121.136 -0.977 . . . . 0.0 111.167 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.98 170.42 16.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 123.954 0.784 . . . . 0.0 111.826 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -69.04 115.34 8.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 mm -72.14 158.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.23 0.538 . . . . 0.0 110.291 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.5 m 60.72 84.02 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.032 1.733 . . . . 0.0 109.786 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.06 -27.59 29.62 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.643 1.562 . . . . 0.0 111.158 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -136.34 144.87 44.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.153 1.381 . . . . 0.0 110.815 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -52.35 -37.96 57.5 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.484 1.914 . . . . 0.0 112.833 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.63 -37.63 68.44 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.375 0.989 . . . . 0.0 112.002 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -60.28 -25.72 65.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.427 0.691 . . . . 0.0 111.869 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -67.04 -48.16 69.18 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -19.5 61.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 125.413 1.485 . . . . 0.0 113.401 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.26 -15.21 62.88 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.497 -0.752 . . . . 0.0 110.888 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.9 mt -124.18 154.83 39.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.444 1.498 . . . . 0.0 108.519 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -67.59 152.52 96.19 Favored Pre-proline 0 CA--C 1.54 0.576 0 O-C-N 121.663 -0.648 . . . . 0.0 110.133 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.2 -36.27 7.45 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.109 2.539 . . . . 0.0 114.675 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -63.59 -43.18 97.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.437 0.562 . . . . 0.0 111.088 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -23.28 62.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.353 1.461 . . . . 0.0 111.667 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -70.45 -22.63 62.67 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.561 1.073 . . . . 0.0 110.621 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.61 -23.74 67.36 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.35 1.06 . . . . 0.0 111.189 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.36 -17.38 60.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.256 1.022 . . . . 0.0 113.424 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.67 14.94 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.46 168.78 4.28 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 122.723 1.249 . . . . 0.0 112.083 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -159.93 177.97 10.22 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 129.008 2.923 . . . . 0.0 105.168 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -64.12 99.01 0.24 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.492 1.117 . . . . 0.0 111.097 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.88 -84.88 0.47 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 124.588 1.09 . . . . 0.0 110.892 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 153.46 41.84 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.784 0.802 . . . . 0.0 109.968 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.6 mt -91.62 152.06 20.42 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.4 pt -111.77 -27.73 2.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.831 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.92 174.76 14.68 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.478 1.035 . . . . 0.0 108.771 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.7 150.5 68.62 Favored Pre-proline 0 C--O 1.239 0.517 0 C-N-CA 124.386 1.075 . . . . 0.0 110.209 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.83 141.68 41.45 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.266 2.644 . . . . 0.0 107.851 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.3 mm -126.44 -45.51 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.691 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.37 122.34 10.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -90.36 118.68 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.482 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 54.7 mt . . . . . 0 C--O 1.236 0.387 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.6 p90 . . . . . 0 N--CA 1.451 -0.38 0 C-N-CA 124.799 1.239 . . . . 0.0 110.576 -179.673 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo . . . . . 0 N--CA 1.46 -0.486 0 N-CA-C 110.868 -0.474 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -118.13 -2.5 11.2 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.296 -0.877 . . . . 0.0 112.71 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -169.41 160.48 9.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.416 1.087 . . . . 0.0 108.443 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -67.88 -24.57 65.25 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.091 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -69.93 -13.92 62.47 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.228 0.922 . . . . 0.0 112.183 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -90.67 -21.67 21.54 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.337 1.055 . . . . 0.0 110.209 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.3 mm -55.76 -57.37 21.87 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-O 117.83 -1.081 . . . . 0.0 109.214 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.87 -20.4 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 120.983 1.387 . . . . 0.0 113.163 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.58 -40.45 66.6 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.249 1.02 . . . . 0.0 112.067 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 27.5 tp -94.85 -22.92 17.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.492 1.117 . . . . 0.0 112.077 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -61.28 -35.39 77.17 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.785 -1.197 . . . . 0.0 111.252 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -75.54 -33.94 60.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.885 1.274 . . . . 0.0 111.188 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -70.21 -45.5 66.47 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.43 -32.37 73.2 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.77 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -70.96 -28.95 64.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.597 0.635 . . . . 0.0 109.566 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.88 -26.6 63.32 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.404 0.547 . . . . 0.0 111.102 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.61 -1.21 16.94 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.122 0.969 . . . . 0.0 112.812 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.21 -98.72 0.12 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -142.18 178.74 7.34 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.623 1.169 . . . . 0.0 112.062 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.2 p -53.98 156.09 3.13 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.74 1.616 . . . . 0.0 113.088 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.74 -58.51 2.55 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.678 1.591 . . . . 0.0 109.959 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.51 142.69 47.35 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.484 0.714 . . . . 0.0 112.075 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 55.5 mtp -144.97 135.48 24.32 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 128.308 2.643 . . . . 0.0 105.749 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -156.19 168.63 26.69 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.069 1.748 . . . . 0.0 107.48 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.606 HD21 ' HB2' ' A' ' 210' ' ' TYR . 37.9 t-20 -75.93 126.26 30.66 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.9 mp -114.62 -8.14 12.72 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.607 0.639 . . . . 0.0 110.623 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -80.0 -10.28 59.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.307 2.243 . . . . 0.0 112.213 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -115.64 137.55 23.27 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 119.628 1.104 . . . . 0.0 108.206 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.59 -27.66 32.43 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.617 1.545 . . . . 0.0 112.14 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -65.95 -25.3 67.06 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 118.938 0.79 . . . . 0.0 112.015 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -85.58 -9.88 56.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.431 1.014 . . . . 0.0 112.286 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 13.1 p -112.58 -19.86 11.93 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.024 0.929 . . . . 0.0 110.343 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -54.84 41.31 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.01 -24.72 59.19 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.17 1.913 . . . . 0.0 113.515 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.7 tt -69.17 -65.38 0.72 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 37.0 pt -58.66 -28.94 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.981 0.913 . . . . 0.0 113.179 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.78 -22.15 63.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.752 0.821 . . . . 0.0 112.62 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -49.18 -57.12 7.25 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.904 2.081 . . . . 0.0 114.863 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -67.1 -49.2 65.79 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.293 0.371 . . . . 0.0 111.785 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.55 49.19 0.05 OUTLIER Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.517 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -116.76 133.27 10.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -147.51 143.7 28.02 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.91 -68.14 0.46 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -139.01 151.09 46.54 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.557 0.743 . . . . 0.0 111.474 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -74.51 128.77 36.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -151.46 104.46 3.07 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -155.87 155.03 32.2 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 55.03 20.87 3.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.328 1.451 . . . . 0.0 114.429 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.4 6.51 83.76 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 119.416 1.007 . . . . 0.0 113.082 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.65 117.65 32.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 125.703 1.601 . . . . 0.0 107.641 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -116.85 119.17 34.56 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.749 2.02 . . . . 0.0 106.14 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -135.72 110.61 8.77 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.519 0.728 . . . . 0.0 109.059 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.44 0.39 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.215 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -76.98 -19.61 57.1 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.971 -1.081 . . . . 0.0 110.712 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -102.83 96.49 6.87 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.628 1.971 . . . . 0.0 106.52 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 70.8 t -125.68 147.24 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.83 1.252 . . . . 0.0 110.612 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -127.99 22.26 5.43 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 118.333 -1.26 . . . . 0.0 115.574 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.26 -40.33 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.807 2.303 . . . . 0.0 111.907 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -90.47 19.5 5.22 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.496 0.718 . . . . 0.0 112.786 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -70.61 155.23 41.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 120.384 -1.447 . . . . 0.0 110.487 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.51 92.0 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.398 0.679 . . . . 0.0 109.482 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.58 95.78 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.56 -50.82 56.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 117.324 0.562 . . . . 0.0 110.197 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -63.1 -36.21 82.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.583 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.31 74.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.91 0.884 . . . . 0.0 112.187 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -84.85 -24.47 45.28 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 118.612 0.642 . . . . 0.0 112.229 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 52.3 tp -76.39 -49.55 16.47 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.181 0.993 . . . . 0.0 112.401 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.4 -31.99 56.21 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 118.606 0.639 . . . . 0.0 110.433 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -56.57 -44.08 80.65 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.555 1.542 . . . . 0.0 109.891 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -40.74 94.63 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.238 -0.914 . . . . 0.0 110.548 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 22.2 t -64.14 -38.55 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 C-N-CA 125.028 1.331 . . . . 0.0 109.347 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -59.92 -46.95 87.75 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.328 1.451 . . . . 0.0 110.792 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.3 mt -65.9 -37.8 87.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.03 0.832 . . . . 0.0 109.85 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 59.7 mt -67.46 -37.73 79.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -61.47 -41.72 97.68 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.25 -14.76 62.34 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.673 1.189 . . . . 0.0 111.715 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt 60.99 4.44 0.81 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.433 2.693 . . . . 0.0 112.77 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.79 -12.91 60.27 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.312 -0.243 . . . . 0.0 110.862 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 4.2 tpt -88.97 154.78 19.94 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.56 -0.712 . . . . 0.0 110.646 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -82.84 64.3 7.39 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.14 -14.49 4.07 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.59 -15.07 27.35 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.989 1.316 . . . . 0.0 112.761 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 57.4 m -66.71 137.59 56.79 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.094 0.958 . . . . 0.0 111.929 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -131.13 -176.73 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.49 1.916 . . . . 0.0 107.603 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . 0.606 ' HB2' HD21 ' A' ' 150' ' ' ASN . 54.1 t80 -57.53 -45.56 84.9 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.31 -0.244 . . . . 0.0 111.294 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.68 -47.65 76.42 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.189 1.796 . . . . 0.0 111.029 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.89 -48.08 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.844 1.257 . . . . 0.0 110.57 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.16 83.28 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.814 0.734 . . . . 0.0 110.674 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.93 -52.1 40.08 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.27 -49.07 77.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.894 0.478 . . . . 0.0 111.612 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.62 -44.22 89.9 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -61.29 -40.66 94.96 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -58.97 -16.11 16.37 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.623 1.169 . . . . 0.0 113.513 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.0 -13.39 14.1 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.684 1.194 . . . . 0.0 111.387 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.49 18.82 58.07 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.832 1.206 . . . . 0.0 111.098 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -66.97 -12.23 59.14 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.818 1.247 . . . . 0.0 111.606 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 43.6 p -113.36 141.84 46.58 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.646 1.978 . . . . 0.0 109.681 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -82.57 -34.79 27.63 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -146.3 164.24 32.99 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.784 2.034 . . . . 0.0 111.304 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.5 t -164.79 169.62 16.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.082 1.353 . . . . 0.0 107.687 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mt . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.71 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 C--O 1.239 0.501 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -71.36 134.46 24.72 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.927 1.751 . . . . 0.0 108.805 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.6 p -147.26 -172.49 4.02 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.466 1.506 . . . . 0.0 107.574 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.68 137.02 32.8 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -51.37 128.97 23.97 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.426 -0.796 . . . . 0.0 109.936 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.43 -10.5 6.35 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.863 1.105 . . . . 0.0 115.863 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.65 92.37 14.97 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 120.113 1.957 . . . . 0.0 107.943 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.55 161.96 43.75 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.489 2.126 . . . . 0.0 112.293 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 40.8 t -66.54 150.32 49.16 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.913 1.285 . . . . 0.0 108.763 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -139.22 89.19 12.51 Favored Pre-proline 0 N--CA 1.456 -0.171 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -80.94 -174.58 2.29 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.545 2.83 . . . . 0.0 110.476 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 125.121 1.369 . . . . 0.0 109.49 178.387 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.809 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.85 128.6 50.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.682 0.793 . . . . 0.0 110.409 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.5 tt -62.96 138.23 58.5 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.982 1.313 . . . . 0.0 107.646 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.6 m -118.76 144.23 46.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.826 0.822 . . . . 0.0 110.836 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -138.86 136.9 36.06 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -149.66 145.36 13.46 Favored Glycine 0 C--O 1.236 0.232 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 34.5 mt -69.32 134.52 30.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.229 1.012 . . . . 0.0 108.991 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -90.38 113.61 25.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.16 -14.41 37.13 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.958 1.303 . . . . 0.0 112.934 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.71 78.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.366 0.985 . . . . 0.0 111.88 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 48.7 m -62.13 164.86 9.66 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 123.101 0.25 . . . . 0.0 110.654 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -89.43 -26.17 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.797 2.331 . . . . 0.0 117.06 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -127.68 90.03 3.04 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.664 1.12 . . . . 0.0 110.537 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -62.99 -14.99 54.61 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.656 0.382 . . . . 0.0 111.907 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -66.03 -41.35 91.06 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 75.3 mt -57.0 -37.51 71.78 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.375 -0.828 . . . . 0.0 110.148 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.92 -48.04 60.09 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 122.041 -0.412 . . . . 0.0 110.789 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -31.44 71.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.981 -0.533 . . . . 0.0 111.152 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -75.86 -42.51 49.19 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.95 -46.04 90.69 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.952 1.251 . . . . 0.0 108.855 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.9 mp -63.65 -48.1 78.59 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 117.509 -1.234 . . . . 0.0 110.973 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -79.9 -20.55 45.56 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -97.79 -20.18 17.7 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.949 1.704 . . . . 0.0 113.019 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -138.6 -33.55 0.66 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-O 117.503 -1.237 . . . . 0.0 114.198 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.4 -57.1 4.09 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 121.167 1.803 . . . . 0.0 111.797 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.46 23.54 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 128.1 2.56 . . . . 0.0 114.137 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 77.2 p -98.65 160.99 13.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -65.08 -30.67 71.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -71.0 -47.43 58.87 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.353 1.061 . . . . 0.0 111.202 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -63.43 -47.34 88.3 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.12 -41.03 97.84 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.299 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -64.17 -43.27 95.64 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.434 0.561 . . . . 0.0 109.539 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.67 -43.5 85.07 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.587 0.631 . . . . 0.0 112.385 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 41.4 t -71.05 -38.45 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.718 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -68.54 -26.75 65.58 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.449 0.568 . . . . 0.0 111.797 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -66.43 -50.97 61.6 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.76 -52.12 65.54 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 119.085 -0.483 . . . . 0.0 112.23 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -140.6 147.42 48.99 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-N 119.04 0.836 . . . . 0.0 109.419 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.93 123.26 11.36 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.33 2.02 . . . . 0.0 111.06 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 28.5 mt -94.52 -6.91 42.69 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.728 1.211 . . . . 0.0 112.519 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 63.12 -141.92 46.91 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 107.018 -2.433 . . . . 0.0 107.018 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.1 176.45 9.66 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.95 157.11 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 120.683 -1.26 . . . . 0.0 112.941 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -82.4 -25.3 33.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.34 111.2 7.33 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -56.8 -33.56 66.81 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.8 m -54.67 -57.26 12.19 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.842 1.257 . . . . 0.0 110.35 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -81.03 -13.04 59.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.684 0.794 . . . . 0.0 112.414 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -63.73 -33.13 74.96 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -69.52 -17.33 63.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.379 0.672 . . . . 0.0 111.284 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.472 ' HA ' ' HE2' ' A' ' 313' ' ' LYS . 45.1 mm-40 -93.73 -46.15 7.36 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.471 1.508 . . . . 0.0 109.415 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 7.1 mt -69.15 -34.37 74.89 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.264 -0.897 . . . . 0.0 110.463 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.05 -15.97 48.59 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 310' ' ' GLU . 54.2 mttm -54.3 -34.64 61.35 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 118.912 0.778 . . . . 0.0 110.699 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -93.22 136.01 24.95 Favored Pre-proline 0 N--CA 1.448 -0.549 0 C-N-CA 123.983 0.913 . . . . 0.0 110.35 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.98 -23.03 75.38 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.372 2.048 . . . . 0.0 114.472 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.72 -47.9 81.09 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 119.24 0.927 . . . . 0.0 109.752 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.2 mp -67.82 -59.2 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.079 1.352 . . . . 0.0 109.526 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.94 -46.52 64.76 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.61 -37.82 76.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 119.39 0.995 . . . . 0.0 112.597 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 88.6 m -68.68 -37.1 79.32 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.038 0.935 . . . . 0.0 108.97 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.6 tpt -66.04 -48.13 72.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.273 1.029 . . . . 0.0 109.883 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -58.82 -37.59 76.73 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.993 0.815 . . . . 0.0 110.412 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -69.39 -37.28 77.46 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.537 0 CA-C-N 118.959 0.799 . . . . 0.0 110.829 178.271 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.456 -0.7 0 CA-C-O 121.42 0.508 . . . . 0.0 113.24 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -81.53 73.79 8.55 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 6.1 pt -132.15 157.77 77.34 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 126.177 1.791 . . . . 0.0 109.935 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -71.15 -33.82 11.03 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.952 1.768 . . . . 0.0 111.76 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.77 -19.64 29.51 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 6.2 mmt -64.62 -29.73 70.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.656 0.662 . . . . 0.0 109.644 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 20.1 m -56.38 -53.49 56.75 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.001 0.92 . . . . 0.0 110.544 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.41 -39.75 64.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.644 -1.169 . . . . 0.0 110.549 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -48.39 -55.87 9.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.433 1.015 . . . . 0.0 112.147 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -60.31 -53.04 62.37 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.946 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -60.23 -42.65 95.67 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 118.705 0.684 . . . . 0.0 112.766 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -58.84 -56.68 19.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.132 1.373 . . . . 0.0 110.254 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 33.6 t -65.96 -38.78 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 118.47 -0.776 . . . . 0.0 110.023 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -54.11 -45.77 71.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.685 1.13 . . . . 0.0 108.18 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 28.0 m -70.13 -46.35 64.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.584 -0.722 . . . . 0.0 110.253 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -51.21 -45.04 61.75 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.189 0.904 . . . . 0.0 112.661 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.08 -57.96 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 125.126 1.37 . . . . 0.0 108.457 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 48.0 mm -60.57 -38.46 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.264 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -60.03 -48.14 82.96 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.669 1.122 . . . . 0.0 109.288 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.93 -49.14 60.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.858 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.51 -23.67 66.08 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.934 1.294 . . . . 0.0 113.319 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.3 m -94.79 -2.66 50.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.397 0.679 . . . . 0.0 109.945 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.41 12.63 69.86 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.753 0.706 . . . . 0.0 111.534 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -69.93 -36.04 75.01 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.02 0.928 . . . . 0.0 109.827 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -142.18 164.83 29.09 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.44 HG23 ' H ' ' A' ' 359' ' ' GLU . 15.4 t -81.37 159.96 24.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.07 -52.63 42.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 124.917 1.287 . . . . 0.0 109.843 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.47 -47.81 69.43 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 127.115 2.166 . . . . 0.0 111.42 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . 0.44 ' H ' HG23 ' A' ' 356' ' ' THR . 47.6 mm-40 -75.46 -33.26 60.85 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.733 0.697 . . . . 0.0 111.174 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.56 85.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.1 mp -68.35 -45.91 71.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.571 1.949 . . . . 0.0 110.445 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -55.52 -58.09 9.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.24 1.016 . . . . 0.0 108.536 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -53.3 -42.25 66.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.166 2.187 . . . . 0.0 112.084 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -68.66 -49.82 56.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.878 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -58.68 -32.25 68.95 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.21 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 6.6 m -63.38 -36.48 83.85 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.93 1.241 . . . . 0.0 110.62 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 12.2 mtt85 -65.84 -30.84 71.53 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.95 -1.094 . . . . 0.0 110.908 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 36.5 mt -82.58 -37.98 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.633 1.573 . . . . 0.0 111.15 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 65.9 p -78.29 -12.09 59.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.763 1.165 . . . . 0.0 112.921 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? . . . . . 0 C--O 1.254 1.294 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.025 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 . . . . . 0 C--O 1.232 0.137 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -81.18 -176.08 5.78 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.808 2.043 . . . . 0.0 109.342 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.33 29.48 73.29 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.129 -0.982 . . . . 0.0 114.759 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.99 162.12 37.69 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.252 1.021 . . . . 0.0 111.285 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.6 mt -152.53 147.4 26.16 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 130.095 3.358 . . . . 0.0 106.59 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.5 t -144.95 146.46 19.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.123 1.369 . . . . 0.0 108.639 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.5 mt -134.79 139.4 47.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -126.73 124.49 39.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.436 HG22 ' H ' ' A' ' 12' ' ' ASN . 1.5 mp -131.9 171.63 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.165 1.386 . . . . 0.0 108.327 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.436 ' H ' HG22 ' A' ' 11' ' ' ILE . 14.8 p-10 -103.94 157.28 17.21 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.403 1.481 . . . . 0.0 109.345 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.46 -22.15 60.98 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 125.608 1.575 . . . . 0.0 114.4 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -77.39 -3.11 38.52 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.522 1.661 . . . . 0.0 109.91 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.14 160.86 15.74 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 120.883 -1.136 . . . . 0.0 110.566 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.81 75.55 2.36 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.771 1.177 . . . . 0.0 110.238 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -74.38 -24.6 59.16 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -73.33 -43.1 61.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.744 1.611 . . . . 0.0 110.535 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.75 -30.66 73.18 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.3 tp -74.91 -40.69 60.73 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.804 1.242 . . . . 0.0 110.958 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.14 -46.97 54.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.115 0.566 . . . . 0.0 109.967 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -55.66 -32.85 63.58 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.8 t -64.89 -41.14 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.07 -38.47 73.57 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.021 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -59.36 -43.79 92.77 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.473 1.137 . . . . 0.0 108.325 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -60.22 -55.1 37.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.328 0.651 . . . . 0.0 109.803 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -58.4 -51.84 68.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.749 0.655 . . . . 0.0 111.989 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.43 -31.06 70.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.943 0.897 . . . . 0.0 110.74 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -31.77 71.35 Favored 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 120.752 -1.218 . . . . 0.0 110.198 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.29 -47.12 9.69 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 123.629 0.581 . . . . 0.0 111.961 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -90.05 -32.3 16.79 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 -176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.52 -10.77 72.22 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 120.97 -1.081 . . . . 0.0 111.658 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.29 136.52 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -66.63 134.7 52.83 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 117.785 -1.102 . . . . 0.0 109.359 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -134.31 78.46 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.66 155.55 29.44 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.4 t -141.54 127.91 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -136.53 161.43 35.89 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -123.34 68.13 37.98 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.106 0.963 . . . . 0.0 111.004 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -66.35 170.72 11.61 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.545 2.164 . . . . 0.0 111.114 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -122.97 -3.12 8.63 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.223 -0.923 . . . . 0.0 111.905 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -132.21 12.1 4.62 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.361 1.865 . . . . 0.0 112.785 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.94 -32.48 20.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.073 0.851 . . . . 0.0 112.315 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -52.54 -30.19 29.36 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.51 1.124 . . . . 0.0 112.259 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -116.9 -18.79 10.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.856 0.862 . . . . 0.0 112.206 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -41.38 31.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -51.41 -59.86 6.99 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.762 0.825 . . . . 0.0 109.834 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.47 -17.48 59.74 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 CA-C-N 121.245 1.48 . . . . 0.0 113.617 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -84.08 -5.48 59.24 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.667 1.121 . . . . 0.0 112.391 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.63 -38.85 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.031 0.932 . . . . 0.0 108.805 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.93 -32.54 70.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.213 1.005 . . . . 0.0 111.344 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.98 -31.61 68.91 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.741 0.7 . . . . 0.0 110.562 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.8 m -86.39 -15.97 38.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.598 1.159 . . . . 0.0 110.202 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.79 36.57 5.51 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.198 1.38 . . . . 0.0 110.381 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -132.16 173.71 10.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.691 1.196 . . . . 0.0 108.618 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.13 -160.21 14.77 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 126.497 1.998 . . . . 0.0 113.554 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.27 175.83 2.4 Favored 'Trans proline' 0 C--N 1.356 0.964 1 C-N-CA 125.861 4.374 . . . . 0.0 114.113 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -106.96 -18.59 13.87 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.8 -1.187 . . . . 0.0 113.999 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.4 mt -148.22 135.15 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.33 1.052 . . . . 0.0 109.006 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.2 tt -115.19 142.06 29.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -129.95 107.57 9.46 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.45 1.5 . . . . 0.0 108.16 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.8 t-105 -156.13 -176.67 6.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.966 0.803 . . . . 0.0 111.553 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.35 138.14 51.16 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -46.37 -43.44 16.17 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 126.157 1.783 . . . . 0.0 113.619 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -55.53 -27.76 50.73 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -81.47 -18.66 44.44 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.764 0.711 . . . . 0.0 111.567 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -76.32 -13.51 60.14 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 118.465 -0.779 . . . . 0.0 112.833 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.13 -11.69 33.69 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.284 0.945 . . . . 0.0 113.544 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.95 -63.03 0.92 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -47.53 -56.37 7.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.043 1.737 . . . . 0.0 114.331 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.27 91.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.21 0.604 . . . . 0.0 111.758 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.31 -43.91 75.29 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.068 1.347 . . . . 0.0 109.717 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.5 m -74.87 -1.25 21.49 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.486 1.115 . . . . 0.0 113.347 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.77 18.15 64.22 Favored Glycine 0 C--N 1.337 0.626 0 O-C-N 120.805 -1.184 . . . . 0.0 113.602 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.6 mt -77.65 -32.91 53.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.687 1.244 . . . . 0.0 112.359 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.2 mt -91.45 142.1 28.03 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.476 -0.765 . . . . 0.0 111.706 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.88 172.24 14.05 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.857 1.263 . . . . 0.0 113.167 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -69.93 100.13 1.52 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.585 1.954 . . . . 0.0 108.911 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.9 mm -63.33 153.75 6.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.912 0.863 . . . . 0.0 110.107 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.9 m 60.86 77.44 0.37 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 127.376 2.27 . . . . 0.0 109.725 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 -26.17 21.53 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.274 1.316 . . . . 0.0 110.252 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -129.94 138.09 50.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.523 1.529 . . . . 0.0 110.754 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -57.49 -37.0 72.22 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.74 -24.42 56.9 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.308 1.413 . . . . 0.0 112.953 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.8 -28.23 68.85 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.693 0.679 . . . . 0.0 110.648 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -66.01 -43.96 86.17 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -64.95 -11.84 43.0 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.45 0.7 . . . . 0.0 111.894 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -87.19 -15.89 36.97 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 120.767 -1.208 . . . . 0.0 112.578 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.41 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 25.2 mt -124.17 163.12 22.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.475 1.034 . . . . 0.0 112.625 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -81.23 153.33 71.68 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 123.71 0.804 . . . . 0.0 112.03 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.05 -47.78 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 124.378 3.385 . . . . 0.0 114.216 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -54.05 -36.74 63.4 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.078 1.308 . . . . 0.0 111.937 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.5 -27.68 61.51 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.726 1.61 . . . . 0.0 110.634 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.41 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 12.9 m95 -69.5 -36.79 76.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.631 1.105 . . . . 0.0 109.999 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -63.2 -27.43 69.36 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.632 -0.667 . . . . 0.0 111.063 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.76 -4.16 22.43 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.291 1.437 . . . . 0.0 113.979 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.34 6.91 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 125.4 1.48 . . . . 0.0 111.206 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -71.6 170.67 12.92 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -149.14 -152.14 0.43 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -57.48 -11.76 2.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.536 1.934 . . . . 0.0 115.708 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.38 -85.14 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 105.563 -3.015 . . . . 0.0 105.563 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 162.08 16.98 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.425 0.69 . . . . 0.0 110.706 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.11 158.46 18.56 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.245 1.018 . . . . 0.0 109.614 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.0 pt -117.62 -24.5 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.651 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.81 -178.46 7.38 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.811 1.244 . . . . 0.0 110.051 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.82 149.52 67.1 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 123.895 0.878 . . . . 0.0 111.355 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.01 142.62 28.05 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.843 2.362 . . . . 0.0 109.891 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.3 mm -124.56 -52.76 2.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.698 1.599 . . . . 0.0 108.173 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.34 148.81 43.27 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.827 1.251 . . . . 0.0 109.824 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.5 t -130.51 95.67 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.095 0.958 . . . . 0.0 109.254 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 N--CA 1.472 0.652 0 C-N-CA 124.491 1.117 . . . . 0.0 109.277 178.638 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.9 p90 . . . . . 0 C--O 1.236 0.39 0 C-N-CA 123.96 0.904 . . . . 0.0 109.086 178.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.455 -0.745 0 N-CA-C 108.721 -1.3 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -80.72 -25.55 38.01 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.045 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.6 t -154.67 162.69 41.02 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.413 1.006 . . . . 0.0 109.689 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -65.75 -25.79 67.44 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 123.864 0.866 . . . . 0.0 111.786 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -71.56 -19.27 62.17 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.923 1.238 . . . . 0.0 109.79 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -89.37 -22.88 22.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.368 1.067 . . . . 0.0 111.125 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 15.8 mm -54.73 -59.33 10.81 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.195 -0.907 . . . . 0.0 108.796 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -69.87 -25.02 28.5 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.222 1.281 . . . . 0.0 111.47 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.16 -50.36 70.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 64.0 tp -70.13 -31.74 69.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -59.09 -44.76 91.95 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 118.684 0.674 . . . . 0.0 111.305 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -30.12 61.37 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.551 0.614 . . . . 0.0 110.832 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -66.27 -50.89 62.17 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.1 mt -67.48 -33.01 74.24 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.562 -1.208 . . . . 0.0 110.287 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -68.87 -34.62 75.74 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.931 1.241 . . . . 0.0 108.971 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.38 -16.36 62.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.378 0.536 . . . . 0.0 112.018 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.24 7.5 6.5 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.173 1.389 . . . . 0.0 112.121 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 170.92 -94.52 0.1 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 115.737 1.055 . . . . 0.0 115.737 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.74 -178.88 5.44 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.38 1.072 . . . . 0.0 113.58 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.64 169.08 9.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.803 1.287 . . . . 0.0 112.612 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -93.26 -73.12 0.57 Allowed 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.066 1.746 . . . . 0.0 109.292 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.9 tp -103.42 130.4 50.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.261 1.024 . . . . 0.0 112.749 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 76.7 mtp -131.37 117.3 18.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -143.22 156.31 44.72 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.69 88.22 0.35 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.746 1.618 . . . . 0.0 109.577 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -18.04 63.38 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.067 1.347 . . . . 0.0 109.812 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -71.41 -13.14 61.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.536 0.734 . . . . 0.0 112.644 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -103.76 129.3 25.57 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 119.19 0.905 . . . . 0.0 109.739 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.92 -10.41 23.03 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.786 2.324 . . . . 0.0 113.248 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -65.44 -42.09 92.75 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.796 1.638 . . . . 0.0 112.758 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -79.52 -32.67 42.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.6 p -84.33 -11.68 55.93 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.274 0.63 . . . . 0.0 111.77 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -53.75 -58.86 11.33 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 117.625 -1.178 . . . . 0.0 112.044 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.53 -18.01 58.53 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.281 1.493 . . . . 0.0 114.055 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.0 tp -71.35 -63.77 1.05 Allowed 'General case' 0 C--N 1.34 0.193 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.4 pt -66.41 -36.03 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.26 -12.97 59.54 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.121 -0.943 . . . . 0.0 113.095 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -44.63 -55.95 4.78 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 125.513 1.525 . . . . 0.0 114.06 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.78 -34.68 74.86 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.53 19.73 0.02 OUTLIER Glycine 0 C--N 1.332 0.335 0 CA-C-O 118.294 -1.281 . . . . 0.0 116.068 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.13 144.1 34.21 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 119.402 1.601 . . . . 0.0 111.548 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.428 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 51.7 p90 -153.86 144.99 22.85 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.46 -49.56 12.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -145.9 133.67 21.16 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.646 0.778 . . . . 0.0 109.658 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.428 ' HE2' ' CE1' ' A' ' 167' ' ' TYR . 14.5 tppt? -70.65 149.53 46.92 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.522 0.729 . . . . 0.0 110.037 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -143.32 113.06 7.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -156.07 170.03 23.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 55.96 26.96 10.49 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.603 1.161 . . . . 0.0 111.495 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 56.17 43.79 88.88 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -149.5 166.54 28.85 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 126.69 1.996 . . . . 0.0 108.198 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.19 127.65 54.96 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -126.7 87.78 2.72 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 123.117 1.437 . . . . 0.0 112.184 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -8.92 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.403 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -74.54 -12.34 60.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.373 1.069 . . . . 0.0 108.987 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -118.94 93.57 4.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.244 1.417 . . . . 0.0 108.349 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 86.8 t -99.03 147.2 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -129.89 44.77 1.19 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-O 119.185 -0.786 . . . . 0.0 111.947 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.3 t -86.76 -63.42 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 124.958 1.303 . . . . 0.0 108.725 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -85.9 67.63 10.08 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 122.538 1.161 . . . . 0.0 110.029 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -121.48 159.34 26.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.93 -38.89 70.89 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -56.46 -46.66 87.24 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.702 0.683 . . . . 0.0 113.503 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.43 -52.6 60.84 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.891 0.476 . . . . 0.0 111.349 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -64.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 118.318 -0.849 . . . . 0.0 111.879 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.31 -51.91 39.44 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.73 -38.99 94.68 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 56.1 tp -70.61 -45.2 65.71 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 118.291 -0.862 . . . . 0.0 111.324 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.12 -37.92 67.51 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 117.313 -1.327 . . . . 0.0 110.736 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -52.17 -48.71 64.83 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.784 1.629 . . . . 0.0 111.344 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.7 tt -69.22 -48.01 63.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.114 0.566 . . . . 0.0 110.645 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.66 -35.15 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 121.38 -0.825 . . . . 0.0 111.41 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.01 -29.6 69.47 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.204 -0.935 . . . . 0.0 109.279 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.94 -42.3 60.74 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 65.8 mt -58.38 -47.9 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -52.18 -51.29 58.98 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.181 1.392 . . . . 0.0 109.73 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -78.47 0.9 24.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.158 0.983 . . . . 0.0 112.087 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt 60.78 12.06 3.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 128.109 2.564 . . . . 0.0 113.812 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.79 6.35 1.2 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 127.272 2.229 . . . . 0.0 111.806 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 14.3 ttt -147.49 143.8 28.11 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.108 1.322 . . . . 0.0 109.649 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -83.36 70.28 10.14 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -47.81 -40.31 20.75 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.492 2.717 . . . . 0.0 116.388 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -72.02 0.23 9.95 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.044 1.738 . . . . 0.0 114.113 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.8 m -65.37 123.18 18.93 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.008 -1.058 . . . . 0.0 110.512 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.1 -172.65 2.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.073 1.749 . . . . 0.0 108.241 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -60.2 -50.57 73.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.649 0.38 . . . . 0.0 110.91 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.1 m -60.89 -41.07 95.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.537 0.735 . . . . 0.0 111.132 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 41.4 mm -65.59 -49.33 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.879 -1.058 . . . . 0.0 108.556 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.16 -46.15 90.27 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.235 1.014 . . . . 0.0 111.707 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -62.78 -48.08 80.68 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.91 1.284 . . . . 0.0 108.888 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.53 87.81 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.94 99.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -62.22 -39.08 91.61 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -57.32 -20.2 27.06 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.558 1.543 . . . . 0.0 111.774 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.38 -13.14 12.9 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.889 -1.132 . . . . 0.0 112.095 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.44 28.31 40.26 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.213 1.387 . . . . 0.0 110.47 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.83 7.18 4.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.585 1.954 . . . . 0.0 113.372 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.06 160.49 43.28 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 120.683 -1.261 . . . . 0.0 108.905 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -106.34 -15.14 14.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.536 1.534 . . . . 0.0 113.606 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -159.88 153.46 22.57 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.889 1.276 . . . . 0.0 109.976 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 4.3 t -150.02 161.1 43.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 -179.791 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.59 159.43 53.61 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.572 1.515 . . . . 0.0 109.622 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 68.1 p -120.68 -176.4 3.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.369 1.068 . . . . 0.0 109.987 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -100.16 169.35 9.21 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.568 1.076 . . . . 0.0 109.762 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -66.86 126.31 28.66 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.24 3.41 57.02 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 117.848 -1.529 . . . . 0.0 115.327 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.32 137.19 9.2 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 121.706 2.753 . . . . 0.0 114.347 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.42 146.7 40.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.881 2.387 . . . . 0.0 108.568 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.4 p -72.62 173.46 8.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . 0.344 12.8 ptmt -133.32 71.87 75.99 Favored Pre-proline 0 C--O 1.238 0.495 0 O-C-N 120.857 -1.152 . . . . 0.0 112.843 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.88 166.18 30.31 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.704 3.603 . . . . 0.0 113.291 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 . . . . . 0 C--O 1.237 0.439 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.005 179.668 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.99 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 14.9 m -138.21 168.4 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 119.794 1.797 . . . . 0.0 110.979 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 15.6 tp -74.96 152.2 38.8 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.0 m -133.87 129.6 36.64 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 121.122 1.783 . . . . 0.0 111.885 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -116.01 132.87 56.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.1 134.15 6.74 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.101 0.864 . . . . 0.0 112.608 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 81.5 mt -74.58 145.93 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 117.67 0.735 . . . . 0.0 109.842 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -75.52 124.98 28.11 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.315 1.446 . . . . 0.0 109.028 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.12 -22.29 65.8 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.251 -0.906 . . . . 0.0 113.06 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -77.82 -10.61 59.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.696 1.199 . . . . 0.0 112.606 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 70.4 m -65.96 146.45 99.01 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.97 -38.64 3.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.663 1.575 . . . . 0.0 112.672 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -132.23 88.22 2.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.649 0.78 . . . . 0.0 109.419 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -54.7 -22.97 15.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.123 0.969 . . . . 0.0 112.011 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -61.87 -30.68 71.02 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.06 1.344 . . . . 0.0 111.27 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.34 -42.01 94.77 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 121.183 -0.948 . . . . 0.0 108.553 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.19 -40.29 68.0 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.79 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -37.68 86.68 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 118.585 0.63 . . . . 0.0 109.957 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -73.64 -41.01 63.33 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -57.84 -49.69 75.83 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.703 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.8 mp -64.32 -49.36 72.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 119.104 -0.475 . . . . 0.0 111.53 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -71.29 -15.68 62.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -105.7 -19.7 13.68 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.969 1.713 . . . . 0.0 113.961 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -137.52 -45.51 0.55 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 117.923 -1.037 . . . . 0.0 111.843 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -59.15 -55.83 29.9 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.059 1.299 . . . . 0.0 111.68 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.5 mt -84.12 63.41 7.64 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.624 2.37 . . . . 0.0 110.38 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 68.9 p -138.87 161.55 36.99 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.95 -21.72 66.88 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 122.839 0.456 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -96.37 -27.68 14.82 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.052 0.941 . . . . 0.0 110.79 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -80.51 -43.96 8.94 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.568 1.08 . . . . 0.0 112.116 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 35.7 mt -65.22 -40.7 94.44 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -58.13 -47.23 83.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.783 1.233 . . . . 0.0 109.425 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.43 74.52 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.464 1.029 . . . . 0.0 112.839 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 24.8 t -73.54 -35.72 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 118.912 -0.566 . . . . 0.0 109.924 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -68.94 -29.87 68.2 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.807 0.731 . . . . 0.0 110.775 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -64.12 -38.27 90.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -51.14 35.83 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 123.518 0.511 . . . . 0.0 110.21 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -147.79 150.61 36.68 Favored Pre-proline 0 C--N 1.344 0.356 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.693 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.57 115.1 2.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.709 2.939 . . . . 0.0 110.792 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 90.9 mt -91.57 -20.94 21.14 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.23 -158.41 24.65 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.25 175.64 4.48 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 35.8 m -127.71 146.9 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 120.043 -1.661 . . . . 0.0 110.329 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.29 -29.47 63.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.662 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 22.3 tp -68.52 106.31 2.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -52.23 -27.33 14.41 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.007 0.923 . . . . 0.0 112.405 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.4 m -61.64 -70.94 0.16 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.663 0.785 . . . . 0.0 111.042 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -66.98 -21.14 65.97 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.188 0.449 . . . . 0.0 111.39 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -65.08 -25.51 67.83 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.24 -18.21 61.84 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.153 -1.592 . . . . 0.0 110.009 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -89.04 -51.77 5.43 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.999 1.32 . . . . 0.0 107.527 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 47.7 mt -61.26 -41.52 97.05 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.59 3.32 1.9 Allowed 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.672 0.789 . . . . 0.0 112.563 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -59.66 -25.73 64.96 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.486 1.494 . . . . 0.0 109.219 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.91 147.56 37.48 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.52 -14.22 43.16 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.138 2.559 . . . . 0.0 114.585 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -62.1 -56.31 20.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.784 1.174 . . . . 0.0 108.975 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.2 mp -62.85 -51.78 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 125.306 1.442 . . . . 0.0 108.616 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.49 -48.4 62.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 123.447 0.467 . . . . 0.0 110.56 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.22 -33.69 71.28 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 1.3 m -67.21 -41.62 85.46 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -38.79 66.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.084 0.554 . . . . 0.0 111.973 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -53.41 -39.02 64.0 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 124.626 1.17 . . . . 0.0 109.323 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.06 -30.87 68.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.273 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.539 0.772 0 N-CA-C 110.883 -0.468 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -61.02 0.31 0.24 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 22.7 pt -69.5 150.13 96.98 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 120.549 1.522 . . . . 0.0 114.223 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.97 -13.69 39.03 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.236 2.624 . . . . 0.0 114.396 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -71.34 -13.08 61.75 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.998 -1.064 . . . . 0.0 110.727 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 73.8 mmm -66.09 -28.7 69.02 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 121.373 -0.829 . . . . 0.0 111.759 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 29.9 t -55.35 -51.51 66.54 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.98 -39.1 87.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.954 0.901 . . . . 0.0 110.987 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -51.94 -54.76 25.82 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.923 0.889 . . . . 0.0 110.148 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -64.26 -45.65 87.19 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.643 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -53.71 -42.16 67.76 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.377 0.671 . . . . 0.0 110.725 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.0 -62.57 1.32 Allowed 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 125.601 1.56 . . . . 0.0 112.637 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.57 -36.8 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.977 0.911 . . . . 0.0 111.827 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.47 -49.4 45.64 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.75 1.159 . . . . 0.0 110.356 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 6.6 m -73.53 -42.63 61.49 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.14 57.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.822 1.192 . . . . 0.0 112.745 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.2 t -61.28 -56.1 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 32.3 mm -59.96 -37.2 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.24 0.616 . . . . 0.0 110.657 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -57.21 -47.59 80.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.337 0.972 . . . . 0.0 109.539 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.0 -47.95 55.91 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.566 0.747 . . . . 0.0 110.816 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.89 -24.67 66.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.978 0.911 . . . . 0.0 112.924 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 18.5 m -92.16 -8.51 45.39 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.669 1.188 . . . . 0.0 110.513 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 69.97 16.18 72.42 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.608 0.64 . . . . 0.0 111.76 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -76.62 -33.44 58.39 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 118.092 0.946 . . . . 0.0 110.019 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -143.52 148.95 36.76 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 8.9 t -65.98 156.99 32.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 64.6 t -56.88 -47.99 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 123.742 0.817 . . . . 0.0 109.786 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -52.39 -46.6 66.31 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.31 0.644 . . . . 0.0 111.036 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -69.48 -36.46 76.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 119.457 -0.306 . . . . 0.0 111.048 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.09 -45.03 90.49 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 8.1 mt -69.18 -41.31 77.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.345 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -56.58 -49.47 74.77 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.911 1.285 . . . . 0.0 109.307 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -51.94 -56.4 14.42 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.261 1.824 . . . . 0.0 108.786 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.78 -49.85 76.11 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.182 1.393 . . . . 0.0 113.403 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -55.3 -38.5 68.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.579 1.551 . . . . 0.0 109.196 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.7 m -65.75 -42.79 90.52 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.425 -0.797 . . . . 0.0 109.855 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -59.2 -26.59 64.96 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.272 0.942 . . . . 0.0 113.233 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.7 mt -79.51 -25.1 12.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.047 0.939 . . . . 0.0 109.531 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 43.9 p -93.39 -23.65 18.35 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.491 0.716 . . . . 0.0 112.271 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.445 1.498 . . . . 0.0 108.346 -178.55 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -75.57 82.12 2.59 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.2 2.2 . . . . 0.0 108.325 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.71 32.43 0.04 OUTLIER Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.21 -1.359 . . . . 0.0 115.312 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -145.8 166.63 25.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.34 1.57 . . . . 0.0 111.357 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 mt -146.41 145.8 30.38 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.781 2.032 . . . . 0.0 107.195 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.82 144.55 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.945 1.298 . . . . 0.0 108.363 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.1 mt -131.74 135.16 59.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 126.606 1.963 . . . . 0.0 108.243 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -126.05 111.82 15.15 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -140.88 148.11 22.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 C-N-CA 124.426 1.09 . . . . 0.0 109.035 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.31 177.56 11.22 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.196 -0.94 . . . . 0.0 110.384 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.13 55.4 7.93 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-O 118.734 -1.036 . . . . 0.0 110.98 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.3 34.52 20.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.728 1.211 . . . . 0.0 113.424 177.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 20.32 0.06 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 116.261 1.949 . . . . 0.0 116.261 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.11 44.18 98.48 Favored Glycine 0 CA--C 1.536 1.396 0 O-C-N 120.678 -1.264 . . . . 0.0 111.318 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -60.35 -40.2 89.84 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -68.34 -39.79 81.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.026 1.284 . . . . 0.0 108.721 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.06 -35.08 91.6 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.7 tp -71.43 -35.46 70.95 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.799 -0.824 . . . . 0.0 111.546 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.71 -43.1 68.72 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.052 0.842 . . . . 0.0 110.25 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -57.83 -21.46 42.5 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.127 1.371 . . . . 0.0 113.953 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 t -86.34 -47.81 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.23 -41.29 96.9 Favored Glycine 0 C--N 1.335 0.512 0 O-C-N 121.01 -1.056 . . . . 0.0 112.237 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -37.64 88.15 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 117.998 0.899 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -61.23 -53.34 58.14 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -58.96 -47.82 83.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.765 0.426 . . . . 0.0 111.804 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -15.75 53.75 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.789 1.636 . . . . 0.0 110.728 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.488 ' HZ3' ' HA ' ' A' ' 29' ' ' LYS . 1.1 tppm? -94.99 -0.19 54.06 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 120.296 -1.503 . . . . 0.0 113.438 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -115.33 -51.83 2.69 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.894 1.678 . . . . 0.0 107.58 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -93.75 -21.68 19.17 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.27 -18.12 19.75 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.674 -1.266 . . . . 0.0 113.905 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.6 mm -61.47 118.04 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.011 1.406 . . . . 0.0 107.616 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -56.57 145.2 29.0 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 124.869 1.268 . . . . 0.0 112.463 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.1 t -130.16 104.41 10.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.8 m -91.84 127.18 37.2 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.43 115.17 46.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.356 -2.091 . . . . 0.0 105.356 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -127.13 171.73 11.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.345 1.058 . . . . 0.0 110.275 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -138.08 68.16 48.66 Favored Pre-proline 0 N--CA 1.455 -0.199 0 C-N-CA 123.619 0.768 . . . . 0.0 112.894 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.29 139.95 19.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 N-CA-C 107.997 -1.578 . . . . 0.0 107.997 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.58 9.52 41.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.555 1.542 . . . . 0.0 108.978 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.36 2.66 10.28 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.514 1.926 . . . . 0.0 114.112 -177.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pp -53.53 -25.58 17.46 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 117.677 -1.154 . . . . 0.0 113.738 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -57.09 -23.4 46.66 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.988 1.315 . . . . 0.0 113.092 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -124.46 -24.02 4.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.801 0.84 . . . . 0.0 112.368 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -77.88 -48.58 16.07 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.27 1.428 . . . . 0.0 110.77 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -45.12 -56.86 8.23 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 117.85 -1.072 . . . . 0.0 111.376 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.56 -39.58 81.74 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 CA-C-N 120.577 1.242 . . . . 0.0 115.211 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -67.43 -46.58 72.73 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.583 1.083 . . . . 0.0 112.326 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.2 t -68.96 -41.55 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.1 -32.38 71.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.189 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.7 -19.05 57.73 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.951 0.796 . . . . 0.0 110.459 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 m -99.82 -41.7 7.14 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.431 1.492 . . . . 0.0 107.599 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.61 9.14 10.4 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.274 1.416 . . . . 0.0 114.769 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -89.04 -8.53 53.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.374 1.087 . . . . 0.0 112.965 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.83 171.26 45.3 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.442 1.02 . . . . 0.0 114.639 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -64.09 167.79 13.6 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.219 2.613 . . . . 0.0 110.18 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.0 -19.36 22.47 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 126.16 1.784 . . . . 0.0 110.564 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.0 mt -124.24 148.02 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 123.817 0.847 . . . . 0.0 109.812 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.3 tt -141.04 136.64 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -133.37 107.96 8.41 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -154.58 170.87 20.47 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.493 1.042 . . . . 0.0 108.978 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.06 158.27 31.49 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.748 -0.595 . . . . 0.0 110.358 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -55.14 -32.89 62.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.101 0.96 . . . . 0.0 110.168 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.34 -11.11 0.46 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 129.062 2.945 . . . . 0.0 114.912 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -129.63 13.36 5.93 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.014 2.125 . . . . 0.0 109.431 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -115.73 26.48 9.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.655 1.982 . . . . 0.0 111.275 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.27 -19.89 15.21 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 120.467 -1.396 . . . . 0.0 111.894 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -107.05 -35.5 2.73 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 117.948 -1.473 . . . . 0.0 116.075 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -51.68 -45.33 63.42 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.593 2.196 . . . . 0.0 111.464 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.59 95.99 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -32.45 73.2 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.003 1.321 . . . . 0.0 109.592 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.7 m -80.57 -4.62 54.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.386 1.474 . . . . 0.0 110.129 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.54 18.04 76.49 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.912 1.244 . . . . 0.0 112.257 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.5 mt -88.46 -17.58 30.08 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.893 1.346 . . . . 0.0 113.756 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.2 mt -99.41 126.83 45.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.395 0.998 . . . . 0.0 111.277 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.56 164.73 26.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.435 1.094 . . . . 0.0 110.818 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -71.32 94.32 1.2 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.957 1.303 . . . . 0.0 109.17 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.1 pp -74.71 172.91 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 m 67.37 82.75 0.19 Allowed Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 126.141 1.776 . . . . 0.0 111.495 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.91 -34.64 8.36 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.712 1.608 . . . . 0.0 108.529 178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -147.0 155.72 42.47 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.926 0.869 . . . . 0.0 111.817 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -56.36 -33.86 66.09 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.783 2.433 . . . . 0.0 112.896 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.08 -26.75 66.43 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 120.191 1.36 . . . . 0.0 113.214 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -76.09 -26.32 56.33 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 120.25 1.386 . . . . 0.0 109.09 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -62.87 -46.82 86.08 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.229 1.012 . . . . 0.0 109.117 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.48 -14.1 62.02 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -14.73 61.43 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 120.861 -1.149 . . . . 0.0 109.916 178.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mt -120.98 164.37 16.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.292 1.837 . . . . 0.0 107.758 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.86 150.45 81.41 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 121.059 -1.026 . . . . 0.0 111.719 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.06 -49.21 2.17 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.569 2.846 . . . . 0.0 112.118 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -57.79 -25.21 60.22 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.18 -20.33 41.43 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.809 -1.182 . . . . 0.0 110.574 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -72.92 -26.97 61.59 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -53.26 -41.94 65.98 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.91 1.684 . . . . 0.0 110.091 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.17 -6.43 4.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.923 1.289 . . . . 0.0 113.428 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.15 -0.18 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.104 1.361 . . . . 0.0 111.832 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 -63.16 148.98 46.46 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.089 1.313 . . . . 0.0 108.375 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CE1' ' HE2' ' A' ' 102' ' ' LYS . 26.0 t80 -142.02 167.33 22.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -63.7 114.52 4.04 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.455 0.702 . . . . 0.0 110.801 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.9 -84.33 0.3 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 124.65 1.119 . . . . 0.0 111.34 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.445 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -72.83 166.03 23.73 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.21 0.604 . . . . 0.0 109.876 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.73 166.31 10.56 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.38 -40.17 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.96 174.01 11.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.649 0.659 . . . . 0.0 111.096 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -131.68 149.55 73.78 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 124.76 1.224 . . . . 0.0 110.419 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.27 145.62 30.78 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.198 2.599 . . . . 0.0 110.043 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -128.12 -53.66 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.261 1.425 . . . . 0.0 111.043 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.77 155.6 43.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.998 0.817 . . . . 0.0 112.45 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.5 t -130.95 110.1 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.059 0.544 . . . . 0.0 110.652 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 . . . . . 0 N--CA 1.474 0.729 0 CA-C-N 118.716 0.689 . . . . 0.0 112.746 177.717 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mm . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 44.1 p90 . . . . . 0 C--O 1.24 0.59 0 C-N-CA 126.653 1.981 . . . . 0.0 106.565 179.335 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 N--CA 1.454 -0.832 0 N-CA-C 110.137 -0.755 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -143.31 -31.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.715 1.206 . . . . 0.0 112.186 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.39 141.3 27.06 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -64.25 -16.1 61.38 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.039 -1.663 . . . . 0.0 113.203 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.84 -13.12 59.63 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.376 -0.827 . . . . 0.0 111.942 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -90.03 -14.01 34.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.326 0.65 . . . . 0.0 110.377 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.7 mm -53.39 -55.73 31.64 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 125.302 1.441 . . . . 0.0 110.424 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.98 -25.56 51.83 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 CA-C-N 120.693 1.283 . . . . 0.0 112.414 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.03 -60.52 2.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.61 -25.26 68.01 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.39 -0.819 . . . . 0.0 110.4 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.97 -47.81 76.29 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -67.67 -31.38 71.32 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 119.181 0.9 . . . . 0.0 110.997 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.06 -49.53 74.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 63.2 mt -76.68 -28.58 55.97 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.961 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -67.47 -34.25 76.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 119.785 1.175 . . . . 0.0 108.648 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.59 -15.19 62.49 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.16 5.62 5.87 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.918 1.287 . . . . 0.0 111.958 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.52 -97.76 0.12 Allowed Glycine 0 C--N 1.341 0.808 0 CA-C-N 119.686 1.13 . . . . 0.0 113.829 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -141.45 -162.1 1.33 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.941 1.297 . . . . 0.0 110.128 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.35 178.83 0.18 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.903 2.481 . . . . 0.0 115.766 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.96 -36.11 3.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.585 1.954 . . . . 0.0 111.069 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.2 tp -123.56 110.0 14.49 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.143 1.777 . . . . 0.0 108.343 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 49.0 ttm -121.2 106.77 11.83 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.407 1.083 . . . . 0.0 108.585 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -135.02 167.74 20.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.933 0.788 . . . . 0.0 110.722 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -67.0 89.0 0.16 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.722 1.609 . . . . 0.0 109.561 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.1 mt -81.91 -5.22 58.1 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.904 1.281 . . . . 0.0 111.602 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -85.57 -8.01 58.53 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -120.41 130.17 24.98 Favored Pre-proline 0 C--O 1.236 0.382 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.54 -15.96 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.884 1.723 . . . . 0.0 113.584 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -55.47 -36.22 66.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.593 0.757 . . . . 0.0 112.236 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -81.35 -37.76 27.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.572 0.749 . . . . 0.0 112.027 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.7 p -82.84 -10.96 58.6 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.878 0.763 . . . . 0.0 112.297 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -60.8 -59.49 13.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 O-C-N 120.912 -1.117 . . . . 0.0 113.507 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -68.04 -3.5 10.74 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 121.326 1.509 . . . . 0.0 114.585 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.0 tp -79.24 -66.67 0.84 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 8.2 pt -68.7 -25.43 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.59 -23.58 67.11 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.821 -1.175 . . . . 0.0 110.591 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -45.53 -60.04 2.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.937 2.095 . . . . 0.0 111.099 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -58.98 -57.3 13.67 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.31 5.19 0.03 OUTLIER Glycine 0 C--N 1.334 0.441 0 CA-C-O 116.991 -2.005 . . . . 0.0 117.713 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -61.35 134.34 48.14 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -141.64 121.91 13.93 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.54 -53.9 44.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.378 -0.201 . . . . 0.0 110.965 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -142.81 132.22 23.54 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -71.3 151.42 44.21 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -141.41 99.12 3.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -71.31 178.09 3.56 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -60.44 22.14 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.084 2.554 . . . . 0.0 116.747 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.57 -4.58 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 127.294 2.378 . . . . 0.0 111.866 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -113.8 107.88 16.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.613 1.706 . . . . 0.0 108.738 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.97 47.04 0.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.082 1.353 . . . . 0.0 109.58 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.88 92.64 1.27 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.25 1.42 . . . . 0.0 112.259 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.82 -1.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 130.303 3.441 . . . . 0.0 113.532 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -70.7 -33.93 71.4 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -82.72 100.89 10.52 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.1 t -116.48 102.34 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 126.56 1.944 . . . . 0.0 111.487 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -90.96 40.15 3.01 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 126.276 1.893 . . . . 0.0 113.842 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.94 -19.99 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.526 0.73 . . . . 0.0 111.063 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -108.34 51.04 0.75 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.976 1.369 . . . . 0.0 108.08 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -106.64 153.44 22.38 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.496 1.118 . . . . 0.0 109.913 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.56 -40.99 66.01 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.055 1.342 . . . . 0.0 111.729 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -59.67 -42.04 97.69 Favored Glycine 0 CA--C 1.523 0.588 0 O-C-N 121.474 -0.766 . . . . 0.0 112.656 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.22 -52.15 60.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -62.74 -32.73 73.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.241 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.1 -60.42 3.62 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.316 1.416 . . . . 0.0 110.065 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.65 -34.44 86.32 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 36.5 tp -70.48 -54.87 10.53 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.525 0.662 . . . . 0.0 110.1 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.62 -36.43 71.79 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.706 0.802 . . . . 0.0 109.616 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.86 -41.58 87.35 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.553 1.069 . . . . 0.0 109.595 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.5 tt -73.76 -45.54 51.14 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.248 -0.907 . . . . 0.0 109.671 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.61 -36.64 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.833 1.253 . . . . 0.0 110.037 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -58.28 -31.56 67.57 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.092 1.357 . . . . 0.0 111.138 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 49.5 mt -73.71 -40.94 63.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.52 -40.84 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -55.23 -37.67 67.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.122 0.969 . . . . 0.0 109.634 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -88.69 0.18 56.69 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.5 1.52 . . . . 0.0 112.37 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? 58.72 10.12 1.36 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 128.131 2.572 . . . . 0.0 114.759 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -42.9 89.83 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.8 tpt -92.64 142.32 27.5 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.88 1.272 . . . . 0.0 107.991 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -82.65 110.15 17.46 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.33 -8.04 54.87 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.906 0.882 . . . . 0.0 112.765 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -100.75 0.53 39.02 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.355 1.062 . . . . 0.0 112.807 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 93.6 m -63.93 130.04 42.48 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -129.8 -179.68 5.34 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.573 1.149 . . . . 0.0 108.696 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -55.12 -47.36 75.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.427 -0.32 . . . . 0.0 110.792 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.6 m -57.56 -45.58 85.0 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.408 1.483 . . . . 0.0 111.105 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 17.5 mm -64.19 -50.21 77.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.21 99.28 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.855 0.722 . . . . 0.0 111.927 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -59.23 -45.63 90.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.085 1.754 . . . . 0.0 110.574 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.15 -48.61 64.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.34 -51.46 68.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.023 0.929 . . . . 0.0 111.366 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -56.12 -39.37 72.13 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.669 0.788 . . . . 0.0 110.458 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -61.08 -25.01 66.66 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.998 -0.439 . . . . 0.0 112.117 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -94.5 -15.04 24.53 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.409 0.684 . . . . 0.0 111.138 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.04 11.94 58.2 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.311 1.434 . . . . 0.0 112.135 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -53.26 -70.08 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.672 2.389 . . . . 0.0 112.588 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.1 t -72.5 153.21 41.46 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -111.04 -18.59 13.0 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.022 0.529 . . . . 0.0 112.347 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -149.28 139.79 22.49 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.801 1.64 . . . . 0.0 108.669 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.7 t -160.29 -177.49 6.29 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 179.137 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.238 0.448 0 CA-C-O 119.262 -0.399 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.48 154.29 74.88 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 N-CA-C 107.745 -1.675 . . . . 0.0 107.745 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.0 p -115.28 179.0 4.09 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.926 0.891 . . . . 0.0 112.282 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -102.27 148.5 25.37 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 120.377 -1.452 . . . . 0.0 108.027 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.29 104.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.222 1.409 . . . . 0.0 110.592 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 95.61 -5.41 67.1 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.778 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.41 120.53 4.46 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 120.426 2.113 . . . . 0.0 112.578 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.07 159.28 33.91 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.968 3.112 . . . . 0.0 110.712 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 4.2 p -77.62 167.47 21.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.79 0.805 . . . . 0.0 110.131 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -147.33 78.17 10.33 Favored Pre-proline 0 N--CA 1.453 -0.305 0 C-N-CA 123.622 0.769 . . . . 0.0 110.344 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.05 172.31 16.2 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.86 1.707 . . . . 0.0 110.343 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 . . . . . 0 C--O 1.24 0.603 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.948 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.02 0 N-CA-C 105.502 -3.039 . . . . 0.0 105.502 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 8.4 m -143.91 147.56 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.11 159.23 24.75 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.5 m -133.09 144.52 50.03 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.899 0.772 . . . . 0.0 109.64 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.23 139.91 51.66 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 121.453 -0.779 . . . . 0.0 109.122 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.91 177.23 18.57 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.965 0.793 . . . . 0.0 113.076 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.3 mt -122.01 119.39 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 125.408 1.483 . . . . 0.0 107.229 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.98 123.02 21.08 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 120.499 -1.376 . . . . 0.0 107.945 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.51 -5.4 7.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.297 1.439 . . . . 0.0 112.739 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -67.2 -42.54 83.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 127.292 2.237 . . . . 0.0 113.671 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.8 m -57.39 152.49 32.52 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 123.98 0.912 . . . . 0.0 113.307 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.34 -51.45 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.772 2.315 . . . . 0.0 110.594 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -123.06 109.63 14.31 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -67.08 -24.29 65.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.71 -34.52 62.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.138 1.375 . . . . 0.0 111.56 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 78.2 mt -60.42 -36.17 77.53 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.327 -0.858 . . . . 0.0 110.146 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -81.25 -39.43 25.31 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.236 -0.887 . . . . 0.0 111.315 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.41 83.36 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.153 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -67.58 -49.4 63.35 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -56.41 -49.78 73.51 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.36 -0.838 . . . . 0.0 110.764 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.53 -21.94 66.62 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.81 -14.9 14.68 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -103.32 -24.27 13.52 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.986 0.812 . . . . 0.0 112.242 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -139.43 -32.18 0.66 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -67.07 -47.95 69.72 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.443 1.474 . . . . 0.0 112.847 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.05 73.13 5.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 71.4 p -138.72 153.98 48.53 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.88 -24.37 67.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -86.85 -43.67 12.29 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.175 1.79 . . . . 0.0 110.898 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -68.52 -44.93 70.2 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 54.1 mt -67.61 -34.74 77.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -62.15 -49.01 77.55 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.412 ' HA ' ' HE2' ' A' ' 295' ' ' LYS . . . -54.4 -42.84 70.9 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 119.595 1.089 . . . . 0.0 110.926 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.4 t -63.56 -41.18 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.804 1.242 . . . . 0.0 108.797 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -64.14 -38.92 92.79 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.126 1.371 . . . . 0.0 112.059 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 292' ' ' ALA . 21.9 mtmt -56.78 -54.7 43.32 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.246 -0.909 . . . . 0.0 108.755 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -55.18 -52.87 61.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.058 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -147.78 156.33 44.6 Favored Pre-proline 0 N--CA 1.473 0.715 0 O-C-N 120.799 -1.188 . . . . 0.0 111.799 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -61.34 130.9 33.81 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 N-CA-C 105.963 -2.36 . . . . 0.0 105.963 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -95.38 -15.78 22.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.342 -0.837 . . . . 0.0 112.882 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.36 -157.27 47.81 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.16 164.12 25.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 22.7 m -125.91 148.89 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 O-C-N 121.246 -0.909 . . . . 0.0 109.852 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.05 -22.47 58.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.675 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 62.7 tp -66.93 105.4 1.61 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.789 1.635 . . . . 0.0 109.365 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -61.41 -1.86 0.61 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.6 t -92.9 -66.64 0.91 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -63.51 -19.32 64.67 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.438 -0.789 . . . . 0.0 110.877 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -60.2 -35.5 75.55 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -68.22 -20.43 64.83 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.072 0.851 . . . . 0.0 111.687 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -88.12 -50.36 6.44 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.582 1.153 . . . . 0.0 108.403 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 48.7 mt -67.64 -35.32 78.69 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.012 0.525 . . . . 0.0 110.554 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.3 1.92 4.37 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.182 -0.949 . . . . 0.0 112.686 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -62.53 -20.88 65.08 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 120.111 1.323 . . . . 0.0 109.575 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -109.82 129.22 24.17 Favored Pre-proline 0 C--O 1.24 0.554 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.7 -8.41 9.21 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.378 2.719 . . . . 0.0 114.54 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -67.23 -54.48 20.58 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 119.68 1.127 . . . . 0.0 108.607 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.7 -49.55 83.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.45 -50.56 62.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 123.75 0.656 . . . . 0.0 109.947 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.81 -41.35 86.59 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.9 m -62.16 -37.76 86.46 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.8 tpt -68.2 -46.62 70.13 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.257 0.623 . . . . 0.0 110.596 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -60.68 -30.07 69.69 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.019 0.928 . . . . 0.0 113.111 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -74.82 -35.35 62.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 C-N-CA 123.777 0.831 . . . . 0.0 111.315 179.01 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.538 0.721 0 N-CA-C 113.557 0.561 . . . . 0.0 113.557 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -84.22 70.4 10.56 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.657 1.583 . . . . 0.0 106.992 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 30.1 pt -124.08 152.09 66.47 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 124.396 1.078 . . . . 0.0 110.549 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -68.78 -30.94 26.4 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.09 2.526 . . . . 0.0 113.106 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -65.66 -17.19 64.42 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -61.43 -31.35 71.29 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.986 0.812 . . . . 0.0 109.563 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 4.6 t -57.57 -46.09 84.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.457 0.703 . . . . 0.0 110.712 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -79.6 -36.25 38.33 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.604 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.0 -52.35 63.42 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.786 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -58.26 -40.47 81.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.865 1.211 . . . . 0.0 111.1 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -65.64 -23.13 66.73 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.962 0.905 . . . . 0.0 111.46 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.3 -50.73 8.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.538 1.135 . . . . 0.0 110.272 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 11.2 t -60.7 -49.81 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.612 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.01 -54.33 13.28 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.637 0.653 . . . . 0.0 110.275 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.3 m -64.3 -43.18 95.54 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.296 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.27 -43.07 87.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.122 1.328 . . . . 0.0 111.519 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.82 -52.68 51.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 125.041 1.336 . . . . 0.0 108.897 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 30.1 mm -60.5 -43.18 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.151 0.58 . . . . 0.0 110.13 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -59.88 -47.36 86.06 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.738 0.699 . . . . 0.0 110.265 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.26 72.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.719 0.808 . . . . 0.0 110.679 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.66 -32.17 72.32 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.246 1.019 . . . . 0.0 111.97 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 14.1 m -85.15 -11.75 54.37 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.739 0.816 . . . . 0.0 109.723 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.74 10.04 66.75 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 123.667 0.651 . . . . 0.0 112.428 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -69.15 -34.48 75.04 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 118.158 0.979 . . . . 0.0 109.985 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -134.93 148.04 49.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 359' ' ' GLU . 11.9 t -68.34 156.24 38.15 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 26.0 t -58.14 -40.43 77.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 125.011 1.325 . . . . 0.0 110.086 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.06 -47.84 84.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.956 0.502 . . . . 0.0 109.738 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . 0.408 ' H ' HG22 ' A' ' 356' ' ' THR . 52.6 mm-40 -68.92 -37.82 79.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 122.147 -0.345 . . . . 0.0 111.21 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.4 -39.87 73.72 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.97 -41.3 59.84 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.567 1.147 . . . . 0.0 110.296 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -55.45 -50.16 70.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.493 0.717 . . . . 0.0 109.363 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -49.85 76.32 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 127.042 2.137 . . . . 0.0 111.1 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.21 -52.15 66.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.076 0.95 . . . . 0.0 112.209 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -52.84 -33.04 47.72 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.551 0.74 . . . . 0.0 110.482 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.3 m -64.22 -48.03 77.41 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.413 1.006 . . . . 0.0 109.451 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -57.25 -23.35 47.54 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.3 mt -96.14 -10.41 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.025 1.33 . . . . 0.0 111.565 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 55.5 p -120.08 1.72 10.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.673 1.189 . . . . 0.0 112.491 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 36.1 tptt . . . . . 0 C--O 1.251 1.179 0 C-N-CA 127.665 2.386 . . . . 0.0 105.547 178.401 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -79.12 175.07 10.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.53 1.532 . . . . 0.0 109.384 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.95 22.71 77.68 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.427 1.013 . . . . 0.0 113.302 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -146.87 166.48 26.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.992 0.896 . . . . 0.0 112.664 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.2 mt -151.32 142.93 23.64 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.939 2.895 . . . . 0.0 106.681 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.26 126.61 49.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 mt -108.07 136.11 44.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 125.81 1.644 . . . . 0.0 108.146 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -127.76 130.6 49.02 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.035 1.734 . . . . 0.0 106.511 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.8 pt -131.76 165.65 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 127.26 2.224 . . . . 0.0 110.383 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.35 165.57 33.66 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.367 1.067 . . . . 0.0 112.975 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.68 40.5 7.68 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-O 118.466 -1.185 . . . . 0.0 111.855 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 54.51 32.85 17.65 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.622 1.169 . . . . 0.0 108.213 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.77 163.37 1.92 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.539 1.536 . . . . 0.0 113.372 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.09 76.35 1.44 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -66.17 -39.52 89.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.611 1.164 . . . . 0.0 109.352 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -58.57 -59.76 4.87 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 125.875 1.67 . . . . 0.0 110.526 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.27 94.53 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.7 tp -62.94 -42.55 99.84 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 117.889 0.845 . . . . 0.0 108.944 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.63 73.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.863 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -62.39 -27.89 69.4 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.452 1.024 . . . . 0.0 110.443 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.9 t -79.31 -46.47 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.28 -39.07 97.24 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 121.257 -0.902 . . . . 0.0 113.069 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -37.62 68.35 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 117.776 -1.107 . . . . 0.0 109.1 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -58.42 -57.33 13.41 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.38 -48.03 80.13 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.937 -0.554 . . . . 0.0 110.384 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.48 -22.96 66.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.958 1.254 . . . . 0.0 112.61 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tppm? -85.74 -23.22 27.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 117.876 -1.059 . . . . 0.0 110.805 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -102.83 -22.59 13.86 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.925 0.765 . . . . 0.0 112.71 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -114.79 -35.95 4.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.468 1.107 . . . . 0.0 111.355 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.17 -18.74 56.95 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.121 0.867 . . . . 0.0 113.414 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.8 mm -60.45 125.63 16.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.418 ' CE ' ' HA ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -63.77 127.93 33.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.107 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.7 t -123.2 104.91 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -93.97 139.14 31.3 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.3 t -130.67 118.46 42.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -128.84 158.99 37.18 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -116.85 60.64 2.38 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.664 1.186 . . . . 0.0 110.185 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -62.09 160.41 30.34 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 121.867 1.711 . . . . 0.0 109.966 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -117.79 9.12 12.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.596 0.758 . . . . 0.0 111.709 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.17 17.69 2.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.073 1.749 . . . . 0.0 112.876 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.534 HD21 ' H ' ' A' ' 43' ' ' LEU . 1.3 pt? -56.11 -24.15 38.74 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.627 -1.295 . . . . 0.0 111.797 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.99 -24.95 57.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.203 1.401 . . . . 0.0 112.104 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -121.57 -22.27 5.94 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.219 1.008 . . . . 0.0 111.218 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -41.92 59.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 117.24 -1.362 . . . . 0.0 110.9 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -52.49 -58.71 10.73 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 120.642 1.565 . . . . 0.0 110.111 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.78 -17.3 54.28 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.501 1.467 . . . . 0.0 113.553 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -88.7 2.12 53.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.649 1.58 . . . . 0.0 113.638 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.3 -34.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.18 0.9 . . . . 0.0 109.61 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.77 66.12 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.708 -1.245 . . . . 0.0 110.011 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.73 -2.92 5.55 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.887 0.875 . . . . 0.0 112.368 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.2 p -126.33 -11.72 6.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.461 1.504 . . . . 0.0 110.256 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.6 15.76 67.61 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.277 0.942 . . . . 0.0 111.892 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -106.38 6.44 30.43 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.007 0.904 . . . . 0.0 110.684 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.41 -167.59 43.39 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 127.001 2.239 . . . . 0.0 116.371 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.92 -179.32 2.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.634 2.89 . . . . 0.0 110.136 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.95 -18.28 8.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.8 mt -135.44 143.84 35.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.428 1.091 . . . . 0.0 109.306 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tt -130.02 143.2 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 C-N-CA 125.014 1.326 . . . . 0.0 110.953 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -137.92 109.83 7.19 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.823 1.649 . . . . 0.0 107.609 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 29.2 t-105 -159.88 178.91 9.27 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.438 1.017 . . . . 0.0 108.981 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.36 153.55 43.42 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -60.16 -19.14 52.52 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.362 1.465 . . . . 0.0 111.658 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -53.07 -61.95 1.96 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.895 1.278 . . . . 0.0 111.322 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -68.15 -18.22 64.56 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.598 -0.689 . . . . 0.0 111.088 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -68.67 -30.43 69.11 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.483 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.8 -12.79 49.44 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.99 0.805 . . . . 0.0 112.296 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -104.58 -45.72 1.39 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -60.47 -52.04 66.9 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.554 -0.968 . . . . 0.0 111.322 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.62 84.22 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.692 0.678 . . . . 0.0 111.235 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.21 -47.31 69.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.776 1.23 . . . . 0.0 108.71 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -72.21 -6.89 46.09 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.43 9.85 80.91 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.781 1.181 . . . . 0.0 112.296 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 mt -73.21 -22.03 60.53 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.389 1.094 . . . . 0.0 111.156 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -103.87 140.28 37.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.12 -171.95 3.31 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -76.93 159.72 29.76 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -137.73 172.04 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.727 1.211 . . . . 0.0 110.184 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.4 m 42.36 77.24 0.45 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.105 2.162 . . . . 0.0 114.552 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.88 -22.0 27.51 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.084 2.523 . . . . 0.0 115.291 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -120.16 135.24 55.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.22 1.373 . . . . 0.0 111.526 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -51.32 -39.11 56.26 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.781 2.032 . . . . 0.0 112.265 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.5 -27.18 62.31 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -66.46 -37.11 84.41 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -64.54 -42.86 95.45 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 118.845 0.748 . . . . 0.0 109.284 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -57.0 -30.11 63.87 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.52 1.528 . . . . 0.0 112.718 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -75.4 -2.24 27.64 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mt -130.18 154.15 47.83 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 120.728 -1.232 . . . . 0.0 110.892 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -69.12 155.83 92.78 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 122.436 -0.165 . . . . 0.0 110.786 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.41 -45.68 2.46 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.906 3.07 . . . . 0.0 114.241 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -58.01 -38.62 76.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.565 1.075 . . . . 0.0 111.143 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -25.58 66.24 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.555 1.142 . . . . 0.0 110.722 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -77.94 -44.45 26.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.411 0.684 . . . . 0.0 110.119 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.71 -33.38 64.14 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.56 -7.4 4.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.4 1.48 . . . . 0.0 114.179 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.73 10.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.966 1.706 . . . . 0.0 111.887 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.9 mtp85 -70.28 160.48 32.12 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -132.7 -165.11 1.56 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -70.37 81.25 0.55 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.291 1.036 . . . . 0.0 109.401 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.35 -60.81 4.84 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.368 0.985 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -178.56 5.07 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.32 0.648 . . . . 0.0 109.881 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 34.5 mt -115.9 169.95 8.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.161 1.385 . . . . 0.0 109.248 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 pt -138.65 -28.88 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.79 175.32 13.0 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.456 1.026 . . . . 0.0 109.701 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -133.31 150.02 74.09 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.9 143.73 29.77 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.966 2.444 . . . . 0.0 110.888 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -131.53 -50.65 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.808 2.443 . . . . 0.0 111.546 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.71 131.51 52.55 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 110.396 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.65 95.99 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 122.605 1.193 . . . . 0.0 110.164 179.904 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 43.8 p90 . . . . . 0 C--O 1.235 0.299 0 O-C-N 120.777 -1.202 . . . . 0.0 110.952 178.772 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo . . . . . 0 N--CA 1.453 -0.864 0 N-CA-C 110.441 -0.638 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.35 -31.6 2.77 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 124.441 1.096 . . . . 0.0 113.325 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.95 152.4 9.46 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.269 1.395 . . . . 0.0 109.832 -178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -56.1 -27.68 54.7 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.46 -16.52 24.35 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.283 0.947 . . . . 0.0 113.132 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -92.23 -14.22 29.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.062 0.847 . . . . 0.0 111.212 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 26.0 mm -59.65 -57.89 23.51 Favored Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -69.9 -25.54 27.86 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 CA-C-N 120.306 1.145 . . . . 0.0 110.967 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.64 71.65 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 118.67 0.668 . . . . 0.0 109.863 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 61.5 tp -88.84 -29.88 19.36 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.737 0.815 . . . . 0.0 109.585 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -59.08 -45.74 90.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.402 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 5.5 ptmm? -64.06 -32.19 73.65 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.534 0.334 . . . . 0.0 111.832 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -71.62 -43.04 66.87 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.203 0.601 . . . . 0.0 110.206 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.4 mt -75.8 -32.18 59.76 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -67.81 -33.33 74.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.609 -1.307 . . . . 0.0 108.498 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.1 -14.08 59.62 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 3.24 5.45 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.179 0.992 . . . . 0.0 112.127 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.65 -99.67 0.13 Allowed Glycine 0 CA--C 1.523 0.566 0 CA-C-N 119.267 0.94 . . . . 0.0 113.448 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -138.12 -177.75 4.97 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.433 1.493 . . . . 0.0 111.719 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.5 p -56.16 168.76 0.47 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.064 1.746 . . . . 0.0 113.817 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.89 -74.14 0.6 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.745 1.618 . . . . 0.0 110.183 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.8 tp -88.66 147.32 24.59 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.896 0.878 . . . . 0.0 110.701 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 11.3 mtp -149.0 113.97 5.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -138.1 172.3 13.12 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.978 2.111 . . . . 0.0 108.474 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.41 124.74 28.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.623 0.769 . . . . 0.0 112.86 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.3 mp -111.15 7.85 21.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.085 0.954 . . . . 0.0 111.166 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -97.57 -23.12 16.14 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -102.29 128.17 28.98 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.167 0.987 . . . . 0.0 108.913 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.67 -14.85 27.28 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.657 2.238 . . . . 0.0 114.32 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -59.01 -41.75 88.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.851 1.261 . . . . 0.0 113.397 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -79.83 -41.11 27.06 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.065 0.46 . . . . 0.0 111.767 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.4 p -69.93 -24.59 63.39 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.746 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -53.3 -63.02 2.75 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -61.69 -14.71 37.56 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.109 1.872 . . . . 0.0 115.076 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.4 tp -78.56 -63.83 1.32 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.8 pt -63.05 -32.61 56.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.825 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.81 -14.36 62.98 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.528 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -52.94 -45.37 67.64 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.927 1.239 . . . . 0.0 113.603 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.67 -43.82 98.13 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 172.33 43.15 0.04 OUTLIER Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.952 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -99.55 155.51 19.79 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -160.73 119.26 2.54 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 118.278 1.039 . . . . 0.0 109.019 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.95 84.31 7.48 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 70.05 105.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.754 2.421 . . . . 0.0 107.874 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -72.25 134.78 45.78 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.636 -0.665 . . . . 0.0 109.314 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -131.65 120.05 22.27 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.515 ' HG2' ' H ' ' A' ' 173' ' ' ASN . 5.6 tt0 -102.78 -159.15 0.71 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.584 1.154 . . . . 0.0 108.428 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.515 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 78.5 m-20 -66.84 78.63 0.12 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.66 1.984 . . . . 0.0 110.708 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.66 10.91 84.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.269 0.938 . . . . 0.0 112.597 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -112.15 103.46 11.63 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.34 113.24 18.58 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -131.07 100.7 5.31 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.93 -9.38 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -69.48 -29.34 66.98 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.891 -1.131 . . . . 0.0 108.324 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -75.29 75.29 2.41 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.606 1.563 . . . . 0.0 110.863 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.7 t -97.11 113.82 32.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 126.414 1.886 . . . . 0.0 108.737 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -109.32 96.1 0.94 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 45.8 t -138.38 -43.47 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 117.822 0.811 . . . . 0.0 109.579 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -108.84 77.04 1.05 Allowed 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -128.97 163.1 26.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.778 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -50.03 -41.52 47.62 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.2 1.4 . . . . 0.0 113.197 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.95 -43.41 95.99 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.581 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.6 -51.35 65.69 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.432 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -58.78 -36.64 74.76 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.135 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.23 -38.61 87.27 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.212 0.915 . . . . 0.0 110.386 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -82.43 -26.54 46.82 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.82 -0.55 . . . . 0.0 112.826 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.5 tp -76.29 -41.82 47.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.08 -1.247 . . . . 0.0 107.792 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 7.4 t -65.08 -27.62 68.9 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.987 0.812 . . . . 0.0 109.065 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -58.19 -52.06 67.13 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.96 -46.24 88.54 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.764 1.226 . . . . 0.0 110.144 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 42.7 t -60.58 -38.91 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 117.639 -1.172 . . . . 0.0 110.506 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.507 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 14.2 t0 -56.6 -50.11 72.96 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.213 1.405 . . . . 0.0 114.009 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.11 -38.7 91.54 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.548 0.689 . . . . 0.0 109.693 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.17 -31.8 51.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -63.76 -44.7 92.66 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 126.125 1.77 . . . . 0.0 107.887 178.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -71.97 -10.92 60.46 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.377 0.671 . . . . 0.0 109.424 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt 60.96 15.6 6.23 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 128.175 2.59 . . . . 0.0 112.513 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -83.08 -14.04 54.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.04 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.24 124.98 52.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.813 1.645 . . . . 0.0 110.028 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.65 84.66 0.29 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.745 2.018 . . . . 0.0 110.69 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -58.53 -16.53 15.88 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.549 1.94 . . . . 0.0 115.011 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.08 -7.08 54.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.252 1.821 . . . . 0.0 114.097 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.3 m -60.99 134.48 57.14 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 118.941 0.791 . . . . 0.0 110.408 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.0 -178.43 4.18 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.542 1.937 . . . . 0.0 107.08 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -57.89 -38.56 76.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.391 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -55.38 26.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.321 1.048 . . . . 0.0 110.456 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.22 -45.13 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 123.57 0.748 . . . . 0.0 110.38 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.45 -51.13 67.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.724 0.693 . . . . 0.0 110.816 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -63.35 -43.97 96.17 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.82 1.191 . . . . 0.0 110.313 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.09 -55.77 30.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.06 0.544 . . . . 0.0 109.548 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.84 -46.07 74.58 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.56 1.144 . . . . 0.0 110.425 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -58.42 -44.19 88.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.24 0.616 . . . . 0.0 109.429 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.46 -21.73 66.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.689 0.795 . . . . 0.0 112.203 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -91.97 -10.64 38.64 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.665 0.786 . . . . 0.0 110.008 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.82 18.44 70.2 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -80.78 0.72 33.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.947 1.299 . . . . 0.0 113.745 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 27.3 p -124.04 149.79 45.69 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.532 1.133 . . . . 0.0 108.184 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.3 -21.31 19.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.264 0.625 . . . . 0.0 111.469 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 14.0 ptt? -158.28 157.48 32.58 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.8 t -150.89 171.38 17.34 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 122.535 1.16 . . . . 0.0 109.792 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 5.9 mt . . . . . 0 N--CA 1.443 -0.824 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.262 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.543 0.679 0 CA-C-O 118.869 -0.586 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.07 -84.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.834 3.023 . . . . 0.0 111.073 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . 0.292 0.5 OUTLIER 92.38 -164.69 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.483 3.113 . . . . 0.0 108.052 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.27 131.83 47.11 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.02 120.31 7.25 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.52 -0.738 . . . . 0.0 109.181 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.91 -7.12 56.83 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.511 -1.16 . . . . 0.0 113.928 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.39 102.65 14.03 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.317 2.059 . . . . 0.0 109.801 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.78 143.49 21.1 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.223 1.948 . . . . 0.0 113.606 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.2 m -68.66 159.56 31.87 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.148 0.979 . . . . 0.0 109.234 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.08 55.72 19.85 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.61 161.65 34.58 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 121.788 1.659 . . . . 0.0 111.406 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.233 0.236 0 CA-C-O 121.604 0.716 . . . . 0.0 111.142 179.587 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.633 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.43 172.22 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 119.403 1.601 . . . . 0.0 111.545 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 34.5 tp -84.41 156.52 21.77 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.055 -1.653 . . . . 0.0 107.569 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.7 m -131.76 137.17 48.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 120.481 1.492 . . . . 0.0 109.001 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -115.24 130.67 56.98 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.349 1.059 . . . . 0.0 109.513 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.14 170.59 21.73 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.308 1.432 . . . . 0.0 111.804 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 76.3 mt -119.19 134.72 61.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -68.09 122.54 18.48 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.61 -10.78 60.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.13 7.33 46.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.84 0.856 . . . . 0.0 112.459 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.5 m -69.33 157.49 89.25 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.418 1.087 . . . . 0.0 108.712 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.13 -50.82 2.55 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.906 1.737 . . . . 0.0 111.005 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -135.5 100.36 4.48 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -19.68 49.31 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.47 -0.769 . . . . 0.0 112.437 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -64.63 -32.9 74.76 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.049 0.386 . . . . 0.0 110.123 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.87 -38.63 79.23 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.379 -0.825 . . . . 0.0 108.897 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.66 -42.29 42.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 117.903 -1.046 . . . . 0.0 111.671 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -41.3 91.99 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.3 0.954 . . . . 0.0 108.788 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -66.94 -50.93 60.79 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 124.619 1.199 . . . . 0.0 109.434 -177.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -53.22 -51.69 61.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.194 -0.431 . . . . 0.0 110.335 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.11 -48.04 80.22 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.332 6.7 pt-20 -78.74 -4.35 48.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -177.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -108.45 -19.45 13.45 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.311 1.414 . . . . 0.0 112.211 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -135.61 -53.3 0.77 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.789 1.177 . . . . 0.0 110.735 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -48.04 39.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.753 0.821 . . . . 0.0 112.515 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.66 29.03 0.93 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.948 2.099 . . . . 0.0 114.505 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 19.4 p -116.29 165.18 13.47 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 120.411 1.459 . . . . 0.0 108.097 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.66 -44.06 85.41 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.46 -33.63 75.53 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.506 0.722 . . . . 0.0 112.787 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.53 -46.08 12.58 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 51.8 mt -62.52 -47.12 85.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -57.78 -44.49 86.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.678 1.191 . . . . 0.0 110.647 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.0 -46.78 71.84 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 117.93 0.332 . . . . 0.0 110.963 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.65 -40.32 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 117.047 -1.454 . . . . 0.0 109.723 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -63.15 -34.33 77.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.311 0.959 . . . . 0.0 112.754 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -63.49 -61.34 2.39 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.8 -48.33 80.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 117.219 -1.372 . . . . 0.0 112.387 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -137.7 150.47 68.13 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 121.509 1.959 . . . . 0.0 109.137 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.77 101.95 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.254 1.969 . . . . 0.0 114.21 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 7.8 mt -76.03 -32.86 59.55 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 123.608 0.763 . . . . 0.0 109.731 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 80.87 -115.64 4.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.95 160.8 14.01 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.206 1.003 . . . . 0.0 111.698 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.16 162.7 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 124.479 1.112 . . . . 0.0 110.179 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.36 -29.44 22.95 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 28.0 tp -65.07 104.07 0.83 Allowed 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.749 0.82 . . . . 0.0 111.166 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -49.53 -33.43 14.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.143 1.377 . . . . 0.0 112.482 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.3 t -62.53 -57.46 11.07 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.877 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -78.19 -20.72 51.33 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.923 1.238 . . . . 0.0 111.262 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -57.6 -43.13 84.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.25 -13.02 46.72 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.005 0.82 . . . . 0.0 113.207 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -94.12 -37.54 11.55 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 63.2 mt -74.95 -26.02 59.3 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.515 -1.366 . . . . 0.0 109.035 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.87 -1.63 7.7 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.544 1.538 . . . . 0.0 112.918 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -65.11 -19.45 65.99 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.807 0.843 . . . . 0.0 110.846 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -120.36 131.95 24.28 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 124.526 1.13 . . . . 0.0 108.189 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -59.84 -15.05 30.18 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.215 2.61 . . . . 0.0 116.368 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -66.5 -39.5 88.75 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 121.93 2.15 . . . . 0.0 108.602 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.7 mp -70.77 -46.38 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.43 -49.54 72.15 Favored 'General case' 0 C--O 1.222 -0.395 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.166 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.17 -37.55 77.62 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.085 -1.009 . . . . 0.0 112.101 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 55.1 m -61.06 -39.1 88.59 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -81.35 -37.23 28.63 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 123.585 0.754 . . . . 0.0 111.434 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -55.17 -37.35 66.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.134 0.973 . . . . 0.0 108.837 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -63.9 -38.54 91.48 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.471 0 C-N-CA 123.385 0.674 . . . . 0.0 110.171 178.168 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo . . . . . 0 N--CA 1.453 -0.888 0 N-CA-C 108.374 -1.433 . . . . 0.0 108.374 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -120.81 23.49 10.7 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.0 pt -137.8 141.37 32.66 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 118.953 0.797 . . . . 0.0 110.454 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.82 -9.94 27.3 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 124.001 3.134 . . . . 0.0 113.82 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -64.69 -24.05 67.45 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.417 1.087 . . . . 0.0 109.539 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 91.1 mmm -58.99 -22.39 60.47 Favored 'General case' 0 C--N 1.342 0.247 0 O-C-N 120.744 -1.222 . . . . 0.0 113.571 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 80.4 p -64.24 -33.11 75.06 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.369 1.44 . . . . 0.0 108.821 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.5 -41.97 65.35 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 121.247 -0.908 . . . . 0.0 108.894 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -49.96 -57.08 8.26 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.081 0.952 . . . . 0.0 109.584 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -64.02 -35.4 80.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -68.07 -37.43 81.24 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.158 0.583 . . . . 0.0 111.671 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.52 -55.16 6.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.868 2.067 . . . . 0.0 112.496 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 67.3 t -57.33 -33.55 43.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.378 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -54.63 -58.38 7.74 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.747 1.158 . . . . 0.0 108.859 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.4 m -61.38 -37.32 82.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.984 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.13 82.37 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 121.003 1.729 . . . . 0.0 111.403 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 75.2 t -58.82 -56.46 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.5 mm -61.21 -32.94 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.2 0.6 . . . . 0.0 111.803 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.44 -52.72 62.42 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.638 -1.288 . . . . 0.0 110.158 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.23 -43.68 64.04 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.217 0.607 . . . . 0.0 111.233 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -56.38 -41.6 76.51 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.306 1.042 . . . . 0.0 111.246 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.8 m -85.09 -17.48 37.22 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.443 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.5 28.48 47.7 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 123.583 0.611 . . . . 0.0 112.314 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -81.84 -27.63 33.46 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.735 -0.862 . . . . 0.0 109.976 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -142.7 151.52 41.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.6 m -58.95 153.82 16.63 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.014 0.926 . . . . 0.0 109.485 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 90.5 t -52.56 -56.26 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.224 1.009 . . . . 0.0 110.133 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.1 -49.06 74.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.213 1.405 . . . . 0.0 110.825 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -68.65 -25.57 64.89 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.93 83.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 74.9 mt -68.35 -43.5 77.35 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -50.54 -51.82 44.44 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.293 1.437 . . . . 0.0 109.536 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -54.42 -43.46 71.56 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.324 1.849 . . . . 0.0 110.757 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -68.86 -50.75 47.15 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 118.725 -0.655 . . . . 0.0 109.488 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -52.01 -38.71 57.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.757 1.223 . . . . 0.0 108.773 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.2 m -59.68 -54.3 47.96 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.953 1.301 . . . . 0.0 108.283 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -58.56 -39.95 81.7 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.764 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.93 -41.55 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.074 0.852 . . . . 0.0 109.653 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 38.7 p -80.32 -11.66 59.69 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 36.3 tttm . . . . . 0 C--O 1.245 0.82 0 C-N-CA 126.036 1.734 . . . . 0.0 108.45 178.661 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.95 103.28 15.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.55 21.37 0.31 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.333 0.968 . . . . 0.0 114.344 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -143.56 155.55 44.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.721 1.76 . . . . 0.0 113.126 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.9 mt -137.72 151.37 48.14 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.101 1.76 . . . . 0.0 108.328 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 77.2 t -138.92 132.42 39.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 125.501 1.52 . . . . 0.0 108.431 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.482 ' CG2' ' HH ' ' A' ' 17' ' ' TYR . 30.7 mt -129.15 134.27 64.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.652 1.181 . . . . 0.0 108.116 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -118.68 157.22 27.87 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.957 1.303 . . . . 0.0 109.369 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.0 pt -144.97 165.63 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 125.631 1.572 . . . . 0.0 108.252 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -68.88 -33.29 73.55 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.014 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 15' ' ' LYS . . . 146.19 -73.17 0.31 Allowed Glycine 0 C--N 1.342 0.876 0 C-N-CA 123.68 0.657 . . . . 0.0 113.37 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -70.85 26.9 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 129.424 3.089 . . . . 0.0 116.134 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 13' ' ' GLY . 11.3 mmtm -75.21 -45.79 38.1 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 125.123 1.369 . . . . 0.0 114.615 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.0 42.46 0.72 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 126.841 2.163 . . . . 0.0 111.96 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.482 ' HH ' ' CG2' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -56.68 -16.93 7.21 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -178.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -52.62 -45.14 66.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 121.826 2.103 . . . . 0.0 112.056 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.09 -40.22 35.32 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 121.435 0.464 . . . . 0.0 112.032 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.77 -36.86 85.67 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.771 1.228 . . . . 0.0 114.242 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.37 64.55 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.675 0.79 . . . . 0.0 111.051 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -59.62 -33.99 72.21 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.96 -40.86 90.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.97 -34.99 83.37 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -68.58 -47.39 66.9 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 118.752 1.276 . . . . 0.0 108.322 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.05 -59.39 4.81 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.378 1.071 . . . . 0.0 109.101 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -56.5 -44.95 81.22 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.881 -0.581 . . . . 0.0 111.31 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -64.32 -16.38 62.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 120.395 1.452 . . . . 0.0 111.929 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.496 ' HA ' ' HZ2' ' A' ' 29' ' ' LYS . 1.2 tppm? -96.86 -16.36 20.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 117.295 -1.336 . . . . 0.0 112.708 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -106.54 -37.59 6.42 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 124.791 1.307 . . . . 0.0 110.434 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.3 p -101.15 -34.0 9.87 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.147 -0.97 . . . . 0.0 110.739 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.06 -11.79 67.37 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 121.146 -0.971 . . . . 0.0 113.396 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.0 132.9 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -67.51 150.03 49.39 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.161 -0.962 . . . . 0.0 109.677 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.9 t -140.49 97.78 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.585 1.554 . . . . 0.0 108.976 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.7 m -77.14 153.48 34.17 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.55 110.62 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 104.224 -2.509 . . . . 0.0 104.224 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -135.14 161.55 35.01 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -127.26 61.01 46.27 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.463 1.505 . . . . 0.0 113.969 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.46 143.24 38.23 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.424 1.416 . . . . 0.0 110.35 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -97.2 21.6 9.71 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.4 3.09 2.1 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.93 -22.75 5.96 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.005 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -48.84 -34.56 12.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.442 1.497 . . . . 0.0 112.096 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -122.32 -24.42 5.04 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.109 0.963 . . . . 0.0 111.937 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.78 -39.25 76.73 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.008 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -55.96 -59.53 11.39 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 119.988 1.267 . . . . 0.0 109.259 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.05 -29.4 89.16 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 CA-C-N 120.909 1.36 . . . . 0.0 113.916 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -77.23 0.49 21.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.101 1.319 . . . . 0.0 113.645 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 t -131.73 -32.97 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.76 -26.65 60.76 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.837 -1.165 . . . . 0.0 110.053 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.86 -30.66 65.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.787 -0.571 . . . . 0.0 109.803 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 p -90.94 -16.45 28.06 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.351 1.06 . . . . 0.0 112.834 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.96 26.19 10.64 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-O 118.178 -1.346 . . . . 0.0 116.388 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -131.01 5.91 4.56 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.828 1.314 . . . . 0.0 110.084 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.1 -178.54 47.43 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.447 1.499 . . . . 0.0 114.941 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.34 169.78 9.0 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.416 2.077 . . . . 0.0 109.938 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -105.71 -16.8 14.58 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -139.38 145.66 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.45 144.8 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.691 1.196 . . . . 0.0 108.955 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -129.49 108.63 10.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.933 1.693 . . . . 0.0 110.429 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -152.41 -174.53 4.93 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.174 -0.954 . . . . 0.0 110.869 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.03 158.04 36.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.816 1.246 . . . . 0.0 108.558 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -63.8 -25.75 68.32 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.376 -0.203 . . . . 0.0 111.322 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.48 -62.01 2.2 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 126.027 1.731 . . . . 0.0 111.398 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -61.5 -19.88 62.57 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.492 0.717 . . . . 0.0 112.601 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -78.93 -20.75 48.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.789 -0.624 . . . . 0.0 111.896 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.56 -39.57 95.19 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.13 -50.5 5.79 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.765 1.174 . . . . 0.0 111.613 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -55.41 -42.66 74.4 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.422 1.111 . . . . 0.0 112.215 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.92 -43.13 79.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.639 0.654 . . . . 0.0 110.451 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.01 -50.8 68.13 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.487 1.115 . . . . 0.0 108.81 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 m -63.85 -5.11 3.85 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.319 1.848 . . . . 0.0 113.505 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.17 10.33 86.18 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.36 1.457 . . . . 0.0 113.392 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.7 mt -73.18 -18.95 61.21 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.305 1.053 . . . . 0.0 110.851 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.71 146.15 26.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.96 0.8 . . . . 0.0 109.949 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.1 -178.9 4.93 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.684 1.994 . . . . 0.0 110.321 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -72.43 128.61 36.14 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.623 1.569 . . . . 0.0 107.629 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.15 159.19 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.836 0.744 . . . . 0.0 110.67 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 m 47.27 75.03 0.71 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.468 2.307 . . . . 0.0 113.517 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -67.06 -45.13 4.25 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.0 1.8 . . . . 0.0 111.878 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -94.15 132.81 38.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.071 1.348 . . . . 0.0 112.019 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -65.13 -31.63 72.93 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.83 -36.41 64.97 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 121.081 1.764 . . . . 0.0 112.137 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -59.82 -30.78 69.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.783 0.719 . . . . 0.0 110.772 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -70.35 -29.83 66.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.99 -1.068 . . . . 0.0 112.124 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -78.39 -21.55 49.19 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.352 0.661 . . . . 0.0 111.47 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -69.44 -12.51 61.71 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.176 -0.953 . . . . 0.0 111.672 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 mt -120.61 164.04 17.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.127 1.771 . . . . 0.0 111.555 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -66.2 160.65 63.15 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.73 -49.3 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.66 2.24 . . . . 0.0 112.491 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -51.78 -41.08 61.38 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.856 0.862 . . . . 0.0 113.229 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -28.12 65.54 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.495 -0.753 . . . . 0.0 111.177 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -78.03 -46.57 20.57 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -21.22 23.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.252 1.021 . . . . 0.0 112.507 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.15 -28.9 57.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.488 1.515 . . . . 0.0 111.085 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.71 0.64 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.531 1.532 . . . . 0.0 113.056 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -65.27 162.87 16.46 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.862 0.756 . . . . 0.0 109.515 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -145.51 176.84 9.3 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.283 1.833 . . . . 0.0 107.256 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -55.09 104.47 0.12 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.451 1.1 . . . . 0.0 109.186 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.16 -85.12 0.31 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 125.161 1.362 . . . . 0.0 111.317 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 170.09 4.29 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.711 1.604 . . . . 0.0 112.5 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -98.91 169.97 9.07 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.452 1.501 . . . . 0.0 108.531 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.7 pt -135.55 -37.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.37 172.34 14.58 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.914 1.686 . . . . 0.0 108.419 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.66 149.81 69.28 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.359 0.664 . . . . 0.0 111.352 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.22 140.84 38.1 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 124.645 3.563 . . . . 0.0 110.902 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.3 mm -121.04 -45.5 2.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 124.853 1.261 . . . . 0.0 112.808 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.43 161.53 37.82 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.891 0.876 . . . . 0.0 109.63 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.65 107.37 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.871 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 C-N-CA 126.561 1.944 . . . . 0.0 106.703 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 N--CA 1.454 -0.809 0 N-CA-C 110.214 -0.725 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -100.37 -38.48 8.42 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.824 1.25 . . . . 0.0 112.677 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 t -157.22 157.17 33.84 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.585 1.084 . . . . 0.0 110.881 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -58.29 -30.42 66.62 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 118.334 -0.841 . . . . 0.0 113.12 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -66.36 -14.48 62.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.504 1.047 . . . . 0.0 112.052 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -101.63 -18.74 15.74 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.012 1.325 . . . . 0.0 111.239 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 26.1 mm -49.99 -56.24 18.94 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 120.736 1.607 . . . . 0.0 111.501 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.1 -20.07 25.54 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 CA-C-N 119.88 0.993 . . . . 0.0 112.557 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.65 -34.48 46.37 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 124.932 1.293 . . . . 0.0 111.453 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.8 -31.39 28.21 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.59 1.556 . . . . 0.0 108.55 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -59.43 -44.07 92.95 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.325 0.65 . . . . 0.0 109.625 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -65.51 -31.26 72.23 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 122.839 0.456 . . . . 0.0 111.319 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -69.79 -47.27 63.49 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 26.7 mt -66.57 -32.85 74.46 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.627 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -70.68 -27.73 64.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.098 0.863 . . . . 0.0 110.076 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.84 -27.79 63.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 118.219 0.463 . . . . 0.0 110.481 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.1 -1.42 20.42 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.377 0.671 . . . . 0.0 112.569 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -177.22 -101.6 0.15 Allowed Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 118.989 0.813 . . . . 0.0 112.36 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -137.23 -179.5 5.76 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.942 2.097 . . . . 0.0 109.208 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 p -51.59 172.27 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.438 1.895 . . . . 0.0 115.569 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -106.19 -55.46 2.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.755 1.622 . . . . 0.0 112.343 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.4 tp -133.1 146.39 51.6 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.814 1.246 . . . . 0.0 110.844 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 90.2 mtp -146.1 127.99 15.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -149.27 166.84 27.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.17 136.73 33.08 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.57 -4.58 9.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.165 0.986 . . . . 0.0 108.912 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -65.56 -19.99 66.15 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 125.297 1.439 . . . . 0.0 110.823 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -127.8 143.14 46.55 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.094 0.958 . . . . 0.0 109.493 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -72.49 -12.75 27.36 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.095 3.197 . . . . 0.0 114.121 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -51.41 -45.76 62.67 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.276 0.944 . . . . 0.0 111.948 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.12 -37.71 19.93 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-O 119.157 -0.449 . . . . 0.0 112.128 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.0 p -72.93 -14.03 61.38 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.102 0.864 . . . . 0.0 111.448 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -53.84 -63.05 2.91 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.574 1.149 . . . . 0.0 111.866 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.14 -6.18 10.92 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.226 1.951 . . . . 0.0 114.325 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 28.2 tp -82.5 -62.88 1.49 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.41 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 12.5 pt -58.77 -42.2 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.35 2.61 3.65 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.402 ' HB2' ' HG ' ' A' ' 255' ' ' SER . . . -61.59 -37.07 82.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -177.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -86.86 -48.52 8.11 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.43 1.014 . . . . 0.0 108.606 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.71 63.55 0.07 OUTLIER Glycine 0 C--N 1.336 0.553 0 CA-C-N 118.964 0.802 . . . . 0.0 113.632 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -117.18 140.42 15.82 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 105.835 -2.906 . . . . 0.0 105.835 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -151.36 151.32 31.58 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.298 1.549 . . . . 0.0 109.315 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.13 -65.21 1.0 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -136.71 150.35 48.4 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.624 0.77 . . . . 0.0 111.056 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -86.03 149.9 24.84 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -150.85 106.2 3.35 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.73 57.31 4.43 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.734 1.614 . . . . 0.0 112.276 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 49.99 16.39 0.23 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.092 2.157 . . . . 0.0 116.522 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.41 -15.34 0.06 OUTLIER Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.392 0.996 . . . . 0.0 112.282 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -117.67 130.54 56.41 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -126.7 131.17 51.44 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 124.944 1.402 . . . . 0.0 108.315 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.2 146.48 33.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.144 0.973 . . . . 0.0 109.955 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -0.71 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.827 1.651 . . . . 0.0 110.749 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -80.1 -37.4 33.8 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -81.93 100.71 9.81 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.22 150.65 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.419 1.487 . . . . 0.0 109.889 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.52 16.17 5.42 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.032 0.825 . . . . 0.0 115.149 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.0 t -54.83 -33.24 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.181 1.792 . . . . 0.0 115.01 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.61 14.48 12.69 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.27 0.628 . . . . 0.0 111.68 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -62.18 164.93 6.29 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.437 0.636 . . . . 0.0 110.1 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -50.95 -34.63 29.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.953 0.901 . . . . 0.0 112.093 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.21 -47.01 47.18 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.968 0.804 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -55.89 -48.78 74.99 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.969 -0.724 . . . . 0.0 109.415 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -67.04 -40.42 87.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 117.726 -1.131 . . . . 0.0 111.025 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.55 -49.64 76.68 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.133 0.879 . . . . 0.0 111.563 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -71.55 -27.93 70.34 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.319 -0.944 . . . . 0.0 112.057 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 14.2 tp -77.35 -34.14 55.22 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.773 1.287 . . . . 0.0 112.355 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.4 t -55.9 -45.31 78.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 117.452 -1.261 . . . . 0.0 108.805 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -52.39 -53.91 38.86 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.271 1.428 . . . . 0.0 111.237 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.6 tt -54.12 -48.39 70.81 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.122 0.969 . . . . 0.0 111.278 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 38.6 t -73.41 -21.95 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.39 0.676 . . . . 0.0 110.492 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.405 ' HA ' ' CE ' ' A' ' 200' ' ' LYS . 2.8 t70 -63.37 -36.85 85.1 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.768 1.227 . . . . 0.0 109.749 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.8 mt -71.9 -41.73 67.59 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 79.5 mt -63.09 -39.48 85.38 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -54.71 -34.27 62.18 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.817 1.247 . . . . 0.0 109.769 178.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -91.47 -9.93 42.73 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.693 1.197 . . . . 0.0 111.906 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 64.82 6.53 3.38 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 128.735 2.814 . . . . 0.0 113.387 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -67.54 -36.22 80.56 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.541 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 8.4 tpt -77.96 154.07 31.91 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -88.43 91.18 8.7 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.459 -0.775 . . . . 0.0 110.573 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.3 -28.93 70.05 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.376 -0.827 . . . . 0.0 112.49 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.11 -4.65 48.47 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.8 m -71.46 126.98 31.09 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.274 -1.516 . . . . 0.0 109.053 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.03 -178.08 3.86 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.863 1.665 . . . . 0.0 107.095 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -58.11 -37.74 75.12 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.093 0.557 . . . . 0.0 111.404 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 39.5 m -73.59 -40.1 64.12 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.54 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 19.4 mm -64.58 -50.99 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 120.839 1.654 . . . . 0.0 109.053 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -55.94 -44.06 78.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.854 0.752 . . . . 0.0 110.631 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -67.48 -40.69 85.26 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.555 0.742 . . . . 0.0 111.762 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.31 -56.51 8.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.699 0.8 . . . . 0.0 109.594 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.99 -39.44 66.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.415 1.486 . . . . 0.0 110.519 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -60.15 -45.93 91.39 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -64.06 -30.54 71.61 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.076 -0.488 . . . . 0.0 111.793 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -77.21 -11.38 59.82 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.969 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.97 19.82 49.34 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 125.174 1.369 . . . . 0.0 112.21 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.07 -48.76 19.58 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 118.385 1.093 . . . . 0.0 111.016 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -104.12 153.37 21.0 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -105.5 -25.38 12.34 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.676 0.79 . . . . 0.0 110.322 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -129.07 170.04 13.99 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.625 1.17 . . . . 0.0 109.716 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.7 t -161.06 178.92 8.86 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.182 1.793 . . . . 0.0 107.169 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.1 mt . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 179.457 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.239 0.528 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.0 123.52 10.1 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.418 2.079 . . . . 0.0 109.207 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.5 p -100.53 169.28 9.17 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -77.85 167.11 22.03 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -51.35 104.64 0.08 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 126.003 1.721 . . . . 0.0 110.249 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.52 8.21 44.69 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 117.97 -1.461 . . . . 0.0 116.556 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.59 124.25 10.35 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 121.569 2.685 . . . . 0.0 112.193 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.51 123.25 8.49 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.215 3.276 . . . . 0.0 113.576 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.402 ' HG ' ' HB2' ' A' ' 163' ' ' ALA . 20.0 m -62.37 159.06 16.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.578 1.151 . . . . 0.0 111.621 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -147.35 100.53 3.83 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.902 1.281 . . . . 0.0 111.172 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -69.97 -63.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.693 0 N-CA-C 107.274 -1.856 . . . . 0.0 107.274 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 . . . . . 0 CA--C 1.545 0.767 0 C-N-CA 129.153 2.981 . . . . 0.0 106.702 178.906 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.696 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.46 140.49 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.9 tt -81.35 140.42 34.77 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.3 m -126.9 154.28 44.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 122.903 0.481 . . . . 0.0 111.286 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -132.67 146.2 51.68 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.153 0.981 . . . . 0.0 108.579 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -139.85 148.62 20.19 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 82.6 mt -95.12 137.36 23.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -72.13 133.5 45.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.046 0.385 . . . . 0.0 110.296 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -79.29 -25.11 42.5 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.031 -0.985 . . . . 0.0 113.33 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -74.22 -12.69 60.64 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.531 1.06 . . . . 0.0 113.325 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 61.9 m -60.15 165.51 4.89 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.49 -41.23 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 CA-C-N 120.59 1.246 . . . . 0.0 110.58 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -122.71 168.55 12.07 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.717 1.607 . . . . 0.0 108.164 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -132.88 -26.73 1.73 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.199 1.399 . . . . 0.0 110.303 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -61.47 -40.1 93.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.32 -34.56 72.49 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.827 -1.171 . . . . 0.0 111.195 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.61 -45.43 37.46 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.134 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -36.54 83.96 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.784 0.72 . . . . 0.0 109.154 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -64.78 -46.11 83.46 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -60.84 -37.41 81.98 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 120.102 1.319 . . . . 0.0 108.175 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.3 mp -77.24 -0.05 23.82 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 117.63 -1.176 . . . . 0.0 114.019 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -137.58 2.31 2.44 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 120.867 1.667 . . . . 0.0 113.587 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.52 -55.94 3.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.949 1.249 . . . . 0.0 110.613 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -126.11 -29.25 3.06 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.784 1.634 . . . . 0.0 113.299 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -55.21 -35.1 64.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.486 1.039 . . . . 0.0 111.885 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.36 74.57 0.96 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.329 1.052 . . . . 0.0 108.41 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 22.9 p -137.11 163.39 30.92 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.19 -17.41 63.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.25 1.82 . . . . 0.0 112.628 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -116.07 -36.56 4.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.602 1.561 . . . . 0.0 110.927 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.57 -31.04 59.18 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-O 118.846 -0.974 . . . . 0.0 110.883 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 29.7 mt -73.34 -41.79 63.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 119.577 1.689 . . . . 0.0 106.631 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -56.13 -47.32 78.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.555 1.142 . . . . 0.0 110.667 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.75 -29.44 64.8 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 48.5 t -91.08 -34.32 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 C-N-CA 124.477 1.111 . . . . 0.0 110.119 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -62.13 -30.4 71.0 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.067 0.849 . . . . 0.0 110.158 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -61.92 -17.81 58.09 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.969 0.908 . . . . 0.0 111.216 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -122.4 -76.27 0.59 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -61.66 142.69 94.33 Favored Pre-proline 0 C--O 1.234 0.272 0 O-C-N 121.189 -0.944 . . . . 0.0 111.457 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.08 93.1 1.03 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 N-CA-C 106.415 -2.186 . . . . 0.0 106.415 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.3 mt -77.23 -19.58 56.43 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 117.234 -1.365 . . . . 0.0 111.16 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 55.12 -138.98 41.89 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -85.75 165.57 16.8 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.42 155.56 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 O-C-N 120.306 -1.496 . . . . 0.0 110.814 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.52 70.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.111 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.21 101.05 0.26 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.872 1.269 . . . . 0.0 111.089 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -65.37 -20.73 66.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.785 178.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.91 -21.62 62.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.011 0.924 . . . . 0.0 111.494 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -113.6 -11.13 13.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.977 1.262 . . . . 0.0 110.559 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -59.86 -41.78 92.23 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.451 1.1 . . . . 0.0 108.355 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.88 -17.02 61.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.917 1.287 . . . . 0.0 112.817 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -95.96 -52.61 3.98 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 8.5 mt -56.62 -38.71 72.45 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.479 -0.763 . . . . 0.0 110.906 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.59 -6.66 5.58 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.262 1.425 . . . . 0.0 114.121 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -63.23 -13.61 39.75 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.4 1.08 . . . . 0.0 111.439 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -123.66 139.54 32.39 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.27 1.028 . . . . 0.0 109.255 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.47 -20.28 48.26 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.908 2.405 . . . . 0.0 112.941 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -63.93 -24.65 67.81 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.737 0.699 . . . . 0.0 112.684 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.09 -56.84 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.39 -51.77 10.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.318 1.047 . . . . 0.0 112.576 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.23 -42.76 91.8 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.616 -0.678 . . . . 0.0 112.334 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 14.5 m -66.57 -34.19 77.35 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -53.76 43.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -55.49 -36.14 66.33 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.494 0.718 . . . . 0.0 111.432 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -67.7 -31.05 70.74 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.796 0.839 . . . . 0.0 111.128 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.368 0 O-C-N 121.595 -0.691 . . . . 0.0 109.667 178.038 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo . . . . . 0 CA--C 1.535 0.569 0 N-CA-C 114.444 0.902 . . . . 0.0 114.444 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -133.18 5.42 3.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.161 1.784 . . . . 0.0 112.277 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.6 pt -89.1 144.56 32.81 Favored Pre-proline 0 CA--C 1.537 0.452 0 O-C-N 121.233 -0.917 . . . . 0.0 109.287 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.01 -12.71 32.94 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.108 2.539 . . . . 0.0 114.398 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.57 -20.89 35.32 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.277 1.031 . . . . 0.0 111.792 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.0 mmm -62.06 -24.76 67.29 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.341 -0.849 . . . . 0.0 110.58 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 61.0 p -63.75 -28.16 69.69 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.768 -1.208 . . . . 0.0 110.05 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -90.45 -30.66 17.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.808 1.643 . . . . 0.0 111.266 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -53.68 -60.77 2.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.391 1.077 . . . . 0.0 109.124 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -56.85 -43.01 80.7 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.745 0.418 . . . . 0.0 111.215 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -60.85 -27.47 68.12 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.05 0.54 . . . . 0.0 111.952 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.12 -61.74 1.86 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.613 0.765 . . . . 0.0 110.538 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 1.6 m -56.44 -25.84 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.364 0.666 . . . . 0.0 111.677 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -54.0 -56.8 14.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.967 0.907 . . . . 0.0 108.694 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.6 m -66.3 -38.35 87.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.186 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.04 77.05 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.47 -49.87 75.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 124.652 1.181 . . . . 0.0 109.024 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 32.7 mm -62.71 -38.55 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.148 0.886 . . . . 0.0 110.591 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -61.15 -41.91 97.6 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.122 -0.986 . . . . 0.0 110.774 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.35 -46.72 59.83 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 123.275 0.359 . . . . 0.0 110.328 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.93 98.34 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.703 1.201 . . . . 0.0 113.327 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 19.2 m -87.93 -1.32 57.91 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.659 0.783 . . . . 0.0 110.297 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 71.05 14.11 73.29 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-O 119.433 -0.649 . . . . 0.0 114.608 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -65.56 -26.97 68.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.541 1.171 . . . . 0.0 109.031 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -153.76 167.63 28.99 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.957 0.903 . . . . 0.0 109.65 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.6 m -72.26 156.14 39.44 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 39.6 t -54.95 -56.4 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.93 -51.47 40.78 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.641 2.376 . . . . 0.0 112.894 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -72.57 -32.69 66.23 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.86 71.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 24.6 mt -70.18 -43.35 70.97 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -51.76 -54.84 24.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.969 1.707 . . . . 0.0 108.178 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -52.31 -47.58 65.87 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.381 1.072 . . . . 0.0 109.317 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.92 -46.6 87.02 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 117.597 -1.192 . . . . 0.0 111.736 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.13 -39.78 72.75 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.406 1.003 . . . . 0.0 108.708 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 3.1 m -62.58 -25.08 67.89 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.184 0.993 . . . . 0.0 112.235 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -83.07 -14.32 54.0 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.642 -1.287 . . . . 0.0 112.085 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 9.9 mt -105.85 -30.47 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.556 0.616 . . . . 0.0 109.426 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 24.0 p -69.42 -37.87 77.63 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 27.6 tptt . . . . . 0 C--O 1.246 0.886 0 C-N-CA 126.371 1.868 . . . . 0.0 107.933 178.413 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -83.66 175.31 9.8 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.163 0.985 . . . . 0.0 108.684 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.64 35.62 86.59 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.374 1.464 . . . . 0.0 115.651 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -147.11 167.69 23.48 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 119.246 1.523 . . . . 0.0 112.658 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.0 mt -150.08 145.6 26.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.519 2.728 . . . . 0.0 105.664 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.443 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 50.4 t -139.56 134.68 39.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.9 mt -125.6 136.21 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.079 1.352 . . . . 0.0 110.092 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -127.07 154.66 44.41 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.0 pt -145.21 163.46 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 123.597 0.759 . . . . 0.0 111.348 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -0.95 2.27 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.52 -76.01 0.22 Allowed Glycine 0 C--N 1.332 0.354 0 CA-C-N 120.098 1.317 . . . . 0.0 112.438 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -63.26 17.11 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 130.121 3.369 . . . . 0.0 115.219 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -84.9 165.79 17.36 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.733 1.213 . . . . 0.0 112.309 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.02 83.14 1.6 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 103.466 -3.854 . . . . 0.0 103.466 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -95.59 -20.7 18.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -58.73 -42.05 87.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.699 1.136 . . . . 0.0 110.934 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.96 -41.39 40.91 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.6 tp -59.76 -43.13 94.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.08 0.94 . . . . 0.0 111.434 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.15 -38.8 71.34 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.881 -1.057 . . . . 0.0 111.17 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -60.0 -35.51 75.19 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.121 0.873 . . . . 0.0 111.852 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.6 -42.97 90.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.91 -39.98 96.9 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -63.34 -51.31 66.5 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 118.542 1.171 . . . . 0.0 108.695 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -53.71 -57.65 10.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.689 1.195 . . . . 0.0 108.544 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -58.01 -45.17 87.28 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.879 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -66.31 -8.29 24.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.036 1.289 . . . . 0.0 111.25 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -109.08 -8.28 15.19 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 119.994 -1.691 . . . . 0.0 112.657 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -110.79 -38.26 5.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.898 1.279 . . . . 0.0 108.801 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.9 p -104.16 -32.71 9.02 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.016 0.926 . . . . 0.0 111.249 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.47 -12.09 69.38 Favored Glycine 0 C--N 1.342 0.904 0 O-C-N 121.452 -0.78 . . . . 0.0 111.787 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.2 128.79 24.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -60.09 138.76 57.81 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.972 0.509 . . . . 0.0 111.22 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.05 119.73 17.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.8 m -114.62 148.88 37.48 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -137.29 113.64 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -130.67 166.06 21.52 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.144 0.977 . . . . 0.0 108.621 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -127.27 57.16 21.98 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.52 0.728 . . . . 0.0 111.65 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.09 149.77 65.22 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 N-CA-C 107.71 -1.688 . . . . 0.0 107.71 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -95.97 -37.23 10.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 121.245 -0.91 . . . . 0.0 108.656 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -3.84 4.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.117 1.367 . . . . 0.0 111.816 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.11 -31.63 13.84 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.296 1.038 . . . . 0.0 109.417 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -50.0 -29.87 9.49 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.289 2.236 . . . . 0.0 112.433 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -125.5 -20.62 4.7 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.433 1.015 . . . . 0.0 110.569 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -73.65 -49.96 23.36 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 116.384 -1.77 . . . . 0.0 111.548 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -45.87 -57.58 7.76 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 120.114 1.325 . . . . 0.0 109.879 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.09 -18.11 63.47 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 N-CA-C 115.896 1.46 . . . . 0.0 115.896 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -92.34 -46.34 7.74 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.959 1.708 . . . . 0.0 112.289 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 t -69.45 -39.37 78.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 O-C-N 121.261 -0.899 . . . . 0.0 108.665 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.45 -16.34 61.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.402 -0.812 . . . . 0.0 110.847 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.34 7.43 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.072 0.949 . . . . 0.0 110.912 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -130.73 -39.6 1.24 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.764 2.026 . . . . 0.0 106.414 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.56 6.77 12.76 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 124.564 1.078 . . . . 0.0 114.737 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.45 -0.52 54.69 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.036 1.418 . . . . 0.0 111.238 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.73 -175.0 30.61 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 126.972 2.225 . . . . 0.0 116.529 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -67.35 -178.76 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.377 3.385 . . . . 0.0 112.0 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 9.9 m-20 -115.81 -20.03 10.21 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.5 mt -141.68 143.62 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.14 144.08 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.832 1.653 . . . . 0.0 108.144 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -131.28 114.66 15.3 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.836 1.654 . . . . 0.0 110.358 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -156.04 172.84 17.72 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.997 0.817 . . . . 0.0 111.538 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.43 149.31 50.61 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -55.6 -31.75 62.51 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.09 -12.76 61.97 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -109.44 -0.65 18.83 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.971 1.26 . . . . 0.0 109.544 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -92.88 -11.52 33.3 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.292 1.837 . . . . 0.0 112.225 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.62 -10.39 86.26 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.638 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.12 -60.61 1.17 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.087 1.327 . . . . 0.0 111.007 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -43.91 -44.14 6.89 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.543 1.537 . . . . 0.0 114.692 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.56 -41.5 72.36 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.085 0.857 . . . . 0.0 110.946 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -36.31 70.58 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.12 0.968 . . . . 0.0 109.003 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 m -67.99 -44.74 75.92 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.358 1.063 . . . . 0.0 108.697 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.77 -2.24 8.01 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.978 1.751 . . . . 0.0 113.345 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.0 mp -68.79 -11.0 59.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.514 1.657 . . . . 0.0 114.461 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.5 mt -108.85 129.36 55.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.324 0.966 . . . . 0.0 108.511 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.84 167.22 13.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.172 1.789 . . . . 0.0 110.701 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -69.1 101.5 1.45 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.471 1.108 . . . . 0.0 109.656 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 pp -76.28 165.56 3.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 124.491 1.116 . . . . 0.0 111.424 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.4 m 48.08 97.71 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 128.581 2.752 . . . . 0.0 114.908 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.31 -22.95 21.3 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.916 2.411 . . . . 0.0 114.135 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -133.95 151.91 51.66 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -60.98 -32.68 72.24 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.5 1.52 . . . . 0.0 112.719 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.9 -42.12 65.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 120.07 1.305 . . . . 0.0 112.303 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.69 -30.72 71.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.886 0.475 . . . . 0.0 110.894 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -69.13 -37.42 78.31 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.142 -0.974 . . . . 0.0 111.379 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.26 -19.13 65.82 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.342 0.519 . . . . 0.0 111.484 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -79.08 -2.46 40.59 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.3 mt -130.38 151.6 50.69 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.329 1.052 . . . . 0.0 109.206 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -72.26 151.12 92.19 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 119.589 -0.845 . . . . 0.0 109.985 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.47 -45.47 3.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.282 3.322 . . . . 0.0 113.704 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -60.01 -33.51 72.09 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.428 1.013 . . . . 0.0 110.094 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.8 m -68.86 -36.19 77.83 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.806 0.843 . . . . 0.0 109.342 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -65.67 -45.18 83.88 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.141 0.977 . . . . 0.0 110.032 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.31 -33.71 13.88 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.438 1.495 . . . . 0.0 112.39 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.84 -35.27 22.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.207 1.403 . . . . 0.0 111.267 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.39 6.36 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.419 1.888 . . . . 0.0 113.328 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -69.02 156.67 38.23 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -138.5 175.59 9.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -62.97 111.18 2.05 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.596 0.758 . . . . 0.0 110.06 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.98 -77.76 0.67 Allowed Glycine 0 CA--C 1.522 0.514 0 C-N-CA 124.804 1.192 . . . . 0.0 114.169 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 166.03 22.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.06 0.944 . . . . 0.0 110.778 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.71 170.01 8.44 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.746 1.218 . . . . 0.0 110.052 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.1 pt -138.17 -35.42 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.72 176.93 11.54 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.235 1.414 . . . . 0.0 108.61 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -131.76 150.41 76.16 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.526 0.731 . . . . 0.0 110.94 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.57 151.95 53.37 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.591 2.86 . . . . 0.0 109.639 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mm -128.79 -45.09 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 123.972 0.909 . . . . 0.0 111.125 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.41 157.78 44.71 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 123.141 0.577 . . . . 0.0 112.007 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.7 t -132.4 100.15 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 C--O 1.237 0.428 0 C-N-CA 124.998 1.319 . . . . 0.0 107.754 178.789 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.2 p90 . . . . . 0 C--O 1.233 0.231 0 C-N-CA 124.788 1.235 . . . . 0.0 110.208 -178.56 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo . . . . . 0 N--CA 1.458 -0.609 0 N-CA-C 112.925 0.317 . . . . 0.0 112.925 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -126.5 -9.14 6.28 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 t -168.26 154.49 7.27 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -69.31 -18.94 63.88 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.947 -0.471 . . . . 0.0 111.061 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -75.43 -18.8 59.81 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.916 0.78 . . . . 0.0 110.291 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -87.22 -26.39 23.54 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.906 0.882 . . . . 0.0 109.783 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.1 mm -51.46 -60.43 5.87 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.0 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.83 -25.57 23.48 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 CA-C-N 120.631 1.261 . . . . 0.0 110.981 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.18 96.81 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.584 0.754 . . . . 0.0 109.227 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.9 tp -79.67 -27.89 40.78 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.705 1.202 . . . . 0.0 110.637 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -57.02 -46.36 82.41 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.788 0.722 . . . . 0.0 110.496 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -69.52 -28.48 66.07 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -74.37 -44.62 51.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.1 mt -72.2 -34.68 68.56 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 119.167 -0.444 . . . . 0.0 109.824 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -66.12 -32.34 73.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.81 -15.87 63.28 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 119.082 -0.485 . . . . 0.0 112.166 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.69 5.95 6.15 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.879 1.272 . . . . 0.0 112.832 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.21 -101.98 0.16 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 118.97 0.805 . . . . 0.0 111.329 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -139.42 -176.23 4.46 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.091 1.357 . . . . 0.0 111.519 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.23 162.13 2.17 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.416 1.486 . . . . 0.0 114.185 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.27 -45.32 8.28 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.723 1.209 . . . . 0.0 111.466 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.6 tp -124.88 149.67 47.29 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.571 1.549 . . . . 0.0 107.289 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.0 ttm -154.33 103.08 2.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -121.96 158.98 27.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.525 1.057 . . . . 0.0 111.112 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -69.14 98.15 0.98 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.98 -11.74 60.01 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.808 0.843 . . . . 0.0 110.883 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -78.88 -23.52 44.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.962 1.305 . . . . 0.0 113.683 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -95.38 132.01 28.59 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 119.976 1.262 . . . . 0.0 110.772 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.29 -22.8 39.46 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 121.897 1.731 . . . . 0.0 114.468 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -68.97 -14.89 63.31 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.263 1.392 . . . . 0.0 113.104 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -95.82 -25.56 15.98 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.486 1.039 . . . . 0.0 109.066 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 p -88.7 -28.51 20.52 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.838 -1.164 . . . . 0.0 110.516 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -51.69 79.02 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 120.069 -1.644 . . . . 0.0 113.239 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.0 -5.03 12.54 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.857 1.705 . . . . 0.0 111.651 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.1 tp -85.76 -62.33 1.55 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . 0.27 0.2 OUTLIER -70.52 -27.59 31.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.56 -25.09 36.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.721 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -49.46 -47.3 48.4 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.174 1.39 . . . . 0.0 113.023 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -66.29 -45.37 80.64 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.456 0.702 . . . . 0.0 111.291 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -176.43 -26.04 0.03 OUTLIER Glycine 0 C--N 1.338 0.653 0 CA-C-O 117.255 -1.858 . . . . 0.0 115.937 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -42.01 133.06 4.11 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.204 1.383 . . . . 0.0 112.876 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -139.01 122.81 17.62 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.35 -55.1 37.62 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.64 -0.662 . . . . 0.0 112.043 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -140.41 145.17 36.69 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -71.65 139.44 49.25 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 121.648 -0.658 . . . . 0.0 111.683 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -141.84 138.17 31.97 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.367 -2.456 . . . . 0.0 104.367 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -110.36 -120.33 0.28 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.455 1.102 . . . . 0.0 108.555 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -111.03 53.85 0.69 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 128.252 2.621 . . . . 0.0 108.011 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.02 9.29 34.71 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.694 -1.059 . . . . 0.0 113.568 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -118.47 125.17 49.35 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -116.96 133.79 55.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.716 2.006 . . . . 0.0 106.933 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -138.91 110.4 7.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.787 0.803 . . . . 0.0 111.641 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -2.73 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.09 1.356 . . . . 0.0 112.493 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -93.42 -0.59 56.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.06 1.344 . . . . 0.0 111.73 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -127.17 106.18 9.07 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.975 1.71 . . . . 0.0 107.247 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 96.9 t -122.76 122.9 67.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.995 2.118 . . . . 0.0 109.81 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -107.69 54.95 0.54 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.84 1.21 . . . . 0.0 114.555 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -93.9 -50.42 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 123.415 0.686 . . . . 0.0 109.287 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -81.83 63.39 6.06 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.504 1.522 . . . . 0.0 107.457 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -124.14 152.25 43.02 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.138 0.975 . . . . 0.0 109.77 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.24 -40.73 67.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.544 1.138 . . . . 0.0 112.638 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.18 -31.36 77.3 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.129 -0.982 . . . . 0.0 112.566 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.05 -48.13 54.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.791 0.796 . . . . 0.0 109.213 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -63.42 -35.41 80.33 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.747 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -55.01 -55.44 30.84 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.823 0.849 . . . . 0.0 112.023 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -69.52 -29.9 71.32 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 41.4 tp -67.87 -46.53 71.44 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.136 -1.214 . . . . 0.0 109.803 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -34.21 63.9 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.97 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -60.15 -58.76 7.12 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.065 1.302 . . . . 0.0 109.651 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.9 -48.69 77.62 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.336 1.055 . . . . 0.0 110.102 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.19 -28.04 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 123.634 0.774 . . . . 0.0 110.664 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.42 -37.17 86.59 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 119.509 1.05 . . . . 0.0 111.855 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.4 mt -71.95 -40.52 68.63 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.39 -41.46 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.151 0.98 . . . . 0.0 108.365 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -54.59 -41.12 69.53 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.496 1.119 . . . . 0.0 108.956 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -86.45 -1.84 57.93 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.396 1.879 . . . . 0.0 113.133 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.2 mptt 57.7 6.55 0.45 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.049 2.539 . . . . 0.0 114.842 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -76.72 -10.7 59.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.121 0.873 . . . . 0.0 111.802 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.9 tpt -95.24 150.99 19.63 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.377 1.071 . . . . 0.0 109.735 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.31 67.06 8.61 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.39 -19.67 3.72 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.665 1.986 . . . . 0.0 115.676 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -86.27 0.71 53.21 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.952 2.101 . . . . 0.0 111.811 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 42.7 m -70.12 131.24 43.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.684 1.129 . . . . 0.0 109.768 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -127.6 -178.63 4.55 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.906 1.682 . . . . 0.0 106.612 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -56.03 -46.82 78.72 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.324 0.65 . . . . 0.0 112.52 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 68.4 m -56.28 -49.49 74.07 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.484 1.114 . . . . 0.0 110.519 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 53.4 mt -64.09 -43.87 97.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.605 0.762 . . . . 0.0 109.429 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.86 -53.71 52.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.982 0.913 . . . . 0.0 112.592 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -65.36 -33.66 76.49 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.783 -0.573 . . . . 0.0 110.144 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.9 -51.39 64.73 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.83 -33.98 73.86 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.59 0.632 . . . . 0.0 111.129 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -65.6 -45.58 82.65 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -60.63 -35.17 75.5 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -69.45 -16.45 63.48 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.979 -1.01 . . . . 0.0 111.759 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.0 13.86 65.66 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 119.591 1.087 . . . . 0.0 111.645 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -84.23 -43.27 15.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.099 0.95 . . . . 0.0 112.47 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 58.4 p -75.48 107.72 7.8 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.234 0.47 . . . . 0.0 111.66 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.91 -26.37 66.83 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -146.51 158.12 43.85 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.878 1.671 . . . . 0.0 110.127 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 5.9 t -149.5 154.0 38.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--N 1.331 -0.212 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -179.2 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.77 132.25 24.54 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 120.506 1.216 . . . . 0.0 109.383 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 25.4 p -116.57 172.83 6.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.086 1.354 . . . . 0.0 109.347 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -84.65 169.36 14.4 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.576 0.703 . . . . 0.0 110.249 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -62.13 117.99 6.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.59 11.91 57.93 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.63 145.18 18.08 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-N 121.351 2.575 . . . . 0.0 111.71 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.04 171.7 17.01 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 124.305 3.337 . . . . 0.0 111.289 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.6 p -93.12 137.01 32.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -129.27 74.84 80.76 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.468 1.907 . . . . 0.0 109.217 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.08 -83.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.706 2.271 . . . . 0.0 109.893 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.439 0 C-N-CA 126.806 2.042 . . . . 0.0 107.866 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.455 0 N-CA-C 106.008 -2.837 . . . . 0.0 106.008 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.06 148.61 23.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 118.891 1.345 . . . . 0.0 112.083 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.0 tp -84.59 133.94 34.41 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.8 m -113.06 157.33 21.7 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.279 1.032 . . . . 0.0 111.595 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -135.5 138.5 43.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.476 1.11 . . . . 0.0 108.87 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.33 163.57 25.13 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 71.2 mt -109.57 142.66 21.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -74.18 116.08 14.41 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.51 -24.98 59.04 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.833 -0.604 . . . . 0.0 112.028 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -70.94 -9.46 57.9 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 118.195 -0.907 . . . . 0.0 113.302 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 6.9 t -62.56 144.24 95.89 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.4 -34.89 52.66 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.239 1.292 . . . . 0.0 109.887 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -141.73 109.53 5.74 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -14.53 63.02 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.691 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.6 -33.42 75.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.067 0.547 . . . . 0.0 111.05 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.38 -37.83 76.06 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.282 -0.886 . . . . 0.0 109.573 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.59 -45.94 41.92 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.777 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -34.41 78.06 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 118.862 -0.59 . . . . 0.0 110.114 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -73.29 -41.16 63.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.545 0.611 . . . . 0.0 109.593 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -58.35 -47.0 85.2 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.996 -1.065 . . . . 0.0 109.109 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.77 -45.57 81.99 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.528 -0.749 . . . . 0.0 111.571 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -77.01 -12.93 60.0 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -106.44 -17.62 14.22 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.727 1.603 . . . . 0.0 113.306 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -136.99 -51.11 0.66 Allowed 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 119.51 1.05 . . . . 0.0 111.484 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -5.69 20.05 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.97 31.03 6.97 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.013 -1.68 . . . . 0.0 111.523 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 70.7 p -116.31 163.66 15.68 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -40.79 95.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.206 1.403 . . . . 0.0 107.443 178.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.0 -48.68 73.08 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.976 1.71 . . . . 0.0 110.903 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -62.75 -50.47 63.8 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 58.1 mt -60.21 -44.64 94.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.125 0.57 . . . . 0.0 109.841 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -62.59 -42.87 99.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.848 0.459 . . . . 0.0 109.976 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.52 74.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.232 0.469 . . . . 0.0 110.407 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.7 t -73.6 -36.55 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.288 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -63.46 -31.09 72.15 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.815 1.646 . . . . 0.0 112.417 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -62.2 -45.85 91.54 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.467 -0.771 . . . . 0.0 112.156 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -65.1 -50.85 64.47 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.417 ' HE2' ' HD2' ' A' ' 298' ' ' PRO . 10.4 mmmm -138.24 146.64 52.46 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.417 ' HD2' ' HE2' ' A' ' 297' ' ' LYS . 36.7 Cg_endo -61.64 124.18 14.13 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.307 2.671 . . . . 0.0 109.985 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 29.1 mt -102.82 -13.64 16.91 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 67.89 -146.93 47.36 Favored Glycine 0 C--O 1.241 0.544 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.71 178.34 2.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 122.759 1.266 . . . . 0.0 110.08 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.3 m -131.69 152.17 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 O-C-N 120.934 -1.104 . . . . 0.0 109.087 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.12 -29.46 60.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.73 108.56 3.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.831 1.252 . . . . 0.0 108.883 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -55.47 -21.89 18.32 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.7 m -68.15 -49.59 60.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.538 1.063 . . . . 0.0 113.409 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -89.11 -9.31 51.57 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.886 0.874 . . . . 0.0 110.792 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.64 -47.22 80.22 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -60.6 -31.95 71.09 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.112 1.365 . . . . 0.0 113.914 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -81.0 -44.22 18.42 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.922 0.889 . . . . 0.0 109.612 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 20.9 mt -66.36 -33.6 76.09 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.59 -9.07 7.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.655 1.582 . . . . 0.0 112.794 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -63.92 -28.23 69.69 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.212 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -98.41 136.51 20.84 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.71 -21.82 71.0 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 123.695 2.93 . . . . 0.0 117.125 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -71.43 -30.02 65.56 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.507 1.048 . . . . 0.0 110.438 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.9 mp -79.07 -56.42 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -44.02 -60.76 1.71 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.113 1.365 . . . . 0.0 113.751 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.75 -44.38 90.53 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.947 0.794 . . . . 0.0 112.898 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 16.9 m -59.41 -35.55 74.2 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -44.38 52.67 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 121.611 -0.681 . . . . 0.0 109.274 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.94 -30.03 67.57 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.513 -0.742 . . . . 0.0 109.789 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -75.83 -31.33 59.32 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.46 -0.775 . . . . 0.0 109.529 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.334 0 CA-C-N 119.167 0.894 . . . . 0.0 109.643 177.63 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo . . . . . 0 N--CA 1.462 -0.378 0 N-CA-C 113.307 0.464 . . . . 0.0 113.307 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 92.68 14.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 130.472 3.509 . . . . 0.0 110.819 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.8 pt -57.42 143.83 73.16 Favored Pre-proline 0 CA--C 1.538 0.505 0 O-C-N 121.487 -0.758 . . . . 0.0 109.081 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.37 -21.13 47.74 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.487 1.458 . . . . 0.0 112.996 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -63.71 -22.23 66.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.299 1.04 . . . . 0.0 110.256 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 8.0 mtt -61.4 -29.38 69.89 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.225 0.92 . . . . 0.0 110.589 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 37.1 t -56.07 -43.0 77.53 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 118.53 0.605 . . . . 0.0 109.653 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.56 -41.27 47.05 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.17 0.588 . . . . 0.0 109.79 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -48.47 -46.65 38.32 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.472 1.109 . . . . 0.0 111.871 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -66.42 -54.0 29.21 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.004 -0.435 . . . . 0.0 110.918 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -60.33 -29.94 69.2 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.94 0.791 . . . . 0.0 112.406 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.98 -60.48 2.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.272 1.029 . . . . 0.0 111.073 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 22.5 t -69.2 -34.93 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 117.44 -1.266 . . . . 0.0 112.439 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.37 -28.98 60.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.485 1.493 . . . . 0.0 110.321 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 61.1 m -81.32 -51.69 8.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.389 1.076 . . . . 0.0 108.2 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -49.77 -45.91 50.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.533 1.06 . . . . 0.0 113.513 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 38.7 t -57.3 -52.66 53.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.061 0.944 . . . . 0.0 109.685 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.49 -38.58 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.212 0.605 . . . . 0.0 109.842 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -59.7 -48.67 80.75 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 118.825 0.738 . . . . 0.0 109.842 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.66 75.22 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.149 0.579 . . . . 0.0 110.775 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.95 80.94 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 10.9 m -89.34 -8.98 52.13 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.914 0.885 . . . . 0.0 110.812 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 73.34 15.28 78.95 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.154 -0.804 . . . . 0.0 112.547 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -64.52 -31.62 72.91 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.906 1.353 . . . . 0.0 109.233 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -148.31 156.12 42.14 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 14.2 t -73.2 162.61 29.21 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 54.1 t -52.45 -51.04 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 126.153 1.781 . . . . 0.0 109.536 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.14 -46.83 75.67 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.177 1.791 . . . . 0.0 112.711 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -75.61 -39.65 57.59 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.873 0.869 . . . . 0.0 111.744 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.42 -44.04 84.3 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.79 -43.51 83.76 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.854 0.862 . . . . 0.0 110.287 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -55.98 -59.28 5.12 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.58 -44.3 26.23 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.883 1.673 . . . . 0.0 110.914 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.45 -44.81 70.51 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.757 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -58.28 -37.07 74.27 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.028 1.285 . . . . 0.0 109.208 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 2.3 m -57.17 -40.63 77.69 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 123.429 0.692 . . . . 0.0 111.285 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -65.46 -18.37 65.27 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.53 -1.356 . . . . 0.0 114.136 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.2 mp -95.23 -41.77 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 20.6 p -71.91 -16.08 62.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.396 0.544 . . . . 0.0 111.831 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 39.4 tptt . . . . . 0 C--O 1.25 1.131 0 C-N-CA 127.032 2.133 . . . . 0.0 105.867 178.851 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 . . . . . 0 C--O 1.234 0.261 0 N-CA-C 104.843 -2.281 . . . . 0.0 104.843 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -99.52 136.32 39.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.76 1.624 . . . . 0.0 109.216 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.1 25.1 17.79 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.874 0.75 . . . . 0.0 112.819 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.34 165.81 29.05 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.468 1.107 . . . . 0.0 109.482 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.6 mt -138.55 151.39 47.28 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.8 t -143.12 144.37 23.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.2 mt -134.56 144.64 34.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 123.835 0.854 . . . . 0.0 109.231 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -134.84 132.85 39.1 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.309 1.444 . . . . 0.0 107.903 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -105.77 169.6 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -83.3 -39.56 20.65 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.0 -79.98 0.09 OUTLIER Glycine 0 C--N 1.339 0.71 0 CA-C-N 119.14 0.882 . . . . 0.0 112.271 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.99 -3.12 9.02 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -61.21 157.35 16.38 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 120.789 -1.194 . . . . 0.0 109.416 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.48 69.11 0.76 Allowed Glycine 0 CA--C 1.518 0.258 0 O-C-N 121.78 -0.575 . . . . 0.0 112.038 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -54.2 -19.97 6.07 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.904 1.681 . . . . 0.0 113.623 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -62.97 -58.17 8.25 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.456 1.48 . . . . 0.0 108.238 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.63 -36.76 79.94 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 123.382 0.515 . . . . 0.0 111.915 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.9 -32.06 73.35 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.923 -0.751 . . . . 0.0 110.578 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.01 -43.36 81.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.576 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -58.16 -41.93 84.89 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.647 0.779 . . . . 0.0 110.672 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.65 -50.86 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.53 -45.38 95.97 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 121.421 -0.799 . . . . 0.0 113.247 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -34.0 75.05 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.213 1.007 . . . . 0.0 110.831 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -66.13 -54.8 21.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -56.0 -42.43 76.4 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.332 0.969 . . . . 0.0 110.854 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.86 -27.41 69.15 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.214 -0.929 . . . . 0.0 110.085 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HZ1' ' HA ' ' A' ' 29' ' ' LYS . 1.3 tppm? -84.66 -18.93 33.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.769 -1.207 . . . . 0.0 112.703 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -102.79 -16.25 16.01 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 124.219 0.949 . . . . 0.0 111.162 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.5 p -124.86 -31.95 3.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.23 61.36 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.232 -0.917 . . . . 0.0 112.903 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.4 129.83 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -66.04 148.55 51.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 123.835 0.854 . . . . 0.0 109.253 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 t -139.53 156.18 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.2 m -144.22 141.65 30.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.3 t -130.56 122.94 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -137.81 163.63 30.92 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.764 0.826 . . . . 0.0 110.469 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -121.66 57.9 8.05 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.782 1.233 . . . . 0.0 112.679 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.11 165.1 31.86 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.299 1.333 . . . . 0.0 111.658 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.86 -30.0 6.88 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -16.75 62.48 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.696 1.599 . . . . 0.0 114.063 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -46.27 -34.2 4.28 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.733 1.213 . . . . 0.0 114.213 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -57.61 -24.03 54.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.117 0.967 . . . . 0.0 113.451 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -128.2 -8.21 5.34 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.716 0.806 . . . . 0.0 112.1 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -84.47 -47.35 10.71 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.242 1.417 . . . . 0.0 107.369 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -46.18 -52.32 28.4 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 119.233 0.924 . . . . 0.0 112.656 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.81 -17.6 59.97 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.626 1.551 . . . . 0.0 114.386 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -85.45 -4.24 59.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.3 1.04 . . . . 0.0 111.896 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.7 -39.57 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.752 0.821 . . . . 0.0 110.214 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.49 73.0 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.85 -0.531 . . . . 0.0 110.345 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.12 10.15 1.03 Allowed 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.041 -1.037 . . . . 0.0 112.0 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.7 m -131.88 -0.99 3.78 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.779 1.172 . . . . 0.0 113.64 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.52 56.18 2.86 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -166.23 -176.93 3.88 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 128.824 2.85 . . . . 0.0 105.796 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.27 179.12 31.4 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.168 1.366 . . . . 0.0 114.196 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.07 167.18 16.66 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.456 2.104 . . . . 0.0 110.068 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.14 -21.72 18.32 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.0 mt -138.28 143.94 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 tt -130.51 135.91 59.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.317 1.847 . . . . 0.0 106.197 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.17 109.5 11.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.841 1.256 . . . . 0.0 110.117 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -154.94 169.38 24.18 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.46 152.6 37.92 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.809 0.814 . . . . 0.0 110.013 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -55.15 -30.02 58.96 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.801 1.24 . . . . 0.0 111.537 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.34 -12.54 9.47 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.196 1.798 . . . . 0.0 115.733 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -123.3 2.36 9.13 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.787 1.176 . . . . 0.0 109.909 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -85.24 -5.96 59.29 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.304 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.3 -17.22 79.65 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.889 1.222 . . . . 0.0 111.185 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.65 -66.69 1.1 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-O 118.513 -1.159 . . . . 0.0 113.266 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -44.19 -46.92 9.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.201 1.0 . . . . 0.0 113.22 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.58 -55.15 36.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.786 0.835 . . . . 0.0 110.081 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.36 -49.57 61.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.57 1.148 . . . . 0.0 109.314 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.4 m -58.63 -7.17 0.88 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.48 1.912 . . . . 0.0 112.953 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.77 17.59 72.43 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 125.712 1.625 . . . . 0.0 112.805 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.2 mt -85.86 -15.92 40.29 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.245 1.023 . . . . 0.0 113.507 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.9 mt -105.48 136.01 45.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.88 1.218 . . . . 0.0 111.65 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.51 164.37 25.96 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.62 1.168 . . . . 0.0 111.959 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.09 105.9 5.52 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.3 mm -67.42 152.46 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.39 1.076 . . . . 0.0 112.087 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.2 m 78.09 88.84 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 129.68 3.192 . . . . 0.0 110.058 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -72.44 -28.88 14.26 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.206 1.937 . . . . 0.0 110.755 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -141.58 147.0 36.96 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.221 1.408 . . . . 0.0 109.411 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -54.95 -34.25 63.1 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.805 1.642 . . . . 0.0 112.96 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.46 -35.04 60.08 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.119 0.968 . . . . 0.0 113.037 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -63.51 -28.05 69.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.434 0.561 . . . . 0.0 111.418 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -67.27 -33.08 74.56 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 120.972 -1.08 . . . . 0.0 111.534 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.0 -18.49 55.85 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.207 0.603 . . . . 0.0 111.481 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -74.72 -17.9 60.59 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.7 mt -123.03 155.76 36.21 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.398 0.679 . . . . 0.0 111.671 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -68.94 151.28 97.33 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 122.853 0.461 . . . . 0.0 111.175 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.5 -46.03 2.17 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.433 2.089 . . . . 0.0 112.509 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -54.77 -45.79 74.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.184 0.902 . . . . 0.0 111.68 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.59 -20.64 57.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.019 1.328 . . . . 0.0 112.607 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -72.62 -28.7 62.92 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.904 1.229 . . . . 0.0 109.903 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.92 -34.79 72.12 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.872 1.215 . . . . 0.0 110.902 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.74 -17.34 55.47 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.045 1.338 . . . . 0.0 114.475 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.8 m -127.49 4.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.014 1.326 . . . . 0.0 111.6 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -66.26 157.47 31.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.333 1.064 . . . . 0.0 108.871 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -150.43 -177.33 5.9 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -68.86 108.2 3.37 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.609 1.164 . . . . 0.0 111.969 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.57 -53.65 0.48 Allowed Glycine 0 N--CA 1.47 0.901 0 C-N-CA 128.273 2.844 . . . . 0.0 117.337 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 163.38 12.31 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.198 1.399 . . . . 0.0 107.986 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -97.15 159.55 14.85 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 pt -121.32 -25.25 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.755 -1.111 . . . . 0.0 113.287 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.43 176.96 11.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.275 1.03 . . . . 0.0 108.318 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.53 145.8 58.78 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 124.558 1.143 . . . . 0.0 108.917 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.76 150.98 51.05 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.467 2.111 . . . . 0.0 109.354 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.2 mm -127.82 -53.71 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.131 1.772 . . . . 0.0 110.56 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -124.78 147.24 48.8 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.587 0.755 . . . . 0.0 112.462 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.4 t -122.47 104.17 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.465 1.506 . . . . 0.0 107.464 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.478 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 CA--C 1.52 -0.181 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 39.7 p90 . . . . . 0 C--O 1.236 0.39 0 C-N-CA 124.713 1.205 . . . . 0.0 109.893 -179.081 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo . . . . . 0 N--CA 1.457 -0.659 0 N-CA-C 109.905 -0.844 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -118.8 -12.78 9.59 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.258 1.023 . . . . 0.0 112.426 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.3 t -167.11 162.72 15.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.777 1.231 . . . . 0.0 108.413 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -65.62 -24.86 67.15 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.537 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.5 -15.47 63.69 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.211 1.369 . . . . 0.0 112.926 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.51 -21.41 28.63 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.409 0.683 . . . . 0.0 110.08 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.73 -58.38 19.85 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-O 117.235 -1.364 . . . . 0.0 109.237 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.2 -26.98 49.05 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 CA-C-N 121.45 1.554 . . . . 0.0 111.751 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.92 67.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.728 0.811 . . . . 0.0 110.032 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 64.2 tp -75.81 -26.42 57.23 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.093 1.357 . . . . 0.0 110.999 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.89 -42.32 99.73 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.496 0.718 . . . . 0.0 110.126 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.423 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 7.2 ptmm? -72.4 -32.53 66.45 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.248 -0.908 . . . . 0.0 111.126 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -69.28 -44.79 71.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.666 0.387 . . . . 0.0 110.675 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.7 -30.54 36.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.147 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.21 -33.17 71.36 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 120.182 1.356 . . . . 0.0 109.095 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.99 -7.69 42.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.85 0.07 2.88 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.66 0.784 . . . . 0.0 111.895 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -162.84 -107.0 0.21 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.399 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -141.69 -173.33 3.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.323 1.449 . . . . 0.0 109.581 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.9 p -62.55 152.5 34.66 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.155 0.889 . . . . 0.0 113.024 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.44 -49.57 13.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.345 1.458 . . . . 0.0 114.228 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.9 tp -134.66 143.37 47.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.125 0.97 . . . . 0.0 110.887 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -137.06 138.21 40.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.255 1.422 . . . . 0.0 107.606 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -151.29 166.49 30.79 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.925 1.239 . . . . 0.0 111.941 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -70.17 91.13 0.69 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.405 1.882 . . . . 0.0 106.629 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.2 tt -87.47 -35.6 18.14 Favored 'General case' 0 CA--C 1.524 -0.052 0 C-N-CA 125.715 1.606 . . . . 0.0 112.566 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -64.2 -12.45 40.66 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -103.78 122.48 44.47 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 118.689 0.677 . . . . 0.0 109.992 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.86 -16.48 49.58 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 120.723 0.949 . . . . 0.0 110.639 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -47.66 -44.44 27.21 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 127.54 2.336 . . . . 0.0 111.671 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -98.84 -33.41 10.9 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 p -69.82 -27.35 64.8 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.352 1.433 . . . . 0.0 110.338 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -53.6 -60.61 6.69 Favored Pre-proline 0 C--N 1.343 0.308 0 C-N-CA 124.875 1.27 . . . . 0.0 113.392 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -57.28 -15.92 20.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.913 1.742 . . . . 0.0 114.537 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 8.6 tt -75.44 -66.57 0.75 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.2 pt -56.69 -34.62 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.217 1.007 . . . . 0.0 112.845 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.03 -26.23 64.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.028 -1.045 . . . . 0.0 112.86 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.43 86.88 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.498 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.07 -42.65 73.05 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.412 0.685 . . . . 0.0 111.439 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.83 -13.96 0.09 OUTLIER Glycine 0 CA--C 1.526 0.753 0 CA-C-O 117.959 -1.467 . . . . 0.0 113.025 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -49.4 133.12 25.57 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -138.02 144.97 41.3 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 119.719 1.76 . . . . 0.0 111.509 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.79 -59.49 2.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -141.65 171.42 14.08 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.901 2.08 . . . . 0.0 106.658 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -119.85 139.83 51.76 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 119.528 1.058 . . . . 0.0 112.643 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.17 105.73 12.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.698 1.199 . . . . 0.0 108.448 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -173.13 1.13 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.306 2.242 . . . . 0.0 109.098 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -51.31 -20.71 1.79 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.13 2.172 . . . . 0.0 115.012 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.94 3.09 0.04 OUTLIER Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.112 0.863 . . . . 0.0 113.693 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.44 151.55 48.68 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 119.531 1.666 . . . . 0.0 107.314 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -122.13 126.04 47.48 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 125.534 1.534 . . . . 0.0 108.203 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.79 150.81 52.12 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 122.512 1.149 . . . . 0.0 113.566 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.09 1.58 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.843 -1.98 . . . . 0.0 110.133 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -75.97 -35.7 59.55 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.2 97.16 10.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.82 121.09 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.44 1.896 . . . . 0.0 106.827 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -122.83 38.69 2.45 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 123.924 0.773 . . . . 0.0 114.862 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.72 -25.03 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.117 0.967 . . . . 0.0 111.17 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.84 17.22 19.98 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -66.19 164.2 16.2 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 121.596 -0.69 . . . . 0.0 110.995 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.9 65.27 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.9 -36.8 93.76 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.898 0.772 . . . . 0.0 111.651 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.58 -50.55 64.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.791 0.796 . . . . 0.0 109.24 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -63.82 -32.2 73.63 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 117.869 -1.063 . . . . 0.0 111.616 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.54 -51.25 70.66 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.244 0.929 . . . . 0.0 110.217 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.14 -28.95 69.36 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 29.9 tp -69.74 -55.96 8.49 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.605 1.203 . . . . 0.0 110.785 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.43 -26.47 53.69 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.6 0.76 . . . . 0.0 112.152 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -56.66 -42.1 78.38 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.126 -0.984 . . . . 0.0 108.953 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 19.6 tp -69.25 -48.95 60.4 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.835 1.254 . . . . 0.0 108.456 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 47.4 t -54.48 -34.05 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.517 1.527 . . . . 0.0 109.78 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.18 -42.56 88.75 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.553 1.541 . . . . 0.0 110.778 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.62 -40.25 84.67 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.245 -0.909 . . . . 0.0 108.564 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 89.4 mt -66.85 -36.93 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -60.33 -36.89 79.0 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.992 -1.693 . . . . 0.0 108.473 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -82.3 -2.11 51.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.288 1.435 . . . . 0.0 111.272 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? 56.46 9.56 0.56 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.707 2.403 . . . . 0.0 114.394 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -82.46 -14.68 54.66 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ttp -112.17 147.97 35.03 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.46 1.104 . . . . 0.0 110.074 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -85.58 103.57 14.53 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.897 1.279 . . . . 0.0 107.919 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -77.51 -21.62 52.45 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -91.67 0.12 57.52 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.5 m -60.88 131.48 50.82 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.526 1.13 . . . . 0.0 110.315 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.54 -173.51 2.75 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.785 1.234 . . . . 0.0 108.048 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -56.53 -45.81 80.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.074 0.949 . . . . 0.0 109.725 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.86 -49.68 75.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.948 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 46.3 mm -59.0 -48.75 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.621 1.101 . . . . 0.0 110.356 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.09 87.08 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -74.59 -57.42 3.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -50.81 -55.89 14.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.754 1.621 . . . . 0.0 112.241 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.42 76.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.139 0.881 . . . . 0.0 110.734 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.5 -38.8 90.79 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -63.1 -35.69 81.11 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.89 0.876 . . . . 0.0 109.708 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -72.78 -22.79 60.78 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.01 18.61 21.82 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 126.143 1.83 . . . . 0.0 112.68 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.88 -71.74 0.31 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.233 1.016 . . . . 0.0 113.648 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . 0.28 4.2 t -68.55 152.81 44.86 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.27 0.557 . . . . 0.0 112.365 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.83 31.42 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.612 0.765 . . . . 0.0 112.454 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -152.85 155.66 37.51 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.506 1.123 . . . . 0.0 108.234 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.5 t -147.78 159.05 44.24 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.5 mt . . . . . 0 C--O 1.238 0.461 0 CA-C-N 119.408 1.004 . . . . 0.0 110.236 -179.563 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.94 141.41 30.0 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.71 2.273 . . . . 0.0 111.559 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.1 p -149.48 -172.23 4.09 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 127.793 2.437 . . . . 0.0 107.512 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -87.5 144.95 26.46 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -55.73 119.77 6.27 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.984 0.914 . . . . 0.0 110.389 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.01 -4.9 44.11 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.055 0.836 . . . . 0.0 114.321 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.57 87.14 32.56 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.927 1.863 . . . . 0.0 109.543 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.48 152.7 60.45 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.721 1.614 . . . . 0.0 110.661 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 19.5 m -72.2 134.81 45.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.65 0.78 . . . . 0.0 109.913 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.492 ' HZ3' ' ND2' ' A' ' 323' ' ' ASN . 0.2 OUTLIER -140.39 87.18 12.04 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.528 1.531 . . . . 0.0 108.01 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.15 -90.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.628 2.218 . . . . 0.0 109.35 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.444 -0.725 0 C-N-CA 127.517 2.327 . . . . 0.0 106.046 179.729 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.867 0 N-CA-C 106.555 -2.618 . . . . 0.0 106.555 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.0 164.37 33.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.169 0.509 . . . . 0.0 109.947 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.68 173.19 10.83 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.608 0.763 . . . . 0.0 109.726 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -148.39 141.3 24.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.722 -1.236 . . . . 0.0 110.135 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.29 132.46 47.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.7 152.18 19.79 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.218 -0.768 . . . . 0.0 111.362 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.1 mt -89.83 135.63 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -71.35 120.29 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.424 1.09 . . . . 0.0 109.14 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.24 -20.66 62.21 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -75.88 -4.14 39.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.059 1.744 . . . . 0.0 114.924 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 33.1 m -71.7 167.49 30.4 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 124.894 1.278 . . . . 0.0 110.672 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -80.75 -43.45 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.196 1.264 . . . . 0.0 110.605 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -139.23 106.84 5.59 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.032 0.933 . . . . 0.0 109.379 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -19.79 63.11 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.115 0.966 . . . . 0.0 112.045 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.11 -40.57 81.57 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 68.3 mt -57.62 -36.58 71.98 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.722 -0.612 . . . . 0.0 111.492 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.81 -45.45 28.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.976 0.511 . . . . 0.0 112.024 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -32.72 74.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.2 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -70.34 -56.45 6.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -52.52 -46.14 66.59 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.238 -0.914 . . . . 0.0 111.255 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 4.1 tt -66.81 -42.54 85.75 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.517 -1.23 . . . . 0.0 113.063 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.3 -15.74 39.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.51 1.504 . . . . 0.0 114.713 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -109.55 -17.58 13.71 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -131.29 -51.5 1.02 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 118.993 0.815 . . . . 0.0 111.471 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.86 -55.7 20.89 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.338 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 55.3 mt -88.34 77.26 8.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.74 0.816 . . . . 0.0 109.91 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 39.8 p -140.8 159.43 42.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.23 -38.04 89.15 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -81.87 -29.25 32.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.009 0.524 . . . . 0.0 112.227 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.04 -43.84 20.55 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.97 -39.83 90.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.31 -46.57 85.9 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -53.52 -46.78 70.25 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.736 0.698 . . . . 0.0 111.214 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.66 -37.79 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.19 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -72.01 -22.45 61.41 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.774 1.629 . . . . 0.0 113.584 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -69.29 -44.97 70.72 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.626 0.771 . . . . 0.0 109.01 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -71.76 -48.31 47.68 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -135.08 152.92 77.98 Favored Pre-proline 0 N--CA 1.461 0.082 0 C-N-CA 123.992 0.917 . . . . 0.0 109.909 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.9 125.57 10.01 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.086 1.857 . . . . 0.0 110.937 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 86.7 mt -99.89 -24.23 14.71 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.535 -0.745 . . . . 0.0 112.335 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 81.26 -155.02 35.66 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.22 168.93 14.72 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 12.7 m -121.68 162.2 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 O-C-N 120.641 -1.287 . . . . 0.0 110.991 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.33 -13.59 49.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.286 0.634 . . . . 0.0 110.434 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.31 112.5 12.86 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 127.239 2.216 . . . . 0.0 107.703 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -62.89 -36.51 83.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.071 0.462 . . . . 0.0 110.32 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -52.15 64.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.434 1.894 . . . . 0.0 111.172 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -84.84 -11.8 54.9 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.815 0.846 . . . . 0.0 112.224 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -60.49 -42.77 96.99 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -63.24 -9.89 13.38 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.43 1.492 . . . . 0.0 112.164 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -109.61 -36.8 5.86 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.051 0.94 . . . . 0.0 110.495 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 14.7 mt -74.27 -24.32 59.24 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.453 -1.405 . . . . 0.0 108.521 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.56 -8.05 17.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.495 1.118 . . . . 0.0 112.382 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -56.59 -37.76 71.07 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.03 133.31 24.32 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.39 -24.69 71.17 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.578 2.185 . . . . 0.0 113.332 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -62.57 -30.71 71.52 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.77 0.714 . . . . 0.0 109.851 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.9 mp -77.54 -61.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -44.13 -55.99 4.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.164 1.386 . . . . 0.0 114.342 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.18 -32.41 68.21 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.596 -0.69 . . . . 0.0 112.859 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 24.7 m -74.74 -36.54 62.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.687 0.795 . . . . 0.0 109.164 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.8 tpt -66.75 -43.15 84.92 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.219 1.007 . . . . 0.0 109.084 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -55.74 -41.01 73.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.595 0.758 . . . . 0.0 110.419 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.492 ' ND2' ' HZ3' ' A' ' 256' ' ' LYS . 1.3 t30 -63.28 -26.85 68.97 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.728 -0.608 . . . . 0.0 112.324 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.485 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 CA--C 1.538 0.685 0 N-CA-C 115.595 1.344 . . . . 0.0 115.595 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 66.96 34.52 5.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.687 1.995 . . . . 0.0 112.002 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.2 pt -132.33 156.48 80.04 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 123.845 0.858 . . . . 0.0 110.937 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.46 -25.99 24.74 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.002 2.468 . . . . 0.0 113.666 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -57.66 -16.91 12.11 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.227 0.921 . . . . 0.0 113.343 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -22.83 65.69 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.16 -0.963 . . . . 0.0 111.411 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.4 t -65.62 -54.72 23.74 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.56 -34.97 78.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.499 1.12 . . . . 0.0 111.302 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -50.34 -56.81 9.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.805 0.842 . . . . 0.0 111.658 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -65.98 -40.9 91.64 Favored 'General case' 0 CA--C 1.522 -0.118 0 O-C-N 121.247 -0.908 . . . . 0.0 111.404 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.57 -45.77 84.77 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.155 0.503 . . . . 0.0 110.518 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.39 -51.68 64.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.647 1.179 . . . . 0.0 111.581 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.84 -27.46 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.707 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -53.99 -50.1 67.35 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.352 1.433 . . . . 0.0 107.596 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.5 m -68.51 -44.43 74.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.051 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.86 -47.03 68.09 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.948 1.249 . . . . 0.0 113.768 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 24.2 t -56.08 -51.68 59.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 124.61 1.164 . . . . 0.0 109.113 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.03 -37.45 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -58.75 -46.06 88.29 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.177 -1.577 . . . . 0.0 110.947 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.35 -45.46 59.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.634 0.773 . . . . 0.0 110.48 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.14 -44.42 97.36 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.33 0.514 . . . . 0.0 111.623 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 59.8 m -75.04 -25.91 59.05 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.899 0.879 . . . . 0.0 109.313 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.86 32.77 44.01 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -85.14 -21.29 29.3 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.846 0.858 . . . . 0.0 110.62 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -147.42 151.42 36.43 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.6 m -58.65 152.21 19.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.991 0.916 . . . . 0.0 109.293 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 61.8 t -57.2 -44.77 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 118.988 0.813 . . . . 0.0 109.414 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -52.18 66.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.469 1.108 . . . . 0.0 110.009 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -63.87 -37.71 88.41 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.262 0.625 . . . . 0.0 111.838 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.93 92.48 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 38.2 mt -73.15 -38.85 66.1 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.597 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -57.88 -53.46 57.99 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 119.681 1.128 . . . . 0.0 109.807 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -29.93 70.76 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -70.99 -55.34 8.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 118.114 -0.946 . . . . 0.0 108.895 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -49.66 -38.57 33.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.178 1.391 . . . . 0.0 110.069 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 26.4 m -57.93 -45.64 86.27 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.008 0.523 . . . . 0.0 110.452 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -61.67 -8.63 4.81 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.147 2.179 . . . . 0.0 114.027 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 2.3 mp -104.17 -40.11 6.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.1 p -68.76 -25.43 64.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.402 0.547 . . . . 0.0 110.801 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? . . . . . 0 C--O 1.245 0.85 0 C-N-CA 127.135 2.174 . . . . 0.0 108.36 -179.089 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -71.92 69.49 0.71 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.718 1.207 . . . . 0.0 113.786 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.57 30.95 0.02 OUTLIER Glycine 0 CA--C 1.526 0.731 0 O-C-N 121.352 -0.843 . . . . 0.0 114.017 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -143.5 172.06 13.3 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.253 1.027 . . . . 0.0 110.259 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.6 mt -150.81 140.13 21.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 127.682 2.393 . . . . 0.0 106.506 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.8 t -137.06 148.05 26.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.43 142.4 43.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.606 1.562 . . . . 0.0 109.119 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -137.76 134.08 34.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.8 147.68 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -60.31 -35.57 75.89 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.27 168.72 11.45 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t0 48.66 30.25 2.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.107 1.363 . . . . 0.0 110.961 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.38 -14.58 16.21 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -177.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.66 30.57 4.56 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.909 1.719 . . . . 0.0 112.972 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -45.82 -46.21 15.39 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.66 1.184 . . . . 0.0 113.723 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -58.19 -41.37 83.79 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.445 1.02 . . . . 0.0 112.874 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.57 -42.18 41.25 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.8 tp -58.42 -39.21 79.16 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.928 1.291 . . . . 0.0 110.238 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.78 -46.7 64.25 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.729 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.36 -39.5 79.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.269 1.028 . . . . 0.0 111.573 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 t -59.95 -42.78 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.72 -39.57 96.77 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -62.47 -46.87 86.51 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 119.651 1.725 . . . . 0.0 109.012 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -59.65 -56.19 24.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -55.55 -47.07 76.96 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.628 0.649 . . . . 0.0 112.017 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.24 -28.85 69.99 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 121.103 -0.998 . . . . 0.0 110.794 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.64 -23.0 37.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.904 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -100.3 -11.05 20.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.409 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.3 p -127.34 -32.39 2.46 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.478 1.035 . . . . 0.0 113.693 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.2 -14.73 62.86 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 119.393 0.997 . . . . 0.0 112.818 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.6 mm -69.24 122.81 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.26 145.49 47.24 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 123.345 0.658 . . . . 0.0 110.13 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.8 t -133.0 136.38 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -128.96 138.54 52.03 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.8 t -133.94 128.55 53.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.7 1.2 . . . . 0.0 107.931 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -140.55 160.09 40.78 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.14 1.776 . . . . 0.0 107.184 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -122.26 59.03 10.89 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.094 0.958 . . . . 0.0 111.708 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.84 136.41 20.73 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.906 2.404 . . . . 0.0 109.32 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.31 -33.41 63.19 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.561 0.948 . . . . 0.0 113.561 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -99.27 24.23 8.24 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -178.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 pp -49.2 -29.3 5.41 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.266 -0.896 . . . . 0.0 112.287 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -57.69 -24.98 59.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.359 1.864 . . . . 0.0 114.518 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -110.05 -19.29 13.12 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.555 0.693 . . . . 0.0 111.023 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -81.08 -50.29 9.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.357 -0.84 . . . . 0.0 108.874 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -44.12 -55.98 8.58 Favored Pre-proline 0 CA--C 1.529 0.146 0 CA-C-O 117.334 -1.317 . . . . 0.0 111.937 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.98 -28.51 86.4 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 120.813 1.326 . . . . 0.0 115.402 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -83.05 -32.87 26.62 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.401 1.455 . . . . 0.0 112.154 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 t -87.37 -40.52 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.221 0.464 . . . . 0.0 110.258 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.26 -32.28 73.87 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 120.483 -1.385 . . . . 0.0 110.034 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.2 -20.03 38.2 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.107 1.363 . . . . 0.0 112.585 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.1 p -113.37 2.91 15.64 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.993 0.917 . . . . 0.0 112.897 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.49 12.54 83.64 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.071 0.851 . . . . 0.0 111.287 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -103.97 -10.27 18.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.544 1.138 . . . . 0.0 111.468 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.92 174.27 55.29 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.017 1.294 . . . . 0.0 115.333 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.71 172.0 7.59 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.41 3.406 . . . . 0.0 113.389 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -101.43 -20.19 15.25 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.39 127.12 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.707 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 tp -107.67 144.72 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 127.202 2.201 . . . . 0.0 106.846 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -131.97 107.74 8.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.744 1.218 . . . . 0.0 110.637 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -157.24 -175.82 5.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.065 0.946 . . . . 0.0 110.076 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.4 151.0 33.02 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -52.3 -33.41 42.18 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.553 1.541 . . . . 0.0 113.409 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.42 -18.08 48.53 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -103.31 -7.61 20.96 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.163 -1.585 . . . . 0.0 110.514 178.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.433 ' C ' ' H ' ' A' ' 69' ' ' GLY . 7.1 m-30 -91.32 -28.69 17.58 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.755 -0.59 . . . . 0.0 112.388 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.04 14.08 1.26 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.905 1.241 . . . . 0.0 113.725 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 67' ' ' PHE . . . -119.87 -59.9 0.25 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 129.394 3.378 . . . . 0.0 105.853 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -50.11 -51.75 40.52 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.024 0.93 . . . . 0.0 110.665 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.66 95.81 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.14 0.495 . . . . 0.0 111.135 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.24 -13.34 58.09 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.857 0.863 . . . . 0.0 112.44 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.4 m -106.52 -6.32 18.18 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.745 2.418 . . . . 0.0 112.473 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.42 16.49 39.97 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.1 mt -96.18 -15.01 22.32 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 73.5 mt -106.53 139.77 40.48 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.832 1.651 . . . . 0.0 110.755 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.56 -178.36 7.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -69.34 106.74 3.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.418 2.287 . . . . 0.0 106.373 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 mm -80.4 148.7 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 t 38.96 80.37 0.28 Allowed Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 129.026 2.931 . . . . 0.0 111.499 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.82 -24.9 68.02 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 121.635 1.557 . . . . 0.0 111.848 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -123.62 142.59 50.9 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.267 1.427 . . . . 0.0 109.138 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -61.44 -27.51 68.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.205 2.202 . . . . 0.0 109.98 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.69 63.25 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.202 0.91 . . . . 0.0 112.905 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -76.62 -31.09 57.2 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.314 0.961 . . . . 0.0 108.925 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -67.05 -39.5 86.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.205 -0.935 . . . . 0.0 109.816 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -57.3 -28.4 63.0 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.502 1.121 . . . . 0.0 112.077 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -75.06 -18.24 60.34 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.4 mt -117.17 162.05 18.47 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.131 0.878 . . . . 0.0 110.782 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -75.0 148.65 84.69 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.783 0.833 . . . . 0.0 109.972 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.52 -42.51 3.58 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.596 2.198 . . . . 0.0 113.342 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -60.57 -40.01 90.12 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.55 0.614 . . . . 0.0 109.991 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.02 -28.34 70.03 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.73 -1.231 . . . . 0.0 109.98 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -71.84 -33.3 68.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.214 0.915 . . . . 0.0 109.951 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.11 -38.73 73.84 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.262 0.937 . . . . 0.0 110.42 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.94 -7.47 3.85 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.79 8.21 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.222 1.409 . . . . 0.0 112.167 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -63.75 162.67 12.94 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.502 1.144 . . . . 0.0 111.182 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -145.71 -174.91 4.54 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.759 1.624 . . . . 0.0 108.408 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.68 105.15 0.61 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.304 1.442 . . . . 0.0 107.84 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.05 -78.06 0.29 Allowed Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.795 1.188 . . . . 0.0 113.637 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -178.86 7.21 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.614 1.566 . . . . 0.0 110.57 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.51 169.35 8.71 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.842 0.83 . . . . 0.0 111.403 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.5 pt -130.07 -22.41 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.082 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.71 167.86 29.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.877 0.871 . . . . 0.0 109.051 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.94 150.35 62.39 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.583 1.153 . . . . 0.0 109.383 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -72.74 144.45 39.33 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.764 2.309 . . . . 0.0 109.371 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -126.26 -46.82 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.877 0.871 . . . . 0.0 111.608 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.8 144.9 49.29 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.25 119.03 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 124.096 0.958 . . . . 0.0 111.265 -178.406 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 68.9 mt . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 30.1 p90 . . . . . 0 C--O 1.234 0.242 0 C-N-CA 125.62 1.568 . . . . 0.0 109.59 -179.081 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.458 -0.607 0 N-CA-C 110.921 -0.453 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -136.41 -8.8 1.95 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 117.401 -1.285 . . . . 0.0 112.449 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.6 t -147.1 144.63 29.18 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 121.714 2.052 . . . . 0.0 112.287 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -61.48 -19.99 62.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.627 1.171 . . . . 0.0 112.974 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -74.74 -15.86 60.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.615 1.098 . . . . 0.0 112.642 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -92.51 -26.92 17.72 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.987 0.812 . . . . 0.0 110.474 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.5 mm -48.69 -56.77 13.29 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 125.382 1.473 . . . . 0.0 110.951 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.69 -22.36 32.5 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 CA-C-N 120.487 1.209 . . . . 0.0 112.236 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.57 -36.7 63.07 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.1 tp -78.49 -28.55 46.4 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.861 1.264 . . . . 0.0 110.068 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.04 -50.21 71.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.71 0.687 . . . . 0.0 110.062 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.7 ptmm? -63.52 -31.85 73.13 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.044 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.59 -42.21 52.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.358 0.526 . . . . 0.0 109.697 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.8 mt -71.35 -31.41 67.33 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -67.42 -29.98 69.62 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.59 -3.53 18.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.128 0.571 . . . . 0.0 112.071 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.31 3.86 2.17 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.402 1.481 . . . . 0.0 111.478 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.87 -95.59 0.1 Allowed Glycine 0 CA--C 1.524 0.647 0 CA-C-N 120.077 1.308 . . . . 0.0 115.344 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -138.72 -171.6 3.11 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 125.341 1.456 . . . . 0.0 110.738 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.0 p -62.22 154.1 28.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.913 0.885 . . . . 0.0 110.599 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -76.85 -39.58 50.7 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.669 1.188 . . . . 0.0 110.805 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.2 tp -130.46 147.82 52.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.216 1.006 . . . . 0.0 112.5 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 25.4 mtp -150.75 127.84 11.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.642 2.377 . . . . 0.0 105.243 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -158.71 173.61 16.3 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -78.99 84.63 4.99 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.128 -0.982 . . . . 0.0 110.636 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 mp -71.61 -28.59 63.9 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.051 0.387 . . . . 0.0 109.986 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -61.42 -15.14 34.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -115.21 130.24 24.41 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 119.478 1.035 . . . . 0.0 110.605 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.04 -21.67 72.83 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.324 1.349 . . . . 0.0 112.394 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -54.4 -31.42 54.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.263 1.025 . . . . 0.0 113.461 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.12 -24.8 15.15 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.2 p -90.89 -15.93 29.04 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.33 0.968 . . . . 0.0 111.456 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -62.23 -35.3 19.6 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.08 -11.54 30.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 123.276 2.206 . . . . 0.0 113.98 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.7 tp -68.31 -67.05 0.49 Allowed 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.51 1.524 . . . . 0.0 111.621 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.28 -24.7 35.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.616 1.166 . . . . 0.0 113.295 -179.26 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.35 -16.15 63.29 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.865 -0.522 . . . . 0.0 111.035 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.85 -60.54 2.77 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.153 1.381 . . . . 0.0 109.568 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.76 -54.99 38.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.0 15.79 0.02 OUTLIER Glycine 0 C--N 1.337 0.629 0 CA-C-O 117.887 -1.507 . . . . 0.0 116.149 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.66 147.97 41.07 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 120.804 2.302 . . . . 0.0 109.639 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -151.9 128.24 10.59 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.89 -48.97 62.04 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -143.66 149.51 37.36 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -101.84 159.28 15.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.217 -0.927 . . . . 0.0 109.315 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -155.59 113.98 3.45 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 102.011 -3.329 . . . . 0.0 102.011 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -73.67 -168.59 0.59 Allowed 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.308 1.843 . . . . 0.0 108.429 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -57.13 -34.56 68.51 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.741 -1.224 . . . . 0.0 110.765 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -154.56 8.28 0.36 Allowed Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.284 -1.287 . . . . 0.0 114.558 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -112.49 130.46 55.99 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.366 2.083 . . . . 0.0 107.06 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.17 115.37 17.58 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.96 1.704 . . . . 0.0 109.368 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -132.56 111.78 11.52 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -10.45 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.869 0.867 . . . . 0.0 112.789 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -77.13 -28.78 54.42 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.821 0.848 . . . . 0.0 109.937 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -73.76 80.98 1.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.911 1.284 . . . . 0.0 110.619 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 63.7 t -108.19 141.77 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 127.591 2.357 . . . . 0.0 108.851 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -132.16 34.04 2.59 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.093 1.33 . . . . 0.0 115.092 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.17 -37.76 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 117.301 -1.333 . . . . 0.0 113.796 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.446 ' OD2' ' HE3' ' A' ' 362' ' ' LYS 0.293 21.4 t70 -108.8 34.91 3.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.53 1.514 . . . . 0.0 113.279 -178.613 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -79.14 151.69 31.18 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -47.75 -24.8 1.04 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.17 -19.74 68.88 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 120.145 1.339 . . . . 0.0 111.738 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.66 -45.07 47.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.809 0.844 . . . . 0.0 108.981 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -64.39 -54.56 30.92 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.71 -45.07 70.32 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.56 -30.43 77.58 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 118.814 -0.992 . . . . 0.0 112.128 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 46.0 tp -84.09 -40.46 18.27 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.206 1.402 . . . . 0.0 110.881 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.4 m -44.24 -54.49 5.66 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 127.763 2.425 . . . . 0.0 112.156 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.02 -44.41 91.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.778 0.717 . . . . 0.0 111.769 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.66 -46.05 91.39 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.636 -0.665 . . . . 0.0 109.38 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.78 -34.42 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.65 -43.32 99.12 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.531 1.06 . . . . 0.0 111.811 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 75.7 mt -65.12 -50.76 64.82 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.678 0.791 . . . . 0.0 109.103 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.48 -35.97 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.406 1.083 . . . . 0.0 110.572 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -58.61 -49.13 78.62 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.345 0.975 . . . . 0.0 108.545 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.88 4.27 17.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.843 1.257 . . . . 0.0 112.286 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 58.39 20.49 7.42 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.919 1.288 . . . . 0.0 112.292 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.79 9.63 6.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.366 1.466 . . . . 0.0 110.882 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.2 ttt -146.91 148.05 31.4 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 121.206 -0.934 . . . . 0.0 108.6 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -78.15 78.63 4.63 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.25 -13.08 61.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.861 1.665 . . . . 0.0 114.782 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -92.88 -8.2 44.03 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.58 0.752 . . . . 0.0 112.372 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.7 m -61.97 127.66 32.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 122.522 1.153 . . . . 0.0 110.065 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 29.5 p30 -119.16 -177.52 3.36 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.711 2.004 . . . . 0.0 106.683 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.44 -42.9 99.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.4 m -60.11 -45.59 92.46 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 118.522 -0.751 . . . . 0.0 109.56 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.93 -56.26 19.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -54.49 -59.44 4.69 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.942 1.697 . . . . 0.0 112.982 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -58.19 -44.58 88.11 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.845 0.748 . . . . 0.0 111.475 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.8 -45.65 91.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.434 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.82 95.25 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.411 1.084 . . . . 0.0 112.166 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -63.3 -38.59 91.75 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.098 0.559 . . . . 0.0 110.056 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -59.68 -46.07 90.16 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -68.46 -42.9 78.1 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.341 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.64 36.5 2.05 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.283 1.421 . . . . 0.0 109.596 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -78.22 -62.02 1.81 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.746 -0.856 . . . . 0.0 109.298 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.4 t -73.27 137.1 44.7 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.552 1.541 . . . . 0.0 108.075 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.05 -15.65 57.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.163 0.585 . . . . 0.0 112.53 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -159.29 168.4 26.53 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.919 1.688 . . . . 0.0 109.443 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -155.81 -179.56 8.24 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.452 1.501 . . . . 0.0 109.046 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.3 mt . . . . . 0 C--O 1.236 0.384 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 178.868 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 32.0 mt . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.46 153.7 77.03 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.277 1.985 . . . . 0.0 111.849 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 36.7 p -113.81 -165.38 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.265 1.426 . . . . 0.0 109.149 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -125.98 149.88 48.45 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -51.09 120.24 4.74 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.618 1.167 . . . . 0.0 109.616 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.61 -4.13 57.43 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 117.621 -1.655 . . . . 0.0 114.615 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.69 115.01 3.51 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 121.777 2.789 . . . . 0.0 115.191 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.29 147.07 28.84 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.709 2.939 . . . . 0.0 111.254 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.4 p -64.81 155.52 33.67 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -133.02 66.69 76.59 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.512 1.525 . . . . 0.0 108.599 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.15 179.68 6.27 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.426 2.751 . . . . 0.0 113.174 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 . . . . . 0 C--O 1.234 0.288 0 CA-C-O 121.903 0.859 . . . . 0.0 112.155 -179.928 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.855 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.89 154.96 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 119.114 1.457 . . . . 0.0 111.829 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.37 117.46 11.03 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.4 m -104.49 144.98 30.93 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.561 1.144 . . . . 0.0 110.811 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.0 129.7 47.15 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.76 131.54 8.55 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 123.556 0.535 . . . . 0.0 111.891 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 85.5 mt -75.09 131.15 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -71.33 120.27 16.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.708 0.803 . . . . 0.0 109.143 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.47 -12.39 60.18 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.951 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.85 -6.67 59.48 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.164 0.893 . . . . 0.0 112.96 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.5 m -63.05 161.3 31.85 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.268 1.027 . . . . 0.0 108.681 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.88 -53.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 121.204 1.466 . . . . 0.0 109.417 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -132.75 104.32 6.56 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . 0.43 ' H ' ' HD2' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -60.06 -19.04 51.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.318 -1.31 . . . . 0.0 113.389 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.34 -33.2 72.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.02 -36.52 83.85 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.882 -1.136 . . . . 0.0 110.993 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.31 -47.23 28.8 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 122.646 0.378 . . . . 0.0 110.565 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.459 ' HZ1' ' CD ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -61.46 -35.73 78.44 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.206 -179.599 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -70.37 -55.34 9.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -51.48 -46.89 63.3 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 120.225 1.375 . . . . 0.0 112.322 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.25 -23.72 66.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 116.944 -1.503 . . . . 0.0 112.294 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.459 ' CD ' ' HZ1' ' A' ' 277' ' ' LYS . 14.8 pt-20 -108.63 -17.91 13.85 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.7 1.591 . . . . 0.0 113.606 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -80.47 -33.38 36.69 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.461 1.104 . . . . 0.0 108.816 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -133.66 -46.09 0.81 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.102 -0.952 . . . . 0.0 111.079 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . 0.256 0.1 OUTLIER -67.85 0.24 3.58 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 120.71 1.595 . . . . 0.0 114.831 -179.462 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 58.7 mt -130.17 40.47 3.53 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 119.524 -1.985 . . . . 0.0 108.863 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 63.9 p -117.5 156.42 28.05 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.24 -43.38 98.96 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -73.31 -33.04 64.95 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -75.44 -42.25 28.06 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.09 -44.47 76.16 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -54.83 -47.17 74.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.189 0.996 . . . . 0.0 109.52 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.24 -42.32 63.52 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 22.5 t -75.34 -36.52 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -61.54 -20.47 63.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.482 0.713 . . . . 0.0 110.97 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -67.85 -45.45 74.57 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 121.163 -0.961 . . . . 0.0 110.139 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.42 -39.77 58.51 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -146.35 156.72 49.75 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.245 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.32 114.08 3.67 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.761 1.641 . . . . 0.0 109.299 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.47 -32.47 37.11 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 119.37 -0.348 . . . . 0.0 110.074 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.57 -167.81 47.07 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -59.13 157.63 10.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.56 0.695 . . . . 0.0 109.932 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.8 156.27 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.723 0.773 . . . . 0.0 111.191 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.63 -35.12 67.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.67 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.38 103.6 0.32 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.729 1.211 . . . . 0.0 112.332 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -47.95 -33.4 7.69 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.587 1.555 . . . . 0.0 112.703 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.8 -49.93 68.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.469 1.108 . . . . 0.0 113.211 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -96.41 -10.58 27.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.242 0.928 . . . . 0.0 111.504 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.27 -46.71 87.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.331 1.452 . . . . 0.0 108.098 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -69.16 -22.58 63.92 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 119.074 -0.488 . . . . 0.0 112.046 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -78.94 -49.57 12.59 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 7.1 mt -62.69 -38.16 89.29 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.61 -2.41 2.39 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.531 1.132 . . . . 0.0 114.043 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -66.71 -35.79 80.97 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.445 1.02 . . . . 0.0 108.529 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.9 150.49 58.89 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 123.747 0.819 . . . . 0.0 109.643 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.14 -24.59 20.03 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.466 2.11 . . . . 0.0 115.23 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -48.0 77.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.385 0.993 . . . . 0.0 109.447 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.9 mp -64.04 -55.77 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.5 -53.39 23.57 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 123.926 0.766 . . . . 0.0 111.967 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.44 -47.13 87.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 87.0 m -67.57 -29.71 69.14 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 7.8 tpt -71.91 -39.52 69.46 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 120.9 -1.125 . . . . 0.0 109.136 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -56.78 -26.81 58.54 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.62 0.768 . . . . 0.0 110.223 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -66.18 -36.86 84.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.263 0.625 . . . . 0.0 112.332 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.483 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo . . . . . 0 CA--C 1.534 0.482 0 N-CA-C 112.576 0.183 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -134.23 38.53 3.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.88 1.272 . . . . 0.0 112.764 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.1 pt -114.05 152.09 45.47 Favored Pre-proline 0 N--CA 1.472 0.656 0 O-C-N 120.879 -1.138 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.98 -17.22 36.69 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.581 2.188 . . . . 0.0 113.969 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -56.23 -22.83 31.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.103 1.761 . . . . 0.0 112.024 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -32.51 65.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.849 1.26 . . . . 0.0 111.544 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -48.57 76.65 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.404 1.002 . . . . 0.0 109.208 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.5 87.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -58.87 -54.51 46.28 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.354 0.525 . . . . 0.0 110.393 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -61.29 -42.37 98.54 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.561 -0.712 . . . . 0.0 109.989 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -63.93 -23.04 67.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.069 0.948 . . . . 0.0 112.307 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -85.02 -57.73 2.98 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 120.955 -1.09 . . . . 0.0 110.639 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 19.3 t -57.84 -38.74 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 118.068 -0.968 . . . . 0.0 111.946 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -52.15 -48.57 64.84 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.145 1.339 . . . . 0.0 111.365 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 8.5 m -66.4 -40.22 89.48 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.375 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.56 83.74 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.373 0.988 . . . . 0.0 111.413 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 36.2 t -60.69 -55.38 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.784 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.8 mm -66.26 -33.38 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 123.575 0.547 . . . . 0.0 110.652 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -61.09 -46.02 92.34 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.425 -1.422 . . . . 0.0 108.8 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.9 -50.18 44.87 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.881 0.872 . . . . 0.0 109.729 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -57.08 -37.79 72.39 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 69.0 m -87.55 -7.13 57.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.548 0.739 . . . . 0.0 110.256 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.62 13.71 71.72 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 118.491 0.587 . . . . 0.0 111.78 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 -65.98 -28.61 69.02 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.311 1.056 . . . . 0.0 109.633 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -149.25 153.24 37.26 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 9.0 m -66.07 150.71 48.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.448 1.099 . . . . 0.0 108.671 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 18.8 t -52.52 -54.53 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.911 1.285 . . . . 0.0 108.339 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.38 -44.91 55.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.344 2.257 . . . . 0.0 112.597 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -82.6 -26.92 31.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.48 85.57 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 76.4 mt -68.87 -39.44 79.84 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.73 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.446 ' HE3' ' OD2' ' A' ' 184' ' ' ASP . 2.1 tppp? -58.33 -35.81 72.44 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.896 0.878 . . . . 0.0 110.545 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.22 -32.74 22.46 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.789 0.722 . . . . 0.0 110.98 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.17 -40.16 90.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.564 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.64 -37.9 76.95 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.878 0.763 . . . . 0.0 109.606 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 4.3 m -67.53 -19.58 65.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.209 1.404 . . . . 0.0 113.141 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -80.66 -11.94 59.56 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.141 -0.975 . . . . 0.0 110.874 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.11 -42.02 11.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.5 p -68.02 -13.75 62.43 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.451 0.569 . . . . 0.0 111.859 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 32.2 tptt . . . . . 0 C--O 1.245 0.828 0 C-N-CA 125.868 1.667 . . . . 0.0 107.087 179.278 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -65.51 133.05 50.41 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.52 22.02 72.97 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 126.915 2.198 . . . . 0.0 114.634 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -153.7 167.04 30.94 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 119.215 1.507 . . . . 0.0 110.279 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -137.09 158.39 44.55 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 127.583 2.353 . . . . 0.0 108.07 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.7 t -143.42 134.51 22.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 125.803 1.641 . . . . 0.0 107.21 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.72 141.7 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.172 1.389 . . . . 0.0 109.491 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -130.1 162.51 28.64 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -126.73 170.18 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 124.504 1.122 . . . . 0.0 108.74 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -74.31 -25.19 59.42 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.02 -30.53 3.19 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 120.138 1.335 . . . . 0.0 115.331 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -113.13 6.5 17.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.436 1.494 . . . . 0.0 113.335 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' A' ' 297' ' ' LYS . 34.0 mmtm -75.59 -168.14 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.447 1.499 . . . . 0.0 110.448 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.04 65.53 0.37 Allowed Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -52.53 -34.82 51.69 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.853 0.826 . . . . 0.0 112.528 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -58.18 -55.22 37.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.605 0.639 . . . . 0.0 110.251 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.63 -31.17 77.76 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.6 tp -67.45 -35.53 79.4 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.214 -1.168 . . . . 0.0 110.333 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.39 -40.91 83.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 117.904 -1.046 . . . . 0.0 108.918 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -54.68 -45.02 73.84 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.451 1.1 . . . . 0.0 110.731 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 t -57.01 -47.14 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.63 -35.35 85.94 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.682 -1.065 . . . . 0.0 110.88 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm -64.26 -46.52 83.38 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.289 1.544 . . . . 0.0 108.696 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -57.74 11.26 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -55.64 -49.76 72.0 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 117.641 0.201 . . . . 0.0 111.418 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.16 -30.09 69.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.524 1.129 . . . . 0.0 111.545 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -25.39 45.09 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 117.726 -1.131 . . . . 0.0 110.759 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -100.68 -4.04 29.08 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.513 1.133 . . . . 0.0 111.767 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.2 p -132.52 -38.68 1.03 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.82 -18.36 56.06 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 121.201 -0.937 . . . . 0.0 112.779 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.2 mm -66.79 116.15 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 147.33 49.84 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.753 -0.592 . . . . 0.0 110.141 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.2 t -132.54 104.63 7.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 125.89 1.676 . . . . 0.0 109.154 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 m -84.7 141.77 30.34 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.92 115.95 19.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -125.65 167.67 14.78 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.21 0.604 . . . . 0.0 112.001 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -120.13 65.95 11.09 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.509 1.124 . . . . 0.0 112.945 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.7 161.61 36.46 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.14 1.893 . . . . 0.0 109.843 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -124.85 17.21 8.64 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.288 1.035 . . . . 0.0 110.648 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.98 8.23 2.5 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.844 1.658 . . . . 0.0 111.809 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -51.32 -26.78 8.1 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.249 1.42 . . . . 0.0 114.188 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.2 pm0 -61.07 -25.75 67.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.497 1.044 . . . . 0.0 111.437 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -115.5 -28.01 6.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -44.25 78.49 Favored 'General case' 0 C--O 1.221 -0.447 0 O-C-N 119.813 -1.804 . . . . 0.0 109.687 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -52.98 -59.8 8.16 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 120.503 1.501 . . . . 0.0 109.343 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.34 -13.72 37.7 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 121.75 1.633 . . . . 0.0 114.213 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -90.07 -9.87 46.88 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.795 1.634 . . . . 0.0 111.69 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.2 -34.88 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 119.941 1.246 . . . . 0.0 112.036 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.96 -34.04 74.12 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.38 -14.76 30.19 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.611 1.164 . . . . 0.0 112.316 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.88 5.51 17.44 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.222 1.809 . . . . 0.0 110.509 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.6 30.28 76.13 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.37 7.43 7.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.736 1.214 . . . . 0.0 112.283 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.73 -171.51 43.68 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.139 1.828 . . . . 0.0 111.961 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.67 178.15 2.93 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.348 2.699 . . . . 0.0 111.27 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -104.2 -17.69 14.78 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.557 -0.714 . . . . 0.0 111.939 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.17 157.22 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.5 tp -143.9 142.68 24.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -131.2 107.38 8.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.817 1.247 . . . . 0.0 108.684 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -151.95 172.62 15.96 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.387 1.075 . . . . 0.0 108.579 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.27 162.46 28.43 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.827 1.194 . . . . 0.0 110.641 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -55.13 -26.34 37.74 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.77 1.628 . . . . 0.0 112.493 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -58.87 -64.77 0.82 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 118.015 -0.993 . . . . 0.0 112.462 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -62.5 -23.23 66.83 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 121.213 1.824 . . . . 0.0 109.918 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -72.78 -15.64 61.65 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.6 -0.687 . . . . 0.0 111.359 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.56 -21.5 60.43 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.23 1.395 . . . . 0.0 112.776 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.09 -33.89 2.09 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.477 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -53.65 -47.57 70.2 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.792 1.796 . . . . 0.0 114.241 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.07 -43.65 91.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.606 1.094 . . . . 0.0 110.417 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -56.61 -49.52 74.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.9 m -62.51 -3.25 1.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.952 1.701 . . . . 0.0 113.845 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.12 11.11 85.68 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 119.778 1.172 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -81.36 -21.32 39.17 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.026 1.413 . . . . 0.0 110.555 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.6 mt -111.44 140.98 45.59 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.356 0.98 . . . . 0.0 109.594 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.77 176.13 6.47 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.595 1.558 . . . . 0.0 110.469 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.54 144.36 49.6 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.576 1.15 . . . . 0.0 109.205 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.5 163.87 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.841 1.256 . . . . 0.0 109.665 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.2 m 65.39 81.8 0.21 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.767 1.627 . . . . 0.0 112.227 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.87 -65.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.964 1.776 . . . . 0.0 108.51 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.27 155.02 17.39 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.631 1.172 . . . . 0.0 110.07 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tptp -65.58 -28.51 69.2 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.74 1.216 . . . . 0.0 113.081 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.06 -36.65 60.86 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.288 0.949 . . . . 0.0 111.663 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -63.09 -28.11 69.85 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.861 -0.524 . . . . 0.0 111.084 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -73.75 -43.19 59.78 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.272 0.942 . . . . 0.0 110.176 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.19 -27.97 67.58 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.478 1.111 . . . . 0.0 112.476 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -66.03 -16.72 64.16 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.696 0.798 . . . . 0.0 111.559 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.1 mt -119.88 163.45 17.52 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.465 1.506 . . . . 0.0 109.13 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -69.86 147.79 96.2 Favored Pre-proline 0 C--O 1.235 0.292 0 O-C-N 121.403 -0.81 . . . . 0.0 110.245 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.89 -51.01 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.59 2.193 . . . . 0.0 113.083 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -55.2 -44.67 75.54 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.739 0.7 . . . . 0.0 109.944 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -27.47 57.13 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.23 1.012 . . . . 0.0 112.69 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -73.52 -33.28 64.68 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.651 1.114 . . . . 0.0 111.451 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -59.86 -37.02 78.1 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.225 0.61 . . . . 0.0 111.82 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.54 -3.31 4.31 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.994 -1.003 . . . . 0.0 113.002 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -132.19 11.89 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.369 1.468 . . . . 0.0 111.571 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.5 mtp-105 -76.26 156.36 33.56 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 121.038 -1.039 . . . . 0.0 109.404 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -131.13 177.78 7.2 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.846 1.658 . . . . 0.0 107.156 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -65.57 100.17 0.49 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.261 1.025 . . . . 0.0 109.298 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.61 -76.62 1.69 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.227 1.394 . . . . 0.0 110.701 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 166.69 20.51 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mt -100.34 160.13 14.58 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.769 1.627 . . . . 0.0 108.087 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.1 pt -133.52 -19.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.44 164.81 26.96 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.591 1.542 . . . . 0.0 108.165 178.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.2 137.51 22.53 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-O 118.747 -0.644 . . . . 0.0 110.443 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.49 129.44 18.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.777 2.318 . . . . 0.0 108.73 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 mm -121.2 -46.34 2.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.55 148.8 52.38 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 67.8 t -121.18 111.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.212 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.2 p90 . . . . . 0 C--O 1.237 0.432 0 C-N-CA 126.421 1.888 . . . . 0.0 108.758 179.745 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.452 -0.925 0 N-CA-C 110.226 -0.721 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -138.52 -19.06 1.08 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 116.437 -1.744 . . . . 0.0 114.159 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.76 136.38 32.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.716 1.598 . . . . 0.0 111.219 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -65.93 -26.09 67.43 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.167 -0.958 . . . . 0.0 110.89 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.32 -12.88 62.04 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.834 0.743 . . . . 0.0 112.748 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -92.45 -11.53 34.49 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.711 0.804 . . . . 0.0 111.171 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.58 -59.0 12.9 Favored Pre-proline 0 C--O 1.233 0.186 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.58 -23.31 49.86 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 CA-C-N 119.826 0.974 . . . . 0.0 110.978 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.89 89.76 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.738 0.699 . . . . 0.0 109.887 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.6 tp -80.79 -27.49 36.65 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -57.19 -47.58 80.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 124.292 1.037 . . . . 0.0 111.205 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.412 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 8.2 ptmm? -66.69 -28.44 68.45 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 122.994 0.518 . . . . 0.0 112.064 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -75.89 -42.4 49.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 56.9 mt -78.82 -32.84 46.38 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.722 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.85 -35.89 79.35 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.63 67.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.204 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -5.62 15.41 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.471 1.108 . . . . 0.0 112.414 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.69 -94.57 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 119.159 0.89 . . . . 0.0 113.556 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HE2' ' OE2' ' A' ' 221' ' ' GLU . 27.9 mmtm -132.92 172.15 13.0 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.511 1.124 . . . . 0.0 110.849 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.56 162.73 3.63 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.424 1.49 . . . . 0.0 111.696 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.54 -55.99 4.14 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.8 tp -115.96 157.18 24.96 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.155 0.982 . . . . 0.0 110.818 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.3 mtp -148.7 114.17 5.6 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -140.5 174.01 10.93 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.799 0.84 . . . . 0.0 109.171 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -69.42 76.05 0.39 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.864 2.065 . . . . 0.0 109.978 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.3 mt -73.07 -23.15 60.51 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -79.66 -1.73 39.56 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.655 0.782 . . . . 0.0 112.672 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -117.75 129.74 25.16 Favored Pre-proline 0 CA--C 1.529 0.147 0 C-N-CA 123.962 0.905 . . . . 0.0 112.878 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.11 -13.31 17.24 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.352 2.035 . . . . 0.0 112.286 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -59.04 -44.62 91.79 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.873 0.869 . . . . 0.0 110.4 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -91.92 -28.29 17.36 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.395 0.543 . . . . 0.0 111.42 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.5 p -80.16 -2.13 43.34 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 119.133 0.879 . . . . 0.0 110.47 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 32.8 t-105 -56.97 -66.3 1.29 Allowed Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 120.421 -1.424 . . . . 0.0 111.093 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.46 -20.39 60.96 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 CA-C-N 120.242 1.122 . . . . 0.0 112.899 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.82 -43.2 90.56 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-O 118.341 -0.838 . . . . 0.0 108.829 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 9.3 pt -93.01 -32.12 4.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.441 0.564 . . . . 0.0 111.663 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.86 -6.94 18.32 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.118 -0.988 . . . . 0.0 113.256 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -54.01 -46.21 71.72 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.903 1.281 . . . . 0.0 112.968 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -63.84 -50.4 69.0 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.521 0.601 . . . . 0.0 109.843 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.47 42.77 0.05 OUTLIER Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.329 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.03 154.6 24.63 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -159.91 121.99 3.32 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.33 -47.8 80.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -146.01 131.45 18.67 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -58.28 126.73 28.75 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -150.63 101.25 2.92 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.18 158.57 43.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 119.109 0.868 . . . . 0.0 108.888 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 47.9 27.33 1.13 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.156 1.783 . . . . 0.0 112.445 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 79.42 18.87 72.83 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.576 -1.125 . . . . 0.0 114.04 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -120.99 115.25 22.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.55 1.675 . . . . 0.0 107.372 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -106.08 121.24 43.73 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.287 1.435 . . . . 0.0 108.881 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -130.7 110.89 11.69 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 122.394 1.093 . . . . 0.0 111.094 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.55 0.29 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 124.307 1.043 . . . . 0.0 109.367 177.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -84.19 -11.52 56.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.488 2.315 . . . . 0.0 111.623 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -127.4 105.69 8.69 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.67 140.4 49.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -124.52 29.8 4.89 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 117.871 -1.516 . . . . 0.0 116.188 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.38 -11.54 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.221 2.011 . . . . 0.0 113.693 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.14 10.25 10.0 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.472 1.033 . . . . 0.0 112.166 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.09 159.93 13.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.846 0.858 . . . . 0.0 110.055 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.79 -35.58 61.5 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.292 1.037 . . . . 0.0 110.862 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.85 -41.6 97.41 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 118.373 0.533 . . . . 0.0 112.366 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.07 64.98 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.16 0.98 . . . . 0.0 109.911 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -63.08 -37.79 88.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 118.566 -0.73 . . . . 0.0 110.671 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.23 71.9 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.646 0.778 . . . . 0.0 111.863 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.09 -28.03 24.22 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 19.8 tp -74.92 -39.03 61.63 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.281 -1.717 . . . . 0.0 111.618 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.2 t -56.58 -33.61 66.37 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.923 0.489 . . . . 0.0 111.511 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -60.01 -54.62 43.9 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 119.389 0.995 . . . . 0.0 109.459 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 7.4 tt -56.38 -45.0 80.74 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.458 1.103 . . . . 0.0 110.233 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.31 -32.96 52.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.713 0.805 . . . . 0.0 109.893 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.57 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 19.1 t70 -63.72 -46.37 85.74 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.859 1.209 . . . . 0.0 112.726 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.62 -39.52 94.08 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.688 0.795 . . . . 0.0 109.76 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 75.5 mt -68.69 -40.29 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -52.67 -40.79 63.21 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.659 1.183 . . . . 0.0 109.7 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -90.99 0.87 57.43 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.121 1.768 . . . . 0.0 113.22 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.9 mptt 52.91 17.55 0.9 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 128.452 2.701 . . . . 0.0 114.972 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -82.27 -24.97 34.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.983 0.81 . . . . 0.0 109.315 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.0 tpt -77.94 163.38 26.04 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -82.52 51.19 1.8 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.68 -22.41 8.91 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 127.347 2.259 . . . . 0.0 115.905 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.99 8.63 43.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.506 1.522 . . . . 0.0 112.398 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 71.4 m -101.06 144.31 30.14 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.762 1.625 . . . . 0.0 111.158 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.78 -177.54 4.32 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.596 1.958 . . . . 0.0 108.85 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -48.48 -51.0 29.28 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.814 0.846 . . . . 0.0 112.884 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.26 -43.76 90.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.274 0.629 . . . . 0.0 111.142 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.09 -49.05 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.755 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.94 -47.53 86.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.5 1.12 . . . . 0.0 110.885 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.03 -42.68 80.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.138 0.575 . . . . 0.0 111.547 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.55 -48.18 35.03 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 122.023 -0.423 . . . . 0.0 110.146 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.25 -39.33 56.44 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.031 1.732 . . . . 0.0 111.775 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -53.79 -55.0 30.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.168 1.387 . . . . 0.0 109.079 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -62.13 -38.15 87.86 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.44 -17.67 64.72 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.627 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.62 11.9 76.35 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 119.117 0.871 . . . . 0.0 111.024 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.475 ' OE2' ' HE2' ' A' ' 144' ' ' LYS . 7.4 mm-40 -65.52 -60.63 2.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.544 1.137 . . . . 0.0 110.332 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.8 t -87.82 141.77 28.33 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.961 0.904 . . . . 0.0 109.444 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.19 -35.24 59.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -127.13 164.19 22.17 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.317 0.647 . . . . 0.0 109.545 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 52.4 m -151.13 155.29 38.61 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.763 0.825 . . . . 0.0 108.871 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 178.684 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -64.97 155.0 70.49 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.487 2.125 . . . . 0.0 108.798 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 61.6 p -97.45 179.76 4.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.356 1.062 . . . . 0.0 110.427 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -107.84 164.75 11.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -59.34 114.21 2.55 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.068 0.395 . . . . 0.0 110.201 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 69.92 15.29 71.5 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 118.364 -1.242 . . . . 0.0 113.965 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.46 117.9 3.23 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 120.639 2.22 . . . . 0.0 111.668 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.34 113.49 3.12 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.854 2.37 . . . . 0.0 111.165 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 31.6 t -57.82 157.03 7.97 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.215 1.006 . . . . 0.0 108.382 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -132.86 60.8 52.41 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 125.634 1.574 . . . . 0.0 112.792 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.88 164.59 31.06 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.542 1.495 . . . . 0.0 109.452 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 . . . . . 0 C--O 1.237 0.444 0 CA-C-O 122.642 1.211 . . . . 0.0 112.966 -179.327 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.552 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 19.0 t -145.11 148.93 17.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.43 1.092 . . . . 0.0 109.56 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.02 149.49 35.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.3 m -126.38 154.2 43.91 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.814 0.846 . . . . 0.0 111.828 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -136.93 134.48 36.81 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.471 1.108 . . . . 0.0 108.277 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -142.53 154.99 25.51 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 75.1 mt -93.55 136.37 25.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.974 1.309 . . . . 0.0 107.591 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -72.72 113.78 10.14 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.9 -20.07 66.25 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.184 -0.912 . . . . 0.0 113.429 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -73.74 -16.35 61.18 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.7 m -70.27 163.56 61.07 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 119.084 0.856 . . . . 0.0 110.514 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.69 -46.06 2.88 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.331 2.021 . . . . 0.0 115.327 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -137.42 114.7 10.93 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 119.078 0.854 . . . . 0.0 112.203 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -18.32 64.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.024 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -59.83 -40.36 88.19 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 98.9 mt -57.8 -41.22 81.72 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.496 -0.752 . . . . 0.0 111.093 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -77.91 -42.76 32.11 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -33.94 76.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.431 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -68.76 -52.57 29.05 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -55.33 -43.54 75.03 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.204 -0.935 . . . . 0.0 112.326 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -61.03 -51.23 70.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.486 1.114 . . . . 0.0 110.09 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -75.07 -17.81 60.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -105.79 -26.45 11.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.06 -1.448 . . . . 0.0 113.858 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -131.18 -37.41 1.26 Allowed 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 120.719 1.6 . . . . 0.0 113.609 -178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.0 -50.0 73.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 116.516 -2.073 . . . . 0.0 107.415 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 90.6 mt -82.91 52.5 2.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.586 1.954 . . . . 0.0 115.883 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 13.2 p -131.01 160.34 34.85 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -63.19 -47.01 84.41 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -70.44 -32.63 70.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.524 1.13 . . . . 0.0 111.074 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.87 -42.76 44.38 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 54.7 mt -70.37 -46.54 63.88 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.428 ' HB2' ' HH ' ' A' ' 307' ' ' TYR . 30.1 tt0 -56.67 -43.55 80.54 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.491 0.716 . . . . 0.0 109.954 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.34 61.18 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 5.0 t -88.27 -31.4 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 122.842 0.457 . . . . 0.0 109.886 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -71.62 -23.92 61.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.763 0.425 . . . . 0.0 111.251 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -59.71 -47.35 86.01 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.17 -59.62 4.51 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.106 0.962 . . . . 0.0 112.033 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -137.87 160.46 64.55 Favored Pre-proline 0 N--CA 1.463 0.211 0 O-C-N 121.389 -0.82 . . . . 0.0 112.293 -178.576 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -69.92 110.07 2.5 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.691 1.594 . . . . 0.0 108.164 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.41 -9.75 58.84 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 85.22 -166.58 40.52 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 119.709 1.141 . . . . 0.0 110.276 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -73.67 168.43 19.37 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.026 0.93 . . . . 0.0 110.765 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.16 153.9 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 123.61 0.764 . . . . 0.0 110.831 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.0 41.17 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.947 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 63.5 tp -65.75 100.46 0.54 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.52 1.928 . . . . 0.0 106.869 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -47.5 -37.72 12.5 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.353 1.061 . . . . 0.0 112.983 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.8 m -55.41 -60.48 3.35 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.693 0.797 . . . . 0.0 112.768 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.428 ' HH ' ' HB2' ' A' ' 291' ' ' GLU . 6.6 t80 -83.77 -9.97 58.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.822 1.249 . . . . 0.0 111.806 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -61.5 -42.62 99.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -67.47 -37.79 83.43 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 124.39 1.056 . . . . 0.0 111.272 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -65.16 -50.74 64.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.6 -38.62 89.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.86 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.64 -15.97 33.89 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.561 1.145 . . . . 0.0 113.662 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -60.25 -16.02 30.09 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.973 0.806 . . . . 0.0 111.605 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.3 135.26 19.68 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 119.335 0.97 . . . . 0.0 110.597 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.43 -34.46 94.63 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.288 2.659 . . . . 0.0 112.805 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.62 -33.47 75.07 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.029 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.9 mp -79.68 -54.26 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -43.96 -55.21 4.78 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.507 1.123 . . . . 0.0 112.211 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.22 -30.03 70.18 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 9.8 m -77.55 -32.54 53.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.765 0.826 . . . . 0.0 109.259 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.0 tpt -74.39 -41.84 60.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -49.64 -42.02 44.03 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 125.384 1.474 . . . . 0.0 111.288 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -59.27 -44.51 92.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.815 2.046 . . . . 0.0 110.368 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.519 0 O-C-N 122.222 -0.299 . . . . 0.0 110.815 178.184 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo . . . . . 0 N--CA 1.455 -0.792 0 CA-C-O 122.725 1.052 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -134.19 16.58 3.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.43 1.892 . . . . 0.0 112.056 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.3 pt -116.91 153.72 49.47 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.709 1.204 . . . . 0.0 112.021 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.28 -5.42 17.13 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.771 2.981 . . . . 0.0 115.406 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -57.79 -19.24 26.96 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.768 -1.207 . . . . 0.0 111.884 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 2.2 mtp -61.85 -24.07 66.67 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.772 -0.58 . . . . 0.0 110.472 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 40.3 t -54.57 -53.56 52.9 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.073 1.349 . . . . 0.0 109.004 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.22 -43.71 90.6 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.824 0.449 . . . . 0.0 110.514 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -53.67 -54.09 42.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.816 0.846 . . . . 0.0 110.773 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -59.96 -50.0 75.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.133 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -55.38 -42.75 74.42 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.473 0.579 . . . . 0.0 111.217 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.32 -57.3 11.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.468 1.107 . . . . 0.0 111.979 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.5 t -63.58 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.109 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -50.87 -41.31 58.07 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.539 1.063 . . . . 0.0 110.041 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.0 m -79.94 -47.14 15.48 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.415 -0.803 . . . . 0.0 110.525 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.07 -44.74 64.46 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 36.4 t -60.51 -47.69 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.34 -36.18 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.45 0.568 . . . . 0.0 109.766 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -59.41 -49.88 76.12 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.438 1.017 . . . . 0.0 109.527 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.36 -43.49 73.48 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.081 0.552 . . . . 0.0 110.79 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.84 -29.03 70.43 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.778 0.831 . . . . 0.0 112.37 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 6.7 m -92.45 -10.31 38.39 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.651 0.78 . . . . 0.0 110.076 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 72.73 10.39 76.38 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.194 -0.781 . . . . 0.0 112.572 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -67.15 -29.41 69.11 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.935 1.367 . . . . 0.0 111.883 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -140.09 157.5 45.53 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.4 m -62.3 152.56 33.39 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.855 0.862 . . . . 0.0 109.214 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.8 -48.49 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.35 -49.52 72.03 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.976 1.71 . . . . 0.0 111.159 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -75.53 -30.79 59.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.31 -41.32 98.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 7.9 mp -73.21 -38.62 66.02 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.243 1.017 . . . . 0.0 109.518 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -57.29 13.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.579 1.081 . . . . 0.0 110.389 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -55.42 -36.32 66.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 122.386 1.089 . . . . 0.0 109.951 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -68.57 -46.99 67.97 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 117.537 -1.221 . . . . 0.0 111.236 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -52.72 -39.29 61.92 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.538 1.063 . . . . 0.0 109.655 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 4.4 m -63.77 -26.15 68.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 112.828 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -72.89 -18.92 61.37 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.448 -1.407 . . . . 0.0 111.028 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.9 mp -92.68 -38.46 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.214 1.006 . . . . 0.0 109.105 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 7.7 p -69.19 -15.67 63.45 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.373 0.988 . . . . 0.0 111.668 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 51.6 tttm . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.955 2.102 . . . . 0.0 110.309 179.155 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 . . . . . 0 N--CA 1.45 -0.473 1 N-CA-C 97.888 -4.856 . . . . 0.0 97.888 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -77.03 171.16 15.24 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.764 0.711 . . . . 0.0 111.818 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.49 38.89 71.97 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.812 1.196 . . . . 0.0 115.78 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -145.77 173.5 12.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.864 0.832 . . . . 0.0 110.031 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.3 mt -142.13 154.49 44.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.951 2.101 . . . . 0.0 107.519 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.4 t -144.53 117.33 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.5 mt -99.4 126.52 52.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -112.93 140.37 47.8 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mp -129.79 148.84 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 C-N-CA 125.588 1.555 . . . . 0.0 109.846 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.76 -64.75 1.01 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.3 169.45 42.28 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.629 1.585 . . . . 0.0 109.149 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 52.45 3.17 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.22 3.008 . . . . 0.0 115.775 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.56 -28.85 68.13 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.763 1.625 . . . . 0.0 115.376 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.7 36.15 6.98 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -51.61 -34.23 36.53 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.47 -40.51 87.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.645 0.778 . . . . 0.0 112.087 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.59 -30.81 26.07 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -62.71 -38.01 88.73 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.603 1.161 . . . . 0.0 111.552 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.22 -46.3 62.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.66 0.784 . . . . 0.0 110.945 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -60.0 -35.5 75.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.844 -0.598 . . . . 0.0 112.438 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.2 t -62.32 -43.98 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.88 -40.89 93.67 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -63.39 -40.92 98.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.216 1.008 . . . . 0.0 109.52 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -63.64 -57.71 9.19 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -55.0 -43.61 73.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.637 0.653 . . . . 0.0 111.992 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.86 -28.19 69.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.448 1.022 . . . . 0.0 110.651 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.4 -23.04 35.11 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.058 -1.026 . . . . 0.0 112.272 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -99.83 -17.95 17.4 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.264 0.978 . . . . 0.0 111.979 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.3 p -122.76 -34.4 3.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.161 0.891 . . . . 0.0 113.184 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.38 -15.05 64.04 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.992 -0.893 . . . . 0.0 111.682 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.0 mm -66.86 120.15 13.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -61.79 146.4 49.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.9 t -135.51 143.49 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.7 m -125.12 143.06 51.12 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.74 119.01 23.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.41 163.23 25.32 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.128 0.971 . . . . 0.0 109.915 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -139.09 65.34 36.14 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.161 0.585 . . . . 0.0 111.262 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.86 173.09 14.06 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 125.054 3.836 . . . . 0.0 109.123 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -123.5 1.14 8.92 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.622 0.769 . . . . 0.0 111.828 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -119.29 6.84 11.19 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.172 0.989 . . . . 0.0 111.097 178.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -59.32 -20.71 56.76 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.709 -1.244 . . . . 0.0 112.072 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -60.58 -21.29 62.46 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.729 0.811 . . . . 0.0 112.499 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -122.63 -23.01 5.23 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.715 1.606 . . . . 0.0 111.026 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -78.07 -38.84 43.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.927 1.291 . . . . 0.0 110.693 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -52.02 -57.22 15.83 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 120.376 1.443 . . . . 0.0 110.094 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.82 -16.23 52.19 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.77 1.646 . . . . 0.0 114.385 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -84.54 -12.63 53.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.698 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.82 -40.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 120.154 1.343 . . . . 0.0 109.746 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.34 -43.09 53.84 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.803 1.241 . . . . 0.0 112.498 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.55 70.94 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.546 -0.721 . . . . 0.0 111.689 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 m -74.79 -5.89 45.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.204 1.402 . . . . 0.0 112.79 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.18 47.62 10.77 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -158.42 176.23 12.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 130.99 3.716 . . . . 0.0 104.111 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.6 -170.55 13.59 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.669 -1.269 . . . . 0.0 110.472 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -78.07 -177.16 3.66 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.637 2.892 . . . . 0.0 110.289 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.3 -20.16 13.36 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.573 -0.705 . . . . 0.0 111.972 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mt -137.92 151.84 25.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.546 0.689 . . . . 0.0 110.552 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.02 139.73 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.656 1.182 . . . . 0.0 109.106 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.82 114.43 17.23 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.984 1.314 . . . . 0.0 109.695 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -165.35 -166.01 0.94 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.295 0.952 . . . . 0.0 112.072 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.34 133.4 44.94 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.077 2.151 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -60.08 -29.47 68.58 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.579 1.952 . . . . 0.0 112.308 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.98 -37.6 78.84 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.844 0.747 . . . . 0.0 110.403 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -24.46 56.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -68.66 -30.84 69.62 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.79 -36.26 86.01 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.84 -52.54 14.42 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -56.16 -34.66 66.36 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.531 1.165 . . . . 0.0 111.057 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -45.67 83.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -40.78 88.09 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.1 m -63.66 -12.47 34.24 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.611 -0.68 . . . . 0.0 110.138 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.55 16.22 76.23 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.744 1.64 . . . . 0.0 112.215 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.1 mt -88.15 -10.25 50.58 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mt -96.14 140.9 30.18 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.778 0.717 . . . . 0.0 110.954 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.03 172.2 8.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.981 1.312 . . . . 0.0 112.152 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -78.11 90.18 4.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.453 1.501 . . . . 0.0 111.834 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -73.23 178.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.815 1.246 . . . . 0.0 111.444 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.337 0.5 OUTLIER 57.77 74.42 0.65 Allowed Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 127.602 2.361 . . . . 0.0 106.363 -178.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.42 -24.49 64.1 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.72 2.28 . . . . 0.0 113.605 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -147.13 148.59 31.73 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.709 0.804 . . . . 0.0 109.805 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.411 ' HZ2' ' NE2' ' A' ' 86' ' ' GLN . 14.9 tppt? -55.64 -29.46 59.28 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.842 2.057 . . . . 0.0 112.977 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.25 -36.24 77.34 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.331 0.514 . . . . 0.0 110.102 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -58.6 -32.64 69.17 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.514 0.726 . . . . 0.0 111.595 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.411 ' NE2' ' HZ2' ' A' ' 83' ' ' LYS . 4.3 mp0 -64.27 -46.52 83.32 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.675 -0.64 . . . . 0.0 110.587 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -66.95 -19.15 65.67 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -74.26 -11.47 60.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.348 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mt -124.55 160.91 27.31 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.272 1.429 . . . . 0.0 110.545 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -72.07 150.27 92.4 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.96 -44.45 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.075 2.516 . . . . 0.0 114.416 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -58.19 -34.32 70.23 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.029 0.832 . . . . 0.0 111.782 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -29.82 71.08 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.049 -1.032 . . . . 0.0 111.024 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -73.72 -35.23 65.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.32 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.76 -31.55 64.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.231 0.923 . . . . 0.0 112.501 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.3 -29.75 67.67 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.58 2.64 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.559 1.144 . . . . 0.0 113.733 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -63.79 160.38 17.41 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 122.328 1.061 . . . . 0.0 110.163 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -143.92 175.0 10.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -70.6 110.16 5.29 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.456 0.702 . . . . 0.0 110.463 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.88 -78.29 0.77 Allowed Glycine 0 C--N 1.335 0.486 0 C-N-CA 125.862 1.696 . . . . 0.0 111.028 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.04 166.25 21.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.69 165.5 11.12 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 pt -128.51 -30.52 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.88 176.78 12.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 119.148 0.885 . . . . 0.0 108.62 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.56 145.92 58.95 Favored Pre-proline 0 C--O 1.238 0.473 0 O-C-N 123.083 0.239 . . . . 0.0 110.852 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -66.47 147.96 83.2 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.561 2.841 . . . . 0.0 107.847 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 mm -133.43 -52.44 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 124.043 0.937 . . . . 0.0 110.67 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -131.38 167.29 19.53 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.336 0.398 . . . . 0.0 111.297 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.5 t -135.31 141.15 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 C--N 1.328 -0.366 0 C-N-CA 125.679 1.592 . . . . 0.0 107.525 177.664 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.7 mt . . . . . 0 C--O 1.236 0.394 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 30.6 p90 . . . . . 0 C--O 1.239 0.543 0 C-N-CA 124.361 1.064 . . . . 0.0 109.878 179.952 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 N-CA-C 110.164 -0.745 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -136.75 -33.66 0.77 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.834 1.253 . . . . 0.0 111.804 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.2 162.62 33.79 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 117.974 0.352 . . . . 0.0 110.844 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -67.23 -18.23 65.15 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.999 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -64.51 -8.5 14.05 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.877 1.271 . . . . 0.0 113.4 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -107.08 -18.76 13.81 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.668 1.587 . . . . 0.0 110.996 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.6 mm -56.9 -58.18 19.36 Favored Pre-proline 0 C--N 1.333 -0.141 0 O-C-N 120.823 -1.173 . . . . 0.0 111.822 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -67.41 -25.61 41.74 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 120.501 1.215 . . . . 0.0 110.717 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.85 -41.16 83.34 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.631 1.173 . . . . 0.0 110.349 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.6 tp -82.46 -27.89 31.58 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.148 0.885 . . . . 0.0 109.759 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.71 -44.91 96.02 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 121.325 -0.86 . . . . 0.0 109.615 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -64.54 -28.42 69.63 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.558 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -75.11 -43.35 53.34 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 123.102 0.561 . . . . 0.0 110.658 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 54.2 mt -75.38 -29.96 60.0 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.465 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.14 -38.04 81.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.8 -22.16 66.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.704 1.202 . . . . 0.0 113.07 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.12 4.92 9.81 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 125.445 1.498 . . . . 0.0 112.358 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.92 -95.47 0.1 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 119.37 0.986 . . . . 0.0 113.634 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -142.1 178.21 7.69 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.84 1.256 . . . . 0.0 111.617 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.18 154.01 10.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.878 1.271 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.93 -63.54 1.34 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.954 1.302 . . . . 0.0 111.999 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 41.2 tp -97.43 138.08 35.42 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.323 1.049 . . . . 0.0 110.707 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 94.3 mtp -145.44 110.25 5.12 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -142.19 157.18 45.15 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -72.97 137.66 45.61 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.615 0.722 . . . . 0.0 110.744 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.8 mt -121.01 -9.51 9.21 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.807 1.643 . . . . 0.0 111.276 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -72.14 -22.26 61.34 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.625 0.77 . . . . 0.0 112.53 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -113.99 152.05 45.39 Favored Pre-proline 0 N--CA 1.468 0.425 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.46 -11.83 10.46 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.594 2.196 . . . . 0.0 114.791 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -60.57 -41.85 95.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 120.896 1.68 . . . . 0.0 111.986 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -76.42 -28.81 56.78 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 79.0 p -91.43 -9.4 44.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.474 0.71 . . . . 0.0 111.001 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -62.36 -61.13 8.19 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 121.173 -0.954 . . . . 0.0 111.84 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.19 -19.79 69.44 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 121.216 1.47 . . . . 0.0 112.625 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.1 tp -68.19 -61.6 1.78 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 15.8 pt -67.03 -27.33 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.254 0.479 . . . . 0.0 111.687 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.1 0.58 27.49 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.762 -1.211 . . . . 0.0 112.929 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.99 -52.34 66.19 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 119.408 1.004 . . . . 0.0 112.076 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -58.3 -58.43 8.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.744 0.817 . . . . 0.0 110.757 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -176.61 25.78 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.543 -1.143 . . . . 0.0 113.492 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.21 149.44 37.42 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -152.61 138.8 18.32 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.54 -64.79 0.92 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.86 126.64 32.68 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -69.8 148.97 48.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.992 0.517 . . . . 0.0 110.297 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -148.85 105.63 3.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.419 ' C ' ' H ' ' A' ' 174' ' ' GLY . 62.5 mt-10 -77.71 -166.41 0.77 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.85 1.26 . . . . 0.0 109.036 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -62.18 16.97 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.475 2.71 . . . . 0.0 113.403 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 172' ' ' GLU . . . 149.22 -2.8 0.62 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.989 1.757 . . . . 0.0 113.761 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -112.25 120.38 41.56 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.462 1.631 . . . . 0.0 107.732 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -118.43 112.88 20.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -125.86 106.3 9.56 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.46 -6.82 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.313 1.445 . . . . 0.0 112.183 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -31.79 57.81 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.857 1.663 . . . . 0.0 110.723 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.86 101.34 12.22 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.0 t -120.8 135.87 59.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 125.694 1.598 . . . . 0.0 109.784 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -114.3 18.1 18.52 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.202 -0.776 . . . . 0.0 114.664 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 66.4 t -49.52 -40.99 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.133 1.773 . . . . 0.0 114.051 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.8 23.91 12.6 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -70.56 167.6 18.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.406 0.622 . . . . 0.0 111.022 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.61 60.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.714 1.205 . . . . 0.0 113.691 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.85 -35.3 65.77 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 118.617 0.644 . . . . 0.0 112.288 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -68.23 -51.63 43.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.677 0.791 . . . . 0.0 109.459 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -61.75 -36.59 81.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.374 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.92 -48.91 79.65 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.668 0.667 . . . . 0.0 109.98 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.75 -36.88 93.89 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 27.3 tp -72.16 -51.09 22.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.47 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 6.2 t -56.21 -32.99 64.92 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.623 1.101 . . . . 0.0 111.122 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -58.66 -59.44 5.39 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.464 1.029 . . . . 0.0 109.232 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.06 -45.55 94.28 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.317 0.647 . . . . 0.0 110.529 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.8 t -57.87 -32.03 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.369 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.496 ' CG ' ' HZ3' ' A' ' 200' ' ' LYS . 0.3 OUTLIER -65.02 -35.84 82.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.983 1.265 . . . . 0.0 111.1 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 25.1 mt -64.73 -36.19 83.5 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.25 -41.88 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.094 1.358 . . . . 0.0 109.182 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.496 ' HZ3' ' CG ' ' A' ' 197' ' ' ASP . 34.6 mtpt -52.55 -45.56 66.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.97 1.308 . . . . 0.0 108.917 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -88.24 2.76 51.58 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.148 1.779 . . . . 0.0 112.749 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.1 mptt 56.51 19.93 4.49 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.319 2.248 . . . . 0.0 112.934 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -31.45 65.07 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.429 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.0 tpt -89.19 -176.61 5.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.811 1.645 . . . . 0.0 111.514 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -125.63 73.14 1.31 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.576 1.55 . . . . 0.0 108.84 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.73 -18.77 56.53 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -79.81 -7.12 58.49 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.418 1.887 . . . . 0.0 112.564 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 51.9 m -72.19 120.81 18.31 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.303 1.049 . . . . 0.0 109.339 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -118.7 175.1 5.89 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -48.73 -41.23 31.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.507 0.723 . . . . 0.0 112.262 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.8 t -57.35 -51.96 67.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.562 1.945 . . . . 0.0 111.954 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.5 mm -61.75 -47.71 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 124.406 1.082 . . . . 0.0 111.323 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.1 -45.84 66.11 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.969 -178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -56.94 -45.09 83.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.451 0.569 . . . . 0.0 111.023 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.86 -57.91 10.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.207 0.603 . . . . 0.0 109.97 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.35 -47.28 69.53 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.694 0.798 . . . . 0.0 110.826 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -59.03 -41.47 87.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.9 1.28 . . . . 0.0 111.622 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -61.03 -37.01 81.05 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.763 0.711 . . . . 0.0 110.413 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -74.48 -45.09 48.3 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 116.06 14.3 7.9 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.916 2.198 . . . . 0.0 109.755 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -70.29 21.34 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.763 3.225 . . . . 0.0 112.789 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.2 p -130.48 174.74 9.59 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.57 2.348 . . . . 0.0 109.345 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.09 -33.73 2.4 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.742 0.817 . . . . 0.0 112.106 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 7.8 ptt? -152.86 161.15 42.92 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.847 0.859 . . . . 0.0 109.05 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.0 t -151.83 173.07 15.22 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 14.4 mt . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.296 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.78 125.97 10.38 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.527 2.152 . . . . 0.0 109.947 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 43.4 p -143.5 -151.44 0.36 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.44 141.8 39.77 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 177.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -53.0 125.83 18.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.415 1.886 . . . . 0.0 110.386 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 61.63 11.67 30.27 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.808 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.57 75.75 5.06 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.1 154.87 57.38 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.971 1.781 . . . . 0.0 114.112 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 33.8 m -65.01 140.88 58.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.19 93.32 5.09 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 125.227 1.411 . . . . 0.0 109.053 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.32 -63.01 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.327 2.018 . . . . 0.0 111.472 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 . . . . . 0 C--O 1.232 0.162 0 C-N-CA 125.667 1.587 . . . . 0.0 108.366 179.812 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.365 0 N-CA-C 105.398 -3.081 . . . . 0.0 105.398 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.48 156.77 42.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-N 117.852 0.826 . . . . 0.0 109.851 -178.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.7 139.97 30.01 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.017 0.927 . . . . 0.0 109.115 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.2 m -131.75 169.11 16.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.154 0.982 . . . . 0.0 112.138 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -134.69 140.42 45.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.865 1.266 . . . . 0.0 108.325 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.64 167.69 16.92 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.9 mt -117.48 135.59 57.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.07 115.28 14.53 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.82 -15.53 21.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.65 0.78 . . . . 0.0 113.012 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -66.29 -23.24 66.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.332 1.053 . . . . 0.0 111.663 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 11.2 m -60.42 154.81 52.08 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 126.187 1.795 . . . . 0.0 112.649 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.5 -47.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.347 2.032 . . . . 0.0 111.801 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.44 86.25 2.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.701 0.8 . . . . 0.0 109.477 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -52.84 -24.05 8.23 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.236 1.414 . . . . 0.0 112.332 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -59.37 -34.68 72.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.193 1.797 . . . . 0.0 110.15 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.24 -36.98 81.43 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 120.713 -1.242 . . . . 0.0 110.009 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.23 57.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.948 -0.549 . . . . 0.0 111.028 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -37.4 87.07 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.845 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -71.54 -51.24 24.57 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 124.024 0.828 . . . . 0.0 109.747 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -48.87 -52.91 21.75 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.913 0.485 . . . . 0.0 110.295 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.86 -55.23 31.96 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.321 0.248 . . . . 0.0 111.353 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.318 7.6 pt-20 -71.57 1.65 6.28 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -177.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -115.11 -21.0 10.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.229 -1.367 . . . . 0.0 111.226 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -132.5 -59.21 0.92 Allowed 'General case' 0 C--N 1.346 0.418 0 CA-C-N 119.998 1.272 . . . . 0.0 109.673 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.65 -42.48 62.11 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 44.0 mt -82.91 27.52 0.54 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 14.8 p -113.7 167.77 10.34 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.57 -38.51 90.35 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -71.41 -38.55 71.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.982 0.913 . . . . 0.0 111.604 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -69.08 -45.7 61.36 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.94 -46.41 81.72 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -57.1 -43.57 82.35 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.802 0.841 . . . . 0.0 110.291 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.2 -49.92 68.28 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.65 -36.33 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 119.375 -0.345 . . . . 0.0 110.24 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -63.75 -27.43 69.19 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.706 0.803 . . . . 0.0 111.656 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -67.44 -43.64 80.65 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.759 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -70.24 -56.44 6.76 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.878 0.763 . . . . 0.0 109.749 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -134.92 145.04 52.95 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.27 136.37 40.09 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.518 2.145 . . . . 0.0 112.252 -178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 80.3 mt -78.48 -29.84 46.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 101.09 -78.39 0.4 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 105.9 -2.88 . . . . 0.0 105.9 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -149.35 171.09 17.09 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 131.577 3.951 . . . . 0.0 104.93 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 35.9 m -132.18 149.88 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 O-C-N 120.656 -1.277 . . . . 0.0 112.244 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.69 -21.33 55.52 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.623 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.93 105.26 1.94 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 126.287 1.835 . . . . 0.0 107.256 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -53.57 -27.63 27.47 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.9 m -73.11 -61.18 1.91 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 118.552 0.614 . . . . 0.0 111.246 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -67.36 -23.63 65.62 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.571 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -63.95 -21.41 66.47 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.206 0.912 . . . . 0.0 108.719 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -72.97 -37.51 67.05 Favored 'General case' 0 C--N 1.342 0.245 0 O-C-N 120.286 -1.509 . . . . 0.0 108.725 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -70.26 -46.91 63.42 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.185 0.994 . . . . 0.0 108.607 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 23.1 mt -63.31 -40.71 98.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.17 -11.63 9.79 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.82 -11.48 27.47 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.488 1.04 . . . . 0.0 111.201 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.52 133.66 23.53 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -56.78 -23.85 52.38 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.133 2.555 . . . . 0.0 115.946 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -44.18 96.92 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.298 1.408 . . . . 0.0 110.802 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.8 mp -74.55 -46.38 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.55 -52.23 48.82 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.291 0.496 . . . . 0.0 110.112 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.85 -35.63 78.85 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.722 -0.611 . . . . 0.0 112.059 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.0 m -62.04 -39.25 91.71 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.58 -40.77 48.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.694 0.398 . . . . 0.0 110.55 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -53.05 -45.78 68.21 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.436 1.495 . . . . 0.0 109.784 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -41.35 94.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.551 0 CA-C-N 118.838 0.745 . . . . 0.0 111.414 178.901 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.537 0.663 0 CA-C-O 122.007 0.753 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -138.77 10.09 2.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.794 1.638 . . . . 0.0 110.99 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.9 pt -82.3 154.59 69.33 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 120.341 -1.475 . . . . 0.0 111.213 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.46 -17.01 16.78 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.163 2.575 . . . . 0.0 113.497 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -57.45 -21.57 37.85 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.501 1.12 . . . . 0.0 112.506 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 73.8 mmm -57.83 -31.13 66.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.336 1.054 . . . . 0.0 111.154 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 22.4 t -57.3 -53.04 62.65 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.88 -29.64 65.79 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 118.401 -0.809 . . . . 0.0 112.101 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -57.75 -58.53 7.97 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.573 0.624 . . . . 0.0 109.754 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -56.25 -44.01 79.25 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -59.09 -39.92 83.71 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.113 0.415 . . . . 0.0 110.942 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.38 -59.98 2.95 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.157 0.583 . . . . 0.0 111.675 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 3.2 m -59.27 -36.73 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 118.944 -0.551 . . . . 0.0 111.901 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 56.9 ttp85 -56.75 -37.22 70.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.261 0.937 . . . . 0.0 109.774 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 54.0 m -79.93 -44.49 20.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.683 -0.675 . . . . 0.0 109.834 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.45 -46.05 69.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.384 0.993 . . . . 0.0 112.882 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 89.0 t -59.11 -52.78 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.8 mm -64.08 -35.51 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.845 0.748 . . . . 0.0 110.491 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -61.22 -45.83 92.96 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.623 -1.298 . . . . 0.0 110.537 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.57 -50.32 32.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.128 0.571 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.42 -35.54 77.84 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.461 1.504 . . . . 0.0 114.895 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 28.9 m -91.22 0.33 57.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.206 0.602 . . . . 0.0 109.87 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 71.13 12.87 72.5 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 119.379 -0.679 . . . . 0.0 113.534 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -64.54 -32.96 74.82 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.313 1.056 . . . . 0.0 108.469 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -147.3 163.65 35.72 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.3 m -66.45 155.94 36.13 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.272 1.029 . . . . 0.0 108.917 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.58 -52.64 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.776 0.83 . . . . 0.0 110.001 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.66 -50.8 71.02 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.486 1.115 . . . . 0.0 110.159 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -62.0 -42.06 98.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.52 94.27 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 122.025 -0.422 . . . . 0.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 46.6 mt -71.23 -42.89 68.3 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.341 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -54.63 -50.74 67.4 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.396 1.079 . . . . 0.0 108.838 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.7 -49.95 69.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.42 87.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.159 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -58.84 -38.18 78.12 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.27 0.941 . . . . 0.0 108.676 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.4 m -64.22 -47.16 80.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.913 0.885 . . . . 0.0 109.309 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 72.0 mtt-85 -57.89 -25.71 61.17 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.321 0.964 . . . . 0.0 113.212 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 70.1 mt -94.57 -19.26 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 126.925 2.09 . . . . 0.0 112.101 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 66.5 p -113.56 1.95 15.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.24 1.382 . . . . 0.0 114.459 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? . . . . . 0 C--O 1.248 1.013 0 C-N-CA 125.179 1.392 . . . . 0.0 109.134 179.5 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.82 165.44 14.13 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.727 0.694 . . . . 0.0 111.037 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.15 35.78 89.16 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.101 1.334 . . . . 0.0 114.768 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -143.51 169.58 17.44 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.809 1.304 . . . . 0.0 112.974 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.1 mt -151.98 141.24 21.41 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.207 3.003 . . . . 0.0 108.012 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.08 134.44 36.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 119.784 1.175 . . . . 0.0 108.78 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.2 mt -124.11 128.69 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 125.244 1.417 . . . . 0.0 108.752 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -114.61 138.99 49.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.38 159.98 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.924 0.783 . . . . 0.0 109.502 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -154.39 166.43 33.26 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.27 24.2 27.29 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-O 117.823 -1.543 . . . . 0.0 114.857 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.1 t70 68.97 24.1 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.427 1.491 . . . . 0.0 114.413 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -59.39 157.2 11.48 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.444 1.897 . . . . 0.0 112.591 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.15 67.32 3.63 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.794 1.664 . . . . 0.0 109.818 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -58.75 -33.74 70.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.839 0.819 . . . . 0.0 112.484 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -61.17 -45.69 93.6 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.525 0.602 . . . . 0.0 109.791 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.77 -37.59 94.53 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.7 tp -69.93 -35.98 74.97 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 121.634 -0.921 . . . . 0.0 110.977 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.49 -40.14 36.32 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 117.681 -1.152 . . . . 0.0 112.821 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.78 -37.62 74.03 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.843 1.257 . . . . 0.0 113.386 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 t -61.54 -52.12 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.67 76.65 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -64.37 -29.42 70.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 118.817 1.308 . . . . 0.0 109.83 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HB2' ' HZ2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -81.12 -52.04 7.81 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -53.31 -48.21 68.61 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.017 0.371 . . . . 0.0 110.453 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -60.38 -39.15 86.24 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.728 -1.232 . . . . 0.0 110.802 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -67.19 -28.3 67.98 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.554 0.742 . . . . 0.0 111.476 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -98.34 -3.89 36.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.935 1.294 . . . . 0.0 112.434 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.3 p -135.8 -36.04 0.77 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.45 -15.97 61.32 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.281 1.42 . . . . 0.0 112.054 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.85 130.38 28.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -68.44 130.26 42.35 Favored 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 121.498 -0.751 . . . . 0.0 109.414 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 t -128.46 118.34 47.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 33.9 m -114.34 142.96 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.614 0.766 . . . . 0.0 110.903 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.0 t -120.18 131.19 73.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -137.05 169.04 18.44 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.28 1.032 . . . . 0.0 109.404 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -140.25 54.55 5.3 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.26 168.31 25.11 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.877 2.385 . . . . 0.0 110.509 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -124.76 -7.71 7.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.258 1.023 . . . . 0.0 111.142 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.14 2.52 55.08 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.39 1.876 . . . . 0.0 111.103 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.55 -34.09 10.81 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 124.193 0.997 . . . . 0.0 111.988 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -46.7 -33.57 4.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.04 2.136 . . . . 0.0 111.93 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -120.04 -21.25 7.15 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 125.92 1.688 . . . . 0.0 111.067 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -46.68 21.51 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.383 -1.448 . . . . 0.0 110.879 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -49.66 -55.62 21.87 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.41 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.7 0.33 3.1 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.899 1.733 . . . . 0.0 114.962 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -109.72 -15.48 14.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.865 1.211 . . . . 0.0 112.548 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.41 -28.36 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.64 1.176 . . . . 0.0 110.215 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.48 -18.27 59.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.075 -1.016 . . . . 0.0 110.725 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.98 -20.27 62.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.137 0.975 . . . . 0.0 110.985 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.7 p -119.96 -2.47 10.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.563 1.545 . . . . 0.0 112.572 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.14 8.94 85.82 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.8 -14.05 59.47 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.362 -1.081 . . . . 0.0 109.947 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.37 -172.85 48.4 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.898 1.714 . . . . 0.0 115.104 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -64.95 -178.05 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.73 3.62 . . . . 0.0 112.507 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -116.31 -12.85 11.08 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.5 mt -140.87 150.61 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 tt -137.62 132.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.22 107.99 13.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.25 1.82 . . . . 0.0 108.235 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -151.46 -175.67 5.28 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.49 147.01 40.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.02 -1.05 . . . . 0.0 108.662 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -49.19 -45.44 44.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.237 1.415 . . . . 0.0 112.223 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -62.31 -4.73 1.94 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.683 1.993 . . . . 0.0 115.534 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -110.55 -4.25 15.57 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.215 0.916 . . . . 0.0 110.871 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -97.32 -18.98 18.83 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.42 -44.58 77.01 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 120.207 1.367 . . . . 0.0 112.217 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.75 -47.88 30.97 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.722 -1.043 . . . . 0.0 112.014 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -55.78 -39.12 70.82 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.985 1.393 . . . . 0.0 110.465 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.61 -47.34 76.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.706 -0.664 . . . . 0.0 109.429 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -37.14 80.18 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.529 0.604 . . . . 0.0 110.012 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.8 m -63.97 -13.74 48.52 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.13 -0.981 . . . . 0.0 110.686 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.34 10.94 67.51 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 126.168 1.842 . . . . 0.0 113.426 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.5 mt -83.68 -3.71 57.99 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.949 1.374 . . . . 0.0 114.203 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.8 mt -109.0 137.57 46.7 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.048 1.294 . . . . 0.0 110.139 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.94 179.56 5.49 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.604 1.162 . . . . 0.0 111.812 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -92.19 92.04 8.03 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pp -69.28 169.35 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.991 0.916 . . . . 0.0 112.413 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.283 7.6 p 49.51 73.69 0.95 Allowed Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 127.459 2.304 . . . . 0.0 112.054 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.11 -22.68 46.96 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.628 2.219 . . . . 0.0 112.667 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -128.81 164.31 23.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.616 1.967 . . . . 0.0 108.895 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -85.52 -34.9 21.44 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.76 -21.59 19.79 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.456 1.48 . . . . 0.0 114.531 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -68.5 -30.18 68.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -64.69 -41.08 96.29 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 120.964 -1.085 . . . . 0.0 110.024 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.81 -16.46 63.11 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.556 1.542 . . . . 0.0 112.123 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -84.66 -2.56 57.69 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 120.896 -1.127 . . . . 0.0 110.967 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt -131.14 159.22 38.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.371 1.068 . . . . 0.0 110.493 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -77.68 152.43 80.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.452 0.701 . . . . 0.0 109.272 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.88 -42.56 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.719 2.946 . . . . 0.0 114.75 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -58.09 -44.31 87.53 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.668 1.122 . . . . 0.0 110.707 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.75 -28.33 69.51 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.102 1.361 . . . . 0.0 111.26 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -71.3 -42.63 68.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.24 0.616 . . . . 0.0 110.331 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.12 -28.23 51.15 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.903 0.881 . . . . 0.0 111.647 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.37 -23.73 65.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.07 1.348 . . . . 0.0 114.263 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.57 11.61 6.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.375 1.07 . . . . 0.0 112.368 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -72.25 147.72 46.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.288 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.465 ' CD1' ' HE3' ' A' ' 102' ' ' LYS . 51.2 t80 -131.84 178.69 6.57 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.935 1.294 . . . . 0.0 108.543 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -57.67 89.82 0.01 OUTLIER 'General case' 0 C--O 1.235 0.308 0 C-N-CA 127.711 2.404 . . . . 0.0 109.546 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.14 -77.93 1.13 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.465 ' HE3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -66.83 177.03 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.8 1.24 . . . . 0.0 109.395 179.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.7 mt -116.52 -179.54 3.71 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 110.893 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.9 pt -133.74 -29.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.5 177.64 9.3 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.969 0.804 . . . . 0.0 109.443 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.38 145.93 54.58 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 124.238 1.015 . . . . 0.0 108.733 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.37 145.73 54.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.925 2.417 . . . . 0.0 108.17 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.0 mm -129.0 -50.56 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 123.369 0.668 . . . . 0.0 109.963 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.25 157.39 44.49 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.932 0.396 . . . . 0.0 111.169 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.15 119.37 26.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.006 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 . . . . . 0 CA--C 1.536 0.407 0 C-N-CA 124.172 0.989 . . . . 0.0 109.313 178.459 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 mt . . . . . 0 CA--C 1.532 0.28 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.2 p90 . . . . . 0 C--O 1.239 0.509 0 C-N-CA 126.581 1.952 . . . . 0.0 107.404 179.666 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.458 -0.573 0 CA-C-O 121.711 0.63 . . . . 0.0 113.571 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -123.85 -17.13 6.42 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 117.192 -1.385 . . . . 0.0 112.776 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.65 143.93 31.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.84 1.655 . . . . 0.0 112.205 -178.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -65.24 -22.77 66.92 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.394 -0.816 . . . . 0.0 111.911 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -72.19 -12.78 61.33 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.371 0.668 . . . . 0.0 111.934 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -98.85 -19.02 17.61 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.094 1.758 . . . . 0.0 111.014 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.33 -52.62 70.04 Favored Pre-proline 0 N--CA 1.465 0.319 0 C-N-CA 124.6 1.16 . . . . 0.0 109.851 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -69.37 -24.76 31.12 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 120.248 1.124 . . . . 0.0 111.771 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.35 -54.23 27.01 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.08 -30.02 70.71 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.175 -0.953 . . . . 0.0 110.316 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -61.78 -45.18 95.0 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.616 1.166 . . . . 0.0 110.352 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -74.39 -25.48 59.5 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.523 -0.736 . . . . 0.0 111.688 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.58 -45.84 61.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.675 -0.679 . . . . 0.0 110.249 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . 0.259 6.2 mt -80.1 -24.18 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 117.876 -1.53 . . . . 0.0 110.799 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -66.96 -31.56 72.21 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.19 -11.89 60.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.56 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.67 0.77 8.16 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.516 1.527 . . . . 0.0 111.932 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 172.14 -91.05 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 119.467 1.031 . . . . 0.0 113.721 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.08 -175.83 4.38 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.802 0.841 . . . . 0.0 109.659 -178.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.7 p -74.34 166.2 23.88 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.37 -63.9 1.31 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.039 2.536 . . . . 0.0 112.268 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.4 tp -102.92 137.15 41.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.473 1.509 . . . . 0.0 107.941 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 65.6 mtp -148.34 103.07 3.4 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 128.373 2.669 . . . . 0.0 105.721 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -128.33 161.93 28.27 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -72.38 93.56 1.54 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.007 0.908 . . . . 0.0 112.114 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.5 mt -73.48 -8.81 57.46 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.631 1.572 . . . . 0.0 110.288 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -70.58 -19.12 62.88 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.403 1.481 . . . . 0.0 112.597 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -115.66 135.62 22.69 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.619 1.1 . . . . 0.0 111.896 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.05 -21.93 48.48 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.759 2.306 . . . . 0.0 112.961 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -59.96 -27.34 66.73 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.505 0.593 . . . . 0.0 112.237 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -86.85 -44.91 11.34 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.791 0.723 . . . . 0.0 111.307 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.5 p -76.99 -17.2 59.02 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -62.12 -60.85 8.95 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 117.844 -1.074 . . . . 0.0 113.073 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.9 -23.53 76.05 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.318 1.863 . . . . 0.0 111.422 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.34 -57.59 10.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 22.6 pt -69.19 -25.25 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.028 0.442 . . . . 0.0 111.229 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.56 -23.14 65.39 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 120.901 -1.124 . . . . 0.0 111.06 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.76 87.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -57.96 -58.9 6.37 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.92 5.1 0.03 OUTLIER Glycine 0 CA--C 1.522 0.523 0 CA-C-O 118.688 -1.062 . . . . 0.0 115.064 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.62 129.88 33.72 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.244 1.522 . . . . 0.0 109.329 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -138.46 149.24 45.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.821 1.31 . . . . 0.0 108.092 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.09 -66.62 0.74 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -140.19 173.22 11.73 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.266 1.427 . . . . 0.0 107.869 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -114.5 139.59 49.43 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -155.74 117.1 3.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.229 1.412 . . . . 0.0 107.792 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -160.32 163.33 33.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.898 1.279 . . . . 0.0 108.706 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 49.74 26.87 2.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.269 1.828 . . . . 0.0 112.961 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.83 9.25 87.26 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.265 -1.297 . . . . 0.0 113.469 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -115.06 118.94 34.8 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.93 1.865 . . . . 0.0 107.612 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.06 116.69 23.22 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.118 1.767 . . . . 0.0 109.451 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -130.3 104.09 7.08 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.414 HD12 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -64.6 -3.36 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 125.152 1.381 . . . . 0.0 112.341 178.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -72.89 -36.25 67.28 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.676 1.191 . . . . 0.0 111.015 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -89.78 72.31 7.64 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.94 0.896 . . . . 0.0 111.112 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.2 138.76 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 128.295 2.638 . . . . 0.0 111.446 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.83 15.16 10.44 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -1.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 120.116 1.958 . . . . 0.0 115.36 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -125.52 14.03 8.17 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.641 1.564 . . . . 0.0 111.639 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -71.09 158.4 36.53 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.941 -1.099 . . . . 0.0 108.456 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -48.69 -31.77 7.35 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.12 -37.59 42.51 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 119.504 1.047 . . . . 0.0 112.845 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.83 88.25 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -71.42 -35.5 70.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.415 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -56.65 -50.76 71.11 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.012 1.278 . . . . 0.0 111.209 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.83 -34.44 88.68 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.612 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 60.3 tp -70.05 -55.17 10.2 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.948 0.874 . . . . 0.0 110.476 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.0 t -55.2 -41.71 72.35 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.585 -1.198 . . . . 0.0 108.989 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -57.01 -54.05 51.1 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.707 1.14 . . . . 0.0 109.278 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.29 -44.58 88.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.801 0.841 . . . . 0.0 111.33 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 72.6 t -67.16 -31.2 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 121.431 -0.793 . . . . 0.0 109.783 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -39.91 82.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 O-C-N 121.283 -0.885 . . . . 0.0 109.141 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.54 -45.53 90.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 70.2 mt -59.37 -49.0 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -54.69 -37.96 66.44 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.979 0.912 . . . . 0.0 110.534 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -92.44 8.02 40.49 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 64.8 22.16 12.49 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.976 1.71 . . . . 0.0 113.256 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -85.94 -3.97 59.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.769 1.228 . . . . 0.0 110.669 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 77.4 mtp -143.64 167.33 22.51 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.504 1.922 . . . . 0.0 107.703 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -120.9 92.71 3.82 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.851 1.26 . . . . 0.0 109.728 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.99 -11.58 14.22 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.017 1.327 . . . . 0.0 114.38 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -89.1 -5.24 57.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.388 1.475 . . . . 0.0 111.762 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.7 m -69.96 131.1 43.87 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.74 0.816 . . . . 0.0 110.48 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.433 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 7.6 p30 -129.38 -177.5 4.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.704 2.002 . . . . 0.0 108.281 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -62.92 -26.66 68.91 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.6 m -91.4 -34.66 14.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.257 1.423 . . . . 0.0 109.562 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.433 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 33.1 mm -66.13 -49.12 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.39 -53.15 61.57 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.946 0.898 . . . . 0.0 109.039 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -60.16 -33.88 72.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.238 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.94 -54.28 23.52 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 119.309 0.959 . . . . 0.0 108.738 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.88 82.91 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.843 0.857 . . . . 0.0 109.865 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.96 -37.73 88.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.26 0.624 . . . . 0.0 110.244 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.06 -23.71 67.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.906 0.775 . . . . 0.0 109.786 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -87.84 -20.25 26.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.247 1.019 . . . . 0.0 109.658 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.36 12.65 72.6 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.514 1.531 . . . . 0.0 111.752 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -66.23 -45.85 79.21 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.911 0.855 . . . . 0.0 110.87 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 43.5 p -71.38 171.5 11.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.919 1.688 . . . . 0.0 109.069 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -129.38 -13.48 4.37 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -157.21 -179.63 8.38 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 121.745 -0.597 . . . . 0.0 110.653 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.3 t -164.53 174.29 11.07 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.475 1.51 . . . . 0.0 107.39 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.4 mt . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.859 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--O 1.237 0.408 0 CA-C-O 118.878 -0.582 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.91 134.49 23.68 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.802 1.668 . . . . 0.0 109.924 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 65.1 p -129.78 176.58 7.91 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.883 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -88.73 140.25 29.63 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -52.89 131.76 36.11 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.519 -1.363 . . . . 0.0 110.871 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.38 -1.36 50.91 Favored Glycine 0 CA--C 1.519 0.285 0 CA-C-O 118.54 -1.144 . . . . 0.0 114.635 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.93 103.39 3.19 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 119.647 1.723 . . . . 0.0 111.842 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.17 170.23 15.0 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.345 2.696 . . . . 0.0 114.376 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 74.9 m -57.75 140.79 50.67 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.164 1.386 . . . . 0.0 110.648 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -140.25 73.95 30.56 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.478 1.111 . . . . 0.0 108.439 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.98 -95.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.578 3.518 . . . . 0.0 109.121 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 . . . . . 0 C--O 1.236 0.343 0 C-N-CA 128.623 2.769 . . . . 0.0 107.631 179.095 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.413 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 1.5 p -69.18 112.98 4.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 121.427 0.632 . . . . 0.0 109.301 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 8.8 tt -77.87 134.75 37.88 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.5 m -125.7 168.31 13.93 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.616 1.167 . . . . 0.0 110.712 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -137.05 140.99 42.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.03 147.59 19.27 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 69.8 mt -90.32 136.77 23.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -71.73 128.24 35.13 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.4 8.23 2.38 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -116.25 3.41 13.41 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.09 1.314 . . . . 0.0 112.48 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 62.7 m -63.5 160.51 42.23 Favored Pre-proline 0 C--O 1.237 0.447 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.8 -60.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 108.333 -1.449 . . . . 0.0 108.333 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -123.78 102.68 7.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -16.19 37.38 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.239 0.472 . . . . 0.0 110.595 178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -57.17 -41.9 80.09 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 127.456 2.303 . . . . 0.0 108.469 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.02 -37.09 76.12 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.018 -1.051 . . . . 0.0 110.852 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.06 -46.82 40.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 122.094 -0.379 . . . . 0.0 109.994 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -34.48 76.46 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.704 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.51 -55.24 10.76 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -52.55 -46.26 66.71 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.042 -1.036 . . . . 0.0 111.617 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -51.66 68.7 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 119.264 -0.398 . . . . 0.0 110.929 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -10.98 59.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -108.59 -27.73 9.7 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -138.11 -25.62 0.95 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 120.102 1.319 . . . . 0.0 114.04 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.51 -51.02 10.58 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.681 1.128 . . . . 0.0 110.859 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 88.7 mt -86.57 68.36 10.15 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.602 1.161 . . . . 0.0 110.819 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.8 p -135.21 162.62 32.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -75.75 5.0 6.82 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.395 0.617 . . . . 0.0 110.457 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -113.26 -42.82 3.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.091 2.156 . . . . 0.0 109.478 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.93 -37.11 87.64 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.18 1.371 . . . . 0.0 111.884 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.09 -36.06 61.74 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.556 1.178 . . . . 0.0 109.267 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -70.33 -39.26 74.83 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.807 0.843 . . . . 0.0 110.044 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -53.73 -38.31 64.22 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.16 0.891 . . . . 0.0 112.707 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 20.2 t -81.34 -35.47 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.148 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -63.35 -33.34 75.31 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.852 0.861 . . . . 0.0 111.356 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -61.33 -54.06 48.75 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.139 1.376 . . . . 0.0 108.784 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -42.42 99.14 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -152.42 141.76 14.43 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 124.873 1.269 . . . . 0.0 107.801 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.75 110.56 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.435 2.09 . . . . 0.0 109.031 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 12.5 mt -75.22 -22.25 58.07 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.27 -155.7 19.91 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.504 -1.839 . . . . 0.0 108.504 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.6 178.06 5.63 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.965 0.888 . . . . 0.0 109.398 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.74 150.55 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 C-N-CA 123.753 0.821 . . . . 0.0 109.198 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.24 -20.86 40.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.625 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.1 106.9 6.83 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.971 1.708 . . . . 0.0 110.165 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -56.42 -26.55 53.89 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.8 m -57.13 -54.79 42.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.635 1.107 . . . . 0.0 110.663 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -90.46 -17.96 26.21 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.517 0.727 . . . . 0.0 111.803 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -60.88 -39.77 90.47 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.895 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -66.58 -15.89 63.76 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.529 1.059 . . . . 0.0 113.033 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -95.73 -23.49 16.95 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.704 2.001 . . . . 0.0 110.323 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 32.4 mt -86.69 -44.4 11.85 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.76 -17.9 57.78 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.888 2.075 . . . . 0.0 112.03 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.489 ' HE3' ' HB2' ' A' ' 314' ' ' ASP . 0.1 OUTLIER -69.81 -16.91 63.36 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.695 -0.628 . . . . 0.0 109.561 178.071 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.489 ' HB2' ' HE3' ' A' ' 313' ' ' LYS . 2.5 t70 -103.94 131.51 21.9 Favored Pre-proline 0 N--CA 1.438 -1.051 0 C-N-CA 125.91 1.684 . . . . 0.0 107.562 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.81 -23.63 67.86 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.497 2.131 . . . . 0.0 114.43 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 -60.39 -54.98 39.16 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.848 1.259 . . . . 0.0 111.009 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.4 mp -71.96 -49.37 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.92 -52.06 36.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 123.948 0.78 . . . . 0.0 111.903 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.22 -28.45 70.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.511 0.596 . . . . 0.0 112.566 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 24.0 m -76.61 -37.45 56.4 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.1 tpt -71.84 -33.1 68.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.715 1.206 . . . . 0.0 111.393 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -55.99 -35.37 66.7 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.691 0.796 . . . . 0.0 109.696 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -63.23 -36.85 85.03 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.968 0.907 . . . . 0.0 111.486 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.376 0 C-N-CA 123.967 0.907 . . . . 0.0 109.522 178.74 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.453 -0.873 0 N-CA-C 109.713 -0.918 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -83.0 4.21 26.97 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 48.6 pt -60.89 151.93 71.73 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.38 1.072 . . . . 0.0 111.263 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.61 -21.8 21.69 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.52 2.147 . . . . 0.0 113.771 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -68.78 -18.41 64.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.233 0.924 . . . . 0.0 111.67 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 64.3 mmm -61.85 -29.23 70.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.349 0.977 . . . . 0.0 109.867 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.1 m -63.7 -52.0 62.56 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.96 86.37 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.074 0.549 . . . . 0.0 110.105 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -56.93 -54.86 41.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.821 1.248 . . . . 0.0 109.86 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -60.56 -39.97 89.92 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.98 0.809 . . . . 0.0 110.599 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -68.09 -25.89 65.55 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.96 -59.17 2.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.814 1.246 . . . . 0.0 110.552 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.9 t -55.95 -38.97 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.655 0.782 . . . . 0.0 110.667 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.68 -46.59 74.11 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.177 1.353 . . . . 0.0 110.8 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 47.7 m -67.71 -46.4 72.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.627 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -56.48 -43.41 79.62 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.47 1.032 . . . . 0.0 112.652 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.72 -53.5 46.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 125.041 1.336 . . . . 0.0 109.14 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.77 -40.78 88.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 122.809 0.444 . . . . 0.0 109.833 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -56.08 -45.23 79.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 120.969 -1.082 . . . . 0.0 110.984 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.72 -46.94 34.23 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.24 0.616 . . . . 0.0 111.015 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -63.1 -42.07 99.51 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.138 0.975 . . . . 0.0 113.266 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 36.4 m -84.87 -5.29 59.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.396 0.678 . . . . 0.0 109.362 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.86 12.55 71.14 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 118.538 0.608 . . . . 0.0 113.711 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -65.56 -28.01 68.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.134 0.967 . . . . 0.0 109.707 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -142.98 156.96 44.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 9.0 m -66.71 148.73 51.52 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 83.6 t -51.27 -57.24 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.436 1.094 . . . . 0.0 111.272 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -63.56 -39.93 95.67 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -70.06 -25.45 63.55 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.774 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.49 76.39 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.507 0.723 . . . . 0.0 109.309 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.56 -36.21 60.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 118.686 -0.674 . . . . 0.0 110.297 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -55.63 -54.67 41.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.205 1.402 . . . . 0.0 108.115 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -51.19 -61.35 2.29 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.873 2.469 . . . . 0.0 110.338 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.75 77.07 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 127.047 2.139 . . . . 0.0 114.092 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -59.62 -36.07 75.62 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 16.7 m -64.11 -38.8 92.37 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.307 0.575 . . . . 0.0 110.567 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -61.21 -24.04 66.05 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.074 -1.016 . . . . 0.0 111.787 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.8 mt -91.52 -29.94 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.793 1.237 . . . . 0.0 110.17 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 17.3 p -76.8 -20.96 55.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.299 0.954 . . . . 0.0 110.026 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? . . . . . 0 C--O 1.247 0.955 0 C-N-CA 126.156 1.782 . . . . 0.0 108.355 179.301 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.1 mp -82.42 165.16 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 125.307 1.629 . . . . 0.0 109.764 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.49 119.54 16.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -91.4 167.12 12.5 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.25 24.31 75.68 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 117.099 1.6 . . . . 0.0 117.099 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -148.24 157.92 43.78 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 121.145 2.472 . . . . 0.0 113.856 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.2 mt -144.95 152.19 39.8 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.346 2.258 . . . . 0.0 108.604 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -134.82 139.78 46.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 126.641 1.976 . . . . 0.0 106.97 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.2 mt -122.77 121.23 62.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.697 1.199 . . . . 0.0 108.99 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -115.95 137.08 52.44 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 mt -128.59 159.22 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -52.74 -20.35 3.1 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.17 155.13 30.22 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 104.846 -3.302 . . . . 0.0 104.846 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.89 0.57 0.38 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.261 1.424 . . . . 0.0 113.943 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -82.23 172.5 13.07 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.0 2.12 . . . . 0.0 111.885 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.61 51.01 2.97 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.062 1.791 . . . . 0.0 113.355 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -57.42 -35.98 70.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.76 1.224 . . . . 0.0 113.978 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -62.21 -38.51 89.41 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.871 0.76 . . . . 0.0 111.031 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.11 -35.72 57.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.8 tp -70.9 -32.46 69.41 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 123.119 0.568 . . . . 0.0 111.535 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.28 -48.64 71.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.298 0.639 . . . . 0.0 110.851 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -53.31 -38.47 63.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.33 -46.66 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.82 -29.42 72.61 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 124.539 1.066 . . . . 0.0 111.215 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -68.06 -43.77 77.87 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 118.851 1.326 . . . . 0.0 107.448 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -60.47 3.29 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -52.69 -54.17 37.33 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.984 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.18 -29.74 65.88 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.553 1.524 . . . . 0.0 112.292 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -28.39 58.74 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.601 -1.312 . . . . 0.0 109.83 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -91.63 -38.33 12.52 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.223 0.952 . . . . 0.0 112.05 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.5 p -102.62 -31.54 10.33 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.45 -17.35 54.69 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 121.106 -0.996 . . . . 0.0 112.206 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.3 mm -62.76 119.96 8.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.4 143.08 15.91 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 t -138.83 105.88 2.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 123.649 0.779 . . . . 0.0 109.128 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.5 m -96.96 153.45 17.89 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.82 127.28 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.88 154.79 51.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -122.58 57.29 9.22 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.08 1.752 . . . . 0.0 110.281 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.46 167.26 27.48 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.187 2.592 . . . . 0.0 112.299 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -121.71 1.78 10.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.221 1.008 . . . . 0.0 112.874 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 14.37 6.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.886 1.674 . . . . 0.0 112.117 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -58.33 -26.36 63.0 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 120.588 -1.32 . . . . 0.0 113.083 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -58.58 -27.51 64.68 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.845 1.202 . . . . 0.0 113.635 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -106.17 -24.55 12.3 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 123.66 0.784 . . . . 0.0 110.192 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.35 28.03 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.716 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -48.78 -60.06 5.23 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 117.629 -1.177 . . . . 0.0 109.403 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.28 -17.12 57.46 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.602 1.535 . . . . 0.0 114.004 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -89.03 -28.54 20.09 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.34 1.427 . . . . 0.0 111.753 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.8 -45.73 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 120.01 1.277 . . . . 0.0 109.651 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.26 -22.95 66.4 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 122.061 -0.399 . . . . 0.0 111.315 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.72 -24.31 67.61 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.23 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -103.23 4.86 37.16 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.59 1.556 . . . . 0.0 109.917 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.35 36.54 78.53 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.797 -1.189 . . . . 0.0 111.64 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -128.39 1.97 5.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.855 1.662 . . . . 0.0 112.915 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.41 -169.94 44.47 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.892 1.234 . . . . 0.0 113.693 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.36 162.24 34.41 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.189 1.926 . . . . 0.0 109.768 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -94.47 -19.2 20.77 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 124.545 1.138 . . . . 0.0 111.225 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -138.9 147.96 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tp -134.4 145.98 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.625 1.17 . . . . 0.0 108.622 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -130.55 108.94 10.3 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.714 1.606 . . . . 0.0 109.707 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -156.4 167.22 31.12 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 123.878 0.871 . . . . 0.0 109.975 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.76 155.33 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -57.29 -29.42 63.87 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -49.89 -59.06 4.21 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -66.09 -17.56 64.78 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.547 -0.721 . . . . 0.0 111.659 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -83.17 -5.11 59.0 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.497 -0.752 . . . . 0.0 110.3 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.4 -13.96 46.39 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.052 1.311 . . . . 0.0 113.591 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -125.06 -31.41 0.86 Allowed Glycine 0 CA--C 1.526 0.727 0 CA-C-N 118.827 1.314 . . . . 0.0 114.128 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -57.51 -41.74 81.41 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.017 1.408 . . . . 0.0 112.822 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.8 -40.72 79.42 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.58 1.082 . . . . 0.0 110.705 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -41.79 87.55 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.5 m -68.44 -8.12 37.85 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.079 0.952 . . . . 0.0 111.781 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.74 1.24 83.08 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 126.545 2.021 . . . . 0.0 113.016 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.38 -41.07 89.96 Favored 'General case' 0 C--N 1.338 0.067 0 CA-C-N 118.899 1.35 . . . . 0.0 113.232 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 mt -85.5 130.47 34.57 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.18 164.94 19.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.464 1.106 . . . . 0.0 112.082 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -73.8 131.34 41.44 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pp -113.99 -174.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.315 1.446 . . . . 0.0 109.191 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m 60.08 75.73 0.47 Allowed Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.502 1.121 . . . . 0.0 111.051 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.16 -23.64 15.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.021 2.481 . . . . 0.0 113.984 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -140.95 -162.67 1.4 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.518 1.927 . . . . 0.0 108.575 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -110.56 -19.92 12.74 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.793 1.237 . . . . 0.0 113.376 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.25 83.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.97 -1.081 . . . . 0.0 113.586 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -61.76 -28.28 69.33 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.862 1.265 . . . . 0.0 110.356 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -68.57 -44.51 74.29 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.294 0.952 . . . . 0.0 108.916 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.26 -21.53 66.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.228 0.467 . . . . 0.0 111.762 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -68.04 -12.04 60.08 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.526 0.603 . . . . 0.0 110.509 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -122.07 165.78 15.54 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.833 1.653 . . . . 0.0 111.211 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -77.1 155.69 82.33 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.31 -43.1 3.26 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.325 2.684 . . . . 0.0 114.295 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -57.2 -41.99 80.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.543 1.065 . . . . 0.0 112.354 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.96 -25.63 67.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.649 1.18 . . . . 0.0 111.051 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -76.26 -40.67 51.23 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -37.99 81.3 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.8 0.75 0.75 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.474 1.51 . . . . 0.0 114.002 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.04 3.91 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-N 120.487 1.494 . . . . 0.0 111.693 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.9 mtt-85 -63.08 170.46 2.79 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 123.3 1.524 . . . . 0.0 113.418 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -149.92 179.47 8.02 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 128.17 2.588 . . . . 0.0 105.868 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -68.21 99.9 0.96 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.79 -72.9 1.74 Allowed Glycine 0 CA--C 1.521 0.466 0 C-N-CA 125.012 1.291 . . . . 0.0 111.782 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 167.67 13.49 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 122.53 1.157 . . . . 0.0 112.374 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.14 154.1 22.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.266 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.3 pt -134.2 -15.08 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.9 172.55 13.84 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.084 1.311 . . . . 0.0 108.029 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.22 150.5 75.52 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 123.842 0.857 . . . . 0.0 110.829 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.94 144.63 53.67 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 124.336 3.358 . . . . 0.0 111.387 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.58 -55.53 3.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 126.105 1.762 . . . . 0.0 111.596 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.06 162.0 33.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.1 t -128.69 75.07 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -128.99 101.96 6.29 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.67 71.82 1.2 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 126.681 1.992 . . . . 0.0 109.011 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -160.1 121.46 3.14 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 m -160.95 154.16 21.56 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.583 1.553 . . . . 0.0 108.104 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.0 tp -158.48 137.48 11.39 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.676 1.59 . . . . 0.0 108.033 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.5 mt -93.52 156.08 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.404 1.482 . . . . 0.0 110.204 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -142.72 173.82 11.2 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.553 1.941 . . . . 0.0 110.529 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -58.04 171.79 0.49 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.712 1.205 . . . . 0.0 111.913 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -61.09 -17.68 53.88 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.301 -0.874 . . . . 0.0 112.629 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -90.1 127.64 36.13 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.391 1.476 . . . . 0.0 110.086 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.47 36.16 0.1 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.531 1.932 . . . . 0.0 113.304 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.87 108.2 17.42 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.17 95.3 1.03 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.371 2.714 . . . . 0.0 112.31 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -140.75 74.35 27.1 Favored Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -78.58 150.91 25.02 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.835 2.357 . . . . 0.0 112.126 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.82 148.25 86.23 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.968 2.445 . . . . 0.0 111.584 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -86.6 -26.04 24.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.913 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.9 t -170.96 161.13 6.88 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.953 1.252 . . . . 0.0 108.822 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -64.81 -29.22 70.18 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.61 -12.67 61.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.625 0.648 . . . . 0.0 112.485 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -90.38 -21.3 22.04 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.743 1.217 . . . . 0.0 109.951 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.43 -57.34 21.18 Favored Pre-proline 0 N--CA 1.456 -0.158 0 CA-C-O 117.441 -1.266 . . . . 0.0 110.762 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.75 -23.4 62.98 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 CA-C-N 120.769 1.31 . . . . 0.0 111.815 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.58 -39.83 57.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.488 0.715 . . . . 0.0 110.494 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.0 tp -79.39 -31.44 42.81 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.306 1.443 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.57 -46.84 80.53 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.617 1.167 . . . . 0.0 110.862 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -70.74 -29.42 65.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.35 0.66 . . . . 0.0 112.139 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -75.0 -41.43 59.52 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.56 -33.99 67.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -65.24 -32.91 74.82 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.22 -14.67 61.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 4.38 5.76 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.098 1.359 . . . . 0.0 111.879 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 174.08 -96.21 0.11 Allowed Glycine 0 CA--C 1.526 0.719 0 CA-C-N 119.748 1.158 . . . . 0.0 115.007 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -134.97 -173.54 3.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.145 0.973 . . . . 0.0 112.493 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.4 p -62.8 161.62 12.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.429 1.892 . . . . 0.0 112.055 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.82 -68.05 0.79 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.809 1.244 . . . . 0.0 109.375 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.4 tp -125.93 141.23 52.07 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.451 1.5 . . . . 0.0 110.577 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.6 mtp -139.43 149.1 43.65 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.739 1.616 . . . . 0.0 107.452 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -163.76 173.56 12.68 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.126 0.97 . . . . 0.0 109.766 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -75.36 80.73 2.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.207 1.803 . . . . 0.0 108.904 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mp -72.63 -16.23 61.72 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 121.031 -1.043 . . . . 0.0 110.12 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -70.05 -14.06 62.5 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -121.29 155.12 58.99 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 121.718 2.054 . . . . 0.0 114.845 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.0 -28.71 12.71 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.521 2.147 . . . . 0.0 115.619 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -56.13 -41.51 75.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -89.93 -25.31 21.0 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 119.252 -0.404 . . . . 0.0 111.387 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . 0.25 53.3 p -85.33 -13.39 49.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.011 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -61.54 -53.48 61.21 Favored Pre-proline 0 CA--C 1.532 0.258 0 O-C-N 120.605 -1.309 . . . . 0.0 111.159 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.18 -7.81 14.75 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 CA-C-N 120.574 1.241 . . . . 0.0 112.746 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.79 -67.84 0.63 Allowed 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 121.424 1.92 . . . . 0.0 107.979 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.41 -27.09 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 126.005 1.722 . . . . 0.0 115.014 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.74 -18.72 56.32 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.774 -0.579 . . . . 0.0 111.01 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.89 -47.1 75.97 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.13 -33.24 73.08 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 154.56 -9.79 0.41 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-O 117.188 -1.895 . . . . 0.0 116.756 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.02 149.28 38.47 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-N 120.242 2.021 . . . . 0.0 112.798 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -151.29 143.42 24.0 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.232 1.016 . . . . 0.0 109.285 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.46 -67.99 0.42 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.832 0.853 . . . . 0.0 112.126 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -139.0 143.53 38.52 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.476 1.11 . . . . 0.0 108.695 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -76.85 141.01 40.81 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.26 102.33 3.96 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -70.87 -174.12 0.89 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -67.02 34.43 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.449 1.899 . . . . 0.0 114.262 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 138.6 -3.51 2.93 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.47 1.986 . . . . 0.0 112.645 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.65 127.5 56.13 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.875 1.838 . . . . 0.0 106.68 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -120.82 152.2 38.67 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.894 0.746 . . . . 0.0 110.962 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.12 161.14 40.4 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 128.989 2.916 . . . . 0.0 106.093 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.73 -3.66 10.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.376 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -75.15 -30.7 60.84 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.281 0.632 . . . . 0.0 112.394 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.67 87.34 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.949 0.88 . . . . 0.0 110.606 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -105.91 110.48 31.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.756 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -81.23 28.67 2.93 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.029 1.776 . . . . 0.0 114.046 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 37.5 t -74.23 -57.13 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -80.11 57.6 2.74 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 122.183 0.992 . . . . 0.0 110.18 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -127.09 142.25 51.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -51.0 -34.56 29.73 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.417 1.087 . . . . 0.0 113.755 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.63 -38.66 96.78 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 119.474 1.034 . . . . 0.0 112.162 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.98 51.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 117.679 0.739 . . . . 0.0 109.397 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.468 ' HE3' ' OD2' ' A' ' 358' ' ' ASP . 2.6 ptmm? -62.44 -38.45 89.81 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -54.64 -53.3 56.54 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.823 1.249 . . . . 0.0 111.8 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -74.01 -29.81 62.19 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 13.0 tp -70.2 -37.23 75.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.727 1.264 . . . . 0.0 112.856 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 6.6 t -67.53 -19.1 65.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 117.397 -1.287 . . . . 0.0 110.97 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -65.65 -50.58 64.45 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.412 1.46 . . . . 0.0 107.84 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.9 tt -52.9 -49.91 64.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.273 1.429 . . . . 0.0 109.761 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.45 -27.68 42.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 124.401 1.08 . . . . 0.0 111.041 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.625 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 18.2 t0 -65.43 -31.73 72.98 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.933 1.242 . . . . 0.0 112.848 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.4 mt -76.46 -48.31 20.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 51.6 mt -59.75 -36.13 64.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.145 0.978 . . . . 0.0 109.488 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.625 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -52.18 -43.82 64.35 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.076 1.35 . . . . 0.0 110.666 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -90.77 -2.91 57.76 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.319 1.848 . . . . 0.0 112.189 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 59.22 9.8 1.49 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.887 2.475 . . . . 0.0 113.679 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -28.68 67.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.582 0.628 . . . . 0.0 109.934 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.7 tpt -90.88 154.37 19.53 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.402 0.681 . . . . 0.0 109.759 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -75.59 88.26 2.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.51 -8.08 55.82 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.28 1.032 . . . . 0.0 112.232 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -105.63 8.19 33.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.892 1.277 . . . . 0.0 113.882 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.8 m -87.12 127.61 35.13 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.524 -0.735 . . . . 0.0 109.494 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.25 -172.08 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.476 1.91 . . . . 0.0 107.412 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -51.67 60.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.893 1.277 . . . . 0.0 109.267 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -50.13 70.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.771 1.229 . . . . 0.0 111.428 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.86 -46.53 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.35 0.66 . . . . 0.0 111.506 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.38 79.05 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.463 1.105 . . . . 0.0 113.156 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -59.18 -54.77 43.15 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.084 1.353 . . . . 0.0 108.885 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.52 -55.79 25.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 124.393 1.058 . . . . 0.0 110.771 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.27 -35.39 64.96 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.719 0.69 . . . . 0.0 111.956 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -69.83 -43.04 72.79 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -58.25 -40.13 80.98 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -66.95 -21.18 65.98 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.337 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.28 12.47 63.15 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.297 0.951 . . . . 0.0 111.998 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -79.99 -49.71 11.44 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.483 1.142 . . . . 0.0 112.502 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.3 p -64.8 119.99 11.65 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.77 -17.33 62.94 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.361 0.528 . . . . 0.0 112.406 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -158.54 166.56 31.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.405 1.082 . . . . 0.0 109.151 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 2.0 t -159.06 170.81 21.21 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.0 mt -132.07 150.44 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 126.064 1.746 . . . . 0.0 106.744 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -153.22 177.27 11.03 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.261 1.424 . . . . 0.0 108.242 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 147.59 -82.75 0.19 Allowed Glycine 0 CA--C 1.523 0.545 0 CA-C-O 117.977 -1.457 . . . . 0.0 114.846 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.56 161.65 44.23 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.964 2.443 . . . . 0.0 113.401 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -115.25 105.78 13.28 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.318 1.447 . . . . 0.0 110.458 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.79 -60.64 1.93 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.844 1.258 . . . . 0.0 108.937 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 51.4 m0 -67.53 159.09 30.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.664 0.786 . . . . 0.0 109.295 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 17.7 t -70.8 -8.95 56.19 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.895 -0.503 . . . . 0.0 112.036 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -155.31 157.33 37.02 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.272 1.429 . . . . 0.0 109.574 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.58 141.4 28.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -119.82 -7.14 10.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.439 1.096 . . . . 0.0 112.767 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.07 119.87 9.27 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.196 1.398 . . . . 0.0 107.337 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 9.6 t -121.35 128.29 52.12 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.888 0.851 . . . . 0.0 110.376 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -93.75 164.13 13.26 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.067 1.347 . . . . 0.0 107.798 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.46 162.65 32.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -160.33 136.99 8.95 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.796 -0.565 . . . . 0.0 110.255 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -92.61 155.29 17.86 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 54.51 -160.76 4.79 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.98 0.8 . . . . 0.0 113.422 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.85 163.67 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 125.018 1.327 . . . . 0.0 109.007 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 27.2 m -144.86 157.11 44.27 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 14.5 p -73.58 -179.53 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.5 tt -139.8 127.27 12.81 Favored Pre-proline 0 C--O 1.236 0.358 0 O-C-N 120.017 -1.677 . . . . 0.0 108.041 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.74 156.29 65.95 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.938 2.425 . . . . 0.0 108.721 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.4 p -131.25 -173.22 3.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.15 0.98 . . . . 0.0 110.936 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -91.1 171.87 8.96 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -51.65 102.38 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.328 2.251 . . . . 0.0 110.09 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 63.85 23.63 67.59 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 117.603 -1.665 . . . . 0.0 114.726 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.8 128.41 4.74 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-N 121.291 2.546 . . . . 0.0 111.196 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.67 159.55 52.36 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.016 2.477 . . . . 0.0 111.473 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.6 m -92.3 162.88 14.1 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -150.51 91.68 4.08 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.198 1.399 . . . . 0.0 110.877 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.21 -77.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.197 2.598 . . . . 0.0 109.644 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -154.81 164.31 39.0 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.049 2.139 . . . . 0.0 106.876 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 40.2 t -86.19 95.16 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -101.85 106.82 3.07 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.9 165.47 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.172 0.989 . . . . 0.0 110.985 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.16 140.98 30.51 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.034 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.3 m -133.09 168.27 18.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.114 0.87 . . . . 0.0 111.356 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -139.6 147.57 41.29 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.296 1.439 . . . . 0.0 108.606 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.26 155.01 23.2 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.57 138.74 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -71.98 132.22 44.0 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.49 0.662 . . . . 0.0 109.892 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -73.67 -17.4 61.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -80.54 -18.88 47.08 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 116.954 -1.498 . . . . 0.0 114.953 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 40.8 m -55.06 154.26 10.55 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 119.577 1.08 . . . . 0.0 109.974 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -69.51 -54.64 0.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.84 1.693 . . . . 0.0 111.229 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -125.16 92.85 3.72 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.512 1.925 . . . . 0.0 110.444 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -55.62 -18.34 7.54 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.512 1.925 . . . . 0.0 112.199 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.85 -35.78 77.44 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.969 1.308 . . . . 0.0 109.807 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 95.9 mt -56.51 -44.41 80.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.989 0.813 . . . . 0.0 110.123 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.4 -48.52 60.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.175 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -38.04 81.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 123.5 0.5 . . . . 0.0 110.614 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -68.34 -53.47 23.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.491 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -49.14 -46.66 45.42 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 119.328 0.967 . . . . 0.0 111.434 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.46 -50.74 72.04 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.799 0.84 . . . . 0.0 111.105 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.262 4.8 pt-20 -95.59 26.96 3.64 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -135.31 -35.51 0.82 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 110.73 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -130.17 -39.19 1.37 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 119.454 1.025 . . . . 0.0 112.453 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 12.4 tp -62.67 -58.48 7.33 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 119.504 1.047 . . . . 0.0 110.331 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 40.0 mt -78.79 60.46 2.81 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.434 1.494 . . . . 0.0 113.059 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 43.7 p -133.98 162.31 32.41 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.21 -3.22 15.94 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.734 0.813 . . . . 0.0 111.629 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -109.28 -44.3 3.96 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.247 1.419 . . . . 0.0 109.691 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.29 -50.57 21.14 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 124.924 1.249 . . . . 0.0 110.304 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.53 -38.01 85.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.054 0.927 . . . . 0.0 109.414 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -63.05 -45.43 92.26 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 124.468 1.105 . . . . 0.0 108.521 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.78 82.66 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 123.808 0.843 . . . . 0.0 111.698 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.5 t -68.9 -38.55 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -67.55 -28.96 68.24 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.496 0.589 . . . . 0.0 111.405 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -68.12 -42.55 80.06 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.0 -32.71 73.28 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -160.03 147.06 12.41 Favored Pre-proline 0 N--CA 1.467 0.379 0 C-N-CA 125.341 1.456 . . . . 0.0 108.931 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.06 123.94 9.22 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.566 2.177 . . . . 0.0 108.681 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 32.7 mt -107.1 -4.36 18.98 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.463 1.505 . . . . 0.0 112.971 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 62.05 -153.17 42.37 Favored Glycine 0 C--N 1.335 0.498 0 CA-C-N 119.23 0.923 . . . . 0.0 111.391 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.65 159.03 7.05 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.965 0.906 . . . . 0.0 112.65 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 4.1 m -125.57 155.27 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 124.072 0.949 . . . . 0.0 109.797 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.67 -36.12 62.8 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.187 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.18 105.56 0.73 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.93 1.292 . . . . 0.0 110.43 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -53.71 -38.16 63.99 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.244 1.018 . . . . 0.0 112.547 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 21.4 m -56.1 -35.02 66.56 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.626 0.77 . . . . 0.0 112.937 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -109.28 -5.87 15.73 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.187 0.995 . . . . 0.0 110.942 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -60.94 -50.0 75.19 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -58.16 -33.35 69.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.457 1.103 . . . . 0.0 111.733 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -69.62 -49.21 56.07 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.7 0.8 . . . . 0.0 109.896 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 21.1 mt -68.82 -34.15 75.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.23 -5.3 6.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.618 1.567 . . . . 0.0 112.444 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -62.11 -21.05 64.68 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.31 0.959 . . . . 0.0 109.439 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.13 142.33 26.65 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 119.266 0.939 . . . . 0.0 109.171 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.82 -30.67 84.69 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.55 2.833 . . . . 0.0 115.038 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -58.08 -36.47 72.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.303 0.956 . . . . 0.0 110.148 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.5 mp -77.89 -61.02 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.83 -54.78 7.53 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.992 0.917 . . . . 0.0 113.222 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.94 86.04 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.252 -0.905 . . . . 0.0 112.513 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 55.6 m -68.5 -33.17 73.67 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.153 0.581 . . . . 0.0 109.482 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.0 tpt -69.27 -45.37 69.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -59.12 -35.47 73.52 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 122.709 0.404 . . . . 0.0 110.093 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -62.56 -27.63 69.31 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.713 -0.617 . . . . 0.0 111.186 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -84.2 -34.65 23.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.864 0.757 . . . . 0.0 108.977 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -63.25 -47.46 82.32 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.463 1.105 . . . . 0.0 110.164 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -3.04 49.42 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.044 0.937 . . . . 0.0 113.005 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.42 174.28 41.46 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.723 1.154 . . . . 0.0 112.673 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.65 153.36 33.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.296 2.239 . . . . 0.0 110.583 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 98.9 mt -104.41 138.24 29.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 38.8 ttp -62.16 123.86 79.86 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.0 -178.04 3.89 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.055 2.503 . . . . 0.0 112.906 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -129.19 24.42 5.57 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.249 1.82 . . . . 0.0 110.429 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 20.5 pt -86.04 153.08 56.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.857 1.263 . . . . 0.0 113.101 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -72.95 -21.63 20.71 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.446 2.097 . . . . 0.0 111.935 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.55 -21.99 41.9 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.36 1.864 . . . . 0.0 111.258 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 67.7 mtp -57.09 -35.1 69.0 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.814 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 10.2 t -60.04 -49.52 77.33 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.902 1.228 . . . . 0.0 109.295 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.92 92.4 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 122.544 0.338 . . . . 0.0 110.633 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -58.64 -53.58 56.8 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.514 1.126 . . . . 0.0 110.031 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -62.66 -41.69 99.2 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.142 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -65.79 -38.32 88.7 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.253 0.479 . . . . 0.0 110.849 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.78 -57.06 5.56 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.637 1.175 . . . . 0.0 113.054 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.24 -39.59 74.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 122.922 0.489 . . . . 0.0 110.261 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -53.43 28.09 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.768 0.827 . . . . 0.0 109.037 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 27.4 m -62.4 -39.66 93.98 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.441 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.75 99.68 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.008 1.276 . . . . 0.0 112.173 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.1 -48.69 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 24.4 mm -58.39 -40.48 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 118.481 0.582 . . . . 0.0 109.494 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -61.25 -44.61 96.97 Favored 'General case' 0 CA--C 1.522 -0.121 0 O-C-N 121.206 -0.933 . . . . 0.0 110.839 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.31 -43.93 69.31 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 118.25 0.477 . . . . 0.0 110.431 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.69 89.49 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.936 0.895 . . . . 0.0 111.977 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 46.6 m -83.88 -14.54 50.88 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.199 1.0 . . . . 0.0 109.587 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 74.36 17.05 79.68 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -66.9 -31.3 71.8 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.848 1.259 . . . . 0.0 110.363 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -147.73 159.67 43.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.8 m -66.64 150.14 49.48 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.3 t -57.27 -52.72 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . 0.468 ' OD2' ' HE3' ' A' ' 189' ' ' LYS . 0.8 OUTLIER -47.35 -49.98 23.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 129.411 3.084 . . . . 0.0 111.881 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.59 -35.62 58.02 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.16 77.6 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.202 -0.936 . . . . 0.0 109.66 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.1 mp -66.59 -49.44 66.35 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.552 1.941 . . . . 0.0 108.635 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -55.39 -49.73 71.55 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.464 1.105 . . . . 0.0 108.726 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -56.92 -53.1 61.77 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.977 1.311 . . . . 0.0 109.746 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.95 -47.81 83.76 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.544 1.138 . . . . 0.0 113.56 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -60.06 -37.61 80.37 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.0 m -64.19 -37.49 87.64 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -62.6 -17.17 59.65 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.447 -1.408 . . . . 0.0 112.374 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.3 mt -98.07 -20.58 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.369 1.068 . . . . 0.0 110.733 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 80.7 p -105.77 -12.19 15.98 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.807 -1.183 . . . . 0.0 112.412 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 46.3 pttt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 117.368 -1.301 . . . . 0.0 111.06 -178.77 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.7 tptp . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.8 mt -141.37 149.17 20.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -69.34 111.79 5.47 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.48 168.2 9.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.72 1.608 . . . . 0.0 110.128 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.66 33.8 73.97 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.913 1.244 . . . . 0.0 115.072 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -145.36 172.86 12.57 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 118.372 1.086 . . . . 0.0 110.34 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.6 mt -150.56 144.77 25.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.944 2.098 . . . . 0.0 107.297 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.8 140.0 41.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.6 mt -125.12 133.0 70.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 C-N-CA 127.149 2.179 . . . . 0.0 106.558 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -122.72 136.76 54.97 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.7 mm -121.91 165.69 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.424 0.689 . . . . 0.0 110.279 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -77.98 -15.35 59.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 117.441 2.385 . . . . 0.0 117.441 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.29 -13.79 58.4 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 120.506 1.503 . . . . 0.0 116.347 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -116.92 -13.81 10.66 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.748 1.219 . . . . 0.0 111.222 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -83.81 167.87 16.68 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.845 -0.534 . . . . 0.0 110.383 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.3 72.64 2.3 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.359 1.457 . . . . 0.0 109.712 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -73.89 -28.87 61.77 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.55 -0.971 . . . . 0.0 111.664 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.12 -45.03 86.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.417 1.008 . . . . 0.0 109.2 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.43 94.88 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.8 tp -70.23 -32.56 70.49 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.638 -0.919 . . . . 0.0 110.442 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.14 80.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 117.773 -1.108 . . . . 0.0 109.41 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -59.89 -33.7 72.18 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.007 0.821 . . . . 0.0 111.456 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.4 t -68.48 -50.99 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.83 -41.9 99.68 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.232 -0.918 . . . . 0.0 114.228 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -29.69 69.37 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.42 -1.047 . . . . 0.0 110.341 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -71.03 -53.53 14.42 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -54.82 -46.55 74.58 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.699 0.227 . . . . 0.0 110.661 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.46 -28.72 70.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.92 0.888 . . . . 0.0 111.017 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -74.0 -26.61 60.54 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.446 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.25 -35.25 10.41 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 124.113 0.883 . . . . 0.0 112.176 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.5 p -101.77 -27.8 12.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.494 1.043 . . . . 0.0 113.424 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.6 -15.65 53.68 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.181 -0.949 . . . . 0.0 111.718 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.8 mm -65.74 120.6 13.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -55.9 140.34 43.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.815 0.846 . . . . 0.0 112.203 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.1 102.43 5.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.9 m -91.63 139.79 30.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.71 117.73 45.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -123.38 158.14 31.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.743 0.817 . . . . 0.0 109.337 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -124.77 67.12 50.23 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.546 1.139 . . . . 0.0 108.813 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -73.7 175.29 10.93 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.094 1.862 . . . . 0.0 108.821 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.41 -18.28 6.78 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.373 0.669 . . . . 0.0 111.063 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.34 1.33 49.31 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.731 2.012 . . . . 0.0 112.897 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.92 -23.32 2.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.126 1.37 . . . . 0.0 114.196 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -55.14 -36.1 65.41 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.439 1.096 . . . . 0.0 111.275 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -118.53 -26.33 6.22 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.578 1.551 . . . . 0.0 110.092 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -67.98 -42.88 80.14 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 117.245 -1.36 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.54 -58.5 15.17 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 120.524 1.511 . . . . 0.0 109.776 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.41 -25.99 81.71 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 121.027 1.403 . . . . 0.0 113.67 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -75.03 -54.85 6.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.631 1.105 . . . . 0.0 112.165 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.57 -40.53 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.099 0.56 . . . . 0.0 110.634 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.75 -29.45 70.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.095 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 -17.17 17.83 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.497 1.044 . . . . 0.0 113.053 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.8 t -123.26 17.5 9.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.586 0.754 . . . . 0.0 112.108 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.05 7.44 66.8 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.16 -10.68 32.41 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.193 1.496 . . . . 0.0 111.776 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.32 -177.85 34.72 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.616 1.579 . . . . 0.0 116.212 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.11 176.9 3.44 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.427 2.751 . . . . 0.0 111.084 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -108.6 -21.15 12.83 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.4 mt -136.6 148.55 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.8 tt -133.12 135.62 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.27 1.428 . . . . 0.0 108.494 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -130.15 101.06 5.64 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.651 1.58 . . . . 0.0 109.306 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -151.66 178.42 9.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.312 0.96 . . . . 0.0 109.99 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.02 154.48 39.36 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -57.77 -27.49 63.12 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.512 0.725 . . . . 0.0 109.844 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.28 -58.79 5.56 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.517 1.127 . . . . 0.0 111.556 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -69.99 -14.48 62.72 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.619 -1.301 . . . . 0.0 111.276 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.18 11.96 8.87 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.369 -0.832 . . . . 0.0 109.512 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.41 0.43 77.79 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.114 -1.381 . . . . 0.0 112.983 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.9 -27.65 0.23 Allowed Glycine 0 CA--C 1.535 1.338 0 CA-C-N 120.351 2.075 . . . . 0.0 116.576 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -56.44 -44.08 80.1 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.945 1.872 . . . . 0.0 113.401 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.71 -41.18 99.02 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.3 -0.875 . . . . 0.0 110.076 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -29.89 59.21 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.961 1.304 . . . . 0.0 110.474 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.6 m -86.62 1.05 53.21 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.702 1.201 . . . . 0.0 112.388 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.94 16.77 80.48 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.886 1.708 . . . . 0.0 110.931 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.3 mt -83.49 -11.98 56.81 Favored 'General case' 0 CA--C 1.527 0.072 0 O-C-N 121.017 -1.284 . . . . 0.0 114.018 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.7 mt -114.15 142.54 46.1 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 119.7 1.136 . . . . 0.0 111.039 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.02 -161.57 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.508 1.923 . . . . 0.0 113.316 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.3 86.43 2.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.851 1.661 . . . . 0.0 110.152 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.26 174.22 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.973 1.309 . . . . 0.0 111.933 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.9 m 61.77 82.2 0.22 Allowed Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 126.119 1.768 . . . . 0.0 110.681 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.81 -28.93 7.47 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.416 2.077 . . . . 0.0 111.377 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -139.81 165.82 26.28 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.488 1.915 . . . . 0.0 109.277 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -63.29 -34.94 78.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.638 1.175 . . . . 0.0 110.985 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.46 -43.06 44.74 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.399 1.08 . . . . 0.0 112.371 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -60.0 -33.62 72.24 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.617 -0.677 . . . . 0.0 111.483 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -69.53 -44.29 71.29 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.479 -0.763 . . . . 0.0 109.576 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -62.2 -26.38 68.32 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.418 1.087 . . . . 0.0 112.536 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -71.35 -11.52 60.95 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.042 0.937 . . . . 0.0 111.062 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 mt -126.51 164.91 20.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.202 0.91 . . . . 0.0 110.539 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -75.26 149.92 84.86 Favored Pre-proline 0 CA--C 1.544 0.742 0 O-C-N 121.514 -0.741 . . . . 0.0 110.817 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.73 -46.75 1.12 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.514 2.809 . . . . 0.0 114.789 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -61.26 -33.93 74.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.968 1.258 . . . . 0.0 111.824 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -21.81 64.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.517 0.727 . . . . 0.0 110.716 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -70.84 -37.13 73.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.317 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.44 -28.11 64.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.476 1.035 . . . . 0.0 113.141 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.72 -23.35 67.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.444 0.698 . . . . 0.0 111.787 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.1 m -120.57 6.86 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.227 1.411 . . . . 0.0 112.284 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -72.66 170.25 14.89 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.806 0.813 . . . . 0.0 108.965 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -153.26 -174.52 4.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.487 1.115 . . . . 0.0 108.048 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -73.54 107.94 6.1 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.95 -77.68 0.53 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.719 1.628 . . . . 0.0 112.835 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 174.92 2.67 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.408 1.083 . . . . 0.0 111.928 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.75 156.22 27.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.99 1.316 . . . . 0.0 109.932 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.3 pt -126.04 -17.96 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.66 178.04 4.28 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.589 1.541 . . . . 0.0 109.291 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.62 148.39 69.83 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 124.27 1.028 . . . . 0.0 110.522 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.42 148.7 38.52 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.226 3.284 . . . . 0.0 109.265 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.3 mm -130.07 -53.01 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.982 1.313 . . . . 0.0 110.898 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -130.8 156.01 45.72 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.2 t -136.11 101.86 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.3 1.04 . . . . 0.0 110.551 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -144.2 113.88 7.16 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.117 -0.989 . . . . 0.0 109.064 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -133.01 89.32 2.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.911 1.284 . . . . 0.0 112.192 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.2 162.05 17.27 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.952 2.101 . . . . 0.0 111.027 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 m -179.57 127.03 0.09 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.999 2.52 . . . . 0.0 111.202 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.6 tp -120.09 155.23 33.39 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.394 1.877 . . . . 0.0 108.516 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 88.7 mt -128.11 90.64 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -107.49 171.3 7.46 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.146 0.978 . . . . 0.0 109.359 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -54.97 166.32 0.53 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -99.78 1.04 42.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.416 1.487 . . . . 0.0 111.619 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -74.01 173.61 9.77 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.142 2.577 . . . . 0.0 110.175 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -93.39 19.22 8.55 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 35.0 tp -112.36 70.24 1.05 Allowed Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.956 1.303 . . . . 0.0 112.449 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.64 94.59 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.81 3.007 . . . . 0.0 110.984 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -128.52 72.97 80.71 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -73.44 159.16 47.02 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.088 3.192 . . . . 0.0 113.875 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.37 152.6 44.33 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.886 3.057 . . . . 0.0 110.384 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -104.64 -17.23 14.75 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.6 t -166.34 160.34 15.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.393 1.451 . . . . 0.0 108.481 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -70.1 -27.86 64.93 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 121.325 -0.859 . . . . 0.0 112.156 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -70.04 -16.11 63.11 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.138 0.881 . . . . 0.0 111.226 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -88.2 -23.98 23.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 110.544 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 40.2 mm -54.34 -58.84 12.06 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.58 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.77 -21.33 38.63 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 CA-C-N 120.429 1.189 . . . . 0.0 111.581 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.98 -36.92 64.58 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.975 1.31 . . . . 0.0 111.25 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 68.4 tp -88.23 -30.04 20.0 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.338 1.455 . . . . 0.0 110.712 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.45 -45.0 85.2 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -66.65 -33.14 74.99 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.572 0.749 . . . . 0.0 112.22 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -72.35 -44.45 62.59 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.7 mt -72.93 -33.27 65.84 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.672 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -34.75 77.26 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.62 -13.02 60.6 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 0.12 7.3 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 124.815 1.246 . . . . 0.0 111.903 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.53 -90.08 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 119.231 0.923 . . . . 0.0 114.961 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 176.22 8.88 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.146 0.978 . . . . 0.0 112.231 -177.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.95 160.68 7.51 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.852 1.261 . . . . 0.0 112.811 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.89 -71.01 0.66 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.0 0.92 . . . . 0.0 109.043 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.3 tp -106.15 135.54 47.44 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.81 1.244 . . . . 0.0 109.45 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.6 ttm -147.46 104.85 3.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -126.97 163.07 24.5 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -77.89 144.92 36.53 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.6 mt -120.56 -9.82 9.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.724 0.81 . . . . 0.0 111.87 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -69.32 -16.58 63.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -113.56 124.04 32.0 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.652 1.581 . . . . 0.0 110.81 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.09 -14.06 42.68 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.347 2.031 . . . . 0.0 114.911 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.436 ' CE2' ' HA3' ' A' ' 228' ' ' GLY . 82.0 t80 -60.83 -27.93 68.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.826 1.194 . . . . 0.0 112.258 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -88.99 -36.71 15.69 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.184 0.994 . . . . 0.0 113.194 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -86.52 -21.68 26.8 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -51.65 -54.29 41.21 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -64.91 -19.32 64.0 Favored 'Trans proline' 0 C--N 1.348 0.513 0 CA-C-N 121.163 1.451 . . . . 0.0 113.883 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.58 -57.35 3.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 46.2 pt -63.04 -29.39 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 119.213 0.915 . . . . 0.0 112.131 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.66 -20.01 66.05 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.281 0.633 . . . . 0.0 111.914 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -43.16 -60.65 1.58 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.246 1.818 . . . . 0.0 113.065 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.69 -46.37 81.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.984 0.514 . . . . 0.0 111.977 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -175.52 -23.7 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.681 0 CA-C-O 116.99 -2.005 . . . . 0.0 114.497 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -37.09 123.46 0.95 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.387 1.946 . . . . 0.0 114.089 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -139.59 140.8 37.13 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.98 -59.11 2.86 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -135.8 149.67 49.19 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 125.294 1.438 . . . . 0.0 108.691 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.419 ' HE3' ' OD2' ' A' ' 180' ' ' ASP . 10.9 tppt? -76.75 145.14 38.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.886 0.85 . . . . 0.0 109.931 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -142.21 104.83 4.51 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -74.79 -171.08 1.2 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -51.25 -20.39 1.6 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.08 22.36 0.05 OUTLIER Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.92 1.724 . . . . 0.0 111.277 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -125.5 106.27 9.66 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 118.61 1.205 . . . . 0.0 107.822 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -97.14 137.08 36.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.86 147.64 28.96 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.176 1.39 . . . . 0.0 108.808 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.79 -0.31 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.944 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.06 -42.57 69.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.419 ' OD2' ' HE3' ' A' ' 170' ' ' LYS . 56.2 t0 -90.2 107.69 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.658 1.583 . . . . 0.0 109.622 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.3 t -118.37 157.73 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.25 2.22 . . . . 0.0 107.55 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -143.39 29.7 2.02 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 118.536 0.607 . . . . 0.0 114.508 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.04 -42.93 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 C-N-CA 125.049 1.34 . . . . 0.0 111.217 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -96.12 61.45 2.09 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -117.23 154.35 31.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.231 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -48.93 -38.31 22.46 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.4 -35.56 82.27 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 118.774 0.715 . . . . 0.0 112.703 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.6 -49.0 65.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.032 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.79 -42.52 99.1 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-O 118.856 -0.592 . . . . 0.0 109.446 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.25 95.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.12 0.968 . . . . 0.0 109.81 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.13 -26.41 71.49 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.859 -0.967 . . . . 0.0 112.383 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.43 -44.46 12.73 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.262 1.031 . . . . 0.0 111.77 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.4 t -55.01 -28.5 52.52 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.023 0.829 . . . . 0.0 111.86 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -60.21 -50.91 71.78 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.6 tp -59.82 -51.92 67.65 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.721 1.208 . . . . 0.0 109.832 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 56.2 t -55.55 -30.41 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 117.429 -1.272 . . . . 0.0 109.949 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.597 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 12.7 t0 -66.58 -44.52 82.03 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 120.431 1.469 . . . . 0.0 111.857 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.6 mt -66.66 -40.04 88.46 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 83.9 mt -66.01 -36.44 77.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.597 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -60.95 -46.82 89.18 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.116 1.367 . . . . 0.0 108.247 178.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -79.22 -2.32 40.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.157 0.983 . . . . 0.0 110.703 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt 55.38 1.56 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 130.126 3.37 . . . . 0.0 116.636 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -66.36 -26.94 67.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 11.1 ttt -81.64 141.39 33.71 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -79.57 77.91 6.14 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.0 -5.0 18.98 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.04 1.736 . . . . 0.0 114.176 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -94.67 -20.96 19.1 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 128.0 2.52 . . . . 0.0 111.457 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.2 m -58.14 137.2 57.17 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.061 0.945 . . . . 0.0 110.58 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -130.78 -178.82 4.97 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 127.481 2.312 . . . . 0.0 106.195 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -54.87 -44.79 74.36 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -46.74 88.6 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 123.694 0.798 . . . . 0.0 110.4 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.6 mt -67.37 -48.99 75.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.926 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.39 76.96 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.956 0.798 . . . . 0.0 110.485 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.03 -46.44 65.04 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.34 -55.19 34.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.008 0.923 . . . . 0.0 110.178 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.79 -49.93 61.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.818 2.047 . . . . 0.0 109.86 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -61.69 -38.15 86.76 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.853 -0.529 . . . . 0.0 110.524 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -63.87 -11.03 24.02 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.75 0.82 . . . . 0.0 112.167 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -111.6 -8.13 14.24 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.188 1.795 . . . . 0.0 112.128 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.01 27.79 25.1 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.457 1.027 . . . . 0.0 111.79 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -87.48 -0.35 56.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.289 1.045 . . . . 0.0 112.424 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.8 p -138.84 160.49 39.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.914 0.886 . . . . 0.0 109.274 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -117.24 -19.62 9.55 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.395 1.078 . . . . 0.0 109.544 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -159.2 164.91 34.68 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.952 0.901 . . . . 0.0 111.693 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.6 t -165.78 174.03 10.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.826 2.45 . . . . 0.0 106.975 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 41.6 mt -147.76 121.27 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -108.97 154.68 21.82 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.003 1.721 . . . . 0.0 106.855 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.436 ' HA3' ' CE2' ' A' ' 155' ' ' TYR . . . -62.4 174.64 7.71 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 123.935 0.779 . . . . 0.0 113.456 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -67.77 166.97 22.53 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.216 2.611 . . . . 0.0 112.727 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -74.82 62.01 1.06 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.728 1.611 . . . . 0.0 110.13 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.36 -171.81 2.92 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.59 1.156 . . . . 0.0 110.953 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -61.08 120.9 11.17 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.841 1.256 . . . . 0.0 108.686 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.7 t -148.3 172.6 14.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.696 1.198 . . . . 0.0 109.878 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -89.62 -2.81 58.42 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.85 1.66 . . . . 0.0 112.069 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 7.4 tp -145.82 153.71 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.199 1.4 . . . . 0.0 107.936 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.92 156.08 39.22 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.957 1.303 . . . . 0.0 109.992 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.7 135.32 38.8 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.504 1.522 . . . . 0.0 108.972 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 28.2 t -74.69 158.67 33.19 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.844 1.257 . . . . 0.0 110.883 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -124.79 7.6 8.13 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.095 1.758 . . . . 0.0 110.712 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . 0.256 10.4 t -64.2 -11.07 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 O-C-N 121.252 -0.905 . . . . 0.0 111.94 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -126.67 147.67 49.91 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.487 1.494 . . . . 0.0 110.245 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -148.98 112.6 5.06 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 102.63 -3.1 . . . . 0.0 102.63 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 163.72 70.32 0.02 OUTLIER Glycine 0 CA--C 1.521 0.442 0 CA-C-N 119.316 0.962 . . . . 0.0 111.941 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 11.0 p -35.02 117.18 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 128.179 2.591 . . . . 0.0 112.786 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.6 t -162.24 176.94 10.08 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.859 -0.526 . . . . 0.0 110.149 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.482 HG13 ' H ' ' A' ' 247' ' ' LEU . 4.5 t -81.84 -169.29 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.48 1.912 . . . . 0.0 107.018 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.482 ' H ' HG13 ' A' ' 246' ' ' VAL . 0.3 OUTLIER -142.05 163.32 40.83 Favored Pre-proline 0 CA--C 1.537 0.449 0 O-C-N 119.597 -1.94 . . . . 0.0 107.191 178.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.2 149.73 64.53 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 60.6 p -124.28 167.49 14.26 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -73.54 153.5 40.24 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -64.82 135.0 55.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.68 -11.23 10.66 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 117.62 -1.655 . . . . 0.0 115.425 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.2 124.32 5.32 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 120.693 2.246 . . . . 0.0 113.591 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.48 146.22 34.69 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.146 2.564 . . . . 0.0 110.86 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.1 m -66.81 157.94 31.7 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -133.6 100.28 13.73 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.62 -175.76 2.74 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.73 2.287 . . . . 0.0 110.638 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -82.57 176.24 9.54 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.096 1.758 . . . . 0.0 108.878 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.8 149.03 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.16 -0.962 . . . . 0.0 108.713 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -162.7 110.84 0.45 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 104.341 -3.504 . . . . 0.0 104.341 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 26.4 m -133.11 137.05 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 119.761 1.781 . . . . 0.0 111.213 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.49 138.32 57.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 m -124.37 148.41 47.55 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.864 0.866 . . . . 0.0 110.269 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.11 139.39 52.53 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 123.461 0.704 . . . . 0.0 109.449 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -137.16 164.16 25.31 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.59 1.09 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 61.9 mt -113.31 136.18 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -67.48 117.61 9.67 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.95 -22.23 64.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 118.475 -0.774 . . . . 0.0 112.642 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -74.62 -13.27 60.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 72.5 m -59.99 155.28 44.41 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 118.819 0.736 . . . . 0.0 109.597 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.92 -60.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.514 1.476 . . . . 0.0 110.117 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -108.9 88.43 2.72 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -54.7 -23.72 18.84 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.4 1.08 . . . . 0.0 111.169 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -64.82 -31.28 72.44 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.848 1.259 . . . . 0.0 112.235 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.76 -40.28 83.44 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.048 -1.033 . . . . 0.0 109.402 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.88 -42.94 63.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.53 -0.747 . . . . 0.0 111.407 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -34.92 79.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.718 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -70.84 -56.12 7.01 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -48.78 -49.09 40.3 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 119.18 0.9 . . . . 0.0 110.854 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.7 tt -62.31 -45.83 91.45 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.006 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -79.21 -18.54 52.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.744 -1.223 . . . . 0.0 114.148 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -90.34 -33.88 15.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 117.612 -1.185 . . . . 0.0 112.344 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -137.52 -23.24 1.1 Allowed 'General case' 0 C--N 1.347 0.457 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.01 -50.89 13.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.184 1.356 . . . . 0.0 109.09 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.47 67.27 9.28 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.63 1.572 . . . . 0.0 109.47 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.8 p -144.12 166.22 25.62 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -67.42 -41.36 84.96 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -73.42 -29.75 62.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.323 1.049 . . . . 0.0 111.092 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.79 -51.19 11.63 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.987 1.279 . . . . 0.0 110.036 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 27.8 mt -59.85 -45.28 92.92 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.64 -45.85 84.91 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.359 1.064 . . . . 0.0 109.793 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.56 -44.4 89.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.6 1.091 . . . . 0.0 112.292 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.6 t -72.59 -34.35 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.657 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -68.2 -38.02 81.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.233 1.413 . . . . 0.0 110.319 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -60.47 -43.9 96.44 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.44 1.496 . . . . 0.0 110.252 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.26 -43.88 69.62 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.482 0.313 . . . . 0.0 111.484 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -151.69 152.27 30.02 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 124.808 1.243 . . . . 0.0 108.389 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.11 137.13 73.53 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.771 2.981 . . . . 0.0 113.92 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 23.2 mt -124.0 -7.39 7.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.574 1.549 . . . . 0.0 112.958 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 65.26 -131.56 35.67 Favored Glycine 0 N--CA 1.464 0.559 0 C-N-CA 126.068 1.794 . . . . 0.0 112.186 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.62 177.41 8.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 17.9 m -135.44 153.67 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 O-C-N 120.626 -1.296 . . . . 0.0 110.434 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.27 -26.93 56.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.494 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.85 106.7 1.96 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -54.94 -31.87 60.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 57.8 m -68.59 -52.8 27.67 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.612 1.096 . . . . 0.0 111.064 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -72.14 -17.64 61.94 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.152 0.433 . . . . 0.0 110.664 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -61.7 -39.35 91.17 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -62.71 -39.83 95.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.708 0.685 . . . . 0.0 111.413 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -66.19 -49.99 65.42 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.683 1.193 . . . . 0.0 109.837 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.54 -34.45 74.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.679 -0.677 . . . . 0.0 110.135 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.13 -2.85 4.59 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.513 1.525 . . . . 0.0 112.469 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -58.13 -14.46 6.91 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.647 1.112 . . . . 0.0 110.387 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.95 145.5 52.2 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 124.914 1.286 . . . . 0.0 109.194 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.57 -17.56 43.22 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.692 2.261 . . . . 0.0 113.138 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -59.87 -48.52 81.34 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.6 mp -68.33 -57.73 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.449 1.1 . . . . 0.0 108.255 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.6 -43.38 62.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.31 -35.73 81.14 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 120.402 1.456 . . . . 0.0 112.407 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.7 m -65.43 -37.25 86.37 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 7.2 tpt -61.55 -49.5 76.44 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -61.0 -27.95 68.69 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.71 1.204 . . . . 0.0 113.464 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -76.75 -42.77 39.74 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -67.16 -32.07 72.91 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -62.1 -49.38 76.16 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.601 0.637 . . . . 0.0 110.189 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -5.72 59.1 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.591 1.156 . . . . 0.0 113.92 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -82.17 178.91 53.41 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-O 122.991 1.329 . . . . 0.0 113.6 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -110.45 128.11 55.44 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 128.903 2.881 . . . . 0.0 107.793 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 11.4 mt -92.4 94.77 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 12.3 ptp 38.58 83.96 0.19 Allowed Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 127.776 2.431 . . . . 0.0 111.88 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -66.44 85.71 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.679 2.919 . . . . 0.0 111.391 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -78.4 65.35 3.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.553 1.941 . . . . 0.0 108.905 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.8 pt -130.35 144.18 52.22 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 120.558 -1.339 . . . . 0.0 112.247 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.86 -15.29 37.31 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.341 2.694 . . . . 0.0 114.634 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -80.22 -18.28 49.96 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.462 -0.774 . . . . 0.0 110.864 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 59.6 mmm -70.22 -34.43 72.89 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.123 -0.986 . . . . 0.0 111.565 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.3 p -66.1 -42.31 89.42 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.338 -1.476 . . . . 0.0 108.522 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.61 -46.35 88.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -51.7 -51.46 55.86 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.841 1.656 . . . . 0.0 110.254 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -59.06 -36.2 74.65 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.024 -1.047 . . . . 0.0 113.18 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -76.26 -42.17 46.55 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.172 0.51 . . . . 0.0 109.835 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.8 72.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.442 1.497 . . . . 0.0 110.903 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 44.7 t -68.53 -46.25 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 117.223 -1.37 . . . . 0.0 111.483 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -55.76 -42.55 75.61 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 121.391 1.905 . . . . 0.0 108.832 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 20.0 m -65.0 -44.88 87.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.02 0.528 . . . . 0.0 109.751 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -56.91 -37.26 71.2 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.311 -0.868 . . . . 0.0 112.193 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 71.2 t -69.27 -58.79 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.2 mm -53.45 -46.62 59.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.86 0.864 . . . . 0.0 111.47 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -51.84 -49.68 62.38 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 121.924 -0.485 . . . . 0.0 110.842 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -77.95 -37.66 47.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.25 71.24 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.189 0.904 . . . . 0.0 110.69 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.3 m -94.74 -9.22 35.34 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.442 1.097 . . . . 0.0 110.593 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.51 14.79 82.11 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 118.843 0.747 . . . . 0.0 112.695 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -64.16 -40.06 95.34 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -147.75 154.64 40.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.1 m -61.77 155.14 23.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.826 1.25 . . . . 0.0 111.449 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.97 -53.02 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.201 1.0 . . . . 0.0 109.063 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.83 -50.12 61.49 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.844 2.057 . . . . 0.0 111.549 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -70.52 -42.51 71.15 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.951 1.301 . . . . 0.0 112.166 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.18 77.12 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.566 -0.709 . . . . 0.0 110.426 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.2 mp -72.69 -43.96 62.4 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.047 0.939 . . . . 0.0 109.243 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -54.45 -48.67 71.47 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.21 -34.3 74.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.304 1.042 . . . . 0.0 111.105 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.94 -48.36 66.14 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.825 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -52.16 -39.88 60.63 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.572 0.749 . . . . 0.0 109.746 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.4 m -62.46 -24.82 67.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.461 0.704 . . . . 0.0 112.184 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -81.5 -15.48 54.81 Favored 'General case' 0 C--O 1.226 -0.145 0 O-C-N 120.603 -1.311 . . . . 0.0 111.409 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.5 mt -98.16 -31.45 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.782 1.633 . . . . 0.0 110.398 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 3.2 p -81.55 -17.99 46.5 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.879 -0.513 . . . . 0.0 111.145 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt . . . . . 0 C--O 1.251 1.178 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 177.446 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.1 mm -62.26 138.83 21.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 O-C-N 125.175 1.547 . . . . 0.0 108.762 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -95.28 137.28 34.55 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.38 162.18 14.91 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.1 41.88 99.71 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.231 0.923 . . . . 0.0 115.037 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -149.18 169.22 21.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.33 1.052 . . . . 0.0 109.844 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.0 mt -146.19 135.85 23.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.616 1.567 . . . . 0.0 108.208 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.0 t -127.21 136.84 59.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.0 mt -135.71 142.11 40.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.888 1.275 . . . . 0.0 109.393 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -120.54 154.41 35.37 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.0 mm -116.52 147.29 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.913 2.085 . . . . 0.0 106.104 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.4 118.07 5.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.502 1.121 . . . . 0.0 109.916 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.46 20.3 6.26 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.576 -1.125 . . . . 0.0 112.86 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 53.75 30.55 11.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.296 1.838 . . . . 0.0 111.155 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -58.35 172.11 0.51 Allowed 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 127.672 2.389 . . . . 0.0 114.194 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.85 50.85 1.2 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.676 2.084 . . . . 0.0 113.474 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -56.14 -30.4 62.11 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.475 1.11 . . . . 0.0 111.467 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -58.19 -30.6 66.56 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.233 1.013 . . . . 0.0 111.42 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.56 -33.96 17.78 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.6 tp -71.75 -31.18 66.39 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.257 1.423 . . . . 0.0 112.711 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.8 86.01 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.33 1.052 . . . . 0.0 109.889 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -58.89 -37.82 77.47 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.368 1.867 . . . . 0.0 110.287 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 95.0 t -70.09 -48.34 62.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.528 1.131 . . . . 0.0 109.2 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.2 -43.54 99.26 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.755 -0.591 . . . . 0.0 111.722 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -33.27 71.24 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 121.687 -0.89 . . . . 0.0 111.05 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -63.88 -53.02 57.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -56.7 -43.02 80.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.046 0.839 . . . . 0.0 110.774 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -13.42 58.61 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.698 1.199 . . . . 0.0 110.821 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HZ1' ' HA ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -101.34 -14.94 17.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.619 -1.926 . . . . 0.0 111.86 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -105.79 -10.93 16.46 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.062 0.851 . . . . 0.0 109.95 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.0 p -130.45 -35.16 1.54 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.488 1.115 . . . . 0.0 112.346 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.64 -13.31 67.45 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.384 -0.823 . . . . 0.0 111.229 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.4 mm -64.3 130.92 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.74 145.55 54.54 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.646 1.179 . . . . 0.0 110.719 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.8 t -140.27 126.7 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.5 m -114.97 141.77 47.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.074 1.35 . . . . 0.0 108.257 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.25 121.31 45.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 126.022 1.729 . . . . 0.0 106.682 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -140.35 157.77 45.04 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.702 0.683 . . . . 0.0 109.651 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -126.38 71.03 71.06 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.407 1.083 . . . . 0.0 111.748 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.68 165.75 30.85 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.463 2.775 . . . . 0.0 111.526 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.56 5.24 15.42 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.774 1.63 . . . . 0.0 110.214 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.52 2.58 7.64 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.457 1.103 . . . . 0.0 113.481 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -52.62 -24.93 9.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.419 1.009 . . . . 0.0 113.677 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.48 -24.32 65.17 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.444 1.098 . . . . 0.0 112.284 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -120.53 -22.16 6.52 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.002 1.321 . . . . 0.0 110.175 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -47.59 26.05 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 117.575 -1.202 . . . . 0.0 109.407 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -48.25 -58.21 8.62 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 120.328 1.422 . . . . 0.0 111.157 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.03 -18.2 63.97 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 121.857 1.705 . . . . 0.0 114.187 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -92.87 -1.11 57.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.909 1.284 . . . . 0.0 112.927 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 t -128.13 -37.74 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 120.287 1.403 . . . . 0.0 110.268 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.83 77.62 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.864 -0.588 . . . . 0.0 111.996 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.05 73.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.413 0.551 . . . . 0.0 110.764 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -77.11 -43.73 33.09 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.847 -0.533 . . . . 0.0 110.809 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.92 19.2 4.89 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -114.82 3.53 14.66 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.261 1.031 . . . . 0.0 111.705 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.32 -170.07 26.84 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.805 1.669 . . . . 0.0 113.82 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.15 178.15 7.31 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.822 2.348 . . . . 0.0 111.916 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -99.99 -24.36 14.65 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 120.593 -1.317 . . . . 0.0 111.526 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.2 mt -140.08 156.37 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 124.832 1.253 . . . . 0.0 107.904 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 tt -142.9 147.27 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.398 1.479 . . . . 0.0 107.863 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -140.05 107.26 5.49 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.635 1.174 . . . . 0.0 110.187 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.402 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 41.5 t-105 -153.0 -165.88 2.3 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.838 1.199 . . . . 0.0 110.576 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 62' ' ' TRP . . . -73.44 147.81 43.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.061 1.344 . . . . 0.0 110.163 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -61.04 -27.38 68.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.239 0.542 . . . . 0.0 112.116 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -58.87 -31.43 68.56 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -104.33 -6.0 21.24 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.473 0.579 . . . . 0.0 109.796 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.16 -35.57 61.6 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.434 0.694 . . . . 0.0 111.267 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.89 -4.64 59.26 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.83 -60.78 1.4 Allowed Glycine 0 C--N 1.336 0.556 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -51.85 -43.47 63.22 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.082 0.953 . . . . 0.0 113.208 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.9 -46.34 85.31 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 119.211 0.914 . . . . 0.0 111.266 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -48.86 70.74 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.1 m -61.06 -14.39 23.4 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.532 1.533 . . . . 0.0 112.909 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.45 24.65 33.0 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 124.578 1.085 . . . . 0.0 112.548 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.23 6.97 44.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.3 1.05 . . . . 0.0 113.241 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 98.6 mt -128.88 138.64 52.14 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 120.076 -1.64 . . . . 0.0 108.345 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.5 160.16 28.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.03 101.31 0.12 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.171 2.189 . . . . 0.0 106.459 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -67.0 152.7 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 122.086 0.946 . . . . 0.0 111.77 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.3 m 56.22 93.91 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 129.889 3.276 . . . . 0.0 115.574 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.74 -41.66 10.43 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.805 1.67 . . . . 0.0 110.909 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -131.07 142.64 50.31 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.905 0.882 . . . . 0.0 112.912 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -44.76 -43.18 8.35 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 128.073 2.549 . . . . 0.0 116.994 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.01 -34.03 12.35 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.24 1.382 . . . . 0.0 114.698 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -64.55 -25.36 67.95 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.456 -0.778 . . . . 0.0 111.338 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -72.04 -44.88 62.66 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -61.85 -22.68 65.72 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.789 1.236 . . . . 0.0 112.261 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -75.4 -13.74 60.42 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.477 1.111 . . . . 0.0 112.25 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mt -124.38 154.51 40.27 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.159 0.891 . . . . 0.0 112.838 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -69.98 146.87 95.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.95 -41.39 7.74 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.173 2.582 . . . . 0.0 114.124 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -59.72 -37.21 78.29 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.138 0.881 . . . . 0.0 111.629 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -26.2 66.69 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.268 1.027 . . . . 0.0 111.56 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -73.74 -30.98 63.13 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 121.471 -0.768 . . . . 0.0 111.387 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.0 -29.33 65.19 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.208 0.913 . . . . 0.0 111.919 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.64 -16.91 63.5 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.524 1.129 . . . . 0.0 112.978 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 m -132.23 18.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.666 1.586 . . . . 0.0 112.167 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -70.65 165.54 22.67 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 122.275 1.036 . . . . 0.0 110.509 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -152.33 -177.02 5.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.419 1.488 . . . . 0.0 107.155 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -69.71 102.02 1.8 Allowed 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.21 -81.53 0.47 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.447 1.499 . . . . 0.0 112.323 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.91 170.26 4.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.393 0.596 . . . . 0.0 109.595 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.94 162.03 13.94 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.86 0.864 . . . . 0.0 109.432 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 37.7 pt -123.67 -14.58 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.182 0.993 . . . . 0.0 112.599 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.3 175.4 4.89 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.04 1.736 . . . . 0.0 107.977 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -134.3 148.29 67.14 Favored Pre-proline 0 C--O 1.242 0.684 0 C-N-CA 124.83 1.252 . . . . 0.0 111.58 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.02 143.7 26.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.301 2.668 . . . . 0.0 108.267 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.3 mm -134.42 -52.08 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 C-N-CA 125.128 1.371 . . . . 0.0 109.773 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.42 148.86 44.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.507 0.723 . . . . 0.0 111.008 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.1 t -137.82 110.37 7.04 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.116 0 C-N-CA 123.478 0.711 . . . . 0.0 110.106 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -146.83 138.55 24.43 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -125.43 85.09 2.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.315 1.846 . . . . 0.0 111.759 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.3 pp -171.92 167.24 6.25 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.896 1.278 . . . . 0.0 111.17 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.1 t 177.59 160.59 0.48 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 128.544 2.737 . . . . 0.0 106.289 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.7 tp -161.26 139.52 9.56 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.1 mt -122.41 138.69 51.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -149.33 -179.58 7.17 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.342 1.057 . . . . 0.0 111.196 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -60.81 167.93 2.56 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.749 2.02 . . . . 0.0 111.813 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.36 3.62 2.18 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -77.97 168.09 20.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.866 1.666 . . . . 0.0 110.482 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -75.6 -11.18 59.96 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.594 -1.316 . . . . 0.0 111.907 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.6 tp 45.22 71.61 1.48 Allowed Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 128.111 2.565 . . . . 0.0 110.326 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -73.47 -17.3 23.84 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.146 2.564 . . . . 0.0 112.442 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -124.58 68.63 52.2 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 124.624 1.17 . . . . 0.0 108.614 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.31 159.11 47.56 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.959 2.439 . . . . 0.0 111.737 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.98 162.02 44.11 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.699 2.266 . . . . 0.0 109.781 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -132.27 -25.01 2.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.046 1.338 . . . . 0.0 112.091 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.6 t -147.75 152.58 37.98 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.569 1.077 . . . . 0.0 109.337 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -67.34 -15.85 63.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.28 -24.41 61.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.846 1.203 . . . . 0.0 112.329 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -86.41 -16.26 37.78 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 118.292 0.497 . . . . 0.0 110.691 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.66 -57.12 29.04 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 124.775 1.23 . . . . 0.0 107.988 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.25 -24.76 31.64 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 CA-C-N 120.804 1.323 . . . . 0.0 111.023 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.09 -52.7 38.67 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.18 -26.16 68.03 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.187 0.995 . . . . 0.0 109.838 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.37 -41.25 89.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.098 0.863 . . . . 0.0 111.25 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -75.67 -31.16 59.65 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.936 -0.477 . . . . 0.0 110.376 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -70.49 -46.75 63.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 42.2 mt -74.01 -32.44 63.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.766 -1.111 . . . . 0.0 110.294 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -67.88 -36.32 80.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 120.54 1.518 . . . . 0.0 108.707 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.69 -9.78 15.85 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.41 0.684 . . . . 0.0 112.796 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.56 11.27 2.29 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.321 1.449 . . . . 0.0 111.829 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.01 -111.95 0.32 Allowed Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -142.46 -170.25 3.15 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.488 1.915 . . . . 0.0 110.558 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 p -52.38 148.69 6.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.17 1.788 . . . . 0.0 112.802 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.09 -57.0 3.95 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.64 1.176 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.11 146.23 29.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.012 1.725 . . . . 0.0 107.604 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.7 ttm -145.88 105.76 4.0 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -138.23 163.47 31.66 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -72.18 91.81 1.31 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.273 1.429 . . . . 0.0 112.452 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -16.69 61.44 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.212 1.405 . . . . 0.0 109.188 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -75.37 -9.47 58.59 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.991 0.916 . . . . 0.0 112.358 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -119.47 123.34 28.74 Favored Pre-proline 0 C--N 1.34 0.19 0 C-N-CA 124.029 0.932 . . . . 0.0 108.728 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.01 -10.55 27.47 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.714 2.276 . . . . 0.0 115.749 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -61.07 -37.64 83.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -90.13 -23.5 21.34 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.335 0.516 . . . . 0.0 112.179 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.7 p -83.59 -25.87 30.51 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.146 0.43 . . . . 0.0 110.363 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -55.44 -55.87 35.27 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.204 -0.903 . . . . 0.0 112.608 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -62.66 -21.01 72.51 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.62 1.547 . . . . 0.0 112.071 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.2 tp -70.93 -59.48 2.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 25.3 pt -64.74 -30.8 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 117.573 -1.203 . . . . 0.0 113.793 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.68 -4.34 11.82 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 120.822 1.646 . . . . 0.0 113.883 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.35 -50.24 65.45 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.468 1.107 . . . . 0.0 113.801 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.97 -44.57 97.16 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 120.803 -1.186 . . . . 0.0 111.644 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 175.35 13.28 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.807 -0.996 . . . . 0.0 115.248 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.52 151.46 48.72 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 118.78 1.29 . . . . 0.0 111.624 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -164.25 151.34 11.69 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.31 -55.46 3.66 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -141.93 167.83 21.21 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.468 0.707 . . . . 0.0 112.038 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -101.12 155.23 18.12 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.936 0.874 . . . . 0.0 108.691 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -155.56 118.87 4.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.613 1.565 . . . . 0.0 107.574 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -92.58 67.72 4.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 33.6 47.6 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.391 2.276 . . . . 0.0 115.232 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.51 -18.91 1.67 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 126.157 1.837 . . . . 0.0 112.057 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -117.97 106.19 12.68 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.13 128.91 34.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -132.0 88.69 2.58 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-O 123.705 1.716 . . . . 0.0 109.512 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -5.2 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.306 1.443 . . . . 0.0 114.06 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -70.01 -40.39 75.29 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 120.11 1.323 . . . . 0.0 108.25 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -76.76 108.05 9.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.2 t -129.08 140.32 49.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -129.63 16.92 5.57 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 118.283 -1.287 . . . . 0.0 115.676 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.13 -13.99 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.164 1.982 . . . . 0.0 115.341 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -119.12 10.15 12.0 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 120.841 -1.162 . . . . 0.0 111.083 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -65.38 155.75 34.4 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -49.08 -35.66 16.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.562 0.745 . . . . 0.0 112.198 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.27 -40.13 98.61 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 119.878 1.217 . . . . 0.0 114.055 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.91 -52.1 52.85 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.622 1.211 . . . . 0.0 109.189 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -63.0 -39.9 96.14 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 119.095 -0.479 . . . . 0.0 110.598 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.78 65.61 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.72 0.808 . . . . 0.0 111.92 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -94.14 -34.76 6.3 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 31.5 tp -70.72 -40.13 72.97 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.481 0.712 . . . . 0.0 111.269 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.4 t -50.55 -45.76 57.12 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 116.672 -1.633 . . . . 0.0 109.848 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -55.64 -56.75 16.71 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 120.547 1.521 . . . . 0.0 111.054 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 64.6 tp -56.04 -49.36 73.94 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.583 0.753 . . . . 0.0 110.934 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.07 -27.89 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.135 0.974 . . . . 0.0 110.895 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.12 -40.16 96.79 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.998 1.319 . . . . 0.0 110.135 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 9.7 mt -66.23 -45.52 80.38 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.28 -40.6 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.458 1.103 . . . . 0.0 108.891 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -56.62 -37.48 70.77 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.779 -1.2 . . . . 0.0 109.588 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -88.27 -4.17 58.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.767 1.627 . . . . 0.0 112.268 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 56.65 14.51 1.77 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.5 2.32 . . . . 0.0 113.758 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -83.42 -5.31 59.11 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.381 -0.825 . . . . 0.0 111.251 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.7 tpt -109.07 154.59 22.04 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.726 0.81 . . . . 0.0 111.382 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -76.18 71.09 2.89 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 108.767 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.3 -10.66 59.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.324 1.05 . . . . 0.0 112.003 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -85.85 -15.84 40.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 129.517 3.127 . . . . 0.0 115.086 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 12.4 m -67.16 127.76 33.82 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.03 1.332 . . . . 0.0 113.244 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -122.24 -178.37 3.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -62.47 -31.63 72.4 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.258 -0.901 . . . . 0.0 113.002 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 t -64.98 -48.8 72.7 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.223 1.009 . . . . 0.0 109.842 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 13.8 mm -61.39 -47.9 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.783 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.68 -52.74 59.34 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.428 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.96 -44.31 94.5 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.62 1.1 . . . . 0.0 110.164 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.81 -54.2 45.42 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.601 0.36 . . . . 0.0 110.35 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.9 79.36 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.655 0.661 . . . . 0.0 111.556 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.85 -44.72 92.29 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -59.22 -42.17 90.37 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -68.45 -27.72 66.42 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.219 -0.925 . . . . 0.0 111.717 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.68 63.48 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.57 1.557 . . . . 0.0 111.948 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.15 -60.85 2.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.442 1.497 . . . . 0.0 111.503 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.2 t -69.04 151.29 46.66 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.67 -26.92 13.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.305 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -130.29 158.66 39.19 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 3.1 t -173.23 -179.72 2.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.09 2.156 . . . . 0.0 108.424 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 63.4 mt -149.11 131.32 5.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -137.63 166.89 22.84 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.86 75.1 0.97 Allowed Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.11 -72.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.846 3.03 . . . . 0.0 110.044 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -69.26 -17.12 63.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.197 0.599 . . . . 0.0 111.996 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 74.94 -1.34 3.11 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.542 2.737 . . . . 0.0 113.567 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -70.69 167.25 19.07 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.232 0.924 . . . . 0.0 109.654 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 70.5 m -65.48 109.26 2.26 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.42 HD22 ' HB2' ' A' ' 236' ' ' ASP . 15.8 t30 -146.3 162.77 37.4 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 126.387 1.875 . . . . 0.0 106.896 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 20.9 mt -133.86 -49.82 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . 0.42 ' HB2' HD22 ' A' ' 234' ' ' ASN . 4.4 t70 59.06 29.63 19.24 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.995 1.318 . . . . 0.0 111.546 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 30.9 m 69.8 -6.95 0.97 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.814 1.646 . . . . 0.0 111.697 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 11.7 m -80.03 173.4 12.63 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.721 1.609 . . . . 0.0 110.61 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -138.92 119.5 13.98 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.8 172.29 12.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 123.404 0.682 . . . . 0.0 109.894 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -119.23 141.84 48.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.411 1.085 . . . . 0.0 109.458 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -71.15 160.81 32.2 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 174.67 144.88 5.08 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.778 0.704 . . . . 0.0 112.089 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.35 119.31 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 126.01 1.724 . . . . 0.0 107.918 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.4 t -157.93 176.84 12.03 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.959 1.304 . . . . 0.0 107.581 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.09 125.2 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -101.77 153.41 37.96 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.65 152.77 79.99 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.324 2.016 . . . . 0.0 111.75 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 69.8 p -119.6 171.45 8.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.245 1.418 . . . . 0.0 111.033 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -84.81 158.97 20.51 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -59.11 122.94 15.04 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 120.82 -1.175 . . . . 0.0 109.762 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 71.01 7.74 63.04 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 117.712 -1.605 . . . . 0.0 114.215 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.38 127.02 6.08 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 121.269 2.535 . . . . 0.0 112.574 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.02 161.13 47.13 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.728 2.952 . . . . 0.0 113.693 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 89.4 p -83.24 139.3 33.19 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.829 0.852 . . . . 0.0 108.77 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -132.77 76.17 71.52 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.831 1.652 . . . . 0.0 107.967 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -77.01 -170.32 0.9 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.324 3.349 . . . . 0.0 112.139 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -54.03 155.73 3.36 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.982 0.913 . . . . 0.0 110.869 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 33.5 t -94.38 106.24 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -98.87 147.5 18.52 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.37 127.18 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.83 158.7 35.04 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.1 m -131.05 140.66 50.11 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 120.917 -1.114 . . . . 0.0 110.551 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.4 128.2 40.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.967 1.707 . . . . 0.0 107.407 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.61 160.45 24.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 58.8 mt -95.16 130.11 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -77.51 133.34 38.58 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -82.46 -5.02 58.44 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -62.33 -31.05 71.62 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 49.7 m -78.5 157.15 77.79 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.156 1.782 . . . . 0.0 112.564 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.32 -59.64 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.028 3.152 . . . . 0.0 113.335 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -104.68 98.84 8.53 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -13.76 61.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.758 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -59.81 -41.04 90.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.251 1.42 . . . . 0.0 109.926 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.75 -39.49 84.96 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.3 -44.44 62.71 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.942 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -29.72 68.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.046 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -79.46 -49.92 11.56 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.94 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -55.93 -45.38 78.77 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.889 1.677 . . . . 0.0 109.726 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.36 -30.03 70.89 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.102 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -99.26 -17.4 18.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 120.337 1.426 . . . . 0.0 114.55 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -84.11 -35.9 23.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.899 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -139.23 -32.37 0.66 Allowed 'General case' 0 C--N 1.344 0.329 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -21.2 63.46 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.6 1.545 . . . . 0.0 112.002 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 57.6 mt -110.35 41.6 1.72 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.825 1.65 . . . . 0.0 109.837 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.0 p -128.47 160.08 33.43 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.4 -38.59 66.39 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -68.68 -43.79 75.36 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.33 -42.22 66.05 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.32 -43.04 92.25 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.636 1.174 . . . . 0.0 110.213 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.33 -43.53 90.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.68 -43.63 80.65 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.101 0.961 . . . . 0.0 112.323 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.7 t -71.3 -39.94 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.46 1.027 . . . . 0.0 108.341 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -62.26 -35.43 78.94 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.026 0.531 . . . . 0.0 111.215 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -60.91 -47.95 84.06 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 121.283 -0.885 . . . . 0.0 109.695 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -41.05 66.54 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -143.98 148.33 41.62 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.01 131.29 23.49 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.594 2.196 . . . . 0.0 111.809 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 24.6 mt -119.35 -17.8 8.72 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.723 0.809 . . . . 0.0 112.592 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 70.06 -150.75 49.33 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 119.629 1.104 . . . . 0.0 110.69 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -65.53 167.82 8.31 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.525 1.53 . . . . 0.0 112.206 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.03 165.43 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 124.05 1.881 . . . . 0.0 111.086 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.58 -23.11 29.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.055 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.02 107.71 6.38 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 125.177 1.391 . . . . 0.0 110.57 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -61.1 1.87 0.15 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.192 1.397 . . . . 0.0 114.676 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.7 m -95.97 -67.75 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -68.62 -22.33 64.43 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.86 0.755 . . . . 0.0 111.263 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -62.67 -32.16 73.18 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 118.955 0.798 . . . . 0.0 109.186 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.89 -34.11 77.61 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.005 1.275 . . . . 0.0 110.244 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -79.18 -42.31 26.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.771 1.228 . . . . 0.0 110.45 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 19.3 mt -68.15 -39.31 82.67 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.07 -7.85 10.04 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.78 1.232 . . . . 0.0 112.361 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -62.44 -30.27 71.12 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.188 -0.945 . . . . 0.0 108.677 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.6 142.06 25.34 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 124.238 1.015 . . . . 0.0 108.934 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.74 -25.2 46.52 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.524 2.15 . . . . 0.0 113.138 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -58.47 -49.8 76.03 Favored 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.01 -42.01 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.334 1.054 . . . . 0.0 109.05 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.66 -47.6 73.36 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.148 0.431 . . . . 0.0 110.166 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.24 91.63 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.641 -0.662 . . . . 0.0 111.503 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.6 m -61.88 -37.47 84.67 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 60.7 tpp -73.05 -42.31 63.25 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 118.584 0.629 . . . . 0.0 109.974 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -56.78 -38.96 73.21 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -57.9 -41.82 83.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.401 0.28 . . . . 0.0 110.399 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.13 -32.17 72.27 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.861 -0.524 . . . . 0.0 111.125 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -78.56 -15.81 58.14 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.588 -0.695 . . . . 0.0 112.505 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 -10.69 9.69 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -99.08 -162.89 29.71 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 125.311 1.434 . . . . 0.0 111.22 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.6 122.13 14.17 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.645 0.778 . . . . 0.0 112.996 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 87.3 mt -78.89 105.48 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 1.5 mpt? 35.4 75.84 0.47 Allowed Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.231 1.412 . . . . 0.0 113.665 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.12 138.88 37.69 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 124.012 3.141 . . . . 0.0 111.559 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -129.58 73.96 1.56 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 pt -129.67 153.73 80.82 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.501 1.121 . . . . 0.0 111.225 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.41 -32.73 49.43 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.33 2.687 . . . . 0.0 113.453 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -63.26 -24.24 67.78 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.106 -0.996 . . . . 0.0 111.084 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 26.3 mmm -68.64 -26.36 65.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.239 0.927 . . . . 0.0 111.102 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.5 m -62.53 -48.82 77.86 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.72 -31.03 67.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.409 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -55.92 -58.87 6.05 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.305 0.957 . . . . 0.0 109.909 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -60.55 -37.77 82.32 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.943 -0.473 . . . . 0.0 111.742 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -62.56 -44.33 96.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.403 0.681 . . . . 0.0 109.226 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.63 -50.99 67.16 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.056 1.342 . . . . 0.0 110.698 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 2.1 t -59.19 -43.76 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.069 0.395 . . . . 0.0 110.236 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -53.65 -38.55 64.23 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.684 0.794 . . . . 0.0 110.833 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 5.7 m -82.4 -50.44 8.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.522 1.055 . . . . 0.0 110.067 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.84 63.46 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.37 -49.12 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 118.051 -0.975 . . . . 0.0 109.918 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.6 mm -65.31 -35.4 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 119.836 1.198 . . . . 0.0 109.67 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -64.73 -45.97 84.25 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.143 -0.973 . . . . 0.0 109.93 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.46 65.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.701 0.8 . . . . 0.0 111.003 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.91 -36.81 84.6 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 125.328 1.451 . . . . 0.0 113.497 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 42.4 m -92.22 -2.7 56.34 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.443 0.697 . . . . 0.0 110.707 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 76.32 13.01 83.76 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 115.532 0.973 . . . . 0.0 115.532 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -66.36 -30.78 71.24 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 119.06 1.43 . . . . 0.0 109.945 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.12 156.09 43.69 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.4 m -66.99 156.23 36.53 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.69 -51.66 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.14 -50.93 65.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.362 1.465 . . . . 0.0 111.621 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.41 -39.14 74.63 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.15 89.31 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 121.463 -0.773 . . . . 0.0 109.605 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.7 mp -72.13 -43.42 64.7 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.396 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.6 tptt -53.14 -55.07 26.97 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.122 1.369 . . . . 0.0 110.228 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -53.9 -49.16 69.21 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 127.99 2.516 . . . . 0.0 112.281 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.48 -50.11 74.88 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 125.668 1.587 . . . . 0.0 111.408 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -56.44 -33.09 65.53 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.485 1.039 . . . . 0.0 110.625 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 14.0 m -62.14 -37.01 83.55 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.806 0.73 . . . . 0.0 109.873 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -65.84 -20.39 66.22 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.154 -0.966 . . . . 0.0 112.244 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 5.7 mt -88.7 -29.21 5.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.274 1.03 . . . . 0.0 109.732 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.0 p -92.55 -7.74 46.37 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.672 -0.643 . . . . 0.0 110.709 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 25.5 tptt . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.312 1.445 . . . . 0.0 110.97 -178.55 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 27.6 tptp . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.9 mt -127.15 151.46 34.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -68.88 89.93 0.42 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 129.74 3.216 . . . . 0.0 110.637 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -92.02 99.36 12.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 145.76 19.86 0.14 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-O 119.239 -0.756 . . . . 0.0 114.958 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -141.11 172.2 13.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.55 1.175 . . . . 0.0 110.933 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.1 mt -153.53 147.03 24.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 128.521 2.728 . . . . 0.0 106.314 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.8 t -142.02 136.12 29.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.6 mt -124.02 137.79 55.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 126.348 1.859 . . . . 0.0 108.82 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -128.42 149.91 50.35 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.2 pt -136.25 168.08 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -158.91 150.95 21.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 128.121 2.569 . . . . 0.0 108.933 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.74 16.3 49.17 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-O 117.432 -1.76 . . . . 0.0 115.577 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 70.12 37.64 1.64 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.728 2.011 . . . . 0.0 110.675 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -57.61 157.05 7.48 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.299 1.047 . . . . 0.0 111.345 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.96 56.89 4.58 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.788 -0.642 . . . . 0.0 114.071 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -50.54 -39.45 49.17 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -66.51 -12.37 57.2 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.86 -45.53 1.49 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.6 tp -61.45 -37.87 85.15 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.466 0.706 . . . . 0.0 111.9 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.69 -41.76 64.16 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.705 0.802 . . . . 0.0 111.92 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -62.82 -33.15 74.62 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.3 t -65.18 -47.13 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.33 -35.77 92.5 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -62.88 -45.72 91.21 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.215 -0.898 . . . . 0.0 109.083 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -58.89 -54.94 41.48 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -52.36 -48.87 65.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.996 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -66.08 -32.51 74.01 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.858 1.208 . . . . 0.0 110.721 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.3 tppt? -68.93 -28.05 66.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 118.171 -0.919 . . . . 0.0 112.604 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.62 -0.43 20.23 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.255 0.972 . . . . 0.0 112.903 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.2 p -130.6 -38.79 1.3 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.61 1.096 . . . . 0.0 112.259 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.72 -10.91 66.57 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.832 -0.982 . . . . 0.0 113.74 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 40.0 mm -70.31 132.28 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 147.39 53.53 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.897 -0.502 . . . . 0.0 111.373 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 t -137.84 125.94 31.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.8 m -118.46 142.49 47.52 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.5 t -132.14 120.97 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -136.29 164.95 26.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.089 1.356 . . . . 0.0 110.245 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -122.4 58.22 10.14 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.126 1.37 . . . . 0.0 112.063 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.93 136.49 16.66 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.212 1.941 . . . . 0.0 110.611 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.12 -18.4 25.92 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.236 -0.915 . . . . 0.0 110.403 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.418 ' HD2' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -83.66 -2.11 55.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 128.12 2.568 . . . . 0.0 112.761 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.47 -31.6 10.28 Favored 'General case' 0 N--CA 1.461 0.085 0 C-N-CA 124.586 1.154 . . . . 0.0 113.459 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -52.6 -33.44 46.33 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.62 1.168 . . . . 0.0 113.561 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -119.14 -21.6 7.54 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 123.375 0.67 . . . . 0.0 110.967 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -72.55 -42.78 64.31 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 117.717 -1.135 . . . . 0.0 109.122 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -51.26 -60.51 5.58 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 117.558 -1.211 . . . . 0.0 109.96 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.52 -24.57 75.37 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.146 1.23 . . . . 0.0 113.142 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -69.4 -55.26 10.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.087 0.858 . . . . 0.0 111.337 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 t -77.06 -37.47 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.696 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.07 90.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.782 -0.627 . . . . 0.0 109.31 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.0 -15.4 43.85 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 118.925 -0.56 . . . . 0.0 111.979 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.8 m -102.85 -9.23 20.09 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.036 1.734 . . . . 0.0 111.825 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.88 10.06 73.05 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.897 -1.127 . . . . 0.0 112.393 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -112.21 2.09 16.48 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.109 1.364 . . . . 0.0 112.582 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.45 176.9 34.23 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.958 -1.089 . . . . 0.0 114.848 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.23 -178.41 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.97 3.113 . . . . 0.0 110.818 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.56 -22.16 12.11 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 120.982 -1.074 . . . . 0.0 112.272 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mt -139.23 148.14 23.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.8 tp -129.35 144.45 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.974 1.71 . . . . 0.0 107.573 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -132.82 102.29 5.59 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.757 1.223 . . . . 0.0 108.808 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -153.13 171.39 18.52 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.053 0.842 . . . . 0.0 111.782 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.19 161.11 31.34 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.745 -1.222 . . . . 0.0 110.984 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -54.54 -32.14 57.72 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.794 1.638 . . . . 0.0 114.736 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.12 -58.15 8.84 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.622 1.169 . . . . 0.0 111.175 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -73.52 -9.39 58.63 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 121.156 -0.965 . . . . 0.0 111.592 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -93.75 12.1 26.83 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.218 1.807 . . . . 0.0 110.035 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 -9.9 56.61 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.815 -0.991 . . . . 0.0 112.006 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.56 -31.26 1.39 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.708 1.754 . . . . 0.0 116.211 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -53.02 -53.98 42.01 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.247 2.024 . . . . 0.0 111.863 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.21 89.75 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.427 -0.796 . . . . 0.0 109.412 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -40.86 76.91 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.804 0.842 . . . . 0.0 109.292 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 m -73.98 -38.01 64.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.694 0.797 . . . . 0.0 108.877 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.07 8.73 6.46 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.97 1.272 . . . . 0.0 114.549 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.8 mt -76.94 -8.01 56.6 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 mt -108.34 139.83 42.48 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.808 1.64 . . . . 0.0 111.857 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.32 175.12 8.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.625 0.77 . . . . 0.0 112.096 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -71.04 135.62 47.87 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.922 0.889 . . . . 0.0 109.326 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 pp -125.74 161.35 30.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 123.474 0.709 . . . . 0.0 110.805 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.9 m 50.87 82.58 0.24 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 127.122 2.169 . . . . 0.0 113.971 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.6 -21.68 25.32 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.349 2.7 . . . . 0.0 113.68 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -134.79 159.63 40.73 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.067 1.303 . . . . 0.0 113.106 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -70.78 -35.81 72.76 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.139 1.376 . . . . 0.0 113.021 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.73 -35.17 60.92 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.776 1.171 . . . . 0.0 112.213 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -65.58 -32.94 74.8 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 122.12 -0.363 . . . . 0.0 111.079 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -66.2 -43.19 87.5 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.607 -0.683 . . . . 0.0 109.54 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -60.0 -27.49 66.91 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.77 1.628 . . . . 0.0 112.938 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -72.17 -2.93 20.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.987 0.915 . . . . 0.0 111.627 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mt -132.81 156.36 47.26 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.185 1.394 . . . . 0.0 110.561 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -68.38 156.47 90.26 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.26 -50.89 0.86 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.187 3.258 . . . . 0.0 114.613 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -52.45 -36.51 54.77 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.374 0.988 . . . . 0.0 112.067 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -31.13 72.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.958 0.903 . . . . 0.0 111.28 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -75.75 -42.51 50.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.813 0.733 . . . . 0.0 110.599 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.402 ' HA ' ' CG ' ' A' ' 98' ' ' ARG . 4.0 m-20 -55.19 -36.08 65.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.086 0.403 . . . . 0.0 110.02 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.47 -2.51 4.72 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 m -133.06 15.96 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 120.146 1.339 . . . . 0.0 110.17 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.402 ' CG ' ' HA ' ' A' ' 95' ' ' ASP . 10.4 mmt180 -71.26 161.65 30.74 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 123.932 0.893 . . . . 0.0 110.832 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -152.05 179.29 8.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.616 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -63.43 97.77 0.14 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.692 1.197 . . . . 0.0 109.537 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.55 -80.96 1.0 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.443 1.496 . . . . 0.0 111.029 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 170.19 13.47 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.962 -0.728 . . . . 0.0 111.06 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.8 163.97 12.76 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.769 1.227 . . . . 0.0 109.385 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.6 pt -129.04 -34.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 116.752 -1.594 . . . . 0.0 114.03 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -143.83 -179.29 6.38 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.994 1.725 . . . . 0.0 109.165 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -132.51 148.13 68.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.251 1.02 . . . . 0.0 111.303 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.66 151.88 32.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.676 2.918 . . . . 0.0 109.388 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -133.05 -55.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.695 1.198 . . . . 0.0 110.745 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.81 161.04 31.66 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.44 108.32 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -155.02 146.2 22.8 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.15 85.93 1.09 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.093 1.757 . . . . 0.0 107.066 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -170.85 160.22 6.67 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.881 1.673 . . . . 0.0 111.228 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.6 p -179.6 158.41 0.82 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.089 1.756 . . . . 0.0 110.285 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.7 tp -153.78 149.23 27.22 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.13 164.86 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -152.93 -177.61 6.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.834 -1.166 . . . . 0.0 110.425 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -64.55 164.36 11.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.148 1.379 . . . . 0.0 110.974 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -65.51 -15.54 62.78 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.835 -1.166 . . . . 0.0 112.455 178.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -69.87 176.96 3.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 130.02 3.328 . . . . 0.0 110.258 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.5 mt -78.58 -22.68 46.75 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.963 1.305 . . . . 0.0 110.539 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.82 162.33 0.11 Allowed Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 128.999 2.92 . . . . 0.0 113.92 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.405 ' HG2' ' H ' ' A' ' 124' ' ' ASN . 81.6 Cg_endo -73.12 -82.08 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.888 2.392 . . . . 0.0 109.362 178.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.405 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 71.8 m-80 -153.3 150.35 23.5 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 127.137 2.175 . . . . 0.0 107.079 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.24 161.12 45.97 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.653 2.236 . . . . 0.0 110.862 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.0 159.51 53.69 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.876 2.384 . . . . 0.0 114.458 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -101.29 -33.12 10.17 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.944 2.898 . . . . 0.0 114.493 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 t -161.13 152.38 18.85 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.8 0.727 . . . . 0.0 110.47 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -64.96 -28.06 69.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.761 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -67.39 -17.27 64.66 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.886 0.766 . . . . 0.0 112.97 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -94.38 -18.6 21.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.962 0.905 . . . . 0.0 109.534 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.6 mm -52.5 -56.83 18.95 Favored Pre-proline 0 C--O 1.234 0.279 0 O-C-N 121.259 -0.901 . . . . 0.0 110.391 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.44 -29.77 44.83 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 CA-C-N 120.34 1.157 . . . . 0.0 111.608 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.25 -15.08 62.42 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.793 1.637 . . . . 0.0 112.474 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 36.6 tp -104.88 -24.57 12.85 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.798 1.639 . . . . 0.0 107.225 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.69 -49.21 69.39 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -65.51 -27.4 68.44 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.14 -42.77 30.74 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.5 mt -70.85 -33.27 70.47 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.31 68.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 123.615 0.572 . . . . 0.0 111.948 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.02 0.73 16.08 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.766 1.226 . . . . 0.0 112.982 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 179.59 -97.65 0.11 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 119.203 0.911 . . . . 0.0 113.134 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -140.55 -176.19 4.55 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.152 0.981 . . . . 0.0 111.165 -177.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.3 p -52.99 166.46 0.22 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.343 1.857 . . . . 0.0 115.181 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -95.45 -69.47 0.75 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.137 1.375 . . . . 0.0 109.828 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.7 tp -121.32 152.5 38.88 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.73 2.012 . . . . 0.0 110.687 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 88.0 mtp -149.76 131.51 15.03 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.741 2.416 . . . . 0.0 105.399 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -148.58 164.58 33.82 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.8 1.24 . . . . 0.0 110.639 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.66 94.43 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.885 1.274 . . . . 0.0 113.828 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.4 mt -85.07 -19.5 31.83 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.668 -1.27 . . . . 0.0 110.342 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -77.13 -0.81 26.32 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.784 0.834 . . . . 0.0 112.85 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -125.24 122.43 25.19 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.903 0.881 . . . . 0.0 109.735 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.1 -15.09 32.19 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.417 1.411 . . . . 0.0 112.395 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -48.7 -42.19 34.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.921 1.288 . . . . 0.0 113.3 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -93.77 -33.72 13.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.8 0.727 . . . . 0.0 112.354 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 82.6 p -72.28 -28.56 63.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.018 0.826 . . . . 0.0 111.914 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -47.46 -63.33 1.49 Allowed Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.137 1.775 . . . . 0.0 112.458 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -66.4 -11.86 33.26 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.737 1.624 . . . . 0.0 114.482 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.2 tp -78.89 -55.61 5.02 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.6 pt -62.48 -34.14 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.539 0.609 . . . . 0.0 111.79 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.44 -12.42 60.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.677 -1.154 . . . . 0.0 112.206 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -48.4 -54.37 14.27 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.191 1.396 . . . . 0.0 112.396 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -53.14 -49.81 65.81 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.455 0.57 . . . . 0.0 111.447 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.81 1.54 0.03 OUTLIER Glycine 0 CA--C 1.523 0.537 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.645 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -54.83 144.5 30.89 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 119.408 1.604 . . . . 0.0 110.19 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.414 ' CE1' ' HA3' ' A' ' 182' ' ' GLY . 37.6 p90 -148.83 136.71 20.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 118.568 1.184 . . . . 0.0 108.924 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.54 -67.77 0.71 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -133.91 134.31 42.5 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -75.49 124.28 26.9 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -131.71 100.78 5.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 173' ' ' ASN . 7.3 tt0 -79.57 -173.72 3.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.421 1.488 . . . . 0.0 107.724 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.408 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 32.9 m-80 -46.9 -27.59 1.3 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.822 1.649 . . . . 0.0 114.25 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.57 13.82 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 CA-C-O 118.535 -1.147 . . . . 0.0 113.848 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -122.67 132.34 54.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.684 1.742 . . . . 0.0 108.891 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.01 114.36 19.65 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -139.52 96.01 3.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 122.442 1.115 . . . . 0.0 110.428 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.59 -3.41 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 127.622 2.369 . . . . 0.0 114.789 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -76.87 -36.74 56.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.04 93.94 5.85 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.88 151.21 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 126.246 1.819 . . . . 0.0 107.623 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.414 ' HA3' ' CE1' ' A' ' 167' ' ' TYR . . . -148.69 31.99 1.22 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.68 1.133 . . . . 0.0 112.246 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.05 -24.04 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 121.712 -0.875 . . . . 0.0 111.48 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -112.86 18.52 18.11 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.314 1.445 . . . . 0.0 112.814 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -61.57 160.38 11.44 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.591 0.71 . . . . 0.0 109.161 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.68 -26.27 63.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.636 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -72.45 -33.38 61.3 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.132 -0.98 . . . . 0.0 112.447 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.38 43.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.182 0.993 . . . . 0.0 109.758 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -59.79 -34.56 73.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.497 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.66 -54.34 48.21 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.709 0.686 . . . . 0.0 110.562 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.92 -32.06 81.5 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.848 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.87 -44.52 63.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.234 1.017 . . . . 0.0 111.143 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 12.9 t -62.27 -29.1 70.17 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 117.427 -1.273 . . . . 0.0 110.233 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -57.49 -46.6 83.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 120.205 1.366 . . . . 0.0 108.922 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.35 -51.56 67.12 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.918 0.887 . . . . 0.0 109.683 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.67 -32.71 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.526 0.73 . . . . 0.0 110.66 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -32.23 73.68 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.974 0.91 . . . . 0.0 110.601 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.16 -45.26 57.66 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 50.5 mt -60.81 -39.79 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.173 0.989 . . . . 0.0 108.627 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -54.69 -35.79 63.98 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.049 0.94 . . . . 0.0 109.627 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -93.15 -1.97 55.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.736 2.015 . . . . 0.0 113.131 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 9.1 mptt 55.98 11.82 0.8 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.317 2.647 . . . . 0.0 115.503 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -79.91 -8.41 59.3 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.947 -1.095 . . . . 0.0 112.362 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.62 136.44 50.84 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.236 1.014 . . . . 0.0 109.766 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -76.87 79.28 3.45 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.49 77.46 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.18 -2.25 9.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.906 2.082 . . . . 0.0 114.554 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 43.4 m -63.04 126.95 29.04 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.611 1.164 . . . . 0.0 113.629 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.82 179.38 4.03 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.954 2.102 . . . . 0.0 107.097 177.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -57.05 -45.54 83.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -40.25 97.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.148 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 59.6 mt -68.4 -48.86 70.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.42 85.51 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.088 0.555 . . . . 0.0 111.907 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -77.26 -49.55 14.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.047 0.839 . . . . 0.0 111.718 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.69 -50.54 71.84 Favored 'General case' 0 C--N 1.337 0.054 0 CA-C-N 119.114 0.87 . . . . 0.0 110.737 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.34 -44.6 84.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.292 1.037 . . . . 0.0 109.761 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -60.76 -44.06 97.22 Favored 'General case' 0 CA--C 1.524 -0.053 0 C-N-CA 123.501 0.72 . . . . 0.0 109.243 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -55.78 -42.76 76.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.797 0.839 . . . . 0.0 110.05 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -74.51 -21.33 59.6 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.265 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.96 20.26 13.17 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.981 -0.899 . . . . 0.0 112.537 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -73.46 -31.71 63.94 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.513 1.656 . . . . 0.0 112.701 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.7 t -124.2 146.57 48.62 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.796 1.639 . . . . 0.0 106.743 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -106.5 -9.63 16.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.31 1.044 . . . . 0.0 112.241 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.67 153.7 41.89 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.2 t -164.84 157.53 16.43 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.8 mt -142.59 155.59 18.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -156.47 151.11 25.78 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.623 0.725 . . . . 0.0 109.819 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -159.9 -67.39 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 128.567 2.984 . . . . 0.0 107.709 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.6 179.68 3.97 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.24 2.627 . . . . 0.0 112.935 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -113.83 130.18 56.5 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.15 -177.9 6.81 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 122.482 1.134 . . . . 0.0 112.969 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -120.28 10.55 11.32 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.994 2.117 . . . . 0.0 111.22 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 15.9 m -114.45 112.27 22.74 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.266 1.827 . . . . 0.0 108.483 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -65.59 121.72 15.58 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 8.2 tp -149.71 143.63 17.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.427 1.091 . . . . 0.0 109.076 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.89 114.62 26.26 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 10.2 t -85.98 169.65 13.03 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.761 1.624 . . . . 0.0 108.883 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 61.1 p -148.61 19.88 1.04 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.252 0.621 . . . . 0.0 112.122 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -139.21 162.74 34.23 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.557 1.143 . . . . 0.0 108.031 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 14.1 m -143.24 139.05 26.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.189 1.796 . . . . 0.0 107.448 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -122.52 147.5 46.29 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -151.08 -174.77 4.91 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.664 1.186 . . . . 0.0 108.373 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 67.47 -175.76 25.06 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.6 m -114.44 144.7 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 O-C-N 121.96 -0.73 . . . . 0.0 109.174 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 95.2 m -149.27 134.34 18.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.53 153.28 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.266 1.426 . . . . 0.0 109.462 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.4 pp -121.4 160.42 45.97 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.095 0.958 . . . . 0.0 111.085 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.73 153.81 68.59 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.395 1.396 . . . . 0.0 109.062 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.5 p -125.64 163.97 21.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -83.41 139.55 32.91 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 135.39 52.16 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.745 -1.222 . . . . 0.0 109.573 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 71.59 -1.61 27.93 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.182 -1.343 . . . . 0.0 113.974 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.99 105.14 2.64 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 121.283 2.542 . . . . 0.0 111.67 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.15 144.29 56.79 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.754 1.636 . . . . 0.0 110.809 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.39 146.86 46.85 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.504 1.522 . . . . 0.0 108.019 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -140.26 92.01 9.65 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.169 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -81.97 -165.07 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 125.244 3.963 . . . . 0.0 112.082 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -69.05 174.45 4.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.741 1.216 . . . . 0.0 109.386 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.9 t -97.86 150.68 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 121.465 -0.772 . . . . 0.0 108.973 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -165.8 58.34 0.24 Allowed Glycine 0 C--N 1.334 0.465 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.7 149.48 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 123.217 0.607 . . . . 0.0 110.34 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.9 tt -82.69 127.63 33.59 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.4 m -111.05 159.59 17.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.851 1.261 . . . . 0.0 107.871 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -139.07 151.49 46.78 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.427 0.691 . . . . 0.0 109.849 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -147.77 164.38 28.83 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 124.739 1.274 . . . . 0.0 113.128 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 45.7 mt -103.67 133.83 46.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.309 1.444 . . . . 0.0 108.366 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -69.91 118.82 13.24 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.04 -13.27 62.35 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.619 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -73.28 -26.49 61.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.45 1.023 . . . . 0.0 112.729 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 48.8 m -62.55 161.52 26.53 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.007 0.523 . . . . 0.0 110.782 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.3 -44.79 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.541 1.494 . . . . 0.0 114.892 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -133.92 100.62 4.8 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 119.61 1.096 . . . . 0.0 109.861 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -58.01 -20.73 40.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.247 1.019 . . . . 0.0 113.092 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -60.76 -32.09 71.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.426 0.69 . . . . 0.0 111.214 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.31 -27.89 67.69 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.42 -0.8 . . . . 0.0 110.802 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -85.22 -40.21 16.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.403 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.46 83.51 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 118.888 0.767 . . . . 0.0 110.189 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -71.29 -43.89 66.26 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.03 -49.66 77.03 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.122 -0.986 . . . . 0.0 109.28 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.3 mp -59.42 -50.6 73.32 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 118.19 -0.909 . . . . 0.0 112.712 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -76.17 -21.32 56.66 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -93.7 -23.83 18.08 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 117.06 -1.448 . . . . 0.0 112.075 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -137.17 -28.18 0.94 Allowed 'General case' 0 C--N 1.346 0.424 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -83.5 -16.16 46.66 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.86 1.664 . . . . 0.0 112.442 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 67.6 mt -121.98 68.02 0.92 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.35 1.06 . . . . 0.0 109.702 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 65.6 p -139.44 154.84 47.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.959 1.704 . . . . 0.0 107.137 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.1 1.67 7.06 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.387 1.875 . . . . 0.0 112.246 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -113.21 -48.82 2.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.672 2.389 . . . . 0.0 111.058 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.52 -35.71 62.83 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.17 -42.88 99.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -60.39 -46.47 89.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 123.933 0.77 . . . . 0.0 109.545 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.84 -32.35 60.47 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 118.035 -0.984 . . . . 0.0 113.39 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 7.1 t -84.29 -24.57 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 120.406 1.457 . . . . 0.0 109.967 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -72.06 -23.85 61.43 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.285 0.948 . . . . 0.0 110.064 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -57.76 -49.9 75.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -64.67 -50.49 66.83 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 157.19 69.42 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 118.553 0.615 . . . . 0.0 112.296 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.89 101.18 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.776 2.317 . . . . 0.0 108.323 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 71.0 mt -81.27 -12.28 59.13 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 67.47 -154.04 52.93 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 120.168 1.349 . . . . 0.0 110.313 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.89 170.24 10.05 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.423 1.089 . . . . 0.0 112.639 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 18.7 m -133.64 155.84 40.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.45 1.5 . . . . 0.0 109.003 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.08 -24.37 59.48 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.659 -0.651 . . . . 0.0 109.378 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.48 102.61 0.91 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 127.57 2.348 . . . . 0.0 110.893 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -58.76 -24.13 61.19 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.2 p -64.69 -53.36 48.54 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 120.437 -1.414 . . . . 0.0 111.16 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -86.62 -19.68 28.97 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -62.12 -36.85 83.01 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.22 -10.44 23.42 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.127 0.876 . . . . 0.0 111.672 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -97.02 -45.31 6.63 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.424 1.49 . . . . 0.0 109.049 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 27.5 mt -67.51 -41.83 83.79 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.566 1.146 . . . . 0.0 109.043 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.55 0.87 0.42 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.633 1.973 . . . . 0.0 114.256 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -67.09 -18.44 65.32 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 120.244 1.384 . . . . 0.0 110.631 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -117.57 141.03 28.23 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.52 1.128 . . . . 0.0 109.486 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.97 -16.67 46.81 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.583 2.856 . . . . 0.0 116.462 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.44 -23.95 64.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 121.201 1.819 . . . . 0.0 109.581 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.2 mp -86.46 -65.43 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.01 -52.03 15.79 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.21 -22.17 66.84 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.699 -1.251 . . . . 0.0 114.088 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 41.0 m -85.11 -31.0 23.57 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.739 1.215 . . . . 0.0 108.069 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.8 tpt -71.26 -38.56 71.87 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.41 -29.93 68.1 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.539 1.136 . . . . 0.0 110.004 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -65.93 -42.56 89.93 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.278 0.631 . . . . 0.0 110.941 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.4 -33.43 74.23 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.148 0.431 . . . . 0.0 110.085 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -63.41 -48.98 75.57 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.381 0.673 . . . . 0.0 110.791 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.53 -25.71 26.64 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.67 175.08 17.47 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 124.913 1.245 . . . . 0.0 113.121 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -118.72 119.57 34.82 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 126.196 1.798 . . . . 0.0 109.171 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 42.3 mt -83.94 94.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 31.5 ttp 48.09 82.11 0.24 Allowed Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 126.552 1.941 . . . . 0.0 111.684 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.48 78.14 0.93 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.102 2.535 . . . . 0.0 111.456 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.71 61.34 4.34 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.035 1.334 . . . . 0.0 108.526 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 44.8 pt -126.3 147.24 59.13 Favored Pre-proline 0 CA--C 1.535 0.387 0 O-C-N 121.093 -1.004 . . . . 0.0 111.288 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.36 -19.16 67.6 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.263 2.642 . . . . 0.0 114.354 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -66.95 -22.84 65.92 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.66 -0.65 . . . . 0.0 110.298 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 97.6 mmm -64.85 -27.6 68.98 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.757 0.708 . . . . 0.0 110.387 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 7.4 t -56.73 -52.22 65.83 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.561 1.144 . . . . 0.0 108.103 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.19 68.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.316 -0.849 . . . . 0.0 110.781 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -48.31 -57.7 5.63 Favored 'General case' 0 CA--C 1.524 -0.055 0 C-N-CA 123.788 0.835 . . . . 0.0 112.574 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -62.19 -50.04 73.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -61.34 -39.84 92.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.18 -57.65 6.33 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.428 1.091 . . . . 0.0 109.922 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.65 -42.97 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.816 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -53.66 -53.51 50.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.038 1.29 . . . . 0.0 108.419 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 18.8 m -60.22 -42.56 95.45 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.829 0.452 . . . . 0.0 110.833 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.11 94.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.244 0.929 . . . . 0.0 111.638 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.75 -49.81 83.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 123.7 0.8 . . . . 0.0 109.112 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.1 mm -65.84 -38.4 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.9 0.773 . . . . 0.0 109.034 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -57.77 -49.25 77.21 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.178 -0.951 . . . . 0.0 109.979 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.24 -50.58 60.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.814 0.845 . . . . 0.0 111.936 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.18 70.71 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.165 1.386 . . . . 0.0 114.235 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 49.4 m -97.71 3.12 50.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.641 0.777 . . . . 0.0 110.284 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.51 11.26 68.17 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 121.168 -0.958 . . . . 0.0 114.577 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 31.8 ttm-85 -68.13 -27.95 66.9 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 118.128 0.964 . . . . 0.0 110.014 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -149.55 156.13 41.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.8 m -71.11 155.84 40.3 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 80.0 t -52.57 -54.14 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.575 1.15 . . . . 0.0 109.346 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.71 -47.64 73.49 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.741 1.616 . . . . 0.0 112.127 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -71.6 -34.83 70.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.38 98.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 9.9 mt -72.11 -41.68 66.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.766 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -53.52 -46.18 70.01 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.724 0.81 . . . . 0.0 110.634 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.55 -48.06 83.13 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.567 1.547 . . . . 0.0 111.793 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.65 80.2 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.823 2.049 . . . . 0.0 111.959 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.68 -36.26 61.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.518 0.599 . . . . 0.0 110.898 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.83 -44.79 84.53 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.046 0.385 . . . . 0.0 111.322 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -61.02 -25.36 66.85 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.365 -0.835 . . . . 0.0 112.591 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 48.8 mt -90.46 -21.65 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.627 1.571 . . . . 0.0 113.683 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . 0.331 1.6 t -116.66 5.84 13.27 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.339 0.972 . . . . 0.0 111.731 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? . . . . . 0 C--O 1.247 0.939 0 C-N-CA 126.667 1.987 . . . . 0.0 110.312 178.593 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.4 tppm? . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.67 154.26 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 O-C-N 124.762 1.289 . . . . 0.0 108.302 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -68.39 121.6 16.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.781 1.632 . . . . 0.0 107.779 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.78 -173.36 2.7 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.896 0.878 . . . . 0.0 109.463 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.1 27.22 68.56 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.429 -0.794 . . . . 0.0 114.184 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -144.68 168.08 21.02 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.596 1.198 . . . . 0.0 112.44 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.2 mt -151.65 149.12 28.77 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 129.516 3.127 . . . . 0.0 107.221 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -145.13 146.16 20.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 124.72 1.208 . . . . 0.0 108.627 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.1 mt -136.0 139.8 45.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 126.155 1.782 . . . . 0.0 107.958 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -123.91 155.07 38.78 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.2 mp -135.94 136.79 49.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 125.53 1.532 . . . . 0.0 109.799 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -78.4 -50.35 11.87 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.709 0.804 . . . . 0.0 108.872 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.52 177.85 39.28 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.258 1.408 . . . . 0.0 109.779 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 64.23 -1.23 0.74 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.402 2.281 . . . . 0.0 115.448 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -85.97 170.98 11.79 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.473 -1.392 . . . . 0.0 112.862 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.17 62.79 0.49 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 126.163 1.84 . . . . 0.0 109.872 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -55.68 -34.3 64.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.61 -0.709 . . . . 0.0 112.444 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -59.2 -36.76 75.96 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.854 0.752 . . . . 0.0 111.954 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.69 -39.21 10.81 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.61 -44.74 89.6 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.656 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.52 -49.38 26.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.854 0.721 . . . . 0.0 110.491 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -57.47 -31.76 66.29 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.4 -42.68 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.67 -40.96 90.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 123.729 0.681 . . . . 0.0 111.415 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -64.37 -42.41 96.2 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.79 1.295 . . . . 0.0 109.324 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -58.24 -59.66 4.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -59.28 -42.85 92.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.075 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -66.21 -27.76 68.23 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 120.776 1.625 . . . . 0.0 110.557 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.9 -28.88 55.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.421 -1.425 . . . . 0.0 110.37 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -84.39 -47.14 10.99 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.069 1.748 . . . . 0.0 111.928 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.3 p -100.39 -32.09 11.0 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.11 -12.76 68.77 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.904 -1.122 . . . . 0.0 111.36 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.9 mm -66.86 130.58 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 142.52 58.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 118.926 -0.559 . . . . 0.0 111.807 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -135.85 102.11 3.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.2 m -96.9 142.43 28.89 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.185 0.994 . . . . 0.0 108.8 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.95 129.84 58.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -137.39 164.55 28.35 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.43 1.092 . . . . 0.0 108.662 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -133.44 61.51 54.49 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.297 1.039 . . . . 0.0 109.821 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -69.64 155.13 67.15 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.161 2.574 . . . . 0.0 111.64 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -100.61 -0.04 38.35 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.72 18.43 3.55 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -55.97 -23.95 35.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 117.829 -1.081 . . . . 0.0 113.625 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -59.7 -23.71 63.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.109 1.322 . . . . 0.0 112.491 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.38 -30.15 6.66 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.929 0.871 . . . . 0.0 109.407 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -70.43 -28.06 64.75 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.191 -0.943 . . . . 0.0 109.149 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -66.67 -60.61 6.18 Favored Pre-proline 0 CA--C 1.536 0.433 0 O-C-N 119.961 -1.712 . . . . 0.0 108.448 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.06 -25.72 80.53 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.277 1.985 . . . . 0.0 114.716 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.66 -0.63 18.59 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.278 1.031 . . . . 0.0 112.758 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.2 -36.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.85 74.19 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.73 -30.74 70.3 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.893 0.477 . . . . 0.0 110.903 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.0 m -81.43 -14.41 57.12 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.564 1.946 . . . . 0.0 110.919 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.81 56.57 2.32 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.41 -172.48 2.96 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.593 2.357 . . . . 0.0 106.382 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.72 -162.61 14.76 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 120.239 -1.538 . . . . 0.0 113.9 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.53 -179.05 3.36 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.001 3.134 . . . . 0.0 110.33 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -109.29 -24.37 11.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.409 -0.807 . . . . 0.0 112.135 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.9 mt -145.41 148.87 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 tp -132.78 141.34 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -128.97 107.32 9.52 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.875 1.67 . . . . 0.0 107.776 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -152.84 -150.71 0.35 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.945 1.248 . . . . 0.0 113.47 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.15 136.52 32.98 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.589 2.356 . . . . 0.0 110.152 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -48.66 -48.82 39.49 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.441 1.496 . . . . 0.0 112.489 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.45 -5.47 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 129.272 3.029 . . . . 0.0 113.972 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -108.84 -12.18 14.94 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.532 1.133 . . . . 0.0 109.633 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -94.34 -26.01 16.74 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 124.231 1.012 . . . . 0.0 112.304 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -49.97 -41.12 36.49 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.31 -55.79 16.79 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.949 0.785 . . . . 0.0 111.621 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -53.99 -42.48 69.08 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.55 1.14 . . . . 0.0 111.663 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.65 90.3 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 122.843 0.457 . . . . 0.0 111.086 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -44.65 96.72 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.2 m -66.87 -4.38 9.22 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.433 1.493 . . . . 0.0 113.319 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.99 6.66 88.72 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.375 0.988 . . . . 0.0 112.985 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.43 -22.87 64.58 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.6 mt -95.24 133.15 39.44 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.81 155.28 40.6 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -64.35 118.91 9.38 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.8 mm -71.58 165.33 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 122.351 1.072 . . . . 0.0 111.099 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.2 m 71.29 92.85 0.05 OUTLIER Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 129.031 2.932 . . . . 0.0 108.096 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.94 -34.54 10.49 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.463 1.442 . . . . 0.0 109.744 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.57 150.46 36.43 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.501 1.12 . . . . 0.0 109.128 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -57.27 -34.1 68.3 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.472 1.109 . . . . 0.0 112.041 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.24 -27.27 63.83 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.64 1.109 . . . . 0.0 111.898 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.31 -36.64 84.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.277 0.944 . . . . 0.0 109.008 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -59.29 -38.36 79.99 Favored 'General case' 0 C--N 1.343 0.284 0 O-C-N 121.044 -1.035 . . . . 0.0 112.707 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -65.67 -17.8 64.87 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.567 0.747 . . . . 0.0 111.6 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.14 -10.25 58.75 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.53 156.36 40.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.519 1.054 . . . . 0.0 111.962 -178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -70.52 156.17 92.32 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.971 0.908 . . . . 0.0 110.705 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.16 -41.15 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.181 2.587 . . . . 0.0 113.821 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -63.81 -27.62 69.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.038 0.835 . . . . 0.0 110.87 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.05 -28.17 54.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.837 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -70.57 -39.21 74.04 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 118.717 0.69 . . . . 0.0 109.874 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.63 -27.57 68.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.36 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.57 -4.78 36.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.88 12.52 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.605 1.162 . . . . 0.0 111.773 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -65.74 165.27 13.0 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 122.449 1.119 . . . . 0.0 111.547 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -154.42 -171.04 3.72 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.09 1.756 . . . . 0.0 107.123 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -66.23 98.78 0.48 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.171 1.388 . . . . 0.0 109.047 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.49 -74.27 0.42 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.085 1.802 . . . . 0.0 113.433 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.52 166.62 22.31 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.766 0.827 . . . . 0.0 110.735 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mt -100.15 145.88 27.48 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.0 pt -110.19 -25.87 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.29 171.97 18.41 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.01 146.82 62.28 Favored Pre-proline 0 C--O 1.242 0.668 0 C-N-CA 123.529 0.732 . . . . 0.0 110.106 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.3 149.01 44.59 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.885 2.39 . . . . 0.0 110.09 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.5 mm -138.73 -52.06 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.835 2.054 . . . . 0.0 109.421 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.51 150.91 46.99 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.594 1.158 . . . . 0.0 112.671 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.3 t -126.12 118.36 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.436 1.894 . . . . 0.0 107.723 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -125.21 141.57 52.01 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.371 1.068 . . . . 0.0 108.411 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.37 106.58 4.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mp -67.91 176.99 2.31 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.522 1.529 . . . . 0.0 109.845 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.9 p -84.33 -175.8 5.96 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.686 1.194 . . . . 0.0 109.389 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.98 156.74 16.21 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.2 mp -88.28 98.39 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.64 171.55 7.67 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.559 1.944 . . . . 0.0 109.46 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -68.26 161.24 27.68 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -65.36 -19.8 66.11 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -58.47 142.77 47.77 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.993 1.269 . . . . 0.0 110.079 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -70.54 4.69 2.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.918 1.287 . . . . 0.0 112.558 179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.3 tp -121.86 64.3 17.35 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 126.25 1.82 . . . . 0.0 106.554 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.26 -3.19 13.42 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.517 2.145 . . . . 0.0 114.216 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 21.91 82.77 0.12 Allowed Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 129.416 3.086 . . . . 0.0 112.953 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.16 160.86 42.8 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.379 2.719 . . . . 0.0 116.584 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.43 170.8 16.52 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.221 3.281 . . . . 0.0 111.101 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -126.74 -31.88 2.64 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.827 0.851 . . . . 0.0 111.212 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.68 154.81 14.02 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.582 1.083 . . . . 0.0 109.783 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -61.79 -22.61 65.59 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 121.232 -0.917 . . . . 0.0 110.936 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -71.39 -12.41 61.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.567 1.076 . . . . 0.0 111.07 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -108.73 -17.02 14.05 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.973 2.509 . . . . 0.0 111.817 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.2 mm -58.66 -63.01 4.58 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 121.161 -0.962 . . . . 0.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.63 -18.76 37.45 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.773 1.649 . . . . 0.0 111.745 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.71 -49.61 57.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.514 1.126 . . . . 0.0 108.52 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.8 tp -72.1 -30.59 65.23 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.794 0.838 . . . . 0.0 109.781 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.38 -48.02 72.01 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.761 0.824 . . . . 0.0 111.645 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -70.17 -31.12 68.45 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.465 0.306 . . . . 0.0 111.069 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -67.83 -45.05 75.76 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.7 mt -71.32 -30.28 66.03 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.243 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -67.8 -34.51 76.89 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 119.79 1.177 . . . . 0.0 108.14 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.43 -7.69 27.21 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.323 1.049 . . . . 0.0 111.965 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 6.12 3.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.312 1.445 . . . . 0.0 111.614 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.0 -76.42 0.1 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.02 176.09 12.97 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.45 1.1 . . . . 0.0 110.175 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.65 165.1 8.66 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.902 0.858 . . . . 0.0 111.561 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -84.85 -70.09 0.6 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.289 1.436 . . . . 0.0 111.3 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.2 tp -103.22 157.72 16.81 Favored 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 125.893 1.677 . . . . 0.0 113.334 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 92.4 mtp -150.06 118.69 6.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.466 2.306 . . . . 0.0 106.093 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -142.13 155.23 45.32 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.803 0.729 . . . . 0.0 109.281 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -68.06 96.53 0.62 Allowed 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.338 -0.851 . . . . 0.0 111.79 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.51 -10.67 58.18 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.239 1.016 . . . . 0.0 110.806 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -75.79 -29.78 58.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.566 -0.73 . . . . 0.0 112.099 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -99.55 133.0 22.2 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 119.485 1.039 . . . . 0.0 109.491 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.41 -5.39 14.97 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.68 2.92 . . . . 0.0 113.719 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -66.84 -37.62 84.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.524 1.13 . . . . 0.0 110.506 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -75.74 -46.12 32.7 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 122.034 -0.416 . . . . 0.0 112.084 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.9 p -73.96 -17.2 61.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -53.68 -61.28 5.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.69 -3.8 10.98 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.324 2.016 . . . . 0.0 114.111 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.99 -59.24 2.28 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 30.5 pt -61.84 -49.41 84.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 116.977 -1.487 . . . . 0.0 111.708 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -49.36 -8.88 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.277 2.631 . . . . 0.0 115.236 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.75 85.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.399 1.08 . . . . 0.0 111.221 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -67.87 -50.13 58.14 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 177.8 11.96 0.02 OUTLIER Glycine 0 CA--C 1.534 1.265 0 O-C-N 121.251 -0.905 . . . . 0.0 115.154 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.77 131.35 10.43 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 125.869 1.699 . . . . 0.0 111.026 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -146.76 143.32 28.59 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.55 -45.73 13.21 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.23 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -148.69 126.94 12.15 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -76.01 145.88 39.9 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.859 0.754 . . . . 0.0 111.219 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -140.46 116.27 10.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -91.75 -174.81 3.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.347 1.059 . . . . 0.0 108.306 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -56.51 -9.22 0.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.513 1.925 . . . . 0.0 115.185 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -178.9 13.41 0.03 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.208 1.861 . . . . 0.0 112.85 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -132.52 106.2 7.7 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.955 1.378 . . . . 0.0 110.47 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -104.09 125.8 50.71 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.62 110.66 8.28 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -8.61 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.058 0.543 . . . . 0.0 112.446 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -77.53 -31.19 53.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.568 1.147 . . . . 0.0 110.544 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -84.18 87.71 7.18 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 74.7 t -104.57 152.82 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.884 1.674 . . . . 0.0 108.86 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -145.25 24.83 1.88 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.881 1.229 . . . . 0.0 113.766 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.09 -22.56 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 120.796 -1.414 . . . . 0.0 113.013 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -106.27 5.93 30.21 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.125 1.77 . . . . 0.0 111.807 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -59.82 157.13 12.82 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.584 -0.698 . . . . 0.0 110.38 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.92 -34.43 55.21 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.193 0.997 . . . . 0.0 110.755 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.99 -33.01 65.68 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.9 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.45 -49.87 61.74 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.579 1.69 . . . . 0.0 107.743 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -61.85 -41.05 97.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.068 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.1 -46.6 89.93 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.054 0.942 . . . . 0.0 110.216 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.72 -36.72 93.7 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 31.5 tp -75.02 -49.36 20.08 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.998 0.919 . . . . 0.0 113.164 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.7 t -52.95 -33.7 52.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.123 0.969 . . . . 0.0 112.993 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -58.93 -51.91 68.02 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.234 1.379 . . . . 0.0 109.466 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.0 tt -64.57 -46.38 83.02 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.308 1.043 . . . . 0.0 110.264 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.61 -34.45 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 123.751 0.82 . . . . 0.0 110.695 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.605 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.3 OUTLIER -63.57 -33.46 75.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.017 0.826 . . . . 0.0 111.876 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 13.8 mt -71.65 -43.92 65.23 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 44.6 mt -60.18 -41.47 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.605 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.7 OUTLIER -55.83 -30.48 61.48 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.995 -1.066 . . . . 0.0 110.346 178.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -93.3 -5.3 50.03 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.367 1.467 . . . . 0.0 112.093 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? 58.13 18.19 5.09 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.918 2.487 . . . . 0.0 113.891 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -91.2 -13.3 33.1 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 9.1 tpt -92.86 167.13 12.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.934 0.788 . . . . 0.0 111.496 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -76.25 42.69 0.27 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.906 2.882 . . . . 0.0 109.424 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.18 -33.41 75.42 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 126.059 1.744 . . . . 0.0 115.22 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.34 -9.22 57.9 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.487 1.115 . . . . 0.0 112.685 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.3 m -78.17 131.4 37.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.165 1.386 . . . . 0.0 111.036 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -119.04 179.39 4.18 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.411 1.884 . . . . 0.0 107.821 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -52.69 -46.69 67.4 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.816 0.846 . . . . 0.0 113.082 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 54.0 m -63.31 -36.94 85.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.571 0.749 . . . . 0.0 110.785 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 28.0 mm -68.64 -49.94 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 117.78 -1.105 . . . . 0.0 108.512 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.33 -47.82 82.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.999 1.272 . . . . 0.0 111.938 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -56.62 -48.62 77.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.843 0.457 . . . . 0.0 110.164 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.96 -52.39 56.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.55 0.74 . . . . 0.0 110.744 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.71 -43.12 68.76 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.841 1.657 . . . . 0.0 110.75 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -60.41 -39.5 87.58 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.23 -43.84 97.92 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -69.31 -12.09 61.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.915 1.286 . . . . 0.0 112.704 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.69 13.31 70.23 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 120.193 1.36 . . . . 0.0 111.613 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -74.51 -9.06 58.21 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 116.609 2.078 . . . . 0.0 116.609 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.03 157.04 47.96 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 120.345 1.43 . . . . 0.0 110.543 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.41 -35.12 14.56 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.217 1.007 . . . . 0.0 110.368 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -145.05 145.66 31.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.41 1.084 . . . . 0.0 110.369 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.06 155.48 47.02 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 78.2 mt -128.1 92.41 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -121.24 -110.57 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -158.97 -88.14 0.07 OUTLIER Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.8 139.1 32.91 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.166 1.91 . . . . 0.0 111.023 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -93.22 -6.26 48.09 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.283 1.033 . . . . 0.0 111.181 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -52.9 164.13 0.42 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.342 1.857 . . . . 0.0 112.252 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -99.95 -27.82 13.4 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 14.8 m -73.9 -45.62 49.56 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 120.124 1.329 . . . . 0.0 111.557 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 57.86 1.11 0.13 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 27.6 pt -67.55 -10.61 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.677 1.991 . . . . 0.0 111.563 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.27 168.03 3.71 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.746 1.619 . . . . 0.0 112.324 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.3 t -127.15 9.82 6.81 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.32 1.048 . . . . 0.0 111.105 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 8.4 p -118.44 158.53 25.15 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.55 1.54 . . . . 0.0 109.842 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -146.39 73.4 1.32 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 31.5 m -104.38 163.64 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 123.821 0.848 . . . . 0.0 110.736 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 60.6 t30 46.61 42.41 11.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.886 2.074 . . . . 0.0 110.408 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -90.31 166.66 13.19 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 127.003 2.121 . . . . 0.0 111.267 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 165.88 174.62 35.56 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 19.1 m -151.76 167.57 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 124.949 1.3 . . . . 0.0 109.806 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.2 t -74.58 169.95 16.75 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.0 t -53.8 116.15 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.184 0.994 . . . . 0.0 109.384 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.0 mp -69.69 145.91 95.3 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.37 156.13 37.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.273 2.649 . . . . 0.0 110.782 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.497 HG21 ' H ' ' A' ' 255' ' ' SER . 75.3 p -99.48 176.11 5.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.682 1.193 . . . . 0.0 108.722 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -107.79 159.25 16.64 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -55.15 103.52 0.09 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.815 0.846 . . . . 0.0 111.936 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.58 -5.65 63.89 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-O 118.176 -1.347 . . . . 0.0 113.223 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.84 108.32 32.92 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 120.206 2.003 . . . . 0.0 110.48 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.17 131.79 31.72 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.643 1.562 . . . . 0.0 109.334 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.497 ' H ' HG21 ' A' ' 249' ' ' THR . 10.1 p -64.13 160.1 19.03 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.39 1.076 . . . . 0.0 109.928 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -132.75 71.68 78.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 118.348 0.522 . . . . 0.0 110.596 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.43 156.64 65.33 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.831 2.354 . . . . 0.0 111.46 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -74.23 160.98 30.4 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 69.4 t -129.21 133.35 65.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.13 0.972 . . . . 0.0 110.856 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.06 141.84 17.27 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 11.4 m -144.69 157.15 14.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 118.561 1.181 . . . . 0.0 109.779 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.75 147.69 52.98 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.198 0.999 . . . . 0.0 108.322 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -133.01 127.31 33.85 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.606 1.094 . . . . 0.0 109.277 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -110.26 138.77 46.19 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.344 1.858 . . . . 0.0 106.959 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -145.5 141.06 9.46 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.221 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 67.4 mt -78.48 137.8 21.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -72.65 129.26 37.85 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.43 -15.93 60.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -67.19 -40.7 86.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.095 -0.955 . . . . 0.0 113.071 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.9 m -47.41 148.85 2.14 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 125.048 1.339 . . . . 0.0 113.78 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.96 -56.02 0.23 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.479 2.119 . . . . 0.0 112.479 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -113.7 102.4 10.22 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.176 1.353 . . . . 0.0 110.392 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.63 -16.82 63.45 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 122.024 -0.423 . . . . 0.0 111.794 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -64.62 -38.08 89.77 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.969 0.907 . . . . 0.0 110.017 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.74 -39.69 81.66 Favored 'General case' 0 N--CA 1.461 0.102 0 O-C-N 121.627 -0.67 . . . . 0.0 110.504 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.89 -44.8 68.99 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -32.53 72.31 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.314 -0.85 . . . . 0.0 111.348 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -74.26 -44.75 51.66 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -58.84 -39.31 80.9 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.57 -48.06 76.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.845 -0.597 . . . . 0.0 111.107 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -79.34 -18.61 52.17 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -107.07 -16.79 14.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.645 1.111 . . . . 0.0 113.932 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -136.82 -40.04 0.62 Allowed 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.235 0.925 . . . . 0.0 113.459 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.65 -36.98 65.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.262 0.937 . . . . 0.0 111.076 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 30.5 mt -107.65 63.45 0.62 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.36 1.464 . . . . 0.0 111.79 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 23.5 p -134.15 155.2 50.53 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.35 -37.8 88.68 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.93 -31.87 61.62 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -75.78 -45.81 16.02 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 65.2 mt -61.66 -43.17 99.36 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.805 0.842 . . . . 0.0 109.598 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -56.67 -41.51 77.41 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.882 0.738 . . . . 0.0 110.249 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.5 93.0 Favored 'General case' 0 C--N 1.343 0.292 0 O-C-N 121.246 -0.909 . . . . 0.0 112.463 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 4.5 t -67.14 -41.82 87.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -65.27 -27.72 68.84 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.705 0.764 . . . . 0.0 112.51 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -70.86 -35.49 72.41 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 117.232 -1.366 . . . . 0.0 109.707 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.61 -45.4 21.69 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.595 1.543 . . . . 0.0 111.791 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -138.33 152.3 71.15 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.757 1.223 . . . . 0.0 108.851 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.65 123.43 10.13 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.556 1.504 . . . . 0.0 109.641 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 20.8 mt -79.21 -30.05 43.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 119.016 -0.516 . . . . 0.0 109.703 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.4 -155.64 22.91 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 106.098 -2.801 . . . . 0.0 106.098 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -75.43 171.58 14.0 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.29 157.01 30.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 123.58 1.657 . . . . 0.0 114.163 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.76 -17.32 59.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.852 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.04 104.76 3.1 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 125.672 1.589 . . . . 0.0 109.146 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -57.48 -29.17 64.03 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 20.5 t -63.37 -66.58 0.52 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.686 1.994 . . . . 0.0 110.304 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.93 -17.5 60.55 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -63.96 -32.29 73.78 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -70.15 -11.35 60.83 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.34 -0.85 . . . . 0.0 111.19 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -98.18 -49.15 4.83 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.97 2.108 . . . . 0.0 108.991 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 64.6 mt -69.8 -31.23 69.02 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 121.865 -0.522 . . . . 0.0 110.143 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.17 -3.78 4.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.263 0.938 . . . . 0.0 112.207 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -64.07 -10.99 25.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.553 1.141 . . . . 0.0 110.88 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.23 144.13 35.62 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 126.162 1.785 . . . . 0.0 107.376 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.78 -24.89 46.48 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.344 2.696 . . . . 0.0 114.805 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 16.9 mmm-85 -62.45 -48.21 80.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.733 0.697 . . . . 0.0 109.151 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.1 mp -65.02 -50.48 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.45 -52.25 39.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 124.197 0.935 . . . . 0.0 109.736 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.8 -36.32 76.51 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.393 -0.817 . . . . 0.0 112.404 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 88.2 m -65.56 -38.52 89.81 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 49.7 tpp -76.51 -38.34 55.34 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.351 0.523 . . . . 0.0 109.818 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -58.23 -34.07 70.03 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 123.942 0.897 . . . . 0.0 109.096 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -61.8 -38.45 88.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.042 -0.411 . . . . 0.0 109.898 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.25 -35.67 66.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -64.34 -49.84 70.13 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.792 0.837 . . . . 0.0 111.345 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -4.38 42.45 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.418 1.087 . . . . 0.0 113.402 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -107.21 -156.6 20.41 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 125.403 1.478 . . . . 0.0 110.645 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -158.94 179.34 9.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.609 1.964 . . . . 0.0 108.525 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 27.3 mm -112.43 132.71 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 123.343 0.657 . . . . 0.0 110.089 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 22.4 ptp -63.77 135.83 96.46 Favored Pre-proline 0 CA--C 1.54 0.586 0 O-C-N 124.825 1.328 . . . . 0.0 107.507 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.51 144.8 51.03 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.844 1.696 . . . . 0.0 111.501 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -103.07 73.18 1.22 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.5 pt -138.55 146.23 49.93 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.734 0.813 . . . . 0.0 109.076 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.78 -18.43 53.02 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.676 2.917 . . . . 0.0 114.478 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -65.43 -17.7 64.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.522 1.129 . . . . 0.0 109.84 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 85.6 mmm -61.64 -32.5 72.66 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.313 0.645 . . . . 0.0 111.381 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 70.5 m -64.89 -45.24 86.8 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.403 1.001 . . . . 0.0 109.478 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.76 80.23 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -64.79 -51.44 62.21 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.395 1.478 . . . . 0.0 109.794 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -58.6 -45.94 88.08 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.45 1.023 . . . . 0.0 110.727 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -58.91 -47.21 85.79 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -56.19 -57.08 13.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.227 1.011 . . . . 0.0 113.052 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 23.5 t -62.41 -35.59 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.217 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.407 ' NH1' ' HG1' ' A' ' 345' ' ' THR . 7.4 tmm_? -54.08 -50.07 67.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.73 1.605 . . . . 0.0 110.119 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' THR . . . . . 0.407 ' HG1' ' NH1' ' A' ' 344' ' ' ARG . 32.2 m -67.02 -40.88 87.34 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.743 -0.598 . . . . 0.0 110.516 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.77 98.99 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.578 1.081 . . . . 0.0 113.426 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.48 -46.99 95.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 33.1 mm -68.7 -37.12 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 118.544 0.611 . . . . 0.0 110.068 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -57.21 -46.94 82.44 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.245 -0.909 . . . . 0.0 108.942 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.27 -53.77 32.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.417 1.087 . . . . 0.0 110.789 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -57.61 -34.19 69.02 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.469 1.508 . . . . 0.0 114.372 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 52.1 m -97.39 0.48 47.89 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.1 0.56 . . . . 0.0 111.173 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 67.89 12.33 62.17 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.93 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -62.98 -31.49 72.63 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.557 1.179 . . . . 0.0 108.481 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -147.18 152.95 39.24 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 7.5 m -61.52 153.13 28.31 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.283 1.433 . . . . 0.0 108.674 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 11.1 t -58.81 -45.72 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 119.435 1.016 . . . . 0.0 108.386 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.26 -48.56 76.31 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.168 1.387 . . . . 0.0 111.28 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -68.42 -44.92 73.96 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.879 1.271 . . . . 0.0 111.988 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.24 -44.04 83.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.308 0.643 . . . . 0.0 110.58 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.3 mp -70.17 -39.97 74.98 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.555 0.742 . . . . 0.0 110.602 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -57.37 -47.55 81.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.1 -54.29 45.03 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.517 1.527 . . . . 0.0 108.206 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -54.33 -50.82 66.52 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.411 1.485 . . . . 0.0 112.902 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -54.71 -39.68 68.44 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 5.6 m -69.78 -22.98 63.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.162 0.585 . . . . 0.0 111.565 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -78.41 -4.74 49.81 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 120.139 -1.6 . . . . 0.0 112.135 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 5.2 mt -112.68 -29.19 2.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 124.063 0.945 . . . . 0.0 110.252 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 20.4 p -75.7 -23.95 56.2 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.595 1.089 . . . . 0.0 110.445 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 CA-C-O 117.444 -1.265 . . . . 0.0 108.989 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.432 ' CG2' ' HD3' ' A' ' 271' ' ' PRO . 4.1 mp -80.58 131.71 33.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 102.617 -3.105 . . . . 0.0 102.617 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -72.3 104.97 3.88 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -74.27 115.45 13.79 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 126.411 1.884 . . . . 0.0 107.715 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.63 31.86 1.42 Allowed Glycine 0 CA--C 1.532 1.1 0 N-CA-C 115.284 0.873 . . . . 0.0 115.284 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.39 169.72 20.2 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.217 -1.167 . . . . 0.0 110.829 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.6 mt -150.7 148.92 29.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.573 2.749 . . . . 0.0 105.743 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.5 t -140.7 128.72 23.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 18.7 mt -108.4 137.4 40.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 125.169 1.388 . . . . 0.0 107.501 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -135.57 129.48 33.03 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.333 1.853 . . . . 0.0 106.364 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -149.05 163.94 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 126.533 1.933 . . . . 0.0 108.106 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -78.55 170.92 15.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.817 0.847 . . . . 0.0 111.727 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.14 -43.24 73.71 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 127.217 2.342 . . . . 0.0 117.006 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -68.51 -13.37 62.28 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.342 1.071 . . . . 0.0 112.631 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -70.63 160.23 32.95 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 123.563 1.649 . . . . 0.0 113.132 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.39 60.09 4.75 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 106.306 -2.718 . . . . 0.0 106.306 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -60.11 -46.69 88.76 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 124.448 1.099 . . . . 0.0 109.693 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -61.82 -49.61 75.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.3 94.79 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.6 tp -68.99 -34.68 75.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.142 0.977 . . . . 0.0 110.972 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.68 74.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.352 -0.833 . . . . 0.0 109.602 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -58.72 -34.35 71.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.381 1.072 . . . . 0.0 111.946 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 t -76.8 -45.12 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.455 1.502 . . . . 0.0 108.291 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.58 -46.83 93.48 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 124.104 0.859 . . . . 0.0 112.222 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -37.22 84.91 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 117.886 -1.054 . . . . 0.0 108.72 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -61.33 -54.27 46.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -53.73 -46.23 70.76 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.552 0.614 . . . . 0.0 110.668 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -65.34 -32.26 73.82 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.044 -1.035 . . . . 0.0 111.0 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -71.93 -28.52 63.53 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.986 0.914 . . . . 0.0 110.879 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -95.98 -16.05 21.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.667 1.187 . . . . 0.0 111.97 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -126.33 -27.87 3.15 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.25 -14.49 63.54 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 120.866 -1.146 . . . . 0.0 113.654 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 mm -70.67 130.58 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 120.078 1.939 . . . . 0.0 106.81 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.435 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -58.11 145.28 37.28 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.82 87.65 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.505 1.122 . . . . 0.0 109.215 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 m -78.35 136.44 37.69 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.5 t -130.26 119.88 47.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -133.34 164.17 27.69 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.016 1.326 . . . . 0.0 107.838 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -120.26 62.15 8.6 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.661 1.585 . . . . 0.0 110.8 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.18 152.13 81.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.915 1.743 . . . . 0.0 110.662 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -120.42 19.84 11.98 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.683 1.593 . . . . 0.0 109.628 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.45 12.64 0.73 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.292 2.237 . . . . 0.0 112.683 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -56.48 -27.93 58.36 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 120.315 -1.49 . . . . 0.0 112.921 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -59.07 -20.03 49.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.29 1.436 . . . . 0.0 113.532 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -120.36 -18.02 8.04 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.756 -0.59 . . . . 0.0 110.948 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -46.7 15.43 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.491 1.116 . . . . 0.0 110.917 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -46.32 -57.38 8.59 Favored Pre-proline 0 N--CA 1.468 0.444 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.628 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.15 -18.9 64.58 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.778 1.652 . . . . 0.0 114.592 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -89.07 -8.68 53.42 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 119.995 1.27 . . . . 0.0 112.987 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.1 -36.01 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 119.191 0.905 . . . . 0.0 111.105 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -28.18 67.99 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.044 -1.035 . . . . 0.0 109.848 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.75 -5.58 4.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.581 1.152 . . . . 0.0 113.248 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.0 t -131.33 7.57 4.58 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.742 2.017 . . . . 0.0 109.585 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.37 5.6 72.89 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 119.955 -1.716 . . . . 0.0 114.881 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.53 -2.48 57.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.216 1.008 . . . . 0.0 110.103 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.55 -172.28 48.38 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.401 1.953 . . . . 0.0 115.778 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -69.82 173.92 10.31 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.188 3.259 . . . . 0.0 111.907 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -108.36 -18.4 13.76 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -141.45 145.37 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.907 1.283 . . . . 0.0 107.664 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 tt -137.06 141.19 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.701 1.6 . . . . 0.0 107.408 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -130.32 113.36 14.28 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.086 1.355 . . . . 0.0 109.608 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -157.68 171.11 20.91 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.722 0.809 . . . . 0.0 109.257 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.42 162.21 25.96 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -52.25 -25.51 9.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.327 1.451 . . . . 0.0 112.2 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -50.22 -65.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.96 1.704 . . . . 0.0 113.64 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -69.55 -18.93 63.69 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 122.151 -0.343 . . . . 0.0 110.291 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -78.03 -20.96 51.46 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.65 -5.05 7.88 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 117.836 -1.535 . . . . 0.0 112.939 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.74 -17.91 0.55 Allowed Glycine 0 CA--C 1.535 1.331 0 CA-C-O 117.26 -1.855 . . . . 0.0 115.816 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -65.09 -33.89 77.11 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.027 2.414 . . . . 0.0 112.865 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.94 -36.39 75.25 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 119.411 1.005 . . . . 0.0 108.316 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -48.04 79.77 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.8 m -65.61 -5.39 8.14 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.128 1.771 . . . . 0.0 112.856 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.29 16.95 79.99 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 126.761 2.124 . . . . 0.0 113.048 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.5 mt -87.63 -18.11 30.35 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.5 mt -96.93 135.44 38.91 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.962 0.801 . . . . 0.0 109.21 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.421 ' HB3' ' HE2' ' A' ' 273' ' ' LYS . . . -81.68 161.32 23.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.274 1.029 . . . . 0.0 111.314 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -68.34 105.46 2.16 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.593 1.157 . . . . 0.0 108.058 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.83 163.67 2.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 118.753 0.706 . . . . 0.0 111.034 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.4 m 114.77 91.21 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.525 1 C-N-CA 132.668 4.387 . . . . 0.0 108.788 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.87 -54.51 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.436 2.091 . . . . 0.0 109.106 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -148.23 152.58 37.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.175 1.79 . . . . 0.0 106.83 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -62.31 -33.76 75.29 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 118.99 -0.529 . . . . 0.0 111.084 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.05 -28.5 52.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.371 0.987 . . . . 0.0 112.306 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -68.93 -30.61 69.1 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.652 0.66 . . . . 0.0 109.989 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -69.1 -41.64 77.18 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.584 1.084 . . . . 0.0 110.707 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.07 -28.37 69.03 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.969 0.908 . . . . 0.0 111.716 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -69.03 -7.71 38.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.85 0.86 . . . . 0.0 112.952 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -117.93 149.58 40.65 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.692 1.133 . . . . 0.0 113.417 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.463 ' HH ' ' HG2' ' A' ' 308' ' ' GLU . 59.5 m-85 -63.54 150.64 89.76 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.582 0.753 . . . . 0.0 110.33 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.54 -43.63 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.657 2.238 . . . . 0.0 112.95 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -61.52 -42.08 98.28 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 121.809 -0.557 . . . . 0.0 110.973 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.69 -28.93 68.1 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -49.16 66.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.84 0.856 . . . . 0.0 109.592 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -16.72 51.43 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.9 -41.83 82.11 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.755 0.707 . . . . 0.0 109.964 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.5 m -86.08 -15.38 10.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.071 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -51.74 149.54 4.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.767 1.167 . . . . 0.0 113.612 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.5 -174.48 3.13 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 126.367 1.867 . . . . 0.0 107.381 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -63.32 100.74 0.26 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.313 0.645 . . . . 0.0 109.323 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.27 -83.04 0.25 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 124.83 1.205 . . . . 0.0 111.05 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.2 173.84 2.32 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.691 1.196 . . . . 0.0 111.661 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.4 mt -106.54 169.83 8.29 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.216 1.007 . . . . 0.0 111.358 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.7 pt -143.48 -28.18 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.03 1.732 . . . . 0.0 114.232 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.1 177.76 10.97 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.659 1.572 . . . . 0.0 111.167 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -122.16 145.65 44.62 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 125.057 1.343 . . . . 0.0 110.469 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.34 149.83 45.78 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.667 2.911 . . . . 0.0 108.171 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.8 mm -125.98 -44.99 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.109 1.364 . . . . 0.0 111.797 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.1 159.34 43.41 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.368 0.531 . . . . 0.0 110.992 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.4 t -122.45 116.01 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.657 1.183 . . . . 0.0 108.018 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -144.98 148.79 34.17 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 125.255 1.422 . . . . 0.0 107.63 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.98 176.39 8.47 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 68.2 mt -61.37 162.31 8.04 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.939 0.876 . . . . 0.0 110.568 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.6 p -137.43 161.03 37.42 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.934 0.893 . . . . 0.0 111.996 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.8 tp -73.43 154.77 39.85 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.743 1.217 . . . . 0.0 110.033 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.33 101.28 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -78.28 174.14 11.54 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -82.77 -172.74 4.26 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.487 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -74.29 1.57 11.21 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.31 1.844 . . . . 0.0 111.335 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -98.36 144.18 28.03 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.722 2.009 . . . . 0.0 110.707 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.05 5.36 16.77 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 32.1 tp -36.82 109.59 0.44 Allowed Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 125.191 1.396 . . . . 0.0 110.823 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.84 -169.12 0.36 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.773 2.982 . . . . 0.0 110.956 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.7 t30 64.9 69.87 0.64 Allowed Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 126.019 1.728 . . . . 0.0 110.602 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.94 167.07 24.39 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.284 2.656 . . . . 0.0 110.846 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.02 168.87 23.73 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.959 1.773 . . . . 0.0 110.303 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -134.98 -30.74 1.04 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.838 1.255 . . . . 0.0 112.731 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.404 ' HA ' ' H ' ' A' ' 249' ' ' THR . 14.9 t -158.96 157.73 31.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -65.43 -22.4 66.76 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.815 1.246 . . . . 0.0 112.426 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -69.85 -27.46 64.86 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.912 1.685 . . . . 0.0 110.469 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -89.61 -22.02 22.53 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.217 1.807 . . . . 0.0 111.983 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.6 mm -54.4 -56.02 31.11 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 117.889 -1.053 . . . . 0.0 110.355 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.85 -24.47 46.53 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 CA-C-N 120.398 1.178 . . . . 0.0 112.026 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.49 -55.4 10.35 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.5 tp -64.13 -27.23 68.94 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.529 -1.357 . . . . 0.0 110.244 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.44 -43.95 95.96 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 121.782 -0.574 . . . . 0.0 109.78 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -71.87 -27.45 62.87 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 119.116 -0.469 . . . . 0.0 111.182 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -70.69 -48.24 55.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.3 -33.46 73.21 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.501 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -67.96 -36.91 80.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.12 -27.05 69.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.863 0.756 . . . . 0.0 111.656 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.9 3.22 20.37 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.923 0.889 . . . . 0.0 112.673 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.41 -102.65 0.17 Allowed Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 118.825 0.739 . . . . 0.0 111.585 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -137.5 178.54 7.02 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.397 1.079 . . . . 0.0 110.693 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 p -54.99 157.6 3.18 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.923 1.689 . . . . 0.0 114.208 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.9 -69.14 0.73 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.644 1.578 . . . . 0.0 112.31 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.2 tp -99.2 132.64 44.37 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.029 1.332 . . . . 0.0 110.218 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.2 ttm -142.47 133.26 25.53 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -161.75 172.93 15.36 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.952 1.301 . . . . 0.0 108.954 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -69.77 92.31 0.67 Allowed 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 mt -77.12 -14.66 59.76 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.219 -0.926 . . . . 0.0 110.105 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -68.74 -31.87 71.23 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.051 -1.452 . . . . 0.0 114.742 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -104.05 154.96 37.78 Favored Pre-proline 0 C--N 1.343 0.316 0 CA-C-N 121.661 2.028 . . . . 0.0 114.147 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.16 -15.05 11.76 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.212 1.941 . . . . 0.0 114.158 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -61.04 -39.62 90.49 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.771 1.623 . . . . 0.0 111.805 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -82.28 -33.45 29.1 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -81.75 -15.84 53.0 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.242 0.928 . . . . 0.0 111.319 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -46.34 -58.21 7.02 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.04 -16.94 29.01 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.591 1.527 . . . . 0.0 115.086 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.7 tp -67.4 -62.22 1.53 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 120.262 1.392 . . . . 0.0 107.393 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 6.2 pt -68.63 -24.88 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.494 1.118 . . . . 0.0 112.649 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.62 -18.21 62.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.485 -0.759 . . . . 0.0 111.127 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -56.6 -53.84 52.95 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.655 1.182 . . . . 0.0 111.229 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -61.84 -58.19 8.92 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.26 22.37 0.03 OUTLIER Glycine 0 C--N 1.333 0.376 0 CA-C-O 118.611 -1.105 . . . . 0.0 115.126 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.29 134.11 13.36 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -137.51 140.77 41.34 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.859 1.83 . . . . 0.0 114.022 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.92 81.12 4.15 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.718 2.007 . . . . 0.0 106.992 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 67.22 164.75 0.21 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 127.166 2.186 . . . . 0.0 111.061 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -127.75 138.52 52.79 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.177 0.591 . . . . 0.0 109.51 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.58 119.66 25.19 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.604 1.962 . . . . 0.0 105.77 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -96.96 41.38 1.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.932 2.093 . . . . 0.0 111.521 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 55.33 81.21 0.12 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.743 1.217 . . . . 0.0 110.974 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 101.98 -18.62 51.82 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.728 -1.04 . . . . 0.0 113.301 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -117.54 122.75 44.52 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -131.55 115.99 16.85 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 125.733 1.613 . . . . 0.0 108.431 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -124.54 93.18 3.83 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.28 -7.33 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.524 1.929 . . . . 0.0 112.894 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -75.88 -30.89 59.01 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 120.898 -1.126 . . . . 0.0 109.422 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -81.9 67.84 8.05 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.121 0.968 . . . . 0.0 109.288 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 45.3 t -80.78 156.0 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.62 40.11 1.7 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-O 118.122 -1.377 . . . . 0.0 113.53 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.0 t -95.64 -27.64 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 120.029 1.914 . . . . 0.0 112.692 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -90.72 10.7 24.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.804 1.638 . . . . 0.0 109.995 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -60.31 152.2 25.69 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.808 -1.182 . . . . 0.0 109.311 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.73 -27.22 62.79 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.972 0.509 . . . . 0.0 111.7 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.98 -40.16 44.31 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 123.566 0.603 . . . . 0.0 112.286 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.1 -51.14 70.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -60.31 -42.83 96.38 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.561 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.41 -46.51 86.3 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.836 0.744 . . . . 0.0 110.943 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -72.62 -29.54 65.48 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 119.462 -0.632 . . . . 0.0 113.944 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 18.2 tp -80.21 -39.88 28.23 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.2 t -57.83 -34.16 69.39 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.85 0.75 . . . . 0.0 109.885 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -59.46 -48.12 82.86 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.58 0.627 . . . . 0.0 109.852 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.57 -45.53 88.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.362 0.665 . . . . 0.0 109.843 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.03 -29.4 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.148 0.579 . . . . 0.0 110.26 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -62.25 -39.25 92.24 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.085 -1.009 . . . . 0.0 112.387 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.5 mt -70.92 -43.47 68.16 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 55.4 mt -64.06 -39.84 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -52.27 -46.6 65.9 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.06 -1.025 . . . . 0.0 108.849 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -80.66 -0.98 40.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.093 2.157 . . . . 0.0 113.82 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.1 mptt 57.58 4.64 0.25 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.671 2.388 . . . . 0.0 115.424 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -71.57 -31.74 67.3 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.686 -0.634 . . . . 0.0 112.097 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.5 tpt -69.01 163.31 24.93 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 118.554 0.616 . . . . 0.0 109.97 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -91.34 52.18 2.05 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.51 -11.27 1.87 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.979 2.512 . . . . 0.0 115.606 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -102.81 0.23 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.679 0.791 . . . . 0.0 111.921 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 85.9 m -74.19 124.7 26.86 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.879 1.272 . . . . 0.0 110.908 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.61 177.31 4.88 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -53.14 -45.94 68.61 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.522 0.677 . . . . 0.0 112.268 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.5 m -63.88 -29.41 70.59 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.787 2.435 . . . . 0.0 112.577 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 77.0 mt -81.35 -49.11 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.77 72.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.09 -45.8 93.22 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.699 0.681 . . . . 0.0 111.205 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.15 -55.65 31.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.55 -38.15 77.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.548 0.739 . . . . 0.0 111.761 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -61.26 -46.55 89.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -64.69 -35.76 82.08 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -68.46 -18.93 64.52 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.951 -1.093 . . . . 0.0 111.735 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.88 16.89 66.69 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -86.81 -8.13 57.61 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 35.1 p -113.33 136.97 52.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.731 1.612 . . . . 0.0 106.71 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.07 -21.39 46.83 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.288 -0.883 . . . . 0.0 111.081 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -164.99 170.05 15.65 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.592 -0.692 . . . . 0.0 109.721 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 4.4 t -162.95 -178.44 6.09 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.486 1.914 . . . . 0.0 106.498 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.43 154.32 39.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -153.29 151.23 29.78 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.495 -0.753 . . . . 0.0 108.985 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -102.94 -179.98 26.34 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.897 1.237 . . . . 0.0 111.107 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.0 -49.27 8.5 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.768 2.979 . . . . 0.0 110.693 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -133.84 133.27 41.38 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.041 2.136 . . . . 0.0 105.763 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -112.19 109.75 19.61 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -61.48 130.09 44.32 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.3 t -167.67 168.51 12.55 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.301 1.84 . . . . 0.0 106.644 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -139.24 29.45 2.22 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.219 1.408 . . . . 0.0 108.282 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 12.5 tt -158.45 150.42 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 128.429 2.691 . . . . 0.0 105.688 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 32.57 55.3 0.38 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 129.514 3.126 . . . . 0.0 113.075 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.6 p -69.32 87.13 0.43 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.442 1.497 . . . . 0.0 109.829 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 19.9 m -127.42 167.67 15.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.971 1.708 . . . . 0.0 108.232 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -155.85 162.88 40.38 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.007 -1.058 . . . . 0.0 110.056 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.65 149.49 32.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 123.405 0.682 . . . . 0.0 109.64 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -72.89 158.26 35.86 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.341 0.656 . . . . 0.0 109.458 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -140.27 170.4 15.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.837 1.255 . . . . 0.0 110.199 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -125.51 177.53 16.96 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.131 1.824 . . . . 0.0 109.528 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.4 p -100.63 110.4 27.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 O-C-N 121.352 -1.087 . . . . 0.0 111.529 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.0 t -142.32 173.81 11.19 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.871 0.868 . . . . 0.0 108.814 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.91 162.13 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 127.21 2.204 . . . . 0.0 110.519 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pp -143.77 152.14 55.07 Favored Pre-proline 0 C--O 1.239 0.527 0 C-N-CA 125.033 1.333 . . . . 0.0 108.105 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.19 150.36 87.67 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.114 1.876 . . . . 0.0 110.793 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 255' ' ' SER . 57.4 p -129.51 165.57 21.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.855 2.062 . . . . 0.0 110.234 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -85.29 159.86 19.96 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.136 0.88 . . . . 0.0 109.176 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -49.81 103.54 0.05 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.284 1.434 . . . . 0.0 113.287 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.17 1.52 90.49 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 117.225 -1.875 . . . . 0.0 115.279 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.26 122.19 11.54 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 121.39 2.595 . . . . 0.0 113.437 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.95 147.83 85.24 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.149 1.9 . . . . 0.0 111.374 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.422 ' H ' HG23 ' A' ' 249' ' ' THR . 48.0 t -64.13 152.41 40.63 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.804 1.241 . . . . 0.0 109.426 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.425 ' HD3' ' HE3' ' A' ' 326' ' ' LYS . 69.9 mttt -134.21 77.68 60.3 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.365 1.466 . . . . 0.0 107.693 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -82.62 -175.37 2.43 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.298 3.332 . . . . 0.0 111.437 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -66.86 166.65 12.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.621 0.768 . . . . 0.0 108.957 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 26.5 t -96.22 164.47 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -147.49 150.99 23.3 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 75.4 t -135.22 112.04 13.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.582 0.706 . . . . 0.0 109.448 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.91 126.82 28.89 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 12.5 m -117.32 164.56 14.64 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.215 1.006 . . . . 0.0 110.933 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -134.27 135.54 42.95 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.693 1.597 . . . . 0.0 107.495 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -127.42 166.54 20.11 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 62.6 mt -114.19 133.35 60.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.07 122.97 23.51 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.23 -15.07 63.43 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.197 -1.382 . . . . 0.0 114.641 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -76.63 -14.02 60.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.649 1.568 . . . . 0.0 114.373 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 36.5 m -61.98 154.24 69.48 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 123.838 0.855 . . . . 0.0 109.361 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.432 ' HD3' ' CG2' ' A' ' 2' ' ' ILE . 52.2 Cg_endo -68.04 -58.5 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.967 1.778 . . . . 0.0 110.914 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -118.15 100.26 7.41 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.989 1.316 . . . . 0.0 108.254 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -59.0 -15.77 14.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.787 0.435 . . . . 0.0 112.139 178.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -59.97 -34.19 72.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.391 1.476 . . . . 0.0 110.105 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.9 mt -57.69 -44.03 85.55 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.58 -37.05 63.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.139 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -35.43 79.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.026 0.83 . . . . 0.0 109.651 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -69.97 -55.19 10.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.947 -0.549 . . . . 0.0 109.727 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -52.19 -46.51 65.6 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.049 0.841 . . . . 0.0 111.58 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.4 tt -64.63 -40.82 96.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -90.11 -3.9 57.64 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -105.96 -23.68 12.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.051 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -143.24 -36.72 0.37 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.901 1.228 . . . . 0.0 114.017 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.14 -32.7 71.26 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.105 1.321 . . . . 0.0 113.678 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.57 51.31 0.94 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.333 1.853 . . . . 0.0 110.242 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 47.7 p -120.55 163.13 18.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.26 -39.26 92.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -70.97 -41.91 70.4 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.269 0.628 . . . . 0.0 111.438 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.6 67.12 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 78.9 mt -67.62 -43.16 81.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.93 -44.5 94.3 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.2 -41.57 88.84 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.343 1.057 . . . . 0.0 113.606 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 92.9 t -76.84 -36.29 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -66.82 -36.41 82.3 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -66.96 -32.91 74.48 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.729 -0.607 . . . . 0.0 111.055 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.34 -50.49 15.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.517 1.127 . . . . 0.0 110.585 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -141.79 150.94 58.47 Favored Pre-proline 0 N--CA 1.47 0.535 0 O-C-N 121.045 -1.034 . . . . 0.0 109.299 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.01 115.77 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.202 2.602 . . . . 0.0 110.777 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 14.4 mt -84.0 -31.93 25.23 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.673 -0.642 . . . . 0.0 111.54 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 93.02 -146.91 18.34 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 106.343 -2.703 . . . . 0.0 106.343 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.66 173.28 11.5 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.01 153.34 38.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 123.193 1.473 . . . . 0.0 113.475 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.97 -30.92 62.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.914 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 58.7 tp -66.29 104.93 1.3 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.43 1.892 . . . . 0.0 107.968 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -56.66 -23.05 38.91 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.662 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 40.1 m -72.38 -61.73 1.69 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.909 0.777 . . . . 0.0 110.825 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -71.5 -19.19 62.23 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.102 0.864 . . . . 0.0 112.769 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.463 ' HG2' ' HH ' ' A' ' 90' ' ' TYR . 44.6 tp10 -63.62 -31.37 72.51 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -67.95 -15.2 63.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.364 0.984 . . . . 0.0 111.264 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.471 ' HA ' ' HE3' ' A' ' 313' ' ' LYS . 29.3 mm-40 -94.71 -48.47 6.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.259 1.424 . . . . 0.0 108.264 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 7.2 mt -64.65 -41.25 96.25 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.36 -0.55 0.59 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 310' ' ' GLU . 90.6 mttt -67.58 -13.51 62.13 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.376 1.07 . . . . 0.0 111.835 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.0 151.21 68.6 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 119.756 1.162 . . . . 0.0 109.711 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.64 -23.8 63.28 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.095 2.53 . . . . 0.0 113.84 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -61.57 -27.99 69.02 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.661 0.664 . . . . 0.0 110.551 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.2 mp -91.08 -52.32 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -48.09 -50.37 28.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.905 0.753 . . . . 0.0 110.679 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.25 -32.52 71.22 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 13.6 m -68.91 -41.04 78.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.492 1.042 . . . . 0.0 108.21 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.8 tpp -69.53 -41.57 75.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.843 -0.599 . . . . 0.0 109.457 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -53.35 -43.31 67.63 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -58.68 -46.66 86.75 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.36 1.064 . . . . 0.0 109.268 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.41 -25.33 67.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.424 0.69 . . . . 0.0 111.433 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -82.03 -26.45 33.78 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.824 0.738 . . . . 0.0 111.422 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.425 ' HE3' ' HD3' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -103.79 -8.25 19.94 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -86.4 -147.75 11.19 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 125.327 1.441 . . . . 0.0 112.396 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -145.94 130.3 17.69 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.264 1.826 . . . . 0.0 106.483 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 67.3 mt -104.91 97.49 5.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 127.001 2.12 . . . . 0.0 107.27 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.54 73.99 0.6 Allowed Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 126.824 2.05 . . . . 0.0 111.454 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.75 130.0 25.02 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.904 3.069 . . . . 0.0 113.985 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -116.4 76.25 1.01 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.607 1.563 . . . . 0.0 108.925 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.64 147.69 49.97 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.995 1.318 . . . . 0.0 110.922 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.46 -18.67 33.55 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.497 2.131 . . . . 0.0 111.799 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -72.49 -23.02 60.97 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 120.921 -1.112 . . . . 0.0 109.09 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -40.45 83.94 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.518 1.508 . . . . 0.0 109.42 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 p -69.0 -34.25 74.98 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.383 -0.823 . . . . 0.0 109.242 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -69.63 -42.64 74.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -53.84 -54.56 36.74 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 126.557 1.943 . . . . 0.0 109.849 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -60.89 -45.66 93.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.579 0.627 . . . . 0.0 110.084 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -63.15 -26.72 68.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.99 -60.87 2.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.702 1.201 . . . . 0.0 109.41 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -24.71 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.353 -0.842 . . . . 0.0 111.795 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 26.7 ttt-85 -56.71 -27.65 59.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.356 1.062 . . . . 0.0 110.788 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 1.5 m -97.79 -37.92 9.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.48 -48.3 66.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.874 0.761 . . . . 0.0 112.66 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.09 -56.88 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 37.4 mm -58.07 -36.5 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.289 0.635 . . . . 0.0 110.265 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -56.65 -48.99 76.35 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.843 -1.161 . . . . 0.0 110.094 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.42 -42.42 59.21 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.433 -0.318 . . . . 0.0 111.337 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -59.72 -37.14 78.09 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.468 0.707 . . . . 0.0 112.079 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.0 m -86.85 -7.72 57.96 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.148 0.979 . . . . 0.0 109.64 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 75.99 17.62 79.94 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 118.905 0.775 . . . . 0.0 113.018 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -73.3 -30.71 63.57 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.151 0.981 . . . . 0.0 110.699 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -150.75 166.45 30.42 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.032 0.833 . . . . 0.0 110.519 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.9 m -71.91 152.72 42.35 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.0 t -52.37 -56.19 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.455 1.102 . . . . 0.0 108.306 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.66 -44.73 77.5 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 124.777 1.231 . . . . 0.0 113.461 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -71.97 -36.49 69.85 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.649 0.659 . . . . 0.0 111.964 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.11 -35.25 80.14 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 10.7 tp -73.07 -42.48 63.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.949 1.699 . . . . 0.0 110.673 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -58.29 -52.86 63.82 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.461 1.504 . . . . 0.0 108.095 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -49.87 -56.73 9.35 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 126.283 1.833 . . . . 0.0 108.916 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.94 -48.61 80.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.934 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -57.39 -37.04 72.07 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.9 m -62.66 -43.97 97.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.407 0.683 . . . . 0.0 110.069 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 45.4 mtt-85 -57.97 -27.7 63.68 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.445 -0.784 . . . . 0.0 111.563 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.7 mt -86.12 -39.28 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.986 0.914 . . . . 0.0 110.459 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 22.4 p -70.17 -31.1 68.42 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.518 1.054 . . . . 0.0 112.434 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.541 1.537 . . . . 0.0 110.855 -178.787 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 26.4 tptt . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.2 mt -126.92 154.52 37.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.87 88.04 4.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 123.353 1.549 . . . . 0.0 111.277 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -71.94 107.24 4.58 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.129 1.772 . . . . 0.0 108.647 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.62 22.64 3.01 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 116.063 1.185 . . . . 0.0 116.063 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -136.43 170.91 15.27 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 119.218 1.509 . . . . 0.0 110.19 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.0 mt -148.38 152.87 37.76 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 128.695 2.798 . . . . 0.0 107.63 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.75 149.65 16.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.3 mt -128.82 120.69 52.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 126.893 2.077 . . . . 0.0 105.95 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -119.2 114.72 22.87 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.533 1.133 . . . . 0.0 109.124 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.7 mt -122.92 164.58 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.962 1.305 . . . . 0.0 108.074 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -84.11 4.43 30.35 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.89 175.68 49.29 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 59.51 22.42 10.99 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.234 1.017 . . . . 0.0 111.359 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -125.64 166.08 17.39 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 126.655 1.982 . . . . 0.0 108.041 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.34 47.21 2.63 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 119.062 -0.855 . . . . 0.0 114.791 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -50.83 -38.86 51.36 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.036 0.934 . . . . 0.0 113.08 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -58.57 -47.23 84.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.012 0.823 . . . . 0.0 110.303 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.96 -38.02 93.77 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.37 -35.64 78.01 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.752 0.821 . . . . 0.0 111.164 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.26 -37.44 64.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.376 0.67 . . . . 0.0 110.23 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -67.33 -30.05 69.78 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.117 0.872 . . . . 0.0 111.963 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 t -69.26 -43.94 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.58 -41.17 94.21 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -60.21 -45.73 92.18 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -58.25 -55.04 40.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -52.19 -55.6 20.02 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 117.892 0.315 . . . . 0.0 110.927 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.93 -35.68 73.5 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.144 -0.973 . . . . 0.0 111.191 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -69.06 -28.34 66.44 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 120.931 -1.106 . . . . 0.0 111.285 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -98.53 -5.86 31.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.591 1.156 . . . . 0.0 111.519 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.1 p -134.96 -35.46 0.85 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.44 -11.5 63.28 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.356 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.9 mm -67.58 137.27 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -70.64 139.8 51.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 117.652 -1.166 . . . . 0.0 109.727 -179.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.0 t -135.18 121.12 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.5 m -114.14 145.15 42.04 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.831 2.052 . . . . 0.0 110.87 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -137.24 128.52 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.84 1.656 . . . . 0.0 107.319 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -140.55 160.64 39.57 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.639 0.776 . . . . 0.0 111.68 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -127.07 68.06 71.35 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.214 1.405 . . . . 0.0 112.559 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.83 168.72 20.54 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 124.812 3.675 . . . . 0.0 111.267 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -110.8 8.11 22.25 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.709 1.604 . . . . 0.0 110.758 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.67 11.79 4.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -52.07 -30.74 27.22 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -63.7 -20.45 65.73 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.874 2.07 . . . . 0.0 113.438 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -117.82 -24.32 7.2 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 123.841 0.856 . . . . 0.0 109.498 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.2 mmpt? -74.76 -46.09 39.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.795 -1.097 . . . . 0.0 110.886 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -50.73 -57.44 13.42 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 120.296 1.407 . . . . 0.0 110.199 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.46 -0.19 5.54 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 121.767 1.644 . . . . 0.0 114.558 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -112.05 -0.15 15.77 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.753 1.221 . . . . 0.0 111.561 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.4 t -130.59 -42.63 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.349 1.06 . . . . 0.0 108.657 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.33 73.73 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 120.995 -1.066 . . . . 0.0 108.759 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.01 -13.36 4.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.021 1.328 . . . . 0.0 113.266 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.2 p -118.95 -0.76 11.11 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.91 1.232 . . . . 0.0 111.445 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.31 15.15 64.91 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.33 0.967 . . . . 0.0 111.56 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -106.79 -6.01 18.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.649 1.224 . . . . 0.0 113.633 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.01 -173.56 32.34 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.896 1.236 . . . . 0.0 115.228 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -70.78 179.29 4.37 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 124.205 3.27 . . . . 0.0 111.435 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -105.57 -20.18 13.55 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 121.264 -0.898 . . . . 0.0 113.045 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 mt -140.92 149.85 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.5 tt -128.71 148.88 33.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 126.293 1.837 . . . . 0.0 106.695 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -138.87 99.3 3.75 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.752 1.221 . . . . 0.0 109.785 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -153.11 177.81 10.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.133 0.968 . . . . 0.0 111.667 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.52 134.33 53.16 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.781 1.632 . . . . 0.0 107.345 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -52.63 -27.84 18.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 129.01 2.924 . . . . 0.0 112.279 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.95 -26.4 65.95 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.427 0.691 . . . . 0.0 109.717 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -102.73 12.48 36.23 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 127.507 2.323 . . . . 0.0 110.852 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -108.02 -30.83 8.23 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.825 1.648 . . . . 0.0 111.227 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.8 -10.48 38.64 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.801 -1.0 . . . . 0.0 113.865 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.27 -47.59 3.26 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 119.928 1.864 . . . . 0.0 109.229 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -55.31 -46.74 76.26 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.709 1.604 . . . . 0.0 111.68 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.14 93.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.734 1.152 . . . . 0.0 109.673 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.91 1.09 4.81 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.972 1.709 . . . . 0.0 111.149 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -122.68 2.32 9.5 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.305 2.642 . . . . 0.0 109.511 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.62 -1.03 68.29 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 125.656 1.598 . . . . 0.0 112.401 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -69.04 -34.3 74.99 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.566 1.183 . . . . 0.0 112.848 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.5 mt -89.15 127.88 35.75 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.44 170.34 16.07 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.692 0.797 . . . . 0.0 112.602 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -60.11 117.31 4.97 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 mm -70.96 166.19 2.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 m -39.58 113.96 0.9 Allowed Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.265 1.826 . . . . 0.0 110.955 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.77 -53.32 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.434 2.756 . . . . 0.0 113.364 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -62.26 116.75 5.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.427 1.108 . . . . 0.0 111.731 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -54.33 -28.59 43.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.479 1.512 . . . . 0.0 111.971 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.82 -32.5 67.66 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.861 1.209 . . . . 0.0 112.786 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -68.98 -39.44 79.39 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -66.22 -37.73 86.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.722 1.209 . . . . 0.0 110.329 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.8 -13.4 59.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.311 1.845 . . . . 0.0 112.186 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -76.97 -9.65 58.84 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.757 -1.214 . . . . 0.0 110.591 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.9 mt -118.29 157.51 26.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.529 1.932 . . . . 0.0 108.614 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.402 ' CD1' ' HG2' ' A' ' 305' ' ' LYS . 48.9 m-85 -64.93 152.71 90.28 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 119.118 0.872 . . . . 0.0 109.497 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.53 -35.72 9.94 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.763 2.308 . . . . 0.0 114.531 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -64.18 -32.82 74.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.863 0.756 . . . . 0.0 110.902 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.77 -21.77 66.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.301 1.04 . . . . 0.0 110.401 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -77.43 -32.77 54.82 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.413 -0.804 . . . . 0.0 109.827 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.81 -4.03 3.97 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.493 1.517 . . . . 0.0 111.083 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.62 -7.0 22.16 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.032 2.133 . . . . 0.0 111.995 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.48 11.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.997 1.319 . . . . 0.0 113.179 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -69.32 169.44 12.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 122.43 1.109 . . . . 0.0 112.15 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -159.7 168.1 26.77 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 127.868 2.467 . . . . 0.0 105.469 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -60.95 108.02 0.8 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.876 1.67 . . . . 0.0 111.091 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.34 -83.39 0.87 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.62 1.105 . . . . 0.0 111.366 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.1 173.43 6.58 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.84 0.856 . . . . 0.0 111.788 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.2 157.46 18.77 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.9 pt -119.53 -26.23 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.706 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.39 178.16 8.9 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.195 0.998 . . . . 0.0 109.177 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.63 148.66 70.32 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.75 0.82 . . . . 0.0 109.864 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.71 142.24 43.26 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.569 2.846 . . . . 0.0 108.917 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.0 mm -129.9 -49.09 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 124.656 1.182 . . . . 0.0 111.422 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.01 147.08 46.52 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.033 0.833 . . . . 0.0 109.614 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.24 104.82 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -157.34 130.49 7.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 102.005 -3.331 . . . . 0.0 102.005 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.79 69.5 0.74 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 127.057 2.143 . . . . 0.0 106.889 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 pp -164.46 154.38 14.13 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.809 0.844 . . . . 0.0 111.001 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.7 m 179.91 156.81 0.64 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 130.418 3.487 . . . . 0.0 106.895 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp -149.5 160.64 43.3 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.52 140.61 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -141.9 -177.35 5.16 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.483 1.513 . . . . 0.0 108.127 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -60.29 147.51 40.07 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.718 -0.614 . . . . 0.0 110.547 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -64.68 -9.91 23.26 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.072 0.949 . . . . 0.0 112.281 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -62.28 -177.89 0.15 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.611 1.164 . . . . 0.0 111.821 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.11 20.38 19.09 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.248 1.819 . . . . 0.0 113.255 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -119.78 72.07 15.71 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.79 89.79 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.08 2.52 . . . . 0.0 110.338 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -113.01 73.03 1.54 Allowed Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 123.781 0.832 . . . . 0.0 109.006 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -74.99 156.55 43.05 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.711 1.607 . . . . 0.0 111.639 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.13 167.26 27.81 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.942 2.428 . . . . 0.0 107.575 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -113.57 -10.07 13.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.047 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.7 t -153.86 157.35 39.16 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.15 1.341 . . . . 0.0 110.98 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -72.98 -24.73 60.81 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.675 -0.641 . . . . 0.0 111.261 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -70.92 -17.04 62.7 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.0 0.818 . . . . 0.0 109.956 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -86.99 -24.34 24.72 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 125.513 1.525 . . . . 0.0 110.243 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 33.7 mm -52.69 -58.97 9.88 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.894 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.77 -22.32 27.61 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 CA-C-N 120.253 1.126 . . . . 0.0 112.164 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.99 -31.05 62.8 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.271 1.428 . . . . 0.0 111.834 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.6 tp -91.89 -31.37 15.7 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.184 1.393 . . . . 0.0 110.134 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -58.57 -44.17 89.64 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.671 0.748 . . . . 0.0 110.675 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.416 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 8.6 ptmm? -65.17 -30.38 71.28 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.967 0.907 . . . . 0.0 112.316 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -77.43 -42.35 36.41 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 20.3 mt -72.58 -31.67 65.39 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.534 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.89 -34.88 79.14 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.81 -13.02 61.89 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.02 -5.4 8.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.052 0.941 . . . . 0.0 112.471 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -173.31 -89.46 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 118.868 0.758 . . . . 0.0 112.885 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.409 ' HE3' ' OE2' ' A' ' 221' ' ' GLU . 62.2 mttm -146.22 -177.45 5.62 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.515 1.526 . . . . 0.0 109.082 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 p -57.78 166.97 1.25 Allowed 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.839 0.856 . . . . 0.0 111.508 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.83 -76.51 0.46 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.5 tp -90.18 133.27 35.0 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.464 1.506 . . . . 0.0 110.207 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 53.9 ttm -139.82 107.17 5.53 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.84 160.85 37.3 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.364 1.465 . . . . 0.0 109.196 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -67.93 120.09 13.64 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.106 0.962 . . . . 0.0 110.994 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.3 mt -106.97 -9.76 16.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.659 1.984 . . . . 0.0 111.909 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -77.67 -17.61 57.52 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.337 -0.852 . . . . 0.0 111.733 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -109.57 147.44 36.08 Favored Pre-proline 0 N--CA 1.469 0.486 0 C-N-CA 124.467 1.107 . . . . 0.0 109.347 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -82.07 -18.26 7.6 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.832 2.354 . . . . 0.0 114.138 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -58.94 -37.6 77.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.445 1.021 . . . . 0.0 111.974 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -71.54 -43.67 66.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.794 0.838 . . . . 0.0 112.445 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.2 p -80.9 -14.18 58.24 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.071 0.549 . . . . 0.0 112.16 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -54.99 -57.3 20.23 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.657 -1.164 . . . . 0.0 113.509 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.5 -26.38 81.81 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 121.763 1.665 . . . . 0.0 113.332 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.82 -56.02 9.33 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.4 pt -67.6 -25.71 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.144 0.884 . . . . 0.0 111.685 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.77 -4.1 25.8 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.283 -0.886 . . . . 0.0 110.912 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.6 -54.49 42.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.698 0.799 . . . . 0.0 110.534 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -55.15 -61.23 2.46 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.105 0.479 . . . . 0.0 111.121 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.26 6.41 0.03 OUTLIER Glycine 0 CA--C 1.524 0.6 0 CA-C-O 118.47 -1.183 . . . . 0.0 115.261 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -53.37 133.08 42.76 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 118.277 1.038 . . . . 0.0 112.155 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -142.66 120.41 11.89 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.131 0.967 . . . . 0.0 110.681 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.7 85.57 5.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 66.54 165.84 0.2 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.6 1.56 . . . . 0.0 108.445 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -132.54 159.25 40.01 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 120.819 -1.175 . . . . 0.0 109.258 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -149.09 104.62 3.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.284 -1.746 . . . . 0.0 106.284 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.1 -174.79 0.84 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -52.5 -35.79 53.82 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.061 -1.024 . . . . 0.0 110.986 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -145.29 6.89 1.54 Allowed Glycine 0 CA--C 1.533 1.212 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.756 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -122.43 121.48 36.73 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 120.999 2.4 . . . . 0.0 109.275 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.48 123.6 50.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -146.36 83.49 1.61 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -0.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -83.5 -25.76 30.8 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 119.67 -1.894 . . . . 0.0 107.774 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -96.0 103.78 15.68 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 127.727 2.411 . . . . 0.0 106.798 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.7 t -142.95 165.12 16.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -140.63 35.71 1.84 Allowed Glycine 0 CA--C 1.533 1.163 0 N-CA-C 115.025 0.77 . . . . 0.0 115.025 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.0 t -60.11 -17.04 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 119.436 1.618 . . . . 0.0 114.617 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.273 0.0 OUTLIER -117.86 20.49 13.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.554 1.541 . . . . 0.0 111.255 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -69.71 159.04 34.25 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 120.601 -1.312 . . . . 0.0 108.176 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.34 -30.18 62.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.549 0.74 . . . . 0.0 112.422 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.23 -41.11 94.95 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.511 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.1 -52.92 56.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.918 0.487 . . . . 0.0 109.938 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -62.64 -36.93 84.41 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 117.921 -1.038 . . . . 0.0 111.656 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.57 -49.71 76.45 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.24 0.927 . . . . 0.0 110.234 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.85 -15.12 75.91 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.308 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 44.0 tp -89.12 -50.21 6.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.195 0.998 . . . . 0.0 110.996 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.6 t -55.61 -38.63 69.71 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.824 -1.084 . . . . 0.0 111.856 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -54.6 -54.52 40.26 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.173 1.351 . . . . 0.0 111.028 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 9.9 tt -62.01 -49.73 74.9 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.687 1.195 . . . . 0.0 109.563 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.26 -29.23 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.105 0.962 . . . . 0.0 110.601 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.494 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.9 OUTLIER -67.35 -37.03 82.6 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 119.043 0.838 . . . . 0.0 111.476 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.57 -39.55 88.53 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 37.3 mt -61.95 -48.61 87.77 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -51.39 -40.18 58.73 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.731 1.612 . . . . 0.0 111.567 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -84.77 2.23 43.1 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.969 1.308 . . . . 0.0 112.745 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? 48.32 46.72 20.16 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.776 2.03 . . . . 0.0 111.396 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 -2.31 9.18 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.7 ttp -114.49 153.52 29.84 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.28 49.92 0.73 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.453 1.501 . . . . 0.0 110.671 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.63 -11.37 11.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.481 2.712 . . . . 0.0 115.046 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -91.72 -13.51 31.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.979 1.711 . . . . 0.0 110.815 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.7 m -61.31 162.14 8.14 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.524 1.929 . . . . 0.0 108.562 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.77 -174.19 4.55 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -56.17 -45.63 79.63 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.865 0.466 . . . . 0.0 111.001 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.3 m -64.39 -44.21 92.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.984 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 22.5 mm -62.34 -51.9 66.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -56.26 -59.09 5.45 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.516 1.126 . . . . 0.0 111.829 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -55.7 -40.67 72.72 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.345 0.658 . . . . 0.0 111.99 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.09 -53.82 39.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.09 -35.52 71.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.548 0.739 . . . . 0.0 111.317 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.05 -48.96 74.22 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.62 -27.75 68.88 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.075 0.55 . . . . 0.0 110.131 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -76.49 -10.97 59.79 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.719 -1.238 . . . . 0.0 111.431 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.87 24.7 73.53 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.409 ' OE2' ' HE3' ' A' ' 144' ' ' LYS . 5.4 mm-40 -93.68 -30.26 15.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 69.9 p -87.77 146.68 25.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.996 0.816 . . . . 0.0 110.386 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -85.26 -31.25 23.21 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -160.03 166.71 29.45 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.44 0.564 . . . . 0.0 112.396 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 6.3 t -147.39 161.99 39.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.081 1.352 . . . . 0.0 107.889 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.9 mt -131.78 122.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -142.06 -178.64 5.8 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.945 1.698 . . . . 0.0 108.527 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -170.44 -169.57 33.71 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.649 -0.657 . . . . 0.0 112.532 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -63.06 -178.68 0.45 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.228 3.285 . . . . 0.0 112.724 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -141.05 139.28 34.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.924 1.29 . . . . 0.0 108.351 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -112.43 149.74 32.13 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.337 1.455 . . . . 0.0 110.659 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 47.1 m95 50.5 21.1 0.79 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.561 1.944 . . . . 0.0 114.069 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 35.4 t -119.47 162.4 18.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.06 1.744 . . . . 0.0 109.431 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -61.61 153.94 26.43 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.5 -0.75 . . . . 0.0 111.664 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.62 -6.21 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -137.81 104.69 5.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.547 1.939 . . . . 0.0 106.648 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 16.6 p -136.26 -73.96 0.44 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 9.1 p -157.55 149.45 22.24 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.843 1.257 . . . . 0.0 110.355 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.65 150.96 5.02 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.076 1.351 . . . . 0.0 110.64 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m -144.92 0.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.5 1.12 . . . . 0.0 112.784 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -47.62 131.59 14.26 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.762 1.225 . . . . 0.0 112.83 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -158.67 130.74 6.73 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.592 1.557 . . . . 0.0 107.177 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 68.72 174.16 9.08 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 121.57 0.539 . . . . 0.0 111.993 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 85.2 t -145.67 128.79 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.5 t -155.44 169.42 24.29 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.7 t -68.82 122.0 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.442 1.097 . . . . 0.0 111.196 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -79.33 154.87 76.94 Favored Pre-proline 0 C--O 1.237 0.409 0 C-N-CA 123.383 0.673 . . . . 0.0 109.348 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.69 146.89 80.43 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.6 1.533 . . . . 0.0 109.257 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 255' ' ' SER . 20.4 p -129.32 156.24 44.33 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.181 0.992 . . . . 0.0 108.822 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -81.33 155.26 26.09 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.103 -0.998 . . . . 0.0 108.896 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.71 119.98 7.06 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.145 -0.972 . . . . 0.0 112.523 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.39 5.52 63.33 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.667 1.603 . . . . 0.0 113.982 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -148.12 115.46 4.0 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 119.907 1.854 . . . . 0.0 114.379 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.86 141.98 15.48 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.17 2.58 . . . . 0.0 112.574 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.423 ' H ' HG22 ' A' ' 249' ' ' THR . 58.8 m -59.88 140.12 56.87 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 84.17 15.01 Favored Pre-proline 0 N--CA 1.466 0.329 0 O-C-N 121.802 -0.561 . . . . 0.0 109.929 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -77.05 -175.57 2.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.762 2.308 . . . . 0.0 110.259 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -67.55 162.45 23.34 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.59 130.2 36.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -140.18 159.04 26.07 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 106.355 -2.698 . . . . 0.0 106.355 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.49 176.55 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.196 0.998 . . . . 0.0 108.365 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 5.7 tt -106.42 151.62 24.68 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.7 m -140.49 169.5 17.54 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.571 0.623 . . . . 0.0 112.18 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -132.54 137.83 47.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.835 1.654 . . . . 0.0 107.082 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.35 134.97 7.46 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.092 0.87 . . . . 0.0 111.69 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 54.2 mt -75.44 136.72 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.298 1.049 . . . . 0.0 110.431 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . 0.401 HD22 ' HB3' ' A' ' 269' ' ' ALA . 23.5 t30 -71.91 123.61 23.08 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.22 -28.64 64.34 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.69 -0.671 . . . . 0.0 112.166 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . 0.401 ' HB3' HD22 ' A' ' 267' ' ' ASN . . . -69.37 -8.42 46.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 59.9 m -64.61 163.15 29.34 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.267 1.027 . . . . 0.0 108.285 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -74.16 -56.58 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.653 1.569 . . . . 0.0 110.421 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -128.86 102.47 6.55 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.82 -17.51 16.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -59.42 -31.58 69.4 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.553 0.741 . . . . 0.0 110.721 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 98.8 mt -60.36 -43.34 96.6 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.104 -0.998 . . . . 0.0 109.777 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.38 -43.22 41.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.739 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -34.79 75.95 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.675 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -73.41 -52.75 12.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -52.55 -50.98 61.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.059 0.845 . . . . 0.0 112.826 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.6 tt -62.35 -20.12 64.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -111.88 -8.9 14.08 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -97.3 -31.95 12.15 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.937 1.244 . . . . 0.0 112.336 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -133.18 -37.86 0.97 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.048 0.84 . . . . 0.0 113.115 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.5 -25.47 67.28 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 63.3 mt -112.11 50.53 0.85 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.598 1.159 . . . . 0.0 111.2 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 50.8 p -125.37 157.89 35.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -60.49 -44.19 96.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -65.0 -38.65 91.65 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.093 0.957 . . . . 0.0 111.883 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.57 -44.84 56.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 16.2 mt -65.35 -49.87 67.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.879 0.839 . . . . 0.0 108.852 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.18 -40.26 76.98 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.824 1.25 . . . . 0.0 111.719 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.26 74.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 118.99 0.814 . . . . 0.0 112.692 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 20.5 t -79.25 -37.95 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.203 0.601 . . . . 0.0 109.846 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -63.78 -30.43 71.53 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.607 0.718 . . . . 0.0 111.904 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -64.55 -37.18 86.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.395 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.87 -42.49 39.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.43 1.013 . . . . 0.0 111.673 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 297' ' ' LYS . 8.2 mmpt? -145.52 148.1 35.79 Favored Pre-proline 0 N--CA 1.464 0.274 0 C-N-CA 123.716 0.806 . . . . 0.0 109.361 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.6 126.95 15.54 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.378 2.052 . . . . 0.0 108.778 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 70.2 mt -102.36 -9.9 19.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 77.38 -155.97 44.4 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.46 170.59 15.39 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 23.3 m -130.32 156.71 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 121.039 -1.038 . . . . 0.0 109.569 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.14 -28.71 42.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.147 0.979 . . . . 0.0 110.96 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.19 106.91 1.78 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.471 1.109 . . . . 0.0 108.624 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.402 ' HG2' ' CD1' ' A' ' 90' ' ' TYR . 18.0 mtmt -52.89 -40.8 63.78 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.391 0.676 . . . . 0.0 112.335 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 5.1 m -53.48 -29.84 37.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.076 1.75 . . . . 0.0 112.768 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -112.75 -12.26 13.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.629 0.649 . . . . 0.0 110.196 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -64.36 -42.19 96.32 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.9 -23.37 66.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.042 0.937 . . . . 0.0 112.493 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -90.35 -44.76 9.46 Favored 'General case' 0 N--CA 1.46 0.058 0 C-N-CA 124.417 1.087 . . . . 0.0 109.014 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 6.3 mt -62.86 -35.01 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.245 -0.91 . . . . 0.0 109.888 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.02 -6.54 6.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.259 1.424 . . . . 0.0 113.242 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -68.83 -14.65 63.16 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.26 1.024 . . . . 0.0 111.377 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.93 137.51 20.12 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -14.76 37.08 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.233 2.622 . . . . 0.0 110.762 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.55 -48.05 70.92 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.186 0.994 . . . . 0.0 108.608 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.9 mp -67.97 -52.63 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.58 -49.49 26.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.92 0.888 . . . . 0.0 112.349 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.02 -11.01 2.95 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 29.6 m -98.51 -40.21 8.36 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.3 tpt -69.45 -30.17 68.03 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.837 0.455 . . . . 0.0 111.676 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -62.11 -28.5 69.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.896 -0.573 . . . . 0.0 109.81 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -61.14 -46.34 90.94 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 124.892 1.277 . . . . 0.0 110.697 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -55.79 -41.15 73.69 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.681 0.392 . . . . 0.0 111.486 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -71.38 -18.98 62.33 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.846 1.658 . . . . 0.0 113.344 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.33 1.43 15.14 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.75 0.82 . . . . 0.0 111.493 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -112.81 -165.84 16.69 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.712 1.148 . . . . 0.0 112.485 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.27 136.95 43.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.672 1.589 . . . . 0.0 112.588 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.7 mt -104.54 86.57 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 2.5 mpt? 54.02 84.17 0.21 Allowed Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.897 1.279 . . . . 0.0 111.51 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.29 104.62 1.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.864 3.042 . . . . 0.0 110.636 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -77.02 56.73 1.26 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.665 1.186 . . . . 0.0 111.486 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.81 147.86 49.53 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.46 1.104 . . . . 0.0 111.422 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.48 -28.89 38.15 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.144 2.563 . . . . 0.0 110.959 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -54.23 -29.04 45.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.154 0.982 . . . . 0.0 111.81 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 5.7 mmt -62.77 -35.63 80.45 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.717 1.144 . . . . 0.0 110.729 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 8.7 t -60.8 -46.2 91.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.93 -41.61 86.73 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.423 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -56.37 -53.81 52.99 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 125.142 1.377 . . . . 0.0 109.88 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -60.16 -52.57 64.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.451 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -57.21 -38.11 73.21 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.903 0.774 . . . . 0.0 111.646 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.3 -60.71 2.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.335 1.054 . . . . 0.0 111.793 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 18.2 t -62.59 -33.0 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.377 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -34.71 70.89 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 21.4 m -80.58 -43.96 19.75 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.43 -50.83 64.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.202 1.001 . . . . 0.0 112.773 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.0 -48.99 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 123.447 0.699 . . . . 0.0 109.335 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mm -65.86 -32.79 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.909 0.777 . . . . 0.0 110.019 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -62.21 -51.11 69.11 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.822 -1.174 . . . . 0.0 109.011 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.51 -48.07 76.52 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.451 0.701 . . . . 0.0 110.602 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.37 69.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.284 1.034 . . . . 0.0 113.153 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 16.4 m -92.22 -3.33 55.69 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.591 0.757 . . . . 0.0 110.148 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 68.7 16.23 69.73 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 118.955 0.798 . . . . 0.0 111.715 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -74.74 -28.89 60.97 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.495 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -147.23 158.54 43.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.836 0.744 . . . . 0.0 109.591 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.2 m -62.71 149.9 42.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.631 1.173 . . . . 0.0 108.782 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 42.1 t -60.17 -45.71 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.83 -51.23 70.9 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 123.78 0.832 . . . . 0.0 110.097 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -66.87 -27.86 67.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.42 -38.94 91.64 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 19.5 mt -78.92 -33.99 44.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.829 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -55.18 -47.5 75.11 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.34 1.056 . . . . 0.0 108.475 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -58.32 -55.94 28.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.09 1.756 . . . . 0.0 109.265 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -55.36 -50.56 69.36 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.435 1.494 . . . . 0.0 113.533 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -37.52 73.61 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 28.3 m -66.46 -48.63 69.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 117.563 -1.208 . . . . 0.0 109.166 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -58.65 -14.58 8.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.014 1.279 . . . . 0.0 113.761 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 35.7 mt -101.51 -26.2 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.755 1.622 . . . . 0.0 110.339 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 40.1 p -101.31 8.11 42.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.011 1.324 . . . . 0.0 110.678 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? . . . . . 0 C--O 1.254 1.311 0 C-N-CA 130.347 3.459 . . . . 0.0 104.54 178.34 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.5 mt -68.36 173.67 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.12 32.3 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.746 2.419 . . . . 0.0 114.558 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.58 128.35 31.88 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.73 6.57 21.09 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 126.66 2.076 . . . . 0.0 113.958 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.32 170.91 14.83 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.765 1.626 . . . . 0.0 108.502 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -145.88 147.35 31.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.464 2.306 . . . . 0.0 105.724 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.53 143.23 39.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.6 mt -128.8 127.36 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -115.2 105.77 13.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.1 mp -71.28 155.45 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -122.63 108.0 12.6 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.827 0.851 . . . . 0.0 112.541 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.67 24.32 7.44 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 49.65 41.78 22.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.899 1.35 . . . . 0.0 110.085 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -63.36 -178.04 0.23 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.67 1.988 . . . . 0.0 113.286 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.51 51.86 2.64 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.27 1.891 . . . . 0.0 110.74 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -60.09 -20.7 59.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.571 1.548 . . . . 0.0 112.777 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -58.7 -44.55 90.37 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.543 1.065 . . . . 0.0 111.013 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.24 -31.38 78.95 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.0 tp -71.83 -38.35 70.17 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.002 0.921 . . . . 0.0 110.819 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.98 -42.75 65.85 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.965 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -58.43 -34.12 70.45 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.953 0.797 . . . . 0.0 111.39 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -68.68 -45.09 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.658 1.583 . . . . 0.0 106.981 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.83 -37.82 95.51 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -66.12 -42.86 88.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 117.848 -1.072 . . . . 0.0 108.522 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -57.62 -56.5 21.16 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -54.89 -48.83 72.49 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.325 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.93 -31.78 72.12 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.891 0.768 . . . . 0.0 111.103 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -73.26 -27.13 61.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.818 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -97.25 -36.26 10.48 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.823 0.849 . . . . 0.0 112.816 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.3 p -102.18 -27.73 12.71 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.397 0.999 . . . . 0.0 113.245 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.82 -15.73 56.72 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.623 -1.098 . . . . 0.0 112.581 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.8 mm -69.07 133.11 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.443 ' HE3' ' CA ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.69 151.57 46.24 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.716 -0.615 . . . . 0.0 111.327 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.2 t -136.68 112.06 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.9 m -102.92 123.47 46.62 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.27 115.71 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 105.933 -1.876 . . . . 0.0 105.933 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -130.7 159.47 37.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.642 0.655 . . . . 0.0 109.7 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -125.23 63.39 42.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.57 1.148 . . . . 0.0 108.888 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.87 146.49 42.41 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.494 2.129 . . . . 0.0 111.807 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -101.06 24.22 9.68 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.87 0.868 . . . . 0.0 110.185 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.67 14.09 0.84 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.586 -0.696 . . . . 0.0 112.657 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.18 -27.98 56.49 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.472 -1.393 . . . . 0.0 112.491 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.89 -25.3 56.63 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.91 1.284 . . . . 0.0 112.4 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.61 -25.26 7.93 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.222 1.009 . . . . 0.0 109.428 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -45.8 65.08 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 120.263 -1.523 . . . . 0.0 109.878 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -49.75 -59.2 7.24 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 117.598 -1.191 . . . . 0.0 110.06 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.58 -18.83 65.71 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.135 1.89 . . . . 0.0 114.559 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -89.73 1.13 56.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.313 1.445 . . . . 0.0 113.147 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 t -131.27 -41.21 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 119.481 1.037 . . . . 0.0 108.388 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.09 -30.56 71.09 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 122.038 -0.414 . . . . 0.0 110.629 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.28 95.19 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.65 -41.18 79.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.431 0.692 . . . . 0.0 110.43 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.39 19.9 1.47 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.131 -1.372 . . . . 0.0 114.324 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -134.96 -160.72 1.08 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.896 1.678 . . . . 0.0 107.038 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.78 -160.54 13.39 Favored Glycine 0 C--N 1.339 0.729 0 O-C-N 120.078 -1.639 . . . . 0.0 114.262 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.51 -179.66 5.03 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.08 2.52 . . . . 0.0 109.8 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -111.87 -23.56 10.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 121.564 -0.71 . . . . 0.0 112.418 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.1 mt -145.51 142.72 22.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.119 0.968 . . . . 0.0 108.851 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.2 tt -127.38 142.43 43.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.531 1.532 . . . . 0.0 107.412 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.64 116.85 22.35 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.69 1.196 . . . . 0.0 109.866 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -158.59 170.61 21.78 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.676 0.79 . . . . 0.0 109.371 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.58 153.64 40.97 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -58.19 -23.0 54.06 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.85 -54.63 42.29 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.853 -1.154 . . . . 0.0 111.731 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -63.7 -22.65 67.02 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 119.255 -0.402 . . . . 0.0 110.828 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -77.76 -2.75 37.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.724 0.41 . . . . 0.0 111.205 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.95 -9.13 75.3 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 120.852 -1.155 . . . . 0.0 110.871 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.97 -42.23 0.38 Allowed Glycine 0 CA--C 1.533 1.156 0 N-CA-C 117.938 1.935 . . . . 0.0 117.938 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -46.28 -44.79 16.84 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.874 2.337 . . . . 0.0 115.403 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.02 -41.49 82.07 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 119.585 1.084 . . . . 0.0 110.078 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -28.45 69.63 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.237 -0.915 . . . . 0.0 109.82 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.5 m -77.58 -2.96 38.36 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.013 1.325 . . . . 0.0 111.29 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.13 42.74 23.34 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.4 mt -126.81 -2.1 6.61 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.7 mt -121.69 135.75 54.95 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.98 1.718 . . . . 0.0 110.944 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.98 162.75 22.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.295 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -75.65 104.79 6.36 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 103.555 -2.758 . . . . 0.0 103.555 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.52 168.55 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.815 1.246 . . . . 0.0 112.982 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.5 m 57.02 91.36 0.08 OUTLIER Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 127.205 2.202 . . . . 0.0 115.049 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.36 -27.81 9.12 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.177 1.918 . . . . 0.0 112.563 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -124.99 137.69 54.24 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.856 1.207 . . . . 0.0 113.012 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.411 ' HZ3' ' NE2' ' A' ' 86' ' ' GLN . 15.8 tppt? -58.1 -22.97 53.02 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.778 2.431 . . . . 0.0 115.766 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.67 70.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 120.188 1.358 . . . . 0.0 111.699 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -59.33 -31.56 69.28 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.477 0.711 . . . . 0.0 110.881 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.411 ' NE2' ' HZ3' ' A' ' 83' ' ' LYS . 15.9 mp0 -65.36 -45.02 85.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.63 0.772 . . . . 0.0 110.302 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.22 -15.53 60.17 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.302 1.041 . . . . 0.0 112.815 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -84.39 -6.41 59.38 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.239 1.016 . . . . 0.0 111.043 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mt -126.7 159.44 33.68 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.882 1.673 . . . . 0.0 108.771 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -76.99 158.19 80.51 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 121.501 -0.749 . . . . 0.0 109.215 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.83 -47.56 1.84 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.636 2.89 . . . . 0.0 113.386 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -56.71 -30.49 63.54 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.765 0.711 . . . . 0.0 111.734 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -30.8 69.42 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.275 -0.891 . . . . 0.0 110.092 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -79.23 -40.75 29.88 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.096 0.958 . . . . 0.0 110.206 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -55.72 -21.88 20.85 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.673 1.189 . . . . 0.0 112.74 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.28 3.68 55.25 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.029 2.132 . . . . 0.0 113.997 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.18 0.53 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.48 1.112 . . . . 0.0 111.336 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -68.04 155.26 39.91 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.298 -0.877 . . . . 0.0 108.685 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -136.1 169.92 16.85 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -57.83 102.6 0.1 Allowed 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.442 0.697 . . . . 0.0 111.336 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.46 -81.68 0.95 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.521 1.058 . . . . 0.0 110.911 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.66 169.69 13.86 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.904 0.852 . . . . 0.0 110.816 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.9 mt -105.06 168.92 8.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.78 1.232 . . . . 0.0 108.502 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.6 pt -138.77 -25.88 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.17 173.25 16.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.874 1.215 . . . . 0.0 109.631 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.49 149.69 74.25 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 123.659 0.784 . . . . 0.0 109.217 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.72 141.78 38.33 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.182 2.588 . . . . 0.0 109.0 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -121.55 -51.1 3.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.431 0.692 . . . . 0.0 109.331 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.51 166.85 22.23 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.085 0.402 . . . . 0.0 111.282 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -136.67 123.64 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -118.43 175.1 5.87 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -160.31 162.35 33.52 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.844 0.857 . . . . 0.0 110.461 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.08 133.69 55.62 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 125.953 1.701 . . . . 0.0 108.878 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 71.6 m -131.77 169.27 16.44 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.285 1.834 . . . . 0.0 109.996 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 tp -92.44 149.71 21.23 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.635 0.774 . . . . 0.0 111.527 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.99 131.5 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 126.312 1.845 . . . . 0.0 106.269 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -135.2 177.66 7.64 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.605 1.162 . . . . 0.0 108.754 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -82.62 174.87 10.63 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -79.17 -1.18 34.98 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.161 1.384 . . . . 0.0 112.849 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -65.74 164.86 13.75 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.98 0.895 . . . . 0.0 111.722 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -75.02 -10.44 59.48 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.8 tp -115.71 91.72 31.16 Favored Pre-proline 0 C--O 1.236 0.367 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.15 -29.0 18.13 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.664 2.242 . . . . 0.0 112.607 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 42.26 62.73 7.58 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 127.237 2.215 . . . . 0.0 111.248 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.5 124.75 9.59 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.278 2.652 . . . . 0.0 111.227 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -78.96 174.9 11.58 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.471 2.114 . . . . 0.0 109.185 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -130.66 -38.31 1.32 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.843 0.857 . . . . 0.0 109.609 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.16 150.67 47.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.802 0.335 . . . . 0.0 110.89 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -64.29 -20.52 66.13 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.994 -1.003 . . . . 0.0 111.464 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.64 -11.55 60.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.785 1.175 . . . . 0.0 110.951 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -99.02 -28.56 13.35 Favored 'General case' 0 C--O 1.222 -0.364 0 O-C-N 120.929 -1.107 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.9 mm -52.04 -56.31 22.93 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 119.657 1.117 . . . . 0.0 111.256 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -71.13 -20.12 28.92 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 CA-C-N 120.976 1.384 . . . . 0.0 112.42 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.9 -36.46 56.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.926 1.29 . . . . 0.0 110.887 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.15 -30.52 16.65 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 126.517 1.927 . . . . 0.0 112.402 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.8 -45.79 85.57 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.406 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 9.5 ptmm? -64.1 -35.66 81.5 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.581 0.752 . . . . 0.0 111.768 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.52 -43.67 69.14 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.7 mt -73.33 -30.83 63.61 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.765 -0.635 . . . . 0.0 110.182 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -67.41 -39.64 85.53 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.68 -16.23 60.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 123.764 0.665 . . . . 0.0 112.727 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.45 4.25 8.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.629 1.171 . . . . 0.0 112.208 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.84 -99.93 0.13 Allowed Glycine 0 C--N 1.337 0.629 0 CA-C-N 118.746 0.703 . . . . 0.0 114.706 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -139.5 -176.09 4.42 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.659 2.384 . . . . 0.0 109.135 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.87 163.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.73 -52.32 5.38 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.486 1.514 . . . . 0.0 109.423 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.3 tp -137.68 150.78 47.62 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 127.621 2.369 . . . . 0.0 108.244 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -156.24 128.94 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -147.88 163.79 35.68 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -67.03 110.15 3.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.121 0.963 . . . . 0.0 108.41 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.15 -13.2 22.28 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -76.79 -15.13 59.83 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -99.72 130.73 25.96 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 119.805 1.184 . . . . 0.0 111.356 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.84 -14.05 35.29 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 121.594 1.529 . . . . 0.0 110.902 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -64.63 -42.17 95.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.609 1.964 . . . . 0.0 110.109 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -86.08 -30.36 22.65 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.358 0.663 . . . . 0.0 112.687 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.7 p -84.47 -7.51 59.26 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.09 0.859 . . . . 0.0 110.625 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -55.31 -57.94 17.72 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.546 -1.346 . . . . 0.0 112.521 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.33 -25.32 56.14 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.703 1.602 . . . . 0.0 112.95 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -66.18 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.045 1.338 . . . . 0.0 108.04 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 39.4 pt -64.82 -27.13 41.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 O-C-N 121.74 -0.6 . . . . 0.0 111.938 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.38 -16.88 61.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.947 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.0 -59.46 4.51 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.973 0.909 . . . . 0.0 113.161 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -62.33 -54.42 40.72 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.39 12.09 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 CA-C-O 118.553 -1.137 . . . . 0.0 114.51 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.57 133.97 41.53 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 119.842 1.821 . . . . 0.0 109.903 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.407 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 48.9 p90 -145.56 137.46 25.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.05 -48.68 12.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -144.46 141.11 29.36 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.046 0.939 . . . . 0.0 108.951 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.407 ' HE2' ' CE1' ' A' ' 167' ' ' TYR . 10.3 tppt? -91.2 153.06 20.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -159.38 102.35 1.57 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -138.3 160.37 39.66 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 56.77 11.74 0.99 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.209 1.803 . . . . 0.0 111.334 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.84 16.29 80.18 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -114.84 110.26 19.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 126.18 1.792 . . . . 0.0 108.928 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -81.12 143.62 32.27 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -145.32 76.05 1.46 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 119.833 1.197 . . . . 0.0 113.271 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.56 -6.94 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -41.38 80.82 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.963 1.705 . . . . 0.0 108.186 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -87.78 105.3 17.3 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.34 1.056 . . . . 0.0 108.849 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 81.1 t -127.49 98.62 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -76.0 18.0 3.49 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 117.272 1.669 . . . . 0.0 117.272 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.0 t -70.2 -20.18 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.531 2.165 . . . . 0.0 112.863 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.53 2.09 25.91 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.813 0.733 . . . . 0.0 111.854 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -66.29 165.49 13.88 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.541 1.136 . . . . 0.0 111.369 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.14 -41.39 71.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.403 1.081 . . . . 0.0 111.308 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.0 -27.96 73.53 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 120.995 -1.066 . . . . 0.0 113.394 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.91 -38.09 54.14 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.417 1.109 . . . . 0.0 110.11 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -73.55 -33.19 64.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.786 -0.571 . . . . 0.0 110.988 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -54.73 -48.64 72.28 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.478 1.111 . . . . 0.0 112.457 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -75.87 -19.08 79.2 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.95 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.9 tp -77.61 -53.12 7.96 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 122.95 0.5 . . . . 0.0 112.247 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.2 t -54.78 -32.94 60.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.417 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -53.06 -53.2 53.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.359 0.981 . . . . 0.0 110.697 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 27.4 tp -63.41 -48.78 76.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.723 0.409 . . . . 0.0 110.473 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.16 -31.61 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 123.998 0.919 . . . . 0.0 110.025 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -48.18 80.14 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.895 1.278 . . . . 0.0 110.53 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.24 -39.26 93.58 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.932 -0.48 . . . . 0.0 109.863 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 73.3 mt -67.4 -38.2 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.971 0.908 . . . . 0.0 108.753 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -57.71 -47.61 81.91 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.538 -1.351 . . . . 0.0 108.015 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -80.77 -0.13 37.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.29 1.436 . . . . 0.0 112.459 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp 56.26 6.39 0.25 Allowed 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 129.829 3.252 . . . . 0.0 116.729 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -71.45 -20.6 62.07 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.922 -0.711 . . . . 0.0 112.447 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.7 tpt -82.97 159.27 22.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.287 1.035 . . . . 0.0 112.485 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -95.94 76.09 3.12 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.34 -7.36 30.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.291 1.436 . . . . 0.0 113.598 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.61 -22.69 26.06 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 130.519 3.528 . . . . 0.0 112.179 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.6 m -58.84 127.79 33.95 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -128.62 -178.43 4.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.367 1.867 . . . . 0.0 107.513 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -59.34 -39.49 83.35 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -53.51 56.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.522 1.129 . . . . 0.0 109.121 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 60.5 mt -61.98 -55.93 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.831 1.252 . . . . 0.0 110.848 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.65 94.22 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.628 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.82 -45.27 82.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.294 1.407 . . . . 0.0 110.904 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.47 -55.43 27.65 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.485 1.114 . . . . 0.0 110.403 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.92 -38.7 76.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.397 1.079 . . . . 0.0 110.16 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -62.03 -30.65 71.11 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.456 0.571 . . . . 0.0 109.581 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.57 -35.84 65.52 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 120.923 -1.11 . . . . 0.0 109.443 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -77.01 -12.38 59.93 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.574 1.149 . . . . 0.0 113.622 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.1 16.53 59.18 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-N 120.683 1.583 . . . . 0.0 111.442 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -78.99 -9.4 59.52 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.031 1.732 . . . . 0.0 114.349 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -146.62 127.1 14.09 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.082 -1.011 . . . . 0.0 108.702 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.71 -24.77 66.29 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.322 -0.862 . . . . 0.0 111.575 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -140.92 166.64 24.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.567 1.147 . . . . 0.0 111.603 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.9 t -153.15 166.65 31.85 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.279 1.831 . . . . 0.0 107.179 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.5 mt -123.79 120.97 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -150.98 175.26 12.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.422 1.489 . . . . 0.0 107.075 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.96 76.83 0.03 OUTLIER Glycine 0 CA--C 1.522 0.495 0 CA-C-O 118.222 -1.321 . . . . 0.0 110.048 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -75.97 68.07 6.59 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.036 3.157 . . . . 0.0 110.635 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 37.4 t90 -63.83 -42.41 97.63 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.171 1.388 . . . . 0.0 109.161 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.58 -171.26 3.14 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -107.19 -10.76 15.76 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.724 -1.235 . . . . 0.0 113.076 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.9 m -72.73 1.34 8.63 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -121.02 163.27 18.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.993 1.317 . . . . 0.0 107.576 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.5 tt -127.31 135.71 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.659 1.184 . . . . 0.0 109.684 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -158.7 178.04 10.54 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 128.36 2.664 . . . . 0.0 106.088 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 70.5 p -75.4 -30.83 60.23 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.883 -1.136 . . . . 0.0 109.738 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 31.0 m 53.26 21.67 2.37 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.742 1.617 . . . . 0.0 112.661 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -77.32 108.64 10.59 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.246 1.418 . . . . 0.0 109.787 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.7 m -57.38 134.46 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -150.32 171.37 17.1 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.373 -0.829 . . . . 0.0 112.113 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -85.15 147.72 26.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.608 1.163 . . . . 0.0 109.822 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 87.0 99.5 0.83 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.15 167.65 26.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 126.466 1.906 . . . . 0.0 106.913 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -155.17 177.81 10.91 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.138 -0.976 . . . . 0.0 110.577 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.7 t -76.17 151.44 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 126.7 2.0 . . . . 0.0 109.181 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.5 pp -100.04 157.06 34.55 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.489 1.116 . . . . 0.0 108.699 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.41 144.56 62.04 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.511 1.474 . . . . 0.0 109.211 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 81.6 p -136.03 -161.63 1.18 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.915 0.886 . . . . 0.0 110.262 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.5 143.65 40.53 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -55.65 134.75 51.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.569 -0.707 . . . . 0.0 110.033 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 70.58 -7.81 4.75 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.42 98.47 4.26 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 119.293 1.547 . . . . 0.0 112.1 -178.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.07 158.24 55.45 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.327 1.352 . . . . 0.0 110.788 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 80.7 p -83.07 142.53 31.22 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 120.893 -1.13 . . . . 0.0 110.116 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -142.5 118.15 6.77 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.832 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -75.76 -61.89 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.731 2.287 . . . . 0.0 110.904 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -159.11 164.31 35.4 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 129.613 3.165 . . . . 0.0 105.953 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.53 167.66 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -151.91 116.3 0.75 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.82 122.4 62.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 117.604 0.702 . . . . 0.0 112.535 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.7 tt -77.77 128.04 33.39 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.4 m -114.97 163.42 15.61 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.28 0.632 . . . . 0.0 112.179 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -139.26 139.98 37.54 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.19 0.996 . . . . 0.0 109.27 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -129.44 153.94 20.14 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.035 1.778 . . . . 0.0 108.896 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 75.9 mt -104.41 137.97 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 125.139 1.376 . . . . 0.0 107.654 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -68.05 114.46 6.6 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -63.22 -24.71 68.0 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.334 -0.854 . . . . 0.0 110.946 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -69.84 -16.72 63.31 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 118.451 -0.785 . . . . 0.0 113.079 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 44.7 m -58.3 150.42 53.69 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 118.985 0.812 . . . . 0.0 109.781 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.83 -37.24 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.195 1.93 . . . . 0.0 112.221 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -135.81 89.03 2.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -57.31 -18.57 17.52 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.622 0.369 . . . . 0.0 111.084 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.85 -42.33 84.24 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.557 1.943 . . . . 0.0 108.409 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.08 -37.84 81.12 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.905 -1.122 . . . . 0.0 110.674 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.35 -45.53 38.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -35.33 77.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.473 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -71.71 -52.63 16.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.215 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -54.89 -47.99 73.61 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 120.657 1.572 . . . . 0.0 111.167 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.31 -45.73 91.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.772 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -83.42 -7.3 59.58 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -108.17 -24.32 11.59 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 116.92 -1.514 . . . . 0.0 114.603 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -139.65 -35.67 0.53 Allowed 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.457 1.026 . . . . 0.0 112.256 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -64.82 -44.76 88.83 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.397 1.453 . . . . 0.0 108.549 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 77.7 mt -96.86 53.97 1.26 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.358 1.863 . . . . 0.0 112.834 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.1 p -131.75 157.47 43.72 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.29 -38.49 89.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -69.44 -39.1 78.02 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.71 -0.619 . . . . 0.0 110.885 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.84 -32.26 61.34 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 121.769 -0.582 . . . . 0.0 112.122 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.9 mt -74.75 -44.17 51.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.31 -45.26 84.4 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.377 1.071 . . . . 0.0 108.541 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.69 -50.42 63.35 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.435 1.094 . . . . 0.0 112.289 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 65.4 t -72.94 -34.57 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.209 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -68.92 -32.91 72.87 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.452 0.569 . . . . 0.0 111.386 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -62.63 -35.18 78.76 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -67.17 -72.44 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.57 154.51 77.6 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 124.493 1.117 . . . . 0.0 111.581 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.44 108.1 2.54 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.44 2.093 . . . . 0.0 109.868 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.22 -30.51 70.45 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.03 -116.47 5.59 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 106.49 -2.644 . . . . 0.0 106.49 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -109.9 169.13 8.92 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.993 1.396 . . . . 0.0 108.328 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 18.6 m -131.74 153.1 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 O-C-N 121.377 -0.827 . . . . 0.0 110.977 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.11 -34.34 50.12 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.974 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 15.4 tp -69.34 102.19 1.69 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.303 1.041 . . . . 0.0 108.327 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -53.2 -28.44 26.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.608 1.563 . . . . 0.0 115.217 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -62.37 1.7 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.764 1.165 . . . . 0.0 111.483 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -78.96 -14.01 59.46 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 125.246 1.418 . . . . 0.0 112.691 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -58.88 -32.23 69.3 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.66 -30.87 71.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.711 1.204 . . . . 0.0 112.601 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -82.38 -39.46 22.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.641 1.176 . . . . 0.0 110.009 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 12.6 mt -69.14 -34.82 75.6 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.33 -6.96 1.72 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.089 1.756 . . . . 0.0 113.497 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -62.05 -33.06 73.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.797 0.726 . . . . 0.0 109.913 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.14 142.81 25.17 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.04 -13.2 37.54 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.149 1.899 . . . . 0.0 113.509 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.5 mtm-85 -64.5 -45.14 88.58 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.757 -1.215 . . . . 0.0 109.384 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.3 mp -67.25 -57.68 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 124.596 1.158 . . . . 0.0 107.965 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.63 -54.97 18.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 124.176 0.923 . . . . 0.0 110.171 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.33 -30.8 71.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.694 -1.254 . . . . 0.0 113.171 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 16.7 m -66.5 -42.92 86.66 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.3 tpt -67.33 -51.42 52.63 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.807 1.643 . . . . 0.0 110.393 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -55.16 -33.05 62.61 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.217 1.007 . . . . 0.0 112.427 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -81.97 -38.34 25.3 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.813 0.845 . . . . 0.0 108.976 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.18 82.88 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.714 0.688 . . . . 0.0 110.48 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -63.78 -51.14 66.14 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.268 1.027 . . . . 0.0 110.778 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -20.97 54.26 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -64.55 176.99 9.95 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 125.257 1.408 . . . . 0.0 115.085 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.96 133.76 49.2 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.674 1.99 . . . . 0.0 109.26 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 93.7 mt -71.83 136.31 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 37.0 tpp -56.27 112.83 4.87 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.867 1.267 . . . . 0.0 110.53 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.52 178.5 7.29 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.425 3.417 . . . . 0.0 112.833 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -148.65 46.35 1.03 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.976 0.91 . . . . 0.0 111.768 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.41 155.43 43.71 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.553 1.541 . . . . 0.0 113.063 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.39 -19.43 61.46 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.094 3.196 . . . . 0.0 115.448 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -56.35 -24.01 41.28 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.592 1.157 . . . . 0.0 111.574 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 87.4 mmm -59.28 -33.59 71.24 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.685 0.794 . . . . 0.0 111.504 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 13.1 t -58.68 -49.3 78.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.681 0.673 . . . . 0.0 110.315 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.86 82.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.751 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -56.09 -48.93 75.2 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.892 0.877 . . . . 0.0 110.035 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 21.6 m95 -56.95 -44.34 82.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.428 0.558 . . . . 0.0 111.349 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -66.93 -45.12 78.82 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.967 -0.458 . . . . 0.0 110.258 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -52.93 -56.19 17.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.136 1.774 . . . . 0.0 112.149 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 18.1 t -68.45 -40.2 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 117.616 -1.183 . . . . 0.0 109.561 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -52.28 -50.73 61.56 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.875 1.67 . . . . 0.0 109.023 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 2.1 m -67.45 -45.01 77.24 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.58 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.06 -42.1 68.89 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.878 1.217 . . . . 0.0 111.964 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 44.1 t -58.28 -57.38 11.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.354 1.062 . . . . 0.0 109.43 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.9 mm -67.09 -26.47 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 119.344 -0.36 . . . . 0.0 110.687 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -64.94 -51.39 62.12 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 119.85 -1.781 . . . . 0.0 109.088 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.52 -44.57 70.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.383 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.24 -29.02 70.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.4 m -85.71 -12.36 51.36 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.095 0.861 . . . . 0.0 109.571 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 73.33 8.73 75.99 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.416 -0.658 . . . . 0.0 111.676 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -66.78 -34.62 78.23 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.681 1.241 . . . . 0.0 108.915 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -138.99 155.86 47.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.0 t -76.11 166.47 23.43 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.8 t -55.73 -56.07 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.142 1.377 . . . . 0.0 109.901 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -51.75 -41.25 61.45 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.59 1.556 . . . . 0.0 113.478 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -77.28 -36.48 54.2 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.19 0.196 . . . . 0.0 111.099 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.61 -50.26 72.5 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.49 -0.756 . . . . 0.0 109.74 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.04 -39.18 89.96 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.108 -0.949 . . . . 0.0 111.157 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -57.55 -56.25 24.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.815 0.734 . . . . 0.0 110.395 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.95 -38.57 91.61 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 124.274 0.984 . . . . 0.0 111.012 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.59 92.61 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.682 -0.636 . . . . 0.0 110.452 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.38 -36.36 68.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.585 0.754 . . . . 0.0 109.792 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 5.8 m -59.69 -39.08 83.36 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.62 0.645 . . . . 0.0 110.398 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -65.75 -15.67 63.06 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.092 -1.005 . . . . 0.0 112.34 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 7.8 mt -102.56 -8.62 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.988 1.315 . . . . 0.0 109.974 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 19.7 p -113.36 -2.52 13.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.802 1.641 . . . . 0.0 111.874 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.106 0 C-N-CA 127.344 2.257 . . . . 0.0 106.544 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.3 mm -89.43 146.4 6.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -101.62 106.78 17.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 122.216 1.007 . . . . 0.0 108.521 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.433 ' CG ' ' H ' ' A' ' 5' ' ' GLY . 4.8 tt0 -73.04 -176.03 1.97 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.812 2.445 . . . . 0.0 113.018 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.433 ' H ' ' CG ' ' A' ' 4' ' ' GLU . . . 79.94 17.27 75.17 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.106 0.86 . . . . 0.0 111.963 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.594 ' HZ3' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -147.47 163.36 36.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.173 1.389 . . . . 0.0 110.656 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.6 mt -148.99 150.28 32.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 129.237 3.015 . . . . 0.0 104.933 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.594 ' CG2' ' HZ3' ' A' ' 6' ' ' LYS . 44.5 t -139.52 134.36 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.2 mt -114.43 123.55 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -121.45 118.93 30.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -145.81 154.78 13.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.37 1.068 . . . . 0.0 110.726 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -69.52 150.8 46.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.25 -26.79 37.48 Favored Glycine 0 N--CA 1.465 0.569 0 C-N-CA 126.161 1.839 . . . . 0.0 115.034 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.82 -19.77 63.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.605 0.703 . . . . 0.0 110.554 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -73.09 164.8 26.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 122.167 0.984 . . . . 0.0 109.962 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.69 63.5 4.35 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -68.51 -45.87 71.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.326 1.05 . . . . 0.0 110.959 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -38.63 80.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.92 -38.74 22.39 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.47 -34.95 78.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.204 1.002 . . . . 0.0 110.545 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.93 -44.66 82.68 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.142 0.577 . . . . 0.0 109.567 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -56.11 -43.1 77.8 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.527 0.731 . . . . 0.0 111.635 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.1 -44.52 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.509 1.524 . . . . 0.0 107.362 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.73 -42.84 95.05 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.305 -0.872 . . . . 0.0 110.994 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -43.25 99.2 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.052 0.926 . . . . 0.0 108.724 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -62.74 -50.32 71.56 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.613 1.165 . . . . 0.0 108.942 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -56.77 -41.89 78.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.561 1.073 . . . . 0.0 110.272 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.93 -35.93 79.86 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.965 -1.084 . . . . 0.0 108.7 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -74.18 3.77 6.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.3 1.84 . . . . 0.0 111.263 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -125.4 -37.4 2.37 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.79 1.636 . . . . 0.0 112.604 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.0 p -112.29 -22.0 11.13 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.716 0.806 . . . . 0.0 113.013 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.44 53.01 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.063 -1.023 . . . . 0.0 112.954 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.77 133.06 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 119.145 1.473 . . . . 0.0 107.468 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.494 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -66.81 146.03 54.86 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.262 -0.899 . . . . 0.0 108.812 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.3 t -136.75 91.59 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.8 m -80.73 134.28 35.8 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.2 t -130.84 129.4 63.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -140.01 166.23 25.22 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -118.54 58.66 3.55 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 123.59 0.756 . . . . 0.0 111.606 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.32 159.97 51.64 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.18 1.253 . . . . 0.0 109.24 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -120.45 -23.08 6.23 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.375 0.67 . . . . 0.0 110.501 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.2 9.13 41.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.913 1.285 . . . . 0.0 110.543 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -56.86 -30.74 64.12 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 120.565 -1.334 . . . . 0.0 112.286 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.26 -23.81 64.4 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.22 1.373 . . . . 0.0 113.652 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -105.14 -28.03 11.24 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.164 0.438 . . . . 0.0 110.272 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -51.29 10.88 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 124.492 1.117 . . . . 0.0 110.647 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -41.92 -58.25 3.46 Favored Pre-proline 0 N--CA 1.457 -0.079 0 CA-C-O 116.321 -1.799 . . . . 0.0 109.883 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.99 1.37 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.27 1.98 . . . . 0.0 116.93 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.36 -52.86 2.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.802 1.183 . . . . 0.0 108.752 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.17 -40.95 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.58 -31.04 59.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.378 -0.827 . . . . 0.0 111.144 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.15 -13.44 60.81 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.033 0.533 . . . . 0.0 111.011 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 m -93.33 -82.34 0.34 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 163.36 37.77 0.02 OUTLIER Glycine 0 CA--C 1.524 0.612 0 C-N-CA 125.598 1.57 . . . . 0.0 109.291 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.79 -3.32 2.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.812 1.645 . . . . 0.0 113.292 -176.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.9 176.27 21.66 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 116.933 1.533 . . . . 0.0 116.933 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.92 172.38 7.28 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.766 2.311 . . . . 0.0 109.584 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -107.92 -18.5 13.79 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -142.36 143.05 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.348 1.459 . . . . 0.0 108.726 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.8 tt -135.29 140.6 44.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 125.608 1.563 . . . . 0.0 108.277 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -132.45 116.32 16.64 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -154.73 179.29 9.21 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.72 0.691 . . . . 0.0 110.726 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.41 152.95 40.63 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -61.81 -25.62 67.61 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -61.52 -23.79 66.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -98.76 -4.9 32.39 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.797 -0.564 . . . . 0.0 110.78 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -92.46 20.87 5.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.004 1.322 . . . . 0.0 109.73 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.79 -14.03 51.16 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 120.667 -1.271 . . . . 0.0 111.391 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.65 -27.45 1.94 Allowed Glycine 0 C--N 1.344 0.982 0 CA-C-N 119.304 1.552 . . . . 0.0 116.498 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -53.75 -47.37 70.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.114 1.957 . . . . 0.0 111.763 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.21 -40.91 94.78 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -27.08 54.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.303 1.041 . . . . 0.0 112.223 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.0 m -96.88 3.07 52.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.353 1.461 . . . . 0.0 112.045 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.66 16.76 78.72 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.421 1.01 . . . . 0.0 112.267 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.7 mt -88.73 9.47 24.27 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.142 0.977 . . . . 0.0 113.425 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.0 mt -131.29 146.01 52.12 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 120.979 -1.076 . . . . 0.0 108.244 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.41 161.58 14.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -78.7 94.21 5.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.43 ' CD1' ' HG1' ' A' ' 80' ' ' THR . 2.6 pp -62.11 175.21 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 127.103 2.161 . . . . 0.0 112.212 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.43 ' HG1' ' CD1' ' A' ' 79' ' ' ILE . 89.4 m 66.64 95.88 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 126.777 2.031 . . . . 0.0 111.013 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.92 -48.24 1.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.339 1.359 . . . . 0.0 110.749 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.84 154.65 51.55 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.079 0.951 . . . . 0.0 110.509 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -49.34 -38.85 29.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.07 2.548 . . . . 0.0 111.768 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.98 -25.55 44.49 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.189 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -68.77 -28.64 66.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.718 1.145 . . . . 0.0 109.963 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -64.05 -36.37 83.79 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 120.76 -1.212 . . . . 0.0 110.76 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.18 -15.3 61.02 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.065 0.946 . . . . 0.0 112.286 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -70.85 -20.92 62.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.717 1.207 . . . . 0.0 111.771 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.0 mt -122.93 161.16 24.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.799 1.64 . . . . 0.0 108.541 -178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -72.98 157.76 88.15 Favored Pre-proline 0 N--CA 1.476 0.847 0 CA-C-N 120.23 1.377 . . . . 0.0 108.91 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.9 -46.18 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.08 2.52 . . . . 0.0 114.168 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -60.1 -30.93 69.58 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.259 0.936 . . . . 0.0 111.34 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.11 -29.46 69.21 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.233 -0.917 . . . . 0.0 110.15 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -72.88 -30.29 63.84 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.966 0.803 . . . . 0.0 110.684 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -62.99 -16.5 59.92 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.45 -5.18 59.08 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.326 0.65 . . . . 0.0 112.506 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.5 m -133.3 27.82 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.882 1.273 . . . . 0.0 112.238 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.6 mtp85 -86.37 164.11 17.24 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.199 0.999 . . . . 0.0 110.878 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -149.95 175.5 11.62 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.174 1.39 . . . . 0.0 107.603 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -66.55 101.19 0.74 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.559 0.743 . . . . 0.0 112.157 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.84 -69.95 2.8 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.099 1.333 . . . . 0.0 111.974 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.86 162.04 27.95 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.141 0.47 . . . . 0.0 110.064 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.84 155.21 17.16 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.742 1.617 . . . . 0.0 108.557 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.1 pt -123.09 -32.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.72 -178.58 7.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 119.925 1.239 . . . . 0.0 109.912 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -133.36 147.53 65.3 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 124.668 1.187 . . . . 0.0 109.431 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.93 153.8 63.4 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.651 2.9 . . . . 0.0 109.665 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.9 mm -125.84 -47.63 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 125.364 1.466 . . . . 0.0 110.979 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.26 165.7 26.7 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 117.877 0.308 . . . . 0.0 110.739 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.7 t -127.02 121.43 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 124.281 0.988 . . . . 0.0 109.399 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -108.44 122.29 46.71 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -159.37 176.57 11.98 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.341 1.457 . . . . 0.0 110.298 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.93 -164.57 1.17 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.697 1.999 . . . . 0.0 111.133 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.3 p -167.21 171.5 10.76 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.668 1.987 . . . . 0.0 110.27 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.5 tp -109.54 146.91 33.86 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 120.251 1.387 . . . . 0.0 107.821 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.4 mt -122.3 151.61 26.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -152.29 162.21 41.48 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.544 0.738 . . . . 0.0 109.484 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -50.75 140.46 14.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.861 1.264 . . . . 0.0 109.239 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -11.27 5.21 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.304 1.442 . . . . 0.0 114.046 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.05 170.78 14.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.729 1.604 . . . . 0.0 110.35 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 pp -93.08 8.31 40.55 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.28 1.032 . . . . 0.0 112.844 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -34.88 107.68 0.32 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 128.198 2.599 . . . . 0.0 110.462 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.35 -173.96 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.364 3.376 . . . . 0.0 115.93 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 47.7 67.35 4.57 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 128.027 2.531 . . . . 0.0 110.897 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.26 158.87 37.76 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 121.956 1.77 . . . . 0.0 111.749 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.52 153.06 74.5 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.959 3.106 . . . . 0.0 112.748 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.83 -12.03 3.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.068 0.547 . . . . 0.0 112.365 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.33 154.84 45.91 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.128 -0.983 . . . . 0.0 111.949 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -80.05 -22.92 41.79 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.23 -18.29 47.66 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.79 -5.13 21.5 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.264 1.025 . . . . 0.0 111.511 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.4 mm -61.05 -52.53 71.29 Favored Pre-proline 0 C--N 1.339 0.128 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.82 -23.75 54.92 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 CA-C-N 120.997 1.392 . . . . 0.0 111.503 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.43 -44.39 75.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.4 tp -80.43 -27.29 38.02 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.219 1.008 . . . . 0.0 111.928 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.9 -44.51 82.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 123.943 0.897 . . . . 0.0 110.736 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -68.41 -31.2 70.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.407 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -71.34 -46.78 59.7 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 61.0 mt -72.57 -31.48 65.28 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.402 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -71.17 -37.37 72.2 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.01 68.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.538 0.608 . . . . 0.0 111.89 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.68 6.15 16.75 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.978 0.911 . . . . 0.0 112.534 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 179.42 -104.46 0.18 Allowed Glycine 0 CA--C 1.524 0.626 0 CA-C-N 119.141 0.882 . . . . 0.0 112.792 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -136.91 178.08 7.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.134 2.174 . . . . 0.0 109.978 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.01 155.36 3.54 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.36 1.064 . . . . 0.0 113.674 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.07 -47.61 35.42 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.7 tp -125.48 155.55 40.35 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.192 1.397 . . . . 0.0 110.247 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.1 ttm -150.68 130.5 13.25 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -159.91 168.93 24.6 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.865 1.666 . . . . 0.0 115.399 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.52 83.11 0.06 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 126.766 2.026 . . . . 0.0 112.095 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.5 mt -80.83 -20.87 41.47 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 125.842 1.657 . . . . 0.0 110.724 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.3 mm-40 -78.92 -6.53 56.41 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -112.62 129.92 23.93 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 119.163 0.892 . . . . 0.0 112.105 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.64 -13.73 24.69 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.156 1.904 . . . . 0.0 112.318 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -64.6 -40.09 94.88 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.854 1.662 . . . . 0.0 113.311 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -95.13 -29.6 14.48 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.5 p -72.75 -28.43 62.62 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.336 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -56.6 -58.67 15.65 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -56.02 -16.36 16.26 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.586 2.191 . . . . 0.0 115.842 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 66.4 tp -82.11 -59.17 2.65 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.811 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.8 pt -68.21 -27.42 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 119.403 1.001 . . . . 0.0 111.768 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.25 -20.89 66.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.449 0.699 . . . . 0.0 110.917 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.61 -54.01 43.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.153 1.381 . . . . 0.0 112.244 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.21 -41.75 84.7 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.364 0.529 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 165.88 26.13 0.02 OUTLIER Glycine 0 C--N 1.34 0.778 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -88.92 131.95 10.98 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -147.27 151.44 36.64 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.115 1.457 . . . . 0.0 112.059 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -85.17 -63.01 1.4 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.775 1.23 . . . . 0.0 112.542 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -138.37 126.24 22.47 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.309 1.444 . . . . 0.0 108.832 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -73.38 129.37 37.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.425 1.011 . . . . 0.0 112.156 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.85 122.18 38.87 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.542 ' HG2' ' H ' ' A' ' 173' ' ' ASN . 14.9 tt0 -93.82 -163.57 1.07 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.987 1.315 . . . . 0.0 109.45 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.542 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 71.0 m-80 -56.77 -8.84 0.65 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.249 2.22 . . . . 0.0 115.731 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.36 11.62 0.02 OUTLIER Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.224 1.392 . . . . 0.0 113.861 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.6 156.7 40.5 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.808 2.443 . . . . 0.0 105.078 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -144.93 148.71 34.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -147.88 141.03 25.04 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.8 -8.67 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.664 1.186 . . . . 0.0 110.3 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -40.01 73.51 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -78.33 92.48 4.54 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.587 1.155 . . . . 0.0 111.009 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.9 t -115.96 150.29 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.885 1.674 . . . . 0.0 108.996 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -146.08 48.58 0.68 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.55 1.548 . . . . 0.0 111.629 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 80.3 t -81.3 -55.2 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 125.1 1.36 . . . . 0.0 107.937 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -87.51 67.22 9.31 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -113.03 155.95 23.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 126.317 1.847 . . . . 0.0 110.435 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.15 -39.05 66.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.992 1.317 . . . . 0.0 113.152 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.21 -45.96 76.08 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.08 -56.59 19.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -58.87 -34.49 71.69 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 117.438 -1.268 . . . . 0.0 112.768 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.05 -52.09 66.42 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.608 1.094 . . . . 0.0 109.286 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -68.3 -30.31 73.48 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.77 -53.72 20.12 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.332 1.066 . . . . 0.0 108.442 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.4 t -61.14 -33.66 73.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.327 0.651 . . . . 0.0 110.303 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.85 -55.07 34.38 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.6 tt -60.58 -47.89 84.22 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.445 1.498 . . . . 0.0 110.323 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 70.9 t -57.1 -36.23 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 118.18 -0.914 . . . . 0.0 109.75 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.427 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.3 OUTLIER -65.04 -35.51 81.39 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 120.033 1.288 . . . . 0.0 112.122 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.04 -41.23 99.46 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 85.7 mt -67.98 -42.76 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -57.83 -31.69 66.89 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.575 1.55 . . . . 0.0 109.841 178.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -88.69 -5.29 58.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.764 1.625 . . . . 0.0 111.246 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? 60.39 16.88 6.66 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.321 2.648 . . . . 0.0 113.755 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -86.3 -34.53 20.31 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.4 tpt -85.44 128.37 34.7 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -76.68 120.68 22.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -88.92 -3.12 58.83 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -95.72 -15.34 22.7 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.603 1.961 . . . . 0.0 115.144 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 3.3 m -67.55 128.43 36.4 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.957 0.903 . . . . 0.0 112.197 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -126.95 172.32 10.55 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.761 2.024 . . . . 0.0 108.114 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -47.66 -39.81 18.17 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 57.8 m -63.14 -45.91 89.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.743 1.217 . . . . 0.0 110.45 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 58.1 mt -66.9 -48.47 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 117.063 -1.446 . . . . 0.0 110.868 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.76 91.06 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.798 1.635 . . . . 0.0 112.717 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.42 -35.32 80.58 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.047 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.26 -55.9 20.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.62 -43.14 75.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.939 2.495 . . . . 0.0 112.119 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.417 ' HB2' ' HG1' ' A' ' 225' ' ' THR . 67.9 t80 -62.49 -45.68 91.91 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.986 1.266 . . . . 0.0 108.543 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -37.9 82.59 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 118.44 -0.791 . . . . 0.0 109.192 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -74.56 -23.08 58.71 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.089 1.313 . . . . 0.0 111.618 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.47 38.25 5.36 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.415 1.483 . . . . 0.0 111.081 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -93.74 -31.1 14.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.672 1.236 . . . . 0.0 113.764 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.5 t -115.15 152.01 33.35 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.612 1.165 . . . . 0.0 109.24 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -87.88 -27.95 21.88 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.781 0.832 . . . . 0.0 111.498 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -136.51 145.49 45.16 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.927 1.291 . . . . 0.0 108.224 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.417 ' HG1' ' HB2' ' A' ' 217' ' ' PHE . 23.0 m -149.4 149.72 31.28 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.666 1.186 . . . . 0.0 108.919 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 27.6 mt -124.68 127.17 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.84 157.78 45.43 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.223 1.409 . . . . 0.0 107.313 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -101.95 -163.52 26.81 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 119.124 -0.82 . . . . 0.0 113.391 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.74 73.56 2.93 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.95 3.1 . . . . 0.0 108.457 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -67.73 -63.5 1.05 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.854 0.861 . . . . 0.0 110.806 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -159.36 -90.96 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.085 0.954 . . . . 0.0 109.586 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -121.32 176.83 5.44 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.802 1.241 . . . . 0.0 112.4 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.4 m -63.58 172.23 2.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.369 1.868 . . . . 0.0 111.613 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -132.73 -35.25 1.11 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.8 mt -132.54 71.26 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 120.074 1.307 . . . . 0.0 108.1 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -71.23 -17.17 62.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.202 1.801 . . . . 0.0 112.815 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 m -85.15 -59.92 2.19 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.917 0.781 . . . . 0.0 111.805 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' SER . . . . . 0.405 ' O ' ' HE3' ' A' ' 239' ' ' LYS . 3.8 m -71.2 73.66 0.67 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.713 1.205 . . . . 0.0 110.508 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' A' ' 238' ' ' SER . 0.0 OUTLIER -124.28 97.29 5.26 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.309 1.444 . . . . 0.0 110.762 -178.157 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.92 17.28 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.048 1.739 . . . . 0.0 109.527 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -103.11 173.06 6.47 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.976 2.51 . . . . 0.0 109.376 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -81.3 173.22 12.7 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -55.62 -37.66 68.69 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 123.97 0.795 . . . . 0.0 113.738 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.25 169.48 11.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 124.97 1.308 . . . . 0.0 107.962 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.9 t -132.98 151.42 52.07 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.22 144.6 14.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 124.469 1.108 . . . . 0.0 110.417 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -116.0 154.96 48.45 Favored Pre-proline 0 CA--C 1.528 0.128 0 C-N-CA 124.866 1.266 . . . . 0.0 111.049 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.24 143.56 39.82 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.431 1.421 . . . . 0.0 110.041 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 47.8 p -135.51 -145.0 0.21 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.834 2.054 . . . . 0.0 108.231 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -124.12 141.59 51.93 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 12.0 pttp -54.02 107.1 0.23 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.279 1.031 . . . . 0.0 109.049 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.76 84.43 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.772 1.177 . . . . 0.0 114.394 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.08 93.64 43.23 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.865 1.333 . . . . 0.0 108.936 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.4 144.17 25.55 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.976 2.451 . . . . 0.0 109.433 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 37.3 p -63.33 141.41 58.78 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 121.058 -1.026 . . . . 0.0 108.804 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -116.39 88.14 22.59 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.511 1.125 . . . . 0.0 110.398 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -82.16 168.08 15.42 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.382 2.055 . . . . 0.0 112.239 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -95.83 164.7 12.63 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.621 1.168 . . . . 0.0 108.446 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 19.9 t -141.3 127.04 19.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -126.07 122.07 4.33 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.49 136.64 54.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 118.042 0.921 . . . . 0.0 112.092 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 tp -68.86 137.48 53.92 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.1 m -121.99 158.23 29.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.494 1.043 . . . . 0.0 113.568 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -135.33 141.2 45.57 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.194 1.798 . . . . 0.0 110.004 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.78 167.46 23.22 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.441 1.496 . . . . 0.0 110.196 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 56.2 mt -119.46 132.25 69.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.508 1.523 . . . . 0.0 107.363 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -74.1 130.5 39.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -76.2 -19.48 58.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 117.797 -1.097 . . . . 0.0 113.518 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -72.94 -7.74 52.46 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.574 1.079 . . . . 0.0 113.182 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 66.8 m -63.06 154.72 76.26 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -62.29 -53.69 1.79 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 121.877 1.718 . . . . 0.0 108.052 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -132.42 125.55 31.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 -16.59 60.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.718 0.807 . . . . 0.0 111.406 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -61.55 -33.78 74.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.707 0.803 . . . . 0.0 112.517 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 61.9 mt -59.3 -40.74 87.14 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.791 -0.568 . . . . 0.0 111.031 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.42 -43.63 48.88 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.771 0.429 . . . . 0.0 111.057 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . 0.261 0.0 OUTLIER -63.9 -32.95 74.65 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.768 -0.634 . . . . 0.0 111.331 -179.084 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -72.44 -48.07 44.01 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -51.47 -49.89 60.9 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.23 -54.42 47.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.4 -22.55 66.99 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -97.55 -24.6 15.48 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 117.817 -1.087 . . . . 0.0 113.55 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -138.66 -36.42 0.56 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.99 -25.29 62.63 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.468 1.031 . . . . 0.0 110.692 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 89.7 mt -105.57 24.97 11.34 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.445 1.498 . . . . 0.0 113.711 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 6.8 p -103.07 158.19 16.47 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.48 -42.81 99.75 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -71.41 -30.73 66.44 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.582 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.05 -48.89 14.34 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 63.8 mt -62.0 -43.86 97.94 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -62.23 -42.5 99.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.03 -35.14 68.93 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.823 0.738 . . . . 0.0 110.996 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 76.0 t -72.25 -42.01 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -60.01 -29.99 68.84 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.399 1.079 . . . . 0.0 112.705 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -52.56 -47.36 66.86 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 118.272 0.487 . . . . 0.0 110.708 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.91 -73.98 0.24 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -101.47 144.64 28.96 Favored Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 121.051 -1.031 . . . . 0.0 111.615 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.62 108.48 2.64 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.256 2.637 . . . . 0.0 111.556 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 66.8 mt -73.18 -31.47 64.23 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.967 0.907 . . . . 0.0 110.908 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 71.08 -103.71 1.28 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 108.244 -1.942 . . . . 0.0 108.244 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.02 168.44 10.27 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 10.8 m -140.17 153.12 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 120.869 -1.144 . . . . 0.0 110.97 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.06 -18.73 49.29 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.773 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 21.0 tp -81.36 111.83 18.08 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -56.6 -34.16 66.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 119.198 -0.429 . . . . 0.0 111.84 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -37.49 65.96 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.25 1.42 . . . . 0.0 112.186 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -101.43 -16.85 16.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.266 0.485 . . . . 0.0 109.742 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -63.76 -38.76 92.32 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.36 -23.4 62.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.138 0.881 . . . . 0.0 111.331 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -89.39 -51.37 5.59 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.614 1.166 . . . . 0.0 109.058 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 22.0 mt -61.43 -34.66 75.77 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.757 -0.59 . . . . 0.0 110.093 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.68 -3.0 5.58 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.392 1.477 . . . . 0.0 112.964 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -61.62 -28.81 69.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.386 1.448 . . . . 0.0 107.445 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -94.54 135.63 23.91 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.9 -11.99 33.27 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.483 2.122 . . . . 0.0 113.285 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -64.83 -46.29 82.54 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.56 -48.65 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 124.412 1.085 . . . . 0.0 108.531 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.77 -49.49 65.43 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 123.545 0.528 . . . . 0.0 110.684 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.8 84.77 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.775 -0.578 . . . . 0.0 111.823 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 21.0 m -61.46 -35.2 76.95 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.0 tpt -71.12 -48.07 54.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 122.857 0.463 . . . . 0.0 110.42 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -58.45 -30.63 67.09 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.54 1.136 . . . . 0.0 111.985 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -64.32 -28.74 69.92 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.2 -0.937 . . . . 0.0 110.335 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -79.63 -28.17 40.92 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.774 0.716 . . . . 0.0 109.979 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -71.6 -15.92 62.27 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.275 1.43 . . . . 0.0 109.348 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.13 -7.4 7.12 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -107.4 -168.59 21.97 Favored Glycine 0 N--CA 1.467 0.721 0 CA-C-N 119.413 1.006 . . . . 0.0 110.88 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -136.55 155.02 50.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.425 1.113 . . . . 0.0 110.216 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 16.6 mt -59.69 133.28 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 127.042 2.137 . . . . 0.0 111.818 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 82.9 mtp -58.32 162.03 6.67 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 126.491 1.916 . . . . 0.0 111.12 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.42 160.22 28.97 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.925 1.75 . . . . 0.0 108.487 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -101.14 29.84 4.46 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.423 2.289 . . . . 0.0 112.63 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.1 pt -130.24 154.45 81.41 Favored Pre-proline 0 N--CA 1.47 0.573 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.1 -14.15 31.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.135 3.223 . . . . 0.0 115.163 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -57.04 -16.27 6.85 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.449 1.499 . . . . 0.0 112.394 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -32.98 71.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.443 0.697 . . . . 0.0 110.141 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 37.4 p -60.85 -48.25 82.66 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 119.115 0.87 . . . . 0.0 111.405 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.54 94.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.608 0.763 . . . . 0.0 109.147 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -52.98 -53.99 41.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.459 1.104 . . . . 0.0 111.692 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -62.63 -47.22 84.7 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.804 0.729 . . . . 0.0 110.42 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -60.59 -31.33 70.48 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.782 0.433 . . . . 0.0 111.654 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.74 -57.33 5.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.4 1.48 . . . . 0.0 110.617 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.89 -38.16 75.17 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.15 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -48.83 -56.15 9.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.263 0.938 . . . . 0.0 110.994 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -45.7 85.4 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.748 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.82 -41.88 71.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.3 -53.31 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.513 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 49.3 mm -62.76 -36.54 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.014 0.824 . . . . 0.0 110.064 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.32 -50.62 73.29 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.114 0.87 . . . . 0.0 109.599 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.49 -52.24 58.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.647 0.779 . . . . 0.0 111.152 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -59.26 -29.01 67.25 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.036 1.334 . . . . 0.0 114.115 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 7.7 m -93.26 -3.9 52.83 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.581 0.752 . . . . 0.0 110.95 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 69.02 23.35 76.07 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 35.4 mtt-85 -80.73 -33.22 35.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -150.45 148.03 28.25 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 10.8 t -71.55 166.6 21.49 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.592 0.71 . . . . 0.0 109.426 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.78 -44.65 99.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.174 1.79 . . . . 0.0 110.771 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -55.4 -47.06 76.47 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.158 0.583 . . . . 0.0 111.251 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -78.47 -38.02 42.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.113 0.565 . . . . 0.0 111.262 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.13 89.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.454 -0.779 . . . . 0.0 110.825 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.0 mt -77.25 -30.06 54.29 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.26 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -58.22 -49.2 77.91 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.349 1.431 . . . . 0.0 108.645 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -51.03 -54.53 23.81 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.737 2.015 . . . . 0.0 108.638 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.84 -49.77 76.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.605 1.562 . . . . 0.0 112.879 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -54.76 -37.15 65.62 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.11 1.364 . . . . 0.0 109.412 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 20.0 m -66.4 -37.96 86.42 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.127 0.571 . . . . 0.0 110.944 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -66.11 -31.02 71.63 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.247 -0.908 . . . . 0.0 109.912 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.0 mt -80.22 -38.26 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.762 0.825 . . . . 0.0 111.292 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.5 p -73.61 -12.98 60.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.468 1.031 . . . . 0.0 110.9 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 51.3 tttm . . . . . 0 C--O 1.251 1.139 0 C-N-CA 124.689 1.196 . . . . 0.0 109.01 178.842 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.8 mt -131.18 152.16 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -83.71 66.87 9.25 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -62.33 123.87 19.38 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 131.18 3.792 . . . . 0.0 109.491 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.97 39.54 93.27 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.995 1.284 . . . . 0.0 112.634 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -146.08 -179.15 6.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.468 1.107 . . . . 0.0 108.392 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.1 mt -145.6 144.64 30.59 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 128.539 2.735 . . . . 0.0 106.864 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.0 t -145.37 129.88 12.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.727 1.611 . . . . 0.0 107.222 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.59 141.59 46.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.773 0.829 . . . . 0.0 109.391 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -120.42 164.87 15.71 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.313 1.045 . . . . 0.0 111.812 177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.404 HG22 ' H ' ' A' ' 13' ' ' GLY . 3.6 mt -136.79 136.32 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.828 1.251 . . . . 0.0 111.545 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -117.66 12.01 13.87 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.963 1.705 . . . . 0.0 110.655 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 11' ' ' ILE . . . -161.74 59.18 0.29 Allowed Glycine 0 C--N 1.339 0.724 0 O-C-N 119.974 -1.704 . . . . 0.0 115.689 -177.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 33.23 48.93 0.18 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.552 1.941 . . . . 0.0 115.019 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 168.8 10.7 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.32 64.89 3.71 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -69.74 -23.57 63.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.079 -0.962 . . . . 0.0 112.757 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -64.72 -57.28 9.4 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-N 119.428 1.013 . . . . 0.0 108.856 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.98 -40.52 73.5 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.3 tp -68.19 -35.92 78.76 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.077 0.951 . . . . 0.0 112.034 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.47 97.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.169 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.38 -35.13 73.35 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.919 0.781 . . . . 0.0 110.096 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.69 -42.61 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.39 -38.77 95.3 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -63.45 -47.03 83.55 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.729 1.265 . . . . 0.0 107.909 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -58.76 -58.38 8.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -53.1 -45.11 68.09 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.909 1.232 . . . . 0.0 112.236 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.19 -23.33 66.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.434 1.494 . . . . 0.0 110.937 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HA ' ' HZ2' ' A' ' 29' ' ' LYS . 1.1 tppm? -92.16 -17.28 25.13 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.277 -1.514 . . . . 0.0 112.437 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.73 -7.0 22.05 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 124.247 0.967 . . . . 0.0 109.551 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 59.1 p -133.47 -34.42 1.05 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.495 1.118 . . . . 0.0 113.823 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.64 -17.91 58.44 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.696 1.141 . . . . 0.0 112.808 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.9 128.01 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.33 145.79 52.89 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.8 t -138.44 83.25 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.3 m -73.62 151.25 40.9 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.3 t -139.81 118.52 11.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.541 1.537 . . . . 0.0 107.942 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -143.86 157.34 44.43 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.855 0.752 . . . . 0.0 111.247 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -117.95 54.82 1.91 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.37 1.468 . . . . 0.0 112.218 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -69.42 123.89 10.67 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.83 2.353 . . . . 0.0 111.59 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -13.64 58.99 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 127.818 2.447 . . . . 0.0 114.398 -178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.24 21.1 11.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.245 1.418 . . . . 0.0 113.727 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.37 -23.35 56.7 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.16 -26.75 61.09 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -106.72 -20.57 13.31 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.205 0.526 . . . . 0.0 110.675 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -75.92 -56.42 4.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -40.01 -57.82 2.54 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-O 116.743 -1.599 . . . . 0.0 112.354 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.96 -44.29 25.67 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.803 1.669 . . . . 0.0 114.219 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.5 mm100 -64.01 -49.13 73.64 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.472 1.109 . . . . 0.0 112.337 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 t -72.08 -39.18 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.474 0.71 . . . . 0.0 110.366 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.62 -28.61 63.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 120.949 -1.094 . . . . 0.0 113.018 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.47 -14.32 27.92 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.165 0.893 . . . . 0.0 112.813 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.9 m -118.15 4.22 12.0 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.945 1.298 . . . . 0.0 111.081 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.52 0.43 88.12 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.279 0.942 . . . . 0.0 113.71 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.23 -10.61 58.47 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.643 -1.504 . . . . 0.0 113.277 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.92 -179.05 19.84 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.69 -177.78 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 125.222 3.948 . . . . 0.0 113.45 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.53 -25.88 13.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.262 0.554 . . . . 0.0 111.057 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 mt -146.27 154.63 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 tp -137.31 146.28 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -132.2 111.9 11.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.61 1.564 . . . . 0.0 108.02 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -156.99 -167.04 2.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.161 0.892 . . . . 0.0 112.271 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.01 143.62 50.72 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.127 0.971 . . . . 0.0 110.865 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -56.8 -41.62 78.08 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.775 1.23 . . . . 0.0 109.541 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -67.84 -5.37 16.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.436 2.294 . . . . 0.0 114.101 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -111.91 -10.18 13.99 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.891 0.876 . . . . 0.0 110.301 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -86.73 4.04 42.4 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.415 1.486 . . . . 0.0 110.254 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.24 -9.6 84.84 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.369 -1.457 . . . . 0.0 109.6 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.56 -70.59 1.16 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.542 1.544 . . . . 0.0 112.191 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -46.7 -47.56 20.41 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.707 1.603 . . . . 0.0 112.966 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.36 -45.06 94.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.379 1.071 . . . . 0.0 111.343 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.53 -46.66 83.58 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.3 m -65.61 -4.86 6.8 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.256 0.623 . . . . 0.0 112.289 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.87 13.32 83.54 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.837 1.684 . . . . 0.0 112.274 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.2 mt -73.87 -17.82 61.0 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.211 1.006 . . . . 0.0 111.67 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mt -95.22 136.41 35.59 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 121.136 -0.977 . . . . 0.0 111.167 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.98 170.42 16.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 123.954 0.784 . . . . 0.0 111.826 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -69.04 115.34 8.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 mm -72.14 158.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.23 0.538 . . . . 0.0 110.291 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.5 m 60.72 84.02 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.032 1.733 . . . . 0.0 109.786 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.06 -27.59 29.62 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.643 1.562 . . . . 0.0 111.158 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -136.34 144.87 44.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.153 1.381 . . . . 0.0 110.815 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -52.35 -37.96 57.5 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.484 1.914 . . . . 0.0 112.833 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.63 -37.63 68.44 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.375 0.989 . . . . 0.0 112.002 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -60.28 -25.72 65.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.427 0.691 . . . . 0.0 111.869 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -67.04 -48.16 69.18 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -19.5 61.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 125.413 1.485 . . . . 0.0 113.401 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.26 -15.21 62.88 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.497 -0.752 . . . . 0.0 110.888 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.9 mt -124.18 154.83 39.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.444 1.498 . . . . 0.0 108.519 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -67.59 152.52 96.19 Favored Pre-proline 0 CA--C 1.54 0.576 0 O-C-N 121.663 -0.648 . . . . 0.0 110.133 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.2 -36.27 7.45 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.109 2.539 . . . . 0.0 114.675 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -63.59 -43.18 97.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.437 0.562 . . . . 0.0 111.088 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -23.28 62.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.353 1.461 . . . . 0.0 111.667 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -70.45 -22.63 62.67 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.561 1.073 . . . . 0.0 110.621 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.61 -23.74 67.36 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.35 1.06 . . . . 0.0 111.189 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.36 -17.38 60.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.256 1.022 . . . . 0.0 113.424 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.67 14.94 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.46 168.78 4.28 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 122.723 1.249 . . . . 0.0 112.083 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -159.93 177.97 10.22 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 129.008 2.923 . . . . 0.0 105.168 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -64.12 99.01 0.24 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.492 1.117 . . . . 0.0 111.097 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.88 -84.88 0.47 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 124.588 1.09 . . . . 0.0 110.892 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 153.46 41.84 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.784 0.802 . . . . 0.0 109.968 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.6 mt -91.62 152.06 20.42 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.4 pt -111.77 -27.73 2.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.831 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.92 174.76 14.68 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.478 1.035 . . . . 0.0 108.771 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -125.7 150.5 68.62 Favored Pre-proline 0 C--O 1.239 0.517 0 C-N-CA 124.386 1.075 . . . . 0.0 110.209 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.83 141.68 41.45 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.266 2.644 . . . . 0.0 107.851 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.3 mm -126.44 -45.51 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.691 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.37 122.34 10.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -90.36 118.68 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -141.98 107.09 4.95 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.99 170.43 16.26 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.9 tp -43.21 134.14 3.77 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.212 1.805 . . . . 0.0 113.592 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.8 m -126.64 149.83 49.28 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.089 1.756 . . . . 0.0 109.374 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 51.7 tp -76.83 149.19 36.21 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 54.7 mt -123.87 139.01 51.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -143.43 173.11 11.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.799 1.239 . . . . 0.0 110.576 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -59.29 166.1 2.38 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.938 1.295 . . . . 0.0 110.103 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -54.01 -26.74 27.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.093 1.357 . . . . 0.0 113.757 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -65.08 164.59 12.66 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.344 0.657 . . . . 0.0 110.16 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 pp -74.08 -8.46 56.22 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 121.548 -0.72 . . . . 0.0 111.993 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.4 tp 52.52 79.91 0.32 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.524 1.93 . . . . 0.0 109.961 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.42 2.78 5.34 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.487 2.792 . . . . 0.0 113.286 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -140.21 69.22 34.11 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 124.938 1.295 . . . . 0.0 111.059 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.12 159.68 37.06 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.449 2.099 . . . . 0.0 110.215 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.45 158.02 25.6 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.761 2.307 . . . . 0.0 110.868 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -118.13 -2.5 11.2 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.296 -0.877 . . . . 0.0 112.71 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -169.41 160.48 9.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.416 1.087 . . . . 0.0 108.443 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -67.88 -24.57 65.25 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.091 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -69.93 -13.92 62.47 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.228 0.922 . . . . 0.0 112.183 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -90.67 -21.67 21.54 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.337 1.055 . . . . 0.0 110.209 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.3 mm -55.76 -57.37 21.87 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-O 117.83 -1.081 . . . . 0.0 109.214 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.87 -20.4 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 120.983 1.387 . . . . 0.0 113.163 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.58 -40.45 66.6 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.249 1.02 . . . . 0.0 112.067 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 27.5 tp -94.85 -22.92 17.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.492 1.117 . . . . 0.0 112.077 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -61.28 -35.39 77.17 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.785 -1.197 . . . . 0.0 111.252 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -75.54 -33.94 60.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.885 1.274 . . . . 0.0 111.188 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -70.21 -45.5 66.47 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.43 -32.37 73.2 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.77 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -70.96 -28.95 64.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.597 0.635 . . . . 0.0 109.566 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.88 -26.6 63.32 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.404 0.547 . . . . 0.0 111.102 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.61 -1.21 16.94 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.122 0.969 . . . . 0.0 112.812 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.21 -98.72 0.12 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -142.18 178.74 7.34 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.623 1.169 . . . . 0.0 112.062 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.2 p -53.98 156.09 3.13 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.74 1.616 . . . . 0.0 113.088 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.74 -58.51 2.55 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.678 1.591 . . . . 0.0 109.959 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.51 142.69 47.35 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.484 0.714 . . . . 0.0 112.075 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 55.5 mtp -144.97 135.48 24.32 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 128.308 2.643 . . . . 0.0 105.749 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -156.19 168.63 26.69 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.069 1.748 . . . . 0.0 107.48 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.606 HD21 ' HB2' ' A' ' 210' ' ' TYR . 37.9 t-20 -75.93 126.26 30.66 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.9 mp -114.62 -8.14 12.72 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.607 0.639 . . . . 0.0 110.623 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -80.0 -10.28 59.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.307 2.243 . . . . 0.0 112.213 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -115.64 137.55 23.27 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 119.628 1.104 . . . . 0.0 108.206 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.59 -27.66 32.43 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.617 1.545 . . . . 0.0 112.14 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -65.95 -25.3 67.06 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 118.938 0.79 . . . . 0.0 112.015 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -85.58 -9.88 56.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.431 1.014 . . . . 0.0 112.286 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 13.1 p -112.58 -19.86 11.93 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.024 0.929 . . . . 0.0 110.343 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -54.84 41.31 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.01 -24.72 59.19 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.17 1.913 . . . . 0.0 113.515 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.7 tt -69.17 -65.38 0.72 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 37.0 pt -58.66 -28.94 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.981 0.913 . . . . 0.0 113.179 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.78 -22.15 63.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.752 0.821 . . . . 0.0 112.62 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -49.18 -57.12 7.25 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.904 2.081 . . . . 0.0 114.863 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -67.1 -49.2 65.79 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.293 0.371 . . . . 0.0 111.785 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.55 49.19 0.05 OUTLIER Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.517 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -116.76 133.27 10.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -147.51 143.7 28.02 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.91 -68.14 0.46 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -139.01 151.09 46.54 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.557 0.743 . . . . 0.0 111.474 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -74.51 128.77 36.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -151.46 104.46 3.07 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -155.87 155.03 32.2 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 55.03 20.87 3.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.328 1.451 . . . . 0.0 114.429 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.4 6.51 83.76 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 119.416 1.007 . . . . 0.0 113.082 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.65 117.65 32.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 125.703 1.601 . . . . 0.0 107.641 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -116.85 119.17 34.56 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.749 2.02 . . . . 0.0 106.14 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -135.72 110.61 8.77 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.519 0.728 . . . . 0.0 109.059 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.44 0.39 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.215 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -76.98 -19.61 57.1 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.971 -1.081 . . . . 0.0 110.712 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -102.83 96.49 6.87 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.628 1.971 . . . . 0.0 106.52 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 70.8 t -125.68 147.24 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.83 1.252 . . . . 0.0 110.612 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -127.99 22.26 5.43 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 118.333 -1.26 . . . . 0.0 115.574 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.26 -40.33 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.807 2.303 . . . . 0.0 111.907 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -90.47 19.5 5.22 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.496 0.718 . . . . 0.0 112.786 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -70.61 155.23 41.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 120.384 -1.447 . . . . 0.0 110.487 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.51 92.0 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.398 0.679 . . . . 0.0 109.482 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.58 95.78 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.56 -50.82 56.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 117.324 0.562 . . . . 0.0 110.197 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -63.1 -36.21 82.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.583 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.31 74.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.91 0.884 . . . . 0.0 112.187 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -84.85 -24.47 45.28 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 118.612 0.642 . . . . 0.0 112.229 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 52.3 tp -76.39 -49.55 16.47 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.181 0.993 . . . . 0.0 112.401 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.4 -31.99 56.21 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 118.606 0.639 . . . . 0.0 110.433 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -56.57 -44.08 80.65 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.555 1.542 . . . . 0.0 109.891 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -40.74 94.63 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.238 -0.914 . . . . 0.0 110.548 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 22.2 t -64.14 -38.55 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 C-N-CA 125.028 1.331 . . . . 0.0 109.347 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -59.92 -46.95 87.75 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.328 1.451 . . . . 0.0 110.792 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.3 mt -65.9 -37.8 87.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.03 0.832 . . . . 0.0 109.85 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 59.7 mt -67.46 -37.73 79.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -61.47 -41.72 97.68 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.25 -14.76 62.34 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.673 1.189 . . . . 0.0 111.715 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt 60.99 4.44 0.81 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.433 2.693 . . . . 0.0 112.77 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.79 -12.91 60.27 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.312 -0.243 . . . . 0.0 110.862 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 4.2 tpt -88.97 154.78 19.94 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.56 -0.712 . . . . 0.0 110.646 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -82.84 64.3 7.39 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.14 -14.49 4.07 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.59 -15.07 27.35 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.989 1.316 . . . . 0.0 112.761 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 57.4 m -66.71 137.59 56.79 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.094 0.958 . . . . 0.0 111.929 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -131.13 -176.73 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.49 1.916 . . . . 0.0 107.603 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . 0.606 ' HB2' HD21 ' A' ' 150' ' ' ASN . 54.1 t80 -57.53 -45.56 84.9 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.31 -0.244 . . . . 0.0 111.294 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.68 -47.65 76.42 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.189 1.796 . . . . 0.0 111.029 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.89 -48.08 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.844 1.257 . . . . 0.0 110.57 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.16 83.28 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.814 0.734 . . . . 0.0 110.674 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.93 -52.1 40.08 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.27 -49.07 77.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.894 0.478 . . . . 0.0 111.612 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.62 -44.22 89.9 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -61.29 -40.66 94.96 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -58.97 -16.11 16.37 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.623 1.169 . . . . 0.0 113.513 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.0 -13.39 14.1 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.684 1.194 . . . . 0.0 111.387 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.49 18.82 58.07 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.832 1.206 . . . . 0.0 111.098 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -66.97 -12.23 59.14 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.818 1.247 . . . . 0.0 111.606 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 43.6 p -113.36 141.84 46.58 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.646 1.978 . . . . 0.0 109.681 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -82.57 -34.79 27.63 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -146.3 164.24 32.99 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.784 2.034 . . . . 0.0 111.304 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.5 t -164.79 169.62 16.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.082 1.353 . . . . 0.0 107.687 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mt -133.96 114.21 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -139.73 145.86 38.83 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.392 2.277 . . . . 0.0 105.215 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -68.86 165.37 48.44 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.787 0.708 . . . . 0.0 112.785 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.93 108.42 2.44 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.42 2.747 . . . . 0.0 109.152 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 86.4 m95 42.33 57.07 3.49 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.973 2.509 . . . . 0.0 113.845 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.0 -157.87 0.47 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -55.5 92.82 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.63 1.572 . . . . 0.0 111.48 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 19.3 m -108.78 91.2 3.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.436 1.494 . . . . 0.0 106.99 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -61.88 -9.87 7.9 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.879 0.872 . . . . 0.0 112.725 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 17.2 tt -150.21 128.59 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -78.88 132.52 36.82 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.0 p -121.67 125.59 47.01 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.173 0.511 . . . . 0.0 109.92 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.8 p -71.4 75.77 0.76 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.201 1.8 . . . . 0.0 108.353 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -71.64 -40.58 69.62 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.448 1.099 . . . . 0.0 109.798 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 3.0 t 48.78 31.9 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 125.871 1.668 . . . . 0.0 111.502 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -151.09 140.52 21.47 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.808 1.643 . . . . 0.0 109.037 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -163.92 144.99 8.73 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 127.795 2.438 . . . . 0.0 105.873 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -176.63 178.03 47.97 Favored Glycine 0 C--O 1.241 0.574 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.7 p -117.52 111.99 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.166 1.387 . . . . 0.0 108.228 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.1 t -133.18 165.24 25.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.4 108.02 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 124.903 1.281 . . . . 0.0 110.223 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -86.08 151.09 53.86 Favored Pre-proline 0 C--O 1.239 0.501 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -71.36 134.46 24.72 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.927 1.751 . . . . 0.0 108.805 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.6 p -147.26 -172.49 4.02 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.466 1.506 . . . . 0.0 107.574 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.68 137.02 32.8 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -51.37 128.97 23.97 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.426 -0.796 . . . . 0.0 109.936 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.43 -10.5 6.35 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.863 1.105 . . . . 0.0 115.863 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.65 92.37 14.97 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 120.113 1.957 . . . . 0.0 107.943 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.55 161.96 43.75 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.489 2.126 . . . . 0.0 112.293 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 40.8 t -66.54 150.32 49.16 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.913 1.285 . . . . 0.0 108.763 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -139.22 89.19 12.51 Favored Pre-proline 0 N--CA 1.456 -0.171 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -80.94 -174.58 2.29 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.545 2.83 . . . . 0.0 110.476 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -63.47 -178.86 0.3 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.121 1.369 . . . . 0.0 109.49 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.98 85.75 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 O-C-N 121.068 -1.02 . . . . 0.0 108.43 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -76.56 136.77 19.85 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.85 128.6 50.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.682 0.793 . . . . 0.0 110.409 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.5 tt -62.96 138.23 58.5 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.982 1.313 . . . . 0.0 107.646 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.6 m -118.76 144.23 46.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.826 0.822 . . . . 0.0 110.836 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -138.86 136.9 36.06 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -149.66 145.36 13.46 Favored Glycine 0 C--O 1.236 0.232 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 34.5 mt -69.32 134.52 30.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.229 1.012 . . . . 0.0 108.991 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -90.38 113.61 25.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.16 -14.41 37.13 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.958 1.303 . . . . 0.0 112.934 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.71 78.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.366 0.985 . . . . 0.0 111.88 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 48.7 m -62.13 164.86 9.66 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 123.101 0.25 . . . . 0.0 110.654 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -89.43 -26.17 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.797 2.331 . . . . 0.0 117.06 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -127.68 90.03 3.04 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.664 1.12 . . . . 0.0 110.537 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -62.99 -14.99 54.61 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.656 0.382 . . . . 0.0 111.907 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -66.03 -41.35 91.06 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 75.3 mt -57.0 -37.51 71.78 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.375 -0.828 . . . . 0.0 110.148 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.92 -48.04 60.09 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 122.041 -0.412 . . . . 0.0 110.789 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -31.44 71.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.981 -0.533 . . . . 0.0 111.152 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -75.86 -42.51 49.19 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.95 -46.04 90.69 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.952 1.251 . . . . 0.0 108.855 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.9 mp -63.65 -48.1 78.59 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 117.509 -1.234 . . . . 0.0 110.973 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -79.9 -20.55 45.56 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -97.79 -20.18 17.7 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.949 1.704 . . . . 0.0 113.019 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -138.6 -33.55 0.66 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-O 117.503 -1.237 . . . . 0.0 114.198 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.4 -57.1 4.09 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 121.167 1.803 . . . . 0.0 111.797 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.46 23.54 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 128.1 2.56 . . . . 0.0 114.137 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 77.2 p -98.65 160.99 13.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -65.08 -30.67 71.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -71.0 -47.43 58.87 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.353 1.061 . . . . 0.0 111.202 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -63.43 -47.34 88.3 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.12 -41.03 97.84 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.299 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -64.17 -43.27 95.64 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.434 0.561 . . . . 0.0 109.539 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.67 -43.5 85.07 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.587 0.631 . . . . 0.0 112.385 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 41.4 t -71.05 -38.45 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.718 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -68.54 -26.75 65.58 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.449 0.568 . . . . 0.0 111.797 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -66.43 -50.97 61.6 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.76 -52.12 65.54 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 119.085 -0.483 . . . . 0.0 112.23 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -140.6 147.42 48.99 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-N 119.04 0.836 . . . . 0.0 109.419 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.93 123.26 11.36 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.33 2.02 . . . . 0.0 111.06 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 28.5 mt -94.52 -6.91 42.69 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.728 1.211 . . . . 0.0 112.519 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 63.12 -141.92 46.91 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 107.018 -2.433 . . . . 0.0 107.018 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.1 176.45 9.66 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.95 157.11 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 120.683 -1.26 . . . . 0.0 112.941 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -82.4 -25.3 33.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.34 111.2 7.33 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -56.8 -33.56 66.81 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.8 m -54.67 -57.26 12.19 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.842 1.257 . . . . 0.0 110.35 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -81.03 -13.04 59.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.684 0.794 . . . . 0.0 112.414 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -63.73 -33.13 74.96 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -69.52 -17.33 63.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.379 0.672 . . . . 0.0 111.284 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.472 ' HA ' ' HE2' ' A' ' 313' ' ' LYS . 45.1 mm-40 -93.73 -46.15 7.36 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.471 1.508 . . . . 0.0 109.415 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 7.1 mt -69.15 -34.37 74.89 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.264 -0.897 . . . . 0.0 110.463 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.05 -15.97 48.59 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 310' ' ' GLU . 54.2 mttm -54.3 -34.64 61.35 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 118.912 0.778 . . . . 0.0 110.699 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -93.22 136.01 24.95 Favored Pre-proline 0 N--CA 1.448 -0.549 0 C-N-CA 123.983 0.913 . . . . 0.0 110.35 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.98 -23.03 75.38 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.372 2.048 . . . . 0.0 114.472 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.72 -47.9 81.09 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 119.24 0.927 . . . . 0.0 109.752 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.2 mp -67.82 -59.2 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.079 1.352 . . . . 0.0 109.526 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.94 -46.52 64.76 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.61 -37.82 76.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 119.39 0.995 . . . . 0.0 112.597 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 88.6 m -68.68 -37.1 79.32 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.038 0.935 . . . . 0.0 108.97 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.6 tpt -66.04 -48.13 72.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.273 1.029 . . . . 0.0 109.883 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -58.82 -37.59 76.73 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.993 0.815 . . . . 0.0 110.412 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -69.39 -37.28 77.46 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.59 -34.12 73.75 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.959 0.799 . . . . 0.0 110.829 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -72.68 -28.57 62.78 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.76 -19.29 16.8 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.647 -0.658 . . . . 0.0 112.536 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -83.54 177.3 52.62 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -105.38 127.19 52.84 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.621 1.568 . . . . 0.0 111.952 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 45.9 mt -94.45 132.38 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 8.6 tpt 5.18 86.56 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 129.102 2.961 . . . . 0.0 112.068 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.76 87.66 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.36 2.707 . . . . 0.0 113.24 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -81.53 73.79 8.55 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 6.1 pt -132.15 157.77 77.34 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 126.177 1.791 . . . . 0.0 109.935 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -71.15 -33.82 11.03 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.952 1.768 . . . . 0.0 111.76 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.77 -19.64 29.51 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 6.2 mmt -64.62 -29.73 70.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.656 0.662 . . . . 0.0 109.644 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 20.1 m -56.38 -53.49 56.75 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.001 0.92 . . . . 0.0 110.544 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.41 -39.75 64.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.644 -1.169 . . . . 0.0 110.549 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -48.39 -55.87 9.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.433 1.015 . . . . 0.0 112.147 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -60.31 -53.04 62.37 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.946 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -60.23 -42.65 95.67 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 118.705 0.684 . . . . 0.0 112.766 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -58.84 -56.68 19.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.132 1.373 . . . . 0.0 110.254 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 33.6 t -65.96 -38.78 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 118.47 -0.776 . . . . 0.0 110.023 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -54.11 -45.77 71.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.685 1.13 . . . . 0.0 108.18 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 28.0 m -70.13 -46.35 64.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.584 -0.722 . . . . 0.0 110.253 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -51.21 -45.04 61.75 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.189 0.904 . . . . 0.0 112.661 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.08 -57.96 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 125.126 1.37 . . . . 0.0 108.457 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 48.0 mm -60.57 -38.46 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.264 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -60.03 -48.14 82.96 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.669 1.122 . . . . 0.0 109.288 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.93 -49.14 60.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.858 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.51 -23.67 66.08 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.934 1.294 . . . . 0.0 113.319 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.3 m -94.79 -2.66 50.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.397 0.679 . . . . 0.0 109.945 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.41 12.63 69.86 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.753 0.706 . . . . 0.0 111.534 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -69.93 -36.04 75.01 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.02 0.928 . . . . 0.0 109.827 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -142.18 164.83 29.09 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.44 HG23 ' H ' ' A' ' 359' ' ' GLU . 15.4 t -81.37 159.96 24.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.07 -52.63 42.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 124.917 1.287 . . . . 0.0 109.843 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.47 -47.81 69.43 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 127.115 2.166 . . . . 0.0 111.42 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.44 ' H ' HG23 ' A' ' 356' ' ' THR . 47.6 mm-40 -75.46 -33.26 60.85 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.733 0.697 . . . . 0.0 111.174 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.56 85.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.1 mp -68.35 -45.91 71.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.571 1.949 . . . . 0.0 110.445 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -55.52 -58.09 9.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.24 1.016 . . . . 0.0 108.536 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -53.3 -42.25 66.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.166 2.187 . . . . 0.0 112.084 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -68.66 -49.82 56.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.878 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -58.68 -32.25 68.95 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.21 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 6.6 m -63.38 -36.48 83.85 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.93 1.241 . . . . 0.0 110.62 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 12.2 mtt85 -65.84 -30.84 71.53 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.95 -1.094 . . . . 0.0 110.908 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 36.5 mt -82.58 -37.98 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.633 1.573 . . . . 0.0 111.15 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 65.9 p -78.29 -12.09 59.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.763 1.165 . . . . 0.0 112.921 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? . . . . . 0 C--O 1.254 1.294 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.025 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.456 ' HZ2' ' CD ' ' A' ' 3' ' ' GLU . 29.9 tttm . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.5 mt -117.29 159.7 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.456 ' CD ' ' HZ2' ' A' ' 1' ' ' LYS . 44.4 mm-40 -91.29 112.74 24.77 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -81.18 -176.08 5.78 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.808 2.043 . . . . 0.0 109.342 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.33 29.48 73.29 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.129 -0.982 . . . . 0.0 114.759 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.99 162.12 37.69 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.252 1.021 . . . . 0.0 111.285 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.6 mt -152.53 147.4 26.16 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 130.095 3.358 . . . . 0.0 106.59 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.5 t -144.95 146.46 19.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.123 1.369 . . . . 0.0 108.639 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.5 mt -134.79 139.4 47.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -126.73 124.49 39.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.436 HG22 ' H ' ' A' ' 12' ' ' ASN . 1.5 mp -131.9 171.63 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.165 1.386 . . . . 0.0 108.327 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.436 ' H ' HG22 ' A' ' 11' ' ' ILE . 14.8 p-10 -103.94 157.28 17.21 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.403 1.481 . . . . 0.0 109.345 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.46 -22.15 60.98 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 125.608 1.575 . . . . 0.0 114.4 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -77.39 -3.11 38.52 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.522 1.661 . . . . 0.0 109.91 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.14 160.86 15.74 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 120.883 -1.136 . . . . 0.0 110.566 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.81 75.55 2.36 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.771 1.177 . . . . 0.0 110.238 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -74.38 -24.6 59.16 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -73.33 -43.1 61.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.744 1.611 . . . . 0.0 110.535 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.75 -30.66 73.18 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.3 tp -74.91 -40.69 60.73 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.804 1.242 . . . . 0.0 110.958 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.14 -46.97 54.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.115 0.566 . . . . 0.0 109.967 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -55.66 -32.85 63.58 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.8 t -64.89 -41.14 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.07 -38.47 73.57 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.021 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -59.36 -43.79 92.77 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.473 1.137 . . . . 0.0 108.325 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -60.22 -55.1 37.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.328 0.651 . . . . 0.0 109.803 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -58.4 -51.84 68.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.749 0.655 . . . . 0.0 111.989 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.43 -31.06 70.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.943 0.897 . . . . 0.0 110.74 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.41 -31.77 71.35 Favored 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 120.752 -1.218 . . . . 0.0 110.198 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.29 -47.12 9.69 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 123.629 0.581 . . . . 0.0 111.961 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -90.05 -32.3 16.79 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 -176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.52 -10.77 72.22 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 120.97 -1.081 . . . . 0.0 111.658 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.29 136.52 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -66.63 134.7 52.83 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 117.785 -1.102 . . . . 0.0 109.359 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -134.31 78.46 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.66 155.55 29.44 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 94.4 t -141.54 127.91 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -136.53 161.43 35.89 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -123.34 68.13 37.98 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.106 0.963 . . . . 0.0 111.004 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -66.35 170.72 11.61 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.545 2.164 . . . . 0.0 111.114 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -122.97 -3.12 8.63 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.223 -0.923 . . . . 0.0 111.905 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -132.21 12.1 4.62 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.361 1.865 . . . . 0.0 112.785 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.94 -32.48 20.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.073 0.851 . . . . 0.0 112.315 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -52.54 -30.19 29.36 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.51 1.124 . . . . 0.0 112.259 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -116.9 -18.79 10.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.856 0.862 . . . . 0.0 112.206 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -41.38 31.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -51.41 -59.86 6.99 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.762 0.825 . . . . 0.0 109.834 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.47 -17.48 59.74 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 CA-C-N 121.245 1.48 . . . . 0.0 113.617 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -84.08 -5.48 59.24 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.667 1.121 . . . . 0.0 112.391 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.63 -38.85 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.031 0.932 . . . . 0.0 108.805 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.93 -32.54 70.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.213 1.005 . . . . 0.0 111.344 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.98 -31.61 68.91 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.741 0.7 . . . . 0.0 110.562 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.8 m -86.39 -15.97 38.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.598 1.159 . . . . 0.0 110.202 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.79 36.57 5.51 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.198 1.38 . . . . 0.0 110.381 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -132.16 173.71 10.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.691 1.196 . . . . 0.0 108.618 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.13 -160.21 14.77 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 126.497 1.998 . . . . 0.0 113.554 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.27 175.83 2.4 Favored 'Trans proline' 0 C--N 1.356 0.964 1 C-N-CA 125.861 4.374 . . . . 0.0 114.113 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -106.96 -18.59 13.87 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.8 -1.187 . . . . 0.0 113.999 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.4 mt -148.22 135.15 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.33 1.052 . . . . 0.0 109.006 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.2 tt -115.19 142.06 29.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -129.95 107.57 9.46 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.45 1.5 . . . . 0.0 108.16 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.8 t-105 -156.13 -176.67 6.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.966 0.803 . . . . 0.0 111.553 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.35 138.14 51.16 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -46.37 -43.44 16.17 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 126.157 1.783 . . . . 0.0 113.619 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -55.53 -27.76 50.73 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -81.47 -18.66 44.44 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.764 0.711 . . . . 0.0 111.567 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -76.32 -13.51 60.14 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 118.465 -0.779 . . . . 0.0 112.833 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.13 -11.69 33.69 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.284 0.945 . . . . 0.0 113.544 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.95 -63.03 0.92 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -47.53 -56.37 7.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.043 1.737 . . . . 0.0 114.331 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.27 91.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.21 0.604 . . . . 0.0 111.758 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.31 -43.91 75.29 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.068 1.347 . . . . 0.0 109.717 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.5 m -74.87 -1.25 21.49 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.486 1.115 . . . . 0.0 113.347 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.77 18.15 64.22 Favored Glycine 0 C--N 1.337 0.626 0 O-C-N 120.805 -1.184 . . . . 0.0 113.602 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.6 mt -77.65 -32.91 53.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.687 1.244 . . . . 0.0 112.359 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.2 mt -91.45 142.1 28.03 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.476 -0.765 . . . . 0.0 111.706 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.88 172.24 14.05 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.857 1.263 . . . . 0.0 113.167 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -69.93 100.13 1.52 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.585 1.954 . . . . 0.0 108.911 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 9.9 mm -63.33 153.75 6.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.912 0.863 . . . . 0.0 110.107 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.9 m 60.86 77.44 0.37 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 127.376 2.27 . . . . 0.0 109.725 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 -26.17 21.53 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.274 1.316 . . . . 0.0 110.252 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -129.94 138.09 50.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.523 1.529 . . . . 0.0 110.754 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -57.49 -37.0 72.22 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.74 -24.42 56.9 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.308 1.413 . . . . 0.0 112.953 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.8 -28.23 68.85 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.693 0.679 . . . . 0.0 110.648 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -66.01 -43.96 86.17 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -64.95 -11.84 43.0 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.45 0.7 . . . . 0.0 111.894 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -87.19 -15.89 36.97 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 120.767 -1.208 . . . . 0.0 112.578 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.41 HD13 ' CZ2' ' A' ' 94' ' ' TRP . 25.2 mt -124.17 163.12 22.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.475 1.034 . . . . 0.0 112.625 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -81.23 153.33 71.68 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 123.71 0.804 . . . . 0.0 112.03 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.05 -47.78 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 124.378 3.385 . . . . 0.0 114.216 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -54.05 -36.74 63.4 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.078 1.308 . . . . 0.0 111.937 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.5 -27.68 61.51 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.726 1.61 . . . . 0.0 110.634 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.41 ' CZ2' HD13 ' A' ' 89' ' ' LEU . 12.9 m95 -69.5 -36.79 76.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.631 1.105 . . . . 0.0 109.999 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -63.2 -27.43 69.36 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.632 -0.667 . . . . 0.0 111.063 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.76 -4.16 22.43 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.291 1.437 . . . . 0.0 113.979 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.34 6.91 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 125.4 1.48 . . . . 0.0 111.206 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -71.6 170.67 12.92 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -149.14 -152.14 0.43 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -57.48 -11.76 2.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.536 1.934 . . . . 0.0 115.708 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.38 -85.14 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 105.563 -3.015 . . . . 0.0 105.563 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 162.08 16.98 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.425 0.69 . . . . 0.0 110.706 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.11 158.46 18.56 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.245 1.018 . . . . 0.0 109.614 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.0 pt -117.62 -24.5 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.651 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -156.81 -178.46 7.38 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.811 1.244 . . . . 0.0 110.051 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.82 149.52 67.1 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 123.895 0.878 . . . . 0.0 111.355 178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.01 142.62 28.05 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.843 2.362 . . . . 0.0 109.891 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.3 mm -124.56 -52.76 2.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.698 1.599 . . . . 0.0 108.173 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.34 148.81 43.27 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.827 1.251 . . . . 0.0 109.824 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.5 t -130.51 95.67 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.095 0.958 . . . . 0.0 109.254 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -94.71 164.46 12.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.491 1.117 . . . . 0.0 109.277 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -159.19 172.59 17.79 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.745 2.418 . . . . 0.0 106.721 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.3 mt -124.21 -170.22 2.1 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.695 1.198 . . . . 0.0 110.022 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.51 140.42 44.76 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.063 0.945 . . . . 0.0 109.847 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.7 168.82 7.13 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.074 0.949 . . . . 0.0 111.611 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.3 mp -93.47 138.98 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.233 1.013 . . . . 0.0 109.202 -179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -155.79 155.53 33.18 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.96 0.904 . . . . 0.0 109.086 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -47.42 124.27 6.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.598 1.959 . . . . 0.0 109.061 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -65.89 9.69 0.13 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.096 1.358 . . . . 0.0 114.318 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.93 158.62 27.59 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 120.805 -1.185 . . . . 0.0 110.461 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -82.57 21.66 0.95 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.551 1.14 . . . . 0.0 110.695 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.8 tt -119.49 78.18 20.17 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.395 1.478 . . . . 0.0 108.99 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -74.93 115.27 4.24 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.599 2.199 . . . . 0.0 109.989 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -146.45 85.94 7.09 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.38 163.54 29.83 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.371 2.714 . . . . 0.0 114.571 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -77.32 124.06 6.94 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.129 3.219 . . . . 0.0 108.721 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -80.72 -25.55 38.01 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.045 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.6 t -154.67 162.69 41.02 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.413 1.006 . . . . 0.0 109.689 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -65.75 -25.79 67.44 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 123.864 0.866 . . . . 0.0 111.786 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -71.56 -19.27 62.17 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.923 1.238 . . . . 0.0 109.79 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -89.37 -22.88 22.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.368 1.067 . . . . 0.0 111.125 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 15.8 mm -54.73 -59.33 10.81 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.195 -0.907 . . . . 0.0 108.796 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -69.87 -25.02 28.5 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.222 1.281 . . . . 0.0 111.47 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.16 -50.36 70.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 64.0 tp -70.13 -31.74 69.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -59.09 -44.76 91.95 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 118.684 0.674 . . . . 0.0 111.305 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -30.12 61.37 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.551 0.614 . . . . 0.0 110.832 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -66.27 -50.89 62.17 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.1 mt -67.48 -33.01 74.24 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.562 -1.208 . . . . 0.0 110.287 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -68.87 -34.62 75.74 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.931 1.241 . . . . 0.0 108.971 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.38 -16.36 62.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.378 0.536 . . . . 0.0 112.018 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.24 7.5 6.5 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.173 1.389 . . . . 0.0 112.121 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 170.92 -94.52 0.1 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 115.737 1.055 . . . . 0.0 115.737 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.74 -178.88 5.44 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.38 1.072 . . . . 0.0 113.58 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.64 169.08 9.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.803 1.287 . . . . 0.0 112.612 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -93.26 -73.12 0.57 Allowed 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.066 1.746 . . . . 0.0 109.292 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.9 tp -103.42 130.4 50.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.261 1.024 . . . . 0.0 112.749 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 76.7 mtp -131.37 117.3 18.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -143.22 156.31 44.72 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.69 88.22 0.35 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.746 1.618 . . . . 0.0 109.577 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -18.04 63.38 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.067 1.347 . . . . 0.0 109.812 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -71.41 -13.14 61.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.536 0.734 . . . . 0.0 112.644 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -103.76 129.3 25.57 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 119.19 0.905 . . . . 0.0 109.739 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.92 -10.41 23.03 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.786 2.324 . . . . 0.0 113.248 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -65.44 -42.09 92.75 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.796 1.638 . . . . 0.0 112.758 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -79.52 -32.67 42.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.6 p -84.33 -11.68 55.93 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.274 0.63 . . . . 0.0 111.77 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -53.75 -58.86 11.33 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 117.625 -1.178 . . . . 0.0 112.044 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.53 -18.01 58.53 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.281 1.493 . . . . 0.0 114.055 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.0 tp -71.35 -63.77 1.05 Allowed 'General case' 0 C--N 1.34 0.193 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.4 pt -66.41 -36.03 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.26 -12.97 59.54 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.121 -0.943 . . . . 0.0 113.095 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -44.63 -55.95 4.78 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 125.513 1.525 . . . . 0.0 114.06 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.78 -34.68 74.86 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.53 19.73 0.02 OUTLIER Glycine 0 C--N 1.332 0.335 0 CA-C-O 118.294 -1.281 . . . . 0.0 116.068 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.13 144.1 34.21 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 119.402 1.601 . . . . 0.0 111.548 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.428 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 51.7 p90 -153.86 144.99 22.85 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.46 -49.56 12.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -145.9 133.67 21.16 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.646 0.778 . . . . 0.0 109.658 -178.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.428 ' HE2' ' CE1' ' A' ' 167' ' ' TYR . 14.5 tppt? -70.65 149.53 46.92 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.522 0.729 . . . . 0.0 110.037 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -143.32 113.06 7.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -156.07 170.03 23.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 55.96 26.96 10.49 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.603 1.161 . . . . 0.0 111.495 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 56.17 43.79 88.88 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -149.5 166.54 28.85 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 126.69 1.996 . . . . 0.0 108.198 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.19 127.65 54.96 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -126.7 87.78 2.72 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 123.117 1.437 . . . . 0.0 112.184 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.61 -8.92 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.403 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -74.54 -12.34 60.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.373 1.069 . . . . 0.0 108.987 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -118.94 93.57 4.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.244 1.417 . . . . 0.0 108.349 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 86.8 t -99.03 147.2 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -129.89 44.77 1.19 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-O 119.185 -0.786 . . . . 0.0 111.947 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.3 t -86.76 -63.42 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 124.958 1.303 . . . . 0.0 108.725 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -85.9 67.63 10.08 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 122.538 1.161 . . . . 0.0 110.029 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -121.48 159.34 26.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.93 -38.89 70.89 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -56.46 -46.66 87.24 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.702 0.683 . . . . 0.0 113.503 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.43 -52.6 60.84 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.891 0.476 . . . . 0.0 111.349 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -64.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 118.318 -0.849 . . . . 0.0 111.879 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.31 -51.91 39.44 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.73 -38.99 94.68 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 56.1 tp -70.61 -45.2 65.71 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 118.291 -0.862 . . . . 0.0 111.324 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.12 -37.92 67.51 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 117.313 -1.327 . . . . 0.0 110.736 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -52.17 -48.71 64.83 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.784 1.629 . . . . 0.0 111.344 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.7 tt -69.22 -48.01 63.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.114 0.566 . . . . 0.0 110.645 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.66 -35.15 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 121.38 -0.825 . . . . 0.0 111.41 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.01 -29.6 69.47 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.204 -0.935 . . . . 0.0 109.279 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.94 -42.3 60.74 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 65.8 mt -58.38 -47.9 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -52.18 -51.29 58.98 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.181 1.392 . . . . 0.0 109.73 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -78.47 0.9 24.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.158 0.983 . . . . 0.0 112.087 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt 60.78 12.06 3.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 128.109 2.564 . . . . 0.0 113.812 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.79 6.35 1.2 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 127.272 2.229 . . . . 0.0 111.806 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 14.3 ttt -147.49 143.8 28.11 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.108 1.322 . . . . 0.0 109.649 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -83.36 70.28 10.14 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -47.81 -40.31 20.75 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.492 2.717 . . . . 0.0 116.388 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -72.02 0.23 9.95 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.044 1.738 . . . . 0.0 114.113 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.8 m -65.37 123.18 18.93 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.008 -1.058 . . . . 0.0 110.512 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.1 -172.65 2.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.073 1.749 . . . . 0.0 108.241 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -60.2 -50.57 73.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.649 0.38 . . . . 0.0 110.91 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.1 m -60.89 -41.07 95.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.537 0.735 . . . . 0.0 111.132 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 41.4 mm -65.59 -49.33 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.879 -1.058 . . . . 0.0 108.556 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.16 -46.15 90.27 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.235 1.014 . . . . 0.0 111.707 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -62.78 -48.08 80.68 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.91 1.284 . . . . 0.0 108.888 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.53 87.81 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.94 99.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -62.22 -39.08 91.61 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -57.32 -20.2 27.06 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.558 1.543 . . . . 0.0 111.774 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.38 -13.14 12.9 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.889 -1.132 . . . . 0.0 112.095 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.44 28.31 40.26 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.213 1.387 . . . . 0.0 110.47 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.83 7.18 4.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.585 1.954 . . . . 0.0 113.372 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.06 160.49 43.28 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 120.683 -1.261 . . . . 0.0 108.905 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -106.34 -15.14 14.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.536 1.534 . . . . 0.0 113.606 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -159.88 153.46 22.57 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.889 1.276 . . . . 0.0 109.976 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 4.3 t -150.02 161.1 43.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.4 mt -132.23 106.94 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -156.7 -175.01 5.2 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.954 1.702 . . . . 0.0 107.451 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -75.85 172.21 54.17 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 123.689 0.661 . . . . 0.0 113.846 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -67.19 179.79 2.2 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 125.123 3.882 . . . . 0.0 112.553 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.424 ' CE3' ' HE3' ' A' ' 239' ' ' LYS . 26.3 t90 63.51 23.59 13.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.355 1.862 . . . . 0.0 113.358 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.39 160.63 30.06 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.495 -1.378 . . . . 0.0 108.597 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -65.47 -15.08 62.28 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.664 1.221 . . . . 0.0 110.365 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 4.1 m -61.71 -24.57 66.87 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.014 1.325 . . . . 0.0 110.847 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 41.8 p30 -125.47 175.12 7.73 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.742 1.617 . . . . 0.0 109.183 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.9 mm -110.1 -19.45 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -71.55 152.62 42.81 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 120.746 -1.221 . . . . 0.0 108.993 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 66.6 p -120.53 87.58 2.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.842 0.857 . . . . 0.0 109.444 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 93.8 p -126.57 156.87 40.17 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 120.689 -1.257 . . . . 0.0 110.527 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . 0.424 ' HE3' ' CE3' ' A' ' 230' ' ' TRP . 8.1 mptt -134.94 134.2 40.34 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.5 p -176.16 167.77 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 128.823 2.849 . . . . 0.0 104.852 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -140.43 28.83 2.0 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.752 0.705 . . . . 0.0 112.615 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -145.51 150.34 36.28 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.999 1.272 . . . . 0.0 111.383 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 73.76 131.77 0.2 Allowed Glycine 0 C--N 1.337 0.618 0 C-N-CA 126.285 1.898 . . . . 0.0 114.746 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.13 -175.48 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.969 1.308 . . . . 0.0 109.276 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.5 t -98.82 -175.22 2.99 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 125.794 1.638 . . . . 0.0 107.942 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 14.5 p -50.8 149.45 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.097 1.359 . . . . 0.0 109.057 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.77 155.97 52.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 124.387 1.075 . . . . 0.0 110.487 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.59 159.43 53.61 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.572 1.515 . . . . 0.0 109.622 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 68.1 p -120.68 -176.4 3.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.369 1.068 . . . . 0.0 109.987 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -100.16 169.35 9.21 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.568 1.076 . . . . 0.0 109.762 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -66.86 126.31 28.66 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.24 3.41 57.02 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 117.848 -1.529 . . . . 0.0 115.327 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.32 137.19 9.2 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 121.706 2.753 . . . . 0.0 114.347 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.42 146.7 40.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.881 2.387 . . . . 0.0 108.568 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 10.4 p -72.62 173.46 8.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . 0.344 12.8 ptmt -133.32 71.87 75.99 Favored Pre-proline 0 C--O 1.238 0.495 0 O-C-N 120.857 -1.152 . . . . 0.0 112.843 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.88 166.18 30.31 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.704 3.603 . . . . 0.0 113.291 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -85.88 161.78 18.91 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.005 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 77.5 t -145.01 162.04 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 128.942 2.897 . . . . 0.0 107.198 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -156.71 146.95 14.7 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 14.9 m -138.21 168.4 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 119.794 1.797 . . . . 0.0 110.979 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 15.6 tp -74.96 152.2 38.8 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.0 m -133.87 129.6 36.64 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 121.122 1.783 . . . . 0.0 111.885 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -116.01 132.87 56.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.1 134.15 6.74 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.101 0.864 . . . . 0.0 112.608 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 81.5 mt -74.58 145.93 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 117.67 0.735 . . . . 0.0 109.842 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -75.52 124.98 28.11 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.315 1.446 . . . . 0.0 109.028 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.12 -22.29 65.8 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.251 -0.906 . . . . 0.0 113.06 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -77.82 -10.61 59.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.696 1.199 . . . . 0.0 112.606 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 70.4 m -65.96 146.45 99.01 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.97 -38.64 3.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.663 1.575 . . . . 0.0 112.672 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -132.23 88.22 2.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.649 0.78 . . . . 0.0 109.419 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -54.7 -22.97 15.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.123 0.969 . . . . 0.0 112.011 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -61.87 -30.68 71.02 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.06 1.344 . . . . 0.0 111.27 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.34 -42.01 94.77 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 121.183 -0.948 . . . . 0.0 108.553 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.19 -40.29 68.0 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.79 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -37.68 86.68 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 118.585 0.63 . . . . 0.0 109.957 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -73.64 -41.01 63.33 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -57.84 -49.69 75.83 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.703 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.8 mp -64.32 -49.36 72.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 119.104 -0.475 . . . . 0.0 111.53 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -71.29 -15.68 62.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -105.7 -19.7 13.68 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.969 1.713 . . . . 0.0 113.961 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -137.52 -45.51 0.55 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 117.923 -1.037 . . . . 0.0 111.843 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -59.15 -55.83 29.9 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.059 1.299 . . . . 0.0 111.68 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.5 mt -84.12 63.41 7.64 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.624 2.37 . . . . 0.0 110.38 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 68.9 p -138.87 161.55 36.99 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.95 -21.72 66.88 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 122.839 0.456 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -96.37 -27.68 14.82 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.052 0.941 . . . . 0.0 110.79 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -80.51 -43.96 8.94 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.568 1.08 . . . . 0.0 112.116 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 35.7 mt -65.22 -40.7 94.44 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -58.13 -47.23 83.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.783 1.233 . . . . 0.0 109.425 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.43 74.52 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.464 1.029 . . . . 0.0 112.839 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 24.8 t -73.54 -35.72 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 118.912 -0.566 . . . . 0.0 109.924 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -68.94 -29.87 68.2 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.807 0.731 . . . . 0.0 110.775 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -64.12 -38.27 90.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -51.14 35.83 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 123.518 0.511 . . . . 0.0 110.21 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -147.79 150.61 36.68 Favored Pre-proline 0 C--N 1.344 0.356 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.693 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.57 115.1 2.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.709 2.939 . . . . 0.0 110.792 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 90.9 mt -91.57 -20.94 21.14 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.23 -158.41 24.65 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.25 175.64 4.48 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 35.8 m -127.71 146.9 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 120.043 -1.661 . . . . 0.0 110.329 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.29 -29.47 63.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.662 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 22.3 tp -68.52 106.31 2.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -52.23 -27.33 14.41 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.007 0.923 . . . . 0.0 112.405 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.4 m -61.64 -70.94 0.16 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.663 0.785 . . . . 0.0 111.042 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -66.98 -21.14 65.97 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.188 0.449 . . . . 0.0 111.39 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -65.08 -25.51 67.83 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.24 -18.21 61.84 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.153 -1.592 . . . . 0.0 110.009 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -89.04 -51.77 5.43 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.999 1.32 . . . . 0.0 107.527 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 47.7 mt -61.26 -41.52 97.05 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.59 3.32 1.9 Allowed 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.672 0.789 . . . . 0.0 112.563 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -59.66 -25.73 64.96 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.486 1.494 . . . . 0.0 109.219 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.91 147.56 37.48 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.52 -14.22 43.16 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.138 2.559 . . . . 0.0 114.585 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -62.1 -56.31 20.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.784 1.174 . . . . 0.0 108.975 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.2 mp -62.85 -51.78 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 125.306 1.442 . . . . 0.0 108.616 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.49 -48.4 62.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 123.447 0.467 . . . . 0.0 110.56 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.22 -33.69 71.28 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 1.3 m -67.21 -41.62 85.46 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -38.79 66.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.084 0.554 . . . . 0.0 111.973 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -53.41 -39.02 64.0 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 124.626 1.17 . . . . 0.0 109.323 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.06 -30.87 68.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -75.38 -38.41 60.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -61.16 -45.73 93.45 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.84 1.256 . . . . 0.0 110.206 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.95 6.47 39.28 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.52 1.128 . . . . 0.0 112.378 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -101.54 -179.82 28.18 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.006 1.765 . . . . 0.0 111.016 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -142.98 165.45 27.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.743 2.417 . . . . 0.0 105.382 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.33 154.08 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 120.087 -1.633 . . . . 0.0 111.162 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 40.5 ttp -70.9 125.62 92.03 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.505 1.122 . . . . 0.0 108.376 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.85 100.85 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.271 2.647 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -61.02 0.31 0.24 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 22.7 pt -69.5 150.13 96.98 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 120.549 1.522 . . . . 0.0 114.223 -178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.97 -13.69 39.03 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.236 2.624 . . . . 0.0 114.396 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -71.34 -13.08 61.75 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.998 -1.064 . . . . 0.0 110.727 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 73.8 mmm -66.09 -28.7 69.02 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 121.373 -0.829 . . . . 0.0 111.759 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 29.9 t -55.35 -51.51 66.54 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.98 -39.1 87.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.954 0.901 . . . . 0.0 110.987 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -51.94 -54.76 25.82 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.923 0.889 . . . . 0.0 110.148 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -64.26 -45.65 87.19 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.643 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -53.71 -42.16 67.76 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.377 0.671 . . . . 0.0 110.725 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.0 -62.57 1.32 Allowed 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 125.601 1.56 . . . . 0.0 112.637 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.57 -36.8 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.977 0.911 . . . . 0.0 111.827 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.47 -49.4 45.64 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.75 1.159 . . . . 0.0 110.356 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 6.6 m -73.53 -42.63 61.49 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.14 57.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.822 1.192 . . . . 0.0 112.745 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.2 t -61.28 -56.1 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 32.3 mm -59.96 -37.2 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.24 0.616 . . . . 0.0 110.657 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -57.21 -47.59 80.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.337 0.972 . . . . 0.0 109.539 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.0 -47.95 55.91 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.566 0.747 . . . . 0.0 110.816 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.89 -24.67 66.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.978 0.911 . . . . 0.0 112.924 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 18.5 m -92.16 -8.51 45.39 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.669 1.188 . . . . 0.0 110.513 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 69.97 16.18 72.42 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.608 0.64 . . . . 0.0 111.76 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -76.62 -33.44 58.39 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 118.092 0.946 . . . . 0.0 110.019 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -143.52 148.95 36.76 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 8.9 t -65.98 156.99 32.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 64.6 t -56.88 -47.99 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 123.742 0.817 . . . . 0.0 109.786 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -52.39 -46.6 66.31 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.31 0.644 . . . . 0.0 111.036 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -69.48 -36.46 76.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 119.457 -0.306 . . . . 0.0 111.048 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.09 -45.03 90.49 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 8.1 mt -69.18 -41.31 77.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.345 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -56.58 -49.47 74.77 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.911 1.285 . . . . 0.0 109.307 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -51.94 -56.4 14.42 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.261 1.824 . . . . 0.0 108.786 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.78 -49.85 76.11 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.182 1.393 . . . . 0.0 113.403 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -55.3 -38.5 68.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.579 1.551 . . . . 0.0 109.196 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.7 m -65.75 -42.79 90.52 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.425 -0.797 . . . . 0.0 109.855 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -59.2 -26.59 64.96 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.272 0.942 . . . . 0.0 113.233 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.7 mt -79.51 -25.1 12.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.047 0.939 . . . . 0.0 109.531 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 43.9 p -93.39 -23.65 18.35 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.491 0.716 . . . . 0.0 112.271 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.445 1.498 . . . . 0.0 108.346 -178.55 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.517 ' H1 ' ' CD ' ' A' ' 4' ' ' GLU . 62.9 mttt . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.8 mt -85.38 179.06 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.903 0 N-CA-C 101.14 -3.652 . . . . 0.0 101.14 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.53 75.35 1.46 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.517 ' CD ' ' H1 ' ' A' ' 1' ' ' LYS . 37.2 mt-10 -75.57 82.12 2.59 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.2 2.2 . . . . 0.0 108.325 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.71 32.43 0.04 OUTLIER Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.21 -1.359 . . . . 0.0 115.312 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -145.8 166.63 25.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.34 1.57 . . . . 0.0 111.357 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 mt -146.41 145.8 30.38 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.781 2.032 . . . . 0.0 107.195 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.82 144.55 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.945 1.298 . . . . 0.0 108.363 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.1 mt -131.74 135.16 59.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 126.606 1.963 . . . . 0.0 108.243 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -126.05 111.82 15.15 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -140.88 148.11 22.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 C-N-CA 124.426 1.09 . . . . 0.0 109.035 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.31 177.56 11.22 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.196 -0.94 . . . . 0.0 110.384 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.13 55.4 7.93 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-O 118.734 -1.036 . . . . 0.0 110.98 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.3 34.52 20.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.728 1.211 . . . . 0.0 113.424 177.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 20.32 0.06 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 116.261 1.949 . . . . 0.0 116.261 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.11 44.18 98.48 Favored Glycine 0 CA--C 1.536 1.396 0 O-C-N 120.678 -1.264 . . . . 0.0 111.318 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -60.35 -40.2 89.84 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -68.34 -39.79 81.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.026 1.284 . . . . 0.0 108.721 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.06 -35.08 91.6 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.7 tp -71.43 -35.46 70.95 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.799 -0.824 . . . . 0.0 111.546 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.71 -43.1 68.72 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.052 0.842 . . . . 0.0 110.25 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -57.83 -21.46 42.5 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.127 1.371 . . . . 0.0 113.953 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 t -86.34 -47.81 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.23 -41.29 96.9 Favored Glycine 0 C--N 1.335 0.512 0 O-C-N 121.01 -1.056 . . . . 0.0 112.237 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -37.64 88.15 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 117.998 0.899 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -61.23 -53.34 58.14 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -58.96 -47.82 83.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.765 0.426 . . . . 0.0 111.804 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -15.75 53.75 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.789 1.636 . . . . 0.0 110.728 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.488 ' HZ3' ' HA ' ' A' ' 29' ' ' LYS . 1.1 tppm? -94.99 -0.19 54.06 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 120.296 -1.503 . . . . 0.0 113.438 -179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -115.33 -51.83 2.69 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.894 1.678 . . . . 0.0 107.58 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -93.75 -21.68 19.17 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.27 -18.12 19.75 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.674 -1.266 . . . . 0.0 113.905 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.6 mm -61.47 118.04 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.011 1.406 . . . . 0.0 107.616 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -56.57 145.2 29.0 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 124.869 1.268 . . . . 0.0 112.463 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.1 t -130.16 104.41 10.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.8 m -91.84 127.18 37.2 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.43 115.17 46.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.356 -2.091 . . . . 0.0 105.356 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -127.13 171.73 11.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.345 1.058 . . . . 0.0 110.275 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -138.08 68.16 48.66 Favored Pre-proline 0 N--CA 1.455 -0.199 0 C-N-CA 123.619 0.768 . . . . 0.0 112.894 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.29 139.95 19.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 N-CA-C 107.997 -1.578 . . . . 0.0 107.997 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.58 9.52 41.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.555 1.542 . . . . 0.0 108.978 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.36 2.66 10.28 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.514 1.926 . . . . 0.0 114.112 -177.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pp -53.53 -25.58 17.46 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 117.677 -1.154 . . . . 0.0 113.738 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -57.09 -23.4 46.66 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.988 1.315 . . . . 0.0 113.092 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -124.46 -24.02 4.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.801 0.84 . . . . 0.0 112.368 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -77.88 -48.58 16.07 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.27 1.428 . . . . 0.0 110.77 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -45.12 -56.86 8.23 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 117.85 -1.072 . . . . 0.0 111.376 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.56 -39.58 81.74 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 CA-C-N 120.577 1.242 . . . . 0.0 115.211 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -67.43 -46.58 72.73 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.583 1.083 . . . . 0.0 112.326 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 22.2 t -68.96 -41.55 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.1 -32.38 71.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.189 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.7 -19.05 57.73 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.951 0.796 . . . . 0.0 110.459 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 m -99.82 -41.7 7.14 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.431 1.492 . . . . 0.0 107.599 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.61 9.14 10.4 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.274 1.416 . . . . 0.0 114.769 178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -89.04 -8.53 53.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.374 1.087 . . . . 0.0 112.965 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.83 171.26 45.3 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.442 1.02 . . . . 0.0 114.639 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -64.09 167.79 13.6 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.219 2.613 . . . . 0.0 110.18 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.0 -19.36 22.47 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 126.16 1.784 . . . . 0.0 110.564 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.0 mt -124.24 148.02 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 123.817 0.847 . . . . 0.0 109.812 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.3 tt -141.04 136.64 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -133.37 107.96 8.41 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -154.58 170.87 20.47 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.493 1.042 . . . . 0.0 108.978 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.06 158.27 31.49 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.748 -0.595 . . . . 0.0 110.358 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -55.14 -32.89 62.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.101 0.96 . . . . 0.0 110.168 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.34 -11.11 0.46 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 129.062 2.945 . . . . 0.0 114.912 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -129.63 13.36 5.93 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.014 2.125 . . . . 0.0 109.431 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -115.73 26.48 9.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.655 1.982 . . . . 0.0 111.275 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.27 -19.89 15.21 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 120.467 -1.396 . . . . 0.0 111.894 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -107.05 -35.5 2.73 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 117.948 -1.473 . . . . 0.0 116.075 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -51.68 -45.33 63.42 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.593 2.196 . . . . 0.0 111.464 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.59 95.99 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -32.45 73.2 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.003 1.321 . . . . 0.0 109.592 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.7 m -80.57 -4.62 54.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.386 1.474 . . . . 0.0 110.129 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.54 18.04 76.49 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.912 1.244 . . . . 0.0 112.257 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.5 mt -88.46 -17.58 30.08 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.893 1.346 . . . . 0.0 113.756 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.2 mt -99.41 126.83 45.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.395 0.998 . . . . 0.0 111.277 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.56 164.73 26.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.435 1.094 . . . . 0.0 110.818 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -71.32 94.32 1.2 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.957 1.303 . . . . 0.0 109.17 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.1 pp -74.71 172.91 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 m 67.37 82.75 0.19 Allowed Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 126.141 1.776 . . . . 0.0 111.495 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.91 -34.64 8.36 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.712 1.608 . . . . 0.0 108.529 178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -147.0 155.72 42.47 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.926 0.869 . . . . 0.0 111.817 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -56.36 -33.86 66.09 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.783 2.433 . . . . 0.0 112.896 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.08 -26.75 66.43 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 120.191 1.36 . . . . 0.0 113.214 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -76.09 -26.32 56.33 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 120.25 1.386 . . . . 0.0 109.09 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -62.87 -46.82 86.08 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.229 1.012 . . . . 0.0 109.117 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.48 -14.1 62.02 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -14.73 61.43 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 120.861 -1.149 . . . . 0.0 109.916 178.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mt -120.98 164.37 16.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.292 1.837 . . . . 0.0 107.758 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.86 150.45 81.41 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 121.059 -1.026 . . . . 0.0 111.719 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.06 -49.21 2.17 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.569 2.846 . . . . 0.0 112.118 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -57.79 -25.21 60.22 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.18 -20.33 41.43 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.809 -1.182 . . . . 0.0 110.574 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -72.92 -26.97 61.59 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -53.26 -41.94 65.98 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.91 1.684 . . . . 0.0 110.091 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.17 -6.43 4.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.923 1.289 . . . . 0.0 113.428 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.15 -0.18 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.104 1.361 . . . . 0.0 111.832 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 -63.16 148.98 46.46 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.089 1.313 . . . . 0.0 108.375 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CE1' ' HE2' ' A' ' 102' ' ' LYS . 26.0 t80 -142.02 167.33 22.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -63.7 114.52 4.04 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.455 0.702 . . . . 0.0 110.801 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.9 -84.33 0.3 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 124.65 1.119 . . . . 0.0 111.34 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.445 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -72.83 166.03 23.73 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.21 0.604 . . . . 0.0 109.876 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.73 166.31 10.56 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.38 -40.17 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.96 174.01 11.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.649 0.659 . . . . 0.0 111.096 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -131.68 149.55 73.78 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 124.76 1.224 . . . . 0.0 110.419 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.27 145.62 30.78 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.198 2.599 . . . . 0.0 110.043 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -128.12 -53.66 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.261 1.425 . . . . 0.0 111.043 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.77 155.6 43.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.998 0.817 . . . . 0.0 112.45 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.5 t -130.95 110.1 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.059 0.544 . . . . 0.0 110.652 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -143.47 126.15 16.01 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.716 0.689 . . . . 0.0 112.746 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.63 84.72 0.97 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.807 2.043 . . . . 0.0 108.126 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -153.91 138.32 16.73 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 120.568 -1.333 . . . . 0.0 107.437 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.8 p -176.07 125.33 0.2 Allowed 'General case' 0 C--O 1.237 0.42 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.8 tp -140.28 158.7 43.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.74 0.7 . . . . 0.0 109.483 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mm -125.56 137.09 58.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -161.49 164.79 29.46 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 126.653 1.981 . . . . 0.0 106.565 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -64.89 134.51 54.17 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.878 0.471 . . . . 0.0 111.061 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -83.39 -12.53 56.38 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 121.821 -0.55 . . . . 0.0 112.317 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.24 174.85 0.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.749 2.42 . . . . 0.0 111.273 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.12 -11.68 9.66 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.762 1.225 . . . . 0.0 111.671 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 tt -115.87 70.35 3.64 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.847 2.459 . . . . 0.0 107.64 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -81.71 5.22 6.44 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.39 2.727 . . . . 0.0 114.811 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.3 t30 23.32 76.33 0.24 Allowed Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 128.754 2.822 . . . . 0.0 112.521 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.6 111.09 2.25 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.706 2.271 . . . . 0.0 110.747 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -82.0 173.69 10.81 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.518 2.145 . . . . 0.0 110.137 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -143.31 -31.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.715 1.206 . . . . 0.0 112.186 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.39 141.3 27.06 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -64.25 -16.1 61.38 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.039 -1.663 . . . . 0.0 113.203 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.84 -13.12 59.63 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.376 -0.827 . . . . 0.0 111.942 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -90.03 -14.01 34.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.326 0.65 . . . . 0.0 110.377 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.7 mm -53.39 -55.73 31.64 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 125.302 1.441 . . . . 0.0 110.424 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.98 -25.56 51.83 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 CA-C-N 120.693 1.283 . . . . 0.0 112.414 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.03 -60.52 2.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.61 -25.26 68.01 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.39 -0.819 . . . . 0.0 110.4 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.97 -47.81 76.29 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -67.67 -31.38 71.32 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 119.181 0.9 . . . . 0.0 110.997 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.06 -49.53 74.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 63.2 mt -76.68 -28.58 55.97 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.961 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -67.47 -34.25 76.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 119.785 1.175 . . . . 0.0 108.648 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.59 -15.19 62.49 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.16 5.62 5.87 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.918 1.287 . . . . 0.0 111.958 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.52 -97.76 0.12 Allowed Glycine 0 C--N 1.341 0.808 0 CA-C-N 119.686 1.13 . . . . 0.0 113.829 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -141.45 -162.1 1.33 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.941 1.297 . . . . 0.0 110.128 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.35 178.83 0.18 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.903 2.481 . . . . 0.0 115.766 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.96 -36.11 3.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.585 1.954 . . . . 0.0 111.069 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.2 tp -123.56 110.0 14.49 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.143 1.777 . . . . 0.0 108.343 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 49.0 ttm -121.2 106.77 11.83 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.407 1.083 . . . . 0.0 108.585 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -135.02 167.74 20.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.933 0.788 . . . . 0.0 110.722 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -67.0 89.0 0.16 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.722 1.609 . . . . 0.0 109.561 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.1 mt -81.91 -5.22 58.1 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.904 1.281 . . . . 0.0 111.602 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -85.57 -8.01 58.53 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -120.41 130.17 24.98 Favored Pre-proline 0 C--O 1.236 0.382 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.54 -15.96 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.884 1.723 . . . . 0.0 113.584 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -55.47 -36.22 66.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.593 0.757 . . . . 0.0 112.236 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -81.35 -37.76 27.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.572 0.749 . . . . 0.0 112.027 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.7 p -82.84 -10.96 58.6 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.878 0.763 . . . . 0.0 112.297 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -60.8 -59.49 13.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 O-C-N 120.912 -1.117 . . . . 0.0 113.507 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -68.04 -3.5 10.74 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 121.326 1.509 . . . . 0.0 114.585 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.0 tp -79.24 -66.67 0.84 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 8.2 pt -68.7 -25.43 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.59 -23.58 67.11 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.821 -1.175 . . . . 0.0 110.591 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -45.53 -60.04 2.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.937 2.095 . . . . 0.0 111.099 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -58.98 -57.3 13.67 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.31 5.19 0.03 OUTLIER Glycine 0 C--N 1.334 0.441 0 CA-C-O 116.991 -2.005 . . . . 0.0 117.713 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -61.35 134.34 48.14 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -141.64 121.91 13.93 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.54 -53.9 44.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.378 -0.201 . . . . 0.0 110.965 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -142.81 132.22 23.54 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -71.3 151.42 44.21 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -141.41 99.12 3.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -71.31 178.09 3.56 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -60.44 22.14 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.084 2.554 . . . . 0.0 116.747 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.57 -4.58 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 127.294 2.378 . . . . 0.0 111.866 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -113.8 107.88 16.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.613 1.706 . . . . 0.0 108.738 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.97 47.04 0.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.082 1.353 . . . . 0.0 109.58 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.88 92.64 1.27 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.25 1.42 . . . . 0.0 112.259 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.82 -1.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 130.303 3.441 . . . . 0.0 113.532 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -70.7 -33.93 71.4 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -82.72 100.89 10.52 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.1 t -116.48 102.34 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 126.56 1.944 . . . . 0.0 111.487 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -90.96 40.15 3.01 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 126.276 1.893 . . . . 0.0 113.842 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.94 -19.99 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.526 0.73 . . . . 0.0 111.063 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -108.34 51.04 0.75 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.976 1.369 . . . . 0.0 108.08 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -106.64 153.44 22.38 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.496 1.118 . . . . 0.0 109.913 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.56 -40.99 66.01 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.055 1.342 . . . . 0.0 111.729 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -59.67 -42.04 97.69 Favored Glycine 0 CA--C 1.523 0.588 0 O-C-N 121.474 -0.766 . . . . 0.0 112.656 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.22 -52.15 60.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -62.74 -32.73 73.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.241 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.1 -60.42 3.62 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.316 1.416 . . . . 0.0 110.065 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.65 -34.44 86.32 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 36.5 tp -70.48 -54.87 10.53 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.525 0.662 . . . . 0.0 110.1 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.62 -36.43 71.79 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.706 0.802 . . . . 0.0 109.616 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.86 -41.58 87.35 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.553 1.069 . . . . 0.0 109.595 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.5 tt -73.76 -45.54 51.14 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.248 -0.907 . . . . 0.0 109.671 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.61 -36.64 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.833 1.253 . . . . 0.0 110.037 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -58.28 -31.56 67.57 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.092 1.357 . . . . 0.0 111.138 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 49.5 mt -73.71 -40.94 63.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.52 -40.84 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -55.23 -37.67 67.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.122 0.969 . . . . 0.0 109.634 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -88.69 0.18 56.69 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.5 1.52 . . . . 0.0 112.37 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? 58.72 10.12 1.36 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 128.131 2.572 . . . . 0.0 114.759 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -42.9 89.83 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.8 tpt -92.64 142.32 27.5 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.88 1.272 . . . . 0.0 107.991 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -82.65 110.15 17.46 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.33 -8.04 54.87 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.906 0.882 . . . . 0.0 112.765 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -100.75 0.53 39.02 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.355 1.062 . . . . 0.0 112.807 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 93.6 m -63.93 130.04 42.48 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -129.8 -179.68 5.34 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.573 1.149 . . . . 0.0 108.696 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -55.12 -47.36 75.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.427 -0.32 . . . . 0.0 110.792 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.6 m -57.56 -45.58 85.0 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.408 1.483 . . . . 0.0 111.105 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 17.5 mm -64.19 -50.21 77.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.21 99.28 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.855 0.722 . . . . 0.0 111.927 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -59.23 -45.63 90.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.085 1.754 . . . . 0.0 110.574 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.15 -48.61 64.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.34 -51.46 68.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.023 0.929 . . . . 0.0 111.366 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -56.12 -39.37 72.13 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.669 0.788 . . . . 0.0 110.458 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -61.08 -25.01 66.66 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.998 -0.439 . . . . 0.0 112.117 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -94.5 -15.04 24.53 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.409 0.684 . . . . 0.0 111.138 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.04 11.94 58.2 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.311 1.434 . . . . 0.0 112.135 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -53.26 -70.08 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.672 2.389 . . . . 0.0 112.588 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.1 t -72.5 153.21 41.46 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -111.04 -18.59 13.0 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.022 0.529 . . . . 0.0 112.347 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -149.28 139.79 22.49 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.801 1.64 . . . . 0.0 108.669 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.7 t -160.29 -177.49 6.29 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 58.5 mt -137.42 138.39 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -131.31 167.05 19.9 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.194 1.398 . . . . 0.0 107.885 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 157.62 -165.18 33.41 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.87 -177.66 2.69 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.873 3.715 . . . . 0.0 111.75 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -119.04 -8.76 10.15 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.159 0.984 . . . . 0.0 111.295 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.8 -65.15 0.26 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.945 1.298 . . . . 0.0 109.919 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -128.12 145.09 51.12 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.612 1.165 . . . . 0.0 109.122 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 8.2 p -69.26 1.59 3.63 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.967 1.707 . . . . 0.0 115.157 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -75.1 69.69 2.01 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.134 1.374 . . . . 0.0 109.719 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 44.5 pt -132.64 147.39 31.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 C-N-CA 126.107 1.763 . . . . 0.0 106.428 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -82.75 -159.17 0.31 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.873 1.269 . . . . 0.0 110.253 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 32.4 p 46.94 38.3 6.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.952 2.101 . . . . 0.0 113.055 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 15.7 p -51.4 112.65 0.78 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.06 2.144 . . . . 0.0 109.081 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -72.87 42.26 0.1 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.839 1.656 . . . . 0.0 112.753 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 23.5 m -53.28 -23.0 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.641 1.576 . . . . 0.0 113.791 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -74.91 -16.19 60.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.838 0.855 . . . . 0.0 112.275 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -65.96 -179.69 0.77 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.281 1.032 . . . . 0.0 111.55 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -62.64 173.04 9.4 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 123.774 0.702 . . . . 0.0 111.542 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 11.3 t -142.58 98.65 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.251 9.7 t -137.02 -162.54 1.3 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.67 135.75 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.404 1.082 . . . . 0.0 109.244 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -67.47 148.47 98.65 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 123.85 0.86 . . . . 0.0 110.659 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.48 154.29 74.88 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 N-CA-C 107.745 -1.675 . . . . 0.0 107.745 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.0 p -115.28 179.0 4.09 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.926 0.891 . . . . 0.0 112.282 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -102.27 148.5 25.37 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 120.377 -1.452 . . . . 0.0 108.027 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.29 104.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.222 1.409 . . . . 0.0 110.592 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 95.61 -5.41 67.1 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.778 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.41 120.53 4.46 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 120.426 2.113 . . . . 0.0 112.578 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.07 159.28 33.91 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.968 3.112 . . . . 0.0 110.712 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 4.2 p -77.62 167.47 21.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.79 0.805 . . . . 0.0 110.131 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.402 ' HE2' ' HE3' ' A' ' 326' ' ' LYS . 13.2 ptpt -147.33 78.17 10.33 Favored Pre-proline 0 N--CA 1.453 -0.305 0 C-N-CA 123.622 0.769 . . . . 0.0 110.344 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.05 172.31 16.2 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.86 1.707 . . . . 0.0 110.343 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -65.21 152.38 43.8 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.8 144.69 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -132.83 139.28 10.81 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 105.502 -3.039 . . . . 0.0 105.502 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 8.4 m -143.91 147.56 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.11 159.23 24.75 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.5 m -133.09 144.52 50.03 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.899 0.772 . . . . 0.0 109.64 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.23 139.91 51.66 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 121.453 -0.779 . . . . 0.0 109.122 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.91 177.23 18.57 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.965 0.793 . . . . 0.0 113.076 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.3 mt -122.01 119.39 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 125.408 1.483 . . . . 0.0 107.229 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.98 123.02 21.08 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 120.499 -1.376 . . . . 0.0 107.945 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.51 -5.4 7.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.297 1.439 . . . . 0.0 112.739 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -67.2 -42.54 83.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 127.292 2.237 . . . . 0.0 113.671 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.8 m -57.39 152.49 32.52 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 123.98 0.912 . . . . 0.0 113.307 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.34 -51.45 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.772 2.315 . . . . 0.0 110.594 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -123.06 109.63 14.31 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -67.08 -24.29 65.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.71 -34.52 62.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.138 1.375 . . . . 0.0 111.56 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 78.2 mt -60.42 -36.17 77.53 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.327 -0.858 . . . . 0.0 110.146 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -81.25 -39.43 25.31 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.236 -0.887 . . . . 0.0 111.315 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.41 83.36 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.153 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -67.58 -49.4 63.35 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -56.41 -49.78 73.51 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.36 -0.838 . . . . 0.0 110.764 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.53 -21.94 66.62 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.81 -14.9 14.68 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -103.32 -24.27 13.52 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.986 0.812 . . . . 0.0 112.242 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -139.43 -32.18 0.66 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -67.07 -47.95 69.72 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.443 1.474 . . . . 0.0 112.847 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.05 73.13 5.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 71.4 p -138.72 153.98 48.53 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.88 -24.37 67.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -86.85 -43.67 12.29 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.175 1.79 . . . . 0.0 110.898 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -68.52 -44.93 70.2 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 54.1 mt -67.61 -34.74 77.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -62.15 -49.01 77.55 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.412 ' HA ' ' HE2' ' A' ' 295' ' ' LYS . . . -54.4 -42.84 70.9 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 119.595 1.089 . . . . 0.0 110.926 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.4 t -63.56 -41.18 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.804 1.242 . . . . 0.0 108.797 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -64.14 -38.92 92.79 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.126 1.371 . . . . 0.0 112.059 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 292' ' ' ALA . 21.9 mtmt -56.78 -54.7 43.32 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.246 -0.909 . . . . 0.0 108.755 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -55.18 -52.87 61.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.058 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -147.78 156.33 44.6 Favored Pre-proline 0 N--CA 1.473 0.715 0 O-C-N 120.799 -1.188 . . . . 0.0 111.799 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -61.34 130.9 33.81 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 N-CA-C 105.963 -2.36 . . . . 0.0 105.963 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -95.38 -15.78 22.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.342 -0.837 . . . . 0.0 112.882 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.36 -157.27 47.81 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.16 164.12 25.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 22.7 m -125.91 148.89 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 O-C-N 121.246 -0.909 . . . . 0.0 109.852 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.05 -22.47 58.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.675 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 62.7 tp -66.93 105.4 1.61 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.789 1.635 . . . . 0.0 109.365 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -61.41 -1.86 0.61 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.6 t -92.9 -66.64 0.91 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -63.51 -19.32 64.67 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.438 -0.789 . . . . 0.0 110.877 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -60.2 -35.5 75.55 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -68.22 -20.43 64.83 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.072 0.851 . . . . 0.0 111.687 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -88.12 -50.36 6.44 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.582 1.153 . . . . 0.0 108.403 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 48.7 mt -67.64 -35.32 78.69 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.012 0.525 . . . . 0.0 110.554 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.3 1.92 4.37 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.182 -0.949 . . . . 0.0 112.686 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -62.53 -20.88 65.08 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 120.111 1.323 . . . . 0.0 109.575 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -109.82 129.22 24.17 Favored Pre-proline 0 C--O 1.24 0.554 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.7 -8.41 9.21 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.378 2.719 . . . . 0.0 114.54 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -67.23 -54.48 20.58 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 119.68 1.127 . . . . 0.0 108.607 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.7 -49.55 83.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.45 -50.56 62.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 123.75 0.656 . . . . 0.0 109.947 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.81 -41.35 86.59 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.9 m -62.16 -37.76 86.46 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.8 tpt -68.2 -46.62 70.13 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.257 0.623 . . . . 0.0 110.596 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -60.68 -30.07 69.69 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.019 0.928 . . . . 0.0 113.111 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -74.82 -35.35 62.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -69.19 -36.38 77.24 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.777 0.831 . . . . 0.0 111.315 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -65.96 -41.22 91.5 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.564 1.145 . . . . 0.0 111.856 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.402 ' HE3' ' HE2' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -95.95 -3.18 45.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 116.676 -1.63 . . . . 0.0 115.117 -177.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -109.52 170.34 14.33 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 120.173 1.351 . . . . 0.0 114.975 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.26 129.04 34.91 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.709 0.803 . . . . 0.0 109.38 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 35.0 mt -98.13 121.43 48.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 45.9 mtm 24.32 76.57 0.25 Allowed Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 127.438 2.295 . . . . 0.0 112.178 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.66 80.27 0.47 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.8 3.0 . . . . 0.0 113.557 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -84.22 70.4 10.56 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.657 1.583 . . . . 0.0 106.992 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 30.1 pt -124.08 152.09 66.47 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 124.396 1.078 . . . . 0.0 110.549 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -68.78 -30.94 26.4 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.09 2.526 . . . . 0.0 113.106 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -65.66 -17.19 64.42 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -61.43 -31.35 71.29 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.986 0.812 . . . . 0.0 109.563 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 4.6 t -57.57 -46.09 84.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.457 0.703 . . . . 0.0 110.712 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -79.6 -36.25 38.33 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.604 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.0 -52.35 63.42 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.786 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -58.26 -40.47 81.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.865 1.211 . . . . 0.0 111.1 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -65.64 -23.13 66.73 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.962 0.905 . . . . 0.0 111.46 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.3 -50.73 8.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.538 1.135 . . . . 0.0 110.272 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 11.2 t -60.7 -49.81 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.612 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.01 -54.33 13.28 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.637 0.653 . . . . 0.0 110.275 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.3 m -64.3 -43.18 95.54 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.296 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.27 -43.07 87.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.122 1.328 . . . . 0.0 111.519 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.82 -52.68 51.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 125.041 1.336 . . . . 0.0 108.897 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 30.1 mm -60.5 -43.18 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.151 0.58 . . . . 0.0 110.13 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -59.88 -47.36 86.06 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.738 0.699 . . . . 0.0 110.265 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.26 72.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.719 0.808 . . . . 0.0 110.679 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.66 -32.17 72.32 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.246 1.019 . . . . 0.0 111.97 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 14.1 m -85.15 -11.75 54.37 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.739 0.816 . . . . 0.0 109.723 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.74 10.04 66.75 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 123.667 0.651 . . . . 0.0 112.428 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -69.15 -34.48 75.04 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 118.158 0.979 . . . . 0.0 109.985 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -134.93 148.04 49.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 359' ' ' GLU . 11.9 t -68.34 156.24 38.15 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 26.0 t -58.14 -40.43 77.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 125.011 1.325 . . . . 0.0 110.086 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.06 -47.84 84.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.956 0.502 . . . . 0.0 109.738 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . 0.408 ' H ' HG22 ' A' ' 356' ' ' THR . 52.6 mm-40 -68.92 -37.82 79.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 122.147 -0.345 . . . . 0.0 111.21 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.4 -39.87 73.72 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.97 -41.3 59.84 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.567 1.147 . . . . 0.0 110.296 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -55.45 -50.16 70.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.493 0.717 . . . . 0.0 109.363 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -49.85 76.32 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 127.042 2.137 . . . . 0.0 111.1 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.21 -52.15 66.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.076 0.95 . . . . 0.0 112.209 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -52.84 -33.04 47.72 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.551 0.74 . . . . 0.0 110.482 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.3 m -64.22 -48.03 77.41 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.413 1.006 . . . . 0.0 109.451 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -57.25 -23.35 47.54 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.3 mt -96.14 -10.41 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.025 1.33 . . . . 0.0 111.565 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 55.5 p -120.08 1.72 10.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.673 1.189 . . . . 0.0 112.491 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 36.1 tptt . . . . . 0 C--O 1.251 1.179 0 C-N-CA 127.665 2.386 . . . . 0.0 105.547 178.401 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.433 ' HZ2' ' CD ' ' A' ' 3' ' ' GLU . 43.4 tttm . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.8 mm -91.13 142.38 13.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.433 ' CD ' ' HZ2' ' A' ' 1' ' ' LYS . 42.5 mm-40 -108.33 112.69 25.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -79.12 175.07 10.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.53 1.532 . . . . 0.0 109.384 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.95 22.71 77.68 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.427 1.013 . . . . 0.0 113.302 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -146.87 166.48 26.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.992 0.896 . . . . 0.0 112.664 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.2 mt -151.32 142.93 23.64 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.939 2.895 . . . . 0.0 106.681 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.26 126.61 49.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 mt -108.07 136.11 44.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 125.81 1.644 . . . . 0.0 108.146 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -127.76 130.6 49.02 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.035 1.734 . . . . 0.0 106.511 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.8 pt -131.76 165.65 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 127.26 2.224 . . . . 0.0 110.383 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.35 165.57 33.66 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.367 1.067 . . . . 0.0 112.975 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.68 40.5 7.68 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-O 118.466 -1.185 . . . . 0.0 111.855 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 54.51 32.85 17.65 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.622 1.169 . . . . 0.0 108.213 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.77 163.37 1.92 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.539 1.536 . . . . 0.0 113.372 -177.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.09 76.35 1.44 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -66.17 -39.52 89.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.611 1.164 . . . . 0.0 109.352 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -58.57 -59.76 4.87 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 125.875 1.67 . . . . 0.0 110.526 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.27 94.53 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.7 tp -62.94 -42.55 99.84 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 117.889 0.845 . . . . 0.0 108.944 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.63 73.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.863 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -62.39 -27.89 69.4 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.452 1.024 . . . . 0.0 110.443 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.9 t -79.31 -46.47 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.28 -39.07 97.24 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 121.257 -0.902 . . . . 0.0 113.069 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -37.62 68.35 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 117.776 -1.107 . . . . 0.0 109.1 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -58.42 -57.33 13.41 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.38 -48.03 80.13 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.937 -0.554 . . . . 0.0 110.384 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.48 -22.96 66.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.958 1.254 . . . . 0.0 112.61 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tppm? -85.74 -23.22 27.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 117.876 -1.059 . . . . 0.0 110.805 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -102.83 -22.59 13.86 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.925 0.765 . . . . 0.0 112.71 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -114.79 -35.95 4.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.468 1.107 . . . . 0.0 111.355 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.17 -18.74 56.95 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.121 0.867 . . . . 0.0 113.414 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.8 mm -60.45 125.63 16.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.418 ' CE ' ' HA ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -63.77 127.93 33.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.107 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.7 t -123.2 104.91 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -93.97 139.14 31.3 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.3 t -130.67 118.46 42.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -128.84 158.99 37.18 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -116.85 60.64 2.38 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.664 1.186 . . . . 0.0 110.185 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -62.09 160.41 30.34 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 121.867 1.711 . . . . 0.0 109.966 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -117.79 9.12 12.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.596 0.758 . . . . 0.0 111.709 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.17 17.69 2.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.073 1.749 . . . . 0.0 112.876 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.534 HD21 ' H ' ' A' ' 43' ' ' LEU . 1.3 pt? -56.11 -24.15 38.74 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.627 -1.295 . . . . 0.0 111.797 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.99 -24.95 57.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.203 1.401 . . . . 0.0 112.104 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -121.57 -22.27 5.94 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.219 1.008 . . . . 0.0 111.218 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -41.92 59.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 117.24 -1.362 . . . . 0.0 110.9 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -52.49 -58.71 10.73 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 120.642 1.565 . . . . 0.0 110.111 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.78 -17.3 54.28 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.501 1.467 . . . . 0.0 113.553 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -88.7 2.12 53.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.649 1.58 . . . . 0.0 113.638 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.3 -34.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.18 0.9 . . . . 0.0 109.61 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.77 66.12 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.708 -1.245 . . . . 0.0 110.011 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.73 -2.92 5.55 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.887 0.875 . . . . 0.0 112.368 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.2 p -126.33 -11.72 6.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.461 1.504 . . . . 0.0 110.256 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.6 15.76 67.61 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.277 0.942 . . . . 0.0 111.892 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -106.38 6.44 30.43 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.007 0.904 . . . . 0.0 110.684 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.41 -167.59 43.39 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 127.001 2.239 . . . . 0.0 116.371 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.92 -179.32 2.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.634 2.89 . . . . 0.0 110.136 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.95 -18.28 8.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.8 mt -135.44 143.84 35.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.428 1.091 . . . . 0.0 109.306 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tt -130.02 143.2 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 C-N-CA 125.014 1.326 . . . . 0.0 110.953 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -137.92 109.83 7.19 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.823 1.649 . . . . 0.0 107.609 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 29.2 t-105 -159.88 178.91 9.27 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.438 1.017 . . . . 0.0 108.981 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.36 153.55 43.42 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -60.16 -19.14 52.52 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.362 1.465 . . . . 0.0 111.658 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -53.07 -61.95 1.96 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.895 1.278 . . . . 0.0 111.322 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -68.15 -18.22 64.56 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.598 -0.689 . . . . 0.0 111.088 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -68.67 -30.43 69.11 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.483 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.8 -12.79 49.44 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.99 0.805 . . . . 0.0 112.296 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -104.58 -45.72 1.39 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -60.47 -52.04 66.9 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.554 -0.968 . . . . 0.0 111.322 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.62 84.22 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.692 0.678 . . . . 0.0 111.235 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.21 -47.31 69.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.776 1.23 . . . . 0.0 108.71 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -72.21 -6.89 46.09 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.43 9.85 80.91 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.781 1.181 . . . . 0.0 112.296 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 mt -73.21 -22.03 60.53 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.389 1.094 . . . . 0.0 111.156 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -103.87 140.28 37.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.12 -171.95 3.31 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -76.93 159.72 29.76 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -137.73 172.04 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.727 1.211 . . . . 0.0 110.184 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.4 m 42.36 77.24 0.45 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.105 2.162 . . . . 0.0 114.552 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.88 -22.0 27.51 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.084 2.523 . . . . 0.0 115.291 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -120.16 135.24 55.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.22 1.373 . . . . 0.0 111.526 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -51.32 -39.11 56.26 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.781 2.032 . . . . 0.0 112.265 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.5 -27.18 62.31 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -66.46 -37.11 84.41 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -64.54 -42.86 95.45 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 118.845 0.748 . . . . 0.0 109.284 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -57.0 -30.11 63.87 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.52 1.528 . . . . 0.0 112.718 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -75.4 -2.24 27.64 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mt -130.18 154.15 47.83 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 120.728 -1.232 . . . . 0.0 110.892 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -69.12 155.83 92.78 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 122.436 -0.165 . . . . 0.0 110.786 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.41 -45.68 2.46 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.906 3.07 . . . . 0.0 114.241 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -58.01 -38.62 76.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.565 1.075 . . . . 0.0 111.143 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -25.58 66.24 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.555 1.142 . . . . 0.0 110.722 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -77.94 -44.45 26.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.411 0.684 . . . . 0.0 110.119 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.71 -33.38 64.14 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.56 -7.4 4.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.4 1.48 . . . . 0.0 114.179 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.73 10.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.966 1.706 . . . . 0.0 111.887 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.9 mtp85 -70.28 160.48 32.12 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -132.7 -165.11 1.56 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -70.37 81.25 0.55 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.291 1.036 . . . . 0.0 109.401 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.35 -60.81 4.84 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.368 0.985 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -178.56 5.07 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.32 0.648 . . . . 0.0 109.881 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 34.5 mt -115.9 169.95 8.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.161 1.385 . . . . 0.0 109.248 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 pt -138.65 -28.88 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.79 175.32 13.0 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.456 1.026 . . . . 0.0 109.701 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -133.31 150.02 74.09 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.9 143.73 29.77 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.966 2.444 . . . . 0.0 110.888 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -131.53 -50.65 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.808 2.443 . . . . 0.0 111.546 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.71 131.51 52.55 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 110.396 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.65 95.99 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -72.29 162.15 29.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.605 1.193 . . . . 0.0 110.164 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.38 168.84 26.11 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.134 1.374 . . . . 0.0 109.291 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.0 141.13 56.33 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.5 m -118.92 172.68 7.37 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.896 1.278 . . . . 0.0 112.162 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -144.44 147.4 33.29 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.919 1.288 . . . . 0.0 108.923 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.26 121.02 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.821 1.248 . . . . 0.0 108.775 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -145.94 127.63 15.23 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.777 -1.202 . . . . 0.0 110.952 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -94.94 49.43 1.23 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.88 -60.32 3.89 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -167.39 -177.12 3.49 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -93.22 -14.06 27.54 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.181 0.446 . . . . 0.0 110.729 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.21 157.56 70.67 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 124.595 1.158 . . . . 0.0 108.818 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.01 82.19 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.502 2.801 . . . . 0.0 110.576 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -126.62 79.19 71.85 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.259 1.424 . . . . 0.0 108.271 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.21 161.88 31.83 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.264 2.643 . . . . 0.0 114.079 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.16 159.79 40.37 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.516 2.811 . . . . 0.0 110.441 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.35 -31.6 2.77 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 124.441 1.096 . . . . 0.0 113.325 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.95 152.4 9.46 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.269 1.395 . . . . 0.0 109.832 -178.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -56.1 -27.68 54.7 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.46 -16.52 24.35 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.283 0.947 . . . . 0.0 113.132 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -92.23 -14.22 29.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.062 0.847 . . . . 0.0 111.212 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 26.0 mm -59.65 -57.89 23.51 Favored Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -69.9 -25.54 27.86 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 CA-C-N 120.306 1.145 . . . . 0.0 110.967 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.64 71.65 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 118.67 0.668 . . . . 0.0 109.863 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 61.5 tp -88.84 -29.88 19.36 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.737 0.815 . . . . 0.0 109.585 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -59.08 -45.74 90.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.402 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 5.5 ptmm? -64.06 -32.19 73.65 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.534 0.334 . . . . 0.0 111.832 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -71.62 -43.04 66.87 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.203 0.601 . . . . 0.0 110.206 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.4 mt -75.8 -32.18 59.76 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -67.81 -33.33 74.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.609 -1.307 . . . . 0.0 108.498 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.1 -14.08 59.62 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 3.24 5.45 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.179 0.992 . . . . 0.0 112.127 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.65 -99.67 0.13 Allowed Glycine 0 CA--C 1.523 0.566 0 CA-C-N 119.267 0.94 . . . . 0.0 113.448 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -138.12 -177.75 4.97 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.433 1.493 . . . . 0.0 111.719 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.5 p -56.16 168.76 0.47 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.064 1.746 . . . . 0.0 113.817 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.89 -74.14 0.6 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.745 1.618 . . . . 0.0 110.183 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.8 tp -88.66 147.32 24.59 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.896 0.878 . . . . 0.0 110.701 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 11.3 mtp -149.0 113.97 5.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -138.1 172.3 13.12 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.978 2.111 . . . . 0.0 108.474 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.41 124.74 28.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.623 0.769 . . . . 0.0 112.86 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.3 mp -111.15 7.85 21.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.085 0.954 . . . . 0.0 111.166 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -97.57 -23.12 16.14 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -102.29 128.17 28.98 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.167 0.987 . . . . 0.0 108.913 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.67 -14.85 27.28 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.657 2.238 . . . . 0.0 114.32 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -59.01 -41.75 88.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.851 1.261 . . . . 0.0 113.397 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -79.83 -41.11 27.06 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.065 0.46 . . . . 0.0 111.767 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.4 p -69.93 -24.59 63.39 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.746 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -53.3 -63.02 2.75 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -61.69 -14.71 37.56 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.109 1.872 . . . . 0.0 115.076 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.4 tp -78.56 -63.83 1.32 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.8 pt -63.05 -32.61 56.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.825 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.81 -14.36 62.98 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.528 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -52.94 -45.37 67.64 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.927 1.239 . . . . 0.0 113.603 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.67 -43.82 98.13 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 172.33 43.15 0.04 OUTLIER Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.952 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -99.55 155.51 19.79 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -160.73 119.26 2.54 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 118.278 1.039 . . . . 0.0 109.019 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.95 84.31 7.48 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 70.05 105.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.754 2.421 . . . . 0.0 107.874 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -72.25 134.78 45.78 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.636 -0.665 . . . . 0.0 109.314 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -131.65 120.05 22.27 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.515 ' HG2' ' H ' ' A' ' 173' ' ' ASN . 5.6 tt0 -102.78 -159.15 0.71 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.584 1.154 . . . . 0.0 108.428 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.515 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 78.5 m-20 -66.84 78.63 0.12 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.66 1.984 . . . . 0.0 110.708 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.66 10.91 84.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.269 0.938 . . . . 0.0 112.597 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -112.15 103.46 11.63 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.34 113.24 18.58 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -131.07 100.7 5.31 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.93 -9.38 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -69.48 -29.34 66.98 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.891 -1.131 . . . . 0.0 108.324 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -75.29 75.29 2.41 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.606 1.563 . . . . 0.0 110.863 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.7 t -97.11 113.82 32.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 126.414 1.886 . . . . 0.0 108.737 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -109.32 96.1 0.94 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 45.8 t -138.38 -43.47 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 117.822 0.811 . . . . 0.0 109.579 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -108.84 77.04 1.05 Allowed 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -128.97 163.1 26.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.778 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -50.03 -41.52 47.62 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.2 1.4 . . . . 0.0 113.197 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.95 -43.41 95.99 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.581 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.6 -51.35 65.69 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.432 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -58.78 -36.64 74.76 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.135 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.23 -38.61 87.27 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.212 0.915 . . . . 0.0 110.386 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -82.43 -26.54 46.82 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.82 -0.55 . . . . 0.0 112.826 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.5 tp -76.29 -41.82 47.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.08 -1.247 . . . . 0.0 107.792 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 7.4 t -65.08 -27.62 68.9 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.987 0.812 . . . . 0.0 109.065 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -58.19 -52.06 67.13 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.96 -46.24 88.54 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.764 1.226 . . . . 0.0 110.144 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 42.7 t -60.58 -38.91 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 117.639 -1.172 . . . . 0.0 110.506 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.507 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 14.2 t0 -56.6 -50.11 72.96 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.213 1.405 . . . . 0.0 114.009 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.11 -38.7 91.54 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.548 0.689 . . . . 0.0 109.693 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.17 -31.8 51.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -63.76 -44.7 92.66 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 126.125 1.77 . . . . 0.0 107.887 178.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -71.97 -10.92 60.46 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.377 0.671 . . . . 0.0 109.424 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt 60.96 15.6 6.23 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 128.175 2.59 . . . . 0.0 112.513 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -83.08 -14.04 54.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.04 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.24 124.98 52.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.813 1.645 . . . . 0.0 110.028 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.65 84.66 0.29 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.745 2.018 . . . . 0.0 110.69 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -58.53 -16.53 15.88 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.549 1.94 . . . . 0.0 115.011 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.08 -7.08 54.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.252 1.821 . . . . 0.0 114.097 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.3 m -60.99 134.48 57.14 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 118.941 0.791 . . . . 0.0 110.408 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.0 -178.43 4.18 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.542 1.937 . . . . 0.0 107.08 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -57.89 -38.56 76.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.391 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -55.38 26.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.321 1.048 . . . . 0.0 110.456 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.22 -45.13 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 123.57 0.748 . . . . 0.0 110.38 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.45 -51.13 67.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.724 0.693 . . . . 0.0 110.816 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -63.35 -43.97 96.17 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.82 1.191 . . . . 0.0 110.313 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.09 -55.77 30.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.06 0.544 . . . . 0.0 109.548 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.84 -46.07 74.58 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.56 1.144 . . . . 0.0 110.425 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -58.42 -44.19 88.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.24 0.616 . . . . 0.0 109.429 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.46 -21.73 66.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.689 0.795 . . . . 0.0 112.203 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -91.97 -10.64 38.64 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.665 0.786 . . . . 0.0 110.008 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.82 18.44 70.2 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -80.78 0.72 33.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.947 1.299 . . . . 0.0 113.745 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 27.3 p -124.04 149.79 45.69 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.532 1.133 . . . . 0.0 108.184 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.3 -21.31 19.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.264 0.625 . . . . 0.0 111.469 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 14.0 ptt? -158.28 157.48 32.58 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.8 t -150.89 171.38 17.34 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 122.535 1.16 . . . . 0.0 109.792 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 5.9 mt -141.65 140.0 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -153.1 139.2 18.27 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 173.14 -52.88 0.16 Allowed Glycine 0 CA--C 1.53 0.978 0 CA-C-O 117.782 -1.566 . . . . 0.0 112.54 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -78.19 73.08 5.94 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 CA-C-N 120.902 2.351 . . . . 0.0 108.241 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -77.42 128.97 35.15 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 126.02 1.728 . . . . 0.0 106.561 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.42 -178.6 0.39 Allowed 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 127.542 2.337 . . . . 0.0 110.26 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 16.8 p-90 -147.66 145.29 28.87 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 120.71 -1.243 . . . . 0.0 109.372 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.83 143.74 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.899 2.08 . . . . 0.0 109.523 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.7 m120 64.4 10.64 5.87 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.374 1.07 . . . . 0.0 111.892 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 17.9 tt -161.23 154.58 3.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 C-N-CA 129.316 3.047 . . . . 0.0 105.891 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -80.42 154.06 27.88 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.929 -0.482 . . . . 0.0 110.349 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 49.4 m -88.94 56.84 3.88 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.4 p -81.61 172.31 13.6 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.229 2.212 . . . . 0.0 111.305 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -164.94 171.98 13.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.548 1.139 . . . . 0.0 111.499 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.16 168.79 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.887 1.275 . . . . 0.0 109.641 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -142.6 92.54 2.42 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 125.741 1.616 . . . . 0.0 108.372 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -139.96 167.5 21.98 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.886 2.074 . . . . 0.0 108.493 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -67.07 129.59 29.44 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 121.177 -0.952 . . . . 0.0 111.843 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 29.6 m -63.63 149.59 10.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 118.006 0.903 . . . . 0.0 109.921 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.8 t -147.72 -178.05 6.05 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.115 0.966 . . . . 0.0 109.396 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 14.2 p -93.11 137.18 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.522 1.129 . . . . 0.0 109.677 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.06 157.65 62.58 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.144 0.978 . . . . 0.0 111.692 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.07 -84.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.834 3.023 . . . . 0.0 111.073 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . 0.292 0.5 OUTLIER 92.38 -164.69 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.483 3.113 . . . . 0.0 108.052 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.27 131.83 47.11 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.02 120.31 7.25 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.52 -0.738 . . . . 0.0 109.181 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.91 -7.12 56.83 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.511 -1.16 . . . . 0.0 113.928 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.39 102.65 14.03 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.317 2.059 . . . . 0.0 109.801 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.78 143.49 21.1 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.223 1.948 . . . . 0.0 113.606 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.2 m -68.66 159.56 31.87 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.148 0.979 . . . . 0.0 109.234 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.08 55.72 19.85 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.61 161.65 34.58 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 121.788 1.659 . . . . 0.0 111.406 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -75.02 172.21 12.73 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.604 0.716 . . . . 0.0 111.142 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 13.6 t -114.39 155.26 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -172.12 148.41 10.78 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.43 172.22 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 119.403 1.601 . . . . 0.0 111.545 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 34.5 tp -84.41 156.52 21.77 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.055 -1.653 . . . . 0.0 107.569 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.7 m -131.76 137.17 48.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 120.481 1.492 . . . . 0.0 109.001 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -115.24 130.67 56.98 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.349 1.059 . . . . 0.0 109.513 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.14 170.59 21.73 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.308 1.432 . . . . 0.0 111.804 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 76.3 mt -119.19 134.72 61.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -68.09 122.54 18.48 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.61 -10.78 60.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -95.13 7.33 46.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.84 0.856 . . . . 0.0 112.459 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.5 m -69.33 157.49 89.25 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.418 1.087 . . . . 0.0 108.712 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.13 -50.82 2.55 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.906 1.737 . . . . 0.0 111.005 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -135.5 100.36 4.48 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -19.68 49.31 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.47 -0.769 . . . . 0.0 112.437 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -64.63 -32.9 74.76 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.049 0.386 . . . . 0.0 110.123 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.87 -38.63 79.23 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.379 -0.825 . . . . 0.0 108.897 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.66 -42.29 42.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 117.903 -1.046 . . . . 0.0 111.671 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -41.3 91.99 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.3 0.954 . . . . 0.0 108.788 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -66.94 -50.93 60.79 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 124.619 1.199 . . . . 0.0 109.434 -177.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -53.22 -51.69 61.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.194 -0.431 . . . . 0.0 110.335 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.2 mp -63.11 -48.04 80.22 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.332 6.7 pt-20 -78.74 -4.35 48.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -177.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -108.45 -19.45 13.45 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.311 1.414 . . . . 0.0 112.211 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -135.61 -53.3 0.77 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.789 1.177 . . . . 0.0 110.735 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.61 -48.04 39.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.753 0.821 . . . . 0.0 112.515 -179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.66 29.03 0.93 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.948 2.099 . . . . 0.0 114.505 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 19.4 p -116.29 165.18 13.47 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 120.411 1.459 . . . . 0.0 108.097 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.66 -44.06 85.41 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.46 -33.63 75.53 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.506 0.722 . . . . 0.0 112.787 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.53 -46.08 12.58 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 51.8 mt -62.52 -47.12 85.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -57.78 -44.49 86.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.678 1.191 . . . . 0.0 110.647 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.0 -46.78 71.84 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 117.93 0.332 . . . . 0.0 110.963 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.65 -40.32 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 117.047 -1.454 . . . . 0.0 109.723 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -63.15 -34.33 77.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.311 0.959 . . . . 0.0 112.754 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -63.49 -61.34 2.39 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.8 -48.33 80.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 117.219 -1.372 . . . . 0.0 112.387 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -137.7 150.47 68.13 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 121.509 1.959 . . . . 0.0 109.137 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.77 101.95 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.254 1.969 . . . . 0.0 114.21 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 7.8 mt -76.03 -32.86 59.55 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 123.608 0.763 . . . . 0.0 109.731 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 80.87 -115.64 4.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.95 160.8 14.01 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.206 1.003 . . . . 0.0 111.698 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.16 162.7 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 124.479 1.112 . . . . 0.0 110.179 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.36 -29.44 22.95 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 28.0 tp -65.07 104.07 0.83 Allowed 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.749 0.82 . . . . 0.0 111.166 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -49.53 -33.43 14.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.143 1.377 . . . . 0.0 112.482 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.3 t -62.53 -57.46 11.07 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.877 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -78.19 -20.72 51.33 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.923 1.238 . . . . 0.0 111.262 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -57.6 -43.13 84.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.25 -13.02 46.72 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.005 0.82 . . . . 0.0 113.207 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -94.12 -37.54 11.55 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 63.2 mt -74.95 -26.02 59.3 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.515 -1.366 . . . . 0.0 109.035 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.87 -1.63 7.7 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.544 1.538 . . . . 0.0 112.918 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -65.11 -19.45 65.99 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.807 0.843 . . . . 0.0 110.846 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -120.36 131.95 24.28 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 124.526 1.13 . . . . 0.0 108.189 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -59.84 -15.05 30.18 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.215 2.61 . . . . 0.0 116.368 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -66.5 -39.5 88.75 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 121.93 2.15 . . . . 0.0 108.602 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.7 mp -70.77 -46.38 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.43 -49.54 72.15 Favored 'General case' 0 C--O 1.222 -0.395 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.166 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.17 -37.55 77.62 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.085 -1.009 . . . . 0.0 112.101 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 55.1 m -61.06 -39.1 88.59 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -81.35 -37.23 28.63 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 123.585 0.754 . . . . 0.0 111.434 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -55.17 -37.35 66.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.134 0.973 . . . . 0.0 108.837 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -63.9 -38.54 91.48 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.53 -33.67 64.85 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.385 0.674 . . . . 0.0 110.171 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -68.12 -48.15 66.21 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.049 1.34 . . . . 0.0 110.294 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -27.38 45.99 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -86.59 -172.32 48.38 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 124.581 1.086 . . . . 0.0 114.531 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.4 135.85 37.33 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.935 1.694 . . . . 0.0 107.082 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 85.7 mt -76.56 111.6 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 10.9 ptp 52.61 161.31 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 130.972 3.709 . . . . 0.0 115.833 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.7 160.73 40.62 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 N-CA-C 108.374 -1.433 . . . . 0.0 108.374 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -120.81 23.49 10.7 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.0 pt -137.8 141.37 32.66 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 118.953 0.797 . . . . 0.0 110.454 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.82 -9.94 27.3 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 124.001 3.134 . . . . 0.0 113.82 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -64.69 -24.05 67.45 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.417 1.087 . . . . 0.0 109.539 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 91.1 mmm -58.99 -22.39 60.47 Favored 'General case' 0 C--N 1.342 0.247 0 O-C-N 120.744 -1.222 . . . . 0.0 113.571 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 80.4 p -64.24 -33.11 75.06 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.369 1.44 . . . . 0.0 108.821 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.5 -41.97 65.35 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 121.247 -0.908 . . . . 0.0 108.894 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -49.96 -57.08 8.26 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.081 0.952 . . . . 0.0 109.584 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -64.02 -35.4 80.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -68.07 -37.43 81.24 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.158 0.583 . . . . 0.0 111.671 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.52 -55.16 6.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.868 2.067 . . . . 0.0 112.496 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 67.3 t -57.33 -33.55 43.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.378 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -54.63 -58.38 7.74 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.747 1.158 . . . . 0.0 108.859 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.4 m -61.38 -37.32 82.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.984 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.13 82.37 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 121.003 1.729 . . . . 0.0 111.403 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 75.2 t -58.82 -56.46 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.5 mm -61.21 -32.94 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.2 0.6 . . . . 0.0 111.803 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.44 -52.72 62.42 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.638 -1.288 . . . . 0.0 110.158 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.23 -43.68 64.04 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.217 0.607 . . . . 0.0 111.233 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -56.38 -41.6 76.51 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.306 1.042 . . . . 0.0 111.246 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.8 m -85.09 -17.48 37.22 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.443 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.5 28.48 47.7 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 123.583 0.611 . . . . 0.0 112.314 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -81.84 -27.63 33.46 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.735 -0.862 . . . . 0.0 109.976 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -142.7 151.52 41.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.6 m -58.95 153.82 16.63 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.014 0.926 . . . . 0.0 109.485 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 90.5 t -52.56 -56.26 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.224 1.009 . . . . 0.0 110.133 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.1 -49.06 74.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.213 1.405 . . . . 0.0 110.825 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -68.65 -25.57 64.89 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.93 83.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 74.9 mt -68.35 -43.5 77.35 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -50.54 -51.82 44.44 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.293 1.437 . . . . 0.0 109.536 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -54.42 -43.46 71.56 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.324 1.849 . . . . 0.0 110.757 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -68.86 -50.75 47.15 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 118.725 -0.655 . . . . 0.0 109.488 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -52.01 -38.71 57.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.757 1.223 . . . . 0.0 108.773 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.2 m -59.68 -54.3 47.96 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.953 1.301 . . . . 0.0 108.283 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -58.56 -39.95 81.7 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.764 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.93 -41.55 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.074 0.852 . . . . 0.0 109.653 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 38.7 p -80.32 -11.66 59.69 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 36.3 tttm . . . . . 0 C--O 1.245 0.82 0 C-N-CA 126.036 1.734 . . . . 0.0 108.45 178.661 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 mt -63.47 146.46 12.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 112.454 -2.157 . . . . 0.0 109.266 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -112.42 130.54 55.94 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.95 103.28 15.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.55 21.37 0.31 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.333 0.968 . . . . 0.0 114.344 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -143.56 155.55 44.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.721 1.76 . . . . 0.0 113.126 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.9 mt -137.72 151.37 48.14 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.101 1.76 . . . . 0.0 108.328 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 77.2 t -138.92 132.42 39.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 125.501 1.52 . . . . 0.0 108.431 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.482 ' CG2' ' HH ' ' A' ' 17' ' ' TYR . 30.7 mt -129.15 134.27 64.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.652 1.181 . . . . 0.0 108.116 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -118.68 157.22 27.87 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.957 1.303 . . . . 0.0 109.369 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.0 pt -144.97 165.63 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 125.631 1.572 . . . . 0.0 108.252 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -68.88 -33.29 73.55 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.014 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 15' ' ' LYS . . . 146.19 -73.17 0.31 Allowed Glycine 0 C--N 1.342 0.876 0 C-N-CA 123.68 0.657 . . . . 0.0 113.37 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -70.85 26.9 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 129.424 3.089 . . . . 0.0 116.134 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 13' ' ' GLY . 11.3 mmtm -75.21 -45.79 38.1 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 125.123 1.369 . . . . 0.0 114.615 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.0 42.46 0.72 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 126.841 2.163 . . . . 0.0 111.96 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.482 ' HH ' ' CG2' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -56.68 -16.93 7.21 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -178.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -52.62 -45.14 66.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 121.826 2.103 . . . . 0.0 112.056 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.09 -40.22 35.32 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 121.435 0.464 . . . . 0.0 112.032 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 33.1 tp -64.77 -36.86 85.67 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.771 1.228 . . . . 0.0 114.242 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.37 64.55 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.675 0.79 . . . . 0.0 111.051 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -59.62 -33.99 72.21 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.96 -40.86 90.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.97 -34.99 83.37 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -68.58 -47.39 66.9 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 118.752 1.276 . . . . 0.0 108.322 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.05 -59.39 4.81 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.378 1.071 . . . . 0.0 109.101 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -56.5 -44.95 81.22 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.881 -0.581 . . . . 0.0 111.31 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -64.32 -16.38 62.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 120.395 1.452 . . . . 0.0 111.929 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.496 ' HA ' ' HZ2' ' A' ' 29' ' ' LYS . 1.2 tppm? -96.86 -16.36 20.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 117.295 -1.336 . . . . 0.0 112.708 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -106.54 -37.59 6.42 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 124.791 1.307 . . . . 0.0 110.434 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.3 p -101.15 -34.0 9.87 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.147 -0.97 . . . . 0.0 110.739 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.06 -11.79 67.37 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 121.146 -0.971 . . . . 0.0 113.396 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.0 132.9 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -67.51 150.03 49.39 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.161 -0.962 . . . . 0.0 109.677 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.9 t -140.49 97.78 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.585 1.554 . . . . 0.0 108.976 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.7 m -77.14 153.48 34.17 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.55 110.62 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 104.224 -2.509 . . . . 0.0 104.224 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -135.14 161.55 35.01 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -127.26 61.01 46.27 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.463 1.505 . . . . 0.0 113.969 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.46 143.24 38.23 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.424 1.416 . . . . 0.0 110.35 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -97.2 21.6 9.71 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.4 3.09 2.1 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.93 -22.75 5.96 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.005 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -48.84 -34.56 12.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.442 1.497 . . . . 0.0 112.096 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -122.32 -24.42 5.04 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.109 0.963 . . . . 0.0 111.937 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.78 -39.25 76.73 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.008 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -55.96 -59.53 11.39 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 119.988 1.267 . . . . 0.0 109.259 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.05 -29.4 89.16 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 CA-C-N 120.909 1.36 . . . . 0.0 113.916 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -77.23 0.49 21.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.101 1.319 . . . . 0.0 113.645 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.7 t -131.73 -32.97 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.76 -26.65 60.76 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.837 -1.165 . . . . 0.0 110.053 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.86 -30.66 65.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.787 -0.571 . . . . 0.0 109.803 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 p -90.94 -16.45 28.06 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.351 1.06 . . . . 0.0 112.834 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 96.96 26.19 10.64 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-O 118.178 -1.346 . . . . 0.0 116.388 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -131.01 5.91 4.56 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.828 1.314 . . . . 0.0 110.084 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.1 -178.54 47.43 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.447 1.499 . . . . 0.0 114.941 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.34 169.78 9.0 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.416 2.077 . . . . 0.0 109.938 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -105.71 -16.8 14.58 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -139.38 145.66 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.45 144.8 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.691 1.196 . . . . 0.0 108.955 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -129.49 108.63 10.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.933 1.693 . . . . 0.0 110.429 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -152.41 -174.53 4.93 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.174 -0.954 . . . . 0.0 110.869 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.03 158.04 36.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.816 1.246 . . . . 0.0 108.558 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -63.8 -25.75 68.32 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.376 -0.203 . . . . 0.0 111.322 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.48 -62.01 2.2 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 126.027 1.731 . . . . 0.0 111.398 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -61.5 -19.88 62.57 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.492 0.717 . . . . 0.0 112.601 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -78.93 -20.75 48.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.789 -0.624 . . . . 0.0 111.896 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.56 -39.57 95.19 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.13 -50.5 5.79 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.765 1.174 . . . . 0.0 111.613 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -55.41 -42.66 74.4 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.422 1.111 . . . . 0.0 112.215 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.92 -43.13 79.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.639 0.654 . . . . 0.0 110.451 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.01 -50.8 68.13 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.487 1.115 . . . . 0.0 108.81 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 m -63.85 -5.11 3.85 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.319 1.848 . . . . 0.0 113.505 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.17 10.33 86.18 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.36 1.457 . . . . 0.0 113.392 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.7 mt -73.18 -18.95 61.21 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.305 1.053 . . . . 0.0 110.851 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.71 146.15 26.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.96 0.8 . . . . 0.0 109.949 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.1 -178.9 4.93 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.684 1.994 . . . . 0.0 110.321 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -72.43 128.61 36.14 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.623 1.569 . . . . 0.0 107.629 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.15 159.19 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.836 0.744 . . . . 0.0 110.67 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 m 47.27 75.03 0.71 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.468 2.307 . . . . 0.0 113.517 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -67.06 -45.13 4.25 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.0 1.8 . . . . 0.0 111.878 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -94.15 132.81 38.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.071 1.348 . . . . 0.0 112.019 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -65.13 -31.63 72.93 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.83 -36.41 64.97 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 121.081 1.764 . . . . 0.0 112.137 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -59.82 -30.78 69.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.783 0.719 . . . . 0.0 110.772 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -70.35 -29.83 66.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.99 -1.068 . . . . 0.0 112.124 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -78.39 -21.55 49.19 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.352 0.661 . . . . 0.0 111.47 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -69.44 -12.51 61.71 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.176 -0.953 . . . . 0.0 111.672 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 mt -120.61 164.04 17.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.127 1.771 . . . . 0.0 111.555 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -66.2 160.65 63.15 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.73 -49.3 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.66 2.24 . . . . 0.0 112.491 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -51.78 -41.08 61.38 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.856 0.862 . . . . 0.0 113.229 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -28.12 65.54 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.495 -0.753 . . . . 0.0 111.177 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -78.03 -46.57 20.57 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -21.22 23.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.252 1.021 . . . . 0.0 112.507 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.15 -28.9 57.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.488 1.515 . . . . 0.0 111.085 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.71 0.64 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.531 1.532 . . . . 0.0 113.056 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -65.27 162.87 16.46 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.862 0.756 . . . . 0.0 109.515 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -145.51 176.84 9.3 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.283 1.833 . . . . 0.0 107.256 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -55.09 104.47 0.12 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.451 1.1 . . . . 0.0 109.186 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.16 -85.12 0.31 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 125.161 1.362 . . . . 0.0 111.317 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 170.09 4.29 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.711 1.604 . . . . 0.0 112.5 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -98.91 169.97 9.07 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.452 1.501 . . . . 0.0 108.531 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.7 pt -135.55 -37.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.37 172.34 14.58 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.914 1.686 . . . . 0.0 108.419 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.66 149.81 69.28 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.359 0.664 . . . . 0.0 111.352 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.22 140.84 38.1 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 124.645 3.563 . . . . 0.0 110.902 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.3 mm -121.04 -45.5 2.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 124.853 1.261 . . . . 0.0 112.808 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.43 161.53 37.82 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.891 0.876 . . . . 0.0 109.63 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.65 107.37 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -152.77 135.72 15.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.03 74.52 1.49 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.813 0.845 . . . . 0.0 109.237 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.3 pp -161.9 158.84 25.95 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.66 1.184 . . . . 0.0 110.277 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.9 p 156.65 153.6 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.519 1 C-N-CA 131.947 4.099 . . . . 0.0 110.798 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.6 tp -147.1 157.25 43.54 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 73.9 mt -114.22 128.73 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 120.396 -1.44 . . . . 0.0 110.142 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.81 143.79 23.0 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.561 1.944 . . . . 0.0 106.703 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -63.72 159.36 19.38 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.183 1.393 . . . . 0.0 113.94 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.71 14.2 0.11 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.603 1.961 . . . . 0.0 113.306 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.85 159.22 35.0 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.159 1.384 . . . . 0.0 112.746 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -78.26 9.37 3.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.459 1.104 . . . . 0.0 113.902 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -109.5 79.24 1.27 Allowed Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 119.753 1.161 . . . . 0.0 111.587 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.07 129.74 10.74 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.512 2.141 . . . . 0.0 108.612 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -131.95 58.35 36.71 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.154 1.382 . . . . 0.0 109.624 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.8 112.46 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.811 3.007 . . . . 0.0 112.263 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.15 144.86 27.04 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.741 2.294 . . . . 0.0 110.214 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -100.37 -38.48 8.42 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.824 1.25 . . . . 0.0 112.677 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 t -157.22 157.17 33.84 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.585 1.084 . . . . 0.0 110.881 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -58.29 -30.42 66.62 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 118.334 -0.841 . . . . 0.0 113.12 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -66.36 -14.48 62.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.504 1.047 . . . . 0.0 112.052 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -101.63 -18.74 15.74 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.012 1.325 . . . . 0.0 111.239 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 26.1 mm -49.99 -56.24 18.94 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 120.736 1.607 . . . . 0.0 111.501 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.1 -20.07 25.54 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 CA-C-N 119.88 0.993 . . . . 0.0 112.557 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.65 -34.48 46.37 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 124.932 1.293 . . . . 0.0 111.453 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.8 -31.39 28.21 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.59 1.556 . . . . 0.0 108.55 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -59.43 -44.07 92.95 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.325 0.65 . . . . 0.0 109.625 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -65.51 -31.26 72.23 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 122.839 0.456 . . . . 0.0 111.319 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -69.79 -47.27 63.49 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 26.7 mt -66.57 -32.85 74.46 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.627 -179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -70.68 -27.73 64.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.098 0.863 . . . . 0.0 110.076 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.84 -27.79 63.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 118.219 0.463 . . . . 0.0 110.481 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.1 -1.42 20.42 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.377 0.671 . . . . 0.0 112.569 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -177.22 -101.6 0.15 Allowed Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 118.989 0.813 . . . . 0.0 112.36 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -137.23 -179.5 5.76 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.942 2.097 . . . . 0.0 109.208 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 p -51.59 172.27 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.438 1.895 . . . . 0.0 115.569 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -106.19 -55.46 2.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.755 1.622 . . . . 0.0 112.343 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.4 tp -133.1 146.39 51.6 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.814 1.246 . . . . 0.0 110.844 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 90.2 mtp -146.1 127.99 15.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -149.27 166.84 27.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.17 136.73 33.08 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.57 -4.58 9.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.165 0.986 . . . . 0.0 108.912 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -65.56 -19.99 66.15 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 125.297 1.439 . . . . 0.0 110.823 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -127.8 143.14 46.55 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.094 0.958 . . . . 0.0 109.493 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -72.49 -12.75 27.36 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.095 3.197 . . . . 0.0 114.121 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -51.41 -45.76 62.67 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.276 0.944 . . . . 0.0 111.948 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.12 -37.71 19.93 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-O 119.157 -0.449 . . . . 0.0 112.128 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.0 p -72.93 -14.03 61.38 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.102 0.864 . . . . 0.0 111.448 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -53.84 -63.05 2.91 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.574 1.149 . . . . 0.0 111.866 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.14 -6.18 10.92 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.226 1.951 . . . . 0.0 114.325 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 28.2 tp -82.5 -62.88 1.49 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.41 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 12.5 pt -58.77 -42.2 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.35 2.61 3.65 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.402 ' HB2' ' HG ' ' A' ' 255' ' ' SER . . . -61.59 -37.07 82.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -177.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -86.86 -48.52 8.11 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.43 1.014 . . . . 0.0 108.606 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.71 63.55 0.07 OUTLIER Glycine 0 C--N 1.336 0.553 0 CA-C-N 118.964 0.802 . . . . 0.0 113.632 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -117.18 140.42 15.82 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 105.835 -2.906 . . . . 0.0 105.835 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -151.36 151.32 31.58 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.298 1.549 . . . . 0.0 109.315 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.13 -65.21 1.0 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -136.71 150.35 48.4 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.624 0.77 . . . . 0.0 111.056 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -86.03 149.9 24.84 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -150.85 106.2 3.35 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.73 57.31 4.43 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.734 1.614 . . . . 0.0 112.276 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 49.99 16.39 0.23 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.092 2.157 . . . . 0.0 116.522 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.41 -15.34 0.06 OUTLIER Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.392 0.996 . . . . 0.0 112.282 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -117.67 130.54 56.41 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -126.7 131.17 51.44 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 124.944 1.402 . . . . 0.0 108.315 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.2 146.48 33.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.144 0.973 . . . . 0.0 109.955 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -0.71 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.827 1.651 . . . . 0.0 110.749 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -80.1 -37.4 33.8 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -81.93 100.71 9.81 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.22 150.65 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.419 1.487 . . . . 0.0 109.889 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.52 16.17 5.42 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.032 0.825 . . . . 0.0 115.149 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.0 t -54.83 -33.24 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.181 1.792 . . . . 0.0 115.01 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.61 14.48 12.69 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.27 0.628 . . . . 0.0 111.68 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -62.18 164.93 6.29 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.437 0.636 . . . . 0.0 110.1 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -50.95 -34.63 29.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.953 0.901 . . . . 0.0 112.093 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.21 -47.01 47.18 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.968 0.804 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -55.89 -48.78 74.99 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.969 -0.724 . . . . 0.0 109.415 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -67.04 -40.42 87.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 117.726 -1.131 . . . . 0.0 111.025 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.55 -49.64 76.68 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.133 0.879 . . . . 0.0 111.563 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -71.55 -27.93 70.34 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.319 -0.944 . . . . 0.0 112.057 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 14.2 tp -77.35 -34.14 55.22 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.773 1.287 . . . . 0.0 112.355 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.4 t -55.9 -45.31 78.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 117.452 -1.261 . . . . 0.0 108.805 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -52.39 -53.91 38.86 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.271 1.428 . . . . 0.0 111.237 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.6 tt -54.12 -48.39 70.81 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.122 0.969 . . . . 0.0 111.278 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 38.6 t -73.41 -21.95 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.39 0.676 . . . . 0.0 110.492 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.405 ' HA ' ' CE ' ' A' ' 200' ' ' LYS . 2.8 t70 -63.37 -36.85 85.1 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.768 1.227 . . . . 0.0 109.749 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.8 mt -71.9 -41.73 67.59 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 79.5 mt -63.09 -39.48 85.38 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.405 ' CE ' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -54.71 -34.27 62.18 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.817 1.247 . . . . 0.0 109.769 178.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -91.47 -9.93 42.73 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.693 1.197 . . . . 0.0 111.906 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 64.82 6.53 3.38 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 128.735 2.814 . . . . 0.0 113.387 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -67.54 -36.22 80.56 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.541 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 8.4 tpt -77.96 154.07 31.91 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -88.43 91.18 8.7 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.459 -0.775 . . . . 0.0 110.573 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.3 -28.93 70.05 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.376 -0.827 . . . . 0.0 112.49 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.11 -4.65 48.47 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.8 m -71.46 126.98 31.09 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.274 -1.516 . . . . 0.0 109.053 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.03 -178.08 3.86 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.863 1.665 . . . . 0.0 107.095 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -58.11 -37.74 75.12 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.093 0.557 . . . . 0.0 111.404 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 39.5 m -73.59 -40.1 64.12 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.54 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 19.4 mm -64.58 -50.99 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 120.839 1.654 . . . . 0.0 109.053 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -55.94 -44.06 78.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.854 0.752 . . . . 0.0 110.631 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -67.48 -40.69 85.26 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.555 0.742 . . . . 0.0 111.762 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.31 -56.51 8.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.699 0.8 . . . . 0.0 109.594 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.99 -39.44 66.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.415 1.486 . . . . 0.0 110.519 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -60.15 -45.93 91.39 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -64.06 -30.54 71.61 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.076 -0.488 . . . . 0.0 111.793 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -77.21 -11.38 59.82 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.969 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.97 19.82 49.34 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 125.174 1.369 . . . . 0.0 112.21 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.07 -48.76 19.58 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 118.385 1.093 . . . . 0.0 111.016 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -104.12 153.37 21.0 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -105.5 -25.38 12.34 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.676 0.79 . . . . 0.0 110.322 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -129.07 170.04 13.99 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.625 1.17 . . . . 0.0 109.716 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.7 t -161.06 178.92 8.86 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.182 1.793 . . . . 0.0 107.169 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.1 mt -134.32 139.55 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -148.2 170.9 16.84 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -138.9 -177.91 15.84 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -58.56 -39.36 83.7 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 CA-C-N 119.069 1.435 . . . . 0.0 109.063 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -161.14 164.94 30.27 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 127.24 2.216 . . . . 0.0 106.374 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -133.61 152.64 51.93 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.072 2.149 . . . . 0.0 106.467 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -75.94 160.75 29.56 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 t 54.4 26.65 7.25 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 119.274 0.943 . . . . 0.0 112.238 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -58.28 114.4 2.39 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.128 0.971 . . . . 0.0 109.704 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.2 tt -97.25 -37.9 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.46 1.104 . . . . 0.0 110.888 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -98.79 -89.6 0.31 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.332 1.053 . . . . 0.0 108.759 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.3 t -153.12 -164.83 2.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.299 1.047 . . . . 0.0 111.004 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.3 m -132.53 133.4 43.7 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 130.873 3.669 . . . . 0.0 101.177 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -130.5 123.35 29.48 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 120.564 1.529 . . . . 0.0 110.85 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.3 m -52.51 140.9 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 126.444 1.897 . . . . 0.0 113.826 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.27 172.14 10.71 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.146 0.978 . . . . 0.0 109.047 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -163.67 -177.56 5.26 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.706 1.203 . . . . 0.0 109.204 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 64.74 -159.6 42.5 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.0 p -160.48 120.77 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.53 1.132 . . . . 0.0 108.728 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.8 t -153.23 -173.64 4.65 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.697 -0.627 . . . . 0.0 110.827 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 38.6 t -72.97 167.14 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 127.962 2.505 . . . . 0.0 109.285 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.55 129.64 17.63 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.0 123.52 10.1 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.418 2.079 . . . . 0.0 109.207 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.5 p -100.53 169.28 9.17 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -77.85 167.11 22.03 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -51.35 104.64 0.08 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 126.003 1.721 . . . . 0.0 110.249 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.52 8.21 44.69 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 117.97 -1.461 . . . . 0.0 116.556 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.59 124.25 10.35 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 121.569 2.685 . . . . 0.0 112.193 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.51 123.25 8.49 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.215 3.276 . . . . 0.0 113.576 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.402 ' HG ' ' HB2' ' A' ' 163' ' ' ALA . 20.0 m -62.37 159.06 16.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.578 1.151 . . . . 0.0 111.621 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -147.35 100.53 3.83 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.902 1.281 . . . . 0.0 111.172 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -69.97 -63.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.693 0 N-CA-C 107.274 -1.856 . . . . 0.0 107.274 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -160.66 -173.15 3.81 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.153 2.981 . . . . 0.0 106.702 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.6 120.46 56.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 126.811 2.044 . . . . 0.0 106.829 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -103.05 132.61 11.08 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.46 140.49 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.9 tt -81.35 140.42 34.77 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.3 m -126.9 154.28 44.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 122.903 0.481 . . . . 0.0 111.286 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -132.67 146.2 51.68 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.153 0.981 . . . . 0.0 108.579 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -139.85 148.62 20.19 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 82.6 mt -95.12 137.36 23.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -72.13 133.5 45.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.046 0.385 . . . . 0.0 110.296 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -79.29 -25.11 42.5 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.031 -0.985 . . . . 0.0 113.33 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -74.22 -12.69 60.64 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.531 1.06 . . . . 0.0 113.325 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 61.9 m -60.15 165.51 4.89 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.49 -41.23 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 CA-C-N 120.59 1.246 . . . . 0.0 110.58 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -122.71 168.55 12.07 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.717 1.607 . . . . 0.0 108.164 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -132.88 -26.73 1.73 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.199 1.399 . . . . 0.0 110.303 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -61.47 -40.1 93.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.32 -34.56 72.49 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.827 -1.171 . . . . 0.0 111.195 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.61 -45.43 37.46 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.134 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -36.54 83.96 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.784 0.72 . . . . 0.0 109.154 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -64.78 -46.11 83.46 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -60.84 -37.41 81.98 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 120.102 1.319 . . . . 0.0 108.175 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.3 mp -77.24 -0.05 23.82 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 117.63 -1.176 . . . . 0.0 114.019 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -137.58 2.31 2.44 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 120.867 1.667 . . . . 0.0 113.587 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.52 -55.94 3.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.949 1.249 . . . . 0.0 110.613 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -126.11 -29.25 3.06 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.784 1.634 . . . . 0.0 113.299 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -55.21 -35.1 64.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.486 1.039 . . . . 0.0 111.885 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.36 74.57 0.96 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.329 1.052 . . . . 0.0 108.41 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 22.9 p -137.11 163.39 30.92 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.19 -17.41 63.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.25 1.82 . . . . 0.0 112.628 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -116.07 -36.56 4.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.602 1.561 . . . . 0.0 110.927 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.57 -31.04 59.18 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-O 118.846 -0.974 . . . . 0.0 110.883 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 29.7 mt -73.34 -41.79 63.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 119.577 1.689 . . . . 0.0 106.631 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -56.13 -47.32 78.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.555 1.142 . . . . 0.0 110.667 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.75 -29.44 64.8 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 48.5 t -91.08 -34.32 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 C-N-CA 124.477 1.111 . . . . 0.0 110.119 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -62.13 -30.4 71.0 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.067 0.849 . . . . 0.0 110.158 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -61.92 -17.81 58.09 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.969 0.908 . . . . 0.0 111.216 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -122.4 -76.27 0.59 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -61.66 142.69 94.33 Favored Pre-proline 0 C--O 1.234 0.272 0 O-C-N 121.189 -0.944 . . . . 0.0 111.457 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.08 93.1 1.03 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 N-CA-C 106.415 -2.186 . . . . 0.0 106.415 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.3 mt -77.23 -19.58 56.43 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 117.234 -1.365 . . . . 0.0 111.16 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 55.12 -138.98 41.89 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -85.75 165.57 16.8 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.42 155.56 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 O-C-N 120.306 -1.496 . . . . 0.0 110.814 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.52 70.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.111 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.21 101.05 0.26 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.872 1.269 . . . . 0.0 111.089 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -65.37 -20.73 66.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.785 178.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.91 -21.62 62.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.011 0.924 . . . . 0.0 111.494 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -113.6 -11.13 13.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.977 1.262 . . . . 0.0 110.559 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -59.86 -41.78 92.23 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.451 1.1 . . . . 0.0 108.355 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.88 -17.02 61.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.917 1.287 . . . . 0.0 112.817 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -95.96 -52.61 3.98 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 8.5 mt -56.62 -38.71 72.45 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.479 -0.763 . . . . 0.0 110.906 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.59 -6.66 5.58 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.262 1.425 . . . . 0.0 114.121 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -63.23 -13.61 39.75 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.4 1.08 . . . . 0.0 111.439 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -123.66 139.54 32.39 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.27 1.028 . . . . 0.0 109.255 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.47 -20.28 48.26 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.908 2.405 . . . . 0.0 112.941 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -63.93 -24.65 67.81 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.737 0.699 . . . . 0.0 112.684 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.3 mp -96.09 -56.84 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.39 -51.77 10.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.318 1.047 . . . . 0.0 112.576 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.23 -42.76 91.8 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.616 -0.678 . . . . 0.0 112.334 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 14.5 m -66.57 -34.19 77.35 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -53.76 43.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -55.49 -36.14 66.33 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.494 0.718 . . . . 0.0 111.432 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -67.7 -31.05 70.74 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.796 0.839 . . . . 0.0 111.128 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -83.61 -34.06 25.18 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.595 -0.691 . . . . 0.0 109.667 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -65.64 -48.25 72.84 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 125.191 1.396 . . . . 0.0 110.303 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -2.49 21.86 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -108.89 177.09 20.27 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-O 122.561 1.089 . . . . 0.0 113.481 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.2 161.84 29.2 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 127.694 2.398 . . . . 0.0 109.596 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 32.4 mt -90.86 155.85 3.05 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 7.4 ptp -60.86 148.57 82.91 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.611 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.98 -179.65 4.84 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 124.099 3.2 . . . . 0.0 114.444 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -133.18 5.42 3.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.161 1.784 . . . . 0.0 112.277 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.6 pt -89.1 144.56 32.81 Favored Pre-proline 0 CA--C 1.537 0.452 0 O-C-N 121.233 -0.917 . . . . 0.0 109.287 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.01 -12.71 32.94 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.108 2.539 . . . . 0.0 114.398 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.57 -20.89 35.32 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.277 1.031 . . . . 0.0 111.792 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.0 mmm -62.06 -24.76 67.29 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.341 -0.849 . . . . 0.0 110.58 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 61.0 p -63.75 -28.16 69.69 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.768 -1.208 . . . . 0.0 110.05 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -90.45 -30.66 17.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.808 1.643 . . . . 0.0 111.266 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -53.68 -60.77 2.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.391 1.077 . . . . 0.0 109.124 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -56.85 -43.01 80.7 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.745 0.418 . . . . 0.0 111.215 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -60.85 -27.47 68.12 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.05 0.54 . . . . 0.0 111.952 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.12 -61.74 1.86 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.613 0.765 . . . . 0.0 110.538 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 1.6 m -56.44 -25.84 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.364 0.666 . . . . 0.0 111.677 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -54.0 -56.8 14.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.967 0.907 . . . . 0.0 108.694 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 88.6 m -66.3 -38.35 87.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.186 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.04 77.05 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.47 -49.87 75.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 124.652 1.181 . . . . 0.0 109.024 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 32.7 mm -62.71 -38.55 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.148 0.886 . . . . 0.0 110.591 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -61.15 -41.91 97.6 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.122 -0.986 . . . . 0.0 110.774 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.35 -46.72 59.83 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 123.275 0.359 . . . . 0.0 110.328 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.93 98.34 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.703 1.201 . . . . 0.0 113.327 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 19.2 m -87.93 -1.32 57.91 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.659 0.783 . . . . 0.0 110.297 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 71.05 14.11 73.29 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-O 119.433 -0.649 . . . . 0.0 114.608 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -65.56 -26.97 68.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.541 1.171 . . . . 0.0 109.031 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -153.76 167.63 28.99 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.957 0.903 . . . . 0.0 109.65 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.6 m -72.26 156.14 39.44 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 39.6 t -54.95 -56.4 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.93 -51.47 40.78 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.641 2.376 . . . . 0.0 112.894 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -72.57 -32.69 66.23 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.86 71.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 24.6 mt -70.18 -43.35 70.97 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -51.76 -54.84 24.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.969 1.707 . . . . 0.0 108.178 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -52.31 -47.58 65.87 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.381 1.072 . . . . 0.0 109.317 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.92 -46.6 87.02 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 117.597 -1.192 . . . . 0.0 111.736 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.13 -39.78 72.75 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.406 1.003 . . . . 0.0 108.708 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 3.1 m -62.58 -25.08 67.89 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.184 0.993 . . . . 0.0 112.235 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -83.07 -14.32 54.0 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.642 -1.287 . . . . 0.0 112.085 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 9.9 mt -105.85 -30.47 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.556 0.616 . . . . 0.0 109.426 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 24.0 p -69.42 -37.87 77.63 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 27.6 tptt . . . . . 0 C--O 1.246 0.886 0 C-N-CA 126.371 1.868 . . . . 0.0 107.933 178.413 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.2 mt -140.44 167.63 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -79.16 103.78 9.33 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -83.66 175.31 9.8 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.163 0.985 . . . . 0.0 108.684 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.64 35.62 86.59 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.374 1.464 . . . . 0.0 115.651 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -147.11 167.69 23.48 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 119.246 1.523 . . . . 0.0 112.658 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.0 mt -150.08 145.6 26.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.519 2.728 . . . . 0.0 105.664 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.443 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 50.4 t -139.56 134.68 39.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.9 mt -125.6 136.21 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.079 1.352 . . . . 0.0 110.092 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -127.07 154.66 44.41 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.0 pt -145.21 163.46 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 123.597 0.759 . . . . 0.0 111.348 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -0.95 2.27 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.52 -76.01 0.22 Allowed Glycine 0 C--N 1.332 0.354 0 CA-C-N 120.098 1.317 . . . . 0.0 112.438 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -63.26 17.11 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 130.121 3.369 . . . . 0.0 115.219 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -84.9 165.79 17.36 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.733 1.213 . . . . 0.0 112.309 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.02 83.14 1.6 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 103.466 -3.854 . . . . 0.0 103.466 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -95.59 -20.7 18.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -58.73 -42.05 87.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.699 1.136 . . . . 0.0 110.934 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.96 -41.39 40.91 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.6 tp -59.76 -43.13 94.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.08 0.94 . . . . 0.0 111.434 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.15 -38.8 71.34 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.881 -1.057 . . . . 0.0 111.17 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -60.0 -35.51 75.19 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.121 0.873 . . . . 0.0 111.852 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.6 -42.97 90.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.91 -39.98 96.9 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -63.34 -51.31 66.5 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 118.542 1.171 . . . . 0.0 108.695 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -53.71 -57.65 10.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.689 1.195 . . . . 0.0 108.544 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -58.01 -45.17 87.28 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.879 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -66.31 -8.29 24.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.036 1.289 . . . . 0.0 111.25 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -109.08 -8.28 15.19 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 119.994 -1.691 . . . . 0.0 112.657 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -110.79 -38.26 5.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.898 1.279 . . . . 0.0 108.801 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.9 p -104.16 -32.71 9.02 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.016 0.926 . . . . 0.0 111.249 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.47 -12.09 69.38 Favored Glycine 0 C--N 1.342 0.904 0 O-C-N 121.452 -0.78 . . . . 0.0 111.787 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.2 128.79 24.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -60.09 138.76 57.81 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.972 0.509 . . . . 0.0 111.22 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.05 119.73 17.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.8 m -114.62 148.88 37.48 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -137.29 113.64 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -130.67 166.06 21.52 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.144 0.977 . . . . 0.0 108.621 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -127.27 57.16 21.98 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.52 0.728 . . . . 0.0 111.65 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.09 149.77 65.22 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 N-CA-C 107.71 -1.688 . . . . 0.0 107.71 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -95.97 -37.23 10.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 121.245 -0.91 . . . . 0.0 108.656 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -3.84 4.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.117 1.367 . . . . 0.0 111.816 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.11 -31.63 13.84 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.296 1.038 . . . . 0.0 109.417 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -50.0 -29.87 9.49 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.289 2.236 . . . . 0.0 112.433 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -125.5 -20.62 4.7 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.433 1.015 . . . . 0.0 110.569 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -73.65 -49.96 23.36 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 116.384 -1.77 . . . . 0.0 111.548 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -45.87 -57.58 7.76 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 120.114 1.325 . . . . 0.0 109.879 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.09 -18.11 63.47 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 N-CA-C 115.896 1.46 . . . . 0.0 115.896 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -92.34 -46.34 7.74 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.959 1.708 . . . . 0.0 112.289 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 t -69.45 -39.37 78.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 O-C-N 121.261 -0.899 . . . . 0.0 108.665 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.45 -16.34 61.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.402 -0.812 . . . . 0.0 110.847 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.34 7.43 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.072 0.949 . . . . 0.0 110.912 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -130.73 -39.6 1.24 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.764 2.026 . . . . 0.0 106.414 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.56 6.77 12.76 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 124.564 1.078 . . . . 0.0 114.737 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.45 -0.52 54.69 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.036 1.418 . . . . 0.0 111.238 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.73 -175.0 30.61 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 126.972 2.225 . . . . 0.0 116.529 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -67.35 -178.76 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.377 3.385 . . . . 0.0 112.0 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 9.9 m-20 -115.81 -20.03 10.21 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.5 mt -141.68 143.62 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.14 144.08 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.832 1.653 . . . . 0.0 108.144 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -131.28 114.66 15.3 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.836 1.654 . . . . 0.0 110.358 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -156.04 172.84 17.72 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.997 0.817 . . . . 0.0 111.538 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.43 149.31 50.61 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -55.6 -31.75 62.51 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.09 -12.76 61.97 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -109.44 -0.65 18.83 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.971 1.26 . . . . 0.0 109.544 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -92.88 -11.52 33.3 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.292 1.837 . . . . 0.0 112.225 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.62 -10.39 86.26 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.638 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.12 -60.61 1.17 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.087 1.327 . . . . 0.0 111.007 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -43.91 -44.14 6.89 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.543 1.537 . . . . 0.0 114.692 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.56 -41.5 72.36 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.085 0.857 . . . . 0.0 110.946 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -36.31 70.58 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.12 0.968 . . . . 0.0 109.003 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 m -67.99 -44.74 75.92 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.358 1.063 . . . . 0.0 108.697 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.77 -2.24 8.01 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.978 1.751 . . . . 0.0 113.345 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.0 mp -68.79 -11.0 59.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.514 1.657 . . . . 0.0 114.461 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.5 mt -108.85 129.36 55.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.324 0.966 . . . . 0.0 108.511 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.84 167.22 13.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.172 1.789 . . . . 0.0 110.701 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -69.1 101.5 1.45 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.471 1.108 . . . . 0.0 109.656 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 pp -76.28 165.56 3.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 124.491 1.116 . . . . 0.0 111.424 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.4 m 48.08 97.71 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 128.581 2.752 . . . . 0.0 114.908 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.31 -22.95 21.3 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.916 2.411 . . . . 0.0 114.135 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -133.95 151.91 51.66 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -60.98 -32.68 72.24 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.5 1.52 . . . . 0.0 112.719 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.9 -42.12 65.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 120.07 1.305 . . . . 0.0 112.303 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.69 -30.72 71.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.886 0.475 . . . . 0.0 110.894 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -69.13 -37.42 78.31 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.142 -0.974 . . . . 0.0 111.379 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.26 -19.13 65.82 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.342 0.519 . . . . 0.0 111.484 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -79.08 -2.46 40.59 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.3 mt -130.38 151.6 50.69 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.329 1.052 . . . . 0.0 109.206 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -72.26 151.12 92.19 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 119.589 -0.845 . . . . 0.0 109.985 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.47 -45.47 3.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.282 3.322 . . . . 0.0 113.704 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -60.01 -33.51 72.09 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.428 1.013 . . . . 0.0 110.094 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.8 m -68.86 -36.19 77.83 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.806 0.843 . . . . 0.0 109.342 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -65.67 -45.18 83.88 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.141 0.977 . . . . 0.0 110.032 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.31 -33.71 13.88 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.438 1.495 . . . . 0.0 112.39 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.84 -35.27 22.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.207 1.403 . . . . 0.0 111.267 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.39 6.36 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.419 1.888 . . . . 0.0 113.328 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -69.02 156.67 38.23 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -138.5 175.59 9.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -62.97 111.18 2.05 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.596 0.758 . . . . 0.0 110.06 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.98 -77.76 0.67 Allowed Glycine 0 CA--C 1.522 0.514 0 C-N-CA 124.804 1.192 . . . . 0.0 114.169 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 166.03 22.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.06 0.944 . . . . 0.0 110.778 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.71 170.01 8.44 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.746 1.218 . . . . 0.0 110.052 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.1 pt -138.17 -35.42 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.72 176.93 11.54 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.235 1.414 . . . . 0.0 108.61 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -131.76 150.41 76.16 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.526 0.731 . . . . 0.0 110.94 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.57 151.95 53.37 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.591 2.86 . . . . 0.0 109.639 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mm -128.79 -45.09 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 123.972 0.909 . . . . 0.0 111.125 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.41 157.78 44.71 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 123.141 0.577 . . . . 0.0 112.007 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.7 t -132.4 100.15 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -127.34 121.52 31.24 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.998 1.319 . . . . 0.0 107.754 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.88 71.48 1.4 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.955 1.302 . . . . 0.0 109.025 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.14 151.12 9.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.806 0.842 . . . . 0.0 111.399 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 p -179.2 155.37 0.71 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.676 1.19 . . . . 0.0 111.062 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.5 tp -153.91 136.27 14.95 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.193 1.797 . . . . 0.0 108.193 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.1 mp -103.22 125.6 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -143.41 163.28 33.51 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.788 1.235 . . . . 0.0 110.208 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -85.02 141.23 30.45 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.113 1.365 . . . . 0.0 111.801 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -79.42 2.09 23.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.366 1.467 . . . . 0.0 112.316 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -63.94 166.19 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 121.02 -1.05 . . . . 0.0 111.435 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.58 -1.47 13.65 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.92 0.888 . . . . 0.0 111.534 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.0 tp -128.15 67.21 74.33 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 128.624 2.769 . . . . 0.0 105.767 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.68 -24.47 6.15 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.763 2.976 . . . . 0.0 114.873 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 46.35 71.61 1.51 Allowed Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 127.024 2.13 . . . . 0.0 114.598 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.69 119.63 6.55 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.22 2.613 . . . . 0.0 107.99 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -81.53 162.98 19.27 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.901 1.734 . . . . 0.0 112.925 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -126.5 -9.14 6.28 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 t -168.26 154.49 7.27 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -69.31 -18.94 63.88 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.947 -0.471 . . . . 0.0 111.061 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -75.43 -18.8 59.81 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.916 0.78 . . . . 0.0 110.291 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -87.22 -26.39 23.54 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.906 0.882 . . . . 0.0 109.783 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.1 mm -51.46 -60.43 5.87 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.0 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.83 -25.57 23.48 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 CA-C-N 120.631 1.261 . . . . 0.0 110.981 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.18 96.81 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.584 0.754 . . . . 0.0 109.227 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.9 tp -79.67 -27.89 40.78 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.705 1.202 . . . . 0.0 110.637 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -57.02 -46.36 82.41 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.788 0.722 . . . . 0.0 110.496 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -69.52 -28.48 66.07 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -74.37 -44.62 51.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.1 mt -72.2 -34.68 68.56 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 119.167 -0.444 . . . . 0.0 109.824 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -66.12 -32.34 73.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.81 -15.87 63.28 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 119.082 -0.485 . . . . 0.0 112.166 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.69 5.95 6.15 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.879 1.272 . . . . 0.0 112.832 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.21 -101.98 0.16 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 118.97 0.805 . . . . 0.0 111.329 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -139.42 -176.23 4.46 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.091 1.357 . . . . 0.0 111.519 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.23 162.13 2.17 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.416 1.486 . . . . 0.0 114.185 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.27 -45.32 8.28 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.723 1.209 . . . . 0.0 111.466 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.6 tp -124.88 149.67 47.29 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.571 1.549 . . . . 0.0 107.289 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.0 ttm -154.33 103.08 2.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -121.96 158.98 27.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.525 1.057 . . . . 0.0 111.112 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 -69.14 98.15 0.98 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.98 -11.74 60.01 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.808 0.843 . . . . 0.0 110.883 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -78.88 -23.52 44.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.962 1.305 . . . . 0.0 113.683 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -95.38 132.01 28.59 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 119.976 1.262 . . . . 0.0 110.772 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.29 -22.8 39.46 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 121.897 1.731 . . . . 0.0 114.468 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -68.97 -14.89 63.31 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.263 1.392 . . . . 0.0 113.104 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -95.82 -25.56 15.98 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.486 1.039 . . . . 0.0 109.066 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 p -88.7 -28.51 20.52 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.838 -1.164 . . . . 0.0 110.516 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -51.69 79.02 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 120.069 -1.644 . . . . 0.0 113.239 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.0 -5.03 12.54 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.857 1.705 . . . . 0.0 111.651 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.1 tp -85.76 -62.33 1.55 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . 0.27 0.2 OUTLIER -70.52 -27.59 31.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.56 -25.09 36.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.721 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -49.46 -47.3 48.4 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.174 1.39 . . . . 0.0 113.023 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -66.29 -45.37 80.64 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.456 0.702 . . . . 0.0 111.291 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -176.43 -26.04 0.03 OUTLIER Glycine 0 C--N 1.338 0.653 0 CA-C-O 117.255 -1.858 . . . . 0.0 115.937 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -42.01 133.06 4.11 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.204 1.383 . . . . 0.0 112.876 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -139.01 122.81 17.62 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.35 -55.1 37.62 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.64 -0.662 . . . . 0.0 112.043 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -140.41 145.17 36.69 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -71.65 139.44 49.25 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 121.648 -0.658 . . . . 0.0 111.683 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -141.84 138.17 31.97 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.367 -2.456 . . . . 0.0 104.367 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -110.36 -120.33 0.28 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.455 1.102 . . . . 0.0 108.555 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -111.03 53.85 0.69 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 128.252 2.621 . . . . 0.0 108.011 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.02 9.29 34.71 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.694 -1.059 . . . . 0.0 113.568 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -118.47 125.17 49.35 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -116.96 133.79 55.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.716 2.006 . . . . 0.0 106.933 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -138.91 110.4 7.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.787 0.803 . . . . 0.0 111.641 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -2.73 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.09 1.356 . . . . 0.0 112.493 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -93.42 -0.59 56.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.06 1.344 . . . . 0.0 111.73 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -127.17 106.18 9.07 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.975 1.71 . . . . 0.0 107.247 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 96.9 t -122.76 122.9 67.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.995 2.118 . . . . 0.0 109.81 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -107.69 54.95 0.54 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.84 1.21 . . . . 0.0 114.555 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -93.9 -50.42 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 123.415 0.686 . . . . 0.0 109.287 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -81.83 63.39 6.06 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.504 1.522 . . . . 0.0 107.457 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -124.14 152.25 43.02 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.138 0.975 . . . . 0.0 109.77 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.24 -40.73 67.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.544 1.138 . . . . 0.0 112.638 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.18 -31.36 77.3 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.129 -0.982 . . . . 0.0 112.566 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.05 -48.13 54.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.791 0.796 . . . . 0.0 109.213 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -63.42 -35.41 80.33 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.747 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -55.01 -55.44 30.84 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.823 0.849 . . . . 0.0 112.023 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -69.52 -29.9 71.32 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 41.4 tp -67.87 -46.53 71.44 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.136 -1.214 . . . . 0.0 109.803 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -34.21 63.9 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.97 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -60.15 -58.76 7.12 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.065 1.302 . . . . 0.0 109.651 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.9 -48.69 77.62 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.336 1.055 . . . . 0.0 110.102 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.19 -28.04 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 123.634 0.774 . . . . 0.0 110.664 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.42 -37.17 86.59 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 119.509 1.05 . . . . 0.0 111.855 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.4 mt -71.95 -40.52 68.63 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.39 -41.46 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.151 0.98 . . . . 0.0 108.365 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -54.59 -41.12 69.53 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.496 1.119 . . . . 0.0 108.956 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -86.45 -1.84 57.93 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.396 1.879 . . . . 0.0 113.133 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.2 mptt 57.7 6.55 0.45 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.049 2.539 . . . . 0.0 114.842 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -76.72 -10.7 59.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.121 0.873 . . . . 0.0 111.802 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.9 tpt -95.24 150.99 19.63 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.377 1.071 . . . . 0.0 109.735 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.31 67.06 8.61 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.39 -19.67 3.72 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.665 1.986 . . . . 0.0 115.676 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -86.27 0.71 53.21 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.952 2.101 . . . . 0.0 111.811 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 42.7 m -70.12 131.24 43.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.684 1.129 . . . . 0.0 109.768 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -127.6 -178.63 4.55 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.906 1.682 . . . . 0.0 106.612 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -56.03 -46.82 78.72 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.324 0.65 . . . . 0.0 112.52 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 68.4 m -56.28 -49.49 74.07 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.484 1.114 . . . . 0.0 110.519 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 53.4 mt -64.09 -43.87 97.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.605 0.762 . . . . 0.0 109.429 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.86 -53.71 52.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.982 0.913 . . . . 0.0 112.592 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -65.36 -33.66 76.49 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.783 -0.573 . . . . 0.0 110.144 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.9 -51.39 64.73 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.83 -33.98 73.86 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.59 0.632 . . . . 0.0 111.129 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -65.6 -45.58 82.65 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -60.63 -35.17 75.5 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -69.45 -16.45 63.48 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.979 -1.01 . . . . 0.0 111.759 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.0 13.86 65.66 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 119.591 1.087 . . . . 0.0 111.645 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -84.23 -43.27 15.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.099 0.95 . . . . 0.0 112.47 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 58.4 p -75.48 107.72 7.8 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.234 0.47 . . . . 0.0 111.66 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.91 -26.37 66.83 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -146.51 158.12 43.85 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.878 1.671 . . . . 0.0 110.127 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 5.9 t -149.5 154.0 38.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt -122.86 116.19 48.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -158.77 158.7 34.11 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.471 1.908 . . . . 0.0 108.949 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -66.03 -68.84 1.52 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.834 1.683 . . . . 0.0 114.723 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.7 109.17 2.39 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.338 2.692 . . . . 0.0 110.859 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -78.8 30.49 0.2 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.686 1.195 . . . . 0.0 111.083 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -51.73 138.31 23.69 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.433 1.093 . . . . 0.0 111.318 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -65.33 -14.8 61.63 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.029 1.332 . . . . 0.0 114.068 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.0 p -162.77 156.44 20.32 Favored 'General case' 0 C--O 1.241 0.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.42 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -148.28 -99.83 0.08 Allowed 'General case' 0 C--O 1.232 0.142 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.9 pt -68.98 -31.87 52.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 C-N-CA 124.284 1.034 . . . . 0.0 112.144 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -143.32 165.29 27.9 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 5.1 m -82.14 68.87 8.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 125.365 1.466 . . . . 0.0 109.052 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 70.0 m -78.4 86.6 4.45 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -61.86 70.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 127.471 2.309 . . . . 0.0 113.768 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 9.7 p -75.29 169.85 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 126.167 1.787 . . . . 0.0 109.328 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -103.03 166.03 10.68 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -114.17 156.3 24.5 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.775 0.83 . . . . 0.0 110.373 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 156.53 -166.86 33.42 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 125.6 1.572 . . . . 0.0 111.625 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 59.8 t -137.6 127.88 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.3 t -141.55 164.27 30.67 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 57.6 t -61.11 135.1 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -100.5 158.74 31.36 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.77 132.25 24.54 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 120.506 1.216 . . . . 0.0 109.383 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 25.4 p -116.57 172.83 6.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.086 1.354 . . . . 0.0 109.347 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -84.65 169.36 14.4 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.576 0.703 . . . . 0.0 110.249 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -62.13 117.99 6.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.59 11.91 57.93 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.63 145.18 18.08 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-N 121.351 2.575 . . . . 0.0 111.71 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.04 171.7 17.01 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 124.305 3.337 . . . . 0.0 111.289 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.6 p -93.12 137.01 32.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -129.27 74.84 80.76 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.468 1.907 . . . . 0.0 109.217 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.08 -83.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.706 2.271 . . . . 0.0 109.893 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.2 -179.08 6.49 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.806 2.042 . . . . 0.0 107.866 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.5 t -126.58 159.91 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -161.31 148.31 15.92 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 106.008 -2.837 . . . . 0.0 106.008 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.06 148.61 23.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 118.891 1.345 . . . . 0.0 112.083 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.0 tp -84.59 133.94 34.41 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.8 m -113.06 157.33 21.7 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.279 1.032 . . . . 0.0 111.595 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -135.5 138.5 43.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.476 1.11 . . . . 0.0 108.87 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.33 163.57 25.13 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 71.2 mt -109.57 142.66 21.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -74.18 116.08 14.41 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.51 -24.98 59.04 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.833 -0.604 . . . . 0.0 112.028 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -70.94 -9.46 57.9 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 118.195 -0.907 . . . . 0.0 113.302 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 6.9 t -62.56 144.24 95.89 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.4 -34.89 52.66 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.239 1.292 . . . . 0.0 109.887 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -141.73 109.53 5.74 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -14.53 63.02 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.691 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.6 -33.42 75.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.067 0.547 . . . . 0.0 111.05 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.38 -37.83 76.06 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.282 -0.886 . . . . 0.0 109.573 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.59 -45.94 41.92 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.777 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -34.41 78.06 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 118.862 -0.59 . . . . 0.0 110.114 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -73.29 -41.16 63.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.545 0.611 . . . . 0.0 109.593 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -58.35 -47.0 85.2 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.996 -1.065 . . . . 0.0 109.109 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.77 -45.57 81.99 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.528 -0.749 . . . . 0.0 111.571 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -77.01 -12.93 60.0 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -106.44 -17.62 14.22 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.727 1.603 . . . . 0.0 113.306 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -136.99 -51.11 0.66 Allowed 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 119.51 1.05 . . . . 0.0 111.484 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -5.69 20.05 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.97 31.03 6.97 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.013 -1.68 . . . . 0.0 111.523 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 70.7 p -116.31 163.66 15.68 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -40.79 95.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.206 1.403 . . . . 0.0 107.443 178.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.0 -48.68 73.08 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.976 1.71 . . . . 0.0 110.903 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -62.75 -50.47 63.8 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 58.1 mt -60.21 -44.64 94.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.125 0.57 . . . . 0.0 109.841 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -62.59 -42.87 99.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.848 0.459 . . . . 0.0 109.976 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.52 74.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.232 0.469 . . . . 0.0 110.407 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.7 t -73.6 -36.55 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.288 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -63.46 -31.09 72.15 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.815 1.646 . . . . 0.0 112.417 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -62.2 -45.85 91.54 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.467 -0.771 . . . . 0.0 112.156 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -65.1 -50.85 64.47 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.417 ' HE2' ' HD2' ' A' ' 298' ' ' PRO . 10.4 mmmm -138.24 146.64 52.46 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.417 ' HD2' ' HE2' ' A' ' 297' ' ' LYS . 36.7 Cg_endo -61.64 124.18 14.13 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.307 2.671 . . . . 0.0 109.985 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 29.1 mt -102.82 -13.64 16.91 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 67.89 -146.93 47.36 Favored Glycine 0 C--O 1.241 0.544 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.71 178.34 2.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 122.759 1.266 . . . . 0.0 110.08 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.3 m -131.69 152.17 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 O-C-N 120.934 -1.104 . . . . 0.0 109.087 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.12 -29.46 60.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.73 108.56 3.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.831 1.252 . . . . 0.0 108.883 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -55.47 -21.89 18.32 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.7 m -68.15 -49.59 60.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.538 1.063 . . . . 0.0 113.409 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -89.11 -9.31 51.57 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.886 0.874 . . . . 0.0 110.792 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.64 -47.22 80.22 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -60.6 -31.95 71.09 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.112 1.365 . . . . 0.0 113.914 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -81.0 -44.22 18.42 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.922 0.889 . . . . 0.0 109.612 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 20.9 mt -66.36 -33.6 76.09 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.59 -9.07 7.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.655 1.582 . . . . 0.0 112.794 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -63.92 -28.23 69.69 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.212 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -98.41 136.51 20.84 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.71 -21.82 71.0 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 123.695 2.93 . . . . 0.0 117.125 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -71.43 -30.02 65.56 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.507 1.048 . . . . 0.0 110.438 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.9 mp -79.07 -56.42 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -44.02 -60.76 1.71 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.113 1.365 . . . . 0.0 113.751 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.75 -44.38 90.53 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.947 0.794 . . . . 0.0 112.898 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 16.9 m -59.41 -35.55 74.2 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -44.38 52.67 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 121.611 -0.681 . . . . 0.0 109.274 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.94 -30.03 67.57 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.513 -0.742 . . . . 0.0 109.789 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -75.83 -31.33 59.32 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.46 -0.775 . . . . 0.0 109.529 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -74.63 -35.33 62.89 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 119.167 0.894 . . . . 0.0 109.643 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -65.06 -18.63 65.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.293 1.437 . . . . 0.0 112.146 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.49 0.61 9.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.572 1.549 . . . . 0.0 112.073 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -109.39 -167.0 20.3 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 127.165 2.317 . . . . 0.0 107.991 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -157.12 161.67 39.4 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 58.7 mt -107.12 123.46 62.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 127.777 2.431 . . . . 0.0 108.086 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 46.6 ttm 17.13 90.53 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 129.655 3.182 . . . . 0.0 114.323 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.79 -71.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.59 2.86 . . . . 0.0 113.307 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 92.68 14.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 130.472 3.509 . . . . 0.0 110.819 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.8 pt -57.42 143.83 73.16 Favored Pre-proline 0 CA--C 1.538 0.505 0 O-C-N 121.487 -0.758 . . . . 0.0 109.081 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.37 -21.13 47.74 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.487 1.458 . . . . 0.0 112.996 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -63.71 -22.23 66.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.299 1.04 . . . . 0.0 110.256 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 8.0 mtt -61.4 -29.38 69.89 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.225 0.92 . . . . 0.0 110.589 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 37.1 t -56.07 -43.0 77.53 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 118.53 0.605 . . . . 0.0 109.653 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.56 -41.27 47.05 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.17 0.588 . . . . 0.0 109.79 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -48.47 -46.65 38.32 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.472 1.109 . . . . 0.0 111.871 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -66.42 -54.0 29.21 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.004 -0.435 . . . . 0.0 110.918 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -60.33 -29.94 69.2 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.94 0.791 . . . . 0.0 112.406 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.98 -60.48 2.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.272 1.029 . . . . 0.0 111.073 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 22.5 t -69.2 -34.93 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 117.44 -1.266 . . . . 0.0 112.439 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.37 -28.98 60.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.485 1.493 . . . . 0.0 110.321 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 61.1 m -81.32 -51.69 8.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.389 1.076 . . . . 0.0 108.2 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -49.77 -45.91 50.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.533 1.06 . . . . 0.0 113.513 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 38.7 t -57.3 -52.66 53.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.061 0.944 . . . . 0.0 109.685 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.49 -38.58 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.212 0.605 . . . . 0.0 109.842 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -59.7 -48.67 80.75 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 118.825 0.738 . . . . 0.0 109.842 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.66 75.22 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.149 0.579 . . . . 0.0 110.775 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.95 80.94 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 10.9 m -89.34 -8.98 52.13 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.914 0.885 . . . . 0.0 110.812 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 73.34 15.28 78.95 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.154 -0.804 . . . . 0.0 112.547 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -64.52 -31.62 72.91 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.906 1.353 . . . . 0.0 109.233 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -148.31 156.12 42.14 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 14.2 t -73.2 162.61 29.21 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 54.1 t -52.45 -51.04 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 126.153 1.781 . . . . 0.0 109.536 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.14 -46.83 75.67 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.177 1.791 . . . . 0.0 112.711 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -75.61 -39.65 57.59 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.873 0.869 . . . . 0.0 111.744 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.42 -44.04 84.3 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.79 -43.51 83.76 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.854 0.862 . . . . 0.0 110.287 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -55.98 -59.28 5.12 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.58 -44.3 26.23 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.883 1.673 . . . . 0.0 110.914 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.45 -44.81 70.51 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.757 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -58.28 -37.07 74.27 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.028 1.285 . . . . 0.0 109.208 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 2.3 m -57.17 -40.63 77.69 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 123.429 0.692 . . . . 0.0 111.285 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -65.46 -18.37 65.27 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.53 -1.356 . . . . 0.0 114.136 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.2 mp -95.23 -41.77 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 20.6 p -71.91 -16.08 62.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.396 0.544 . . . . 0.0 111.831 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 39.4 tptt . . . . . 0 C--O 1.25 1.131 0 C-N-CA 127.032 2.133 . . . . 0.0 105.867 178.851 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.8 tptm . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 mt -58.41 135.96 22.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 O-C-N 125.596 1.81 . . . . 0.0 108.521 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -71.9 105.48 3.85 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 104.843 -2.281 . . . . 0.0 104.843 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -99.52 136.32 39.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.76 1.624 . . . . 0.0 109.216 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.1 25.1 17.79 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.874 0.75 . . . . 0.0 112.819 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.34 165.81 29.05 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.468 1.107 . . . . 0.0 109.482 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.6 mt -138.55 151.39 47.28 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.8 t -143.12 144.37 23.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.2 mt -134.56 144.64 34.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 123.835 0.854 . . . . 0.0 109.231 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -134.84 132.85 39.1 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.309 1.444 . . . . 0.0 107.903 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -105.77 169.6 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -83.3 -39.56 20.65 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.0 -79.98 0.09 OUTLIER Glycine 0 C--N 1.339 0.71 0 CA-C-N 119.14 0.882 . . . . 0.0 112.271 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.99 -3.12 9.02 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -61.21 157.35 16.38 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 120.789 -1.194 . . . . 0.0 109.416 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.48 69.11 0.76 Allowed Glycine 0 CA--C 1.518 0.258 0 O-C-N 121.78 -0.575 . . . . 0.0 112.038 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -54.2 -19.97 6.07 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.904 1.681 . . . . 0.0 113.623 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -62.97 -58.17 8.25 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.456 1.48 . . . . 0.0 108.238 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.63 -36.76 79.94 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 123.382 0.515 . . . . 0.0 111.915 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.9 -32.06 73.35 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.923 -0.751 . . . . 0.0 110.578 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.01 -43.36 81.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.576 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -58.16 -41.93 84.89 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.647 0.779 . . . . 0.0 110.672 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.65 -50.86 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.53 -45.38 95.97 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 121.421 -0.799 . . . . 0.0 113.247 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -34.0 75.05 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.213 1.007 . . . . 0.0 110.831 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -66.13 -54.8 21.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -56.0 -42.43 76.4 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.332 0.969 . . . . 0.0 110.854 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.86 -27.41 69.15 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.214 -0.929 . . . . 0.0 110.085 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HZ1' ' HA ' ' A' ' 29' ' ' LYS . 1.3 tppm? -84.66 -18.93 33.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.769 -1.207 . . . . 0.0 112.703 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -102.79 -16.25 16.01 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 124.219 0.949 . . . . 0.0 111.162 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.5 p -124.86 -31.95 3.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.23 61.36 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.232 -0.917 . . . . 0.0 112.903 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.4 129.83 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -66.04 148.55 51.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 123.835 0.854 . . . . 0.0 109.253 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 t -139.53 156.18 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.2 m -144.22 141.65 30.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.3 t -130.56 122.94 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -137.81 163.63 30.92 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.764 0.826 . . . . 0.0 110.469 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -121.66 57.9 8.05 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.782 1.233 . . . . 0.0 112.679 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.11 165.1 31.86 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.299 1.333 . . . . 0.0 111.658 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.86 -30.0 6.88 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -16.75 62.48 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.696 1.599 . . . . 0.0 114.063 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -46.27 -34.2 4.28 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.733 1.213 . . . . 0.0 114.213 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -57.61 -24.03 54.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.117 0.967 . . . . 0.0 113.451 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -128.2 -8.21 5.34 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.716 0.806 . . . . 0.0 112.1 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -84.47 -47.35 10.71 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.242 1.417 . . . . 0.0 107.369 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -46.18 -52.32 28.4 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 119.233 0.924 . . . . 0.0 112.656 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.81 -17.6 59.97 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.626 1.551 . . . . 0.0 114.386 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -85.45 -4.24 59.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.3 1.04 . . . . 0.0 111.896 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.7 -39.57 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.752 0.821 . . . . 0.0 110.214 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.49 73.0 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.85 -0.531 . . . . 0.0 110.345 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.12 10.15 1.03 Allowed 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.041 -1.037 . . . . 0.0 112.0 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.7 m -131.88 -0.99 3.78 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.779 1.172 . . . . 0.0 113.64 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.52 56.18 2.86 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -166.23 -176.93 3.88 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 128.824 2.85 . . . . 0.0 105.796 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.27 179.12 31.4 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.168 1.366 . . . . 0.0 114.196 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.07 167.18 16.66 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.456 2.104 . . . . 0.0 110.068 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.14 -21.72 18.32 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.0 mt -138.28 143.94 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 tt -130.51 135.91 59.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.317 1.847 . . . . 0.0 106.197 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.17 109.5 11.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.841 1.256 . . . . 0.0 110.117 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -154.94 169.38 24.18 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.46 152.6 37.92 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.809 0.814 . . . . 0.0 110.013 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -55.15 -30.02 58.96 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.801 1.24 . . . . 0.0 111.537 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.34 -12.54 9.47 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.196 1.798 . . . . 0.0 115.733 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -123.3 2.36 9.13 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.787 1.176 . . . . 0.0 109.909 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -85.24 -5.96 59.29 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.304 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.3 -17.22 79.65 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.889 1.222 . . . . 0.0 111.185 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.65 -66.69 1.1 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-O 118.513 -1.159 . . . . 0.0 113.266 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -44.19 -46.92 9.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.201 1.0 . . . . 0.0 113.22 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.58 -55.15 36.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.786 0.835 . . . . 0.0 110.081 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.36 -49.57 61.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.57 1.148 . . . . 0.0 109.314 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.4 m -58.63 -7.17 0.88 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.48 1.912 . . . . 0.0 112.953 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.77 17.59 72.43 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 125.712 1.625 . . . . 0.0 112.805 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.2 mt -85.86 -15.92 40.29 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.245 1.023 . . . . 0.0 113.507 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.9 mt -105.48 136.01 45.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.88 1.218 . . . . 0.0 111.65 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.51 164.37 25.96 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.62 1.168 . . . . 0.0 111.959 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.09 105.9 5.52 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.3 mm -67.42 152.46 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.39 1.076 . . . . 0.0 112.087 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.2 m 78.09 88.84 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 129.68 3.192 . . . . 0.0 110.058 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -72.44 -28.88 14.26 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.206 1.937 . . . . 0.0 110.755 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -141.58 147.0 36.96 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.221 1.408 . . . . 0.0 109.411 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -54.95 -34.25 63.1 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.805 1.642 . . . . 0.0 112.96 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.46 -35.04 60.08 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.119 0.968 . . . . 0.0 113.037 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -63.51 -28.05 69.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.434 0.561 . . . . 0.0 111.418 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -67.27 -33.08 74.56 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 120.972 -1.08 . . . . 0.0 111.534 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.0 -18.49 55.85 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.207 0.603 . . . . 0.0 111.481 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -74.72 -17.9 60.59 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.7 mt -123.03 155.76 36.21 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.398 0.679 . . . . 0.0 111.671 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -68.94 151.28 97.33 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 122.853 0.461 . . . . 0.0 111.175 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.5 -46.03 2.17 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.433 2.089 . . . . 0.0 112.509 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -54.77 -45.79 74.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.184 0.902 . . . . 0.0 111.68 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.59 -20.64 57.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.019 1.328 . . . . 0.0 112.607 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -72.62 -28.7 62.92 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.904 1.229 . . . . 0.0 109.903 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.92 -34.79 72.12 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.872 1.215 . . . . 0.0 110.902 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.74 -17.34 55.47 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.045 1.338 . . . . 0.0 114.475 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.8 m -127.49 4.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.014 1.326 . . . . 0.0 111.6 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -66.26 157.47 31.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.333 1.064 . . . . 0.0 108.871 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -150.43 -177.33 5.9 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -68.86 108.2 3.37 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.609 1.164 . . . . 0.0 111.969 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.57 -53.65 0.48 Allowed Glycine 0 N--CA 1.47 0.901 0 C-N-CA 128.273 2.844 . . . . 0.0 117.337 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 163.38 12.31 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.198 1.399 . . . . 0.0 107.986 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -97.15 159.55 14.85 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 pt -121.32 -25.25 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.755 -1.111 . . . . 0.0 113.287 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.43 176.96 11.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.275 1.03 . . . . 0.0 108.318 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.53 145.8 58.78 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 124.558 1.143 . . . . 0.0 108.917 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.76 150.98 51.05 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.467 2.111 . . . . 0.0 109.354 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.2 mm -127.82 -53.71 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.131 1.772 . . . . 0.0 110.56 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -124.78 147.24 48.8 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.587 0.755 . . . . 0.0 112.462 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.4 t -122.47 104.17 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.465 1.506 . . . . 0.0 107.464 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -119.67 172.43 7.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.51 -177.23 4.57 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -55.69 154.35 6.94 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.594 1.558 . . . . 0.0 112.104 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.4 m -138.15 174.44 10.56 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.634 0.774 . . . . 0.0 109.868 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.56 ' CD1' ' H ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -127.82 168.55 15.0 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.56 ' H ' ' CD1' ' A' ' 115' ' ' LEU . 4.2 mp -134.24 122.05 39.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -131.29 170.99 13.85 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.713 1.205 . . . . 0.0 109.893 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -61.43 132.31 53.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.69 1.196 . . . . 0.0 109.52 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -59.17 -2.97 0.32 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 116.231 1.938 . . . . 0.0 116.231 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -63.18 156.39 25.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 119.732 1.151 . . . . 0.0 109.875 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -73.02 -2.23 20.35 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.4 tp -145.96 70.54 13.46 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 118.874 0.761 . . . . 0.0 109.735 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -82.84 -3.82 11.24 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 124.323 3.349 . . . . 0.0 116.728 -178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 56.4 t30 32.48 80.46 0.25 Allowed Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 127.181 2.193 . . . . 0.0 114.465 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -64.31 156.59 59.02 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.065 1.843 . . . . 0.0 112.614 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.17 172.53 15.82 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.751 2.967 . . . . 0.0 109.905 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -118.8 -12.78 9.59 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.258 1.023 . . . . 0.0 112.426 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.3 t -167.11 162.72 15.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.777 1.231 . . . . 0.0 108.413 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -65.62 -24.86 67.15 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.537 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.5 -15.47 63.69 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.211 1.369 . . . . 0.0 112.926 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.51 -21.41 28.63 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.409 0.683 . . . . 0.0 110.08 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.73 -58.38 19.85 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-O 117.235 -1.364 . . . . 0.0 109.237 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.2 -26.98 49.05 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 CA-C-N 121.45 1.554 . . . . 0.0 111.751 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.92 67.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.728 0.811 . . . . 0.0 110.032 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 64.2 tp -75.81 -26.42 57.23 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.093 1.357 . . . . 0.0 110.999 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.89 -42.32 99.73 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.496 0.718 . . . . 0.0 110.126 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.423 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 7.2 ptmm? -72.4 -32.53 66.45 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.248 -0.908 . . . . 0.0 111.126 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -69.28 -44.79 71.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.666 0.387 . . . . 0.0 110.675 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.7 -30.54 36.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.147 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.21 -33.17 71.36 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 120.182 1.356 . . . . 0.0 109.095 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.99 -7.69 42.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.85 0.07 2.88 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.66 0.784 . . . . 0.0 111.895 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -162.84 -107.0 0.21 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.399 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -141.69 -173.33 3.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.323 1.449 . . . . 0.0 109.581 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.9 p -62.55 152.5 34.66 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.155 0.889 . . . . 0.0 113.024 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.44 -49.57 13.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.345 1.458 . . . . 0.0 114.228 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.9 tp -134.66 143.37 47.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.125 0.97 . . . . 0.0 110.887 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -137.06 138.21 40.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.255 1.422 . . . . 0.0 107.606 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -151.29 166.49 30.79 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.925 1.239 . . . . 0.0 111.941 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -70.17 91.13 0.69 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.405 1.882 . . . . 0.0 106.629 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.2 tt -87.47 -35.6 18.14 Favored 'General case' 0 CA--C 1.524 -0.052 0 C-N-CA 125.715 1.606 . . . . 0.0 112.566 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -64.2 -12.45 40.66 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -103.78 122.48 44.47 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 118.689 0.677 . . . . 0.0 109.992 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.86 -16.48 49.58 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 120.723 0.949 . . . . 0.0 110.639 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -47.66 -44.44 27.21 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 127.54 2.336 . . . . 0.0 111.671 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -98.84 -33.41 10.9 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 p -69.82 -27.35 64.8 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.352 1.433 . . . . 0.0 110.338 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -53.6 -60.61 6.69 Favored Pre-proline 0 C--N 1.343 0.308 0 C-N-CA 124.875 1.27 . . . . 0.0 113.392 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -57.28 -15.92 20.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.913 1.742 . . . . 0.0 114.537 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 8.6 tt -75.44 -66.57 0.75 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.2 pt -56.69 -34.62 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.217 1.007 . . . . 0.0 112.845 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.03 -26.23 64.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.028 -1.045 . . . . 0.0 112.86 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.43 86.88 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.498 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.07 -42.65 73.05 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.412 0.685 . . . . 0.0 111.439 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.83 -13.96 0.09 OUTLIER Glycine 0 CA--C 1.526 0.753 0 CA-C-O 117.959 -1.467 . . . . 0.0 113.025 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -49.4 133.12 25.57 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -138.02 144.97 41.3 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 119.719 1.76 . . . . 0.0 111.509 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.79 -59.49 2.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -141.65 171.42 14.08 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.901 2.08 . . . . 0.0 106.658 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -119.85 139.83 51.76 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 119.528 1.058 . . . . 0.0 112.643 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.17 105.73 12.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.698 1.199 . . . . 0.0 108.448 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -173.13 1.13 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.306 2.242 . . . . 0.0 109.098 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -51.31 -20.71 1.79 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.13 2.172 . . . . 0.0 115.012 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.94 3.09 0.04 OUTLIER Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.112 0.863 . . . . 0.0 113.693 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.44 151.55 48.68 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 119.531 1.666 . . . . 0.0 107.314 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -122.13 126.04 47.48 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 125.534 1.534 . . . . 0.0 108.203 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.79 150.81 52.12 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 122.512 1.149 . . . . 0.0 113.566 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.09 1.58 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.843 -1.98 . . . . 0.0 110.133 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -75.97 -35.7 59.55 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.2 97.16 10.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.82 121.09 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.44 1.896 . . . . 0.0 106.827 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -122.83 38.69 2.45 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 123.924 0.773 . . . . 0.0 114.862 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.72 -25.03 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.117 0.967 . . . . 0.0 111.17 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.84 17.22 19.98 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -66.19 164.2 16.2 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 121.596 -0.69 . . . . 0.0 110.995 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.9 65.27 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.9 -36.8 93.76 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.898 0.772 . . . . 0.0 111.651 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.58 -50.55 64.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.791 0.796 . . . . 0.0 109.24 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -63.82 -32.2 73.63 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 117.869 -1.063 . . . . 0.0 111.616 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.54 -51.25 70.66 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.244 0.929 . . . . 0.0 110.217 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.14 -28.95 69.36 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 29.9 tp -69.74 -55.96 8.49 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.605 1.203 . . . . 0.0 110.785 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.43 -26.47 53.69 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.6 0.76 . . . . 0.0 112.152 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -56.66 -42.1 78.38 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.126 -0.984 . . . . 0.0 108.953 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 19.6 tp -69.25 -48.95 60.4 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.835 1.254 . . . . 0.0 108.456 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 47.4 t -54.48 -34.05 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.517 1.527 . . . . 0.0 109.78 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.18 -42.56 88.75 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.553 1.541 . . . . 0.0 110.778 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.62 -40.25 84.67 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.245 -0.909 . . . . 0.0 108.564 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 89.4 mt -66.85 -36.93 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -60.33 -36.89 79.0 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.992 -1.693 . . . . 0.0 108.473 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -82.3 -2.11 51.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.288 1.435 . . . . 0.0 111.272 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? 56.46 9.56 0.56 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.707 2.403 . . . . 0.0 114.394 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -82.46 -14.68 54.66 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ttp -112.17 147.97 35.03 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.46 1.104 . . . . 0.0 110.074 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -85.58 103.57 14.53 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.897 1.279 . . . . 0.0 107.919 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -77.51 -21.62 52.45 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -91.67 0.12 57.52 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.5 m -60.88 131.48 50.82 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.526 1.13 . . . . 0.0 110.315 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.54 -173.51 2.75 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.785 1.234 . . . . 0.0 108.048 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -56.53 -45.81 80.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.074 0.949 . . . . 0.0 109.725 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.86 -49.68 75.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.948 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 46.3 mm -59.0 -48.75 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.621 1.101 . . . . 0.0 110.356 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.09 87.08 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -74.59 -57.42 3.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -50.81 -55.89 14.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.754 1.621 . . . . 0.0 112.241 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.42 76.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.139 0.881 . . . . 0.0 110.734 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.5 -38.8 90.79 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -63.1 -35.69 81.11 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.89 0.876 . . . . 0.0 109.708 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -72.78 -22.79 60.78 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.01 18.61 21.82 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 126.143 1.83 . . . . 0.0 112.68 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.88 -71.74 0.31 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.233 1.016 . . . . 0.0 113.648 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . 0.28 4.2 t -68.55 152.81 44.86 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.27 0.557 . . . . 0.0 112.365 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.83 31.42 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.612 0.765 . . . . 0.0 112.454 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -152.85 155.66 37.51 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.506 1.123 . . . . 0.0 108.234 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.5 t -147.78 159.05 44.24 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.85 122.61 54.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 119.408 1.004 . . . . 0.0 110.236 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -130.36 133.92 46.78 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.936 1.694 . . . . 0.0 109.761 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -92.85 -75.3 1.3 Allowed Glycine 0 CA--C 1.534 1.262 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.52 86.92 1.56 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.762 2.975 . . . . 0.0 110.635 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -53.54 94.91 0.01 OUTLIER 'General case' 0 C--O 1.238 0.487 0 C-N-CA 127.249 2.22 . . . . 0.0 111.38 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.49 172.26 13.27 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.43 1.492 . . . . 0.0 112.505 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -68.26 -176.42 0.74 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.487 1.915 . . . . 0.0 109.113 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 38.5 t -144.39 173.6 11.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -94.88 8.6 42.2 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.323 1.049 . . . . 0.0 110.348 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.4 tp -152.95 123.73 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 127.787 2.435 . . . . 0.0 105.517 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.48 85.98 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.609 1.163 . . . . 0.0 108.783 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 10.8 m -96.33 95.53 8.14 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 14.6 m -91.43 -3.88 56.19 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.145 0.578 . . . . 0.0 111.615 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -84.4 77.35 10.02 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.241 -1.537 . . . . 0.0 112.493 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.34 166.04 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -70.4 176.84 3.71 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.704 0.802 . . . . 0.0 109.949 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -117.01 99.92 7.4 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.774 0.829 . . . . 0.0 112.338 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 86.74 164.18 39.56 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 125.09 1.329 . . . . 0.0 114.24 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 13.6 p -87.61 143.06 12.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.7 t -111.03 172.35 6.93 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.299 0.64 . . . . 0.0 109.434 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.5 t -71.63 143.1 14.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pp -122.07 154.19 61.35 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.56 1.144 . . . . 0.0 109.326 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.94 141.41 30.0 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.71 2.273 . . . . 0.0 111.559 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.1 p -149.48 -172.23 4.09 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 127.793 2.437 . . . . 0.0 107.512 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -87.5 144.95 26.46 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -55.73 119.77 6.27 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.984 0.914 . . . . 0.0 110.389 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.01 -4.9 44.11 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.055 0.836 . . . . 0.0 114.321 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.57 87.14 32.56 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.927 1.863 . . . . 0.0 109.543 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.48 152.7 60.45 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.721 1.614 . . . . 0.0 110.661 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 19.5 m -72.2 134.81 45.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.65 0.78 . . . . 0.0 109.913 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.492 ' HZ3' ' ND2' ' A' ' 323' ' ' ASN . 0.2 OUTLIER -140.39 87.18 12.04 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.528 1.531 . . . . 0.0 108.01 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.15 -90.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.628 2.218 . . . . 0.0 109.35 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -145.88 167.97 21.96 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.517 2.327 . . . . 0.0 106.046 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 46.0 t -94.68 155.94 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -154.74 139.67 6.88 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 106.555 -2.618 . . . . 0.0 106.555 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.0 164.37 33.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.169 0.509 . . . . 0.0 109.947 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.68 173.19 10.83 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.608 0.763 . . . . 0.0 109.726 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -148.39 141.3 24.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.722 -1.236 . . . . 0.0 110.135 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.29 132.46 47.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.7 152.18 19.79 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.218 -0.768 . . . . 0.0 111.362 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.1 mt -89.83 135.63 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -71.35 120.29 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.424 1.09 . . . . 0.0 109.14 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.24 -20.66 62.21 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -75.88 -4.14 39.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.059 1.744 . . . . 0.0 114.924 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 33.1 m -71.7 167.49 30.4 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 124.894 1.278 . . . . 0.0 110.672 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -80.75 -43.45 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.196 1.264 . . . . 0.0 110.605 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -139.23 106.84 5.59 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.032 0.933 . . . . 0.0 109.379 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -19.79 63.11 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.115 0.966 . . . . 0.0 112.045 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.11 -40.57 81.57 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 68.3 mt -57.62 -36.58 71.98 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.722 -0.612 . . . . 0.0 111.492 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.81 -45.45 28.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.976 0.511 . . . . 0.0 112.024 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -32.72 74.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.2 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -70.34 -56.45 6.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -52.52 -46.14 66.59 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.238 -0.914 . . . . 0.0 111.255 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 4.1 tt -66.81 -42.54 85.75 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.517 -1.23 . . . . 0.0 113.063 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.3 -15.74 39.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.51 1.504 . . . . 0.0 114.713 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -109.55 -17.58 13.71 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -131.29 -51.5 1.02 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 118.993 0.815 . . . . 0.0 111.471 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.86 -55.7 20.89 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.338 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 55.3 mt -88.34 77.26 8.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.74 0.816 . . . . 0.0 109.91 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 39.8 p -140.8 159.43 42.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.23 -38.04 89.15 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -81.87 -29.25 32.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.009 0.524 . . . . 0.0 112.227 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.04 -43.84 20.55 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.97 -39.83 90.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.31 -46.57 85.9 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -53.52 -46.78 70.25 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.736 0.698 . . . . 0.0 111.214 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.66 -37.79 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.19 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -72.01 -22.45 61.41 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.774 1.629 . . . . 0.0 113.584 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -69.29 -44.97 70.72 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.626 0.771 . . . . 0.0 109.01 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -71.76 -48.31 47.68 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -135.08 152.92 77.98 Favored Pre-proline 0 N--CA 1.461 0.082 0 C-N-CA 123.992 0.917 . . . . 0.0 109.909 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.9 125.57 10.01 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.086 1.857 . . . . 0.0 110.937 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 86.7 mt -99.89 -24.23 14.71 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.535 -0.745 . . . . 0.0 112.335 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 81.26 -155.02 35.66 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.22 168.93 14.72 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 12.7 m -121.68 162.2 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 O-C-N 120.641 -1.287 . . . . 0.0 110.991 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.33 -13.59 49.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.286 0.634 . . . . 0.0 110.434 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.31 112.5 12.86 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 127.239 2.216 . . . . 0.0 107.703 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -62.89 -36.51 83.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.071 0.462 . . . . 0.0 110.32 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -52.15 64.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.434 1.894 . . . . 0.0 111.172 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -84.84 -11.8 54.9 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.815 0.846 . . . . 0.0 112.224 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -60.49 -42.77 96.99 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -63.24 -9.89 13.38 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.43 1.492 . . . . 0.0 112.164 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -109.61 -36.8 5.86 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.051 0.94 . . . . 0.0 110.495 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 14.7 mt -74.27 -24.32 59.24 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.453 -1.405 . . . . 0.0 108.521 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.56 -8.05 17.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.495 1.118 . . . . 0.0 112.382 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -56.59 -37.76 71.07 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.03 133.31 24.32 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.39 -24.69 71.17 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.578 2.185 . . . . 0.0 113.332 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -62.57 -30.71 71.52 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.77 0.714 . . . . 0.0 109.851 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.9 mp -77.54 -61.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -44.13 -55.99 4.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.164 1.386 . . . . 0.0 114.342 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.18 -32.41 68.21 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.596 -0.69 . . . . 0.0 112.859 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 24.7 m -74.74 -36.54 62.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.687 0.795 . . . . 0.0 109.164 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.8 tpt -66.75 -43.15 84.92 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.219 1.007 . . . . 0.0 109.084 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -55.74 -41.01 73.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.595 0.758 . . . . 0.0 110.419 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.492 ' ND2' ' HZ3' ' A' ' 256' ' ' LYS . 1.3 t30 -63.28 -26.85 68.97 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.728 -0.608 . . . . 0.0 112.324 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -76.68 -40.19 49.68 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -61.73 -45.37 94.24 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.249 0.619 . . . . 0.0 111.023 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -15.59 58.22 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.59 -165.09 37.23 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -142.31 134.15 27.08 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 63.7 mt -81.82 88.24 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 10.9 mtp 59.07 165.19 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 126.461 1.904 . . . . 0.0 113.363 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -80.5 -26.18 4.13 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.141 1.894 . . . . 0.0 115.595 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 66.96 34.52 5.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.687 1.995 . . . . 0.0 112.002 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.2 pt -132.33 156.48 80.04 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 123.845 0.858 . . . . 0.0 110.937 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.46 -25.99 24.74 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.002 2.468 . . . . 0.0 113.666 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -57.66 -16.91 12.11 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.227 0.921 . . . . 0.0 113.343 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -22.83 65.69 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.16 -0.963 . . . . 0.0 111.411 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.4 t -65.62 -54.72 23.74 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.56 -34.97 78.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.499 1.12 . . . . 0.0 111.302 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -50.34 -56.81 9.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.805 0.842 . . . . 0.0 111.658 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -65.98 -40.9 91.64 Favored 'General case' 0 CA--C 1.522 -0.118 0 O-C-N 121.247 -0.908 . . . . 0.0 111.404 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.57 -45.77 84.77 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.155 0.503 . . . . 0.0 110.518 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.39 -51.68 64.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.647 1.179 . . . . 0.0 111.581 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.84 -27.46 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.707 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -53.99 -50.1 67.35 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.352 1.433 . . . . 0.0 107.596 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.5 m -68.51 -44.43 74.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.051 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.86 -47.03 68.09 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.948 1.249 . . . . 0.0 113.768 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 24.2 t -56.08 -51.68 59.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 124.61 1.164 . . . . 0.0 109.113 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.03 -37.45 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -58.75 -46.06 88.29 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.177 -1.577 . . . . 0.0 110.947 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.35 -45.46 59.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.634 0.773 . . . . 0.0 110.48 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.14 -44.42 97.36 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.33 0.514 . . . . 0.0 111.623 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 59.8 m -75.04 -25.91 59.05 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.899 0.879 . . . . 0.0 109.313 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.86 32.77 44.01 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -85.14 -21.29 29.3 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.846 0.858 . . . . 0.0 110.62 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -147.42 151.42 36.43 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.6 m -58.65 152.21 19.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.991 0.916 . . . . 0.0 109.293 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 61.8 t -57.2 -44.77 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 118.988 0.813 . . . . 0.0 109.414 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -52.18 66.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.469 1.108 . . . . 0.0 110.009 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -63.87 -37.71 88.41 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.262 0.625 . . . . 0.0 111.838 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.93 92.48 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 38.2 mt -73.15 -38.85 66.1 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.597 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -57.88 -53.46 57.99 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 119.681 1.128 . . . . 0.0 109.807 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -29.93 70.76 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -70.99 -55.34 8.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 118.114 -0.946 . . . . 0.0 108.895 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -49.66 -38.57 33.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.178 1.391 . . . . 0.0 110.069 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 26.4 m -57.93 -45.64 86.27 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.008 0.523 . . . . 0.0 110.452 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -61.67 -8.63 4.81 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.147 2.179 . . . . 0.0 114.027 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 2.3 mp -104.17 -40.11 6.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.1 p -68.76 -25.43 64.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.402 0.547 . . . . 0.0 110.801 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? . . . . . 0 C--O 1.245 0.85 0 C-N-CA 127.135 2.174 . . . . 0.0 108.36 -179.089 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.2 mt -148.09 148.81 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 103.705 -2.702 . . . . 0.0 103.705 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -98.97 100.79 12.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -71.92 69.49 0.71 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.718 1.207 . . . . 0.0 113.786 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.57 30.95 0.02 OUTLIER Glycine 0 CA--C 1.526 0.731 0 O-C-N 121.352 -0.843 . . . . 0.0 114.017 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -143.5 172.06 13.3 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.253 1.027 . . . . 0.0 110.259 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.6 mt -150.81 140.13 21.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 127.682 2.393 . . . . 0.0 106.506 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.8 t -137.06 148.05 26.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.43 142.4 43.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.606 1.562 . . . . 0.0 109.119 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -137.76 134.08 34.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.8 147.68 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -60.31 -35.57 75.89 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.27 168.72 11.45 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t0 48.66 30.25 2.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.107 1.363 . . . . 0.0 110.961 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.38 -14.58 16.21 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -177.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.66 30.57 4.56 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.909 1.719 . . . . 0.0 112.972 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -45.82 -46.21 15.39 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.66 1.184 . . . . 0.0 113.723 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -58.19 -41.37 83.79 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.445 1.02 . . . . 0.0 112.874 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.57 -42.18 41.25 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.8 tp -58.42 -39.21 79.16 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.928 1.291 . . . . 0.0 110.238 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.78 -46.7 64.25 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.729 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.36 -39.5 79.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.269 1.028 . . . . 0.0 111.573 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 t -59.95 -42.78 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.72 -39.57 96.77 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -62.47 -46.87 86.51 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 119.651 1.725 . . . . 0.0 109.012 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -59.65 -56.19 24.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -55.55 -47.07 76.96 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.628 0.649 . . . . 0.0 112.017 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.24 -28.85 69.99 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 121.103 -0.998 . . . . 0.0 110.794 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.64 -23.0 37.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.904 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -100.3 -11.05 20.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.409 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.3 p -127.34 -32.39 2.46 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.478 1.035 . . . . 0.0 113.693 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.2 -14.73 62.86 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 119.393 0.997 . . . . 0.0 112.818 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.6 mm -69.24 122.81 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.26 145.49 47.24 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 123.345 0.658 . . . . 0.0 110.13 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.8 t -133.0 136.38 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -128.96 138.54 52.03 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.8 t -133.94 128.55 53.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.7 1.2 . . . . 0.0 107.931 -179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -140.55 160.09 40.78 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.14 1.776 . . . . 0.0 107.184 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -122.26 59.03 10.89 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.094 0.958 . . . . 0.0 111.708 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.84 136.41 20.73 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.906 2.404 . . . . 0.0 109.32 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.31 -33.41 63.19 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.561 0.948 . . . . 0.0 113.561 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -99.27 24.23 8.24 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -178.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 pp -49.2 -29.3 5.41 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.266 -0.896 . . . . 0.0 112.287 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -57.69 -24.98 59.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.359 1.864 . . . . 0.0 114.518 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -110.05 -19.29 13.12 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.555 0.693 . . . . 0.0 111.023 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -81.08 -50.29 9.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.357 -0.84 . . . . 0.0 108.874 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -44.12 -55.98 8.58 Favored Pre-proline 0 CA--C 1.529 0.146 0 CA-C-O 117.334 -1.317 . . . . 0.0 111.937 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.98 -28.51 86.4 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 120.813 1.326 . . . . 0.0 115.402 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -83.05 -32.87 26.62 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.401 1.455 . . . . 0.0 112.154 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 t -87.37 -40.52 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.221 0.464 . . . . 0.0 110.258 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.26 -32.28 73.87 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 120.483 -1.385 . . . . 0.0 110.034 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.2 -20.03 38.2 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.107 1.363 . . . . 0.0 112.585 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.1 p -113.37 2.91 15.64 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.993 0.917 . . . . 0.0 112.897 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.49 12.54 83.64 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.071 0.851 . . . . 0.0 111.287 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -103.97 -10.27 18.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.544 1.138 . . . . 0.0 111.468 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.92 174.27 55.29 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.017 1.294 . . . . 0.0 115.333 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.71 172.0 7.59 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.41 3.406 . . . . 0.0 113.389 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -101.43 -20.19 15.25 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.39 127.12 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.707 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 tp -107.67 144.72 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 127.202 2.201 . . . . 0.0 106.846 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -131.97 107.74 8.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.744 1.218 . . . . 0.0 110.637 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -157.24 -175.82 5.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.065 0.946 . . . . 0.0 110.076 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.4 151.0 33.02 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -52.3 -33.41 42.18 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.553 1.541 . . . . 0.0 113.409 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.42 -18.08 48.53 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -103.31 -7.61 20.96 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.163 -1.585 . . . . 0.0 110.514 178.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.433 ' C ' ' H ' ' A' ' 69' ' ' GLY . 7.1 m-30 -91.32 -28.69 17.58 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.755 -0.59 . . . . 0.0 112.388 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.04 14.08 1.26 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.905 1.241 . . . . 0.0 113.725 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 67' ' ' PHE . . . -119.87 -59.9 0.25 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 129.394 3.378 . . . . 0.0 105.853 178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -50.11 -51.75 40.52 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.024 0.93 . . . . 0.0 110.665 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.66 95.81 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.14 0.495 . . . . 0.0 111.135 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.24 -13.34 58.09 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.857 0.863 . . . . 0.0 112.44 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.4 m -106.52 -6.32 18.18 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.745 2.418 . . . . 0.0 112.473 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.42 16.49 39.97 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.1 mt -96.18 -15.01 22.32 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 73.5 mt -106.53 139.77 40.48 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.832 1.651 . . . . 0.0 110.755 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.56 -178.36 7.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -69.34 106.74 3.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.418 2.287 . . . . 0.0 106.373 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.6 mm -80.4 148.7 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 t 38.96 80.37 0.28 Allowed Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 129.026 2.931 . . . . 0.0 111.499 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.82 -24.9 68.02 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 121.635 1.557 . . . . 0.0 111.848 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -123.62 142.59 50.9 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.267 1.427 . . . . 0.0 109.138 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -61.44 -27.51 68.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.205 2.202 . . . . 0.0 109.98 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.69 63.25 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.202 0.91 . . . . 0.0 112.905 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -76.62 -31.09 57.2 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.314 0.961 . . . . 0.0 108.925 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -67.05 -39.5 86.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.205 -0.935 . . . . 0.0 109.816 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -57.3 -28.4 63.0 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.502 1.121 . . . . 0.0 112.077 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -75.06 -18.24 60.34 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.4 mt -117.17 162.05 18.47 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.131 0.878 . . . . 0.0 110.782 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -75.0 148.65 84.69 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.783 0.833 . . . . 0.0 109.972 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.52 -42.51 3.58 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.596 2.198 . . . . 0.0 113.342 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -60.57 -40.01 90.12 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.55 0.614 . . . . 0.0 109.991 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.02 -28.34 70.03 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.73 -1.231 . . . . 0.0 109.98 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -71.84 -33.3 68.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.214 0.915 . . . . 0.0 109.951 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.11 -38.73 73.84 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.262 0.937 . . . . 0.0 110.42 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.94 -7.47 3.85 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.79 8.21 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.222 1.409 . . . . 0.0 112.167 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -63.75 162.67 12.94 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.502 1.144 . . . . 0.0 111.182 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -145.71 -174.91 4.54 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.759 1.624 . . . . 0.0 108.408 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.68 105.15 0.61 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.304 1.442 . . . . 0.0 107.84 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.05 -78.06 0.29 Allowed Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.795 1.188 . . . . 0.0 113.637 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -178.86 7.21 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.614 1.566 . . . . 0.0 110.57 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.51 169.35 8.71 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.842 0.83 . . . . 0.0 111.403 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.5 pt -130.07 -22.41 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.082 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.71 167.86 29.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.877 0.871 . . . . 0.0 109.051 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.94 150.35 62.39 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.583 1.153 . . . . 0.0 109.383 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -72.74 144.45 39.33 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.764 2.309 . . . . 0.0 109.371 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -126.26 -46.82 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.877 0.871 . . . . 0.0 111.608 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.8 144.9 49.29 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.25 119.03 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -125.93 177.21 6.46 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.096 0.958 . . . . 0.0 111.265 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.0 -172.79 3.14 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.267 1.427 . . . . 0.0 109.065 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.03 172.76 12.56 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 127.844 2.458 . . . . 0.0 108.714 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.0 m -142.37 174.77 10.32 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.094 1.357 . . . . 0.0 110.975 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.3 tp -71.37 152.13 43.45 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 68.9 mt -107.49 107.44 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -131.48 164.7 25.19 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.62 1.568 . . . . 0.0 109.59 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -53.34 151.37 5.47 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.838 1.255 . . . . 0.0 111.841 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.16 -4.2 3.39 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -75.69 156.78 34.4 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 pp -73.89 -2.08 22.3 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.755 1.622 . . . . 0.0 113.338 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.7 tp -33.65 105.06 0.25 Allowed Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 127.514 2.326 . . . . 0.0 112.742 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -70.93 176.2 7.98 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.549 2.166 . . . . 0.0 109.266 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 38.1 t30 60.31 73.81 0.6 Allowed Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.394 1.477 . . . . 0.0 110.907 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.63 160.67 31.38 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.645 2.23 . . . . 0.0 111.711 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.74 148.53 65.42 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.12 2.547 . . . . 0.0 110.921 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -136.41 -8.8 1.95 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 117.401 -1.285 . . . . 0.0 112.449 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.6 t -147.1 144.63 29.18 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 121.714 2.052 . . . . 0.0 112.287 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -61.48 -19.99 62.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.627 1.171 . . . . 0.0 112.974 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -74.74 -15.86 60.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.615 1.098 . . . . 0.0 112.642 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -92.51 -26.92 17.72 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.987 0.812 . . . . 0.0 110.474 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.5 mm -48.69 -56.77 13.29 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 125.382 1.473 . . . . 0.0 110.951 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.69 -22.36 32.5 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 CA-C-N 120.487 1.209 . . . . 0.0 112.236 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.57 -36.7 63.07 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.1 tp -78.49 -28.55 46.4 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.861 1.264 . . . . 0.0 110.068 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.04 -50.21 71.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.71 0.687 . . . . 0.0 110.062 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.7 ptmm? -63.52 -31.85 73.13 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.044 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.59 -42.21 52.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.358 0.526 . . . . 0.0 109.697 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.8 mt -71.35 -31.41 67.33 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -67.42 -29.98 69.62 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.59 -3.53 18.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.128 0.571 . . . . 0.0 112.071 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.31 3.86 2.17 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.402 1.481 . . . . 0.0 111.478 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.87 -95.59 0.1 Allowed Glycine 0 CA--C 1.524 0.647 0 CA-C-N 120.077 1.308 . . . . 0.0 115.344 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -138.72 -171.6 3.11 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 125.341 1.456 . . . . 0.0 110.738 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.0 p -62.22 154.1 28.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.913 0.885 . . . . 0.0 110.599 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -76.85 -39.58 50.7 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.669 1.188 . . . . 0.0 110.805 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.2 tp -130.46 147.82 52.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.216 1.006 . . . . 0.0 112.5 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 25.4 mtp -150.75 127.84 11.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.642 2.377 . . . . 0.0 105.243 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -158.71 173.61 16.3 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -78.99 84.63 4.99 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.128 -0.982 . . . . 0.0 110.636 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 mp -71.61 -28.59 63.9 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.051 0.387 . . . . 0.0 109.986 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -61.42 -15.14 34.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -115.21 130.24 24.41 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 119.478 1.035 . . . . 0.0 110.605 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.04 -21.67 72.83 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.324 1.349 . . . . 0.0 112.394 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -54.4 -31.42 54.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.263 1.025 . . . . 0.0 113.461 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.12 -24.8 15.15 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.2 p -90.89 -15.93 29.04 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.33 0.968 . . . . 0.0 111.456 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -62.23 -35.3 19.6 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.08 -11.54 30.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 123.276 2.206 . . . . 0.0 113.98 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.7 tp -68.31 -67.05 0.49 Allowed 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.51 1.524 . . . . 0.0 111.621 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.28 -24.7 35.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.616 1.166 . . . . 0.0 113.295 -179.26 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.35 -16.15 63.29 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.865 -0.522 . . . . 0.0 111.035 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.85 -60.54 2.77 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.153 1.381 . . . . 0.0 109.568 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.76 -54.99 38.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.0 15.79 0.02 OUTLIER Glycine 0 C--N 1.337 0.629 0 CA-C-O 117.887 -1.507 . . . . 0.0 116.149 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.66 147.97 41.07 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 120.804 2.302 . . . . 0.0 109.639 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -151.9 128.24 10.59 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.89 -48.97 62.04 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -143.66 149.51 37.36 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -101.84 159.28 15.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.217 -0.927 . . . . 0.0 109.315 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -155.59 113.98 3.45 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 102.011 -3.329 . . . . 0.0 102.011 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -73.67 -168.59 0.59 Allowed 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.308 1.843 . . . . 0.0 108.429 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -57.13 -34.56 68.51 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.741 -1.224 . . . . 0.0 110.765 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -154.56 8.28 0.36 Allowed Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.284 -1.287 . . . . 0.0 114.558 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -112.49 130.46 55.99 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.366 2.083 . . . . 0.0 107.06 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.17 115.37 17.58 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.96 1.704 . . . . 0.0 109.368 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -132.56 111.78 11.52 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -10.45 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.869 0.867 . . . . 0.0 112.789 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -77.13 -28.78 54.42 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.821 0.848 . . . . 0.0 109.937 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -73.76 80.98 1.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.911 1.284 . . . . 0.0 110.619 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 63.7 t -108.19 141.77 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 127.591 2.357 . . . . 0.0 108.851 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -132.16 34.04 2.59 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.093 1.33 . . . . 0.0 115.092 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.17 -37.76 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 117.301 -1.333 . . . . 0.0 113.796 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.446 ' OD2' ' HE3' ' A' ' 362' ' ' LYS 0.293 21.4 t70 -108.8 34.91 3.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.53 1.514 . . . . 0.0 113.279 -178.613 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -79.14 151.69 31.18 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -47.75 -24.8 1.04 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.17 -19.74 68.88 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 120.145 1.339 . . . . 0.0 111.738 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.66 -45.07 47.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.809 0.844 . . . . 0.0 108.981 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -64.39 -54.56 30.92 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.71 -45.07 70.32 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.56 -30.43 77.58 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 118.814 -0.992 . . . . 0.0 112.128 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 46.0 tp -84.09 -40.46 18.27 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.206 1.402 . . . . 0.0 110.881 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.4 m -44.24 -54.49 5.66 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 127.763 2.425 . . . . 0.0 112.156 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.02 -44.41 91.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.778 0.717 . . . . 0.0 111.769 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.66 -46.05 91.39 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.636 -0.665 . . . . 0.0 109.38 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.78 -34.42 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.65 -43.32 99.12 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.531 1.06 . . . . 0.0 111.811 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 75.7 mt -65.12 -50.76 64.82 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.678 0.791 . . . . 0.0 109.103 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.48 -35.97 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.406 1.083 . . . . 0.0 110.572 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -58.61 -49.13 78.62 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.345 0.975 . . . . 0.0 108.545 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.88 4.27 17.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.843 1.257 . . . . 0.0 112.286 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 58.39 20.49 7.42 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.919 1.288 . . . . 0.0 112.292 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.79 9.63 6.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.366 1.466 . . . . 0.0 110.882 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.2 ttt -146.91 148.05 31.4 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 121.206 -0.934 . . . . 0.0 108.6 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -78.15 78.63 4.63 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.25 -13.08 61.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.861 1.665 . . . . 0.0 114.782 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -92.88 -8.2 44.03 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.58 0.752 . . . . 0.0 112.372 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.7 m -61.97 127.66 32.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 122.522 1.153 . . . . 0.0 110.065 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 29.5 p30 -119.16 -177.52 3.36 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.711 2.004 . . . . 0.0 106.683 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.44 -42.9 99.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.4 m -60.11 -45.59 92.46 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 118.522 -0.751 . . . . 0.0 109.56 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.93 -56.26 19.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -54.49 -59.44 4.69 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.942 1.697 . . . . 0.0 112.982 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -58.19 -44.58 88.11 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.845 0.748 . . . . 0.0 111.475 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.8 -45.65 91.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.434 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.82 95.25 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.411 1.084 . . . . 0.0 112.166 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -63.3 -38.59 91.75 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.098 0.559 . . . . 0.0 110.056 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -59.68 -46.07 90.16 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -68.46 -42.9 78.1 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.341 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.64 36.5 2.05 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.283 1.421 . . . . 0.0 109.596 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -78.22 -62.02 1.81 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.746 -0.856 . . . . 0.0 109.298 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.4 t -73.27 137.1 44.7 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.552 1.541 . . . . 0.0 108.075 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.05 -15.65 57.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.163 0.585 . . . . 0.0 112.53 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -159.29 168.4 26.53 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.919 1.688 . . . . 0.0 109.443 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -155.81 -179.56 8.24 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.452 1.501 . . . . 0.0 109.046 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.3 mt -144.3 109.08 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -138.89 173.55 11.45 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.886 2.075 . . . . 0.0 107.59 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -77.86 -90.24 0.33 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-O 118.989 -0.895 . . . . 0.0 113.383 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.11 169.96 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.091 2.527 . . . . 0.0 116.194 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -76.09 -13.97 60.2 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.358 1.063 . . . . 0.0 113.599 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -134.7 178.04 7.31 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.882 1.219 . . . . 0.0 112.115 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -134.06 -36.45 0.92 Allowed 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.489 0.715 . . . . 0.0 111.818 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.9 m -78.51 -65.23 1.01 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -154.8 160.45 41.28 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 129.447 3.099 . . . . 0.0 106.083 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 11.2 mt -91.35 115.29 30.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -134.12 89.53 2.58 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.711 0.804 . . . . 0.0 111.698 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 5.1 p -88.71 167.45 13.31 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 84.0 p -135.47 -45.64 0.68 Allowed 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.37 0.668 . . . . 0.0 110.957 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -145.48 169.64 17.96 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.65 0.78 . . . . 0.0 110.966 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 9.4 p -76.53 164.79 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.806 1.243 . . . . 0.0 109.809 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.85 178.83 8.18 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.521 1.129 . . . . 0.0 109.293 178.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -142.91 175.51 9.78 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.868 1.667 . . . . 0.0 109.151 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 85.76 111.95 0.77 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 106.541 -2.623 . . . . 0.0 106.541 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.78 138.91 53.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 117.134 0.467 . . . . 0.0 110.232 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 23.7 m -125.92 124.29 40.49 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.2 t -81.55 154.3 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.97 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 32.0 mt -67.21 149.69 98.31 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.46 153.7 77.03 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.277 1.985 . . . . 0.0 111.849 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 36.7 p -113.81 -165.38 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.265 1.426 . . . . 0.0 109.149 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -125.98 149.88 48.45 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -51.09 120.24 4.74 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.618 1.167 . . . . 0.0 109.616 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.61 -4.13 57.43 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 117.621 -1.655 . . . . 0.0 114.615 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.69 115.01 3.51 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 121.777 2.789 . . . . 0.0 115.191 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.29 147.07 28.84 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.709 2.939 . . . . 0.0 111.254 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 5.4 p -64.81 155.52 33.67 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -133.02 66.69 76.59 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.512 1.525 . . . . 0.0 108.599 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.15 179.68 6.27 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.426 2.751 . . . . 0.0 113.174 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -77.2 152.09 34.92 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.903 0.859 . . . . 0.0 112.155 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 82.7 t -110.74 158.83 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.04 1.736 . . . . 0.0 108.064 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -145.83 146.78 17.27 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.89 154.96 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 119.114 1.457 . . . . 0.0 111.829 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.37 117.46 11.03 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.4 m -104.49 144.98 30.93 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.561 1.144 . . . . 0.0 110.811 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.0 129.7 47.15 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.76 131.54 8.55 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 123.556 0.535 . . . . 0.0 111.891 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 85.5 mt -75.09 131.15 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -71.33 120.27 16.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.708 0.803 . . . . 0.0 109.143 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.47 -12.39 60.18 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.951 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.85 -6.67 59.48 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.164 0.893 . . . . 0.0 112.96 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.5 m -63.05 161.3 31.85 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.268 1.027 . . . . 0.0 108.681 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.88 -53.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 121.204 1.466 . . . . 0.0 109.417 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -132.75 104.32 6.56 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . 0.43 ' H ' ' HD2' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -60.06 -19.04 51.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.318 -1.31 . . . . 0.0 113.389 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.34 -33.2 72.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.02 -36.52 83.85 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.882 -1.136 . . . . 0.0 110.993 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.31 -47.23 28.8 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 122.646 0.378 . . . . 0.0 110.565 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.459 ' HZ1' ' CD ' ' A' ' 281' ' ' GLU . 0.0 OUTLIER -61.46 -35.73 78.44 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.206 -179.599 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -70.37 -55.34 9.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -51.48 -46.89 63.3 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 120.225 1.375 . . . . 0.0 112.322 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.25 -23.72 66.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 116.944 -1.503 . . . . 0.0 112.294 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.459 ' CD ' ' HZ1' ' A' ' 277' ' ' LYS . 14.8 pt-20 -108.63 -17.91 13.85 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.7 1.591 . . . . 0.0 113.606 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -80.47 -33.38 36.69 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.461 1.104 . . . . 0.0 108.816 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -133.66 -46.09 0.81 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.102 -0.952 . . . . 0.0 111.079 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . 0.256 0.1 OUTLIER -67.85 0.24 3.58 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 120.71 1.595 . . . . 0.0 114.831 -179.462 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 58.7 mt -130.17 40.47 3.53 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 119.524 -1.985 . . . . 0.0 108.863 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 63.9 p -117.5 156.42 28.05 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.24 -43.38 98.96 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -73.31 -33.04 64.95 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -75.44 -42.25 28.06 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.09 -44.47 76.16 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -54.83 -47.17 74.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.189 0.996 . . . . 0.0 109.52 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.24 -42.32 63.52 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 22.5 t -75.34 -36.52 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -61.54 -20.47 63.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.482 0.713 . . . . 0.0 110.97 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -67.85 -45.45 74.57 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 121.163 -0.961 . . . . 0.0 110.139 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.42 -39.77 58.51 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -146.35 156.72 49.75 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.245 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.32 114.08 3.67 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.761 1.641 . . . . 0.0 109.299 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.47 -32.47 37.11 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 119.37 -0.348 . . . . 0.0 110.074 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.57 -167.81 47.07 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -59.13 157.63 10.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.56 0.695 . . . . 0.0 109.932 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.8 156.27 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.723 0.773 . . . . 0.0 111.191 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.63 -35.12 67.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.67 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.38 103.6 0.32 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.729 1.211 . . . . 0.0 112.332 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -47.95 -33.4 7.69 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.587 1.555 . . . . 0.0 112.703 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.8 -49.93 68.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.469 1.108 . . . . 0.0 113.211 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -96.41 -10.58 27.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.242 0.928 . . . . 0.0 111.504 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.27 -46.71 87.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.331 1.452 . . . . 0.0 108.098 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -69.16 -22.58 63.92 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 119.074 -0.488 . . . . 0.0 112.046 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -78.94 -49.57 12.59 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 7.1 mt -62.69 -38.16 89.29 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.61 -2.41 2.39 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.531 1.132 . . . . 0.0 114.043 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -66.71 -35.79 80.97 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.445 1.02 . . . . 0.0 108.529 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.9 150.49 58.89 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 123.747 0.819 . . . . 0.0 109.643 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.14 -24.59 20.03 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.466 2.11 . . . . 0.0 115.23 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -48.0 77.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.385 0.993 . . . . 0.0 109.447 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.9 mp -64.04 -55.77 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.5 -53.39 23.57 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 123.926 0.766 . . . . 0.0 111.967 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.44 -47.13 87.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 87.0 m -67.57 -29.71 69.14 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 7.8 tpt -71.91 -39.52 69.46 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 120.9 -1.125 . . . . 0.0 109.136 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -56.78 -26.81 58.54 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.62 0.768 . . . . 0.0 110.223 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -66.18 -36.86 84.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.263 0.625 . . . . 0.0 112.332 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -76.91 -35.25 57.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -64.81 -52.25 57.79 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.129 0.972 . . . . 0.0 109.99 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -10.34 59.42 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -86.54 -169.73 46.2 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -148.33 113.16 5.42 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.75 149.0 11.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.239 1.816 . . . . 0.0 110.81 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 34.9 mtp -62.26 149.92 85.96 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.738 1.215 . . . . 0.0 112.707 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -83.29 -179.42 4.31 Favored 'Trans proline' 0 C--N 1.348 0.534 1 C-N-CA 125.563 4.175 . . . . 0.0 112.576 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -134.23 38.53 3.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.88 1.272 . . . . 0.0 112.764 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.1 pt -114.05 152.09 45.47 Favored Pre-proline 0 N--CA 1.472 0.656 0 O-C-N 120.879 -1.138 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.98 -17.22 36.69 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.581 2.188 . . . . 0.0 113.969 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -56.23 -22.83 31.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.103 1.761 . . . . 0.0 112.024 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -32.51 65.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.849 1.26 . . . . 0.0 111.544 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -48.57 76.65 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.404 1.002 . . . . 0.0 109.208 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.5 87.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -58.87 -54.51 46.28 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.354 0.525 . . . . 0.0 110.393 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -61.29 -42.37 98.54 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.561 -0.712 . . . . 0.0 109.989 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -63.93 -23.04 67.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.069 0.948 . . . . 0.0 112.307 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -85.02 -57.73 2.98 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 120.955 -1.09 . . . . 0.0 110.639 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 19.3 t -57.84 -38.74 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 118.068 -0.968 . . . . 0.0 111.946 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -52.15 -48.57 64.84 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.145 1.339 . . . . 0.0 111.365 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 8.5 m -66.4 -40.22 89.48 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.375 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.56 83.74 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.373 0.988 . . . . 0.0 111.413 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 36.2 t -60.69 -55.38 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.784 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.8 mm -66.26 -33.38 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 123.575 0.547 . . . . 0.0 110.652 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -61.09 -46.02 92.34 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.425 -1.422 . . . . 0.0 108.8 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.9 -50.18 44.87 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.881 0.872 . . . . 0.0 109.729 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -57.08 -37.79 72.39 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 69.0 m -87.55 -7.13 57.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.548 0.739 . . . . 0.0 110.256 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.62 13.71 71.72 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 118.491 0.587 . . . . 0.0 111.78 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 -65.98 -28.61 69.02 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.311 1.056 . . . . 0.0 109.633 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -149.25 153.24 37.26 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 9.0 m -66.07 150.71 48.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.448 1.099 . . . . 0.0 108.671 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 18.8 t -52.52 -54.53 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.911 1.285 . . . . 0.0 108.339 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.38 -44.91 55.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.344 2.257 . . . . 0.0 112.597 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -82.6 -26.92 31.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.48 85.57 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 76.4 mt -68.87 -39.44 79.84 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.73 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.446 ' HE3' ' OD2' ' A' ' 184' ' ' ASP . 2.1 tppp? -58.33 -35.81 72.44 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.896 0.878 . . . . 0.0 110.545 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.22 -32.74 22.46 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.789 0.722 . . . . 0.0 110.98 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.17 -40.16 90.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.564 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.64 -37.9 76.95 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.878 0.763 . . . . 0.0 109.606 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 4.3 m -67.53 -19.58 65.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.209 1.404 . . . . 0.0 113.141 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -80.66 -11.94 59.56 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.141 -0.975 . . . . 0.0 110.874 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.11 -42.02 11.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.5 p -68.02 -13.75 62.43 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.451 0.569 . . . . 0.0 111.859 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 32.2 tptt . . . . . 0 C--O 1.245 0.828 0 C-N-CA 125.868 1.667 . . . . 0.0 107.087 179.278 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.8 tptm . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 120.904 0.383 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 68.8 mt -70.79 133.71 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.31 41.26 0.24 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.435 1.47 . . . . 0.0 114.21 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -65.51 133.05 50.41 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.52 22.02 72.97 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 126.915 2.198 . . . . 0.0 114.634 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -153.7 167.04 30.94 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 119.215 1.507 . . . . 0.0 110.279 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -137.09 158.39 44.55 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 127.583 2.353 . . . . 0.0 108.07 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.7 t -143.42 134.51 22.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 125.803 1.641 . . . . 0.0 107.21 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.72 141.7 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.172 1.389 . . . . 0.0 109.491 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -130.1 162.51 28.64 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -126.73 170.18 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 124.504 1.122 . . . . 0.0 108.74 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -74.31 -25.19 59.42 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.02 -30.53 3.19 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 120.138 1.335 . . . . 0.0 115.331 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -113.13 6.5 17.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.436 1.494 . . . . 0.0 113.335 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' A' ' 297' ' ' LYS . 34.0 mmtm -75.59 -168.14 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.447 1.499 . . . . 0.0 110.448 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.04 65.53 0.37 Allowed Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -52.53 -34.82 51.69 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.853 0.826 . . . . 0.0 112.528 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -58.18 -55.22 37.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.605 0.639 . . . . 0.0 110.251 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.63 -31.17 77.76 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.6 tp -67.45 -35.53 79.4 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.214 -1.168 . . . . 0.0 110.333 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.39 -40.91 83.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 117.904 -1.046 . . . . 0.0 108.918 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -54.68 -45.02 73.84 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.451 1.1 . . . . 0.0 110.731 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 t -57.01 -47.14 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.63 -35.35 85.94 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.682 -1.065 . . . . 0.0 110.88 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm -64.26 -46.52 83.38 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.289 1.544 . . . . 0.0 108.696 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -57.74 11.26 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -55.64 -49.76 72.0 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 117.641 0.201 . . . . 0.0 111.418 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.16 -30.09 69.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.524 1.129 . . . . 0.0 111.545 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -25.39 45.09 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 117.726 -1.131 . . . . 0.0 110.759 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -100.68 -4.04 29.08 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.513 1.133 . . . . 0.0 111.767 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.2 p -132.52 -38.68 1.03 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.82 -18.36 56.06 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 121.201 -0.937 . . . . 0.0 112.779 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.2 mm -66.79 116.15 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 147.33 49.84 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.753 -0.592 . . . . 0.0 110.141 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.2 t -132.54 104.63 7.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 125.89 1.676 . . . . 0.0 109.154 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 m -84.7 141.77 30.34 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.92 115.95 19.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -125.65 167.67 14.78 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.21 0.604 . . . . 0.0 112.001 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -120.13 65.95 11.09 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.509 1.124 . . . . 0.0 112.945 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.7 161.61 36.46 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.14 1.893 . . . . 0.0 109.843 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -124.85 17.21 8.64 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.288 1.035 . . . . 0.0 110.648 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.98 8.23 2.5 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.844 1.658 . . . . 0.0 111.809 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -51.32 -26.78 8.1 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.249 1.42 . . . . 0.0 114.188 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.2 pm0 -61.07 -25.75 67.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.497 1.044 . . . . 0.0 111.437 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -115.5 -28.01 6.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -44.25 78.49 Favored 'General case' 0 C--O 1.221 -0.447 0 O-C-N 119.813 -1.804 . . . . 0.0 109.687 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -52.98 -59.8 8.16 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 120.503 1.501 . . . . 0.0 109.343 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.34 -13.72 37.7 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 121.75 1.633 . . . . 0.0 114.213 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -90.07 -9.87 46.88 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.795 1.634 . . . . 0.0 111.69 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.2 -34.88 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 119.941 1.246 . . . . 0.0 112.036 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.96 -34.04 74.12 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.38 -14.76 30.19 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.611 1.164 . . . . 0.0 112.316 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.88 5.51 17.44 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.222 1.809 . . . . 0.0 110.509 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.6 30.28 76.13 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.37 7.43 7.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.736 1.214 . . . . 0.0 112.283 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.73 -171.51 43.68 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.139 1.828 . . . . 0.0 111.961 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.67 178.15 2.93 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.348 2.699 . . . . 0.0 111.27 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -104.2 -17.69 14.78 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.557 -0.714 . . . . 0.0 111.939 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.17 157.22 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.5 tp -143.9 142.68 24.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -131.2 107.38 8.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.817 1.247 . . . . 0.0 108.684 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -151.95 172.62 15.96 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.387 1.075 . . . . 0.0 108.579 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.27 162.46 28.43 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.827 1.194 . . . . 0.0 110.641 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -55.13 -26.34 37.74 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.77 1.628 . . . . 0.0 112.493 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -58.87 -64.77 0.82 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 118.015 -0.993 . . . . 0.0 112.462 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -62.5 -23.23 66.83 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 121.213 1.824 . . . . 0.0 109.918 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -72.78 -15.64 61.65 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.6 -0.687 . . . . 0.0 111.359 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.56 -21.5 60.43 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.23 1.395 . . . . 0.0 112.776 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.09 -33.89 2.09 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.477 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -53.65 -47.57 70.2 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.792 1.796 . . . . 0.0 114.241 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.07 -43.65 91.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.606 1.094 . . . . 0.0 110.417 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -56.61 -49.52 74.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.9 m -62.51 -3.25 1.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.952 1.701 . . . . 0.0 113.845 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.12 11.11 85.68 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 119.778 1.172 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -81.36 -21.32 39.17 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.026 1.413 . . . . 0.0 110.555 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.6 mt -111.44 140.98 45.59 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.356 0.98 . . . . 0.0 109.594 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.77 176.13 6.47 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.595 1.558 . . . . 0.0 110.469 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.54 144.36 49.6 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.576 1.15 . . . . 0.0 109.205 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.5 163.87 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.841 1.256 . . . . 0.0 109.665 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.2 m 65.39 81.8 0.21 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.767 1.627 . . . . 0.0 112.227 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.87 -65.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.964 1.776 . . . . 0.0 108.51 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.27 155.02 17.39 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.631 1.172 . . . . 0.0 110.07 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tptp -65.58 -28.51 69.2 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.74 1.216 . . . . 0.0 113.081 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.06 -36.65 60.86 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.288 0.949 . . . . 0.0 111.663 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -63.09 -28.11 69.85 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.861 -0.524 . . . . 0.0 111.084 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -73.75 -43.19 59.78 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.272 0.942 . . . . 0.0 110.176 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.19 -27.97 67.58 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.478 1.111 . . . . 0.0 112.476 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -66.03 -16.72 64.16 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.696 0.798 . . . . 0.0 111.559 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.1 mt -119.88 163.45 17.52 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.465 1.506 . . . . 0.0 109.13 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -69.86 147.79 96.2 Favored Pre-proline 0 C--O 1.235 0.292 0 O-C-N 121.403 -0.81 . . . . 0.0 110.245 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.89 -51.01 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.59 2.193 . . . . 0.0 113.083 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -55.2 -44.67 75.54 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.739 0.7 . . . . 0.0 109.944 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -27.47 57.13 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.23 1.012 . . . . 0.0 112.69 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -73.52 -33.28 64.68 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.651 1.114 . . . . 0.0 111.451 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -59.86 -37.02 78.1 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.225 0.61 . . . . 0.0 111.82 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.54 -3.31 4.31 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.994 -1.003 . . . . 0.0 113.002 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -132.19 11.89 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.369 1.468 . . . . 0.0 111.571 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.5 mtp-105 -76.26 156.36 33.56 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 121.038 -1.039 . . . . 0.0 109.404 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -131.13 177.78 7.2 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.846 1.658 . . . . 0.0 107.156 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -65.57 100.17 0.49 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.261 1.025 . . . . 0.0 109.298 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.61 -76.62 1.69 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.227 1.394 . . . . 0.0 110.701 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 166.69 20.51 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mt -100.34 160.13 14.58 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.769 1.627 . . . . 0.0 108.087 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.1 pt -133.52 -19.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.44 164.81 26.96 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.591 1.542 . . . . 0.0 108.165 178.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.2 137.51 22.53 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-O 118.747 -0.644 . . . . 0.0 110.443 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.49 129.44 18.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.777 2.318 . . . . 0.0 108.73 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 mm -121.2 -46.34 2.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.55 148.8 52.38 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 67.8 t -121.18 111.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -120.04 167.58 12.04 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.62 130.69 50.98 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.6 168.92 12.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.634 1.574 . . . . 0.0 113.544 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.8 m -144.48 115.98 8.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.03 1.732 . . . . 0.0 111.689 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.69 170.17 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 129.39 3.076 . . . . 0.0 117.209 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.2 mp -86.98 136.34 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.717 1.207 . . . . 0.0 108.655 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -147.14 167.19 24.76 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.421 1.888 . . . . 0.0 108.758 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -74.46 147.32 42.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.269 1.028 . . . . 0.0 111.351 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -66.93 28.2 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.894 2.878 . . . . 0.0 114.745 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -84.36 -163.06 0.74 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.686 1.194 . . . . 0.0 107.992 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -60.57 -20.7 61.23 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 51.2 tp 50.99 80.71 0.28 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.69 1.596 . . . . 0.0 109.168 -178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -75.66 74.92 4.17 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.884 3.056 . . . . 0.0 110.455 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m120 64.08 161.71 0.12 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 128.781 2.832 . . . . 0.0 111.571 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.88 163.23 38.24 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 121.546 1.498 . . . . 0.0 109.416 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.11 157.89 53.28 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.042 1.161 . . . . 0.0 110.226 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -138.52 -19.06 1.08 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 116.437 -1.744 . . . . 0.0 114.159 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.76 136.38 32.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.716 1.598 . . . . 0.0 111.219 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -65.93 -26.09 67.43 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.167 -0.958 . . . . 0.0 110.89 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.32 -12.88 62.04 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.834 0.743 . . . . 0.0 112.748 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -92.45 -11.53 34.49 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.711 0.804 . . . . 0.0 111.171 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.58 -59.0 12.9 Favored Pre-proline 0 C--O 1.233 0.186 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.58 -23.31 49.86 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 CA-C-N 119.826 0.974 . . . . 0.0 110.978 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.89 89.76 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.738 0.699 . . . . 0.0 109.887 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.6 tp -80.79 -27.49 36.65 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -57.19 -47.58 80.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 124.292 1.037 . . . . 0.0 111.205 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.412 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 8.2 ptmm? -66.69 -28.44 68.45 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 122.994 0.518 . . . . 0.0 112.064 179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -75.89 -42.4 49.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 56.9 mt -78.82 -32.84 46.38 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.722 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.85 -35.89 79.35 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.63 67.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.204 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -5.62 15.41 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.471 1.108 . . . . 0.0 112.414 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.69 -94.57 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 119.159 0.89 . . . . 0.0 113.556 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HE2' ' OE2' ' A' ' 221' ' ' GLU . 27.9 mmtm -132.92 172.15 13.0 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.511 1.124 . . . . 0.0 110.849 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.56 162.73 3.63 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.424 1.49 . . . . 0.0 111.696 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.54 -55.99 4.14 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.8 tp -115.96 157.18 24.96 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.155 0.982 . . . . 0.0 110.818 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.3 mtp -148.7 114.17 5.6 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -140.5 174.01 10.93 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.799 0.84 . . . . 0.0 109.171 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -69.42 76.05 0.39 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.864 2.065 . . . . 0.0 109.978 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.3 mt -73.07 -23.15 60.51 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -79.66 -1.73 39.56 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.655 0.782 . . . . 0.0 112.672 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -117.75 129.74 25.16 Favored Pre-proline 0 CA--C 1.529 0.147 0 C-N-CA 123.962 0.905 . . . . 0.0 112.878 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.11 -13.31 17.24 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.352 2.035 . . . . 0.0 112.286 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -59.04 -44.62 91.79 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.873 0.869 . . . . 0.0 110.4 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -91.92 -28.29 17.36 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.395 0.543 . . . . 0.0 111.42 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.5 p -80.16 -2.13 43.34 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 119.133 0.879 . . . . 0.0 110.47 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 32.8 t-105 -56.97 -66.3 1.29 Allowed Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 120.421 -1.424 . . . . 0.0 111.093 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.46 -20.39 60.96 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 CA-C-N 120.242 1.122 . . . . 0.0 112.899 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.82 -43.2 90.56 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-O 118.341 -0.838 . . . . 0.0 108.829 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 9.3 pt -93.01 -32.12 4.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.441 0.564 . . . . 0.0 111.663 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.86 -6.94 18.32 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.118 -0.988 . . . . 0.0 113.256 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -54.01 -46.21 71.72 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.903 1.281 . . . . 0.0 112.968 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -63.84 -50.4 69.0 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.521 0.601 . . . . 0.0 109.843 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.47 42.77 0.05 OUTLIER Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.329 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.03 154.6 24.63 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -159.91 121.99 3.32 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.33 -47.8 80.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -146.01 131.45 18.67 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -58.28 126.73 28.75 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -150.63 101.25 2.92 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.18 158.57 43.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 119.109 0.868 . . . . 0.0 108.888 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 47.9 27.33 1.13 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.156 1.783 . . . . 0.0 112.445 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 79.42 18.87 72.83 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.576 -1.125 . . . . 0.0 114.04 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -120.99 115.25 22.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.55 1.675 . . . . 0.0 107.372 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -106.08 121.24 43.73 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.287 1.435 . . . . 0.0 108.881 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -130.7 110.89 11.69 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 122.394 1.093 . . . . 0.0 111.094 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.55 0.29 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 124.307 1.043 . . . . 0.0 109.367 177.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -84.19 -11.52 56.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.488 2.315 . . . . 0.0 111.623 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -127.4 105.69 8.69 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.67 140.4 49.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -124.52 29.8 4.89 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 117.871 -1.516 . . . . 0.0 116.188 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.38 -11.54 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.221 2.011 . . . . 0.0 113.693 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.14 10.25 10.0 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.472 1.033 . . . . 0.0 112.166 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.09 159.93 13.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.846 0.858 . . . . 0.0 110.055 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.79 -35.58 61.5 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.292 1.037 . . . . 0.0 110.862 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.85 -41.6 97.41 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 118.373 0.533 . . . . 0.0 112.366 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.07 64.98 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.16 0.98 . . . . 0.0 109.911 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -63.08 -37.79 88.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 118.566 -0.73 . . . . 0.0 110.671 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.23 71.9 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.646 0.778 . . . . 0.0 111.863 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.09 -28.03 24.22 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 19.8 tp -74.92 -39.03 61.63 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.281 -1.717 . . . . 0.0 111.618 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.2 t -56.58 -33.61 66.37 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.923 0.489 . . . . 0.0 111.511 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -60.01 -54.62 43.9 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 119.389 0.995 . . . . 0.0 109.459 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 7.4 tt -56.38 -45.0 80.74 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.458 1.103 . . . . 0.0 110.233 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.31 -32.96 52.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.713 0.805 . . . . 0.0 109.893 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.57 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 19.1 t70 -63.72 -46.37 85.74 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.859 1.209 . . . . 0.0 112.726 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.62 -39.52 94.08 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.688 0.795 . . . . 0.0 109.76 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 75.5 mt -68.69 -40.29 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.57 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -52.67 -40.79 63.21 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.659 1.183 . . . . 0.0 109.7 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -90.99 0.87 57.43 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.121 1.768 . . . . 0.0 113.22 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.9 mptt 52.91 17.55 0.9 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 128.452 2.701 . . . . 0.0 114.972 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -82.27 -24.97 34.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.983 0.81 . . . . 0.0 109.315 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.0 tpt -77.94 163.38 26.04 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -82.52 51.19 1.8 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.68 -22.41 8.91 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 127.347 2.259 . . . . 0.0 115.905 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.99 8.63 43.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.506 1.522 . . . . 0.0 112.398 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 71.4 m -101.06 144.31 30.14 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.762 1.625 . . . . 0.0 111.158 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.78 -177.54 4.32 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.596 1.958 . . . . 0.0 108.85 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -48.48 -51.0 29.28 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.814 0.846 . . . . 0.0 112.884 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.26 -43.76 90.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.274 0.629 . . . . 0.0 111.142 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.09 -49.05 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.755 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.94 -47.53 86.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.5 1.12 . . . . 0.0 110.885 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.03 -42.68 80.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.138 0.575 . . . . 0.0 111.547 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.55 -48.18 35.03 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 122.023 -0.423 . . . . 0.0 110.146 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.25 -39.33 56.44 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.031 1.732 . . . . 0.0 111.775 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -53.79 -55.0 30.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.168 1.387 . . . . 0.0 109.079 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -62.13 -38.15 87.86 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.44 -17.67 64.72 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.627 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.62 11.9 76.35 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 119.117 0.871 . . . . 0.0 111.024 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.475 ' OE2' ' HE2' ' A' ' 144' ' ' LYS . 7.4 mm-40 -65.52 -60.63 2.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.544 1.137 . . . . 0.0 110.332 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.8 t -87.82 141.77 28.33 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.961 0.904 . . . . 0.0 109.444 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.19 -35.24 59.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -127.13 164.19 22.17 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.317 0.647 . . . . 0.0 109.545 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 52.4 m -151.13 155.29 38.61 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.763 0.825 . . . . 0.0 108.871 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt -133.73 126.93 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -143.81 178.5 7.78 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 130.208 3.403 . . . . 0.0 110.014 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.27 64.85 1.02 Allowed Glycine 0 CA--C 1.531 1.047 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.04 156.33 65.57 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.313 2.675 . . . . 0.0 110.773 178.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -89.0 112.72 23.71 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.55 62.44 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.147 2.179 . . . . 0.0 113.044 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -144.15 116.21 8.38 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.54 1.936 . . . . 0.0 105.988 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 28.0 m 63.58 -13.01 0.09 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.465 1.906 . . . . 0.0 115.193 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -68.31 172.99 5.21 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.376 1.47 . . . . 0.0 110.509 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.13 -14.76 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -72.95 157.38 37.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.407 1.458 . . . . 0.0 108.178 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 8.8 t -148.52 137.52 21.68 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.1 t -140.49 162.31 35.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.944 1.698 . . . . 0.0 107.818 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -80.77 0.22 35.72 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 9.1 p -147.13 151.84 13.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -155.35 64.93 0.62 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.614 0.643 . . . . 0.0 110.382 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -65.35 163.65 15.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.478 0.656 . . . . 0.0 111.439 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -117.29 83.46 0.34 Allowed Glycine 0 C--N 1.335 0.524 0 N-CA-C 106.694 -2.563 . . . . 0.0 106.694 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 1.3 m -134.55 91.21 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.709 2.404 . . . . 0.0 107.575 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.1 m -142.24 -171.51 3.4 Favored 'General case' 0 C--O 1.217 -0.612 0 O-C-N 118.892 -2.38 . . . . 0.0 111.03 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 11.6 p -141.56 176.8 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 120.832 1.651 . . . . 0.0 109.618 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.7 59.79 47.45 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.788 1.235 . . . . 0.0 113.648 -178.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -64.97 155.0 70.49 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.487 2.125 . . . . 0.0 108.798 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 61.6 p -97.45 179.76 4.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.356 1.062 . . . . 0.0 110.427 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -107.84 164.75 11.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -59.34 114.21 2.55 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.068 0.395 . . . . 0.0 110.201 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 69.92 15.29 71.5 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 118.364 -1.242 . . . . 0.0 113.965 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.46 117.9 3.23 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 120.639 2.22 . . . . 0.0 111.668 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.34 113.49 3.12 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.854 2.37 . . . . 0.0 111.165 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 31.6 t -57.82 157.03 7.97 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.215 1.006 . . . . 0.0 108.382 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -132.86 60.8 52.41 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 125.634 1.574 . . . . 0.0 112.792 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.88 164.59 31.06 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.542 1.495 . . . . 0.0 109.452 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -63.62 170.88 2.93 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.642 1.211 . . . . 0.0 112.966 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 77.0 t -106.21 157.11 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.149 1.78 . . . . 0.0 108.489 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -138.22 149.52 20.53 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 19.0 t -145.11 148.93 17.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.43 1.092 . . . . 0.0 109.56 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 1.1 tt -77.02 149.49 35.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.3 m -126.38 154.2 43.91 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.814 0.846 . . . . 0.0 111.828 -178.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -136.93 134.48 36.81 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.471 1.108 . . . . 0.0 108.277 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -142.53 154.99 25.51 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 75.1 mt -93.55 136.37 25.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.974 1.309 . . . . 0.0 107.591 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -72.72 113.78 10.14 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.9 -20.07 66.25 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.184 -0.912 . . . . 0.0 113.429 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -73.74 -16.35 61.18 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.7 m -70.27 163.56 61.07 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 119.084 0.856 . . . . 0.0 110.514 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.69 -46.06 2.88 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.331 2.021 . . . . 0.0 115.327 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -137.42 114.7 10.93 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 119.078 0.854 . . . . 0.0 112.203 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -18.32 64.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.024 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -59.83 -40.36 88.19 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 98.9 mt -57.8 -41.22 81.72 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.496 -0.752 . . . . 0.0 111.093 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -77.91 -42.76 32.11 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -33.94 76.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.431 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -68.76 -52.57 29.05 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -55.33 -43.54 75.03 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.204 -0.935 . . . . 0.0 112.326 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -61.03 -51.23 70.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.486 1.114 . . . . 0.0 110.09 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -75.07 -17.81 60.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -105.79 -26.45 11.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.06 -1.448 . . . . 0.0 113.858 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -131.18 -37.41 1.26 Allowed 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 120.719 1.6 . . . . 0.0 113.609 -178.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -62.0 -50.0 73.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 116.516 -2.073 . . . . 0.0 107.415 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 90.6 mt -82.91 52.5 2.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.586 1.954 . . . . 0.0 115.883 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 13.2 p -131.01 160.34 34.85 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -63.19 -47.01 84.41 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -70.44 -32.63 70.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.524 1.13 . . . . 0.0 111.074 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.87 -42.76 44.38 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 54.7 mt -70.37 -46.54 63.88 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.428 ' HB2' ' HH ' ' A' ' 307' ' ' TYR . 30.1 tt0 -56.67 -43.55 80.54 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.491 0.716 . . . . 0.0 109.954 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.34 61.18 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 5.0 t -88.27 -31.4 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 122.842 0.457 . . . . 0.0 109.886 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -71.62 -23.92 61.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.763 0.425 . . . . 0.0 111.251 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -59.71 -47.35 86.01 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.17 -59.62 4.51 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.106 0.962 . . . . 0.0 112.033 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -137.87 160.46 64.55 Favored Pre-proline 0 N--CA 1.463 0.211 0 O-C-N 121.389 -0.82 . . . . 0.0 112.293 -178.576 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -69.92 110.07 2.5 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.691 1.594 . . . . 0.0 108.164 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.41 -9.75 58.84 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 85.22 -166.58 40.52 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 119.709 1.141 . . . . 0.0 110.276 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -73.67 168.43 19.37 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.026 0.93 . . . . 0.0 110.765 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.16 153.9 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 123.61 0.764 . . . . 0.0 110.831 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.0 41.17 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.947 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 63.5 tp -65.75 100.46 0.54 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.52 1.928 . . . . 0.0 106.869 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -47.5 -37.72 12.5 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.353 1.061 . . . . 0.0 112.983 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.8 m -55.41 -60.48 3.35 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.693 0.797 . . . . 0.0 112.768 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.428 ' HH ' ' HB2' ' A' ' 291' ' ' GLU . 6.6 t80 -83.77 -9.97 58.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.822 1.249 . . . . 0.0 111.806 -178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -61.5 -42.62 99.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -67.47 -37.79 83.43 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 124.39 1.056 . . . . 0.0 111.272 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -65.16 -50.74 64.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.6 -38.62 89.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.86 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.64 -15.97 33.89 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.561 1.145 . . . . 0.0 113.662 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -60.25 -16.02 30.09 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.973 0.806 . . . . 0.0 111.605 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.3 135.26 19.68 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 119.335 0.97 . . . . 0.0 110.597 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.43 -34.46 94.63 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.288 2.659 . . . . 0.0 112.805 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.62 -33.47 75.07 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.029 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.9 mp -79.68 -54.26 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -43.96 -55.21 4.78 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.507 1.123 . . . . 0.0 112.211 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.22 -30.03 70.18 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 9.8 m -77.55 -32.54 53.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.765 0.826 . . . . 0.0 109.259 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.0 tpt -74.39 -41.84 60.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -49.64 -42.02 44.03 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 125.384 1.474 . . . . 0.0 111.288 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -59.27 -44.51 92.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.815 2.046 . . . . 0.0 110.368 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -75.87 -22.37 56.25 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.222 -0.299 . . . . 0.0 110.815 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -88.5 -14.06 38.72 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.492 1.117 . . . . 0.0 112.756 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.42 -3.2 25.76 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.159 1.384 . . . . 0.0 112.09 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -114.68 -178.64 18.89 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -135.9 141.99 44.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 90.7 mt -72.61 153.66 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.537 1.135 . . . . 0.0 110.097 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 31.8 mtp -62.67 162.98 17.1 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.023 0.929 . . . . 0.0 112.155 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -71.57 178.23 5.91 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.49 2.127 . . . . 0.0 112.399 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -134.19 16.58 3.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.43 1.892 . . . . 0.0 112.056 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.3 pt -116.91 153.72 49.47 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.709 1.204 . . . . 0.0 112.021 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.28 -5.42 17.13 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.771 2.981 . . . . 0.0 115.406 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -57.79 -19.24 26.96 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.768 -1.207 . . . . 0.0 111.884 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 2.2 mtp -61.85 -24.07 66.67 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.772 -0.58 . . . . 0.0 110.472 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 40.3 t -54.57 -53.56 52.9 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.073 1.349 . . . . 0.0 109.004 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.22 -43.71 90.6 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.824 0.449 . . . . 0.0 110.514 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -53.67 -54.09 42.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.816 0.846 . . . . 0.0 110.773 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -59.96 -50.0 75.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.133 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -55.38 -42.75 74.42 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.473 0.579 . . . . 0.0 111.217 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -62.32 -57.3 11.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.468 1.107 . . . . 0.0 111.979 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.5 t -63.58 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.109 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -50.87 -41.31 58.07 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.539 1.063 . . . . 0.0 110.041 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.0 m -79.94 -47.14 15.48 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.415 -0.803 . . . . 0.0 110.525 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.07 -44.74 64.46 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 36.4 t -60.51 -47.69 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.34 -36.18 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.45 0.568 . . . . 0.0 109.766 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -59.41 -49.88 76.12 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.438 1.017 . . . . 0.0 109.527 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.36 -43.49 73.48 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.081 0.552 . . . . 0.0 110.79 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.84 -29.03 70.43 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.778 0.831 . . . . 0.0 112.37 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 6.7 m -92.45 -10.31 38.39 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.651 0.78 . . . . 0.0 110.076 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 72.73 10.39 76.38 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.194 -0.781 . . . . 0.0 112.572 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -67.15 -29.41 69.11 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.935 1.367 . . . . 0.0 111.883 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -140.09 157.5 45.53 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.4 m -62.3 152.56 33.39 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.855 0.862 . . . . 0.0 109.214 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.8 -48.49 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.35 -49.52 72.03 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.976 1.71 . . . . 0.0 111.159 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -75.53 -30.79 59.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.31 -41.32 98.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 7.9 mp -73.21 -38.62 66.02 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.243 1.017 . . . . 0.0 109.518 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -57.29 13.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.579 1.081 . . . . 0.0 110.389 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -55.42 -36.32 66.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 122.386 1.089 . . . . 0.0 109.951 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -68.57 -46.99 67.97 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 117.537 -1.221 . . . . 0.0 111.236 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -52.72 -39.29 61.92 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.538 1.063 . . . . 0.0 109.655 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 4.4 m -63.77 -26.15 68.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 112.828 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -72.89 -18.92 61.37 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.448 -1.407 . . . . 0.0 111.028 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.9 mp -92.68 -38.46 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.214 1.006 . . . . 0.0 109.105 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 7.7 p -69.19 -15.67 63.45 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.373 0.988 . . . . 0.0 111.668 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 51.6 tttm . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.955 2.102 . . . . 0.0 110.309 179.155 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.54 ' H1 ' ' CG ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 117.445 -1.264 . . . . 0.0 113.401 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.6 mm 48.26 167.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 131.308 3.843 . . . . 0.0 115.604 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -132.37 116.7 17.18 Favored 'General case' 0 N--CA 1.45 -0.473 1 N-CA-C 97.888 -4.856 . . . . 0.0 97.888 177.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -77.03 171.16 15.24 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.764 0.711 . . . . 0.0 111.818 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.49 38.89 71.97 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.812 1.196 . . . . 0.0 115.78 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -145.77 173.5 12.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.864 0.832 . . . . 0.0 110.031 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.3 mt -142.13 154.49 44.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.951 2.101 . . . . 0.0 107.519 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.4 t -144.53 117.33 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 40.5 mt -99.4 126.52 52.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -112.93 140.37 47.8 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mp -129.79 148.84 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 C-N-CA 125.588 1.555 . . . . 0.0 109.846 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.76 -64.75 1.01 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.3 169.45 42.28 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.629 1.585 . . . . 0.0 109.149 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 52.45 3.17 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.22 3.008 . . . . 0.0 115.775 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.56 -28.85 68.13 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.763 1.625 . . . . 0.0 115.376 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.7 36.15 6.98 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -51.61 -34.23 36.53 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.47 -40.51 87.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.645 0.778 . . . . 0.0 112.087 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.59 -30.81 26.07 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -62.71 -38.01 88.73 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.603 1.161 . . . . 0.0 111.552 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.22 -46.3 62.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.66 0.784 . . . . 0.0 110.945 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -60.0 -35.5 75.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.844 -0.598 . . . . 0.0 112.438 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.2 t -62.32 -43.98 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.88 -40.89 93.67 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -63.39 -40.92 98.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.216 1.008 . . . . 0.0 109.52 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -63.64 -57.71 9.19 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -55.0 -43.61 73.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.637 0.653 . . . . 0.0 111.992 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.86 -28.19 69.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.448 1.022 . . . . 0.0 110.651 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.4 -23.04 35.11 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.058 -1.026 . . . . 0.0 112.272 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -99.83 -17.95 17.4 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.264 0.978 . . . . 0.0 111.979 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.3 p -122.76 -34.4 3.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.161 0.891 . . . . 0.0 113.184 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.38 -15.05 64.04 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.992 -0.893 . . . . 0.0 111.682 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.0 mm -66.86 120.15 13.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -61.79 146.4 49.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.9 t -135.51 143.49 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.7 m -125.12 143.06 51.12 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.74 119.01 23.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.41 163.23 25.32 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.128 0.971 . . . . 0.0 109.915 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -139.09 65.34 36.14 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.161 0.585 . . . . 0.0 111.262 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.86 173.09 14.06 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 125.054 3.836 . . . . 0.0 109.123 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -123.5 1.14 8.92 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.622 0.769 . . . . 0.0 111.828 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -119.29 6.84 11.19 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.172 0.989 . . . . 0.0 111.097 178.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -59.32 -20.71 56.76 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.709 -1.244 . . . . 0.0 112.072 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -60.58 -21.29 62.46 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.729 0.811 . . . . 0.0 112.499 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -122.63 -23.01 5.23 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.715 1.606 . . . . 0.0 111.026 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -78.07 -38.84 43.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.927 1.291 . . . . 0.0 110.693 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -52.02 -57.22 15.83 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 120.376 1.443 . . . . 0.0 110.094 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.82 -16.23 52.19 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.77 1.646 . . . . 0.0 114.385 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -84.54 -12.63 53.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.698 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.82 -40.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 120.154 1.343 . . . . 0.0 109.746 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.34 -43.09 53.84 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.803 1.241 . . . . 0.0 112.498 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.55 70.94 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.546 -0.721 . . . . 0.0 111.689 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 m -74.79 -5.89 45.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.204 1.402 . . . . 0.0 112.79 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.18 47.62 10.77 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.54 ' CG ' ' H1 ' ' A' ' 1' ' ' LYS . 13.6 m-20 -158.42 176.23 12.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 130.99 3.716 . . . . 0.0 104.111 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.6 -170.55 13.59 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.669 -1.269 . . . . 0.0 110.472 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -78.07 -177.16 3.66 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.637 2.892 . . . . 0.0 110.289 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.3 -20.16 13.36 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.573 -0.705 . . . . 0.0 111.972 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mt -137.92 151.84 25.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.546 0.689 . . . . 0.0 110.552 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.02 139.73 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.656 1.182 . . . . 0.0 109.106 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.82 114.43 17.23 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.984 1.314 . . . . 0.0 109.695 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -165.35 -166.01 0.94 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.295 0.952 . . . . 0.0 112.072 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.34 133.4 44.94 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.077 2.151 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -60.08 -29.47 68.58 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.579 1.952 . . . . 0.0 112.308 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.98 -37.6 78.84 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.844 0.747 . . . . 0.0 110.403 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -24.46 56.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -68.66 -30.84 69.62 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.79 -36.26 86.01 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.84 -52.54 14.42 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -56.16 -34.66 66.36 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.531 1.165 . . . . 0.0 111.057 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -45.67 83.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -40.78 88.09 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.1 m -63.66 -12.47 34.24 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.611 -0.68 . . . . 0.0 110.138 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.55 16.22 76.23 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.744 1.64 . . . . 0.0 112.215 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.1 mt -88.15 -10.25 50.58 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mt -96.14 140.9 30.18 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.778 0.717 . . . . 0.0 110.954 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.03 172.2 8.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.981 1.312 . . . . 0.0 112.152 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -78.11 90.18 4.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.453 1.501 . . . . 0.0 111.834 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -73.23 178.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.815 1.246 . . . . 0.0 111.444 179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.337 0.5 OUTLIER 57.77 74.42 0.65 Allowed Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 127.602 2.361 . . . . 0.0 106.363 -178.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.42 -24.49 64.1 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.72 2.28 . . . . 0.0 113.605 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -147.13 148.59 31.73 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.709 0.804 . . . . 0.0 109.805 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.411 ' HZ2' ' NE2' ' A' ' 86' ' ' GLN . 14.9 tppt? -55.64 -29.46 59.28 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.842 2.057 . . . . 0.0 112.977 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.25 -36.24 77.34 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.331 0.514 . . . . 0.0 110.102 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -58.6 -32.64 69.17 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.514 0.726 . . . . 0.0 111.595 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.411 ' NE2' ' HZ2' ' A' ' 83' ' ' LYS . 4.3 mp0 -64.27 -46.52 83.32 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.675 -0.64 . . . . 0.0 110.587 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -66.95 -19.15 65.67 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -74.26 -11.47 60.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.348 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mt -124.55 160.91 27.31 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.272 1.429 . . . . 0.0 110.545 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -72.07 150.27 92.4 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.96 -44.45 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.075 2.516 . . . . 0.0 114.416 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -58.19 -34.32 70.23 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.029 0.832 . . . . 0.0 111.782 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -29.82 71.08 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.049 -1.032 . . . . 0.0 111.024 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -73.72 -35.23 65.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.32 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.76 -31.55 64.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.231 0.923 . . . . 0.0 112.501 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.3 -29.75 67.67 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.58 2.64 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.559 1.144 . . . . 0.0 113.733 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -63.79 160.38 17.41 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 122.328 1.061 . . . . 0.0 110.163 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -143.92 175.0 10.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -70.6 110.16 5.29 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.456 0.702 . . . . 0.0 110.463 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.88 -78.29 0.77 Allowed Glycine 0 C--N 1.335 0.486 0 C-N-CA 125.862 1.696 . . . . 0.0 111.028 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.04 166.25 21.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.69 165.5 11.12 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 pt -128.51 -30.52 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.88 176.78 12.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 119.148 0.885 . . . . 0.0 108.62 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.56 145.92 58.95 Favored Pre-proline 0 C--O 1.238 0.473 0 O-C-N 123.083 0.239 . . . . 0.0 110.852 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -66.47 147.96 83.2 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.561 2.841 . . . . 0.0 107.847 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 mm -133.43 -52.44 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 124.043 0.937 . . . . 0.0 110.67 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -131.38 167.29 19.53 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.336 0.398 . . . . 0.0 111.297 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.5 t -135.31 141.15 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -137.07 165.6 25.65 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.679 1.592 . . . . 0.0 107.525 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.03 176.23 12.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.581 1.552 . . . . 0.0 107.838 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.57 166.61 6.57 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.742 0.817 . . . . 0.0 109.912 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.5 p -146.62 159.38 43.52 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.5 tp -76.8 146.05 38.09 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.7 mt -121.86 133.07 69.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -118.43 174.72 6.08 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.361 1.064 . . . . 0.0 109.878 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -73.27 -179.04 3.18 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.678 0.791 . . . . 0.0 112.847 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.93 -9.88 48.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.367 1.067 . . . . 0.0 113.214 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.82 -172.96 0.57 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.237 1.815 . . . . 0.0 108.317 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.96 1.29 8.64 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.208 1.003 . . . . 0.0 109.199 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -42.88 101.44 0.25 Allowed Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 129.796 3.239 . . . . 0.0 109.966 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.56 106.31 1.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.73 2.953 . . . . 0.0 111.437 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -155.61 75.4 5.11 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.9 116.65 4.73 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.877 3.051 . . . . 0.0 116.708 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -81.77 171.59 13.03 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.607 2.871 . . . . 0.0 110.164 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -136.75 -33.66 0.77 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.834 1.253 . . . . 0.0 111.804 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.2 162.62 33.79 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 117.974 0.352 . . . . 0.0 110.844 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -67.23 -18.23 65.15 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.999 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -64.51 -8.5 14.05 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.877 1.271 . . . . 0.0 113.4 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -107.08 -18.76 13.81 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.668 1.587 . . . . 0.0 110.996 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.6 mm -56.9 -58.18 19.36 Favored Pre-proline 0 C--N 1.333 -0.141 0 O-C-N 120.823 -1.173 . . . . 0.0 111.822 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -67.41 -25.61 41.74 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 120.501 1.215 . . . . 0.0 110.717 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.85 -41.16 83.34 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.631 1.173 . . . . 0.0 110.349 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.6 tp -82.46 -27.89 31.58 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.148 0.885 . . . . 0.0 109.759 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.71 -44.91 96.02 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 121.325 -0.86 . . . . 0.0 109.615 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -64.54 -28.42 69.63 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.558 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -75.11 -43.35 53.34 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 123.102 0.561 . . . . 0.0 110.658 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 54.2 mt -75.38 -29.96 60.0 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.465 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.14 -38.04 81.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.8 -22.16 66.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.704 1.202 . . . . 0.0 113.07 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.12 4.92 9.81 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 125.445 1.498 . . . . 0.0 112.358 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.92 -95.47 0.1 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 119.37 0.986 . . . . 0.0 113.634 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -142.1 178.21 7.69 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.84 1.256 . . . . 0.0 111.617 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.18 154.01 10.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.878 1.271 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.93 -63.54 1.34 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.954 1.302 . . . . 0.0 111.999 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 41.2 tp -97.43 138.08 35.42 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.323 1.049 . . . . 0.0 110.707 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 94.3 mtp -145.44 110.25 5.12 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -142.19 157.18 45.15 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -72.97 137.66 45.61 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.615 0.722 . . . . 0.0 110.744 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.8 mt -121.01 -9.51 9.21 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.807 1.643 . . . . 0.0 111.276 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -72.14 -22.26 61.34 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.625 0.77 . . . . 0.0 112.53 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -113.99 152.05 45.39 Favored Pre-proline 0 N--CA 1.468 0.425 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.46 -11.83 10.46 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.594 2.196 . . . . 0.0 114.791 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -60.57 -41.85 95.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 120.896 1.68 . . . . 0.0 111.986 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -76.42 -28.81 56.78 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 79.0 p -91.43 -9.4 44.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.474 0.71 . . . . 0.0 111.001 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -62.36 -61.13 8.19 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 121.173 -0.954 . . . . 0.0 111.84 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.19 -19.79 69.44 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 121.216 1.47 . . . . 0.0 112.625 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 47.1 tp -68.19 -61.6 1.78 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 15.8 pt -67.03 -27.33 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.254 0.479 . . . . 0.0 111.687 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.1 0.58 27.49 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.762 -1.211 . . . . 0.0 112.929 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.99 -52.34 66.19 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 119.408 1.004 . . . . 0.0 112.076 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -58.3 -58.43 8.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.744 0.817 . . . . 0.0 110.757 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -176.61 25.78 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.543 -1.143 . . . . 0.0 113.492 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.21 149.44 37.42 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -152.61 138.8 18.32 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.54 -64.79 0.92 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.86 126.64 32.68 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -69.8 148.97 48.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.992 0.517 . . . . 0.0 110.297 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -148.85 105.63 3.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.419 ' C ' ' H ' ' A' ' 174' ' ' GLY . 62.5 mt-10 -77.71 -166.41 0.77 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.85 1.26 . . . . 0.0 109.036 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -62.18 16.97 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.475 2.71 . . . . 0.0 113.403 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 172' ' ' GLU . . . 149.22 -2.8 0.62 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.989 1.757 . . . . 0.0 113.761 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -112.25 120.38 41.56 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.462 1.631 . . . . 0.0 107.732 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -118.43 112.88 20.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -125.86 106.3 9.56 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.46 -6.82 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.313 1.445 . . . . 0.0 112.183 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -31.79 57.81 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.857 1.663 . . . . 0.0 110.723 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.86 101.34 12.22 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.0 t -120.8 135.87 59.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 125.694 1.598 . . . . 0.0 109.784 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -114.3 18.1 18.52 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.202 -0.776 . . . . 0.0 114.664 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 66.4 t -49.52 -40.99 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.133 1.773 . . . . 0.0 114.051 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.8 23.91 12.6 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -70.56 167.6 18.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.406 0.622 . . . . 0.0 111.022 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.61 60.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.714 1.205 . . . . 0.0 113.691 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.85 -35.3 65.77 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 118.617 0.644 . . . . 0.0 112.288 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -68.23 -51.63 43.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.677 0.791 . . . . 0.0 109.459 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -61.75 -36.59 81.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.374 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.92 -48.91 79.65 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.668 0.667 . . . . 0.0 109.98 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.75 -36.88 93.89 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 27.3 tp -72.16 -51.09 22.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.47 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 6.2 t -56.21 -32.99 64.92 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.623 1.101 . . . . 0.0 111.122 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -58.66 -59.44 5.39 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.464 1.029 . . . . 0.0 109.232 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.06 -45.55 94.28 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.317 0.647 . . . . 0.0 110.529 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.8 t -57.87 -32.03 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.369 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.496 ' CG ' ' HZ3' ' A' ' 200' ' ' LYS . 0.3 OUTLIER -65.02 -35.84 82.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.983 1.265 . . . . 0.0 111.1 179.388 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 25.1 mt -64.73 -36.19 83.5 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.25 -41.88 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.094 1.358 . . . . 0.0 109.182 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.496 ' HZ3' ' CG ' ' A' ' 197' ' ' ASP . 34.6 mtpt -52.55 -45.56 66.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.97 1.308 . . . . 0.0 108.917 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -88.24 2.76 51.58 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.148 1.779 . . . . 0.0 112.749 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.1 mptt 56.51 19.93 4.49 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.319 2.248 . . . . 0.0 112.934 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -31.45 65.07 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.429 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.0 tpt -89.19 -176.61 5.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.811 1.645 . . . . 0.0 111.514 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -125.63 73.14 1.31 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.576 1.55 . . . . 0.0 108.84 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.73 -18.77 56.53 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -79.81 -7.12 58.49 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.418 1.887 . . . . 0.0 112.564 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 51.9 m -72.19 120.81 18.31 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.303 1.049 . . . . 0.0 109.339 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -118.7 175.1 5.89 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -48.73 -41.23 31.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.507 0.723 . . . . 0.0 112.262 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.8 t -57.35 -51.96 67.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.562 1.945 . . . . 0.0 111.954 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 16.5 mm -61.75 -47.71 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 124.406 1.082 . . . . 0.0 111.323 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.1 -45.84 66.11 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.969 -178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -56.94 -45.09 83.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.451 0.569 . . . . 0.0 111.023 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.86 -57.91 10.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.207 0.603 . . . . 0.0 109.97 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.35 -47.28 69.53 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.694 0.798 . . . . 0.0 110.826 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -59.03 -41.47 87.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.9 1.28 . . . . 0.0 111.622 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -61.03 -37.01 81.05 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.763 0.711 . . . . 0.0 110.413 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -74.48 -45.09 48.3 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 116.06 14.3 7.9 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.916 2.198 . . . . 0.0 109.755 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -70.29 21.34 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.763 3.225 . . . . 0.0 112.789 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.2 p -130.48 174.74 9.59 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.57 2.348 . . . . 0.0 109.345 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.09 -33.73 2.4 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.742 0.817 . . . . 0.0 112.106 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 7.8 ptt? -152.86 161.15 42.92 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.847 0.859 . . . . 0.0 109.05 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.0 t -151.83 173.07 15.22 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 14.4 mt -139.89 93.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -132.47 166.14 22.71 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.017 0.927 . . . . 0.0 109.188 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -125.52 171.78 17.45 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.111 0.862 . . . . 0.0 113.899 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.12 173.89 5.54 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 125.152 3.901 . . . . 0.0 112.881 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 14.3 t90 68.85 -12.45 0.38 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.762 2.425 . . . . 0.0 112.366 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.72 95.75 1.93 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -78.63 100.99 7.23 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 14.4 m -117.3 -42.84 2.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.318 1.047 . . . . 0.0 110.726 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -130.99 177.47 7.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.301 1.841 . . . . 0.0 108.212 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 60.6 mt -124.9 95.11 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 102.175 -3.269 . . . . 0.0 102.175 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -134.71 137.27 43.37 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.832 1.253 . . . . 0.0 107.618 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 24.3 m -83.09 104.99 13.7 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.455 1.102 . . . . 0.0 110.015 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 17.0 p -68.78 97.69 0.84 Allowed 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.648 1.179 . . . . 0.0 109.748 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -139.45 144.77 38.19 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.117 0.967 . . . . 0.0 108.83 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . 0.371 10.3 p 55.45 38.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 125.572 1.549 . . . . 0.0 110.165 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -76.99 74.4 3.57 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -94.03 167.54 11.53 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.748 0.819 . . . . 0.0 109.844 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 84.71 133.44 2.7 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -144.62 159.55 14.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.2 t -163.11 171.0 17.02 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.64 161.31 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.81 156.17 45.33 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 124.26 1.024 . . . . 0.0 109.185 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.78 125.97 10.38 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.527 2.152 . . . . 0.0 109.947 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 43.4 p -143.5 -151.44 0.36 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.44 141.8 39.77 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 177.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -53.0 125.83 18.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.415 1.886 . . . . 0.0 110.386 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 61.63 11.67 30.27 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.808 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.57 75.75 5.06 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.1 154.87 57.38 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.971 1.781 . . . . 0.0 114.112 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 33.8 m -65.01 140.88 58.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.19 93.32 5.09 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 125.227 1.411 . . . . 0.0 109.053 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.32 -63.01 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.327 2.018 . . . . 0.0 111.472 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -153.06 174.35 14.3 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.667 1.587 . . . . 0.0 108.366 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.9 113.99 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.12 132.8 9.3 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 105.398 -3.081 . . . . 0.0 105.398 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.48 156.77 42.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-N 117.852 0.826 . . . . 0.0 109.851 -178.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.7 139.97 30.01 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.017 0.927 . . . . 0.0 109.115 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.2 m -131.75 169.11 16.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.154 0.982 . . . . 0.0 112.138 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -134.69 140.42 45.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.865 1.266 . . . . 0.0 108.325 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.64 167.69 16.92 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.9 mt -117.48 135.59 57.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.07 115.28 14.53 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.82 -15.53 21.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.65 0.78 . . . . 0.0 113.012 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -66.29 -23.24 66.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.332 1.053 . . . . 0.0 111.663 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 11.2 m -60.42 154.81 52.08 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 126.187 1.795 . . . . 0.0 112.649 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.5 -47.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.347 2.032 . . . . 0.0 111.801 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.44 86.25 2.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.701 0.8 . . . . 0.0 109.477 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -52.84 -24.05 8.23 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.236 1.414 . . . . 0.0 112.332 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -59.37 -34.68 72.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.193 1.797 . . . . 0.0 110.15 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.24 -36.98 81.43 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 120.713 -1.242 . . . . 0.0 110.009 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.23 57.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.948 -0.549 . . . . 0.0 111.028 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -37.4 87.07 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.845 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -71.54 -51.24 24.57 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 124.024 0.828 . . . . 0.0 109.747 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -48.87 -52.91 21.75 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.913 0.485 . . . . 0.0 110.295 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.86 -55.23 31.96 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.321 0.248 . . . . 0.0 111.353 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.318 7.6 pt-20 -71.57 1.65 6.28 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -177.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -115.11 -21.0 10.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.229 -1.367 . . . . 0.0 111.226 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -132.5 -59.21 0.92 Allowed 'General case' 0 C--N 1.346 0.418 0 CA-C-N 119.998 1.272 . . . . 0.0 109.673 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.65 -42.48 62.11 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 44.0 mt -82.91 27.52 0.54 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 14.8 p -113.7 167.77 10.34 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.57 -38.51 90.35 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -71.41 -38.55 71.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.982 0.913 . . . . 0.0 111.604 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -69.08 -45.7 61.36 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.94 -46.41 81.72 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -57.1 -43.57 82.35 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.802 0.841 . . . . 0.0 110.291 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.2 -49.92 68.28 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.65 -36.33 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 119.375 -0.345 . . . . 0.0 110.24 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -63.75 -27.43 69.19 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.706 0.803 . . . . 0.0 111.656 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -67.44 -43.64 80.65 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.759 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -70.24 -56.44 6.76 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.878 0.763 . . . . 0.0 109.749 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -134.92 145.04 52.95 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.27 136.37 40.09 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.518 2.145 . . . . 0.0 112.252 -178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 80.3 mt -78.48 -29.84 46.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 101.09 -78.39 0.4 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 105.9 -2.88 . . . . 0.0 105.9 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -149.35 171.09 17.09 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 131.577 3.951 . . . . 0.0 104.93 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 35.9 m -132.18 149.88 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 O-C-N 120.656 -1.277 . . . . 0.0 112.244 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.69 -21.33 55.52 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.623 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.93 105.26 1.94 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 126.287 1.835 . . . . 0.0 107.256 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -53.57 -27.63 27.47 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.9 m -73.11 -61.18 1.91 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 118.552 0.614 . . . . 0.0 111.246 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -67.36 -23.63 65.62 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.571 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -63.95 -21.41 66.47 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.206 0.912 . . . . 0.0 108.719 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -72.97 -37.51 67.05 Favored 'General case' 0 C--N 1.342 0.245 0 O-C-N 120.286 -1.509 . . . . 0.0 108.725 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -70.26 -46.91 63.42 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.185 0.994 . . . . 0.0 108.607 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 23.1 mt -63.31 -40.71 98.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.17 -11.63 9.79 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.82 -11.48 27.47 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.488 1.04 . . . . 0.0 111.201 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.52 133.66 23.53 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -56.78 -23.85 52.38 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.133 2.555 . . . . 0.0 115.946 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -44.18 96.92 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.298 1.408 . . . . 0.0 110.802 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.8 mp -74.55 -46.38 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.55 -52.23 48.82 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.291 0.496 . . . . 0.0 110.112 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.85 -35.63 78.85 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.722 -0.611 . . . . 0.0 112.059 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.0 m -62.04 -39.25 91.71 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.58 -40.77 48.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.694 0.398 . . . . 0.0 110.55 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -53.05 -45.78 68.21 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.436 1.495 . . . . 0.0 109.784 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -41.35 94.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.76 -36.5 83.27 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.838 0.745 . . . . 0.0 111.414 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -63.66 -30.52 71.62 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.455 1.502 . . . . 0.0 110.622 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.28 10.11 41.72 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.176 0.99 . . . . 0.0 111.807 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -118.87 -179.59 16.83 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 115.086 0.794 . . . . 0.0 115.086 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.98 164.33 30.31 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.041 1.337 . . . . 0.0 110.596 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 31.4 mt -78.16 160.73 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 125.521 1.529 . . . . 0.0 108.128 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 46.3 ttp -66.33 139.99 96.54 Favored Pre-proline 0 CA--C 1.538 0.494 0 O-C-N 121.085 -1.01 . . . . 0.0 108.512 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.29 179.5 6.31 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.505 2.137 . . . . 0.0 112.482 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -138.77 10.09 2.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.794 1.638 . . . . 0.0 110.99 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.9 pt -82.3 154.59 69.33 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 120.341 -1.475 . . . . 0.0 111.213 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.46 -17.01 16.78 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.163 2.575 . . . . 0.0 113.497 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -57.45 -21.57 37.85 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.501 1.12 . . . . 0.0 112.506 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 73.8 mmm -57.83 -31.13 66.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.336 1.054 . . . . 0.0 111.154 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 22.4 t -57.3 -53.04 62.65 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.88 -29.64 65.79 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 118.401 -0.809 . . . . 0.0 112.101 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -57.75 -58.53 7.97 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.573 0.624 . . . . 0.0 109.754 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -56.25 -44.01 79.25 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -59.09 -39.92 83.71 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.113 0.415 . . . . 0.0 110.942 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.38 -59.98 2.95 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.157 0.583 . . . . 0.0 111.675 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 3.2 m -59.27 -36.73 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 118.944 -0.551 . . . . 0.0 111.901 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 56.9 ttp85 -56.75 -37.22 70.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.261 0.937 . . . . 0.0 109.774 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 54.0 m -79.93 -44.49 20.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.683 -0.675 . . . . 0.0 109.834 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.45 -46.05 69.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.384 0.993 . . . . 0.0 112.882 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 89.0 t -59.11 -52.78 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.8 mm -64.08 -35.51 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.845 0.748 . . . . 0.0 110.491 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -61.22 -45.83 92.96 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.623 -1.298 . . . . 0.0 110.537 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.57 -50.32 32.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.128 0.571 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.42 -35.54 77.84 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.461 1.504 . . . . 0.0 114.895 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 28.9 m -91.22 0.33 57.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.206 0.602 . . . . 0.0 109.87 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 71.13 12.87 72.5 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 119.379 -0.679 . . . . 0.0 113.534 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -64.54 -32.96 74.82 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.313 1.056 . . . . 0.0 108.469 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -147.3 163.65 35.72 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.3 m -66.45 155.94 36.13 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.272 1.029 . . . . 0.0 108.917 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.58 -52.64 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.776 0.83 . . . . 0.0 110.001 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.66 -50.8 71.02 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.486 1.115 . . . . 0.0 110.159 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -62.0 -42.06 98.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.52 94.27 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 122.025 -0.422 . . . . 0.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 46.6 mt -71.23 -42.89 68.3 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.341 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -54.63 -50.74 67.4 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.396 1.079 . . . . 0.0 108.838 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.7 -49.95 69.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.42 87.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.159 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -58.84 -38.18 78.12 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.27 0.941 . . . . 0.0 108.676 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.4 m -64.22 -47.16 80.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.913 0.885 . . . . 0.0 109.309 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 72.0 mtt-85 -57.89 -25.71 61.17 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.321 0.964 . . . . 0.0 113.212 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 70.1 mt -94.57 -19.26 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 126.925 2.09 . . . . 0.0 112.101 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 66.5 p -113.56 1.95 15.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.24 1.382 . . . . 0.0 114.459 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? . . . . . 0 C--O 1.248 1.013 0 C-N-CA 125.179 1.392 . . . . 0.0 109.134 179.5 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.3 tptt . . . . . 0 N--CA 1.467 0.411 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 57.5 mt -92.79 128.13 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.92 121.3 20.75 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.939 1.696 . . . . 0.0 107.409 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.82 165.44 14.13 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.727 0.694 . . . . 0.0 111.037 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.15 35.78 89.16 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.101 1.334 . . . . 0.0 114.768 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -143.51 169.58 17.44 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.809 1.304 . . . . 0.0 112.974 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.1 mt -151.98 141.24 21.41 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.207 3.003 . . . . 0.0 108.012 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.08 134.44 36.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 119.784 1.175 . . . . 0.0 108.78 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.2 mt -124.11 128.69 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 125.244 1.417 . . . . 0.0 108.752 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -114.61 138.99 49.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.38 159.98 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.924 0.783 . . . . 0.0 109.502 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -154.39 166.43 33.26 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.27 24.2 27.29 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-O 117.823 -1.543 . . . . 0.0 114.857 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.1 t70 68.97 24.1 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.427 1.491 . . . . 0.0 114.413 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -59.39 157.2 11.48 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.444 1.897 . . . . 0.0 112.591 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.15 67.32 3.63 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.794 1.664 . . . . 0.0 109.818 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -58.75 -33.74 70.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.839 0.819 . . . . 0.0 112.484 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -61.17 -45.69 93.6 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.525 0.602 . . . . 0.0 109.791 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.77 -37.59 94.53 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.7 tp -69.93 -35.98 74.97 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 121.634 -0.921 . . . . 0.0 110.977 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.49 -40.14 36.32 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 117.681 -1.152 . . . . 0.0 112.821 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.78 -37.62 74.03 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.843 1.257 . . . . 0.0 113.386 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 t -61.54 -52.12 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.67 76.65 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -64.37 -29.42 70.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 118.817 1.308 . . . . 0.0 109.83 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HB2' ' HZ2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -81.12 -52.04 7.81 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -53.31 -48.21 68.61 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.017 0.371 . . . . 0.0 110.453 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -60.38 -39.15 86.24 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.728 -1.232 . . . . 0.0 110.802 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 tppt? -67.19 -28.3 67.98 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.554 0.742 . . . . 0.0 111.476 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -98.34 -3.89 36.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.935 1.294 . . . . 0.0 112.434 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.3 p -135.8 -36.04 0.77 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.45 -15.97 61.32 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.281 1.42 . . . . 0.0 112.054 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.85 130.38 28.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -68.44 130.26 42.35 Favored 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 121.498 -0.751 . . . . 0.0 109.414 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 t -128.46 118.34 47.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 33.9 m -114.34 142.96 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.614 0.766 . . . . 0.0 110.903 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.0 t -120.18 131.19 73.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -137.05 169.04 18.44 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.28 1.032 . . . . 0.0 109.404 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -140.25 54.55 5.3 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.26 168.31 25.11 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.877 2.385 . . . . 0.0 110.509 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -124.76 -7.71 7.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.258 1.023 . . . . 0.0 111.142 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.14 2.52 55.08 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.39 1.876 . . . . 0.0 111.103 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -48.55 -34.09 10.81 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 124.193 0.997 . . . . 0.0 111.988 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -46.7 -33.57 4.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.04 2.136 . . . . 0.0 111.93 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -120.04 -21.25 7.15 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 125.92 1.688 . . . . 0.0 111.067 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -46.68 21.51 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.383 -1.448 . . . . 0.0 110.879 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -49.66 -55.62 21.87 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.41 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.7 0.33 3.1 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.899 1.733 . . . . 0.0 114.962 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -109.72 -15.48 14.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.865 1.211 . . . . 0.0 112.548 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.41 -28.36 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.64 1.176 . . . . 0.0 110.215 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.48 -18.27 59.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.075 -1.016 . . . . 0.0 110.725 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.98 -20.27 62.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.137 0.975 . . . . 0.0 110.985 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.7 p -119.96 -2.47 10.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.563 1.545 . . . . 0.0 112.572 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.14 8.94 85.82 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.8 -14.05 59.47 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.362 -1.081 . . . . 0.0 109.947 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.37 -172.85 48.4 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.898 1.714 . . . . 0.0 115.104 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -64.95 -178.05 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.73 3.62 . . . . 0.0 112.507 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -116.31 -12.85 11.08 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.5 mt -140.87 150.61 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 tt -137.62 132.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.22 107.99 13.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.25 1.82 . . . . 0.0 108.235 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -151.46 -175.67 5.28 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.49 147.01 40.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.02 -1.05 . . . . 0.0 108.662 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -49.19 -45.44 44.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.237 1.415 . . . . 0.0 112.223 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -62.31 -4.73 1.94 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.683 1.993 . . . . 0.0 115.534 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -110.55 -4.25 15.57 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.215 0.916 . . . . 0.0 110.871 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -97.32 -18.98 18.83 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.42 -44.58 77.01 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 120.207 1.367 . . . . 0.0 112.217 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.75 -47.88 30.97 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.722 -1.043 . . . . 0.0 112.014 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -55.78 -39.12 70.82 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.985 1.393 . . . . 0.0 110.465 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.61 -47.34 76.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.706 -0.664 . . . . 0.0 109.429 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -37.14 80.18 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.529 0.604 . . . . 0.0 110.012 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.8 m -63.97 -13.74 48.52 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.13 -0.981 . . . . 0.0 110.686 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.34 10.94 67.51 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 126.168 1.842 . . . . 0.0 113.426 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.5 mt -83.68 -3.71 57.99 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.949 1.374 . . . . 0.0 114.203 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.8 mt -109.0 137.57 46.7 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.048 1.294 . . . . 0.0 110.139 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.94 179.56 5.49 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.604 1.162 . . . . 0.0 111.812 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -92.19 92.04 8.03 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pp -69.28 169.35 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.991 0.916 . . . . 0.0 112.413 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.283 7.6 p 49.51 73.69 0.95 Allowed Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 127.459 2.304 . . . . 0.0 112.054 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.11 -22.68 46.96 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.628 2.219 . . . . 0.0 112.667 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -128.81 164.31 23.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.616 1.967 . . . . 0.0 108.895 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -85.52 -34.9 21.44 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.76 -21.59 19.79 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.456 1.48 . . . . 0.0 114.531 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -68.5 -30.18 68.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -64.69 -41.08 96.29 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 120.964 -1.085 . . . . 0.0 110.024 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.81 -16.46 63.11 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.556 1.542 . . . . 0.0 112.123 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -84.66 -2.56 57.69 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 120.896 -1.127 . . . . 0.0 110.967 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt -131.14 159.22 38.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.371 1.068 . . . . 0.0 110.493 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -77.68 152.43 80.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.452 0.701 . . . . 0.0 109.272 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.88 -42.56 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.719 2.946 . . . . 0.0 114.75 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -58.09 -44.31 87.53 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.668 1.122 . . . . 0.0 110.707 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.75 -28.33 69.51 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.102 1.361 . . . . 0.0 111.26 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -71.3 -42.63 68.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.24 0.616 . . . . 0.0 110.331 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.12 -28.23 51.15 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.903 0.881 . . . . 0.0 111.647 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.37 -23.73 65.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.07 1.348 . . . . 0.0 114.263 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.57 11.61 6.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.375 1.07 . . . . 0.0 112.368 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -72.25 147.72 46.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.288 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.465 ' CD1' ' HE3' ' A' ' 102' ' ' LYS . 51.2 t80 -131.84 178.69 6.57 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.935 1.294 . . . . 0.0 108.543 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -57.67 89.82 0.01 OUTLIER 'General case' 0 C--O 1.235 0.308 0 C-N-CA 127.711 2.404 . . . . 0.0 109.546 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.14 -77.93 1.13 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.465 ' HE3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -66.83 177.03 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.8 1.24 . . . . 0.0 109.395 179.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.7 mt -116.52 -179.54 3.71 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 110.893 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.9 pt -133.74 -29.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.5 177.64 9.3 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.969 0.804 . . . . 0.0 109.443 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.38 145.93 54.58 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 124.238 1.015 . . . . 0.0 108.733 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.37 145.73 54.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.925 2.417 . . . . 0.0 108.17 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.0 mm -129.0 -50.56 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 123.369 0.668 . . . . 0.0 109.963 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.25 157.39 44.49 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.932 0.396 . . . . 0.0 111.169 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.15 119.37 26.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.006 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -161.2 149.99 16.21 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.172 0.989 . . . . 0.0 109.313 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.4 81.64 1.67 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.696 1.198 . . . . 0.0 110.523 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.94 107.62 1.28 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.949 1.3 . . . . 0.0 109.447 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.1 p -149.0 131.29 15.56 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.492 1.117 . . . . 0.0 110.694 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.8 tp -136.13 170.2 16.39 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.645 1.178 . . . . 0.0 110.56 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 mt -135.55 140.16 45.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 126.288 1.835 . . . . 0.0 106.9 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -141.33 171.26 14.31 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.581 1.952 . . . . 0.0 107.404 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.69 157.48 9.3 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.234 0.54 . . . . 0.0 111.438 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -70.61 -6.91 40.23 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.024 0.93 . . . . 0.0 112.76 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -69.16 158.32 35.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.896 0.855 . . . . 0.0 110.378 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.96 9.78 0.86 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.05 2.14 . . . . 0.0 115.65 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.25 69.27 2.6 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.145 1.378 . . . . 0.0 113.717 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.01 89.29 1.25 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.676 2.917 . . . . 0.0 112.19 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -129.83 68.08 80.23 Favored Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -72.11 168.08 25.03 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.061 2.508 . . . . 0.0 113.014 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.7 171.25 13.58 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.75 2.967 . . . . 0.0 113.571 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -123.85 -17.13 6.42 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 117.192 -1.385 . . . . 0.0 112.776 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.65 143.93 31.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.84 1.655 . . . . 0.0 112.205 -178.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -65.24 -22.77 66.92 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.394 -0.816 . . . . 0.0 111.911 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -72.19 -12.78 61.33 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.371 0.668 . . . . 0.0 111.934 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -98.85 -19.02 17.61 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.094 1.758 . . . . 0.0 111.014 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.33 -52.62 70.04 Favored Pre-proline 0 N--CA 1.465 0.319 0 C-N-CA 124.6 1.16 . . . . 0.0 109.851 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -69.37 -24.76 31.12 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 120.248 1.124 . . . . 0.0 111.771 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.35 -54.23 27.01 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.08 -30.02 70.71 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.175 -0.953 . . . . 0.0 110.316 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -61.78 -45.18 95.0 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.616 1.166 . . . . 0.0 110.352 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -74.39 -25.48 59.5 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.523 -0.736 . . . . 0.0 111.688 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.58 -45.84 61.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.675 -0.679 . . . . 0.0 110.249 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . 0.259 6.2 mt -80.1 -24.18 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 117.876 -1.53 . . . . 0.0 110.799 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -66.96 -31.56 72.21 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.19 -11.89 60.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.56 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.67 0.77 8.16 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.516 1.527 . . . . 0.0 111.932 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 172.14 -91.05 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 119.467 1.031 . . . . 0.0 113.721 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.08 -175.83 4.38 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.802 0.841 . . . . 0.0 109.659 -178.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.7 p -74.34 166.2 23.88 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.37 -63.9 1.31 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.039 2.536 . . . . 0.0 112.268 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.4 tp -102.92 137.15 41.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.473 1.509 . . . . 0.0 107.941 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 65.6 mtp -148.34 103.07 3.4 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 128.373 2.669 . . . . 0.0 105.721 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -128.33 161.93 28.27 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -72.38 93.56 1.54 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.007 0.908 . . . . 0.0 112.114 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.5 mt -73.48 -8.81 57.46 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.631 1.572 . . . . 0.0 110.288 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -70.58 -19.12 62.88 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.403 1.481 . . . . 0.0 112.597 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -115.66 135.62 22.69 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.619 1.1 . . . . 0.0 111.896 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.05 -21.93 48.48 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.759 2.306 . . . . 0.0 112.961 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -59.96 -27.34 66.73 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.505 0.593 . . . . 0.0 112.237 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -86.85 -44.91 11.34 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.791 0.723 . . . . 0.0 111.307 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.5 p -76.99 -17.2 59.02 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -62.12 -60.85 8.95 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 117.844 -1.074 . . . . 0.0 113.073 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.9 -23.53 76.05 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.318 1.863 . . . . 0.0 111.422 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.34 -57.59 10.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 22.6 pt -69.19 -25.25 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.028 0.442 . . . . 0.0 111.229 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.56 -23.14 65.39 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 120.901 -1.124 . . . . 0.0 111.06 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.76 87.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -57.96 -58.9 6.37 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.92 5.1 0.03 OUTLIER Glycine 0 CA--C 1.522 0.523 0 CA-C-O 118.688 -1.062 . . . . 0.0 115.064 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.62 129.88 33.72 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.244 1.522 . . . . 0.0 109.329 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -138.46 149.24 45.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.821 1.31 . . . . 0.0 108.092 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.09 -66.62 0.74 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -140.19 173.22 11.73 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.266 1.427 . . . . 0.0 107.869 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -114.5 139.59 49.43 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -155.74 117.1 3.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.229 1.412 . . . . 0.0 107.792 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -160.32 163.33 33.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.898 1.279 . . . . 0.0 108.706 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 49.74 26.87 2.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.269 1.828 . . . . 0.0 112.961 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.83 9.25 87.26 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.265 -1.297 . . . . 0.0 113.469 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -115.06 118.94 34.8 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.93 1.865 . . . . 0.0 107.612 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.06 116.69 23.22 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.118 1.767 . . . . 0.0 109.451 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -130.3 104.09 7.08 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.414 HD12 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -64.6 -3.36 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 125.152 1.381 . . . . 0.0 112.341 178.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -72.89 -36.25 67.28 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.676 1.191 . . . . 0.0 111.015 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -89.78 72.31 7.64 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.94 0.896 . . . . 0.0 111.112 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.2 138.76 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 128.295 2.638 . . . . 0.0 111.446 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.83 15.16 10.44 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -1.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 120.116 1.958 . . . . 0.0 115.36 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -125.52 14.03 8.17 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.641 1.564 . . . . 0.0 111.639 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -71.09 158.4 36.53 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.941 -1.099 . . . . 0.0 108.456 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -48.69 -31.77 7.35 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.12 -37.59 42.51 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 119.504 1.047 . . . . 0.0 112.845 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.83 88.25 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -71.42 -35.5 70.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.415 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -56.65 -50.76 71.11 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.012 1.278 . . . . 0.0 111.209 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.83 -34.44 88.68 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.612 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 60.3 tp -70.05 -55.17 10.2 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.948 0.874 . . . . 0.0 110.476 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.0 t -55.2 -41.71 72.35 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.585 -1.198 . . . . 0.0 108.989 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -57.01 -54.05 51.1 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.707 1.14 . . . . 0.0 109.278 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.29 -44.58 88.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.801 0.841 . . . . 0.0 111.33 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 72.6 t -67.16 -31.2 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 121.431 -0.793 . . . . 0.0 109.783 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -39.91 82.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 O-C-N 121.283 -0.885 . . . . 0.0 109.141 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.54 -45.53 90.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 70.2 mt -59.37 -49.0 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -54.69 -37.96 66.44 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.979 0.912 . . . . 0.0 110.534 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -92.44 8.02 40.49 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 64.8 22.16 12.49 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.976 1.71 . . . . 0.0 113.256 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -85.94 -3.97 59.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.769 1.228 . . . . 0.0 110.669 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 77.4 mtp -143.64 167.33 22.51 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.504 1.922 . . . . 0.0 107.703 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -120.9 92.71 3.82 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.851 1.26 . . . . 0.0 109.728 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.99 -11.58 14.22 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.017 1.327 . . . . 0.0 114.38 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -89.1 -5.24 57.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.388 1.475 . . . . 0.0 111.762 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.7 m -69.96 131.1 43.87 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.74 0.816 . . . . 0.0 110.48 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.433 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 7.6 p30 -129.38 -177.5 4.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.704 2.002 . . . . 0.0 108.281 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -62.92 -26.66 68.91 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.6 m -91.4 -34.66 14.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.257 1.423 . . . . 0.0 109.562 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.433 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 33.1 mm -66.13 -49.12 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.39 -53.15 61.57 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.946 0.898 . . . . 0.0 109.039 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -60.16 -33.88 72.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.238 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.94 -54.28 23.52 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 119.309 0.959 . . . . 0.0 108.738 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.88 82.91 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.843 0.857 . . . . 0.0 109.865 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.96 -37.73 88.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.26 0.624 . . . . 0.0 110.244 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.06 -23.71 67.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.906 0.775 . . . . 0.0 109.786 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -87.84 -20.25 26.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.247 1.019 . . . . 0.0 109.658 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.36 12.65 72.6 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.514 1.531 . . . . 0.0 111.752 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -66.23 -45.85 79.21 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.911 0.855 . . . . 0.0 110.87 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 43.5 p -71.38 171.5 11.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.919 1.688 . . . . 0.0 109.069 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -129.38 -13.48 4.37 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -157.21 -179.63 8.38 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 121.745 -0.597 . . . . 0.0 110.653 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.3 t -164.53 174.29 11.07 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.475 1.51 . . . . 0.0 107.39 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.4 mt -148.19 109.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -148.68 164.59 33.89 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.327 1.051 . . . . 0.0 108.452 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 159.32 81.87 0.04 OUTLIER Glycine 0 CA--C 1.523 0.544 0 N-CA-C 107.927 -2.069 . . . . 0.0 107.927 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -76.03 46.89 1.84 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.746 3.631 . . . . 0.0 112.648 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -74.12 51.97 0.43 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.511 1.524 . . . . 0.0 111.929 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.97 124.55 23.64 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.765 1.626 . . . . 0.0 108.524 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 64.1 t-105 46.75 43.6 13.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.451 1.5 . . . . 0.0 111.804 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 72.7 m 45.58 39.21 4.63 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.08 1.752 . . . . 0.0 113.192 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -60.76 146.27 46.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.8 pt -65.92 173.97 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.527 0.731 . . . . 0.0 109.479 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 80.4 6.54 1.58 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 128.117 2.567 . . . . 0.0 113.151 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 4.5 m -59.73 -30.8 69.08 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.554 -1.341 . . . . 0.0 110.809 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 10.7 p -81.18 5.86 15.63 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.022 1.329 . . . . 0.0 113.123 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -53.41 -29.95 37.67 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.943 1.247 . . . . 0.0 112.341 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 1.9 p -115.97 123.71 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 102.331 -3.211 . . . . 0.0 102.331 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -64.29 -49.4 71.97 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.301 0.64 . . . . 0.0 109.575 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -178.18 178.07 0.94 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 128.188 2.595 . . . . 0.0 107.081 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 148.01 142.51 3.67 Favored Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 107.564 -2.214 . . . . 0.0 107.564 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.88 130.43 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 118.248 1.024 . . . . 0.0 108.332 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.0 t -169.97 172.12 6.72 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.393 0.677 . . . . 0.0 109.681 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 14.9 p -67.88 160.16 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -131.61 155.89 80.84 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 118.506 0.594 . . . . 0.0 111.382 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.91 134.49 23.68 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.802 1.668 . . . . 0.0 109.924 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 65.1 p -129.78 176.58 7.91 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.883 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -88.73 140.25 29.63 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -52.89 131.76 36.11 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.519 -1.363 . . . . 0.0 110.871 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.38 -1.36 50.91 Favored Glycine 0 CA--C 1.519 0.285 0 CA-C-O 118.54 -1.144 . . . . 0.0 114.635 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.93 103.39 3.19 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 119.647 1.723 . . . . 0.0 111.842 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.17 170.23 15.0 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.345 2.696 . . . . 0.0 114.376 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 74.9 m -57.75 140.79 50.67 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.164 1.386 . . . . 0.0 110.648 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -140.25 73.95 30.56 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.478 1.111 . . . . 0.0 108.439 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.98 -95.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.578 3.518 . . . . 0.0 109.121 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -136.2 178.32 7.15 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 128.623 2.769 . . . . 0.0 107.631 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 85.3 t -96.91 130.98 44.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.59 59.94 0.41 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 1.5 p -69.18 112.98 4.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 121.427 0.632 . . . . 0.0 109.301 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 8.8 tt -77.87 134.75 37.88 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.5 m -125.7 168.31 13.93 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.616 1.167 . . . . 0.0 110.712 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -137.05 140.99 42.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.03 147.59 19.27 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 69.8 mt -90.32 136.77 23.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -71.73 128.24 35.13 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.4 8.23 2.38 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -116.25 3.41 13.41 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.09 1.314 . . . . 0.0 112.48 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 62.7 m -63.5 160.51 42.23 Favored Pre-proline 0 C--O 1.237 0.447 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.8 -60.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 108.333 -1.449 . . . . 0.0 108.333 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -123.78 102.68 7.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -16.19 37.38 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.239 0.472 . . . . 0.0 110.595 178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -57.17 -41.9 80.09 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 127.456 2.303 . . . . 0.0 108.469 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.02 -37.09 76.12 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.018 -1.051 . . . . 0.0 110.852 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.06 -46.82 40.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 122.094 -0.379 . . . . 0.0 109.994 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -34.48 76.46 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.704 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.51 -55.24 10.76 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -52.55 -46.26 66.71 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.042 -1.036 . . . . 0.0 111.617 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -51.66 68.7 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 119.264 -0.398 . . . . 0.0 110.929 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -10.98 59.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -108.59 -27.73 9.7 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -138.11 -25.62 0.95 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 120.102 1.319 . . . . 0.0 114.04 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.51 -51.02 10.58 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.681 1.128 . . . . 0.0 110.859 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 88.7 mt -86.57 68.36 10.15 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.602 1.161 . . . . 0.0 110.819 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.8 p -135.21 162.62 32.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -75.75 5.0 6.82 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.395 0.617 . . . . 0.0 110.457 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -113.26 -42.82 3.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.091 2.156 . . . . 0.0 109.478 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.93 -37.11 87.64 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.18 1.371 . . . . 0.0 111.884 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.09 -36.06 61.74 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.556 1.178 . . . . 0.0 109.267 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -70.33 -39.26 74.83 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.807 0.843 . . . . 0.0 110.044 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -53.73 -38.31 64.22 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.16 0.891 . . . . 0.0 112.707 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 20.2 t -81.34 -35.47 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.148 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -63.35 -33.34 75.31 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.852 0.861 . . . . 0.0 111.356 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -61.33 -54.06 48.75 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.139 1.376 . . . . 0.0 108.784 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -42.42 99.14 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -152.42 141.76 14.43 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 124.873 1.269 . . . . 0.0 107.801 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.75 110.56 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.435 2.09 . . . . 0.0 109.031 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 12.5 mt -75.22 -22.25 58.07 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.27 -155.7 19.91 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.504 -1.839 . . . . 0.0 108.504 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.6 178.06 5.63 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.965 0.888 . . . . 0.0 109.398 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.74 150.55 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 C-N-CA 123.753 0.821 . . . . 0.0 109.198 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.24 -20.86 40.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.625 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.1 106.9 6.83 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.971 1.708 . . . . 0.0 110.165 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -56.42 -26.55 53.89 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.8 m -57.13 -54.79 42.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.635 1.107 . . . . 0.0 110.663 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -90.46 -17.96 26.21 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.517 0.727 . . . . 0.0 111.803 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -60.88 -39.77 90.47 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.895 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -66.58 -15.89 63.76 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.529 1.059 . . . . 0.0 113.033 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -95.73 -23.49 16.95 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.704 2.001 . . . . 0.0 110.323 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 32.4 mt -86.69 -44.4 11.85 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.76 -17.9 57.78 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.888 2.075 . . . . 0.0 112.03 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.489 ' HE3' ' HB2' ' A' ' 314' ' ' ASP . 0.1 OUTLIER -69.81 -16.91 63.36 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.695 -0.628 . . . . 0.0 109.561 178.071 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.489 ' HB2' ' HE3' ' A' ' 313' ' ' LYS . 2.5 t70 -103.94 131.51 21.9 Favored Pre-proline 0 N--CA 1.438 -1.051 0 C-N-CA 125.91 1.684 . . . . 0.0 107.562 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.81 -23.63 67.86 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.497 2.131 . . . . 0.0 114.43 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 -60.39 -54.98 39.16 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.848 1.259 . . . . 0.0 111.009 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.4 mp -71.96 -49.37 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.92 -52.06 36.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 123.948 0.78 . . . . 0.0 111.903 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.22 -28.45 70.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.511 0.596 . . . . 0.0 112.566 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 24.0 m -76.61 -37.45 56.4 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.1 tpt -71.84 -33.1 68.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.715 1.206 . . . . 0.0 111.393 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -55.99 -35.37 66.7 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.691 0.796 . . . . 0.0 109.696 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -63.23 -36.85 85.03 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.968 0.907 . . . . 0.0 111.486 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -76.92 -35.14 57.56 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.967 0.907 . . . . 0.0 109.522 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -69.53 -18.11 63.64 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.502 1.121 . . . . 0.0 112.923 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.11 -18.83 9.94 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.367 1.067 . . . . 0.0 112.793 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -72.73 -167.14 10.33 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 125.184 1.373 . . . . 0.0 114.403 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -125.32 139.39 53.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.947 1.299 . . . . 0.0 108.375 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 50.1 mt -112.04 100.24 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 10.4 tmm? 32.35 89.01 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 128.161 2.584 . . . . 0.0 112.846 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.55 102.82 1.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.783 2.322 . . . . 0.0 109.713 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -83.0 4.21 26.97 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 48.6 pt -60.89 151.93 71.73 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.38 1.072 . . . . 0.0 111.263 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.61 -21.8 21.69 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.52 2.147 . . . . 0.0 113.771 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -68.78 -18.41 64.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.233 0.924 . . . . 0.0 111.67 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 64.3 mmm -61.85 -29.23 70.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.349 0.977 . . . . 0.0 109.867 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.1 m -63.7 -52.0 62.56 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.96 86.37 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.074 0.549 . . . . 0.0 110.105 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -56.93 -54.86 41.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.821 1.248 . . . . 0.0 109.86 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -60.56 -39.97 89.92 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.98 0.809 . . . . 0.0 110.599 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -68.09 -25.89 65.55 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.96 -59.17 2.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.814 1.246 . . . . 0.0 110.552 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.9 t -55.95 -38.97 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.655 0.782 . . . . 0.0 110.667 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.68 -46.59 74.11 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.177 1.353 . . . . 0.0 110.8 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 47.7 m -67.71 -46.4 72.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.627 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -56.48 -43.41 79.62 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.47 1.032 . . . . 0.0 112.652 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.72 -53.5 46.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 125.041 1.336 . . . . 0.0 109.14 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.77 -40.78 88.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 122.809 0.444 . . . . 0.0 109.833 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -56.08 -45.23 79.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 120.969 -1.082 . . . . 0.0 110.984 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.72 -46.94 34.23 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.24 0.616 . . . . 0.0 111.015 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -63.1 -42.07 99.51 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.138 0.975 . . . . 0.0 113.266 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 36.4 m -84.87 -5.29 59.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.396 0.678 . . . . 0.0 109.362 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.86 12.55 71.14 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 118.538 0.608 . . . . 0.0 113.711 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -65.56 -28.01 68.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.134 0.967 . . . . 0.0 109.707 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -142.98 156.96 44.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 9.0 m -66.71 148.73 51.52 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 83.6 t -51.27 -57.24 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.436 1.094 . . . . 0.0 111.272 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -63.56 -39.93 95.67 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -70.06 -25.45 63.55 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.774 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.49 76.39 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.507 0.723 . . . . 0.0 109.309 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.56 -36.21 60.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 118.686 -0.674 . . . . 0.0 110.297 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -55.63 -54.67 41.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.205 1.402 . . . . 0.0 108.115 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -51.19 -61.35 2.29 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.873 2.469 . . . . 0.0 110.338 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.75 77.07 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 127.047 2.139 . . . . 0.0 114.092 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -59.62 -36.07 75.62 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 16.7 m -64.11 -38.8 92.37 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.307 0.575 . . . . 0.0 110.567 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -61.21 -24.04 66.05 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.074 -1.016 . . . . 0.0 111.787 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.8 mt -91.52 -29.94 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.793 1.237 . . . . 0.0 110.17 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 17.3 p -76.8 -20.96 55.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.299 0.954 . . . . 0.0 110.026 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? . . . . . 0 C--O 1.247 0.955 0 C-N-CA 126.156 1.782 . . . . 0.0 108.355 179.301 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -91.4 167.12 12.5 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.25 24.31 75.68 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 117.099 1.6 . . . . 0.0 117.099 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -148.24 157.92 43.78 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 121.145 2.472 . . . . 0.0 113.856 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.2 mt -144.95 152.19 39.8 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.346 2.258 . . . . 0.0 108.604 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -134.82 139.78 46.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 126.641 1.976 . . . . 0.0 106.97 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.2 mt -122.77 121.23 62.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.697 1.199 . . . . 0.0 108.99 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -115.95 137.08 52.44 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 mt -128.59 159.22 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -52.74 -20.35 3.1 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.17 155.13 30.22 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 104.846 -3.302 . . . . 0.0 104.846 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.89 0.57 0.38 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.261 1.424 . . . . 0.0 113.943 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -82.23 172.5 13.07 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.0 2.12 . . . . 0.0 111.885 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.61 51.01 2.97 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.062 1.791 . . . . 0.0 113.355 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -57.42 -35.98 70.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.76 1.224 . . . . 0.0 113.978 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -62.21 -38.51 89.41 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.871 0.76 . . . . 0.0 111.031 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.11 -35.72 57.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.8 tp -70.9 -32.46 69.41 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 123.119 0.568 . . . . 0.0 111.535 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.28 -48.64 71.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.298 0.639 . . . . 0.0 110.851 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -53.31 -38.47 63.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.42 HG11 ' HA ' ' A' ' 284' ' ' LEU . 21.4 t -57.33 -46.66 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.82 -29.42 72.61 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 124.539 1.066 . . . . 0.0 111.215 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -68.06 -43.77 77.87 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 118.851 1.326 . . . . 0.0 107.448 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -60.47 3.29 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -52.69 -54.17 37.33 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.984 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.18 -29.74 65.88 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.553 1.524 . . . . 0.0 112.292 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -28.39 58.74 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.601 -1.312 . . . . 0.0 109.83 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -91.63 -38.33 12.52 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.223 0.952 . . . . 0.0 112.05 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.5 p -102.62 -31.54 10.33 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.45 -17.35 54.69 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 121.106 -0.996 . . . . 0.0 112.206 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.3 mm -62.76 119.96 8.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.4 143.08 15.91 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 t -138.83 105.88 2.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 123.649 0.779 . . . . 0.0 109.128 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.5 m -96.96 153.45 17.89 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.82 127.28 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.88 154.79 51.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -122.58 57.29 9.22 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.08 1.752 . . . . 0.0 110.281 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.46 167.26 27.48 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.187 2.592 . . . . 0.0 112.299 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -121.71 1.78 10.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.221 1.008 . . . . 0.0 112.874 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 14.37 6.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.886 1.674 . . . . 0.0 112.117 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -58.33 -26.36 63.0 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 120.588 -1.32 . . . . 0.0 113.083 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -58.58 -27.51 64.68 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.845 1.202 . . . . 0.0 113.635 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -106.17 -24.55 12.3 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 123.66 0.784 . . . . 0.0 110.192 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.35 28.03 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.716 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -48.78 -60.06 5.23 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 117.629 -1.177 . . . . 0.0 109.403 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.28 -17.12 57.46 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.602 1.535 . . . . 0.0 114.004 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -89.03 -28.54 20.09 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.34 1.427 . . . . 0.0 111.753 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.8 -45.73 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 120.01 1.277 . . . . 0.0 109.651 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.26 -22.95 66.4 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 122.061 -0.399 . . . . 0.0 111.315 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.72 -24.31 67.61 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.23 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -103.23 4.86 37.16 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.59 1.556 . . . . 0.0 109.917 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.35 36.54 78.53 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.797 -1.189 . . . . 0.0 111.64 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -128.39 1.97 5.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.855 1.662 . . . . 0.0 112.915 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.41 -169.94 44.47 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.892 1.234 . . . . 0.0 113.693 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.36 162.24 34.41 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.189 1.926 . . . . 0.0 109.768 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -94.47 -19.2 20.77 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 124.545 1.138 . . . . 0.0 111.225 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -138.9 147.96 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tp -134.4 145.98 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.625 1.17 . . . . 0.0 108.622 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -130.55 108.94 10.3 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.714 1.606 . . . . 0.0 109.707 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -156.4 167.22 31.12 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 123.878 0.871 . . . . 0.0 109.975 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.76 155.33 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -57.29 -29.42 63.87 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -49.89 -59.06 4.21 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -66.09 -17.56 64.78 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.547 -0.721 . . . . 0.0 111.659 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -83.17 -5.11 59.0 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.497 -0.752 . . . . 0.0 110.3 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.4 -13.96 46.39 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.052 1.311 . . . . 0.0 113.591 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -125.06 -31.41 0.86 Allowed Glycine 0 CA--C 1.526 0.727 0 CA-C-N 118.827 1.314 . . . . 0.0 114.128 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -57.51 -41.74 81.41 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.017 1.408 . . . . 0.0 112.822 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.8 -40.72 79.42 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.58 1.082 . . . . 0.0 110.705 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -41.79 87.55 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.5 m -68.44 -8.12 37.85 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.079 0.952 . . . . 0.0 111.781 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.74 1.24 83.08 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 126.545 2.021 . . . . 0.0 113.016 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.38 -41.07 89.96 Favored 'General case' 0 C--N 1.338 0.067 0 CA-C-N 118.899 1.35 . . . . 0.0 113.232 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 mt -85.5 130.47 34.57 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.18 164.94 19.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.464 1.106 . . . . 0.0 112.082 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -73.8 131.34 41.44 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pp -113.99 -174.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.315 1.446 . . . . 0.0 109.191 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m 60.08 75.73 0.47 Allowed Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.502 1.121 . . . . 0.0 111.051 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.16 -23.64 15.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.021 2.481 . . . . 0.0 113.984 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -140.95 -162.67 1.4 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.518 1.927 . . . . 0.0 108.575 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -110.56 -19.92 12.74 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.793 1.237 . . . . 0.0 113.376 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.25 83.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.97 -1.081 . . . . 0.0 113.586 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -61.76 -28.28 69.33 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.862 1.265 . . . . 0.0 110.356 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -68.57 -44.51 74.29 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.294 0.952 . . . . 0.0 108.916 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.26 -21.53 66.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.228 0.467 . . . . 0.0 111.762 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -68.04 -12.04 60.08 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.526 0.603 . . . . 0.0 110.509 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -122.07 165.78 15.54 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.833 1.653 . . . . 0.0 111.211 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -77.1 155.69 82.33 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.31 -43.1 3.26 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.325 2.684 . . . . 0.0 114.295 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -57.2 -41.99 80.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.543 1.065 . . . . 0.0 112.354 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.96 -25.63 67.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.649 1.18 . . . . 0.0 111.051 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -76.26 -40.67 51.23 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -37.99 81.3 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.8 0.75 0.75 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.474 1.51 . . . . 0.0 114.002 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.04 3.91 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-N 120.487 1.494 . . . . 0.0 111.693 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.9 mtt-85 -63.08 170.46 2.79 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 123.3 1.524 . . . . 0.0 113.418 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -149.92 179.47 8.02 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 128.17 2.588 . . . . 0.0 105.868 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -68.21 99.9 0.96 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.79 -72.9 1.74 Allowed Glycine 0 CA--C 1.521 0.466 0 C-N-CA 125.012 1.291 . . . . 0.0 111.782 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 167.67 13.49 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 122.53 1.157 . . . . 0.0 112.374 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.14 154.1 22.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.266 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.3 pt -134.2 -15.08 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.9 172.55 13.84 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.084 1.311 . . . . 0.0 108.029 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.22 150.5 75.52 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 123.842 0.857 . . . . 0.0 110.829 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.94 144.63 53.67 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 124.336 3.358 . . . . 0.0 111.387 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.58 -55.53 3.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 126.105 1.762 . . . . 0.0 111.596 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.06 162.0 33.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.1 t -128.69 75.07 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 . . . . . 0 C--N 1.331 -0.229 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.73 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.5 mt . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.3 p90 . . . . . 0 CA--C 1.537 0.443 0 C-N-CA 126.553 1.941 . . . . 0.0 110.529 -179.847 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo . . . . . 0 N--CA 1.459 -0.559 0 CA-C-O 121.375 0.49 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -86.6 -26.04 24.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.913 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.9 t -170.96 161.13 6.88 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.953 1.252 . . . . 0.0 108.822 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -64.81 -29.22 70.18 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.61 -12.67 61.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.625 0.648 . . . . 0.0 112.485 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -90.38 -21.3 22.04 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.743 1.217 . . . . 0.0 109.951 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.43 -57.34 21.18 Favored Pre-proline 0 N--CA 1.456 -0.158 0 CA-C-O 117.441 -1.266 . . . . 0.0 110.762 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.75 -23.4 62.98 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 CA-C-N 120.769 1.31 . . . . 0.0 111.815 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.58 -39.83 57.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.488 0.715 . . . . 0.0 110.494 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.0 tp -79.39 -31.44 42.81 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.306 1.443 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.57 -46.84 80.53 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.617 1.167 . . . . 0.0 110.862 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -70.74 -29.42 65.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.35 0.66 . . . . 0.0 112.139 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -75.0 -41.43 59.52 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.56 -33.99 67.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -65.24 -32.91 74.82 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.22 -14.67 61.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 4.38 5.76 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.098 1.359 . . . . 0.0 111.879 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 174.08 -96.21 0.11 Allowed Glycine 0 CA--C 1.526 0.719 0 CA-C-N 119.748 1.158 . . . . 0.0 115.007 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -134.97 -173.54 3.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.145 0.973 . . . . 0.0 112.493 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.4 p -62.8 161.62 12.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.429 1.892 . . . . 0.0 112.055 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.82 -68.05 0.79 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.809 1.244 . . . . 0.0 109.375 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.4 tp -125.93 141.23 52.07 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.451 1.5 . . . . 0.0 110.577 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.6 mtp -139.43 149.1 43.65 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.739 1.616 . . . . 0.0 107.452 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -163.76 173.56 12.68 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.126 0.97 . . . . 0.0 109.766 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -75.36 80.73 2.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.207 1.803 . . . . 0.0 108.904 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mp -72.63 -16.23 61.72 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 121.031 -1.043 . . . . 0.0 110.12 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -70.05 -14.06 62.5 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -121.29 155.12 58.99 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 121.718 2.054 . . . . 0.0 114.845 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.0 -28.71 12.71 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.521 2.147 . . . . 0.0 115.619 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -56.13 -41.51 75.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -89.93 -25.31 21.0 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 119.252 -0.404 . . . . 0.0 111.387 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . 0.25 53.3 p -85.33 -13.39 49.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.011 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -61.54 -53.48 61.21 Favored Pre-proline 0 CA--C 1.532 0.258 0 O-C-N 120.605 -1.309 . . . . 0.0 111.159 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.18 -7.81 14.75 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 CA-C-N 120.574 1.241 . . . . 0.0 112.746 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.79 -67.84 0.63 Allowed 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 121.424 1.92 . . . . 0.0 107.979 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.41 -27.09 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 126.005 1.722 . . . . 0.0 115.014 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.74 -18.72 56.32 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.774 -0.579 . . . . 0.0 111.01 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.89 -47.1 75.97 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.13 -33.24 73.08 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 154.56 -9.79 0.41 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-O 117.188 -1.895 . . . . 0.0 116.756 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.02 149.28 38.47 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-N 120.242 2.021 . . . . 0.0 112.798 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -151.29 143.42 24.0 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.232 1.016 . . . . 0.0 109.285 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.46 -67.99 0.42 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.832 0.853 . . . . 0.0 112.126 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -139.0 143.53 38.52 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.476 1.11 . . . . 0.0 108.695 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -76.85 141.01 40.81 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.26 102.33 3.96 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -70.87 -174.12 0.89 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -67.02 34.43 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.449 1.899 . . . . 0.0 114.262 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 138.6 -3.51 2.93 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.47 1.986 . . . . 0.0 112.645 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.65 127.5 56.13 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.875 1.838 . . . . 0.0 106.68 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -120.82 152.2 38.67 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.894 0.746 . . . . 0.0 110.962 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.12 161.14 40.4 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 128.989 2.916 . . . . 0.0 106.093 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.73 -3.66 10.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.376 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -75.15 -30.7 60.84 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.281 0.632 . . . . 0.0 112.394 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.67 87.34 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.949 0.88 . . . . 0.0 110.606 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -105.91 110.48 31.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.756 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -81.23 28.67 2.93 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.029 1.776 . . . . 0.0 114.046 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 37.5 t -74.23 -57.13 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -80.11 57.6 2.74 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 122.183 0.992 . . . . 0.0 110.18 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -127.09 142.25 51.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -51.0 -34.56 29.73 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.417 1.087 . . . . 0.0 113.755 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.63 -38.66 96.78 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 119.474 1.034 . . . . 0.0 112.162 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.98 51.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 117.679 0.739 . . . . 0.0 109.397 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.457 ' HE3' ' OD2' ' A' ' 358' ' ' ASP . 2.6 ptmm? -62.44 -38.45 89.81 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -54.64 -53.3 56.54 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.823 1.249 . . . . 0.0 111.8 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -74.01 -29.81 62.19 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 13.0 tp -70.2 -37.23 75.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.727 1.264 . . . . 0.0 112.856 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 6.6 t -67.53 -19.1 65.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 117.397 -1.287 . . . . 0.0 110.97 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -65.65 -50.58 64.45 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.412 1.46 . . . . 0.0 107.84 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.9 tt -52.9 -49.91 64.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.273 1.429 . . . . 0.0 109.761 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.45 -27.68 42.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 124.401 1.08 . . . . 0.0 111.041 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.71 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 18.2 t0 -65.43 -31.73 72.98 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.933 1.242 . . . . 0.0 112.848 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.4 mt -76.46 -48.31 20.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 51.6 mt -59.75 -36.13 64.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.145 0.978 . . . . 0.0 109.488 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.71 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -52.18 -43.82 64.35 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.076 1.35 . . . . 0.0 110.666 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -90.77 -2.91 57.76 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.319 1.848 . . . . 0.0 112.189 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 59.22 9.8 1.49 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.887 2.475 . . . . 0.0 113.679 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -68.66 -28.68 67.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.582 0.628 . . . . 0.0 109.934 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.7 tpt -90.88 154.37 19.53 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.402 0.681 . . . . 0.0 109.759 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -75.59 88.26 2.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.51 -8.08 55.82 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.28 1.032 . . . . 0.0 112.232 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -105.63 8.19 33.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.892 1.277 . . . . 0.0 113.882 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.8 m -87.12 127.61 35.13 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.524 -0.735 . . . . 0.0 109.494 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.25 -172.08 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.476 1.91 . . . . 0.0 107.412 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -51.67 60.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.893 1.277 . . . . 0.0 109.267 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -50.13 70.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.771 1.229 . . . . 0.0 111.428 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.86 -46.53 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.35 0.66 . . . . 0.0 111.506 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.38 79.05 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.463 1.105 . . . . 0.0 113.156 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -59.18 -54.77 43.15 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.084 1.353 . . . . 0.0 108.885 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.52 -55.79 25.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 124.393 1.058 . . . . 0.0 110.771 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.27 -35.39 64.96 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.719 0.69 . . . . 0.0 111.956 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -69.83 -43.04 72.79 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -58.25 -40.13 80.98 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -66.95 -21.18 65.98 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.337 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.28 12.47 63.15 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.297 0.951 . . . . 0.0 111.998 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -79.99 -49.71 11.44 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.483 1.142 . . . . 0.0 112.502 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.3 p -64.8 119.99 11.65 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.77 -17.33 62.94 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.361 0.528 . . . . 0.0 112.406 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -158.54 166.56 31.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.405 1.082 . . . . 0.0 109.151 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 2.0 t -159.06 170.81 21.21 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.453 -0.317 0 C-N-CA 126.064 1.746 . . . . 0.0 106.744 179.168 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--O 1.236 0.358 0 CA-C-O 117.73 -1.129 . . . . 0.0 108.041 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.74 156.29 65.95 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.938 2.425 . . . . 0.0 108.721 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.4 p -131.25 -173.22 3.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.15 0.98 . . . . 0.0 110.936 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -91.1 171.87 8.96 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -51.65 102.38 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.328 2.251 . . . . 0.0 110.09 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 63.85 23.63 67.59 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 117.603 -1.665 . . . . 0.0 114.726 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.8 128.41 4.74 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-N 121.291 2.546 . . . . 0.0 111.196 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.67 159.55 52.36 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.016 2.477 . . . . 0.0 111.473 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.6 m -92.3 162.88 14.1 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.553 ' HA ' ' HE2' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -150.51 91.68 4.08 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.198 1.399 . . . . 0.0 110.877 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.21 -77.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.197 2.598 . . . . 0.0 109.644 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 127.049 2.139 . . . . 0.0 106.876 179.369 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.209 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.9 165.47 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.172 0.989 . . . . 0.0 110.985 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.16 140.98 30.51 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.034 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.3 m -133.09 168.27 18.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.114 0.87 . . . . 0.0 111.356 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -139.6 147.57 41.29 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.296 1.439 . . . . 0.0 108.606 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.26 155.01 23.2 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.57 138.74 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -71.98 132.22 44.0 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.49 0.662 . . . . 0.0 109.892 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -73.67 -17.4 61.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -80.54 -18.88 47.08 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 116.954 -1.498 . . . . 0.0 114.953 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 40.8 m -55.06 154.26 10.55 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 119.577 1.08 . . . . 0.0 109.974 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -69.51 -54.64 0.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.84 1.693 . . . . 0.0 111.229 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -125.16 92.85 3.72 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.512 1.925 . . . . 0.0 110.444 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -55.62 -18.34 7.54 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.512 1.925 . . . . 0.0 112.199 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.85 -35.78 77.44 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.969 1.308 . . . . 0.0 109.807 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 95.9 mt -56.51 -44.41 80.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.989 0.813 . . . . 0.0 110.123 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.4 -48.52 60.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.175 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -38.04 81.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 123.5 0.5 . . . . 0.0 110.614 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -68.34 -53.47 23.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.491 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -49.14 -46.66 45.42 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 119.328 0.967 . . . . 0.0 111.434 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.46 -50.74 72.04 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.799 0.84 . . . . 0.0 111.105 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.262 4.8 pt-20 -95.59 26.96 3.64 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -135.31 -35.51 0.82 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 110.73 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -130.17 -39.19 1.37 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 119.454 1.025 . . . . 0.0 112.453 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.42 ' HA ' HG11 ' A' ' 23' ' ' VAL . 12.4 tp -62.67 -58.48 7.33 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 119.504 1.047 . . . . 0.0 110.331 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 40.0 mt -78.79 60.46 2.81 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.434 1.494 . . . . 0.0 113.059 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 43.7 p -133.98 162.31 32.41 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.21 -3.22 15.94 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.734 0.813 . . . . 0.0 111.629 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -109.28 -44.3 3.96 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.247 1.419 . . . . 0.0 109.691 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.29 -50.57 21.14 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 124.924 1.249 . . . . 0.0 110.304 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.53 -38.01 85.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.054 0.927 . . . . 0.0 109.414 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -63.05 -45.43 92.26 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 124.468 1.105 . . . . 0.0 108.521 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.78 82.66 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 123.808 0.843 . . . . 0.0 111.698 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.5 t -68.9 -38.55 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -67.55 -28.96 68.24 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.496 0.589 . . . . 0.0 111.405 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -68.12 -42.55 80.06 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.0 -32.71 73.28 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -160.03 147.06 12.41 Favored Pre-proline 0 N--CA 1.467 0.379 0 C-N-CA 125.341 1.456 . . . . 0.0 108.931 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.06 123.94 9.22 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.566 2.177 . . . . 0.0 108.681 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 32.7 mt -107.1 -4.36 18.98 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.463 1.505 . . . . 0.0 112.971 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 62.05 -153.17 42.37 Favored Glycine 0 C--N 1.335 0.498 0 CA-C-N 119.23 0.923 . . . . 0.0 111.391 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.65 159.03 7.05 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.965 0.906 . . . . 0.0 112.65 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 4.1 m -125.57 155.27 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 124.072 0.949 . . . . 0.0 109.797 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.67 -36.12 62.8 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.187 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.18 105.56 0.73 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.93 1.292 . . . . 0.0 110.43 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -53.71 -38.16 63.99 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.244 1.018 . . . . 0.0 112.547 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 21.4 m -56.1 -35.02 66.56 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.626 0.77 . . . . 0.0 112.937 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -109.28 -5.87 15.73 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.187 0.995 . . . . 0.0 110.942 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -60.94 -50.0 75.19 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -58.16 -33.35 69.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.457 1.103 . . . . 0.0 111.733 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -69.62 -49.21 56.07 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.7 0.8 . . . . 0.0 109.896 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 21.1 mt -68.82 -34.15 75.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.23 -5.3 6.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.618 1.567 . . . . 0.0 112.444 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -62.11 -21.05 64.68 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.31 0.959 . . . . 0.0 109.439 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.13 142.33 26.65 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 119.266 0.939 . . . . 0.0 109.171 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.82 -30.67 84.69 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.55 2.833 . . . . 0.0 115.038 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -58.08 -36.47 72.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.303 0.956 . . . . 0.0 110.148 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.5 mp -77.89 -61.02 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.83 -54.78 7.53 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.992 0.917 . . . . 0.0 113.222 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.94 86.04 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.252 -0.905 . . . . 0.0 112.513 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 55.6 m -68.5 -33.17 73.67 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.153 0.581 . . . . 0.0 109.482 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.0 tpt -69.27 -45.37 69.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -59.12 -35.47 73.52 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 122.709 0.404 . . . . 0.0 110.093 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -62.56 -27.63 69.31 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.713 -0.617 . . . . 0.0 111.186 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 CA-C-N 118.864 0.757 . . . . 0.0 108.977 178.121 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 CA--C 1.538 0.692 0 CA-C-O 121.818 0.674 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -129.19 24.42 5.57 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.249 1.82 . . . . 0.0 110.429 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 20.5 pt -86.04 153.08 56.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.857 1.263 . . . . 0.0 113.101 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -72.95 -21.63 20.71 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.446 2.097 . . . . 0.0 111.935 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.55 -21.99 41.9 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.36 1.864 . . . . 0.0 111.258 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 67.7 mtp -57.09 -35.1 69.0 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.814 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 10.2 t -60.04 -49.52 77.33 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.902 1.228 . . . . 0.0 109.295 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.92 92.4 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 122.544 0.338 . . . . 0.0 110.633 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -58.64 -53.58 56.8 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.514 1.126 . . . . 0.0 110.031 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -62.66 -41.69 99.2 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.142 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -65.79 -38.32 88.7 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.253 0.479 . . . . 0.0 110.849 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.78 -57.06 5.56 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.637 1.175 . . . . 0.0 113.054 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.24 -39.59 74.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 122.922 0.489 . . . . 0.0 110.261 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -53.43 28.09 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.768 0.827 . . . . 0.0 109.037 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 27.4 m -62.4 -39.66 93.98 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.441 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.75 99.68 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.008 1.276 . . . . 0.0 112.173 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.1 -48.69 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 24.4 mm -58.39 -40.48 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 118.481 0.582 . . . . 0.0 109.494 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -61.25 -44.61 96.97 Favored 'General case' 0 CA--C 1.522 -0.121 0 O-C-N 121.206 -0.933 . . . . 0.0 110.839 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.31 -43.93 69.31 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 118.25 0.477 . . . . 0.0 110.431 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.69 89.49 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.936 0.895 . . . . 0.0 111.977 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 46.6 m -83.88 -14.54 50.88 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.199 1.0 . . . . 0.0 109.587 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 74.36 17.05 79.68 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -66.9 -31.3 71.8 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.848 1.259 . . . . 0.0 110.363 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -147.73 159.67 43.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.8 m -66.64 150.14 49.48 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.3 t -57.27 -52.72 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ASP . . . . . 0.457 ' OD2' ' HE3' ' A' ' 189' ' ' LYS . 0.8 OUTLIER -47.35 -49.98 23.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 129.411 3.084 . . . . 0.0 111.881 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.59 -35.62 58.02 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.16 77.6 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.202 -0.936 . . . . 0.0 109.66 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.1 mp -66.59 -49.44 66.35 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.552 1.941 . . . . 0.0 108.635 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -55.39 -49.73 71.55 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.464 1.105 . . . . 0.0 108.726 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -56.92 -53.1 61.77 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.977 1.311 . . . . 0.0 109.746 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.95 -47.81 83.76 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.544 1.138 . . . . 0.0 113.56 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -60.06 -37.61 80.37 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.0 m -64.19 -37.49 87.64 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -62.6 -17.17 59.65 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.447 -1.408 . . . . 0.0 112.374 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.3 mt -98.07 -20.58 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.369 1.068 . . . . 0.0 110.733 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 80.7 p -105.77 -12.19 15.98 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.807 -1.183 . . . . 0.0 112.412 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 46.3 pttt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 117.368 -1.301 . . . . 0.0 111.06 -178.77 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.48 168.2 9.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.72 1.608 . . . . 0.0 110.128 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.66 33.8 73.97 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.913 1.244 . . . . 0.0 115.072 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -145.36 172.86 12.57 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 118.372 1.086 . . . . 0.0 110.34 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.6 mt -150.56 144.77 25.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.944 2.098 . . . . 0.0 107.297 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.8 140.0 41.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.6 mt -125.12 133.0 70.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 C-N-CA 127.149 2.179 . . . . 0.0 106.558 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -122.72 136.76 54.97 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.7 mm -121.91 165.69 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.424 0.689 . . . . 0.0 110.279 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -77.98 -15.35 59.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 117.441 2.385 . . . . 0.0 117.441 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.29 -13.79 58.4 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 120.506 1.503 . . . . 0.0 116.347 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -116.92 -13.81 10.66 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.748 1.219 . . . . 0.0 111.222 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -83.81 167.87 16.68 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.845 -0.534 . . . . 0.0 110.383 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.3 72.64 2.3 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.359 1.457 . . . . 0.0 109.712 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -73.89 -28.87 61.77 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.55 -0.971 . . . . 0.0 111.664 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.12 -45.03 86.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.417 1.008 . . . . 0.0 109.2 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.43 94.88 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.8 tp -70.23 -32.56 70.49 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.638 -0.919 . . . . 0.0 110.442 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.14 80.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 117.773 -1.108 . . . . 0.0 109.41 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -59.89 -33.7 72.18 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.007 0.821 . . . . 0.0 111.456 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.4 t -68.48 -50.99 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.83 -41.9 99.68 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.232 -0.918 . . . . 0.0 114.228 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -29.69 69.37 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.42 -1.047 . . . . 0.0 110.341 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -71.03 -53.53 14.42 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -54.82 -46.55 74.58 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.699 0.227 . . . . 0.0 110.661 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.46 -28.72 70.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.92 0.888 . . . . 0.0 111.017 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 11.0 tppt? -74.0 -26.61 60.54 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.446 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.25 -35.25 10.41 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 124.113 0.883 . . . . 0.0 112.176 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.5 p -101.77 -27.8 12.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.494 1.043 . . . . 0.0 113.424 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.6 -15.65 53.68 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.181 -0.949 . . . . 0.0 111.718 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.8 mm -65.74 120.6 13.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -55.9 140.34 43.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.815 0.846 . . . . 0.0 112.203 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.1 102.43 5.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.9 m -91.63 139.79 30.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.71 117.73 45.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -123.38 158.14 31.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.743 0.817 . . . . 0.0 109.337 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -124.77 67.12 50.23 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.546 1.139 . . . . 0.0 108.813 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -73.7 175.29 10.93 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.094 1.862 . . . . 0.0 108.821 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.41 -18.28 6.78 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.373 0.669 . . . . 0.0 111.063 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.34 1.33 49.31 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.731 2.012 . . . . 0.0 112.897 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.92 -23.32 2.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.126 1.37 . . . . 0.0 114.196 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -55.14 -36.1 65.41 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.439 1.096 . . . . 0.0 111.275 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -118.53 -26.33 6.22 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.578 1.551 . . . . 0.0 110.092 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -67.98 -42.88 80.14 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 117.245 -1.36 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.54 -58.5 15.17 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 120.524 1.511 . . . . 0.0 109.776 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.41 -25.99 81.71 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 121.027 1.403 . . . . 0.0 113.67 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -75.03 -54.85 6.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.631 1.105 . . . . 0.0 112.165 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.57 -40.53 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.099 0.56 . . . . 0.0 110.634 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.75 -29.45 70.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.095 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 -17.17 17.83 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.497 1.044 . . . . 0.0 113.053 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.8 t -123.26 17.5 9.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.586 0.754 . . . . 0.0 112.108 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.05 7.44 66.8 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.16 -10.68 32.41 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.193 1.496 . . . . 0.0 111.776 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.32 -177.85 34.72 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.616 1.579 . . . . 0.0 116.212 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.11 176.9 3.44 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.427 2.751 . . . . 0.0 111.084 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -108.6 -21.15 12.83 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.4 mt -136.6 148.55 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.8 tt -133.12 135.62 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.27 1.428 . . . . 0.0 108.494 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -130.15 101.06 5.64 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.651 1.58 . . . . 0.0 109.306 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -151.66 178.42 9.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.312 0.96 . . . . 0.0 109.99 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.02 154.48 39.36 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -57.77 -27.49 63.12 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.512 0.725 . . . . 0.0 109.844 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.28 -58.79 5.56 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.517 1.127 . . . . 0.0 111.556 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -69.99 -14.48 62.72 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.619 -1.301 . . . . 0.0 111.276 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.18 11.96 8.87 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.369 -0.832 . . . . 0.0 109.512 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.41 0.43 77.79 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.114 -1.381 . . . . 0.0 112.983 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.9 -27.65 0.23 Allowed Glycine 0 CA--C 1.535 1.338 0 CA-C-N 120.351 2.075 . . . . 0.0 116.576 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -56.44 -44.08 80.1 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.945 1.872 . . . . 0.0 113.401 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.71 -41.18 99.02 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.3 -0.875 . . . . 0.0 110.076 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -55.34 -29.89 59.21 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.961 1.304 . . . . 0.0 110.474 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.6 m -86.62 1.05 53.21 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.702 1.201 . . . . 0.0 112.388 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.94 16.77 80.48 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.886 1.708 . . . . 0.0 110.931 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.3 mt -83.49 -11.98 56.81 Favored 'General case' 0 CA--C 1.527 0.072 0 O-C-N 121.017 -1.284 . . . . 0.0 114.018 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.7 mt -114.15 142.54 46.1 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 119.7 1.136 . . . . 0.0 111.039 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.02 -161.57 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.508 1.923 . . . . 0.0 113.316 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.3 86.43 2.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.851 1.661 . . . . 0.0 110.152 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.26 174.22 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.973 1.309 . . . . 0.0 111.933 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.9 m 61.77 82.2 0.22 Allowed Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 126.119 1.768 . . . . 0.0 110.681 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.81 -28.93 7.47 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.416 2.077 . . . . 0.0 111.377 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -139.81 165.82 26.28 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.488 1.915 . . . . 0.0 109.277 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -63.29 -34.94 78.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.638 1.175 . . . . 0.0 110.985 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.46 -43.06 44.74 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.399 1.08 . . . . 0.0 112.371 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -60.0 -33.62 72.24 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.617 -0.677 . . . . 0.0 111.483 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -69.53 -44.29 71.29 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.479 -0.763 . . . . 0.0 109.576 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -62.2 -26.38 68.32 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.418 1.087 . . . . 0.0 112.536 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -71.35 -11.52 60.95 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.042 0.937 . . . . 0.0 111.062 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 mt -126.51 164.91 20.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.202 0.91 . . . . 0.0 110.539 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -75.26 149.92 84.86 Favored Pre-proline 0 CA--C 1.544 0.742 0 O-C-N 121.514 -0.741 . . . . 0.0 110.817 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.73 -46.75 1.12 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.514 2.809 . . . . 0.0 114.789 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -61.26 -33.93 74.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.968 1.258 . . . . 0.0 111.824 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -21.81 64.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.517 0.727 . . . . 0.0 110.716 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -70.84 -37.13 73.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.317 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.44 -28.11 64.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.476 1.035 . . . . 0.0 113.141 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.72 -23.35 67.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.444 0.698 . . . . 0.0 111.787 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.1 m -120.57 6.86 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.227 1.411 . . . . 0.0 112.284 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -72.66 170.25 14.89 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.806 0.813 . . . . 0.0 108.965 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -153.26 -174.52 4.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.487 1.115 . . . . 0.0 108.048 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -73.54 107.94 6.1 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.95 -77.68 0.53 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.719 1.628 . . . . 0.0 112.835 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 174.92 2.67 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.408 1.083 . . . . 0.0 111.928 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.75 156.22 27.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.99 1.316 . . . . 0.0 109.932 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.3 pt -126.04 -17.96 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.66 178.04 4.28 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.589 1.541 . . . . 0.0 109.291 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.62 148.39 69.83 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 124.27 1.028 . . . . 0.0 110.522 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.42 148.7 38.52 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.226 3.284 . . . . 0.0 109.265 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.3 mm -130.07 -53.01 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.982 1.313 . . . . 0.0 110.898 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -130.8 156.01 45.72 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.2 t -136.11 101.86 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.3 1.04 . . . . 0.0 110.551 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 . . . . . 0 N--CA 1.465 0.317 0 O-C-N 121.117 -0.989 . . . . 0.0 109.064 179.098 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.233 0.217 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.6 p90 . . . . . 0 C--O 1.238 0.48 0 C-N-CA 124.146 0.978 . . . . 0.0 109.359 179.271 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 N--CA 1.458 -0.589 0 N-CA-C 110.384 -0.66 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -104.64 -17.23 14.75 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.6 t -166.34 160.34 15.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.393 1.451 . . . . 0.0 108.481 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -70.1 -27.86 64.93 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 121.325 -0.859 . . . . 0.0 112.156 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -70.04 -16.11 63.11 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.138 0.881 . . . . 0.0 111.226 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -88.2 -23.98 23.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 110.544 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 40.2 mm -54.34 -58.84 12.06 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.58 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.77 -21.33 38.63 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 CA-C-N 120.429 1.189 . . . . 0.0 111.581 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.98 -36.92 64.58 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.975 1.31 . . . . 0.0 111.25 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 68.4 tp -88.23 -30.04 20.0 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.338 1.455 . . . . 0.0 110.712 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.45 -45.0 85.2 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -66.65 -33.14 74.99 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.572 0.749 . . . . 0.0 112.22 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -72.35 -44.45 62.59 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.7 mt -72.93 -33.27 65.84 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.672 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -34.75 77.26 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.62 -13.02 60.6 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 0.12 7.3 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 124.815 1.246 . . . . 0.0 111.903 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.53 -90.08 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 119.231 0.923 . . . . 0.0 114.961 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 176.22 8.88 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.146 0.978 . . . . 0.0 112.231 -177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.95 160.68 7.51 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.852 1.261 . . . . 0.0 112.811 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.89 -71.01 0.66 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.0 0.92 . . . . 0.0 109.043 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.3 tp -106.15 135.54 47.44 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.81 1.244 . . . . 0.0 109.45 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.6 ttm -147.46 104.85 3.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -126.97 163.07 24.5 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -77.89 144.92 36.53 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.6 mt -120.56 -9.82 9.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.724 0.81 . . . . 0.0 111.87 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -69.32 -16.58 63.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -113.56 124.04 32.0 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.652 1.581 . . . . 0.0 110.81 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.09 -14.06 42.68 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.347 2.031 . . . . 0.0 114.911 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -60.83 -27.93 68.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.826 1.194 . . . . 0.0 112.258 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -88.99 -36.71 15.69 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.184 0.994 . . . . 0.0 113.194 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -86.52 -21.68 26.8 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -51.65 -54.29 41.21 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -64.91 -19.32 64.0 Favored 'Trans proline' 0 C--N 1.348 0.513 0 CA-C-N 121.163 1.451 . . . . 0.0 113.883 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.58 -57.35 3.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.528 HG21 HD22 ' A' ' 192' ' ' LEU . 46.2 pt -63.04 -29.39 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 119.213 0.915 . . . . 0.0 112.131 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.66 -20.01 66.05 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.281 0.633 . . . . 0.0 111.914 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -43.16 -60.65 1.58 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.246 1.818 . . . . 0.0 113.065 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.69 -46.37 81.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.984 0.514 . . . . 0.0 111.977 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -175.52 -23.7 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.681 0 CA-C-O 116.99 -2.005 . . . . 0.0 114.497 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -37.09 123.46 0.95 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.387 1.946 . . . . 0.0 114.089 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -139.59 140.8 37.13 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.98 -59.11 2.86 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -135.8 149.67 49.19 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 125.294 1.438 . . . . 0.0 108.691 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.459 ' HE3' ' OD2' ' A' ' 180' ' ' ASP . 10.9 tppt? -76.75 145.14 38.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.886 0.85 . . . . 0.0 109.931 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -142.21 104.83 4.51 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -74.79 -171.08 1.2 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -51.25 -20.39 1.6 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.08 22.36 0.05 OUTLIER Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.92 1.724 . . . . 0.0 111.277 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -125.5 106.27 9.66 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 118.61 1.205 . . . . 0.0 107.822 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -97.14 137.08 36.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.86 147.64 28.96 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.176 1.39 . . . . 0.0 108.808 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.79 -0.31 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.944 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.06 -42.57 69.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.459 ' OD2' ' HE3' ' A' ' 170' ' ' LYS . 56.2 t0 -90.2 107.69 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.658 1.583 . . . . 0.0 109.622 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.3 t -118.37 157.73 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.25 2.22 . . . . 0.0 107.55 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -143.39 29.7 2.02 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 118.536 0.607 . . . . 0.0 114.508 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.04 -42.93 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 C-N-CA 125.049 1.34 . . . . 0.0 111.217 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -96.12 61.45 2.09 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -117.23 154.35 31.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.231 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -48.93 -38.31 22.46 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.4 -35.56 82.27 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 118.774 0.715 . . . . 0.0 112.703 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.6 -49.0 65.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.032 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.79 -42.52 99.1 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-O 118.856 -0.592 . . . . 0.0 109.446 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.25 95.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.12 0.968 . . . . 0.0 109.81 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.13 -26.41 71.49 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.859 -0.967 . . . . 0.0 112.383 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.528 HD22 HG21 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -85.43 -44.46 12.73 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.262 1.031 . . . . 0.0 111.77 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.4 t -55.01 -28.5 52.52 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.023 0.829 . . . . 0.0 111.86 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -60.21 -50.91 71.78 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.6 tp -59.82 -51.92 67.65 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.721 1.208 . . . . 0.0 109.832 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 56.2 t -55.55 -30.41 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 117.429 -1.272 . . . . 0.0 109.949 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.618 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 12.7 t0 -66.58 -44.52 82.03 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 120.431 1.469 . . . . 0.0 111.857 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.6 mt -66.66 -40.04 88.46 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 83.9 mt -66.01 -36.44 77.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.618 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -60.95 -46.82 89.18 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.116 1.367 . . . . 0.0 108.247 178.778 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -79.22 -2.32 40.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.157 0.983 . . . . 0.0 110.703 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt 55.38 1.56 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 130.126 3.37 . . . . 0.0 116.636 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -66.36 -26.94 67.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 11.1 ttt -81.64 141.39 33.71 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -79.57 77.91 6.14 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.0 -5.0 18.98 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.04 1.736 . . . . 0.0 114.176 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -94.67 -20.96 19.1 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 128.0 2.52 . . . . 0.0 111.457 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.2 m -58.14 137.2 57.17 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.061 0.945 . . . . 0.0 110.58 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -130.78 -178.82 4.97 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 127.481 2.312 . . . . 0.0 106.195 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -54.87 -44.79 74.36 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -46.74 88.6 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 123.694 0.798 . . . . 0.0 110.4 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.6 mt -67.37 -48.99 75.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.926 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.39 76.96 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.956 0.798 . . . . 0.0 110.485 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.03 -46.44 65.04 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.34 -55.19 34.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.008 0.923 . . . . 0.0 110.178 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.79 -49.93 61.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.818 2.047 . . . . 0.0 109.86 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -61.69 -38.15 86.76 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.853 -0.529 . . . . 0.0 110.524 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -63.87 -11.03 24.02 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.75 0.82 . . . . 0.0 112.167 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -111.6 -8.13 14.24 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.188 1.795 . . . . 0.0 112.128 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.01 27.79 25.1 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.457 1.027 . . . . 0.0 111.79 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -87.48 -0.35 56.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.289 1.045 . . . . 0.0 112.424 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.8 p -138.84 160.49 39.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.914 0.886 . . . . 0.0 109.274 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -117.24 -19.62 9.55 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.395 1.078 . . . . 0.0 109.544 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -159.2 164.91 34.68 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.952 0.901 . . . . 0.0 111.693 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.6 t -165.78 174.03 10.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.826 2.45 . . . . 0.0 106.975 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 41.6 mt . . . . . 0 C--O 1.236 0.376 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.716 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.2 149.73 64.53 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 60.6 p -124.28 167.49 14.26 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -73.54 153.5 40.24 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -64.82 135.0 55.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.68 -11.23 10.66 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 117.62 -1.655 . . . . 0.0 115.425 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.2 124.32 5.32 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 120.693 2.246 . . . . 0.0 113.591 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.48 146.22 34.69 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.146 2.564 . . . . 0.0 110.86 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.1 m -66.81 157.94 31.7 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -133.6 100.28 13.73 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.62 -175.76 2.74 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.73 2.287 . . . . 0.0 110.638 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 CA--C 1.541 0.616 0 C-N-CA 126.096 1.758 . . . . 0.0 108.878 178.137 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.466 0 N-CA-C 104.341 -3.504 . . . . 0.0 104.341 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 26.4 m -133.11 137.05 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 119.761 1.781 . . . . 0.0 111.213 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.49 138.32 57.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 m -124.37 148.41 47.55 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.864 0.866 . . . . 0.0 110.269 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.11 139.39 52.53 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 123.461 0.704 . . . . 0.0 109.449 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -137.16 164.16 25.31 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.59 1.09 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 61.9 mt -113.31 136.18 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -67.48 117.61 9.67 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.95 -22.23 64.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 118.475 -0.774 . . . . 0.0 112.642 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -74.62 -13.27 60.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 72.5 m -59.99 155.28 44.41 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 118.819 0.736 . . . . 0.0 109.597 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.92 -60.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.514 1.476 . . . . 0.0 110.117 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -108.9 88.43 2.72 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -54.7 -23.72 18.84 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.4 1.08 . . . . 0.0 111.169 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -64.82 -31.28 72.44 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.848 1.259 . . . . 0.0 112.235 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.76 -40.28 83.44 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.048 -1.033 . . . . 0.0 109.402 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.88 -42.94 63.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.53 -0.747 . . . . 0.0 111.407 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -34.92 79.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.718 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -70.84 -56.12 7.01 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -48.78 -49.09 40.3 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 119.18 0.9 . . . . 0.0 110.854 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.7 tt -62.31 -45.83 91.45 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.006 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -79.21 -18.54 52.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.744 -1.223 . . . . 0.0 114.148 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -90.34 -33.88 15.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 117.612 -1.185 . . . . 0.0 112.344 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -137.52 -23.24 1.1 Allowed 'General case' 0 C--N 1.347 0.457 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.01 -50.89 13.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.184 1.356 . . . . 0.0 109.09 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.47 67.27 9.28 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.63 1.572 . . . . 0.0 109.47 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.8 p -144.12 166.22 25.62 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -67.42 -41.36 84.96 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -73.42 -29.75 62.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.323 1.049 . . . . 0.0 111.092 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.79 -51.19 11.63 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.987 1.279 . . . . 0.0 110.036 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 27.8 mt -59.85 -45.28 92.92 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.64 -45.85 84.91 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.359 1.064 . . . . 0.0 109.793 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.56 -44.4 89.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.6 1.091 . . . . 0.0 112.292 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.6 t -72.59 -34.35 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.657 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -68.2 -38.02 81.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.233 1.413 . . . . 0.0 110.319 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -60.47 -43.9 96.44 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.44 1.496 . . . . 0.0 110.252 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.26 -43.88 69.62 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.482 0.313 . . . . 0.0 111.484 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -151.69 152.27 30.02 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 124.808 1.243 . . . . 0.0 108.389 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.11 137.13 73.53 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.771 2.981 . . . . 0.0 113.92 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 23.2 mt -124.0 -7.39 7.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.574 1.549 . . . . 0.0 112.958 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 65.26 -131.56 35.67 Favored Glycine 0 N--CA 1.464 0.559 0 C-N-CA 126.068 1.794 . . . . 0.0 112.186 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.62 177.41 8.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 17.9 m -135.44 153.67 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 O-C-N 120.626 -1.296 . . . . 0.0 110.434 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.27 -26.93 56.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.494 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.85 106.7 1.96 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -54.94 -31.87 60.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 57.8 m -68.59 -52.8 27.67 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.612 1.096 . . . . 0.0 111.064 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -72.14 -17.64 61.94 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.152 0.433 . . . . 0.0 110.664 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -61.7 -39.35 91.17 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -62.71 -39.83 95.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.708 0.685 . . . . 0.0 111.413 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -66.19 -49.99 65.42 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.683 1.193 . . . . 0.0 109.837 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.54 -34.45 74.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.679 -0.677 . . . . 0.0 110.135 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.13 -2.85 4.59 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.513 1.525 . . . . 0.0 112.469 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -58.13 -14.46 6.91 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.647 1.112 . . . . 0.0 110.387 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.95 145.5 52.2 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 124.914 1.286 . . . . 0.0 109.194 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.57 -17.56 43.22 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.692 2.261 . . . . 0.0 113.138 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -59.87 -48.52 81.34 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 317' ' ' ILE . 4.6 mp -68.33 -57.73 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.449 1.1 . . . . 0.0 108.255 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.6 -43.38 62.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.31 -35.73 81.14 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 120.402 1.456 . . . . 0.0 112.407 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.7 m -65.43 -37.25 86.37 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 7.2 tpt -61.55 -49.5 76.44 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -61.0 -27.95 68.69 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.71 1.204 . . . . 0.0 113.464 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -76.75 -42.77 39.74 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.554 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 CA--C 1.536 0.604 0 CA-C-O 122.114 0.797 . . . . 0.0 111.391 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -78.4 65.35 3.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.553 1.941 . . . . 0.0 108.905 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.8 pt -130.35 144.18 52.22 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 120.558 -1.339 . . . . 0.0 112.247 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.86 -15.29 37.31 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.341 2.694 . . . . 0.0 114.634 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -80.22 -18.28 49.96 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.462 -0.774 . . . . 0.0 110.864 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 59.6 mmm -70.22 -34.43 72.89 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.123 -0.986 . . . . 0.0 111.565 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.3 p -66.1 -42.31 89.42 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.338 -1.476 . . . . 0.0 108.522 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.61 -46.35 88.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -51.7 -51.46 55.86 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.841 1.656 . . . . 0.0 110.254 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -59.06 -36.2 74.65 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.024 -1.047 . . . . 0.0 113.18 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -76.26 -42.17 46.55 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.172 0.51 . . . . 0.0 109.835 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.8 72.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.442 1.497 . . . . 0.0 110.903 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 44.7 t -68.53 -46.25 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 117.223 -1.37 . . . . 0.0 111.483 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -55.76 -42.55 75.61 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 121.391 1.905 . . . . 0.0 108.832 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 20.0 m -65.0 -44.88 87.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.02 0.528 . . . . 0.0 109.751 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -56.91 -37.26 71.2 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.311 -0.868 . . . . 0.0 112.193 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 71.2 t -69.27 -58.79 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.2 mm -53.45 -46.62 59.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.86 0.864 . . . . 0.0 111.47 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -51.84 -49.68 62.38 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 121.924 -0.485 . . . . 0.0 110.842 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -77.95 -37.66 47.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.25 71.24 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.189 0.904 . . . . 0.0 110.69 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.3 m -94.74 -9.22 35.34 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.442 1.097 . . . . 0.0 110.593 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.51 14.79 82.11 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 118.843 0.747 . . . . 0.0 112.695 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -64.16 -40.06 95.34 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -147.75 154.64 40.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.1 m -61.77 155.14 23.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.826 1.25 . . . . 0.0 111.449 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.97 -53.02 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.201 1.0 . . . . 0.0 109.063 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.83 -50.12 61.49 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.844 2.057 . . . . 0.0 111.549 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -70.52 -42.51 71.15 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.951 1.301 . . . . 0.0 112.166 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.18 77.12 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.566 -0.709 . . . . 0.0 110.426 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.2 mp -72.69 -43.96 62.4 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.047 0.939 . . . . 0.0 109.243 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -54.45 -48.67 71.47 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.21 -34.3 74.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.304 1.042 . . . . 0.0 111.105 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.94 -48.36 66.14 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.825 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -52.16 -39.88 60.63 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.572 0.749 . . . . 0.0 109.746 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.4 m -62.46 -24.82 67.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.461 0.704 . . . . 0.0 112.184 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -81.5 -15.48 54.81 Favored 'General case' 0 C--O 1.226 -0.145 0 O-C-N 120.603 -1.311 . . . . 0.0 111.409 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.5 mt -98.16 -31.45 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.782 1.633 . . . . 0.0 110.398 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 3.2 p -81.55 -17.99 46.5 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.879 -0.513 . . . . 0.0 111.145 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt . . . . . 0 C--O 1.251 1.178 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 177.446 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.38 162.18 14.91 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.1 41.88 99.71 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.231 0.923 . . . . 0.0 115.037 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -149.18 169.22 21.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.33 1.052 . . . . 0.0 109.844 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.0 mt -146.19 135.85 23.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.616 1.567 . . . . 0.0 108.208 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.0 t -127.21 136.84 59.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.0 mt -135.71 142.11 40.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.888 1.275 . . . . 0.0 109.393 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -120.54 154.41 35.37 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.0 mm -116.52 147.29 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.913 2.085 . . . . 0.0 106.104 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.654 ' HB3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -152.4 118.07 5.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.502 1.121 . . . . 0.0 109.916 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.46 20.3 6.26 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.576 -1.125 . . . . 0.0 112.86 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 53.75 30.55 11.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.296 1.838 . . . . 0.0 111.155 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -58.35 172.11 0.51 Allowed 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 127.672 2.389 . . . . 0.0 114.194 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.85 50.85 1.2 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.676 2.084 . . . . 0.0 113.474 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -56.14 -30.4 62.11 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.475 1.11 . . . . 0.0 111.467 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -58.19 -30.6 66.56 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.233 1.013 . . . . 0.0 111.42 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.56 -33.96 17.78 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.6 tp -71.75 -31.18 66.39 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.257 1.423 . . . . 0.0 112.711 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.8 86.01 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.33 1.052 . . . . 0.0 109.889 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -58.89 -37.82 77.47 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.368 1.867 . . . . 0.0 110.287 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.469 HG13 ' HB3' ' A' ' 283' ' ' TYR . 95.0 t -70.09 -48.34 62.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.528 1.131 . . . . 0.0 109.2 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.2 -43.54 99.26 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.755 -0.591 . . . . 0.0 111.722 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -33.27 71.24 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 121.687 -0.89 . . . . 0.0 111.05 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -63.88 -53.02 57.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -56.7 -43.02 80.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.046 0.839 . . . . 0.0 110.774 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -13.42 58.61 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.698 1.199 . . . . 0.0 110.821 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.34 -14.94 17.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.619 -1.926 . . . . 0.0 111.86 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -105.79 -10.93 16.46 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.062 0.851 . . . . 0.0 109.95 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.0 p -130.45 -35.16 1.54 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.488 1.115 . . . . 0.0 112.346 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.64 -13.31 67.45 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.384 -0.823 . . . . 0.0 111.229 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.4 mm -64.3 130.92 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.74 145.55 54.54 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.646 1.179 . . . . 0.0 110.719 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.8 t -140.27 126.7 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.5 m -114.97 141.77 47.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.074 1.35 . . . . 0.0 108.257 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.25 121.31 45.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 126.022 1.729 . . . . 0.0 106.682 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -140.35 157.77 45.04 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.702 0.683 . . . . 0.0 109.651 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -126.38 71.03 71.06 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.407 1.083 . . . . 0.0 111.748 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.68 165.75 30.85 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.463 2.775 . . . . 0.0 111.526 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.56 5.24 15.42 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.774 1.63 . . . . 0.0 110.214 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.52 2.58 7.64 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.457 1.103 . . . . 0.0 113.481 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.654 HD21 ' HB3' ' A' ' 12' ' ' ASN . 2.1 pt? -52.62 -24.93 9.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.419 1.009 . . . . 0.0 113.677 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.48 -24.32 65.17 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.444 1.098 . . . . 0.0 112.284 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -120.53 -22.16 6.52 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.002 1.321 . . . . 0.0 110.175 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -47.59 26.05 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 117.575 -1.202 . . . . 0.0 109.407 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -48.25 -58.21 8.62 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 120.328 1.422 . . . . 0.0 111.157 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.03 -18.2 63.97 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 121.857 1.705 . . . . 0.0 114.187 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -92.87 -1.11 57.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.909 1.284 . . . . 0.0 112.927 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 t -128.13 -37.74 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 120.287 1.403 . . . . 0.0 110.268 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.83 77.62 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.864 -0.588 . . . . 0.0 111.996 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.05 73.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.413 0.551 . . . . 0.0 110.764 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -77.11 -43.73 33.09 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.847 -0.533 . . . . 0.0 110.809 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.92 19.2 4.89 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -114.82 3.53 14.66 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.261 1.031 . . . . 0.0 111.705 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.32 -170.07 26.84 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.805 1.669 . . . . 0.0 113.82 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.15 178.15 7.31 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.822 2.348 . . . . 0.0 111.916 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -99.99 -24.36 14.65 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 120.593 -1.317 . . . . 0.0 111.526 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.2 mt -140.08 156.37 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 124.832 1.253 . . . . 0.0 107.904 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 tt -142.9 147.27 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.398 1.479 . . . . 0.0 107.863 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -140.05 107.26 5.49 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.635 1.174 . . . . 0.0 110.187 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.402 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 41.5 t-105 -153.0 -165.88 2.3 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.838 1.199 . . . . 0.0 110.576 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 62' ' ' TRP . . . -73.44 147.81 43.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.061 1.344 . . . . 0.0 110.163 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -61.04 -27.38 68.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.239 0.542 . . . . 0.0 112.116 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -58.87 -31.43 68.56 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -104.33 -6.0 21.24 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.473 0.579 . . . . 0.0 109.796 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.16 -35.57 61.6 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.434 0.694 . . . . 0.0 111.267 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.89 -4.64 59.26 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.83 -60.78 1.4 Allowed Glycine 0 C--N 1.336 0.556 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -51.85 -43.47 63.22 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.082 0.953 . . . . 0.0 113.208 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.558 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -63.9 -46.34 85.31 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 119.211 0.914 . . . . 0.0 111.266 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -48.86 70.74 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.1 m -61.06 -14.39 23.4 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.532 1.533 . . . . 0.0 112.909 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.45 24.65 33.0 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 124.578 1.085 . . . . 0.0 112.548 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.23 6.97 44.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.3 1.05 . . . . 0.0 113.241 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 71' ' ' ALA . 98.6 mt -128.88 138.64 52.14 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 120.076 -1.64 . . . . 0.0 108.345 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.5 160.16 28.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.03 101.31 0.12 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.171 2.189 . . . . 0.0 106.459 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -67.0 152.7 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 122.086 0.946 . . . . 0.0 111.77 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.419 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 35.3 m 56.22 93.91 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 129.889 3.276 . . . . 0.0 115.574 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 80' ' ' THR . 34.9 Cg_endo -66.74 -41.66 10.43 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.805 1.67 . . . . 0.0 110.909 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -131.07 142.64 50.31 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.905 0.882 . . . . 0.0 112.912 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -44.76 -43.18 8.35 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 128.073 2.549 . . . . 0.0 116.994 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.01 -34.03 12.35 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.24 1.382 . . . . 0.0 114.698 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -64.55 -25.36 67.95 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.456 -0.778 . . . . 0.0 111.338 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -72.04 -44.88 62.66 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -61.85 -22.68 65.72 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.789 1.236 . . . . 0.0 112.261 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -75.4 -13.74 60.42 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.477 1.111 . . . . 0.0 112.25 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mt -124.38 154.51 40.27 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.159 0.891 . . . . 0.0 112.838 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -69.98 146.87 95.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.95 -41.39 7.74 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.173 2.582 . . . . 0.0 114.124 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -59.72 -37.21 78.29 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.138 0.881 . . . . 0.0 111.629 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -26.2 66.69 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.268 1.027 . . . . 0.0 111.56 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -73.74 -30.98 63.13 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 121.471 -0.768 . . . . 0.0 111.387 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.0 -29.33 65.19 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.208 0.913 . . . . 0.0 111.919 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.64 -16.91 63.5 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.524 1.129 . . . . 0.0 112.978 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 m -132.23 18.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.666 1.586 . . . . 0.0 112.167 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -70.65 165.54 22.67 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 122.275 1.036 . . . . 0.0 110.509 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -152.33 -177.02 5.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.419 1.488 . . . . 0.0 107.155 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -69.71 102.02 1.8 Allowed 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.21 -81.53 0.47 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.447 1.499 . . . . 0.0 112.323 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.91 170.26 4.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.393 0.596 . . . . 0.0 109.595 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.94 162.03 13.94 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.86 0.864 . . . . 0.0 109.432 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 37.7 pt -123.67 -14.58 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.182 0.993 . . . . 0.0 112.599 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.3 175.4 4.89 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.04 1.736 . . . . 0.0 107.977 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -134.3 148.29 67.14 Favored Pre-proline 0 C--O 1.242 0.684 0 C-N-CA 124.83 1.252 . . . . 0.0 111.58 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.02 143.7 26.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.301 2.668 . . . . 0.0 108.267 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.3 mm -134.42 -52.08 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 C-N-CA 125.128 1.371 . . . . 0.0 109.773 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.42 148.86 44.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.507 0.723 . . . . 0.0 111.008 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.1 t -137.82 110.37 7.04 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.116 0 C-N-CA 123.478 0.711 . . . . 0.0 110.106 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 . . . . . 0 C--O 1.238 0.45 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.054 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.1 mt . . . . . 0 C--O 1.238 0.466 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 35.9 p90 . . . . . 0 C--O 1.236 0.379 0 C-N-CA 124.342 1.057 . . . . 0.0 111.196 -178.587 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo . . . . . 0 C--O 1.238 0.498 0 N-CA-C 109.781 -0.892 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -132.27 -25.01 2.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.046 1.338 . . . . 0.0 112.091 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.6 t -147.75 152.58 37.98 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.569 1.077 . . . . 0.0 109.337 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -67.34 -15.85 63.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.28 -24.41 61.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.846 1.203 . . . . 0.0 112.329 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -86.41 -16.26 37.78 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 118.292 0.497 . . . . 0.0 110.691 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.66 -57.12 29.04 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 124.775 1.23 . . . . 0.0 107.988 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.25 -24.76 31.64 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 CA-C-N 120.804 1.323 . . . . 0.0 111.023 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.09 -52.7 38.67 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.18 -26.16 68.03 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.187 0.995 . . . . 0.0 109.838 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.37 -41.25 89.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.098 0.863 . . . . 0.0 111.25 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -75.67 -31.16 59.65 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.936 -0.477 . . . . 0.0 110.376 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -70.49 -46.75 63.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 42.2 mt -74.01 -32.44 63.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.766 -1.111 . . . . 0.0 110.294 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -67.88 -36.32 80.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 120.54 1.518 . . . . 0.0 108.707 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.69 -9.78 15.85 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.41 0.684 . . . . 0.0 112.796 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.56 11.27 2.29 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.321 1.449 . . . . 0.0 111.829 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.01 -111.95 0.32 Allowed Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -142.46 -170.25 3.15 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.488 1.915 . . . . 0.0 110.558 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 p -52.38 148.69 6.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.17 1.788 . . . . 0.0 112.802 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.09 -57.0 3.95 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.64 1.176 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.11 146.23 29.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.012 1.725 . . . . 0.0 107.604 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.7 ttm -145.88 105.76 4.0 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -138.23 163.47 31.66 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -72.18 91.81 1.31 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.273 1.429 . . . . 0.0 112.452 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -16.69 61.44 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.212 1.405 . . . . 0.0 109.188 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -75.37 -9.47 58.59 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.991 0.916 . . . . 0.0 112.358 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -119.47 123.34 28.74 Favored Pre-proline 0 C--N 1.34 0.19 0 C-N-CA 124.029 0.932 . . . . 0.0 108.728 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.01 -10.55 27.47 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.714 2.276 . . . . 0.0 115.749 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -61.07 -37.64 83.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -90.13 -23.5 21.34 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.335 0.516 . . . . 0.0 112.179 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.7 p -83.59 -25.87 30.51 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.146 0.43 . . . . 0.0 110.363 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -55.44 -55.87 35.27 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.204 -0.903 . . . . 0.0 112.608 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -62.66 -21.01 72.51 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.62 1.547 . . . . 0.0 112.071 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.2 tp -70.93 -59.48 2.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 25.3 pt -64.74 -30.8 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 117.573 -1.203 . . . . 0.0 113.793 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.68 -4.34 11.82 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 120.822 1.646 . . . . 0.0 113.883 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.35 -50.24 65.45 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.468 1.107 . . . . 0.0 113.801 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.97 -44.57 97.16 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 120.803 -1.186 . . . . 0.0 111.644 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 175.35 13.28 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.807 -0.996 . . . . 0.0 115.248 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.52 151.46 48.72 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 118.78 1.29 . . . . 0.0 111.624 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -164.25 151.34 11.69 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.31 -55.46 3.66 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -141.93 167.83 21.21 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.468 0.707 . . . . 0.0 112.038 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -101.12 155.23 18.12 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.936 0.874 . . . . 0.0 108.691 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -155.56 118.87 4.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.613 1.565 . . . . 0.0 107.574 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -92.58 67.72 4.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 33.6 47.6 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.391 2.276 . . . . 0.0 115.232 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.51 -18.91 1.67 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 126.157 1.837 . . . . 0.0 112.057 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -117.97 106.19 12.68 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.13 128.91 34.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -132.0 88.69 2.58 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-O 123.705 1.716 . . . . 0.0 109.512 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -5.2 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.306 1.443 . . . . 0.0 114.06 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -70.01 -40.39 75.29 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 120.11 1.323 . . . . 0.0 108.25 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -76.76 108.05 9.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.2 t -129.08 140.32 49.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -129.63 16.92 5.57 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 118.283 -1.287 . . . . 0.0 115.676 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.537 HG21 HD13 ' A' ' 368' ' ' ILE . 0.0 OUTLIER -62.13 -13.99 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.164 1.982 . . . . 0.0 115.341 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 365' ' ' GLN . 4.4 p-10 -119.12 10.15 12.0 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 120.841 -1.162 . . . . 0.0 111.083 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -65.38 155.75 34.4 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -49.08 -35.66 16.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.562 0.745 . . . . 0.0 112.198 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.27 -40.13 98.61 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 119.878 1.217 . . . . 0.0 114.055 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.91 -52.1 52.85 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.622 1.211 . . . . 0.0 109.189 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -63.0 -39.9 96.14 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 119.095 -0.479 . . . . 0.0 110.598 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.78 65.61 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.72 0.808 . . . . 0.0 111.92 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -94.14 -34.76 6.3 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 31.5 tp -70.72 -40.13 72.97 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.481 0.712 . . . . 0.0 111.269 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.4 t -50.55 -45.76 57.12 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 116.672 -1.633 . . . . 0.0 109.848 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -55.64 -56.75 16.71 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 120.547 1.521 . . . . 0.0 111.054 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 64.6 tp -56.04 -49.36 73.94 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.583 0.753 . . . . 0.0 110.934 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.07 -27.89 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.135 0.974 . . . . 0.0 110.895 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.12 -40.16 96.79 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.998 1.319 . . . . 0.0 110.135 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 9.7 mt -66.23 -45.52 80.38 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.28 -40.6 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.458 1.103 . . . . 0.0 108.891 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -56.62 -37.48 70.77 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.779 -1.2 . . . . 0.0 109.588 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -88.27 -4.17 58.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.767 1.627 . . . . 0.0 112.268 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 56.65 14.51 1.77 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.5 2.32 . . . . 0.0 113.758 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -83.42 -5.31 59.11 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.381 -0.825 . . . . 0.0 111.251 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.7 tpt -109.07 154.59 22.04 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.726 0.81 . . . . 0.0 111.382 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -76.18 71.09 2.89 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 108.767 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.3 -10.66 59.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.324 1.05 . . . . 0.0 112.003 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -85.85 -15.84 40.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 129.517 3.127 . . . . 0.0 115.086 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 12.4 m -67.16 127.76 33.82 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.03 1.332 . . . . 0.0 113.244 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -122.24 -178.37 3.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -62.47 -31.63 72.4 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.258 -0.901 . . . . 0.0 113.002 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 t -64.98 -48.8 72.7 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.223 1.009 . . . . 0.0 109.842 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 13.8 mm -61.39 -47.9 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.783 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.68 -52.74 59.34 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.428 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.96 -44.31 94.5 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.62 1.1 . . . . 0.0 110.164 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.81 -54.2 45.42 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.601 0.36 . . . . 0.0 110.35 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.9 79.36 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.655 0.661 . . . . 0.0 111.556 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.85 -44.72 92.29 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -59.22 -42.17 90.37 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -68.45 -27.72 66.42 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.219 -0.925 . . . . 0.0 111.717 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.68 63.48 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.57 1.557 . . . . 0.0 111.948 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.15 -60.85 2.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.442 1.497 . . . . 0.0 111.503 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.2 t -69.04 151.29 46.66 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.67 -26.92 13.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.305 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -130.29 158.66 39.19 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 3.1 t -173.23 -179.72 2.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.09 2.156 . . . . 0.0 108.424 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 63.4 mt . . . . . 0 C--O 1.235 0.321 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.335 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.65 152.77 79.99 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.324 2.016 . . . . 0.0 111.75 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 69.8 p -119.6 171.45 8.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.245 1.418 . . . . 0.0 111.033 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -84.81 158.97 20.51 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -59.11 122.94 15.04 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 120.82 -1.175 . . . . 0.0 109.762 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 71.01 7.74 63.04 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 117.712 -1.605 . . . . 0.0 114.215 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.38 127.02 6.08 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 121.269 2.535 . . . . 0.0 112.574 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.02 161.13 47.13 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.728 2.952 . . . . 0.0 113.693 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 89.4 p -83.24 139.3 33.19 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.829 0.852 . . . . 0.0 108.77 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -132.77 76.17 71.52 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.831 1.652 . . . . 0.0 107.967 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -77.01 -170.32 0.9 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.324 3.349 . . . . 0.0 112.139 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.47 0.546 0 C-N-CA 123.982 0.913 . . . . 0.0 110.869 179.535 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.533 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.37 127.18 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.83 158.7 35.04 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.1 m -131.05 140.66 50.11 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 120.917 -1.114 . . . . 0.0 110.551 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.4 128.2 40.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.967 1.707 . . . . 0.0 107.407 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.61 160.45 24.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 58.8 mt -95.16 130.11 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -77.51 133.34 38.58 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -82.46 -5.02 58.44 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -62.33 -31.05 71.62 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 49.7 m -78.5 157.15 77.79 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.156 1.782 . . . . 0.0 112.564 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.32 -59.64 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.028 3.152 . . . . 0.0 113.335 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -104.68 98.84 8.53 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -13.76 61.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.758 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.412 ' HA ' ' HG3' ' A' ' 277' ' ' LYS . 1.1 tt0 -59.81 -41.04 90.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.251 1.42 . . . . 0.0 109.926 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.75 -39.49 84.96 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.3 -44.44 62.71 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.942 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.412 ' HG3' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -67.89 -29.72 68.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.046 -179.327 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -79.46 -49.92 11.56 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.94 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -55.93 -45.38 78.77 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.889 1.677 . . . . 0.0 109.726 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.36 -30.03 70.89 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.102 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -99.26 -17.4 18.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 120.337 1.426 . . . . 0.0 114.55 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -84.11 -35.9 23.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.899 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.469 ' HB3' HG13 ' A' ' 23' ' ' VAL . 39.1 m-85 -139.23 -32.37 0.66 Allowed 'General case' 0 C--N 1.344 0.329 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -21.2 63.46 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.6 1.545 . . . . 0.0 112.002 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.432 ' CD2' HD21 ' A' ' 304' ' ' LEU . 57.6 mt -110.35 41.6 1.72 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.825 1.65 . . . . 0.0 109.837 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.0 p -128.47 160.08 33.43 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.4 -38.59 66.39 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -68.68 -43.79 75.36 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.33 -42.22 66.05 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.32 -43.04 92.25 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.636 1.174 . . . . 0.0 110.213 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.33 -43.53 90.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.68 -43.63 80.65 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.101 0.961 . . . . 0.0 112.323 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.7 t -71.3 -39.94 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.46 1.027 . . . . 0.0 108.341 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -62.26 -35.43 78.94 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.026 0.531 . . . . 0.0 111.215 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -60.91 -47.95 84.06 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 121.283 -0.885 . . . . 0.0 109.695 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -41.05 66.54 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -143.98 148.33 41.62 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.01 131.29 23.49 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.594 2.196 . . . . 0.0 111.809 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 24.6 mt -119.35 -17.8 8.72 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.723 0.809 . . . . 0.0 112.592 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 70.06 -150.75 49.33 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 119.629 1.104 . . . . 0.0 110.69 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -65.53 167.82 8.31 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.525 1.53 . . . . 0.0 112.206 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.03 165.43 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 124.05 1.881 . . . . 0.0 111.086 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.58 -23.11 29.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.055 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.432 HD21 ' CD2' ' A' ' 285' ' ' LEU . 4.0 mm? -74.02 107.71 6.38 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 125.177 1.391 . . . . 0.0 110.57 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -61.1 1.87 0.15 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.192 1.397 . . . . 0.0 114.676 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.7 m -95.97 -67.75 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -68.62 -22.33 64.43 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.86 0.755 . . . . 0.0 111.263 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -62.67 -32.16 73.18 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 118.955 0.798 . . . . 0.0 109.186 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.89 -34.11 77.61 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.005 1.275 . . . . 0.0 110.244 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -79.18 -42.31 26.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.771 1.228 . . . . 0.0 110.45 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 19.3 mt -68.15 -39.31 82.67 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.07 -7.85 10.04 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.78 1.232 . . . . 0.0 112.361 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -62.44 -30.27 71.12 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.188 -0.945 . . . . 0.0 108.677 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.6 142.06 25.34 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 124.238 1.015 . . . . 0.0 108.934 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.74 -25.2 46.52 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.524 2.15 . . . . 0.0 113.138 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -58.47 -49.8 76.03 Favored 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.44 HD12 ' H ' ' A' ' 317' ' ' ILE . 4.2 mp -69.01 -42.01 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.334 1.054 . . . . 0.0 109.05 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.66 -47.6 73.36 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.148 0.431 . . . . 0.0 110.166 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.24 91.63 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.641 -0.662 . . . . 0.0 111.503 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.6 m -61.88 -37.47 84.67 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 60.7 tpp -73.05 -42.31 63.25 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 118.584 0.629 . . . . 0.0 109.974 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -56.78 -38.96 73.21 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -57.9 -41.82 83.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.401 0.28 . . . . 0.0 110.399 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.36 0 O-C-N 121.861 -0.524 . . . . 0.0 111.125 178.718 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.461 -0.428 0 N-CA-C 111.559 -0.208 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -129.58 73.96 1.56 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 pt -129.67 153.73 80.82 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.501 1.121 . . . . 0.0 111.225 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.41 -32.73 49.43 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.33 2.687 . . . . 0.0 113.453 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -63.26 -24.24 67.78 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.106 -0.996 . . . . 0.0 111.084 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 26.3 mmm -68.64 -26.36 65.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.239 0.927 . . . . 0.0 111.102 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.5 m -62.53 -48.82 77.86 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.72 -31.03 67.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.409 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.609 ' O ' HG23 ' A' ' 343' ' ' VAL . 30.8 t80 -55.92 -58.87 6.05 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.305 0.957 . . . . 0.0 109.909 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -60.55 -37.77 82.32 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.943 -0.473 . . . . 0.0 111.742 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -62.56 -44.33 96.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.403 0.681 . . . . 0.0 109.226 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.63 -50.99 67.16 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.056 1.342 . . . . 0.0 110.698 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 339' ' ' PHE . 2.1 t -59.19 -43.76 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.069 0.395 . . . . 0.0 110.236 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -53.65 -38.55 64.23 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.684 0.794 . . . . 0.0 110.833 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 5.7 m -82.4 -50.44 8.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.522 1.055 . . . . 0.0 110.067 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.84 63.46 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.37 -49.12 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 118.051 -0.975 . . . . 0.0 109.918 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.6 mm -65.31 -35.4 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 119.836 1.198 . . . . 0.0 109.67 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -64.73 -45.97 84.25 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.143 -0.973 . . . . 0.0 109.93 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.46 65.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.701 0.8 . . . . 0.0 111.003 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.91 -36.81 84.6 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 125.328 1.451 . . . . 0.0 113.497 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 42.4 m -92.22 -2.7 56.34 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.443 0.697 . . . . 0.0 110.707 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 76.32 13.01 83.76 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 115.532 0.973 . . . . 0.0 115.532 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -66.36 -30.78 71.24 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 119.06 1.43 . . . . 0.0 109.945 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -145.12 156.09 43.69 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.4 m -66.99 156.23 36.53 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.69 -51.66 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.14 -50.93 65.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.362 1.465 . . . . 0.0 111.621 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.41 -39.14 74.63 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.15 89.31 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 121.463 -0.773 . . . . 0.0 109.605 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.7 mp -72.13 -43.42 64.7 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.396 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.6 tptt -53.14 -55.07 26.97 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.122 1.369 . . . . 0.0 110.228 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -53.9 -49.16 69.21 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 127.99 2.516 . . . . 0.0 112.281 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.48 -50.11 74.88 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 125.668 1.587 . . . . 0.0 111.408 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 184' ' ' ASP . 1.3 tm0? -56.44 -33.09 65.53 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.485 1.039 . . . . 0.0 110.625 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 14.0 m -62.14 -37.01 83.55 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.806 0.73 . . . . 0.0 109.873 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -65.84 -20.39 66.22 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.154 -0.966 . . . . 0.0 112.244 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.537 HD13 HG21 ' A' ' 183' ' ' VAL . 5.7 mt -88.7 -29.21 5.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.274 1.03 . . . . 0.0 109.732 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.0 p -92.55 -7.74 46.37 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.672 -0.643 . . . . 0.0 110.709 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 25.5 tptt . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.312 1.445 . . . . 0.0 110.97 -178.55 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.655 0.74 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -92.02 99.36 12.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 145.76 19.86 0.14 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-O 119.239 -0.756 . . . . 0.0 114.958 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -141.11 172.2 13.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.55 1.175 . . . . 0.0 110.933 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.1 mt -153.53 147.03 24.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 128.521 2.728 . . . . 0.0 106.314 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.8 t -142.02 136.12 29.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.6 mt -124.02 137.79 55.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 126.348 1.859 . . . . 0.0 108.82 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -128.42 149.91 50.35 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.2 pt -136.25 168.08 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -158.91 150.95 21.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 128.121 2.569 . . . . 0.0 108.933 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.74 16.3 49.17 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-O 117.432 -1.76 . . . . 0.0 115.577 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 70.12 37.64 1.64 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.728 2.011 . . . . 0.0 110.675 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -57.61 157.05 7.48 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.299 1.047 . . . . 0.0 111.345 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.96 56.89 4.58 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.788 -0.642 . . . . 0.0 114.071 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -50.54 -39.45 49.17 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -66.51 -12.37 57.2 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.86 -45.53 1.49 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.6 tp -61.45 -37.87 85.15 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.466 0.706 . . . . 0.0 111.9 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.69 -41.76 64.16 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.705 0.802 . . . . 0.0 111.92 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -62.82 -33.15 74.62 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.3 t -65.18 -47.13 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.33 -35.77 92.5 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -62.88 -45.72 91.21 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.215 -0.898 . . . . 0.0 109.083 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -58.89 -54.94 41.48 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -52.36 -48.87 65.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.996 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -66.08 -32.51 74.01 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.858 1.208 . . . . 0.0 110.721 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 8.3 tppt? -68.93 -28.05 66.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 118.171 -0.919 . . . . 0.0 112.604 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.62 -0.43 20.23 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.255 0.972 . . . . 0.0 112.903 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.2 p -130.6 -38.79 1.3 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.61 1.096 . . . . 0.0 112.259 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.72 -10.91 66.57 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.832 -0.982 . . . . 0.0 113.74 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 40.0 mm -70.31 132.28 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 147.39 53.53 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.897 -0.502 . . . . 0.0 111.373 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 t -137.84 125.94 31.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.8 m -118.46 142.49 47.52 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.5 t -132.14 120.97 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -136.29 164.95 26.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.089 1.356 . . . . 0.0 110.245 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -122.4 58.22 10.14 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.126 1.37 . . . . 0.0 112.063 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.93 136.49 16.66 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.212 1.941 . . . . 0.0 110.611 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.12 -18.4 25.92 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.236 -0.915 . . . . 0.0 110.403 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.445 ' H ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -83.66 -2.11 55.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 128.12 2.568 . . . . 0.0 112.761 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.47 -31.6 10.28 Favored 'General case' 0 N--CA 1.461 0.085 0 C-N-CA 124.586 1.154 . . . . 0.0 113.459 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -52.6 -33.44 46.33 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.62 1.168 . . . . 0.0 113.561 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -119.14 -21.6 7.54 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 123.375 0.67 . . . . 0.0 110.967 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -72.55 -42.78 64.31 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 117.717 -1.135 . . . . 0.0 109.122 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -51.26 -60.51 5.58 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 117.558 -1.211 . . . . 0.0 109.96 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.52 -24.57 75.37 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.146 1.23 . . . . 0.0 113.142 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -69.4 -55.26 10.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.087 0.858 . . . . 0.0 111.337 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.412 HG12 ' C ' ' A' ' 55' ' ' ASP . 2.5 t -77.06 -37.47 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.696 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.07 90.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.782 -0.627 . . . . 0.0 109.31 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.0 -15.4 43.85 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 118.925 -0.56 . . . . 0.0 111.979 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.8 m -102.85 -9.23 20.09 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.036 1.734 . . . . 0.0 111.825 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.88 10.06 73.05 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.897 -1.127 . . . . 0.0 112.393 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.412 ' C ' HG12 ' A' ' 50' ' ' VAL . 1.4 m-20 -112.21 2.09 16.48 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.109 1.364 . . . . 0.0 112.582 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.45 176.9 34.23 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.958 -1.089 . . . . 0.0 114.848 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.23 -178.41 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.97 3.113 . . . . 0.0 110.818 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.56 -22.16 12.11 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 120.982 -1.074 . . . . 0.0 112.272 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mt -139.23 148.14 23.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.8 tp -129.35 144.45 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.974 1.71 . . . . 0.0 107.573 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -132.82 102.29 5.59 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.757 1.223 . . . . 0.0 108.808 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -153.13 171.39 18.52 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.053 0.842 . . . . 0.0 111.782 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.19 161.11 31.34 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.745 -1.222 . . . . 0.0 110.984 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -54.54 -32.14 57.72 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.794 1.638 . . . . 0.0 114.736 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.12 -58.15 8.84 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.622 1.169 . . . . 0.0 111.175 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -73.52 -9.39 58.63 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 121.156 -0.965 . . . . 0.0 111.592 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -93.75 12.1 26.83 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.218 1.807 . . . . 0.0 110.035 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 -9.9 56.61 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.815 -0.991 . . . . 0.0 112.006 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.56 -31.26 1.39 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.708 1.754 . . . . 0.0 116.211 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -53.02 -53.98 42.01 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.247 2.024 . . . . 0.0 111.863 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.21 89.75 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.427 -0.796 . . . . 0.0 109.412 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -40.86 76.91 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.804 0.842 . . . . 0.0 109.292 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 m -73.98 -38.01 64.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.694 0.797 . . . . 0.0 108.877 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.07 8.73 6.46 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.97 1.272 . . . . 0.0 114.549 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.8 mt -76.94 -8.01 56.6 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 mt -108.34 139.83 42.48 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.808 1.64 . . . . 0.0 111.857 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.32 175.12 8.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.625 0.77 . . . . 0.0 112.096 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -71.04 135.62 47.87 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.922 0.889 . . . . 0.0 109.326 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 pp -125.74 161.35 30.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 123.474 0.709 . . . . 0.0 110.805 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.9 m 50.87 82.58 0.24 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 127.122 2.169 . . . . 0.0 113.971 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.6 -21.68 25.32 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.349 2.7 . . . . 0.0 113.68 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -134.79 159.63 40.73 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.067 1.303 . . . . 0.0 113.106 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -70.78 -35.81 72.76 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.139 1.376 . . . . 0.0 113.021 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.73 -35.17 60.92 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.776 1.171 . . . . 0.0 112.213 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -65.58 -32.94 74.8 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 122.12 -0.363 . . . . 0.0 111.079 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -66.2 -43.19 87.5 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.607 -0.683 . . . . 0.0 109.54 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -60.0 -27.49 66.91 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.77 1.628 . . . . 0.0 112.938 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -72.17 -2.93 20.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.987 0.915 . . . . 0.0 111.627 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mt -132.81 156.36 47.26 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.185 1.394 . . . . 0.0 110.561 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -68.38 156.47 90.26 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.26 -50.89 0.86 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.187 3.258 . . . . 0.0 114.613 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -52.45 -36.51 54.77 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.374 0.988 . . . . 0.0 112.067 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -31.13 72.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.958 0.903 . . . . 0.0 111.28 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -75.75 -42.51 50.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.813 0.733 . . . . 0.0 110.599 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.491 ' HA ' ' HG3' ' A' ' 98' ' ' ARG . 4.0 m-20 -55.19 -36.08 65.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.086 0.403 . . . . 0.0 110.02 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.47 -2.51 4.72 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 m -133.06 15.96 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 120.146 1.339 . . . . 0.0 110.17 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 10.4 mmt180 -71.26 161.65 30.74 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 123.932 0.893 . . . . 0.0 110.832 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -152.05 179.29 8.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.616 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -63.43 97.77 0.14 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.692 1.197 . . . . 0.0 109.537 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.55 -80.96 1.0 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.443 1.496 . . . . 0.0 111.029 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 170.19 13.47 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.962 -0.728 . . . . 0.0 111.06 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.8 163.97 12.76 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.769 1.227 . . . . 0.0 109.385 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.6 pt -129.04 -34.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 116.752 -1.594 . . . . 0.0 114.03 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -143.83 -179.29 6.38 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.994 1.725 . . . . 0.0 109.165 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 264' ' ' ALA . 6.3 p90 -132.51 148.13 68.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.251 1.02 . . . . 0.0 111.303 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.66 151.88 32.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.676 2.918 . . . . 0.0 109.388 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -133.05 -55.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.695 1.198 . . . . 0.0 110.745 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.81 161.04 31.66 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.44 108.32 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.253 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 p90 . . . . . 0 N--CA 1.451 -0.388 0 O-C-N 120.834 -1.166 . . . . 0.0 110.425 -177.965 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.456 -0.725 0 CA-C-O 123.428 1.345 . . . . 0.0 114.458 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -101.29 -33.12 10.17 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.944 2.898 . . . . 0.0 114.493 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 t -161.13 152.38 18.85 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.8 0.727 . . . . 0.0 110.47 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -64.96 -28.06 69.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.761 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -67.39 -17.27 64.66 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.886 0.766 . . . . 0.0 112.97 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -94.38 -18.6 21.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.962 0.905 . . . . 0.0 109.534 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.6 mm -52.5 -56.83 18.95 Favored Pre-proline 0 C--O 1.234 0.279 0 O-C-N 121.259 -0.901 . . . . 0.0 110.391 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.44 -29.77 44.83 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 CA-C-N 120.34 1.157 . . . . 0.0 111.608 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.25 -15.08 62.42 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.793 1.637 . . . . 0.0 112.474 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 36.6 tp -104.88 -24.57 12.85 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.798 1.639 . . . . 0.0 107.225 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.69 -49.21 69.39 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -65.51 -27.4 68.44 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.14 -42.77 30.74 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.5 mt -70.85 -33.27 70.47 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.31 68.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 123.615 0.572 . . . . 0.0 111.948 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.02 0.73 16.08 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.766 1.226 . . . . 0.0 112.982 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 179.59 -97.65 0.11 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 119.203 0.911 . . . . 0.0 113.134 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -140.55 -176.19 4.55 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.152 0.981 . . . . 0.0 111.165 -177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.3 p -52.99 166.46 0.22 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.343 1.857 . . . . 0.0 115.181 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -95.45 -69.47 0.75 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.137 1.375 . . . . 0.0 109.828 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.7 tp -121.32 152.5 38.88 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.73 2.012 . . . . 0.0 110.687 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 88.0 mtp -149.76 131.51 15.03 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.741 2.416 . . . . 0.0 105.399 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -148.58 164.58 33.82 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.8 1.24 . . . . 0.0 110.639 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.66 94.43 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.885 1.274 . . . . 0.0 113.828 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.4 mt -85.07 -19.5 31.83 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.668 -1.27 . . . . 0.0 110.342 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -77.13 -0.81 26.32 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.784 0.834 . . . . 0.0 112.85 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -125.24 122.43 25.19 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.903 0.881 . . . . 0.0 109.735 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.1 -15.09 32.19 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.417 1.411 . . . . 0.0 112.395 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -48.7 -42.19 34.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.921 1.288 . . . . 0.0 113.3 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -93.77 -33.72 13.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.8 0.727 . . . . 0.0 112.354 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 82.6 p -72.28 -28.56 63.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.018 0.826 . . . . 0.0 111.914 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -47.46 -63.33 1.49 Allowed Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.137 1.775 . . . . 0.0 112.458 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -66.4 -11.86 33.26 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.737 1.624 . . . . 0.0 114.482 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.2 tp -78.89 -55.61 5.02 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.6 pt -62.48 -34.14 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.539 0.609 . . . . 0.0 111.79 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.44 -12.42 60.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.677 -1.154 . . . . 0.0 112.206 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -48.4 -54.37 14.27 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.191 1.396 . . . . 0.0 112.396 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -53.14 -49.81 65.81 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.455 0.57 . . . . 0.0 111.447 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.81 1.54 0.03 OUTLIER Glycine 0 CA--C 1.523 0.537 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.645 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -54.83 144.5 30.89 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 119.408 1.604 . . . . 0.0 110.19 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.424 ' CE1' ' HA3' ' A' ' 182' ' ' GLY . 37.6 p90 -148.83 136.71 20.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 118.568 1.184 . . . . 0.0 108.924 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.54 -67.77 0.71 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 335' ' ' GLN . 62.0 m-85 -133.91 134.31 42.5 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -75.49 124.28 26.9 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -131.71 100.78 5.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -79.57 -173.72 3.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.421 1.488 . . . . 0.0 107.724 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -46.9 -27.59 1.3 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.822 1.649 . . . . 0.0 114.25 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.57 13.82 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 CA-C-O 118.535 -1.147 . . . . 0.0 113.848 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -122.67 132.34 54.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.684 1.742 . . . . 0.0 108.891 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.01 114.36 19.65 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -139.52 96.01 3.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 122.442 1.115 . . . . 0.0 110.428 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.59 -3.41 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 127.622 2.369 . . . . 0.0 114.789 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -76.87 -36.74 56.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.04 93.94 5.85 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.88 151.21 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 126.246 1.819 . . . . 0.0 107.623 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.424 ' HA3' ' CE1' ' A' ' 167' ' ' TYR . . . -148.69 31.99 1.22 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.68 1.133 . . . . 0.0 112.246 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.05 -24.04 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 121.712 -0.875 . . . . 0.0 111.48 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -112.86 18.52 18.11 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.314 1.445 . . . . 0.0 112.814 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -61.57 160.38 11.44 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.591 0.71 . . . . 0.0 109.161 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.68 -26.27 63.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.636 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -72.45 -33.38 61.3 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.132 -0.98 . . . . 0.0 112.447 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.38 43.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.182 0.993 . . . . 0.0 109.758 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -59.79 -34.56 73.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.497 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.66 -54.34 48.21 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.709 0.686 . . . . 0.0 110.562 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.92 -32.06 81.5 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.848 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.87 -44.52 63.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.234 1.017 . . . . 0.0 111.143 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 12.9 t -62.27 -29.1 70.17 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 117.427 -1.273 . . . . 0.0 110.233 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -57.49 -46.6 83.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 120.205 1.366 . . . . 0.0 108.922 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.35 -51.56 67.12 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.918 0.887 . . . . 0.0 109.683 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.67 -32.71 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.526 0.73 . . . . 0.0 110.66 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -32.23 73.68 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.974 0.91 . . . . 0.0 110.601 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.16 -45.26 57.66 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 50.5 mt -60.81 -39.79 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.173 0.989 . . . . 0.0 108.627 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -54.69 -35.79 63.98 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.049 0.94 . . . . 0.0 109.627 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -93.15 -1.97 55.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.736 2.015 . . . . 0.0 113.131 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 9.1 mptt 55.98 11.82 0.8 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.317 2.647 . . . . 0.0 115.503 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -79.91 -8.41 59.3 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.947 -1.095 . . . . 0.0 112.362 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.62 136.44 50.84 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.236 1.014 . . . . 0.0 109.766 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -76.87 79.28 3.45 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.49 77.46 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.18 -2.25 9.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.906 2.082 . . . . 0.0 114.554 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 43.4 m -63.04 126.95 29.04 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.611 1.164 . . . . 0.0 113.629 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.82 179.38 4.03 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.954 2.102 . . . . 0.0 107.097 177.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -57.05 -45.54 83.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -40.25 97.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.148 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 59.6 mt -68.4 -48.86 70.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.42 85.51 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.088 0.555 . . . . 0.0 111.907 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -77.26 -49.55 14.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.047 0.839 . . . . 0.0 111.718 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.69 -50.54 71.84 Favored 'General case' 0 C--N 1.337 0.054 0 CA-C-N 119.114 0.87 . . . . 0.0 110.737 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.34 -44.6 84.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.292 1.037 . . . . 0.0 109.761 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -60.76 -44.06 97.22 Favored 'General case' 0 CA--C 1.524 -0.053 0 C-N-CA 123.501 0.72 . . . . 0.0 109.243 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -55.78 -42.76 76.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.797 0.839 . . . . 0.0 110.05 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -74.51 -21.33 59.6 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.265 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.96 20.26 13.17 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.981 -0.899 . . . . 0.0 112.537 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -73.46 -31.71 63.94 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.513 1.656 . . . . 0.0 112.701 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.7 t -124.2 146.57 48.62 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.796 1.639 . . . . 0.0 106.743 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -106.5 -9.63 16.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.31 1.044 . . . . 0.0 112.241 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.67 153.7 41.89 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.2 t -164.84 157.53 16.43 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 0 C--O 1.234 0.261 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.625 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.541 0.622 0 CA-C-O 119.587 -0.244 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.73 153.81 68.59 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.395 1.396 . . . . 0.0 109.062 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.5 p -125.64 163.97 21.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -83.41 139.55 32.91 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 135.39 52.16 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.745 -1.222 . . . . 0.0 109.573 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 71.59 -1.61 27.93 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.182 -1.343 . . . . 0.0 113.974 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.99 105.14 2.64 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 121.283 2.542 . . . . 0.0 111.67 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.15 144.29 56.79 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.754 1.636 . . . . 0.0 110.809 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.39 146.86 46.85 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.504 1.522 . . . . 0.0 108.019 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -140.26 92.01 9.65 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.169 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -81.97 -165.07 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 125.244 3.963 . . . . 0.0 112.082 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 124.741 1.216 . . . . 0.0 109.386 178.404 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.269 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.7 149.48 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 123.217 0.607 . . . . 0.0 110.34 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.9 tt -82.69 127.63 33.59 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.4 m -111.05 159.59 17.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.851 1.261 . . . . 0.0 107.871 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.43 ' HB3' ' CE1' ' A' ' 106' ' ' TYR . . . -139.07 151.49 46.78 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.427 0.691 . . . . 0.0 109.849 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -147.77 164.38 28.83 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 124.739 1.274 . . . . 0.0 113.128 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 45.7 mt -103.67 133.83 46.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.309 1.444 . . . . 0.0 108.366 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -69.91 118.82 13.24 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.04 -13.27 62.35 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.619 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -73.28 -26.49 61.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.45 1.023 . . . . 0.0 112.729 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 48.8 m -62.55 161.52 26.53 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.007 0.523 . . . . 0.0 110.782 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.3 -44.79 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.541 1.494 . . . . 0.0 114.892 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -133.92 100.62 4.8 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 119.61 1.096 . . . . 0.0 109.861 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -58.01 -20.73 40.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.247 1.019 . . . . 0.0 113.092 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -60.76 -32.09 71.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.426 0.69 . . . . 0.0 111.214 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.31 -27.89 67.69 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.42 -0.8 . . . . 0.0 110.802 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -85.22 -40.21 16.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.403 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.46 83.51 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 118.888 0.767 . . . . 0.0 110.189 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -71.29 -43.89 66.26 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.03 -49.66 77.03 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.122 -0.986 . . . . 0.0 109.28 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.3 mp -59.42 -50.6 73.32 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 118.19 -0.909 . . . . 0.0 112.712 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -76.17 -21.32 56.66 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -93.7 -23.83 18.08 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 117.06 -1.448 . . . . 0.0 112.075 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -137.17 -28.18 0.94 Allowed 'General case' 0 C--N 1.346 0.424 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 284' ' ' LEU . 1.2 tm? -83.5 -16.16 46.66 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.86 1.664 . . . . 0.0 112.442 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.552 HD22 HD21 ' A' ' 304' ' ' LEU . 67.6 mt -121.98 68.02 0.92 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.35 1.06 . . . . 0.0 109.702 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 65.6 p -139.44 154.84 47.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.959 1.704 . . . . 0.0 107.137 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.1 1.67 7.06 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.387 1.875 . . . . 0.0 112.246 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -113.21 -48.82 2.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.672 2.389 . . . . 0.0 111.058 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.52 -35.71 62.83 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.17 -42.88 99.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -60.39 -46.47 89.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 123.933 0.77 . . . . 0.0 109.545 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.84 -32.35 60.47 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 118.035 -0.984 . . . . 0.0 113.39 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 7.1 t -84.29 -24.57 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 120.406 1.457 . . . . 0.0 109.967 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -72.06 -23.85 61.43 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.285 0.948 . . . . 0.0 110.064 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -57.76 -49.9 75.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -64.67 -50.49 66.83 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 157.19 69.42 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 118.553 0.615 . . . . 0.0 112.296 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.89 101.18 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.776 2.317 . . . . 0.0 108.323 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 71.0 mt -81.27 -12.28 59.13 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 67.47 -154.04 52.93 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 120.168 1.349 . . . . 0.0 110.313 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.89 170.24 10.05 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.423 1.089 . . . . 0.0 112.639 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 18.7 m -133.64 155.84 40.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.45 1.5 . . . . 0.0 109.003 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.08 -24.37 59.48 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.659 -0.651 . . . . 0.0 109.378 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.552 HD21 HD22 ' A' ' 285' ' ' LEU . 4.4 mm? -66.48 102.61 0.91 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 127.57 2.348 . . . . 0.0 110.893 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -58.76 -24.13 61.19 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.2 p -64.69 -53.36 48.54 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 120.437 -1.414 . . . . 0.0 111.16 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -86.62 -19.68 28.97 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -62.12 -36.85 83.01 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.22 -10.44 23.42 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.127 0.876 . . . . 0.0 111.672 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -97.02 -45.31 6.63 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.424 1.49 . . . . 0.0 109.049 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 27.5 mt -67.51 -41.83 83.79 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.566 1.146 . . . . 0.0 109.043 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.55 0.87 0.42 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.633 1.973 . . . . 0.0 114.256 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -67.09 -18.44 65.32 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 120.244 1.384 . . . . 0.0 110.631 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -117.57 141.03 28.23 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.52 1.128 . . . . 0.0 109.486 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.97 -16.67 46.81 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.583 2.856 . . . . 0.0 116.462 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.44 -23.95 64.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 121.201 1.819 . . . . 0.0 109.581 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.2 mp -86.46 -65.43 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.01 -52.03 15.79 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.21 -22.17 66.84 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.699 -1.251 . . . . 0.0 114.088 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 41.0 m -85.11 -31.0 23.57 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.739 1.215 . . . . 0.0 108.069 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.8 tpt -71.26 -38.56 71.87 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.41 -29.93 68.1 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.539 1.136 . . . . 0.0 110.004 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -65.93 -42.56 89.93 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.278 0.631 . . . . 0.0 110.941 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.365 0 CA-C-N 118.148 0.431 . . . . 0.0 110.085 179.021 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 CA--C 1.54 0.804 0 CA-C-O 121.683 0.618 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.71 61.34 4.34 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.035 1.334 . . . . 0.0 108.526 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 44.8 pt -126.3 147.24 59.13 Favored Pre-proline 0 CA--C 1.535 0.387 0 O-C-N 121.093 -1.004 . . . . 0.0 111.288 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.36 -19.16 67.6 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.263 2.642 . . . . 0.0 114.354 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 169' ' ' PHE . 4.2 mp0 -66.95 -22.84 65.92 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.66 -0.65 . . . . 0.0 110.298 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 97.6 mmm -64.85 -27.6 68.98 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.757 0.708 . . . . 0.0 110.387 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 7.4 t -56.73 -52.22 65.83 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.561 1.144 . . . . 0.0 108.103 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.19 68.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.316 -0.849 . . . . 0.0 110.781 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -48.31 -57.7 5.63 Favored 'General case' 0 CA--C 1.524 -0.055 0 C-N-CA 123.788 0.835 . . . . 0.0 112.574 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -62.19 -50.04 73.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -61.34 -39.84 92.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.18 -57.65 6.33 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.428 1.091 . . . . 0.0 109.922 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.65 -42.97 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.816 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -53.66 -53.51 50.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.038 1.29 . . . . 0.0 108.419 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 18.8 m -60.22 -42.56 95.45 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.829 0.452 . . . . 0.0 110.833 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.11 94.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.244 0.929 . . . . 0.0 111.638 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.75 -49.81 83.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 123.7 0.8 . . . . 0.0 109.112 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.1 mm -65.84 -38.4 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.9 0.773 . . . . 0.0 109.034 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -57.77 -49.25 77.21 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.178 -0.951 . . . . 0.0 109.979 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.24 -50.58 60.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.814 0.845 . . . . 0.0 111.936 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.18 70.71 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.165 1.386 . . . . 0.0 114.235 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 49.4 m -97.71 3.12 50.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.641 0.777 . . . . 0.0 110.284 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.51 11.26 68.17 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 121.168 -0.958 . . . . 0.0 114.577 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 31.8 ttm-85 -68.13 -27.95 66.9 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 118.128 0.964 . . . . 0.0 110.014 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -149.55 156.13 41.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.8 m -71.11 155.84 40.3 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 80.0 t -52.57 -54.14 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.575 1.15 . . . . 0.0 109.346 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.71 -47.64 73.49 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.741 1.616 . . . . 0.0 112.127 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -71.6 -34.83 70.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.38 98.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 9.9 mt -72.11 -41.68 66.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.766 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -53.52 -46.18 70.01 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.724 0.81 . . . . 0.0 110.634 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.55 -48.06 83.13 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.567 1.547 . . . . 0.0 111.793 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.65 80.2 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.823 2.049 . . . . 0.0 111.959 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.68 -36.26 61.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.518 0.599 . . . . 0.0 110.898 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.83 -44.79 84.53 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.046 0.385 . . . . 0.0 111.322 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -61.02 -25.36 66.85 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.365 -0.835 . . . . 0.0 112.591 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 48.8 mt -90.46 -21.65 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.627 1.571 . . . . 0.0 113.683 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . 0.331 1.6 t -116.66 5.84 13.27 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.339 0.972 . . . . 0.0 111.731 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? . . . . . 0 C--O 1.247 0.939 0 C-N-CA 126.667 1.987 . . . . 0.0 110.312 178.593 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.78 -173.36 2.7 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.896 0.878 . . . . 0.0 109.463 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.1 27.22 68.56 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.429 -0.794 . . . . 0.0 114.184 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -144.68 168.08 21.02 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.596 1.198 . . . . 0.0 112.44 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.2 mt -151.65 149.12 28.77 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 129.516 3.127 . . . . 0.0 107.221 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -145.13 146.16 20.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 124.72 1.208 . . . . 0.0 108.627 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.1 mt -136.0 139.8 45.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 126.155 1.782 . . . . 0.0 107.958 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -123.91 155.07 38.78 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.2 mp -135.94 136.79 49.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 125.53 1.532 . . . . 0.0 109.799 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -78.4 -50.35 11.87 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.709 0.804 . . . . 0.0 108.872 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.52 177.85 39.28 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.258 1.408 . . . . 0.0 109.779 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 64.23 -1.23 0.74 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.402 2.281 . . . . 0.0 115.448 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -85.97 170.98 11.79 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.473 -1.392 . . . . 0.0 112.862 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.17 62.79 0.49 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 126.163 1.84 . . . . 0.0 109.872 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -55.68 -34.3 64.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.61 -0.709 . . . . 0.0 112.444 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -59.2 -36.76 75.96 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.854 0.752 . . . . 0.0 111.954 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.69 -39.21 10.81 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.61 -44.74 89.6 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.656 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.52 -49.38 26.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.854 0.721 . . . . 0.0 110.491 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -57.47 -31.76 66.29 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.4 -42.68 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.67 -40.96 90.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 123.729 0.681 . . . . 0.0 111.415 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -64.37 -42.41 96.2 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.79 1.295 . . . . 0.0 109.324 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -58.24 -59.66 4.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -59.28 -42.85 92.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.075 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -66.21 -27.76 68.23 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 120.776 1.625 . . . . 0.0 110.557 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.9 -28.88 55.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.421 -1.425 . . . . 0.0 110.37 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -84.39 -47.14 10.99 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.069 1.748 . . . . 0.0 111.928 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.3 p -100.39 -32.09 11.0 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.11 -12.76 68.77 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.904 -1.122 . . . . 0.0 111.36 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.9 mm -66.86 130.58 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 142.52 58.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 118.926 -0.559 . . . . 0.0 111.807 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -135.85 102.11 3.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.2 m -96.9 142.43 28.89 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.185 0.994 . . . . 0.0 108.8 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.95 129.84 58.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -137.39 164.55 28.35 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.43 1.092 . . . . 0.0 108.662 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -133.44 61.51 54.49 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.297 1.039 . . . . 0.0 109.821 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.404 ' HG2' ' HB3' ' A' ' 43' ' ' LEU . 87.4 Cg_endo -69.64 155.13 67.15 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.161 2.574 . . . . 0.0 111.64 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -100.61 -0.04 38.35 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.72 18.43 3.55 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.1 pt? -55.97 -23.95 35.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 117.829 -1.081 . . . . 0.0 113.625 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -59.7 -23.71 63.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.109 1.322 . . . . 0.0 112.491 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.38 -30.15 6.66 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.929 0.871 . . . . 0.0 109.407 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -70.43 -28.06 64.75 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.191 -0.943 . . . . 0.0 109.149 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -66.67 -60.61 6.18 Favored Pre-proline 0 CA--C 1.536 0.433 0 O-C-N 119.961 -1.712 . . . . 0.0 108.448 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.06 -25.72 80.53 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.277 1.985 . . . . 0.0 114.716 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.66 -0.63 18.59 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.278 1.031 . . . . 0.0 112.758 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.2 -36.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.85 74.19 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.73 -30.74 70.3 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.893 0.477 . . . . 0.0 110.903 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.0 m -81.43 -14.41 57.12 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.564 1.946 . . . . 0.0 110.919 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.81 56.57 2.32 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.41 -172.48 2.96 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.593 2.357 . . . . 0.0 106.382 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.72 -162.61 14.76 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 120.239 -1.538 . . . . 0.0 113.9 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.53 -179.05 3.36 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.001 3.134 . . . . 0.0 110.33 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -109.29 -24.37 11.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.409 -0.807 . . . . 0.0 112.135 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.9 mt -145.41 148.87 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 tp -132.78 141.34 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -128.97 107.32 9.52 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.875 1.67 . . . . 0.0 107.776 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -152.84 -150.71 0.35 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.945 1.248 . . . . 0.0 113.47 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.15 136.52 32.98 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.589 2.356 . . . . 0.0 110.152 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -48.66 -48.82 39.49 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.441 1.496 . . . . 0.0 112.489 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.45 -5.47 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 129.272 3.029 . . . . 0.0 113.972 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -108.84 -12.18 14.94 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.532 1.133 . . . . 0.0 109.633 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -94.34 -26.01 16.74 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 124.231 1.012 . . . . 0.0 112.304 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -49.97 -41.12 36.49 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.31 -55.79 16.79 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.949 0.785 . . . . 0.0 111.621 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -53.99 -42.48 69.08 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.55 1.14 . . . . 0.0 111.663 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.65 90.3 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 122.843 0.457 . . . . 0.0 111.086 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -44.65 96.72 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.2 m -66.87 -4.38 9.22 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.433 1.493 . . . . 0.0 113.319 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.99 6.66 88.72 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.375 0.988 . . . . 0.0 112.985 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.43 -22.87 64.58 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.6 mt -95.24 133.15 39.44 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.81 155.28 40.6 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -64.35 118.91 9.38 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.457 HG13 ' CA ' ' A' ' 105' ' ' ALA . 9.8 mm -71.58 165.33 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 122.351 1.072 . . . . 0.0 111.099 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.2 m 71.29 92.85 0.05 OUTLIER Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 129.031 2.932 . . . . 0.0 108.096 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.94 -34.54 10.49 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.463 1.442 . . . . 0.0 109.744 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.57 150.46 36.43 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.501 1.12 . . . . 0.0 109.128 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -57.27 -34.1 68.3 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.472 1.109 . . . . 0.0 112.041 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.24 -27.27 63.83 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.64 1.109 . . . . 0.0 111.898 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.31 -36.64 84.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.277 0.944 . . . . 0.0 109.008 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -59.29 -38.36 79.99 Favored 'General case' 0 C--N 1.343 0.284 0 O-C-N 121.044 -1.035 . . . . 0.0 112.707 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -65.67 -17.8 64.87 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.567 0.747 . . . . 0.0 111.6 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.14 -10.25 58.75 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.424 HD13 ' CE2' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -126.53 156.36 40.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.519 1.054 . . . . 0.0 111.962 -178.212 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -70.52 156.17 92.32 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.971 0.908 . . . . 0.0 110.705 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.16 -41.15 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.181 2.587 . . . . 0.0 113.821 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -63.81 -27.62 69.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.038 0.835 . . . . 0.0 110.87 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.05 -28.17 54.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.837 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.424 ' CE2' HD13 ' A' ' 89' ' ' LEU . 4.1 m95 -70.57 -39.21 74.04 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 118.717 0.69 . . . . 0.0 109.874 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.63 -27.57 68.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.36 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.57 -4.78 36.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.88 12.52 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.605 1.162 . . . . 0.0 111.773 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -65.74 165.27 13.0 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 122.449 1.119 . . . . 0.0 111.547 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -154.42 -171.04 3.72 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.09 1.756 . . . . 0.0 107.123 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -66.23 98.78 0.48 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.171 1.388 . . . . 0.0 109.047 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.49 -74.27 0.42 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.085 1.802 . . . . 0.0 113.433 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.52 166.62 22.31 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.766 0.827 . . . . 0.0 110.735 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mt -100.15 145.88 27.48 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.0 pt -110.19 -25.87 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.457 ' CA ' HG13 ' A' ' 79' ' ' ILE . . . -154.29 171.97 18.41 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.01 146.82 62.28 Favored Pre-proline 0 C--O 1.242 0.668 0 C-N-CA 123.529 0.732 . . . . 0.0 110.106 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.3 149.01 44.59 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.885 2.39 . . . . 0.0 110.09 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.5 mm -138.73 -52.06 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.835 2.054 . . . . 0.0 109.421 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.51 150.91 46.99 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.594 1.158 . . . . 0.0 112.671 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.3 t -126.12 118.36 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.436 1.894 . . . . 0.0 107.723 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--O 1.236 0.354 0 C-N-CA 124.371 1.068 . . . . 0.0 108.411 179.651 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.237 0.436 0 C-N-CA 126.559 1.944 . . . . 0.0 109.46 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.457 -0.619 0 CA-C-O 121.497 0.54 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -126.74 -31.88 2.64 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.827 0.851 . . . . 0.0 111.212 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.68 154.81 14.02 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.582 1.083 . . . . 0.0 109.783 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -61.79 -22.61 65.59 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 121.232 -0.917 . . . . 0.0 110.936 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -71.39 -12.41 61.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.567 1.076 . . . . 0.0 111.07 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -108.73 -17.02 14.05 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.973 2.509 . . . . 0.0 111.817 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.2 mm -58.66 -63.01 4.58 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 121.161 -0.962 . . . . 0.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.63 -18.76 37.45 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.773 1.649 . . . . 0.0 111.745 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.71 -49.61 57.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.514 1.126 . . . . 0.0 108.52 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.8 tp -72.1 -30.59 65.23 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.794 0.838 . . . . 0.0 109.781 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.38 -48.02 72.01 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.761 0.824 . . . . 0.0 111.645 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -70.17 -31.12 68.45 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.465 0.306 . . . . 0.0 111.069 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -67.83 -45.05 75.76 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.7 mt -71.32 -30.28 66.03 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.243 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -67.8 -34.51 76.89 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 119.79 1.177 . . . . 0.0 108.14 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.43 -7.69 27.21 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.323 1.049 . . . . 0.0 111.965 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 6.12 3.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.312 1.445 . . . . 0.0 111.614 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.0 -76.42 0.1 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.02 176.09 12.97 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.45 1.1 . . . . 0.0 110.175 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.65 165.1 8.66 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.902 0.858 . . . . 0.0 111.561 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -84.85 -70.09 0.6 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.289 1.436 . . . . 0.0 111.3 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.2 tp -103.22 157.72 16.81 Favored 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 125.893 1.677 . . . . 0.0 113.334 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 92.4 mtp -150.06 118.69 6.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.466 2.306 . . . . 0.0 106.093 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -142.13 155.23 45.32 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.803 0.729 . . . . 0.0 109.281 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -68.06 96.53 0.62 Allowed 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.338 -0.851 . . . . 0.0 111.79 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.51 -10.67 58.18 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.239 1.016 . . . . 0.0 110.806 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -75.79 -29.78 58.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.566 -0.73 . . . . 0.0 112.099 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -99.55 133.0 22.2 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 119.485 1.039 . . . . 0.0 109.491 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.41 -5.39 14.97 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.68 2.92 . . . . 0.0 113.719 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -66.84 -37.62 84.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.524 1.13 . . . . 0.0 110.506 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -75.74 -46.12 32.7 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 122.034 -0.416 . . . . 0.0 112.084 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.9 p -73.96 -17.2 61.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -53.68 -61.28 5.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.69 -3.8 10.98 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.324 2.016 . . . . 0.0 114.111 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.99 -59.24 2.28 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 30.5 pt -61.84 -49.41 84.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 116.977 -1.487 . . . . 0.0 111.708 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -49.36 -8.88 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.277 2.631 . . . . 0.0 115.236 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.75 85.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.399 1.08 . . . . 0.0 111.221 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -67.87 -50.13 58.14 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 177.8 11.96 0.02 OUTLIER Glycine 0 CA--C 1.534 1.265 0 O-C-N 121.251 -0.905 . . . . 0.0 115.154 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.77 131.35 10.43 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 125.869 1.699 . . . . 0.0 111.026 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -146.76 143.32 28.59 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.55 -45.73 13.21 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.23 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -148.69 126.94 12.15 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -76.01 145.88 39.9 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.859 0.754 . . . . 0.0 111.219 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -140.46 116.27 10.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -91.75 -174.81 3.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.347 1.059 . . . . 0.0 108.306 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -56.51 -9.22 0.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.513 1.925 . . . . 0.0 115.185 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -178.9 13.41 0.03 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.208 1.861 . . . . 0.0 112.85 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -132.52 106.2 7.7 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.955 1.378 . . . . 0.0 110.47 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -104.09 125.8 50.71 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.62 110.66 8.28 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -8.61 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.058 0.543 . . . . 0.0 112.446 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -77.53 -31.19 53.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.568 1.147 . . . . 0.0 110.544 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -84.18 87.71 7.18 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 74.7 t -104.57 152.82 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.884 1.674 . . . . 0.0 108.86 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -145.25 24.83 1.88 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.881 1.229 . . . . 0.0 113.766 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.09 -22.56 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 120.796 -1.414 . . . . 0.0 113.013 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -106.27 5.93 30.21 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.125 1.77 . . . . 0.0 111.807 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -59.82 157.13 12.82 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.584 -0.698 . . . . 0.0 110.38 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.92 -34.43 55.21 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.193 0.997 . . . . 0.0 110.755 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.99 -33.01 65.68 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.9 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.45 -49.87 61.74 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.579 1.69 . . . . 0.0 107.743 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -61.85 -41.05 97.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.068 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.1 -46.6 89.93 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.054 0.942 . . . . 0.0 110.216 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.72 -36.72 93.7 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 31.5 tp -75.02 -49.36 20.08 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.998 0.919 . . . . 0.0 113.164 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.7 t -52.95 -33.7 52.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.123 0.969 . . . . 0.0 112.993 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -58.93 -51.91 68.02 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.234 1.379 . . . . 0.0 109.466 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.0 tt -64.57 -46.38 83.02 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.308 1.043 . . . . 0.0 110.264 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.61 -34.45 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 123.751 0.82 . . . . 0.0 110.695 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.674 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.3 OUTLIER -63.57 -33.46 75.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.017 0.826 . . . . 0.0 111.876 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 13.8 mt -71.65 -43.92 65.23 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 44.6 mt -60.18 -41.47 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.674 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.7 OUTLIER -55.83 -30.48 61.48 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.995 -1.066 . . . . 0.0 110.346 178.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -93.3 -5.3 50.03 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.367 1.467 . . . . 0.0 112.093 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? 58.13 18.19 5.09 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.918 2.487 . . . . 0.0 113.891 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -91.2 -13.3 33.1 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 9.1 tpt -92.86 167.13 12.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.934 0.788 . . . . 0.0 111.496 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -76.25 42.69 0.27 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.906 2.882 . . . . 0.0 109.424 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.18 -33.41 75.42 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 126.059 1.744 . . . . 0.0 115.22 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.34 -9.22 57.9 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.487 1.115 . . . . 0.0 112.685 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.3 m -78.17 131.4 37.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.165 1.386 . . . . 0.0 111.036 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -119.04 179.39 4.18 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.411 1.884 . . . . 0.0 107.821 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -52.69 -46.69 67.4 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.816 0.846 . . . . 0.0 113.082 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 54.0 m -63.31 -36.94 85.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.571 0.749 . . . . 0.0 110.785 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 28.0 mm -68.64 -49.94 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 117.78 -1.105 . . . . 0.0 108.512 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.33 -47.82 82.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.999 1.272 . . . . 0.0 111.938 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -56.62 -48.62 77.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.843 0.457 . . . . 0.0 110.164 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.96 -52.39 56.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.55 0.74 . . . . 0.0 110.744 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.71 -43.12 68.76 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.841 1.657 . . . . 0.0 110.75 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -60.41 -39.5 87.58 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.23 -43.84 97.92 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -69.31 -12.09 61.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.915 1.286 . . . . 0.0 112.704 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.69 13.31 70.23 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 120.193 1.36 . . . . 0.0 111.613 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -74.51 -9.06 58.21 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 116.609 2.078 . . . . 0.0 116.609 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.03 157.04 47.96 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 120.345 1.43 . . . . 0.0 110.543 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.41 -35.12 14.56 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.217 1.007 . . . . 0.0 110.368 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -145.05 145.66 31.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.41 1.084 . . . . 0.0 110.369 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.06 155.48 47.02 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 78.2 mt . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.306 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.37 156.13 37.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.273 2.649 . . . . 0.0 110.782 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 255' ' ' SER . 75.3 p -99.48 176.11 5.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.682 1.193 . . . . 0.0 108.722 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -107.79 159.25 16.64 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -55.15 103.52 0.09 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.815 0.846 . . . . 0.0 111.936 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.58 -5.65 63.89 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-O 118.176 -1.347 . . . . 0.0 113.223 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -122.84 108.32 32.92 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 120.206 2.003 . . . . 0.0 110.48 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.17 131.79 31.72 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.643 1.562 . . . . 0.0 109.334 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.473 ' H ' HG22 ' A' ' 249' ' ' THR . 10.1 p -64.13 160.1 19.03 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.39 1.076 . . . . 0.0 109.928 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -132.75 71.68 78.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 118.348 0.522 . . . . 0.0 110.596 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.43 156.64 65.33 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.831 2.354 . . . . 0.0 111.46 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 . . . . . 0 C--O 1.238 0.48 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.41 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.828 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 11.4 m -144.69 157.15 14.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 118.561 1.181 . . . . 0.0 109.779 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.75 147.69 52.98 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.198 0.999 . . . . 0.0 108.322 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -133.01 127.31 33.85 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.606 1.094 . . . . 0.0 109.277 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -110.26 138.77 46.19 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.344 1.858 . . . . 0.0 106.959 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -145.5 141.06 9.46 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.221 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 67.4 mt -78.48 137.8 21.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -72.65 129.26 37.85 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.43 -15.93 60.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -67.19 -40.7 86.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.095 -0.955 . . . . 0.0 113.071 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.9 m -47.41 148.85 2.14 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 125.048 1.339 . . . . 0.0 113.78 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.96 -56.02 0.23 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.479 2.119 . . . . 0.0 112.479 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -113.7 102.4 10.22 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.176 1.353 . . . . 0.0 110.392 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.63 -16.82 63.45 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 122.024 -0.423 . . . . 0.0 111.794 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -64.62 -38.08 89.77 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.969 0.907 . . . . 0.0 110.017 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.74 -39.69 81.66 Favored 'General case' 0 N--CA 1.461 0.102 0 O-C-N 121.627 -0.67 . . . . 0.0 110.504 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.89 -44.8 68.99 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -32.53 72.31 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.314 -0.85 . . . . 0.0 111.348 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -74.26 -44.75 51.66 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -58.84 -39.31 80.9 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.57 -48.06 76.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.845 -0.597 . . . . 0.0 111.107 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -79.34 -18.61 52.17 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -107.07 -16.79 14.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.645 1.111 . . . . 0.0 113.932 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -136.82 -40.04 0.62 Allowed 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.235 0.925 . . . . 0.0 113.459 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.65 -36.98 65.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.262 0.937 . . . . 0.0 111.076 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.407 HD22 HD21 ' A' ' 304' ' ' LEU . 30.5 mt -107.65 63.45 0.62 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.36 1.464 . . . . 0.0 111.79 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 23.5 p -134.15 155.2 50.53 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.35 -37.8 88.68 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.93 -31.87 61.62 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -75.78 -45.81 16.02 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 65.2 mt -61.66 -43.17 99.36 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.805 0.842 . . . . 0.0 109.598 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -56.67 -41.51 77.41 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.882 0.738 . . . . 0.0 110.249 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.5 93.0 Favored 'General case' 0 C--N 1.343 0.292 0 O-C-N 121.246 -0.909 . . . . 0.0 112.463 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 4.5 t -67.14 -41.82 87.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -65.27 -27.72 68.84 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.705 0.764 . . . . 0.0 112.51 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -70.86 -35.49 72.41 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 117.232 -1.366 . . . . 0.0 109.707 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.61 -45.4 21.69 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.595 1.543 . . . . 0.0 111.791 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -138.33 152.3 71.15 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.757 1.223 . . . . 0.0 108.851 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.65 123.43 10.13 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.556 1.504 . . . . 0.0 109.641 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 20.8 mt -79.21 -30.05 43.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 119.016 -0.516 . . . . 0.0 109.703 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.4 -155.64 22.91 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 106.098 -2.801 . . . . 0.0 106.098 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -75.43 171.58 14.0 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.29 157.01 30.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 123.58 1.657 . . . . 0.0 114.163 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.76 -17.32 59.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.852 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.407 HD21 HD22 ' A' ' 285' ' ' LEU . 4.4 mm? -71.04 104.76 3.1 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 125.672 1.589 . . . . 0.0 109.146 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -57.48 -29.17 64.03 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 20.5 t -63.37 -66.58 0.52 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.686 1.994 . . . . 0.0 110.304 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.93 -17.5 60.55 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -63.96 -32.29 73.78 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -70.15 -11.35 60.83 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.34 -0.85 . . . . 0.0 111.19 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -98.18 -49.15 4.83 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.97 2.108 . . . . 0.0 108.991 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 64.6 mt -69.8 -31.23 69.02 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 121.865 -0.522 . . . . 0.0 110.143 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.17 -3.78 4.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.263 0.938 . . . . 0.0 112.207 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -64.07 -10.99 25.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.553 1.141 . . . . 0.0 110.88 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.23 144.13 35.62 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 126.162 1.785 . . . . 0.0 107.376 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.78 -24.89 46.48 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.344 2.696 . . . . 0.0 114.805 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 16.9 mmm-85 -62.45 -48.21 80.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.733 0.697 . . . . 0.0 109.151 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.1 mp -65.02 -50.48 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.45 -52.25 39.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 124.197 0.935 . . . . 0.0 109.736 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.8 -36.32 76.51 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.393 -0.817 . . . . 0.0 112.404 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 88.2 m -65.56 -38.52 89.81 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 49.7 tpp -76.51 -38.34 55.34 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.351 0.523 . . . . 0.0 109.818 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -58.23 -34.07 70.03 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 123.942 0.897 . . . . 0.0 109.096 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -61.8 -38.45 88.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.042 -0.411 . . . . 0.0 109.898 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.472 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo . . . . . 0 N--CA 1.454 -0.799 0 CA-C-O 122.142 0.809 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -103.07 73.18 1.22 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.5 pt -138.55 146.23 49.93 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.734 0.813 . . . . 0.0 109.076 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.78 -18.43 53.02 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.676 2.917 . . . . 0.0 114.478 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -65.43 -17.7 64.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.522 1.129 . . . . 0.0 109.84 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 85.6 mmm -61.64 -32.5 72.66 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.313 0.645 . . . . 0.0 111.381 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 70.5 m -64.89 -45.24 86.8 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.403 1.001 . . . . 0.0 109.478 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.76 80.23 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -64.79 -51.44 62.21 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.395 1.478 . . . . 0.0 109.794 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -58.6 -45.94 88.08 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.45 1.023 . . . . 0.0 110.727 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -58.91 -47.21 85.79 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -56.19 -57.08 13.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.227 1.011 . . . . 0.0 113.052 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 23.5 t -62.41 -35.59 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.217 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -54.08 -50.07 67.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.73 1.605 . . . . 0.0 110.119 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 32.2 m -67.02 -40.88 87.34 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.743 -0.598 . . . . 0.0 110.516 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.77 98.99 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.578 1.081 . . . . 0.0 113.426 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.48 -46.99 95.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 33.1 mm -68.7 -37.12 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 118.544 0.611 . . . . 0.0 110.068 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -57.21 -46.94 82.44 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.245 -0.909 . . . . 0.0 108.942 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.27 -53.77 32.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.417 1.087 . . . . 0.0 110.789 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -57.61 -34.19 69.02 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.469 1.508 . . . . 0.0 114.372 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 52.1 m -97.39 0.48 47.89 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.1 0.56 . . . . 0.0 111.173 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 67.89 12.33 62.17 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.93 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -62.98 -31.49 72.63 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.557 1.179 . . . . 0.0 108.481 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -147.18 152.95 39.24 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 7.5 m -61.52 153.13 28.31 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.283 1.433 . . . . 0.0 108.674 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 11.1 t -58.81 -45.72 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 119.435 1.016 . . . . 0.0 108.386 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.26 -48.56 76.31 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.168 1.387 . . . . 0.0 111.28 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -68.42 -44.92 73.96 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.879 1.271 . . . . 0.0 111.988 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.24 -44.04 83.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.308 0.643 . . . . 0.0 110.58 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.3 mp -70.17 -39.97 74.98 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.555 0.742 . . . . 0.0 110.602 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -57.37 -47.55 81.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.1 -54.29 45.03 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.517 1.527 . . . . 0.0 108.206 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -54.33 -50.82 66.52 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.411 1.485 . . . . 0.0 112.902 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -54.71 -39.68 68.44 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 5.6 m -69.78 -22.98 63.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.162 0.585 . . . . 0.0 111.565 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -78.41 -4.74 49.81 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 120.139 -1.6 . . . . 0.0 112.135 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 5.2 mt -112.68 -29.19 2.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 124.063 0.945 . . . . 0.0 110.252 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 20.4 p -75.7 -23.95 56.2 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.595 1.089 . . . . 0.0 110.445 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 CA-C-O 117.444 -1.265 . . . . 0.0 108.989 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -74.27 115.45 13.79 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 126.411 1.884 . . . . 0.0 107.715 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.63 31.86 1.42 Allowed Glycine 0 CA--C 1.532 1.1 0 N-CA-C 115.284 0.873 . . . . 0.0 115.284 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.39 169.72 20.2 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.217 -1.167 . . . . 0.0 110.829 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.6 mt -150.7 148.92 29.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.573 2.749 . . . . 0.0 105.743 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.5 t -140.7 128.72 23.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.53 HD12 HG22 ' A' ' 37' ' ' VAL . 18.7 mt -108.4 137.4 40.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 125.169 1.388 . . . . 0.0 107.501 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -135.57 129.48 33.03 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.333 1.853 . . . . 0.0 106.364 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -149.05 163.94 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 126.533 1.933 . . . . 0.0 108.106 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -78.55 170.92 15.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.817 0.847 . . . . 0.0 111.727 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.14 -43.24 73.71 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 127.217 2.342 . . . . 0.0 117.006 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -68.51 -13.37 62.28 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.342 1.071 . . . . 0.0 112.631 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -70.63 160.23 32.95 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 123.563 1.649 . . . . 0.0 113.132 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.39 60.09 4.75 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 106.306 -2.718 . . . . 0.0 106.306 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -60.11 -46.69 88.76 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 124.448 1.099 . . . . 0.0 109.693 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -61.82 -49.61 75.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.3 94.79 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.6 tp -68.99 -34.68 75.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.142 0.977 . . . . 0.0 110.972 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.68 74.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.352 -0.833 . . . . 0.0 109.602 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -58.72 -34.35 71.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.381 1.072 . . . . 0.0 111.946 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 t -76.8 -45.12 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.455 1.502 . . . . 0.0 108.291 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.58 -46.83 93.48 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 124.104 0.859 . . . . 0.0 112.222 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -37.22 84.91 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 117.886 -1.054 . . . . 0.0 108.72 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -61.33 -54.27 46.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -53.73 -46.23 70.76 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.552 0.614 . . . . 0.0 110.668 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -65.34 -32.26 73.82 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.044 -1.035 . . . . 0.0 111.0 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -71.93 -28.52 63.53 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.986 0.914 . . . . 0.0 110.879 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -95.98 -16.05 21.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.667 1.187 . . . . 0.0 111.97 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -126.33 -27.87 3.15 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.25 -14.49 63.54 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 120.866 -1.146 . . . . 0.0 113.654 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 mm -70.67 130.58 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 120.078 1.939 . . . . 0.0 106.81 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.432 ' H ' ' HE2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -58.11 145.28 37.28 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.219 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.82 87.65 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.505 1.122 . . . . 0.0 109.215 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 m -78.35 136.44 37.69 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.53 HG22 HD12 ' A' ' 9' ' ' ILE . 25.5 t -130.26 119.88 47.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -133.34 164.17 27.69 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.016 1.326 . . . . 0.0 107.838 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -120.26 62.15 8.6 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.661 1.585 . . . . 0.0 110.8 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.18 152.13 81.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.915 1.743 . . . . 0.0 110.662 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -120.42 19.84 11.98 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.683 1.593 . . . . 0.0 109.628 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.45 12.64 0.73 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.292 2.237 . . . . 0.0 112.683 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.2 pt? -56.48 -27.93 58.36 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 120.315 -1.49 . . . . 0.0 112.921 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -59.07 -20.03 49.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.29 1.436 . . . . 0.0 113.532 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -120.36 -18.02 8.04 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.756 -0.59 . . . . 0.0 110.948 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -46.7 15.43 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.491 1.116 . . . . 0.0 110.917 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -46.32 -57.38 8.59 Favored Pre-proline 0 N--CA 1.468 0.444 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.628 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.15 -18.9 64.58 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.778 1.652 . . . . 0.0 114.592 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -89.07 -8.68 53.42 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 119.995 1.27 . . . . 0.0 112.987 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.1 -36.01 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 119.191 0.905 . . . . 0.0 111.105 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -28.18 67.99 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.044 -1.035 . . . . 0.0 109.848 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.75 -5.58 4.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.581 1.152 . . . . 0.0 113.248 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.0 t -131.33 7.57 4.58 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.742 2.017 . . . . 0.0 109.585 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.37 5.6 72.89 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 119.955 -1.716 . . . . 0.0 114.881 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.53 -2.48 57.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.216 1.008 . . . . 0.0 110.103 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.55 -172.28 48.38 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.401 1.953 . . . . 0.0 115.778 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -69.82 173.92 10.31 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.188 3.259 . . . . 0.0 111.907 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -108.36 -18.4 13.76 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -141.45 145.37 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.907 1.283 . . . . 0.0 107.664 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 tt -137.06 141.19 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.701 1.6 . . . . 0.0 107.408 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -130.32 113.36 14.28 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.086 1.355 . . . . 0.0 109.608 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -157.68 171.11 20.91 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.722 0.809 . . . . 0.0 109.257 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.42 162.21 25.96 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -52.25 -25.51 9.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.327 1.451 . . . . 0.0 112.2 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -50.22 -65.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.96 1.704 . . . . 0.0 113.64 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -69.55 -18.93 63.69 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 122.151 -0.343 . . . . 0.0 110.291 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -78.03 -20.96 51.46 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.65 -5.05 7.88 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 117.836 -1.535 . . . . 0.0 112.939 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.74 -17.91 0.55 Allowed Glycine 0 CA--C 1.535 1.331 0 CA-C-O 117.26 -1.855 . . . . 0.0 115.816 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -65.09 -33.89 77.11 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.027 2.414 . . . . 0.0 112.865 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.94 -36.39 75.25 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 119.411 1.005 . . . . 0.0 108.316 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -48.04 79.77 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.8 m -65.61 -5.39 8.14 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.128 1.771 . . . . 0.0 112.856 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.29 16.95 79.99 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 126.761 2.124 . . . . 0.0 113.048 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.5 mt -87.63 -18.11 30.35 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.5 mt -96.93 135.44 38.91 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.962 0.801 . . . . 0.0 109.21 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -81.68 161.32 23.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.274 1.029 . . . . 0.0 111.314 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -68.34 105.46 2.16 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.593 1.157 . . . . 0.0 108.058 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.83 163.67 2.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 118.753 0.706 . . . . 0.0 111.034 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.4 m 114.77 91.21 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.525 1 C-N-CA 132.668 4.387 . . . . 0.0 108.788 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.87 -54.51 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.436 2.091 . . . . 0.0 109.106 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -148.23 152.58 37.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.175 1.79 . . . . 0.0 106.83 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -62.31 -33.76 75.29 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 118.99 -0.529 . . . . 0.0 111.084 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.05 -28.5 52.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.371 0.987 . . . . 0.0 112.306 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -68.93 -30.61 69.1 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.652 0.66 . . . . 0.0 109.989 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -69.1 -41.64 77.18 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.584 1.084 . . . . 0.0 110.707 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.07 -28.37 69.03 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.969 0.908 . . . . 0.0 111.716 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -69.03 -7.71 38.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.85 0.86 . . . . 0.0 112.952 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -117.93 149.58 40.65 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.692 1.133 . . . . 0.0 113.417 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -63.54 150.64 89.76 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.582 0.753 . . . . 0.0 110.33 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.54 -43.63 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.657 2.238 . . . . 0.0 112.95 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -61.52 -42.08 98.28 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 121.809 -0.557 . . . . 0.0 110.973 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.69 -28.93 68.1 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -49.16 66.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.84 0.856 . . . . 0.0 109.592 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -16.72 51.43 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.9 -41.83 82.11 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.755 0.707 . . . . 0.0 109.964 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.5 m -86.08 -15.38 10.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.071 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -51.74 149.54 4.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.767 1.167 . . . . 0.0 113.612 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.5 -174.48 3.13 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 126.367 1.867 . . . . 0.0 107.381 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -63.32 100.74 0.26 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.313 0.645 . . . . 0.0 109.323 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.27 -83.04 0.25 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 124.83 1.205 . . . . 0.0 111.05 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.2 173.84 2.32 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.691 1.196 . . . . 0.0 111.661 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.4 mt -106.54 169.83 8.29 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.216 1.007 . . . . 0.0 111.358 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.7 pt -143.48 -28.18 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.03 1.732 . . . . 0.0 114.232 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.1 177.76 10.97 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.659 1.572 . . . . 0.0 111.167 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -122.16 145.65 44.62 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 125.057 1.343 . . . . 0.0 110.469 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.34 149.83 45.78 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.667 2.911 . . . . 0.0 108.171 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.463 HG13 ' HB2' ' A' ' 264' ' ' ALA . 29.8 mm -125.98 -44.99 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.109 1.364 . . . . 0.0 111.797 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.1 159.34 43.41 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.368 0.531 . . . . 0.0 110.992 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.4 t -122.45 116.01 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.657 1.183 . . . . 0.0 108.018 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 CA--C 1.519 -0.25 0 C-N-CA 125.255 1.422 . . . . 0.0 107.63 178.874 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 71.3 mt . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 . . . . . 0 C--O 1.241 0.644 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.39 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 N--CA 1.452 -0.954 0 N-CA-C 110.303 -0.691 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -134.98 -30.74 1.04 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.838 1.255 . . . . 0.0 112.731 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.457 ' HA ' ' H ' ' A' ' 249' ' ' THR . 14.9 t -158.96 157.73 31.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -65.43 -22.4 66.76 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.815 1.246 . . . . 0.0 112.426 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 4.1 mm-40 -69.85 -27.46 64.86 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.912 1.685 . . . . 0.0 110.469 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -89.61 -22.02 22.53 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.217 1.807 . . . . 0.0 111.983 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.6 mm -54.4 -56.02 31.11 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 117.889 -1.053 . . . . 0.0 110.355 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.85 -24.47 46.53 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 CA-C-N 120.398 1.178 . . . . 0.0 112.026 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.49 -55.4 10.35 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.5 tp -64.13 -27.23 68.94 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.529 -1.357 . . . . 0.0 110.244 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.44 -43.95 95.96 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 121.782 -0.574 . . . . 0.0 109.78 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -71.87 -27.45 62.87 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 119.116 -0.469 . . . . 0.0 111.182 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -70.69 -48.24 55.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.3 -33.46 73.21 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.501 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -67.96 -36.91 80.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.12 -27.05 69.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.863 0.756 . . . . 0.0 111.656 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.9 3.22 20.37 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.923 0.889 . . . . 0.0 112.673 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.41 -102.65 0.17 Allowed Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 118.825 0.739 . . . . 0.0 111.585 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -137.5 178.54 7.02 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.397 1.079 . . . . 0.0 110.693 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 p -54.99 157.6 3.18 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.923 1.689 . . . . 0.0 114.208 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.9 -69.14 0.73 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.644 1.578 . . . . 0.0 112.31 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.2 tp -99.2 132.64 44.37 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.029 1.332 . . . . 0.0 110.218 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.2 ttm -142.47 133.26 25.53 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -161.75 172.93 15.36 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.952 1.301 . . . . 0.0 108.954 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -69.77 92.31 0.67 Allowed 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 mt -77.12 -14.66 59.76 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.219 -0.926 . . . . 0.0 110.105 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -68.74 -31.87 71.23 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.051 -1.452 . . . . 0.0 114.742 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -104.05 154.96 37.78 Favored Pre-proline 0 C--N 1.343 0.316 0 CA-C-N 121.661 2.028 . . . . 0.0 114.147 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.16 -15.05 11.76 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.212 1.941 . . . . 0.0 114.158 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -61.04 -39.62 90.49 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.771 1.623 . . . . 0.0 111.805 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -82.28 -33.45 29.1 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -81.75 -15.84 53.0 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.242 0.928 . . . . 0.0 111.319 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -46.34 -58.21 7.02 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.04 -16.94 29.01 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.591 1.527 . . . . 0.0 115.086 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.7 tp -67.4 -62.22 1.53 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 120.262 1.392 . . . . 0.0 107.393 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 6.2 pt -68.63 -24.88 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.494 1.118 . . . . 0.0 112.649 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.62 -18.21 62.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.485 -0.759 . . . . 0.0 111.127 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -56.6 -53.84 52.95 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.655 1.182 . . . . 0.0 111.229 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -61.84 -58.19 8.92 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.26 22.37 0.03 OUTLIER Glycine 0 C--N 1.333 0.376 0 CA-C-O 118.611 -1.105 . . . . 0.0 115.126 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.29 134.11 13.36 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -137.51 140.77 41.34 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.859 1.83 . . . . 0.0 114.022 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.92 81.12 4.15 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.718 2.007 . . . . 0.0 106.992 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 67.22 164.75 0.21 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 127.166 2.186 . . . . 0.0 111.061 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -127.75 138.52 52.79 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.177 0.591 . . . . 0.0 109.51 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.58 119.66 25.19 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.604 1.962 . . . . 0.0 105.77 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -96.96 41.38 1.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.932 2.093 . . . . 0.0 111.521 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 55.33 81.21 0.12 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.743 1.217 . . . . 0.0 110.974 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 101.98 -18.62 51.82 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.728 -1.04 . . . . 0.0 113.301 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -117.54 122.75 44.52 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -131.55 115.99 16.85 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 125.733 1.613 . . . . 0.0 108.431 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -124.54 93.18 3.83 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.492 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -55.28 -7.33 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.524 1.929 . . . . 0.0 112.894 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -75.88 -30.89 59.01 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 120.898 -1.126 . . . . 0.0 109.422 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -81.9 67.84 8.05 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.121 0.968 . . . . 0.0 109.288 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 45.3 t -80.78 156.0 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.62 40.11 1.7 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-O 118.122 -1.377 . . . . 0.0 113.53 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.0 t -95.64 -27.64 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 120.029 1.914 . . . . 0.0 112.692 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -90.72 10.7 24.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.804 1.638 . . . . 0.0 109.995 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -60.31 152.2 25.69 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.808 -1.182 . . . . 0.0 109.311 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.73 -27.22 62.79 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.972 0.509 . . . . 0.0 111.7 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.98 -40.16 44.31 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 123.566 0.603 . . . . 0.0 112.286 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.1 -51.14 70.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -60.31 -42.83 96.38 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.561 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.41 -46.51 86.3 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.836 0.744 . . . . 0.0 110.943 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -72.62 -29.54 65.48 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 119.462 -0.632 . . . . 0.0 113.944 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 18.2 tp -80.21 -39.88 28.23 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.2 t -57.83 -34.16 69.39 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.85 0.75 . . . . 0.0 109.885 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -59.46 -48.12 82.86 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.58 0.627 . . . . 0.0 109.852 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.57 -45.53 88.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.362 0.665 . . . . 0.0 109.843 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.03 -29.4 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.148 0.579 . . . . 0.0 110.26 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -62.25 -39.25 92.24 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.085 -1.009 . . . . 0.0 112.387 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.5 mt -70.92 -43.47 68.16 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 55.4 mt -64.06 -39.84 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -52.27 -46.6 65.9 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.06 -1.025 . . . . 0.0 108.849 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -80.66 -0.98 40.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.093 2.157 . . . . 0.0 113.82 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.1 mptt 57.58 4.64 0.25 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.671 2.388 . . . . 0.0 115.424 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -71.57 -31.74 67.3 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.686 -0.634 . . . . 0.0 112.097 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.5 tpt -69.01 163.31 24.93 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 118.554 0.616 . . . . 0.0 109.97 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -91.34 52.18 2.05 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.51 -11.27 1.87 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.979 2.512 . . . . 0.0 115.606 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -102.81 0.23 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.679 0.791 . . . . 0.0 111.921 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 85.9 m -74.19 124.7 26.86 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.879 1.272 . . . . 0.0 110.908 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.61 177.31 4.88 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -53.14 -45.94 68.61 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.522 0.677 . . . . 0.0 112.268 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.5 m -63.88 -29.41 70.59 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.787 2.435 . . . . 0.0 112.577 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 77.0 mt -81.35 -49.11 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.77 72.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.09 -45.8 93.22 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.699 0.681 . . . . 0.0 111.205 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.15 -55.65 31.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.55 -38.15 77.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.548 0.739 . . . . 0.0 111.761 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -61.26 -46.55 89.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -64.69 -35.76 82.08 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -68.46 -18.93 64.52 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.951 -1.093 . . . . 0.0 111.735 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.88 16.89 66.69 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -86.81 -8.13 57.61 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 35.1 p -113.33 136.97 52.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.731 1.612 . . . . 0.0 106.71 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.07 -21.39 46.83 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.288 -0.883 . . . . 0.0 111.081 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -164.99 170.05 15.65 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.592 -0.692 . . . . 0.0 109.721 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 4.4 t -162.95 -178.44 6.09 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.486 1.914 . . . . 0.0 106.498 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 C--N 1.324 -0.523 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 178.829 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--O 1.239 0.527 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.19 150.36 87.67 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.114 1.876 . . . . 0.0 110.793 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.686 HG22 ' H ' ' A' ' 255' ' ' SER . 57.4 p -129.51 165.57 21.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.855 2.062 . . . . 0.0 110.234 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -85.29 159.86 19.96 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.136 0.88 . . . . 0.0 109.176 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -49.81 103.54 0.05 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.284 1.434 . . . . 0.0 113.287 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.17 1.52 90.49 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 117.225 -1.875 . . . . 0.0 115.279 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.26 122.19 11.54 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 121.39 2.595 . . . . 0.0 113.437 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.95 147.83 85.24 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.149 1.9 . . . . 0.0 111.374 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.686 ' H ' HG22 ' A' ' 249' ' ' THR . 48.0 t -64.13 152.41 40.63 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.804 1.241 . . . . 0.0 109.426 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -134.21 77.68 60.3 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.365 1.466 . . . . 0.0 107.693 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -82.62 -175.37 2.43 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.298 3.332 . . . . 0.0 111.437 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 123.621 0.768 . . . . 0.0 108.957 177.995 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.715 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 75.4 t -135.22 112.04 13.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.582 0.706 . . . . 0.0 109.448 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.91 126.82 28.89 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 12.5 m -117.32 164.56 14.64 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.215 1.006 . . . . 0.0 110.933 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.463 ' HB2' HG13 ' A' ' 108' ' ' ILE . . . -134.27 135.54 42.95 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.693 1.597 . . . . 0.0 107.495 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -127.42 166.54 20.11 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 62.6 mt -114.19 133.35 60.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.07 122.97 23.51 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -68.23 -15.07 63.43 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.197 -1.382 . . . . 0.0 114.641 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -76.63 -14.02 60.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.649 1.568 . . . . 0.0 114.373 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 36.5 m -61.98 154.24 69.48 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 123.838 0.855 . . . . 0.0 109.361 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.04 -58.5 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.967 1.778 . . . . 0.0 110.914 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -118.15 100.26 7.41 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.989 1.316 . . . . 0.0 108.254 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.408 ' HE2' ' HB1' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -59.0 -15.77 14.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.787 0.435 . . . . 0.0 112.139 178.813 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -59.97 -34.19 72.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.391 1.476 . . . . 0.0 110.105 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.9 mt -57.69 -44.03 85.55 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.58 -37.05 63.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.139 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -35.43 79.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.026 0.83 . . . . 0.0 109.651 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -69.97 -55.19 10.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.947 -0.549 . . . . 0.0 109.727 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -52.19 -46.51 65.6 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.049 0.841 . . . . 0.0 111.58 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.4 tt -64.63 -40.82 96.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -90.11 -3.9 57.64 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -105.96 -23.68 12.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.051 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -143.24 -36.72 0.37 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.901 1.228 . . . . 0.0 114.017 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.14 -32.7 71.26 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.105 1.321 . . . . 0.0 113.678 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.57 51.31 0.94 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.333 1.853 . . . . 0.0 110.242 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 47.7 p -120.55 163.13 18.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.26 -39.26 92.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -70.97 -41.91 70.4 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.269 0.628 . . . . 0.0 111.438 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.6 67.12 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 78.9 mt -67.62 -43.16 81.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.93 -44.5 94.3 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.2 -41.57 88.84 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.343 1.057 . . . . 0.0 113.606 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 92.9 t -76.84 -36.29 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -66.82 -36.41 82.3 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -66.96 -32.91 74.48 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.729 -0.607 . . . . 0.0 111.055 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.34 -50.49 15.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.517 1.127 . . . . 0.0 110.585 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -141.79 150.94 58.47 Favored Pre-proline 0 N--CA 1.47 0.535 0 O-C-N 121.045 -1.034 . . . . 0.0 109.299 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.01 115.77 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.202 2.602 . . . . 0.0 110.777 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 14.4 mt -84.0 -31.93 25.23 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.673 -0.642 . . . . 0.0 111.54 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 93.02 -146.91 18.34 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 106.343 -2.703 . . . . 0.0 106.343 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.66 173.28 11.5 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.01 153.34 38.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 123.193 1.473 . . . . 0.0 113.475 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.97 -30.92 62.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.914 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 58.7 tp -66.29 104.93 1.3 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.43 1.892 . . . . 0.0 107.968 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -56.66 -23.05 38.91 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.662 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 40.1 m -72.38 -61.73 1.69 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.909 0.777 . . . . 0.0 110.825 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -71.5 -19.19 62.23 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.102 0.864 . . . . 0.0 112.769 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -63.62 -31.37 72.51 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -67.95 -15.2 63.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.364 0.984 . . . . 0.0 111.264 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.46 ' HA ' ' HE3' ' A' ' 313' ' ' LYS . 29.3 mm-40 -94.71 -48.47 6.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.259 1.424 . . . . 0.0 108.264 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.453 ' HB3' HG21 ' A' ' 317' ' ' ILE . 7.2 mt -64.65 -41.25 96.25 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.36 -0.55 0.59 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 310' ' ' GLU . 90.6 mttt -67.58 -13.51 62.13 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.376 1.07 . . . . 0.0 111.835 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.0 151.21 68.6 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 119.756 1.162 . . . . 0.0 109.711 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.64 -23.8 63.28 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.095 2.53 . . . . 0.0 113.84 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -61.57 -27.99 69.02 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.661 0.664 . . . . 0.0 110.551 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 311' ' ' LEU . 4.2 mp -91.08 -52.32 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -48.09 -50.37 28.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.905 0.753 . . . . 0.0 110.679 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.25 -32.52 71.22 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 13.6 m -68.91 -41.04 78.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.492 1.042 . . . . 0.0 108.21 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.8 tpp -69.53 -41.57 75.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.843 -0.599 . . . . 0.0 109.457 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -53.35 -43.31 67.63 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -58.68 -46.66 86.75 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.36 1.064 . . . . 0.0 109.268 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 123.424 0.69 . . . . 0.0 111.433 178.531 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 N--CA 1.462 -0.339 0 N-CA-C 113.985 0.725 . . . . 0.0 113.985 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -116.4 76.25 1.01 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.607 1.563 . . . . 0.0 108.925 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.64 147.69 49.97 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.995 1.318 . . . . 0.0 110.922 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.46 -18.67 33.55 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.497 2.131 . . . . 0.0 111.799 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -72.49 -23.02 60.97 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 120.921 -1.112 . . . . 0.0 109.09 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -40.45 83.94 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.518 1.508 . . . . 0.0 109.42 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 p -69.0 -34.25 74.98 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.383 -0.823 . . . . 0.0 109.242 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -69.63 -42.64 74.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -53.84 -54.56 36.74 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 126.557 1.943 . . . . 0.0 109.849 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -60.89 -45.66 93.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.579 0.627 . . . . 0.0 110.084 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -63.15 -26.72 68.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.99 -60.87 2.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.702 1.201 . . . . 0.0 109.41 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -24.71 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.353 -0.842 . . . . 0.0 111.795 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 26.7 ttt-85 -56.71 -27.65 59.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.356 1.062 . . . . 0.0 110.788 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 1.5 m -97.79 -37.92 9.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.48 -48.3 66.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.874 0.761 . . . . 0.0 112.66 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.09 -56.88 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 37.4 mm -58.07 -36.5 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.289 0.635 . . . . 0.0 110.265 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -56.65 -48.99 76.35 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.843 -1.161 . . . . 0.0 110.094 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.42 -42.42 59.21 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.433 -0.318 . . . . 0.0 111.337 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -59.72 -37.14 78.09 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.468 0.707 . . . . 0.0 112.079 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.0 m -86.85 -7.72 57.96 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.148 0.979 . . . . 0.0 109.64 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 75.99 17.62 79.94 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 118.905 0.775 . . . . 0.0 113.018 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -73.3 -30.71 63.57 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.151 0.981 . . . . 0.0 110.699 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -150.75 166.45 30.42 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.032 0.833 . . . . 0.0 110.519 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.9 m -71.91 152.72 42.35 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.0 t -52.37 -56.19 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.455 1.102 . . . . 0.0 108.306 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.66 -44.73 77.5 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 124.777 1.231 . . . . 0.0 113.461 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -71.97 -36.49 69.85 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.649 0.659 . . . . 0.0 111.964 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.11 -35.25 80.14 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 10.7 tp -73.07 -42.48 63.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.949 1.699 . . . . 0.0 110.673 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -58.29 -52.86 63.82 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.461 1.504 . . . . 0.0 108.095 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -49.87 -56.73 9.35 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 126.283 1.833 . . . . 0.0 108.916 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.94 -48.61 80.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.934 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -57.39 -37.04 72.07 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.9 m -62.66 -43.97 97.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.407 0.683 . . . . 0.0 110.069 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 45.4 mtt-85 -57.97 -27.7 63.68 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.445 -0.784 . . . . 0.0 111.563 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.7 mt -86.12 -39.28 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.986 0.914 . . . . 0.0 110.459 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 22.4 p -70.17 -31.1 68.42 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.518 1.054 . . . . 0.0 112.434 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.541 1.537 . . . . 0.0 110.855 -178.787 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 123.353 1.549 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -71.94 107.24 4.58 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.129 1.772 . . . . 0.0 108.647 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.62 22.64 3.01 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 116.063 1.185 . . . . 0.0 116.063 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -136.43 170.91 15.27 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 119.218 1.509 . . . . 0.0 110.19 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.0 mt -148.38 152.87 37.76 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 128.695 2.798 . . . . 0.0 107.63 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.75 149.65 16.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.458 HG21 HD21 ' A' ' 20' ' ' LEU . 67.3 mt -128.82 120.69 52.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 126.893 2.077 . . . . 0.0 105.95 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -119.2 114.72 22.87 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.533 1.133 . . . . 0.0 109.124 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.7 mt -122.92 164.58 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.962 1.305 . . . . 0.0 108.074 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -84.11 4.43 30.35 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.89 175.68 49.29 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 59.51 22.42 10.99 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.234 1.017 . . . . 0.0 111.359 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -125.64 166.08 17.39 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 126.655 1.982 . . . . 0.0 108.041 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.34 47.21 2.63 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 119.062 -0.855 . . . . 0.0 114.791 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -50.83 -38.86 51.36 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.036 0.934 . . . . 0.0 113.08 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -58.57 -47.23 84.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.012 0.823 . . . . 0.0 110.303 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.96 -38.02 93.77 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.458 HD21 HG21 ' A' ' 9' ' ' ILE . 46.6 tp -68.37 -35.64 78.01 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.752 0.821 . . . . 0.0 111.164 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.26 -37.44 64.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.376 0.67 . . . . 0.0 110.23 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -67.33 -30.05 69.78 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.117 0.872 . . . . 0.0 111.963 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 t -69.26 -43.94 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.58 -41.17 94.21 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -60.21 -45.73 92.18 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -58.25 -55.04 40.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -52.19 -55.6 20.02 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 117.892 0.315 . . . . 0.0 110.927 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.93 -35.68 73.5 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.144 -0.973 . . . . 0.0 111.191 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -69.06 -28.34 66.44 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 120.931 -1.106 . . . . 0.0 111.285 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -98.53 -5.86 31.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.591 1.156 . . . . 0.0 111.519 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.1 p -134.96 -35.46 0.85 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.44 -11.5 63.28 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.356 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.9 mm -67.58 137.27 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -70.64 139.8 51.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 117.652 -1.166 . . . . 0.0 109.727 -179.394 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.0 t -135.18 121.12 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.5 m -114.14 145.15 42.04 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.831 2.052 . . . . 0.0 110.87 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.432 HG22 HD12 ' A' ' 9' ' ' ILE . 20.6 t -137.24 128.52 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.84 1.656 . . . . 0.0 107.319 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -140.55 160.64 39.57 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.639 0.776 . . . . 0.0 111.68 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -127.07 68.06 71.35 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.214 1.405 . . . . 0.0 112.559 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.83 168.72 20.54 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 124.812 3.675 . . . . 0.0 111.267 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -110.8 8.11 22.25 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.709 1.604 . . . . 0.0 110.758 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.67 11.79 4.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 43' ' ' LEU . 1.5 pt? -52.07 -30.74 27.22 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -63.7 -20.45 65.73 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.874 2.07 . . . . 0.0 113.438 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -117.82 -24.32 7.2 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 123.841 0.856 . . . . 0.0 109.498 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.412 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.2 mmpt? -74.76 -46.09 39.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.795 -1.097 . . . . 0.0 110.886 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -50.73 -57.44 13.42 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 120.296 1.407 . . . . 0.0 110.199 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.46 -0.19 5.54 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 121.767 1.644 . . . . 0.0 114.558 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -112.05 -0.15 15.77 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.753 1.221 . . . . 0.0 111.561 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 46' ' ' LYS . 6.4 t -130.59 -42.63 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.349 1.06 . . . . 0.0 108.657 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.33 73.73 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 120.995 -1.066 . . . . 0.0 108.759 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.01 -13.36 4.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.021 1.328 . . . . 0.0 113.266 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.2 p -118.95 -0.76 11.11 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.91 1.232 . . . . 0.0 111.445 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.31 15.15 64.91 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.33 0.967 . . . . 0.0 111.56 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -106.79 -6.01 18.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.649 1.224 . . . . 0.0 113.633 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.01 -173.56 32.34 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.896 1.236 . . . . 0.0 115.228 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -70.78 179.29 4.37 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 124.205 3.27 . . . . 0.0 111.435 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -105.57 -20.18 13.55 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 121.264 -0.898 . . . . 0.0 113.045 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 mt -140.92 149.85 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.5 tt -128.71 148.88 33.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 126.293 1.837 . . . . 0.0 106.695 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -138.87 99.3 3.75 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.752 1.221 . . . . 0.0 109.785 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -153.11 177.81 10.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.133 0.968 . . . . 0.0 111.667 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.52 134.33 53.16 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.781 1.632 . . . . 0.0 107.345 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -52.63 -27.84 18.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 129.01 2.924 . . . . 0.0 112.279 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.95 -26.4 65.95 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.427 0.691 . . . . 0.0 109.717 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -102.73 12.48 36.23 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 127.507 2.323 . . . . 0.0 110.852 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -108.02 -30.83 8.23 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.825 1.648 . . . . 0.0 111.227 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.8 -10.48 38.64 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.801 -1.0 . . . . 0.0 113.865 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.27 -47.59 3.26 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 119.928 1.864 . . . . 0.0 109.229 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -55.31 -46.74 76.26 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.709 1.604 . . . . 0.0 111.68 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.14 93.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.734 1.152 . . . . 0.0 109.673 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.91 1.09 4.81 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.972 1.709 . . . . 0.0 111.149 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -122.68 2.32 9.5 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.305 2.642 . . . . 0.0 109.511 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.62 -1.03 68.29 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 125.656 1.598 . . . . 0.0 112.401 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -69.04 -34.3 74.99 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.566 1.183 . . . . 0.0 112.848 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.5 mt -89.15 127.88 35.75 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.654 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -81.44 170.34 16.07 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.692 0.797 . . . . 0.0 112.602 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -60.11 117.31 4.97 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.508 ' HA ' HD13 ' A' ' 79' ' ' ILE . 1.4 mm -70.96 166.19 2.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 m -39.58 113.96 0.9 Allowed Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.265 1.826 . . . . 0.0 110.955 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.77 -53.32 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.434 2.756 . . . . 0.0 113.364 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -62.26 116.75 5.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.427 1.108 . . . . 0.0 111.731 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -54.33 -28.59 43.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.479 1.512 . . . . 0.0 111.971 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.82 -32.5 67.66 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.861 1.209 . . . . 0.0 112.786 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -68.98 -39.44 79.39 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -66.22 -37.73 86.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.722 1.209 . . . . 0.0 110.329 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.8 -13.4 59.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.311 1.845 . . . . 0.0 112.186 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -76.97 -9.65 58.84 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.757 -1.214 . . . . 0.0 110.591 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.9 mt -118.29 157.51 26.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.529 1.932 . . . . 0.0 108.614 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.404 ' CD1' ' HG2' ' A' ' 305' ' ' LYS . 48.9 m-85 -64.93 152.71 90.28 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 119.118 0.872 . . . . 0.0 109.497 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.53 -35.72 9.94 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.763 2.308 . . . . 0.0 114.531 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -64.18 -32.82 74.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.863 0.756 . . . . 0.0 110.902 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.77 -21.77 66.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.301 1.04 . . . . 0.0 110.401 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -77.43 -32.77 54.82 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.413 -0.804 . . . . 0.0 109.827 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.81 -4.03 3.97 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.493 1.517 . . . . 0.0 111.083 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.62 -7.0 22.16 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.032 2.133 . . . . 0.0 111.995 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.48 11.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.997 1.319 . . . . 0.0 113.179 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -69.32 169.44 12.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 122.43 1.109 . . . . 0.0 112.15 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -159.7 168.1 26.77 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 127.868 2.467 . . . . 0.0 105.469 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -60.95 108.02 0.8 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.876 1.67 . . . . 0.0 111.091 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.34 -83.39 0.87 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.62 1.105 . . . . 0.0 111.366 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.1 173.43 6.58 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.84 0.856 . . . . 0.0 111.788 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 103' ' ' LEU . 3.4 mm? -109.2 157.46 18.77 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.9 pt -119.53 -26.23 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.706 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.39 178.16 8.9 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.195 0.998 . . . . 0.0 109.177 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.473 ' CE2' HD12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -129.63 148.66 70.32 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.75 0.82 . . . . 0.0 109.864 178.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.71 142.24 43.26 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.569 2.846 . . . . 0.0 108.917 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.0 mm -129.9 -49.09 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 124.656 1.182 . . . . 0.0 111.422 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 262' ' ' LEU . . . -122.01 147.08 46.52 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.033 0.833 . . . . 0.0 109.614 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.24 104.82 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 102.005 -3.331 . . . . 0.0 102.005 177.659 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 CA--C 1.53 0.197 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.0 p90 . . . . . 0 C--N 1.325 -0.494 0 C-N-CA 125.483 1.513 . . . . 0.0 108.127 -179.824 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.453 -0.853 0 N-CA-C 107.575 -1.74 . . . . 0.0 107.575 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -113.57 -10.07 13.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.047 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.7 t -153.86 157.35 39.16 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.15 1.341 . . . . 0.0 110.98 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -72.98 -24.73 60.81 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.675 -0.641 . . . . 0.0 111.261 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -70.92 -17.04 62.7 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.0 0.818 . . . . 0.0 109.956 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -86.99 -24.34 24.72 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 125.513 1.525 . . . . 0.0 110.243 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 33.7 mm -52.69 -58.97 9.88 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.894 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.77 -22.32 27.61 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 CA-C-N 120.253 1.126 . . . . 0.0 112.164 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.99 -31.05 62.8 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.271 1.428 . . . . 0.0 111.834 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.6 tp -91.89 -31.37 15.7 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.184 1.393 . . . . 0.0 110.134 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -58.57 -44.17 89.64 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.671 0.748 . . . . 0.0 110.675 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -65.17 -30.38 71.28 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.967 0.907 . . . . 0.0 112.316 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -77.43 -42.35 36.41 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 20.3 mt -72.58 -31.67 65.39 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.534 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.89 -34.88 79.14 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.81 -13.02 61.89 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.02 -5.4 8.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.052 0.941 . . . . 0.0 112.471 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -173.31 -89.46 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 118.868 0.758 . . . . 0.0 112.885 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.42 ' HE3' ' OE2' ' A' ' 221' ' ' GLU . 62.2 mttm -146.22 -177.45 5.62 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.515 1.526 . . . . 0.0 109.082 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 p -57.78 166.97 1.25 Allowed 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.839 0.856 . . . . 0.0 111.508 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.83 -76.51 0.46 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.5 tp -90.18 133.27 35.0 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.464 1.506 . . . . 0.0 110.207 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 53.9 ttm -139.82 107.17 5.53 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.84 160.85 37.3 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.364 1.465 . . . . 0.0 109.196 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -67.93 120.09 13.64 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.106 0.962 . . . . 0.0 110.994 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.3 mt -106.97 -9.76 16.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.659 1.984 . . . . 0.0 111.909 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -77.67 -17.61 57.52 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.337 -0.852 . . . . 0.0 111.733 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -109.57 147.44 36.08 Favored Pre-proline 0 N--CA 1.469 0.486 0 C-N-CA 124.467 1.107 . . . . 0.0 109.347 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -82.07 -18.26 7.6 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.832 2.354 . . . . 0.0 114.138 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -58.94 -37.6 77.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.445 1.021 . . . . 0.0 111.974 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -71.54 -43.67 66.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.794 0.838 . . . . 0.0 112.445 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.2 p -80.9 -14.18 58.24 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.071 0.549 . . . . 0.0 112.16 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -54.99 -57.3 20.23 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.657 -1.164 . . . . 0.0 113.509 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.5 -26.38 81.81 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 121.763 1.665 . . . . 0.0 113.332 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.82 -56.02 9.33 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.4 pt -67.6 -25.71 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.144 0.884 . . . . 0.0 111.685 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.77 -4.1 25.8 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.283 -0.886 . . . . 0.0 110.912 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.6 -54.49 42.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.698 0.799 . . . . 0.0 110.534 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -55.15 -61.23 2.46 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.105 0.479 . . . . 0.0 111.121 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.26 6.41 0.03 OUTLIER Glycine 0 CA--C 1.524 0.6 0 CA-C-O 118.47 -1.183 . . . . 0.0 115.261 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -53.37 133.08 42.76 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 118.277 1.038 . . . . 0.0 112.155 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -142.66 120.41 11.89 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.131 0.967 . . . . 0.0 110.681 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.7 85.57 5.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 335' ' ' GLN . 11.0 m-85 66.54 165.84 0.2 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.6 1.56 . . . . 0.0 108.445 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -132.54 159.25 40.01 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 120.819 -1.175 . . . . 0.0 109.258 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -149.09 104.62 3.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.284 -1.746 . . . . 0.0 106.284 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.1 -174.79 0.84 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -52.5 -35.79 53.82 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.061 -1.024 . . . . 0.0 110.986 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -145.29 6.89 1.54 Allowed Glycine 0 CA--C 1.533 1.212 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.756 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -122.43 121.48 36.73 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 120.999 2.4 . . . . 0.0 109.275 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.48 123.6 50.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -146.36 83.49 1.61 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -0.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -83.5 -25.76 30.8 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 119.67 -1.894 . . . . 0.0 107.774 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -96.0 103.78 15.68 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 127.727 2.411 . . . . 0.0 106.798 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.7 t -142.95 165.12 16.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -140.63 35.71 1.84 Allowed Glycine 0 CA--C 1.533 1.163 0 N-CA-C 115.025 0.77 . . . . 0.0 115.025 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.0 t -60.11 -17.04 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 119.436 1.618 . . . . 0.0 114.617 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.273 0.0 OUTLIER -117.86 20.49 13.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.554 1.541 . . . . 0.0 111.255 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -69.71 159.04 34.25 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 120.601 -1.312 . . . . 0.0 108.176 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.34 -30.18 62.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.549 0.74 . . . . 0.0 112.422 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.23 -41.11 94.95 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.511 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.1 -52.92 56.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.918 0.487 . . . . 0.0 109.938 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -62.64 -36.93 84.41 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 117.921 -1.038 . . . . 0.0 111.656 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.57 -49.71 76.45 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.24 0.927 . . . . 0.0 110.234 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.85 -15.12 75.91 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.308 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 44.0 tp -89.12 -50.21 6.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.195 0.998 . . . . 0.0 110.996 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.6 t -55.61 -38.63 69.71 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.824 -1.084 . . . . 0.0 111.856 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -54.6 -54.52 40.26 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.173 1.351 . . . . 0.0 111.028 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 9.9 tt -62.01 -49.73 74.9 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.687 1.195 . . . . 0.0 109.563 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.26 -29.23 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.105 0.962 . . . . 0.0 110.601 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.51 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.9 OUTLIER -67.35 -37.03 82.6 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 119.043 0.838 . . . . 0.0 111.476 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.57 -39.55 88.53 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 37.3 mt -61.95 -48.61 87.77 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.51 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -51.39 -40.18 58.73 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.731 1.612 . . . . 0.0 111.567 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -84.77 2.23 43.1 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.969 1.308 . . . . 0.0 112.745 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? 48.32 46.72 20.16 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.776 2.03 . . . . 0.0 111.396 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 -2.31 9.18 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.7 ttp -114.49 153.52 29.84 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.28 49.92 0.73 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.453 1.501 . . . . 0.0 110.671 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.63 -11.37 11.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.481 2.712 . . . . 0.0 115.046 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -91.72 -13.51 31.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.979 1.711 . . . . 0.0 110.815 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.7 m -61.31 162.14 8.14 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.524 1.929 . . . . 0.0 108.562 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.77 -174.19 4.55 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -56.17 -45.63 79.63 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.865 0.466 . . . . 0.0 111.001 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.3 m -64.39 -44.21 92.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.984 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 22.5 mm -62.34 -51.9 66.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -56.26 -59.09 5.45 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.516 1.126 . . . . 0.0 111.829 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -55.7 -40.67 72.72 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.345 0.658 . . . . 0.0 111.99 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.09 -53.82 39.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.09 -35.52 71.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.548 0.739 . . . . 0.0 111.317 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.05 -48.96 74.22 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.62 -27.75 68.88 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.075 0.55 . . . . 0.0 110.131 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -76.49 -10.97 59.79 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.719 -1.238 . . . . 0.0 111.431 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.87 24.7 73.53 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.42 ' OE2' ' HE3' ' A' ' 144' ' ' LYS . 5.4 mm-40 -93.68 -30.26 15.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 69.9 p -87.77 146.68 25.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.996 0.816 . . . . 0.0 110.386 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -85.26 -31.25 23.21 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -160.03 166.71 29.45 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.44 0.564 . . . . 0.0 112.396 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 6.3 t -147.39 161.99 39.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.081 1.352 . . . . 0.0 107.889 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.9 mt . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -179.644 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.237 0.409 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.69 146.89 80.43 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.6 1.533 . . . . 0.0 109.257 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 255' ' ' SER . 20.4 p -129.32 156.24 44.33 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.181 0.992 . . . . 0.0 108.822 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -81.33 155.26 26.09 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.103 -0.998 . . . . 0.0 108.896 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.71 119.98 7.06 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.145 -0.972 . . . . 0.0 112.523 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.39 5.52 63.33 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.667 1.603 . . . . 0.0 113.982 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -148.12 115.46 4.0 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 119.907 1.854 . . . . 0.0 114.379 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.86 141.98 15.48 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.17 2.58 . . . . 0.0 112.574 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.472 ' H ' HG22 ' A' ' 249' ' ' THR . 58.8 m -59.88 140.12 56.87 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 84.17 15.01 Favored Pre-proline 0 N--CA 1.466 0.329 0 O-C-N 121.802 -0.561 . . . . 0.0 109.929 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -77.05 -175.57 2.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.762 2.308 . . . . 0.0 110.259 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 . . . . . 0 C--O 1.236 0.38 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.792 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 106.355 -2.698 . . . . 0.0 106.355 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.49 176.55 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.196 0.998 . . . . 0.0 108.365 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 5.7 tt -106.42 151.62 24.68 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.7 m -140.49 169.5 17.54 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.571 0.623 . . . . 0.0 112.18 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -132.54 137.83 47.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.835 1.654 . . . . 0.0 107.082 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.35 134.97 7.46 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.092 0.87 . . . . 0.0 111.69 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 54.2 mt -75.44 136.72 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.298 1.049 . . . . 0.0 110.431 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -71.91 123.61 23.08 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.654 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -71.22 -28.64 64.34 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.69 -0.671 . . . . 0.0 112.166 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -69.37 -8.42 46.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 59.9 m -64.61 163.15 29.34 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.267 1.027 . . . . 0.0 108.285 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -74.16 -56.58 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.653 1.569 . . . . 0.0 110.421 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -128.86 102.47 6.55 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.507 ' HE2' ' HB1' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -57.82 -17.51 16.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -59.42 -31.58 69.4 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.553 0.741 . . . . 0.0 110.721 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 98.8 mt -60.36 -43.34 96.6 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.104 -0.998 . . . . 0.0 109.777 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.38 -43.22 41.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.739 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -34.79 75.95 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.675 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -73.41 -52.75 12.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -52.55 -50.98 61.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.059 0.845 . . . . 0.0 112.826 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.6 tt -62.35 -20.12 64.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -111.88 -8.9 14.08 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -97.3 -31.95 12.15 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.937 1.244 . . . . 0.0 112.336 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -133.18 -37.86 0.97 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.048 0.84 . . . . 0.0 113.115 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.5 -25.47 67.28 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 63.3 mt -112.11 50.53 0.85 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.598 1.159 . . . . 0.0 111.2 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 50.8 p -125.37 157.89 35.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -60.49 -44.19 96.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -65.0 -38.65 91.65 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.093 0.957 . . . . 0.0 111.883 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.57 -44.84 56.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 16.2 mt -65.35 -49.87 67.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.879 0.839 . . . . 0.0 108.852 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.18 -40.26 76.98 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.824 1.25 . . . . 0.0 111.719 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.26 74.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 118.99 0.814 . . . . 0.0 112.692 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 20.5 t -79.25 -37.95 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.203 0.601 . . . . 0.0 109.846 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -63.78 -30.43 71.53 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.607 0.718 . . . . 0.0 111.904 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -64.55 -37.18 86.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.395 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.87 -42.49 39.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.43 1.013 . . . . 0.0 111.673 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.518 ' HA ' ' HE2' ' A' ' 297' ' ' LYS . 8.2 mmpt? -145.52 148.1 35.79 Favored Pre-proline 0 N--CA 1.464 0.274 0 C-N-CA 123.716 0.806 . . . . 0.0 109.361 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.6 126.95 15.54 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.378 2.052 . . . . 0.0 108.778 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 70.2 mt -102.36 -9.9 19.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 77.38 -155.97 44.4 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.46 170.59 15.39 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 23.3 m -130.32 156.71 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 121.039 -1.038 . . . . 0.0 109.569 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.14 -28.71 42.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.147 0.979 . . . . 0.0 110.96 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.19 106.91 1.78 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.471 1.109 . . . . 0.0 108.624 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.404 ' HG2' ' CD1' ' A' ' 90' ' ' TYR . 18.0 mtmt -52.89 -40.8 63.78 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.391 0.676 . . . . 0.0 112.335 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 5.1 m -53.48 -29.84 37.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.076 1.75 . . . . 0.0 112.768 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -112.75 -12.26 13.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.629 0.649 . . . . 0.0 110.196 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -64.36 -42.19 96.32 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.9 -23.37 66.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.042 0.937 . . . . 0.0 112.493 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -90.35 -44.76 9.46 Favored 'General case' 0 N--CA 1.46 0.058 0 C-N-CA 124.417 1.087 . . . . 0.0 109.014 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 6.3 mt -62.86 -35.01 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.245 -0.91 . . . . 0.0 109.888 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.02 -6.54 6.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.259 1.424 . . . . 0.0 113.242 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -68.83 -14.65 63.16 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.26 1.024 . . . . 0.0 111.377 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.93 137.51 20.12 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -14.76 37.08 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.233 2.622 . . . . 0.0 110.762 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.55 -48.05 70.92 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.186 0.994 . . . . 0.0 108.608 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.9 mp -67.97 -52.63 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.58 -49.49 26.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.92 0.888 . . . . 0.0 112.349 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.02 -11.01 2.95 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 29.6 m -98.51 -40.21 8.36 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.3 tpt -69.45 -30.17 68.03 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.837 0.455 . . . . 0.0 111.676 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -62.11 -28.5 69.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.896 -0.573 . . . . 0.0 109.81 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -61.14 -46.34 90.94 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 124.892 1.277 . . . . 0.0 110.697 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.21 0 C-N-CA 122.681 0.392 . . . . 0.0 111.486 -179.414 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.458 -0.607 0 N-CA-C 110.636 -0.563 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -77.02 56.73 1.26 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.665 1.186 . . . . 0.0 111.486 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.81 147.86 49.53 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.46 1.104 . . . . 0.0 111.422 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.48 -28.89 38.15 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.144 2.563 . . . . 0.0 110.959 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 169' ' ' PHE . 21.8 mp0 -54.23 -29.04 45.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.154 0.982 . . . . 0.0 111.81 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 5.7 mmt -62.77 -35.63 80.45 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.717 1.144 . . . . 0.0 110.729 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 8.7 t -60.8 -46.2 91.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.93 -41.61 86.73 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.423 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -56.37 -53.81 52.99 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 125.142 1.377 . . . . 0.0 109.88 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -60.16 -52.57 64.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.451 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -57.21 -38.11 73.21 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.903 0.774 . . . . 0.0 111.646 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.3 -60.71 2.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.335 1.054 . . . . 0.0 111.793 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 18.2 t -62.59 -33.0 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.377 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -34.71 70.89 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 21.4 m -80.58 -43.96 19.75 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.43 -50.83 64.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.202 1.001 . . . . 0.0 112.773 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.0 -48.99 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 123.447 0.699 . . . . 0.0 109.335 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mm -65.86 -32.79 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.909 0.777 . . . . 0.0 110.019 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -62.21 -51.11 69.11 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.822 -1.174 . . . . 0.0 109.011 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.51 -48.07 76.52 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.451 0.701 . . . . 0.0 110.602 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.37 69.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.284 1.034 . . . . 0.0 113.153 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 16.4 m -92.22 -3.33 55.69 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.591 0.757 . . . . 0.0 110.148 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 68.7 16.23 69.73 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 118.955 0.798 . . . . 0.0 111.715 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -74.74 -28.89 60.97 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.495 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -147.23 158.54 43.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.836 0.744 . . . . 0.0 109.591 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.2 m -62.71 149.9 42.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.631 1.173 . . . . 0.0 108.782 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 42.1 t -60.17 -45.71 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.83 -51.23 70.9 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 123.78 0.832 . . . . 0.0 110.097 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -66.87 -27.86 67.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.42 -38.94 91.64 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 19.5 mt -78.92 -33.99 44.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.829 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -55.18 -47.5 75.11 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.34 1.056 . . . . 0.0 108.475 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -58.32 -55.94 28.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.09 1.756 . . . . 0.0 109.265 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -55.36 -50.56 69.36 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.435 1.494 . . . . 0.0 113.533 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -37.52 73.61 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 28.3 m -66.46 -48.63 69.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 117.563 -1.208 . . . . 0.0 109.166 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -58.65 -14.58 8.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.014 1.279 . . . . 0.0 113.761 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 35.7 mt -101.51 -26.2 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.755 1.622 . . . . 0.0 110.339 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 40.1 p -101.31 8.11 42.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.011 1.324 . . . . 0.0 110.678 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? . . . . . 0 C--O 1.254 1.311 0 C-N-CA 130.347 3.459 . . . . 0.0 104.54 178.34 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.58 128.35 31.88 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.73 6.57 21.09 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 126.66 2.076 . . . . 0.0 113.958 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.32 170.91 14.83 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.765 1.626 . . . . 0.0 108.502 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -145.88 147.35 31.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.464 2.306 . . . . 0.0 105.724 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.53 143.23 39.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.6 mt -128.8 127.36 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -115.2 105.77 13.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.1 mp -71.28 155.45 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.406 HD21 HD11 ' A' ' 43' ' ' LEU . 4.8 m-80 -122.63 108.0 12.6 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.827 0.851 . . . . 0.0 112.541 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.67 24.32 7.44 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 49.65 41.78 22.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.899 1.35 . . . . 0.0 110.085 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -63.36 -178.04 0.23 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.67 1.988 . . . . 0.0 113.286 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.51 51.86 2.64 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.27 1.891 . . . . 0.0 110.74 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -60.09 -20.7 59.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.571 1.548 . . . . 0.0 112.777 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -58.7 -44.55 90.37 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.543 1.065 . . . . 0.0 111.013 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.24 -31.38 78.95 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.0 tp -71.83 -38.35 70.17 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.002 0.921 . . . . 0.0 110.819 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.98 -42.75 65.85 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.965 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -58.43 -34.12 70.45 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.953 0.797 . . . . 0.0 111.39 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -68.68 -45.09 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.658 1.583 . . . . 0.0 106.981 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.83 -37.82 95.51 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -66.12 -42.86 88.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 117.848 -1.072 . . . . 0.0 108.522 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -57.62 -56.5 21.16 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -54.89 -48.83 72.49 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.325 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.93 -31.78 72.12 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.891 0.768 . . . . 0.0 111.103 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -73.26 -27.13 61.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.818 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -97.25 -36.26 10.48 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.823 0.849 . . . . 0.0 112.816 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.3 p -102.18 -27.73 12.71 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.397 0.999 . . . . 0.0 113.245 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.82 -15.73 56.72 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.623 -1.098 . . . . 0.0 112.581 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.8 mm -69.07 133.11 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' CA ' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.69 151.57 46.24 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.716 -0.615 . . . . 0.0 111.327 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.2 t -136.68 112.06 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.9 m -102.92 123.47 46.62 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.27 115.71 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 105.933 -1.876 . . . . 0.0 105.933 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -130.7 159.47 37.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.642 0.655 . . . . 0.0 109.7 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -125.23 63.39 42.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.57 1.148 . . . . 0.0 108.888 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.87 146.49 42.41 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.494 2.129 . . . . 0.0 111.807 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -101.06 24.22 9.68 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.87 0.868 . . . . 0.0 110.185 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.67 14.09 0.84 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.586 -0.696 . . . . 0.0 112.657 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.406 HD11 HD21 ' A' ' 12' ' ' ASN . 0.8 OUTLIER -56.18 -27.98 56.49 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.472 -1.393 . . . . 0.0 112.491 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.89 -25.3 56.63 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.91 1.284 . . . . 0.0 112.4 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.61 -25.26 7.93 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.222 1.009 . . . . 0.0 109.428 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -45.8 65.08 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 120.263 -1.523 . . . . 0.0 109.878 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -49.75 -59.2 7.24 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 117.598 -1.191 . . . . 0.0 110.06 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.58 -18.83 65.71 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.135 1.89 . . . . 0.0 114.559 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -89.73 1.13 56.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.313 1.445 . . . . 0.0 113.147 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 t -131.27 -41.21 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 119.481 1.037 . . . . 0.0 108.388 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.09 -30.56 71.09 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 122.038 -0.414 . . . . 0.0 110.629 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.28 95.19 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.65 -41.18 79.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.431 0.692 . . . . 0.0 110.43 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.39 19.9 1.47 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.131 -1.372 . . . . 0.0 114.324 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -134.96 -160.72 1.08 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.896 1.678 . . . . 0.0 107.038 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.78 -160.54 13.39 Favored Glycine 0 C--N 1.339 0.729 0 O-C-N 120.078 -1.639 . . . . 0.0 114.262 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.51 -179.66 5.03 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.08 2.52 . . . . 0.0 109.8 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -111.87 -23.56 10.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 121.564 -0.71 . . . . 0.0 112.418 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.1 mt -145.51 142.72 22.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.119 0.968 . . . . 0.0 108.851 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.2 tt -127.38 142.43 43.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.531 1.532 . . . . 0.0 107.412 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.64 116.85 22.35 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.69 1.196 . . . . 0.0 109.866 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -158.59 170.61 21.78 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.676 0.79 . . . . 0.0 109.371 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.58 153.64 40.97 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -58.19 -23.0 54.06 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.85 -54.63 42.29 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.853 -1.154 . . . . 0.0 111.731 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -63.7 -22.65 67.02 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 119.255 -0.402 . . . . 0.0 110.828 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -77.76 -2.75 37.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.724 0.41 . . . . 0.0 111.205 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.95 -9.13 75.3 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 120.852 -1.155 . . . . 0.0 110.871 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.97 -42.23 0.38 Allowed Glycine 0 CA--C 1.533 1.156 0 N-CA-C 117.938 1.935 . . . . 0.0 117.938 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -46.28 -44.79 16.84 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.874 2.337 . . . . 0.0 115.403 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.02 -41.49 82.07 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 119.585 1.084 . . . . 0.0 110.078 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -28.45 69.63 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.237 -0.915 . . . . 0.0 109.82 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.5 m -77.58 -2.96 38.36 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.013 1.325 . . . . 0.0 111.29 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.13 42.74 23.34 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.4 mt -126.81 -2.1 6.61 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.7 mt -121.69 135.75 54.95 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.98 1.718 . . . . 0.0 110.944 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -81.98 162.75 22.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.295 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -75.65 104.79 6.36 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 103.555 -2.758 . . . . 0.0 103.555 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.52 168.55 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.815 1.246 . . . . 0.0 112.982 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.5 m 57.02 91.36 0.08 OUTLIER Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 127.205 2.202 . . . . 0.0 115.049 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.36 -27.81 9.12 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.177 1.918 . . . . 0.0 112.563 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -124.99 137.69 54.24 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.856 1.207 . . . . 0.0 113.012 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -58.1 -22.97 53.02 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.778 2.431 . . . . 0.0 115.766 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.67 70.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 120.188 1.358 . . . . 0.0 111.699 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -59.33 -31.56 69.28 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.477 0.711 . . . . 0.0 110.881 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -65.36 -45.02 85.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.63 0.772 . . . . 0.0 110.302 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.22 -15.53 60.17 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.302 1.041 . . . . 0.0 112.815 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -84.39 -6.41 59.38 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.239 1.016 . . . . 0.0 111.043 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mt -126.7 159.44 33.68 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.882 1.673 . . . . 0.0 108.771 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -76.99 158.19 80.51 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 121.501 -0.749 . . . . 0.0 109.215 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.83 -47.56 1.84 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.636 2.89 . . . . 0.0 113.386 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -56.71 -30.49 63.54 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.765 0.711 . . . . 0.0 111.734 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -30.8 69.42 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.275 -0.891 . . . . 0.0 110.092 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -79.23 -40.75 29.88 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.096 0.958 . . . . 0.0 110.206 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -55.72 -21.88 20.85 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.673 1.189 . . . . 0.0 112.74 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.28 3.68 55.25 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.029 2.132 . . . . 0.0 113.997 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.18 0.53 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.48 1.112 . . . . 0.0 111.336 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -68.04 155.26 39.91 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.298 -0.877 . . . . 0.0 108.685 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -136.1 169.92 16.85 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -57.83 102.6 0.1 Allowed 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.442 0.697 . . . . 0.0 111.336 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.46 -81.68 0.95 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.521 1.058 . . . . 0.0 110.911 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.66 169.69 13.86 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.904 0.852 . . . . 0.0 110.816 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.9 mt -105.06 168.92 8.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.78 1.232 . . . . 0.0 108.502 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.6 pt -138.77 -25.88 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.17 173.25 16.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.874 1.215 . . . . 0.0 109.631 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.49 149.69 74.25 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 123.659 0.784 . . . . 0.0 109.217 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.72 141.78 38.33 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.182 2.588 . . . . 0.0 109.0 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -121.55 -51.1 3.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.431 0.692 . . . . 0.0 109.331 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.51 166.85 22.23 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.085 0.402 . . . . 0.0 111.282 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -136.67 123.64 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.579 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.4 p90 . . . . . 0 C--O 1.239 0.551 0 C-N-CA 124.605 1.162 . . . . 0.0 108.754 179.48 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 N--CA 1.45 -1.03 0 N-CA-C 109.185 -1.121 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -130.66 -38.31 1.32 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.843 0.857 . . . . 0.0 109.609 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.16 150.67 47.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.802 0.335 . . . . 0.0 110.89 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -64.29 -20.52 66.13 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.994 -1.003 . . . . 0.0 111.464 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.64 -11.55 60.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.785 1.175 . . . . 0.0 110.951 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -99.02 -28.56 13.35 Favored 'General case' 0 C--O 1.222 -0.364 0 O-C-N 120.929 -1.107 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.9 mm -52.04 -56.31 22.93 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 119.657 1.117 . . . . 0.0 111.256 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -71.13 -20.12 28.92 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 CA-C-N 120.976 1.384 . . . . 0.0 112.42 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.9 -36.46 56.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.926 1.29 . . . . 0.0 110.887 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.15 -30.52 16.65 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 126.517 1.927 . . . . 0.0 112.402 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.8 -45.79 85.57 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.402 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 9.5 ptmm? -64.1 -35.66 81.5 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.581 0.752 . . . . 0.0 111.768 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.52 -43.67 69.14 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.7 mt -73.33 -30.83 63.61 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.765 -0.635 . . . . 0.0 110.182 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -67.41 -39.64 85.53 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.68 -16.23 60.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 123.764 0.665 . . . . 0.0 112.727 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.45 4.25 8.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.629 1.171 . . . . 0.0 112.208 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.84 -99.93 0.13 Allowed Glycine 0 C--N 1.337 0.629 0 CA-C-N 118.746 0.703 . . . . 0.0 114.706 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -139.5 -176.09 4.42 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.659 2.384 . . . . 0.0 109.135 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.87 163.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.73 -52.32 5.38 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.486 1.514 . . . . 0.0 109.423 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.3 tp -137.68 150.78 47.62 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 127.621 2.369 . . . . 0.0 108.244 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -156.24 128.94 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -147.88 163.79 35.68 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -67.03 110.15 3.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.121 0.963 . . . . 0.0 108.41 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.15 -13.2 22.28 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -76.79 -15.13 59.83 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -99.72 130.73 25.96 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 119.805 1.184 . . . . 0.0 111.356 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.84 -14.05 35.29 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 121.594 1.529 . . . . 0.0 110.902 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -64.63 -42.17 95.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.609 1.964 . . . . 0.0 110.109 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -86.08 -30.36 22.65 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.358 0.663 . . . . 0.0 112.687 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.7 p -84.47 -7.51 59.26 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.09 0.859 . . . . 0.0 110.625 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -55.31 -57.94 17.72 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.546 -1.346 . . . . 0.0 112.521 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.33 -25.32 56.14 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.703 1.602 . . . . 0.0 112.95 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -66.18 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.045 1.338 . . . . 0.0 108.04 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 39.4 pt -64.82 -27.13 41.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 O-C-N 121.74 -0.6 . . . . 0.0 111.938 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.38 -16.88 61.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.947 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.0 -59.46 4.51 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.973 0.909 . . . . 0.0 113.161 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -62.33 -54.42 40.72 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.39 12.09 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 CA-C-O 118.553 -1.137 . . . . 0.0 114.51 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.57 133.97 41.53 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 119.842 1.821 . . . . 0.0 109.903 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.418 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 48.9 p90 -145.56 137.46 25.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.05 -48.68 12.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -144.46 141.11 29.36 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.046 0.939 . . . . 0.0 108.951 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.418 ' HE2' ' CE1' ' A' ' 167' ' ' TYR . 10.3 tppt? -91.2 153.06 20.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -159.38 102.35 1.57 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -138.3 160.37 39.66 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 56.77 11.74 0.99 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.209 1.803 . . . . 0.0 111.334 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.84 16.29 80.18 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -178.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -114.84 110.26 19.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 126.18 1.792 . . . . 0.0 108.928 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -81.12 143.62 32.27 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -145.32 76.05 1.46 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 119.833 1.197 . . . . 0.0 113.271 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.56 -6.94 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -41.38 80.82 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.963 1.705 . . . . 0.0 108.186 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -87.78 105.3 17.3 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.34 1.056 . . . . 0.0 108.849 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 81.1 t -127.49 98.62 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -76.0 18.0 3.49 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 117.272 1.669 . . . . 0.0 117.272 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.0 t -70.2 -20.18 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.531 2.165 . . . . 0.0 112.863 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.53 2.09 25.91 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.813 0.733 . . . . 0.0 111.854 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -66.29 165.49 13.88 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.541 1.136 . . . . 0.0 111.369 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.14 -41.39 71.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.403 1.081 . . . . 0.0 111.308 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.0 -27.96 73.53 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 120.995 -1.066 . . . . 0.0 113.394 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.91 -38.09 54.14 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.417 1.109 . . . . 0.0 110.11 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -73.55 -33.19 64.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.786 -0.571 . . . . 0.0 110.988 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -54.73 -48.64 72.28 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.478 1.111 . . . . 0.0 112.457 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -75.87 -19.08 79.2 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.95 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.9 tp -77.61 -53.12 7.96 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 122.95 0.5 . . . . 0.0 112.247 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.2 t -54.78 -32.94 60.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.417 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -53.06 -53.2 53.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.359 0.981 . . . . 0.0 110.697 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 27.4 tp -63.41 -48.78 76.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.723 0.409 . . . . 0.0 110.473 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.16 -31.61 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 123.998 0.919 . . . . 0.0 110.025 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -48.18 80.14 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.895 1.278 . . . . 0.0 110.53 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.24 -39.26 93.58 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.932 -0.48 . . . . 0.0 109.863 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 73.3 mt -67.4 -38.2 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.971 0.908 . . . . 0.0 108.753 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -57.71 -47.61 81.91 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.538 -1.351 . . . . 0.0 108.015 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -80.77 -0.13 37.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.29 1.436 . . . . 0.0 112.459 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp 56.26 6.39 0.25 Allowed 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 129.829 3.252 . . . . 0.0 116.729 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -71.45 -20.6 62.07 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.922 -0.711 . . . . 0.0 112.447 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.7 tpt -82.97 159.27 22.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.287 1.035 . . . . 0.0 112.485 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -95.94 76.09 3.12 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.34 -7.36 30.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.291 1.436 . . . . 0.0 113.598 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.61 -22.69 26.06 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 130.519 3.528 . . . . 0.0 112.179 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.6 m -58.84 127.79 33.95 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -128.62 -178.43 4.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.367 1.867 . . . . 0.0 107.513 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -59.34 -39.49 83.35 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -53.51 56.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.522 1.129 . . . . 0.0 109.121 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 60.5 mt -61.98 -55.93 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.831 1.252 . . . . 0.0 110.848 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.65 94.22 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.628 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.82 -45.27 82.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.294 1.407 . . . . 0.0 110.904 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.47 -55.43 27.65 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.485 1.114 . . . . 0.0 110.403 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.92 -38.7 76.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.397 1.079 . . . . 0.0 110.16 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -62.03 -30.65 71.11 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.456 0.571 . . . . 0.0 109.581 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.57 -35.84 65.52 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 120.923 -1.11 . . . . 0.0 109.443 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -77.01 -12.38 59.93 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.574 1.149 . . . . 0.0 113.622 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.1 16.53 59.18 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-N 120.683 1.583 . . . . 0.0 111.442 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -78.99 -9.4 59.52 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.031 1.732 . . . . 0.0 114.349 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -146.62 127.1 14.09 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.082 -1.011 . . . . 0.0 108.702 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.71 -24.77 66.29 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.322 -0.862 . . . . 0.0 111.575 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -140.92 166.64 24.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.567 1.147 . . . . 0.0 111.603 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.9 t -153.15 166.65 31.85 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.279 1.831 . . . . 0.0 107.179 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.5 mt . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 179.413 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.41 144.56 62.04 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.511 1.474 . . . . 0.0 109.211 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 254' ' ' PRO . 81.6 p -136.03 -161.63 1.18 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.915 0.886 . . . . 0.0 110.262 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.5 143.65 40.53 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -55.65 134.75 51.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.569 -0.707 . . . . 0.0 110.033 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 70.58 -7.81 4.75 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -146.42 98.47 4.26 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 119.293 1.547 . . . . 0.0 112.1 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 249' ' ' THR . 37.8 Cg_endo -66.07 158.24 55.45 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.327 1.352 . . . . 0.0 110.788 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 80.7 p -83.07 142.53 31.22 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 120.893 -1.13 . . . . 0.0 110.116 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -142.5 118.15 6.77 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.832 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -75.76 -61.89 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.731 2.287 . . . . 0.0 110.904 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 . . . . . 0 C--O 1.24 0.591 0 C-N-CA 129.613 3.165 . . . . 0.0 105.953 179.678 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.123 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.82 122.4 62.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 117.604 0.702 . . . . 0.0 112.535 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.7 tt -77.77 128.04 33.39 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.4 m -114.97 163.42 15.61 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.28 0.632 . . . . 0.0 112.179 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -139.26 139.98 37.54 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.19 0.996 . . . . 0.0 109.27 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -129.44 153.94 20.14 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.035 1.778 . . . . 0.0 108.896 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 75.9 mt -104.41 137.97 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 125.139 1.376 . . . . 0.0 107.654 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -68.05 114.46 6.6 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -63.22 -24.71 68.0 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.334 -0.854 . . . . 0.0 110.946 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -69.84 -16.72 63.31 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 118.451 -0.785 . . . . 0.0 113.079 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 44.7 m -58.3 150.42 53.69 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 118.985 0.812 . . . . 0.0 109.781 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.83 -37.24 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.195 1.93 . . . . 0.0 112.221 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -135.81 89.03 2.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -57.31 -18.57 17.52 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.622 0.369 . . . . 0.0 111.084 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.85 -42.33 84.24 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.557 1.943 . . . . 0.0 108.409 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.08 -37.84 81.12 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.905 -1.122 . . . . 0.0 110.674 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.35 -45.53 38.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -35.33 77.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.473 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -71.71 -52.63 16.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.215 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -54.89 -47.99 73.61 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 120.657 1.572 . . . . 0.0 111.167 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.31 -45.73 91.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.772 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -83.42 -7.3 59.58 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -108.17 -24.32 11.59 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 116.92 -1.514 . . . . 0.0 114.603 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -139.65 -35.67 0.53 Allowed 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.457 1.026 . . . . 0.0 112.256 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -64.82 -44.76 88.83 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.397 1.453 . . . . 0.0 108.549 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 77.7 mt -96.86 53.97 1.26 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.358 1.863 . . . . 0.0 112.834 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.1 p -131.75 157.47 43.72 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.29 -38.49 89.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -69.44 -39.1 78.02 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.71 -0.619 . . . . 0.0 110.885 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.84 -32.26 61.34 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 121.769 -0.582 . . . . 0.0 112.122 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.9 mt -74.75 -44.17 51.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.31 -45.26 84.4 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.377 1.071 . . . . 0.0 108.541 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.69 -50.42 63.35 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.435 1.094 . . . . 0.0 112.289 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 65.4 t -72.94 -34.57 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.209 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -68.92 -32.91 72.87 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.452 0.569 . . . . 0.0 111.386 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -62.63 -35.18 78.76 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -67.17 -72.44 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.57 154.51 77.6 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 124.493 1.117 . . . . 0.0 111.581 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.44 108.1 2.54 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.44 2.093 . . . . 0.0 109.868 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.22 -30.51 70.45 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.03 -116.47 5.59 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 106.49 -2.644 . . . . 0.0 106.49 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -109.9 169.13 8.92 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.993 1.396 . . . . 0.0 108.328 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 18.6 m -131.74 153.1 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 O-C-N 121.377 -0.827 . . . . 0.0 110.977 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.11 -34.34 50.12 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.974 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 15.4 tp -69.34 102.19 1.69 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.303 1.041 . . . . 0.0 108.327 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -53.2 -28.44 26.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.608 1.563 . . . . 0.0 115.217 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -62.37 1.7 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.764 1.165 . . . . 0.0 111.483 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -78.96 -14.01 59.46 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 125.246 1.418 . . . . 0.0 112.691 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -58.88 -32.23 69.3 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.66 -30.87 71.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.711 1.204 . . . . 0.0 112.601 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -82.38 -39.46 22.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.641 1.176 . . . . 0.0 110.009 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.439 ' HB3' HG21 ' A' ' 317' ' ' ILE . 12.6 mt -69.14 -34.82 75.6 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.33 -6.96 1.72 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.089 1.756 . . . . 0.0 113.497 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -62.05 -33.06 73.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.797 0.726 . . . . 0.0 109.913 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.14 142.81 25.17 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.04 -13.2 37.54 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.149 1.899 . . . . 0.0 113.509 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.5 mtm-85 -64.5 -45.14 88.58 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.757 -1.215 . . . . 0.0 109.384 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.562 HD12 ' H ' ' A' ' 317' ' ' ILE . 4.3 mp -67.25 -57.68 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 124.596 1.158 . . . . 0.0 107.965 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.63 -54.97 18.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 124.176 0.923 . . . . 0.0 110.171 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.33 -30.8 71.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.694 -1.254 . . . . 0.0 113.171 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 16.7 m -66.5 -42.92 86.66 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.3 tpt -67.33 -51.42 52.63 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.807 1.643 . . . . 0.0 110.393 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -55.16 -33.05 62.61 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.217 1.007 . . . . 0.0 112.427 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -81.97 -38.34 25.3 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.813 0.845 . . . . 0.0 108.976 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.483 0 CA-C-N 118.714 0.688 . . . . 0.0 110.48 178.851 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 CA--C 1.539 0.765 0 N-CA-C 112.833 0.282 . . . . 0.0 112.833 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -148.65 46.35 1.03 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.976 0.91 . . . . 0.0 111.768 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.41 155.43 43.71 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.553 1.541 . . . . 0.0 113.063 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.39 -19.43 61.46 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.094 3.196 . . . . 0.0 115.448 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -56.35 -24.01 41.28 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.592 1.157 . . . . 0.0 111.574 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 87.4 mmm -59.28 -33.59 71.24 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.685 0.794 . . . . 0.0 111.504 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 13.1 t -58.68 -49.3 78.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.681 0.673 . . . . 0.0 110.315 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.86 82.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.751 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -56.09 -48.93 75.2 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.892 0.877 . . . . 0.0 110.035 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 21.6 m95 -56.95 -44.34 82.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.428 0.558 . . . . 0.0 111.349 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -66.93 -45.12 78.82 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.967 -0.458 . . . . 0.0 110.258 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -52.93 -56.19 17.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.136 1.774 . . . . 0.0 112.149 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 18.1 t -68.45 -40.2 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 117.616 -1.183 . . . . 0.0 109.561 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -52.28 -50.73 61.56 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.875 1.67 . . . . 0.0 109.023 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 2.1 m -67.45 -45.01 77.24 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.58 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.06 -42.1 68.89 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.878 1.217 . . . . 0.0 111.964 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 44.1 t -58.28 -57.38 11.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.354 1.062 . . . . 0.0 109.43 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.9 mm -67.09 -26.47 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 119.344 -0.36 . . . . 0.0 110.687 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -64.94 -51.39 62.12 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 119.85 -1.781 . . . . 0.0 109.088 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.52 -44.57 70.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.383 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.24 -29.02 70.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.4 m -85.71 -12.36 51.36 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.095 0.861 . . . . 0.0 109.571 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 73.33 8.73 75.99 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.416 -0.658 . . . . 0.0 111.676 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -66.78 -34.62 78.23 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.681 1.241 . . . . 0.0 108.915 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -138.99 155.86 47.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.0 t -76.11 166.47 23.43 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.8 t -55.73 -56.07 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.142 1.377 . . . . 0.0 109.901 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -51.75 -41.25 61.45 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.59 1.556 . . . . 0.0 113.478 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -77.28 -36.48 54.2 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.19 0.196 . . . . 0.0 111.099 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.61 -50.26 72.5 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.49 -0.756 . . . . 0.0 109.74 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.04 -39.18 89.96 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.108 -0.949 . . . . 0.0 111.157 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -57.55 -56.25 24.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.815 0.734 . . . . 0.0 110.395 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.95 -38.57 91.61 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 124.274 0.984 . . . . 0.0 111.012 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.59 92.61 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.682 -0.636 . . . . 0.0 110.452 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.38 -36.36 68.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.585 0.754 . . . . 0.0 109.792 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 5.8 m -59.69 -39.08 83.36 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.62 0.645 . . . . 0.0 110.398 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -65.75 -15.67 63.06 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.092 -1.005 . . . . 0.0 112.34 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 7.8 mt -102.56 -8.62 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.988 1.315 . . . . 0.0 109.974 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 19.7 p -113.36 -2.52 13.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.802 1.641 . . . . 0.0 111.874 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.106 0 C-N-CA 127.344 2.257 . . . . 0.0 106.544 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 122.216 1.007 . . . . 0.0 108.521 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -73.04 -176.03 1.97 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.812 2.445 . . . . 0.0 113.018 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.94 17.27 75.17 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.106 0.86 . . . . 0.0 111.963 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.47 163.36 36.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.173 1.389 . . . . 0.0 110.656 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.6 mt -148.99 150.28 32.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 129.237 3.015 . . . . 0.0 104.933 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.52 134.36 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.581 HD12 HG22 ' A' ' 37' ' ' VAL . 42.2 mt -114.43 123.55 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -121.45 118.93 30.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -145.81 154.78 13.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.37 1.068 . . . . 0.0 110.726 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -69.52 150.8 46.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.25 -26.79 37.48 Favored Glycine 0 N--CA 1.465 0.569 0 C-N-CA 126.161 1.839 . . . . 0.0 115.034 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.82 -19.77 63.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.605 0.703 . . . . 0.0 110.554 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -73.09 164.8 26.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 122.167 0.984 . . . . 0.0 109.962 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.69 63.5 4.35 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -68.51 -45.87 71.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.326 1.05 . . . . 0.0 110.959 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -38.63 80.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.92 -38.74 22.39 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.47 -34.95 78.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.204 1.002 . . . . 0.0 110.545 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HA ' HG21 ' A' ' 37' ' ' VAL . . . -56.93 -44.66 82.68 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.142 0.577 . . . . 0.0 109.567 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -56.11 -43.1 77.8 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.527 0.731 . . . . 0.0 111.635 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.1 -44.52 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.509 1.524 . . . . 0.0 107.362 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.73 -42.84 95.05 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.305 -0.872 . . . . 0.0 110.994 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -43.25 99.2 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.052 0.926 . . . . 0.0 108.724 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -62.74 -50.32 71.56 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.613 1.165 . . . . 0.0 108.942 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -56.77 -41.89 78.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.561 1.073 . . . . 0.0 110.272 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.93 -35.93 79.86 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.965 -1.084 . . . . 0.0 108.7 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -74.18 3.77 6.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.3 1.84 . . . . 0.0 111.263 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -125.4 -37.4 2.37 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.79 1.636 . . . . 0.0 112.604 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.0 p -112.29 -22.0 11.13 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.716 0.806 . . . . 0.0 113.013 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.44 53.01 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.063 -1.023 . . . . 0.0 112.954 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.77 133.06 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 119.145 1.473 . . . . 0.0 107.468 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -66.81 146.03 54.86 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.262 -0.899 . . . . 0.0 108.812 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.3 t -136.75 91.59 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.8 m -80.73 134.28 35.8 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.581 HG22 HD12 ' A' ' 9' ' ' ILE . 27.2 t -130.84 129.4 63.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -140.01 166.23 25.22 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -118.54 58.66 3.55 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 123.59 0.756 . . . . 0.0 111.606 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.32 159.97 51.64 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.18 1.253 . . . . 0.0 109.24 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -120.45 -23.08 6.23 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.375 0.67 . . . . 0.0 110.501 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.2 9.13 41.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.913 1.285 . . . . 0.0 110.543 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.3 pt? -56.86 -30.74 64.12 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 120.565 -1.334 . . . . 0.0 112.286 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.26 -23.81 64.4 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.22 1.373 . . . . 0.0 113.652 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -105.14 -28.03 11.24 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.164 0.438 . . . . 0.0 110.272 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -51.29 10.88 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 124.492 1.117 . . . . 0.0 110.647 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -41.92 -58.25 3.46 Favored Pre-proline 0 N--CA 1.457 -0.079 0 CA-C-O 116.321 -1.799 . . . . 0.0 109.883 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.99 1.37 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.27 1.98 . . . . 0.0 116.93 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.36 -52.86 2.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.802 1.183 . . . . 0.0 108.752 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.466 HG12 ' C ' ' A' ' 55' ' ' ASP . 2.3 t -63.17 -40.95 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.58 -31.04 59.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.378 -0.827 . . . . 0.0 111.144 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.15 -13.44 60.81 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.033 0.533 . . . . 0.0 111.011 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 m -93.33 -82.34 0.34 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 163.36 37.77 0.02 OUTLIER Glycine 0 CA--C 1.524 0.612 0 C-N-CA 125.598 1.57 . . . . 0.0 109.291 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.466 ' C ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -136.79 -3.32 2.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.812 1.645 . . . . 0.0 113.292 -176.699 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.9 176.27 21.66 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 116.933 1.533 . . . . 0.0 116.933 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.92 172.38 7.28 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.766 2.311 . . . . 0.0 109.584 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -107.92 -18.5 13.79 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -142.36 143.05 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.348 1.459 . . . . 0.0 108.726 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.8 tt -135.29 140.6 44.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 125.608 1.563 . . . . 0.0 108.277 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -132.45 116.32 16.64 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -154.73 179.29 9.21 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.72 0.691 . . . . 0.0 110.726 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.41 152.95 40.63 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -61.81 -25.62 67.61 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -61.52 -23.79 66.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -98.76 -4.9 32.39 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.797 -0.564 . . . . 0.0 110.78 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -92.46 20.87 5.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.004 1.322 . . . . 0.0 109.73 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.79 -14.03 51.16 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 120.667 -1.271 . . . . 0.0 111.391 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.65 -27.45 1.94 Allowed Glycine 0 C--N 1.344 0.982 0 CA-C-N 119.304 1.552 . . . . 0.0 116.498 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -53.75 -47.37 70.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.114 1.957 . . . . 0.0 111.763 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.21 -40.91 94.78 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -27.08 54.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.303 1.041 . . . . 0.0 112.223 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.0 m -96.88 3.07 52.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.353 1.461 . . . . 0.0 112.045 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.66 16.76 78.72 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.421 1.01 . . . . 0.0 112.267 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.7 mt -88.73 9.47 24.27 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.142 0.977 . . . . 0.0 113.425 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.0 mt -131.29 146.01 52.12 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 120.979 -1.076 . . . . 0.0 108.244 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.41 161.58 14.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -78.7 94.21 5.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.11 175.21 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 127.103 2.161 . . . . 0.0 112.212 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.4 m 66.64 95.88 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 126.777 2.031 . . . . 0.0 111.013 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.92 -48.24 1.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.339 1.359 . . . . 0.0 110.749 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.84 154.65 51.55 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.079 0.951 . . . . 0.0 110.509 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -49.34 -38.85 29.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.07 2.548 . . . . 0.0 111.768 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.98 -25.55 44.49 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.189 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -68.77 -28.64 66.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.718 1.145 . . . . 0.0 109.963 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -64.05 -36.37 83.79 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 120.76 -1.212 . . . . 0.0 110.76 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.18 -15.3 61.02 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.065 0.946 . . . . 0.0 112.286 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -70.85 -20.92 62.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.717 1.207 . . . . 0.0 111.771 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.415 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 8.0 mt -122.93 161.16 24.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.799 1.64 . . . . 0.0 108.541 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -72.98 157.76 88.15 Favored Pre-proline 0 N--CA 1.476 0.847 0 CA-C-N 120.23 1.377 . . . . 0.0 108.91 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.9 -46.18 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.08 2.52 . . . . 0.0 114.168 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -60.1 -30.93 69.58 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.259 0.936 . . . . 0.0 111.34 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.11 -29.46 69.21 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.233 -0.917 . . . . 0.0 110.15 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.415 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 73.7 m95 -72.88 -30.29 63.84 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.966 0.803 . . . . 0.0 110.684 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -62.99 -16.5 59.92 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.45 -5.18 59.08 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.326 0.65 . . . . 0.0 112.506 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.5 m -133.3 27.82 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.882 1.273 . . . . 0.0 112.238 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.6 mtp85 -86.37 164.11 17.24 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.199 0.999 . . . . 0.0 110.878 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -149.95 175.5 11.62 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.174 1.39 . . . . 0.0 107.603 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -66.55 101.19 0.74 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.559 0.743 . . . . 0.0 112.157 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.84 -69.95 2.8 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.099 1.333 . . . . 0.0 111.974 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.86 162.04 27.95 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.141 0.47 . . . . 0.0 110.064 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.84 155.21 17.16 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.742 1.617 . . . . 0.0 108.557 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.1 pt -123.09 -32.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.72 -178.58 7.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 119.925 1.239 . . . . 0.0 109.912 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -133.36 147.53 65.3 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 124.668 1.187 . . . . 0.0 109.431 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.93 153.8 63.4 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.651 2.9 . . . . 0.0 109.665 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 264' ' ' ALA . 18.9 mm -125.84 -47.63 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 125.364 1.466 . . . . 0.0 110.979 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.26 165.7 26.7 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 117.877 0.308 . . . . 0.0 110.739 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.7 t -127.02 121.43 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 124.281 0.988 . . . . 0.0 109.399 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.88 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--O 1.242 0.68 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--O 1.237 0.396 0 C-N-CA 123.544 0.738 . . . . 0.0 109.484 179.154 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.457 -0.648 0 N-CA-C 112.748 0.249 . . . . 0.0 112.748 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.83 -12.03 3.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.068 0.547 . . . . 0.0 112.365 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.33 154.84 45.91 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.128 -0.983 . . . . 0.0 111.949 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -80.05 -22.92 41.79 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.23 -18.29 47.66 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.79 -5.13 21.5 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.264 1.025 . . . . 0.0 111.511 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.4 mm -61.05 -52.53 71.29 Favored Pre-proline 0 C--N 1.339 0.128 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.82 -23.75 54.92 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 CA-C-N 120.997 1.392 . . . . 0.0 111.503 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.43 -44.39 75.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.4 tp -80.43 -27.29 38.02 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.219 1.008 . . . . 0.0 111.928 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.9 -44.51 82.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 123.943 0.897 . . . . 0.0 110.736 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -68.41 -31.2 70.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.407 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -71.34 -46.78 59.7 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 61.0 mt -72.57 -31.48 65.28 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.402 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -71.17 -37.37 72.2 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.01 68.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.538 0.608 . . . . 0.0 111.89 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.68 6.15 16.75 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.978 0.911 . . . . 0.0 112.534 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 179.42 -104.46 0.18 Allowed Glycine 0 CA--C 1.524 0.626 0 CA-C-N 119.141 0.882 . . . . 0.0 112.792 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -136.91 178.08 7.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.134 2.174 . . . . 0.0 109.978 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.01 155.36 3.54 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.36 1.064 . . . . 0.0 113.674 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.07 -47.61 35.42 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.7 tp -125.48 155.55 40.35 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.192 1.397 . . . . 0.0 110.247 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.457 ' CG ' HG21 ' A' ' 208' ' ' THR . 45.1 ttm -150.68 130.5 13.25 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -159.91 168.93 24.6 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.865 1.666 . . . . 0.0 115.399 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.52 83.11 0.06 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 126.766 2.026 . . . . 0.0 112.095 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.5 mt -80.83 -20.87 41.47 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 125.842 1.657 . . . . 0.0 110.724 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.3 mm-40 -78.92 -6.53 56.41 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -112.62 129.92 23.93 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 119.163 0.892 . . . . 0.0 112.105 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.64 -13.73 24.69 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.156 1.904 . . . . 0.0 112.318 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -64.6 -40.09 94.88 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.854 1.662 . . . . 0.0 113.311 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.521 ' CZ ' HG21 ' A' ' 226' ' ' ILE . 30.5 t80 -95.13 -29.6 14.48 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.5 p -72.75 -28.43 62.62 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.336 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -56.6 -58.67 15.65 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -56.02 -16.36 16.26 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.586 2.191 . . . . 0.0 115.842 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 66.4 tp -82.11 -59.17 2.65 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.811 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.402 HG22 ' HA3' ' A' ' 191' ' ' GLY . 17.8 pt -68.21 -27.42 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 119.403 1.001 . . . . 0.0 111.768 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.25 -20.89 66.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.449 0.699 . . . . 0.0 110.917 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.61 -54.01 43.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.153 1.381 . . . . 0.0 112.244 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.21 -41.75 84.7 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.364 0.529 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 165.88 26.13 0.02 OUTLIER Glycine 0 C--N 1.34 0.778 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -88.92 131.95 10.98 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -147.27 151.44 36.64 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.115 1.457 . . . . 0.0 112.059 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.412 ' HB2' ' CE2' ' A' ' 339' ' ' PHE . . . -85.17 -63.01 1.4 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.775 1.23 . . . . 0.0 112.542 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -138.37 126.24 22.47 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.309 1.444 . . . . 0.0 108.832 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -73.38 129.37 37.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.425 1.011 . . . . 0.0 112.156 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.85 122.18 38.87 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.525 ' HG2' ' H ' ' A' ' 173' ' ' ASN . 14.9 tt0 -93.82 -163.57 1.07 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.987 1.315 . . . . 0.0 109.45 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.525 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 71.0 m-80 -56.77 -8.84 0.65 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.249 2.22 . . . . 0.0 115.731 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.36 11.62 0.02 OUTLIER Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.224 1.392 . . . . 0.0 113.861 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.6 156.7 40.5 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.808 2.443 . . . . 0.0 105.078 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -144.93 148.71 34.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -147.88 141.03 25.04 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.1 OUTLIER -94.8 -8.67 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.664 1.186 . . . . 0.0 110.3 178.291 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -40.01 73.51 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -78.33 92.48 4.54 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.587 1.155 . . . . 0.0 111.009 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.9 t -115.96 150.29 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.885 1.674 . . . . 0.0 108.996 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -146.08 48.58 0.68 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.55 1.548 . . . . 0.0 111.629 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 80.3 t -81.3 -55.2 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 125.1 1.36 . . . . 0.0 107.937 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -87.51 67.22 9.31 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -113.03 155.95 23.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 126.317 1.847 . . . . 0.0 110.435 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.15 -39.05 66.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.992 1.317 . . . . 0.0 113.152 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.21 -45.96 76.08 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.08 -56.59 19.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 189' ' ' LYS . 10.7 ptpt -58.87 -34.49 71.69 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 117.438 -1.268 . . . . 0.0 112.768 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.05 -52.09 66.42 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.608 1.094 . . . . 0.0 109.286 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.402 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -68.3 -30.31 73.48 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.77 -53.72 20.12 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.332 1.066 . . . . 0.0 108.442 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.4 t -61.14 -33.66 73.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.327 0.651 . . . . 0.0 110.303 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.85 -55.07 34.38 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.6 tt -60.58 -47.89 84.22 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.445 1.498 . . . . 0.0 110.323 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 70.9 t -57.1 -36.23 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 118.18 -0.914 . . . . 0.0 109.75 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.457 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.3 OUTLIER -65.04 -35.51 81.39 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 120.033 1.288 . . . . 0.0 112.122 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.04 -41.23 99.46 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 85.7 mt -67.98 -42.76 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -57.83 -31.69 66.89 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.575 1.55 . . . . 0.0 109.841 178.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -88.69 -5.29 58.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.764 1.625 . . . . 0.0 111.246 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? 60.39 16.88 6.66 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.321 2.648 . . . . 0.0 113.755 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -86.3 -34.53 20.31 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.4 tpt -85.44 128.37 34.7 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -76.68 120.68 22.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -88.92 -3.12 58.83 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -95.72 -15.34 22.7 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.603 1.961 . . . . 0.0 115.144 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.457 HG21 ' CG ' ' A' ' 148' ' ' MET . 3.3 m -67.55 128.43 36.4 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.957 0.903 . . . . 0.0 112.197 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -126.95 172.32 10.55 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.761 2.024 . . . . 0.0 108.114 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -47.66 -39.81 18.17 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 57.8 m -63.14 -45.91 89.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.743 1.217 . . . . 0.0 110.45 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 58.1 mt -66.9 -48.47 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 117.063 -1.446 . . . . 0.0 110.868 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.76 91.06 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.798 1.635 . . . . 0.0 112.717 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.42 -35.32 80.58 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.047 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.26 -55.9 20.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.62 -43.14 75.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.939 2.495 . . . . 0.0 112.119 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -62.49 -45.68 91.91 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.986 1.266 . . . . 0.0 108.543 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -37.9 82.59 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 118.44 -0.791 . . . . 0.0 109.192 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -74.56 -23.08 58.71 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.089 1.313 . . . . 0.0 111.618 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.47 38.25 5.36 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.415 1.483 . . . . 0.0 111.081 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -93.74 -31.1 14.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.672 1.236 . . . . 0.0 113.764 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.5 t -115.15 152.01 33.35 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.612 1.165 . . . . 0.0 109.24 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -87.88 -27.95 21.88 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.781 0.832 . . . . 0.0 111.498 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -136.51 145.49 45.16 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.927 1.291 . . . . 0.0 108.224 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 23.0 m -149.4 149.72 31.28 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.666 1.186 . . . . 0.0 108.919 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.521 HG21 ' CZ ' ' A' ' 156' ' ' PHE . 27.6 mt . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 119.136 -0.459 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.24 143.56 39.82 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.431 1.421 . . . . 0.0 110.041 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 47.8 p -135.51 -145.0 0.21 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.834 2.054 . . . . 0.0 108.231 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -124.12 141.59 51.93 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 12.0 pttp -54.02 107.1 0.23 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.279 1.031 . . . . 0.0 109.049 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.76 84.43 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.772 1.177 . . . . 0.0 114.394 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.08 93.64 43.23 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.865 1.333 . . . . 0.0 108.936 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.4 144.17 25.55 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.976 2.451 . . . . 0.0 109.433 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 37.3 p -63.33 141.41 58.78 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 121.058 -1.026 . . . . 0.0 108.804 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -116.39 88.14 22.59 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.511 1.125 . . . . 0.0 110.398 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -82.16 168.08 15.42 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.382 2.055 . . . . 0.0 112.239 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 . . . . . 0 C--O 1.237 0.422 0 C-N-CA 124.621 1.168 . . . . 0.0 108.446 178.195 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.551 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.49 136.64 54.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 118.042 0.921 . . . . 0.0 112.092 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 tp -68.86 137.48 53.92 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.1 m -121.99 158.23 29.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.494 1.043 . . . . 0.0 113.568 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.427 ' HB2' HG13 ' A' ' 108' ' ' ILE . . . -135.33 141.2 45.57 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.194 1.798 . . . . 0.0 110.004 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.78 167.46 23.22 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.441 1.496 . . . . 0.0 110.196 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 56.2 mt -119.46 132.25 69.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.508 1.523 . . . . 0.0 107.363 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -74.1 130.5 39.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -76.2 -19.48 58.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 117.797 -1.097 . . . . 0.0 113.518 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -72.94 -7.74 52.46 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.574 1.079 . . . . 0.0 113.182 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 66.8 m -63.06 154.72 76.26 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -62.29 -53.69 1.79 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 121.877 1.718 . . . . 0.0 108.052 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -132.42 125.55 31.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.473 ' HD2' ' H ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -74.39 -16.59 60.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.718 0.807 . . . . 0.0 111.406 178.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.48 ' HA ' ' HG3' ' A' ' 277' ' ' LYS . 3.9 tt0 -61.55 -33.78 74.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.707 0.803 . . . . 0.0 112.517 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 61.9 mt -59.3 -40.74 87.14 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.791 -0.568 . . . . 0.0 111.031 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.42 -43.63 48.88 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.771 0.429 . . . . 0.0 111.057 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.48 ' HG3' ' HA ' ' A' ' 274' ' ' GLU 0.261 0.0 OUTLIER -63.9 -32.95 74.65 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.768 -0.634 . . . . 0.0 111.331 -179.084 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -72.44 -48.07 44.01 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -51.47 -49.89 60.9 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.23 -54.42 47.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.4 -22.55 66.99 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -97.55 -24.6 15.48 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 117.817 -1.087 . . . . 0.0 113.55 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -138.66 -36.42 0.56 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.99 -25.29 62.63 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.468 1.031 . . . . 0.0 110.692 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 89.7 mt -105.57 24.97 11.34 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.445 1.498 . . . . 0.0 113.711 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 6.8 p -103.07 158.19 16.47 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.48 -42.81 99.75 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -71.41 -30.73 66.44 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.582 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.05 -48.89 14.34 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 63.8 mt -62.0 -43.86 97.94 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -62.23 -42.5 99.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.03 -35.14 68.93 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.823 0.738 . . . . 0.0 110.996 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 76.0 t -72.25 -42.01 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -60.01 -29.99 68.84 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.399 1.079 . . . . 0.0 112.705 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -52.56 -47.36 66.86 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 118.272 0.487 . . . . 0.0 110.708 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.91 -73.98 0.24 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -101.47 144.64 28.96 Favored Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 121.051 -1.031 . . . . 0.0 111.615 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.62 108.48 2.64 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.256 2.637 . . . . 0.0 111.556 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 66.8 mt -73.18 -31.47 64.23 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.967 0.907 . . . . 0.0 110.908 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 71.08 -103.71 1.28 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 108.244 -1.942 . . . . 0.0 108.244 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.02 168.44 10.27 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 10.8 m -140.17 153.12 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 120.869 -1.144 . . . . 0.0 110.97 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.06 -18.73 49.29 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.773 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 21.0 tp -81.36 111.83 18.08 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -56.6 -34.16 66.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 119.198 -0.429 . . . . 0.0 111.84 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -37.49 65.96 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.25 1.42 . . . . 0.0 112.186 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -101.43 -16.85 16.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.266 0.485 . . . . 0.0 109.742 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -63.76 -38.76 92.32 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.36 -23.4 62.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.138 0.881 . . . . 0.0 111.331 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -89.39 -51.37 5.59 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.614 1.166 . . . . 0.0 109.058 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 22.0 mt -61.43 -34.66 75.77 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.757 -0.59 . . . . 0.0 110.093 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.68 -3.0 5.58 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.392 1.477 . . . . 0.0 112.964 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -61.62 -28.81 69.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.386 1.448 . . . . 0.0 107.445 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -94.54 135.63 23.91 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.9 -11.99 33.27 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.483 2.122 . . . . 0.0 113.285 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -64.83 -46.29 82.54 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.56 -48.65 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 124.412 1.085 . . . . 0.0 108.531 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.77 -49.49 65.43 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 123.545 0.528 . . . . 0.0 110.684 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.8 84.77 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.775 -0.578 . . . . 0.0 111.823 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 21.0 m -61.46 -35.2 76.95 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.0 tpt -71.12 -48.07 54.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 122.857 0.463 . . . . 0.0 110.42 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -58.45 -30.63 67.09 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.54 1.136 . . . . 0.0 111.985 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -64.32 -28.74 69.92 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.2 -0.937 . . . . 0.0 110.335 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.313 0 CA-C-N 118.774 0.716 . . . . 0.0 109.979 178.106 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.451 -1.013 0 N-CA-C 108.487 -1.39 . . . . 0.0 108.487 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -101.14 29.84 4.46 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.423 2.289 . . . . 0.0 112.63 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.1 pt -130.24 154.45 81.41 Favored Pre-proline 0 N--CA 1.47 0.573 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.1 -14.15 31.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.135 3.223 . . . . 0.0 115.163 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -57.04 -16.27 6.85 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.449 1.499 . . . . 0.0 112.394 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -32.98 71.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.443 0.697 . . . . 0.0 110.141 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 37.4 p -60.85 -48.25 82.66 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 119.115 0.87 . . . . 0.0 111.405 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.54 94.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.608 0.763 . . . . 0.0 109.147 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 168' ' ' ALA . 14.8 t80 -52.98 -53.99 41.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.459 1.104 . . . . 0.0 111.692 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -62.63 -47.22 84.7 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.804 0.729 . . . . 0.0 110.42 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -60.59 -31.33 70.48 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.782 0.433 . . . . 0.0 111.654 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.426 ' HA ' HH11 ' A' ' 367' ' ' ARG . . . -69.74 -57.33 5.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.4 1.48 . . . . 0.0 110.617 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.89 -38.16 75.17 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.15 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -48.83 -56.15 9.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.263 0.938 . . . . 0.0 110.994 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -45.7 85.4 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.748 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.82 -41.88 71.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.3 -53.31 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.513 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 49.3 mm -62.76 -36.54 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.014 0.824 . . . . 0.0 110.064 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.32 -50.62 73.29 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.114 0.87 . . . . 0.0 109.599 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.49 -52.24 58.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.647 0.779 . . . . 0.0 111.152 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -59.26 -29.01 67.25 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.036 1.334 . . . . 0.0 114.115 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 7.7 m -93.26 -3.9 52.83 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.581 0.752 . . . . 0.0 110.95 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 69.02 23.35 76.07 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 35.4 mtt-85 -80.73 -33.22 35.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -150.45 148.03 28.25 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 10.8 t -71.55 166.6 21.49 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.592 0.71 . . . . 0.0 109.426 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.78 -44.65 99.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.174 1.79 . . . . 0.0 110.771 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -55.4 -47.06 76.47 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.158 0.583 . . . . 0.0 111.251 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -78.47 -38.02 42.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.113 0.565 . . . . 0.0 111.262 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.13 89.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.454 -0.779 . . . . 0.0 110.825 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.0 mt -77.25 -30.06 54.29 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.26 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -58.22 -49.2 77.91 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.349 1.431 . . . . 0.0 108.645 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -51.03 -54.53 23.81 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.737 2.015 . . . . 0.0 108.638 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.84 -49.77 76.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.605 1.562 . . . . 0.0 112.879 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -54.76 -37.15 65.62 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.11 1.364 . . . . 0.0 109.412 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 20.0 m -66.4 -37.96 86.42 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.127 0.571 . . . . 0.0 110.944 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.426 HH11 ' HA ' ' A' ' 342' ' ' ALA . 77.0 mtt180 -66.11 -31.02 71.63 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.247 -0.908 . . . . 0.0 109.912 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.0 mt -80.22 -38.26 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.762 0.825 . . . . 0.0 111.292 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.5 p -73.61 -12.98 60.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.468 1.031 . . . . 0.0 110.9 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 51.3 tttm . . . . . 0 C--O 1.251 1.139 0 C-N-CA 124.689 1.196 . . . . 0.0 109.01 178.842 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -62.33 123.87 19.38 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 131.18 3.792 . . . . 0.0 109.491 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.97 39.54 93.27 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.995 1.284 . . . . 0.0 112.634 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -146.08 -179.15 6.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.468 1.107 . . . . 0.0 108.392 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.1 mt -145.6 144.64 30.59 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 128.539 2.735 . . . . 0.0 106.864 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.0 t -145.37 129.88 12.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.727 1.611 . . . . 0.0 107.222 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.59 141.59 46.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.773 0.829 . . . . 0.0 109.391 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.513 ' HB3' HD22 ' A' ' 43' ' ' LEU . 33.4 m0 -120.42 164.87 15.71 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.313 1.045 . . . . 0.0 111.812 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 13' ' ' GLY . 3.6 mt -136.79 136.32 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.828 1.251 . . . . 0.0 111.545 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -117.66 12.01 13.87 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.963 1.705 . . . . 0.0 110.655 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 11' ' ' ILE . . . -161.74 59.18 0.29 Allowed Glycine 0 C--N 1.339 0.724 0 O-C-N 119.974 -1.704 . . . . 0.0 115.689 -177.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 33.23 48.93 0.18 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.552 1.941 . . . . 0.0 115.019 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 168.8 10.7 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.32 64.89 3.71 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -69.74 -23.57 63.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.079 -0.962 . . . . 0.0 112.757 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -64.72 -57.28 9.4 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-N 119.428 1.013 . . . . 0.0 108.856 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.98 -40.52 73.5 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.3 tp -68.19 -35.92 78.76 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.077 0.951 . . . . 0.0 112.034 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.47 97.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.169 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.38 -35.13 73.35 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.919 0.781 . . . . 0.0 110.096 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.69 -42.61 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.39 -38.77 95.3 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -63.45 -47.03 83.55 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.729 1.265 . . . . 0.0 107.909 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -58.76 -58.38 8.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -53.1 -45.11 68.09 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.909 1.232 . . . . 0.0 112.236 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.19 -23.33 66.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.434 1.494 . . . . 0.0 110.937 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -92.16 -17.28 25.13 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.277 -1.514 . . . . 0.0 112.437 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.73 -7.0 22.05 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 124.247 0.967 . . . . 0.0 109.551 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 59.1 p -133.47 -34.42 1.05 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.495 1.118 . . . . 0.0 113.823 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.64 -17.91 58.44 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.696 1.141 . . . . 0.0 112.808 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.9 128.01 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.33 145.79 52.89 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.8 t -138.44 83.25 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.3 m -73.62 151.25 40.9 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.3 t -139.81 118.52 11.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.541 1.537 . . . . 0.0 107.942 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -143.86 157.34 44.43 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.855 0.752 . . . . 0.0 111.247 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -117.95 54.82 1.91 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.37 1.468 . . . . 0.0 112.218 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.486 ' HG2' ' HB3' ' A' ' 43' ' ' LEU . 78.9 Cg_endo -69.42 123.89 10.67 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.83 2.353 . . . . 0.0 111.59 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -13.64 58.99 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 127.818 2.447 . . . . 0.0 114.398 -178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.454 ' H ' ' HE2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -121.24 21.1 11.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.245 1.418 . . . . 0.0 113.727 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 10' ' ' TRP . 0.6 OUTLIER -58.37 -23.35 56.7 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.16 -26.75 61.09 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -106.72 -20.57 13.31 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.205 0.526 . . . . 0.0 110.675 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -75.92 -56.42 4.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -40.01 -57.82 2.54 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-O 116.743 -1.599 . . . . 0.0 112.354 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.96 -44.29 25.67 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.803 1.669 . . . . 0.0 114.219 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.5 mm100 -64.01 -49.13 73.64 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.472 1.109 . . . . 0.0 112.337 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 t -72.08 -39.18 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.474 0.71 . . . . 0.0 110.366 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.62 -28.61 63.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 120.949 -1.094 . . . . 0.0 113.018 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.47 -14.32 27.92 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.165 0.893 . . . . 0.0 112.813 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.9 m -118.15 4.22 12.0 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.945 1.298 . . . . 0.0 111.081 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.52 0.43 88.12 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.279 0.942 . . . . 0.0 113.71 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.23 -10.61 58.47 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.643 -1.504 . . . . 0.0 113.277 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.92 -179.05 19.84 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.69 -177.78 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 125.222 3.948 . . . . 0.0 113.45 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.53 -25.88 13.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.262 0.554 . . . . 0.0 111.057 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 mt -146.27 154.63 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 tp -137.31 146.28 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -132.2 111.9 11.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.61 1.564 . . . . 0.0 108.02 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -156.99 -167.04 2.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.161 0.892 . . . . 0.0 112.271 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.01 143.62 50.72 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.127 0.971 . . . . 0.0 110.865 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -56.8 -41.62 78.08 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.775 1.23 . . . . 0.0 109.541 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -67.84 -5.37 16.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.436 2.294 . . . . 0.0 114.101 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -111.91 -10.18 13.99 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.891 0.876 . . . . 0.0 110.301 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -86.73 4.04 42.4 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.415 1.486 . . . . 0.0 110.254 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.24 -9.6 84.84 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.369 -1.457 . . . . 0.0 109.6 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.56 -70.59 1.16 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.542 1.544 . . . . 0.0 112.191 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -46.7 -47.56 20.41 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.707 1.603 . . . . 0.0 112.966 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.36 -45.06 94.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.379 1.071 . . . . 0.0 111.343 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.53 -46.66 83.58 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.3 m -65.61 -4.86 6.8 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.256 0.623 . . . . 0.0 112.289 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.87 13.32 83.54 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.837 1.684 . . . . 0.0 112.274 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.2 mt -73.87 -17.82 61.0 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.211 1.006 . . . . 0.0 111.67 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mt -95.22 136.41 35.59 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 121.136 -0.977 . . . . 0.0 111.167 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.98 170.42 16.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 123.954 0.784 . . . . 0.0 111.826 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -69.04 115.34 8.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.536 HD12 ' CD2' ' A' ' 106' ' ' TYR . 2.2 mm -72.14 158.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.23 0.538 . . . . 0.0 110.291 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.5 m 60.72 84.02 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.032 1.733 . . . . 0.0 109.786 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.06 -27.59 29.62 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.643 1.562 . . . . 0.0 111.158 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -136.34 144.87 44.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.153 1.381 . . . . 0.0 110.815 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -52.35 -37.96 57.5 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.484 1.914 . . . . 0.0 112.833 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.63 -37.63 68.44 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.375 0.989 . . . . 0.0 112.002 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -60.28 -25.72 65.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.427 0.691 . . . . 0.0 111.869 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -67.04 -48.16 69.18 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -19.5 61.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 125.413 1.485 . . . . 0.0 113.401 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.26 -15.21 62.88 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.497 -0.752 . . . . 0.0 110.888 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.9 mt -124.18 154.83 39.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.444 1.498 . . . . 0.0 108.519 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -67.59 152.52 96.19 Favored Pre-proline 0 CA--C 1.54 0.576 0 O-C-N 121.663 -0.648 . . . . 0.0 110.133 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.2 -36.27 7.45 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.109 2.539 . . . . 0.0 114.675 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -63.59 -43.18 97.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.437 0.562 . . . . 0.0 111.088 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -23.28 62.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.353 1.461 . . . . 0.0 111.667 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -70.45 -22.63 62.67 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.561 1.073 . . . . 0.0 110.621 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.61 -23.74 67.36 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.35 1.06 . . . . 0.0 111.189 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.36 -17.38 60.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.256 1.022 . . . . 0.0 113.424 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.67 14.94 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.46 168.78 4.28 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 122.723 1.249 . . . . 0.0 112.083 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -159.93 177.97 10.22 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 129.008 2.923 . . . . 0.0 105.168 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -64.12 99.01 0.24 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.492 1.117 . . . . 0.0 111.097 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.88 -84.88 0.47 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 124.588 1.09 . . . . 0.0 110.892 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 153.46 41.84 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.784 0.802 . . . . 0.0 109.968 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.6 mt -91.62 152.06 20.42 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.4 pt -111.77 -27.73 2.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.831 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.92 174.76 14.68 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.478 1.035 . . . . 0.0 108.771 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.536 ' CD2' HD12 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -125.7 150.5 68.62 Favored Pre-proline 0 C--O 1.239 0.517 0 C-N-CA 124.386 1.075 . . . . 0.0 110.209 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.83 141.68 41.45 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.266 2.644 . . . . 0.0 107.851 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.3 mm -126.44 -45.51 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.691 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.37 122.34 10.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -90.36 118.68 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.482 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 54.7 mt . . . . . 0 C--O 1.236 0.387 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 27.6 p90 . . . . . 0 N--CA 1.451 -0.38 0 C-N-CA 124.799 1.239 . . . . 0.0 110.576 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo . . . . . 0 N--CA 1.46 -0.486 0 N-CA-C 110.868 -0.474 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -118.13 -2.5 11.2 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.296 -0.877 . . . . 0.0 112.71 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -169.41 160.48 9.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.416 1.087 . . . . 0.0 108.443 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -67.88 -24.57 65.25 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.091 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -69.93 -13.92 62.47 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.228 0.922 . . . . 0.0 112.183 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -90.67 -21.67 21.54 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.337 1.055 . . . . 0.0 110.209 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.3 mm -55.76 -57.37 21.87 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-O 117.83 -1.081 . . . . 0.0 109.214 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.87 -20.4 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 120.983 1.387 . . . . 0.0 113.163 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.58 -40.45 66.6 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.249 1.02 . . . . 0.0 112.067 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 27.5 tp -94.85 -22.92 17.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.492 1.117 . . . . 0.0 112.077 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -61.28 -35.39 77.17 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.785 -1.197 . . . . 0.0 111.252 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -75.54 -33.94 60.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.885 1.274 . . . . 0.0 111.188 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -70.21 -45.5 66.47 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.43 -32.37 73.2 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.77 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -70.96 -28.95 64.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.597 0.635 . . . . 0.0 109.566 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.88 -26.6 63.32 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.404 0.547 . . . . 0.0 111.102 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.61 -1.21 16.94 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.122 0.969 . . . . 0.0 112.812 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.21 -98.72 0.12 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -142.18 178.74 7.34 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.623 1.169 . . . . 0.0 112.062 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.2 p -53.98 156.09 3.13 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.74 1.616 . . . . 0.0 113.088 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.74 -58.51 2.55 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.678 1.591 . . . . 0.0 109.959 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.51 142.69 47.35 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.484 0.714 . . . . 0.0 112.075 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 55.5 mtp -144.97 135.48 24.32 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 128.308 2.643 . . . . 0.0 105.749 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -156.19 168.63 26.69 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.069 1.748 . . . . 0.0 107.48 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.73 HD22 ' HB2' ' A' ' 210' ' ' TYR . 37.9 t-20 -75.93 126.26 30.66 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.9 mp -114.62 -8.14 12.72 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.607 0.639 . . . . 0.0 110.623 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -80.0 -10.28 59.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.307 2.243 . . . . 0.0 112.213 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -115.64 137.55 23.27 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 119.628 1.104 . . . . 0.0 108.206 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.59 -27.66 32.43 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.617 1.545 . . . . 0.0 112.14 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -65.95 -25.3 67.06 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 118.938 0.79 . . . . 0.0 112.015 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -85.58 -9.88 56.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.431 1.014 . . . . 0.0 112.286 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 13.1 p -112.58 -19.86 11.93 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.024 0.929 . . . . 0.0 110.343 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -54.84 41.31 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.01 -24.72 59.19 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.17 1.913 . . . . 0.0 113.515 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.7 tt -69.17 -65.38 0.72 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 37.0 pt -58.66 -28.94 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.981 0.913 . . . . 0.0 113.179 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.78 -22.15 63.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.752 0.821 . . . . 0.0 112.62 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -49.18 -57.12 7.25 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.904 2.081 . . . . 0.0 114.863 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -67.1 -49.2 65.79 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.293 0.371 . . . . 0.0 111.785 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.55 49.19 0.05 OUTLIER Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.517 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -116.76 133.27 10.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -147.51 143.7 28.02 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.91 -68.14 0.46 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -139.01 151.09 46.54 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.557 0.743 . . . . 0.0 111.474 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -74.51 128.77 36.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -151.46 104.46 3.07 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -155.87 155.03 32.2 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 55.03 20.87 3.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.328 1.451 . . . . 0.0 114.429 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.4 6.51 83.76 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 119.416 1.007 . . . . 0.0 113.082 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.65 117.65 32.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 125.703 1.601 . . . . 0.0 107.641 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -116.85 119.17 34.56 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.749 2.02 . . . . 0.0 106.14 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -135.72 110.61 8.77 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.519 0.728 . . . . 0.0 109.059 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.44 0.39 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.215 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -76.98 -19.61 57.1 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.971 -1.081 . . . . 0.0 110.712 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -102.83 96.49 6.87 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.628 1.971 . . . . 0.0 106.52 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 70.8 t -125.68 147.24 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.83 1.252 . . . . 0.0 110.612 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -127.99 22.26 5.43 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 118.333 -1.26 . . . . 0.0 115.574 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.26 -40.33 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.807 2.303 . . . . 0.0 111.907 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -90.47 19.5 5.22 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.496 0.718 . . . . 0.0 112.786 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -70.61 155.23 41.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 120.384 -1.447 . . . . 0.0 110.487 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.51 92.0 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.398 0.679 . . . . 0.0 109.482 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.58 95.78 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.56 -50.82 56.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 117.324 0.562 . . . . 0.0 110.197 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -63.1 -36.21 82.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.583 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.31 74.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.91 0.884 . . . . 0.0 112.187 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -84.85 -24.47 45.28 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 118.612 0.642 . . . . 0.0 112.229 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 52.3 tp -76.39 -49.55 16.47 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.181 0.993 . . . . 0.0 112.401 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.4 -31.99 56.21 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 118.606 0.639 . . . . 0.0 110.433 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -56.57 -44.08 80.65 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.555 1.542 . . . . 0.0 109.891 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -40.74 94.63 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.238 -0.914 . . . . 0.0 110.548 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 22.2 t -64.14 -38.55 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 C-N-CA 125.028 1.331 . . . . 0.0 109.347 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -59.92 -46.95 87.75 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.328 1.451 . . . . 0.0 110.792 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.3 mt -65.9 -37.8 87.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.03 0.832 . . . . 0.0 109.85 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 59.7 mt -67.46 -37.73 79.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -61.47 -41.72 97.68 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.25 -14.76 62.34 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.673 1.189 . . . . 0.0 111.715 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt 60.99 4.44 0.81 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.433 2.693 . . . . 0.0 112.77 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.79 -12.91 60.27 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.312 -0.243 . . . . 0.0 110.862 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 4.2 tpt -88.97 154.78 19.94 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.56 -0.712 . . . . 0.0 110.646 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -82.84 64.3 7.39 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.14 -14.49 4.07 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.59 -15.07 27.35 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.989 1.316 . . . . 0.0 112.761 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 57.4 m -66.71 137.59 56.79 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.094 0.958 . . . . 0.0 111.929 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -131.13 -176.73 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.49 1.916 . . . . 0.0 107.603 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.73 ' HB2' HD22 ' A' ' 150' ' ' ASN . 54.1 t80 -57.53 -45.56 84.9 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.31 -0.244 . . . . 0.0 111.294 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.68 -47.65 76.42 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.189 1.796 . . . . 0.0 111.029 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.89 -48.08 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.844 1.257 . . . . 0.0 110.57 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.16 83.28 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.814 0.734 . . . . 0.0 110.674 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.93 -52.1 40.08 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.27 -49.07 77.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.894 0.478 . . . . 0.0 111.612 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.62 -44.22 89.9 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -61.29 -40.66 94.96 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -58.97 -16.11 16.37 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.623 1.169 . . . . 0.0 113.513 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.0 -13.39 14.1 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.684 1.194 . . . . 0.0 111.387 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.49 18.82 58.07 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.832 1.206 . . . . 0.0 111.098 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -66.97 -12.23 59.14 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.818 1.247 . . . . 0.0 111.606 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 43.6 p -113.36 141.84 46.58 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.646 1.978 . . . . 0.0 109.681 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -82.57 -34.79 27.63 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.42 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 4.2 ptt? -146.3 164.24 32.99 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.784 2.034 . . . . 0.0 111.304 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.5 t -164.79 169.62 16.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.082 1.353 . . . . 0.0 107.687 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mt . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.71 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 C--O 1.239 0.501 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -71.36 134.46 24.72 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.927 1.751 . . . . 0.0 108.805 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.6 p -147.26 -172.49 4.02 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.466 1.506 . . . . 0.0 107.574 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.68 137.02 32.8 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -51.37 128.97 23.97 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.426 -0.796 . . . . 0.0 109.936 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.43 -10.5 6.35 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.863 1.105 . . . . 0.0 115.863 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.65 92.37 14.97 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 120.113 1.957 . . . . 0.0 107.943 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.55 161.96 43.75 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.489 2.126 . . . . 0.0 112.293 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 40.8 t -66.54 150.32 49.16 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.913 1.285 . . . . 0.0 108.763 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -139.22 89.19 12.51 Favored Pre-proline 0 N--CA 1.456 -0.171 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -80.94 -174.58 2.29 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.545 2.83 . . . . 0.0 110.476 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 125.121 1.369 . . . . 0.0 109.49 178.387 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.809 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.85 128.6 50.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.682 0.793 . . . . 0.0 110.409 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.5 tt -62.96 138.23 58.5 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.982 1.313 . . . . 0.0 107.646 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.6 m -118.76 144.23 46.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.826 0.822 . . . . 0.0 110.836 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -138.86 136.9 36.06 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -149.66 145.36 13.46 Favored Glycine 0 C--O 1.236 0.232 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 34.5 mt -69.32 134.52 30.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.229 1.012 . . . . 0.0 108.991 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -90.38 113.61 25.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.16 -14.41 37.13 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.958 1.303 . . . . 0.0 112.934 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.71 78.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.366 0.985 . . . . 0.0 111.88 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 48.7 m -62.13 164.86 9.66 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 123.101 0.25 . . . . 0.0 110.654 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -89.43 -26.17 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.797 2.331 . . . . 0.0 117.06 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -127.68 90.03 3.04 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.664 1.12 . . . . 0.0 110.537 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -62.99 -14.99 54.61 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.656 0.382 . . . . 0.0 111.907 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -66.03 -41.35 91.06 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 75.3 mt -57.0 -37.51 71.78 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.375 -0.828 . . . . 0.0 110.148 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.92 -48.04 60.09 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 122.041 -0.412 . . . . 0.0 110.789 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -31.44 71.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.981 -0.533 . . . . 0.0 111.152 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -75.86 -42.51 49.19 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.95 -46.04 90.69 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.952 1.251 . . . . 0.0 108.855 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.9 mp -63.65 -48.1 78.59 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 117.509 -1.234 . . . . 0.0 110.973 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -79.9 -20.55 45.56 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -97.79 -20.18 17.7 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.949 1.704 . . . . 0.0 113.019 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -138.6 -33.55 0.66 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-O 117.503 -1.237 . . . . 0.0 114.198 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.4 -57.1 4.09 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 121.167 1.803 . . . . 0.0 111.797 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.46 23.54 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 128.1 2.56 . . . . 0.0 114.137 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 77.2 p -98.65 160.99 13.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -65.08 -30.67 71.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -71.0 -47.43 58.87 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.353 1.061 . . . . 0.0 111.202 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -63.43 -47.34 88.3 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.12 -41.03 97.84 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.299 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -64.17 -43.27 95.64 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.434 0.561 . . . . 0.0 109.539 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.67 -43.5 85.07 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.587 0.631 . . . . 0.0 112.385 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 41.4 t -71.05 -38.45 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.718 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -68.54 -26.75 65.58 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.449 0.568 . . . . 0.0 111.797 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -66.43 -50.97 61.6 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.76 -52.12 65.54 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 119.085 -0.483 . . . . 0.0 112.23 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -140.6 147.42 48.99 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-N 119.04 0.836 . . . . 0.0 109.419 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.93 123.26 11.36 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.33 2.02 . . . . 0.0 111.06 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 28.5 mt -94.52 -6.91 42.69 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.728 1.211 . . . . 0.0 112.519 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 63.12 -141.92 46.91 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 107.018 -2.433 . . . . 0.0 107.018 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.1 176.45 9.66 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.95 157.11 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 120.683 -1.26 . . . . 0.0 112.941 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -82.4 -25.3 33.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.34 111.2 7.33 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -56.8 -33.56 66.81 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.8 m -54.67 -57.26 12.19 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.842 1.257 . . . . 0.0 110.35 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -81.03 -13.04 59.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.684 0.794 . . . . 0.0 112.414 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -63.73 -33.13 74.96 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -69.52 -17.33 63.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.379 0.672 . . . . 0.0 111.284 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.503 ' HA ' ' HE2' ' A' ' 313' ' ' LYS . 45.1 mm-40 -93.73 -46.15 7.36 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.471 1.508 . . . . 0.0 109.415 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 7.1 mt -69.15 -34.37 74.89 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.264 -0.897 . . . . 0.0 110.463 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.05 -15.97 48.59 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.503 ' HE2' ' HA ' ' A' ' 310' ' ' GLU . 54.2 mttm -54.3 -34.64 61.35 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 118.912 0.778 . . . . 0.0 110.699 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -93.22 136.01 24.95 Favored Pre-proline 0 N--CA 1.448 -0.549 0 C-N-CA 123.983 0.913 . . . . 0.0 110.35 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.98 -23.03 75.38 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.372 2.048 . . . . 0.0 114.472 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.72 -47.9 81.09 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 119.24 0.927 . . . . 0.0 109.752 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.2 mp -67.82 -59.2 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.079 1.352 . . . . 0.0 109.526 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.94 -46.52 64.76 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.61 -37.82 76.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 119.39 0.995 . . . . 0.0 112.597 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 88.6 m -68.68 -37.1 79.32 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.038 0.935 . . . . 0.0 108.97 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.6 tpt -66.04 -48.13 72.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.273 1.029 . . . . 0.0 109.883 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -58.82 -37.59 76.73 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.993 0.815 . . . . 0.0 110.412 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -69.39 -37.28 77.46 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.537 0 CA-C-N 118.959 0.799 . . . . 0.0 110.829 178.271 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.456 -0.7 0 CA-C-O 121.42 0.508 . . . . 0.0 113.24 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -81.53 73.79 8.55 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 6.1 pt -132.15 157.77 77.34 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 126.177 1.791 . . . . 0.0 109.935 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -71.15 -33.82 11.03 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.952 1.768 . . . . 0.0 111.76 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.77 -19.64 29.51 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 6.2 mmt -64.62 -29.73 70.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.656 0.662 . . . . 0.0 109.644 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 20.1 m -56.38 -53.49 56.75 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.001 0.92 . . . . 0.0 110.544 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.41 -39.75 64.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.644 -1.169 . . . . 0.0 110.549 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -48.39 -55.87 9.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.433 1.015 . . . . 0.0 112.147 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -60.31 -53.04 62.37 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.946 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -60.23 -42.65 95.67 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 118.705 0.684 . . . . 0.0 112.766 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -58.84 -56.68 19.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.132 1.373 . . . . 0.0 110.254 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 33.6 t -65.96 -38.78 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 118.47 -0.776 . . . . 0.0 110.023 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -54.11 -45.77 71.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.685 1.13 . . . . 0.0 108.18 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 28.0 m -70.13 -46.35 64.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.584 -0.722 . . . . 0.0 110.253 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -51.21 -45.04 61.75 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.189 0.904 . . . . 0.0 112.661 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.08 -57.96 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 125.126 1.37 . . . . 0.0 108.457 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 48.0 mm -60.57 -38.46 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.264 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -60.03 -48.14 82.96 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.669 1.122 . . . . 0.0 109.288 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.93 -49.14 60.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.858 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.51 -23.67 66.08 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.934 1.294 . . . . 0.0 113.319 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.3 m -94.79 -2.66 50.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.397 0.679 . . . . 0.0 109.945 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.41 12.63 69.86 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.753 0.706 . . . . 0.0 111.534 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -69.93 -36.04 75.01 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.02 0.928 . . . . 0.0 109.827 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -142.18 164.83 29.09 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 359' ' ' GLU . 15.4 t -81.37 159.96 24.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.07 -52.63 42.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 124.917 1.287 . . . . 0.0 109.843 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.47 -47.81 69.43 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 127.115 2.166 . . . . 0.0 111.42 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLU . . . . . 0.48 ' H ' HG23 ' A' ' 356' ' ' THR . 47.6 mm-40 -75.46 -33.26 60.85 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.733 0.697 . . . . 0.0 111.174 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.56 85.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.1 mp -68.35 -45.91 71.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.571 1.949 . . . . 0.0 110.445 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -55.52 -58.09 9.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.24 1.016 . . . . 0.0 108.536 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -53.3 -42.25 66.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.166 2.187 . . . . 0.0 112.084 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -68.66 -49.82 56.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.878 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -58.68 -32.25 68.95 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.21 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 6.6 m -63.38 -36.48 83.85 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.93 1.241 . . . . 0.0 110.62 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 12.2 mtt85 -65.84 -30.84 71.53 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.95 -1.094 . . . . 0.0 110.908 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 36.5 mt -82.58 -37.98 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.633 1.573 . . . . 0.0 111.15 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 65.9 p -78.29 -12.09 59.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.763 1.165 . . . . 0.0 112.921 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? . . . . . 0 C--O 1.254 1.294 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.025 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 . . . . . 0 C--O 1.232 0.137 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -81.18 -176.08 5.78 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.808 2.043 . . . . 0.0 109.342 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.33 29.48 73.29 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.129 -0.982 . . . . 0.0 114.759 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.99 162.12 37.69 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.252 1.021 . . . . 0.0 111.285 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.6 mt -152.53 147.4 26.16 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 130.095 3.358 . . . . 0.0 106.59 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.408 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 94.5 t -144.95 146.46 19.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.123 1.369 . . . . 0.0 108.639 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.462 HD12 HG22 ' A' ' 37' ' ' VAL . 20.5 mt -134.79 139.4 47.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -126.73 124.49 39.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 12' ' ' ASN . 1.5 mp -131.9 171.63 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.165 1.386 . . . . 0.0 108.327 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.441 ' H ' HG22 ' A' ' 11' ' ' ILE . 14.8 p-10 -103.94 157.28 17.21 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.403 1.481 . . . . 0.0 109.345 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.46 -22.15 60.98 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 125.608 1.575 . . . . 0.0 114.4 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -77.39 -3.11 38.52 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.522 1.661 . . . . 0.0 109.91 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.14 160.86 15.74 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 120.883 -1.136 . . . . 0.0 110.566 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.81 75.55 2.36 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.771 1.177 . . . . 0.0 110.238 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -74.38 -24.6 59.16 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -73.33 -43.1 61.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.744 1.611 . . . . 0.0 110.535 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.75 -30.66 73.18 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.3 tp -74.91 -40.69 60.73 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.804 1.242 . . . . 0.0 110.958 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.14 -46.97 54.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.115 0.566 . . . . 0.0 109.967 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -55.66 -32.85 63.58 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.8 t -64.89 -41.14 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.07 -38.47 73.57 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.021 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -59.36 -43.79 92.77 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.473 1.137 . . . . 0.0 108.325 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -60.22 -55.1 37.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.328 0.651 . . . . 0.0 109.803 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -58.4 -51.84 68.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.749 0.655 . . . . 0.0 111.989 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.43 -31.06 70.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.943 0.897 . . . . 0.0 110.74 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' CE ' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -68.41 -31.77 71.35 Favored 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 120.752 -1.218 . . . . 0.0 110.198 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.29 -47.12 9.69 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 123.629 0.581 . . . . 0.0 111.961 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -90.05 -32.3 16.79 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 -176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.52 -10.77 72.22 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 120.97 -1.081 . . . . 0.0 111.658 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.29 136.52 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HE2' ' N ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -66.63 134.7 52.83 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 117.785 -1.102 . . . . 0.0 109.359 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -134.31 78.46 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.66 155.55 29.44 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.462 HG22 HD12 ' A' ' 9' ' ' ILE . 94.4 t -141.54 127.91 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -136.53 161.43 35.89 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -123.34 68.13 37.98 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.106 0.963 . . . . 0.0 111.004 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -66.35 170.72 11.61 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.545 2.164 . . . . 0.0 111.114 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -122.97 -3.12 8.63 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.223 -0.923 . . . . 0.0 111.905 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -132.21 12.1 4.62 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.361 1.865 . . . . 0.0 112.785 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.94 -32.48 20.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.073 0.851 . . . . 0.0 112.315 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -52.54 -30.19 29.36 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.51 1.124 . . . . 0.0 112.259 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -116.9 -18.79 10.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.856 0.862 . . . . 0.0 112.206 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -41.38 31.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -51.41 -59.86 6.99 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.762 0.825 . . . . 0.0 109.834 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.47 -17.48 59.74 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 CA-C-N 121.245 1.48 . . . . 0.0 113.617 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -84.08 -5.48 59.24 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.667 1.121 . . . . 0.0 112.391 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.63 -38.85 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.031 0.932 . . . . 0.0 108.805 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.93 -32.54 70.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.213 1.005 . . . . 0.0 111.344 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.98 -31.61 68.91 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.741 0.7 . . . . 0.0 110.562 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.8 m -86.39 -15.97 38.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.598 1.159 . . . . 0.0 110.202 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.79 36.57 5.51 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.198 1.38 . . . . 0.0 110.381 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -132.16 173.71 10.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.691 1.196 . . . . 0.0 108.618 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.13 -160.21 14.77 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 126.497 1.998 . . . . 0.0 113.554 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.27 175.83 2.4 Favored 'Trans proline' 0 C--N 1.356 0.964 1 C-N-CA 125.861 4.374 . . . . 0.0 114.113 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 3.9 m-20 -106.96 -18.59 13.87 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.8 -1.187 . . . . 0.0 113.999 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.4 mt -148.22 135.15 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.33 1.052 . . . . 0.0 109.006 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.2 tt -115.19 142.06 29.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -129.95 107.57 9.46 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.45 1.5 . . . . 0.0 108.16 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.8 t-105 -156.13 -176.67 6.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.966 0.803 . . . . 0.0 111.553 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.35 138.14 51.16 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -46.37 -43.44 16.17 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 126.157 1.783 . . . . 0.0 113.619 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -55.53 -27.76 50.73 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -81.47 -18.66 44.44 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.764 0.711 . . . . 0.0 111.567 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -76.32 -13.51 60.14 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 118.465 -0.779 . . . . 0.0 112.833 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.13 -11.69 33.69 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.284 0.945 . . . . 0.0 113.544 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.95 -63.03 0.92 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -47.53 -56.37 7.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.043 1.737 . . . . 0.0 114.331 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.27 91.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.21 0.604 . . . . 0.0 111.758 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.31 -43.91 75.29 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.068 1.347 . . . . 0.0 109.717 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.5 m -74.87 -1.25 21.49 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.486 1.115 . . . . 0.0 113.347 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.77 18.15 64.22 Favored Glycine 0 C--N 1.337 0.626 0 O-C-N 120.805 -1.184 . . . . 0.0 113.602 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.6 mt -77.65 -32.91 53.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.687 1.244 . . . . 0.0 112.359 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.2 mt -91.45 142.1 28.03 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.476 -0.765 . . . . 0.0 111.706 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -78.88 172.24 14.05 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.857 1.263 . . . . 0.0 113.167 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -69.93 100.13 1.52 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.585 1.954 . . . . 0.0 108.911 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.514 HD12 ' CD2' ' A' ' 106' ' ' TYR . 9.9 mm -63.33 153.75 6.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.912 0.863 . . . . 0.0 110.107 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.9 m 60.86 77.44 0.37 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 127.376 2.27 . . . . 0.0 109.725 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 -26.17 21.53 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.274 1.316 . . . . 0.0 110.252 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -129.94 138.09 50.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.523 1.529 . . . . 0.0 110.754 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -57.49 -37.0 72.22 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.74 -24.42 56.9 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.308 1.413 . . . . 0.0 112.953 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.8 -28.23 68.85 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.693 0.679 . . . . 0.0 110.648 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -66.01 -43.96 86.17 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -64.95 -11.84 43.0 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.45 0.7 . . . . 0.0 111.894 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -87.19 -15.89 36.97 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 120.767 -1.208 . . . . 0.0 112.578 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.489 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 25.2 mt -124.17 163.12 22.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.475 1.034 . . . . 0.0 112.625 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -81.23 153.33 71.68 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 123.71 0.804 . . . . 0.0 112.03 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.05 -47.78 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 124.378 3.385 . . . . 0.0 114.216 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -54.05 -36.74 63.4 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.078 1.308 . . . . 0.0 111.937 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.435 HG22 ' CB ' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -73.5 -27.68 61.51 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.726 1.61 . . . . 0.0 110.634 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.489 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 12.9 m95 -69.5 -36.79 76.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.631 1.105 . . . . 0.0 109.999 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -63.2 -27.43 69.36 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.632 -0.667 . . . . 0.0 111.063 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.76 -4.16 22.43 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.291 1.437 . . . . 0.0 113.979 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.34 6.91 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 125.4 1.48 . . . . 0.0 111.206 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -71.6 170.67 12.92 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -149.14 -152.14 0.43 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -57.48 -11.76 2.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.536 1.934 . . . . 0.0 115.708 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.38 -85.14 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 105.563 -3.015 . . . . 0.0 105.563 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 162.08 16.98 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.425 0.69 . . . . 0.0 110.706 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.11 158.46 18.56 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.245 1.018 . . . . 0.0 109.614 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.0 pt -117.62 -24.5 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.651 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.418 ' CA ' HG13 ' A' ' 79' ' ' ILE . . . -156.81 -178.46 7.38 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.811 1.244 . . . . 0.0 110.051 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.514 ' CD2' HD12 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -136.82 149.52 67.1 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 123.895 0.878 . . . . 0.0 111.355 178.48 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.435 ' CB ' HG22 ' A' ' 93' ' ' THR . 96.3 Cg_endo -75.01 142.62 28.05 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.843 2.362 . . . . 0.0 109.891 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.3 mm -124.56 -52.76 2.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.698 1.599 . . . . 0.0 108.173 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.34 148.81 43.27 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.827 1.251 . . . . 0.0 109.824 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.5 t -130.51 95.67 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.095 0.958 . . . . 0.0 109.254 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 N--CA 1.472 0.652 0 C-N-CA 124.491 1.117 . . . . 0.0 109.277 178.638 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.442 ' HB ' HG23 ' A' ' 225' ' ' THR . 5.3 mp . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.9 p90 . . . . . 0 C--O 1.236 0.39 0 C-N-CA 123.96 0.904 . . . . 0.0 109.086 178.984 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.455 -0.745 0 N-CA-C 108.721 -1.3 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -80.72 -25.55 38.01 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.045 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.6 t -154.67 162.69 41.02 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.413 1.006 . . . . 0.0 109.689 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -65.75 -25.79 67.44 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 123.864 0.866 . . . . 0.0 111.786 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -71.56 -19.27 62.17 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.923 1.238 . . . . 0.0 109.79 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -89.37 -22.88 22.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.368 1.067 . . . . 0.0 111.125 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 15.8 mm -54.73 -59.33 10.81 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.195 -0.907 . . . . 0.0 108.796 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -69.87 -25.02 28.5 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.222 1.281 . . . . 0.0 111.47 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.16 -50.36 70.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 64.0 tp -70.13 -31.74 69.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -59.09 -44.76 91.95 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 118.684 0.674 . . . . 0.0 111.305 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -30.12 61.37 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.551 0.614 . . . . 0.0 110.832 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -66.27 -50.89 62.17 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.1 mt -67.48 -33.01 74.24 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.562 -1.208 . . . . 0.0 110.287 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -68.87 -34.62 75.74 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.931 1.241 . . . . 0.0 108.971 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.38 -16.36 62.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.378 0.536 . . . . 0.0 112.018 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.24 7.5 6.5 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.173 1.389 . . . . 0.0 112.121 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 170.92 -94.52 0.1 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 115.737 1.055 . . . . 0.0 115.737 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.74 -178.88 5.44 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.38 1.072 . . . . 0.0 113.58 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.64 169.08 9.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.803 1.287 . . . . 0.0 112.612 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -93.26 -73.12 0.57 Allowed 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.066 1.746 . . . . 0.0 109.292 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.9 tp -103.42 130.4 50.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.261 1.024 . . . . 0.0 112.749 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 76.7 mtp -131.37 117.3 18.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -143.22 156.31 44.72 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.69 88.22 0.35 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.746 1.618 . . . . 0.0 109.577 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -18.04 63.38 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.067 1.347 . . . . 0.0 109.812 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -71.41 -13.14 61.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.536 0.734 . . . . 0.0 112.644 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -103.76 129.3 25.57 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 119.19 0.905 . . . . 0.0 109.739 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.92 -10.41 23.03 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.786 2.324 . . . . 0.0 113.248 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -65.44 -42.09 92.75 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.796 1.638 . . . . 0.0 112.758 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -79.52 -32.67 42.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.6 p -84.33 -11.68 55.93 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.274 0.63 . . . . 0.0 111.77 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -53.75 -58.86 11.33 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 117.625 -1.178 . . . . 0.0 112.044 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.53 -18.01 58.53 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.281 1.493 . . . . 0.0 114.055 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.0 tp -71.35 -63.77 1.05 Allowed 'General case' 0 C--N 1.34 0.193 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.4 pt -66.41 -36.03 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.26 -12.97 59.54 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.121 -0.943 . . . . 0.0 113.095 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -44.63 -55.95 4.78 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 125.513 1.525 . . . . 0.0 114.06 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.78 -34.68 74.86 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.53 19.73 0.02 OUTLIER Glycine 0 C--N 1.332 0.335 0 CA-C-O 118.294 -1.281 . . . . 0.0 116.068 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.13 144.1 34.21 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 119.402 1.601 . . . . 0.0 111.548 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.427 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 51.7 p90 -153.86 144.99 22.85 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.46 -49.56 12.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.499 ' CD2' HD11 ' A' ' 333' ' ' ILE . 65.7 m-85 -145.9 133.67 21.16 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.646 0.778 . . . . 0.0 109.658 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.427 ' HE2' ' CE1' ' A' ' 167' ' ' TYR . 14.5 tppt? -70.65 149.53 46.92 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.522 0.729 . . . . 0.0 110.037 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -143.32 113.06 7.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -156.07 170.03 23.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 55.96 26.96 10.49 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.603 1.161 . . . . 0.0 111.495 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 56.17 43.79 88.88 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -149.5 166.54 28.85 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 126.69 1.996 . . . . 0.0 108.198 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.19 127.65 54.96 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -126.7 87.78 2.72 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 123.117 1.437 . . . . 0.0 112.184 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.439 ' H ' HD13 ' A' ' 178' ' ' ILE . 0.2 OUTLIER -63.61 -8.92 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.403 178.46 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -74.54 -12.34 60.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.373 1.069 . . . . 0.0 108.987 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.412 ' OD2' ' HE3' ' A' ' 170' ' ' LYS . 61.7 t0 -118.94 93.57 4.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.244 1.417 . . . . 0.0 108.349 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 86.8 t -99.03 147.2 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -129.89 44.77 1.19 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-O 119.185 -0.786 . . . . 0.0 111.947 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.3 t -86.76 -63.42 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 124.958 1.303 . . . . 0.0 108.725 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -85.9 67.63 10.08 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 122.538 1.161 . . . . 0.0 110.029 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -121.48 159.34 26.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.93 -38.89 70.89 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -56.46 -46.66 87.24 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.702 0.683 . . . . 0.0 113.503 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.43 -52.6 60.84 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.891 0.476 . . . . 0.0 111.349 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -64.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 118.318 -0.849 . . . . 0.0 111.879 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.31 -51.91 39.44 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.73 -38.99 94.68 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.488 HD23 HG13 ' A' ' 357' ' ' VAL . 56.1 tp -70.61 -45.2 65.71 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 118.291 -0.862 . . . . 0.0 111.324 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.12 -37.92 67.51 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 117.313 -1.327 . . . . 0.0 110.736 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -52.17 -48.71 64.83 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.784 1.629 . . . . 0.0 111.344 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.7 tt -69.22 -48.01 63.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.114 0.566 . . . . 0.0 110.645 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.66 -35.15 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 121.38 -0.825 . . . . 0.0 111.41 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.01 -29.6 69.47 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.204 -0.935 . . . . 0.0 109.279 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.94 -42.3 60.74 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 65.8 mt -58.38 -47.9 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -52.18 -51.29 58.98 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.181 1.392 . . . . 0.0 109.73 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -78.47 0.9 24.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.158 0.983 . . . . 0.0 112.087 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt 60.78 12.06 3.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 128.109 2.564 . . . . 0.0 113.812 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.79 6.35 1.2 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 127.272 2.229 . . . . 0.0 111.806 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 14.3 ttt -147.49 143.8 28.11 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.108 1.322 . . . . 0.0 109.649 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -83.36 70.28 10.14 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -47.81 -40.31 20.75 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.492 2.717 . . . . 0.0 116.388 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -72.02 0.23 9.95 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.044 1.738 . . . . 0.0 114.113 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.8 m -65.37 123.18 18.93 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.008 -1.058 . . . . 0.0 110.512 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.1 -172.65 2.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.073 1.749 . . . . 0.0 108.241 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -60.2 -50.57 73.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.649 0.38 . . . . 0.0 110.91 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.1 m -60.89 -41.07 95.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.537 0.735 . . . . 0.0 111.132 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 41.4 mm -65.59 -49.33 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.879 -1.058 . . . . 0.0 108.556 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.16 -46.15 90.27 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.235 1.014 . . . . 0.0 111.707 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -62.78 -48.08 80.68 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.91 1.284 . . . . 0.0 108.888 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.53 87.81 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.94 99.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -62.22 -39.08 91.61 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -57.32 -20.2 27.06 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.558 1.543 . . . . 0.0 111.774 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.38 -13.14 12.9 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.889 -1.132 . . . . 0.0 112.095 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.44 28.31 40.26 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.213 1.387 . . . . 0.0 110.47 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.83 7.18 4.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.585 1.954 . . . . 0.0 113.372 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.06 160.49 43.28 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 120.683 -1.261 . . . . 0.0 108.905 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -106.34 -15.14 14.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.536 1.534 . . . . 0.0 113.606 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -159.88 153.46 22.57 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.889 1.276 . . . . 0.0 109.976 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.442 HG23 ' HB ' ' A' ' 116' ' ' ILE . 4.3 t -150.02 161.1 43.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 -179.791 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.59 159.43 53.61 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.572 1.515 . . . . 0.0 109.622 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 255' ' ' SER . 68.1 p -120.68 -176.4 3.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.369 1.068 . . . . 0.0 109.987 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -100.16 169.35 9.21 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.568 1.076 . . . . 0.0 109.762 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -66.86 126.31 28.66 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.24 3.41 57.02 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 117.848 -1.529 . . . . 0.0 115.327 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -156.32 137.19 9.2 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 121.706 2.753 . . . . 0.0 114.347 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.42 146.7 40.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.881 2.387 . . . . 0.0 108.568 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.516 ' H ' HG22 ' A' ' 249' ' ' THR . 10.4 p -72.62 173.46 8.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . 0.344 12.8 ptmt -133.32 71.87 75.99 Favored Pre-proline 0 C--O 1.238 0.495 0 O-C-N 120.857 -1.152 . . . . 0.0 112.843 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.88 166.18 30.31 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.704 3.603 . . . . 0.0 113.291 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 . . . . . 0 C--O 1.237 0.439 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.005 179.668 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.99 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 14.9 m -138.21 168.4 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 119.794 1.797 . . . . 0.0 110.979 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 15.6 tp -74.96 152.2 38.8 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.0 m -133.87 129.6 36.64 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 121.122 1.783 . . . . 0.0 111.885 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -116.01 132.87 56.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.1 134.15 6.74 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.101 0.864 . . . . 0.0 112.608 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 81.5 mt -74.58 145.93 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 117.67 0.735 . . . . 0.0 109.842 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -75.52 124.98 28.11 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.315 1.446 . . . . 0.0 109.028 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.12 -22.29 65.8 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.251 -0.906 . . . . 0.0 113.06 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -77.82 -10.61 59.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.696 1.199 . . . . 0.0 112.606 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 70.4 m -65.96 146.45 99.01 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.97 -38.64 3.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.663 1.575 . . . . 0.0 112.672 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -132.23 88.22 2.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.649 0.78 . . . . 0.0 109.419 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -54.7 -22.97 15.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.123 0.969 . . . . 0.0 112.011 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -61.87 -30.68 71.02 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.06 1.344 . . . . 0.0 111.27 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.34 -42.01 94.77 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 121.183 -0.948 . . . . 0.0 108.553 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.19 -40.29 68.0 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.79 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -37.68 86.68 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 118.585 0.63 . . . . 0.0 109.957 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -73.64 -41.01 63.33 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -57.84 -49.69 75.83 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.703 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.8 mp -64.32 -49.36 72.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 119.104 -0.475 . . . . 0.0 111.53 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -71.29 -15.68 62.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -105.7 -19.7 13.68 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.969 1.713 . . . . 0.0 113.961 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -137.52 -45.51 0.55 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 117.923 -1.037 . . . . 0.0 111.843 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -59.15 -55.83 29.9 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.059 1.299 . . . . 0.0 111.68 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.5 mt -84.12 63.41 7.64 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.624 2.37 . . . . 0.0 110.38 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 68.9 p -138.87 161.55 36.99 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.95 -21.72 66.88 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 122.839 0.456 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -96.37 -27.68 14.82 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.052 0.941 . . . . 0.0 110.79 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -80.51 -43.96 8.94 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.568 1.08 . . . . 0.0 112.116 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 35.7 mt -65.22 -40.7 94.44 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -58.13 -47.23 83.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.783 1.233 . . . . 0.0 109.425 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.43 74.52 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.464 1.029 . . . . 0.0 112.839 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 24.8 t -73.54 -35.72 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 118.912 -0.566 . . . . 0.0 109.924 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -68.94 -29.87 68.2 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.807 0.731 . . . . 0.0 110.775 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -64.12 -38.27 90.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -51.14 35.83 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 123.518 0.511 . . . . 0.0 110.21 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -147.79 150.61 36.68 Favored Pre-proline 0 C--N 1.344 0.356 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.693 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.57 115.1 2.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.709 2.939 . . . . 0.0 110.792 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 90.9 mt -91.57 -20.94 21.14 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.23 -158.41 24.65 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.25 175.64 4.48 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 35.8 m -127.71 146.9 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 120.043 -1.661 . . . . 0.0 110.329 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.29 -29.47 63.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.662 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 22.3 tp -68.52 106.31 2.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -52.23 -27.33 14.41 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.007 0.923 . . . . 0.0 112.405 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.4 m -61.64 -70.94 0.16 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.663 0.785 . . . . 0.0 111.042 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -66.98 -21.14 65.97 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.188 0.449 . . . . 0.0 111.39 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -65.08 -25.51 67.83 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.24 -18.21 61.84 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.153 -1.592 . . . . 0.0 110.009 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -89.04 -51.77 5.43 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.999 1.32 . . . . 0.0 107.527 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.471 ' HB3' HG21 ' A' ' 317' ' ' ILE . 47.7 mt -61.26 -41.52 97.05 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.59 3.32 1.9 Allowed 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.672 0.789 . . . . 0.0 112.563 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -59.66 -25.73 64.96 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.486 1.494 . . . . 0.0 109.219 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.91 147.56 37.48 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.52 -14.22 43.16 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.138 2.559 . . . . 0.0 114.585 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -62.1 -56.31 20.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.784 1.174 . . . . 0.0 108.975 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 317' ' ' ILE . 4.2 mp -62.85 -51.78 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 125.306 1.442 . . . . 0.0 108.616 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.49 -48.4 62.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 123.447 0.467 . . . . 0.0 110.56 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.22 -33.69 71.28 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 1.3 m -67.21 -41.62 85.46 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -38.79 66.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.084 0.554 . . . . 0.0 111.973 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -53.41 -39.02 64.0 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 124.626 1.17 . . . . 0.0 109.323 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.06 -30.87 68.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.273 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.539 0.772 0 N-CA-C 110.883 -0.468 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -61.02 0.31 0.24 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 333' ' ' ILE . . . . . 0.499 HD11 ' CD2' ' A' ' 169' ' ' PHE . 22.7 pt -69.5 150.13 96.98 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 120.549 1.522 . . . . 0.0 114.223 -178.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.97 -13.69 39.03 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.236 2.624 . . . . 0.0 114.396 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -71.34 -13.08 61.75 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.998 -1.064 . . . . 0.0 110.727 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 73.8 mmm -66.09 -28.7 69.02 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 121.373 -0.829 . . . . 0.0 111.759 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 29.9 t -55.35 -51.51 66.54 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.98 -39.1 87.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.954 0.901 . . . . 0.0 110.987 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -51.94 -54.76 25.82 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.923 0.889 . . . . 0.0 110.148 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -64.26 -45.65 87.19 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.643 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -53.71 -42.16 67.76 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.377 0.671 . . . . 0.0 110.725 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.0 -62.57 1.32 Allowed 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 125.601 1.56 . . . . 0.0 112.637 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.57 -36.8 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.977 0.911 . . . . 0.0 111.827 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.47 -49.4 45.64 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.75 1.159 . . . . 0.0 110.356 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 6.6 m -73.53 -42.63 61.49 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.14 57.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.822 1.192 . . . . 0.0 112.745 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.2 t -61.28 -56.1 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 32.3 mm -59.96 -37.2 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.24 0.616 . . . . 0.0 110.657 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -57.21 -47.59 80.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.337 0.972 . . . . 0.0 109.539 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.0 -47.95 55.91 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.566 0.747 . . . . 0.0 110.816 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.89 -24.67 66.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.978 0.911 . . . . 0.0 112.924 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 18.5 m -92.16 -8.51 45.39 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.669 1.188 . . . . 0.0 110.513 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 69.97 16.18 72.42 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.608 0.64 . . . . 0.0 111.76 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -76.62 -33.44 58.39 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 118.092 0.946 . . . . 0.0 110.019 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -143.52 148.95 36.76 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 8.9 t -65.98 156.99 32.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.488 HG13 HD23 ' A' ' 192' ' ' LEU . 64.6 t -56.88 -47.99 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 123.742 0.817 . . . . 0.0 109.786 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -52.39 -46.6 66.31 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.31 0.644 . . . . 0.0 111.036 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -69.48 -36.46 76.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 119.457 -0.306 . . . . 0.0 111.048 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.09 -45.03 90.49 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 8.1 mt -69.18 -41.31 77.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.345 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -56.58 -49.47 74.77 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.911 1.285 . . . . 0.0 109.307 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -51.94 -56.4 14.42 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.261 1.824 . . . . 0.0 108.786 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.78 -49.85 76.11 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.182 1.393 . . . . 0.0 113.403 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -55.3 -38.5 68.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.579 1.551 . . . . 0.0 109.196 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.7 m -65.75 -42.79 90.52 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.425 -0.797 . . . . 0.0 109.855 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -59.2 -26.59 64.96 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.272 0.942 . . . . 0.0 113.233 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.7 mt -79.51 -25.1 12.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.047 0.939 . . . . 0.0 109.531 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 43.9 p -93.39 -23.65 18.35 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.491 0.716 . . . . 0.0 112.271 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.445 1.498 . . . . 0.0 108.346 -178.55 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -75.57 82.12 2.59 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.2 2.2 . . . . 0.0 108.325 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.71 32.43 0.04 OUTLIER Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.21 -1.359 . . . . 0.0 115.312 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -145.8 166.63 25.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.34 1.57 . . . . 0.0 111.357 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 mt -146.41 145.8 30.38 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.781 2.032 . . . . 0.0 107.195 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.82 144.55 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.945 1.298 . . . . 0.0 108.363 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.1 mt -131.74 135.16 59.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 126.606 1.963 . . . . 0.0 108.243 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -126.05 111.82 15.15 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -140.88 148.11 22.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 C-N-CA 124.426 1.09 . . . . 0.0 109.035 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.31 177.56 11.22 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.196 -0.94 . . . . 0.0 110.384 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.13 55.4 7.93 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-O 118.734 -1.036 . . . . 0.0 110.98 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.3 34.52 20.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.728 1.211 . . . . 0.0 113.424 177.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 20.32 0.06 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 116.261 1.949 . . . . 0.0 116.261 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.11 44.18 98.48 Favored Glycine 0 CA--C 1.536 1.396 0 O-C-N 120.678 -1.264 . . . . 0.0 111.318 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -60.35 -40.2 89.84 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -68.34 -39.79 81.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.026 1.284 . . . . 0.0 108.721 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.06 -35.08 91.6 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.7 tp -71.43 -35.46 70.95 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.799 -0.824 . . . . 0.0 111.546 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.71 -43.1 68.72 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.052 0.842 . . . . 0.0 110.25 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -57.83 -21.46 42.5 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.127 1.371 . . . . 0.0 113.953 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 t -86.34 -47.81 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.23 -41.29 96.9 Favored Glycine 0 C--N 1.335 0.512 0 O-C-N 121.01 -1.056 . . . . 0.0 112.237 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -37.64 88.15 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 117.998 0.899 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -61.23 -53.34 58.14 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -58.96 -47.82 83.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.765 0.426 . . . . 0.0 111.804 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -15.75 53.75 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.789 1.636 . . . . 0.0 110.728 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -94.99 -0.19 54.06 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 120.296 -1.503 . . . . 0.0 113.438 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -115.33 -51.83 2.69 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.894 1.678 . . . . 0.0 107.58 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -93.75 -21.68 19.17 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.27 -18.12 19.75 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.674 -1.266 . . . . 0.0 113.905 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.6 mm -61.47 118.04 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.011 1.406 . . . . 0.0 107.616 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -56.57 145.2 29.0 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 124.869 1.268 . . . . 0.0 112.463 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.1 t -130.16 104.41 10.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.8 m -91.84 127.18 37.2 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.43 115.17 46.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.356 -2.091 . . . . 0.0 105.356 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -127.13 171.73 11.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.345 1.058 . . . . 0.0 110.275 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -138.08 68.16 48.66 Favored Pre-proline 0 N--CA 1.455 -0.199 0 C-N-CA 123.619 0.768 . . . . 0.0 112.894 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.29 139.95 19.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 N-CA-C 107.997 -1.578 . . . . 0.0 107.997 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.58 9.52 41.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.555 1.542 . . . . 0.0 108.978 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.36 2.66 10.28 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.514 1.926 . . . . 0.0 114.112 -177.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pp -53.53 -25.58 17.46 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 117.677 -1.154 . . . . 0.0 113.738 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -57.09 -23.4 46.66 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.988 1.315 . . . . 0.0 113.092 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -124.46 -24.02 4.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.801 0.84 . . . . 0.0 112.368 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -77.88 -48.58 16.07 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.27 1.428 . . . . 0.0 110.77 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -45.12 -56.86 8.23 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 117.85 -1.072 . . . . 0.0 111.376 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.56 -39.58 81.74 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 CA-C-N 120.577 1.242 . . . . 0.0 115.211 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -67.43 -46.58 72.73 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.583 1.083 . . . . 0.0 112.326 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 56' ' ' GLY . 22.2 t -68.96 -41.55 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.1 -32.38 71.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.189 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.7 -19.05 57.73 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.951 0.796 . . . . 0.0 110.459 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 m -99.82 -41.7 7.14 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.431 1.492 . . . . 0.0 107.599 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.401 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 117.61 9.14 10.4 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.274 1.416 . . . . 0.0 114.769 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -89.04 -8.53 53.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.374 1.087 . . . . 0.0 112.965 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.417 ' N ' HG12 ' A' ' 50' ' ' VAL . . . -70.83 171.26 45.3 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.442 1.02 . . . . 0.0 114.639 -177.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -64.09 167.79 13.6 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.219 2.613 . . . . 0.0 110.18 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.0 -19.36 22.47 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 126.16 1.784 . . . . 0.0 110.564 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.0 mt -124.24 148.02 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 123.817 0.847 . . . . 0.0 109.812 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.3 tt -141.04 136.64 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -133.37 107.96 8.41 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -154.58 170.87 20.47 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.493 1.042 . . . . 0.0 108.978 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.06 158.27 31.49 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.748 -0.595 . . . . 0.0 110.358 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -55.14 -32.89 62.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.101 0.96 . . . . 0.0 110.168 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.34 -11.11 0.46 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 129.062 2.945 . . . . 0.0 114.912 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -129.63 13.36 5.93 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.014 2.125 . . . . 0.0 109.431 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -115.73 26.48 9.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.655 1.982 . . . . 0.0 111.275 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.27 -19.89 15.21 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 120.467 -1.396 . . . . 0.0 111.894 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -107.05 -35.5 2.73 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 117.948 -1.473 . . . . 0.0 116.075 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -51.68 -45.33 63.42 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.593 2.196 . . . . 0.0 111.464 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.59 95.99 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -32.45 73.2 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.003 1.321 . . . . 0.0 109.592 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.7 m -80.57 -4.62 54.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.386 1.474 . . . . 0.0 110.129 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.54 18.04 76.49 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.912 1.244 . . . . 0.0 112.257 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.5 mt -88.46 -17.58 30.08 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.893 1.346 . . . . 0.0 113.756 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.2 mt -99.41 126.83 45.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.395 0.998 . . . . 0.0 111.277 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.56 164.73 26.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.435 1.094 . . . . 0.0 110.818 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -71.32 94.32 1.2 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.957 1.303 . . . . 0.0 109.17 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.1 pp -74.71 172.91 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 m 67.37 82.75 0.19 Allowed Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 126.141 1.776 . . . . 0.0 111.495 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.91 -34.64 8.36 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.712 1.608 . . . . 0.0 108.529 178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -147.0 155.72 42.47 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.926 0.869 . . . . 0.0 111.817 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -56.36 -33.86 66.09 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.783 2.433 . . . . 0.0 112.896 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.08 -26.75 66.43 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 120.191 1.36 . . . . 0.0 113.214 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -76.09 -26.32 56.33 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 120.25 1.386 . . . . 0.0 109.09 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -62.87 -46.82 86.08 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.229 1.012 . . . . 0.0 109.117 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.48 -14.1 62.02 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -14.73 61.43 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 120.861 -1.149 . . . . 0.0 109.916 178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mt -120.98 164.37 16.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.292 1.837 . . . . 0.0 107.758 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.86 150.45 81.41 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 121.059 -1.026 . . . . 0.0 111.719 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.06 -49.21 2.17 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.569 2.846 . . . . 0.0 112.118 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -57.79 -25.21 60.22 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.18 -20.33 41.43 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.809 -1.182 . . . . 0.0 110.574 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -72.92 -26.97 61.59 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -53.26 -41.94 65.98 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.91 1.684 . . . . 0.0 110.091 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.17 -6.43 4.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.923 1.289 . . . . 0.0 113.428 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.15 -0.18 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.104 1.361 . . . . 0.0 111.832 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 -63.16 148.98 46.46 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.089 1.313 . . . . 0.0 108.375 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.451 ' CE1' ' HE2' ' A' ' 102' ' ' LYS . 26.0 t80 -142.02 167.33 22.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -63.7 114.52 4.04 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.455 0.702 . . . . 0.0 110.801 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.9 -84.33 0.3 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 124.65 1.119 . . . . 0.0 111.34 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.451 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -72.83 166.03 23.73 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.21 0.604 . . . . 0.0 109.876 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.73 166.31 10.56 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.38 -40.17 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.96 174.01 11.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.649 0.659 . . . . 0.0 111.096 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -131.68 149.55 73.78 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 124.76 1.224 . . . . 0.0 110.419 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.27 145.62 30.78 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.198 2.599 . . . . 0.0 110.043 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -128.12 -53.66 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.261 1.425 . . . . 0.0 111.043 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.77 155.6 43.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.998 0.817 . . . . 0.0 112.45 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.5 t -130.95 110.1 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.059 0.544 . . . . 0.0 110.652 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 . . . . . 0 N--CA 1.474 0.729 0 CA-C-N 118.716 0.689 . . . . 0.0 112.746 177.717 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mm . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 44.1 p90 . . . . . 0 C--O 1.24 0.59 0 C-N-CA 126.653 1.981 . . . . 0.0 106.565 179.335 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 N--CA 1.454 -0.832 0 N-CA-C 110.137 -0.755 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -143.31 -31.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.715 1.206 . . . . 0.0 112.186 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.39 141.3 27.06 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -64.25 -16.1 61.38 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.039 -1.663 . . . . 0.0 113.203 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.84 -13.12 59.63 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.376 -0.827 . . . . 0.0 111.942 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -90.03 -14.01 34.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.326 0.65 . . . . 0.0 110.377 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.7 mm -53.39 -55.73 31.64 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 125.302 1.441 . . . . 0.0 110.424 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.98 -25.56 51.83 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 CA-C-N 120.693 1.283 . . . . 0.0 112.414 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.03 -60.52 2.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.61 -25.26 68.01 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.39 -0.819 . . . . 0.0 110.4 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.97 -47.81 76.29 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -67.67 -31.38 71.32 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 119.181 0.9 . . . . 0.0 110.997 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.06 -49.53 74.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 63.2 mt -76.68 -28.58 55.97 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.961 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -67.47 -34.25 76.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 119.785 1.175 . . . . 0.0 108.648 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.59 -15.19 62.49 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.16 5.62 5.87 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.918 1.287 . . . . 0.0 111.958 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.52 -97.76 0.12 Allowed Glycine 0 C--N 1.341 0.808 0 CA-C-N 119.686 1.13 . . . . 0.0 113.829 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -141.45 -162.1 1.33 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.941 1.297 . . . . 0.0 110.128 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.35 178.83 0.18 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.903 2.481 . . . . 0.0 115.766 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.96 -36.11 3.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.585 1.954 . . . . 0.0 111.069 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.2 tp -123.56 110.0 14.49 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.143 1.777 . . . . 0.0 108.343 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 49.0 ttm -121.2 106.77 11.83 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.407 1.083 . . . . 0.0 108.585 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -135.02 167.74 20.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.933 0.788 . . . . 0.0 110.722 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -67.0 89.0 0.16 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.722 1.609 . . . . 0.0 109.561 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.1 mt -81.91 -5.22 58.1 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.904 1.281 . . . . 0.0 111.602 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -85.57 -8.01 58.53 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -120.41 130.17 24.98 Favored Pre-proline 0 C--O 1.236 0.382 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.54 -15.96 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.884 1.723 . . . . 0.0 113.584 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -55.47 -36.22 66.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.593 0.757 . . . . 0.0 112.236 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -81.35 -37.76 27.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.572 0.749 . . . . 0.0 112.027 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.7 p -82.84 -10.96 58.6 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.878 0.763 . . . . 0.0 112.297 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -60.8 -59.49 13.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 O-C-N 120.912 -1.117 . . . . 0.0 113.507 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -68.04 -3.5 10.74 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 121.326 1.509 . . . . 0.0 114.585 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.0 tp -79.24 -66.67 0.84 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 8.2 pt -68.7 -25.43 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.59 -23.58 67.11 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.821 -1.175 . . . . 0.0 110.591 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -45.53 -60.04 2.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.937 2.095 . . . . 0.0 111.099 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -58.98 -57.3 13.67 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.31 5.19 0.03 OUTLIER Glycine 0 C--N 1.334 0.441 0 CA-C-O 116.991 -2.005 . . . . 0.0 117.713 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -61.35 134.34 48.14 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -141.64 121.91 13.93 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.54 -53.9 44.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.378 -0.201 . . . . 0.0 110.965 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -142.81 132.22 23.54 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -71.3 151.42 44.21 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -141.41 99.12 3.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -71.31 178.09 3.56 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -60.44 22.14 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.084 2.554 . . . . 0.0 116.747 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.57 -4.58 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 127.294 2.378 . . . . 0.0 111.866 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -113.8 107.88 16.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.613 1.706 . . . . 0.0 108.738 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.97 47.04 0.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.082 1.353 . . . . 0.0 109.58 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.88 92.64 1.27 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.25 1.42 . . . . 0.0 112.259 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -55.82 -1.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 130.303 3.441 . . . . 0.0 113.532 178.029 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -70.7 -33.93 71.4 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -82.72 100.89 10.52 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.1 t -116.48 102.34 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 126.56 1.944 . . . . 0.0 111.487 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -90.96 40.15 3.01 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 126.276 1.893 . . . . 0.0 113.842 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.94 -19.99 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.526 0.73 . . . . 0.0 111.063 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -108.34 51.04 0.75 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.976 1.369 . . . . 0.0 108.08 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -106.64 153.44 22.38 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.496 1.118 . . . . 0.0 109.913 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.56 -40.99 66.01 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.055 1.342 . . . . 0.0 111.729 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -59.67 -42.04 97.69 Favored Glycine 0 CA--C 1.523 0.588 0 O-C-N 121.474 -0.766 . . . . 0.0 112.656 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.22 -52.15 60.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -62.74 -32.73 73.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.241 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.1 -60.42 3.62 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.316 1.416 . . . . 0.0 110.065 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.65 -34.44 86.32 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 36.5 tp -70.48 -54.87 10.53 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.525 0.662 . . . . 0.0 110.1 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.62 -36.43 71.79 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.706 0.802 . . . . 0.0 109.616 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.86 -41.58 87.35 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.553 1.069 . . . . 0.0 109.595 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.5 tt -73.76 -45.54 51.14 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.248 -0.907 . . . . 0.0 109.671 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.61 -36.64 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.833 1.253 . . . . 0.0 110.037 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -58.28 -31.56 67.57 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.092 1.357 . . . . 0.0 111.138 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 49.5 mt -73.71 -40.94 63.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.52 -40.84 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -55.23 -37.67 67.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.122 0.969 . . . . 0.0 109.634 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -88.69 0.18 56.69 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.5 1.52 . . . . 0.0 112.37 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? 58.72 10.12 1.36 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 128.131 2.572 . . . . 0.0 114.759 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -42.9 89.83 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.8 tpt -92.64 142.32 27.5 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.88 1.272 . . . . 0.0 107.991 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -82.65 110.15 17.46 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.33 -8.04 54.87 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.906 0.882 . . . . 0.0 112.765 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -100.75 0.53 39.02 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.355 1.062 . . . . 0.0 112.807 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 93.6 m -63.93 130.04 42.48 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -129.8 -179.68 5.34 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.573 1.149 . . . . 0.0 108.696 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -55.12 -47.36 75.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.427 -0.32 . . . . 0.0 110.792 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.6 m -57.56 -45.58 85.0 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.408 1.483 . . . . 0.0 111.105 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 17.5 mm -64.19 -50.21 77.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.21 99.28 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.855 0.722 . . . . 0.0 111.927 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -59.23 -45.63 90.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.085 1.754 . . . . 0.0 110.574 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.15 -48.61 64.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.34 -51.46 68.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.023 0.929 . . . . 0.0 111.366 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -56.12 -39.37 72.13 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.669 0.788 . . . . 0.0 110.458 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -61.08 -25.01 66.66 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.998 -0.439 . . . . 0.0 112.117 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -94.5 -15.04 24.53 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.409 0.684 . . . . 0.0 111.138 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.04 11.94 58.2 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.311 1.434 . . . . 0.0 112.135 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -53.26 -70.08 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.672 2.389 . . . . 0.0 112.588 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.1 t -72.5 153.21 41.46 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -111.04 -18.59 13.0 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.022 0.529 . . . . 0.0 112.347 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -149.28 139.79 22.49 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.801 1.64 . . . . 0.0 108.669 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.7 t -160.29 -177.49 6.29 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 179.137 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.238 0.448 0 CA-C-O 119.262 -0.399 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.48 154.29 74.88 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 N-CA-C 107.745 -1.675 . . . . 0.0 107.745 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.0 p -115.28 179.0 4.09 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.926 0.891 . . . . 0.0 112.282 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -102.27 148.5 25.37 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 120.377 -1.452 . . . . 0.0 108.027 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.29 104.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.222 1.409 . . . . 0.0 110.592 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 95.61 -5.41 67.1 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.778 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.41 120.53 4.46 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 120.426 2.113 . . . . 0.0 112.578 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.07 159.28 33.91 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.968 3.112 . . . . 0.0 110.712 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 4.2 p -77.62 167.47 21.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.79 0.805 . . . . 0.0 110.131 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -147.33 78.17 10.33 Favored Pre-proline 0 N--CA 1.453 -0.305 0 C-N-CA 123.622 0.769 . . . . 0.0 110.344 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.05 172.31 16.2 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.86 1.707 . . . . 0.0 110.343 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 . . . . . 0 C--O 1.24 0.603 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.948 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.02 0 N-CA-C 105.502 -3.039 . . . . 0.0 105.502 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 8.4 m -143.91 147.56 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.11 159.23 24.75 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.5 m -133.09 144.52 50.03 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.899 0.772 . . . . 0.0 109.64 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.23 139.91 51.66 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 121.453 -0.779 . . . . 0.0 109.122 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.91 177.23 18.57 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.965 0.793 . . . . 0.0 113.076 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.3 mt -122.01 119.39 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 125.408 1.483 . . . . 0.0 107.229 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.98 123.02 21.08 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 120.499 -1.376 . . . . 0.0 107.945 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.51 -5.4 7.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.297 1.439 . . . . 0.0 112.739 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.401 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -67.2 -42.54 83.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 127.292 2.237 . . . . 0.0 113.671 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.8 m -57.39 152.49 32.52 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 123.98 0.912 . . . . 0.0 113.307 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.34 -51.45 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.772 2.315 . . . . 0.0 110.594 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -123.06 109.63 14.31 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.509 ' HD2' ' H ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -67.08 -24.29 65.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.71 -34.52 62.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.138 1.375 . . . . 0.0 111.56 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 78.2 mt -60.42 -36.17 77.53 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.327 -0.858 . . . . 0.0 110.146 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -81.25 -39.43 25.31 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.236 -0.887 . . . . 0.0 111.315 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.41 83.36 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.153 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -67.58 -49.4 63.35 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -56.41 -49.78 73.51 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.36 -0.838 . . . . 0.0 110.764 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.53 -21.94 66.62 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.81 -14.9 14.68 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -103.32 -24.27 13.52 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.986 0.812 . . . . 0.0 112.242 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -139.43 -32.18 0.66 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -67.07 -47.95 69.72 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.443 1.474 . . . . 0.0 112.847 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.05 73.13 5.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 71.4 p -138.72 153.98 48.53 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.88 -24.37 67.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -86.85 -43.67 12.29 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.175 1.79 . . . . 0.0 110.898 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -68.52 -44.93 70.2 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 54.1 mt -67.61 -34.74 77.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -62.15 -49.01 77.55 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.411 ' HA ' ' HE2' ' A' ' 295' ' ' LYS . . . -54.4 -42.84 70.9 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 119.595 1.089 . . . . 0.0 110.926 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.4 t -63.56 -41.18 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.804 1.242 . . . . 0.0 108.797 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -64.14 -38.92 92.79 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.126 1.371 . . . . 0.0 112.059 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 292' ' ' ALA . 21.9 mtmt -56.78 -54.7 43.32 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.246 -0.909 . . . . 0.0 108.755 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -55.18 -52.87 61.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.058 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.481 ' HA ' ' HE3' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -147.78 156.33 44.6 Favored Pre-proline 0 N--CA 1.473 0.715 0 O-C-N 120.799 -1.188 . . . . 0.0 111.799 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -61.34 130.9 33.81 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 N-CA-C 105.963 -2.36 . . . . 0.0 105.963 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -95.38 -15.78 22.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.342 -0.837 . . . . 0.0 112.882 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.36 -157.27 47.81 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.16 164.12 25.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 22.7 m -125.91 148.89 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 O-C-N 121.246 -0.909 . . . . 0.0 109.852 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.05 -22.47 58.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.675 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 62.7 tp -66.93 105.4 1.61 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.789 1.635 . . . . 0.0 109.365 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -61.41 -1.86 0.61 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.6 t -92.9 -66.64 0.91 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -63.51 -19.32 64.67 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.438 -0.789 . . . . 0.0 110.877 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -60.2 -35.5 75.55 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -68.22 -20.43 64.83 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.072 0.851 . . . . 0.0 111.687 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -88.12 -50.36 6.44 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.582 1.153 . . . . 0.0 108.403 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 48.7 mt -67.64 -35.32 78.69 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.012 0.525 . . . . 0.0 110.554 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.3 1.92 4.37 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.182 -0.949 . . . . 0.0 112.686 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -62.53 -20.88 65.08 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 120.111 1.323 . . . . 0.0 109.575 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -109.82 129.22 24.17 Favored Pre-proline 0 C--O 1.24 0.554 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.7 -8.41 9.21 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.378 2.719 . . . . 0.0 114.54 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -67.23 -54.48 20.58 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 119.68 1.127 . . . . 0.0 108.607 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.7 -49.55 83.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.45 -50.56 62.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 123.75 0.656 . . . . 0.0 109.947 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.81 -41.35 86.59 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.9 m -62.16 -37.76 86.46 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.8 tpt -68.2 -46.62 70.13 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.257 0.623 . . . . 0.0 110.596 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -60.68 -30.07 69.69 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.019 0.928 . . . . 0.0 113.111 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -74.82 -35.35 62.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 C-N-CA 123.777 0.831 . . . . 0.0 111.315 179.01 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.538 0.721 0 N-CA-C 113.557 0.561 . . . . 0.0 113.557 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -84.22 70.4 10.56 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.657 1.583 . . . . 0.0 106.992 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 30.1 pt -124.08 152.09 66.47 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 124.396 1.078 . . . . 0.0 110.549 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -68.78 -30.94 26.4 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.09 2.526 . . . . 0.0 113.106 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -65.66 -17.19 64.42 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -61.43 -31.35 71.29 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.986 0.812 . . . . 0.0 109.563 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 4.6 t -57.57 -46.09 84.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.457 0.703 . . . . 0.0 110.712 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -79.6 -36.25 38.33 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.604 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.0 -52.35 63.42 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.786 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -58.26 -40.47 81.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.865 1.211 . . . . 0.0 111.1 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -65.64 -23.13 66.73 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.962 0.905 . . . . 0.0 111.46 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.3 -50.73 8.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.538 1.135 . . . . 0.0 110.272 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 11.2 t -60.7 -49.81 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.612 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.01 -54.33 13.28 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.637 0.653 . . . . 0.0 110.275 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.477 HG21 HH22 ' A' ' 367' ' ' ARG . 87.3 m -64.3 -43.18 95.54 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.296 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.27 -43.07 87.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.122 1.328 . . . . 0.0 111.519 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.82 -52.68 51.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 125.041 1.336 . . . . 0.0 108.897 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 30.1 mm -60.5 -43.18 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.151 0.58 . . . . 0.0 110.13 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -59.88 -47.36 86.06 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.738 0.699 . . . . 0.0 110.265 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.26 72.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.719 0.808 . . . . 0.0 110.679 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.66 -32.17 72.32 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.246 1.019 . . . . 0.0 111.97 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 14.1 m -85.15 -11.75 54.37 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.739 0.816 . . . . 0.0 109.723 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.74 10.04 66.75 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 123.667 0.651 . . . . 0.0 112.428 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -69.15 -34.48 75.04 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 118.158 0.979 . . . . 0.0 109.985 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -134.93 148.04 49.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 356' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 359' ' ' GLU . 11.9 t -68.34 156.24 38.15 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 26.0 t -58.14 -40.43 77.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 125.011 1.325 . . . . 0.0 110.086 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.06 -47.84 84.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.956 0.502 . . . . 0.0 109.738 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' GLU . . . . . 0.449 ' H ' HG23 ' A' ' 356' ' ' THR . 52.6 mm-40 -68.92 -37.82 79.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 122.147 -0.345 . . . . 0.0 111.21 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.4 -39.87 73.72 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.97 -41.3 59.84 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.567 1.147 . . . . 0.0 110.296 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -55.45 -50.16 70.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.493 0.717 . . . . 0.0 109.363 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -49.85 76.32 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 127.042 2.137 . . . . 0.0 111.1 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.21 -52.15 66.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.076 0.95 . . . . 0.0 112.209 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -52.84 -33.04 47.72 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.551 0.74 . . . . 0.0 110.482 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.3 m -64.22 -48.03 77.41 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.413 1.006 . . . . 0.0 109.451 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.477 HH22 HG21 ' A' ' 345' ' ' THR . 79.9 mtt180 -57.25 -23.35 47.54 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.3 mt -96.14 -10.41 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.025 1.33 . . . . 0.0 111.565 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 55.5 p -120.08 1.72 10.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.673 1.189 . . . . 0.0 112.491 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 36.1 tptt . . . . . 0 C--O 1.251 1.179 0 C-N-CA 127.665 2.386 . . . . 0.0 105.547 178.401 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -79.12 175.07 10.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.53 1.532 . . . . 0.0 109.384 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.95 22.71 77.68 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.427 1.013 . . . . 0.0 113.302 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -146.87 166.48 26.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.992 0.896 . . . . 0.0 112.664 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.2 mt -151.32 142.93 23.64 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.939 2.895 . . . . 0.0 106.681 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.26 126.61 49.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 mt -108.07 136.11 44.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 125.81 1.644 . . . . 0.0 108.146 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -127.76 130.6 49.02 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.035 1.734 . . . . 0.0 106.511 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 15' ' ' LYS . 11.8 pt -131.76 165.65 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 127.26 2.224 . . . . 0.0 110.383 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.497 ' HB3' HD21 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -151.35 165.57 33.66 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.367 1.067 . . . . 0.0 112.975 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.68 40.5 7.68 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-O 118.466 -1.185 . . . . 0.0 111.855 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 54.51 32.85 17.65 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.622 1.169 . . . . 0.0 108.213 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HB3' HD12 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -56.77 163.37 1.92 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.539 1.536 . . . . 0.0 113.372 -177.734 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.09 76.35 1.44 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -66.17 -39.52 89.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.611 1.164 . . . . 0.0 109.352 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -58.57 -59.76 4.87 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 125.875 1.67 . . . . 0.0 110.526 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.27 94.53 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.7 tp -62.94 -42.55 99.84 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 117.889 0.845 . . . . 0.0 108.944 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.63 73.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.863 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -62.39 -27.89 69.4 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.452 1.024 . . . . 0.0 110.443 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.9 t -79.31 -46.47 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.28 -39.07 97.24 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 121.257 -0.902 . . . . 0.0 113.069 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -37.62 68.35 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 117.776 -1.107 . . . . 0.0 109.1 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -58.42 -57.33 13.41 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.38 -48.03 80.13 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.937 -0.554 . . . . 0.0 110.384 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.48 -22.96 66.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.958 1.254 . . . . 0.0 112.61 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tppm? -85.74 -23.22 27.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 117.876 -1.059 . . . . 0.0 110.805 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -102.83 -22.59 13.86 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.925 0.765 . . . . 0.0 112.71 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -114.79 -35.95 4.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.468 1.107 . . . . 0.0 111.355 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.17 -18.74 56.95 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.121 0.867 . . . . 0.0 113.414 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.8 mm -60.45 125.63 16.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HA ' ' CE ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -63.77 127.93 33.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.107 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.7 t -123.2 104.91 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -93.97 139.14 31.3 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.3 t -130.67 118.46 42.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -128.84 158.99 37.18 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -116.85 60.64 2.38 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.664 1.186 . . . . 0.0 110.185 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.485 ' HG2' HD22 ' A' ' 43' ' ' LEU . 48.3 Cg_endo -62.09 160.41 30.34 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 121.867 1.711 . . . . 0.0 109.966 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -117.79 9.12 12.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.596 0.758 . . . . 0.0 111.709 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.17 17.69 2.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.073 1.749 . . . . 0.0 112.876 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 43' ' ' LEU . 1.3 pt? -56.11 -24.15 38.74 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.627 -1.295 . . . . 0.0 111.797 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.99 -24.95 57.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.203 1.401 . . . . 0.0 112.104 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -121.57 -22.27 5.94 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.219 1.008 . . . . 0.0 111.218 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -41.92 59.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 117.24 -1.362 . . . . 0.0 110.9 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -52.49 -58.71 10.73 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 120.642 1.565 . . . . 0.0 110.111 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.78 -17.3 54.28 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.501 1.467 . . . . 0.0 113.553 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -88.7 2.12 53.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.649 1.58 . . . . 0.0 113.638 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.3 -34.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.18 0.9 . . . . 0.0 109.61 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.77 66.12 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.708 -1.245 . . . . 0.0 110.011 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.73 -2.92 5.55 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.887 0.875 . . . . 0.0 112.368 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.2 p -126.33 -11.72 6.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.461 1.504 . . . . 0.0 110.256 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.412 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 84.6 15.76 67.61 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.277 0.942 . . . . 0.0 111.892 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -106.38 6.44 30.43 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.007 0.904 . . . . 0.0 110.684 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.41 -167.59 43.39 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 127.001 2.239 . . . . 0.0 116.371 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.92 -179.32 2.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.634 2.89 . . . . 0.0 110.136 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.95 -18.28 8.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.8 mt -135.44 143.84 35.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.428 1.091 . . . . 0.0 109.306 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tt -130.02 143.2 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 C-N-CA 125.014 1.326 . . . . 0.0 110.953 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -137.92 109.83 7.19 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.823 1.649 . . . . 0.0 107.609 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 29.2 t-105 -159.88 178.91 9.27 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.438 1.017 . . . . 0.0 108.981 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.36 153.55 43.42 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -60.16 -19.14 52.52 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.362 1.465 . . . . 0.0 111.658 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -53.07 -61.95 1.96 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.895 1.278 . . . . 0.0 111.322 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -68.15 -18.22 64.56 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.598 -0.689 . . . . 0.0 111.088 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -68.67 -30.43 69.11 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.483 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.8 -12.79 49.44 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.99 0.805 . . . . 0.0 112.296 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -104.58 -45.72 1.39 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -60.47 -52.04 66.9 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.554 -0.968 . . . . 0.0 111.322 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.62 84.22 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.692 0.678 . . . . 0.0 111.235 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.21 -47.31 69.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.776 1.23 . . . . 0.0 108.71 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -72.21 -6.89 46.09 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.43 9.85 80.91 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.781 1.181 . . . . 0.0 112.296 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 mt -73.21 -22.03 60.53 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.389 1.094 . . . . 0.0 111.156 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -103.87 140.28 37.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.12 -171.95 3.31 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -76.93 159.72 29.76 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.414 HD11 ' HB3' ' A' ' 103' ' ' LEU . 2.7 pp -137.73 172.04 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.727 1.211 . . . . 0.0 110.184 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.57 HG23 ' HB3' ' A' ' 85' ' ' PHE . 42.4 m 42.36 77.24 0.45 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.105 2.162 . . . . 0.0 114.552 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.88 -22.0 27.51 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.084 2.523 . . . . 0.0 115.291 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -120.16 135.24 55.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.22 1.373 . . . . 0.0 111.526 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -51.32 -39.11 56.26 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.781 2.032 . . . . 0.0 112.265 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.5 -27.18 62.31 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.57 ' HB3' HG23 ' A' ' 80' ' ' THR . 14.2 t80 -66.46 -37.11 84.41 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -64.54 -42.86 95.45 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 118.845 0.748 . . . . 0.0 109.284 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -57.0 -30.11 63.87 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.52 1.528 . . . . 0.0 112.718 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -75.4 -2.24 27.64 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mt -130.18 154.15 47.83 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 120.728 -1.232 . . . . 0.0 110.892 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -69.12 155.83 92.78 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 122.436 -0.165 . . . . 0.0 110.786 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.41 -45.68 2.46 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.906 3.07 . . . . 0.0 114.241 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -58.01 -38.62 76.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.565 1.075 . . . . 0.0 111.143 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -25.58 66.24 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.555 1.142 . . . . 0.0 110.722 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -77.94 -44.45 26.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.411 0.684 . . . . 0.0 110.119 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.71 -33.38 64.14 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.56 -7.4 4.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.4 1.48 . . . . 0.0 114.179 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.73 10.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.966 1.706 . . . . 0.0 111.887 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.9 mtp85 -70.28 160.48 32.12 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -132.7 -165.11 1.56 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -70.37 81.25 0.55 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.291 1.036 . . . . 0.0 109.401 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.35 -60.81 4.84 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.368 0.985 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -178.56 5.07 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.32 0.648 . . . . 0.0 109.881 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.414 ' HB3' HD11 ' A' ' 79' ' ' ILE . 34.5 mt -115.9 169.95 8.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.161 1.385 . . . . 0.0 109.248 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 pt -138.65 -28.88 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.79 175.32 13.0 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.456 1.026 . . . . 0.0 109.701 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -133.31 150.02 74.09 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.9 143.73 29.77 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.966 2.444 . . . . 0.0 110.888 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -131.53 -50.65 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.808 2.443 . . . . 0.0 111.546 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.71 131.51 52.55 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 110.396 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.65 95.99 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 122.605 1.193 . . . . 0.0 110.164 179.904 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 43.8 p90 . . . . . 0 C--O 1.235 0.299 0 O-C-N 120.777 -1.202 . . . . 0.0 110.952 178.772 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo . . . . . 0 N--CA 1.453 -0.864 0 N-CA-C 110.441 -0.638 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.35 -31.6 2.77 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 124.441 1.096 . . . . 0.0 113.325 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.95 152.4 9.46 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.269 1.395 . . . . 0.0 109.832 -178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -56.1 -27.68 54.7 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.46 -16.52 24.35 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.283 0.947 . . . . 0.0 113.132 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -92.23 -14.22 29.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.062 0.847 . . . . 0.0 111.212 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 26.0 mm -59.65 -57.89 23.51 Favored Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -69.9 -25.54 27.86 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 CA-C-N 120.306 1.145 . . . . 0.0 110.967 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.64 71.65 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 118.67 0.668 . . . . 0.0 109.863 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 61.5 tp -88.84 -29.88 19.36 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.737 0.815 . . . . 0.0 109.585 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -59.08 -45.74 90.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.429 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 5.5 ptmm? -64.06 -32.19 73.65 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.534 0.334 . . . . 0.0 111.832 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -71.62 -43.04 66.87 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.203 0.601 . . . . 0.0 110.206 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.4 mt -75.8 -32.18 59.76 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -67.81 -33.33 74.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.609 -1.307 . . . . 0.0 108.498 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.1 -14.08 59.62 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 3.24 5.45 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.179 0.992 . . . . 0.0 112.127 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.65 -99.67 0.13 Allowed Glycine 0 CA--C 1.523 0.566 0 CA-C-N 119.267 0.94 . . . . 0.0 113.448 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -138.12 -177.75 4.97 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.433 1.493 . . . . 0.0 111.719 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.5 p -56.16 168.76 0.47 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.064 1.746 . . . . 0.0 113.817 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.89 -74.14 0.6 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.745 1.618 . . . . 0.0 110.183 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.8 tp -88.66 147.32 24.59 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.896 0.878 . . . . 0.0 110.701 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 11.3 mtp -149.0 113.97 5.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -138.1 172.3 13.12 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.978 2.111 . . . . 0.0 108.474 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.41 124.74 28.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.623 0.769 . . . . 0.0 112.86 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.3 mp -111.15 7.85 21.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.085 0.954 . . . . 0.0 111.166 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -97.57 -23.12 16.14 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -102.29 128.17 28.98 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.167 0.987 . . . . 0.0 108.913 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.67 -14.85 27.28 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.657 2.238 . . . . 0.0 114.32 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -59.01 -41.75 88.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.851 1.261 . . . . 0.0 113.397 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -79.83 -41.11 27.06 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.065 0.46 . . . . 0.0 111.767 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.4 p -69.93 -24.59 63.39 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.746 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -53.3 -63.02 2.75 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -61.69 -14.71 37.56 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.109 1.872 . . . . 0.0 115.076 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.4 tp -78.56 -63.83 1.32 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.8 pt -63.05 -32.61 56.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.825 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.421 ' HB1' ' HD3' ' A' ' 256' ' ' LYS . . . -68.81 -14.36 62.98 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.528 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -52.94 -45.37 67.64 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.927 1.239 . . . . 0.0 113.603 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.67 -43.82 98.13 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 172.33 43.15 0.04 OUTLIER Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.952 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -99.55 155.51 19.79 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -160.73 119.26 2.54 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 118.278 1.039 . . . . 0.0 109.019 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.95 84.31 7.48 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 70.05 105.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.754 2.421 . . . . 0.0 107.874 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -72.25 134.78 45.78 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.636 -0.665 . . . . 0.0 109.314 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -131.65 120.05 22.27 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 173' ' ' ASN . 5.6 tt0 -102.78 -159.15 0.71 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.584 1.154 . . . . 0.0 108.428 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.491 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 78.5 m-20 -66.84 78.63 0.12 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.66 1.984 . . . . 0.0 110.708 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.66 10.91 84.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.269 0.938 . . . . 0.0 112.597 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -112.15 103.46 11.63 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.34 113.24 18.58 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -131.07 100.7 5.31 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.93 -9.38 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -69.48 -29.34 66.98 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.891 -1.131 . . . . 0.0 108.324 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -75.29 75.29 2.41 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.606 1.563 . . . . 0.0 110.863 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.7 t -97.11 113.82 32.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 126.414 1.886 . . . . 0.0 108.737 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -109.32 96.1 0.94 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 45.8 t -138.38 -43.47 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 117.822 0.811 . . . . 0.0 109.579 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -108.84 77.04 1.05 Allowed 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -128.97 163.1 26.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.778 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -50.03 -41.52 47.62 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.2 1.4 . . . . 0.0 113.197 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.95 -43.41 95.99 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.581 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.6 -51.35 65.69 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.432 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -58.78 -36.64 74.76 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.135 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.23 -38.61 87.27 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.212 0.915 . . . . 0.0 110.386 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -82.43 -26.54 46.82 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.82 -0.55 . . . . 0.0 112.826 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.5 tp -76.29 -41.82 47.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.08 -1.247 . . . . 0.0 107.792 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 7.4 t -65.08 -27.62 68.9 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.987 0.812 . . . . 0.0 109.065 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -58.19 -52.06 67.13 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.96 -46.24 88.54 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.764 1.226 . . . . 0.0 110.144 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 42.7 t -60.58 -38.91 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 117.639 -1.172 . . . . 0.0 110.506 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.517 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 14.2 t0 -56.6 -50.11 72.96 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.213 1.405 . . . . 0.0 114.009 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.11 -38.7 91.54 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.548 0.689 . . . . 0.0 109.693 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.17 -31.8 51.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -63.76 -44.7 92.66 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 126.125 1.77 . . . . 0.0 107.887 178.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -71.97 -10.92 60.46 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.377 0.671 . . . . 0.0 109.424 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt 60.96 15.6 6.23 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 128.175 2.59 . . . . 0.0 112.513 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -83.08 -14.04 54.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.04 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.24 124.98 52.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.813 1.645 . . . . 0.0 110.028 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.65 84.66 0.29 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.745 2.018 . . . . 0.0 110.69 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -58.53 -16.53 15.88 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.549 1.94 . . . . 0.0 115.011 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.08 -7.08 54.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.252 1.821 . . . . 0.0 114.097 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.3 m -60.99 134.48 57.14 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 118.941 0.791 . . . . 0.0 110.408 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.0 -178.43 4.18 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.542 1.937 . . . . 0.0 107.08 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -57.89 -38.56 76.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.391 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -55.38 26.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.321 1.048 . . . . 0.0 110.456 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.22 -45.13 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 123.57 0.748 . . . . 0.0 110.38 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.45 -51.13 67.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.724 0.693 . . . . 0.0 110.816 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -63.35 -43.97 96.17 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.82 1.191 . . . . 0.0 110.313 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.09 -55.77 30.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.06 0.544 . . . . 0.0 109.548 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.84 -46.07 74.58 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.56 1.144 . . . . 0.0 110.425 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -58.42 -44.19 88.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.24 0.616 . . . . 0.0 109.429 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.46 -21.73 66.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.689 0.795 . . . . 0.0 112.203 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -91.97 -10.64 38.64 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.665 0.786 . . . . 0.0 110.008 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.82 18.44 70.2 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -80.78 0.72 33.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.947 1.299 . . . . 0.0 113.745 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 27.3 p -124.04 149.79 45.69 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.532 1.133 . . . . 0.0 108.184 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.3 -21.31 19.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.264 0.625 . . . . 0.0 111.469 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 14.0 ptt? -158.28 157.48 32.58 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.8 t -150.89 171.38 17.34 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 122.535 1.16 . . . . 0.0 109.792 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 5.9 mt . . . . . 0 N--CA 1.443 -0.824 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.262 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.543 0.679 0 CA-C-O 118.869 -0.586 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.07 -84.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.834 3.023 . . . . 0.0 111.073 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . 0.292 0.5 OUTLIER 92.38 -164.69 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.483 3.113 . . . . 0.0 108.052 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.27 131.83 47.11 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.02 120.31 7.25 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.52 -0.738 . . . . 0.0 109.181 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.91 -7.12 56.83 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.511 -1.16 . . . . 0.0 113.928 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.39 102.65 14.03 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.317 2.059 . . . . 0.0 109.801 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.78 143.49 21.1 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.223 1.948 . . . . 0.0 113.606 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.2 m -68.66 159.56 31.87 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.148 0.979 . . . . 0.0 109.234 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.421 ' HD3' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -129.08 55.72 19.85 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.61 161.65 34.58 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 121.788 1.659 . . . . 0.0 111.406 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.233 0.236 0 CA-C-O 121.604 0.716 . . . . 0.0 111.142 179.587 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.633 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.43 172.22 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 119.403 1.601 . . . . 0.0 111.545 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 34.5 tp -84.41 156.52 21.77 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.055 -1.653 . . . . 0.0 107.569 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.7 m -131.76 137.17 48.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 120.481 1.492 . . . . 0.0 109.001 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -115.24 130.67 56.98 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.349 1.059 . . . . 0.0 109.513 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.14 170.59 21.73 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.308 1.432 . . . . 0.0 111.804 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 76.3 mt -119.19 134.72 61.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -68.09 122.54 18.48 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.61 -10.78 60.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.412 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -95.13 7.33 46.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.84 0.856 . . . . 0.0 112.459 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.5 m -69.33 157.49 89.25 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.418 1.087 . . . . 0.0 108.712 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.13 -50.82 2.55 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.906 1.737 . . . . 0.0 111.005 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -135.5 100.36 4.48 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -19.68 49.31 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.47 -0.769 . . . . 0.0 112.437 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -64.63 -32.9 74.76 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.049 0.386 . . . . 0.0 110.123 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.87 -38.63 79.23 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.379 -0.825 . . . . 0.0 108.897 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.66 -42.29 42.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 117.903 -1.046 . . . . 0.0 111.671 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -41.3 91.99 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.3 0.954 . . . . 0.0 108.788 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -66.94 -50.93 60.79 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 124.619 1.199 . . . . 0.0 109.434 -177.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -53.22 -51.69 61.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.194 -0.431 . . . . 0.0 110.335 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 2.2 mp -63.11 -48.04 80.22 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.332 6.7 pt-20 -78.74 -4.35 48.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -177.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -108.45 -19.45 13.45 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.311 1.414 . . . . 0.0 112.211 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -135.61 -53.3 0.77 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.789 1.177 . . . . 0.0 110.735 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 0.2 OUTLIER -48.61 -48.04 39.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.753 0.821 . . . . 0.0 112.515 -179.345 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.66 29.03 0.93 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.948 2.099 . . . . 0.0 114.505 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 19.4 p -116.29 165.18 13.47 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 120.411 1.459 . . . . 0.0 108.097 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.66 -44.06 85.41 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.46 -33.63 75.53 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.506 0.722 . . . . 0.0 112.787 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.53 -46.08 12.58 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 51.8 mt -62.52 -47.12 85.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -57.78 -44.49 86.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.678 1.191 . . . . 0.0 110.647 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.0 -46.78 71.84 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 117.93 0.332 . . . . 0.0 110.963 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.65 -40.32 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 117.047 -1.454 . . . . 0.0 109.723 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -63.15 -34.33 77.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.311 0.959 . . . . 0.0 112.754 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -63.49 -61.34 2.39 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.8 -48.33 80.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 117.219 -1.372 . . . . 0.0 112.387 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -137.7 150.47 68.13 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 121.509 1.959 . . . . 0.0 109.137 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.77 101.95 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.254 1.969 . . . . 0.0 114.21 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 7.8 mt -76.03 -32.86 59.55 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 123.608 0.763 . . . . 0.0 109.731 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 80.87 -115.64 4.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.95 160.8 14.01 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.206 1.003 . . . . 0.0 111.698 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.16 162.7 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 124.479 1.112 . . . . 0.0 110.179 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.36 -29.44 22.95 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 28.0 tp -65.07 104.07 0.83 Allowed 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.749 0.82 . . . . 0.0 111.166 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -49.53 -33.43 14.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.143 1.377 . . . . 0.0 112.482 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.3 t -62.53 -57.46 11.07 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.877 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -78.19 -20.72 51.33 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.923 1.238 . . . . 0.0 111.262 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -57.6 -43.13 84.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.25 -13.02 46.72 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.005 0.82 . . . . 0.0 113.207 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -94.12 -37.54 11.55 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 63.2 mt -74.95 -26.02 59.3 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.515 -1.366 . . . . 0.0 109.035 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.87 -1.63 7.7 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.544 1.538 . . . . 0.0 112.918 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -65.11 -19.45 65.99 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.807 0.843 . . . . 0.0 110.846 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -120.36 131.95 24.28 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 124.526 1.13 . . . . 0.0 108.189 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -59.84 -15.05 30.18 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.215 2.61 . . . . 0.0 116.368 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -66.5 -39.5 88.75 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 121.93 2.15 . . . . 0.0 108.602 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.7 mp -70.77 -46.38 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.43 -49.54 72.15 Favored 'General case' 0 C--O 1.222 -0.395 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.166 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.17 -37.55 77.62 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.085 -1.009 . . . . 0.0 112.101 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 55.1 m -61.06 -39.1 88.59 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -81.35 -37.23 28.63 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 123.585 0.754 . . . . 0.0 111.434 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -55.17 -37.35 66.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.134 0.973 . . . . 0.0 108.837 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -63.9 -38.54 91.48 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.471 0 C-N-CA 123.385 0.674 . . . . 0.0 110.171 178.168 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo . . . . . 0 N--CA 1.453 -0.888 0 N-CA-C 108.374 -1.433 . . . . 0.0 108.374 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -120.81 23.49 10.7 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.0 pt -137.8 141.37 32.66 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 118.953 0.797 . . . . 0.0 110.454 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.82 -9.94 27.3 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 124.001 3.134 . . . . 0.0 113.82 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -64.69 -24.05 67.45 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.417 1.087 . . . . 0.0 109.539 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 91.1 mmm -58.99 -22.39 60.47 Favored 'General case' 0 C--N 1.342 0.247 0 O-C-N 120.744 -1.222 . . . . 0.0 113.571 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 80.4 p -64.24 -33.11 75.06 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.369 1.44 . . . . 0.0 108.821 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.5 -41.97 65.35 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 121.247 -0.908 . . . . 0.0 108.894 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -49.96 -57.08 8.26 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.081 0.952 . . . . 0.0 109.584 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -64.02 -35.4 80.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -68.07 -37.43 81.24 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.158 0.583 . . . . 0.0 111.671 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.52 -55.16 6.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.868 2.067 . . . . 0.0 112.496 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 67.3 t -57.33 -33.55 43.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.378 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -54.63 -58.38 7.74 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.747 1.158 . . . . 0.0 108.859 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.4 m -61.38 -37.32 82.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.984 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.13 82.37 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 121.003 1.729 . . . . 0.0 111.403 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 75.2 t -58.82 -56.46 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.5 mm -61.21 -32.94 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.2 0.6 . . . . 0.0 111.803 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.44 -52.72 62.42 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.638 -1.288 . . . . 0.0 110.158 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.23 -43.68 64.04 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.217 0.607 . . . . 0.0 111.233 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -56.38 -41.6 76.51 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.306 1.042 . . . . 0.0 111.246 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.8 m -85.09 -17.48 37.22 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.443 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.5 28.48 47.7 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 123.583 0.611 . . . . 0.0 112.314 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -81.84 -27.63 33.46 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.735 -0.862 . . . . 0.0 109.976 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -142.7 151.52 41.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.6 m -58.95 153.82 16.63 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.014 0.926 . . . . 0.0 109.485 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 90.5 t -52.56 -56.26 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.224 1.009 . . . . 0.0 110.133 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.1 -49.06 74.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.213 1.405 . . . . 0.0 110.825 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -68.65 -25.57 64.89 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.93 83.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 74.9 mt -68.35 -43.5 77.35 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -50.54 -51.82 44.44 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.293 1.437 . . . . 0.0 109.536 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -54.42 -43.46 71.56 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.324 1.849 . . . . 0.0 110.757 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.437 ' O ' HD12 ' A' ' 368' ' ' ILE . . . -68.86 -50.75 47.15 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 118.725 -0.655 . . . . 0.0 109.488 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -52.01 -38.71 57.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.757 1.223 . . . . 0.0 108.773 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.2 m -59.68 -54.3 47.96 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.953 1.301 . . . . 0.0 108.283 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -58.56 -39.95 81.7 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.764 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.437 HD12 ' O ' ' A' ' 364' ' ' ALA . 1.6 mp -66.93 -41.55 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.074 0.852 . . . . 0.0 109.653 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 38.7 p -80.32 -11.66 59.69 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 36.3 tttm . . . . . 0 C--O 1.245 0.82 0 C-N-CA 126.036 1.734 . . . . 0.0 108.45 178.661 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.95 103.28 15.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.55 21.37 0.31 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.333 0.968 . . . . 0.0 114.344 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -143.56 155.55 44.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.721 1.76 . . . . 0.0 113.126 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.9 mt -137.72 151.37 48.14 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.101 1.76 . . . . 0.0 108.328 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 77.2 t -138.92 132.42 39.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 125.501 1.52 . . . . 0.0 108.431 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.7 mt -129.15 134.27 64.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.652 1.181 . . . . 0.0 108.116 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -118.68 157.22 27.87 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.957 1.303 . . . . 0.0 109.369 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.0 pt -144.97 165.63 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 125.631 1.572 . . . . 0.0 108.252 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -68.88 -33.29 73.55 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.014 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.19 -73.17 0.31 Allowed Glycine 0 C--N 1.342 0.876 0 C-N-CA 123.68 0.657 . . . . 0.0 113.37 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -70.85 26.9 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 129.424 3.089 . . . . 0.0 116.134 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -75.21 -45.79 38.1 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 125.123 1.369 . . . . 0.0 114.615 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.0 42.46 0.72 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 126.841 2.163 . . . . 0.0 111.96 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.525 ' CE1' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -56.68 -16.93 7.21 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -178.692 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -52.62 -45.14 66.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 121.826 2.103 . . . . 0.0 112.056 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.09 -40.22 35.32 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 121.435 0.464 . . . . 0.0 112.032 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.604 ' HA ' HG22 ' A' ' 293' ' ' VAL . 33.1 tp -64.77 -36.86 85.67 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.771 1.228 . . . . 0.0 114.242 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.37 64.55 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.675 0.79 . . . . 0.0 111.051 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -59.62 -33.99 72.21 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.96 -40.86 90.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.97 -34.99 83.37 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -68.58 -47.39 66.9 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 118.752 1.276 . . . . 0.0 108.322 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.05 -59.39 4.81 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.378 1.071 . . . . 0.0 109.101 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -56.5 -44.95 81.22 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.881 -0.581 . . . . 0.0 111.31 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -64.32 -16.38 62.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 120.395 1.452 . . . . 0.0 111.929 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -96.86 -16.36 20.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 117.295 -1.336 . . . . 0.0 112.708 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -106.54 -37.59 6.42 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 124.791 1.307 . . . . 0.0 110.434 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.3 p -101.15 -34.0 9.87 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.147 -0.97 . . . . 0.0 110.739 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.06 -11.79 67.37 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 121.146 -0.971 . . . . 0.0 113.396 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.0 132.9 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -67.51 150.03 49.39 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.161 -0.962 . . . . 0.0 109.677 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.9 t -140.49 97.78 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.585 1.554 . . . . 0.0 108.976 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.7 m -77.14 153.48 34.17 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.525 HG22 ' CE1' ' A' ' 17' ' ' TYR . 2.3 t -138.55 110.62 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 104.224 -2.509 . . . . 0.0 104.224 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -135.14 161.55 35.01 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -127.26 61.01 46.27 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.463 1.505 . . . . 0.0 113.969 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.46 143.24 38.23 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.424 1.416 . . . . 0.0 110.35 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -97.2 21.6 9.71 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.4 3.09 2.1 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.93 -22.75 5.96 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.005 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -48.84 -34.56 12.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.442 1.497 . . . . 0.0 112.096 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -122.32 -24.42 5.04 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.109 0.963 . . . . 0.0 111.937 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.78 -39.25 76.73 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.008 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -55.96 -59.53 11.39 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 119.988 1.267 . . . . 0.0 109.259 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.05 -29.4 89.16 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 CA-C-N 120.909 1.36 . . . . 0.0 113.916 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -77.23 0.49 21.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.101 1.319 . . . . 0.0 113.645 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.43 HG12 ' C ' ' A' ' 55' ' ' ASP . 3.7 t -131.73 -32.97 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.76 -26.65 60.76 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.837 -1.165 . . . . 0.0 110.053 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.86 -30.66 65.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.787 -0.571 . . . . 0.0 109.803 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 p -90.94 -16.45 28.06 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.351 1.06 . . . . 0.0 112.834 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 96.96 26.19 10.64 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-O 118.178 -1.346 . . . . 0.0 116.388 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.43 ' C ' HG12 ' A' ' 50' ' ' VAL . 57.2 m-20 -131.01 5.91 4.56 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.828 1.314 . . . . 0.0 110.084 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.1 -178.54 47.43 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.447 1.499 . . . . 0.0 114.941 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.34 169.78 9.0 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.416 2.077 . . . . 0.0 109.938 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -105.71 -16.8 14.58 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -139.38 145.66 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.45 144.8 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.691 1.196 . . . . 0.0 108.955 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -129.49 108.63 10.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.933 1.693 . . . . 0.0 110.429 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -152.41 -174.53 4.93 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.174 -0.954 . . . . 0.0 110.869 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.03 158.04 36.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.816 1.246 . . . . 0.0 108.558 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -63.8 -25.75 68.32 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.376 -0.203 . . . . 0.0 111.322 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.48 -62.01 2.2 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 126.027 1.731 . . . . 0.0 111.398 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -61.5 -19.88 62.57 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.492 0.717 . . . . 0.0 112.601 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -78.93 -20.75 48.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.789 -0.624 . . . . 0.0 111.896 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.56 -39.57 95.19 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.13 -50.5 5.79 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.765 1.174 . . . . 0.0 111.613 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -55.41 -42.66 74.4 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.422 1.111 . . . . 0.0 112.215 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.92 -43.13 79.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.639 0.654 . . . . 0.0 110.451 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -55.01 -50.8 68.13 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.487 1.115 . . . . 0.0 108.81 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 m -63.85 -5.11 3.85 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.319 1.848 . . . . 0.0 113.505 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.17 10.33 86.18 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.36 1.457 . . . . 0.0 113.392 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.7 mt -73.18 -18.95 61.21 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.305 1.053 . . . . 0.0 110.851 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.71 146.15 26.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.96 0.8 . . . . 0.0 109.949 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -93.1 -178.9 4.93 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.684 1.994 . . . . 0.0 110.321 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -72.43 128.61 36.14 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.623 1.569 . . . . 0.0 107.629 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.15 159.19 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.836 0.744 . . . . 0.0 110.67 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 m 47.27 75.03 0.71 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.468 2.307 . . . . 0.0 113.517 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -67.06 -45.13 4.25 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.0 1.8 . . . . 0.0 111.878 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -94.15 132.81 38.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.071 1.348 . . . . 0.0 112.019 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -65.13 -31.63 72.93 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.83 -36.41 64.97 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 121.081 1.764 . . . . 0.0 112.137 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -59.82 -30.78 69.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.783 0.719 . . . . 0.0 110.772 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -70.35 -29.83 66.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.99 -1.068 . . . . 0.0 112.124 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -78.39 -21.55 49.19 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.352 0.661 . . . . 0.0 111.47 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -69.44 -12.51 61.71 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.176 -0.953 . . . . 0.0 111.672 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.458 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 11.0 mt -120.61 164.04 17.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.127 1.771 . . . . 0.0 111.555 -177.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -66.2 160.65 63.15 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.73 -49.3 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.66 2.24 . . . . 0.0 112.491 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -51.78 -41.08 61.38 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.856 0.862 . . . . 0.0 113.229 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -28.12 65.54 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.495 -0.753 . . . . 0.0 111.177 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.458 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 73.9 m95 -78.03 -46.57 20.57 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -21.22 23.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.252 1.021 . . . . 0.0 112.507 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.15 -28.9 57.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.488 1.515 . . . . 0.0 111.085 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.71 0.64 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.531 1.532 . . . . 0.0 113.056 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -65.27 162.87 16.46 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.862 0.756 . . . . 0.0 109.515 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -145.51 176.84 9.3 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.283 1.833 . . . . 0.0 107.256 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -55.09 104.47 0.12 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.451 1.1 . . . . 0.0 109.186 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.16 -85.12 0.31 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 125.161 1.362 . . . . 0.0 111.317 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 170.09 4.29 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.711 1.604 . . . . 0.0 112.5 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -98.91 169.97 9.07 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.452 1.501 . . . . 0.0 108.531 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.7 pt -135.55 -37.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.37 172.34 14.58 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.914 1.686 . . . . 0.0 108.419 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.66 149.81 69.28 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.359 0.664 . . . . 0.0 111.352 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.22 140.84 38.1 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 124.645 3.563 . . . . 0.0 110.902 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.3 mm -121.04 -45.5 2.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 124.853 1.261 . . . . 0.0 112.808 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.43 161.53 37.82 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.891 0.876 . . . . 0.0 109.63 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.65 107.37 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.871 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 C-N-CA 126.561 1.944 . . . . 0.0 106.703 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 N--CA 1.454 -0.809 0 N-CA-C 110.214 -0.725 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -100.37 -38.48 8.42 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.824 1.25 . . . . 0.0 112.677 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 t -157.22 157.17 33.84 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.585 1.084 . . . . 0.0 110.881 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -58.29 -30.42 66.62 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 118.334 -0.841 . . . . 0.0 113.12 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -66.36 -14.48 62.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.504 1.047 . . . . 0.0 112.052 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -101.63 -18.74 15.74 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.012 1.325 . . . . 0.0 111.239 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 26.1 mm -49.99 -56.24 18.94 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 120.736 1.607 . . . . 0.0 111.501 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.1 -20.07 25.54 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 CA-C-N 119.88 0.993 . . . . 0.0 112.557 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.65 -34.48 46.37 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 124.932 1.293 . . . . 0.0 111.453 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.8 -31.39 28.21 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.59 1.556 . . . . 0.0 108.55 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -59.43 -44.07 92.95 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.325 0.65 . . . . 0.0 109.625 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -65.51 -31.26 72.23 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 122.839 0.456 . . . . 0.0 111.319 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -69.79 -47.27 63.49 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 146' ' ' ALA . 26.7 mt -66.57 -32.85 74.46 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.627 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -70.68 -27.73 64.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.098 0.863 . . . . 0.0 110.076 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.84 -27.79 63.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 118.219 0.463 . . . . 0.0 110.481 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.1 -1.42 20.42 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.377 0.671 . . . . 0.0 112.569 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -177.22 -101.6 0.15 Allowed Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 118.989 0.813 . . . . 0.0 112.36 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -137.23 -179.5 5.76 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.942 2.097 . . . . 0.0 109.208 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 p -51.59 172.27 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.438 1.895 . . . . 0.0 115.569 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.459 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -106.19 -55.46 2.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.755 1.622 . . . . 0.0 112.343 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.4 tp -133.1 146.39 51.6 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.814 1.246 . . . . 0.0 110.844 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 90.2 mtp -146.1 127.99 15.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -149.27 166.84 27.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.17 136.73 33.08 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.57 -4.58 9.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.165 0.986 . . . . 0.0 108.912 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -65.56 -19.99 66.15 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 125.297 1.439 . . . . 0.0 110.823 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -127.8 143.14 46.55 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.094 0.958 . . . . 0.0 109.493 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -72.49 -12.75 27.36 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.095 3.197 . . . . 0.0 114.121 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -51.41 -45.76 62.67 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.276 0.944 . . . . 0.0 111.948 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.12 -37.71 19.93 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-O 119.157 -0.449 . . . . 0.0 112.128 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.0 p -72.93 -14.03 61.38 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.102 0.864 . . . . 0.0 111.448 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -53.84 -63.05 2.91 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.574 1.149 . . . . 0.0 111.866 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.14 -6.18 10.92 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.226 1.951 . . . . 0.0 114.325 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 28.2 tp -82.5 -62.88 1.49 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.448 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 12.5 pt -58.77 -42.2 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.35 2.61 3.65 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.59 -37.07 82.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -86.86 -48.52 8.11 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.43 1.014 . . . . 0.0 108.606 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.71 63.55 0.07 OUTLIER Glycine 0 C--N 1.336 0.553 0 CA-C-N 118.964 0.802 . . . . 0.0 113.632 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -117.18 140.42 15.82 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 105.835 -2.906 . . . . 0.0 105.835 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -151.36 151.32 31.58 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.298 1.549 . . . . 0.0 109.315 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.13 -65.21 1.0 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -136.71 150.35 48.4 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.624 0.77 . . . . 0.0 111.056 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -86.03 149.9 24.84 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -150.85 106.2 3.35 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.73 57.31 4.43 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.734 1.614 . . . . 0.0 112.276 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 49.99 16.39 0.23 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.092 2.157 . . . . 0.0 116.522 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.41 -15.34 0.06 OUTLIER Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.392 0.996 . . . . 0.0 112.282 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -117.67 130.54 56.41 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -126.7 131.17 51.44 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 124.944 1.402 . . . . 0.0 108.315 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.2 146.48 33.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.144 0.973 . . . . 0.0 109.955 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -0.71 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.827 1.651 . . . . 0.0 110.749 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -80.1 -37.4 33.8 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -81.93 100.71 9.81 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.22 150.65 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.419 1.487 . . . . 0.0 109.889 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.52 16.17 5.42 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.032 0.825 . . . . 0.0 115.149 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.0 t -54.83 -33.24 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.181 1.792 . . . . 0.0 115.01 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.61 14.48 12.69 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.27 0.628 . . . . 0.0 111.68 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -62.18 164.93 6.29 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.437 0.636 . . . . 0.0 110.1 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -50.95 -34.63 29.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.953 0.901 . . . . 0.0 112.093 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.21 -47.01 47.18 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.968 0.804 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -55.89 -48.78 74.99 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.969 -0.724 . . . . 0.0 109.415 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -67.04 -40.42 87.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 117.726 -1.131 . . . . 0.0 111.025 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.55 -49.64 76.68 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.133 0.879 . . . . 0.0 111.563 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -71.55 -27.93 70.34 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.319 -0.944 . . . . 0.0 112.057 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 14.2 tp -77.35 -34.14 55.22 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.773 1.287 . . . . 0.0 112.355 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.4 t -55.9 -45.31 78.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 117.452 -1.261 . . . . 0.0 108.805 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -52.39 -53.91 38.86 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.271 1.428 . . . . 0.0 111.237 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.6 tt -54.12 -48.39 70.81 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.122 0.969 . . . . 0.0 111.278 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 38.6 t -73.41 -21.95 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.39 0.676 . . . . 0.0 110.492 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.419 ' HA ' ' CE ' ' A' ' 200' ' ' LYS . 2.8 t70 -63.37 -36.85 85.1 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.768 1.227 . . . . 0.0 109.749 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.8 mt -71.9 -41.73 67.59 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 79.5 mt -63.09 -39.48 85.38 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.419 ' CE ' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -54.71 -34.27 62.18 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.817 1.247 . . . . 0.0 109.769 178.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -91.47 -9.93 42.73 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.693 1.197 . . . . 0.0 111.906 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 64.82 6.53 3.38 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 128.735 2.814 . . . . 0.0 113.387 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -67.54 -36.22 80.56 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.541 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 8.4 tpt -77.96 154.07 31.91 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -88.43 91.18 8.7 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.459 -0.775 . . . . 0.0 110.573 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.3 -28.93 70.05 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.376 -0.827 . . . . 0.0 112.49 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.11 -4.65 48.47 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.8 m -71.46 126.98 31.09 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.274 -1.516 . . . . 0.0 109.053 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.03 -178.08 3.86 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.863 1.665 . . . . 0.0 107.095 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -58.11 -37.74 75.12 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.093 0.557 . . . . 0.0 111.404 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 39.5 m -73.59 -40.1 64.12 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.54 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 19.4 mm -64.58 -50.99 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 120.839 1.654 . . . . 0.0 109.053 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -55.94 -44.06 78.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.854 0.752 . . . . 0.0 110.631 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -67.48 -40.69 85.26 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.555 0.742 . . . . 0.0 111.762 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.31 -56.51 8.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.699 0.8 . . . . 0.0 109.594 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.99 -39.44 66.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.415 1.486 . . . . 0.0 110.519 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -60.15 -45.93 91.39 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -64.06 -30.54 71.61 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.076 -0.488 . . . . 0.0 111.793 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -77.21 -11.38 59.82 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.969 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.97 19.82 49.34 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 125.174 1.369 . . . . 0.0 112.21 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.07 -48.76 19.58 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 118.385 1.093 . . . . 0.0 111.016 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -104.12 153.37 21.0 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -105.5 -25.38 12.34 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.676 0.79 . . . . 0.0 110.322 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -129.07 170.04 13.99 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.625 1.17 . . . . 0.0 109.716 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.7 t -161.06 178.92 8.86 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.182 1.793 . . . . 0.0 107.169 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.1 mt . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 179.457 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.239 0.528 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.0 123.52 10.1 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.418 2.079 . . . . 0.0 109.207 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.5 p -100.53 169.28 9.17 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -77.85 167.11 22.03 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -51.35 104.64 0.08 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 126.003 1.721 . . . . 0.0 110.249 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.52 8.21 44.69 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 117.97 -1.461 . . . . 0.0 116.556 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.59 124.25 10.35 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 121.569 2.685 . . . . 0.0 112.193 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.51 123.25 8.49 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.215 3.276 . . . . 0.0 113.576 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 20.0 m -62.37 159.06 16.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.578 1.151 . . . . 0.0 111.621 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -147.35 100.53 3.83 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.902 1.281 . . . . 0.0 111.172 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -69.97 -63.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.693 0 N-CA-C 107.274 -1.856 . . . . 0.0 107.274 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 . . . . . 0 CA--C 1.545 0.767 0 C-N-CA 129.153 2.981 . . . . 0.0 106.702 178.906 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.696 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.46 140.49 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.9 tt -81.35 140.42 34.77 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.3 m -126.9 154.28 44.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 122.903 0.481 . . . . 0.0 111.286 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -132.67 146.2 51.68 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.153 0.981 . . . . 0.0 108.579 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -139.85 148.62 20.19 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 82.6 mt -95.12 137.36 23.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -72.13 133.5 45.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.046 0.385 . . . . 0.0 110.296 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -79.29 -25.11 42.5 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.031 -0.985 . . . . 0.0 113.33 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ALA . . . . . 0.42 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -74.22 -12.69 60.64 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.531 1.06 . . . . 0.0 113.325 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 61.9 m -60.15 165.51 4.89 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.49 -41.23 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 CA-C-N 120.59 1.246 . . . . 0.0 110.58 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -122.71 168.55 12.07 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.717 1.607 . . . . 0.0 108.164 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -132.88 -26.73 1.73 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.199 1.399 . . . . 0.0 110.303 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -61.47 -40.1 93.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.32 -34.56 72.49 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.827 -1.171 . . . . 0.0 111.195 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.61 -45.43 37.46 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.134 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -36.54 83.96 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.784 0.72 . . . . 0.0 109.154 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -64.78 -46.11 83.46 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -60.84 -37.41 81.98 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 120.102 1.319 . . . . 0.0 108.175 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.3 mp -77.24 -0.05 23.82 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 117.63 -1.176 . . . . 0.0 114.019 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -137.58 2.31 2.44 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 120.867 1.667 . . . . 0.0 113.587 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.52 -55.94 3.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.949 1.249 . . . . 0.0 110.613 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -126.11 -29.25 3.06 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.784 1.634 . . . . 0.0 113.299 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -55.21 -35.1 64.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.486 1.039 . . . . 0.0 111.885 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.36 74.57 0.96 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.329 1.052 . . . . 0.0 108.41 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 22.9 p -137.11 163.39 30.92 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.19 -17.41 63.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.25 1.82 . . . . 0.0 112.628 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -116.07 -36.56 4.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.602 1.561 . . . . 0.0 110.927 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.57 -31.04 59.18 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-O 118.846 -0.974 . . . . 0.0 110.883 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 29.7 mt -73.34 -41.79 63.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 119.577 1.689 . . . . 0.0 106.631 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -56.13 -47.32 78.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.555 1.142 . . . . 0.0 110.667 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.75 -29.44 64.8 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' A' ' 20' ' ' LEU . 48.5 t -91.08 -34.32 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 C-N-CA 124.477 1.111 . . . . 0.0 110.119 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -62.13 -30.4 71.0 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.067 0.849 . . . . 0.0 110.158 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -61.92 -17.81 58.09 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.969 0.908 . . . . 0.0 111.216 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -122.4 -76.27 0.59 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -61.66 142.69 94.33 Favored Pre-proline 0 C--O 1.234 0.272 0 O-C-N 121.189 -0.944 . . . . 0.0 111.457 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.08 93.1 1.03 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 N-CA-C 106.415 -2.186 . . . . 0.0 106.415 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.3 mt -77.23 -19.58 56.43 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 117.234 -1.365 . . . . 0.0 111.16 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 55.12 -138.98 41.89 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -85.75 165.57 16.8 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.42 155.56 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 O-C-N 120.306 -1.496 . . . . 0.0 110.814 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.52 70.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.111 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.21 101.05 0.26 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.872 1.269 . . . . 0.0 111.089 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -65.37 -20.73 66.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.785 178.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.91 -21.62 62.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.011 0.924 . . . . 0.0 111.494 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -113.6 -11.13 13.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.977 1.262 . . . . 0.0 110.559 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -59.86 -41.78 92.23 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.451 1.1 . . . . 0.0 108.355 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.88 -17.02 61.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.917 1.287 . . . . 0.0 112.817 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -95.96 -52.61 3.98 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.444 ' HB3' HG21 ' A' ' 317' ' ' ILE . 8.5 mt -56.62 -38.71 72.45 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.479 -0.763 . . . . 0.0 110.906 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.59 -6.66 5.58 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.262 1.425 . . . . 0.0 114.121 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -63.23 -13.61 39.75 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.4 1.08 . . . . 0.0 111.439 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -123.66 139.54 32.39 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.27 1.028 . . . . 0.0 109.255 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.47 -20.28 48.26 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.908 2.405 . . . . 0.0 112.941 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -63.93 -24.65 67.81 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.737 0.699 . . . . 0.0 112.684 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' A' ' 311' ' ' LEU . 2.3 mp -96.09 -56.84 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.39 -51.77 10.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.318 1.047 . . . . 0.0 112.576 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.23 -42.76 91.8 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.616 -0.678 . . . . 0.0 112.334 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 14.5 m -66.57 -34.19 77.35 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -53.76 43.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -55.49 -36.14 66.33 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.494 0.718 . . . . 0.0 111.432 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -67.7 -31.05 70.74 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.796 0.839 . . . . 0.0 111.128 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.368 0 O-C-N 121.595 -0.691 . . . . 0.0 109.667 178.038 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo . . . . . 0 CA--C 1.535 0.569 0 N-CA-C 114.444 0.902 . . . . 0.0 114.444 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -133.18 5.42 3.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.161 1.784 . . . . 0.0 112.277 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.6 pt -89.1 144.56 32.81 Favored Pre-proline 0 CA--C 1.537 0.452 0 O-C-N 121.233 -0.917 . . . . 0.0 109.287 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.01 -12.71 32.94 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.108 2.539 . . . . 0.0 114.398 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.57 -20.89 35.32 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.277 1.031 . . . . 0.0 111.792 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.0 mmm -62.06 -24.76 67.29 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.341 -0.849 . . . . 0.0 110.58 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 61.0 p -63.75 -28.16 69.69 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.768 -1.208 . . . . 0.0 110.05 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -90.45 -30.66 17.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.808 1.643 . . . . 0.0 111.266 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 343' ' ' VAL . 56.6 t80 -53.68 -60.77 2.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.391 1.077 . . . . 0.0 109.124 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -56.85 -43.01 80.7 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.745 0.418 . . . . 0.0 111.215 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -60.85 -27.47 68.12 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.05 0.54 . . . . 0.0 111.952 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.404 ' HB3' HD11 ' A' ' 368' ' ' ILE . . . -81.12 -61.74 1.86 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.613 0.765 . . . . 0.0 110.538 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 339' ' ' PHE . 1.6 m -56.44 -25.84 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.364 0.666 . . . . 0.0 111.677 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -54.0 -56.8 14.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.967 0.907 . . . . 0.0 108.694 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 345' ' ' THR . . . . . 0.653 HG21 HH22 ' A' ' 367' ' ' ARG . 88.6 m -66.3 -38.35 87.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.186 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.04 77.05 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.47 -49.87 75.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 124.652 1.181 . . . . 0.0 109.024 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 32.7 mm -62.71 -38.55 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.148 0.886 . . . . 0.0 110.591 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -61.15 -41.91 97.6 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.122 -0.986 . . . . 0.0 110.774 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.35 -46.72 59.83 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 123.275 0.359 . . . . 0.0 110.328 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.93 98.34 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.703 1.201 . . . . 0.0 113.327 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 19.2 m -87.93 -1.32 57.91 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.659 0.783 . . . . 0.0 110.297 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 71.05 14.11 73.29 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-O 119.433 -0.649 . . . . 0.0 114.608 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -65.56 -26.97 68.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.541 1.171 . . . . 0.0 109.031 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -153.76 167.63 28.99 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.957 0.903 . . . . 0.0 109.65 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.6 m -72.26 156.14 39.44 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 39.6 t -54.95 -56.4 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.93 -51.47 40.78 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.641 2.376 . . . . 0.0 112.894 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -72.57 -32.69 66.23 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.86 71.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 24.6 mt -70.18 -43.35 70.97 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -51.76 -54.84 24.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.969 1.707 . . . . 0.0 108.178 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -52.31 -47.58 65.87 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.381 1.072 . . . . 0.0 109.317 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.92 -46.6 87.02 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 117.597 -1.192 . . . . 0.0 111.736 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.13 -39.78 72.75 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.406 1.003 . . . . 0.0 108.708 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 3.1 m -62.58 -25.08 67.89 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.184 0.993 . . . . 0.0 112.235 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.653 HH22 HG21 ' A' ' 345' ' ' THR . 93.2 mtt180 -83.07 -14.32 54.0 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.642 -1.287 . . . . 0.0 112.085 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.404 HD11 ' HB3' ' A' ' 342' ' ' ALA . 9.9 mt -105.85 -30.47 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.556 0.616 . . . . 0.0 109.426 -178.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 24.0 p -69.42 -37.87 77.63 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 27.6 tptt . . . . . 0 C--O 1.246 0.886 0 C-N-CA 126.371 1.868 . . . . 0.0 107.933 178.413 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -83.66 175.31 9.8 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.163 0.985 . . . . 0.0 108.684 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.64 35.62 86.59 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.374 1.464 . . . . 0.0 115.651 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -147.11 167.69 23.48 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 119.246 1.523 . . . . 0.0 112.658 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.0 mt -150.08 145.6 26.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.519 2.728 . . . . 0.0 105.664 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.445 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 50.4 t -139.56 134.68 39.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.9 mt -125.6 136.21 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.079 1.352 . . . . 0.0 110.092 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -127.07 154.66 44.41 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.0 pt -145.21 163.46 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 123.597 0.759 . . . . 0.0 111.348 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -0.95 2.27 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.52 -76.01 0.22 Allowed Glycine 0 C--N 1.332 0.354 0 CA-C-N 120.098 1.317 . . . . 0.0 112.438 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -63.26 17.11 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 130.121 3.369 . . . . 0.0 115.219 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -84.9 165.79 17.36 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.733 1.213 . . . . 0.0 112.309 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.02 83.14 1.6 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 103.466 -3.854 . . . . 0.0 103.466 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -95.59 -20.7 18.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -58.73 -42.05 87.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.699 1.136 . . . . 0.0 110.934 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.96 -41.39 40.91 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.6 tp -59.76 -43.13 94.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.08 0.94 . . . . 0.0 111.434 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.15 -38.8 71.34 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.881 -1.057 . . . . 0.0 111.17 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -60.0 -35.51 75.19 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.121 0.873 . . . . 0.0 111.852 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.6 -42.97 90.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.91 -39.98 96.9 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -63.34 -51.31 66.5 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 118.542 1.171 . . . . 0.0 108.695 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -53.71 -57.65 10.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.689 1.195 . . . . 0.0 108.544 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -58.01 -45.17 87.28 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.879 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -66.31 -8.29 24.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.036 1.289 . . . . 0.0 111.25 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -109.08 -8.28 15.19 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 119.994 -1.691 . . . . 0.0 112.657 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -110.79 -38.26 5.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.898 1.279 . . . . 0.0 108.801 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.9 p -104.16 -32.71 9.02 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.016 0.926 . . . . 0.0 111.249 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.47 -12.09 69.38 Favored Glycine 0 C--N 1.342 0.904 0 O-C-N 121.452 -0.78 . . . . 0.0 111.787 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.2 128.79 24.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -60.09 138.76 57.81 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.972 0.509 . . . . 0.0 111.22 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.05 119.73 17.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.8 m -114.62 148.88 37.48 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -137.29 113.64 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -130.67 166.06 21.52 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.144 0.977 . . . . 0.0 108.621 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -127.27 57.16 21.98 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.52 0.728 . . . . 0.0 111.65 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.09 149.77 65.22 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 N-CA-C 107.71 -1.688 . . . . 0.0 107.71 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -95.97 -37.23 10.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 121.245 -0.91 . . . . 0.0 108.656 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' CE ' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -65.44 -3.84 4.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.117 1.367 . . . . 0.0 111.816 178.901 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.11 -31.63 13.84 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.296 1.038 . . . . 0.0 109.417 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -50.0 -29.87 9.49 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.289 2.236 . . . . 0.0 112.433 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -125.5 -20.62 4.7 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.433 1.015 . . . . 0.0 110.569 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -73.65 -49.96 23.36 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 116.384 -1.77 . . . . 0.0 111.548 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -45.87 -57.58 7.76 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 120.114 1.325 . . . . 0.0 109.879 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.09 -18.11 63.47 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 N-CA-C 115.896 1.46 . . . . 0.0 115.896 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -92.34 -46.34 7.74 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.959 1.708 . . . . 0.0 112.289 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 t -69.45 -39.37 78.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 O-C-N 121.261 -0.899 . . . . 0.0 108.665 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.45 -16.34 61.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.402 -0.812 . . . . 0.0 110.847 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.34 7.43 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.072 0.949 . . . . 0.0 110.912 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -130.73 -39.6 1.24 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.764 2.026 . . . . 0.0 106.414 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.56 6.77 12.76 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 124.564 1.078 . . . . 0.0 114.737 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.45 -0.52 54.69 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.036 1.418 . . . . 0.0 111.238 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.73 -175.0 30.61 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 126.972 2.225 . . . . 0.0 116.529 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -67.35 -178.76 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.377 3.385 . . . . 0.0 112.0 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 9.9 m-20 -115.81 -20.03 10.21 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.538 HD11 ' HB1' ' A' ' 276' ' ' ALA . 17.5 mt -141.68 143.62 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.14 144.08 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.832 1.653 . . . . 0.0 108.144 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -131.28 114.66 15.3 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.836 1.654 . . . . 0.0 110.358 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -156.04 172.84 17.72 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.997 0.817 . . . . 0.0 111.538 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.43 149.31 50.61 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -55.6 -31.75 62.51 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.09 -12.76 61.97 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -109.44 -0.65 18.83 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.971 1.26 . . . . 0.0 109.544 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -92.88 -11.52 33.3 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.292 1.837 . . . . 0.0 112.225 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.62 -10.39 86.26 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.638 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.12 -60.61 1.17 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.087 1.327 . . . . 0.0 111.007 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -43.91 -44.14 6.89 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.543 1.537 . . . . 0.0 114.692 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -70.56 -41.5 72.36 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.085 0.857 . . . . 0.0 110.946 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -36.31 70.58 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.12 0.968 . . . . 0.0 109.003 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 m -67.99 -44.74 75.92 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.358 1.063 . . . . 0.0 108.697 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.77 -2.24 8.01 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.978 1.751 . . . . 0.0 113.345 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.0 mp -68.79 -11.0 59.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.514 1.657 . . . . 0.0 114.461 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 71' ' ' ALA . 76.5 mt -108.85 129.36 55.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.324 0.966 . . . . 0.0 108.511 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.84 167.22 13.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.172 1.789 . . . . 0.0 110.701 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -69.1 101.5 1.45 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.471 1.108 . . . . 0.0 109.656 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 pp -76.28 165.56 3.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 124.491 1.116 . . . . 0.0 111.424 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.4 m 48.08 97.71 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 128.581 2.752 . . . . 0.0 114.908 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.31 -22.95 21.3 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.916 2.411 . . . . 0.0 114.135 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -133.95 151.91 51.66 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -60.98 -32.68 72.24 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.5 1.52 . . . . 0.0 112.719 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.9 -42.12 65.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 120.07 1.305 . . . . 0.0 112.303 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.69 -30.72 71.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.886 0.475 . . . . 0.0 110.894 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -69.13 -37.42 78.31 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.142 -0.974 . . . . 0.0 111.379 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.26 -19.13 65.82 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.342 0.519 . . . . 0.0 111.484 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -79.08 -2.46 40.59 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.3 mt -130.38 151.6 50.69 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.329 1.052 . . . . 0.0 109.206 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -72.26 151.12 92.19 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 119.589 -0.845 . . . . 0.0 109.985 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.47 -45.47 3.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.282 3.322 . . . . 0.0 113.704 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -60.01 -33.51 72.09 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.428 1.013 . . . . 0.0 110.094 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.503 HG22 ' CB ' ' A' ' 107' ' ' PRO . 3.8 m -68.86 -36.19 77.83 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.806 0.843 . . . . 0.0 109.342 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -65.67 -45.18 83.88 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.141 0.977 . . . . 0.0 110.032 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.31 -33.71 13.88 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.438 1.495 . . . . 0.0 112.39 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.84 -35.27 22.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.207 1.403 . . . . 0.0 111.267 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.39 6.36 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.419 1.888 . . . . 0.0 113.328 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -69.02 156.67 38.23 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -138.5 175.59 9.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -62.97 111.18 2.05 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.596 0.758 . . . . 0.0 110.06 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.98 -77.76 0.67 Allowed Glycine 0 CA--C 1.522 0.514 0 C-N-CA 124.804 1.192 . . . . 0.0 114.169 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 166.03 22.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.06 0.944 . . . . 0.0 110.778 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.71 170.01 8.44 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.746 1.218 . . . . 0.0 110.052 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.1 pt -138.17 -35.42 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.72 176.93 11.54 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.235 1.414 . . . . 0.0 108.61 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -131.76 150.41 76.16 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.526 0.731 . . . . 0.0 110.94 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.503 ' CB ' HG22 ' A' ' 93' ' ' THR . 72.4 Cg_endo -72.57 151.95 53.37 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.591 2.86 . . . . 0.0 109.639 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mm -128.79 -45.09 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 123.972 0.909 . . . . 0.0 111.125 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.41 157.78 44.71 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 123.141 0.577 . . . . 0.0 112.007 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.7 t -132.4 100.15 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 C--O 1.237 0.428 0 C-N-CA 124.998 1.319 . . . . 0.0 107.754 178.789 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.2 p90 . . . . . 0 C--O 1.233 0.231 0 C-N-CA 124.788 1.235 . . . . 0.0 110.208 -178.56 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo . . . . . 0 N--CA 1.458 -0.609 0 N-CA-C 112.925 0.317 . . . . 0.0 112.925 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -126.5 -9.14 6.28 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 t -168.26 154.49 7.27 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.401 ' CE2' HD13 ' A' ' 160' ' ' LEU . 6.2 m95 -69.31 -18.94 63.88 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.947 -0.471 . . . . 0.0 111.061 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -75.43 -18.8 59.81 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.916 0.78 . . . . 0.0 110.291 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -87.22 -26.39 23.54 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.906 0.882 . . . . 0.0 109.783 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.1 mm -51.46 -60.43 5.87 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.0 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.83 -25.57 23.48 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 CA-C-N 120.631 1.261 . . . . 0.0 110.981 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.18 96.81 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.584 0.754 . . . . 0.0 109.227 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.9 tp -79.67 -27.89 40.78 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.705 1.202 . . . . 0.0 110.637 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -57.02 -46.36 82.41 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.788 0.722 . . . . 0.0 110.496 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -69.52 -28.48 66.07 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -74.37 -44.62 51.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.1 mt -72.2 -34.68 68.56 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 119.167 -0.444 . . . . 0.0 109.824 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -66.12 -32.34 73.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.81 -15.87 63.28 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 119.082 -0.485 . . . . 0.0 112.166 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.69 5.95 6.15 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.879 1.272 . . . . 0.0 112.832 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.21 -101.98 0.16 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 118.97 0.805 . . . . 0.0 111.329 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -139.42 -176.23 4.46 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.091 1.357 . . . . 0.0 111.519 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.23 162.13 2.17 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.416 1.486 . . . . 0.0 114.185 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.27 -45.32 8.28 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.723 1.209 . . . . 0.0 111.466 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.6 tp -124.88 149.67 47.29 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.571 1.549 . . . . 0.0 107.289 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.0 ttm -154.33 103.08 2.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -121.96 158.98 27.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.525 1.057 . . . . 0.0 111.112 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.477 HD22 ' HB2' ' A' ' 210' ' ' TYR . 62.4 t-20 -69.14 98.15 0.98 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.98 -11.74 60.01 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.808 0.843 . . . . 0.0 110.883 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -78.88 -23.52 44.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.962 1.305 . . . . 0.0 113.683 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -95.38 132.01 28.59 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 119.976 1.262 . . . . 0.0 110.772 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.29 -22.8 39.46 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 121.897 1.731 . . . . 0.0 114.468 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -68.97 -14.89 63.31 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.263 1.392 . . . . 0.0 113.104 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -95.82 -25.56 15.98 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.486 1.039 . . . . 0.0 109.066 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 p -88.7 -28.51 20.52 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.838 -1.164 . . . . 0.0 110.516 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -51.69 79.02 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 120.069 -1.644 . . . . 0.0 113.239 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.0 -5.03 12.54 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.857 1.705 . . . . 0.0 111.651 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.401 HD13 ' CE2' ' A' ' 129' ' ' TRP . 15.1 tp -85.76 -62.33 1.55 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . 0.27 0.2 OUTLIER -70.52 -27.59 31.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.391 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.56 -25.09 36.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.721 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -49.46 -47.3 48.4 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.174 1.39 . . . . 0.0 113.023 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -66.29 -45.37 80.64 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.456 0.702 . . . . 0.0 111.291 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -176.43 -26.04 0.03 OUTLIER Glycine 0 C--N 1.338 0.653 0 CA-C-O 117.255 -1.858 . . . . 0.0 115.937 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -42.01 133.06 4.11 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.204 1.383 . . . . 0.0 112.876 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -139.01 122.81 17.62 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.35 -55.1 37.62 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.64 -0.662 . . . . 0.0 112.043 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -140.41 145.17 36.69 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -71.65 139.44 49.25 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 121.648 -0.658 . . . . 0.0 111.683 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -141.84 138.17 31.97 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.367 -2.456 . . . . 0.0 104.367 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -110.36 -120.33 0.28 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.455 1.102 . . . . 0.0 108.555 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -111.03 53.85 0.69 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 128.252 2.621 . . . . 0.0 108.011 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.02 9.29 34.71 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.694 -1.059 . . . . 0.0 113.568 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -118.47 125.17 49.35 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -116.96 133.79 55.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.716 2.006 . . . . 0.0 106.933 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -138.91 110.4 7.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.787 0.803 . . . . 0.0 111.641 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -2.73 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.09 1.356 . . . . 0.0 112.493 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -93.42 -0.59 56.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.06 1.344 . . . . 0.0 111.73 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -127.17 106.18 9.07 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.975 1.71 . . . . 0.0 107.247 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 96.9 t -122.76 122.9 67.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.995 2.118 . . . . 0.0 109.81 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -107.69 54.95 0.54 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.84 1.21 . . . . 0.0 114.555 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -93.9 -50.42 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 123.415 0.686 . . . . 0.0 109.287 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -81.83 63.39 6.06 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.504 1.522 . . . . 0.0 107.457 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -124.14 152.25 43.02 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.138 0.975 . . . . 0.0 109.77 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.24 -40.73 67.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.544 1.138 . . . . 0.0 112.638 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.18 -31.36 77.3 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.129 -0.982 . . . . 0.0 112.566 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.05 -48.13 54.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.791 0.796 . . . . 0.0 109.213 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -63.42 -35.41 80.33 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.747 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -55.01 -55.44 30.84 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.823 0.849 . . . . 0.0 112.023 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -69.52 -29.9 71.32 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.401 HD23 HG13 ' A' ' 357' ' ' VAL . 41.4 tp -67.87 -46.53 71.44 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.136 -1.214 . . . . 0.0 109.803 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -34.21 63.9 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.97 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -60.15 -58.76 7.12 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.065 1.302 . . . . 0.0 109.651 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.9 -48.69 77.62 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.336 1.055 . . . . 0.0 110.102 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.19 -28.04 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 123.634 0.774 . . . . 0.0 110.664 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.42 -37.17 86.59 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 119.509 1.05 . . . . 0.0 111.855 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.4 mt -71.95 -40.52 68.63 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.39 -41.46 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.151 0.98 . . . . 0.0 108.365 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -54.59 -41.12 69.53 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.496 1.119 . . . . 0.0 108.956 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -86.45 -1.84 57.93 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.396 1.879 . . . . 0.0 113.133 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.2 mptt 57.7 6.55 0.45 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.049 2.539 . . . . 0.0 114.842 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -76.72 -10.7 59.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.121 0.873 . . . . 0.0 111.802 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.9 tpt -95.24 150.99 19.63 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.377 1.071 . . . . 0.0 109.735 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -88.31 67.06 8.61 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.39 -19.67 3.72 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.665 1.986 . . . . 0.0 115.676 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -86.27 0.71 53.21 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.952 2.101 . . . . 0.0 111.811 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 42.7 m -70.12 131.24 43.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.684 1.129 . . . . 0.0 109.768 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -127.6 -178.63 4.55 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.906 1.682 . . . . 0.0 106.612 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' TYR . . . . . 0.477 ' HB2' HD22 ' A' ' 150' ' ' ASN . 40.3 t80 -56.03 -46.82 78.72 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.324 0.65 . . . . 0.0 112.52 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 68.4 m -56.28 -49.49 74.07 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.484 1.114 . . . . 0.0 110.519 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 53.4 mt -64.09 -43.87 97.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.605 0.762 . . . . 0.0 109.429 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.86 -53.71 52.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.982 0.913 . . . . 0.0 112.592 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -65.36 -33.66 76.49 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.783 -0.573 . . . . 0.0 110.144 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.9 -51.39 64.73 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.83 -33.98 73.86 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.59 0.632 . . . . 0.0 111.129 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -65.6 -45.58 82.65 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 177.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -60.63 -35.17 75.5 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -69.45 -16.45 63.48 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.979 -1.01 . . . . 0.0 111.759 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.0 13.86 65.66 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 119.591 1.087 . . . . 0.0 111.645 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -84.23 -43.27 15.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.099 0.95 . . . . 0.0 112.47 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 58.4 p -75.48 107.72 7.8 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.234 0.47 . . . . 0.0 111.66 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.91 -26.37 66.83 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -146.51 158.12 43.85 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.878 1.671 . . . . 0.0 110.127 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 5.9 t -149.5 154.0 38.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--N 1.331 -0.212 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -179.2 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.77 132.25 24.54 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 120.506 1.216 . . . . 0.0 109.383 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 25.4 p -116.57 172.83 6.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.086 1.354 . . . . 0.0 109.347 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -84.65 169.36 14.4 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.576 0.703 . . . . 0.0 110.249 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -62.13 117.99 6.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.59 11.91 57.93 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.63 145.18 18.08 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-N 121.351 2.575 . . . . 0.0 111.71 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.04 171.7 17.01 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 124.305 3.337 . . . . 0.0 111.289 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.6 p -93.12 137.01 32.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -129.27 74.84 80.76 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.468 1.907 . . . . 0.0 109.217 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.08 -83.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.706 2.271 . . . . 0.0 109.893 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.439 0 C-N-CA 126.806 2.042 . . . . 0.0 107.866 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.455 0 N-CA-C 106.008 -2.837 . . . . 0.0 106.008 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.06 148.61 23.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 118.891 1.345 . . . . 0.0 112.083 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.0 tp -84.59 133.94 34.41 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.8 m -113.06 157.33 21.7 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.279 1.032 . . . . 0.0 111.595 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -135.5 138.5 43.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.476 1.11 . . . . 0.0 108.87 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.33 163.57 25.13 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 71.2 mt -109.57 142.66 21.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -74.18 116.08 14.41 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.51 -24.98 59.04 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.833 -0.604 . . . . 0.0 112.028 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -70.94 -9.46 57.9 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 118.195 -0.907 . . . . 0.0 113.302 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 6.9 t -62.56 144.24 95.89 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.4 -34.89 52.66 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.239 1.292 . . . . 0.0 109.887 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -141.73 109.53 5.74 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -14.53 63.02 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.691 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.6 -33.42 75.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.067 0.547 . . . . 0.0 111.05 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.38 -37.83 76.06 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.282 -0.886 . . . . 0.0 109.573 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.538 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -74.59 -45.94 41.92 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.777 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -34.41 78.06 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 118.862 -0.59 . . . . 0.0 110.114 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -73.29 -41.16 63.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.545 0.611 . . . . 0.0 109.593 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -58.35 -47.0 85.2 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.996 -1.065 . . . . 0.0 109.109 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.77 -45.57 81.99 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.528 -0.749 . . . . 0.0 111.571 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -77.01 -12.93 60.0 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -106.44 -17.62 14.22 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.727 1.603 . . . . 0.0 113.306 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -136.99 -51.11 0.66 Allowed 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 119.51 1.05 . . . . 0.0 111.484 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -5.69 20.05 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.97 31.03 6.97 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.013 -1.68 . . . . 0.0 111.523 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 70.7 p -116.31 163.66 15.68 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -40.79 95.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.206 1.403 . . . . 0.0 107.443 178.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.0 -48.68 73.08 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.976 1.71 . . . . 0.0 110.903 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -62.75 -50.47 63.8 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 58.1 mt -60.21 -44.64 94.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.125 0.57 . . . . 0.0 109.841 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -62.59 -42.87 99.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.848 0.459 . . . . 0.0 109.976 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.52 74.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.232 0.469 . . . . 0.0 110.407 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.7 t -73.6 -36.55 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.288 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -63.46 -31.09 72.15 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.815 1.646 . . . . 0.0 112.417 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -62.2 -45.85 91.54 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.467 -0.771 . . . . 0.0 112.156 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -65.1 -50.85 64.47 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.428 ' HE2' ' HD2' ' A' ' 298' ' ' PRO . 10.4 mmmm -138.24 146.64 52.46 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.428 ' HD2' ' HE2' ' A' ' 297' ' ' LYS . 36.7 Cg_endo -61.64 124.18 14.13 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.307 2.671 . . . . 0.0 109.985 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 29.1 mt -102.82 -13.64 16.91 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 67.89 -146.93 47.36 Favored Glycine 0 C--O 1.241 0.544 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.71 178.34 2.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 122.759 1.266 . . . . 0.0 110.08 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.3 m -131.69 152.17 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 O-C-N 120.934 -1.104 . . . . 0.0 109.087 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.12 -29.46 60.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.73 108.56 3.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.831 1.252 . . . . 0.0 108.883 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -55.47 -21.89 18.32 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.7 m -68.15 -49.59 60.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.538 1.063 . . . . 0.0 113.409 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -89.11 -9.31 51.57 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.886 0.874 . . . . 0.0 110.792 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.64 -47.22 80.22 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -60.6 -31.95 71.09 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.112 1.365 . . . . 0.0 113.914 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -81.0 -44.22 18.42 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.922 0.889 . . . . 0.0 109.612 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 20.9 mt -66.36 -33.6 76.09 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.59 -9.07 7.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.655 1.582 . . . . 0.0 112.794 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -63.92 -28.23 69.69 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.212 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -98.41 136.51 20.84 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.71 -21.82 71.0 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 123.695 2.93 . . . . 0.0 117.125 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -71.43 -30.02 65.56 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.507 1.048 . . . . 0.0 110.438 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.9 mp -79.07 -56.42 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -44.02 -60.76 1.71 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.113 1.365 . . . . 0.0 113.751 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.75 -44.38 90.53 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.947 0.794 . . . . 0.0 112.898 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 16.9 m -59.41 -35.55 74.2 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -44.38 52.67 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 121.611 -0.681 . . . . 0.0 109.274 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.94 -30.03 67.57 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.513 -0.742 . . . . 0.0 109.789 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -75.83 -31.33 59.32 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.46 -0.775 . . . . 0.0 109.529 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.334 0 CA-C-N 119.167 0.894 . . . . 0.0 109.643 177.63 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo . . . . . 0 N--CA 1.462 -0.378 0 N-CA-C 113.307 0.464 . . . . 0.0 113.307 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 92.68 14.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 130.472 3.509 . . . . 0.0 110.819 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.8 pt -57.42 143.83 73.16 Favored Pre-proline 0 CA--C 1.538 0.505 0 O-C-N 121.487 -0.758 . . . . 0.0 109.081 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.37 -21.13 47.74 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.487 1.458 . . . . 0.0 112.996 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -63.71 -22.23 66.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.299 1.04 . . . . 0.0 110.256 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 8.0 mtt -61.4 -29.38 69.89 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.225 0.92 . . . . 0.0 110.589 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 37.1 t -56.07 -43.0 77.53 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 118.53 0.605 . . . . 0.0 109.653 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.56 -41.27 47.05 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.17 0.588 . . . . 0.0 109.79 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -48.47 -46.65 38.32 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.472 1.109 . . . . 0.0 111.871 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -66.42 -54.0 29.21 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.004 -0.435 . . . . 0.0 110.918 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -60.33 -29.94 69.2 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.94 0.791 . . . . 0.0 112.406 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.98 -60.48 2.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.272 1.029 . . . . 0.0 111.073 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 22.5 t -69.2 -34.93 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 117.44 -1.266 . . . . 0.0 112.439 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.37 -28.98 60.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.485 1.493 . . . . 0.0 110.321 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 61.1 m -81.32 -51.69 8.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.389 1.076 . . . . 0.0 108.2 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -49.77 -45.91 50.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.533 1.06 . . . . 0.0 113.513 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 38.7 t -57.3 -52.66 53.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.061 0.944 . . . . 0.0 109.685 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.49 -38.58 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.212 0.605 . . . . 0.0 109.842 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -59.7 -48.67 80.75 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 118.825 0.738 . . . . 0.0 109.842 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.66 75.22 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.149 0.579 . . . . 0.0 110.775 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.95 80.94 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 10.9 m -89.34 -8.98 52.13 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.914 0.885 . . . . 0.0 110.812 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 73.34 15.28 78.95 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.154 -0.804 . . . . 0.0 112.547 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -64.52 -31.62 72.91 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.906 1.353 . . . . 0.0 109.233 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -148.31 156.12 42.14 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 14.2 t -73.2 162.61 29.21 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.401 HG13 HD23 ' A' ' 192' ' ' LEU . 54.1 t -52.45 -51.04 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 126.153 1.781 . . . . 0.0 109.536 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.14 -46.83 75.67 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.177 1.791 . . . . 0.0 112.711 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -75.61 -39.65 57.59 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.873 0.869 . . . . 0.0 111.744 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.42 -44.04 84.3 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.79 -43.51 83.76 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.854 0.862 . . . . 0.0 110.287 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -55.98 -59.28 5.12 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.58 -44.3 26.23 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.883 1.673 . . . . 0.0 110.914 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.45 -44.81 70.51 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.757 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -58.28 -37.07 74.27 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.028 1.285 . . . . 0.0 109.208 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 2.3 m -57.17 -40.63 77.69 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 123.429 0.692 . . . . 0.0 111.285 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -65.46 -18.37 65.27 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.53 -1.356 . . . . 0.0 114.136 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.2 mp -95.23 -41.77 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 20.6 p -71.91 -16.08 62.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.396 0.544 . . . . 0.0 111.831 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 39.4 tptt . . . . . 0 C--O 1.25 1.131 0 C-N-CA 127.032 2.133 . . . . 0.0 105.867 178.851 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 . . . . . 0 C--O 1.234 0.261 0 N-CA-C 104.843 -2.281 . . . . 0.0 104.843 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -99.52 136.32 39.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.76 1.624 . . . . 0.0 109.216 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.1 25.1 17.79 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.874 0.75 . . . . 0.0 112.819 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.34 165.81 29.05 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.468 1.107 . . . . 0.0 109.482 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.6 mt -138.55 151.39 47.28 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.8 t -143.12 144.37 23.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 37' ' ' VAL . 10.2 mt -134.56 144.64 34.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 123.835 0.854 . . . . 0.0 109.231 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -134.84 132.85 39.1 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.309 1.444 . . . . 0.0 107.903 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -105.77 169.6 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -83.3 -39.56 20.65 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.0 -79.98 0.09 OUTLIER Glycine 0 C--N 1.339 0.71 0 CA-C-N 119.14 0.882 . . . . 0.0 112.271 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.99 -3.12 9.02 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -61.21 157.35 16.38 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 120.789 -1.194 . . . . 0.0 109.416 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.48 69.11 0.76 Allowed Glycine 0 CA--C 1.518 0.258 0 O-C-N 121.78 -0.575 . . . . 0.0 112.038 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -54.2 -19.97 6.07 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.904 1.681 . . . . 0.0 113.623 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -62.97 -58.17 8.25 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.456 1.48 . . . . 0.0 108.238 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.63 -36.76 79.94 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 123.382 0.515 . . . . 0.0 111.915 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.9 -32.06 73.35 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.923 -0.751 . . . . 0.0 110.578 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.01 -43.36 81.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.576 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -58.16 -41.93 84.89 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.647 0.779 . . . . 0.0 110.672 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.65 -50.86 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.53 -45.38 95.97 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 121.421 -0.799 . . . . 0.0 113.247 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -34.0 75.05 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.213 1.007 . . . . 0.0 110.831 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -66.13 -54.8 21.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -56.0 -42.43 76.4 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.332 0.969 . . . . 0.0 110.854 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.86 -27.41 69.15 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.214 -0.929 . . . . 0.0 110.085 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -84.66 -18.93 33.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.769 -1.207 . . . . 0.0 112.703 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -102.79 -16.25 16.01 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 124.219 0.949 . . . . 0.0 111.162 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.5 p -124.86 -31.95 3.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.23 61.36 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.232 -0.917 . . . . 0.0 112.903 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.4 129.83 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -66.04 148.55 51.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 123.835 0.854 . . . . 0.0 109.253 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 t -139.53 156.18 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.2 m -144.22 141.65 30.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.404 HG22 HD12 ' A' ' 9' ' ' ILE . 17.3 t -130.56 122.94 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -137.81 163.63 30.92 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.764 0.826 . . . . 0.0 110.469 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -121.66 57.9 8.05 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.782 1.233 . . . . 0.0 112.679 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.11 165.1 31.86 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.299 1.333 . . . . 0.0 111.658 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.86 -30.0 6.88 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -16.75 62.48 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.696 1.599 . . . . 0.0 114.063 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -46.27 -34.2 4.28 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.733 1.213 . . . . 0.0 114.213 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -57.61 -24.03 54.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.117 0.967 . . . . 0.0 113.451 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -128.2 -8.21 5.34 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.716 0.806 . . . . 0.0 112.1 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -84.47 -47.35 10.71 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.242 1.417 . . . . 0.0 107.369 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -46.18 -52.32 28.4 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 119.233 0.924 . . . . 0.0 112.656 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.81 -17.6 59.97 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.626 1.551 . . . . 0.0 114.386 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -85.45 -4.24 59.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.3 1.04 . . . . 0.0 111.896 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.7 -39.57 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.752 0.821 . . . . 0.0 110.214 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.49 73.0 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.85 -0.531 . . . . 0.0 110.345 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.12 10.15 1.03 Allowed 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.041 -1.037 . . . . 0.0 112.0 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.7 m -131.88 -0.99 3.78 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.779 1.172 . . . . 0.0 113.64 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.52 56.18 2.86 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -166.23 -176.93 3.88 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 128.824 2.85 . . . . 0.0 105.796 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.27 179.12 31.4 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.168 1.366 . . . . 0.0 114.196 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.07 167.18 16.66 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.456 2.104 . . . . 0.0 110.068 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.14 -21.72 18.32 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.0 mt -138.28 143.94 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 tt -130.51 135.91 59.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.317 1.847 . . . . 0.0 106.197 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.17 109.5 11.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.841 1.256 . . . . 0.0 110.117 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -154.94 169.38 24.18 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.46 152.6 37.92 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.809 0.814 . . . . 0.0 110.013 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -55.15 -30.02 58.96 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.801 1.24 . . . . 0.0 111.537 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.34 -12.54 9.47 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.196 1.798 . . . . 0.0 115.733 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -123.3 2.36 9.13 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.787 1.176 . . . . 0.0 109.909 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -85.24 -5.96 59.29 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.304 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.3 -17.22 79.65 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.889 1.222 . . . . 0.0 111.185 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.65 -66.69 1.1 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-O 118.513 -1.159 . . . . 0.0 113.266 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -44.19 -46.92 9.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.201 1.0 . . . . 0.0 113.22 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.58 -55.15 36.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.786 0.835 . . . . 0.0 110.081 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.36 -49.57 61.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.57 1.148 . . . . 0.0 109.314 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.4 m -58.63 -7.17 0.88 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.48 1.912 . . . . 0.0 112.953 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.77 17.59 72.43 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 125.712 1.625 . . . . 0.0 112.805 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.2 mt -85.86 -15.92 40.29 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.245 1.023 . . . . 0.0 113.507 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.9 mt -105.48 136.01 45.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.88 1.218 . . . . 0.0 111.65 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.51 164.37 25.96 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.62 1.168 . . . . 0.0 111.959 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.09 105.9 5.52 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.431 HG13 ' CA ' ' A' ' 105' ' ' ALA . 7.3 mm -67.42 152.46 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.39 1.076 . . . . 0.0 112.087 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.2 m 78.09 88.84 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 129.68 3.192 . . . . 0.0 110.058 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -72.44 -28.88 14.26 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.206 1.937 . . . . 0.0 110.755 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -141.58 147.0 36.96 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.221 1.408 . . . . 0.0 109.411 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -54.95 -34.25 63.1 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.805 1.642 . . . . 0.0 112.96 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.46 -35.04 60.08 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.119 0.968 . . . . 0.0 113.037 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -63.51 -28.05 69.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.434 0.561 . . . . 0.0 111.418 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -67.27 -33.08 74.56 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 120.972 -1.08 . . . . 0.0 111.534 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.0 -18.49 55.85 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.207 0.603 . . . . 0.0 111.481 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -74.72 -17.9 60.59 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.7 mt -123.03 155.76 36.21 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.398 0.679 . . . . 0.0 111.671 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -68.94 151.28 97.33 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 122.853 0.461 . . . . 0.0 111.175 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.5 -46.03 2.17 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.433 2.089 . . . . 0.0 112.509 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -54.77 -45.79 74.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.184 0.902 . . . . 0.0 111.68 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.59 -20.64 57.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.019 1.328 . . . . 0.0 112.607 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -72.62 -28.7 62.92 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.904 1.229 . . . . 0.0 109.903 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.92 -34.79 72.12 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.872 1.215 . . . . 0.0 110.902 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.74 -17.34 55.47 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.045 1.338 . . . . 0.0 114.475 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.8 m -127.49 4.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.014 1.326 . . . . 0.0 111.6 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -66.26 157.47 31.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.333 1.064 . . . . 0.0 108.871 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -150.43 -177.33 5.9 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -68.86 108.2 3.37 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.609 1.164 . . . . 0.0 111.969 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.57 -53.65 0.48 Allowed Glycine 0 N--CA 1.47 0.901 0 C-N-CA 128.273 2.844 . . . . 0.0 117.337 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 163.38 12.31 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.198 1.399 . . . . 0.0 107.986 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -97.15 159.55 14.85 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 pt -121.32 -25.25 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.755 -1.111 . . . . 0.0 113.287 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.431 ' CA ' HG13 ' A' ' 79' ' ' ILE . . . -159.43 176.96 11.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.275 1.03 . . . . 0.0 108.318 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.53 145.8 58.78 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 124.558 1.143 . . . . 0.0 108.917 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.76 150.98 51.05 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.467 2.111 . . . . 0.0 109.354 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.2 mm -127.82 -53.71 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.131 1.772 . . . . 0.0 110.56 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -124.78 147.24 48.8 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.587 0.755 . . . . 0.0 112.462 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.4 t -122.47 104.17 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.465 1.506 . . . . 0.0 107.464 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.478 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 CA--C 1.52 -0.181 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 39.7 p90 . . . . . 0 C--O 1.236 0.39 0 C-N-CA 124.713 1.205 . . . . 0.0 109.893 -179.081 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo . . . . . 0 N--CA 1.457 -0.659 0 N-CA-C 109.905 -0.844 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -118.8 -12.78 9.59 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.258 1.023 . . . . 0.0 112.426 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.3 t -167.11 162.72 15.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.777 1.231 . . . . 0.0 108.413 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -65.62 -24.86 67.15 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.537 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.5 -15.47 63.69 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.211 1.369 . . . . 0.0 112.926 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.51 -21.41 28.63 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.409 0.683 . . . . 0.0 110.08 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.73 -58.38 19.85 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-O 117.235 -1.364 . . . . 0.0 109.237 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.2 -26.98 49.05 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 CA-C-N 121.45 1.554 . . . . 0.0 111.751 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.92 67.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.728 0.811 . . . . 0.0 110.032 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 64.2 tp -75.81 -26.42 57.23 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.093 1.357 . . . . 0.0 110.999 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.89 -42.32 99.73 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.496 0.718 . . . . 0.0 110.126 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 7.2 ptmm? -72.4 -32.53 66.45 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.248 -0.908 . . . . 0.0 111.126 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -69.28 -44.79 71.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.666 0.387 . . . . 0.0 110.675 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.7 -30.54 36.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.147 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.21 -33.17 71.36 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 120.182 1.356 . . . . 0.0 109.095 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.99 -7.69 42.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.85 0.07 2.88 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.66 0.784 . . . . 0.0 111.895 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -162.84 -107.0 0.21 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.399 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -141.69 -173.33 3.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.323 1.449 . . . . 0.0 109.581 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.9 p -62.55 152.5 34.66 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.155 0.889 . . . . 0.0 113.024 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.44 -49.57 13.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.345 1.458 . . . . 0.0 114.228 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.9 tp -134.66 143.37 47.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.125 0.97 . . . . 0.0 110.887 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -137.06 138.21 40.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.255 1.422 . . . . 0.0 107.606 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -151.29 166.49 30.79 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.925 1.239 . . . . 0.0 111.941 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -70.17 91.13 0.69 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.405 1.882 . . . . 0.0 106.629 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.2 tt -87.47 -35.6 18.14 Favored 'General case' 0 CA--C 1.524 -0.052 0 C-N-CA 125.715 1.606 . . . . 0.0 112.566 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -64.2 -12.45 40.66 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -103.78 122.48 44.47 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 118.689 0.677 . . . . 0.0 109.992 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.86 -16.48 49.58 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 120.723 0.949 . . . . 0.0 110.639 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -47.66 -44.44 27.21 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 127.54 2.336 . . . . 0.0 111.671 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -98.84 -33.41 10.9 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 p -69.82 -27.35 64.8 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.352 1.433 . . . . 0.0 110.338 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -53.6 -60.61 6.69 Favored Pre-proline 0 C--N 1.343 0.308 0 C-N-CA 124.875 1.27 . . . . 0.0 113.392 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -57.28 -15.92 20.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.913 1.742 . . . . 0.0 114.537 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 8.6 tt -75.44 -66.57 0.75 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.2 pt -56.69 -34.62 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.217 1.007 . . . . 0.0 112.845 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.03 -26.23 64.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.028 -1.045 . . . . 0.0 112.86 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.43 86.88 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.498 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.07 -42.65 73.05 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.412 0.685 . . . . 0.0 111.439 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.83 -13.96 0.09 OUTLIER Glycine 0 CA--C 1.526 0.753 0 CA-C-O 117.959 -1.467 . . . . 0.0 113.025 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -49.4 133.12 25.57 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -138.02 144.97 41.3 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 119.719 1.76 . . . . 0.0 111.509 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.79 -59.49 2.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -141.65 171.42 14.08 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.901 2.08 . . . . 0.0 106.658 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -119.85 139.83 51.76 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 119.528 1.058 . . . . 0.0 112.643 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.17 105.73 12.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.698 1.199 . . . . 0.0 108.448 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -173.13 1.13 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.306 2.242 . . . . 0.0 109.098 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -51.31 -20.71 1.79 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.13 2.172 . . . . 0.0 115.012 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.94 3.09 0.04 OUTLIER Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.112 0.863 . . . . 0.0 113.693 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.44 151.55 48.68 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 119.531 1.666 . . . . 0.0 107.314 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -122.13 126.04 47.48 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 125.534 1.534 . . . . 0.0 108.203 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.79 150.81 52.12 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 122.512 1.149 . . . . 0.0 113.566 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.09 1.58 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.843 -1.98 . . . . 0.0 110.133 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -75.97 -35.7 59.55 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.2 97.16 10.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.82 121.09 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.44 1.896 . . . . 0.0 106.827 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -122.83 38.69 2.45 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 123.924 0.773 . . . . 0.0 114.862 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.72 -25.03 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.117 0.967 . . . . 0.0 111.17 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.84 17.22 19.98 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -66.19 164.2 16.2 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 121.596 -0.69 . . . . 0.0 110.995 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.9 65.27 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.9 -36.8 93.76 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.898 0.772 . . . . 0.0 111.651 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.58 -50.55 64.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.791 0.796 . . . . 0.0 109.24 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -63.82 -32.2 73.63 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 117.869 -1.063 . . . . 0.0 111.616 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.54 -51.25 70.66 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.244 0.929 . . . . 0.0 110.217 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.14 -28.95 69.36 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 29.9 tp -69.74 -55.96 8.49 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.605 1.203 . . . . 0.0 110.785 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.43 -26.47 53.69 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.6 0.76 . . . . 0.0 112.152 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -56.66 -42.1 78.38 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.126 -0.984 . . . . 0.0 108.953 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 19.6 tp -69.25 -48.95 60.4 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.835 1.254 . . . . 0.0 108.456 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 47.4 t -54.48 -34.05 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.517 1.527 . . . . 0.0 109.78 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.18 -42.56 88.75 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.553 1.541 . . . . 0.0 110.778 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.62 -40.25 84.67 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.245 -0.909 . . . . 0.0 108.564 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 89.4 mt -66.85 -36.93 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -60.33 -36.89 79.0 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.992 -1.693 . . . . 0.0 108.473 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -82.3 -2.11 51.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.288 1.435 . . . . 0.0 111.272 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? 56.46 9.56 0.56 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.707 2.403 . . . . 0.0 114.394 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -82.46 -14.68 54.66 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ttp -112.17 147.97 35.03 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.46 1.104 . . . . 0.0 110.074 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -85.58 103.57 14.53 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.897 1.279 . . . . 0.0 107.919 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -77.51 -21.62 52.45 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -91.67 0.12 57.52 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.5 m -60.88 131.48 50.82 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.526 1.13 . . . . 0.0 110.315 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.54 -173.51 2.75 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.785 1.234 . . . . 0.0 108.048 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -56.53 -45.81 80.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.074 0.949 . . . . 0.0 109.725 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.86 -49.68 75.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.948 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 46.3 mm -59.0 -48.75 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.621 1.101 . . . . 0.0 110.356 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.09 87.08 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -74.59 -57.42 3.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -50.81 -55.89 14.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.754 1.621 . . . . 0.0 112.241 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.42 76.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.139 0.881 . . . . 0.0 110.734 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.5 -38.8 90.79 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -63.1 -35.69 81.11 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.89 0.876 . . . . 0.0 109.708 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -72.78 -22.79 60.78 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.01 18.61 21.82 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 126.143 1.83 . . . . 0.0 112.68 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.88 -71.74 0.31 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.233 1.016 . . . . 0.0 113.648 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . 0.28 4.2 t -68.55 152.81 44.86 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.27 0.557 . . . . 0.0 112.365 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.83 31.42 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.612 0.765 . . . . 0.0 112.454 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -152.85 155.66 37.51 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.506 1.123 . . . . 0.0 108.234 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.5 t -147.78 159.05 44.24 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.5 mt . . . . . 0 C--O 1.238 0.461 0 CA-C-N 119.408 1.004 . . . . 0.0 110.236 -179.563 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.94 141.41 30.0 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.71 2.273 . . . . 0.0 111.559 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.1 p -149.48 -172.23 4.09 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 127.793 2.437 . . . . 0.0 107.512 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -87.5 144.95 26.46 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -55.73 119.77 6.27 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.984 0.914 . . . . 0.0 110.389 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.01 -4.9 44.11 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.055 0.836 . . . . 0.0 114.321 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.57 87.14 32.56 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.927 1.863 . . . . 0.0 109.543 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.48 152.7 60.45 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.721 1.614 . . . . 0.0 110.661 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 19.5 m -72.2 134.81 45.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.65 0.78 . . . . 0.0 109.913 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 256' ' ' LYS . 0.2 OUTLIER -140.39 87.18 12.04 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.528 1.531 . . . . 0.0 108.01 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.15 -90.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.628 2.218 . . . . 0.0 109.35 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.444 -0.725 0 C-N-CA 127.517 2.327 . . . . 0.0 106.046 179.729 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.867 0 N-CA-C 106.555 -2.618 . . . . 0.0 106.555 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.0 164.37 33.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.169 0.509 . . . . 0.0 109.947 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.68 173.19 10.83 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.608 0.763 . . . . 0.0 109.726 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -148.39 141.3 24.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.722 -1.236 . . . . 0.0 110.135 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.29 132.46 47.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.7 152.18 19.79 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.218 -0.768 . . . . 0.0 111.362 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.1 mt -89.83 135.63 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -71.35 120.29 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.424 1.09 . . . . 0.0 109.14 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.24 -20.66 62.21 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -75.88 -4.14 39.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.059 1.744 . . . . 0.0 114.924 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 33.1 m -71.7 167.49 30.4 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 124.894 1.278 . . . . 0.0 110.672 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -80.75 -43.45 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.196 1.264 . . . . 0.0 110.605 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -139.23 106.84 5.59 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.032 0.933 . . . . 0.0 109.379 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.422 ' HD2' ' H ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -61.93 -19.79 63.11 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.115 0.966 . . . . 0.0 112.045 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.11 -40.57 81.57 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 68.3 mt -57.62 -36.58 71.98 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.722 -0.612 . . . . 0.0 111.492 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.81 -45.45 28.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.976 0.511 . . . . 0.0 112.024 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -32.72 74.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.2 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -70.34 -56.45 6.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -52.52 -46.14 66.59 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.238 -0.914 . . . . 0.0 111.255 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 4.1 tt -66.81 -42.54 85.75 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.517 -1.23 . . . . 0.0 113.063 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.3 -15.74 39.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.51 1.504 . . . . 0.0 114.713 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -109.55 -17.58 13.71 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -131.29 -51.5 1.02 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 118.993 0.815 . . . . 0.0 111.471 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.86 -55.7 20.89 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.338 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.52 HD22 HD21 ' A' ' 304' ' ' LEU . 55.3 mt -88.34 77.26 8.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.74 0.816 . . . . 0.0 109.91 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 39.8 p -140.8 159.43 42.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.23 -38.04 89.15 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -81.87 -29.25 32.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.009 0.524 . . . . 0.0 112.227 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.04 -43.84 20.55 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.97 -39.83 90.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.31 -46.57 85.9 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -53.52 -46.78 70.25 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.736 0.698 . . . . 0.0 111.214 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.66 -37.79 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.19 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -72.01 -22.45 61.41 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.774 1.629 . . . . 0.0 113.584 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -69.29 -44.97 70.72 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.626 0.771 . . . . 0.0 109.01 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -71.76 -48.31 47.68 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -135.08 152.92 77.98 Favored Pre-proline 0 N--CA 1.461 0.082 0 C-N-CA 123.992 0.917 . . . . 0.0 109.909 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.9 125.57 10.01 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.086 1.857 . . . . 0.0 110.937 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 86.7 mt -99.89 -24.23 14.71 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.535 -0.745 . . . . 0.0 112.335 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 81.26 -155.02 35.66 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.22 168.93 14.72 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 12.7 m -121.68 162.2 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 O-C-N 120.641 -1.287 . . . . 0.0 110.991 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.33 -13.59 49.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.286 0.634 . . . . 0.0 110.434 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.52 HD21 HD22 ' A' ' 285' ' ' LEU . 4.1 mm? -76.31 112.5 12.86 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 127.239 2.216 . . . . 0.0 107.703 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -62.89 -36.51 83.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.071 0.462 . . . . 0.0 110.32 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -52.15 64.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.434 1.894 . . . . 0.0 111.172 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -84.84 -11.8 54.9 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.815 0.846 . . . . 0.0 112.224 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -60.49 -42.77 96.99 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -63.24 -9.89 13.38 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.43 1.492 . . . . 0.0 112.164 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -109.61 -36.8 5.86 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.051 0.94 . . . . 0.0 110.495 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 14.7 mt -74.27 -24.32 59.24 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.453 -1.405 . . . . 0.0 108.521 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.56 -8.05 17.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.495 1.118 . . . . 0.0 112.382 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -56.59 -37.76 71.07 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.03 133.31 24.32 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.39 -24.69 71.17 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.578 2.185 . . . . 0.0 113.332 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -62.57 -30.71 71.52 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.77 0.714 . . . . 0.0 109.851 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.9 mp -77.54 -61.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -44.13 -55.99 4.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.164 1.386 . . . . 0.0 114.342 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.18 -32.41 68.21 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.596 -0.69 . . . . 0.0 112.859 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 24.7 m -74.74 -36.54 62.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.687 0.795 . . . . 0.0 109.164 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.8 tpt -66.75 -43.15 84.92 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.219 1.007 . . . . 0.0 109.084 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -55.74 -41.01 73.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.595 0.758 . . . . 0.0 110.419 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.28 -26.85 68.97 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.728 -0.608 . . . . 0.0 112.324 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.485 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 CA--C 1.538 0.685 0 N-CA-C 115.595 1.344 . . . . 0.0 115.595 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 66.96 34.52 5.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.687 1.995 . . . . 0.0 112.002 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.2 pt -132.33 156.48 80.04 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 123.845 0.858 . . . . 0.0 110.937 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.46 -25.99 24.74 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.002 2.468 . . . . 0.0 113.666 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -57.66 -16.91 12.11 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.227 0.921 . . . . 0.0 113.343 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -22.83 65.69 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.16 -0.963 . . . . 0.0 111.411 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.4 t -65.62 -54.72 23.74 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.56 -34.97 78.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.499 1.12 . . . . 0.0 111.302 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -50.34 -56.81 9.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.805 0.842 . . . . 0.0 111.658 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -65.98 -40.9 91.64 Favored 'General case' 0 CA--C 1.522 -0.118 0 O-C-N 121.247 -0.908 . . . . 0.0 111.404 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.57 -45.77 84.77 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.155 0.503 . . . . 0.0 110.518 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.39 -51.68 64.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.647 1.179 . . . . 0.0 111.581 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.84 -27.46 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.707 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -53.99 -50.1 67.35 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.352 1.433 . . . . 0.0 107.596 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.5 m -68.51 -44.43 74.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.051 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.86 -47.03 68.09 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.948 1.249 . . . . 0.0 113.768 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 24.2 t -56.08 -51.68 59.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 124.61 1.164 . . . . 0.0 109.113 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.03 -37.45 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -58.75 -46.06 88.29 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.177 -1.577 . . . . 0.0 110.947 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.35 -45.46 59.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.634 0.773 . . . . 0.0 110.48 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.14 -44.42 97.36 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.33 0.514 . . . . 0.0 111.623 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 59.8 m -75.04 -25.91 59.05 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.899 0.879 . . . . 0.0 109.313 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.86 32.77 44.01 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -85.14 -21.29 29.3 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.846 0.858 . . . . 0.0 110.62 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -147.42 151.42 36.43 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.6 m -58.65 152.21 19.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.991 0.916 . . . . 0.0 109.293 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 61.8 t -57.2 -44.77 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 118.988 0.813 . . . . 0.0 109.414 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -52.18 66.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.469 1.108 . . . . 0.0 110.009 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -63.87 -37.71 88.41 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.262 0.625 . . . . 0.0 111.838 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.93 92.48 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 38.2 mt -73.15 -38.85 66.1 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.597 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -57.88 -53.46 57.99 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 119.681 1.128 . . . . 0.0 109.807 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -29.93 70.76 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -70.99 -55.34 8.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 118.114 -0.946 . . . . 0.0 108.895 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -49.66 -38.57 33.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.178 1.391 . . . . 0.0 110.069 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 26.4 m -57.93 -45.64 86.27 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.008 0.523 . . . . 0.0 110.452 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -61.67 -8.63 4.81 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.147 2.179 . . . . 0.0 114.027 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 2.3 mp -104.17 -40.11 6.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.1 p -68.76 -25.43 64.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.402 0.547 . . . . 0.0 110.801 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? . . . . . 0 C--O 1.245 0.85 0 C-N-CA 127.135 2.174 . . . . 0.0 108.36 -179.089 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -71.92 69.49 0.71 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.718 1.207 . . . . 0.0 113.786 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.57 30.95 0.02 OUTLIER Glycine 0 CA--C 1.526 0.731 0 O-C-N 121.352 -0.843 . . . . 0.0 114.017 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -143.5 172.06 13.3 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.253 1.027 . . . . 0.0 110.259 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.6 mt -150.81 140.13 21.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 127.682 2.393 . . . . 0.0 106.506 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.8 t -137.06 148.05 26.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.473 HD12 HG22 ' A' ' 37' ' ' VAL . 11.9 mt -130.43 142.4 43.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.606 1.562 . . . . 0.0 109.119 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -137.76 134.08 34.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.8 147.68 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -60.31 -35.57 75.89 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.27 168.72 11.45 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t0 48.66 30.25 2.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.107 1.363 . . . . 0.0 110.961 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.38 -14.58 16.21 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -177.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.66 30.57 4.56 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.909 1.719 . . . . 0.0 112.972 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -45.82 -46.21 15.39 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.66 1.184 . . . . 0.0 113.723 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -58.19 -41.37 83.79 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.445 1.02 . . . . 0.0 112.874 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.57 -42.18 41.25 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.8 tp -58.42 -39.21 79.16 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.928 1.291 . . . . 0.0 110.238 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.78 -46.7 64.25 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.729 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.36 -39.5 79.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.269 1.028 . . . . 0.0 111.573 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 t -59.95 -42.78 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.72 -39.57 96.77 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -62.47 -46.87 86.51 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 119.651 1.725 . . . . 0.0 109.012 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -59.65 -56.19 24.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -55.55 -47.07 76.96 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.628 0.649 . . . . 0.0 112.017 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.24 -28.85 69.99 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 121.103 -0.998 . . . . 0.0 110.794 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.64 -23.0 37.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.904 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -100.3 -11.05 20.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.409 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.3 p -127.34 -32.39 2.46 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.478 1.035 . . . . 0.0 113.693 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.2 -14.73 62.86 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 119.393 0.997 . . . . 0.0 112.818 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.6 mm -69.24 122.81 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.26 145.49 47.24 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 123.345 0.658 . . . . 0.0 110.13 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.8 t -133.0 136.38 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -128.96 138.54 52.03 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.473 HG22 HD12 ' A' ' 9' ' ' ILE . 24.8 t -133.94 128.55 53.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.7 1.2 . . . . 0.0 107.931 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -140.55 160.09 40.78 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.14 1.776 . . . . 0.0 107.184 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -122.26 59.03 10.89 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.094 0.958 . . . . 0.0 111.708 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.84 136.41 20.73 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.906 2.404 . . . . 0.0 109.32 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.31 -33.41 63.19 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.561 0.948 . . . . 0.0 113.561 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -99.27 24.23 8.24 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -178.403 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 pp -49.2 -29.3 5.41 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.266 -0.896 . . . . 0.0 112.287 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -57.69 -24.98 59.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.359 1.864 . . . . 0.0 114.518 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -110.05 -19.29 13.12 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.555 0.693 . . . . 0.0 111.023 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -81.08 -50.29 9.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.357 -0.84 . . . . 0.0 108.874 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -44.12 -55.98 8.58 Favored Pre-proline 0 CA--C 1.529 0.146 0 CA-C-O 117.334 -1.317 . . . . 0.0 111.937 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 30.6 Cg_endo -60.98 -28.51 86.4 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 120.813 1.326 . . . . 0.0 115.402 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -83.05 -32.87 26.62 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.401 1.455 . . . . 0.0 112.154 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 t -87.37 -40.52 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.221 0.464 . . . . 0.0 110.258 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.26 -32.28 73.87 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 120.483 -1.385 . . . . 0.0 110.034 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 48' ' ' PRO . . . -58.2 -20.03 38.2 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.107 1.363 . . . . 0.0 112.585 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.1 p -113.37 2.91 15.64 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.993 0.917 . . . . 0.0 112.897 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.49 12.54 83.64 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.071 0.851 . . . . 0.0 111.287 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -103.97 -10.27 18.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.544 1.138 . . . . 0.0 111.468 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.92 174.27 55.29 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.017 1.294 . . . . 0.0 115.333 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.71 172.0 7.59 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.41 3.406 . . . . 0.0 113.389 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -101.43 -20.19 15.25 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.39 127.12 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.707 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 tp -107.67 144.72 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 127.202 2.201 . . . . 0.0 106.846 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -131.97 107.74 8.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.744 1.218 . . . . 0.0 110.637 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -157.24 -175.82 5.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.065 0.946 . . . . 0.0 110.076 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.4 151.0 33.02 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -52.3 -33.41 42.18 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.553 1.541 . . . . 0.0 113.409 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.42 -18.08 48.53 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -103.31 -7.61 20.96 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.163 -1.585 . . . . 0.0 110.514 178.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -91.32 -28.69 17.58 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.755 -0.59 . . . . 0.0 112.388 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.04 14.08 1.26 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.905 1.241 . . . . 0.0 113.725 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.87 -59.9 0.25 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 129.394 3.378 . . . . 0.0 105.853 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -50.11 -51.75 40.52 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.024 0.93 . . . . 0.0 110.665 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.66 95.81 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.14 0.495 . . . . 0.0 111.135 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -65.24 -13.34 58.09 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.857 0.863 . . . . 0.0 112.44 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.4 m -106.52 -6.32 18.18 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.745 2.418 . . . . 0.0 112.473 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.42 16.49 39.97 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.1 mt -96.18 -15.01 22.32 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 73.5 mt -106.53 139.77 40.48 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.832 1.651 . . . . 0.0 110.755 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.56 -178.36 7.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -69.34 106.74 3.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.418 2.287 . . . . 0.0 106.373 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 79' ' ' ILE . 1.6 mm -80.4 148.7 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.417 HG22 HG22 ' A' ' 79' ' ' ILE . 3.9 t 38.96 80.37 0.28 Allowed Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 129.026 2.931 . . . . 0.0 111.499 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.82 -24.9 68.02 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 121.635 1.557 . . . . 0.0 111.848 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -123.62 142.59 50.9 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.267 1.427 . . . . 0.0 109.138 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -61.44 -27.51 68.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.205 2.202 . . . . 0.0 109.98 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.69 63.25 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.202 0.91 . . . . 0.0 112.905 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -76.62 -31.09 57.2 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.314 0.961 . . . . 0.0 108.925 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -67.05 -39.5 86.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.205 -0.935 . . . . 0.0 109.816 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -57.3 -28.4 63.0 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.502 1.121 . . . . 0.0 112.077 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -75.06 -18.24 60.34 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.4 mt -117.17 162.05 18.47 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.131 0.878 . . . . 0.0 110.782 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -75.0 148.65 84.69 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.783 0.833 . . . . 0.0 109.972 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.52 -42.51 3.58 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.596 2.198 . . . . 0.0 113.342 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -60.57 -40.01 90.12 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.55 0.614 . . . . 0.0 109.991 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.02 -28.34 70.03 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.73 -1.231 . . . . 0.0 109.98 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.402 ' CZ3' ' HB3' ' A' ' 106' ' ' TYR . 70.6 m95 -71.84 -33.3 68.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.214 0.915 . . . . 0.0 109.951 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.11 -38.73 73.84 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.262 0.937 . . . . 0.0 110.42 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.94 -7.47 3.85 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.79 8.21 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.222 1.409 . . . . 0.0 112.167 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -63.75 162.67 12.94 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.502 1.144 . . . . 0.0 111.182 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -145.71 -174.91 4.54 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.759 1.624 . . . . 0.0 108.408 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.68 105.15 0.61 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.304 1.442 . . . . 0.0 107.84 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.05 -78.06 0.29 Allowed Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.795 1.188 . . . . 0.0 113.637 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -178.86 7.21 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.614 1.566 . . . . 0.0 110.57 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.51 169.35 8.71 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.842 0.83 . . . . 0.0 111.403 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.5 pt -130.07 -22.41 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.082 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.426 ' CA ' HG13 ' A' ' 79' ' ' ILE . . . -155.71 167.86 29.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.877 0.871 . . . . 0.0 109.051 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.402 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -123.94 150.35 62.39 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.583 1.153 . . . . 0.0 109.383 179.112 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -72.74 144.45 39.33 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.764 2.309 . . . . 0.0 109.371 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -126.26 -46.82 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.877 0.871 . . . . 0.0 111.608 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.8 144.9 49.29 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.25 119.03 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 124.096 0.958 . . . . 0.0 111.265 -178.406 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 68.9 mt . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 30.1 p90 . . . . . 0 C--O 1.234 0.242 0 C-N-CA 125.62 1.568 . . . . 0.0 109.59 -179.081 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.458 -0.607 0 N-CA-C 110.921 -0.453 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -136.41 -8.8 1.95 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 117.401 -1.285 . . . . 0.0 112.449 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.6 t -147.1 144.63 29.18 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 121.714 2.052 . . . . 0.0 112.287 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -61.48 -19.99 62.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.627 1.171 . . . . 0.0 112.974 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -74.74 -15.86 60.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.615 1.098 . . . . 0.0 112.642 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -92.51 -26.92 17.72 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.987 0.812 . . . . 0.0 110.474 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.5 mm -48.69 -56.77 13.29 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 125.382 1.473 . . . . 0.0 110.951 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.69 -22.36 32.5 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 CA-C-N 120.487 1.209 . . . . 0.0 112.236 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.57 -36.7 63.07 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.1 tp -78.49 -28.55 46.4 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.861 1.264 . . . . 0.0 110.068 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.04 -50.21 71.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.71 0.687 . . . . 0.0 110.062 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.7 ptmm? -63.52 -31.85 73.13 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.044 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.59 -42.21 52.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.358 0.526 . . . . 0.0 109.697 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.8 mt -71.35 -31.41 67.33 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -67.42 -29.98 69.62 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.59 -3.53 18.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.128 0.571 . . . . 0.0 112.071 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.31 3.86 2.17 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.402 1.481 . . . . 0.0 111.478 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.87 -95.59 0.1 Allowed Glycine 0 CA--C 1.524 0.647 0 CA-C-N 120.077 1.308 . . . . 0.0 115.344 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -138.72 -171.6 3.11 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 125.341 1.456 . . . . 0.0 110.738 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.0 p -62.22 154.1 28.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.913 0.885 . . . . 0.0 110.599 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -76.85 -39.58 50.7 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.669 1.188 . . . . 0.0 110.805 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.2 tp -130.46 147.82 52.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.216 1.006 . . . . 0.0 112.5 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 25.4 mtp -150.75 127.84 11.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.642 2.377 . . . . 0.0 105.243 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -158.71 173.61 16.3 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -78.99 84.63 4.99 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.128 -0.982 . . . . 0.0 110.636 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 mp -71.61 -28.59 63.9 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.051 0.387 . . . . 0.0 109.986 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -61.42 -15.14 34.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -115.21 130.24 24.41 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 119.478 1.035 . . . . 0.0 110.605 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.04 -21.67 72.83 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.324 1.349 . . . . 0.0 112.394 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -54.4 -31.42 54.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.263 1.025 . . . . 0.0 113.461 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.12 -24.8 15.15 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.2 p -90.89 -15.93 29.04 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.33 0.968 . . . . 0.0 111.456 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -62.23 -35.3 19.6 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.08 -11.54 30.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 123.276 2.206 . . . . 0.0 113.98 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.7 tp -68.31 -67.05 0.49 Allowed 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.51 1.524 . . . . 0.0 111.621 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.696 HD13 ' H ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.28 -24.7 35.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.616 1.166 . . . . 0.0 113.295 -179.26 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.35 -16.15 63.29 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.865 -0.522 . . . . 0.0 111.035 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.85 -60.54 2.77 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.153 1.381 . . . . 0.0 109.568 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.76 -54.99 38.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.0 15.79 0.02 OUTLIER Glycine 0 C--N 1.337 0.629 0 CA-C-O 117.887 -1.507 . . . . 0.0 116.149 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.66 147.97 41.07 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 120.804 2.302 . . . . 0.0 109.639 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -151.9 128.24 10.59 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.89 -48.97 62.04 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -143.66 149.51 37.36 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -101.84 159.28 15.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.217 -0.927 . . . . 0.0 109.315 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -155.59 113.98 3.45 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 102.011 -3.329 . . . . 0.0 102.011 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -73.67 -168.59 0.59 Allowed 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.308 1.843 . . . . 0.0 108.429 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -57.13 -34.56 68.51 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.741 -1.224 . . . . 0.0 110.765 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -154.56 8.28 0.36 Allowed Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.284 -1.287 . . . . 0.0 114.558 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -112.49 130.46 55.99 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.366 2.083 . . . . 0.0 107.06 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.17 115.37 17.58 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.96 1.704 . . . . 0.0 109.368 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -132.56 111.78 11.52 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -10.45 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.869 0.867 . . . . 0.0 112.789 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -77.13 -28.78 54.42 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.821 0.848 . . . . 0.0 109.937 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -73.76 80.98 1.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.911 1.284 . . . . 0.0 110.619 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 63.7 t -108.19 141.77 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 127.591 2.357 . . . . 0.0 108.851 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -132.16 34.04 2.59 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.093 1.33 . . . . 0.0 115.092 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.17 -37.76 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 117.301 -1.333 . . . . 0.0 113.796 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.46 ' OD2' ' HE3' ' A' ' 362' ' ' LYS 0.293 21.4 t70 -108.8 34.91 3.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.53 1.514 . . . . 0.0 113.279 -178.613 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -79.14 151.69 31.18 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -47.75 -24.8 1.04 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.17 -19.74 68.88 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 120.145 1.339 . . . . 0.0 111.738 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.66 -45.07 47.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.809 0.844 . . . . 0.0 108.981 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -64.39 -54.56 30.92 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.71 -45.07 70.32 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.617 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -63.56 -30.43 77.58 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 118.814 -0.992 . . . . 0.0 112.128 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 46.0 tp -84.09 -40.46 18.27 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.206 1.402 . . . . 0.0 110.881 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.4 m -44.24 -54.49 5.66 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 127.763 2.425 . . . . 0.0 112.156 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.02 -44.41 91.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.778 0.717 . . . . 0.0 111.769 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.66 -46.05 91.39 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.636 -0.665 . . . . 0.0 109.38 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.78 -34.42 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.65 -43.32 99.12 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.531 1.06 . . . . 0.0 111.811 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 75.7 mt -65.12 -50.76 64.82 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.678 0.791 . . . . 0.0 109.103 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.48 -35.97 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.406 1.083 . . . . 0.0 110.572 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -58.61 -49.13 78.62 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.345 0.975 . . . . 0.0 108.545 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.88 4.27 17.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.843 1.257 . . . . 0.0 112.286 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 58.39 20.49 7.42 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.919 1.288 . . . . 0.0 112.292 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.79 9.63 6.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.366 1.466 . . . . 0.0 110.882 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.2 ttt -146.91 148.05 31.4 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 121.206 -0.934 . . . . 0.0 108.6 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -78.15 78.63 4.63 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.25 -13.08 61.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.861 1.665 . . . . 0.0 114.782 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -92.88 -8.2 44.03 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.58 0.752 . . . . 0.0 112.372 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.7 m -61.97 127.66 32.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 122.522 1.153 . . . . 0.0 110.065 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 29.5 p30 -119.16 -177.52 3.36 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.711 2.004 . . . . 0.0 106.683 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.44 -42.9 99.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.4 m -60.11 -45.59 92.46 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 118.522 -0.751 . . . . 0.0 109.56 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.93 -56.26 19.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -54.49 -59.44 4.69 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.942 1.697 . . . . 0.0 112.982 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -58.19 -44.58 88.11 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.845 0.748 . . . . 0.0 111.475 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.8 -45.65 91.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.434 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.82 95.25 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.411 1.084 . . . . 0.0 112.166 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -63.3 -38.59 91.75 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.098 0.559 . . . . 0.0 110.056 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -59.68 -46.07 90.16 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -68.46 -42.9 78.1 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.341 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.64 36.5 2.05 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.283 1.421 . . . . 0.0 109.596 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -78.22 -62.02 1.81 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.746 -0.856 . . . . 0.0 109.298 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.4 t -73.27 137.1 44.7 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.552 1.541 . . . . 0.0 108.075 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.05 -15.65 57.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.163 0.585 . . . . 0.0 112.53 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -159.29 168.4 26.53 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.919 1.688 . . . . 0.0 109.443 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -155.81 -179.56 8.24 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.452 1.501 . . . . 0.0 109.046 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.3 mt . . . . . 0 C--O 1.236 0.384 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 178.868 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 32.0 mt . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.46 153.7 77.03 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.277 1.985 . . . . 0.0 111.849 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 255' ' ' SER . 36.7 p -113.81 -165.38 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.265 1.426 . . . . 0.0 109.149 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -125.98 149.88 48.45 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -51.09 120.24 4.74 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.618 1.167 . . . . 0.0 109.616 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.61 -4.13 57.43 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 117.621 -1.655 . . . . 0.0 114.615 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.69 115.01 3.51 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 121.777 2.789 . . . . 0.0 115.191 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.29 147.07 28.84 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.709 2.939 . . . . 0.0 111.254 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.419 ' H ' HG22 ' A' ' 249' ' ' THR . 5.4 p -64.81 155.52 33.67 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -133.02 66.69 76.59 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.512 1.525 . . . . 0.0 108.599 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.15 179.68 6.27 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.426 2.751 . . . . 0.0 113.174 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 . . . . . 0 C--O 1.234 0.288 0 CA-C-O 121.903 0.859 . . . . 0.0 112.155 -179.928 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.855 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.89 154.96 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 119.114 1.457 . . . . 0.0 111.829 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.37 117.46 11.03 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.4 m -104.49 144.98 30.93 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.561 1.144 . . . . 0.0 110.811 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.0 129.7 47.15 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.76 131.54 8.55 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 123.556 0.535 . . . . 0.0 111.891 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 85.5 mt -75.09 131.15 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -71.33 120.27 16.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.708 0.803 . . . . 0.0 109.143 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.47 -12.39 60.18 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.951 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.85 -6.67 59.48 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.164 0.893 . . . . 0.0 112.96 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.5 m -63.05 161.3 31.85 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.268 1.027 . . . . 0.0 108.681 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.88 -53.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 121.204 1.466 . . . . 0.0 109.417 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -132.75 104.32 6.56 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' LYS . . . . . 0.506 ' HD2' ' H ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -60.06 -19.04 51.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.318 -1.31 . . . . 0.0 113.389 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.34 -33.2 72.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.02 -36.52 83.85 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.882 -1.136 . . . . 0.0 110.993 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.31 -47.23 28.8 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 122.646 0.378 . . . . 0.0 110.565 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -35.73 78.44 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.206 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -70.37 -55.34 9.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.421 ' HE2' HD11 ' A' ' 9' ' ' ILE . 9.0 t80 -51.48 -46.89 63.3 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 120.225 1.375 . . . . 0.0 112.322 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.25 -23.72 66.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 116.944 -1.503 . . . . 0.0 112.294 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -108.63 -17.91 13.85 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.7 1.591 . . . . 0.0 113.606 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -80.47 -33.38 36.69 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.461 1.104 . . . . 0.0 108.816 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -133.66 -46.09 0.81 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.102 -0.952 . . . . 0.0 111.079 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . 0.256 0.1 OUTLIER -67.85 0.24 3.58 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 120.71 1.595 . . . . 0.0 114.831 -179.462 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 58.7 mt -130.17 40.47 3.53 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 119.524 -1.985 . . . . 0.0 108.863 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 63.9 p -117.5 156.42 28.05 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.24 -43.38 98.96 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -73.31 -33.04 64.95 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -75.44 -42.25 28.06 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.09 -44.47 76.16 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -54.83 -47.17 74.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.189 0.996 . . . . 0.0 109.52 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.24 -42.32 63.52 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 22.5 t -75.34 -36.52 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -61.54 -20.47 63.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.482 0.713 . . . . 0.0 110.97 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -67.85 -45.45 74.57 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 121.163 -0.961 . . . . 0.0 110.139 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.42 -39.77 58.51 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -146.35 156.72 49.75 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.245 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.32 114.08 3.67 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.761 1.641 . . . . 0.0 109.299 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.47 -32.47 37.11 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 119.37 -0.348 . . . . 0.0 110.074 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.57 -167.81 47.07 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -59.13 157.63 10.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.56 0.695 . . . . 0.0 109.932 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.8 156.27 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.723 0.773 . . . . 0.0 111.191 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.63 -35.12 67.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.67 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.38 103.6 0.32 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.729 1.211 . . . . 0.0 112.332 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -47.95 -33.4 7.69 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.587 1.555 . . . . 0.0 112.703 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.8 -49.93 68.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.469 1.108 . . . . 0.0 113.211 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -96.41 -10.58 27.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.242 0.928 . . . . 0.0 111.504 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.27 -46.71 87.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.331 1.452 . . . . 0.0 108.098 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -69.16 -22.58 63.92 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 119.074 -0.488 . . . . 0.0 112.046 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -78.94 -49.57 12.59 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 7.1 mt -62.69 -38.16 89.29 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.61 -2.41 2.39 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.531 1.132 . . . . 0.0 114.043 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -66.71 -35.79 80.97 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.445 1.02 . . . . 0.0 108.529 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.9 150.49 58.89 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 123.747 0.819 . . . . 0.0 109.643 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.14 -24.59 20.03 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.466 2.11 . . . . 0.0 115.23 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -48.0 77.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.385 0.993 . . . . 0.0 109.447 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.501 HD12 ' H ' ' A' ' 317' ' ' ILE . 4.9 mp -64.04 -55.77 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.5 -53.39 23.57 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 123.926 0.766 . . . . 0.0 111.967 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.44 -47.13 87.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 87.0 m -67.57 -29.71 69.14 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 7.8 tpt -71.91 -39.52 69.46 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 120.9 -1.125 . . . . 0.0 109.136 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -56.78 -26.81 58.54 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.62 0.768 . . . . 0.0 110.223 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -66.18 -36.86 84.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.263 0.625 . . . . 0.0 112.332 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.483 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo . . . . . 0 CA--C 1.534 0.482 0 N-CA-C 112.576 0.183 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -134.23 38.53 3.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.88 1.272 . . . . 0.0 112.764 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.1 pt -114.05 152.09 45.47 Favored Pre-proline 0 N--CA 1.472 0.656 0 O-C-N 120.879 -1.138 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.98 -17.22 36.69 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.581 2.188 . . . . 0.0 113.969 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -56.23 -22.83 31.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.103 1.761 . . . . 0.0 112.024 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -32.51 65.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.849 1.26 . . . . 0.0 111.544 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -48.57 76.65 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.404 1.002 . . . . 0.0 109.208 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.5 87.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -58.87 -54.51 46.28 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.354 0.525 . . . . 0.0 110.393 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -61.29 -42.37 98.54 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.561 -0.712 . . . . 0.0 109.989 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -63.93 -23.04 67.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.069 0.948 . . . . 0.0 112.307 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -85.02 -57.73 2.98 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 120.955 -1.09 . . . . 0.0 110.639 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 347' ' ' VAL . 19.3 t -57.84 -38.74 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 118.068 -0.968 . . . . 0.0 111.946 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -52.15 -48.57 64.84 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.145 1.339 . . . . 0.0 111.365 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 8.5 m -66.4 -40.22 89.48 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.375 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.56 83.74 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.373 0.988 . . . . 0.0 111.413 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 343' ' ' VAL . 36.2 t -60.69 -55.38 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.784 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.8 mm -66.26 -33.38 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 123.575 0.547 . . . . 0.0 110.652 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -61.09 -46.02 92.34 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.425 -1.422 . . . . 0.0 108.8 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.9 -50.18 44.87 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.881 0.872 . . . . 0.0 109.729 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -57.08 -37.79 72.39 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 69.0 m -87.55 -7.13 57.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.548 0.739 . . . . 0.0 110.256 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.62 13.71 71.72 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 118.491 0.587 . . . . 0.0 111.78 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 -65.98 -28.61 69.02 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.311 1.056 . . . . 0.0 109.633 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -149.25 153.24 37.26 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 9.0 m -66.07 150.71 48.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.448 1.099 . . . . 0.0 108.671 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 18.8 t -52.52 -54.53 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.911 1.285 . . . . 0.0 108.339 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.38 -44.91 55.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.344 2.257 . . . . 0.0 112.597 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -82.6 -26.92 31.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.48 85.57 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 76.4 mt -68.87 -39.44 79.84 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.73 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.46 ' HE3' ' OD2' ' A' ' 184' ' ' ASP . 2.1 tppp? -58.33 -35.81 72.44 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.896 0.878 . . . . 0.0 110.545 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.22 -32.74 22.46 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.789 0.722 . . . . 0.0 110.98 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.17 -40.16 90.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.564 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.64 -37.9 76.95 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.878 0.763 . . . . 0.0 109.606 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 4.3 m -67.53 -19.58 65.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.209 1.404 . . . . 0.0 113.141 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -80.66 -11.94 59.56 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.141 -0.975 . . . . 0.0 110.874 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.11 -42.02 11.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.5 p -68.02 -13.75 62.43 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.451 0.569 . . . . 0.0 111.859 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 32.2 tptt . . . . . 0 C--O 1.245 0.828 0 C-N-CA 125.868 1.667 . . . . 0.0 107.087 179.278 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -65.51 133.05 50.41 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.52 22.02 72.97 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 126.915 2.198 . . . . 0.0 114.634 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -153.7 167.04 30.94 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 119.215 1.507 . . . . 0.0 110.279 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -137.09 158.39 44.55 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 127.583 2.353 . . . . 0.0 108.07 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.7 t -143.42 134.51 22.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 125.803 1.641 . . . . 0.0 107.21 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.72 141.7 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.172 1.389 . . . . 0.0 109.491 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -130.1 162.51 28.64 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -126.73 170.18 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 124.504 1.122 . . . . 0.0 108.74 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -74.31 -25.19 59.42 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.02 -30.53 3.19 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 120.138 1.335 . . . . 0.0 115.331 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -113.13 6.5 17.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.436 1.494 . . . . 0.0 113.335 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' A' ' 297' ' ' LYS . 34.0 mmtm -75.59 -168.14 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.447 1.499 . . . . 0.0 110.448 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.04 65.53 0.37 Allowed Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -52.53 -34.82 51.69 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.853 0.826 . . . . 0.0 112.528 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -58.18 -55.22 37.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.605 0.639 . . . . 0.0 110.251 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.63 -31.17 77.76 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HA ' HG22 ' A' ' 293' ' ' VAL . 53.6 tp -67.45 -35.53 79.4 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.214 -1.168 . . . . 0.0 110.333 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.39 -40.91 83.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 117.904 -1.046 . . . . 0.0 108.918 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -54.68 -45.02 73.84 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.451 1.1 . . . . 0.0 110.731 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 t -57.01 -47.14 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.63 -35.35 85.94 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.682 -1.065 . . . . 0.0 110.88 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm -64.26 -46.52 83.38 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.289 1.544 . . . . 0.0 108.696 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -57.74 11.26 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -55.64 -49.76 72.0 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 117.641 0.201 . . . . 0.0 111.418 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.16 -30.09 69.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.524 1.129 . . . . 0.0 111.545 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -25.39 45.09 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 117.726 -1.131 . . . . 0.0 110.759 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -100.68 -4.04 29.08 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.513 1.133 . . . . 0.0 111.767 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.2 p -132.52 -38.68 1.03 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.82 -18.36 56.06 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 121.201 -0.937 . . . . 0.0 112.779 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.2 mm -66.79 116.15 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 147.33 49.84 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.753 -0.592 . . . . 0.0 110.141 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.2 t -132.54 104.63 7.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 125.89 1.676 . . . . 0.0 109.154 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 m -84.7 141.77 30.34 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.92 115.95 19.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -125.65 167.67 14.78 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.21 0.604 . . . . 0.0 112.001 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -120.13 65.95 11.09 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.509 1.124 . . . . 0.0 112.945 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.7 161.61 36.46 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.14 1.893 . . . . 0.0 109.843 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -124.85 17.21 8.64 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.288 1.035 . . . . 0.0 110.648 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.98 8.23 2.5 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.844 1.658 . . . . 0.0 111.809 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.0 pt? -51.32 -26.78 8.1 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.249 1.42 . . . . 0.0 114.188 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.2 pm0 -61.07 -25.75 67.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.497 1.044 . . . . 0.0 111.437 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -115.5 -28.01 6.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -67.62 -44.25 78.49 Favored 'General case' 0 C--O 1.221 -0.447 0 O-C-N 119.813 -1.804 . . . . 0.0 109.687 179.226 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -52.98 -59.8 8.16 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 120.503 1.501 . . . . 0.0 109.343 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.34 -13.72 37.7 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 121.75 1.633 . . . . 0.0 114.213 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -90.07 -9.87 46.88 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.795 1.634 . . . . 0.0 111.69 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.2 -34.88 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 119.941 1.246 . . . . 0.0 112.036 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.96 -34.04 74.12 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.38 -14.76 30.19 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.611 1.164 . . . . 0.0 112.316 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.88 5.51 17.44 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.222 1.809 . . . . 0.0 110.509 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.6 30.28 76.13 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.37 7.43 7.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.736 1.214 . . . . 0.0 112.283 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.73 -171.51 43.68 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.139 1.828 . . . . 0.0 111.961 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.67 178.15 2.93 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.348 2.699 . . . . 0.0 111.27 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -104.2 -17.69 14.78 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.557 -0.714 . . . . 0.0 111.939 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.17 157.22 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.5 tp -143.9 142.68 24.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -131.2 107.38 8.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.817 1.247 . . . . 0.0 108.684 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -151.95 172.62 15.96 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.387 1.075 . . . . 0.0 108.579 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.27 162.46 28.43 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.827 1.194 . . . . 0.0 110.641 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -55.13 -26.34 37.74 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.77 1.628 . . . . 0.0 112.493 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -58.87 -64.77 0.82 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 118.015 -0.993 . . . . 0.0 112.462 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -62.5 -23.23 66.83 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 121.213 1.824 . . . . 0.0 109.918 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -72.78 -15.64 61.65 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.6 -0.687 . . . . 0.0 111.359 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.56 -21.5 60.43 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.23 1.395 . . . . 0.0 112.776 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.09 -33.89 2.09 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.477 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -53.65 -47.57 70.2 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.792 1.796 . . . . 0.0 114.241 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.07 -43.65 91.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.606 1.094 . . . . 0.0 110.417 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -56.61 -49.52 74.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.9 m -62.51 -3.25 1.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.952 1.701 . . . . 0.0 113.845 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.12 11.11 85.68 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 119.778 1.172 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -81.36 -21.32 39.17 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.026 1.413 . . . . 0.0 110.555 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.6 mt -111.44 140.98 45.59 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.356 0.98 . . . . 0.0 109.594 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.77 176.13 6.47 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.595 1.558 . . . . 0.0 110.469 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.54 144.36 49.6 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.576 1.15 . . . . 0.0 109.205 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.5 163.87 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.841 1.256 . . . . 0.0 109.665 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.2 m 65.39 81.8 0.21 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.767 1.627 . . . . 0.0 112.227 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.87 -65.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.964 1.776 . . . . 0.0 108.51 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.27 155.02 17.39 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.631 1.172 . . . . 0.0 110.07 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tptp -65.58 -28.51 69.2 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.74 1.216 . . . . 0.0 113.081 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.06 -36.65 60.86 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.288 0.949 . . . . 0.0 111.663 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -63.09 -28.11 69.85 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.861 -0.524 . . . . 0.0 111.084 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -73.75 -43.19 59.78 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.272 0.942 . . . . 0.0 110.176 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.19 -27.97 67.58 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.478 1.111 . . . . 0.0 112.476 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -66.03 -16.72 64.16 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.696 0.798 . . . . 0.0 111.559 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.1 mt -119.88 163.45 17.52 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.465 1.506 . . . . 0.0 109.13 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -69.86 147.79 96.2 Favored Pre-proline 0 C--O 1.235 0.292 0 O-C-N 121.403 -0.81 . . . . 0.0 110.245 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.89 -51.01 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.59 2.193 . . . . 0.0 113.083 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -55.2 -44.67 75.54 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.739 0.7 . . . . 0.0 109.944 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -27.47 57.13 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.23 1.012 . . . . 0.0 112.69 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -73.52 -33.28 64.68 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.651 1.114 . . . . 0.0 111.451 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -59.86 -37.02 78.1 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.225 0.61 . . . . 0.0 111.82 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.54 -3.31 4.31 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.994 -1.003 . . . . 0.0 113.002 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -132.19 11.89 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.369 1.468 . . . . 0.0 111.571 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.5 mtp-105 -76.26 156.36 33.56 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 121.038 -1.039 . . . . 0.0 109.404 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -131.13 177.78 7.2 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.846 1.658 . . . . 0.0 107.156 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -65.57 100.17 0.49 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.261 1.025 . . . . 0.0 109.298 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.61 -76.62 1.69 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.227 1.394 . . . . 0.0 110.701 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 166.69 20.51 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mt -100.34 160.13 14.58 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.769 1.627 . . . . 0.0 108.087 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.1 pt -133.52 -19.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.44 164.81 26.96 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.591 1.542 . . . . 0.0 108.165 178.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.2 137.51 22.53 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-O 118.747 -0.644 . . . . 0.0 110.443 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.49 129.44 18.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.777 2.318 . . . . 0.0 108.73 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 mm -121.2 -46.34 2.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.55 148.8 52.38 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 67.8 t -121.18 111.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.212 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.2 p90 . . . . . 0 C--O 1.237 0.432 0 C-N-CA 126.421 1.888 . . . . 0.0 108.758 179.745 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.452 -0.925 0 N-CA-C 110.226 -0.721 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -138.52 -19.06 1.08 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 116.437 -1.744 . . . . 0.0 114.159 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.76 136.38 32.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.716 1.598 . . . . 0.0 111.219 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -65.93 -26.09 67.43 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.167 -0.958 . . . . 0.0 110.89 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.32 -12.88 62.04 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.834 0.743 . . . . 0.0 112.748 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -92.45 -11.53 34.49 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.711 0.804 . . . . 0.0 111.171 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.58 -59.0 12.9 Favored Pre-proline 0 C--O 1.233 0.186 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.58 -23.31 49.86 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 CA-C-N 119.826 0.974 . . . . 0.0 110.978 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.89 89.76 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.738 0.699 . . . . 0.0 109.887 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.6 tp -80.79 -27.49 36.65 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -57.19 -47.58 80.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 124.292 1.037 . . . . 0.0 111.205 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -66.69 -28.44 68.45 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 122.994 0.518 . . . . 0.0 112.064 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -75.89 -42.4 49.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 56.9 mt -78.82 -32.84 46.38 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.722 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.85 -35.89 79.35 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.63 67.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.204 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -5.62 15.41 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.471 1.108 . . . . 0.0 112.414 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.69 -94.57 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 119.159 0.89 . . . . 0.0 113.556 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.484 ' HE2' ' OE2' ' A' ' 221' ' ' GLU . 27.9 mmtm -132.92 172.15 13.0 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.511 1.124 . . . . 0.0 110.849 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.56 162.73 3.63 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.424 1.49 . . . . 0.0 111.696 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.54 -55.99 4.14 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.8 tp -115.96 157.18 24.96 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.155 0.982 . . . . 0.0 110.818 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.3 mtp -148.7 114.17 5.6 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -140.5 174.01 10.93 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.799 0.84 . . . . 0.0 109.171 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.429 ' H ' HD22 ' A' ' 150' ' ' ASN . 1.2 p30 -69.42 76.05 0.39 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.864 2.065 . . . . 0.0 109.978 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.3 mt -73.07 -23.15 60.51 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -79.66 -1.73 39.56 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.655 0.782 . . . . 0.0 112.672 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -117.75 129.74 25.16 Favored Pre-proline 0 CA--C 1.529 0.147 0 C-N-CA 123.962 0.905 . . . . 0.0 112.878 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.11 -13.31 17.24 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.352 2.035 . . . . 0.0 112.286 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -59.04 -44.62 91.79 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.873 0.869 . . . . 0.0 110.4 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -91.92 -28.29 17.36 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.395 0.543 . . . . 0.0 111.42 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.5 p -80.16 -2.13 43.34 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 119.133 0.879 . . . . 0.0 110.47 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 32.8 t-105 -56.97 -66.3 1.29 Allowed Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 120.421 -1.424 . . . . 0.0 111.093 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.46 -20.39 60.96 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 CA-C-N 120.242 1.122 . . . . 0.0 112.899 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.82 -43.2 90.56 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-O 118.341 -0.838 . . . . 0.0 108.829 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 9.3 pt -93.01 -32.12 4.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.441 0.564 . . . . 0.0 111.663 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.86 -6.94 18.32 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.118 -0.988 . . . . 0.0 113.256 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -54.01 -46.21 71.72 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.903 1.281 . . . . 0.0 112.968 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -63.84 -50.4 69.0 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.521 0.601 . . . . 0.0 109.843 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.47 42.77 0.05 OUTLIER Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.329 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.03 154.6 24.63 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -159.91 121.99 3.32 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.33 -47.8 80.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -146.01 131.45 18.67 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -58.28 126.73 28.75 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -150.63 101.25 2.92 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.18 158.57 43.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 119.109 0.868 . . . . 0.0 108.888 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 47.9 27.33 1.13 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.156 1.783 . . . . 0.0 112.445 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 79.42 18.87 72.83 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.576 -1.125 . . . . 0.0 114.04 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -120.99 115.25 22.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.55 1.675 . . . . 0.0 107.372 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -106.08 121.24 43.73 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.287 1.435 . . . . 0.0 108.881 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -130.7 110.89 11.69 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 122.394 1.093 . . . . 0.0 111.094 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.1 OUTLIER -73.55 0.29 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 124.307 1.043 . . . . 0.0 109.367 177.088 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -84.19 -11.52 56.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.488 2.315 . . . . 0.0 111.623 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -127.4 105.69 8.69 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.67 140.4 49.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -124.52 29.8 4.89 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 117.871 -1.516 . . . . 0.0 116.188 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.38 -11.54 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.221 2.011 . . . . 0.0 113.693 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.14 10.25 10.0 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.472 1.033 . . . . 0.0 112.166 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.09 159.93 13.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.846 0.858 . . . . 0.0 110.055 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.79 -35.58 61.5 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.292 1.037 . . . . 0.0 110.862 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.85 -41.6 97.41 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 118.373 0.533 . . . . 0.0 112.366 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.07 64.98 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.16 0.98 . . . . 0.0 109.911 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -63.08 -37.79 88.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 118.566 -0.73 . . . . 0.0 110.671 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.23 71.9 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.646 0.778 . . . . 0.0 111.863 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.09 -28.03 24.22 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 192' ' ' LEU . 19.8 tp -74.92 -39.03 61.63 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.281 -1.717 . . . . 0.0 111.618 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.2 t -56.58 -33.61 66.37 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.923 0.489 . . . . 0.0 111.511 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -60.01 -54.62 43.9 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 119.389 0.995 . . . . 0.0 109.459 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 7.4 tt -56.38 -45.0 80.74 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.458 1.103 . . . . 0.0 110.233 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.31 -32.96 52.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.713 0.805 . . . . 0.0 109.893 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.589 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 19.1 t70 -63.72 -46.37 85.74 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.859 1.209 . . . . 0.0 112.726 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.62 -39.52 94.08 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.688 0.795 . . . . 0.0 109.76 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 75.5 mt -68.69 -40.29 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -52.67 -40.79 63.21 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.659 1.183 . . . . 0.0 109.7 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -90.99 0.87 57.43 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.121 1.768 . . . . 0.0 113.22 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.9 mptt 52.91 17.55 0.9 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 128.452 2.701 . . . . 0.0 114.972 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -82.27 -24.97 34.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.983 0.81 . . . . 0.0 109.315 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.0 tpt -77.94 163.38 26.04 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -82.52 51.19 1.8 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.68 -22.41 8.91 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 127.347 2.259 . . . . 0.0 115.905 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.99 8.63 43.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.506 1.522 . . . . 0.0 112.398 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 71.4 m -101.06 144.31 30.14 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.762 1.625 . . . . 0.0 111.158 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.78 -177.54 4.32 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.596 1.958 . . . . 0.0 108.85 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -48.48 -51.0 29.28 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.814 0.846 . . . . 0.0 112.884 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.26 -43.76 90.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.274 0.629 . . . . 0.0 111.142 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.09 -49.05 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.755 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.94 -47.53 86.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.5 1.12 . . . . 0.0 110.885 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.03 -42.68 80.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.138 0.575 . . . . 0.0 111.547 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.55 -48.18 35.03 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 122.023 -0.423 . . . . 0.0 110.146 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.25 -39.33 56.44 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.031 1.732 . . . . 0.0 111.775 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -53.79 -55.0 30.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.168 1.387 . . . . 0.0 109.079 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -62.13 -38.15 87.86 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.44 -17.67 64.72 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.627 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.62 11.9 76.35 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 119.117 0.871 . . . . 0.0 111.024 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.484 ' OE2' ' HE2' ' A' ' 144' ' ' LYS . 7.4 mm-40 -65.52 -60.63 2.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.544 1.137 . . . . 0.0 110.332 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.8 t -87.82 141.77 28.33 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.961 0.904 . . . . 0.0 109.444 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.19 -35.24 59.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -127.13 164.19 22.17 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.317 0.647 . . . . 0.0 109.545 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 52.4 m -151.13 155.29 38.61 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.763 0.825 . . . . 0.0 108.871 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 178.684 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -64.97 155.0 70.49 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.487 2.125 . . . . 0.0 108.798 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 61.6 p -97.45 179.76 4.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.356 1.062 . . . . 0.0 110.427 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -107.84 164.75 11.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -59.34 114.21 2.55 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.068 0.395 . . . . 0.0 110.201 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 69.92 15.29 71.5 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 118.364 -1.242 . . . . 0.0 113.965 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.46 117.9 3.23 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 120.639 2.22 . . . . 0.0 111.668 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.34 113.49 3.12 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.854 2.37 . . . . 0.0 111.165 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 31.6 t -57.82 157.03 7.97 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.215 1.006 . . . . 0.0 108.382 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -132.86 60.8 52.41 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 125.634 1.574 . . . . 0.0 112.792 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.88 164.59 31.06 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.542 1.495 . . . . 0.0 109.452 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 . . . . . 0 C--O 1.237 0.444 0 CA-C-O 122.642 1.211 . . . . 0.0 112.966 -179.327 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.552 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 19.0 t -145.11 148.93 17.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.43 1.092 . . . . 0.0 109.56 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 263' ' ' SER . 1.1 tt -77.02 149.49 35.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.57 ' H ' HD23 ' A' ' 262' ' ' LEU . 19.3 m -126.38 154.2 43.91 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.814 0.846 . . . . 0.0 111.828 -178.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -136.93 134.48 36.81 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.471 1.108 . . . . 0.0 108.277 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -142.53 154.99 25.51 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 75.1 mt -93.55 136.37 25.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.974 1.309 . . . . 0.0 107.591 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -72.72 113.78 10.14 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.9 -20.07 66.25 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.184 -0.912 . . . . 0.0 113.429 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -73.74 -16.35 61.18 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.7 m -70.27 163.56 61.07 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 119.084 0.856 . . . . 0.0 110.514 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.69 -46.06 2.88 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.331 2.021 . . . . 0.0 115.327 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -137.42 114.7 10.93 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 119.078 0.854 . . . . 0.0 112.203 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -18.32 64.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.024 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -59.83 -40.36 88.19 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 98.9 mt -57.8 -41.22 81.72 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.496 -0.752 . . . . 0.0 111.093 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -77.91 -42.76 32.11 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -33.94 76.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.431 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -68.76 -52.57 29.05 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -55.33 -43.54 75.03 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.204 -0.935 . . . . 0.0 112.326 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -61.03 -51.23 70.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.486 1.114 . . . . 0.0 110.09 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -75.07 -17.81 60.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -105.79 -26.45 11.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.06 -1.448 . . . . 0.0 113.858 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -131.18 -37.41 1.26 Allowed 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 120.719 1.6 . . . . 0.0 113.609 -178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 284' ' ' LEU . 1.7 tm? -62.0 -50.0 73.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 116.516 -2.073 . . . . 0.0 107.415 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 90.6 mt -82.91 52.5 2.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.586 1.954 . . . . 0.0 115.883 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 13.2 p -131.01 160.34 34.85 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -63.19 -47.01 84.41 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -70.44 -32.63 70.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.524 1.13 . . . . 0.0 111.074 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.87 -42.76 44.38 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 54.7 mt -70.37 -46.54 63.88 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -56.67 -43.55 80.54 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.491 0.716 . . . . 0.0 109.954 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.34 61.18 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 20' ' ' LEU . 5.0 t -88.27 -31.4 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 122.842 0.457 . . . . 0.0 109.886 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -71.62 -23.92 61.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.763 0.425 . . . . 0.0 111.251 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -59.71 -47.35 86.01 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.17 -59.62 4.51 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.106 0.962 . . . . 0.0 112.033 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -137.87 160.46 64.55 Favored Pre-proline 0 N--CA 1.463 0.211 0 O-C-N 121.389 -0.82 . . . . 0.0 112.293 -178.576 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -69.92 110.07 2.5 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.691 1.594 . . . . 0.0 108.164 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.41 -9.75 58.84 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 85.22 -166.58 40.52 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 119.709 1.141 . . . . 0.0 110.276 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -73.67 168.43 19.37 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.026 0.93 . . . . 0.0 110.765 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.16 153.9 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 123.61 0.764 . . . . 0.0 110.831 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.0 41.17 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.947 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 63.5 tp -65.75 100.46 0.54 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.52 1.928 . . . . 0.0 106.869 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -47.5 -37.72 12.5 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.353 1.061 . . . . 0.0 112.983 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.8 m -55.41 -60.48 3.35 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.693 0.797 . . . . 0.0 112.768 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -83.77 -9.97 58.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.822 1.249 . . . . 0.0 111.806 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -61.5 -42.62 99.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -67.47 -37.79 83.43 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 124.39 1.056 . . . . 0.0 111.272 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -65.16 -50.74 64.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.6 -38.62 89.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.86 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.64 -15.97 33.89 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.561 1.145 . . . . 0.0 113.662 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -60.25 -16.02 30.09 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.973 0.806 . . . . 0.0 111.605 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.3 135.26 19.68 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 119.335 0.97 . . . . 0.0 110.597 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.43 -34.46 94.63 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.288 2.659 . . . . 0.0 112.805 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.62 -33.47 75.07 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.029 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.9 mp -79.68 -54.26 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -43.96 -55.21 4.78 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.507 1.123 . . . . 0.0 112.211 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.22 -30.03 70.18 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 9.8 m -77.55 -32.54 53.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.765 0.826 . . . . 0.0 109.259 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.0 tpt -74.39 -41.84 60.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -49.64 -42.02 44.03 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 125.384 1.474 . . . . 0.0 111.288 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -59.27 -44.51 92.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.815 2.046 . . . . 0.0 110.368 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.519 0 O-C-N 122.222 -0.299 . . . . 0.0 110.815 178.184 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo . . . . . 0 N--CA 1.455 -0.792 0 CA-C-O 122.725 1.052 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -134.19 16.58 3.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.43 1.892 . . . . 0.0 112.056 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.3 pt -116.91 153.72 49.47 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.709 1.204 . . . . 0.0 112.021 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.28 -5.42 17.13 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.771 2.981 . . . . 0.0 115.406 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -57.79 -19.24 26.96 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.768 -1.207 . . . . 0.0 111.884 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 2.2 mtp -61.85 -24.07 66.67 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.772 -0.58 . . . . 0.0 110.472 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 40.3 t -54.57 -53.56 52.9 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.073 1.349 . . . . 0.0 109.004 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.22 -43.71 90.6 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.824 0.449 . . . . 0.0 110.514 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -53.67 -54.09 42.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.816 0.846 . . . . 0.0 110.773 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -59.96 -50.0 75.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.133 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -55.38 -42.75 74.42 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.473 0.579 . . . . 0.0 111.217 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.411 ' HB1' ' HB1' ' A' ' 364' ' ' ALA . . . -62.32 -57.3 11.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.468 1.107 . . . . 0.0 111.979 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.5 t -63.58 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.109 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -50.87 -41.31 58.07 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.539 1.063 . . . . 0.0 110.041 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.0 m -79.94 -47.14 15.48 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.415 -0.803 . . . . 0.0 110.525 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.07 -44.74 64.46 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 36.4 t -60.51 -47.69 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.34 -36.18 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.45 0.568 . . . . 0.0 109.766 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -59.41 -49.88 76.12 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.438 1.017 . . . . 0.0 109.527 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.36 -43.49 73.48 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.081 0.552 . . . . 0.0 110.79 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.84 -29.03 70.43 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.778 0.831 . . . . 0.0 112.37 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 6.7 m -92.45 -10.31 38.39 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.651 0.78 . . . . 0.0 110.076 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 72.73 10.39 76.38 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.194 -0.781 . . . . 0.0 112.572 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -67.15 -29.41 69.11 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.935 1.367 . . . . 0.0 111.883 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -140.09 157.5 45.53 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.4 m -62.3 152.56 33.39 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.855 0.862 . . . . 0.0 109.214 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.8 -48.49 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.35 -49.52 72.03 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.976 1.71 . . . . 0.0 111.159 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -75.53 -30.79 59.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.31 -41.32 98.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 7.9 mp -73.21 -38.62 66.02 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.243 1.017 . . . . 0.0 109.518 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -57.29 13.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.579 1.081 . . . . 0.0 110.389 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -55.42 -36.32 66.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 122.386 1.089 . . . . 0.0 109.951 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.411 ' HB1' ' HB1' ' A' ' 342' ' ' ALA . . . -68.57 -46.99 67.97 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 117.537 -1.221 . . . . 0.0 111.236 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -52.72 -39.29 61.92 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.538 1.063 . . . . 0.0 109.655 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 4.4 m -63.77 -26.15 68.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 112.828 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -72.89 -18.92 61.37 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.448 -1.407 . . . . 0.0 111.028 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.9 mp -92.68 -38.46 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.214 1.006 . . . . 0.0 109.105 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 7.7 p -69.19 -15.67 63.45 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.373 0.988 . . . . 0.0 111.668 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 51.6 tttm . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.955 2.102 . . . . 0.0 110.309 179.155 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 . . . . . 0 N--CA 1.45 -0.473 1 N-CA-C 97.888 -4.856 . . . . 0.0 97.888 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -77.03 171.16 15.24 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.764 0.711 . . . . 0.0 111.818 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.49 38.89 71.97 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.812 1.196 . . . . 0.0 115.78 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -145.77 173.5 12.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.864 0.832 . . . . 0.0 110.031 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.3 mt -142.13 154.49 44.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.951 2.101 . . . . 0.0 107.519 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.4 t -144.53 117.33 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.422 HD11 ' CE2' ' A' ' 279' ' ' PHE . 40.5 mt -99.4 126.52 52.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -112.93 140.37 47.8 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mp -129.79 148.84 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 C-N-CA 125.588 1.555 . . . . 0.0 109.846 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.76 -64.75 1.01 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.3 169.45 42.28 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.629 1.585 . . . . 0.0 109.149 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 52.45 3.17 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.22 3.008 . . . . 0.0 115.775 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.56 -28.85 68.13 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.763 1.625 . . . . 0.0 115.376 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.7 36.15 6.98 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -51.61 -34.23 36.53 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -59.47 -40.51 87.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.645 0.778 . . . . 0.0 112.087 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.59 -30.81 26.07 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -62.71 -38.01 88.73 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.603 1.161 . . . . 0.0 111.552 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.22 -46.3 62.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.66 0.784 . . . . 0.0 110.945 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -60.0 -35.5 75.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.844 -0.598 . . . . 0.0 112.438 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.2 t -62.32 -43.98 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.88 -40.89 93.67 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -63.39 -40.92 98.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.216 1.008 . . . . 0.0 109.52 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -63.64 -57.71 9.19 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -55.0 -43.61 73.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.637 0.653 . . . . 0.0 111.992 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.86 -28.19 69.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.448 1.022 . . . . 0.0 110.651 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.4 -23.04 35.11 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.058 -1.026 . . . . 0.0 112.272 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -99.83 -17.95 17.4 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.264 0.978 . . . . 0.0 111.979 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.3 p -122.76 -34.4 3.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.161 0.891 . . . . 0.0 113.184 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.38 -15.05 64.04 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.992 -0.893 . . . . 0.0 111.682 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.0 mm -66.86 120.15 13.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -61.79 146.4 49.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.9 t -135.51 143.49 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.7 m -125.12 143.06 51.12 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.74 119.01 23.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.41 163.23 25.32 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.128 0.971 . . . . 0.0 109.915 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -139.09 65.34 36.14 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.161 0.585 . . . . 0.0 111.262 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.86 173.09 14.06 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 125.054 3.836 . . . . 0.0 109.123 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -123.5 1.14 8.92 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.622 0.769 . . . . 0.0 111.828 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -119.29 6.84 11.19 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.172 0.989 . . . . 0.0 111.097 178.651 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -59.32 -20.71 56.76 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.709 -1.244 . . . . 0.0 112.072 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -60.58 -21.29 62.46 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.729 0.811 . . . . 0.0 112.499 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -122.63 -23.01 5.23 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.715 1.606 . . . . 0.0 111.026 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -78.07 -38.84 43.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.927 1.291 . . . . 0.0 110.693 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -52.02 -57.22 15.83 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 120.376 1.443 . . . . 0.0 110.094 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.82 -16.23 52.19 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.77 1.646 . . . . 0.0 114.385 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -84.54 -12.63 53.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.698 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.82 -40.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 120.154 1.343 . . . . 0.0 109.746 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.34 -43.09 53.84 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.803 1.241 . . . . 0.0 112.498 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.55 70.94 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.546 -0.721 . . . . 0.0 111.689 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 m -74.79 -5.89 45.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.204 1.402 . . . . 0.0 112.79 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.18 47.62 10.77 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -158.42 176.23 12.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 130.99 3.716 . . . . 0.0 104.111 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.6 -170.55 13.59 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.669 -1.269 . . . . 0.0 110.472 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -78.07 -177.16 3.66 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.637 2.892 . . . . 0.0 110.289 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.3 -20.16 13.36 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.573 -0.705 . . . . 0.0 111.972 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mt -137.92 151.84 25.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.546 0.689 . . . . 0.0 110.552 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.02 139.73 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.656 1.182 . . . . 0.0 109.106 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.82 114.43 17.23 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.984 1.314 . . . . 0.0 109.695 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -165.35 -166.01 0.94 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.295 0.952 . . . . 0.0 112.072 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.34 133.4 44.94 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.077 2.151 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -60.08 -29.47 68.58 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.579 1.952 . . . . 0.0 112.308 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.98 -37.6 78.84 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.844 0.747 . . . . 0.0 110.403 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -24.46 56.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -68.66 -30.84 69.62 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.79 -36.26 86.01 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.84 -52.54 14.42 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -56.16 -34.66 66.36 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.531 1.165 . . . . 0.0 111.057 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -45.67 83.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -40.78 88.09 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.1 m -63.66 -12.47 34.24 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.611 -0.68 . . . . 0.0 110.138 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.55 16.22 76.23 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.744 1.64 . . . . 0.0 112.215 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.1 mt -88.15 -10.25 50.58 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mt -96.14 140.9 30.18 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.778 0.717 . . . . 0.0 110.954 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.03 172.2 8.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.981 1.312 . . . . 0.0 112.152 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -78.11 90.18 4.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.453 1.501 . . . . 0.0 111.834 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.447 HD12 ' HB ' ' A' ' 80' ' ' THR . 2.4 pp -73.23 178.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.815 1.246 . . . . 0.0 111.444 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.447 ' HB ' HD12 ' A' ' 79' ' ' ILE 0.337 0.5 OUTLIER 57.77 74.42 0.65 Allowed Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 127.602 2.361 . . . . 0.0 106.363 -178.447 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.42 -24.49 64.1 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.72 2.28 . . . . 0.0 113.605 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -147.13 148.59 31.73 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.709 0.804 . . . . 0.0 109.805 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -55.64 -29.46 59.28 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.842 2.057 . . . . 0.0 112.977 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.25 -36.24 77.34 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.331 0.514 . . . . 0.0 110.102 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -58.6 -32.64 69.17 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.514 0.726 . . . . 0.0 111.595 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -64.27 -46.52 83.32 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.675 -0.64 . . . . 0.0 110.587 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -66.95 -19.15 65.67 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -74.26 -11.47 60.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.348 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mt -124.55 160.91 27.31 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.272 1.429 . . . . 0.0 110.545 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -72.07 150.27 92.4 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.96 -44.45 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.075 2.516 . . . . 0.0 114.416 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -58.19 -34.32 70.23 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.029 0.832 . . . . 0.0 111.782 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -29.82 71.08 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.049 -1.032 . . . . 0.0 111.024 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -73.72 -35.23 65.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.32 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.76 -31.55 64.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.231 0.923 . . . . 0.0 112.501 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.3 -29.75 67.67 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.58 2.64 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.559 1.144 . . . . 0.0 113.733 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -63.79 160.38 17.41 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 122.328 1.061 . . . . 0.0 110.163 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -143.92 175.0 10.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -70.6 110.16 5.29 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.456 0.702 . . . . 0.0 110.463 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.88 -78.29 0.77 Allowed Glycine 0 C--N 1.335 0.486 0 C-N-CA 125.862 1.696 . . . . 0.0 111.028 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.04 166.25 21.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.69 165.5 11.12 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 pt -128.51 -30.52 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.88 176.78 12.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 119.148 0.885 . . . . 0.0 108.62 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.56 145.92 58.95 Favored Pre-proline 0 C--O 1.238 0.473 0 O-C-N 123.083 0.239 . . . . 0.0 110.852 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -66.47 147.96 83.2 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.561 2.841 . . . . 0.0 107.847 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 mm -133.43 -52.44 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 124.043 0.937 . . . . 0.0 110.67 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -131.38 167.29 19.53 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.336 0.398 . . . . 0.0 111.297 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.5 t -135.31 141.15 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 C--N 1.328 -0.366 0 C-N-CA 125.679 1.592 . . . . 0.0 107.525 177.664 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.7 mt . . . . . 0 C--O 1.236 0.394 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 30.6 p90 . . . . . 0 C--O 1.239 0.543 0 C-N-CA 124.361 1.064 . . . . 0.0 109.878 179.952 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 N-CA-C 110.164 -0.745 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -136.75 -33.66 0.77 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.834 1.253 . . . . 0.0 111.804 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.2 162.62 33.79 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 117.974 0.352 . . . . 0.0 110.844 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.405 ' CE2' HD13 ' A' ' 160' ' ' LEU . 28.3 m95 -67.23 -18.23 65.15 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.999 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -64.51 -8.5 14.05 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.877 1.271 . . . . 0.0 113.4 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -107.08 -18.76 13.81 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.668 1.587 . . . . 0.0 110.996 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.6 mm -56.9 -58.18 19.36 Favored Pre-proline 0 C--N 1.333 -0.141 0 O-C-N 120.823 -1.173 . . . . 0.0 111.822 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -67.41 -25.61 41.74 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 120.501 1.215 . . . . 0.0 110.717 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.85 -41.16 83.34 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.631 1.173 . . . . 0.0 110.349 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.6 tp -82.46 -27.89 31.58 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.148 0.885 . . . . 0.0 109.759 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.71 -44.91 96.02 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 121.325 -0.86 . . . . 0.0 109.615 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -64.54 -28.42 69.63 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.558 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -75.11 -43.35 53.34 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 123.102 0.561 . . . . 0.0 110.658 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 54.2 mt -75.38 -29.96 60.0 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.465 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.14 -38.04 81.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.8 -22.16 66.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.704 1.202 . . . . 0.0 113.07 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.12 4.92 9.81 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 125.445 1.498 . . . . 0.0 112.358 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.92 -95.47 0.1 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 119.37 0.986 . . . . 0.0 113.634 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -142.1 178.21 7.69 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.84 1.256 . . . . 0.0 111.617 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.18 154.01 10.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.878 1.271 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.93 -63.54 1.34 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.954 1.302 . . . . 0.0 111.999 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 41.2 tp -97.43 138.08 35.42 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.323 1.049 . . . . 0.0 110.707 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.415 ' CE ' HG22 ' A' ' 212' ' ' ILE . 94.3 mtp -145.44 110.25 5.12 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -142.19 157.18 45.15 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -72.97 137.66 45.61 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.615 0.722 . . . . 0.0 110.744 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.8 mt -121.01 -9.51 9.21 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.807 1.643 . . . . 0.0 111.276 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -72.14 -22.26 61.34 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.625 0.77 . . . . 0.0 112.53 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -113.99 152.05 45.39 Favored Pre-proline 0 N--CA 1.468 0.425 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.46 -11.83 10.46 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.594 2.196 . . . . 0.0 114.791 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -60.57 -41.85 95.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 120.896 1.68 . . . . 0.0 111.986 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -76.42 -28.81 56.78 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 79.0 p -91.43 -9.4 44.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.474 0.71 . . . . 0.0 111.001 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -62.36 -61.13 8.19 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 121.173 -0.954 . . . . 0.0 111.84 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.19 -19.79 69.44 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 121.216 1.47 . . . . 0.0 112.625 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.405 HD13 ' CE2' ' A' ' 129' ' ' TRP . 47.1 tp -68.19 -61.6 1.78 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 15.8 pt -67.03 -27.33 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.254 0.479 . . . . 0.0 111.687 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.1 0.58 27.49 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.762 -1.211 . . . . 0.0 112.929 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.99 -52.34 66.19 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 119.408 1.004 . . . . 0.0 112.076 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -58.3 -58.43 8.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.744 0.817 . . . . 0.0 110.757 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -176.61 25.78 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.543 -1.143 . . . . 0.0 113.492 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.21 149.44 37.42 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -152.61 138.8 18.32 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.54 -64.79 0.92 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.86 126.64 32.68 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -69.8 148.97 48.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.992 0.517 . . . . 0.0 110.297 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -148.85 105.63 3.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -77.71 -166.41 0.77 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.85 1.26 . . . . 0.0 109.036 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -62.18 16.97 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.475 2.71 . . . . 0.0 113.403 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.22 -2.8 0.62 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.989 1.757 . . . . 0.0 113.761 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -112.25 120.38 41.56 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.462 1.631 . . . . 0.0 107.732 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -118.43 112.88 20.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -125.86 106.3 9.56 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -59.46 -6.82 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.313 1.445 . . . . 0.0 112.183 179.247 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -31.79 57.81 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.857 1.663 . . . . 0.0 110.723 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.86 101.34 12.22 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.0 t -120.8 135.87 59.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 125.694 1.598 . . . . 0.0 109.784 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -114.3 18.1 18.52 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.202 -0.776 . . . . 0.0 114.664 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 66.4 t -49.52 -40.99 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.133 1.773 . . . . 0.0 114.051 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.8 23.91 12.6 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -70.56 167.6 18.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.406 0.622 . . . . 0.0 111.022 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.61 60.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.714 1.205 . . . . 0.0 113.691 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.85 -35.3 65.77 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 118.617 0.644 . . . . 0.0 112.288 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -68.23 -51.63 43.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.677 0.791 . . . . 0.0 109.459 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -61.75 -36.59 81.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.374 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.92 -48.91 79.65 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.668 0.667 . . . . 0.0 109.98 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.75 -36.88 93.89 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 27.3 tp -72.16 -51.09 22.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.47 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 6.2 t -56.21 -32.99 64.92 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.623 1.101 . . . . 0.0 111.122 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -58.66 -59.44 5.39 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.464 1.029 . . . . 0.0 109.232 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.06 -45.55 94.28 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.317 0.647 . . . . 0.0 110.529 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.8 t -57.87 -32.03 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.369 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.02 -35.84 82.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.983 1.265 . . . . 0.0 111.1 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 25.1 mt -64.73 -36.19 83.5 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.25 -41.88 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.094 1.358 . . . . 0.0 109.182 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -52.55 -45.56 66.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.97 1.308 . . . . 0.0 108.917 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -88.24 2.76 51.58 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.148 1.779 . . . . 0.0 112.749 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.1 mptt 56.51 19.93 4.49 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.319 2.248 . . . . 0.0 112.934 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -31.45 65.07 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.429 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.0 tpt -89.19 -176.61 5.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.811 1.645 . . . . 0.0 111.514 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -125.63 73.14 1.31 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.576 1.55 . . . . 0.0 108.84 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.73 -18.77 56.53 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -79.81 -7.12 58.49 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.418 1.887 . . . . 0.0 112.564 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 51.9 m -72.19 120.81 18.31 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.303 1.049 . . . . 0.0 109.339 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -118.7 175.1 5.89 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -48.73 -41.23 31.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.507 0.723 . . . . 0.0 112.262 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.8 t -57.35 -51.96 67.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.562 1.945 . . . . 0.0 111.954 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.415 HG22 ' CE ' ' A' ' 148' ' ' MET . 16.5 mm -61.75 -47.71 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 124.406 1.082 . . . . 0.0 111.323 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.1 -45.84 66.11 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.969 -178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -56.94 -45.09 83.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.451 0.569 . . . . 0.0 111.023 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.86 -57.91 10.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.207 0.603 . . . . 0.0 109.97 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.35 -47.28 69.53 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.694 0.798 . . . . 0.0 110.826 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -59.03 -41.47 87.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.9 1.28 . . . . 0.0 111.622 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -61.03 -37.01 81.05 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.763 0.711 . . . . 0.0 110.413 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -74.48 -45.09 48.3 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 116.06 14.3 7.9 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.916 2.198 . . . . 0.0 109.755 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -70.29 21.34 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.763 3.225 . . . . 0.0 112.789 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.2 p -130.48 174.74 9.59 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.57 2.348 . . . . 0.0 109.345 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.09 -33.73 2.4 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.742 0.817 . . . . 0.0 112.106 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 7.8 ptt? -152.86 161.15 42.92 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.847 0.859 . . . . 0.0 109.05 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.0 t -151.83 173.07 15.22 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 14.4 mt . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.296 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.78 125.97 10.38 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.527 2.152 . . . . 0.0 109.947 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 255' ' ' SER . 43.4 p -143.5 -151.44 0.36 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.44 141.8 39.77 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 177.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -53.0 125.83 18.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.415 1.886 . . . . 0.0 110.386 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 61.63 11.67 30.27 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.808 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -155.57 75.75 5.06 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.1 154.87 57.38 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.971 1.781 . . . . 0.0 114.112 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.404 ' H ' ' HB ' ' A' ' 249' ' ' THR . 33.8 m -65.01 140.88 58.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' A' ' 256' ' ' LYS . 0.1 OUTLIER -146.19 93.32 5.09 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 125.227 1.411 . . . . 0.0 109.053 -178.688 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.32 -63.01 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.327 2.018 . . . . 0.0 111.472 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 . . . . . 0 C--O 1.232 0.162 0 C-N-CA 125.667 1.587 . . . . 0.0 108.366 179.812 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.365 0 N-CA-C 105.398 -3.081 . . . . 0.0 105.398 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.48 156.77 42.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-N 117.852 0.826 . . . . 0.0 109.851 -178.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.7 139.97 30.01 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.017 0.927 . . . . 0.0 109.115 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.2 m -131.75 169.11 16.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.154 0.982 . . . . 0.0 112.138 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -134.69 140.42 45.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.865 1.266 . . . . 0.0 108.325 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.64 167.69 16.92 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.9 mt -117.48 135.59 57.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -75.07 115.28 14.53 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.82 -15.53 21.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.65 0.78 . . . . 0.0 113.012 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -66.29 -23.24 66.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.332 1.053 . . . . 0.0 111.663 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 11.2 m -60.42 154.81 52.08 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 126.187 1.795 . . . . 0.0 112.649 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.5 -47.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.347 2.032 . . . . 0.0 111.801 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.44 86.25 2.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.701 0.8 . . . . 0.0 109.477 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -52.84 -24.05 8.23 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.236 1.414 . . . . 0.0 112.332 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -59.37 -34.68 72.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.193 1.797 . . . . 0.0 110.15 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.24 -36.98 81.43 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 120.713 -1.242 . . . . 0.0 110.009 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.23 57.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.948 -0.549 . . . . 0.0 111.028 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -37.4 87.07 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.845 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -71.54 -51.24 24.57 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 124.024 0.828 . . . . 0.0 109.747 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.422 ' CE2' HD11 ' A' ' 9' ' ' ILE . 9.0 t80 -48.87 -52.91 21.75 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.913 0.485 . . . . 0.0 110.295 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.86 -55.23 31.96 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.321 0.248 . . . . 0.0 111.353 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.318 7.6 pt-20 -71.57 1.65 6.28 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -177.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -115.11 -21.0 10.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.229 -1.367 . . . . 0.0 111.226 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -132.5 -59.21 0.92 Allowed 'General case' 0 C--N 1.346 0.418 0 CA-C-N 119.998 1.272 . . . . 0.0 109.673 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.65 -42.48 62.11 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 44.0 mt -82.91 27.52 0.54 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 14.8 p -113.7 167.77 10.34 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.57 -38.51 90.35 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -71.41 -38.55 71.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.982 0.913 . . . . 0.0 111.604 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -69.08 -45.7 61.36 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.94 -46.41 81.72 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -57.1 -43.57 82.35 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.802 0.841 . . . . 0.0 110.291 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.2 -49.92 68.28 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.65 -36.33 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 119.375 -0.345 . . . . 0.0 110.24 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -63.75 -27.43 69.19 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.706 0.803 . . . . 0.0 111.656 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -67.44 -43.64 80.65 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.759 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -70.24 -56.44 6.76 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.878 0.763 . . . . 0.0 109.749 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -134.92 145.04 52.95 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.27 136.37 40.09 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.518 2.145 . . . . 0.0 112.252 -178.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 80.3 mt -78.48 -29.84 46.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 101.09 -78.39 0.4 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 105.9 -2.88 . . . . 0.0 105.9 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -149.35 171.09 17.09 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 131.577 3.951 . . . . 0.0 104.93 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 35.9 m -132.18 149.88 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 O-C-N 120.656 -1.277 . . . . 0.0 112.244 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.69 -21.33 55.52 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.623 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.93 105.26 1.94 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 126.287 1.835 . . . . 0.0 107.256 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -53.57 -27.63 27.47 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.9 m -73.11 -61.18 1.91 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 118.552 0.614 . . . . 0.0 111.246 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -67.36 -23.63 65.62 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.571 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -63.95 -21.41 66.47 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.206 0.912 . . . . 0.0 108.719 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -72.97 -37.51 67.05 Favored 'General case' 0 C--N 1.342 0.245 0 O-C-N 120.286 -1.509 . . . . 0.0 108.725 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -70.26 -46.91 63.42 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.185 0.994 . . . . 0.0 108.607 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.437 ' O ' HD13 ' A' ' 317' ' ' ILE . 23.1 mt -63.31 -40.71 98.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.17 -11.63 9.79 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.82 -11.48 27.47 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.488 1.04 . . . . 0.0 111.201 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.52 133.66 23.53 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -56.78 -23.85 52.38 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.133 2.555 . . . . 0.0 115.946 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.465 ' HG2' HD12 ' A' ' 317' ' ' ILE . 0.0 OUTLIER -62.66 -44.18 96.92 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.298 1.408 . . . . 0.0 110.802 179.546 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.465 HD12 ' HG2' ' A' ' 316' ' ' ARG . 4.8 mp -74.55 -46.38 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.55 -52.23 48.82 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.291 0.496 . . . . 0.0 110.112 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.85 -35.63 78.85 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.722 -0.611 . . . . 0.0 112.059 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.0 m -62.04 -39.25 91.71 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.58 -40.77 48.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.694 0.398 . . . . 0.0 110.55 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -53.05 -45.78 68.21 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.436 1.495 . . . . 0.0 109.784 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -41.35 94.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.551 0 CA-C-N 118.838 0.745 . . . . 0.0 111.414 178.901 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.537 0.663 0 CA-C-O 122.007 0.753 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -138.77 10.09 2.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.794 1.638 . . . . 0.0 110.99 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.9 pt -82.3 154.59 69.33 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 120.341 -1.475 . . . . 0.0 111.213 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.46 -17.01 16.78 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.163 2.575 . . . . 0.0 113.497 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -57.45 -21.57 37.85 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.501 1.12 . . . . 0.0 112.506 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 73.8 mmm -57.83 -31.13 66.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.336 1.054 . . . . 0.0 111.154 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 22.4 t -57.3 -53.04 62.65 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.88 -29.64 65.79 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 118.401 -0.809 . . . . 0.0 112.101 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.57 ' O ' HG22 ' A' ' 343' ' ' VAL . 52.7 t80 -57.75 -58.53 7.97 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.573 0.624 . . . . 0.0 109.754 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -56.25 -44.01 79.25 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -59.09 -39.92 83.71 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.113 0.415 . . . . 0.0 110.942 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.38 -59.98 2.95 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.157 0.583 . . . . 0.0 111.675 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 339' ' ' PHE . 3.2 m -59.27 -36.73 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 118.944 -0.551 . . . . 0.0 111.901 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 56.9 ttp85 -56.75 -37.22 70.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.261 0.937 . . . . 0.0 109.774 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 54.0 m -79.93 -44.49 20.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.683 -0.675 . . . . 0.0 109.834 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.45 -46.05 69.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.384 0.993 . . . . 0.0 112.882 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 89.0 t -59.11 -52.78 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.8 mm -64.08 -35.51 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.845 0.748 . . . . 0.0 110.491 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -61.22 -45.83 92.96 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.623 -1.298 . . . . 0.0 110.537 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.57 -50.32 32.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.128 0.571 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.42 -35.54 77.84 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.461 1.504 . . . . 0.0 114.895 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 28.9 m -91.22 0.33 57.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.206 0.602 . . . . 0.0 109.87 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 71.13 12.87 72.5 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 119.379 -0.679 . . . . 0.0 113.534 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -64.54 -32.96 74.82 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.313 1.056 . . . . 0.0 108.469 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -147.3 163.65 35.72 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.3 m -66.45 155.94 36.13 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.272 1.029 . . . . 0.0 108.917 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.58 -52.64 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.776 0.83 . . . . 0.0 110.001 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.66 -50.8 71.02 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.486 1.115 . . . . 0.0 110.159 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -62.0 -42.06 98.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.52 94.27 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 122.025 -0.422 . . . . 0.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 46.6 mt -71.23 -42.89 68.3 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.341 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -54.63 -50.74 67.4 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.396 1.079 . . . . 0.0 108.838 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.7 -49.95 69.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.42 87.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.159 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -58.84 -38.18 78.12 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.27 0.941 . . . . 0.0 108.676 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.4 m -64.22 -47.16 80.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.913 0.885 . . . . 0.0 109.309 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 72.0 mtt-85 -57.89 -25.71 61.17 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.321 0.964 . . . . 0.0 113.212 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 70.1 mt -94.57 -19.26 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 126.925 2.09 . . . . 0.0 112.101 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 66.5 p -113.56 1.95 15.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.24 1.382 . . . . 0.0 114.459 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? . . . . . 0 C--O 1.248 1.013 0 C-N-CA 125.179 1.392 . . . . 0.0 109.134 179.5 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.82 165.44 14.13 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.727 0.694 . . . . 0.0 111.037 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.15 35.78 89.16 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.101 1.334 . . . . 0.0 114.768 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -143.51 169.58 17.44 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.809 1.304 . . . . 0.0 112.974 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.1 mt -151.98 141.24 21.41 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.207 3.003 . . . . 0.0 108.012 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.08 134.44 36.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 119.784 1.175 . . . . 0.0 108.78 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.2 mt -124.11 128.69 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 125.244 1.417 . . . . 0.0 108.752 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -114.61 138.99 49.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.38 159.98 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.924 0.783 . . . . 0.0 109.502 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -154.39 166.43 33.26 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.27 24.2 27.29 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-O 117.823 -1.543 . . . . 0.0 114.857 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.1 t70 68.97 24.1 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.427 1.491 . . . . 0.0 114.413 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -59.39 157.2 11.48 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.444 1.897 . . . . 0.0 112.591 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.15 67.32 3.63 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.794 1.664 . . . . 0.0 109.818 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -58.75 -33.74 70.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.839 0.819 . . . . 0.0 112.484 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -61.17 -45.69 93.6 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.525 0.602 . . . . 0.0 109.791 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.77 -37.59 94.53 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.7 tp -69.93 -35.98 74.97 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 121.634 -0.921 . . . . 0.0 110.977 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.49 -40.14 36.32 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 117.681 -1.152 . . . . 0.0 112.821 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.78 -37.62 74.03 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.843 1.257 . . . . 0.0 113.386 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 t -61.54 -52.12 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.67 76.65 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -64.37 -29.42 70.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 118.817 1.308 . . . . 0.0 109.83 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.12 -52.04 7.81 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -53.31 -48.21 68.61 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.017 0.371 . . . . 0.0 110.453 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -60.38 -39.15 86.24 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.728 -1.232 . . . . 0.0 110.802 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 29' ' ' LYS . 13.3 tppt? -67.19 -28.3 67.98 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.554 0.742 . . . . 0.0 111.476 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -98.34 -3.89 36.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.935 1.294 . . . . 0.0 112.434 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.3 p -135.8 -36.04 0.77 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.45 -15.97 61.32 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.281 1.42 . . . . 0.0 112.054 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.85 130.38 28.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -68.44 130.26 42.35 Favored 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 121.498 -0.751 . . . . 0.0 109.414 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 t -128.46 118.34 47.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 33.9 m -114.34 142.96 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.614 0.766 . . . . 0.0 110.903 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.0 t -120.18 131.19 73.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -137.05 169.04 18.44 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.28 1.032 . . . . 0.0 109.404 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -140.25 54.55 5.3 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.26 168.31 25.11 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.877 2.385 . . . . 0.0 110.509 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -124.76 -7.71 7.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.258 1.023 . . . . 0.0 111.142 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -95.14 2.52 55.08 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.39 1.876 . . . . 0.0 111.103 -179.305 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.638 HD22 ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -48.55 -34.09 10.81 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 124.193 0.997 . . . . 0.0 111.988 179.297 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.638 ' N ' HD22 ' A' ' 43' ' ' LEU . 11.7 pt-20 -46.7 -33.57 4.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.04 2.136 . . . . 0.0 111.93 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -120.04 -21.25 7.15 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 125.92 1.688 . . . . 0.0 111.067 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -46.68 21.51 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.383 -1.448 . . . . 0.0 110.879 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -49.66 -55.62 21.87 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.41 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.7 0.33 3.1 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.899 1.733 . . . . 0.0 114.962 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -109.72 -15.48 14.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.865 1.211 . . . . 0.0 112.548 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.41 -28.36 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.64 1.176 . . . . 0.0 110.215 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.48 -18.27 59.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.075 -1.016 . . . . 0.0 110.725 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.98 -20.27 62.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.137 0.975 . . . . 0.0 110.985 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.7 p -119.96 -2.47 10.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.563 1.545 . . . . 0.0 112.572 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.14 8.94 85.82 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.8 -14.05 59.47 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.362 -1.081 . . . . 0.0 109.947 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.37 -172.85 48.4 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.898 1.714 . . . . 0.0 115.104 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -64.95 -178.05 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.73 3.62 . . . . 0.0 112.507 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -116.31 -12.85 11.08 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.5 mt -140.87 150.61 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 tt -137.62 132.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.22 107.99 13.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.25 1.82 . . . . 0.0 108.235 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -151.46 -175.67 5.28 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.49 147.01 40.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.02 -1.05 . . . . 0.0 108.662 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -49.19 -45.44 44.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.237 1.415 . . . . 0.0 112.223 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -62.31 -4.73 1.94 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.683 1.993 . . . . 0.0 115.534 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -110.55 -4.25 15.57 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.215 0.916 . . . . 0.0 110.871 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -97.32 -18.98 18.83 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.42 -44.58 77.01 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 120.207 1.367 . . . . 0.0 112.217 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.75 -47.88 30.97 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.722 -1.043 . . . . 0.0 112.014 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -55.78 -39.12 70.82 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.985 1.393 . . . . 0.0 110.465 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -65.61 -47.34 76.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.706 -0.664 . . . . 0.0 109.429 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -37.14 80.18 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.529 0.604 . . . . 0.0 110.012 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.8 m -63.97 -13.74 48.52 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.13 -0.981 . . . . 0.0 110.686 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.34 10.94 67.51 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 126.168 1.842 . . . . 0.0 113.426 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.5 mt -83.68 -3.71 57.99 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.949 1.374 . . . . 0.0 114.203 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 71' ' ' ALA . 28.8 mt -109.0 137.57 46.7 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.048 1.294 . . . . 0.0 110.139 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.94 179.56 5.49 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.604 1.162 . . . . 0.0 111.812 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -92.19 92.04 8.03 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pp -69.28 169.35 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.991 0.916 . . . . 0.0 112.413 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.283 7.6 p 49.51 73.69 0.95 Allowed Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 127.459 2.304 . . . . 0.0 112.054 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.11 -22.68 46.96 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.628 2.219 . . . . 0.0 112.667 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -128.81 164.31 23.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.616 1.967 . . . . 0.0 108.895 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -85.52 -34.9 21.44 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.76 -21.59 19.79 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.456 1.48 . . . . 0.0 114.531 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -68.5 -30.18 68.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -64.69 -41.08 96.29 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 120.964 -1.085 . . . . 0.0 110.024 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.81 -16.46 63.11 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.556 1.542 . . . . 0.0 112.123 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -84.66 -2.56 57.69 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 120.896 -1.127 . . . . 0.0 110.967 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt -131.14 159.22 38.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.371 1.068 . . . . 0.0 110.493 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -77.68 152.43 80.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.452 0.701 . . . . 0.0 109.272 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.88 -42.56 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.719 2.946 . . . . 0.0 114.75 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -58.09 -44.31 87.53 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.668 1.122 . . . . 0.0 110.707 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.75 -28.33 69.51 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.102 1.361 . . . . 0.0 111.26 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -71.3 -42.63 68.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.24 0.616 . . . . 0.0 110.331 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.12 -28.23 51.15 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.903 0.881 . . . . 0.0 111.647 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.37 -23.73 65.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.07 1.348 . . . . 0.0 114.263 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.57 11.61 6.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.375 1.07 . . . . 0.0 112.368 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -72.25 147.72 46.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.288 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.477 ' CD1' ' HE3' ' A' ' 102' ' ' LYS . 51.2 t80 -131.84 178.69 6.57 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.935 1.294 . . . . 0.0 108.543 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -57.67 89.82 0.01 OUTLIER 'General case' 0 C--O 1.235 0.308 0 C-N-CA 127.711 2.404 . . . . 0.0 109.546 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.14 -77.93 1.13 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.477 ' HE3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -66.83 177.03 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.8 1.24 . . . . 0.0 109.395 179.272 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.7 mt -116.52 -179.54 3.71 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 110.893 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.9 pt -133.74 -29.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.5 177.64 9.3 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.969 0.804 . . . . 0.0 109.443 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.38 145.93 54.58 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 124.238 1.015 . . . . 0.0 108.733 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.37 145.73 54.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.925 2.417 . . . . 0.0 108.17 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.0 mm -129.0 -50.56 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 123.369 0.668 . . . . 0.0 109.963 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.25 157.39 44.49 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.932 0.396 . . . . 0.0 111.169 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.15 119.37 26.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.006 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 . . . . . 0 CA--C 1.536 0.407 0 C-N-CA 124.172 0.989 . . . . 0.0 109.313 178.459 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 mt . . . . . 0 CA--C 1.532 0.28 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.2 p90 . . . . . 0 C--O 1.239 0.509 0 C-N-CA 126.581 1.952 . . . . 0.0 107.404 179.666 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.458 -0.573 0 CA-C-O 121.711 0.63 . . . . 0.0 113.571 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -123.85 -17.13 6.42 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 117.192 -1.385 . . . . 0.0 112.776 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.65 143.93 31.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.84 1.655 . . . . 0.0 112.205 -178.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -65.24 -22.77 66.92 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.394 -0.816 . . . . 0.0 111.911 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -72.19 -12.78 61.33 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.371 0.668 . . . . 0.0 111.934 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -98.85 -19.02 17.61 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.094 1.758 . . . . 0.0 111.014 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.33 -52.62 70.04 Favored Pre-proline 0 N--CA 1.465 0.319 0 C-N-CA 124.6 1.16 . . . . 0.0 109.851 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -69.37 -24.76 31.12 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 120.248 1.124 . . . . 0.0 111.771 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.35 -54.23 27.01 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.08 -30.02 70.71 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.175 -0.953 . . . . 0.0 110.316 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -61.78 -45.18 95.0 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.616 1.166 . . . . 0.0 110.352 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -74.39 -25.48 59.5 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.523 -0.736 . . . . 0.0 111.688 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.58 -45.84 61.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.675 -0.679 . . . . 0.0 110.249 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . 0.259 6.2 mt -80.1 -24.18 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 117.876 -1.53 . . . . 0.0 110.799 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -66.96 -31.56 72.21 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.19 -11.89 60.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.56 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.67 0.77 8.16 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.516 1.527 . . . . 0.0 111.932 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 172.14 -91.05 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 119.467 1.031 . . . . 0.0 113.721 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.08 -175.83 4.38 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.802 0.841 . . . . 0.0 109.659 -178.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.7 p -74.34 166.2 23.88 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.37 -63.9 1.31 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.039 2.536 . . . . 0.0 112.268 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.4 tp -102.92 137.15 41.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.473 1.509 . . . . 0.0 107.941 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 65.6 mtp -148.34 103.07 3.4 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 128.373 2.669 . . . . 0.0 105.721 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -128.33 161.93 28.27 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -72.38 93.56 1.54 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.007 0.908 . . . . 0.0 112.114 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.5 mt -73.48 -8.81 57.46 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.631 1.572 . . . . 0.0 110.288 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -70.58 -19.12 62.88 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.403 1.481 . . . . 0.0 112.597 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -115.66 135.62 22.69 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.619 1.1 . . . . 0.0 111.896 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.05 -21.93 48.48 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.759 2.306 . . . . 0.0 112.961 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -59.96 -27.34 66.73 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.505 0.593 . . . . 0.0 112.237 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -86.85 -44.91 11.34 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.791 0.723 . . . . 0.0 111.307 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.5 p -76.99 -17.2 59.02 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -62.12 -60.85 8.95 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 117.844 -1.074 . . . . 0.0 113.073 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.451 ' HA ' ' HB3' ' A' ' 162' ' ' ALA . 30.5 Cg_endo -61.9 -23.53 76.05 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.318 1.863 . . . . 0.0 111.422 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.34 -57.59 10.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 22.6 pt -69.19 -25.25 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.028 0.442 . . . . 0.0 111.229 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 159' ' ' PRO . . . -67.56 -23.14 65.39 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 120.901 -1.124 . . . . 0.0 111.06 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.76 87.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -57.96 -58.9 6.37 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.92 5.1 0.03 OUTLIER Glycine 0 CA--C 1.522 0.523 0 CA-C-O 118.688 -1.062 . . . . 0.0 115.064 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.62 129.88 33.72 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.244 1.522 . . . . 0.0 109.329 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -138.46 149.24 45.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.821 1.31 . . . . 0.0 108.092 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.09 -66.62 0.74 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -140.19 173.22 11.73 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.266 1.427 . . . . 0.0 107.869 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -114.5 139.59 49.43 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -155.74 117.1 3.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.229 1.412 . . . . 0.0 107.792 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -160.32 163.33 33.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.898 1.279 . . . . 0.0 108.706 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 49.74 26.87 2.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.269 1.828 . . . . 0.0 112.961 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.83 9.25 87.26 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.265 -1.297 . . . . 0.0 113.469 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -115.06 118.94 34.8 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.93 1.865 . . . . 0.0 107.612 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.06 116.69 23.22 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.118 1.767 . . . . 0.0 109.451 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -130.3 104.09 7.08 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -64.6 -3.36 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 125.152 1.381 . . . . 0.0 112.341 178.889 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -72.89 -36.25 67.28 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.676 1.191 . . . . 0.0 111.015 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -89.78 72.31 7.64 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.94 0.896 . . . . 0.0 111.112 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.2 138.76 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 128.295 2.638 . . . . 0.0 111.446 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.83 15.16 10.44 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -1.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 120.116 1.958 . . . . 0.0 115.36 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -125.52 14.03 8.17 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.641 1.564 . . . . 0.0 111.639 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -71.09 158.4 36.53 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.941 -1.099 . . . . 0.0 108.456 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -48.69 -31.77 7.35 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.12 -37.59 42.51 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 119.504 1.047 . . . . 0.0 112.845 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.83 88.25 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -71.42 -35.5 70.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.415 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -56.65 -50.76 71.11 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.012 1.278 . . . . 0.0 111.209 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.83 -34.44 88.68 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.612 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 60.3 tp -70.05 -55.17 10.2 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.948 0.874 . . . . 0.0 110.476 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.432 ' HB ' HG11 ' A' ' 357' ' ' VAL . 2.0 t -55.2 -41.71 72.35 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.585 -1.198 . . . . 0.0 108.989 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -57.01 -54.05 51.1 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.707 1.14 . . . . 0.0 109.278 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.29 -44.58 88.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.801 0.841 . . . . 0.0 111.33 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 72.6 t -67.16 -31.2 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 121.431 -0.793 . . . . 0.0 109.783 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -39.91 82.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 O-C-N 121.283 -0.885 . . . . 0.0 109.141 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.54 -45.53 90.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 70.2 mt -59.37 -49.0 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -54.69 -37.96 66.44 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.979 0.912 . . . . 0.0 110.534 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -92.44 8.02 40.49 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 64.8 22.16 12.49 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.976 1.71 . . . . 0.0 113.256 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -85.94 -3.97 59.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.769 1.228 . . . . 0.0 110.669 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 77.4 mtp -143.64 167.33 22.51 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.504 1.922 . . . . 0.0 107.703 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -120.9 92.71 3.82 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.851 1.26 . . . . 0.0 109.728 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.99 -11.58 14.22 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.017 1.327 . . . . 0.0 114.38 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -89.1 -5.24 57.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.388 1.475 . . . . 0.0 111.762 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.7 m -69.96 131.1 43.87 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.74 0.816 . . . . 0.0 110.48 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.445 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 7.6 p30 -129.38 -177.5 4.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.704 2.002 . . . . 0.0 108.281 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -62.92 -26.66 68.91 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.6 m -91.4 -34.66 14.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.257 1.423 . . . . 0.0 109.562 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.445 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 33.1 mm -66.13 -49.12 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.39 -53.15 61.57 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.946 0.898 . . . . 0.0 109.039 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -60.16 -33.88 72.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.238 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.94 -54.28 23.52 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 119.309 0.959 . . . . 0.0 108.738 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.88 82.91 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.843 0.857 . . . . 0.0 109.865 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.96 -37.73 88.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.26 0.624 . . . . 0.0 110.244 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.06 -23.71 67.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.906 0.775 . . . . 0.0 109.786 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -87.84 -20.25 26.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.247 1.019 . . . . 0.0 109.658 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.36 12.65 72.6 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.514 1.531 . . . . 0.0 111.752 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -66.23 -45.85 79.21 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.911 0.855 . . . . 0.0 110.87 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 43.5 p -71.38 171.5 11.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.919 1.688 . . . . 0.0 109.069 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -129.38 -13.48 4.37 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -157.21 -179.63 8.38 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 121.745 -0.597 . . . . 0.0 110.653 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.3 t -164.53 174.29 11.07 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.475 1.51 . . . . 0.0 107.39 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.4 mt . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.859 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--O 1.237 0.408 0 CA-C-O 118.878 -0.582 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.91 134.49 23.68 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.802 1.668 . . . . 0.0 109.924 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 65.1 p -129.78 176.58 7.91 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.883 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -88.73 140.25 29.63 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -52.89 131.76 36.11 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.519 -1.363 . . . . 0.0 110.871 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.38 -1.36 50.91 Favored Glycine 0 CA--C 1.519 0.285 0 CA-C-O 118.54 -1.144 . . . . 0.0 114.635 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.93 103.39 3.19 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 119.647 1.723 . . . . 0.0 111.842 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.17 170.23 15.0 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.345 2.696 . . . . 0.0 114.376 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 74.9 m -57.75 140.79 50.67 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.164 1.386 . . . . 0.0 110.648 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -140.25 73.95 30.56 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.478 1.111 . . . . 0.0 108.439 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.98 -95.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.578 3.518 . . . . 0.0 109.121 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 . . . . . 0 C--O 1.236 0.343 0 C-N-CA 128.623 2.769 . . . . 0.0 107.631 179.095 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.413 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 1.5 p -69.18 112.98 4.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 121.427 0.632 . . . . 0.0 109.301 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 8.8 tt -77.87 134.75 37.88 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.5 m -125.7 168.31 13.93 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.616 1.167 . . . . 0.0 110.712 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -137.05 140.99 42.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.03 147.59 19.27 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 69.8 mt -90.32 136.77 23.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -71.73 128.24 35.13 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.4 8.23 2.38 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -116.25 3.41 13.41 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.09 1.314 . . . . 0.0 112.48 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 62.7 m -63.5 160.51 42.23 Favored Pre-proline 0 C--O 1.237 0.447 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.8 -60.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 108.333 -1.449 . . . . 0.0 108.333 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -123.78 102.68 7.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -16.19 37.38 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.239 0.472 . . . . 0.0 110.595 178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.44 ' HA ' ' HG3' ' A' ' 277' ' ' LYS . 15.3 tt0 -57.17 -41.9 80.09 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 127.456 2.303 . . . . 0.0 108.469 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.02 -37.09 76.12 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.018 -1.051 . . . . 0.0 110.852 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.06 -46.82 40.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 122.094 -0.379 . . . . 0.0 109.994 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.44 ' HG3' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -62.15 -34.48 76.46 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.704 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.51 -55.24 10.76 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -52.55 -46.26 66.71 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.042 -1.036 . . . . 0.0 111.617 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -51.66 68.7 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 119.264 -0.398 . . . . 0.0 110.929 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -10.98 59.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -108.59 -27.73 9.7 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -138.11 -25.62 0.95 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 120.102 1.319 . . . . 0.0 114.04 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.51 -51.02 10.58 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.681 1.128 . . . . 0.0 110.859 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 88.7 mt -86.57 68.36 10.15 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.602 1.161 . . . . 0.0 110.819 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.8 p -135.21 162.62 32.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -75.75 5.0 6.82 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.395 0.617 . . . . 0.0 110.457 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -113.26 -42.82 3.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.091 2.156 . . . . 0.0 109.478 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.93 -37.11 87.64 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.18 1.371 . . . . 0.0 111.884 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.09 -36.06 61.74 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.556 1.178 . . . . 0.0 109.267 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -70.33 -39.26 74.83 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.807 0.843 . . . . 0.0 110.044 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -53.73 -38.31 64.22 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.16 0.891 . . . . 0.0 112.707 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 20.2 t -81.34 -35.47 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.148 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -63.35 -33.34 75.31 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.852 0.861 . . . . 0.0 111.356 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -61.33 -54.06 48.75 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.139 1.376 . . . . 0.0 108.784 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -42.42 99.14 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -152.42 141.76 14.43 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 124.873 1.269 . . . . 0.0 107.801 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.75 110.56 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.435 2.09 . . . . 0.0 109.031 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 12.5 mt -75.22 -22.25 58.07 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.27 -155.7 19.91 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.504 -1.839 . . . . 0.0 108.504 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.6 178.06 5.63 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.965 0.888 . . . . 0.0 109.398 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.74 150.55 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 C-N-CA 123.753 0.821 . . . . 0.0 109.198 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.24 -20.86 40.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.625 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.1 106.9 6.83 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.971 1.708 . . . . 0.0 110.165 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -56.42 -26.55 53.89 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.8 m -57.13 -54.79 42.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.635 1.107 . . . . 0.0 110.663 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -90.46 -17.96 26.21 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.517 0.727 . . . . 0.0 111.803 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -60.88 -39.77 90.47 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.895 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -66.58 -15.89 63.76 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.529 1.059 . . . . 0.0 113.033 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -95.73 -23.49 16.95 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.704 2.001 . . . . 0.0 110.323 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 32.4 mt -86.69 -44.4 11.85 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.76 -17.9 57.78 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.888 2.075 . . . . 0.0 112.03 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 314' ' ' ASP . 0.1 OUTLIER -69.81 -16.91 63.36 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.695 -0.628 . . . . 0.0 109.561 178.071 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.452 ' HB2' ' HE3' ' A' ' 313' ' ' LYS . 2.5 t70 -103.94 131.51 21.9 Favored Pre-proline 0 N--CA 1.438 -1.051 0 C-N-CA 125.91 1.684 . . . . 0.0 107.562 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.81 -23.63 67.86 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.497 2.131 . . . . 0.0 114.43 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 -60.39 -54.98 39.16 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.848 1.259 . . . . 0.0 111.009 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.4 mp -71.96 -49.37 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.92 -52.06 36.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 123.948 0.78 . . . . 0.0 111.903 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.22 -28.45 70.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.511 0.596 . . . . 0.0 112.566 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 24.0 m -76.61 -37.45 56.4 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.1 tpt -71.84 -33.1 68.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.715 1.206 . . . . 0.0 111.393 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -55.99 -35.37 66.7 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.691 0.796 . . . . 0.0 109.696 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -63.23 -36.85 85.03 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.968 0.907 . . . . 0.0 111.486 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.376 0 C-N-CA 123.967 0.907 . . . . 0.0 109.522 178.74 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.453 -0.873 0 N-CA-C 109.713 -0.918 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -83.0 4.21 26.97 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 48.6 pt -60.89 151.93 71.73 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.38 1.072 . . . . 0.0 111.263 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.61 -21.8 21.69 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.52 2.147 . . . . 0.0 113.771 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -68.78 -18.41 64.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.233 0.924 . . . . 0.0 111.67 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 64.3 mmm -61.85 -29.23 70.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.349 0.977 . . . . 0.0 109.867 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.1 m -63.7 -52.0 62.56 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.96 86.37 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.074 0.549 . . . . 0.0 110.105 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -56.93 -54.86 41.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.821 1.248 . . . . 0.0 109.86 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -60.56 -39.97 89.92 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.98 0.809 . . . . 0.0 110.599 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -68.09 -25.89 65.55 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.96 -59.17 2.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.814 1.246 . . . . 0.0 110.552 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.9 t -55.95 -38.97 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.655 0.782 . . . . 0.0 110.667 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.68 -46.59 74.11 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.177 1.353 . . . . 0.0 110.8 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 47.7 m -67.71 -46.4 72.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.627 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -56.48 -43.41 79.62 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.47 1.032 . . . . 0.0 112.652 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.72 -53.5 46.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 125.041 1.336 . . . . 0.0 109.14 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.77 -40.78 88.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 122.809 0.444 . . . . 0.0 109.833 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -56.08 -45.23 79.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 120.969 -1.082 . . . . 0.0 110.984 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.72 -46.94 34.23 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.24 0.616 . . . . 0.0 111.015 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -63.1 -42.07 99.51 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.138 0.975 . . . . 0.0 113.266 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 36.4 m -84.87 -5.29 59.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.396 0.678 . . . . 0.0 109.362 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.86 12.55 71.14 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 118.538 0.608 . . . . 0.0 113.711 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -65.56 -28.01 68.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.134 0.967 . . . . 0.0 109.707 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -142.98 156.96 44.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 9.0 m -66.71 148.73 51.52 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.432 HG11 ' HB ' ' A' ' 193' ' ' THR . 83.6 t -51.27 -57.24 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.436 1.094 . . . . 0.0 111.272 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -63.56 -39.93 95.67 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -70.06 -25.45 63.55 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.774 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.49 76.39 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.507 0.723 . . . . 0.0 109.309 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.56 -36.21 60.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 118.686 -0.674 . . . . 0.0 110.297 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -55.63 -54.67 41.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.205 1.402 . . . . 0.0 108.115 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -51.19 -61.35 2.29 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.873 2.469 . . . . 0.0 110.338 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.75 77.07 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 127.047 2.139 . . . . 0.0 114.092 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -59.62 -36.07 75.62 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 16.7 m -64.11 -38.8 92.37 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.307 0.575 . . . . 0.0 110.567 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -61.21 -24.04 66.05 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.074 -1.016 . . . . 0.0 111.787 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.8 mt -91.52 -29.94 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.793 1.237 . . . . 0.0 110.17 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 17.3 p -76.8 -20.96 55.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.299 0.954 . . . . 0.0 110.026 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? . . . . . 0 C--O 1.247 0.955 0 C-N-CA 126.156 1.782 . . . . 0.0 108.355 179.301 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.413 ' H ' HD12 ' A' ' 2' ' ' ILE . 3.1 mp -82.42 165.16 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 125.307 1.629 . . . . 0.0 109.764 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.49 119.54 16.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -91.4 167.12 12.5 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.25 24.31 75.68 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 117.099 1.6 . . . . 0.0 117.099 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -148.24 157.92 43.78 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 121.145 2.472 . . . . 0.0 113.856 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.2 mt -144.95 152.19 39.8 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.346 2.258 . . . . 0.0 108.604 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -134.82 139.78 46.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 126.641 1.976 . . . . 0.0 106.97 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.2 mt -122.77 121.23 62.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.697 1.199 . . . . 0.0 108.99 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -115.95 137.08 52.44 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 mt -128.59 159.22 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -52.74 -20.35 3.1 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.17 155.13 30.22 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 104.846 -3.302 . . . . 0.0 104.846 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.89 0.57 0.38 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.261 1.424 . . . . 0.0 113.943 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -82.23 172.5 13.07 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.0 2.12 . . . . 0.0 111.885 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.61 51.01 2.97 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.062 1.791 . . . . 0.0 113.355 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -57.42 -35.98 70.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.76 1.224 . . . . 0.0 113.978 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -62.21 -38.51 89.41 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.871 0.76 . . . . 0.0 111.031 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.11 -35.72 57.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.8 tp -70.9 -32.46 69.41 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 123.119 0.568 . . . . 0.0 111.535 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.28 -48.64 71.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.298 0.639 . . . . 0.0 110.851 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -53.31 -38.47 63.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.42 HG11 ' HA ' ' A' ' 284' ' ' LEU . 21.4 t -57.33 -46.66 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.82 -29.42 72.61 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 124.539 1.066 . . . . 0.0 111.215 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -68.06 -43.77 77.87 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 118.851 1.326 . . . . 0.0 107.448 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -60.47 3.29 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -52.69 -54.17 37.33 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.984 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.18 -29.74 65.88 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.553 1.524 . . . . 0.0 112.292 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -28.39 58.74 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.601 -1.312 . . . . 0.0 109.83 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -91.63 -38.33 12.52 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.223 0.952 . . . . 0.0 112.05 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.5 p -102.62 -31.54 10.33 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.45 -17.35 54.69 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 121.106 -0.996 . . . . 0.0 112.206 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.3 mm -62.76 119.96 8.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.4 143.08 15.91 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 t -138.83 105.88 2.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 123.649 0.779 . . . . 0.0 109.128 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.5 m -96.96 153.45 17.89 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.82 127.28 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.88 154.79 51.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -122.58 57.29 9.22 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.08 1.752 . . . . 0.0 110.281 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.46 167.26 27.48 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.187 2.592 . . . . 0.0 112.299 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -121.71 1.78 10.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.221 1.008 . . . . 0.0 112.874 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 14.37 6.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.886 1.674 . . . . 0.0 112.117 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -58.33 -26.36 63.0 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 120.588 -1.32 . . . . 0.0 113.083 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -58.58 -27.51 64.68 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.845 1.202 . . . . 0.0 113.635 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -106.17 -24.55 12.3 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 123.66 0.784 . . . . 0.0 110.192 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.35 28.03 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.716 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -48.78 -60.06 5.23 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 117.629 -1.177 . . . . 0.0 109.403 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.28 -17.12 57.46 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.602 1.535 . . . . 0.0 114.004 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -89.03 -28.54 20.09 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.34 1.427 . . . . 0.0 111.753 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.8 -45.73 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 120.01 1.277 . . . . 0.0 109.651 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.26 -22.95 66.4 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 122.061 -0.399 . . . . 0.0 111.315 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.72 -24.31 67.61 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.23 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -103.23 4.86 37.16 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.59 1.556 . . . . 0.0 109.917 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.35 36.54 78.53 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.797 -1.189 . . . . 0.0 111.64 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -128.39 1.97 5.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.855 1.662 . . . . 0.0 112.915 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.41 -169.94 44.47 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.892 1.234 . . . . 0.0 113.693 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.36 162.24 34.41 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.189 1.926 . . . . 0.0 109.768 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -94.47 -19.2 20.77 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 124.545 1.138 . . . . 0.0 111.225 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -138.9 147.96 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tp -134.4 145.98 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.625 1.17 . . . . 0.0 108.622 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -130.55 108.94 10.3 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.714 1.606 . . . . 0.0 109.707 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -156.4 167.22 31.12 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 123.878 0.871 . . . . 0.0 109.975 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.76 155.33 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -57.29 -29.42 63.87 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -49.89 -59.06 4.21 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -66.09 -17.56 64.78 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.547 -0.721 . . . . 0.0 111.659 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -83.17 -5.11 59.0 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.497 -0.752 . . . . 0.0 110.3 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.4 -13.96 46.39 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.052 1.311 . . . . 0.0 113.591 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -125.06 -31.41 0.86 Allowed Glycine 0 CA--C 1.526 0.727 0 CA-C-N 118.827 1.314 . . . . 0.0 114.128 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -57.51 -41.74 81.41 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.017 1.408 . . . . 0.0 112.822 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.8 -40.72 79.42 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.58 1.082 . . . . 0.0 110.705 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -41.79 87.55 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.5 m -68.44 -8.12 37.85 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.079 0.952 . . . . 0.0 111.781 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.74 1.24 83.08 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 126.545 2.021 . . . . 0.0 113.016 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.38 -41.07 89.96 Favored 'General case' 0 C--N 1.338 0.067 0 CA-C-N 118.899 1.35 . . . . 0.0 113.232 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 mt -85.5 130.47 34.57 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.18 164.94 19.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.464 1.106 . . . . 0.0 112.082 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -73.8 131.34 41.44 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pp -113.99 -174.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.315 1.446 . . . . 0.0 109.191 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m 60.08 75.73 0.47 Allowed Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.502 1.121 . . . . 0.0 111.051 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.16 -23.64 15.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.021 2.481 . . . . 0.0 113.984 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -140.95 -162.67 1.4 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.518 1.927 . . . . 0.0 108.575 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -110.56 -19.92 12.74 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.793 1.237 . . . . 0.0 113.376 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.25 83.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.97 -1.081 . . . . 0.0 113.586 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -61.76 -28.28 69.33 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.862 1.265 . . . . 0.0 110.356 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -68.57 -44.51 74.29 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.294 0.952 . . . . 0.0 108.916 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.26 -21.53 66.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.228 0.467 . . . . 0.0 111.762 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -68.04 -12.04 60.08 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.526 0.603 . . . . 0.0 110.509 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -122.07 165.78 15.54 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.833 1.653 . . . . 0.0 111.211 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -77.1 155.69 82.33 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.31 -43.1 3.26 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.325 2.684 . . . . 0.0 114.295 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -57.2 -41.99 80.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.543 1.065 . . . . 0.0 112.354 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.96 -25.63 67.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.649 1.18 . . . . 0.0 111.051 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -76.26 -40.67 51.23 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -37.99 81.3 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.8 0.75 0.75 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.474 1.51 . . . . 0.0 114.002 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.04 3.91 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-N 120.487 1.494 . . . . 0.0 111.693 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.9 mtt-85 -63.08 170.46 2.79 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 123.3 1.524 . . . . 0.0 113.418 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -149.92 179.47 8.02 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 128.17 2.588 . . . . 0.0 105.868 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -68.21 99.9 0.96 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.79 -72.9 1.74 Allowed Glycine 0 CA--C 1.521 0.466 0 C-N-CA 125.012 1.291 . . . . 0.0 111.782 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 167.67 13.49 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 122.53 1.157 . . . . 0.0 112.374 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.14 154.1 22.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.266 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.3 pt -134.2 -15.08 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.9 172.55 13.84 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.084 1.311 . . . . 0.0 108.029 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.22 150.5 75.52 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 123.842 0.857 . . . . 0.0 110.829 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.94 144.63 53.67 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 124.336 3.358 . . . . 0.0 111.387 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.58 -55.53 3.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 126.105 1.762 . . . . 0.0 111.596 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.06 162.0 33.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.1 t -128.69 75.07 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -128.99 101.96 6.29 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.67 71.82 1.2 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 126.681 1.992 . . . . 0.0 109.011 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -160.1 121.46 3.14 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 m -160.95 154.16 21.56 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.583 1.553 . . . . 0.0 108.104 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.0 tp -158.48 137.48 11.39 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.676 1.59 . . . . 0.0 108.033 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.5 mt -93.52 156.08 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.404 1.482 . . . . 0.0 110.204 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -142.72 173.82 11.2 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.553 1.941 . . . . 0.0 110.529 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -58.04 171.79 0.49 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.712 1.205 . . . . 0.0 111.913 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -61.09 -17.68 53.88 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.301 -0.874 . . . . 0.0 112.629 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -90.1 127.64 36.13 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.391 1.476 . . . . 0.0 110.086 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.47 36.16 0.1 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.531 1.932 . . . . 0.0 113.304 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.87 108.2 17.42 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.17 95.3 1.03 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.371 2.714 . . . . 0.0 112.31 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -140.75 74.35 27.1 Favored Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -78.58 150.91 25.02 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.835 2.357 . . . . 0.0 112.126 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.82 148.25 86.23 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.968 2.445 . . . . 0.0 111.584 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -86.6 -26.04 24.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.913 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.9 t -170.96 161.13 6.88 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.953 1.252 . . . . 0.0 108.822 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -64.81 -29.22 70.18 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.61 -12.67 61.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.625 0.648 . . . . 0.0 112.485 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -90.38 -21.3 22.04 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.743 1.217 . . . . 0.0 109.951 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.43 -57.34 21.18 Favored Pre-proline 0 N--CA 1.456 -0.158 0 CA-C-O 117.441 -1.266 . . . . 0.0 110.762 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.75 -23.4 62.98 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 CA-C-N 120.769 1.31 . . . . 0.0 111.815 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.58 -39.83 57.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.488 0.715 . . . . 0.0 110.494 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.0 tp -79.39 -31.44 42.81 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.306 1.443 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.57 -46.84 80.53 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.617 1.167 . . . . 0.0 110.862 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -70.74 -29.42 65.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.35 0.66 . . . . 0.0 112.139 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -75.0 -41.43 59.52 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.56 -33.99 67.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -65.24 -32.91 74.82 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.22 -14.67 61.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 4.38 5.76 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.098 1.359 . . . . 0.0 111.879 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 174.08 -96.21 0.11 Allowed Glycine 0 CA--C 1.526 0.719 0 CA-C-N 119.748 1.158 . . . . 0.0 115.007 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -134.97 -173.54 3.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.145 0.973 . . . . 0.0 112.493 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.4 p -62.8 161.62 12.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.429 1.892 . . . . 0.0 112.055 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.82 -68.05 0.79 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.809 1.244 . . . . 0.0 109.375 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.4 tp -125.93 141.23 52.07 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.451 1.5 . . . . 0.0 110.577 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.6 mtp -139.43 149.1 43.65 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.739 1.616 . . . . 0.0 107.452 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -163.76 173.56 12.68 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.126 0.97 . . . . 0.0 109.766 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -75.36 80.73 2.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.207 1.803 . . . . 0.0 108.904 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mp -72.63 -16.23 61.72 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 121.031 -1.043 . . . . 0.0 110.12 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -70.05 -14.06 62.5 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -121.29 155.12 58.99 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 121.718 2.054 . . . . 0.0 114.845 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.0 -28.71 12.71 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.521 2.147 . . . . 0.0 115.619 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -56.13 -41.51 75.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -89.93 -25.31 21.0 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 119.252 -0.404 . . . . 0.0 111.387 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . 0.25 53.3 p -85.33 -13.39 49.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.011 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -61.54 -53.48 61.21 Favored Pre-proline 0 CA--C 1.532 0.258 0 O-C-N 120.605 -1.309 . . . . 0.0 111.159 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.18 -7.81 14.75 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 CA-C-N 120.574 1.241 . . . . 0.0 112.746 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.79 -67.84 0.63 Allowed 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 121.424 1.92 . . . . 0.0 107.979 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.41 -27.09 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 126.005 1.722 . . . . 0.0 115.014 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.74 -18.72 56.32 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.774 -0.579 . . . . 0.0 111.01 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.89 -47.1 75.97 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.13 -33.24 73.08 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 154.56 -9.79 0.41 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-O 117.188 -1.895 . . . . 0.0 116.756 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.02 149.28 38.47 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-N 120.242 2.021 . . . . 0.0 112.798 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -151.29 143.42 24.0 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.232 1.016 . . . . 0.0 109.285 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.46 -67.99 0.42 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.832 0.853 . . . . 0.0 112.126 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -139.0 143.53 38.52 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.476 1.11 . . . . 0.0 108.695 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -76.85 141.01 40.81 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.26 102.33 3.96 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -70.87 -174.12 0.89 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -67.02 34.43 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.449 1.899 . . . . 0.0 114.262 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 138.6 -3.51 2.93 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.47 1.986 . . . . 0.0 112.645 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.65 127.5 56.13 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.875 1.838 . . . . 0.0 106.68 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -120.82 152.2 38.67 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.894 0.746 . . . . 0.0 110.962 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.12 161.14 40.4 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 128.989 2.916 . . . . 0.0 106.093 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.73 -3.66 10.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.376 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -75.15 -30.7 60.84 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.281 0.632 . . . . 0.0 112.394 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.67 87.34 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.949 0.88 . . . . 0.0 110.606 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -105.91 110.48 31.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.756 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -81.23 28.67 2.93 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.029 1.776 . . . . 0.0 114.046 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 37.5 t -74.23 -57.13 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -80.11 57.6 2.74 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 122.183 0.992 . . . . 0.0 110.18 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -127.09 142.25 51.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -51.0 -34.56 29.73 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.417 1.087 . . . . 0.0 113.755 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.63 -38.66 96.78 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 119.474 1.034 . . . . 0.0 112.162 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.98 51.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 117.679 0.739 . . . . 0.0 109.397 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.457 ' HE3' ' OD2' ' A' ' 358' ' ' ASP . 2.6 ptmm? -62.44 -38.45 89.81 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -54.64 -53.3 56.54 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.823 1.249 . . . . 0.0 111.8 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -74.01 -29.81 62.19 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 13.0 tp -70.2 -37.23 75.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.727 1.264 . . . . 0.0 112.856 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 6.6 t -67.53 -19.1 65.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 117.397 -1.287 . . . . 0.0 110.97 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -65.65 -50.58 64.45 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.412 1.46 . . . . 0.0 107.84 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.9 tt -52.9 -49.91 64.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.273 1.429 . . . . 0.0 109.761 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.45 -27.68 42.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 124.401 1.08 . . . . 0.0 111.041 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.71 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 18.2 t0 -65.43 -31.73 72.98 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.933 1.242 . . . . 0.0 112.848 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.4 mt -76.46 -48.31 20.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 51.6 mt -59.75 -36.13 64.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.145 0.978 . . . . 0.0 109.488 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.71 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -52.18 -43.82 64.35 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.076 1.35 . . . . 0.0 110.666 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -90.77 -2.91 57.76 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.319 1.848 . . . . 0.0 112.189 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 59.22 9.8 1.49 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.887 2.475 . . . . 0.0 113.679 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -68.66 -28.68 67.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.582 0.628 . . . . 0.0 109.934 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.7 tpt -90.88 154.37 19.53 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.402 0.681 . . . . 0.0 109.759 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -75.59 88.26 2.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.51 -8.08 55.82 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.28 1.032 . . . . 0.0 112.232 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -105.63 8.19 33.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.892 1.277 . . . . 0.0 113.882 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.8 m -87.12 127.61 35.13 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.524 -0.735 . . . . 0.0 109.494 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.25 -172.08 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.476 1.91 . . . . 0.0 107.412 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -51.67 60.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.893 1.277 . . . . 0.0 109.267 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -50.13 70.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.771 1.229 . . . . 0.0 111.428 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.86 -46.53 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.35 0.66 . . . . 0.0 111.506 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.38 79.05 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.463 1.105 . . . . 0.0 113.156 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -59.18 -54.77 43.15 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.084 1.353 . . . . 0.0 108.885 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.52 -55.79 25.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 124.393 1.058 . . . . 0.0 110.771 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.27 -35.39 64.96 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.719 0.69 . . . . 0.0 111.956 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -69.83 -43.04 72.79 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -58.25 -40.13 80.98 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -66.95 -21.18 65.98 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.337 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.28 12.47 63.15 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.297 0.951 . . . . 0.0 111.998 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -79.99 -49.71 11.44 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.483 1.142 . . . . 0.0 112.502 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.3 p -64.8 119.99 11.65 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.77 -17.33 62.94 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.361 0.528 . . . . 0.0 112.406 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -158.54 166.56 31.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.405 1.082 . . . . 0.0 109.151 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 2.0 t -159.06 170.81 21.21 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.0 mt -132.07 150.44 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 126.064 1.746 . . . . 0.0 106.744 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -153.22 177.27 11.03 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.261 1.424 . . . . 0.0 108.242 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 147.59 -82.75 0.19 Allowed Glycine 0 CA--C 1.523 0.545 0 CA-C-O 117.977 -1.457 . . . . 0.0 114.846 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.56 161.65 44.23 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.964 2.443 . . . . 0.0 113.401 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -115.25 105.78 13.28 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.318 1.447 . . . . 0.0 110.458 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.79 -60.64 1.93 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.844 1.258 . . . . 0.0 108.937 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 51.4 m0 -67.53 159.09 30.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.664 0.786 . . . . 0.0 109.295 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 17.7 t -70.8 -8.95 56.19 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.895 -0.503 . . . . 0.0 112.036 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -155.31 157.33 37.02 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.272 1.429 . . . . 0.0 109.574 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.58 141.4 28.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -119.82 -7.14 10.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.439 1.096 . . . . 0.0 112.767 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.07 119.87 9.27 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.196 1.398 . . . . 0.0 107.337 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 9.6 t -121.35 128.29 52.12 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.888 0.851 . . . . 0.0 110.376 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -93.75 164.13 13.26 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.067 1.347 . . . . 0.0 107.798 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.46 162.65 32.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -160.33 136.99 8.95 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.796 -0.565 . . . . 0.0 110.255 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -92.61 155.29 17.86 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 54.51 -160.76 4.79 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.98 0.8 . . . . 0.0 113.422 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.85 163.67 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 125.018 1.327 . . . . 0.0 109.007 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 27.2 m -144.86 157.11 44.27 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.5 HG22 ' H ' ' A' ' 247' ' ' LEU . 14.5 p -73.58 -179.53 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.5 ' H ' HG22 ' A' ' 246' ' ' VAL . 1.5 tt -139.8 127.27 12.81 Favored Pre-proline 0 C--O 1.236 0.358 0 O-C-N 120.017 -1.677 . . . . 0.0 108.041 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.74 156.29 65.95 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.938 2.425 . . . . 0.0 108.721 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.4 p -131.25 -173.22 3.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.15 0.98 . . . . 0.0 110.936 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -91.1 171.87 8.96 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -51.65 102.38 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.328 2.251 . . . . 0.0 110.09 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 63.85 23.63 67.59 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 117.603 -1.665 . . . . 0.0 114.726 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.8 128.41 4.74 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-N 121.291 2.546 . . . . 0.0 111.196 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.67 159.55 52.36 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.016 2.477 . . . . 0.0 111.473 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.6 m -92.3 162.88 14.1 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.553 ' HA ' ' HE2' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -150.51 91.68 4.08 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.198 1.399 . . . . 0.0 110.877 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.21 -77.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.197 2.598 . . . . 0.0 109.644 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -154.81 164.31 39.0 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.049 2.139 . . . . 0.0 106.876 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 40.2 t -86.19 95.16 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -101.85 106.82 3.07 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.9 165.47 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.172 0.989 . . . . 0.0 110.985 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.16 140.98 30.51 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.034 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.3 m -133.09 168.27 18.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.114 0.87 . . . . 0.0 111.356 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -139.6 147.57 41.29 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.296 1.439 . . . . 0.0 108.606 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.26 155.01 23.2 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.57 138.74 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -71.98 132.22 44.0 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.49 0.662 . . . . 0.0 109.892 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -73.67 -17.4 61.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -80.54 -18.88 47.08 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 116.954 -1.498 . . . . 0.0 114.953 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 40.8 m -55.06 154.26 10.55 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 119.577 1.08 . . . . 0.0 109.974 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -69.51 -54.64 0.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.84 1.693 . . . . 0.0 111.229 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -125.16 92.85 3.72 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.512 1.925 . . . . 0.0 110.444 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -55.62 -18.34 7.54 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.512 1.925 . . . . 0.0 112.199 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.85 -35.78 77.44 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.969 1.308 . . . . 0.0 109.807 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 95.9 mt -56.51 -44.41 80.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.989 0.813 . . . . 0.0 110.123 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.4 -48.52 60.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.175 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -38.04 81.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 123.5 0.5 . . . . 0.0 110.614 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -68.34 -53.47 23.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.491 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -49.14 -46.66 45.42 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 119.328 0.967 . . . . 0.0 111.434 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.46 -50.74 72.04 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.799 0.84 . . . . 0.0 111.105 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.262 4.8 pt-20 -95.59 26.96 3.64 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -135.31 -35.51 0.82 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 110.73 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -130.17 -39.19 1.37 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 119.454 1.025 . . . . 0.0 112.453 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.42 ' HA ' HG11 ' A' ' 23' ' ' VAL . 12.4 tp -62.67 -58.48 7.33 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 119.504 1.047 . . . . 0.0 110.331 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 40.0 mt -78.79 60.46 2.81 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.434 1.494 . . . . 0.0 113.059 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 43.7 p -133.98 162.31 32.41 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.21 -3.22 15.94 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.734 0.813 . . . . 0.0 111.629 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -109.28 -44.3 3.96 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.247 1.419 . . . . 0.0 109.691 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.29 -50.57 21.14 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 124.924 1.249 . . . . 0.0 110.304 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.53 -38.01 85.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.054 0.927 . . . . 0.0 109.414 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -63.05 -45.43 92.26 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 124.468 1.105 . . . . 0.0 108.521 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.78 82.66 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 123.808 0.843 . . . . 0.0 111.698 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.5 t -68.9 -38.55 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -67.55 -28.96 68.24 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.496 0.589 . . . . 0.0 111.405 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -68.12 -42.55 80.06 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.0 -32.71 73.28 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -160.03 147.06 12.41 Favored Pre-proline 0 N--CA 1.467 0.379 0 C-N-CA 125.341 1.456 . . . . 0.0 108.931 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.06 123.94 9.22 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.566 2.177 . . . . 0.0 108.681 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 32.7 mt -107.1 -4.36 18.98 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.463 1.505 . . . . 0.0 112.971 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 62.05 -153.17 42.37 Favored Glycine 0 C--N 1.335 0.498 0 CA-C-N 119.23 0.923 . . . . 0.0 111.391 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.65 159.03 7.05 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.965 0.906 . . . . 0.0 112.65 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 4.1 m -125.57 155.27 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 124.072 0.949 . . . . 0.0 109.797 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.67 -36.12 62.8 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.187 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.18 105.56 0.73 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.93 1.292 . . . . 0.0 110.43 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -53.71 -38.16 63.99 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.244 1.018 . . . . 0.0 112.547 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 21.4 m -56.1 -35.02 66.56 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.626 0.77 . . . . 0.0 112.937 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -109.28 -5.87 15.73 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.187 0.995 . . . . 0.0 110.942 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -60.94 -50.0 75.19 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -58.16 -33.35 69.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.457 1.103 . . . . 0.0 111.733 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -69.62 -49.21 56.07 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.7 0.8 . . . . 0.0 109.896 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 21.1 mt -68.82 -34.15 75.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.23 -5.3 6.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.618 1.567 . . . . 0.0 112.444 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -62.11 -21.05 64.68 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.31 0.959 . . . . 0.0 109.439 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.13 142.33 26.65 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 119.266 0.939 . . . . 0.0 109.171 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.82 -30.67 84.69 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.55 2.833 . . . . 0.0 115.038 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -58.08 -36.47 72.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.303 0.956 . . . . 0.0 110.148 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.5 mp -77.89 -61.02 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.83 -54.78 7.53 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.992 0.917 . . . . 0.0 113.222 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.94 86.04 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.252 -0.905 . . . . 0.0 112.513 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 55.6 m -68.5 -33.17 73.67 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.153 0.581 . . . . 0.0 109.482 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.0 tpt -69.27 -45.37 69.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -59.12 -35.47 73.52 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 122.709 0.404 . . . . 0.0 110.093 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -62.56 -27.63 69.31 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.713 -0.617 . . . . 0.0 111.186 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -84.2 -34.65 23.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.864 0.757 . . . . 0.0 108.977 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -63.25 -47.46 82.32 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.463 1.105 . . . . 0.0 110.164 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -3.04 49.42 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.044 0.937 . . . . 0.0 113.005 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.42 174.28 41.46 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.723 1.154 . . . . 0.0 112.673 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.65 153.36 33.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.296 2.239 . . . . 0.0 110.583 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 98.9 mt -104.41 138.24 29.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 38.8 ttp -62.16 123.86 79.86 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.0 -178.04 3.89 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.055 2.503 . . . . 0.0 112.906 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -129.19 24.42 5.57 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.249 1.82 . . . . 0.0 110.429 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 20.5 pt -86.04 153.08 56.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.857 1.263 . . . . 0.0 113.101 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -72.95 -21.63 20.71 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.446 2.097 . . . . 0.0 111.935 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.55 -21.99 41.9 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.36 1.864 . . . . 0.0 111.258 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 67.7 mtp -57.09 -35.1 69.0 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.814 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 10.2 t -60.04 -49.52 77.33 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.902 1.228 . . . . 0.0 109.295 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.92 92.4 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 122.544 0.338 . . . . 0.0 110.633 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -58.64 -53.58 56.8 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.514 1.126 . . . . 0.0 110.031 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -62.66 -41.69 99.2 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.142 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -65.79 -38.32 88.7 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.253 0.479 . . . . 0.0 110.849 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.78 -57.06 5.56 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.637 1.175 . . . . 0.0 113.054 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.24 -39.59 74.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 122.922 0.489 . . . . 0.0 110.261 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -53.43 28.09 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.768 0.827 . . . . 0.0 109.037 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 27.4 m -62.4 -39.66 93.98 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.441 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.75 99.68 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.008 1.276 . . . . 0.0 112.173 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.1 -48.69 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 24.4 mm -58.39 -40.48 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 118.481 0.582 . . . . 0.0 109.494 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -61.25 -44.61 96.97 Favored 'General case' 0 CA--C 1.522 -0.121 0 O-C-N 121.206 -0.933 . . . . 0.0 110.839 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.31 -43.93 69.31 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 118.25 0.477 . . . . 0.0 110.431 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.69 89.49 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.936 0.895 . . . . 0.0 111.977 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 46.6 m -83.88 -14.54 50.88 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.199 1.0 . . . . 0.0 109.587 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 74.36 17.05 79.68 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -66.9 -31.3 71.8 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.848 1.259 . . . . 0.0 110.363 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -147.73 159.67 43.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.8 m -66.64 150.14 49.48 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.3 t -57.27 -52.72 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASP . . . . . 0.457 ' OD2' ' HE3' ' A' ' 189' ' ' LYS . 0.8 OUTLIER -47.35 -49.98 23.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 129.411 3.084 . . . . 0.0 111.881 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.59 -35.62 58.02 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.16 77.6 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.202 -0.936 . . . . 0.0 109.66 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.1 mp -66.59 -49.44 66.35 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.552 1.941 . . . . 0.0 108.635 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -55.39 -49.73 71.55 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.464 1.105 . . . . 0.0 108.726 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -56.92 -53.1 61.77 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.977 1.311 . . . . 0.0 109.746 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.95 -47.81 83.76 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.544 1.138 . . . . 0.0 113.56 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -60.06 -37.61 80.37 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.0 m -64.19 -37.49 87.64 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -62.6 -17.17 59.65 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.447 -1.408 . . . . 0.0 112.374 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.3 mt -98.07 -20.58 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.369 1.068 . . . . 0.0 110.733 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 80.7 p -105.77 -12.19 15.98 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.807 -1.183 . . . . 0.0 112.412 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 46.3 pttt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 117.368 -1.301 . . . . 0.0 111.06 -178.77 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.7 tptp . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.8 mt -141.37 149.17 20.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -69.34 111.79 5.47 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.48 168.2 9.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.72 1.608 . . . . 0.0 110.128 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.66 33.8 73.97 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.913 1.244 . . . . 0.0 115.072 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -145.36 172.86 12.57 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 118.372 1.086 . . . . 0.0 110.34 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.6 mt -150.56 144.77 25.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.944 2.098 . . . . 0.0 107.297 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.8 140.0 41.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.6 mt -125.12 133.0 70.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 C-N-CA 127.149 2.179 . . . . 0.0 106.558 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -122.72 136.76 54.97 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.7 mm -121.91 165.69 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.424 0.689 . . . . 0.0 110.279 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -77.98 -15.35 59.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 117.441 2.385 . . . . 0.0 117.441 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.29 -13.79 58.4 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 120.506 1.503 . . . . 0.0 116.347 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -116.92 -13.81 10.66 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.748 1.219 . . . . 0.0 111.222 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -83.81 167.87 16.68 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.845 -0.534 . . . . 0.0 110.383 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.3 72.64 2.3 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.359 1.457 . . . . 0.0 109.712 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -73.89 -28.87 61.77 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.55 -0.971 . . . . 0.0 111.664 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.12 -45.03 86.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.417 1.008 . . . . 0.0 109.2 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.43 94.88 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.8 tp -70.23 -32.56 70.49 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.638 -0.919 . . . . 0.0 110.442 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.14 80.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 117.773 -1.108 . . . . 0.0 109.41 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -59.89 -33.7 72.18 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.007 0.821 . . . . 0.0 111.456 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.4 t -68.48 -50.99 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.83 -41.9 99.68 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.232 -0.918 . . . . 0.0 114.228 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -29.69 69.37 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.42 -1.047 . . . . 0.0 110.341 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -71.03 -53.53 14.42 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -54.82 -46.55 74.58 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.699 0.227 . . . . 0.0 110.661 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.46 -28.72 70.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.92 0.888 . . . . 0.0 111.017 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 11.0 tppt? -74.0 -26.61 60.54 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.446 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.25 -35.25 10.41 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 124.113 0.883 . . . . 0.0 112.176 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.5 p -101.77 -27.8 12.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.494 1.043 . . . . 0.0 113.424 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.6 -15.65 53.68 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.181 -0.949 . . . . 0.0 111.718 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.8 mm -65.74 120.6 13.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -55.9 140.34 43.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.815 0.846 . . . . 0.0 112.203 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.1 102.43 5.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.9 m -91.63 139.79 30.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.71 117.73 45.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -123.38 158.14 31.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.743 0.817 . . . . 0.0 109.337 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.2 p-80 -124.77 67.12 50.23 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.546 1.139 . . . . 0.0 108.813 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -73.7 175.29 10.93 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.094 1.862 . . . . 0.0 108.821 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.41 -18.28 6.78 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.373 0.669 . . . . 0.0 111.063 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.34 1.33 49.31 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.731 2.012 . . . . 0.0 112.897 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.92 -23.32 2.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.126 1.37 . . . . 0.0 114.196 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -55.14 -36.1 65.41 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.439 1.096 . . . . 0.0 111.275 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -118.53 -26.33 6.22 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.578 1.551 . . . . 0.0 110.092 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -67.98 -42.88 80.14 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 117.245 -1.36 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.54 -58.5 15.17 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 120.524 1.511 . . . . 0.0 109.776 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.41 -25.99 81.71 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 121.027 1.403 . . . . 0.0 113.67 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -75.03 -54.85 6.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.631 1.105 . . . . 0.0 112.165 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.57 -40.53 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.099 0.56 . . . . 0.0 110.634 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.75 -29.45 70.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.095 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 -17.17 17.83 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.497 1.044 . . . . 0.0 113.053 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.8 t -123.26 17.5 9.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.586 0.754 . . . . 0.0 112.108 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.05 7.44 66.8 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.16 -10.68 32.41 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.193 1.496 . . . . 0.0 111.776 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.32 -177.85 34.72 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.616 1.579 . . . . 0.0 116.212 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.11 176.9 3.44 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.427 2.751 . . . . 0.0 111.084 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -108.6 -21.15 12.83 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.4 mt -136.6 148.55 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.8 tt -133.12 135.62 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.27 1.428 . . . . 0.0 108.494 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -130.15 101.06 5.64 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.651 1.58 . . . . 0.0 109.306 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -151.66 178.42 9.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.312 0.96 . . . . 0.0 109.99 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.02 154.48 39.36 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -57.77 -27.49 63.12 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.512 0.725 . . . . 0.0 109.844 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.28 -58.79 5.56 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.517 1.127 . . . . 0.0 111.556 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -69.99 -14.48 62.72 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.619 -1.301 . . . . 0.0 111.276 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.18 11.96 8.87 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.369 -0.832 . . . . 0.0 109.512 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.41 0.43 77.79 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.114 -1.381 . . . . 0.0 112.983 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.9 -27.65 0.23 Allowed Glycine 0 CA--C 1.535 1.338 0 CA-C-N 120.351 2.075 . . . . 0.0 116.576 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -56.44 -44.08 80.1 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.945 1.872 . . . . 0.0 113.401 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.71 -41.18 99.02 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.3 -0.875 . . . . 0.0 110.076 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -55.34 -29.89 59.21 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.961 1.304 . . . . 0.0 110.474 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.6 m -86.62 1.05 53.21 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.702 1.201 . . . . 0.0 112.388 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.94 16.77 80.48 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.886 1.708 . . . . 0.0 110.931 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.3 mt -83.49 -11.98 56.81 Favored 'General case' 0 CA--C 1.527 0.072 0 O-C-N 121.017 -1.284 . . . . 0.0 114.018 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.7 mt -114.15 142.54 46.1 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 119.7 1.136 . . . . 0.0 111.039 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.02 -161.57 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.508 1.923 . . . . 0.0 113.316 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.3 86.43 2.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.851 1.661 . . . . 0.0 110.152 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.26 174.22 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.973 1.309 . . . . 0.0 111.933 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.9 m 61.77 82.2 0.22 Allowed Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 126.119 1.768 . . . . 0.0 110.681 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.81 -28.93 7.47 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.416 2.077 . . . . 0.0 111.377 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -139.81 165.82 26.28 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.488 1.915 . . . . 0.0 109.277 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -63.29 -34.94 78.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.638 1.175 . . . . 0.0 110.985 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.46 -43.06 44.74 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.399 1.08 . . . . 0.0 112.371 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -60.0 -33.62 72.24 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.617 -0.677 . . . . 0.0 111.483 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -69.53 -44.29 71.29 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.479 -0.763 . . . . 0.0 109.576 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -62.2 -26.38 68.32 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.418 1.087 . . . . 0.0 112.536 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -71.35 -11.52 60.95 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.042 0.937 . . . . 0.0 111.062 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 mt -126.51 164.91 20.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.202 0.91 . . . . 0.0 110.539 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -75.26 149.92 84.86 Favored Pre-proline 0 CA--C 1.544 0.742 0 O-C-N 121.514 -0.741 . . . . 0.0 110.817 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.73 -46.75 1.12 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.514 2.809 . . . . 0.0 114.789 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -61.26 -33.93 74.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.968 1.258 . . . . 0.0 111.824 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -21.81 64.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.517 0.727 . . . . 0.0 110.716 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -70.84 -37.13 73.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.317 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.44 -28.11 64.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.476 1.035 . . . . 0.0 113.141 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.72 -23.35 67.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.444 0.698 . . . . 0.0 111.787 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.1 m -120.57 6.86 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.227 1.411 . . . . 0.0 112.284 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -72.66 170.25 14.89 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.806 0.813 . . . . 0.0 108.965 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -153.26 -174.52 4.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.487 1.115 . . . . 0.0 108.048 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -73.54 107.94 6.1 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.95 -77.68 0.53 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.719 1.628 . . . . 0.0 112.835 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 174.92 2.67 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.408 1.083 . . . . 0.0 111.928 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.75 156.22 27.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.99 1.316 . . . . 0.0 109.932 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.3 pt -126.04 -17.96 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.66 178.04 4.28 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.589 1.541 . . . . 0.0 109.291 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.62 148.39 69.83 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 124.27 1.028 . . . . 0.0 110.522 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.42 148.7 38.52 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.226 3.284 . . . . 0.0 109.265 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.3 mm -130.07 -53.01 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.982 1.313 . . . . 0.0 110.898 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -130.8 156.01 45.72 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.2 t -136.11 101.86 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.3 1.04 . . . . 0.0 110.551 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -144.2 113.88 7.16 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.117 -0.989 . . . . 0.0 109.064 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.411 ' H ' ' CG2' ' A' ' 320' ' ' THR . . . -133.01 89.32 2.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.911 1.284 . . . . 0.0 112.192 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 245' ' ' THR . 0.0 OUTLIER -166.2 162.05 17.27 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.952 2.101 . . . . 0.0 111.027 178.243 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 m -179.57 127.03 0.09 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.999 2.52 . . . . 0.0 111.202 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.6 tp -120.09 155.23 33.39 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.394 1.877 . . . . 0.0 108.516 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 88.7 mt -128.11 90.64 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -107.49 171.3 7.46 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.146 0.978 . . . . 0.0 109.359 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -54.97 166.32 0.53 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -99.78 1.04 42.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.416 1.487 . . . . 0.0 111.619 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -74.01 173.61 9.77 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.142 2.577 . . . . 0.0 110.175 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -93.39 19.22 8.55 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 35.0 tp -112.36 70.24 1.05 Allowed Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.956 1.303 . . . . 0.0 112.449 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.64 94.59 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.81 3.007 . . . . 0.0 110.984 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -128.52 72.97 80.71 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -73.44 159.16 47.02 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.088 3.192 . . . . 0.0 113.875 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.37 152.6 44.33 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.886 3.057 . . . . 0.0 110.384 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -104.64 -17.23 14.75 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.6 t -166.34 160.34 15.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.393 1.451 . . . . 0.0 108.481 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -70.1 -27.86 64.93 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 121.325 -0.859 . . . . 0.0 112.156 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -70.04 -16.11 63.11 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.138 0.881 . . . . 0.0 111.226 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -88.2 -23.98 23.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 110.544 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 40.2 mm -54.34 -58.84 12.06 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.58 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.77 -21.33 38.63 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 CA-C-N 120.429 1.189 . . . . 0.0 111.581 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.98 -36.92 64.58 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.975 1.31 . . . . 0.0 111.25 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 68.4 tp -88.23 -30.04 20.0 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.338 1.455 . . . . 0.0 110.712 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.45 -45.0 85.2 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -66.65 -33.14 74.99 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.572 0.749 . . . . 0.0 112.22 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -72.35 -44.45 62.59 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.7 mt -72.93 -33.27 65.84 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.672 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -34.75 77.26 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.62 -13.02 60.6 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 0.12 7.3 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 124.815 1.246 . . . . 0.0 111.903 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.53 -90.08 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 119.231 0.923 . . . . 0.0 114.961 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 176.22 8.88 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.146 0.978 . . . . 0.0 112.231 -177.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.95 160.68 7.51 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.852 1.261 . . . . 0.0 112.811 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.89 -71.01 0.66 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.0 0.92 . . . . 0.0 109.043 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.3 tp -106.15 135.54 47.44 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.81 1.244 . . . . 0.0 109.45 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.6 ttm -147.46 104.85 3.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -126.97 163.07 24.5 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -77.89 144.92 36.53 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.6 mt -120.56 -9.82 9.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.724 0.81 . . . . 0.0 111.87 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -69.32 -16.58 63.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -113.56 124.04 32.0 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.652 1.581 . . . . 0.0 110.81 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.09 -14.06 42.68 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.347 2.031 . . . . 0.0 114.911 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.451 ' CE2' ' HA3' ' A' ' 228' ' ' GLY . 82.0 t80 -60.83 -27.93 68.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.826 1.194 . . . . 0.0 112.258 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -88.99 -36.71 15.69 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.184 0.994 . . . . 0.0 113.194 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -86.52 -21.68 26.8 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -51.65 -54.29 41.21 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -64.91 -19.32 64.0 Favored 'Trans proline' 0 C--N 1.348 0.513 0 CA-C-N 121.163 1.451 . . . . 0.0 113.883 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.58 -57.35 3.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.528 HG21 HD22 ' A' ' 192' ' ' LEU . 46.2 pt -63.04 -29.39 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 119.213 0.915 . . . . 0.0 112.131 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.66 -20.01 66.05 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.281 0.633 . . . . 0.0 111.914 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -43.16 -60.65 1.58 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.246 1.818 . . . . 0.0 113.065 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.69 -46.37 81.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.984 0.514 . . . . 0.0 111.977 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -175.52 -23.7 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.681 0 CA-C-O 116.99 -2.005 . . . . 0.0 114.497 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -37.09 123.46 0.95 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.387 1.946 . . . . 0.0 114.089 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -139.59 140.8 37.13 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.98 -59.11 2.86 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -135.8 149.67 49.19 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 125.294 1.438 . . . . 0.0 108.691 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.459 ' HE3' ' OD2' ' A' ' 180' ' ' ASP . 10.9 tppt? -76.75 145.14 38.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.886 0.85 . . . . 0.0 109.931 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -142.21 104.83 4.51 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -74.79 -171.08 1.2 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -51.25 -20.39 1.6 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.08 22.36 0.05 OUTLIER Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.92 1.724 . . . . 0.0 111.277 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -125.5 106.27 9.66 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 118.61 1.205 . . . . 0.0 107.822 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -97.14 137.08 36.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.86 147.64 28.96 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.176 1.39 . . . . 0.0 108.808 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.79 -0.31 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.944 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.06 -42.57 69.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.459 ' OD2' ' HE3' ' A' ' 170' ' ' LYS . 56.2 t0 -90.2 107.69 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.658 1.583 . . . . 0.0 109.622 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.3 t -118.37 157.73 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.25 2.22 . . . . 0.0 107.55 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -143.39 29.7 2.02 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 118.536 0.607 . . . . 0.0 114.508 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.04 -42.93 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 C-N-CA 125.049 1.34 . . . . 0.0 111.217 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -96.12 61.45 2.09 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -117.23 154.35 31.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.231 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -48.93 -38.31 22.46 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.4 -35.56 82.27 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 118.774 0.715 . . . . 0.0 112.703 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.6 -49.0 65.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.032 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.79 -42.52 99.1 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-O 118.856 -0.592 . . . . 0.0 109.446 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.25 95.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.12 0.968 . . . . 0.0 109.81 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.13 -26.41 71.49 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.859 -0.967 . . . . 0.0 112.383 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.528 HD22 HG21 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -85.43 -44.46 12.73 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.262 1.031 . . . . 0.0 111.77 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.4 t -55.01 -28.5 52.52 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.023 0.829 . . . . 0.0 111.86 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -60.21 -50.91 71.78 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.6 tp -59.82 -51.92 67.65 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.721 1.208 . . . . 0.0 109.832 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 56.2 t -55.55 -30.41 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 117.429 -1.272 . . . . 0.0 109.949 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.618 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 12.7 t0 -66.58 -44.52 82.03 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 120.431 1.469 . . . . 0.0 111.857 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.6 mt -66.66 -40.04 88.46 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 83.9 mt -66.01 -36.44 77.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.618 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -60.95 -46.82 89.18 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.116 1.367 . . . . 0.0 108.247 178.778 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -79.22 -2.32 40.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.157 0.983 . . . . 0.0 110.703 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt 55.38 1.56 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 130.126 3.37 . . . . 0.0 116.636 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -66.36 -26.94 67.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 11.1 ttt -81.64 141.39 33.71 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -79.57 77.91 6.14 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.0 -5.0 18.98 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.04 1.736 . . . . 0.0 114.176 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -94.67 -20.96 19.1 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 128.0 2.52 . . . . 0.0 111.457 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.2 m -58.14 137.2 57.17 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.061 0.945 . . . . 0.0 110.58 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -130.78 -178.82 4.97 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 127.481 2.312 . . . . 0.0 106.195 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -54.87 -44.79 74.36 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -46.74 88.6 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 123.694 0.798 . . . . 0.0 110.4 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.6 mt -67.37 -48.99 75.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.926 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.39 76.96 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.956 0.798 . . . . 0.0 110.485 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.03 -46.44 65.04 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.34 -55.19 34.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.008 0.923 . . . . 0.0 110.178 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.79 -49.93 61.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.818 2.047 . . . . 0.0 109.86 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -61.69 -38.15 86.76 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.853 -0.529 . . . . 0.0 110.524 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -63.87 -11.03 24.02 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.75 0.82 . . . . 0.0 112.167 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -111.6 -8.13 14.24 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.188 1.795 . . . . 0.0 112.128 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.01 27.79 25.1 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.457 1.027 . . . . 0.0 111.79 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -87.48 -0.35 56.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.289 1.045 . . . . 0.0 112.424 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.8 p -138.84 160.49 39.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.914 0.886 . . . . 0.0 109.274 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -117.24 -19.62 9.55 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.395 1.078 . . . . 0.0 109.544 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -159.2 164.91 34.68 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.952 0.901 . . . . 0.0 111.693 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.6 t -165.78 174.03 10.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.826 2.45 . . . . 0.0 106.975 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 41.6 mt -147.76 121.27 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -108.97 154.68 21.82 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.003 1.721 . . . . 0.0 106.855 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 155' ' ' TYR . . . -62.4 174.64 7.71 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 123.935 0.779 . . . . 0.0 113.456 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -67.77 166.97 22.53 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.216 2.611 . . . . 0.0 112.727 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -74.82 62.01 1.06 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.728 1.611 . . . . 0.0 110.13 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.36 -171.81 2.92 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.59 1.156 . . . . 0.0 110.953 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -61.08 120.9 11.17 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.841 1.256 . . . . 0.0 108.686 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.7 t -148.3 172.6 14.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.696 1.198 . . . . 0.0 109.878 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -89.62 -2.81 58.42 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.85 1.66 . . . . 0.0 112.069 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 7.4 tp -145.82 153.71 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.199 1.4 . . . . 0.0 107.936 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.92 156.08 39.22 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.957 1.303 . . . . 0.0 109.992 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.7 135.32 38.8 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.504 1.522 . . . . 0.0 108.972 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 28.2 t -74.69 158.67 33.19 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.844 1.257 . . . . 0.0 110.883 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -124.79 7.6 8.13 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.095 1.758 . . . . 0.0 110.712 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . 0.256 10.4 t -64.2 -11.07 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 O-C-N 121.252 -0.905 . . . . 0.0 111.94 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -126.67 147.67 49.91 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.487 1.494 . . . . 0.0 110.245 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -148.98 112.6 5.06 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 102.63 -3.1 . . . . 0.0 102.63 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 163.72 70.32 0.02 OUTLIER Glycine 0 CA--C 1.521 0.442 0 CA-C-N 119.316 0.962 . . . . 0.0 111.941 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.404 HG23 HD21 ' A' ' 113' ' ' LEU . 11.0 p -35.02 117.18 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 128.179 2.591 . . . . 0.0 112.786 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.453 ' O ' HD23 ' A' ' 113' ' ' LEU . 13.6 t -162.24 176.94 10.08 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.859 -0.526 . . . . 0.0 110.149 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 247' ' ' LEU . 4.5 t -81.84 -169.29 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.48 1.912 . . . . 0.0 107.018 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.679 ' H ' HG12 ' A' ' 246' ' ' VAL . 0.3 OUTLIER -142.05 163.32 40.83 Favored Pre-proline 0 CA--C 1.537 0.449 0 O-C-N 119.597 -1.94 . . . . 0.0 107.191 178.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.2 149.73 64.53 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 60.6 p -124.28 167.49 14.26 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -73.54 153.5 40.24 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -64.82 135.0 55.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.68 -11.23 10.66 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 117.62 -1.655 . . . . 0.0 115.425 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.2 124.32 5.32 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 120.693 2.246 . . . . 0.0 113.591 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.48 146.22 34.69 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.146 2.564 . . . . 0.0 110.86 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.1 m -66.81 157.94 31.7 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -133.6 100.28 13.73 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.62 -175.76 2.74 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.73 2.287 . . . . 0.0 110.638 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -82.57 176.24 9.54 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.096 1.758 . . . . 0.0 108.878 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.8 149.03 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.16 -0.962 . . . . 0.0 108.713 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -162.7 110.84 0.45 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 104.341 -3.504 . . . . 0.0 104.341 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 26.4 m -133.11 137.05 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 119.761 1.781 . . . . 0.0 111.213 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.49 138.32 57.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 m -124.37 148.41 47.55 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.864 0.866 . . . . 0.0 110.269 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.11 139.39 52.53 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 123.461 0.704 . . . . 0.0 109.449 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -137.16 164.16 25.31 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.59 1.09 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 61.9 mt -113.31 136.18 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -67.48 117.61 9.67 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.95 -22.23 64.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 118.475 -0.774 . . . . 0.0 112.642 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -74.62 -13.27 60.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 72.5 m -59.99 155.28 44.41 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 118.819 0.736 . . . . 0.0 109.597 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.92 -60.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.514 1.476 . . . . 0.0 110.117 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -108.9 88.43 2.72 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -54.7 -23.72 18.84 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.4 1.08 . . . . 0.0 111.169 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -64.82 -31.28 72.44 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.848 1.259 . . . . 0.0 112.235 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.76 -40.28 83.44 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.048 -1.033 . . . . 0.0 109.402 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.88 -42.94 63.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.53 -0.747 . . . . 0.0 111.407 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -34.92 79.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.718 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -70.84 -56.12 7.01 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -48.78 -49.09 40.3 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 119.18 0.9 . . . . 0.0 110.854 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.7 tt -62.31 -45.83 91.45 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.006 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -79.21 -18.54 52.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.744 -1.223 . . . . 0.0 114.148 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -90.34 -33.88 15.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 117.612 -1.185 . . . . 0.0 112.344 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -137.52 -23.24 1.1 Allowed 'General case' 0 C--N 1.347 0.457 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.01 -50.89 13.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.184 1.356 . . . . 0.0 109.09 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.47 67.27 9.28 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.63 1.572 . . . . 0.0 109.47 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.8 p -144.12 166.22 25.62 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -67.42 -41.36 84.96 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -73.42 -29.75 62.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.323 1.049 . . . . 0.0 111.092 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.79 -51.19 11.63 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.987 1.279 . . . . 0.0 110.036 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 27.8 mt -59.85 -45.28 92.92 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.64 -45.85 84.91 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.359 1.064 . . . . 0.0 109.793 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.56 -44.4 89.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.6 1.091 . . . . 0.0 112.292 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.6 t -72.59 -34.35 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.657 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -68.2 -38.02 81.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.233 1.413 . . . . 0.0 110.319 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -60.47 -43.9 96.44 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.44 1.496 . . . . 0.0 110.252 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.26 -43.88 69.62 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.482 0.313 . . . . 0.0 111.484 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -151.69 152.27 30.02 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 124.808 1.243 . . . . 0.0 108.389 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.11 137.13 73.53 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.771 2.981 . . . . 0.0 113.92 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 23.2 mt -124.0 -7.39 7.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.574 1.549 . . . . 0.0 112.958 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 65.26 -131.56 35.67 Favored Glycine 0 N--CA 1.464 0.559 0 C-N-CA 126.068 1.794 . . . . 0.0 112.186 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.62 177.41 8.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 17.9 m -135.44 153.67 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 O-C-N 120.626 -1.296 . . . . 0.0 110.434 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.27 -26.93 56.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.494 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.85 106.7 1.96 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -54.94 -31.87 60.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 57.8 m -68.59 -52.8 27.67 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.612 1.096 . . . . 0.0 111.064 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -72.14 -17.64 61.94 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.152 0.433 . . . . 0.0 110.664 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -61.7 -39.35 91.17 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -62.71 -39.83 95.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.708 0.685 . . . . 0.0 111.413 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -66.19 -49.99 65.42 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.683 1.193 . . . . 0.0 109.837 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.54 -34.45 74.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.679 -0.677 . . . . 0.0 110.135 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.13 -2.85 4.59 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.513 1.525 . . . . 0.0 112.469 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -58.13 -14.46 6.91 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.647 1.112 . . . . 0.0 110.387 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.95 145.5 52.2 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 124.914 1.286 . . . . 0.0 109.194 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.57 -17.56 43.22 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.692 2.261 . . . . 0.0 113.138 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -59.87 -48.52 81.34 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 317' ' ' ILE . 4.6 mp -68.33 -57.73 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.449 1.1 . . . . 0.0 108.255 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.6 -43.38 62.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.31 -35.73 81.14 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 120.402 1.456 . . . . 0.0 112.407 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.411 ' CG2' ' H ' ' A' ' 112' ' ' ALA . 3.7 m -65.43 -37.25 86.37 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 7.2 tpt -61.55 -49.5 76.44 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -61.0 -27.95 68.69 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.71 1.204 . . . . 0.0 113.464 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -76.75 -42.77 39.74 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -67.16 -32.07 72.91 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -62.1 -49.38 76.16 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.601 0.637 . . . . 0.0 110.189 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -5.72 59.1 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.591 1.156 . . . . 0.0 113.92 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -82.17 178.91 53.41 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-O 122.991 1.329 . . . . 0.0 113.6 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -110.45 128.11 55.44 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 128.903 2.881 . . . . 0.0 107.793 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 11.4 mt -92.4 94.77 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 12.3 ptp 38.58 83.96 0.19 Allowed Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 127.776 2.431 . . . . 0.0 111.88 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -66.44 85.71 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.679 2.919 . . . . 0.0 111.391 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -78.4 65.35 3.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.553 1.941 . . . . 0.0 108.905 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.8 pt -130.35 144.18 52.22 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 120.558 -1.339 . . . . 0.0 112.247 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.86 -15.29 37.31 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.341 2.694 . . . . 0.0 114.634 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -80.22 -18.28 49.96 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.462 -0.774 . . . . 0.0 110.864 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 59.6 mmm -70.22 -34.43 72.89 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.123 -0.986 . . . . 0.0 111.565 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.3 p -66.1 -42.31 89.42 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.338 -1.476 . . . . 0.0 108.522 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.61 -46.35 88.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -51.7 -51.46 55.86 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.841 1.656 . . . . 0.0 110.254 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -59.06 -36.2 74.65 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.024 -1.047 . . . . 0.0 113.18 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -76.26 -42.17 46.55 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.172 0.51 . . . . 0.0 109.835 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.8 72.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.442 1.497 . . . . 0.0 110.903 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 44.7 t -68.53 -46.25 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 117.223 -1.37 . . . . 0.0 111.483 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -55.76 -42.55 75.61 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 121.391 1.905 . . . . 0.0 108.832 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 20.0 m -65.0 -44.88 87.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.02 0.528 . . . . 0.0 109.751 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -56.91 -37.26 71.2 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.311 -0.868 . . . . 0.0 112.193 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 71.2 t -69.27 -58.79 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.2 mm -53.45 -46.62 59.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.86 0.864 . . . . 0.0 111.47 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -51.84 -49.68 62.38 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 121.924 -0.485 . . . . 0.0 110.842 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -77.95 -37.66 47.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.25 71.24 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.189 0.904 . . . . 0.0 110.69 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.3 m -94.74 -9.22 35.34 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.442 1.097 . . . . 0.0 110.593 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.51 14.79 82.11 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 118.843 0.747 . . . . 0.0 112.695 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -64.16 -40.06 95.34 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -147.75 154.64 40.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.1 m -61.77 155.14 23.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.826 1.25 . . . . 0.0 111.449 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.97 -53.02 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.201 1.0 . . . . 0.0 109.063 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.83 -50.12 61.49 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.844 2.057 . . . . 0.0 111.549 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -70.52 -42.51 71.15 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.951 1.301 . . . . 0.0 112.166 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.18 77.12 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.566 -0.709 . . . . 0.0 110.426 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.2 mp -72.69 -43.96 62.4 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.047 0.939 . . . . 0.0 109.243 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -54.45 -48.67 71.47 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.21 -34.3 74.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.304 1.042 . . . . 0.0 111.105 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.94 -48.36 66.14 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.825 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -52.16 -39.88 60.63 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.572 0.749 . . . . 0.0 109.746 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.4 m -62.46 -24.82 67.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.461 0.704 . . . . 0.0 112.184 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -81.5 -15.48 54.81 Favored 'General case' 0 C--O 1.226 -0.145 0 O-C-N 120.603 -1.311 . . . . 0.0 111.409 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.5 mt -98.16 -31.45 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.782 1.633 . . . . 0.0 110.398 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 3.2 p -81.55 -17.99 46.5 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.879 -0.513 . . . . 0.0 111.145 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt . . . . . 0 C--O 1.251 1.178 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 177.446 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.1 mm -62.26 138.83 21.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 O-C-N 125.175 1.547 . . . . 0.0 108.762 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -95.28 137.28 34.55 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.38 162.18 14.91 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.1 41.88 99.71 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.231 0.923 . . . . 0.0 115.037 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -149.18 169.22 21.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.33 1.052 . . . . 0.0 109.844 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.0 mt -146.19 135.85 23.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.616 1.567 . . . . 0.0 108.208 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.0 t -127.21 136.84 59.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.0 mt -135.71 142.11 40.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.888 1.275 . . . . 0.0 109.393 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -120.54 154.41 35.37 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.0 mm -116.52 147.29 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.913 2.085 . . . . 0.0 106.104 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.654 ' HB3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -152.4 118.07 5.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.502 1.121 . . . . 0.0 109.916 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.46 20.3 6.26 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.576 -1.125 . . . . 0.0 112.86 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 53.75 30.55 11.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.296 1.838 . . . . 0.0 111.155 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -58.35 172.11 0.51 Allowed 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 127.672 2.389 . . . . 0.0 114.194 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.85 50.85 1.2 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.676 2.084 . . . . 0.0 113.474 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -56.14 -30.4 62.11 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.475 1.11 . . . . 0.0 111.467 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -58.19 -30.6 66.56 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.233 1.013 . . . . 0.0 111.42 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.56 -33.96 17.78 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.6 tp -71.75 -31.18 66.39 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.257 1.423 . . . . 0.0 112.711 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.8 86.01 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.33 1.052 . . . . 0.0 109.889 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -58.89 -37.82 77.47 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.368 1.867 . . . . 0.0 110.287 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.469 HG13 ' HB3' ' A' ' 283' ' ' TYR . 95.0 t -70.09 -48.34 62.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.528 1.131 . . . . 0.0 109.2 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.2 -43.54 99.26 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.755 -0.591 . . . . 0.0 111.722 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -33.27 71.24 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 121.687 -0.89 . . . . 0.0 111.05 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -63.88 -53.02 57.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -56.7 -43.02 80.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.046 0.839 . . . . 0.0 110.774 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -13.42 58.61 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.698 1.199 . . . . 0.0 110.821 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.34 -14.94 17.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.619 -1.926 . . . . 0.0 111.86 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -105.79 -10.93 16.46 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.062 0.851 . . . . 0.0 109.95 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.0 p -130.45 -35.16 1.54 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.488 1.115 . . . . 0.0 112.346 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.64 -13.31 67.45 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.384 -0.823 . . . . 0.0 111.229 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.4 mm -64.3 130.92 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.74 145.55 54.54 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.646 1.179 . . . . 0.0 110.719 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.8 t -140.27 126.7 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.5 m -114.97 141.77 47.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.074 1.35 . . . . 0.0 108.257 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.25 121.31 45.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 126.022 1.729 . . . . 0.0 106.682 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -140.35 157.77 45.04 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.702 0.683 . . . . 0.0 109.651 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -126.38 71.03 71.06 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.407 1.083 . . . . 0.0 111.748 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.68 165.75 30.85 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.463 2.775 . . . . 0.0 111.526 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.56 5.24 15.42 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.774 1.63 . . . . 0.0 110.214 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.52 2.58 7.64 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.457 1.103 . . . . 0.0 113.481 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.654 HD21 ' HB3' ' A' ' 12' ' ' ASN . 2.1 pt? -52.62 -24.93 9.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.419 1.009 . . . . 0.0 113.677 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.48 -24.32 65.17 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.444 1.098 . . . . 0.0 112.284 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -120.53 -22.16 6.52 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.002 1.321 . . . . 0.0 110.175 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -47.59 26.05 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 117.575 -1.202 . . . . 0.0 109.407 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -48.25 -58.21 8.62 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 120.328 1.422 . . . . 0.0 111.157 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.03 -18.2 63.97 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 121.857 1.705 . . . . 0.0 114.187 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -92.87 -1.11 57.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.909 1.284 . . . . 0.0 112.927 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 t -128.13 -37.74 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 120.287 1.403 . . . . 0.0 110.268 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.83 77.62 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.864 -0.588 . . . . 0.0 111.996 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.05 73.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.413 0.551 . . . . 0.0 110.764 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -77.11 -43.73 33.09 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.847 -0.533 . . . . 0.0 110.809 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.92 19.2 4.89 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -114.82 3.53 14.66 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.261 1.031 . . . . 0.0 111.705 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.32 -170.07 26.84 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.805 1.669 . . . . 0.0 113.82 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.15 178.15 7.31 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.822 2.348 . . . . 0.0 111.916 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -99.99 -24.36 14.65 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 120.593 -1.317 . . . . 0.0 111.526 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.2 mt -140.08 156.37 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 124.832 1.253 . . . . 0.0 107.904 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 tt -142.9 147.27 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.398 1.479 . . . . 0.0 107.863 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -140.05 107.26 5.49 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.635 1.174 . . . . 0.0 110.187 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.402 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 41.5 t-105 -153.0 -165.88 2.3 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.838 1.199 . . . . 0.0 110.576 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 62' ' ' TRP . . . -73.44 147.81 43.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.061 1.344 . . . . 0.0 110.163 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -61.04 -27.38 68.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.239 0.542 . . . . 0.0 112.116 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -58.87 -31.43 68.56 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -104.33 -6.0 21.24 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.473 0.579 . . . . 0.0 109.796 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.16 -35.57 61.6 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.434 0.694 . . . . 0.0 111.267 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.89 -4.64 59.26 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.83 -60.78 1.4 Allowed Glycine 0 C--N 1.336 0.556 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -51.85 -43.47 63.22 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.082 0.953 . . . . 0.0 113.208 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.558 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -63.9 -46.34 85.31 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 119.211 0.914 . . . . 0.0 111.266 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -48.86 70.74 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.1 m -61.06 -14.39 23.4 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.532 1.533 . . . . 0.0 112.909 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.45 24.65 33.0 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 124.578 1.085 . . . . 0.0 112.548 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.23 6.97 44.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.3 1.05 . . . . 0.0 113.241 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 71' ' ' ALA . 98.6 mt -128.88 138.64 52.14 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 120.076 -1.64 . . . . 0.0 108.345 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.5 160.16 28.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.03 101.31 0.12 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.171 2.189 . . . . 0.0 106.459 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -67.0 152.7 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 122.086 0.946 . . . . 0.0 111.77 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.419 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 35.3 m 56.22 93.91 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 129.889 3.276 . . . . 0.0 115.574 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 80' ' ' THR . 34.9 Cg_endo -66.74 -41.66 10.43 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.805 1.67 . . . . 0.0 110.909 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -131.07 142.64 50.31 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.905 0.882 . . . . 0.0 112.912 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -44.76 -43.18 8.35 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 128.073 2.549 . . . . 0.0 116.994 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.01 -34.03 12.35 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.24 1.382 . . . . 0.0 114.698 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -64.55 -25.36 67.95 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.456 -0.778 . . . . 0.0 111.338 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -72.04 -44.88 62.66 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -61.85 -22.68 65.72 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.789 1.236 . . . . 0.0 112.261 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -75.4 -13.74 60.42 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.477 1.111 . . . . 0.0 112.25 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mt -124.38 154.51 40.27 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.159 0.891 . . . . 0.0 112.838 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -69.98 146.87 95.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.95 -41.39 7.74 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.173 2.582 . . . . 0.0 114.124 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -59.72 -37.21 78.29 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.138 0.881 . . . . 0.0 111.629 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -26.2 66.69 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.268 1.027 . . . . 0.0 111.56 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -73.74 -30.98 63.13 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 121.471 -0.768 . . . . 0.0 111.387 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.0 -29.33 65.19 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.208 0.913 . . . . 0.0 111.919 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.64 -16.91 63.5 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.524 1.129 . . . . 0.0 112.978 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 m -132.23 18.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.666 1.586 . . . . 0.0 112.167 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -70.65 165.54 22.67 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 122.275 1.036 . . . . 0.0 110.509 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -152.33 -177.02 5.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.419 1.488 . . . . 0.0 107.155 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -69.71 102.02 1.8 Allowed 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.21 -81.53 0.47 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.447 1.499 . . . . 0.0 112.323 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.91 170.26 4.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.393 0.596 . . . . 0.0 109.595 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.94 162.03 13.94 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.86 0.864 . . . . 0.0 109.432 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 37.7 pt -123.67 -14.58 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.182 0.993 . . . . 0.0 112.599 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.3 175.4 4.89 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.04 1.736 . . . . 0.0 107.977 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -134.3 148.29 67.14 Favored Pre-proline 0 C--O 1.242 0.684 0 C-N-CA 124.83 1.252 . . . . 0.0 111.58 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.02 143.7 26.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.301 2.668 . . . . 0.0 108.267 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.3 mm -134.42 -52.08 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 C-N-CA 125.128 1.371 . . . . 0.0 109.773 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.42 148.86 44.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.507 0.723 . . . . 0.0 111.008 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.1 t -137.82 110.37 7.04 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.116 0 C-N-CA 123.478 0.711 . . . . 0.0 110.106 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -146.83 138.55 24.43 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -125.43 85.09 2.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.315 1.846 . . . . 0.0 111.759 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.3 pp -171.92 167.24 6.25 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.896 1.278 . . . . 0.0 111.17 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.1 t 177.59 160.59 0.48 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 128.544 2.737 . . . . 0.0 106.289 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.7 tp -161.26 139.52 9.56 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.1 mt -122.41 138.69 51.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -149.33 -179.58 7.17 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.342 1.057 . . . . 0.0 111.196 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -60.81 167.93 2.56 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.749 2.02 . . . . 0.0 111.813 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.36 3.62 2.18 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -77.97 168.09 20.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.866 1.666 . . . . 0.0 110.482 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -75.6 -11.18 59.96 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.594 -1.316 . . . . 0.0 111.907 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.6 tp 45.22 71.61 1.48 Allowed Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 128.111 2.565 . . . . 0.0 110.326 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -73.47 -17.3 23.84 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.146 2.564 . . . . 0.0 112.442 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -124.58 68.63 52.2 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 124.624 1.17 . . . . 0.0 108.614 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.31 159.11 47.56 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.959 2.439 . . . . 0.0 111.737 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.98 162.02 44.11 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.699 2.266 . . . . 0.0 109.781 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -132.27 -25.01 2.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.046 1.338 . . . . 0.0 112.091 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.6 t -147.75 152.58 37.98 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.569 1.077 . . . . 0.0 109.337 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -67.34 -15.85 63.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.28 -24.41 61.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.846 1.203 . . . . 0.0 112.329 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -86.41 -16.26 37.78 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 118.292 0.497 . . . . 0.0 110.691 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.66 -57.12 29.04 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 124.775 1.23 . . . . 0.0 107.988 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.25 -24.76 31.64 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 CA-C-N 120.804 1.323 . . . . 0.0 111.023 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.09 -52.7 38.67 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.18 -26.16 68.03 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.187 0.995 . . . . 0.0 109.838 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.37 -41.25 89.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.098 0.863 . . . . 0.0 111.25 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -75.67 -31.16 59.65 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.936 -0.477 . . . . 0.0 110.376 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -70.49 -46.75 63.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 42.2 mt -74.01 -32.44 63.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.766 -1.111 . . . . 0.0 110.294 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -67.88 -36.32 80.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 120.54 1.518 . . . . 0.0 108.707 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.69 -9.78 15.85 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.41 0.684 . . . . 0.0 112.796 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.56 11.27 2.29 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.321 1.449 . . . . 0.0 111.829 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.01 -111.95 0.32 Allowed Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -142.46 -170.25 3.15 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.488 1.915 . . . . 0.0 110.558 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 p -52.38 148.69 6.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.17 1.788 . . . . 0.0 112.802 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.09 -57.0 3.95 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.64 1.176 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.11 146.23 29.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.012 1.725 . . . . 0.0 107.604 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.7 ttm -145.88 105.76 4.0 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -138.23 163.47 31.66 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -72.18 91.81 1.31 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.273 1.429 . . . . 0.0 112.452 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -16.69 61.44 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.212 1.405 . . . . 0.0 109.188 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -75.37 -9.47 58.59 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.991 0.916 . . . . 0.0 112.358 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -119.47 123.34 28.74 Favored Pre-proline 0 C--N 1.34 0.19 0 C-N-CA 124.029 0.932 . . . . 0.0 108.728 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.01 -10.55 27.47 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.714 2.276 . . . . 0.0 115.749 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -61.07 -37.64 83.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -90.13 -23.5 21.34 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.335 0.516 . . . . 0.0 112.179 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.7 p -83.59 -25.87 30.51 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.146 0.43 . . . . 0.0 110.363 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -55.44 -55.87 35.27 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.204 -0.903 . . . . 0.0 112.608 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -62.66 -21.01 72.51 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.62 1.547 . . . . 0.0 112.071 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.2 tp -70.93 -59.48 2.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 25.3 pt -64.74 -30.8 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 117.573 -1.203 . . . . 0.0 113.793 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.68 -4.34 11.82 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 120.822 1.646 . . . . 0.0 113.883 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.35 -50.24 65.45 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.468 1.107 . . . . 0.0 113.801 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.97 -44.57 97.16 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 120.803 -1.186 . . . . 0.0 111.644 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 175.35 13.28 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.807 -0.996 . . . . 0.0 115.248 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.52 151.46 48.72 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 118.78 1.29 . . . . 0.0 111.624 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -164.25 151.34 11.69 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.31 -55.46 3.66 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -141.93 167.83 21.21 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.468 0.707 . . . . 0.0 112.038 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -101.12 155.23 18.12 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.936 0.874 . . . . 0.0 108.691 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -155.56 118.87 4.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.613 1.565 . . . . 0.0 107.574 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -92.58 67.72 4.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 33.6 47.6 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.391 2.276 . . . . 0.0 115.232 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.51 -18.91 1.67 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 126.157 1.837 . . . . 0.0 112.057 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -117.97 106.19 12.68 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.13 128.91 34.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -132.0 88.69 2.58 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-O 123.705 1.716 . . . . 0.0 109.512 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -5.2 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.306 1.443 . . . . 0.0 114.06 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -70.01 -40.39 75.29 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 120.11 1.323 . . . . 0.0 108.25 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -76.76 108.05 9.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.2 t -129.08 140.32 49.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -129.63 16.92 5.57 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 118.283 -1.287 . . . . 0.0 115.676 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.537 HG21 HD13 ' A' ' 368' ' ' ILE . 0.0 OUTLIER -62.13 -13.99 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.164 1.982 . . . . 0.0 115.341 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 365' ' ' GLN . 4.4 p-10 -119.12 10.15 12.0 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 120.841 -1.162 . . . . 0.0 111.083 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -65.38 155.75 34.4 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -49.08 -35.66 16.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.562 0.745 . . . . 0.0 112.198 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.27 -40.13 98.61 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 119.878 1.217 . . . . 0.0 114.055 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.91 -52.1 52.85 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.622 1.211 . . . . 0.0 109.189 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -63.0 -39.9 96.14 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 119.095 -0.479 . . . . 0.0 110.598 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.78 65.61 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.72 0.808 . . . . 0.0 111.92 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -94.14 -34.76 6.3 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 31.5 tp -70.72 -40.13 72.97 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.481 0.712 . . . . 0.0 111.269 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.4 t -50.55 -45.76 57.12 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 116.672 -1.633 . . . . 0.0 109.848 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -55.64 -56.75 16.71 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 120.547 1.521 . . . . 0.0 111.054 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 64.6 tp -56.04 -49.36 73.94 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.583 0.753 . . . . 0.0 110.934 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.07 -27.89 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.135 0.974 . . . . 0.0 110.895 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.12 -40.16 96.79 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.998 1.319 . . . . 0.0 110.135 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 9.7 mt -66.23 -45.52 80.38 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.28 -40.6 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.458 1.103 . . . . 0.0 108.891 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -56.62 -37.48 70.77 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.779 -1.2 . . . . 0.0 109.588 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -88.27 -4.17 58.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.767 1.627 . . . . 0.0 112.268 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 56.65 14.51 1.77 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.5 2.32 . . . . 0.0 113.758 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -83.42 -5.31 59.11 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.381 -0.825 . . . . 0.0 111.251 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.7 tpt -109.07 154.59 22.04 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.726 0.81 . . . . 0.0 111.382 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -76.18 71.09 2.89 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 108.767 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.3 -10.66 59.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.324 1.05 . . . . 0.0 112.003 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -85.85 -15.84 40.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 129.517 3.127 . . . . 0.0 115.086 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 12.4 m -67.16 127.76 33.82 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.03 1.332 . . . . 0.0 113.244 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -122.24 -178.37 3.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -62.47 -31.63 72.4 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.258 -0.901 . . . . 0.0 113.002 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 t -64.98 -48.8 72.7 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.223 1.009 . . . . 0.0 109.842 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 13.8 mm -61.39 -47.9 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.783 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.68 -52.74 59.34 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.428 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.96 -44.31 94.5 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.62 1.1 . . . . 0.0 110.164 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.81 -54.2 45.42 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.601 0.36 . . . . 0.0 110.35 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.9 79.36 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.655 0.661 . . . . 0.0 111.556 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.85 -44.72 92.29 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -59.22 -42.17 90.37 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -68.45 -27.72 66.42 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.219 -0.925 . . . . 0.0 111.717 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.68 63.48 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.57 1.557 . . . . 0.0 111.948 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.15 -60.85 2.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.442 1.497 . . . . 0.0 111.503 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.2 t -69.04 151.29 46.66 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.67 -26.92 13.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.305 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -130.29 158.66 39.19 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 3.1 t -173.23 -179.72 2.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.09 2.156 . . . . 0.0 108.424 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 63.4 mt -149.11 131.32 5.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -137.63 166.89 22.84 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.86 75.1 0.97 Allowed Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.11 -72.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.846 3.03 . . . . 0.0 110.044 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -69.26 -17.12 63.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.197 0.599 . . . . 0.0 111.996 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 74.94 -1.34 3.11 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.542 2.737 . . . . 0.0 113.567 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -70.69 167.25 19.07 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.232 0.924 . . . . 0.0 109.654 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 70.5 m -65.48 109.26 2.26 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -146.3 162.77 37.4 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 126.387 1.875 . . . . 0.0 106.896 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 20.9 mt -133.86 -49.82 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 4.4 t70 59.06 29.63 19.24 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.995 1.318 . . . . 0.0 111.546 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 30.9 m 69.8 -6.95 0.97 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.814 1.646 . . . . 0.0 111.697 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 11.7 m -80.03 173.4 12.63 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.721 1.609 . . . . 0.0 110.61 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -138.92 119.5 13.98 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.8 172.29 12.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 123.404 0.682 . . . . 0.0 109.894 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -119.23 141.84 48.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.411 1.085 . . . . 0.0 109.458 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -71.15 160.81 32.2 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 174.67 144.88 5.08 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.778 0.704 . . . . 0.0 112.089 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.35 119.31 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 126.01 1.724 . . . . 0.0 107.918 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.4 t -157.93 176.84 12.03 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.959 1.304 . . . . 0.0 107.581 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.09 125.2 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -101.77 153.41 37.96 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.65 152.77 79.99 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.324 2.016 . . . . 0.0 111.75 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 69.8 p -119.6 171.45 8.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.245 1.418 . . . . 0.0 111.033 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -84.81 158.97 20.51 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -59.11 122.94 15.04 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 120.82 -1.175 . . . . 0.0 109.762 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 71.01 7.74 63.04 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 117.712 -1.605 . . . . 0.0 114.215 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.38 127.02 6.08 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 121.269 2.535 . . . . 0.0 112.574 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.02 161.13 47.13 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.728 2.952 . . . . 0.0 113.693 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 89.4 p -83.24 139.3 33.19 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.829 0.852 . . . . 0.0 108.77 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -132.77 76.17 71.52 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.831 1.652 . . . . 0.0 107.967 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -77.01 -170.32 0.9 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.324 3.349 . . . . 0.0 112.139 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -54.03 155.73 3.36 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.982 0.913 . . . . 0.0 110.869 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 33.5 t -94.38 106.24 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -98.87 147.5 18.52 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.37 127.18 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.83 158.7 35.04 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.1 m -131.05 140.66 50.11 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 120.917 -1.114 . . . . 0.0 110.551 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.4 128.2 40.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.967 1.707 . . . . 0.0 107.407 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.61 160.45 24.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 58.8 mt -95.16 130.11 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -77.51 133.34 38.58 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -82.46 -5.02 58.44 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -62.33 -31.05 71.62 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 49.7 m -78.5 157.15 77.79 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.156 1.782 . . . . 0.0 112.564 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.32 -59.64 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.028 3.152 . . . . 0.0 113.335 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -104.68 98.84 8.53 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -13.76 61.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.758 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.412 ' HA ' ' HG3' ' A' ' 277' ' ' LYS . 1.1 tt0 -59.81 -41.04 90.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.251 1.42 . . . . 0.0 109.926 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.75 -39.49 84.96 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.3 -44.44 62.71 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.942 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.412 ' HG3' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -67.89 -29.72 68.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.046 -179.327 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -79.46 -49.92 11.56 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.94 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -55.93 -45.38 78.77 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.889 1.677 . . . . 0.0 109.726 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.36 -30.03 70.89 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.102 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -99.26 -17.4 18.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 120.337 1.426 . . . . 0.0 114.55 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -84.11 -35.9 23.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.899 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.469 ' HB3' HG13 ' A' ' 23' ' ' VAL . 39.1 m-85 -139.23 -32.37 0.66 Allowed 'General case' 0 C--N 1.344 0.329 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -21.2 63.46 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.6 1.545 . . . . 0.0 112.002 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.432 ' CD2' HD21 ' A' ' 304' ' ' LEU . 57.6 mt -110.35 41.6 1.72 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.825 1.65 . . . . 0.0 109.837 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.0 p -128.47 160.08 33.43 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.4 -38.59 66.39 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -68.68 -43.79 75.36 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.33 -42.22 66.05 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.32 -43.04 92.25 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.636 1.174 . . . . 0.0 110.213 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.33 -43.53 90.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.68 -43.63 80.65 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.101 0.961 . . . . 0.0 112.323 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.7 t -71.3 -39.94 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.46 1.027 . . . . 0.0 108.341 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -62.26 -35.43 78.94 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.026 0.531 . . . . 0.0 111.215 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -60.91 -47.95 84.06 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 121.283 -0.885 . . . . 0.0 109.695 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -41.05 66.54 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -143.98 148.33 41.62 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.01 131.29 23.49 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.594 2.196 . . . . 0.0 111.809 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 24.6 mt -119.35 -17.8 8.72 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.723 0.809 . . . . 0.0 112.592 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 70.06 -150.75 49.33 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 119.629 1.104 . . . . 0.0 110.69 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -65.53 167.82 8.31 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.525 1.53 . . . . 0.0 112.206 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.03 165.43 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 124.05 1.881 . . . . 0.0 111.086 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.58 -23.11 29.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.055 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.432 HD21 ' CD2' ' A' ' 285' ' ' LEU . 4.0 mm? -74.02 107.71 6.38 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 125.177 1.391 . . . . 0.0 110.57 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -61.1 1.87 0.15 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.192 1.397 . . . . 0.0 114.676 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.7 m -95.97 -67.75 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -68.62 -22.33 64.43 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.86 0.755 . . . . 0.0 111.263 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -62.67 -32.16 73.18 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 118.955 0.798 . . . . 0.0 109.186 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.89 -34.11 77.61 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.005 1.275 . . . . 0.0 110.244 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -79.18 -42.31 26.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.771 1.228 . . . . 0.0 110.45 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 19.3 mt -68.15 -39.31 82.67 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.07 -7.85 10.04 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.78 1.232 . . . . 0.0 112.361 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -62.44 -30.27 71.12 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.188 -0.945 . . . . 0.0 108.677 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.6 142.06 25.34 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 124.238 1.015 . . . . 0.0 108.934 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.74 -25.2 46.52 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.524 2.15 . . . . 0.0 113.138 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -58.47 -49.8 76.03 Favored 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.44 HD12 ' H ' ' A' ' 317' ' ' ILE . 4.2 mp -69.01 -42.01 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.334 1.054 . . . . 0.0 109.05 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.66 -47.6 73.36 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.148 0.431 . . . . 0.0 110.166 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.24 91.63 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.641 -0.662 . . . . 0.0 111.503 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.6 m -61.88 -37.47 84.67 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 60.7 tpp -73.05 -42.31 63.25 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 118.584 0.629 . . . . 0.0 109.974 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -56.78 -38.96 73.21 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -57.9 -41.82 83.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.401 0.28 . . . . 0.0 110.399 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.13 -32.17 72.27 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.861 -0.524 . . . . 0.0 111.125 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -78.56 -15.81 58.14 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.588 -0.695 . . . . 0.0 112.505 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 -10.69 9.69 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -99.08 -162.89 29.71 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 125.311 1.434 . . . . 0.0 111.22 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.6 122.13 14.17 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.645 0.778 . . . . 0.0 112.996 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 87.3 mt -78.89 105.48 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 1.5 mpt? 35.4 75.84 0.47 Allowed Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.231 1.412 . . . . 0.0 113.665 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.12 138.88 37.69 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 124.012 3.141 . . . . 0.0 111.559 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -129.58 73.96 1.56 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 pt -129.67 153.73 80.82 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.501 1.121 . . . . 0.0 111.225 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.41 -32.73 49.43 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.33 2.687 . . . . 0.0 113.453 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -63.26 -24.24 67.78 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.106 -0.996 . . . . 0.0 111.084 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 26.3 mmm -68.64 -26.36 65.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.239 0.927 . . . . 0.0 111.102 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.5 m -62.53 -48.82 77.86 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.72 -31.03 67.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.409 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.609 ' O ' HG23 ' A' ' 343' ' ' VAL . 30.8 t80 -55.92 -58.87 6.05 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.305 0.957 . . . . 0.0 109.909 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -60.55 -37.77 82.32 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.943 -0.473 . . . . 0.0 111.742 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -62.56 -44.33 96.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.403 0.681 . . . . 0.0 109.226 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.63 -50.99 67.16 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.056 1.342 . . . . 0.0 110.698 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 339' ' ' PHE . 2.1 t -59.19 -43.76 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.069 0.395 . . . . 0.0 110.236 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -53.65 -38.55 64.23 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.684 0.794 . . . . 0.0 110.833 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 5.7 m -82.4 -50.44 8.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.522 1.055 . . . . 0.0 110.067 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.84 63.46 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.37 -49.12 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 118.051 -0.975 . . . . 0.0 109.918 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.6 mm -65.31 -35.4 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 119.836 1.198 . . . . 0.0 109.67 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -64.73 -45.97 84.25 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.143 -0.973 . . . . 0.0 109.93 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.46 65.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.701 0.8 . . . . 0.0 111.003 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.91 -36.81 84.6 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 125.328 1.451 . . . . 0.0 113.497 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 42.4 m -92.22 -2.7 56.34 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.443 0.697 . . . . 0.0 110.707 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 76.32 13.01 83.76 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 115.532 0.973 . . . . 0.0 115.532 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -66.36 -30.78 71.24 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 119.06 1.43 . . . . 0.0 109.945 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -145.12 156.09 43.69 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.4 m -66.99 156.23 36.53 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.69 -51.66 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.14 -50.93 65.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.362 1.465 . . . . 0.0 111.621 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.41 -39.14 74.63 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.15 89.31 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 121.463 -0.773 . . . . 0.0 109.605 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.7 mp -72.13 -43.42 64.7 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.396 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.6 tptt -53.14 -55.07 26.97 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.122 1.369 . . . . 0.0 110.228 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -53.9 -49.16 69.21 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 127.99 2.516 . . . . 0.0 112.281 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.48 -50.11 74.88 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 125.668 1.587 . . . . 0.0 111.408 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 184' ' ' ASP . 1.3 tm0? -56.44 -33.09 65.53 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.485 1.039 . . . . 0.0 110.625 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 14.0 m -62.14 -37.01 83.55 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.806 0.73 . . . . 0.0 109.873 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -65.84 -20.39 66.22 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.154 -0.966 . . . . 0.0 112.244 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.537 HD13 HG21 ' A' ' 183' ' ' VAL . 5.7 mt -88.7 -29.21 5.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.274 1.03 . . . . 0.0 109.732 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.0 p -92.55 -7.74 46.37 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.672 -0.643 . . . . 0.0 110.709 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 25.5 tptt . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.312 1.445 . . . . 0.0 110.97 -178.55 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 27.6 tptp . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.9 mt -127.15 151.46 34.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -68.88 89.93 0.42 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 129.74 3.216 . . . . 0.0 110.637 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -92.02 99.36 12.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 145.76 19.86 0.14 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-O 119.239 -0.756 . . . . 0.0 114.958 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -141.11 172.2 13.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.55 1.175 . . . . 0.0 110.933 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.1 mt -153.53 147.03 24.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 128.521 2.728 . . . . 0.0 106.314 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.8 t -142.02 136.12 29.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.6 mt -124.02 137.79 55.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 126.348 1.859 . . . . 0.0 108.82 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -128.42 149.91 50.35 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.2 pt -136.25 168.08 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -158.91 150.95 21.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 128.121 2.569 . . . . 0.0 108.933 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.74 16.3 49.17 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-O 117.432 -1.76 . . . . 0.0 115.577 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 70.12 37.64 1.64 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.728 2.011 . . . . 0.0 110.675 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -57.61 157.05 7.48 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.299 1.047 . . . . 0.0 111.345 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.96 56.89 4.58 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.788 -0.642 . . . . 0.0 114.071 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -50.54 -39.45 49.17 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -66.51 -12.37 57.2 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.86 -45.53 1.49 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.6 tp -61.45 -37.87 85.15 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.466 0.706 . . . . 0.0 111.9 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.69 -41.76 64.16 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.705 0.802 . . . . 0.0 111.92 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -62.82 -33.15 74.62 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.3 t -65.18 -47.13 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.33 -35.77 92.5 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -62.88 -45.72 91.21 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.215 -0.898 . . . . 0.0 109.083 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -58.89 -54.94 41.48 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -52.36 -48.87 65.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.996 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -66.08 -32.51 74.01 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.858 1.208 . . . . 0.0 110.721 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 8.3 tppt? -68.93 -28.05 66.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 118.171 -0.919 . . . . 0.0 112.604 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.62 -0.43 20.23 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.255 0.972 . . . . 0.0 112.903 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.2 p -130.6 -38.79 1.3 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.61 1.096 . . . . 0.0 112.259 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.72 -10.91 66.57 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.832 -0.982 . . . . 0.0 113.74 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 40.0 mm -70.31 132.28 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 147.39 53.53 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.897 -0.502 . . . . 0.0 111.373 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 t -137.84 125.94 31.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.8 m -118.46 142.49 47.52 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.5 t -132.14 120.97 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -136.29 164.95 26.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.089 1.356 . . . . 0.0 110.245 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -122.4 58.22 10.14 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.126 1.37 . . . . 0.0 112.063 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.93 136.49 16.66 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.212 1.941 . . . . 0.0 110.611 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.12 -18.4 25.92 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.236 -0.915 . . . . 0.0 110.403 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.445 ' H ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -83.66 -2.11 55.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 128.12 2.568 . . . . 0.0 112.761 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.47 -31.6 10.28 Favored 'General case' 0 N--CA 1.461 0.085 0 C-N-CA 124.586 1.154 . . . . 0.0 113.459 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -52.6 -33.44 46.33 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.62 1.168 . . . . 0.0 113.561 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -119.14 -21.6 7.54 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 123.375 0.67 . . . . 0.0 110.967 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -72.55 -42.78 64.31 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 117.717 -1.135 . . . . 0.0 109.122 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -51.26 -60.51 5.58 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 117.558 -1.211 . . . . 0.0 109.96 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.52 -24.57 75.37 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.146 1.23 . . . . 0.0 113.142 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -69.4 -55.26 10.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.087 0.858 . . . . 0.0 111.337 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.412 HG12 ' C ' ' A' ' 55' ' ' ASP . 2.5 t -77.06 -37.47 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.696 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.07 90.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.782 -0.627 . . . . 0.0 109.31 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.0 -15.4 43.85 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 118.925 -0.56 . . . . 0.0 111.979 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.8 m -102.85 -9.23 20.09 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.036 1.734 . . . . 0.0 111.825 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.88 10.06 73.05 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.897 -1.127 . . . . 0.0 112.393 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.412 ' C ' HG12 ' A' ' 50' ' ' VAL . 1.4 m-20 -112.21 2.09 16.48 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.109 1.364 . . . . 0.0 112.582 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.45 176.9 34.23 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.958 -1.089 . . . . 0.0 114.848 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.23 -178.41 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.97 3.113 . . . . 0.0 110.818 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.56 -22.16 12.11 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 120.982 -1.074 . . . . 0.0 112.272 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mt -139.23 148.14 23.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.8 tp -129.35 144.45 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.974 1.71 . . . . 0.0 107.573 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -132.82 102.29 5.59 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.757 1.223 . . . . 0.0 108.808 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -153.13 171.39 18.52 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.053 0.842 . . . . 0.0 111.782 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.19 161.11 31.34 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.745 -1.222 . . . . 0.0 110.984 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -54.54 -32.14 57.72 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.794 1.638 . . . . 0.0 114.736 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.12 -58.15 8.84 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.622 1.169 . . . . 0.0 111.175 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -73.52 -9.39 58.63 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 121.156 -0.965 . . . . 0.0 111.592 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -93.75 12.1 26.83 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.218 1.807 . . . . 0.0 110.035 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 -9.9 56.61 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.815 -0.991 . . . . 0.0 112.006 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.56 -31.26 1.39 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.708 1.754 . . . . 0.0 116.211 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -53.02 -53.98 42.01 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.247 2.024 . . . . 0.0 111.863 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.21 89.75 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.427 -0.796 . . . . 0.0 109.412 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -40.86 76.91 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.804 0.842 . . . . 0.0 109.292 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 m -73.98 -38.01 64.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.694 0.797 . . . . 0.0 108.877 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.07 8.73 6.46 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.97 1.272 . . . . 0.0 114.549 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.8 mt -76.94 -8.01 56.6 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 mt -108.34 139.83 42.48 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.808 1.64 . . . . 0.0 111.857 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.32 175.12 8.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.625 0.77 . . . . 0.0 112.096 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -71.04 135.62 47.87 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.922 0.889 . . . . 0.0 109.326 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 pp -125.74 161.35 30.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 123.474 0.709 . . . . 0.0 110.805 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.9 m 50.87 82.58 0.24 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 127.122 2.169 . . . . 0.0 113.971 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.6 -21.68 25.32 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.349 2.7 . . . . 0.0 113.68 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -134.79 159.63 40.73 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.067 1.303 . . . . 0.0 113.106 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -70.78 -35.81 72.76 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.139 1.376 . . . . 0.0 113.021 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.73 -35.17 60.92 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.776 1.171 . . . . 0.0 112.213 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -65.58 -32.94 74.8 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 122.12 -0.363 . . . . 0.0 111.079 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -66.2 -43.19 87.5 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.607 -0.683 . . . . 0.0 109.54 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -60.0 -27.49 66.91 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.77 1.628 . . . . 0.0 112.938 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -72.17 -2.93 20.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.987 0.915 . . . . 0.0 111.627 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mt -132.81 156.36 47.26 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.185 1.394 . . . . 0.0 110.561 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -68.38 156.47 90.26 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.26 -50.89 0.86 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.187 3.258 . . . . 0.0 114.613 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -52.45 -36.51 54.77 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.374 0.988 . . . . 0.0 112.067 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -31.13 72.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.958 0.903 . . . . 0.0 111.28 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -75.75 -42.51 50.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.813 0.733 . . . . 0.0 110.599 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.491 ' HA ' ' HG3' ' A' ' 98' ' ' ARG . 4.0 m-20 -55.19 -36.08 65.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.086 0.403 . . . . 0.0 110.02 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.47 -2.51 4.72 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 m -133.06 15.96 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 120.146 1.339 . . . . 0.0 110.17 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 10.4 mmt180 -71.26 161.65 30.74 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 123.932 0.893 . . . . 0.0 110.832 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -152.05 179.29 8.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.616 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -63.43 97.77 0.14 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.692 1.197 . . . . 0.0 109.537 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.55 -80.96 1.0 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.443 1.496 . . . . 0.0 111.029 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 170.19 13.47 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.962 -0.728 . . . . 0.0 111.06 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.8 163.97 12.76 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.769 1.227 . . . . 0.0 109.385 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.6 pt -129.04 -34.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 116.752 -1.594 . . . . 0.0 114.03 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -143.83 -179.29 6.38 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.994 1.725 . . . . 0.0 109.165 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 264' ' ' ALA . 6.3 p90 -132.51 148.13 68.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.251 1.02 . . . . 0.0 111.303 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.66 151.88 32.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.676 2.918 . . . . 0.0 109.388 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -133.05 -55.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.695 1.198 . . . . 0.0 110.745 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.81 161.04 31.66 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.44 108.32 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -155.02 146.2 22.8 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.15 85.93 1.09 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.093 1.757 . . . . 0.0 107.066 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -170.85 160.22 6.67 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.881 1.673 . . . . 0.0 111.228 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.6 p -179.6 158.41 0.82 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.089 1.756 . . . . 0.0 110.285 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.7 tp -153.78 149.23 27.22 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.13 164.86 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -152.93 -177.61 6.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.834 -1.166 . . . . 0.0 110.425 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -64.55 164.36 11.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.148 1.379 . . . . 0.0 110.974 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -65.51 -15.54 62.78 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.835 -1.166 . . . . 0.0 112.455 178.352 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -69.87 176.96 3.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 130.02 3.328 . . . . 0.0 110.258 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.5 mt -78.58 -22.68 46.75 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.963 1.305 . . . . 0.0 110.539 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.82 162.33 0.11 Allowed Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 128.999 2.92 . . . . 0.0 113.92 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -73.12 -82.08 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.888 2.392 . . . . 0.0 109.362 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -153.3 150.35 23.5 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 127.137 2.175 . . . . 0.0 107.079 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.24 161.12 45.97 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.653 2.236 . . . . 0.0 110.862 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.0 159.51 53.69 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.876 2.384 . . . . 0.0 114.458 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -101.29 -33.12 10.17 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.944 2.898 . . . . 0.0 114.493 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 t -161.13 152.38 18.85 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.8 0.727 . . . . 0.0 110.47 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -64.96 -28.06 69.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.761 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -67.39 -17.27 64.66 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.886 0.766 . . . . 0.0 112.97 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -94.38 -18.6 21.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.962 0.905 . . . . 0.0 109.534 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.6 mm -52.5 -56.83 18.95 Favored Pre-proline 0 C--O 1.234 0.279 0 O-C-N 121.259 -0.901 . . . . 0.0 110.391 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.44 -29.77 44.83 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 CA-C-N 120.34 1.157 . . . . 0.0 111.608 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.25 -15.08 62.42 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.793 1.637 . . . . 0.0 112.474 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 36.6 tp -104.88 -24.57 12.85 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.798 1.639 . . . . 0.0 107.225 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.69 -49.21 69.39 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -65.51 -27.4 68.44 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.14 -42.77 30.74 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.5 mt -70.85 -33.27 70.47 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.31 68.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 123.615 0.572 . . . . 0.0 111.948 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.02 0.73 16.08 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.766 1.226 . . . . 0.0 112.982 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 179.59 -97.65 0.11 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 119.203 0.911 . . . . 0.0 113.134 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -140.55 -176.19 4.55 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.152 0.981 . . . . 0.0 111.165 -177.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.3 p -52.99 166.46 0.22 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.343 1.857 . . . . 0.0 115.181 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -95.45 -69.47 0.75 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.137 1.375 . . . . 0.0 109.828 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.7 tp -121.32 152.5 38.88 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.73 2.012 . . . . 0.0 110.687 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 88.0 mtp -149.76 131.51 15.03 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.741 2.416 . . . . 0.0 105.399 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -148.58 164.58 33.82 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.8 1.24 . . . . 0.0 110.639 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.66 94.43 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.885 1.274 . . . . 0.0 113.828 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.4 mt -85.07 -19.5 31.83 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.668 -1.27 . . . . 0.0 110.342 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -77.13 -0.81 26.32 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.784 0.834 . . . . 0.0 112.85 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -125.24 122.43 25.19 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.903 0.881 . . . . 0.0 109.735 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.1 -15.09 32.19 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.417 1.411 . . . . 0.0 112.395 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -48.7 -42.19 34.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.921 1.288 . . . . 0.0 113.3 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -93.77 -33.72 13.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.8 0.727 . . . . 0.0 112.354 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 82.6 p -72.28 -28.56 63.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.018 0.826 . . . . 0.0 111.914 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -47.46 -63.33 1.49 Allowed Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.137 1.775 . . . . 0.0 112.458 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -66.4 -11.86 33.26 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.737 1.624 . . . . 0.0 114.482 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.2 tp -78.89 -55.61 5.02 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.6 pt -62.48 -34.14 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.539 0.609 . . . . 0.0 111.79 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.44 -12.42 60.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.677 -1.154 . . . . 0.0 112.206 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -48.4 -54.37 14.27 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.191 1.396 . . . . 0.0 112.396 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -53.14 -49.81 65.81 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.455 0.57 . . . . 0.0 111.447 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.81 1.54 0.03 OUTLIER Glycine 0 CA--C 1.523 0.537 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.645 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -54.83 144.5 30.89 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 119.408 1.604 . . . . 0.0 110.19 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.424 ' CE1' ' HA3' ' A' ' 182' ' ' GLY . 37.6 p90 -148.83 136.71 20.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 118.568 1.184 . . . . 0.0 108.924 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.54 -67.77 0.71 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 335' ' ' GLN . 62.0 m-85 -133.91 134.31 42.5 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -75.49 124.28 26.9 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -131.71 100.78 5.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -79.57 -173.72 3.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.421 1.488 . . . . 0.0 107.724 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -46.9 -27.59 1.3 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.822 1.649 . . . . 0.0 114.25 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.57 13.82 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 CA-C-O 118.535 -1.147 . . . . 0.0 113.848 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -122.67 132.34 54.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.684 1.742 . . . . 0.0 108.891 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.01 114.36 19.65 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -139.52 96.01 3.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 122.442 1.115 . . . . 0.0 110.428 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.59 -3.41 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 127.622 2.369 . . . . 0.0 114.789 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -76.87 -36.74 56.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.04 93.94 5.85 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.88 151.21 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 126.246 1.819 . . . . 0.0 107.623 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.424 ' HA3' ' CE1' ' A' ' 167' ' ' TYR . . . -148.69 31.99 1.22 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.68 1.133 . . . . 0.0 112.246 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.05 -24.04 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 121.712 -0.875 . . . . 0.0 111.48 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -112.86 18.52 18.11 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.314 1.445 . . . . 0.0 112.814 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -61.57 160.38 11.44 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.591 0.71 . . . . 0.0 109.161 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.68 -26.27 63.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.636 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -72.45 -33.38 61.3 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.132 -0.98 . . . . 0.0 112.447 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.38 43.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.182 0.993 . . . . 0.0 109.758 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -59.79 -34.56 73.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.497 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.66 -54.34 48.21 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.709 0.686 . . . . 0.0 110.562 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.92 -32.06 81.5 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.848 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.87 -44.52 63.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.234 1.017 . . . . 0.0 111.143 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 12.9 t -62.27 -29.1 70.17 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 117.427 -1.273 . . . . 0.0 110.233 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -57.49 -46.6 83.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 120.205 1.366 . . . . 0.0 108.922 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.35 -51.56 67.12 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.918 0.887 . . . . 0.0 109.683 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.67 -32.71 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.526 0.73 . . . . 0.0 110.66 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -32.23 73.68 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.974 0.91 . . . . 0.0 110.601 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.16 -45.26 57.66 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 50.5 mt -60.81 -39.79 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.173 0.989 . . . . 0.0 108.627 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -54.69 -35.79 63.98 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.049 0.94 . . . . 0.0 109.627 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -93.15 -1.97 55.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.736 2.015 . . . . 0.0 113.131 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 9.1 mptt 55.98 11.82 0.8 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.317 2.647 . . . . 0.0 115.503 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -79.91 -8.41 59.3 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.947 -1.095 . . . . 0.0 112.362 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.62 136.44 50.84 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.236 1.014 . . . . 0.0 109.766 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -76.87 79.28 3.45 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.49 77.46 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.18 -2.25 9.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.906 2.082 . . . . 0.0 114.554 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 43.4 m -63.04 126.95 29.04 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.611 1.164 . . . . 0.0 113.629 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.82 179.38 4.03 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.954 2.102 . . . . 0.0 107.097 177.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -57.05 -45.54 83.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -40.25 97.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.148 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 59.6 mt -68.4 -48.86 70.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.42 85.51 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.088 0.555 . . . . 0.0 111.907 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -77.26 -49.55 14.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.047 0.839 . . . . 0.0 111.718 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.69 -50.54 71.84 Favored 'General case' 0 C--N 1.337 0.054 0 CA-C-N 119.114 0.87 . . . . 0.0 110.737 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.34 -44.6 84.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.292 1.037 . . . . 0.0 109.761 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -60.76 -44.06 97.22 Favored 'General case' 0 CA--C 1.524 -0.053 0 C-N-CA 123.501 0.72 . . . . 0.0 109.243 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -55.78 -42.76 76.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.797 0.839 . . . . 0.0 110.05 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -74.51 -21.33 59.6 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.265 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.96 20.26 13.17 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.981 -0.899 . . . . 0.0 112.537 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -73.46 -31.71 63.94 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.513 1.656 . . . . 0.0 112.701 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.7 t -124.2 146.57 48.62 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.796 1.639 . . . . 0.0 106.743 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -106.5 -9.63 16.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.31 1.044 . . . . 0.0 112.241 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.67 153.7 41.89 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.2 t -164.84 157.53 16.43 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.8 mt -142.59 155.59 18.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -156.47 151.11 25.78 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.623 0.725 . . . . 0.0 109.819 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -159.9 -67.39 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 128.567 2.984 . . . . 0.0 107.709 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.6 179.68 3.97 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.24 2.627 . . . . 0.0 112.935 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -113.83 130.18 56.5 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.15 -177.9 6.81 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 122.482 1.134 . . . . 0.0 112.969 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -120.28 10.55 11.32 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.994 2.117 . . . . 0.0 111.22 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 15.9 m -114.45 112.27 22.74 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.266 1.827 . . . . 0.0 108.483 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -65.59 121.72 15.58 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 8.2 tp -149.71 143.63 17.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.427 1.091 . . . . 0.0 109.076 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.89 114.62 26.26 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 10.2 t -85.98 169.65 13.03 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.761 1.624 . . . . 0.0 108.883 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 61.1 p -148.61 19.88 1.04 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.252 0.621 . . . . 0.0 112.122 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -139.21 162.74 34.23 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.557 1.143 . . . . 0.0 108.031 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 14.1 m -143.24 139.05 26.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.189 1.796 . . . . 0.0 107.448 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -122.52 147.5 46.29 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -151.08 -174.77 4.91 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.664 1.186 . . . . 0.0 108.373 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 67.47 -175.76 25.06 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.6 m -114.44 144.7 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 O-C-N 121.96 -0.73 . . . . 0.0 109.174 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 95.2 m -149.27 134.34 18.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.53 153.28 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.266 1.426 . . . . 0.0 109.462 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.4 pp -121.4 160.42 45.97 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.095 0.958 . . . . 0.0 111.085 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.73 153.81 68.59 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.395 1.396 . . . . 0.0 109.062 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.5 p -125.64 163.97 21.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -83.41 139.55 32.91 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 135.39 52.16 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.745 -1.222 . . . . 0.0 109.573 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 71.59 -1.61 27.93 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.182 -1.343 . . . . 0.0 113.974 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.99 105.14 2.64 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 121.283 2.542 . . . . 0.0 111.67 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.15 144.29 56.79 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.754 1.636 . . . . 0.0 110.809 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.39 146.86 46.85 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.504 1.522 . . . . 0.0 108.019 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -140.26 92.01 9.65 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.169 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -81.97 -165.07 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 125.244 3.963 . . . . 0.0 112.082 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -69.05 174.45 4.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.741 1.216 . . . . 0.0 109.386 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.9 t -97.86 150.68 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 121.465 -0.772 . . . . 0.0 108.973 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -165.8 58.34 0.24 Allowed Glycine 0 C--N 1.334 0.465 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.7 149.48 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 123.217 0.607 . . . . 0.0 110.34 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.9 tt -82.69 127.63 33.59 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.4 m -111.05 159.59 17.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.851 1.261 . . . . 0.0 107.871 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.43 ' HB3' ' CE1' ' A' ' 106' ' ' TYR . . . -139.07 151.49 46.78 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.427 0.691 . . . . 0.0 109.849 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -147.77 164.38 28.83 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 124.739 1.274 . . . . 0.0 113.128 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 45.7 mt -103.67 133.83 46.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.309 1.444 . . . . 0.0 108.366 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -69.91 118.82 13.24 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.04 -13.27 62.35 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.619 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -73.28 -26.49 61.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.45 1.023 . . . . 0.0 112.729 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 48.8 m -62.55 161.52 26.53 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.007 0.523 . . . . 0.0 110.782 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.3 -44.79 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.541 1.494 . . . . 0.0 114.892 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -133.92 100.62 4.8 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 119.61 1.096 . . . . 0.0 109.861 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -58.01 -20.73 40.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.247 1.019 . . . . 0.0 113.092 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -60.76 -32.09 71.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.426 0.69 . . . . 0.0 111.214 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.31 -27.89 67.69 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.42 -0.8 . . . . 0.0 110.802 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -85.22 -40.21 16.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.403 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.46 83.51 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 118.888 0.767 . . . . 0.0 110.189 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -71.29 -43.89 66.26 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.03 -49.66 77.03 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.122 -0.986 . . . . 0.0 109.28 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.3 mp -59.42 -50.6 73.32 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 118.19 -0.909 . . . . 0.0 112.712 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -76.17 -21.32 56.66 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -93.7 -23.83 18.08 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 117.06 -1.448 . . . . 0.0 112.075 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -137.17 -28.18 0.94 Allowed 'General case' 0 C--N 1.346 0.424 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 284' ' ' LEU . 1.2 tm? -83.5 -16.16 46.66 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.86 1.664 . . . . 0.0 112.442 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.552 HD22 HD21 ' A' ' 304' ' ' LEU . 67.6 mt -121.98 68.02 0.92 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.35 1.06 . . . . 0.0 109.702 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 65.6 p -139.44 154.84 47.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.959 1.704 . . . . 0.0 107.137 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.1 1.67 7.06 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.387 1.875 . . . . 0.0 112.246 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -113.21 -48.82 2.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.672 2.389 . . . . 0.0 111.058 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.52 -35.71 62.83 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.17 -42.88 99.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -60.39 -46.47 89.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 123.933 0.77 . . . . 0.0 109.545 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.84 -32.35 60.47 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 118.035 -0.984 . . . . 0.0 113.39 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 7.1 t -84.29 -24.57 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 120.406 1.457 . . . . 0.0 109.967 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -72.06 -23.85 61.43 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.285 0.948 . . . . 0.0 110.064 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -57.76 -49.9 75.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -64.67 -50.49 66.83 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 157.19 69.42 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 118.553 0.615 . . . . 0.0 112.296 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.89 101.18 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.776 2.317 . . . . 0.0 108.323 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 71.0 mt -81.27 -12.28 59.13 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 67.47 -154.04 52.93 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 120.168 1.349 . . . . 0.0 110.313 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.89 170.24 10.05 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.423 1.089 . . . . 0.0 112.639 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 18.7 m -133.64 155.84 40.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.45 1.5 . . . . 0.0 109.003 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.08 -24.37 59.48 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.659 -0.651 . . . . 0.0 109.378 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.552 HD21 HD22 ' A' ' 285' ' ' LEU . 4.4 mm? -66.48 102.61 0.91 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 127.57 2.348 . . . . 0.0 110.893 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -58.76 -24.13 61.19 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.2 p -64.69 -53.36 48.54 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 120.437 -1.414 . . . . 0.0 111.16 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -86.62 -19.68 28.97 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -62.12 -36.85 83.01 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.22 -10.44 23.42 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.127 0.876 . . . . 0.0 111.672 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -97.02 -45.31 6.63 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.424 1.49 . . . . 0.0 109.049 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 27.5 mt -67.51 -41.83 83.79 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.566 1.146 . . . . 0.0 109.043 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.55 0.87 0.42 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.633 1.973 . . . . 0.0 114.256 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -67.09 -18.44 65.32 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 120.244 1.384 . . . . 0.0 110.631 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -117.57 141.03 28.23 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.52 1.128 . . . . 0.0 109.486 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.97 -16.67 46.81 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.583 2.856 . . . . 0.0 116.462 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.44 -23.95 64.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 121.201 1.819 . . . . 0.0 109.581 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.2 mp -86.46 -65.43 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.01 -52.03 15.79 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.21 -22.17 66.84 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.699 -1.251 . . . . 0.0 114.088 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 41.0 m -85.11 -31.0 23.57 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.739 1.215 . . . . 0.0 108.069 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.8 tpt -71.26 -38.56 71.87 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.41 -29.93 68.1 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.539 1.136 . . . . 0.0 110.004 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -65.93 -42.56 89.93 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.278 0.631 . . . . 0.0 110.941 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.4 -33.43 74.23 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.148 0.431 . . . . 0.0 110.085 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -63.41 -48.98 75.57 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.381 0.673 . . . . 0.0 110.791 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.53 -25.71 26.64 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.67 175.08 17.47 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 124.913 1.245 . . . . 0.0 113.121 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -118.72 119.57 34.82 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 126.196 1.798 . . . . 0.0 109.171 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 42.3 mt -83.94 94.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 31.5 ttp 48.09 82.11 0.24 Allowed Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 126.552 1.941 . . . . 0.0 111.684 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.48 78.14 0.93 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.102 2.535 . . . . 0.0 111.456 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.71 61.34 4.34 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.035 1.334 . . . . 0.0 108.526 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 44.8 pt -126.3 147.24 59.13 Favored Pre-proline 0 CA--C 1.535 0.387 0 O-C-N 121.093 -1.004 . . . . 0.0 111.288 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.36 -19.16 67.6 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.263 2.642 . . . . 0.0 114.354 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 169' ' ' PHE . 4.2 mp0 -66.95 -22.84 65.92 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.66 -0.65 . . . . 0.0 110.298 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 97.6 mmm -64.85 -27.6 68.98 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.757 0.708 . . . . 0.0 110.387 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 7.4 t -56.73 -52.22 65.83 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.561 1.144 . . . . 0.0 108.103 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.19 68.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.316 -0.849 . . . . 0.0 110.781 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -48.31 -57.7 5.63 Favored 'General case' 0 CA--C 1.524 -0.055 0 C-N-CA 123.788 0.835 . . . . 0.0 112.574 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -62.19 -50.04 73.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -61.34 -39.84 92.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.18 -57.65 6.33 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.428 1.091 . . . . 0.0 109.922 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.65 -42.97 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.816 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -53.66 -53.51 50.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.038 1.29 . . . . 0.0 108.419 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 18.8 m -60.22 -42.56 95.45 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.829 0.452 . . . . 0.0 110.833 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.11 94.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.244 0.929 . . . . 0.0 111.638 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.75 -49.81 83.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 123.7 0.8 . . . . 0.0 109.112 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.1 mm -65.84 -38.4 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.9 0.773 . . . . 0.0 109.034 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -57.77 -49.25 77.21 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.178 -0.951 . . . . 0.0 109.979 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.24 -50.58 60.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.814 0.845 . . . . 0.0 111.936 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.18 70.71 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.165 1.386 . . . . 0.0 114.235 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 49.4 m -97.71 3.12 50.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.641 0.777 . . . . 0.0 110.284 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.51 11.26 68.17 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 121.168 -0.958 . . . . 0.0 114.577 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 31.8 ttm-85 -68.13 -27.95 66.9 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 118.128 0.964 . . . . 0.0 110.014 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -149.55 156.13 41.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.8 m -71.11 155.84 40.3 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 80.0 t -52.57 -54.14 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.575 1.15 . . . . 0.0 109.346 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.71 -47.64 73.49 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.741 1.616 . . . . 0.0 112.127 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -71.6 -34.83 70.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.38 98.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 9.9 mt -72.11 -41.68 66.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.766 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -53.52 -46.18 70.01 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.724 0.81 . . . . 0.0 110.634 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.55 -48.06 83.13 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.567 1.547 . . . . 0.0 111.793 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.65 80.2 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.823 2.049 . . . . 0.0 111.959 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.68 -36.26 61.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.518 0.599 . . . . 0.0 110.898 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.83 -44.79 84.53 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.046 0.385 . . . . 0.0 111.322 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -61.02 -25.36 66.85 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.365 -0.835 . . . . 0.0 112.591 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 48.8 mt -90.46 -21.65 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.627 1.571 . . . . 0.0 113.683 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . 0.331 1.6 t -116.66 5.84 13.27 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.339 0.972 . . . . 0.0 111.731 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? . . . . . 0 C--O 1.247 0.939 0 C-N-CA 126.667 1.987 . . . . 0.0 110.312 178.593 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.4 tppm? . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.67 154.26 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 O-C-N 124.762 1.289 . . . . 0.0 108.302 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -68.39 121.6 16.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.781 1.632 . . . . 0.0 107.779 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.78 -173.36 2.7 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.896 0.878 . . . . 0.0 109.463 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.1 27.22 68.56 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.429 -0.794 . . . . 0.0 114.184 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -144.68 168.08 21.02 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.596 1.198 . . . . 0.0 112.44 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.2 mt -151.65 149.12 28.77 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 129.516 3.127 . . . . 0.0 107.221 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -145.13 146.16 20.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 124.72 1.208 . . . . 0.0 108.627 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.1 mt -136.0 139.8 45.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 126.155 1.782 . . . . 0.0 107.958 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -123.91 155.07 38.78 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.2 mp -135.94 136.79 49.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 125.53 1.532 . . . . 0.0 109.799 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -78.4 -50.35 11.87 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.709 0.804 . . . . 0.0 108.872 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.52 177.85 39.28 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.258 1.408 . . . . 0.0 109.779 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 64.23 -1.23 0.74 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.402 2.281 . . . . 0.0 115.448 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -85.97 170.98 11.79 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.473 -1.392 . . . . 0.0 112.862 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.17 62.79 0.49 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 126.163 1.84 . . . . 0.0 109.872 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -55.68 -34.3 64.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.61 -0.709 . . . . 0.0 112.444 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -59.2 -36.76 75.96 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.854 0.752 . . . . 0.0 111.954 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.69 -39.21 10.81 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.61 -44.74 89.6 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.656 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.52 -49.38 26.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.854 0.721 . . . . 0.0 110.491 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -57.47 -31.76 66.29 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.4 -42.68 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.67 -40.96 90.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 123.729 0.681 . . . . 0.0 111.415 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -64.37 -42.41 96.2 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.79 1.295 . . . . 0.0 109.324 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -58.24 -59.66 4.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -59.28 -42.85 92.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.075 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -66.21 -27.76 68.23 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 120.776 1.625 . . . . 0.0 110.557 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.9 -28.88 55.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.421 -1.425 . . . . 0.0 110.37 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -84.39 -47.14 10.99 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.069 1.748 . . . . 0.0 111.928 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.3 p -100.39 -32.09 11.0 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.11 -12.76 68.77 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.904 -1.122 . . . . 0.0 111.36 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.9 mm -66.86 130.58 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 142.52 58.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 118.926 -0.559 . . . . 0.0 111.807 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -135.85 102.11 3.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.2 m -96.9 142.43 28.89 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.185 0.994 . . . . 0.0 108.8 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.95 129.84 58.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -137.39 164.55 28.35 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.43 1.092 . . . . 0.0 108.662 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -133.44 61.51 54.49 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.297 1.039 . . . . 0.0 109.821 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.404 ' HG2' ' HB3' ' A' ' 43' ' ' LEU . 87.4 Cg_endo -69.64 155.13 67.15 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.161 2.574 . . . . 0.0 111.64 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -100.61 -0.04 38.35 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.72 18.43 3.55 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.1 pt? -55.97 -23.95 35.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 117.829 -1.081 . . . . 0.0 113.625 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -59.7 -23.71 63.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.109 1.322 . . . . 0.0 112.491 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.38 -30.15 6.66 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.929 0.871 . . . . 0.0 109.407 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -70.43 -28.06 64.75 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.191 -0.943 . . . . 0.0 109.149 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -66.67 -60.61 6.18 Favored Pre-proline 0 CA--C 1.536 0.433 0 O-C-N 119.961 -1.712 . . . . 0.0 108.448 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.06 -25.72 80.53 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.277 1.985 . . . . 0.0 114.716 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.66 -0.63 18.59 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.278 1.031 . . . . 0.0 112.758 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.2 -36.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.85 74.19 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.73 -30.74 70.3 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.893 0.477 . . . . 0.0 110.903 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.0 m -81.43 -14.41 57.12 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.564 1.946 . . . . 0.0 110.919 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.81 56.57 2.32 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.41 -172.48 2.96 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.593 2.357 . . . . 0.0 106.382 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.72 -162.61 14.76 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 120.239 -1.538 . . . . 0.0 113.9 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.53 -179.05 3.36 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.001 3.134 . . . . 0.0 110.33 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -109.29 -24.37 11.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.409 -0.807 . . . . 0.0 112.135 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.9 mt -145.41 148.87 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 tp -132.78 141.34 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -128.97 107.32 9.52 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.875 1.67 . . . . 0.0 107.776 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -152.84 -150.71 0.35 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.945 1.248 . . . . 0.0 113.47 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.15 136.52 32.98 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.589 2.356 . . . . 0.0 110.152 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -48.66 -48.82 39.49 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.441 1.496 . . . . 0.0 112.489 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.45 -5.47 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 129.272 3.029 . . . . 0.0 113.972 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -108.84 -12.18 14.94 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.532 1.133 . . . . 0.0 109.633 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -94.34 -26.01 16.74 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 124.231 1.012 . . . . 0.0 112.304 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -49.97 -41.12 36.49 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.31 -55.79 16.79 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.949 0.785 . . . . 0.0 111.621 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -53.99 -42.48 69.08 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.55 1.14 . . . . 0.0 111.663 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.65 90.3 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 122.843 0.457 . . . . 0.0 111.086 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -44.65 96.72 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.2 m -66.87 -4.38 9.22 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.433 1.493 . . . . 0.0 113.319 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.99 6.66 88.72 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.375 0.988 . . . . 0.0 112.985 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.43 -22.87 64.58 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.6 mt -95.24 133.15 39.44 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.81 155.28 40.6 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -64.35 118.91 9.38 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.457 HG13 ' CA ' ' A' ' 105' ' ' ALA . 9.8 mm -71.58 165.33 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 122.351 1.072 . . . . 0.0 111.099 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.2 m 71.29 92.85 0.05 OUTLIER Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 129.031 2.932 . . . . 0.0 108.096 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.94 -34.54 10.49 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.463 1.442 . . . . 0.0 109.744 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.57 150.46 36.43 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.501 1.12 . . . . 0.0 109.128 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -57.27 -34.1 68.3 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.472 1.109 . . . . 0.0 112.041 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.24 -27.27 63.83 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.64 1.109 . . . . 0.0 111.898 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.31 -36.64 84.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.277 0.944 . . . . 0.0 109.008 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -59.29 -38.36 79.99 Favored 'General case' 0 C--N 1.343 0.284 0 O-C-N 121.044 -1.035 . . . . 0.0 112.707 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -65.67 -17.8 64.87 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.567 0.747 . . . . 0.0 111.6 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.14 -10.25 58.75 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.424 HD13 ' CE2' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -126.53 156.36 40.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.519 1.054 . . . . 0.0 111.962 -178.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -70.52 156.17 92.32 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.971 0.908 . . . . 0.0 110.705 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.16 -41.15 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.181 2.587 . . . . 0.0 113.821 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -63.81 -27.62 69.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.038 0.835 . . . . 0.0 110.87 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.05 -28.17 54.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.837 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.424 ' CE2' HD13 ' A' ' 89' ' ' LEU . 4.1 m95 -70.57 -39.21 74.04 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 118.717 0.69 . . . . 0.0 109.874 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.63 -27.57 68.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.36 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.57 -4.78 36.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.88 12.52 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.605 1.162 . . . . 0.0 111.773 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -65.74 165.27 13.0 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 122.449 1.119 . . . . 0.0 111.547 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -154.42 -171.04 3.72 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.09 1.756 . . . . 0.0 107.123 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -66.23 98.78 0.48 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.171 1.388 . . . . 0.0 109.047 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.49 -74.27 0.42 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.085 1.802 . . . . 0.0 113.433 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.52 166.62 22.31 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.766 0.827 . . . . 0.0 110.735 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mt -100.15 145.88 27.48 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.0 pt -110.19 -25.87 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.457 ' CA ' HG13 ' A' ' 79' ' ' ILE . . . -154.29 171.97 18.41 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.01 146.82 62.28 Favored Pre-proline 0 C--O 1.242 0.668 0 C-N-CA 123.529 0.732 . . . . 0.0 110.106 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.3 149.01 44.59 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.885 2.39 . . . . 0.0 110.09 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.5 mm -138.73 -52.06 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.835 2.054 . . . . 0.0 109.421 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.51 150.91 46.99 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.594 1.158 . . . . 0.0 112.671 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.3 t -126.12 118.36 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.436 1.894 . . . . 0.0 107.723 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -125.21 141.57 52.01 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.371 1.068 . . . . 0.0 108.411 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.37 106.58 4.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mp -67.91 176.99 2.31 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.522 1.529 . . . . 0.0 109.845 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.9 p -84.33 -175.8 5.96 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.686 1.194 . . . . 0.0 109.389 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.463 ' HB2' HG22 ' A' ' 245' ' ' THR . 0.9 OUTLIER -95.98 156.74 16.21 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 176.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.2 mp -88.28 98.39 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.64 171.55 7.67 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.559 1.944 . . . . 0.0 109.46 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -68.26 161.24 27.68 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -65.36 -19.8 66.11 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -58.47 142.77 47.77 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.993 1.269 . . . . 0.0 110.079 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.7 pt? -70.54 4.69 2.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.918 1.287 . . . . 0.0 112.558 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.3 tp -121.86 64.3 17.35 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 126.25 1.82 . . . . 0.0 106.554 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.26 -3.19 13.42 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.517 2.145 . . . . 0.0 114.216 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 21.91 82.77 0.12 Allowed Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 129.416 3.086 . . . . 0.0 112.953 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.16 160.86 42.8 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.379 2.719 . . . . 0.0 116.584 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.43 170.8 16.52 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.221 3.281 . . . . 0.0 111.101 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -126.74 -31.88 2.64 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.827 0.851 . . . . 0.0 111.212 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.68 154.81 14.02 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.582 1.083 . . . . 0.0 109.783 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -61.79 -22.61 65.59 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 121.232 -0.917 . . . . 0.0 110.936 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -71.39 -12.41 61.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.567 1.076 . . . . 0.0 111.07 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -108.73 -17.02 14.05 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.973 2.509 . . . . 0.0 111.817 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.2 mm -58.66 -63.01 4.58 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 121.161 -0.962 . . . . 0.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.63 -18.76 37.45 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.773 1.649 . . . . 0.0 111.745 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.71 -49.61 57.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.514 1.126 . . . . 0.0 108.52 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.8 tp -72.1 -30.59 65.23 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.794 0.838 . . . . 0.0 109.781 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.38 -48.02 72.01 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.761 0.824 . . . . 0.0 111.645 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -70.17 -31.12 68.45 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.465 0.306 . . . . 0.0 111.069 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -67.83 -45.05 75.76 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.7 mt -71.32 -30.28 66.03 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.243 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -67.8 -34.51 76.89 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 119.79 1.177 . . . . 0.0 108.14 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.43 -7.69 27.21 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.323 1.049 . . . . 0.0 111.965 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 6.12 3.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.312 1.445 . . . . 0.0 111.614 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.0 -76.42 0.1 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.02 176.09 12.97 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.45 1.1 . . . . 0.0 110.175 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.65 165.1 8.66 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.902 0.858 . . . . 0.0 111.561 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -84.85 -70.09 0.6 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.289 1.436 . . . . 0.0 111.3 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.2 tp -103.22 157.72 16.81 Favored 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 125.893 1.677 . . . . 0.0 113.334 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 92.4 mtp -150.06 118.69 6.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.466 2.306 . . . . 0.0 106.093 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -142.13 155.23 45.32 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.803 0.729 . . . . 0.0 109.281 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -68.06 96.53 0.62 Allowed 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.338 -0.851 . . . . 0.0 111.79 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.51 -10.67 58.18 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.239 1.016 . . . . 0.0 110.806 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -75.79 -29.78 58.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.566 -0.73 . . . . 0.0 112.099 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -99.55 133.0 22.2 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 119.485 1.039 . . . . 0.0 109.491 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.41 -5.39 14.97 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.68 2.92 . . . . 0.0 113.719 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -66.84 -37.62 84.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.524 1.13 . . . . 0.0 110.506 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -75.74 -46.12 32.7 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 122.034 -0.416 . . . . 0.0 112.084 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.9 p -73.96 -17.2 61.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -53.68 -61.28 5.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.69 -3.8 10.98 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.324 2.016 . . . . 0.0 114.111 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.99 -59.24 2.28 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 30.5 pt -61.84 -49.41 84.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 116.977 -1.487 . . . . 0.0 111.708 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -49.36 -8.88 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.277 2.631 . . . . 0.0 115.236 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.75 85.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.399 1.08 . . . . 0.0 111.221 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -67.87 -50.13 58.14 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 177.8 11.96 0.02 OUTLIER Glycine 0 CA--C 1.534 1.265 0 O-C-N 121.251 -0.905 . . . . 0.0 115.154 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.77 131.35 10.43 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 125.869 1.699 . . . . 0.0 111.026 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -146.76 143.32 28.59 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.55 -45.73 13.21 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.23 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -148.69 126.94 12.15 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -76.01 145.88 39.9 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.859 0.754 . . . . 0.0 111.219 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -140.46 116.27 10.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -91.75 -174.81 3.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.347 1.059 . . . . 0.0 108.306 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -56.51 -9.22 0.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.513 1.925 . . . . 0.0 115.185 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -178.9 13.41 0.03 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.208 1.861 . . . . 0.0 112.85 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -132.52 106.2 7.7 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.955 1.378 . . . . 0.0 110.47 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -104.09 125.8 50.71 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.62 110.66 8.28 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -8.61 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.058 0.543 . . . . 0.0 112.446 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -77.53 -31.19 53.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.568 1.147 . . . . 0.0 110.544 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -84.18 87.71 7.18 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 74.7 t -104.57 152.82 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.884 1.674 . . . . 0.0 108.86 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -145.25 24.83 1.88 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.881 1.229 . . . . 0.0 113.766 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.09 -22.56 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 120.796 -1.414 . . . . 0.0 113.013 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -106.27 5.93 30.21 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.125 1.77 . . . . 0.0 111.807 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -59.82 157.13 12.82 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.584 -0.698 . . . . 0.0 110.38 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.92 -34.43 55.21 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.193 0.997 . . . . 0.0 110.755 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.99 -33.01 65.68 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.9 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.45 -49.87 61.74 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.579 1.69 . . . . 0.0 107.743 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -61.85 -41.05 97.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.068 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.1 -46.6 89.93 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.054 0.942 . . . . 0.0 110.216 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.72 -36.72 93.7 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 31.5 tp -75.02 -49.36 20.08 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.998 0.919 . . . . 0.0 113.164 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.7 t -52.95 -33.7 52.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.123 0.969 . . . . 0.0 112.993 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -58.93 -51.91 68.02 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.234 1.379 . . . . 0.0 109.466 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.0 tt -64.57 -46.38 83.02 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.308 1.043 . . . . 0.0 110.264 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.61 -34.45 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 123.751 0.82 . . . . 0.0 110.695 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.674 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.3 OUTLIER -63.57 -33.46 75.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.017 0.826 . . . . 0.0 111.876 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 13.8 mt -71.65 -43.92 65.23 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 44.6 mt -60.18 -41.47 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.674 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.7 OUTLIER -55.83 -30.48 61.48 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.995 -1.066 . . . . 0.0 110.346 178.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -93.3 -5.3 50.03 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.367 1.467 . . . . 0.0 112.093 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? 58.13 18.19 5.09 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.918 2.487 . . . . 0.0 113.891 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -91.2 -13.3 33.1 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 9.1 tpt -92.86 167.13 12.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.934 0.788 . . . . 0.0 111.496 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -76.25 42.69 0.27 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.906 2.882 . . . . 0.0 109.424 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.18 -33.41 75.42 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 126.059 1.744 . . . . 0.0 115.22 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.34 -9.22 57.9 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.487 1.115 . . . . 0.0 112.685 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.3 m -78.17 131.4 37.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.165 1.386 . . . . 0.0 111.036 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -119.04 179.39 4.18 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.411 1.884 . . . . 0.0 107.821 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -52.69 -46.69 67.4 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.816 0.846 . . . . 0.0 113.082 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 54.0 m -63.31 -36.94 85.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.571 0.749 . . . . 0.0 110.785 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 28.0 mm -68.64 -49.94 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 117.78 -1.105 . . . . 0.0 108.512 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.33 -47.82 82.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.999 1.272 . . . . 0.0 111.938 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -56.62 -48.62 77.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.843 0.457 . . . . 0.0 110.164 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.96 -52.39 56.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.55 0.74 . . . . 0.0 110.744 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.71 -43.12 68.76 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.841 1.657 . . . . 0.0 110.75 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -60.41 -39.5 87.58 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.23 -43.84 97.92 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -69.31 -12.09 61.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.915 1.286 . . . . 0.0 112.704 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.69 13.31 70.23 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 120.193 1.36 . . . . 0.0 111.613 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -74.51 -9.06 58.21 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 116.609 2.078 . . . . 0.0 116.609 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.03 157.04 47.96 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 120.345 1.43 . . . . 0.0 110.543 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.41 -35.12 14.56 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.217 1.007 . . . . 0.0 110.368 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -145.05 145.66 31.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.41 1.084 . . . . 0.0 110.369 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.06 155.48 47.02 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 78.2 mt -128.1 92.41 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -121.24 -110.57 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -158.97 -88.14 0.07 OUTLIER Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.8 139.1 32.91 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.166 1.91 . . . . 0.0 111.023 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -93.22 -6.26 48.09 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.283 1.033 . . . . 0.0 111.181 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -52.9 164.13 0.42 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.342 1.857 . . . . 0.0 112.252 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -99.95 -27.82 13.4 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 14.8 m -73.9 -45.62 49.56 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 120.124 1.329 . . . . 0.0 111.557 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 57.86 1.11 0.13 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 27.6 pt -67.55 -10.61 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.677 1.991 . . . . 0.0 111.563 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.27 168.03 3.71 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.746 1.619 . . . . 0.0 112.324 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.3 t -127.15 9.82 6.81 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.32 1.048 . . . . 0.0 111.105 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 8.4 p -118.44 158.53 25.15 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.55 1.54 . . . . 0.0 109.842 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -146.39 73.4 1.32 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 31.5 m -104.38 163.64 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 123.821 0.848 . . . . 0.0 110.736 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 60.6 t30 46.61 42.41 11.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.886 2.074 . . . . 0.0 110.408 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -90.31 166.66 13.19 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 127.003 2.121 . . . . 0.0 111.267 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 165.88 174.62 35.56 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 19.1 m -151.76 167.57 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 124.949 1.3 . . . . 0.0 109.806 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.463 HG22 ' HB2' ' A' ' 115' ' ' LEU . 1.2 t -74.58 169.95 16.75 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.0 t -53.8 116.15 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.184 0.994 . . . . 0.0 109.384 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.0 mp -69.69 145.91 95.3 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.37 156.13 37.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.273 2.649 . . . . 0.0 110.782 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 255' ' ' SER . 75.3 p -99.48 176.11 5.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.682 1.193 . . . . 0.0 108.722 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -107.79 159.25 16.64 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -55.15 103.52 0.09 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.815 0.846 . . . . 0.0 111.936 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.58 -5.65 63.89 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-O 118.176 -1.347 . . . . 0.0 113.223 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -122.84 108.32 32.92 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 120.206 2.003 . . . . 0.0 110.48 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.17 131.79 31.72 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.643 1.562 . . . . 0.0 109.334 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.473 ' H ' HG22 ' A' ' 249' ' ' THR . 10.1 p -64.13 160.1 19.03 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.39 1.076 . . . . 0.0 109.928 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -132.75 71.68 78.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 118.348 0.522 . . . . 0.0 110.596 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.43 156.64 65.33 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.831 2.354 . . . . 0.0 111.46 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -74.23 160.98 30.4 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 69.4 t -129.21 133.35 65.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.13 0.972 . . . . 0.0 110.856 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.06 141.84 17.27 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 11.4 m -144.69 157.15 14.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 118.561 1.181 . . . . 0.0 109.779 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.75 147.69 52.98 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.198 0.999 . . . . 0.0 108.322 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -133.01 127.31 33.85 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.606 1.094 . . . . 0.0 109.277 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -110.26 138.77 46.19 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.344 1.858 . . . . 0.0 106.959 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -145.5 141.06 9.46 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.221 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 67.4 mt -78.48 137.8 21.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -72.65 129.26 37.85 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.43 -15.93 60.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -67.19 -40.7 86.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.095 -0.955 . . . . 0.0 113.071 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.9 m -47.41 148.85 2.14 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 125.048 1.339 . . . . 0.0 113.78 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.96 -56.02 0.23 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.479 2.119 . . . . 0.0 112.479 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -113.7 102.4 10.22 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.176 1.353 . . . . 0.0 110.392 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.63 -16.82 63.45 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 122.024 -0.423 . . . . 0.0 111.794 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -64.62 -38.08 89.77 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.969 0.907 . . . . 0.0 110.017 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.74 -39.69 81.66 Favored 'General case' 0 N--CA 1.461 0.102 0 O-C-N 121.627 -0.67 . . . . 0.0 110.504 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.89 -44.8 68.99 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -32.53 72.31 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.314 -0.85 . . . . 0.0 111.348 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -74.26 -44.75 51.66 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -58.84 -39.31 80.9 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.57 -48.06 76.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.845 -0.597 . . . . 0.0 111.107 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -79.34 -18.61 52.17 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -107.07 -16.79 14.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.645 1.111 . . . . 0.0 113.932 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -136.82 -40.04 0.62 Allowed 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.235 0.925 . . . . 0.0 113.459 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.65 -36.98 65.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.262 0.937 . . . . 0.0 111.076 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.407 HD22 HD21 ' A' ' 304' ' ' LEU . 30.5 mt -107.65 63.45 0.62 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.36 1.464 . . . . 0.0 111.79 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 23.5 p -134.15 155.2 50.53 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.35 -37.8 88.68 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.93 -31.87 61.62 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -75.78 -45.81 16.02 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 65.2 mt -61.66 -43.17 99.36 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.805 0.842 . . . . 0.0 109.598 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -56.67 -41.51 77.41 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.882 0.738 . . . . 0.0 110.249 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.5 93.0 Favored 'General case' 0 C--N 1.343 0.292 0 O-C-N 121.246 -0.909 . . . . 0.0 112.463 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 4.5 t -67.14 -41.82 87.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -65.27 -27.72 68.84 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.705 0.764 . . . . 0.0 112.51 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -70.86 -35.49 72.41 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 117.232 -1.366 . . . . 0.0 109.707 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.61 -45.4 21.69 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.595 1.543 . . . . 0.0 111.791 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -138.33 152.3 71.15 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.757 1.223 . . . . 0.0 108.851 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.65 123.43 10.13 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.556 1.504 . . . . 0.0 109.641 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 20.8 mt -79.21 -30.05 43.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 119.016 -0.516 . . . . 0.0 109.703 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.4 -155.64 22.91 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 106.098 -2.801 . . . . 0.0 106.098 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -75.43 171.58 14.0 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.29 157.01 30.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 123.58 1.657 . . . . 0.0 114.163 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.76 -17.32 59.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.852 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.407 HD21 HD22 ' A' ' 285' ' ' LEU . 4.4 mm? -71.04 104.76 3.1 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 125.672 1.589 . . . . 0.0 109.146 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -57.48 -29.17 64.03 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 20.5 t -63.37 -66.58 0.52 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.686 1.994 . . . . 0.0 110.304 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.93 -17.5 60.55 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -63.96 -32.29 73.78 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -70.15 -11.35 60.83 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.34 -0.85 . . . . 0.0 111.19 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -98.18 -49.15 4.83 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.97 2.108 . . . . 0.0 108.991 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 64.6 mt -69.8 -31.23 69.02 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 121.865 -0.522 . . . . 0.0 110.143 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.17 -3.78 4.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.263 0.938 . . . . 0.0 112.207 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -64.07 -10.99 25.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.553 1.141 . . . . 0.0 110.88 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.23 144.13 35.62 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 126.162 1.785 . . . . 0.0 107.376 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.78 -24.89 46.48 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.344 2.696 . . . . 0.0 114.805 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 16.9 mmm-85 -62.45 -48.21 80.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.733 0.697 . . . . 0.0 109.151 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.1 mp -65.02 -50.48 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.45 -52.25 39.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 124.197 0.935 . . . . 0.0 109.736 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.8 -36.32 76.51 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.393 -0.817 . . . . 0.0 112.404 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 88.2 m -65.56 -38.52 89.81 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 49.7 tpp -76.51 -38.34 55.34 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.351 0.523 . . . . 0.0 109.818 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -58.23 -34.07 70.03 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 123.942 0.897 . . . . 0.0 109.096 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -61.8 -38.45 88.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.042 -0.411 . . . . 0.0 109.898 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.25 -35.67 66.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -64.34 -49.84 70.13 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.792 0.837 . . . . 0.0 111.345 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -4.38 42.45 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.418 1.087 . . . . 0.0 113.402 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -107.21 -156.6 20.41 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 125.403 1.478 . . . . 0.0 110.645 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -158.94 179.34 9.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.609 1.964 . . . . 0.0 108.525 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 27.3 mm -112.43 132.71 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 123.343 0.657 . . . . 0.0 110.089 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 22.4 ptp -63.77 135.83 96.46 Favored Pre-proline 0 CA--C 1.54 0.586 0 O-C-N 124.825 1.328 . . . . 0.0 107.507 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.51 144.8 51.03 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.844 1.696 . . . . 0.0 111.501 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -103.07 73.18 1.22 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.5 pt -138.55 146.23 49.93 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.734 0.813 . . . . 0.0 109.076 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.78 -18.43 53.02 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.676 2.917 . . . . 0.0 114.478 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -65.43 -17.7 64.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.522 1.129 . . . . 0.0 109.84 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 85.6 mmm -61.64 -32.5 72.66 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.313 0.645 . . . . 0.0 111.381 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 70.5 m -64.89 -45.24 86.8 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.403 1.001 . . . . 0.0 109.478 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.76 80.23 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -64.79 -51.44 62.21 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.395 1.478 . . . . 0.0 109.794 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -58.6 -45.94 88.08 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.45 1.023 . . . . 0.0 110.727 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -58.91 -47.21 85.79 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -56.19 -57.08 13.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.227 1.011 . . . . 0.0 113.052 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 23.5 t -62.41 -35.59 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.217 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -54.08 -50.07 67.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.73 1.605 . . . . 0.0 110.119 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 32.2 m -67.02 -40.88 87.34 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.743 -0.598 . . . . 0.0 110.516 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.77 98.99 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.578 1.081 . . . . 0.0 113.426 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.48 -46.99 95.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 33.1 mm -68.7 -37.12 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 118.544 0.611 . . . . 0.0 110.068 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -57.21 -46.94 82.44 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.245 -0.909 . . . . 0.0 108.942 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.27 -53.77 32.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.417 1.087 . . . . 0.0 110.789 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -57.61 -34.19 69.02 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.469 1.508 . . . . 0.0 114.372 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 52.1 m -97.39 0.48 47.89 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.1 0.56 . . . . 0.0 111.173 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 67.89 12.33 62.17 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.93 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -62.98 -31.49 72.63 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.557 1.179 . . . . 0.0 108.481 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -147.18 152.95 39.24 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 7.5 m -61.52 153.13 28.31 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.283 1.433 . . . . 0.0 108.674 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 11.1 t -58.81 -45.72 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 119.435 1.016 . . . . 0.0 108.386 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.26 -48.56 76.31 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.168 1.387 . . . . 0.0 111.28 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -68.42 -44.92 73.96 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.879 1.271 . . . . 0.0 111.988 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.24 -44.04 83.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.308 0.643 . . . . 0.0 110.58 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.3 mp -70.17 -39.97 74.98 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.555 0.742 . . . . 0.0 110.602 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -57.37 -47.55 81.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.1 -54.29 45.03 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.517 1.527 . . . . 0.0 108.206 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -54.33 -50.82 66.52 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.411 1.485 . . . . 0.0 112.902 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -54.71 -39.68 68.44 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 5.6 m -69.78 -22.98 63.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.162 0.585 . . . . 0.0 111.565 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -78.41 -4.74 49.81 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 120.139 -1.6 . . . . 0.0 112.135 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 5.2 mt -112.68 -29.19 2.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 124.063 0.945 . . . . 0.0 110.252 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 20.4 p -75.7 -23.95 56.2 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.595 1.089 . . . . 0.0 110.445 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 CA-C-O 117.444 -1.265 . . . . 0.0 108.989 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.441 ' CG2' ' HD3' ' A' ' 271' ' ' PRO . 4.1 mp -80.58 131.71 33.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 102.617 -3.105 . . . . 0.0 102.617 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -72.3 104.97 3.88 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -74.27 115.45 13.79 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 126.411 1.884 . . . . 0.0 107.715 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.63 31.86 1.42 Allowed Glycine 0 CA--C 1.532 1.1 0 N-CA-C 115.284 0.873 . . . . 0.0 115.284 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.39 169.72 20.2 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.217 -1.167 . . . . 0.0 110.829 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.6 mt -150.7 148.92 29.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.573 2.749 . . . . 0.0 105.743 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.5 t -140.7 128.72 23.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.53 HD12 HG22 ' A' ' 37' ' ' VAL . 18.7 mt -108.4 137.4 40.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 125.169 1.388 . . . . 0.0 107.501 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -135.57 129.48 33.03 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.333 1.853 . . . . 0.0 106.364 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -149.05 163.94 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 126.533 1.933 . . . . 0.0 108.106 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -78.55 170.92 15.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.817 0.847 . . . . 0.0 111.727 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.14 -43.24 73.71 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 127.217 2.342 . . . . 0.0 117.006 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -68.51 -13.37 62.28 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.342 1.071 . . . . 0.0 112.631 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -70.63 160.23 32.95 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 123.563 1.649 . . . . 0.0 113.132 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.39 60.09 4.75 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 106.306 -2.718 . . . . 0.0 106.306 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -60.11 -46.69 88.76 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 124.448 1.099 . . . . 0.0 109.693 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -61.82 -49.61 75.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.3 94.79 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.6 tp -68.99 -34.68 75.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.142 0.977 . . . . 0.0 110.972 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.68 74.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.352 -0.833 . . . . 0.0 109.602 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -58.72 -34.35 71.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.381 1.072 . . . . 0.0 111.946 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 t -76.8 -45.12 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.455 1.502 . . . . 0.0 108.291 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.58 -46.83 93.48 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 124.104 0.859 . . . . 0.0 112.222 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -37.22 84.91 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 117.886 -1.054 . . . . 0.0 108.72 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -61.33 -54.27 46.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -53.73 -46.23 70.76 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.552 0.614 . . . . 0.0 110.668 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -65.34 -32.26 73.82 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.044 -1.035 . . . . 0.0 111.0 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -71.93 -28.52 63.53 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.986 0.914 . . . . 0.0 110.879 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -95.98 -16.05 21.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.667 1.187 . . . . 0.0 111.97 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -126.33 -27.87 3.15 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.25 -14.49 63.54 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 120.866 -1.146 . . . . 0.0 113.654 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 mm -70.67 130.58 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 120.078 1.939 . . . . 0.0 106.81 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.432 ' H ' ' HE2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -58.11 145.28 37.28 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.219 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.82 87.65 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.505 1.122 . . . . 0.0 109.215 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 m -78.35 136.44 37.69 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.53 HG22 HD12 ' A' ' 9' ' ' ILE . 25.5 t -130.26 119.88 47.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -133.34 164.17 27.69 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.016 1.326 . . . . 0.0 107.838 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -120.26 62.15 8.6 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.661 1.585 . . . . 0.0 110.8 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.18 152.13 81.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.915 1.743 . . . . 0.0 110.662 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -120.42 19.84 11.98 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.683 1.593 . . . . 0.0 109.628 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.45 12.64 0.73 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.292 2.237 . . . . 0.0 112.683 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.2 pt? -56.48 -27.93 58.36 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 120.315 -1.49 . . . . 0.0 112.921 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -59.07 -20.03 49.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.29 1.436 . . . . 0.0 113.532 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -120.36 -18.02 8.04 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.756 -0.59 . . . . 0.0 110.948 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -46.7 15.43 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.491 1.116 . . . . 0.0 110.917 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -46.32 -57.38 8.59 Favored Pre-proline 0 N--CA 1.468 0.444 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.628 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.15 -18.9 64.58 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.778 1.652 . . . . 0.0 114.592 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -89.07 -8.68 53.42 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 119.995 1.27 . . . . 0.0 112.987 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.1 -36.01 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 119.191 0.905 . . . . 0.0 111.105 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -28.18 67.99 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.044 -1.035 . . . . 0.0 109.848 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.75 -5.58 4.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.581 1.152 . . . . 0.0 113.248 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.0 t -131.33 7.57 4.58 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.742 2.017 . . . . 0.0 109.585 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.37 5.6 72.89 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 119.955 -1.716 . . . . 0.0 114.881 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.53 -2.48 57.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.216 1.008 . . . . 0.0 110.103 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.55 -172.28 48.38 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.401 1.953 . . . . 0.0 115.778 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -69.82 173.92 10.31 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.188 3.259 . . . . 0.0 111.907 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -108.36 -18.4 13.76 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -141.45 145.37 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.907 1.283 . . . . 0.0 107.664 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 tt -137.06 141.19 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.701 1.6 . . . . 0.0 107.408 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -130.32 113.36 14.28 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.086 1.355 . . . . 0.0 109.608 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -157.68 171.11 20.91 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.722 0.809 . . . . 0.0 109.257 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.42 162.21 25.96 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -52.25 -25.51 9.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.327 1.451 . . . . 0.0 112.2 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -50.22 -65.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.96 1.704 . . . . 0.0 113.64 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -69.55 -18.93 63.69 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 122.151 -0.343 . . . . 0.0 110.291 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -78.03 -20.96 51.46 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.65 -5.05 7.88 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 117.836 -1.535 . . . . 0.0 112.939 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.74 -17.91 0.55 Allowed Glycine 0 CA--C 1.535 1.331 0 CA-C-O 117.26 -1.855 . . . . 0.0 115.816 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -65.09 -33.89 77.11 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.027 2.414 . . . . 0.0 112.865 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.94 -36.39 75.25 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 119.411 1.005 . . . . 0.0 108.316 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -48.04 79.77 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.8 m -65.61 -5.39 8.14 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.128 1.771 . . . . 0.0 112.856 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.29 16.95 79.99 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 126.761 2.124 . . . . 0.0 113.048 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.5 mt -87.63 -18.11 30.35 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.5 mt -96.93 135.44 38.91 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.962 0.801 . . . . 0.0 109.21 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -81.68 161.32 23.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.274 1.029 . . . . 0.0 111.314 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -68.34 105.46 2.16 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.593 1.157 . . . . 0.0 108.058 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.83 163.67 2.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 118.753 0.706 . . . . 0.0 111.034 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.4 m 114.77 91.21 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.525 1 C-N-CA 132.668 4.387 . . . . 0.0 108.788 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.87 -54.51 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.436 2.091 . . . . 0.0 109.106 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -148.23 152.58 37.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.175 1.79 . . . . 0.0 106.83 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -62.31 -33.76 75.29 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 118.99 -0.529 . . . . 0.0 111.084 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.05 -28.5 52.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.371 0.987 . . . . 0.0 112.306 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -68.93 -30.61 69.1 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.652 0.66 . . . . 0.0 109.989 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -69.1 -41.64 77.18 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.584 1.084 . . . . 0.0 110.707 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.07 -28.37 69.03 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.969 0.908 . . . . 0.0 111.716 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -69.03 -7.71 38.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.85 0.86 . . . . 0.0 112.952 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -117.93 149.58 40.65 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.692 1.133 . . . . 0.0 113.417 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -63.54 150.64 89.76 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.582 0.753 . . . . 0.0 110.33 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.54 -43.63 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.657 2.238 . . . . 0.0 112.95 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -61.52 -42.08 98.28 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 121.809 -0.557 . . . . 0.0 110.973 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.69 -28.93 68.1 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -49.16 66.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.84 0.856 . . . . 0.0 109.592 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -16.72 51.43 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.9 -41.83 82.11 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.755 0.707 . . . . 0.0 109.964 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.5 m -86.08 -15.38 10.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.071 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -51.74 149.54 4.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.767 1.167 . . . . 0.0 113.612 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.5 -174.48 3.13 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 126.367 1.867 . . . . 0.0 107.381 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -63.32 100.74 0.26 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.313 0.645 . . . . 0.0 109.323 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.27 -83.04 0.25 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 124.83 1.205 . . . . 0.0 111.05 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.2 173.84 2.32 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.691 1.196 . . . . 0.0 111.661 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.4 mt -106.54 169.83 8.29 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.216 1.007 . . . . 0.0 111.358 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.7 pt -143.48 -28.18 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.03 1.732 . . . . 0.0 114.232 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.1 177.76 10.97 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.659 1.572 . . . . 0.0 111.167 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -122.16 145.65 44.62 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 125.057 1.343 . . . . 0.0 110.469 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.34 149.83 45.78 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.667 2.911 . . . . 0.0 108.171 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.463 HG13 ' HB2' ' A' ' 264' ' ' ALA . 29.8 mm -125.98 -44.99 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.109 1.364 . . . . 0.0 111.797 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.1 159.34 43.41 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.368 0.531 . . . . 0.0 110.992 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.4 t -122.45 116.01 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.657 1.183 . . . . 0.0 108.018 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -144.98 148.79 34.17 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 125.255 1.422 . . . . 0.0 107.63 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.98 176.39 8.47 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 68.2 mt -61.37 162.31 8.04 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.939 0.876 . . . . 0.0 110.568 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.6 p -137.43 161.03 37.42 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.934 0.893 . . . . 0.0 111.996 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.8 tp -73.43 154.77 39.85 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.743 1.217 . . . . 0.0 110.033 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.33 101.28 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.472 ' CE2' HG21 ' A' ' 245' ' ' THR . 28.8 m-85 -78.28 174.14 11.54 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -82.77 -172.74 4.26 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.487 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -74.29 1.57 11.21 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.31 1.844 . . . . 0.0 111.335 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -98.36 144.18 28.03 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.722 2.009 . . . . 0.0 110.707 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.05 5.36 16.77 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 32.1 tp -36.82 109.59 0.44 Allowed Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 125.191 1.396 . . . . 0.0 110.823 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.84 -169.12 0.36 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.773 2.982 . . . . 0.0 110.956 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.7 t30 64.9 69.87 0.64 Allowed Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 126.019 1.728 . . . . 0.0 110.602 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.94 167.07 24.39 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.284 2.656 . . . . 0.0 110.846 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.02 168.87 23.73 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.959 1.773 . . . . 0.0 110.303 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -134.98 -30.74 1.04 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.838 1.255 . . . . 0.0 112.731 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.457 ' HA ' ' H ' ' A' ' 249' ' ' THR . 14.9 t -158.96 157.73 31.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -65.43 -22.4 66.76 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.815 1.246 . . . . 0.0 112.426 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 4.1 mm-40 -69.85 -27.46 64.86 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.912 1.685 . . . . 0.0 110.469 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -89.61 -22.02 22.53 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.217 1.807 . . . . 0.0 111.983 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.6 mm -54.4 -56.02 31.11 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 117.889 -1.053 . . . . 0.0 110.355 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.85 -24.47 46.53 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 CA-C-N 120.398 1.178 . . . . 0.0 112.026 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.49 -55.4 10.35 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.5 tp -64.13 -27.23 68.94 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.529 -1.357 . . . . 0.0 110.244 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.44 -43.95 95.96 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 121.782 -0.574 . . . . 0.0 109.78 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -71.87 -27.45 62.87 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 119.116 -0.469 . . . . 0.0 111.182 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -70.69 -48.24 55.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.3 -33.46 73.21 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.501 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -67.96 -36.91 80.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.12 -27.05 69.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.863 0.756 . . . . 0.0 111.656 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.9 3.22 20.37 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.923 0.889 . . . . 0.0 112.673 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.41 -102.65 0.17 Allowed Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 118.825 0.739 . . . . 0.0 111.585 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -137.5 178.54 7.02 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.397 1.079 . . . . 0.0 110.693 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 p -54.99 157.6 3.18 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.923 1.689 . . . . 0.0 114.208 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.9 -69.14 0.73 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.644 1.578 . . . . 0.0 112.31 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.2 tp -99.2 132.64 44.37 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.029 1.332 . . . . 0.0 110.218 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.2 ttm -142.47 133.26 25.53 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -161.75 172.93 15.36 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.952 1.301 . . . . 0.0 108.954 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -69.77 92.31 0.67 Allowed 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 mt -77.12 -14.66 59.76 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.219 -0.926 . . . . 0.0 110.105 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -68.74 -31.87 71.23 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.051 -1.452 . . . . 0.0 114.742 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -104.05 154.96 37.78 Favored Pre-proline 0 C--N 1.343 0.316 0 CA-C-N 121.661 2.028 . . . . 0.0 114.147 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.16 -15.05 11.76 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.212 1.941 . . . . 0.0 114.158 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -61.04 -39.62 90.49 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.771 1.623 . . . . 0.0 111.805 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -82.28 -33.45 29.1 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -81.75 -15.84 53.0 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.242 0.928 . . . . 0.0 111.319 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -46.34 -58.21 7.02 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.04 -16.94 29.01 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.591 1.527 . . . . 0.0 115.086 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.7 tp -67.4 -62.22 1.53 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 120.262 1.392 . . . . 0.0 107.393 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 6.2 pt -68.63 -24.88 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.494 1.118 . . . . 0.0 112.649 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.62 -18.21 62.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.485 -0.759 . . . . 0.0 111.127 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -56.6 -53.84 52.95 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.655 1.182 . . . . 0.0 111.229 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -61.84 -58.19 8.92 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.26 22.37 0.03 OUTLIER Glycine 0 C--N 1.333 0.376 0 CA-C-O 118.611 -1.105 . . . . 0.0 115.126 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.29 134.11 13.36 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -137.51 140.77 41.34 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.859 1.83 . . . . 0.0 114.022 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.92 81.12 4.15 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.718 2.007 . . . . 0.0 106.992 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 67.22 164.75 0.21 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 127.166 2.186 . . . . 0.0 111.061 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -127.75 138.52 52.79 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.177 0.591 . . . . 0.0 109.51 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.58 119.66 25.19 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.604 1.962 . . . . 0.0 105.77 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -96.96 41.38 1.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.932 2.093 . . . . 0.0 111.521 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 55.33 81.21 0.12 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.743 1.217 . . . . 0.0 110.974 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 101.98 -18.62 51.82 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.728 -1.04 . . . . 0.0 113.301 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -117.54 122.75 44.52 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -131.55 115.99 16.85 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 125.733 1.613 . . . . 0.0 108.431 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -124.54 93.18 3.83 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.492 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -55.28 -7.33 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.524 1.929 . . . . 0.0 112.894 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -75.88 -30.89 59.01 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 120.898 -1.126 . . . . 0.0 109.422 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -81.9 67.84 8.05 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.121 0.968 . . . . 0.0 109.288 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 45.3 t -80.78 156.0 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.62 40.11 1.7 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-O 118.122 -1.377 . . . . 0.0 113.53 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.0 t -95.64 -27.64 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 120.029 1.914 . . . . 0.0 112.692 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -90.72 10.7 24.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.804 1.638 . . . . 0.0 109.995 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -60.31 152.2 25.69 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.808 -1.182 . . . . 0.0 109.311 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.73 -27.22 62.79 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.972 0.509 . . . . 0.0 111.7 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.98 -40.16 44.31 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 123.566 0.603 . . . . 0.0 112.286 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.1 -51.14 70.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -60.31 -42.83 96.38 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.561 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.41 -46.51 86.3 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.836 0.744 . . . . 0.0 110.943 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -72.62 -29.54 65.48 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 119.462 -0.632 . . . . 0.0 113.944 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 18.2 tp -80.21 -39.88 28.23 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.2 t -57.83 -34.16 69.39 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.85 0.75 . . . . 0.0 109.885 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -59.46 -48.12 82.86 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.58 0.627 . . . . 0.0 109.852 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.57 -45.53 88.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.362 0.665 . . . . 0.0 109.843 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.03 -29.4 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.148 0.579 . . . . 0.0 110.26 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -62.25 -39.25 92.24 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.085 -1.009 . . . . 0.0 112.387 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.5 mt -70.92 -43.47 68.16 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 55.4 mt -64.06 -39.84 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -52.27 -46.6 65.9 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.06 -1.025 . . . . 0.0 108.849 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -80.66 -0.98 40.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.093 2.157 . . . . 0.0 113.82 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.1 mptt 57.58 4.64 0.25 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.671 2.388 . . . . 0.0 115.424 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -71.57 -31.74 67.3 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.686 -0.634 . . . . 0.0 112.097 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.5 tpt -69.01 163.31 24.93 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 118.554 0.616 . . . . 0.0 109.97 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -91.34 52.18 2.05 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.51 -11.27 1.87 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.979 2.512 . . . . 0.0 115.606 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -102.81 0.23 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.679 0.791 . . . . 0.0 111.921 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 85.9 m -74.19 124.7 26.86 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.879 1.272 . . . . 0.0 110.908 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.61 177.31 4.88 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -53.14 -45.94 68.61 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.522 0.677 . . . . 0.0 112.268 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.5 m -63.88 -29.41 70.59 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.787 2.435 . . . . 0.0 112.577 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 77.0 mt -81.35 -49.11 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.77 72.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.09 -45.8 93.22 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.699 0.681 . . . . 0.0 111.205 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.15 -55.65 31.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.55 -38.15 77.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.548 0.739 . . . . 0.0 111.761 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -61.26 -46.55 89.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -64.69 -35.76 82.08 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -68.46 -18.93 64.52 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.951 -1.093 . . . . 0.0 111.735 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.88 16.89 66.69 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -86.81 -8.13 57.61 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 35.1 p -113.33 136.97 52.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.731 1.612 . . . . 0.0 106.71 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.07 -21.39 46.83 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.288 -0.883 . . . . 0.0 111.081 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -164.99 170.05 15.65 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.592 -0.692 . . . . 0.0 109.721 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 4.4 t -162.95 -178.44 6.09 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.486 1.914 . . . . 0.0 106.498 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.43 154.32 39.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -153.29 151.23 29.78 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.495 -0.753 . . . . 0.0 108.985 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -102.94 -179.98 26.34 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.897 1.237 . . . . 0.0 111.107 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.0 -49.27 8.5 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.768 2.979 . . . . 0.0 110.693 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -133.84 133.27 41.38 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.041 2.136 . . . . 0.0 105.763 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -112.19 109.75 19.61 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -61.48 130.09 44.32 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.3 t -167.67 168.51 12.55 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.301 1.84 . . . . 0.0 106.644 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -139.24 29.45 2.22 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.219 1.408 . . . . 0.0 108.282 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 12.5 tt -158.45 150.42 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 128.429 2.691 . . . . 0.0 105.688 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 32.57 55.3 0.38 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 129.514 3.126 . . . . 0.0 113.075 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.6 p -69.32 87.13 0.43 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.442 1.497 . . . . 0.0 109.829 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 19.9 m -127.42 167.67 15.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.971 1.708 . . . . 0.0 108.232 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -155.85 162.88 40.38 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.007 -1.058 . . . . 0.0 110.056 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.65 149.49 32.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 123.405 0.682 . . . . 0.0 109.64 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -72.89 158.26 35.86 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.341 0.656 . . . . 0.0 109.458 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -140.27 170.4 15.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.837 1.255 . . . . 0.0 110.199 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -125.51 177.53 16.96 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.131 1.824 . . . . 0.0 109.528 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.4 p -100.63 110.4 27.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 O-C-N 121.352 -1.087 . . . . 0.0 111.529 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.472 HG21 ' CE2' ' A' ' 117' ' ' TYR . 5.0 t -142.32 173.81 11.19 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.871 0.868 . . . . 0.0 108.814 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.91 162.13 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 127.21 2.204 . . . . 0.0 110.519 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pp -143.77 152.14 55.07 Favored Pre-proline 0 C--O 1.239 0.527 0 C-N-CA 125.033 1.333 . . . . 0.0 108.105 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.19 150.36 87.67 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.114 1.876 . . . . 0.0 110.793 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.686 HG22 ' H ' ' A' ' 255' ' ' SER . 57.4 p -129.51 165.57 21.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.855 2.062 . . . . 0.0 110.234 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -85.29 159.86 19.96 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.136 0.88 . . . . 0.0 109.176 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -49.81 103.54 0.05 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.284 1.434 . . . . 0.0 113.287 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.17 1.52 90.49 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 117.225 -1.875 . . . . 0.0 115.279 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.26 122.19 11.54 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 121.39 2.595 . . . . 0.0 113.437 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.95 147.83 85.24 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.149 1.9 . . . . 0.0 111.374 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.686 ' H ' HG22 ' A' ' 249' ' ' THR . 48.0 t -64.13 152.41 40.63 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.804 1.241 . . . . 0.0 109.426 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.442 ' HD3' ' HE3' ' A' ' 326' ' ' LYS . 69.9 mttt -134.21 77.68 60.3 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.365 1.466 . . . . 0.0 107.693 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -82.62 -175.37 2.43 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.298 3.332 . . . . 0.0 111.437 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -66.86 166.65 12.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.621 0.768 . . . . 0.0 108.957 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 26.5 t -96.22 164.47 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -147.49 150.99 23.3 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 75.4 t -135.22 112.04 13.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.582 0.706 . . . . 0.0 109.448 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.91 126.82 28.89 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 12.5 m -117.32 164.56 14.64 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.215 1.006 . . . . 0.0 110.933 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.463 ' HB2' HG13 ' A' ' 108' ' ' ILE . . . -134.27 135.54 42.95 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.693 1.597 . . . . 0.0 107.495 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -127.42 166.54 20.11 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 62.6 mt -114.19 133.35 60.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.07 122.97 23.51 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -68.23 -15.07 63.43 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.197 -1.382 . . . . 0.0 114.641 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -76.63 -14.02 60.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.649 1.568 . . . . 0.0 114.373 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 36.5 m -61.98 154.24 69.48 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 123.838 0.855 . . . . 0.0 109.361 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.441 ' HD3' ' CG2' ' A' ' 2' ' ' ILE . 52.2 Cg_endo -68.04 -58.5 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.967 1.778 . . . . 0.0 110.914 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -118.15 100.26 7.41 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.989 1.316 . . . . 0.0 108.254 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.408 ' HE2' ' HB1' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -59.0 -15.77 14.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.787 0.435 . . . . 0.0 112.139 178.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -59.97 -34.19 72.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.391 1.476 . . . . 0.0 110.105 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.9 mt -57.69 -44.03 85.55 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.58 -37.05 63.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.139 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -35.43 79.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.026 0.83 . . . . 0.0 109.651 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -69.97 -55.19 10.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.947 -0.549 . . . . 0.0 109.727 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -52.19 -46.51 65.6 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.049 0.841 . . . . 0.0 111.58 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.4 tt -64.63 -40.82 96.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -90.11 -3.9 57.64 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -105.96 -23.68 12.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.051 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -143.24 -36.72 0.37 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.901 1.228 . . . . 0.0 114.017 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.14 -32.7 71.26 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.105 1.321 . . . . 0.0 113.678 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.57 51.31 0.94 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.333 1.853 . . . . 0.0 110.242 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 47.7 p -120.55 163.13 18.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.26 -39.26 92.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -70.97 -41.91 70.4 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.269 0.628 . . . . 0.0 111.438 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.6 67.12 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 78.9 mt -67.62 -43.16 81.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.93 -44.5 94.3 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.2 -41.57 88.84 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.343 1.057 . . . . 0.0 113.606 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 92.9 t -76.84 -36.29 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -66.82 -36.41 82.3 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -66.96 -32.91 74.48 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.729 -0.607 . . . . 0.0 111.055 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.34 -50.49 15.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.517 1.127 . . . . 0.0 110.585 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -141.79 150.94 58.47 Favored Pre-proline 0 N--CA 1.47 0.535 0 O-C-N 121.045 -1.034 . . . . 0.0 109.299 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.01 115.77 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.202 2.602 . . . . 0.0 110.777 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 14.4 mt -84.0 -31.93 25.23 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.673 -0.642 . . . . 0.0 111.54 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 93.02 -146.91 18.34 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 106.343 -2.703 . . . . 0.0 106.343 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.66 173.28 11.5 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.01 153.34 38.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 123.193 1.473 . . . . 0.0 113.475 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.97 -30.92 62.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.914 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 58.7 tp -66.29 104.93 1.3 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.43 1.892 . . . . 0.0 107.968 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -56.66 -23.05 38.91 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.662 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 40.1 m -72.38 -61.73 1.69 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.909 0.777 . . . . 0.0 110.825 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -71.5 -19.19 62.23 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.102 0.864 . . . . 0.0 112.769 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -63.62 -31.37 72.51 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -67.95 -15.2 63.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.364 0.984 . . . . 0.0 111.264 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.46 ' HA ' ' HE3' ' A' ' 313' ' ' LYS . 29.3 mm-40 -94.71 -48.47 6.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.259 1.424 . . . . 0.0 108.264 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.453 ' HB3' HG21 ' A' ' 317' ' ' ILE . 7.2 mt -64.65 -41.25 96.25 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.36 -0.55 0.59 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 310' ' ' GLU . 90.6 mttt -67.58 -13.51 62.13 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.376 1.07 . . . . 0.0 111.835 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.0 151.21 68.6 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 119.756 1.162 . . . . 0.0 109.711 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.64 -23.8 63.28 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.095 2.53 . . . . 0.0 113.84 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -61.57 -27.99 69.02 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.661 0.664 . . . . 0.0 110.551 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 311' ' ' LEU . 4.2 mp -91.08 -52.32 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -48.09 -50.37 28.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.905 0.753 . . . . 0.0 110.679 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.25 -32.52 71.22 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 13.6 m -68.91 -41.04 78.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.492 1.042 . . . . 0.0 108.21 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.8 tpp -69.53 -41.57 75.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.843 -0.599 . . . . 0.0 109.457 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -53.35 -43.31 67.63 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -58.68 -46.66 86.75 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.36 1.064 . . . . 0.0 109.268 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.41 -25.33 67.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.424 0.69 . . . . 0.0 111.433 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -82.03 -26.45 33.78 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.824 0.738 . . . . 0.0 111.422 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.442 ' HE3' ' HD3' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -103.79 -8.25 19.94 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -86.4 -147.75 11.19 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 125.327 1.441 . . . . 0.0 112.396 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -145.94 130.3 17.69 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.264 1.826 . . . . 0.0 106.483 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 67.3 mt -104.91 97.49 5.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 127.001 2.12 . . . . 0.0 107.27 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.54 73.99 0.6 Allowed Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 126.824 2.05 . . . . 0.0 111.454 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.75 130.0 25.02 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.904 3.069 . . . . 0.0 113.985 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -116.4 76.25 1.01 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.607 1.563 . . . . 0.0 108.925 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.64 147.69 49.97 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.995 1.318 . . . . 0.0 110.922 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.46 -18.67 33.55 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.497 2.131 . . . . 0.0 111.799 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -72.49 -23.02 60.97 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 120.921 -1.112 . . . . 0.0 109.09 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -40.45 83.94 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.518 1.508 . . . . 0.0 109.42 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 p -69.0 -34.25 74.98 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.383 -0.823 . . . . 0.0 109.242 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -69.63 -42.64 74.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -53.84 -54.56 36.74 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 126.557 1.943 . . . . 0.0 109.849 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -60.89 -45.66 93.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.579 0.627 . . . . 0.0 110.084 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -63.15 -26.72 68.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.99 -60.87 2.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.702 1.201 . . . . 0.0 109.41 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -24.71 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.353 -0.842 . . . . 0.0 111.795 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 26.7 ttt-85 -56.71 -27.65 59.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.356 1.062 . . . . 0.0 110.788 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 1.5 m -97.79 -37.92 9.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.48 -48.3 66.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.874 0.761 . . . . 0.0 112.66 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.09 -56.88 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 37.4 mm -58.07 -36.5 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.289 0.635 . . . . 0.0 110.265 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -56.65 -48.99 76.35 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.843 -1.161 . . . . 0.0 110.094 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.42 -42.42 59.21 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.433 -0.318 . . . . 0.0 111.337 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -59.72 -37.14 78.09 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.468 0.707 . . . . 0.0 112.079 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.0 m -86.85 -7.72 57.96 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.148 0.979 . . . . 0.0 109.64 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 75.99 17.62 79.94 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 118.905 0.775 . . . . 0.0 113.018 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -73.3 -30.71 63.57 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.151 0.981 . . . . 0.0 110.699 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -150.75 166.45 30.42 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.032 0.833 . . . . 0.0 110.519 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.9 m -71.91 152.72 42.35 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.0 t -52.37 -56.19 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.455 1.102 . . . . 0.0 108.306 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.66 -44.73 77.5 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 124.777 1.231 . . . . 0.0 113.461 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -71.97 -36.49 69.85 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.649 0.659 . . . . 0.0 111.964 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.11 -35.25 80.14 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 10.7 tp -73.07 -42.48 63.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.949 1.699 . . . . 0.0 110.673 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -58.29 -52.86 63.82 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.461 1.504 . . . . 0.0 108.095 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -49.87 -56.73 9.35 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 126.283 1.833 . . . . 0.0 108.916 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.94 -48.61 80.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.934 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -57.39 -37.04 72.07 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.9 m -62.66 -43.97 97.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.407 0.683 . . . . 0.0 110.069 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 45.4 mtt-85 -57.97 -27.7 63.68 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.445 -0.784 . . . . 0.0 111.563 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.7 mt -86.12 -39.28 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.986 0.914 . . . . 0.0 110.459 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 22.4 p -70.17 -31.1 68.42 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.518 1.054 . . . . 0.0 112.434 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.541 1.537 . . . . 0.0 110.855 -178.787 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 26.4 tptt . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.2 mt -126.92 154.52 37.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.87 88.04 4.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 123.353 1.549 . . . . 0.0 111.277 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -71.94 107.24 4.58 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.129 1.772 . . . . 0.0 108.647 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.62 22.64 3.01 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 116.063 1.185 . . . . 0.0 116.063 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -136.43 170.91 15.27 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 119.218 1.509 . . . . 0.0 110.19 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.0 mt -148.38 152.87 37.76 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 128.695 2.798 . . . . 0.0 107.63 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.75 149.65 16.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.458 HG21 HD21 ' A' ' 20' ' ' LEU . 67.3 mt -128.82 120.69 52.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 126.893 2.077 . . . . 0.0 105.95 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -119.2 114.72 22.87 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.533 1.133 . . . . 0.0 109.124 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.7 mt -122.92 164.58 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.962 1.305 . . . . 0.0 108.074 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -84.11 4.43 30.35 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.89 175.68 49.29 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 59.51 22.42 10.99 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.234 1.017 . . . . 0.0 111.359 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -125.64 166.08 17.39 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 126.655 1.982 . . . . 0.0 108.041 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.34 47.21 2.63 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 119.062 -0.855 . . . . 0.0 114.791 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -50.83 -38.86 51.36 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.036 0.934 . . . . 0.0 113.08 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -58.57 -47.23 84.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.012 0.823 . . . . 0.0 110.303 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.96 -38.02 93.77 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.458 HD21 HG21 ' A' ' 9' ' ' ILE . 46.6 tp -68.37 -35.64 78.01 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.752 0.821 . . . . 0.0 111.164 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.26 -37.44 64.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.376 0.67 . . . . 0.0 110.23 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -67.33 -30.05 69.78 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.117 0.872 . . . . 0.0 111.963 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 t -69.26 -43.94 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.58 -41.17 94.21 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -60.21 -45.73 92.18 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -58.25 -55.04 40.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -52.19 -55.6 20.02 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 117.892 0.315 . . . . 0.0 110.927 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.93 -35.68 73.5 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.144 -0.973 . . . . 0.0 111.191 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -69.06 -28.34 66.44 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 120.931 -1.106 . . . . 0.0 111.285 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -98.53 -5.86 31.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.591 1.156 . . . . 0.0 111.519 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.1 p -134.96 -35.46 0.85 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.44 -11.5 63.28 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.356 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.9 mm -67.58 137.27 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -70.64 139.8 51.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 117.652 -1.166 . . . . 0.0 109.727 -179.394 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.0 t -135.18 121.12 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.5 m -114.14 145.15 42.04 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.831 2.052 . . . . 0.0 110.87 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.432 HG22 HD12 ' A' ' 9' ' ' ILE . 20.6 t -137.24 128.52 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.84 1.656 . . . . 0.0 107.319 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -140.55 160.64 39.57 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.639 0.776 . . . . 0.0 111.68 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -127.07 68.06 71.35 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.214 1.405 . . . . 0.0 112.559 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.83 168.72 20.54 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 124.812 3.675 . . . . 0.0 111.267 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -110.8 8.11 22.25 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.709 1.604 . . . . 0.0 110.758 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.67 11.79 4.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 43' ' ' LEU . 1.5 pt? -52.07 -30.74 27.22 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -63.7 -20.45 65.73 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.874 2.07 . . . . 0.0 113.438 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -117.82 -24.32 7.2 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 123.841 0.856 . . . . 0.0 109.498 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.412 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.2 mmpt? -74.76 -46.09 39.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.795 -1.097 . . . . 0.0 110.886 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -50.73 -57.44 13.42 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 120.296 1.407 . . . . 0.0 110.199 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.46 -0.19 5.54 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 121.767 1.644 . . . . 0.0 114.558 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -112.05 -0.15 15.77 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.753 1.221 . . . . 0.0 111.561 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 46' ' ' LYS . 6.4 t -130.59 -42.63 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.349 1.06 . . . . 0.0 108.657 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.33 73.73 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 120.995 -1.066 . . . . 0.0 108.759 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.01 -13.36 4.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.021 1.328 . . . . 0.0 113.266 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.2 p -118.95 -0.76 11.11 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.91 1.232 . . . . 0.0 111.445 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.31 15.15 64.91 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.33 0.967 . . . . 0.0 111.56 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -106.79 -6.01 18.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.649 1.224 . . . . 0.0 113.633 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.01 -173.56 32.34 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.896 1.236 . . . . 0.0 115.228 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -70.78 179.29 4.37 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 124.205 3.27 . . . . 0.0 111.435 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -105.57 -20.18 13.55 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 121.264 -0.898 . . . . 0.0 113.045 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 mt -140.92 149.85 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.5 tt -128.71 148.88 33.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 126.293 1.837 . . . . 0.0 106.695 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -138.87 99.3 3.75 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.752 1.221 . . . . 0.0 109.785 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -153.11 177.81 10.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.133 0.968 . . . . 0.0 111.667 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.52 134.33 53.16 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.781 1.632 . . . . 0.0 107.345 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -52.63 -27.84 18.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 129.01 2.924 . . . . 0.0 112.279 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.95 -26.4 65.95 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.427 0.691 . . . . 0.0 109.717 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -102.73 12.48 36.23 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 127.507 2.323 . . . . 0.0 110.852 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -108.02 -30.83 8.23 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.825 1.648 . . . . 0.0 111.227 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.8 -10.48 38.64 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.801 -1.0 . . . . 0.0 113.865 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.27 -47.59 3.26 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 119.928 1.864 . . . . 0.0 109.229 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -55.31 -46.74 76.26 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.709 1.604 . . . . 0.0 111.68 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.14 93.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.734 1.152 . . . . 0.0 109.673 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.91 1.09 4.81 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.972 1.709 . . . . 0.0 111.149 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -122.68 2.32 9.5 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.305 2.642 . . . . 0.0 109.511 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.62 -1.03 68.29 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 125.656 1.598 . . . . 0.0 112.401 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -69.04 -34.3 74.99 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.566 1.183 . . . . 0.0 112.848 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.5 mt -89.15 127.88 35.75 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.654 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -81.44 170.34 16.07 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.692 0.797 . . . . 0.0 112.602 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -60.11 117.31 4.97 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.508 ' HA ' HD13 ' A' ' 79' ' ' ILE . 1.4 mm -70.96 166.19 2.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 m -39.58 113.96 0.9 Allowed Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.265 1.826 . . . . 0.0 110.955 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.77 -53.32 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.434 2.756 . . . . 0.0 113.364 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -62.26 116.75 5.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.427 1.108 . . . . 0.0 111.731 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -54.33 -28.59 43.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.479 1.512 . . . . 0.0 111.971 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.82 -32.5 67.66 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.861 1.209 . . . . 0.0 112.786 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -68.98 -39.44 79.39 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -66.22 -37.73 86.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.722 1.209 . . . . 0.0 110.329 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.8 -13.4 59.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.311 1.845 . . . . 0.0 112.186 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -76.97 -9.65 58.84 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.757 -1.214 . . . . 0.0 110.591 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.9 mt -118.29 157.51 26.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.529 1.932 . . . . 0.0 108.614 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.404 ' CD1' ' HG2' ' A' ' 305' ' ' LYS . 48.9 m-85 -64.93 152.71 90.28 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 119.118 0.872 . . . . 0.0 109.497 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.53 -35.72 9.94 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.763 2.308 . . . . 0.0 114.531 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -64.18 -32.82 74.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.863 0.756 . . . . 0.0 110.902 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.77 -21.77 66.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.301 1.04 . . . . 0.0 110.401 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -77.43 -32.77 54.82 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.413 -0.804 . . . . 0.0 109.827 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.81 -4.03 3.97 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.493 1.517 . . . . 0.0 111.083 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.62 -7.0 22.16 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.032 2.133 . . . . 0.0 111.995 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.48 11.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.997 1.319 . . . . 0.0 113.179 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -69.32 169.44 12.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 122.43 1.109 . . . . 0.0 112.15 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -159.7 168.1 26.77 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 127.868 2.467 . . . . 0.0 105.469 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -60.95 108.02 0.8 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.876 1.67 . . . . 0.0 111.091 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.34 -83.39 0.87 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.62 1.105 . . . . 0.0 111.366 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.1 173.43 6.58 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.84 0.856 . . . . 0.0 111.788 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 103' ' ' LEU . 3.4 mm? -109.2 157.46 18.77 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.9 pt -119.53 -26.23 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.706 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.39 178.16 8.9 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.195 0.998 . . . . 0.0 109.177 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.473 ' CE2' HD12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -129.63 148.66 70.32 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.75 0.82 . . . . 0.0 109.864 178.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.71 142.24 43.26 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.569 2.846 . . . . 0.0 108.917 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.0 mm -129.9 -49.09 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 124.656 1.182 . . . . 0.0 111.422 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 262' ' ' LEU . . . -122.01 147.08 46.52 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.033 0.833 . . . . 0.0 109.614 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.24 104.82 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -157.34 130.49 7.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 102.005 -3.331 . . . . 0.0 102.005 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.79 69.5 0.74 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 127.057 2.143 . . . . 0.0 106.889 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 pp -164.46 154.38 14.13 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.809 0.844 . . . . 0.0 111.001 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.7 m 179.91 156.81 0.64 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 130.418 3.487 . . . . 0.0 106.895 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp -149.5 160.64 43.3 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.52 140.61 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -141.9 -177.35 5.16 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.483 1.513 . . . . 0.0 108.127 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -60.29 147.51 40.07 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.718 -0.614 . . . . 0.0 110.547 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -64.68 -9.91 23.26 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.072 0.949 . . . . 0.0 112.281 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -62.28 -177.89 0.15 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.611 1.164 . . . . 0.0 111.821 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.11 20.38 19.09 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.248 1.819 . . . . 0.0 113.255 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -119.78 72.07 15.71 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.79 89.79 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.08 2.52 . . . . 0.0 110.338 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -113.01 73.03 1.54 Allowed Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 123.781 0.832 . . . . 0.0 109.006 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -74.99 156.55 43.05 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.711 1.607 . . . . 0.0 111.639 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.13 167.26 27.81 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.942 2.428 . . . . 0.0 107.575 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -113.57 -10.07 13.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.047 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.7 t -153.86 157.35 39.16 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.15 1.341 . . . . 0.0 110.98 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -72.98 -24.73 60.81 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.675 -0.641 . . . . 0.0 111.261 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -70.92 -17.04 62.7 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.0 0.818 . . . . 0.0 109.956 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -86.99 -24.34 24.72 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 125.513 1.525 . . . . 0.0 110.243 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 33.7 mm -52.69 -58.97 9.88 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.894 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.77 -22.32 27.61 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 CA-C-N 120.253 1.126 . . . . 0.0 112.164 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.99 -31.05 62.8 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.271 1.428 . . . . 0.0 111.834 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.6 tp -91.89 -31.37 15.7 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.184 1.393 . . . . 0.0 110.134 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -58.57 -44.17 89.64 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.671 0.748 . . . . 0.0 110.675 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -65.17 -30.38 71.28 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.967 0.907 . . . . 0.0 112.316 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -77.43 -42.35 36.41 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 20.3 mt -72.58 -31.67 65.39 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.534 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.89 -34.88 79.14 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.81 -13.02 61.89 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.02 -5.4 8.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.052 0.941 . . . . 0.0 112.471 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -173.31 -89.46 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 118.868 0.758 . . . . 0.0 112.885 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.42 ' HE3' ' OE2' ' A' ' 221' ' ' GLU . 62.2 mttm -146.22 -177.45 5.62 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.515 1.526 . . . . 0.0 109.082 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 p -57.78 166.97 1.25 Allowed 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.839 0.856 . . . . 0.0 111.508 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.83 -76.51 0.46 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.5 tp -90.18 133.27 35.0 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.464 1.506 . . . . 0.0 110.207 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 53.9 ttm -139.82 107.17 5.53 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.84 160.85 37.3 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.364 1.465 . . . . 0.0 109.196 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -67.93 120.09 13.64 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.106 0.962 . . . . 0.0 110.994 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.3 mt -106.97 -9.76 16.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.659 1.984 . . . . 0.0 111.909 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -77.67 -17.61 57.52 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.337 -0.852 . . . . 0.0 111.733 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -109.57 147.44 36.08 Favored Pre-proline 0 N--CA 1.469 0.486 0 C-N-CA 124.467 1.107 . . . . 0.0 109.347 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -82.07 -18.26 7.6 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.832 2.354 . . . . 0.0 114.138 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -58.94 -37.6 77.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.445 1.021 . . . . 0.0 111.974 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -71.54 -43.67 66.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.794 0.838 . . . . 0.0 112.445 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.2 p -80.9 -14.18 58.24 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.071 0.549 . . . . 0.0 112.16 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -54.99 -57.3 20.23 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.657 -1.164 . . . . 0.0 113.509 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.5 -26.38 81.81 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 121.763 1.665 . . . . 0.0 113.332 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.82 -56.02 9.33 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.4 pt -67.6 -25.71 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.144 0.884 . . . . 0.0 111.685 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.77 -4.1 25.8 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.283 -0.886 . . . . 0.0 110.912 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.6 -54.49 42.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.698 0.799 . . . . 0.0 110.534 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -55.15 -61.23 2.46 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.105 0.479 . . . . 0.0 111.121 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.26 6.41 0.03 OUTLIER Glycine 0 CA--C 1.524 0.6 0 CA-C-O 118.47 -1.183 . . . . 0.0 115.261 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -53.37 133.08 42.76 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 118.277 1.038 . . . . 0.0 112.155 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -142.66 120.41 11.89 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.131 0.967 . . . . 0.0 110.681 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.7 85.57 5.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 335' ' ' GLN . 11.0 m-85 66.54 165.84 0.2 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.6 1.56 . . . . 0.0 108.445 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -132.54 159.25 40.01 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 120.819 -1.175 . . . . 0.0 109.258 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -149.09 104.62 3.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.284 -1.746 . . . . 0.0 106.284 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.1 -174.79 0.84 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -52.5 -35.79 53.82 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.061 -1.024 . . . . 0.0 110.986 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -145.29 6.89 1.54 Allowed Glycine 0 CA--C 1.533 1.212 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.756 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -122.43 121.48 36.73 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 120.999 2.4 . . . . 0.0 109.275 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.48 123.6 50.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -146.36 83.49 1.61 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -0.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -83.5 -25.76 30.8 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 119.67 -1.894 . . . . 0.0 107.774 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -96.0 103.78 15.68 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 127.727 2.411 . . . . 0.0 106.798 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.7 t -142.95 165.12 16.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -140.63 35.71 1.84 Allowed Glycine 0 CA--C 1.533 1.163 0 N-CA-C 115.025 0.77 . . . . 0.0 115.025 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.0 t -60.11 -17.04 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 119.436 1.618 . . . . 0.0 114.617 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.273 0.0 OUTLIER -117.86 20.49 13.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.554 1.541 . . . . 0.0 111.255 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -69.71 159.04 34.25 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 120.601 -1.312 . . . . 0.0 108.176 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.34 -30.18 62.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.549 0.74 . . . . 0.0 112.422 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.23 -41.11 94.95 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.511 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.1 -52.92 56.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.918 0.487 . . . . 0.0 109.938 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -62.64 -36.93 84.41 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 117.921 -1.038 . . . . 0.0 111.656 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.57 -49.71 76.45 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.24 0.927 . . . . 0.0 110.234 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.85 -15.12 75.91 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.308 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 44.0 tp -89.12 -50.21 6.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.195 0.998 . . . . 0.0 110.996 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.6 t -55.61 -38.63 69.71 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.824 -1.084 . . . . 0.0 111.856 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -54.6 -54.52 40.26 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.173 1.351 . . . . 0.0 111.028 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 9.9 tt -62.01 -49.73 74.9 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.687 1.195 . . . . 0.0 109.563 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.26 -29.23 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.105 0.962 . . . . 0.0 110.601 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.51 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.9 OUTLIER -67.35 -37.03 82.6 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 119.043 0.838 . . . . 0.0 111.476 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.57 -39.55 88.53 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 37.3 mt -61.95 -48.61 87.77 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.51 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -51.39 -40.18 58.73 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.731 1.612 . . . . 0.0 111.567 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -84.77 2.23 43.1 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.969 1.308 . . . . 0.0 112.745 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? 48.32 46.72 20.16 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.776 2.03 . . . . 0.0 111.396 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 -2.31 9.18 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.7 ttp -114.49 153.52 29.84 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.28 49.92 0.73 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.453 1.501 . . . . 0.0 110.671 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.63 -11.37 11.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.481 2.712 . . . . 0.0 115.046 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -91.72 -13.51 31.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.979 1.711 . . . . 0.0 110.815 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.7 m -61.31 162.14 8.14 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.524 1.929 . . . . 0.0 108.562 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.77 -174.19 4.55 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -56.17 -45.63 79.63 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.865 0.466 . . . . 0.0 111.001 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.3 m -64.39 -44.21 92.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.984 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 22.5 mm -62.34 -51.9 66.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -56.26 -59.09 5.45 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.516 1.126 . . . . 0.0 111.829 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -55.7 -40.67 72.72 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.345 0.658 . . . . 0.0 111.99 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.09 -53.82 39.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.09 -35.52 71.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.548 0.739 . . . . 0.0 111.317 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.05 -48.96 74.22 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.62 -27.75 68.88 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.075 0.55 . . . . 0.0 110.131 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -76.49 -10.97 59.79 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.719 -1.238 . . . . 0.0 111.431 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.87 24.7 73.53 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.42 ' OE2' ' HE3' ' A' ' 144' ' ' LYS . 5.4 mm-40 -93.68 -30.26 15.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 69.9 p -87.77 146.68 25.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.996 0.816 . . . . 0.0 110.386 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -85.26 -31.25 23.21 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -160.03 166.71 29.45 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.44 0.564 . . . . 0.0 112.396 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 6.3 t -147.39 161.99 39.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.081 1.352 . . . . 0.0 107.889 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.9 mt -131.78 122.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -142.06 -178.64 5.8 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.945 1.698 . . . . 0.0 108.527 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -170.44 -169.57 33.71 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.649 -0.657 . . . . 0.0 112.532 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -63.06 -178.68 0.45 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.228 3.285 . . . . 0.0 112.724 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -141.05 139.28 34.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.924 1.29 . . . . 0.0 108.351 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -112.43 149.74 32.13 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.337 1.455 . . . . 0.0 110.659 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 47.1 m95 50.5 21.1 0.79 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.561 1.944 . . . . 0.0 114.069 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 35.4 t -119.47 162.4 18.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.06 1.744 . . . . 0.0 109.431 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -61.61 153.94 26.43 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.5 -0.75 . . . . 0.0 111.664 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.62 -6.21 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -137.81 104.69 5.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.547 1.939 . . . . 0.0 106.648 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 16.6 p -136.26 -73.96 0.44 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 9.1 p -157.55 149.45 22.24 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.843 1.257 . . . . 0.0 110.355 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.65 150.96 5.02 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.076 1.351 . . . . 0.0 110.64 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m -144.92 0.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.5 1.12 . . . . 0.0 112.784 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -47.62 131.59 14.26 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.762 1.225 . . . . 0.0 112.83 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -158.67 130.74 6.73 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.592 1.557 . . . . 0.0 107.177 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 68.72 174.16 9.08 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 121.57 0.539 . . . . 0.0 111.993 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 85.2 t -145.67 128.79 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.5 t -155.44 169.42 24.29 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.7 t -68.82 122.0 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.442 1.097 . . . . 0.0 111.196 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -79.33 154.87 76.94 Favored Pre-proline 0 C--O 1.237 0.409 0 C-N-CA 123.383 0.673 . . . . 0.0 109.348 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.69 146.89 80.43 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.6 1.533 . . . . 0.0 109.257 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 255' ' ' SER . 20.4 p -129.32 156.24 44.33 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.181 0.992 . . . . 0.0 108.822 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -81.33 155.26 26.09 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.103 -0.998 . . . . 0.0 108.896 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.71 119.98 7.06 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.145 -0.972 . . . . 0.0 112.523 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.39 5.52 63.33 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.667 1.603 . . . . 0.0 113.982 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -148.12 115.46 4.0 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 119.907 1.854 . . . . 0.0 114.379 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.86 141.98 15.48 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.17 2.58 . . . . 0.0 112.574 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.472 ' H ' HG22 ' A' ' 249' ' ' THR . 58.8 m -59.88 140.12 56.87 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 84.17 15.01 Favored Pre-proline 0 N--CA 1.466 0.329 0 O-C-N 121.802 -0.561 . . . . 0.0 109.929 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -77.05 -175.57 2.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.762 2.308 . . . . 0.0 110.259 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -67.55 162.45 23.34 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.59 130.2 36.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -140.18 159.04 26.07 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 106.355 -2.698 . . . . 0.0 106.355 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.49 176.55 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.196 0.998 . . . . 0.0 108.365 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 5.7 tt -106.42 151.62 24.68 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.7 m -140.49 169.5 17.54 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.571 0.623 . . . . 0.0 112.18 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -132.54 137.83 47.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.835 1.654 . . . . 0.0 107.082 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.35 134.97 7.46 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.092 0.87 . . . . 0.0 111.69 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 54.2 mt -75.44 136.72 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.298 1.049 . . . . 0.0 110.431 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -71.91 123.61 23.08 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.654 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -71.22 -28.64 64.34 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.69 -0.671 . . . . 0.0 112.166 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -69.37 -8.42 46.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 59.9 m -64.61 163.15 29.34 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.267 1.027 . . . . 0.0 108.285 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -74.16 -56.58 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.653 1.569 . . . . 0.0 110.421 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -128.86 102.47 6.55 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.507 ' HE2' ' HB1' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -57.82 -17.51 16.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -59.42 -31.58 69.4 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.553 0.741 . . . . 0.0 110.721 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 98.8 mt -60.36 -43.34 96.6 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.104 -0.998 . . . . 0.0 109.777 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.38 -43.22 41.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.739 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -34.79 75.95 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.675 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -73.41 -52.75 12.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -52.55 -50.98 61.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.059 0.845 . . . . 0.0 112.826 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.6 tt -62.35 -20.12 64.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -111.88 -8.9 14.08 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -97.3 -31.95 12.15 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.937 1.244 . . . . 0.0 112.336 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -133.18 -37.86 0.97 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.048 0.84 . . . . 0.0 113.115 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.5 -25.47 67.28 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 63.3 mt -112.11 50.53 0.85 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.598 1.159 . . . . 0.0 111.2 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 50.8 p -125.37 157.89 35.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -60.49 -44.19 96.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -65.0 -38.65 91.65 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.093 0.957 . . . . 0.0 111.883 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.57 -44.84 56.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 16.2 mt -65.35 -49.87 67.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.879 0.839 . . . . 0.0 108.852 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.18 -40.26 76.98 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.824 1.25 . . . . 0.0 111.719 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.26 74.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 118.99 0.814 . . . . 0.0 112.692 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 20.5 t -79.25 -37.95 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.203 0.601 . . . . 0.0 109.846 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -63.78 -30.43 71.53 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.607 0.718 . . . . 0.0 111.904 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -64.55 -37.18 86.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.395 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.87 -42.49 39.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.43 1.013 . . . . 0.0 111.673 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.518 ' HA ' ' HE2' ' A' ' 297' ' ' LYS . 8.2 mmpt? -145.52 148.1 35.79 Favored Pre-proline 0 N--CA 1.464 0.274 0 C-N-CA 123.716 0.806 . . . . 0.0 109.361 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.6 126.95 15.54 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.378 2.052 . . . . 0.0 108.778 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 70.2 mt -102.36 -9.9 19.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 77.38 -155.97 44.4 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.46 170.59 15.39 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 23.3 m -130.32 156.71 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 121.039 -1.038 . . . . 0.0 109.569 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.14 -28.71 42.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.147 0.979 . . . . 0.0 110.96 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.19 106.91 1.78 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.471 1.109 . . . . 0.0 108.624 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.404 ' HG2' ' CD1' ' A' ' 90' ' ' TYR . 18.0 mtmt -52.89 -40.8 63.78 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.391 0.676 . . . . 0.0 112.335 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 5.1 m -53.48 -29.84 37.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.076 1.75 . . . . 0.0 112.768 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -112.75 -12.26 13.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.629 0.649 . . . . 0.0 110.196 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -64.36 -42.19 96.32 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.9 -23.37 66.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.042 0.937 . . . . 0.0 112.493 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -90.35 -44.76 9.46 Favored 'General case' 0 N--CA 1.46 0.058 0 C-N-CA 124.417 1.087 . . . . 0.0 109.014 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 6.3 mt -62.86 -35.01 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.245 -0.91 . . . . 0.0 109.888 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.02 -6.54 6.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.259 1.424 . . . . 0.0 113.242 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -68.83 -14.65 63.16 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.26 1.024 . . . . 0.0 111.377 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.93 137.51 20.12 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -14.76 37.08 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.233 2.622 . . . . 0.0 110.762 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.55 -48.05 70.92 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.186 0.994 . . . . 0.0 108.608 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.9 mp -67.97 -52.63 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.58 -49.49 26.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.92 0.888 . . . . 0.0 112.349 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.02 -11.01 2.95 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 29.6 m -98.51 -40.21 8.36 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.3 tpt -69.45 -30.17 68.03 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.837 0.455 . . . . 0.0 111.676 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -62.11 -28.5 69.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.896 -0.573 . . . . 0.0 109.81 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -61.14 -46.34 90.94 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 124.892 1.277 . . . . 0.0 110.697 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -55.79 -41.15 73.69 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.681 0.392 . . . . 0.0 111.486 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -71.38 -18.98 62.33 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.846 1.658 . . . . 0.0 113.344 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.33 1.43 15.14 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.75 0.82 . . . . 0.0 111.493 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -112.81 -165.84 16.69 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.712 1.148 . . . . 0.0 112.485 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.27 136.95 43.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.672 1.589 . . . . 0.0 112.588 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.7 mt -104.54 86.57 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 2.5 mpt? 54.02 84.17 0.21 Allowed Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.897 1.279 . . . . 0.0 111.51 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.29 104.62 1.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.864 3.042 . . . . 0.0 110.636 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -77.02 56.73 1.26 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.665 1.186 . . . . 0.0 111.486 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.81 147.86 49.53 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.46 1.104 . . . . 0.0 111.422 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.48 -28.89 38.15 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.144 2.563 . . . . 0.0 110.959 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 169' ' ' PHE . 21.8 mp0 -54.23 -29.04 45.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.154 0.982 . . . . 0.0 111.81 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 5.7 mmt -62.77 -35.63 80.45 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.717 1.144 . . . . 0.0 110.729 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 8.7 t -60.8 -46.2 91.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.93 -41.61 86.73 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.423 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -56.37 -53.81 52.99 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 125.142 1.377 . . . . 0.0 109.88 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -60.16 -52.57 64.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.451 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -57.21 -38.11 73.21 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.903 0.774 . . . . 0.0 111.646 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.3 -60.71 2.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.335 1.054 . . . . 0.0 111.793 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 18.2 t -62.59 -33.0 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.377 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -34.71 70.89 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 21.4 m -80.58 -43.96 19.75 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.43 -50.83 64.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.202 1.001 . . . . 0.0 112.773 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.0 -48.99 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 123.447 0.699 . . . . 0.0 109.335 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mm -65.86 -32.79 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.909 0.777 . . . . 0.0 110.019 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -62.21 -51.11 69.11 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.822 -1.174 . . . . 0.0 109.011 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.51 -48.07 76.52 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.451 0.701 . . . . 0.0 110.602 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.37 69.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.284 1.034 . . . . 0.0 113.153 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 16.4 m -92.22 -3.33 55.69 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.591 0.757 . . . . 0.0 110.148 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 68.7 16.23 69.73 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 118.955 0.798 . . . . 0.0 111.715 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -74.74 -28.89 60.97 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.495 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -147.23 158.54 43.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.836 0.744 . . . . 0.0 109.591 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.2 m -62.71 149.9 42.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.631 1.173 . . . . 0.0 108.782 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 42.1 t -60.17 -45.71 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.83 -51.23 70.9 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 123.78 0.832 . . . . 0.0 110.097 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -66.87 -27.86 67.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.42 -38.94 91.64 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 19.5 mt -78.92 -33.99 44.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.829 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -55.18 -47.5 75.11 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.34 1.056 . . . . 0.0 108.475 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -58.32 -55.94 28.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.09 1.756 . . . . 0.0 109.265 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -55.36 -50.56 69.36 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.435 1.494 . . . . 0.0 113.533 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -37.52 73.61 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 28.3 m -66.46 -48.63 69.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 117.563 -1.208 . . . . 0.0 109.166 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -58.65 -14.58 8.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.014 1.279 . . . . 0.0 113.761 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 35.7 mt -101.51 -26.2 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.755 1.622 . . . . 0.0 110.339 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 40.1 p -101.31 8.11 42.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.011 1.324 . . . . 0.0 110.678 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? . . . . . 0 C--O 1.254 1.311 0 C-N-CA 130.347 3.459 . . . . 0.0 104.54 178.34 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.5 mt -68.36 173.67 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.12 32.3 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.746 2.419 . . . . 0.0 114.558 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.58 128.35 31.88 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.73 6.57 21.09 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 126.66 2.076 . . . . 0.0 113.958 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.32 170.91 14.83 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.765 1.626 . . . . 0.0 108.502 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -145.88 147.35 31.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.464 2.306 . . . . 0.0 105.724 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.53 143.23 39.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.6 mt -128.8 127.36 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -115.2 105.77 13.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.1 mp -71.28 155.45 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.406 HD21 HD11 ' A' ' 43' ' ' LEU . 4.8 m-80 -122.63 108.0 12.6 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.827 0.851 . . . . 0.0 112.541 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.67 24.32 7.44 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 49.65 41.78 22.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.899 1.35 . . . . 0.0 110.085 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -63.36 -178.04 0.23 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.67 1.988 . . . . 0.0 113.286 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.51 51.86 2.64 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.27 1.891 . . . . 0.0 110.74 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -60.09 -20.7 59.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.571 1.548 . . . . 0.0 112.777 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -58.7 -44.55 90.37 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.543 1.065 . . . . 0.0 111.013 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.24 -31.38 78.95 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.0 tp -71.83 -38.35 70.17 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.002 0.921 . . . . 0.0 110.819 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.98 -42.75 65.85 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.965 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -58.43 -34.12 70.45 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.953 0.797 . . . . 0.0 111.39 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -68.68 -45.09 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.658 1.583 . . . . 0.0 106.981 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.83 -37.82 95.51 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -66.12 -42.86 88.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 117.848 -1.072 . . . . 0.0 108.522 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -57.62 -56.5 21.16 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -54.89 -48.83 72.49 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.325 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.93 -31.78 72.12 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.891 0.768 . . . . 0.0 111.103 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -73.26 -27.13 61.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.818 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -97.25 -36.26 10.48 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.823 0.849 . . . . 0.0 112.816 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.3 p -102.18 -27.73 12.71 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.397 0.999 . . . . 0.0 113.245 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.82 -15.73 56.72 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.623 -1.098 . . . . 0.0 112.581 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.8 mm -69.07 133.11 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' CA ' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.69 151.57 46.24 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.716 -0.615 . . . . 0.0 111.327 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.2 t -136.68 112.06 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.9 m -102.92 123.47 46.62 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.27 115.71 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 105.933 -1.876 . . . . 0.0 105.933 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -130.7 159.47 37.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.642 0.655 . . . . 0.0 109.7 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -125.23 63.39 42.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.57 1.148 . . . . 0.0 108.888 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.87 146.49 42.41 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.494 2.129 . . . . 0.0 111.807 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -101.06 24.22 9.68 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.87 0.868 . . . . 0.0 110.185 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.67 14.09 0.84 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.586 -0.696 . . . . 0.0 112.657 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.406 HD11 HD21 ' A' ' 12' ' ' ASN . 0.8 OUTLIER -56.18 -27.98 56.49 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.472 -1.393 . . . . 0.0 112.491 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.89 -25.3 56.63 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.91 1.284 . . . . 0.0 112.4 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.61 -25.26 7.93 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.222 1.009 . . . . 0.0 109.428 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -45.8 65.08 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 120.263 -1.523 . . . . 0.0 109.878 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -49.75 -59.2 7.24 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 117.598 -1.191 . . . . 0.0 110.06 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.58 -18.83 65.71 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.135 1.89 . . . . 0.0 114.559 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -89.73 1.13 56.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.313 1.445 . . . . 0.0 113.147 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 t -131.27 -41.21 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 119.481 1.037 . . . . 0.0 108.388 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.09 -30.56 71.09 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 122.038 -0.414 . . . . 0.0 110.629 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.28 95.19 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.65 -41.18 79.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.431 0.692 . . . . 0.0 110.43 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.39 19.9 1.47 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.131 -1.372 . . . . 0.0 114.324 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -134.96 -160.72 1.08 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.896 1.678 . . . . 0.0 107.038 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.78 -160.54 13.39 Favored Glycine 0 C--N 1.339 0.729 0 O-C-N 120.078 -1.639 . . . . 0.0 114.262 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.51 -179.66 5.03 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.08 2.52 . . . . 0.0 109.8 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -111.87 -23.56 10.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 121.564 -0.71 . . . . 0.0 112.418 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.1 mt -145.51 142.72 22.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.119 0.968 . . . . 0.0 108.851 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.2 tt -127.38 142.43 43.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.531 1.532 . . . . 0.0 107.412 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.64 116.85 22.35 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.69 1.196 . . . . 0.0 109.866 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -158.59 170.61 21.78 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.676 0.79 . . . . 0.0 109.371 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.58 153.64 40.97 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -58.19 -23.0 54.06 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.85 -54.63 42.29 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.853 -1.154 . . . . 0.0 111.731 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -63.7 -22.65 67.02 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 119.255 -0.402 . . . . 0.0 110.828 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -77.76 -2.75 37.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.724 0.41 . . . . 0.0 111.205 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.95 -9.13 75.3 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 120.852 -1.155 . . . . 0.0 110.871 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.97 -42.23 0.38 Allowed Glycine 0 CA--C 1.533 1.156 0 N-CA-C 117.938 1.935 . . . . 0.0 117.938 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -46.28 -44.79 16.84 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.874 2.337 . . . . 0.0 115.403 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.02 -41.49 82.07 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 119.585 1.084 . . . . 0.0 110.078 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -28.45 69.63 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.237 -0.915 . . . . 0.0 109.82 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.5 m -77.58 -2.96 38.36 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.013 1.325 . . . . 0.0 111.29 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.13 42.74 23.34 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.4 mt -126.81 -2.1 6.61 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.7 mt -121.69 135.75 54.95 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.98 1.718 . . . . 0.0 110.944 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -81.98 162.75 22.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.295 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -75.65 104.79 6.36 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 103.555 -2.758 . . . . 0.0 103.555 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.52 168.55 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.815 1.246 . . . . 0.0 112.982 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.5 m 57.02 91.36 0.08 OUTLIER Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 127.205 2.202 . . . . 0.0 115.049 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.36 -27.81 9.12 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.177 1.918 . . . . 0.0 112.563 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -124.99 137.69 54.24 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.856 1.207 . . . . 0.0 113.012 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -58.1 -22.97 53.02 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.778 2.431 . . . . 0.0 115.766 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.67 70.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 120.188 1.358 . . . . 0.0 111.699 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -59.33 -31.56 69.28 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.477 0.711 . . . . 0.0 110.881 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -65.36 -45.02 85.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.63 0.772 . . . . 0.0 110.302 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.22 -15.53 60.17 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.302 1.041 . . . . 0.0 112.815 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -84.39 -6.41 59.38 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.239 1.016 . . . . 0.0 111.043 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mt -126.7 159.44 33.68 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.882 1.673 . . . . 0.0 108.771 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -76.99 158.19 80.51 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 121.501 -0.749 . . . . 0.0 109.215 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.83 -47.56 1.84 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.636 2.89 . . . . 0.0 113.386 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -56.71 -30.49 63.54 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.765 0.711 . . . . 0.0 111.734 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -30.8 69.42 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.275 -0.891 . . . . 0.0 110.092 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -79.23 -40.75 29.88 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.096 0.958 . . . . 0.0 110.206 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -55.72 -21.88 20.85 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.673 1.189 . . . . 0.0 112.74 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.28 3.68 55.25 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.029 2.132 . . . . 0.0 113.997 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.18 0.53 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.48 1.112 . . . . 0.0 111.336 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -68.04 155.26 39.91 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.298 -0.877 . . . . 0.0 108.685 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -136.1 169.92 16.85 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -57.83 102.6 0.1 Allowed 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.442 0.697 . . . . 0.0 111.336 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.46 -81.68 0.95 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.521 1.058 . . . . 0.0 110.911 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.66 169.69 13.86 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.904 0.852 . . . . 0.0 110.816 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.9 mt -105.06 168.92 8.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.78 1.232 . . . . 0.0 108.502 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.6 pt -138.77 -25.88 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.17 173.25 16.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.874 1.215 . . . . 0.0 109.631 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.49 149.69 74.25 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 123.659 0.784 . . . . 0.0 109.217 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.72 141.78 38.33 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.182 2.588 . . . . 0.0 109.0 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -121.55 -51.1 3.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.431 0.692 . . . . 0.0 109.331 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.51 166.85 22.23 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.085 0.402 . . . . 0.0 111.282 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -136.67 123.64 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -118.43 175.1 5.87 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -160.31 162.35 33.52 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.844 0.857 . . . . 0.0 110.461 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.08 133.69 55.62 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 125.953 1.701 . . . . 0.0 108.878 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 71.6 m -131.77 169.27 16.44 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.285 1.834 . . . . 0.0 109.996 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 tp -92.44 149.71 21.23 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.635 0.774 . . . . 0.0 111.527 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.99 131.5 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 126.312 1.845 . . . . 0.0 106.269 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -135.2 177.66 7.64 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.605 1.162 . . . . 0.0 108.754 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -82.62 174.87 10.63 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -79.17 -1.18 34.98 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.161 1.384 . . . . 0.0 112.849 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -65.74 164.86 13.75 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.98 0.895 . . . . 0.0 111.722 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -75.02 -10.44 59.48 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.8 tp -115.71 91.72 31.16 Favored Pre-proline 0 C--O 1.236 0.367 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.15 -29.0 18.13 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.664 2.242 . . . . 0.0 112.607 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 42.26 62.73 7.58 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 127.237 2.215 . . . . 0.0 111.248 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.5 124.75 9.59 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.278 2.652 . . . . 0.0 111.227 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -78.96 174.9 11.58 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.471 2.114 . . . . 0.0 109.185 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -130.66 -38.31 1.32 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.843 0.857 . . . . 0.0 109.609 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.16 150.67 47.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.802 0.335 . . . . 0.0 110.89 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -64.29 -20.52 66.13 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.994 -1.003 . . . . 0.0 111.464 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.64 -11.55 60.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.785 1.175 . . . . 0.0 110.951 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -99.02 -28.56 13.35 Favored 'General case' 0 C--O 1.222 -0.364 0 O-C-N 120.929 -1.107 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.9 mm -52.04 -56.31 22.93 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 119.657 1.117 . . . . 0.0 111.256 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -71.13 -20.12 28.92 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 CA-C-N 120.976 1.384 . . . . 0.0 112.42 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.9 -36.46 56.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.926 1.29 . . . . 0.0 110.887 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.15 -30.52 16.65 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 126.517 1.927 . . . . 0.0 112.402 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.8 -45.79 85.57 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.402 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 9.5 ptmm? -64.1 -35.66 81.5 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.581 0.752 . . . . 0.0 111.768 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.52 -43.67 69.14 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.7 mt -73.33 -30.83 63.61 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.765 -0.635 . . . . 0.0 110.182 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -67.41 -39.64 85.53 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.68 -16.23 60.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 123.764 0.665 . . . . 0.0 112.727 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.45 4.25 8.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.629 1.171 . . . . 0.0 112.208 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.84 -99.93 0.13 Allowed Glycine 0 C--N 1.337 0.629 0 CA-C-N 118.746 0.703 . . . . 0.0 114.706 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -139.5 -176.09 4.42 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.659 2.384 . . . . 0.0 109.135 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.87 163.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.73 -52.32 5.38 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.486 1.514 . . . . 0.0 109.423 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.3 tp -137.68 150.78 47.62 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 127.621 2.369 . . . . 0.0 108.244 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -156.24 128.94 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -147.88 163.79 35.68 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -67.03 110.15 3.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.121 0.963 . . . . 0.0 108.41 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.15 -13.2 22.28 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -76.79 -15.13 59.83 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -99.72 130.73 25.96 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 119.805 1.184 . . . . 0.0 111.356 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.84 -14.05 35.29 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 121.594 1.529 . . . . 0.0 110.902 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -64.63 -42.17 95.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.609 1.964 . . . . 0.0 110.109 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -86.08 -30.36 22.65 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.358 0.663 . . . . 0.0 112.687 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.7 p -84.47 -7.51 59.26 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.09 0.859 . . . . 0.0 110.625 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -55.31 -57.94 17.72 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.546 -1.346 . . . . 0.0 112.521 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.33 -25.32 56.14 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.703 1.602 . . . . 0.0 112.95 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -66.18 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.045 1.338 . . . . 0.0 108.04 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 39.4 pt -64.82 -27.13 41.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 O-C-N 121.74 -0.6 . . . . 0.0 111.938 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.38 -16.88 61.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.947 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.0 -59.46 4.51 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.973 0.909 . . . . 0.0 113.161 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -62.33 -54.42 40.72 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.39 12.09 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 CA-C-O 118.553 -1.137 . . . . 0.0 114.51 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.57 133.97 41.53 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 119.842 1.821 . . . . 0.0 109.903 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.418 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 48.9 p90 -145.56 137.46 25.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.05 -48.68 12.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -144.46 141.11 29.36 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.046 0.939 . . . . 0.0 108.951 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.418 ' HE2' ' CE1' ' A' ' 167' ' ' TYR . 10.3 tppt? -91.2 153.06 20.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -159.38 102.35 1.57 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -138.3 160.37 39.66 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 56.77 11.74 0.99 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.209 1.803 . . . . 0.0 111.334 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.84 16.29 80.18 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -178.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -114.84 110.26 19.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 126.18 1.792 . . . . 0.0 108.928 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -81.12 143.62 32.27 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -145.32 76.05 1.46 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 119.833 1.197 . . . . 0.0 113.271 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.56 -6.94 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -41.38 80.82 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.963 1.705 . . . . 0.0 108.186 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -87.78 105.3 17.3 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.34 1.056 . . . . 0.0 108.849 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 81.1 t -127.49 98.62 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -76.0 18.0 3.49 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 117.272 1.669 . . . . 0.0 117.272 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.0 t -70.2 -20.18 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.531 2.165 . . . . 0.0 112.863 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.53 2.09 25.91 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.813 0.733 . . . . 0.0 111.854 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -66.29 165.49 13.88 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.541 1.136 . . . . 0.0 111.369 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.14 -41.39 71.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.403 1.081 . . . . 0.0 111.308 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.0 -27.96 73.53 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 120.995 -1.066 . . . . 0.0 113.394 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.91 -38.09 54.14 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.417 1.109 . . . . 0.0 110.11 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -73.55 -33.19 64.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.786 -0.571 . . . . 0.0 110.988 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -54.73 -48.64 72.28 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.478 1.111 . . . . 0.0 112.457 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -75.87 -19.08 79.2 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.95 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.9 tp -77.61 -53.12 7.96 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 122.95 0.5 . . . . 0.0 112.247 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.2 t -54.78 -32.94 60.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.417 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -53.06 -53.2 53.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.359 0.981 . . . . 0.0 110.697 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 27.4 tp -63.41 -48.78 76.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.723 0.409 . . . . 0.0 110.473 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.16 -31.61 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 123.998 0.919 . . . . 0.0 110.025 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -48.18 80.14 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.895 1.278 . . . . 0.0 110.53 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.24 -39.26 93.58 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.932 -0.48 . . . . 0.0 109.863 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 73.3 mt -67.4 -38.2 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.971 0.908 . . . . 0.0 108.753 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -57.71 -47.61 81.91 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.538 -1.351 . . . . 0.0 108.015 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -80.77 -0.13 37.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.29 1.436 . . . . 0.0 112.459 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp 56.26 6.39 0.25 Allowed 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 129.829 3.252 . . . . 0.0 116.729 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -71.45 -20.6 62.07 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.922 -0.711 . . . . 0.0 112.447 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.7 tpt -82.97 159.27 22.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.287 1.035 . . . . 0.0 112.485 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -95.94 76.09 3.12 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.34 -7.36 30.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.291 1.436 . . . . 0.0 113.598 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.61 -22.69 26.06 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 130.519 3.528 . . . . 0.0 112.179 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.6 m -58.84 127.79 33.95 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -128.62 -178.43 4.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.367 1.867 . . . . 0.0 107.513 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -59.34 -39.49 83.35 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -53.51 56.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.522 1.129 . . . . 0.0 109.121 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 60.5 mt -61.98 -55.93 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.831 1.252 . . . . 0.0 110.848 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.65 94.22 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.628 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.82 -45.27 82.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.294 1.407 . . . . 0.0 110.904 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.47 -55.43 27.65 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.485 1.114 . . . . 0.0 110.403 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.92 -38.7 76.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.397 1.079 . . . . 0.0 110.16 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -62.03 -30.65 71.11 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.456 0.571 . . . . 0.0 109.581 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.57 -35.84 65.52 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 120.923 -1.11 . . . . 0.0 109.443 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -77.01 -12.38 59.93 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.574 1.149 . . . . 0.0 113.622 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.1 16.53 59.18 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-N 120.683 1.583 . . . . 0.0 111.442 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -78.99 -9.4 59.52 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.031 1.732 . . . . 0.0 114.349 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -146.62 127.1 14.09 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.082 -1.011 . . . . 0.0 108.702 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.71 -24.77 66.29 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.322 -0.862 . . . . 0.0 111.575 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -140.92 166.64 24.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.567 1.147 . . . . 0.0 111.603 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.9 t -153.15 166.65 31.85 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.279 1.831 . . . . 0.0 107.179 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.5 mt -123.79 120.97 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -150.98 175.26 12.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.422 1.489 . . . . 0.0 107.075 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.96 76.83 0.03 OUTLIER Glycine 0 CA--C 1.522 0.495 0 CA-C-O 118.222 -1.321 . . . . 0.0 110.048 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -75.97 68.07 6.59 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.036 3.157 . . . . 0.0 110.635 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 37.4 t90 -63.83 -42.41 97.63 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.171 1.388 . . . . 0.0 109.161 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.58 -171.26 3.14 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -107.19 -10.76 15.76 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.724 -1.235 . . . . 0.0 113.076 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.9 m -72.73 1.34 8.63 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -121.02 163.27 18.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.993 1.317 . . . . 0.0 107.576 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.5 tt -127.31 135.71 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.659 1.184 . . . . 0.0 109.684 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -158.7 178.04 10.54 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 128.36 2.664 . . . . 0.0 106.088 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 70.5 p -75.4 -30.83 60.23 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.883 -1.136 . . . . 0.0 109.738 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 31.0 m 53.26 21.67 2.37 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.742 1.617 . . . . 0.0 112.661 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -77.32 108.64 10.59 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.246 1.418 . . . . 0.0 109.787 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.7 m -57.38 134.46 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -150.32 171.37 17.1 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.373 -0.829 . . . . 0.0 112.113 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -85.15 147.72 26.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.608 1.163 . . . . 0.0 109.822 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 87.0 99.5 0.83 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.15 167.65 26.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 126.466 1.906 . . . . 0.0 106.913 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -155.17 177.81 10.91 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.138 -0.976 . . . . 0.0 110.577 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.7 t -76.17 151.44 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 126.7 2.0 . . . . 0.0 109.181 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.5 pp -100.04 157.06 34.55 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.489 1.116 . . . . 0.0 108.699 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.41 144.56 62.04 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.511 1.474 . . . . 0.0 109.211 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 254' ' ' PRO . 81.6 p -136.03 -161.63 1.18 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.915 0.886 . . . . 0.0 110.262 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.5 143.65 40.53 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -55.65 134.75 51.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.569 -0.707 . . . . 0.0 110.033 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 70.58 -7.81 4.75 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -146.42 98.47 4.26 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 119.293 1.547 . . . . 0.0 112.1 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 249' ' ' THR . 37.8 Cg_endo -66.07 158.24 55.45 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.327 1.352 . . . . 0.0 110.788 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 80.7 p -83.07 142.53 31.22 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 120.893 -1.13 . . . . 0.0 110.116 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -142.5 118.15 6.77 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.832 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -75.76 -61.89 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.731 2.287 . . . . 0.0 110.904 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -159.11 164.31 35.4 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 129.613 3.165 . . . . 0.0 105.953 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.53 167.66 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -151.91 116.3 0.75 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.82 122.4 62.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 117.604 0.702 . . . . 0.0 112.535 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.7 tt -77.77 128.04 33.39 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.4 m -114.97 163.42 15.61 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.28 0.632 . . . . 0.0 112.179 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -139.26 139.98 37.54 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.19 0.996 . . . . 0.0 109.27 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -129.44 153.94 20.14 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.035 1.778 . . . . 0.0 108.896 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 75.9 mt -104.41 137.97 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 125.139 1.376 . . . . 0.0 107.654 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -68.05 114.46 6.6 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -63.22 -24.71 68.0 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.334 -0.854 . . . . 0.0 110.946 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -69.84 -16.72 63.31 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 118.451 -0.785 . . . . 0.0 113.079 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 44.7 m -58.3 150.42 53.69 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 118.985 0.812 . . . . 0.0 109.781 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.83 -37.24 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.195 1.93 . . . . 0.0 112.221 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -135.81 89.03 2.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -57.31 -18.57 17.52 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.622 0.369 . . . . 0.0 111.084 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.85 -42.33 84.24 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.557 1.943 . . . . 0.0 108.409 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.08 -37.84 81.12 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.905 -1.122 . . . . 0.0 110.674 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.35 -45.53 38.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -35.33 77.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.473 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -71.71 -52.63 16.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.215 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -54.89 -47.99 73.61 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 120.657 1.572 . . . . 0.0 111.167 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.31 -45.73 91.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.772 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -83.42 -7.3 59.58 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -108.17 -24.32 11.59 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 116.92 -1.514 . . . . 0.0 114.603 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -139.65 -35.67 0.53 Allowed 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.457 1.026 . . . . 0.0 112.256 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -64.82 -44.76 88.83 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.397 1.453 . . . . 0.0 108.549 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 77.7 mt -96.86 53.97 1.26 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.358 1.863 . . . . 0.0 112.834 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.1 p -131.75 157.47 43.72 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.29 -38.49 89.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -69.44 -39.1 78.02 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.71 -0.619 . . . . 0.0 110.885 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.84 -32.26 61.34 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 121.769 -0.582 . . . . 0.0 112.122 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.9 mt -74.75 -44.17 51.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.31 -45.26 84.4 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.377 1.071 . . . . 0.0 108.541 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.69 -50.42 63.35 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.435 1.094 . . . . 0.0 112.289 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 65.4 t -72.94 -34.57 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.209 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -68.92 -32.91 72.87 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.452 0.569 . . . . 0.0 111.386 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -62.63 -35.18 78.76 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -67.17 -72.44 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.57 154.51 77.6 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 124.493 1.117 . . . . 0.0 111.581 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.44 108.1 2.54 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.44 2.093 . . . . 0.0 109.868 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.22 -30.51 70.45 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.03 -116.47 5.59 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 106.49 -2.644 . . . . 0.0 106.49 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -109.9 169.13 8.92 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.993 1.396 . . . . 0.0 108.328 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 18.6 m -131.74 153.1 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 O-C-N 121.377 -0.827 . . . . 0.0 110.977 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.11 -34.34 50.12 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.974 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 15.4 tp -69.34 102.19 1.69 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.303 1.041 . . . . 0.0 108.327 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -53.2 -28.44 26.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.608 1.563 . . . . 0.0 115.217 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -62.37 1.7 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.764 1.165 . . . . 0.0 111.483 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -78.96 -14.01 59.46 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 125.246 1.418 . . . . 0.0 112.691 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -58.88 -32.23 69.3 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.66 -30.87 71.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.711 1.204 . . . . 0.0 112.601 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -82.38 -39.46 22.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.641 1.176 . . . . 0.0 110.009 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.439 ' HB3' HG21 ' A' ' 317' ' ' ILE . 12.6 mt -69.14 -34.82 75.6 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.33 -6.96 1.72 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.089 1.756 . . . . 0.0 113.497 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -62.05 -33.06 73.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.797 0.726 . . . . 0.0 109.913 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.14 142.81 25.17 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.04 -13.2 37.54 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.149 1.899 . . . . 0.0 113.509 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.5 mtm-85 -64.5 -45.14 88.58 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.757 -1.215 . . . . 0.0 109.384 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.562 HD12 ' H ' ' A' ' 317' ' ' ILE . 4.3 mp -67.25 -57.68 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 124.596 1.158 . . . . 0.0 107.965 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.63 -54.97 18.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 124.176 0.923 . . . . 0.0 110.171 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.33 -30.8 71.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.694 -1.254 . . . . 0.0 113.171 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 16.7 m -66.5 -42.92 86.66 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.3 tpt -67.33 -51.42 52.63 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.807 1.643 . . . . 0.0 110.393 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -55.16 -33.05 62.61 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.217 1.007 . . . . 0.0 112.427 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -81.97 -38.34 25.3 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.813 0.845 . . . . 0.0 108.976 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.18 82.88 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.714 0.688 . . . . 0.0 110.48 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -63.78 -51.14 66.14 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.268 1.027 . . . . 0.0 110.778 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -20.97 54.26 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -64.55 176.99 9.95 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 125.257 1.408 . . . . 0.0 115.085 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.96 133.76 49.2 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.674 1.99 . . . . 0.0 109.26 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 93.7 mt -71.83 136.31 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 37.0 tpp -56.27 112.83 4.87 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.867 1.267 . . . . 0.0 110.53 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.52 178.5 7.29 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.425 3.417 . . . . 0.0 112.833 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -148.65 46.35 1.03 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.976 0.91 . . . . 0.0 111.768 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.41 155.43 43.71 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.553 1.541 . . . . 0.0 113.063 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.39 -19.43 61.46 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.094 3.196 . . . . 0.0 115.448 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -56.35 -24.01 41.28 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.592 1.157 . . . . 0.0 111.574 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 87.4 mmm -59.28 -33.59 71.24 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.685 0.794 . . . . 0.0 111.504 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 13.1 t -58.68 -49.3 78.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.681 0.673 . . . . 0.0 110.315 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.86 82.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.751 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -56.09 -48.93 75.2 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.892 0.877 . . . . 0.0 110.035 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 21.6 m95 -56.95 -44.34 82.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.428 0.558 . . . . 0.0 111.349 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -66.93 -45.12 78.82 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.967 -0.458 . . . . 0.0 110.258 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -52.93 -56.19 17.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.136 1.774 . . . . 0.0 112.149 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 18.1 t -68.45 -40.2 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 117.616 -1.183 . . . . 0.0 109.561 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -52.28 -50.73 61.56 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.875 1.67 . . . . 0.0 109.023 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 2.1 m -67.45 -45.01 77.24 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.58 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.06 -42.1 68.89 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.878 1.217 . . . . 0.0 111.964 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 44.1 t -58.28 -57.38 11.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.354 1.062 . . . . 0.0 109.43 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.9 mm -67.09 -26.47 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 119.344 -0.36 . . . . 0.0 110.687 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -64.94 -51.39 62.12 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 119.85 -1.781 . . . . 0.0 109.088 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.52 -44.57 70.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.383 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.24 -29.02 70.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.4 m -85.71 -12.36 51.36 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.095 0.861 . . . . 0.0 109.571 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 73.33 8.73 75.99 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.416 -0.658 . . . . 0.0 111.676 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -66.78 -34.62 78.23 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.681 1.241 . . . . 0.0 108.915 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -138.99 155.86 47.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.0 t -76.11 166.47 23.43 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.8 t -55.73 -56.07 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.142 1.377 . . . . 0.0 109.901 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -51.75 -41.25 61.45 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.59 1.556 . . . . 0.0 113.478 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -77.28 -36.48 54.2 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.19 0.196 . . . . 0.0 111.099 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.61 -50.26 72.5 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.49 -0.756 . . . . 0.0 109.74 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.04 -39.18 89.96 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.108 -0.949 . . . . 0.0 111.157 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -57.55 -56.25 24.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.815 0.734 . . . . 0.0 110.395 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.95 -38.57 91.61 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 124.274 0.984 . . . . 0.0 111.012 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.59 92.61 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.682 -0.636 . . . . 0.0 110.452 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.38 -36.36 68.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.585 0.754 . . . . 0.0 109.792 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 5.8 m -59.69 -39.08 83.36 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.62 0.645 . . . . 0.0 110.398 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -65.75 -15.67 63.06 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.092 -1.005 . . . . 0.0 112.34 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 7.8 mt -102.56 -8.62 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.988 1.315 . . . . 0.0 109.974 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 19.7 p -113.36 -2.52 13.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.802 1.641 . . . . 0.0 111.874 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.106 0 C-N-CA 127.344 2.257 . . . . 0.0 106.544 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.3 mm -89.43 146.4 6.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -101.62 106.78 17.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 122.216 1.007 . . . . 0.0 108.521 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -73.04 -176.03 1.97 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.812 2.445 . . . . 0.0 113.018 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.94 17.27 75.17 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.106 0.86 . . . . 0.0 111.963 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.47 163.36 36.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.173 1.389 . . . . 0.0 110.656 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.6 mt -148.99 150.28 32.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 129.237 3.015 . . . . 0.0 104.933 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.52 134.36 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.581 HD12 HG22 ' A' ' 37' ' ' VAL . 42.2 mt -114.43 123.55 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -121.45 118.93 30.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -145.81 154.78 13.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.37 1.068 . . . . 0.0 110.726 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -69.52 150.8 46.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.25 -26.79 37.48 Favored Glycine 0 N--CA 1.465 0.569 0 C-N-CA 126.161 1.839 . . . . 0.0 115.034 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.82 -19.77 63.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.605 0.703 . . . . 0.0 110.554 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -73.09 164.8 26.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 122.167 0.984 . . . . 0.0 109.962 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.69 63.5 4.35 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -68.51 -45.87 71.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.326 1.05 . . . . 0.0 110.959 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -38.63 80.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.92 -38.74 22.39 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.47 -34.95 78.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.204 1.002 . . . . 0.0 110.545 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HA ' HG21 ' A' ' 37' ' ' VAL . . . -56.93 -44.66 82.68 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.142 0.577 . . . . 0.0 109.567 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -56.11 -43.1 77.8 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.527 0.731 . . . . 0.0 111.635 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.1 -44.52 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.509 1.524 . . . . 0.0 107.362 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.73 -42.84 95.05 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.305 -0.872 . . . . 0.0 110.994 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -43.25 99.2 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.052 0.926 . . . . 0.0 108.724 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -62.74 -50.32 71.56 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.613 1.165 . . . . 0.0 108.942 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -56.77 -41.89 78.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.561 1.073 . . . . 0.0 110.272 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.93 -35.93 79.86 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.965 -1.084 . . . . 0.0 108.7 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -74.18 3.77 6.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.3 1.84 . . . . 0.0 111.263 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -125.4 -37.4 2.37 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.79 1.636 . . . . 0.0 112.604 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.0 p -112.29 -22.0 11.13 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.716 0.806 . . . . 0.0 113.013 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.44 53.01 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.063 -1.023 . . . . 0.0 112.954 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.77 133.06 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 119.145 1.473 . . . . 0.0 107.468 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HE2' ' N ' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -66.81 146.03 54.86 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.262 -0.899 . . . . 0.0 108.812 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.3 t -136.75 91.59 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.8 m -80.73 134.28 35.8 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.581 HG22 HD12 ' A' ' 9' ' ' ILE . 27.2 t -130.84 129.4 63.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -140.01 166.23 25.22 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -118.54 58.66 3.55 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 123.59 0.756 . . . . 0.0 111.606 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.32 159.97 51.64 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.18 1.253 . . . . 0.0 109.24 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -120.45 -23.08 6.23 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.375 0.67 . . . . 0.0 110.501 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.2 9.13 41.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.913 1.285 . . . . 0.0 110.543 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.3 pt? -56.86 -30.74 64.12 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 120.565 -1.334 . . . . 0.0 112.286 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.26 -23.81 64.4 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.22 1.373 . . . . 0.0 113.652 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -105.14 -28.03 11.24 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.164 0.438 . . . . 0.0 110.272 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -51.29 10.88 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 124.492 1.117 . . . . 0.0 110.647 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -41.92 -58.25 3.46 Favored Pre-proline 0 N--CA 1.457 -0.079 0 CA-C-O 116.321 -1.799 . . . . 0.0 109.883 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.99 1.37 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.27 1.98 . . . . 0.0 116.93 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.36 -52.86 2.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.802 1.183 . . . . 0.0 108.752 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.466 HG12 ' C ' ' A' ' 55' ' ' ASP . 2.3 t -63.17 -40.95 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.58 -31.04 59.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.378 -0.827 . . . . 0.0 111.144 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.15 -13.44 60.81 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.033 0.533 . . . . 0.0 111.011 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 m -93.33 -82.34 0.34 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 163.36 37.77 0.02 OUTLIER Glycine 0 CA--C 1.524 0.612 0 C-N-CA 125.598 1.57 . . . . 0.0 109.291 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.466 ' C ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -136.79 -3.32 2.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.812 1.645 . . . . 0.0 113.292 -176.699 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.9 176.27 21.66 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 116.933 1.533 . . . . 0.0 116.933 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.92 172.38 7.28 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.766 2.311 . . . . 0.0 109.584 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -107.92 -18.5 13.79 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -142.36 143.05 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.348 1.459 . . . . 0.0 108.726 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.8 tt -135.29 140.6 44.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 125.608 1.563 . . . . 0.0 108.277 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -132.45 116.32 16.64 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -154.73 179.29 9.21 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.72 0.691 . . . . 0.0 110.726 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.41 152.95 40.63 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -61.81 -25.62 67.61 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -61.52 -23.79 66.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -98.76 -4.9 32.39 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.797 -0.564 . . . . 0.0 110.78 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -92.46 20.87 5.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.004 1.322 . . . . 0.0 109.73 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.79 -14.03 51.16 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 120.667 -1.271 . . . . 0.0 111.391 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.65 -27.45 1.94 Allowed Glycine 0 C--N 1.344 0.982 0 CA-C-N 119.304 1.552 . . . . 0.0 116.498 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -53.75 -47.37 70.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.114 1.957 . . . . 0.0 111.763 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.21 -40.91 94.78 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -27.08 54.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.303 1.041 . . . . 0.0 112.223 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.0 m -96.88 3.07 52.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.353 1.461 . . . . 0.0 112.045 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.66 16.76 78.72 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.421 1.01 . . . . 0.0 112.267 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.7 mt -88.73 9.47 24.27 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.142 0.977 . . . . 0.0 113.425 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.0 mt -131.29 146.01 52.12 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 120.979 -1.076 . . . . 0.0 108.244 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.41 161.58 14.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -78.7 94.21 5.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.11 175.21 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 127.103 2.161 . . . . 0.0 112.212 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.4 m 66.64 95.88 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 126.777 2.031 . . . . 0.0 111.013 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.92 -48.24 1.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.339 1.359 . . . . 0.0 110.749 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.84 154.65 51.55 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.079 0.951 . . . . 0.0 110.509 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -49.34 -38.85 29.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.07 2.548 . . . . 0.0 111.768 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.98 -25.55 44.49 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.189 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -68.77 -28.64 66.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.718 1.145 . . . . 0.0 109.963 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -64.05 -36.37 83.79 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 120.76 -1.212 . . . . 0.0 110.76 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.18 -15.3 61.02 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.065 0.946 . . . . 0.0 112.286 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -70.85 -20.92 62.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.717 1.207 . . . . 0.0 111.771 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.415 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 8.0 mt -122.93 161.16 24.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.799 1.64 . . . . 0.0 108.541 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -72.98 157.76 88.15 Favored Pre-proline 0 N--CA 1.476 0.847 0 CA-C-N 120.23 1.377 . . . . 0.0 108.91 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.9 -46.18 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.08 2.52 . . . . 0.0 114.168 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -60.1 -30.93 69.58 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.259 0.936 . . . . 0.0 111.34 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.11 -29.46 69.21 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.233 -0.917 . . . . 0.0 110.15 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.415 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 73.7 m95 -72.88 -30.29 63.84 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.966 0.803 . . . . 0.0 110.684 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -62.99 -16.5 59.92 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.45 -5.18 59.08 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.326 0.65 . . . . 0.0 112.506 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.5 m -133.3 27.82 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.882 1.273 . . . . 0.0 112.238 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.6 mtp85 -86.37 164.11 17.24 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.199 0.999 . . . . 0.0 110.878 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -149.95 175.5 11.62 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.174 1.39 . . . . 0.0 107.603 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -66.55 101.19 0.74 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.559 0.743 . . . . 0.0 112.157 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.84 -69.95 2.8 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.099 1.333 . . . . 0.0 111.974 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.86 162.04 27.95 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.141 0.47 . . . . 0.0 110.064 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.84 155.21 17.16 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.742 1.617 . . . . 0.0 108.557 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.1 pt -123.09 -32.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.72 -178.58 7.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 119.925 1.239 . . . . 0.0 109.912 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -133.36 147.53 65.3 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 124.668 1.187 . . . . 0.0 109.431 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.93 153.8 63.4 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.651 2.9 . . . . 0.0 109.665 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 264' ' ' ALA . 18.9 mm -125.84 -47.63 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 125.364 1.466 . . . . 0.0 110.979 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.26 165.7 26.7 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 117.877 0.308 . . . . 0.0 110.739 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.7 t -127.02 121.43 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 124.281 0.988 . . . . 0.0 109.399 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -108.44 122.29 46.71 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -159.37 176.57 11.98 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.341 1.457 . . . . 0.0 110.298 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.93 -164.57 1.17 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.697 1.999 . . . . 0.0 111.133 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.3 p -167.21 171.5 10.76 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.668 1.987 . . . . 0.0 110.27 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.499 HD23 HG23 ' A' ' 245' ' ' THR . 49.5 tp -109.54 146.91 33.86 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 120.251 1.387 . . . . 0.0 107.821 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.4 mt -122.3 151.61 26.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -152.29 162.21 41.48 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.544 0.738 . . . . 0.0 109.484 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -50.75 140.46 14.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.861 1.264 . . . . 0.0 109.239 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.479 ' H ' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -59.91 -11.27 5.21 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.304 1.442 . . . . 0.0 114.046 -178.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.05 170.78 14.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.729 1.604 . . . . 0.0 110.35 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 pp -93.08 8.31 40.55 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.28 1.032 . . . . 0.0 112.844 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -34.88 107.68 0.32 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 128.198 2.599 . . . . 0.0 110.462 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.35 -173.96 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.364 3.376 . . . . 0.0 115.93 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 47.7 67.35 4.57 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 128.027 2.531 . . . . 0.0 110.897 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.26 158.87 37.76 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 121.956 1.77 . . . . 0.0 111.749 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.52 153.06 74.5 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.959 3.106 . . . . 0.0 112.748 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.83 -12.03 3.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.068 0.547 . . . . 0.0 112.365 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.33 154.84 45.91 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.128 -0.983 . . . . 0.0 111.949 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -80.05 -22.92 41.79 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.23 -18.29 47.66 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.79 -5.13 21.5 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.264 1.025 . . . . 0.0 111.511 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.4 mm -61.05 -52.53 71.29 Favored Pre-proline 0 C--N 1.339 0.128 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.82 -23.75 54.92 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 CA-C-N 120.997 1.392 . . . . 0.0 111.503 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.43 -44.39 75.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.4 tp -80.43 -27.29 38.02 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.219 1.008 . . . . 0.0 111.928 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.9 -44.51 82.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 123.943 0.897 . . . . 0.0 110.736 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -68.41 -31.2 70.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.407 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -71.34 -46.78 59.7 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 61.0 mt -72.57 -31.48 65.28 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.402 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -71.17 -37.37 72.2 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.01 68.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.538 0.608 . . . . 0.0 111.89 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.68 6.15 16.75 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.978 0.911 . . . . 0.0 112.534 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 179.42 -104.46 0.18 Allowed Glycine 0 CA--C 1.524 0.626 0 CA-C-N 119.141 0.882 . . . . 0.0 112.792 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -136.91 178.08 7.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.134 2.174 . . . . 0.0 109.978 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.01 155.36 3.54 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.36 1.064 . . . . 0.0 113.674 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.07 -47.61 35.42 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.7 tp -125.48 155.55 40.35 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.192 1.397 . . . . 0.0 110.247 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.457 ' CG ' HG21 ' A' ' 208' ' ' THR . 45.1 ttm -150.68 130.5 13.25 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -159.91 168.93 24.6 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.865 1.666 . . . . 0.0 115.399 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.52 83.11 0.06 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 126.766 2.026 . . . . 0.0 112.095 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.5 mt -80.83 -20.87 41.47 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 125.842 1.657 . . . . 0.0 110.724 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.3 mm-40 -78.92 -6.53 56.41 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -112.62 129.92 23.93 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 119.163 0.892 . . . . 0.0 112.105 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.64 -13.73 24.69 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.156 1.904 . . . . 0.0 112.318 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -64.6 -40.09 94.88 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.854 1.662 . . . . 0.0 113.311 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.521 ' CZ ' HG21 ' A' ' 226' ' ' ILE . 30.5 t80 -95.13 -29.6 14.48 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.5 p -72.75 -28.43 62.62 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.336 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -56.6 -58.67 15.65 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -56.02 -16.36 16.26 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.586 2.191 . . . . 0.0 115.842 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 66.4 tp -82.11 -59.17 2.65 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.811 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.402 HG22 ' HA3' ' A' ' 191' ' ' GLY . 17.8 pt -68.21 -27.42 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 119.403 1.001 . . . . 0.0 111.768 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.25 -20.89 66.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.449 0.699 . . . . 0.0 110.917 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.61 -54.01 43.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.153 1.381 . . . . 0.0 112.244 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.21 -41.75 84.7 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.364 0.529 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 165.88 26.13 0.02 OUTLIER Glycine 0 C--N 1.34 0.778 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -88.92 131.95 10.98 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -147.27 151.44 36.64 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.115 1.457 . . . . 0.0 112.059 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.412 ' HB2' ' CE2' ' A' ' 339' ' ' PHE . . . -85.17 -63.01 1.4 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.775 1.23 . . . . 0.0 112.542 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -138.37 126.24 22.47 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.309 1.444 . . . . 0.0 108.832 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -73.38 129.37 37.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.425 1.011 . . . . 0.0 112.156 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.85 122.18 38.87 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.525 ' HG2' ' H ' ' A' ' 173' ' ' ASN . 14.9 tt0 -93.82 -163.57 1.07 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.987 1.315 . . . . 0.0 109.45 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.525 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 71.0 m-80 -56.77 -8.84 0.65 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.249 2.22 . . . . 0.0 115.731 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.36 11.62 0.02 OUTLIER Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.224 1.392 . . . . 0.0 113.861 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.6 156.7 40.5 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.808 2.443 . . . . 0.0 105.078 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -144.93 148.71 34.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -147.88 141.03 25.04 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.449 ' H ' HD13 ' A' ' 178' ' ' ILE . 0.1 OUTLIER -94.8 -8.67 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.664 1.186 . . . . 0.0 110.3 178.291 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -40.01 73.51 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -78.33 92.48 4.54 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.587 1.155 . . . . 0.0 111.009 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.9 t -115.96 150.29 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.885 1.674 . . . . 0.0 108.996 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -146.08 48.58 0.68 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.55 1.548 . . . . 0.0 111.629 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 80.3 t -81.3 -55.2 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 125.1 1.36 . . . . 0.0 107.937 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -87.51 67.22 9.31 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -113.03 155.95 23.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 126.317 1.847 . . . . 0.0 110.435 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.15 -39.05 66.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.992 1.317 . . . . 0.0 113.152 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.21 -45.96 76.08 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.08 -56.59 19.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 189' ' ' LYS . 10.7 ptpt -58.87 -34.49 71.69 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 117.438 -1.268 . . . . 0.0 112.768 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.05 -52.09 66.42 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.608 1.094 . . . . 0.0 109.286 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.402 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -68.3 -30.31 73.48 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.77 -53.72 20.12 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.332 1.066 . . . . 0.0 108.442 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.4 t -61.14 -33.66 73.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.327 0.651 . . . . 0.0 110.303 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.85 -55.07 34.38 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.6 tt -60.58 -47.89 84.22 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.445 1.498 . . . . 0.0 110.323 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 70.9 t -57.1 -36.23 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 118.18 -0.914 . . . . 0.0 109.75 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.457 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.3 OUTLIER -65.04 -35.51 81.39 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 120.033 1.288 . . . . 0.0 112.122 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.04 -41.23 99.46 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 85.7 mt -67.98 -42.76 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -57.83 -31.69 66.89 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.575 1.55 . . . . 0.0 109.841 178.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -88.69 -5.29 58.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.764 1.625 . . . . 0.0 111.246 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? 60.39 16.88 6.66 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.321 2.648 . . . . 0.0 113.755 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -86.3 -34.53 20.31 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.4 tpt -85.44 128.37 34.7 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -76.68 120.68 22.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -88.92 -3.12 58.83 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -95.72 -15.34 22.7 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.603 1.961 . . . . 0.0 115.144 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.457 HG21 ' CG ' ' A' ' 148' ' ' MET . 3.3 m -67.55 128.43 36.4 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.957 0.903 . . . . 0.0 112.197 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -126.95 172.32 10.55 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.761 2.024 . . . . 0.0 108.114 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -47.66 -39.81 18.17 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 57.8 m -63.14 -45.91 89.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.743 1.217 . . . . 0.0 110.45 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 58.1 mt -66.9 -48.47 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 117.063 -1.446 . . . . 0.0 110.868 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.76 91.06 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.798 1.635 . . . . 0.0 112.717 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.42 -35.32 80.58 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.047 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.26 -55.9 20.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.62 -43.14 75.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.939 2.495 . . . . 0.0 112.119 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -62.49 -45.68 91.91 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.986 1.266 . . . . 0.0 108.543 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -37.9 82.59 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 118.44 -0.791 . . . . 0.0 109.192 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -74.56 -23.08 58.71 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.089 1.313 . . . . 0.0 111.618 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.47 38.25 5.36 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.415 1.483 . . . . 0.0 111.081 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -93.74 -31.1 14.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.672 1.236 . . . . 0.0 113.764 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.5 t -115.15 152.01 33.35 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.612 1.165 . . . . 0.0 109.24 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -87.88 -27.95 21.88 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.781 0.832 . . . . 0.0 111.498 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -136.51 145.49 45.16 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.927 1.291 . . . . 0.0 108.224 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 23.0 m -149.4 149.72 31.28 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.666 1.186 . . . . 0.0 108.919 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.521 HG21 ' CZ ' ' A' ' 156' ' ' PHE . 27.6 mt -124.68 127.17 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.84 157.78 45.43 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.223 1.409 . . . . 0.0 107.313 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -101.95 -163.52 26.81 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 119.124 -0.82 . . . . 0.0 113.391 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.74 73.56 2.93 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.95 3.1 . . . . 0.0 108.457 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -67.73 -63.5 1.05 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.854 0.861 . . . . 0.0 110.806 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -159.36 -90.96 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.085 0.954 . . . . 0.0 109.586 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -121.32 176.83 5.44 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.802 1.241 . . . . 0.0 112.4 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.4 m -63.58 172.23 2.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.369 1.868 . . . . 0.0 111.613 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -132.73 -35.25 1.11 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.8 mt -132.54 71.26 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 120.074 1.307 . . . . 0.0 108.1 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -71.23 -17.17 62.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.202 1.801 . . . . 0.0 112.815 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 m -85.15 -59.92 2.19 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.917 0.781 . . . . 0.0 111.805 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.403 ' O ' ' HE3' ' A' ' 239' ' ' LYS . 3.8 m -71.2 73.66 0.67 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.713 1.205 . . . . 0.0 110.508 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.417 ' HA ' ' HE3' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -124.28 97.29 5.26 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.309 1.444 . . . . 0.0 110.762 -178.157 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.92 17.28 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.048 1.739 . . . . 0.0 109.527 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -103.11 173.06 6.47 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.976 2.51 . . . . 0.0 109.376 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -81.3 173.22 12.7 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -55.62 -37.66 68.69 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 123.97 0.795 . . . . 0.0 113.738 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.25 169.48 11.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 124.97 1.308 . . . . 0.0 107.962 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.499 HG23 HD23 ' A' ' 115' ' ' LEU . 7.9 t -132.98 151.42 52.07 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.22 144.6 14.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 124.469 1.108 . . . . 0.0 110.417 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -116.0 154.96 48.45 Favored Pre-proline 0 CA--C 1.528 0.128 0 C-N-CA 124.866 1.266 . . . . 0.0 111.049 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.24 143.56 39.82 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.431 1.421 . . . . 0.0 110.041 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 47.8 p -135.51 -145.0 0.21 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.834 2.054 . . . . 0.0 108.231 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -124.12 141.59 51.93 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 12.0 pttp -54.02 107.1 0.23 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.279 1.031 . . . . 0.0 109.049 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.76 84.43 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.772 1.177 . . . . 0.0 114.394 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.08 93.64 43.23 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.865 1.333 . . . . 0.0 108.936 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.4 144.17 25.55 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.976 2.451 . . . . 0.0 109.433 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 37.3 p -63.33 141.41 58.78 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 121.058 -1.026 . . . . 0.0 108.804 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -116.39 88.14 22.59 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.511 1.125 . . . . 0.0 110.398 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -82.16 168.08 15.42 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.382 2.055 . . . . 0.0 112.239 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -95.83 164.7 12.63 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.621 1.168 . . . . 0.0 108.446 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 19.9 t -141.3 127.04 19.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -126.07 122.07 4.33 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.49 136.64 54.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 118.042 0.921 . . . . 0.0 112.092 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 tp -68.86 137.48 53.92 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.1 m -121.99 158.23 29.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.494 1.043 . . . . 0.0 113.568 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.427 ' HB2' HG13 ' A' ' 108' ' ' ILE . . . -135.33 141.2 45.57 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.194 1.798 . . . . 0.0 110.004 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.78 167.46 23.22 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.441 1.496 . . . . 0.0 110.196 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 56.2 mt -119.46 132.25 69.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.508 1.523 . . . . 0.0 107.363 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -74.1 130.5 39.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -76.2 -19.48 58.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 117.797 -1.097 . . . . 0.0 113.518 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -72.94 -7.74 52.46 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.574 1.079 . . . . 0.0 113.182 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 66.8 m -63.06 154.72 76.26 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -62.29 -53.69 1.79 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 121.877 1.718 . . . . 0.0 108.052 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -132.42 125.55 31.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.473 ' H ' ' HD2' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -74.39 -16.59 60.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.718 0.807 . . . . 0.0 111.406 178.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.48 ' HA ' ' HG3' ' A' ' 277' ' ' LYS . 3.9 tt0 -61.55 -33.78 74.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.707 0.803 . . . . 0.0 112.517 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 61.9 mt -59.3 -40.74 87.14 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.791 -0.568 . . . . 0.0 111.031 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.42 -43.63 48.88 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.771 0.429 . . . . 0.0 111.057 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.48 ' HG3' ' HA ' ' A' ' 274' ' ' GLU 0.261 0.0 OUTLIER -63.9 -32.95 74.65 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.768 -0.634 . . . . 0.0 111.331 -179.084 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -72.44 -48.07 44.01 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -51.47 -49.89 60.9 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.23 -54.42 47.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.4 -22.55 66.99 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -97.55 -24.6 15.48 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 117.817 -1.087 . . . . 0.0 113.55 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -138.66 -36.42 0.56 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.99 -25.29 62.63 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.468 1.031 . . . . 0.0 110.692 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 89.7 mt -105.57 24.97 11.34 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.445 1.498 . . . . 0.0 113.711 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 6.8 p -103.07 158.19 16.47 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.48 -42.81 99.75 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -71.41 -30.73 66.44 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.582 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.05 -48.89 14.34 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 63.8 mt -62.0 -43.86 97.94 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -62.23 -42.5 99.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.03 -35.14 68.93 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.823 0.738 . . . . 0.0 110.996 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 76.0 t -72.25 -42.01 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -60.01 -29.99 68.84 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.399 1.079 . . . . 0.0 112.705 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -52.56 -47.36 66.86 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 118.272 0.487 . . . . 0.0 110.708 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.91 -73.98 0.24 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -101.47 144.64 28.96 Favored Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 121.051 -1.031 . . . . 0.0 111.615 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.62 108.48 2.64 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.256 2.637 . . . . 0.0 111.556 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 66.8 mt -73.18 -31.47 64.23 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.967 0.907 . . . . 0.0 110.908 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 71.08 -103.71 1.28 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 108.244 -1.942 . . . . 0.0 108.244 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.02 168.44 10.27 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 10.8 m -140.17 153.12 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 120.869 -1.144 . . . . 0.0 110.97 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.06 -18.73 49.29 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.773 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 21.0 tp -81.36 111.83 18.08 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -56.6 -34.16 66.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 119.198 -0.429 . . . . 0.0 111.84 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -37.49 65.96 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.25 1.42 . . . . 0.0 112.186 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -101.43 -16.85 16.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.266 0.485 . . . . 0.0 109.742 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -63.76 -38.76 92.32 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.36 -23.4 62.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.138 0.881 . . . . 0.0 111.331 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -89.39 -51.37 5.59 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.614 1.166 . . . . 0.0 109.058 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 22.0 mt -61.43 -34.66 75.77 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.757 -0.59 . . . . 0.0 110.093 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.68 -3.0 5.58 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.392 1.477 . . . . 0.0 112.964 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -61.62 -28.81 69.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.386 1.448 . . . . 0.0 107.445 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -94.54 135.63 23.91 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.9 -11.99 33.27 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.483 2.122 . . . . 0.0 113.285 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -64.83 -46.29 82.54 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.56 -48.65 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 124.412 1.085 . . . . 0.0 108.531 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.77 -49.49 65.43 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 123.545 0.528 . . . . 0.0 110.684 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.8 84.77 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.775 -0.578 . . . . 0.0 111.823 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 21.0 m -61.46 -35.2 76.95 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.0 tpt -71.12 -48.07 54.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 122.857 0.463 . . . . 0.0 110.42 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -58.45 -30.63 67.09 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.54 1.136 . . . . 0.0 111.985 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -64.32 -28.74 69.92 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.2 -0.937 . . . . 0.0 110.335 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -79.63 -28.17 40.92 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.774 0.716 . . . . 0.0 109.979 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -71.6 -15.92 62.27 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.275 1.43 . . . . 0.0 109.348 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.13 -7.4 7.12 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -107.4 -168.59 21.97 Favored Glycine 0 N--CA 1.467 0.721 0 CA-C-N 119.413 1.006 . . . . 0.0 110.88 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -136.55 155.02 50.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.425 1.113 . . . . 0.0 110.216 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 16.6 mt -59.69 133.28 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 127.042 2.137 . . . . 0.0 111.818 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 82.9 mtp -58.32 162.03 6.67 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 126.491 1.916 . . . . 0.0 111.12 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.42 160.22 28.97 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.925 1.75 . . . . 0.0 108.487 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -101.14 29.84 4.46 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.423 2.289 . . . . 0.0 112.63 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.1 pt -130.24 154.45 81.41 Favored Pre-proline 0 N--CA 1.47 0.573 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.1 -14.15 31.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.135 3.223 . . . . 0.0 115.163 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -57.04 -16.27 6.85 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.449 1.499 . . . . 0.0 112.394 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -32.98 71.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.443 0.697 . . . . 0.0 110.141 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 37.4 p -60.85 -48.25 82.66 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 119.115 0.87 . . . . 0.0 111.405 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.54 94.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.608 0.763 . . . . 0.0 109.147 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 168' ' ' ALA . 14.8 t80 -52.98 -53.99 41.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.459 1.104 . . . . 0.0 111.692 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -62.63 -47.22 84.7 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.804 0.729 . . . . 0.0 110.42 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -60.59 -31.33 70.48 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.782 0.433 . . . . 0.0 111.654 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.426 ' HA ' HH11 ' A' ' 367' ' ' ARG . . . -69.74 -57.33 5.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.4 1.48 . . . . 0.0 110.617 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.89 -38.16 75.17 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.15 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -48.83 -56.15 9.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.263 0.938 . . . . 0.0 110.994 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -45.7 85.4 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.748 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.82 -41.88 71.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.3 -53.31 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.513 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 49.3 mm -62.76 -36.54 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.014 0.824 . . . . 0.0 110.064 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.32 -50.62 73.29 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.114 0.87 . . . . 0.0 109.599 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.49 -52.24 58.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.647 0.779 . . . . 0.0 111.152 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -59.26 -29.01 67.25 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.036 1.334 . . . . 0.0 114.115 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 7.7 m -93.26 -3.9 52.83 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.581 0.752 . . . . 0.0 110.95 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 69.02 23.35 76.07 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 35.4 mtt-85 -80.73 -33.22 35.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -150.45 148.03 28.25 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 10.8 t -71.55 166.6 21.49 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.592 0.71 . . . . 0.0 109.426 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.78 -44.65 99.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.174 1.79 . . . . 0.0 110.771 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -55.4 -47.06 76.47 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.158 0.583 . . . . 0.0 111.251 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -78.47 -38.02 42.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.113 0.565 . . . . 0.0 111.262 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.13 89.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.454 -0.779 . . . . 0.0 110.825 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.0 mt -77.25 -30.06 54.29 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.26 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -58.22 -49.2 77.91 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.349 1.431 . . . . 0.0 108.645 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -51.03 -54.53 23.81 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.737 2.015 . . . . 0.0 108.638 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.84 -49.77 76.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.605 1.562 . . . . 0.0 112.879 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -54.76 -37.15 65.62 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.11 1.364 . . . . 0.0 109.412 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 20.0 m -66.4 -37.96 86.42 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.127 0.571 . . . . 0.0 110.944 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.426 HH11 ' HA ' ' A' ' 342' ' ' ALA . 77.0 mtt180 -66.11 -31.02 71.63 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.247 -0.908 . . . . 0.0 109.912 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.0 mt -80.22 -38.26 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.762 0.825 . . . . 0.0 111.292 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.5 p -73.61 -12.98 60.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.468 1.031 . . . . 0.0 110.9 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 51.3 tttm . . . . . 0 C--O 1.251 1.139 0 C-N-CA 124.689 1.196 . . . . 0.0 109.01 178.842 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.8 mt -131.18 152.16 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -83.71 66.87 9.25 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -62.33 123.87 19.38 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 131.18 3.792 . . . . 0.0 109.491 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.97 39.54 93.27 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.995 1.284 . . . . 0.0 112.634 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -146.08 -179.15 6.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.468 1.107 . . . . 0.0 108.392 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.1 mt -145.6 144.64 30.59 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 128.539 2.735 . . . . 0.0 106.864 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.0 t -145.37 129.88 12.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.727 1.611 . . . . 0.0 107.222 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.59 141.59 46.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.773 0.829 . . . . 0.0 109.391 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.513 ' HB3' HD22 ' A' ' 43' ' ' LEU . 33.4 m0 -120.42 164.87 15.71 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.313 1.045 . . . . 0.0 111.812 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 13' ' ' GLY . 3.6 mt -136.79 136.32 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.828 1.251 . . . . 0.0 111.545 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -117.66 12.01 13.87 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.963 1.705 . . . . 0.0 110.655 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 11' ' ' ILE . . . -161.74 59.18 0.29 Allowed Glycine 0 C--N 1.339 0.724 0 O-C-N 119.974 -1.704 . . . . 0.0 115.689 -177.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 33.23 48.93 0.18 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.552 1.941 . . . . 0.0 115.019 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 168.8 10.7 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.32 64.89 3.71 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -69.74 -23.57 63.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.079 -0.962 . . . . 0.0 112.757 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -64.72 -57.28 9.4 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-N 119.428 1.013 . . . . 0.0 108.856 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.98 -40.52 73.5 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.3 tp -68.19 -35.92 78.76 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.077 0.951 . . . . 0.0 112.034 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.47 97.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.169 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.38 -35.13 73.35 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.919 0.781 . . . . 0.0 110.096 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.69 -42.61 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.39 -38.77 95.3 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -63.45 -47.03 83.55 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.729 1.265 . . . . 0.0 107.909 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -58.76 -58.38 8.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -53.1 -45.11 68.09 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.909 1.232 . . . . 0.0 112.236 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.19 -23.33 66.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.434 1.494 . . . . 0.0 110.937 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -92.16 -17.28 25.13 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.277 -1.514 . . . . 0.0 112.437 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.73 -7.0 22.05 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 124.247 0.967 . . . . 0.0 109.551 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 59.1 p -133.47 -34.42 1.05 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.495 1.118 . . . . 0.0 113.823 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.64 -17.91 58.44 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.696 1.141 . . . . 0.0 112.808 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.9 128.01 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.33 145.79 52.89 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.8 t -138.44 83.25 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.3 m -73.62 151.25 40.9 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.3 t -139.81 118.52 11.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.541 1.537 . . . . 0.0 107.942 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -143.86 157.34 44.43 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.855 0.752 . . . . 0.0 111.247 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -117.95 54.82 1.91 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.37 1.468 . . . . 0.0 112.218 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.486 ' HG2' ' HB3' ' A' ' 43' ' ' LEU . 78.9 Cg_endo -69.42 123.89 10.67 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.83 2.353 . . . . 0.0 111.59 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -13.64 58.99 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 127.818 2.447 . . . . 0.0 114.398 -178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.454 ' H ' ' HE2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -121.24 21.1 11.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.245 1.418 . . . . 0.0 113.727 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 10' ' ' TRP . 0.6 OUTLIER -58.37 -23.35 56.7 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.16 -26.75 61.09 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -106.72 -20.57 13.31 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.205 0.526 . . . . 0.0 110.675 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -75.92 -56.42 4.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -40.01 -57.82 2.54 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-O 116.743 -1.599 . . . . 0.0 112.354 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.96 -44.29 25.67 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.803 1.669 . . . . 0.0 114.219 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.5 mm100 -64.01 -49.13 73.64 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.472 1.109 . . . . 0.0 112.337 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 t -72.08 -39.18 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.474 0.71 . . . . 0.0 110.366 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.62 -28.61 63.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 120.949 -1.094 . . . . 0.0 113.018 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.47 -14.32 27.92 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.165 0.893 . . . . 0.0 112.813 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.9 m -118.15 4.22 12.0 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.945 1.298 . . . . 0.0 111.081 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.52 0.43 88.12 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.279 0.942 . . . . 0.0 113.71 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.23 -10.61 58.47 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.643 -1.504 . . . . 0.0 113.277 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.92 -179.05 19.84 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.69 -177.78 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 125.222 3.948 . . . . 0.0 113.45 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.53 -25.88 13.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.262 0.554 . . . . 0.0 111.057 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 mt -146.27 154.63 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 tp -137.31 146.28 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -132.2 111.9 11.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.61 1.564 . . . . 0.0 108.02 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -156.99 -167.04 2.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.161 0.892 . . . . 0.0 112.271 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.01 143.62 50.72 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.127 0.971 . . . . 0.0 110.865 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -56.8 -41.62 78.08 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.775 1.23 . . . . 0.0 109.541 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -67.84 -5.37 16.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.436 2.294 . . . . 0.0 114.101 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -111.91 -10.18 13.99 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.891 0.876 . . . . 0.0 110.301 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -86.73 4.04 42.4 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.415 1.486 . . . . 0.0 110.254 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.24 -9.6 84.84 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.369 -1.457 . . . . 0.0 109.6 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.56 -70.59 1.16 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.542 1.544 . . . . 0.0 112.191 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -46.7 -47.56 20.41 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.707 1.603 . . . . 0.0 112.966 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.36 -45.06 94.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.379 1.071 . . . . 0.0 111.343 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.53 -46.66 83.58 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.3 m -65.61 -4.86 6.8 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.256 0.623 . . . . 0.0 112.289 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.87 13.32 83.54 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.837 1.684 . . . . 0.0 112.274 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.2 mt -73.87 -17.82 61.0 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.211 1.006 . . . . 0.0 111.67 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mt -95.22 136.41 35.59 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 121.136 -0.977 . . . . 0.0 111.167 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.98 170.42 16.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 123.954 0.784 . . . . 0.0 111.826 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -69.04 115.34 8.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.536 HD12 ' CD2' ' A' ' 106' ' ' TYR . 2.2 mm -72.14 158.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.23 0.538 . . . . 0.0 110.291 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.5 m 60.72 84.02 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.032 1.733 . . . . 0.0 109.786 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.06 -27.59 29.62 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.643 1.562 . . . . 0.0 111.158 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -136.34 144.87 44.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.153 1.381 . . . . 0.0 110.815 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -52.35 -37.96 57.5 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.484 1.914 . . . . 0.0 112.833 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.63 -37.63 68.44 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.375 0.989 . . . . 0.0 112.002 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -60.28 -25.72 65.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.427 0.691 . . . . 0.0 111.869 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -67.04 -48.16 69.18 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -19.5 61.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 125.413 1.485 . . . . 0.0 113.401 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.26 -15.21 62.88 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.497 -0.752 . . . . 0.0 110.888 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.9 mt -124.18 154.83 39.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.444 1.498 . . . . 0.0 108.519 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -67.59 152.52 96.19 Favored Pre-proline 0 CA--C 1.54 0.576 0 O-C-N 121.663 -0.648 . . . . 0.0 110.133 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.2 -36.27 7.45 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.109 2.539 . . . . 0.0 114.675 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -63.59 -43.18 97.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.437 0.562 . . . . 0.0 111.088 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -23.28 62.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.353 1.461 . . . . 0.0 111.667 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -70.45 -22.63 62.67 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.561 1.073 . . . . 0.0 110.621 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.61 -23.74 67.36 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.35 1.06 . . . . 0.0 111.189 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.36 -17.38 60.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.256 1.022 . . . . 0.0 113.424 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.67 14.94 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.46 168.78 4.28 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 122.723 1.249 . . . . 0.0 112.083 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -159.93 177.97 10.22 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 129.008 2.923 . . . . 0.0 105.168 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -64.12 99.01 0.24 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.492 1.117 . . . . 0.0 111.097 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.88 -84.88 0.47 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 124.588 1.09 . . . . 0.0 110.892 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 153.46 41.84 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.784 0.802 . . . . 0.0 109.968 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.6 mt -91.62 152.06 20.42 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.4 pt -111.77 -27.73 2.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.831 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.92 174.76 14.68 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.478 1.035 . . . . 0.0 108.771 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.536 ' CD2' HD12 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -125.7 150.5 68.62 Favored Pre-proline 0 C--O 1.239 0.517 0 C-N-CA 124.386 1.075 . . . . 0.0 110.209 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.83 141.68 41.45 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.266 2.644 . . . . 0.0 107.851 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.3 mm -126.44 -45.51 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.691 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.37 122.34 10.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -90.36 118.68 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -141.98 107.09 4.95 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.99 170.43 16.26 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.9 tp -43.21 134.14 3.77 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.212 1.805 . . . . 0.0 113.592 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.8 m -126.64 149.83 49.28 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.089 1.756 . . . . 0.0 109.374 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD23 HG23 ' A' ' 245' ' ' THR . 51.7 tp -76.83 149.19 36.21 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 54.7 mt -123.87 139.01 51.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 27.6 p90 -143.43 173.11 11.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.799 1.239 . . . . 0.0 110.576 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -59.29 166.1 2.38 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.938 1.295 . . . . 0.0 110.103 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -54.01 -26.74 27.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.093 1.357 . . . . 0.0 113.757 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -65.08 164.59 12.66 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.344 0.657 . . . . 0.0 110.16 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 pp -74.08 -8.46 56.22 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 121.548 -0.72 . . . . 0.0 111.993 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.4 tp 52.52 79.91 0.32 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.524 1.93 . . . . 0.0 109.961 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.42 2.78 5.34 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.487 2.792 . . . . 0.0 113.286 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -140.21 69.22 34.11 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 124.938 1.295 . . . . 0.0 111.059 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.12 159.68 37.06 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.449 2.099 . . . . 0.0 110.215 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.45 158.02 25.6 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.761 2.307 . . . . 0.0 110.868 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -118.13 -2.5 11.2 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.296 -0.877 . . . . 0.0 112.71 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -169.41 160.48 9.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.416 1.087 . . . . 0.0 108.443 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -67.88 -24.57 65.25 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.091 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -69.93 -13.92 62.47 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.228 0.922 . . . . 0.0 112.183 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -90.67 -21.67 21.54 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.337 1.055 . . . . 0.0 110.209 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.3 mm -55.76 -57.37 21.87 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-O 117.83 -1.081 . . . . 0.0 109.214 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.87 -20.4 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 120.983 1.387 . . . . 0.0 113.163 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.58 -40.45 66.6 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.249 1.02 . . . . 0.0 112.067 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 27.5 tp -94.85 -22.92 17.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.492 1.117 . . . . 0.0 112.077 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -61.28 -35.39 77.17 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.785 -1.197 . . . . 0.0 111.252 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -75.54 -33.94 60.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.885 1.274 . . . . 0.0 111.188 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -70.21 -45.5 66.47 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.43 -32.37 73.2 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.77 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -70.96 -28.95 64.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.597 0.635 . . . . 0.0 109.566 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.88 -26.6 63.32 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.404 0.547 . . . . 0.0 111.102 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.61 -1.21 16.94 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.122 0.969 . . . . 0.0 112.812 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.21 -98.72 0.12 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -142.18 178.74 7.34 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.623 1.169 . . . . 0.0 112.062 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.2 p -53.98 156.09 3.13 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.74 1.616 . . . . 0.0 113.088 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.74 -58.51 2.55 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.678 1.591 . . . . 0.0 109.959 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.51 142.69 47.35 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.484 0.714 . . . . 0.0 112.075 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 55.5 mtp -144.97 135.48 24.32 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 128.308 2.643 . . . . 0.0 105.749 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -156.19 168.63 26.69 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.069 1.748 . . . . 0.0 107.48 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.73 HD22 ' HB2' ' A' ' 210' ' ' TYR . 37.9 t-20 -75.93 126.26 30.66 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.9 mp -114.62 -8.14 12.72 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.607 0.639 . . . . 0.0 110.623 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -80.0 -10.28 59.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.307 2.243 . . . . 0.0 112.213 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -115.64 137.55 23.27 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 119.628 1.104 . . . . 0.0 108.206 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.59 -27.66 32.43 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.617 1.545 . . . . 0.0 112.14 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -65.95 -25.3 67.06 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 118.938 0.79 . . . . 0.0 112.015 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -85.58 -9.88 56.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.431 1.014 . . . . 0.0 112.286 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 13.1 p -112.58 -19.86 11.93 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.024 0.929 . . . . 0.0 110.343 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -54.84 41.31 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.01 -24.72 59.19 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.17 1.913 . . . . 0.0 113.515 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.7 tt -69.17 -65.38 0.72 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 37.0 pt -58.66 -28.94 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.981 0.913 . . . . 0.0 113.179 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.78 -22.15 63.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.752 0.821 . . . . 0.0 112.62 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -49.18 -57.12 7.25 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.904 2.081 . . . . 0.0 114.863 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -67.1 -49.2 65.79 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.293 0.371 . . . . 0.0 111.785 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.55 49.19 0.05 OUTLIER Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.517 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -116.76 133.27 10.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -147.51 143.7 28.02 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.91 -68.14 0.46 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -139.01 151.09 46.54 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.557 0.743 . . . . 0.0 111.474 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -74.51 128.77 36.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -151.46 104.46 3.07 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -155.87 155.03 32.2 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 55.03 20.87 3.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.328 1.451 . . . . 0.0 114.429 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.4 6.51 83.76 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 119.416 1.007 . . . . 0.0 113.082 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.65 117.65 32.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 125.703 1.601 . . . . 0.0 107.641 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -116.85 119.17 34.56 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.749 2.02 . . . . 0.0 106.14 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -135.72 110.61 8.77 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.519 0.728 . . . . 0.0 109.059 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.44 0.39 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.215 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -76.98 -19.61 57.1 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.971 -1.081 . . . . 0.0 110.712 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -102.83 96.49 6.87 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.628 1.971 . . . . 0.0 106.52 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 70.8 t -125.68 147.24 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.83 1.252 . . . . 0.0 110.612 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -127.99 22.26 5.43 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 118.333 -1.26 . . . . 0.0 115.574 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.26 -40.33 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.807 2.303 . . . . 0.0 111.907 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -90.47 19.5 5.22 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.496 0.718 . . . . 0.0 112.786 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -70.61 155.23 41.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 120.384 -1.447 . . . . 0.0 110.487 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.51 92.0 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.398 0.679 . . . . 0.0 109.482 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.58 95.78 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.56 -50.82 56.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 117.324 0.562 . . . . 0.0 110.197 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -63.1 -36.21 82.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.583 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.31 74.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.91 0.884 . . . . 0.0 112.187 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -84.85 -24.47 45.28 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 118.612 0.642 . . . . 0.0 112.229 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 52.3 tp -76.39 -49.55 16.47 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.181 0.993 . . . . 0.0 112.401 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.4 -31.99 56.21 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 118.606 0.639 . . . . 0.0 110.433 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -56.57 -44.08 80.65 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.555 1.542 . . . . 0.0 109.891 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -40.74 94.63 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.238 -0.914 . . . . 0.0 110.548 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 22.2 t -64.14 -38.55 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 C-N-CA 125.028 1.331 . . . . 0.0 109.347 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -59.92 -46.95 87.75 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.328 1.451 . . . . 0.0 110.792 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.3 mt -65.9 -37.8 87.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.03 0.832 . . . . 0.0 109.85 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 59.7 mt -67.46 -37.73 79.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -61.47 -41.72 97.68 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.25 -14.76 62.34 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.673 1.189 . . . . 0.0 111.715 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt 60.99 4.44 0.81 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.433 2.693 . . . . 0.0 112.77 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.79 -12.91 60.27 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.312 -0.243 . . . . 0.0 110.862 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 4.2 tpt -88.97 154.78 19.94 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.56 -0.712 . . . . 0.0 110.646 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -82.84 64.3 7.39 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.14 -14.49 4.07 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.59 -15.07 27.35 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.989 1.316 . . . . 0.0 112.761 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 57.4 m -66.71 137.59 56.79 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.094 0.958 . . . . 0.0 111.929 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -131.13 -176.73 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.49 1.916 . . . . 0.0 107.603 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.73 ' HB2' HD22 ' A' ' 150' ' ' ASN . 54.1 t80 -57.53 -45.56 84.9 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.31 -0.244 . . . . 0.0 111.294 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.68 -47.65 76.42 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.189 1.796 . . . . 0.0 111.029 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.89 -48.08 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.844 1.257 . . . . 0.0 110.57 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.16 83.28 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.814 0.734 . . . . 0.0 110.674 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.93 -52.1 40.08 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.27 -49.07 77.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.894 0.478 . . . . 0.0 111.612 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.62 -44.22 89.9 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -61.29 -40.66 94.96 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -58.97 -16.11 16.37 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.623 1.169 . . . . 0.0 113.513 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.0 -13.39 14.1 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.684 1.194 . . . . 0.0 111.387 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.49 18.82 58.07 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.832 1.206 . . . . 0.0 111.098 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -66.97 -12.23 59.14 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.818 1.247 . . . . 0.0 111.606 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 43.6 p -113.36 141.84 46.58 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.646 1.978 . . . . 0.0 109.681 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -82.57 -34.79 27.63 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.42 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 4.2 ptt? -146.3 164.24 32.99 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.784 2.034 . . . . 0.0 111.304 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.5 t -164.79 169.62 16.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.082 1.353 . . . . 0.0 107.687 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mt -133.96 114.21 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -139.73 145.86 38.83 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.392 2.277 . . . . 0.0 105.215 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -68.86 165.37 48.44 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.787 0.708 . . . . 0.0 112.785 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.93 108.42 2.44 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.42 2.747 . . . . 0.0 109.152 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 86.4 m95 42.33 57.07 3.49 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.973 2.509 . . . . 0.0 113.845 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.0 -157.87 0.47 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -55.5 92.82 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.63 1.572 . . . . 0.0 111.48 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 19.3 m -108.78 91.2 3.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.436 1.494 . . . . 0.0 106.99 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -61.88 -9.87 7.9 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.879 0.872 . . . . 0.0 112.725 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 17.2 tt -150.21 128.59 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -78.88 132.52 36.82 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.0 p -121.67 125.59 47.01 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.173 0.511 . . . . 0.0 109.92 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.8 p -71.4 75.77 0.76 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.201 1.8 . . . . 0.0 108.353 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -71.64 -40.58 69.62 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.448 1.099 . . . . 0.0 109.798 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 3.0 t 48.78 31.9 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 125.871 1.668 . . . . 0.0 111.502 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -151.09 140.52 21.47 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.808 1.643 . . . . 0.0 109.037 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -163.92 144.99 8.73 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 127.795 2.438 . . . . 0.0 105.873 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -176.63 178.03 47.97 Favored Glycine 0 C--O 1.241 0.574 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.705 HG11 ' HG3' ' A' ' 316' ' ' ARG . 4.7 p -117.52 111.99 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.166 1.387 . . . . 0.0 108.228 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.494 HG23 HD23 ' A' ' 115' ' ' LEU . 14.1 t -133.18 165.24 25.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.4 108.02 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 124.903 1.281 . . . . 0.0 110.223 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -86.08 151.09 53.86 Favored Pre-proline 0 C--O 1.239 0.501 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -71.36 134.46 24.72 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.927 1.751 . . . . 0.0 108.805 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.6 p -147.26 -172.49 4.02 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.466 1.506 . . . . 0.0 107.574 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.68 137.02 32.8 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -51.37 128.97 23.97 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.426 -0.796 . . . . 0.0 109.936 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.43 -10.5 6.35 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.863 1.105 . . . . 0.0 115.863 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.65 92.37 14.97 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 120.113 1.957 . . . . 0.0 107.943 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.55 161.96 43.75 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.489 2.126 . . . . 0.0 112.293 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 40.8 t -66.54 150.32 49.16 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.913 1.285 . . . . 0.0 108.763 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -139.22 89.19 12.51 Favored Pre-proline 0 N--CA 1.456 -0.171 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -80.94 -174.58 2.29 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.545 2.83 . . . . 0.0 110.476 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -63.47 -178.86 0.3 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.121 1.369 . . . . 0.0 109.49 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.98 85.75 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 O-C-N 121.068 -1.02 . . . . 0.0 108.43 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -76.56 136.77 19.85 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.85 128.6 50.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.682 0.793 . . . . 0.0 110.409 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.5 tt -62.96 138.23 58.5 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.982 1.313 . . . . 0.0 107.646 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.6 m -118.76 144.23 46.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.826 0.822 . . . . 0.0 110.836 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -138.86 136.9 36.06 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -149.66 145.36 13.46 Favored Glycine 0 C--O 1.236 0.232 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 34.5 mt -69.32 134.52 30.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.229 1.012 . . . . 0.0 108.991 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -90.38 113.61 25.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.16 -14.41 37.13 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.958 1.303 . . . . 0.0 112.934 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.71 78.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.366 0.985 . . . . 0.0 111.88 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 48.7 m -62.13 164.86 9.66 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 123.101 0.25 . . . . 0.0 110.654 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -89.43 -26.17 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.797 2.331 . . . . 0.0 117.06 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -127.68 90.03 3.04 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.664 1.12 . . . . 0.0 110.537 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -62.99 -14.99 54.61 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.656 0.382 . . . . 0.0 111.907 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -66.03 -41.35 91.06 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 75.3 mt -57.0 -37.51 71.78 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.375 -0.828 . . . . 0.0 110.148 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.92 -48.04 60.09 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 122.041 -0.412 . . . . 0.0 110.789 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -31.44 71.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.981 -0.533 . . . . 0.0 111.152 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -75.86 -42.51 49.19 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.95 -46.04 90.69 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.952 1.251 . . . . 0.0 108.855 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.9 mp -63.65 -48.1 78.59 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 117.509 -1.234 . . . . 0.0 110.973 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -79.9 -20.55 45.56 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -97.79 -20.18 17.7 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.949 1.704 . . . . 0.0 113.019 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -138.6 -33.55 0.66 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-O 117.503 -1.237 . . . . 0.0 114.198 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.4 -57.1 4.09 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 121.167 1.803 . . . . 0.0 111.797 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.46 23.54 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 128.1 2.56 . . . . 0.0 114.137 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 77.2 p -98.65 160.99 13.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -65.08 -30.67 71.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -71.0 -47.43 58.87 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.353 1.061 . . . . 0.0 111.202 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -63.43 -47.34 88.3 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.12 -41.03 97.84 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.299 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -64.17 -43.27 95.64 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.434 0.561 . . . . 0.0 109.539 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.67 -43.5 85.07 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.587 0.631 . . . . 0.0 112.385 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 41.4 t -71.05 -38.45 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.718 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -68.54 -26.75 65.58 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.449 0.568 . . . . 0.0 111.797 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -66.43 -50.97 61.6 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.76 -52.12 65.54 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 119.085 -0.483 . . . . 0.0 112.23 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -140.6 147.42 48.99 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-N 119.04 0.836 . . . . 0.0 109.419 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.93 123.26 11.36 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.33 2.02 . . . . 0.0 111.06 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 28.5 mt -94.52 -6.91 42.69 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.728 1.211 . . . . 0.0 112.519 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 63.12 -141.92 46.91 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 107.018 -2.433 . . . . 0.0 107.018 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.1 176.45 9.66 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.95 157.11 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 120.683 -1.26 . . . . 0.0 112.941 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -82.4 -25.3 33.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.34 111.2 7.33 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -56.8 -33.56 66.81 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.8 m -54.67 -57.26 12.19 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.842 1.257 . . . . 0.0 110.35 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -81.03 -13.04 59.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.684 0.794 . . . . 0.0 112.414 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -63.73 -33.13 74.96 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -69.52 -17.33 63.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.379 0.672 . . . . 0.0 111.284 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.503 ' HA ' ' HE2' ' A' ' 313' ' ' LYS . 45.1 mm-40 -93.73 -46.15 7.36 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.471 1.508 . . . . 0.0 109.415 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 7.1 mt -69.15 -34.37 74.89 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.264 -0.897 . . . . 0.0 110.463 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.05 -15.97 48.59 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.503 ' HE2' ' HA ' ' A' ' 310' ' ' GLU . 54.2 mttm -54.3 -34.64 61.35 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 118.912 0.778 . . . . 0.0 110.699 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -93.22 136.01 24.95 Favored Pre-proline 0 N--CA 1.448 -0.549 0 C-N-CA 123.983 0.913 . . . . 0.0 110.35 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.98 -23.03 75.38 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.372 2.048 . . . . 0.0 114.472 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.705 ' HG3' HG11 ' A' ' 244' ' ' VAL . 0.2 OUTLIER -57.72 -47.9 81.09 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 119.24 0.927 . . . . 0.0 109.752 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.2 mp -67.82 -59.2 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.079 1.352 . . . . 0.0 109.526 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.94 -46.52 64.76 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.61 -37.82 76.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 119.39 0.995 . . . . 0.0 112.597 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 88.6 m -68.68 -37.1 79.32 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.038 0.935 . . . . 0.0 108.97 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.6 tpt -66.04 -48.13 72.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.273 1.029 . . . . 0.0 109.883 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -58.82 -37.59 76.73 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.993 0.815 . . . . 0.0 110.412 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -69.39 -37.28 77.46 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.59 -34.12 73.75 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.959 0.799 . . . . 0.0 110.829 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -72.68 -28.57 62.78 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.76 -19.29 16.8 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.647 -0.658 . . . . 0.0 112.536 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -83.54 177.3 52.62 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -105.38 127.19 52.84 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.621 1.568 . . . . 0.0 111.952 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 45.9 mt -94.45 132.38 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 8.6 tpt 5.18 86.56 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 129.102 2.961 . . . . 0.0 112.068 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.76 87.66 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.36 2.707 . . . . 0.0 113.24 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -81.53 73.79 8.55 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 6.1 pt -132.15 157.77 77.34 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 126.177 1.791 . . . . 0.0 109.935 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -71.15 -33.82 11.03 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.952 1.768 . . . . 0.0 111.76 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.77 -19.64 29.51 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 6.2 mmt -64.62 -29.73 70.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.656 0.662 . . . . 0.0 109.644 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 20.1 m -56.38 -53.49 56.75 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.001 0.92 . . . . 0.0 110.544 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.41 -39.75 64.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.644 -1.169 . . . . 0.0 110.549 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -48.39 -55.87 9.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.433 1.015 . . . . 0.0 112.147 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -60.31 -53.04 62.37 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.946 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -60.23 -42.65 95.67 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 118.705 0.684 . . . . 0.0 112.766 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -58.84 -56.68 19.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.132 1.373 . . . . 0.0 110.254 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 33.6 t -65.96 -38.78 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 118.47 -0.776 . . . . 0.0 110.023 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -54.11 -45.77 71.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.685 1.13 . . . . 0.0 108.18 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 28.0 m -70.13 -46.35 64.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.584 -0.722 . . . . 0.0 110.253 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -51.21 -45.04 61.75 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.189 0.904 . . . . 0.0 112.661 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.08 -57.96 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 125.126 1.37 . . . . 0.0 108.457 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 48.0 mm -60.57 -38.46 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.264 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -60.03 -48.14 82.96 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.669 1.122 . . . . 0.0 109.288 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.93 -49.14 60.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.858 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.51 -23.67 66.08 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.934 1.294 . . . . 0.0 113.319 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.3 m -94.79 -2.66 50.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.397 0.679 . . . . 0.0 109.945 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.41 12.63 69.86 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.753 0.706 . . . . 0.0 111.534 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -69.93 -36.04 75.01 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.02 0.928 . . . . 0.0 109.827 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -142.18 164.83 29.09 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 359' ' ' GLU . 15.4 t -81.37 159.96 24.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.07 -52.63 42.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 124.917 1.287 . . . . 0.0 109.843 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.47 -47.81 69.43 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 127.115 2.166 . . . . 0.0 111.42 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.48 ' H ' HG23 ' A' ' 356' ' ' THR . 47.6 mm-40 -75.46 -33.26 60.85 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.733 0.697 . . . . 0.0 111.174 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.56 85.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.1 mp -68.35 -45.91 71.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.571 1.949 . . . . 0.0 110.445 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -55.52 -58.09 9.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.24 1.016 . . . . 0.0 108.536 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -53.3 -42.25 66.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.166 2.187 . . . . 0.0 112.084 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -68.66 -49.82 56.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.878 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -58.68 -32.25 68.95 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.21 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 6.6 m -63.38 -36.48 83.85 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.93 1.241 . . . . 0.0 110.62 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 12.2 mtt85 -65.84 -30.84 71.53 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.95 -1.094 . . . . 0.0 110.908 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 36.5 mt -82.58 -37.98 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.633 1.573 . . . . 0.0 111.15 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 65.9 p -78.29 -12.09 59.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.763 1.165 . . . . 0.0 112.921 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? . . . . . 0 C--O 1.254 1.294 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.025 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 29.9 tttm . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.5 mt -117.29 159.7 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -91.29 112.74 24.77 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -81.18 -176.08 5.78 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.808 2.043 . . . . 0.0 109.342 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.33 29.48 73.29 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.129 -0.982 . . . . 0.0 114.759 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.99 162.12 37.69 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.252 1.021 . . . . 0.0 111.285 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.6 mt -152.53 147.4 26.16 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 130.095 3.358 . . . . 0.0 106.59 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.408 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 94.5 t -144.95 146.46 19.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.123 1.369 . . . . 0.0 108.639 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.462 HD12 HG22 ' A' ' 37' ' ' VAL . 20.5 mt -134.79 139.4 47.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -126.73 124.49 39.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 12' ' ' ASN . 1.5 mp -131.9 171.63 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.165 1.386 . . . . 0.0 108.327 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.441 ' H ' HG22 ' A' ' 11' ' ' ILE . 14.8 p-10 -103.94 157.28 17.21 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.403 1.481 . . . . 0.0 109.345 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.46 -22.15 60.98 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 125.608 1.575 . . . . 0.0 114.4 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -77.39 -3.11 38.52 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.522 1.661 . . . . 0.0 109.91 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.14 160.86 15.74 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 120.883 -1.136 . . . . 0.0 110.566 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.81 75.55 2.36 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.771 1.177 . . . . 0.0 110.238 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -74.38 -24.6 59.16 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -73.33 -43.1 61.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.744 1.611 . . . . 0.0 110.535 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.75 -30.66 73.18 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.3 tp -74.91 -40.69 60.73 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.804 1.242 . . . . 0.0 110.958 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.14 -46.97 54.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.115 0.566 . . . . 0.0 109.967 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -55.66 -32.85 63.58 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.8 t -64.89 -41.14 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.07 -38.47 73.57 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.021 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -59.36 -43.79 92.77 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.473 1.137 . . . . 0.0 108.325 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -60.22 -55.1 37.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.328 0.651 . . . . 0.0 109.803 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -58.4 -51.84 68.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.749 0.655 . . . . 0.0 111.989 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.43 -31.06 70.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.943 0.897 . . . . 0.0 110.74 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' CE ' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -68.41 -31.77 71.35 Favored 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 120.752 -1.218 . . . . 0.0 110.198 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.29 -47.12 9.69 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 123.629 0.581 . . . . 0.0 111.961 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -90.05 -32.3 16.79 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 -176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.52 -10.77 72.22 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 120.97 -1.081 . . . . 0.0 111.658 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.29 136.52 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HE2' ' N ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -66.63 134.7 52.83 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 117.785 -1.102 . . . . 0.0 109.359 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -134.31 78.46 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.66 155.55 29.44 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.462 HG22 HD12 ' A' ' 9' ' ' ILE . 94.4 t -141.54 127.91 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -136.53 161.43 35.89 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -123.34 68.13 37.98 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.106 0.963 . . . . 0.0 111.004 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -66.35 170.72 11.61 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.545 2.164 . . . . 0.0 111.114 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -122.97 -3.12 8.63 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.223 -0.923 . . . . 0.0 111.905 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -132.21 12.1 4.62 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.361 1.865 . . . . 0.0 112.785 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.94 -32.48 20.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.073 0.851 . . . . 0.0 112.315 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -52.54 -30.19 29.36 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.51 1.124 . . . . 0.0 112.259 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -116.9 -18.79 10.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.856 0.862 . . . . 0.0 112.206 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -41.38 31.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -51.41 -59.86 6.99 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.762 0.825 . . . . 0.0 109.834 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.47 -17.48 59.74 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 CA-C-N 121.245 1.48 . . . . 0.0 113.617 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -84.08 -5.48 59.24 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.667 1.121 . . . . 0.0 112.391 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.63 -38.85 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.031 0.932 . . . . 0.0 108.805 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.93 -32.54 70.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.213 1.005 . . . . 0.0 111.344 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.98 -31.61 68.91 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.741 0.7 . . . . 0.0 110.562 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.8 m -86.39 -15.97 38.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.598 1.159 . . . . 0.0 110.202 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.79 36.57 5.51 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.198 1.38 . . . . 0.0 110.381 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -132.16 173.71 10.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.691 1.196 . . . . 0.0 108.618 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.13 -160.21 14.77 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 126.497 1.998 . . . . 0.0 113.554 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.27 175.83 2.4 Favored 'Trans proline' 0 C--N 1.356 0.964 1 C-N-CA 125.861 4.374 . . . . 0.0 114.113 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 3.9 m-20 -106.96 -18.59 13.87 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.8 -1.187 . . . . 0.0 113.999 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.4 mt -148.22 135.15 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.33 1.052 . . . . 0.0 109.006 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.2 tt -115.19 142.06 29.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -129.95 107.57 9.46 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.45 1.5 . . . . 0.0 108.16 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.8 t-105 -156.13 -176.67 6.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.966 0.803 . . . . 0.0 111.553 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.35 138.14 51.16 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -46.37 -43.44 16.17 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 126.157 1.783 . . . . 0.0 113.619 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -55.53 -27.76 50.73 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -81.47 -18.66 44.44 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.764 0.711 . . . . 0.0 111.567 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -76.32 -13.51 60.14 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 118.465 -0.779 . . . . 0.0 112.833 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.13 -11.69 33.69 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.284 0.945 . . . . 0.0 113.544 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.95 -63.03 0.92 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -47.53 -56.37 7.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.043 1.737 . . . . 0.0 114.331 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.27 91.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.21 0.604 . . . . 0.0 111.758 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.31 -43.91 75.29 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.068 1.347 . . . . 0.0 109.717 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.5 m -74.87 -1.25 21.49 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.486 1.115 . . . . 0.0 113.347 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.77 18.15 64.22 Favored Glycine 0 C--N 1.337 0.626 0 O-C-N 120.805 -1.184 . . . . 0.0 113.602 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.6 mt -77.65 -32.91 53.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.687 1.244 . . . . 0.0 112.359 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.2 mt -91.45 142.1 28.03 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.476 -0.765 . . . . 0.0 111.706 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -78.88 172.24 14.05 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.857 1.263 . . . . 0.0 113.167 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -69.93 100.13 1.52 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.585 1.954 . . . . 0.0 108.911 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.514 HD12 ' CD2' ' A' ' 106' ' ' TYR . 9.9 mm -63.33 153.75 6.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.912 0.863 . . . . 0.0 110.107 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.9 m 60.86 77.44 0.37 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 127.376 2.27 . . . . 0.0 109.725 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 -26.17 21.53 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.274 1.316 . . . . 0.0 110.252 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -129.94 138.09 50.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.523 1.529 . . . . 0.0 110.754 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -57.49 -37.0 72.22 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.74 -24.42 56.9 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.308 1.413 . . . . 0.0 112.953 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.8 -28.23 68.85 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.693 0.679 . . . . 0.0 110.648 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -66.01 -43.96 86.17 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -64.95 -11.84 43.0 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.45 0.7 . . . . 0.0 111.894 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -87.19 -15.89 36.97 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 120.767 -1.208 . . . . 0.0 112.578 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.489 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 25.2 mt -124.17 163.12 22.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.475 1.034 . . . . 0.0 112.625 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -81.23 153.33 71.68 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 123.71 0.804 . . . . 0.0 112.03 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.05 -47.78 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 124.378 3.385 . . . . 0.0 114.216 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -54.05 -36.74 63.4 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.078 1.308 . . . . 0.0 111.937 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.435 HG22 ' CB ' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -73.5 -27.68 61.51 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.726 1.61 . . . . 0.0 110.634 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.489 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 12.9 m95 -69.5 -36.79 76.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.631 1.105 . . . . 0.0 109.999 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -63.2 -27.43 69.36 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.632 -0.667 . . . . 0.0 111.063 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.76 -4.16 22.43 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.291 1.437 . . . . 0.0 113.979 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.34 6.91 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 125.4 1.48 . . . . 0.0 111.206 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -71.6 170.67 12.92 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -149.14 -152.14 0.43 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -57.48 -11.76 2.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.536 1.934 . . . . 0.0 115.708 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.38 -85.14 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 105.563 -3.015 . . . . 0.0 105.563 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 162.08 16.98 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.425 0.69 . . . . 0.0 110.706 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.11 158.46 18.56 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.245 1.018 . . . . 0.0 109.614 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.0 pt -117.62 -24.5 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.651 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.418 ' CA ' HG13 ' A' ' 79' ' ' ILE . . . -156.81 -178.46 7.38 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.811 1.244 . . . . 0.0 110.051 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.514 ' CD2' HD12 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -136.82 149.52 67.1 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 123.895 0.878 . . . . 0.0 111.355 178.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.435 ' CB ' HG22 ' A' ' 93' ' ' THR . 96.3 Cg_endo -75.01 142.62 28.05 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.843 2.362 . . . . 0.0 109.891 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.3 mm -124.56 -52.76 2.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.698 1.599 . . . . 0.0 108.173 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.34 148.81 43.27 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.827 1.251 . . . . 0.0 109.824 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.5 t -130.51 95.67 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.095 0.958 . . . . 0.0 109.254 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -94.71 164.46 12.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.491 1.117 . . . . 0.0 109.277 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.43 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -159.19 172.59 17.79 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.745 2.418 . . . . 0.0 106.721 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.3 mt -124.21 -170.22 2.1 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.695 1.198 . . . . 0.0 110.022 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.51 140.42 44.76 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.063 0.945 . . . . 0.0 109.847 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.7 168.82 7.13 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.074 0.949 . . . . 0.0 111.611 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.442 ' HB ' HG23 ' A' ' 225' ' ' THR . 5.3 mp -93.47 138.98 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.233 1.013 . . . . 0.0 109.202 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -155.79 155.53 33.18 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.96 0.904 . . . . 0.0 109.086 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -47.42 124.27 6.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.598 1.959 . . . . 0.0 109.061 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -65.89 9.69 0.13 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.096 1.358 . . . . 0.0 114.318 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.93 158.62 27.59 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 120.805 -1.185 . . . . 0.0 110.461 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 121' ' ' LEU . 1.2 pt? -82.57 21.66 0.95 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.551 1.14 . . . . 0.0 110.695 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.8 tt -119.49 78.18 20.17 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.395 1.478 . . . . 0.0 108.99 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -74.93 115.27 4.24 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.599 2.199 . . . . 0.0 109.989 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -146.45 85.94 7.09 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.38 163.54 29.83 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.371 2.714 . . . . 0.0 114.571 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -77.32 124.06 6.94 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.129 3.219 . . . . 0.0 108.721 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -80.72 -25.55 38.01 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.045 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.6 t -154.67 162.69 41.02 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.413 1.006 . . . . 0.0 109.689 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -65.75 -25.79 67.44 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 123.864 0.866 . . . . 0.0 111.786 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -71.56 -19.27 62.17 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.923 1.238 . . . . 0.0 109.79 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -89.37 -22.88 22.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.368 1.067 . . . . 0.0 111.125 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 15.8 mm -54.73 -59.33 10.81 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.195 -0.907 . . . . 0.0 108.796 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -69.87 -25.02 28.5 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.222 1.281 . . . . 0.0 111.47 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.16 -50.36 70.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 64.0 tp -70.13 -31.74 69.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -59.09 -44.76 91.95 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 118.684 0.674 . . . . 0.0 111.305 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -30.12 61.37 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.551 0.614 . . . . 0.0 110.832 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -66.27 -50.89 62.17 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.1 mt -67.48 -33.01 74.24 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.562 -1.208 . . . . 0.0 110.287 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -68.87 -34.62 75.74 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.931 1.241 . . . . 0.0 108.971 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.38 -16.36 62.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.378 0.536 . . . . 0.0 112.018 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.24 7.5 6.5 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.173 1.389 . . . . 0.0 112.121 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 170.92 -94.52 0.1 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 115.737 1.055 . . . . 0.0 115.737 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.74 -178.88 5.44 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.38 1.072 . . . . 0.0 113.58 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.64 169.08 9.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.803 1.287 . . . . 0.0 112.612 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -93.26 -73.12 0.57 Allowed 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.066 1.746 . . . . 0.0 109.292 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.9 tp -103.42 130.4 50.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.261 1.024 . . . . 0.0 112.749 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 76.7 mtp -131.37 117.3 18.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -143.22 156.31 44.72 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.69 88.22 0.35 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.746 1.618 . . . . 0.0 109.577 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -18.04 63.38 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.067 1.347 . . . . 0.0 109.812 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -71.41 -13.14 61.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.536 0.734 . . . . 0.0 112.644 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -103.76 129.3 25.57 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 119.19 0.905 . . . . 0.0 109.739 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.92 -10.41 23.03 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.786 2.324 . . . . 0.0 113.248 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -65.44 -42.09 92.75 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.796 1.638 . . . . 0.0 112.758 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -79.52 -32.67 42.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.6 p -84.33 -11.68 55.93 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.274 0.63 . . . . 0.0 111.77 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -53.75 -58.86 11.33 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 117.625 -1.178 . . . . 0.0 112.044 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.53 -18.01 58.53 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.281 1.493 . . . . 0.0 114.055 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.0 tp -71.35 -63.77 1.05 Allowed 'General case' 0 C--N 1.34 0.193 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.4 pt -66.41 -36.03 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.26 -12.97 59.54 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.121 -0.943 . . . . 0.0 113.095 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -44.63 -55.95 4.78 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 125.513 1.525 . . . . 0.0 114.06 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.78 -34.68 74.86 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.53 19.73 0.02 OUTLIER Glycine 0 C--N 1.332 0.335 0 CA-C-O 118.294 -1.281 . . . . 0.0 116.068 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.13 144.1 34.21 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 119.402 1.601 . . . . 0.0 111.548 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.427 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 51.7 p90 -153.86 144.99 22.85 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.46 -49.56 12.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.499 ' CD2' HD11 ' A' ' 333' ' ' ILE . 65.7 m-85 -145.9 133.67 21.16 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.646 0.778 . . . . 0.0 109.658 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.427 ' HE2' ' CE1' ' A' ' 167' ' ' TYR . 14.5 tppt? -70.65 149.53 46.92 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.522 0.729 . . . . 0.0 110.037 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -143.32 113.06 7.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -156.07 170.03 23.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 55.96 26.96 10.49 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.603 1.161 . . . . 0.0 111.495 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 56.17 43.79 88.88 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -149.5 166.54 28.85 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 126.69 1.996 . . . . 0.0 108.198 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.19 127.65 54.96 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -126.7 87.78 2.72 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 123.117 1.437 . . . . 0.0 112.184 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.439 ' H ' HD13 ' A' ' 178' ' ' ILE . 0.2 OUTLIER -63.61 -8.92 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.403 178.46 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -74.54 -12.34 60.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.373 1.069 . . . . 0.0 108.987 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.412 ' OD2' ' HE3' ' A' ' 170' ' ' LYS . 61.7 t0 -118.94 93.57 4.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.244 1.417 . . . . 0.0 108.349 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 86.8 t -99.03 147.2 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -129.89 44.77 1.19 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-O 119.185 -0.786 . . . . 0.0 111.947 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.3 t -86.76 -63.42 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 124.958 1.303 . . . . 0.0 108.725 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -85.9 67.63 10.08 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 122.538 1.161 . . . . 0.0 110.029 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -121.48 159.34 26.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.93 -38.89 70.89 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -56.46 -46.66 87.24 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.702 0.683 . . . . 0.0 113.503 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.43 -52.6 60.84 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.891 0.476 . . . . 0.0 111.349 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -64.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 118.318 -0.849 . . . . 0.0 111.879 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.31 -51.91 39.44 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.73 -38.99 94.68 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.488 HD23 HG13 ' A' ' 357' ' ' VAL . 56.1 tp -70.61 -45.2 65.71 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 118.291 -0.862 . . . . 0.0 111.324 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.12 -37.92 67.51 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 117.313 -1.327 . . . . 0.0 110.736 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -52.17 -48.71 64.83 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.784 1.629 . . . . 0.0 111.344 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.7 tt -69.22 -48.01 63.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.114 0.566 . . . . 0.0 110.645 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.66 -35.15 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 121.38 -0.825 . . . . 0.0 111.41 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.01 -29.6 69.47 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.204 -0.935 . . . . 0.0 109.279 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.94 -42.3 60.74 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 65.8 mt -58.38 -47.9 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -52.18 -51.29 58.98 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.181 1.392 . . . . 0.0 109.73 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -78.47 0.9 24.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.158 0.983 . . . . 0.0 112.087 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt 60.78 12.06 3.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 128.109 2.564 . . . . 0.0 113.812 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.79 6.35 1.2 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 127.272 2.229 . . . . 0.0 111.806 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 14.3 ttt -147.49 143.8 28.11 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.108 1.322 . . . . 0.0 109.649 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -83.36 70.28 10.14 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -47.81 -40.31 20.75 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.492 2.717 . . . . 0.0 116.388 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -72.02 0.23 9.95 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.044 1.738 . . . . 0.0 114.113 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.8 m -65.37 123.18 18.93 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.008 -1.058 . . . . 0.0 110.512 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.1 -172.65 2.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.073 1.749 . . . . 0.0 108.241 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -60.2 -50.57 73.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.649 0.38 . . . . 0.0 110.91 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.1 m -60.89 -41.07 95.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.537 0.735 . . . . 0.0 111.132 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 41.4 mm -65.59 -49.33 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.879 -1.058 . . . . 0.0 108.556 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.16 -46.15 90.27 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.235 1.014 . . . . 0.0 111.707 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -62.78 -48.08 80.68 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.91 1.284 . . . . 0.0 108.888 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.53 87.81 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.94 99.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -62.22 -39.08 91.61 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -57.32 -20.2 27.06 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.558 1.543 . . . . 0.0 111.774 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.38 -13.14 12.9 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.889 -1.132 . . . . 0.0 112.095 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.44 28.31 40.26 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.213 1.387 . . . . 0.0 110.47 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.83 7.18 4.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.585 1.954 . . . . 0.0 113.372 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.06 160.49 43.28 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 120.683 -1.261 . . . . 0.0 108.905 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -106.34 -15.14 14.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.536 1.534 . . . . 0.0 113.606 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -159.88 153.46 22.57 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.889 1.276 . . . . 0.0 109.976 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.442 HG23 ' HB ' ' A' ' 116' ' ' ILE . 4.3 t -150.02 161.1 43.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.4 mt -132.23 106.94 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -156.7 -175.01 5.2 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.954 1.702 . . . . 0.0 107.451 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -75.85 172.21 54.17 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 123.689 0.661 . . . . 0.0 113.846 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -67.19 179.79 2.2 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 125.123 3.882 . . . . 0.0 112.553 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.443 ' CE3' ' HE3' ' A' ' 239' ' ' LYS . 26.3 t90 63.51 23.59 13.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.355 1.862 . . . . 0.0 113.358 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.39 160.63 30.06 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.495 -1.378 . . . . 0.0 108.597 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -65.47 -15.08 62.28 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.664 1.221 . . . . 0.0 110.365 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 4.1 m -61.71 -24.57 66.87 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.014 1.325 . . . . 0.0 110.847 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 41.8 p30 -125.47 175.12 7.73 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.742 1.617 . . . . 0.0 109.183 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.9 mm -110.1 -19.45 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -71.55 152.62 42.81 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 120.746 -1.221 . . . . 0.0 108.993 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 66.6 p -120.53 87.58 2.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.842 0.857 . . . . 0.0 109.444 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 93.8 p -126.57 156.87 40.17 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 120.689 -1.257 . . . . 0.0 110.527 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LYS . . . . . 0.443 ' HE3' ' CE3' ' A' ' 230' ' ' TRP . 8.1 mptt -134.94 134.2 40.34 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.5 p -176.16 167.77 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 128.823 2.849 . . . . 0.0 104.852 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -140.43 28.83 2.0 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.752 0.705 . . . . 0.0 112.615 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -145.51 150.34 36.28 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.999 1.272 . . . . 0.0 111.383 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 73.76 131.77 0.2 Allowed Glycine 0 C--N 1.337 0.618 0 C-N-CA 126.285 1.898 . . . . 0.0 114.746 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.13 -175.48 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.969 1.308 . . . . 0.0 109.276 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.5 t -98.82 -175.22 2.99 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 125.794 1.638 . . . . 0.0 107.942 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 14.5 p -50.8 149.45 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.097 1.359 . . . . 0.0 109.057 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.77 155.97 52.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 124.387 1.075 . . . . 0.0 110.487 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.59 159.43 53.61 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.572 1.515 . . . . 0.0 109.622 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 255' ' ' SER . 68.1 p -120.68 -176.4 3.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.369 1.068 . . . . 0.0 109.987 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -100.16 169.35 9.21 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.568 1.076 . . . . 0.0 109.762 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -66.86 126.31 28.66 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.24 3.41 57.02 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 117.848 -1.529 . . . . 0.0 115.327 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -156.32 137.19 9.2 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 121.706 2.753 . . . . 0.0 114.347 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.42 146.7 40.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.881 2.387 . . . . 0.0 108.568 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.516 ' H ' HG22 ' A' ' 249' ' ' THR . 10.4 p -72.62 173.46 8.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . 0.344 12.8 ptmt -133.32 71.87 75.99 Favored Pre-proline 0 C--O 1.238 0.495 0 O-C-N 120.857 -1.152 . . . . 0.0 112.843 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.88 166.18 30.31 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.704 3.603 . . . . 0.0 113.291 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -85.88 161.78 18.91 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.005 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 77.5 t -145.01 162.04 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 128.942 2.897 . . . . 0.0 107.198 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -156.71 146.95 14.7 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 14.9 m -138.21 168.4 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 119.794 1.797 . . . . 0.0 110.979 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 15.6 tp -74.96 152.2 38.8 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.0 m -133.87 129.6 36.64 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 121.122 1.783 . . . . 0.0 111.885 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -116.01 132.87 56.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.1 134.15 6.74 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.101 0.864 . . . . 0.0 112.608 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 81.5 mt -74.58 145.93 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 117.67 0.735 . . . . 0.0 109.842 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -75.52 124.98 28.11 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.315 1.446 . . . . 0.0 109.028 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.12 -22.29 65.8 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.251 -0.906 . . . . 0.0 113.06 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -77.82 -10.61 59.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.696 1.199 . . . . 0.0 112.606 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 70.4 m -65.96 146.45 99.01 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.97 -38.64 3.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.663 1.575 . . . . 0.0 112.672 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -132.23 88.22 2.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.649 0.78 . . . . 0.0 109.419 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -54.7 -22.97 15.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.123 0.969 . . . . 0.0 112.011 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -61.87 -30.68 71.02 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.06 1.344 . . . . 0.0 111.27 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.34 -42.01 94.77 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 121.183 -0.948 . . . . 0.0 108.553 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.19 -40.29 68.0 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.79 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -37.68 86.68 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 118.585 0.63 . . . . 0.0 109.957 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -73.64 -41.01 63.33 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -57.84 -49.69 75.83 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.703 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.8 mp -64.32 -49.36 72.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 119.104 -0.475 . . . . 0.0 111.53 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -71.29 -15.68 62.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -105.7 -19.7 13.68 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.969 1.713 . . . . 0.0 113.961 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -137.52 -45.51 0.55 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 117.923 -1.037 . . . . 0.0 111.843 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -59.15 -55.83 29.9 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.059 1.299 . . . . 0.0 111.68 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.5 mt -84.12 63.41 7.64 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.624 2.37 . . . . 0.0 110.38 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 68.9 p -138.87 161.55 36.99 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.95 -21.72 66.88 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 122.839 0.456 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -96.37 -27.68 14.82 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.052 0.941 . . . . 0.0 110.79 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -80.51 -43.96 8.94 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.568 1.08 . . . . 0.0 112.116 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 35.7 mt -65.22 -40.7 94.44 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -58.13 -47.23 83.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.783 1.233 . . . . 0.0 109.425 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.43 74.52 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.464 1.029 . . . . 0.0 112.839 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 24.8 t -73.54 -35.72 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 118.912 -0.566 . . . . 0.0 109.924 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -68.94 -29.87 68.2 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.807 0.731 . . . . 0.0 110.775 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -64.12 -38.27 90.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -51.14 35.83 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 123.518 0.511 . . . . 0.0 110.21 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -147.79 150.61 36.68 Favored Pre-proline 0 C--N 1.344 0.356 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.693 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.57 115.1 2.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.709 2.939 . . . . 0.0 110.792 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 90.9 mt -91.57 -20.94 21.14 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.23 -158.41 24.65 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.25 175.64 4.48 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 35.8 m -127.71 146.9 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 120.043 -1.661 . . . . 0.0 110.329 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.29 -29.47 63.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.662 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 22.3 tp -68.52 106.31 2.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -52.23 -27.33 14.41 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.007 0.923 . . . . 0.0 112.405 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.4 m -61.64 -70.94 0.16 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.663 0.785 . . . . 0.0 111.042 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -66.98 -21.14 65.97 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.188 0.449 . . . . 0.0 111.39 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -65.08 -25.51 67.83 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.24 -18.21 61.84 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.153 -1.592 . . . . 0.0 110.009 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -89.04 -51.77 5.43 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.999 1.32 . . . . 0.0 107.527 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.471 ' HB3' HG21 ' A' ' 317' ' ' ILE . 47.7 mt -61.26 -41.52 97.05 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.59 3.32 1.9 Allowed 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.672 0.789 . . . . 0.0 112.563 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -59.66 -25.73 64.96 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.486 1.494 . . . . 0.0 109.219 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.91 147.56 37.48 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.52 -14.22 43.16 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.138 2.559 . . . . 0.0 114.585 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -62.1 -56.31 20.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.784 1.174 . . . . 0.0 108.975 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 317' ' ' ILE . 4.2 mp -62.85 -51.78 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 125.306 1.442 . . . . 0.0 108.616 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.49 -48.4 62.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 123.447 0.467 . . . . 0.0 110.56 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.22 -33.69 71.28 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 112' ' ' ALA . 1.3 m -67.21 -41.62 85.46 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -38.79 66.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.084 0.554 . . . . 0.0 111.973 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -53.41 -39.02 64.0 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 124.626 1.17 . . . . 0.0 109.323 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.06 -30.87 68.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -75.38 -38.41 60.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -61.16 -45.73 93.45 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.84 1.256 . . . . 0.0 110.206 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.95 6.47 39.28 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.52 1.128 . . . . 0.0 112.378 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -101.54 -179.82 28.18 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.006 1.765 . . . . 0.0 111.016 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -142.98 165.45 27.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.743 2.417 . . . . 0.0 105.382 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.33 154.08 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 120.087 -1.633 . . . . 0.0 111.162 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 40.5 ttp -70.9 125.62 92.03 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.505 1.122 . . . . 0.0 108.376 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.85 100.85 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.271 2.647 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -61.02 0.31 0.24 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.499 HD11 ' CD2' ' A' ' 169' ' ' PHE . 22.7 pt -69.5 150.13 96.98 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 120.549 1.522 . . . . 0.0 114.223 -178.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.97 -13.69 39.03 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.236 2.624 . . . . 0.0 114.396 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -71.34 -13.08 61.75 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.998 -1.064 . . . . 0.0 110.727 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 73.8 mmm -66.09 -28.7 69.02 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 121.373 -0.829 . . . . 0.0 111.759 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 29.9 t -55.35 -51.51 66.54 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.98 -39.1 87.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.954 0.901 . . . . 0.0 110.987 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -51.94 -54.76 25.82 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.923 0.889 . . . . 0.0 110.148 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -64.26 -45.65 87.19 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.643 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -53.71 -42.16 67.76 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.377 0.671 . . . . 0.0 110.725 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.0 -62.57 1.32 Allowed 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 125.601 1.56 . . . . 0.0 112.637 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.57 -36.8 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.977 0.911 . . . . 0.0 111.827 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.47 -49.4 45.64 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.75 1.159 . . . . 0.0 110.356 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 6.6 m -73.53 -42.63 61.49 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.14 57.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.822 1.192 . . . . 0.0 112.745 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.2 t -61.28 -56.1 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 32.3 mm -59.96 -37.2 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.24 0.616 . . . . 0.0 110.657 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -57.21 -47.59 80.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.337 0.972 . . . . 0.0 109.539 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.0 -47.95 55.91 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.566 0.747 . . . . 0.0 110.816 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.89 -24.67 66.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.978 0.911 . . . . 0.0 112.924 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 18.5 m -92.16 -8.51 45.39 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.669 1.188 . . . . 0.0 110.513 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 69.97 16.18 72.42 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.608 0.64 . . . . 0.0 111.76 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -76.62 -33.44 58.39 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 118.092 0.946 . . . . 0.0 110.019 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -143.52 148.95 36.76 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 8.9 t -65.98 156.99 32.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.488 HG13 HD23 ' A' ' 192' ' ' LEU . 64.6 t -56.88 -47.99 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 123.742 0.817 . . . . 0.0 109.786 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -52.39 -46.6 66.31 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.31 0.644 . . . . 0.0 111.036 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -69.48 -36.46 76.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 119.457 -0.306 . . . . 0.0 111.048 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.09 -45.03 90.49 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 8.1 mt -69.18 -41.31 77.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.345 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -56.58 -49.47 74.77 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.911 1.285 . . . . 0.0 109.307 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -51.94 -56.4 14.42 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.261 1.824 . . . . 0.0 108.786 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.78 -49.85 76.11 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.182 1.393 . . . . 0.0 113.403 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -55.3 -38.5 68.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.579 1.551 . . . . 0.0 109.196 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.7 m -65.75 -42.79 90.52 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.425 -0.797 . . . . 0.0 109.855 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -59.2 -26.59 64.96 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.272 0.942 . . . . 0.0 113.233 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.7 mt -79.51 -25.1 12.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.047 0.939 . . . . 0.0 109.531 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 43.9 p -93.39 -23.65 18.35 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.491 0.716 . . . . 0.0 112.271 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.445 1.498 . . . . 0.0 108.346 -178.55 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 62.9 mttt . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.8 mt -85.38 179.06 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.903 0 N-CA-C 101.14 -3.652 . . . . 0.0 101.14 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.53 75.35 1.46 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -75.57 82.12 2.59 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.2 2.2 . . . . 0.0 108.325 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.71 32.43 0.04 OUTLIER Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.21 -1.359 . . . . 0.0 115.312 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -145.8 166.63 25.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.34 1.57 . . . . 0.0 111.357 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 mt -146.41 145.8 30.38 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.781 2.032 . . . . 0.0 107.195 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.82 144.55 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.945 1.298 . . . . 0.0 108.363 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.1 mt -131.74 135.16 59.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 126.606 1.963 . . . . 0.0 108.243 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -126.05 111.82 15.15 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -140.88 148.11 22.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 C-N-CA 124.426 1.09 . . . . 0.0 109.035 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.31 177.56 11.22 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.196 -0.94 . . . . 0.0 110.384 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.13 55.4 7.93 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-O 118.734 -1.036 . . . . 0.0 110.98 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.3 34.52 20.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.728 1.211 . . . . 0.0 113.424 177.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 20.32 0.06 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 116.261 1.949 . . . . 0.0 116.261 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.11 44.18 98.48 Favored Glycine 0 CA--C 1.536 1.396 0 O-C-N 120.678 -1.264 . . . . 0.0 111.318 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -60.35 -40.2 89.84 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -68.34 -39.79 81.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.026 1.284 . . . . 0.0 108.721 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.06 -35.08 91.6 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.7 tp -71.43 -35.46 70.95 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.799 -0.824 . . . . 0.0 111.546 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.71 -43.1 68.72 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.052 0.842 . . . . 0.0 110.25 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -57.83 -21.46 42.5 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.127 1.371 . . . . 0.0 113.953 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 t -86.34 -47.81 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.23 -41.29 96.9 Favored Glycine 0 C--N 1.335 0.512 0 O-C-N 121.01 -1.056 . . . . 0.0 112.237 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -37.64 88.15 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 117.998 0.899 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -61.23 -53.34 58.14 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -58.96 -47.82 83.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.765 0.426 . . . . 0.0 111.804 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -15.75 53.75 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.789 1.636 . . . . 0.0 110.728 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -94.99 -0.19 54.06 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 120.296 -1.503 . . . . 0.0 113.438 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -115.33 -51.83 2.69 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.894 1.678 . . . . 0.0 107.58 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -93.75 -21.68 19.17 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.27 -18.12 19.75 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.674 -1.266 . . . . 0.0 113.905 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.6 mm -61.47 118.04 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.011 1.406 . . . . 0.0 107.616 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -56.57 145.2 29.0 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 124.869 1.268 . . . . 0.0 112.463 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.1 t -130.16 104.41 10.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.8 m -91.84 127.18 37.2 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.43 115.17 46.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.356 -2.091 . . . . 0.0 105.356 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -127.13 171.73 11.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.345 1.058 . . . . 0.0 110.275 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -138.08 68.16 48.66 Favored Pre-proline 0 N--CA 1.455 -0.199 0 C-N-CA 123.619 0.768 . . . . 0.0 112.894 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.29 139.95 19.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 N-CA-C 107.997 -1.578 . . . . 0.0 107.997 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.58 9.52 41.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.555 1.542 . . . . 0.0 108.978 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.36 2.66 10.28 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.514 1.926 . . . . 0.0 114.112 -177.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pp -53.53 -25.58 17.46 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 117.677 -1.154 . . . . 0.0 113.738 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -57.09 -23.4 46.66 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.988 1.315 . . . . 0.0 113.092 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -124.46 -24.02 4.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.801 0.84 . . . . 0.0 112.368 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -77.88 -48.58 16.07 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.27 1.428 . . . . 0.0 110.77 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -45.12 -56.86 8.23 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 117.85 -1.072 . . . . 0.0 111.376 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.56 -39.58 81.74 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 CA-C-N 120.577 1.242 . . . . 0.0 115.211 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -67.43 -46.58 72.73 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.583 1.083 . . . . 0.0 112.326 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 56' ' ' GLY . 22.2 t -68.96 -41.55 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.1 -32.38 71.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.189 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.7 -19.05 57.73 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.951 0.796 . . . . 0.0 110.459 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 m -99.82 -41.7 7.14 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.431 1.492 . . . . 0.0 107.599 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.401 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 117.61 9.14 10.4 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.274 1.416 . . . . 0.0 114.769 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -89.04 -8.53 53.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.374 1.087 . . . . 0.0 112.965 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.417 ' N ' HG12 ' A' ' 50' ' ' VAL . . . -70.83 171.26 45.3 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.442 1.02 . . . . 0.0 114.639 -177.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -64.09 167.79 13.6 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.219 2.613 . . . . 0.0 110.18 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.0 -19.36 22.47 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 126.16 1.784 . . . . 0.0 110.564 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.0 mt -124.24 148.02 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 123.817 0.847 . . . . 0.0 109.812 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.3 tt -141.04 136.64 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -133.37 107.96 8.41 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -154.58 170.87 20.47 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.493 1.042 . . . . 0.0 108.978 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.06 158.27 31.49 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.748 -0.595 . . . . 0.0 110.358 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -55.14 -32.89 62.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.101 0.96 . . . . 0.0 110.168 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.34 -11.11 0.46 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 129.062 2.945 . . . . 0.0 114.912 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -129.63 13.36 5.93 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.014 2.125 . . . . 0.0 109.431 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -115.73 26.48 9.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.655 1.982 . . . . 0.0 111.275 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.27 -19.89 15.21 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 120.467 -1.396 . . . . 0.0 111.894 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -107.05 -35.5 2.73 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 117.948 -1.473 . . . . 0.0 116.075 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -51.68 -45.33 63.42 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.593 2.196 . . . . 0.0 111.464 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.59 95.99 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -32.45 73.2 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.003 1.321 . . . . 0.0 109.592 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.7 m -80.57 -4.62 54.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.386 1.474 . . . . 0.0 110.129 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.54 18.04 76.49 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.912 1.244 . . . . 0.0 112.257 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.5 mt -88.46 -17.58 30.08 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.893 1.346 . . . . 0.0 113.756 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.2 mt -99.41 126.83 45.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.395 0.998 . . . . 0.0 111.277 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.56 164.73 26.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.435 1.094 . . . . 0.0 110.818 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -71.32 94.32 1.2 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.957 1.303 . . . . 0.0 109.17 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.1 pp -74.71 172.91 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 m 67.37 82.75 0.19 Allowed Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 126.141 1.776 . . . . 0.0 111.495 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.91 -34.64 8.36 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.712 1.608 . . . . 0.0 108.529 178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -147.0 155.72 42.47 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.926 0.869 . . . . 0.0 111.817 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -56.36 -33.86 66.09 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.783 2.433 . . . . 0.0 112.896 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.08 -26.75 66.43 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 120.191 1.36 . . . . 0.0 113.214 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -76.09 -26.32 56.33 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 120.25 1.386 . . . . 0.0 109.09 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -62.87 -46.82 86.08 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.229 1.012 . . . . 0.0 109.117 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.48 -14.1 62.02 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -14.73 61.43 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 120.861 -1.149 . . . . 0.0 109.916 178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mt -120.98 164.37 16.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.292 1.837 . . . . 0.0 107.758 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.86 150.45 81.41 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 121.059 -1.026 . . . . 0.0 111.719 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.06 -49.21 2.17 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.569 2.846 . . . . 0.0 112.118 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -57.79 -25.21 60.22 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.18 -20.33 41.43 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.809 -1.182 . . . . 0.0 110.574 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -72.92 -26.97 61.59 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -53.26 -41.94 65.98 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.91 1.684 . . . . 0.0 110.091 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.17 -6.43 4.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.923 1.289 . . . . 0.0 113.428 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.15 -0.18 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.104 1.361 . . . . 0.0 111.832 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 -63.16 148.98 46.46 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.089 1.313 . . . . 0.0 108.375 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.451 ' CE1' ' HE2' ' A' ' 102' ' ' LYS . 26.0 t80 -142.02 167.33 22.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -63.7 114.52 4.04 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.455 0.702 . . . . 0.0 110.801 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.9 -84.33 0.3 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 124.65 1.119 . . . . 0.0 111.34 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.451 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -72.83 166.03 23.73 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.21 0.604 . . . . 0.0 109.876 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.73 166.31 10.56 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.38 -40.17 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.96 174.01 11.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.649 0.659 . . . . 0.0 111.096 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -131.68 149.55 73.78 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 124.76 1.224 . . . . 0.0 110.419 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.27 145.62 30.78 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.198 2.599 . . . . 0.0 110.043 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -128.12 -53.66 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.261 1.425 . . . . 0.0 111.043 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.77 155.6 43.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.998 0.817 . . . . 0.0 112.45 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.5 t -130.95 110.1 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.059 0.544 . . . . 0.0 110.652 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -143.47 126.15 16.01 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.716 0.689 . . . . 0.0 112.746 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.63 84.72 0.97 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.807 2.043 . . . . 0.0 108.126 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -153.91 138.32 16.73 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 120.568 -1.333 . . . . 0.0 107.437 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.8 p -176.07 125.33 0.2 Allowed 'General case' 0 C--O 1.237 0.42 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.8 tp -140.28 158.7 43.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.74 0.7 . . . . 0.0 109.483 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mm -125.56 137.09 58.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -161.49 164.79 29.46 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 126.653 1.981 . . . . 0.0 106.565 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -64.89 134.51 54.17 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.878 0.471 . . . . 0.0 111.061 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -83.39 -12.53 56.38 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 121.821 -0.55 . . . . 0.0 112.317 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.24 174.85 0.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.749 2.42 . . . . 0.0 111.273 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.12 -11.68 9.66 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.762 1.225 . . . . 0.0 111.671 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 tt -115.87 70.35 3.64 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.847 2.459 . . . . 0.0 107.64 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -81.71 5.22 6.44 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.39 2.727 . . . . 0.0 114.811 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.3 t30 23.32 76.33 0.24 Allowed Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 128.754 2.822 . . . . 0.0 112.521 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.6 111.09 2.25 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.706 2.271 . . . . 0.0 110.747 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -82.0 173.69 10.81 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.518 2.145 . . . . 0.0 110.137 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -143.31 -31.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.715 1.206 . . . . 0.0 112.186 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.39 141.3 27.06 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -64.25 -16.1 61.38 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.039 -1.663 . . . . 0.0 113.203 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.84 -13.12 59.63 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.376 -0.827 . . . . 0.0 111.942 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -90.03 -14.01 34.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.326 0.65 . . . . 0.0 110.377 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.7 mm -53.39 -55.73 31.64 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 125.302 1.441 . . . . 0.0 110.424 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.98 -25.56 51.83 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 CA-C-N 120.693 1.283 . . . . 0.0 112.414 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.03 -60.52 2.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.61 -25.26 68.01 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.39 -0.819 . . . . 0.0 110.4 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.97 -47.81 76.29 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -67.67 -31.38 71.32 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 119.181 0.9 . . . . 0.0 110.997 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.06 -49.53 74.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 63.2 mt -76.68 -28.58 55.97 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.961 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -67.47 -34.25 76.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 119.785 1.175 . . . . 0.0 108.648 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.59 -15.19 62.49 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.16 5.62 5.87 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.918 1.287 . . . . 0.0 111.958 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.52 -97.76 0.12 Allowed Glycine 0 C--N 1.341 0.808 0 CA-C-N 119.686 1.13 . . . . 0.0 113.829 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -141.45 -162.1 1.33 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.941 1.297 . . . . 0.0 110.128 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.35 178.83 0.18 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.903 2.481 . . . . 0.0 115.766 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.96 -36.11 3.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.585 1.954 . . . . 0.0 111.069 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.2 tp -123.56 110.0 14.49 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.143 1.777 . . . . 0.0 108.343 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 49.0 ttm -121.2 106.77 11.83 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.407 1.083 . . . . 0.0 108.585 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -135.02 167.74 20.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.933 0.788 . . . . 0.0 110.722 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -67.0 89.0 0.16 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.722 1.609 . . . . 0.0 109.561 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.1 mt -81.91 -5.22 58.1 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.904 1.281 . . . . 0.0 111.602 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -85.57 -8.01 58.53 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -120.41 130.17 24.98 Favored Pre-proline 0 C--O 1.236 0.382 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.54 -15.96 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.884 1.723 . . . . 0.0 113.584 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -55.47 -36.22 66.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.593 0.757 . . . . 0.0 112.236 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -81.35 -37.76 27.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.572 0.749 . . . . 0.0 112.027 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.7 p -82.84 -10.96 58.6 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.878 0.763 . . . . 0.0 112.297 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -60.8 -59.49 13.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 O-C-N 120.912 -1.117 . . . . 0.0 113.507 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -68.04 -3.5 10.74 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 121.326 1.509 . . . . 0.0 114.585 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.0 tp -79.24 -66.67 0.84 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 8.2 pt -68.7 -25.43 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.59 -23.58 67.11 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.821 -1.175 . . . . 0.0 110.591 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -45.53 -60.04 2.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.937 2.095 . . . . 0.0 111.099 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -58.98 -57.3 13.67 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.31 5.19 0.03 OUTLIER Glycine 0 C--N 1.334 0.441 0 CA-C-O 116.991 -2.005 . . . . 0.0 117.713 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -61.35 134.34 48.14 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -141.64 121.91 13.93 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.54 -53.9 44.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.378 -0.201 . . . . 0.0 110.965 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -142.81 132.22 23.54 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -71.3 151.42 44.21 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -141.41 99.12 3.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -71.31 178.09 3.56 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -60.44 22.14 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.084 2.554 . . . . 0.0 116.747 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.57 -4.58 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 127.294 2.378 . . . . 0.0 111.866 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -113.8 107.88 16.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.613 1.706 . . . . 0.0 108.738 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.97 47.04 0.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.082 1.353 . . . . 0.0 109.58 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.88 92.64 1.27 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.25 1.42 . . . . 0.0 112.259 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -55.82 -1.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 130.303 3.441 . . . . 0.0 113.532 178.029 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -70.7 -33.93 71.4 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -82.72 100.89 10.52 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.1 t -116.48 102.34 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 126.56 1.944 . . . . 0.0 111.487 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -90.96 40.15 3.01 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 126.276 1.893 . . . . 0.0 113.842 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.94 -19.99 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.526 0.73 . . . . 0.0 111.063 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -108.34 51.04 0.75 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.976 1.369 . . . . 0.0 108.08 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -106.64 153.44 22.38 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.496 1.118 . . . . 0.0 109.913 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.56 -40.99 66.01 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.055 1.342 . . . . 0.0 111.729 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -59.67 -42.04 97.69 Favored Glycine 0 CA--C 1.523 0.588 0 O-C-N 121.474 -0.766 . . . . 0.0 112.656 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.22 -52.15 60.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -62.74 -32.73 73.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.241 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.1 -60.42 3.62 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.316 1.416 . . . . 0.0 110.065 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.65 -34.44 86.32 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 36.5 tp -70.48 -54.87 10.53 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.525 0.662 . . . . 0.0 110.1 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.62 -36.43 71.79 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.706 0.802 . . . . 0.0 109.616 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.86 -41.58 87.35 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.553 1.069 . . . . 0.0 109.595 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.5 tt -73.76 -45.54 51.14 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.248 -0.907 . . . . 0.0 109.671 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.61 -36.64 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.833 1.253 . . . . 0.0 110.037 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -58.28 -31.56 67.57 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.092 1.357 . . . . 0.0 111.138 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 49.5 mt -73.71 -40.94 63.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.52 -40.84 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -55.23 -37.67 67.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.122 0.969 . . . . 0.0 109.634 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -88.69 0.18 56.69 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.5 1.52 . . . . 0.0 112.37 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? 58.72 10.12 1.36 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 128.131 2.572 . . . . 0.0 114.759 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -42.9 89.83 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.8 tpt -92.64 142.32 27.5 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.88 1.272 . . . . 0.0 107.991 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -82.65 110.15 17.46 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.33 -8.04 54.87 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.906 0.882 . . . . 0.0 112.765 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -100.75 0.53 39.02 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.355 1.062 . . . . 0.0 112.807 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 93.6 m -63.93 130.04 42.48 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -129.8 -179.68 5.34 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.573 1.149 . . . . 0.0 108.696 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -55.12 -47.36 75.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.427 -0.32 . . . . 0.0 110.792 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.6 m -57.56 -45.58 85.0 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.408 1.483 . . . . 0.0 111.105 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 17.5 mm -64.19 -50.21 77.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.21 99.28 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.855 0.722 . . . . 0.0 111.927 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -59.23 -45.63 90.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.085 1.754 . . . . 0.0 110.574 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.15 -48.61 64.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.34 -51.46 68.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.023 0.929 . . . . 0.0 111.366 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -56.12 -39.37 72.13 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.669 0.788 . . . . 0.0 110.458 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -61.08 -25.01 66.66 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.998 -0.439 . . . . 0.0 112.117 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -94.5 -15.04 24.53 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.409 0.684 . . . . 0.0 111.138 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.04 11.94 58.2 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.311 1.434 . . . . 0.0 112.135 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -53.26 -70.08 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.672 2.389 . . . . 0.0 112.588 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.1 t -72.5 153.21 41.46 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -111.04 -18.59 13.0 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.022 0.529 . . . . 0.0 112.347 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -149.28 139.79 22.49 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.801 1.64 . . . . 0.0 108.669 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.7 t -160.29 -177.49 6.29 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 58.5 mt -137.42 138.39 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -131.31 167.05 19.9 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.194 1.398 . . . . 0.0 107.885 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 157.62 -165.18 33.41 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.87 -177.66 2.69 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.873 3.715 . . . . 0.0 111.75 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -119.04 -8.76 10.15 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.159 0.984 . . . . 0.0 111.295 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.8 -65.15 0.26 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.945 1.298 . . . . 0.0 109.919 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -128.12 145.09 51.12 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.612 1.165 . . . . 0.0 109.122 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 8.2 p -69.26 1.59 3.63 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.967 1.707 . . . . 0.0 115.157 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.1 69.69 2.01 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.134 1.374 . . . . 0.0 109.719 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 44.5 pt -132.64 147.39 31.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 C-N-CA 126.107 1.763 . . . . 0.0 106.428 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -82.75 -159.17 0.31 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.873 1.269 . . . . 0.0 110.253 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 32.4 p 46.94 38.3 6.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.952 2.101 . . . . 0.0 113.055 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 15.7 p -51.4 112.65 0.78 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.06 2.144 . . . . 0.0 109.081 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -72.87 42.26 0.1 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.839 1.656 . . . . 0.0 112.753 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 23.5 m -53.28 -23.0 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.641 1.576 . . . . 0.0 113.791 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -74.91 -16.19 60.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.838 0.855 . . . . 0.0 112.275 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -65.96 -179.69 0.77 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.281 1.032 . . . . 0.0 111.55 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -62.64 173.04 9.4 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 123.774 0.702 . . . . 0.0 111.542 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 11.3 t -142.58 98.65 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.251 9.7 t -137.02 -162.54 1.3 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.67 135.75 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.404 1.082 . . . . 0.0 109.244 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -67.47 148.47 98.65 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 123.85 0.86 . . . . 0.0 110.659 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.48 154.29 74.88 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 N-CA-C 107.745 -1.675 . . . . 0.0 107.745 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.0 p -115.28 179.0 4.09 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.926 0.891 . . . . 0.0 112.282 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -102.27 148.5 25.37 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 120.377 -1.452 . . . . 0.0 108.027 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.29 104.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.222 1.409 . . . . 0.0 110.592 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 95.61 -5.41 67.1 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.778 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.41 120.53 4.46 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 120.426 2.113 . . . . 0.0 112.578 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.07 159.28 33.91 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.968 3.112 . . . . 0.0 110.712 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 4.2 p -77.62 167.47 21.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.79 0.805 . . . . 0.0 110.131 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.427 ' HE2' ' HE3' ' A' ' 326' ' ' LYS . 13.2 ptpt -147.33 78.17 10.33 Favored Pre-proline 0 N--CA 1.453 -0.305 0 C-N-CA 123.622 0.769 . . . . 0.0 110.344 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.05 172.31 16.2 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.86 1.707 . . . . 0.0 110.343 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -65.21 152.38 43.8 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.8 144.69 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -132.83 139.28 10.81 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 105.502 -3.039 . . . . 0.0 105.502 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 8.4 m -143.91 147.56 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.11 159.23 24.75 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.5 m -133.09 144.52 50.03 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.899 0.772 . . . . 0.0 109.64 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.23 139.91 51.66 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 121.453 -0.779 . . . . 0.0 109.122 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.91 177.23 18.57 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.965 0.793 . . . . 0.0 113.076 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.3 mt -122.01 119.39 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 125.408 1.483 . . . . 0.0 107.229 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.98 123.02 21.08 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 120.499 -1.376 . . . . 0.0 107.945 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.51 -5.4 7.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.297 1.439 . . . . 0.0 112.739 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.401 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -67.2 -42.54 83.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 127.292 2.237 . . . . 0.0 113.671 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.8 m -57.39 152.49 32.52 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 123.98 0.912 . . . . 0.0 113.307 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.34 -51.45 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.772 2.315 . . . . 0.0 110.594 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -123.06 109.63 14.31 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.509 ' HD2' ' H ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -67.08 -24.29 65.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.71 -34.52 62.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.138 1.375 . . . . 0.0 111.56 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 78.2 mt -60.42 -36.17 77.53 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.327 -0.858 . . . . 0.0 110.146 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -81.25 -39.43 25.31 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.236 -0.887 . . . . 0.0 111.315 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.41 83.36 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.153 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -67.58 -49.4 63.35 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -56.41 -49.78 73.51 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.36 -0.838 . . . . 0.0 110.764 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.53 -21.94 66.62 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.81 -14.9 14.68 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -103.32 -24.27 13.52 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.986 0.812 . . . . 0.0 112.242 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -139.43 -32.18 0.66 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -67.07 -47.95 69.72 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.443 1.474 . . . . 0.0 112.847 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.05 73.13 5.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 71.4 p -138.72 153.98 48.53 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.88 -24.37 67.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -86.85 -43.67 12.29 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.175 1.79 . . . . 0.0 110.898 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -68.52 -44.93 70.2 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 54.1 mt -67.61 -34.74 77.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -62.15 -49.01 77.55 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.411 ' HA ' ' HE2' ' A' ' 295' ' ' LYS . . . -54.4 -42.84 70.9 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 119.595 1.089 . . . . 0.0 110.926 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.4 t -63.56 -41.18 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.804 1.242 . . . . 0.0 108.797 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -64.14 -38.92 92.79 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.126 1.371 . . . . 0.0 112.059 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 292' ' ' ALA . 21.9 mtmt -56.78 -54.7 43.32 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.246 -0.909 . . . . 0.0 108.755 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -55.18 -52.87 61.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.058 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.481 ' HA ' ' HE3' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -147.78 156.33 44.6 Favored Pre-proline 0 N--CA 1.473 0.715 0 O-C-N 120.799 -1.188 . . . . 0.0 111.799 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -61.34 130.9 33.81 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 N-CA-C 105.963 -2.36 . . . . 0.0 105.963 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -95.38 -15.78 22.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.342 -0.837 . . . . 0.0 112.882 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.36 -157.27 47.81 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.16 164.12 25.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 22.7 m -125.91 148.89 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 O-C-N 121.246 -0.909 . . . . 0.0 109.852 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.05 -22.47 58.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.675 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 62.7 tp -66.93 105.4 1.61 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.789 1.635 . . . . 0.0 109.365 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -61.41 -1.86 0.61 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.6 t -92.9 -66.64 0.91 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -63.51 -19.32 64.67 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.438 -0.789 . . . . 0.0 110.877 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -60.2 -35.5 75.55 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -68.22 -20.43 64.83 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.072 0.851 . . . . 0.0 111.687 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -88.12 -50.36 6.44 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.582 1.153 . . . . 0.0 108.403 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 48.7 mt -67.64 -35.32 78.69 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.012 0.525 . . . . 0.0 110.554 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.3 1.92 4.37 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.182 -0.949 . . . . 0.0 112.686 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -62.53 -20.88 65.08 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 120.111 1.323 . . . . 0.0 109.575 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -109.82 129.22 24.17 Favored Pre-proline 0 C--O 1.24 0.554 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.7 -8.41 9.21 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.378 2.719 . . . . 0.0 114.54 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -67.23 -54.48 20.58 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 119.68 1.127 . . . . 0.0 108.607 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.7 -49.55 83.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.45 -50.56 62.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 123.75 0.656 . . . . 0.0 109.947 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.81 -41.35 86.59 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.9 m -62.16 -37.76 86.46 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.8 tpt -68.2 -46.62 70.13 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.257 0.623 . . . . 0.0 110.596 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -60.68 -30.07 69.69 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.019 0.928 . . . . 0.0 113.111 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -74.82 -35.35 62.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -69.19 -36.38 77.24 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.777 0.831 . . . . 0.0 111.315 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -65.96 -41.22 91.5 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.564 1.145 . . . . 0.0 111.856 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.427 ' HE3' ' HE2' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -95.95 -3.18 45.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 116.676 -1.63 . . . . 0.0 115.117 -177.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -109.52 170.34 14.33 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 120.173 1.351 . . . . 0.0 114.975 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.26 129.04 34.91 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.709 0.803 . . . . 0.0 109.38 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 35.0 mt -98.13 121.43 48.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 45.9 mtm 24.32 76.57 0.25 Allowed Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 127.438 2.295 . . . . 0.0 112.178 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.66 80.27 0.47 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.8 3.0 . . . . 0.0 113.557 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -84.22 70.4 10.56 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.657 1.583 . . . . 0.0 106.992 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 30.1 pt -124.08 152.09 66.47 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 124.396 1.078 . . . . 0.0 110.549 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -68.78 -30.94 26.4 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.09 2.526 . . . . 0.0 113.106 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -65.66 -17.19 64.42 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -61.43 -31.35 71.29 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.986 0.812 . . . . 0.0 109.563 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 4.6 t -57.57 -46.09 84.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.457 0.703 . . . . 0.0 110.712 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -79.6 -36.25 38.33 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.604 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.0 -52.35 63.42 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.786 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -58.26 -40.47 81.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.865 1.211 . . . . 0.0 111.1 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -65.64 -23.13 66.73 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.962 0.905 . . . . 0.0 111.46 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.3 -50.73 8.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.538 1.135 . . . . 0.0 110.272 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 11.2 t -60.7 -49.81 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.612 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.01 -54.33 13.28 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.637 0.653 . . . . 0.0 110.275 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.477 HG21 HH22 ' A' ' 367' ' ' ARG . 87.3 m -64.3 -43.18 95.54 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.296 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.27 -43.07 87.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.122 1.328 . . . . 0.0 111.519 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.82 -52.68 51.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 125.041 1.336 . . . . 0.0 108.897 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 30.1 mm -60.5 -43.18 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.151 0.58 . . . . 0.0 110.13 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -59.88 -47.36 86.06 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.738 0.699 . . . . 0.0 110.265 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.26 72.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.719 0.808 . . . . 0.0 110.679 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.66 -32.17 72.32 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.246 1.019 . . . . 0.0 111.97 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 14.1 m -85.15 -11.75 54.37 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.739 0.816 . . . . 0.0 109.723 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.74 10.04 66.75 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 123.667 0.651 . . . . 0.0 112.428 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -69.15 -34.48 75.04 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 118.158 0.979 . . . . 0.0 109.985 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -134.93 148.04 49.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 359' ' ' GLU . 11.9 t -68.34 156.24 38.15 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 26.0 t -58.14 -40.43 77.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 125.011 1.325 . . . . 0.0 110.086 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.06 -47.84 84.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.956 0.502 . . . . 0.0 109.738 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' GLU . . . . . 0.449 ' H ' HG23 ' A' ' 356' ' ' THR . 52.6 mm-40 -68.92 -37.82 79.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 122.147 -0.345 . . . . 0.0 111.21 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.4 -39.87 73.72 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.97 -41.3 59.84 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.567 1.147 . . . . 0.0 110.296 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -55.45 -50.16 70.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.493 0.717 . . . . 0.0 109.363 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -49.85 76.32 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 127.042 2.137 . . . . 0.0 111.1 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.21 -52.15 66.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.076 0.95 . . . . 0.0 112.209 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -52.84 -33.04 47.72 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.551 0.74 . . . . 0.0 110.482 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.3 m -64.22 -48.03 77.41 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.413 1.006 . . . . 0.0 109.451 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.477 HH22 HG21 ' A' ' 345' ' ' THR . 79.9 mtt180 -57.25 -23.35 47.54 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.3 mt -96.14 -10.41 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.025 1.33 . . . . 0.0 111.565 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 55.5 p -120.08 1.72 10.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.673 1.189 . . . . 0.0 112.491 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 36.1 tptt . . . . . 0 C--O 1.251 1.179 0 C-N-CA 127.665 2.386 . . . . 0.0 105.547 178.401 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 43.4 tttm . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.8 mm -91.13 142.38 13.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -108.33 112.69 25.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -79.12 175.07 10.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.53 1.532 . . . . 0.0 109.384 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.95 22.71 77.68 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.427 1.013 . . . . 0.0 113.302 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -146.87 166.48 26.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.992 0.896 . . . . 0.0 112.664 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.2 mt -151.32 142.93 23.64 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.939 2.895 . . . . 0.0 106.681 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.26 126.61 49.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 mt -108.07 136.11 44.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 125.81 1.644 . . . . 0.0 108.146 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -127.76 130.6 49.02 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.035 1.734 . . . . 0.0 106.511 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 15' ' ' LYS . 11.8 pt -131.76 165.65 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 127.26 2.224 . . . . 0.0 110.383 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.497 ' HB3' HD21 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -151.35 165.57 33.66 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.367 1.067 . . . . 0.0 112.975 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.68 40.5 7.68 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-O 118.466 -1.185 . . . . 0.0 111.855 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 54.51 32.85 17.65 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.622 1.169 . . . . 0.0 108.213 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HB3' HD12 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -56.77 163.37 1.92 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.539 1.536 . . . . 0.0 113.372 -177.734 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.09 76.35 1.44 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -66.17 -39.52 89.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.611 1.164 . . . . 0.0 109.352 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -58.57 -59.76 4.87 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 125.875 1.67 . . . . 0.0 110.526 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.27 94.53 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.7 tp -62.94 -42.55 99.84 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 117.889 0.845 . . . . 0.0 108.944 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.63 73.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.863 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -62.39 -27.89 69.4 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.452 1.024 . . . . 0.0 110.443 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.9 t -79.31 -46.47 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.28 -39.07 97.24 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 121.257 -0.902 . . . . 0.0 113.069 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -37.62 68.35 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 117.776 -1.107 . . . . 0.0 109.1 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -58.42 -57.33 13.41 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.38 -48.03 80.13 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.937 -0.554 . . . . 0.0 110.384 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.48 -22.96 66.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.958 1.254 . . . . 0.0 112.61 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tppm? -85.74 -23.22 27.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 117.876 -1.059 . . . . 0.0 110.805 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -102.83 -22.59 13.86 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.925 0.765 . . . . 0.0 112.71 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -114.79 -35.95 4.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.468 1.107 . . . . 0.0 111.355 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.17 -18.74 56.95 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.121 0.867 . . . . 0.0 113.414 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.8 mm -60.45 125.63 16.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HA ' ' CE ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -63.77 127.93 33.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.107 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.7 t -123.2 104.91 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -93.97 139.14 31.3 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.3 t -130.67 118.46 42.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -128.84 158.99 37.18 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -116.85 60.64 2.38 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.664 1.186 . . . . 0.0 110.185 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.485 ' HG2' HD22 ' A' ' 43' ' ' LEU . 48.3 Cg_endo -62.09 160.41 30.34 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 121.867 1.711 . . . . 0.0 109.966 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -117.79 9.12 12.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.596 0.758 . . . . 0.0 111.709 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.17 17.69 2.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.073 1.749 . . . . 0.0 112.876 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 43' ' ' LEU . 1.3 pt? -56.11 -24.15 38.74 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.627 -1.295 . . . . 0.0 111.797 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.99 -24.95 57.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.203 1.401 . . . . 0.0 112.104 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -121.57 -22.27 5.94 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.219 1.008 . . . . 0.0 111.218 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -41.92 59.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 117.24 -1.362 . . . . 0.0 110.9 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -52.49 -58.71 10.73 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 120.642 1.565 . . . . 0.0 110.111 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.78 -17.3 54.28 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.501 1.467 . . . . 0.0 113.553 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -88.7 2.12 53.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.649 1.58 . . . . 0.0 113.638 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.3 -34.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.18 0.9 . . . . 0.0 109.61 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.77 66.12 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.708 -1.245 . . . . 0.0 110.011 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.73 -2.92 5.55 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.887 0.875 . . . . 0.0 112.368 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.2 p -126.33 -11.72 6.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.461 1.504 . . . . 0.0 110.256 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.412 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 84.6 15.76 67.61 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.277 0.942 . . . . 0.0 111.892 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -106.38 6.44 30.43 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.007 0.904 . . . . 0.0 110.684 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.41 -167.59 43.39 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 127.001 2.239 . . . . 0.0 116.371 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.92 -179.32 2.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.634 2.89 . . . . 0.0 110.136 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.95 -18.28 8.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.8 mt -135.44 143.84 35.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.428 1.091 . . . . 0.0 109.306 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tt -130.02 143.2 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 C-N-CA 125.014 1.326 . . . . 0.0 110.953 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -137.92 109.83 7.19 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.823 1.649 . . . . 0.0 107.609 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 29.2 t-105 -159.88 178.91 9.27 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.438 1.017 . . . . 0.0 108.981 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.36 153.55 43.42 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -60.16 -19.14 52.52 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.362 1.465 . . . . 0.0 111.658 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -53.07 -61.95 1.96 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.895 1.278 . . . . 0.0 111.322 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -68.15 -18.22 64.56 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.598 -0.689 . . . . 0.0 111.088 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -68.67 -30.43 69.11 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.483 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.8 -12.79 49.44 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.99 0.805 . . . . 0.0 112.296 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -104.58 -45.72 1.39 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -60.47 -52.04 66.9 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.554 -0.968 . . . . 0.0 111.322 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.62 84.22 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.692 0.678 . . . . 0.0 111.235 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.21 -47.31 69.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.776 1.23 . . . . 0.0 108.71 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -72.21 -6.89 46.09 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.43 9.85 80.91 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.781 1.181 . . . . 0.0 112.296 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 mt -73.21 -22.03 60.53 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.389 1.094 . . . . 0.0 111.156 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -103.87 140.28 37.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.12 -171.95 3.31 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -76.93 159.72 29.76 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.414 HD11 ' HB3' ' A' ' 103' ' ' LEU . 2.7 pp -137.73 172.04 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.727 1.211 . . . . 0.0 110.184 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.57 HG23 ' HB3' ' A' ' 85' ' ' PHE . 42.4 m 42.36 77.24 0.45 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.105 2.162 . . . . 0.0 114.552 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.88 -22.0 27.51 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.084 2.523 . . . . 0.0 115.291 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -120.16 135.24 55.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.22 1.373 . . . . 0.0 111.526 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -51.32 -39.11 56.26 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.781 2.032 . . . . 0.0 112.265 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.5 -27.18 62.31 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.57 ' HB3' HG23 ' A' ' 80' ' ' THR . 14.2 t80 -66.46 -37.11 84.41 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -64.54 -42.86 95.45 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 118.845 0.748 . . . . 0.0 109.284 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -57.0 -30.11 63.87 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.52 1.528 . . . . 0.0 112.718 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -75.4 -2.24 27.64 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mt -130.18 154.15 47.83 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 120.728 -1.232 . . . . 0.0 110.892 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -69.12 155.83 92.78 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 122.436 -0.165 . . . . 0.0 110.786 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.41 -45.68 2.46 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.906 3.07 . . . . 0.0 114.241 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -58.01 -38.62 76.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.565 1.075 . . . . 0.0 111.143 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -25.58 66.24 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.555 1.142 . . . . 0.0 110.722 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -77.94 -44.45 26.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.411 0.684 . . . . 0.0 110.119 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.71 -33.38 64.14 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.56 -7.4 4.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.4 1.48 . . . . 0.0 114.179 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.73 10.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.966 1.706 . . . . 0.0 111.887 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.9 mtp85 -70.28 160.48 32.12 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -132.7 -165.11 1.56 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -70.37 81.25 0.55 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.291 1.036 . . . . 0.0 109.401 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.35 -60.81 4.84 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.368 0.985 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -178.56 5.07 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.32 0.648 . . . . 0.0 109.881 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.414 ' HB3' HD11 ' A' ' 79' ' ' ILE . 34.5 mt -115.9 169.95 8.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.161 1.385 . . . . 0.0 109.248 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 pt -138.65 -28.88 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.79 175.32 13.0 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.456 1.026 . . . . 0.0 109.701 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -133.31 150.02 74.09 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.9 143.73 29.77 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.966 2.444 . . . . 0.0 110.888 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -131.53 -50.65 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.808 2.443 . . . . 0.0 111.546 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.71 131.51 52.55 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 110.396 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.65 95.99 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -72.29 162.15 29.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.605 1.193 . . . . 0.0 110.164 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.408 ' CB ' HG23 ' A' ' 320' ' ' THR . . . -156.38 168.84 26.11 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.134 1.374 . . . . 0.0 109.291 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.0 141.13 56.33 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.5 m -118.92 172.68 7.37 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.896 1.278 . . . . 0.0 112.162 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -144.44 147.4 33.29 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.919 1.288 . . . . 0.0 108.923 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.26 121.02 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.821 1.248 . . . . 0.0 108.775 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -145.94 127.63 15.23 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.777 -1.202 . . . . 0.0 110.952 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -94.94 49.43 1.23 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.45 ' HE3' HD21 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -57.88 -60.32 3.89 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -177.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -167.39 -177.12 3.49 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 121' ' ' LEU . 1.1 pt? -93.22 -14.06 27.54 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.181 0.446 . . . . 0.0 110.729 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.21 157.56 70.67 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 124.595 1.158 . . . . 0.0 108.818 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.01 82.19 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.502 2.801 . . . . 0.0 110.576 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -126.62 79.19 71.85 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.259 1.424 . . . . 0.0 108.271 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.21 161.88 31.83 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.264 2.643 . . . . 0.0 114.079 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.16 159.79 40.37 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.516 2.811 . . . . 0.0 110.441 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.35 -31.6 2.77 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 124.441 1.096 . . . . 0.0 113.325 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.95 152.4 9.46 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.269 1.395 . . . . 0.0 109.832 -178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -56.1 -27.68 54.7 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.46 -16.52 24.35 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.283 0.947 . . . . 0.0 113.132 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -92.23 -14.22 29.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.062 0.847 . . . . 0.0 111.212 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 26.0 mm -59.65 -57.89 23.51 Favored Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -69.9 -25.54 27.86 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 CA-C-N 120.306 1.145 . . . . 0.0 110.967 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.64 71.65 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 118.67 0.668 . . . . 0.0 109.863 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.45 HD21 ' HE3' ' A' ' 119' ' ' LYS . 61.5 tp -88.84 -29.88 19.36 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.737 0.815 . . . . 0.0 109.585 178.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -59.08 -45.74 90.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.429 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 5.5 ptmm? -64.06 -32.19 73.65 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.534 0.334 . . . . 0.0 111.832 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -71.62 -43.04 66.87 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.203 0.601 . . . . 0.0 110.206 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.4 mt -75.8 -32.18 59.76 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -67.81 -33.33 74.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.609 -1.307 . . . . 0.0 108.498 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.1 -14.08 59.62 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 3.24 5.45 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.179 0.992 . . . . 0.0 112.127 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.65 -99.67 0.13 Allowed Glycine 0 CA--C 1.523 0.566 0 CA-C-N 119.267 0.94 . . . . 0.0 113.448 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -138.12 -177.75 4.97 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.433 1.493 . . . . 0.0 111.719 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.5 p -56.16 168.76 0.47 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.064 1.746 . . . . 0.0 113.817 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.89 -74.14 0.6 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.745 1.618 . . . . 0.0 110.183 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.8 tp -88.66 147.32 24.59 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.896 0.878 . . . . 0.0 110.701 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 11.3 mtp -149.0 113.97 5.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -138.1 172.3 13.12 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.978 2.111 . . . . 0.0 108.474 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.41 124.74 28.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.623 0.769 . . . . 0.0 112.86 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.3 mp -111.15 7.85 21.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.085 0.954 . . . . 0.0 111.166 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -97.57 -23.12 16.14 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -102.29 128.17 28.98 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.167 0.987 . . . . 0.0 108.913 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.67 -14.85 27.28 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.657 2.238 . . . . 0.0 114.32 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -59.01 -41.75 88.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.851 1.261 . . . . 0.0 113.397 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -79.83 -41.11 27.06 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.065 0.46 . . . . 0.0 111.767 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.4 p -69.93 -24.59 63.39 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.746 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -53.3 -63.02 2.75 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -61.69 -14.71 37.56 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.109 1.872 . . . . 0.0 115.076 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.4 tp -78.56 -63.83 1.32 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.8 pt -63.05 -32.61 56.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.825 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.421 ' HB1' ' HD3' ' A' ' 256' ' ' LYS . . . -68.81 -14.36 62.98 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.528 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -52.94 -45.37 67.64 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.927 1.239 . . . . 0.0 113.603 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.67 -43.82 98.13 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 172.33 43.15 0.04 OUTLIER Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.952 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -99.55 155.51 19.79 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -160.73 119.26 2.54 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 118.278 1.039 . . . . 0.0 109.019 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.95 84.31 7.48 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 70.05 105.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.754 2.421 . . . . 0.0 107.874 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -72.25 134.78 45.78 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.636 -0.665 . . . . 0.0 109.314 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -131.65 120.05 22.27 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 173' ' ' ASN . 5.6 tt0 -102.78 -159.15 0.71 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.584 1.154 . . . . 0.0 108.428 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.491 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 78.5 m-20 -66.84 78.63 0.12 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.66 1.984 . . . . 0.0 110.708 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.66 10.91 84.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.269 0.938 . . . . 0.0 112.597 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -112.15 103.46 11.63 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.34 113.24 18.58 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -131.07 100.7 5.31 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.93 -9.38 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -69.48 -29.34 66.98 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.891 -1.131 . . . . 0.0 108.324 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -75.29 75.29 2.41 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.606 1.563 . . . . 0.0 110.863 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.7 t -97.11 113.82 32.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 126.414 1.886 . . . . 0.0 108.737 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -109.32 96.1 0.94 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 45.8 t -138.38 -43.47 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 117.822 0.811 . . . . 0.0 109.579 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -108.84 77.04 1.05 Allowed 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -128.97 163.1 26.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.778 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -50.03 -41.52 47.62 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.2 1.4 . . . . 0.0 113.197 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.95 -43.41 95.99 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.581 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.6 -51.35 65.69 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.432 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -58.78 -36.64 74.76 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.135 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.23 -38.61 87.27 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.212 0.915 . . . . 0.0 110.386 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -82.43 -26.54 46.82 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.82 -0.55 . . . . 0.0 112.826 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.5 tp -76.29 -41.82 47.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.08 -1.247 . . . . 0.0 107.792 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 7.4 t -65.08 -27.62 68.9 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.987 0.812 . . . . 0.0 109.065 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -58.19 -52.06 67.13 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.96 -46.24 88.54 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.764 1.226 . . . . 0.0 110.144 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 42.7 t -60.58 -38.91 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 117.639 -1.172 . . . . 0.0 110.506 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.517 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 14.2 t0 -56.6 -50.11 72.96 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.213 1.405 . . . . 0.0 114.009 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.11 -38.7 91.54 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.548 0.689 . . . . 0.0 109.693 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.17 -31.8 51.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -63.76 -44.7 92.66 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 126.125 1.77 . . . . 0.0 107.887 178.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -71.97 -10.92 60.46 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.377 0.671 . . . . 0.0 109.424 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt 60.96 15.6 6.23 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 128.175 2.59 . . . . 0.0 112.513 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -83.08 -14.04 54.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.04 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.24 124.98 52.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.813 1.645 . . . . 0.0 110.028 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.65 84.66 0.29 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.745 2.018 . . . . 0.0 110.69 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -58.53 -16.53 15.88 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.549 1.94 . . . . 0.0 115.011 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.08 -7.08 54.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.252 1.821 . . . . 0.0 114.097 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.3 m -60.99 134.48 57.14 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 118.941 0.791 . . . . 0.0 110.408 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.0 -178.43 4.18 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.542 1.937 . . . . 0.0 107.08 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -57.89 -38.56 76.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.391 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -55.38 26.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.321 1.048 . . . . 0.0 110.456 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.22 -45.13 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 123.57 0.748 . . . . 0.0 110.38 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.45 -51.13 67.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.724 0.693 . . . . 0.0 110.816 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -63.35 -43.97 96.17 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.82 1.191 . . . . 0.0 110.313 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.09 -55.77 30.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.06 0.544 . . . . 0.0 109.548 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.84 -46.07 74.58 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.56 1.144 . . . . 0.0 110.425 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -58.42 -44.19 88.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.24 0.616 . . . . 0.0 109.429 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.46 -21.73 66.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.689 0.795 . . . . 0.0 112.203 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -91.97 -10.64 38.64 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.665 0.786 . . . . 0.0 110.008 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.82 18.44 70.2 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -80.78 0.72 33.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.947 1.299 . . . . 0.0 113.745 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 27.3 p -124.04 149.79 45.69 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.532 1.133 . . . . 0.0 108.184 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.3 -21.31 19.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.264 0.625 . . . . 0.0 111.469 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 14.0 ptt? -158.28 157.48 32.58 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.8 t -150.89 171.38 17.34 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 122.535 1.16 . . . . 0.0 109.792 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 5.9 mt -141.65 140.0 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -153.1 139.2 18.27 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 173.14 -52.88 0.16 Allowed Glycine 0 CA--C 1.53 0.978 0 CA-C-O 117.782 -1.566 . . . . 0.0 112.54 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -78.19 73.08 5.94 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 CA-C-N 120.902 2.351 . . . . 0.0 108.241 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -77.42 128.97 35.15 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 126.02 1.728 . . . . 0.0 106.561 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.42 -178.6 0.39 Allowed 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 127.542 2.337 . . . . 0.0 110.26 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 16.8 p-90 -147.66 145.29 28.87 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 120.71 -1.243 . . . . 0.0 109.372 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.83 143.74 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.899 2.08 . . . . 0.0 109.523 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.7 m120 64.4 10.64 5.87 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.374 1.07 . . . . 0.0 111.892 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 17.9 tt -161.23 154.58 3.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 C-N-CA 129.316 3.047 . . . . 0.0 105.891 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -80.42 154.06 27.88 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.929 -0.482 . . . . 0.0 110.349 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 49.4 m -88.94 56.84 3.88 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.4 p -81.61 172.31 13.6 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.229 2.212 . . . . 0.0 111.305 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -164.94 171.98 13.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.548 1.139 . . . . 0.0 111.499 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.16 168.79 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.887 1.275 . . . . 0.0 109.641 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -142.6 92.54 2.42 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 125.741 1.616 . . . . 0.0 108.372 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -139.96 167.5 21.98 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.886 2.074 . . . . 0.0 108.493 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -67.07 129.59 29.44 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 121.177 -0.952 . . . . 0.0 111.843 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 29.6 m -63.63 149.59 10.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 118.006 0.903 . . . . 0.0 109.921 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.8 t -147.72 -178.05 6.05 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.115 0.966 . . . . 0.0 109.396 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 14.2 p -93.11 137.18 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.522 1.129 . . . . 0.0 109.677 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.06 157.65 62.58 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.144 0.978 . . . . 0.0 111.692 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.07 -84.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.834 3.023 . . . . 0.0 111.073 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . 0.292 0.5 OUTLIER 92.38 -164.69 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.483 3.113 . . . . 0.0 108.052 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.27 131.83 47.11 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.02 120.31 7.25 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.52 -0.738 . . . . 0.0 109.181 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.91 -7.12 56.83 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.511 -1.16 . . . . 0.0 113.928 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.39 102.65 14.03 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.317 2.059 . . . . 0.0 109.801 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.78 143.49 21.1 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.223 1.948 . . . . 0.0 113.606 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.2 m -68.66 159.56 31.87 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.148 0.979 . . . . 0.0 109.234 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.421 ' HD3' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -129.08 55.72 19.85 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.61 161.65 34.58 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 121.788 1.659 . . . . 0.0 111.406 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -75.02 172.21 12.73 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.604 0.716 . . . . 0.0 111.142 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 13.6 t -114.39 155.26 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -172.12 148.41 10.78 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.43 172.22 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 119.403 1.601 . . . . 0.0 111.545 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 34.5 tp -84.41 156.52 21.77 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.055 -1.653 . . . . 0.0 107.569 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.7 m -131.76 137.17 48.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 120.481 1.492 . . . . 0.0 109.001 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -115.24 130.67 56.98 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.349 1.059 . . . . 0.0 109.513 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.14 170.59 21.73 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.308 1.432 . . . . 0.0 111.804 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 76.3 mt -119.19 134.72 61.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -68.09 122.54 18.48 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.61 -10.78 60.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.412 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -95.13 7.33 46.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.84 0.856 . . . . 0.0 112.459 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.5 m -69.33 157.49 89.25 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.418 1.087 . . . . 0.0 108.712 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.13 -50.82 2.55 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.906 1.737 . . . . 0.0 111.005 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -135.5 100.36 4.48 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -19.68 49.31 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.47 -0.769 . . . . 0.0 112.437 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -64.63 -32.9 74.76 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.049 0.386 . . . . 0.0 110.123 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.87 -38.63 79.23 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.379 -0.825 . . . . 0.0 108.897 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.66 -42.29 42.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 117.903 -1.046 . . . . 0.0 111.671 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -41.3 91.99 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.3 0.954 . . . . 0.0 108.788 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -66.94 -50.93 60.79 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 124.619 1.199 . . . . 0.0 109.434 -177.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -53.22 -51.69 61.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.194 -0.431 . . . . 0.0 110.335 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 2.2 mp -63.11 -48.04 80.22 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.332 6.7 pt-20 -78.74 -4.35 48.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -177.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -108.45 -19.45 13.45 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.311 1.414 . . . . 0.0 112.211 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -135.61 -53.3 0.77 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.789 1.177 . . . . 0.0 110.735 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 0.2 OUTLIER -48.61 -48.04 39.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.753 0.821 . . . . 0.0 112.515 -179.345 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.66 29.03 0.93 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.948 2.099 . . . . 0.0 114.505 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 19.4 p -116.29 165.18 13.47 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 120.411 1.459 . . . . 0.0 108.097 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.66 -44.06 85.41 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.46 -33.63 75.53 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.506 0.722 . . . . 0.0 112.787 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.53 -46.08 12.58 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 51.8 mt -62.52 -47.12 85.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -57.78 -44.49 86.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.678 1.191 . . . . 0.0 110.647 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.0 -46.78 71.84 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 117.93 0.332 . . . . 0.0 110.963 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.65 -40.32 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 117.047 -1.454 . . . . 0.0 109.723 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -63.15 -34.33 77.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.311 0.959 . . . . 0.0 112.754 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -63.49 -61.34 2.39 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.8 -48.33 80.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 117.219 -1.372 . . . . 0.0 112.387 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -137.7 150.47 68.13 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 121.509 1.959 . . . . 0.0 109.137 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.77 101.95 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.254 1.969 . . . . 0.0 114.21 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 7.8 mt -76.03 -32.86 59.55 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 123.608 0.763 . . . . 0.0 109.731 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 80.87 -115.64 4.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.95 160.8 14.01 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.206 1.003 . . . . 0.0 111.698 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.16 162.7 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 124.479 1.112 . . . . 0.0 110.179 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.36 -29.44 22.95 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 28.0 tp -65.07 104.07 0.83 Allowed 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.749 0.82 . . . . 0.0 111.166 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -49.53 -33.43 14.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.143 1.377 . . . . 0.0 112.482 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.3 t -62.53 -57.46 11.07 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.877 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -78.19 -20.72 51.33 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.923 1.238 . . . . 0.0 111.262 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -57.6 -43.13 84.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.25 -13.02 46.72 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.005 0.82 . . . . 0.0 113.207 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -94.12 -37.54 11.55 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 63.2 mt -74.95 -26.02 59.3 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.515 -1.366 . . . . 0.0 109.035 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.87 -1.63 7.7 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.544 1.538 . . . . 0.0 112.918 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -65.11 -19.45 65.99 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.807 0.843 . . . . 0.0 110.846 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -120.36 131.95 24.28 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 124.526 1.13 . . . . 0.0 108.189 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -59.84 -15.05 30.18 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.215 2.61 . . . . 0.0 116.368 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -66.5 -39.5 88.75 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 121.93 2.15 . . . . 0.0 108.602 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.7 mp -70.77 -46.38 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.43 -49.54 72.15 Favored 'General case' 0 C--O 1.222 -0.395 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.166 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.17 -37.55 77.62 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.085 -1.009 . . . . 0.0 112.101 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.408 HG23 ' CB ' ' A' ' 112' ' ' ALA . 55.1 m -61.06 -39.1 88.59 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -81.35 -37.23 28.63 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 123.585 0.754 . . . . 0.0 111.434 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -55.17 -37.35 66.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.134 0.973 . . . . 0.0 108.837 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -63.9 -38.54 91.48 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.53 -33.67 64.85 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.385 0.674 . . . . 0.0 110.171 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -68.12 -48.15 66.21 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.049 1.34 . . . . 0.0 110.294 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -27.38 45.99 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -86.59 -172.32 48.38 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 124.581 1.086 . . . . 0.0 114.531 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.4 135.85 37.33 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.935 1.694 . . . . 0.0 107.082 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 85.7 mt -76.56 111.6 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 10.9 ptp 52.61 161.31 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 130.972 3.709 . . . . 0.0 115.833 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.7 160.73 40.62 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 N-CA-C 108.374 -1.433 . . . . 0.0 108.374 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -120.81 23.49 10.7 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.0 pt -137.8 141.37 32.66 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 118.953 0.797 . . . . 0.0 110.454 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.82 -9.94 27.3 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 124.001 3.134 . . . . 0.0 113.82 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -64.69 -24.05 67.45 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.417 1.087 . . . . 0.0 109.539 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 91.1 mmm -58.99 -22.39 60.47 Favored 'General case' 0 C--N 1.342 0.247 0 O-C-N 120.744 -1.222 . . . . 0.0 113.571 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 80.4 p -64.24 -33.11 75.06 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.369 1.44 . . . . 0.0 108.821 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.5 -41.97 65.35 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 121.247 -0.908 . . . . 0.0 108.894 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -49.96 -57.08 8.26 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.081 0.952 . . . . 0.0 109.584 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -64.02 -35.4 80.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -68.07 -37.43 81.24 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.158 0.583 . . . . 0.0 111.671 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.52 -55.16 6.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.868 2.067 . . . . 0.0 112.496 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 67.3 t -57.33 -33.55 43.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.378 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -54.63 -58.38 7.74 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.747 1.158 . . . . 0.0 108.859 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.4 m -61.38 -37.32 82.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.984 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.13 82.37 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 121.003 1.729 . . . . 0.0 111.403 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 75.2 t -58.82 -56.46 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.5 mm -61.21 -32.94 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.2 0.6 . . . . 0.0 111.803 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.44 -52.72 62.42 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.638 -1.288 . . . . 0.0 110.158 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.23 -43.68 64.04 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.217 0.607 . . . . 0.0 111.233 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -56.38 -41.6 76.51 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.306 1.042 . . . . 0.0 111.246 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.8 m -85.09 -17.48 37.22 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.443 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.5 28.48 47.7 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 123.583 0.611 . . . . 0.0 112.314 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -81.84 -27.63 33.46 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.735 -0.862 . . . . 0.0 109.976 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -142.7 151.52 41.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.6 m -58.95 153.82 16.63 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.014 0.926 . . . . 0.0 109.485 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 90.5 t -52.56 -56.26 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.224 1.009 . . . . 0.0 110.133 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.1 -49.06 74.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.213 1.405 . . . . 0.0 110.825 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -68.65 -25.57 64.89 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.93 83.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 74.9 mt -68.35 -43.5 77.35 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -50.54 -51.82 44.44 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.293 1.437 . . . . 0.0 109.536 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -54.42 -43.46 71.56 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.324 1.849 . . . . 0.0 110.757 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.437 ' O ' HD12 ' A' ' 368' ' ' ILE . . . -68.86 -50.75 47.15 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 118.725 -0.655 . . . . 0.0 109.488 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -52.01 -38.71 57.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.757 1.223 . . . . 0.0 108.773 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.2 m -59.68 -54.3 47.96 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.953 1.301 . . . . 0.0 108.283 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -58.56 -39.95 81.7 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.764 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.437 HD12 ' O ' ' A' ' 364' ' ' ALA . 1.6 mp -66.93 -41.55 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.074 0.852 . . . . 0.0 109.653 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 38.7 p -80.32 -11.66 59.69 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 36.3 tttm . . . . . 0 C--O 1.245 0.82 0 C-N-CA 126.036 1.734 . . . . 0.0 108.45 178.661 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.403 HG13 ' H ' ' A' ' 2' ' ' ILE . 1.3 mt -63.47 146.46 12.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 112.454 -2.157 . . . . 0.0 109.266 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -112.42 130.54 55.94 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.95 103.28 15.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.55 21.37 0.31 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.333 0.968 . . . . 0.0 114.344 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -143.56 155.55 44.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.721 1.76 . . . . 0.0 113.126 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.9 mt -137.72 151.37 48.14 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.101 1.76 . . . . 0.0 108.328 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 77.2 t -138.92 132.42 39.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 125.501 1.52 . . . . 0.0 108.431 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.7 mt -129.15 134.27 64.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.652 1.181 . . . . 0.0 108.116 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -118.68 157.22 27.87 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.957 1.303 . . . . 0.0 109.369 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.0 pt -144.97 165.63 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 125.631 1.572 . . . . 0.0 108.252 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -68.88 -33.29 73.55 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.014 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.19 -73.17 0.31 Allowed Glycine 0 C--N 1.342 0.876 0 C-N-CA 123.68 0.657 . . . . 0.0 113.37 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -70.85 26.9 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 129.424 3.089 . . . . 0.0 116.134 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -75.21 -45.79 38.1 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 125.123 1.369 . . . . 0.0 114.615 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.0 42.46 0.72 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 126.841 2.163 . . . . 0.0 111.96 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.525 ' CE1' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -56.68 -16.93 7.21 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -178.692 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -52.62 -45.14 66.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 121.826 2.103 . . . . 0.0 112.056 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.09 -40.22 35.32 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 121.435 0.464 . . . . 0.0 112.032 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.604 ' HA ' HG22 ' A' ' 293' ' ' VAL . 33.1 tp -64.77 -36.86 85.67 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.771 1.228 . . . . 0.0 114.242 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.37 64.55 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.675 0.79 . . . . 0.0 111.051 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -59.62 -33.99 72.21 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.96 -40.86 90.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.97 -34.99 83.37 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -68.58 -47.39 66.9 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 118.752 1.276 . . . . 0.0 108.322 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.05 -59.39 4.81 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.378 1.071 . . . . 0.0 109.101 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -56.5 -44.95 81.22 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.881 -0.581 . . . . 0.0 111.31 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -64.32 -16.38 62.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 120.395 1.452 . . . . 0.0 111.929 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -96.86 -16.36 20.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 117.295 -1.336 . . . . 0.0 112.708 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -106.54 -37.59 6.42 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 124.791 1.307 . . . . 0.0 110.434 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.3 p -101.15 -34.0 9.87 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.147 -0.97 . . . . 0.0 110.739 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.06 -11.79 67.37 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 121.146 -0.971 . . . . 0.0 113.396 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.0 132.9 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -67.51 150.03 49.39 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.161 -0.962 . . . . 0.0 109.677 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.9 t -140.49 97.78 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.585 1.554 . . . . 0.0 108.976 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.7 m -77.14 153.48 34.17 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.525 HG22 ' CE1' ' A' ' 17' ' ' TYR . 2.3 t -138.55 110.62 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 104.224 -2.509 . . . . 0.0 104.224 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -135.14 161.55 35.01 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -127.26 61.01 46.27 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.463 1.505 . . . . 0.0 113.969 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.46 143.24 38.23 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.424 1.416 . . . . 0.0 110.35 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -97.2 21.6 9.71 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.4 3.09 2.1 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.93 -22.75 5.96 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.005 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -48.84 -34.56 12.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.442 1.497 . . . . 0.0 112.096 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -122.32 -24.42 5.04 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.109 0.963 . . . . 0.0 111.937 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.78 -39.25 76.73 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.008 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -55.96 -59.53 11.39 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 119.988 1.267 . . . . 0.0 109.259 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.05 -29.4 89.16 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 CA-C-N 120.909 1.36 . . . . 0.0 113.916 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -77.23 0.49 21.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.101 1.319 . . . . 0.0 113.645 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.43 HG12 ' C ' ' A' ' 55' ' ' ASP . 3.7 t -131.73 -32.97 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.76 -26.65 60.76 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.837 -1.165 . . . . 0.0 110.053 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.86 -30.66 65.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.787 -0.571 . . . . 0.0 109.803 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 p -90.94 -16.45 28.06 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.351 1.06 . . . . 0.0 112.834 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 96.96 26.19 10.64 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-O 118.178 -1.346 . . . . 0.0 116.388 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.43 ' C ' HG12 ' A' ' 50' ' ' VAL . 57.2 m-20 -131.01 5.91 4.56 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.828 1.314 . . . . 0.0 110.084 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.1 -178.54 47.43 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.447 1.499 . . . . 0.0 114.941 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.34 169.78 9.0 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.416 2.077 . . . . 0.0 109.938 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -105.71 -16.8 14.58 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -139.38 145.66 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.45 144.8 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.691 1.196 . . . . 0.0 108.955 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -129.49 108.63 10.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.933 1.693 . . . . 0.0 110.429 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -152.41 -174.53 4.93 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.174 -0.954 . . . . 0.0 110.869 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.03 158.04 36.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.816 1.246 . . . . 0.0 108.558 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -63.8 -25.75 68.32 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.376 -0.203 . . . . 0.0 111.322 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.48 -62.01 2.2 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 126.027 1.731 . . . . 0.0 111.398 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -61.5 -19.88 62.57 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.492 0.717 . . . . 0.0 112.601 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -78.93 -20.75 48.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.789 -0.624 . . . . 0.0 111.896 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.56 -39.57 95.19 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.13 -50.5 5.79 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.765 1.174 . . . . 0.0 111.613 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -55.41 -42.66 74.4 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.422 1.111 . . . . 0.0 112.215 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.92 -43.13 79.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.639 0.654 . . . . 0.0 110.451 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -55.01 -50.8 68.13 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.487 1.115 . . . . 0.0 108.81 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 m -63.85 -5.11 3.85 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.319 1.848 . . . . 0.0 113.505 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.17 10.33 86.18 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.36 1.457 . . . . 0.0 113.392 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.7 mt -73.18 -18.95 61.21 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.305 1.053 . . . . 0.0 110.851 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.71 146.15 26.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.96 0.8 . . . . 0.0 109.949 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -93.1 -178.9 4.93 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.684 1.994 . . . . 0.0 110.321 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -72.43 128.61 36.14 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.623 1.569 . . . . 0.0 107.629 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.15 159.19 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.836 0.744 . . . . 0.0 110.67 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 m 47.27 75.03 0.71 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.468 2.307 . . . . 0.0 113.517 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -67.06 -45.13 4.25 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.0 1.8 . . . . 0.0 111.878 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -94.15 132.81 38.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.071 1.348 . . . . 0.0 112.019 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -65.13 -31.63 72.93 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.83 -36.41 64.97 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 121.081 1.764 . . . . 0.0 112.137 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -59.82 -30.78 69.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.783 0.719 . . . . 0.0 110.772 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -70.35 -29.83 66.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.99 -1.068 . . . . 0.0 112.124 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -78.39 -21.55 49.19 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.352 0.661 . . . . 0.0 111.47 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -69.44 -12.51 61.71 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.176 -0.953 . . . . 0.0 111.672 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.458 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 11.0 mt -120.61 164.04 17.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.127 1.771 . . . . 0.0 111.555 -177.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -66.2 160.65 63.15 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.73 -49.3 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.66 2.24 . . . . 0.0 112.491 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -51.78 -41.08 61.38 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.856 0.862 . . . . 0.0 113.229 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -28.12 65.54 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.495 -0.753 . . . . 0.0 111.177 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.458 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 73.9 m95 -78.03 -46.57 20.57 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -21.22 23.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.252 1.021 . . . . 0.0 112.507 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.15 -28.9 57.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.488 1.515 . . . . 0.0 111.085 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.71 0.64 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.531 1.532 . . . . 0.0 113.056 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -65.27 162.87 16.46 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.862 0.756 . . . . 0.0 109.515 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -145.51 176.84 9.3 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.283 1.833 . . . . 0.0 107.256 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -55.09 104.47 0.12 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.451 1.1 . . . . 0.0 109.186 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.16 -85.12 0.31 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 125.161 1.362 . . . . 0.0 111.317 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 170.09 4.29 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.711 1.604 . . . . 0.0 112.5 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -98.91 169.97 9.07 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.452 1.501 . . . . 0.0 108.531 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.7 pt -135.55 -37.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.37 172.34 14.58 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.914 1.686 . . . . 0.0 108.419 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.66 149.81 69.28 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.359 0.664 . . . . 0.0 111.352 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.22 140.84 38.1 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 124.645 3.563 . . . . 0.0 110.902 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.3 mm -121.04 -45.5 2.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 124.853 1.261 . . . . 0.0 112.808 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.43 161.53 37.82 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.891 0.876 . . . . 0.0 109.63 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.65 107.37 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -152.77 135.72 15.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.03 74.52 1.49 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.813 0.845 . . . . 0.0 109.237 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.3 pp -161.9 158.84 25.95 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.66 1.184 . . . . 0.0 110.277 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.9 p 156.65 153.6 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.519 1 C-N-CA 131.947 4.099 . . . . 0.0 110.798 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 245' ' ' THR . 36.6 tp -147.1 157.25 43.54 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 73.9 mt -114.22 128.73 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 120.396 -1.44 . . . . 0.0 110.142 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.81 143.79 23.0 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.561 1.944 . . . . 0.0 106.703 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -63.72 159.36 19.38 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.183 1.393 . . . . 0.0 113.94 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.71 14.2 0.11 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.603 1.961 . . . . 0.0 113.306 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.85 159.22 35.0 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.159 1.384 . . . . 0.0 112.746 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -78.26 9.37 3.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.459 1.104 . . . . 0.0 113.902 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -109.5 79.24 1.27 Allowed Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 119.753 1.161 . . . . 0.0 111.587 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.07 129.74 10.74 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.512 2.141 . . . . 0.0 108.612 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -131.95 58.35 36.71 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.154 1.382 . . . . 0.0 109.624 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.8 112.46 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.811 3.007 . . . . 0.0 112.263 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.15 144.86 27.04 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.741 2.294 . . . . 0.0 110.214 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -100.37 -38.48 8.42 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.824 1.25 . . . . 0.0 112.677 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 t -157.22 157.17 33.84 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.585 1.084 . . . . 0.0 110.881 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -58.29 -30.42 66.62 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 118.334 -0.841 . . . . 0.0 113.12 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -66.36 -14.48 62.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.504 1.047 . . . . 0.0 112.052 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -101.63 -18.74 15.74 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.012 1.325 . . . . 0.0 111.239 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 26.1 mm -49.99 -56.24 18.94 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 120.736 1.607 . . . . 0.0 111.501 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.1 -20.07 25.54 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 CA-C-N 119.88 0.993 . . . . 0.0 112.557 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.65 -34.48 46.37 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 124.932 1.293 . . . . 0.0 111.453 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.8 -31.39 28.21 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.59 1.556 . . . . 0.0 108.55 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -59.43 -44.07 92.95 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.325 0.65 . . . . 0.0 109.625 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -65.51 -31.26 72.23 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 122.839 0.456 . . . . 0.0 111.319 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -69.79 -47.27 63.49 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 146' ' ' ALA . 26.7 mt -66.57 -32.85 74.46 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.627 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -70.68 -27.73 64.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.098 0.863 . . . . 0.0 110.076 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.84 -27.79 63.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 118.219 0.463 . . . . 0.0 110.481 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.1 -1.42 20.42 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.377 0.671 . . . . 0.0 112.569 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -177.22 -101.6 0.15 Allowed Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 118.989 0.813 . . . . 0.0 112.36 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -137.23 -179.5 5.76 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.942 2.097 . . . . 0.0 109.208 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 p -51.59 172.27 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.438 1.895 . . . . 0.0 115.569 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.459 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -106.19 -55.46 2.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.755 1.622 . . . . 0.0 112.343 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.4 tp -133.1 146.39 51.6 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.814 1.246 . . . . 0.0 110.844 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 90.2 mtp -146.1 127.99 15.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -149.27 166.84 27.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.17 136.73 33.08 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.57 -4.58 9.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.165 0.986 . . . . 0.0 108.912 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -65.56 -19.99 66.15 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 125.297 1.439 . . . . 0.0 110.823 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -127.8 143.14 46.55 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.094 0.958 . . . . 0.0 109.493 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -72.49 -12.75 27.36 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.095 3.197 . . . . 0.0 114.121 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -51.41 -45.76 62.67 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.276 0.944 . . . . 0.0 111.948 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.12 -37.71 19.93 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-O 119.157 -0.449 . . . . 0.0 112.128 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.0 p -72.93 -14.03 61.38 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.102 0.864 . . . . 0.0 111.448 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -53.84 -63.05 2.91 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.574 1.149 . . . . 0.0 111.866 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.14 -6.18 10.92 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.226 1.951 . . . . 0.0 114.325 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 28.2 tp -82.5 -62.88 1.49 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.448 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 12.5 pt -58.77 -42.2 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.35 2.61 3.65 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.59 -37.07 82.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -86.86 -48.52 8.11 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.43 1.014 . . . . 0.0 108.606 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.71 63.55 0.07 OUTLIER Glycine 0 C--N 1.336 0.553 0 CA-C-N 118.964 0.802 . . . . 0.0 113.632 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -117.18 140.42 15.82 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 105.835 -2.906 . . . . 0.0 105.835 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -151.36 151.32 31.58 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.298 1.549 . . . . 0.0 109.315 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.13 -65.21 1.0 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -136.71 150.35 48.4 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.624 0.77 . . . . 0.0 111.056 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -86.03 149.9 24.84 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -150.85 106.2 3.35 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.73 57.31 4.43 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.734 1.614 . . . . 0.0 112.276 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 49.99 16.39 0.23 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.092 2.157 . . . . 0.0 116.522 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.41 -15.34 0.06 OUTLIER Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.392 0.996 . . . . 0.0 112.282 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -117.67 130.54 56.41 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -126.7 131.17 51.44 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 124.944 1.402 . . . . 0.0 108.315 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.2 146.48 33.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.144 0.973 . . . . 0.0 109.955 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -0.71 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.827 1.651 . . . . 0.0 110.749 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -80.1 -37.4 33.8 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -81.93 100.71 9.81 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.22 150.65 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.419 1.487 . . . . 0.0 109.889 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.52 16.17 5.42 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.032 0.825 . . . . 0.0 115.149 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.0 t -54.83 -33.24 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.181 1.792 . . . . 0.0 115.01 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.61 14.48 12.69 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.27 0.628 . . . . 0.0 111.68 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -62.18 164.93 6.29 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.437 0.636 . . . . 0.0 110.1 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -50.95 -34.63 29.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.953 0.901 . . . . 0.0 112.093 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.21 -47.01 47.18 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.968 0.804 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -55.89 -48.78 74.99 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.969 -0.724 . . . . 0.0 109.415 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -67.04 -40.42 87.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 117.726 -1.131 . . . . 0.0 111.025 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.55 -49.64 76.68 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.133 0.879 . . . . 0.0 111.563 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -71.55 -27.93 70.34 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.319 -0.944 . . . . 0.0 112.057 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 14.2 tp -77.35 -34.14 55.22 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.773 1.287 . . . . 0.0 112.355 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.4 t -55.9 -45.31 78.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 117.452 -1.261 . . . . 0.0 108.805 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -52.39 -53.91 38.86 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.271 1.428 . . . . 0.0 111.237 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.6 tt -54.12 -48.39 70.81 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.122 0.969 . . . . 0.0 111.278 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 38.6 t -73.41 -21.95 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.39 0.676 . . . . 0.0 110.492 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.419 ' HA ' ' CE ' ' A' ' 200' ' ' LYS . 2.8 t70 -63.37 -36.85 85.1 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.768 1.227 . . . . 0.0 109.749 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.8 mt -71.9 -41.73 67.59 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 79.5 mt -63.09 -39.48 85.38 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.419 ' CE ' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -54.71 -34.27 62.18 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.817 1.247 . . . . 0.0 109.769 178.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -91.47 -9.93 42.73 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.693 1.197 . . . . 0.0 111.906 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 64.82 6.53 3.38 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 128.735 2.814 . . . . 0.0 113.387 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -67.54 -36.22 80.56 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.541 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 8.4 tpt -77.96 154.07 31.91 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -88.43 91.18 8.7 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.459 -0.775 . . . . 0.0 110.573 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.3 -28.93 70.05 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.376 -0.827 . . . . 0.0 112.49 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.11 -4.65 48.47 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.8 m -71.46 126.98 31.09 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.274 -1.516 . . . . 0.0 109.053 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.03 -178.08 3.86 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.863 1.665 . . . . 0.0 107.095 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -58.11 -37.74 75.12 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.093 0.557 . . . . 0.0 111.404 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 39.5 m -73.59 -40.1 64.12 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.54 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 19.4 mm -64.58 -50.99 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 120.839 1.654 . . . . 0.0 109.053 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -55.94 -44.06 78.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.854 0.752 . . . . 0.0 110.631 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -67.48 -40.69 85.26 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.555 0.742 . . . . 0.0 111.762 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.31 -56.51 8.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.699 0.8 . . . . 0.0 109.594 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.99 -39.44 66.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.415 1.486 . . . . 0.0 110.519 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -60.15 -45.93 91.39 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -64.06 -30.54 71.61 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.076 -0.488 . . . . 0.0 111.793 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -77.21 -11.38 59.82 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.969 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.97 19.82 49.34 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 125.174 1.369 . . . . 0.0 112.21 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.07 -48.76 19.58 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 118.385 1.093 . . . . 0.0 111.016 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -104.12 153.37 21.0 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -105.5 -25.38 12.34 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.676 0.79 . . . . 0.0 110.322 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -129.07 170.04 13.99 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.625 1.17 . . . . 0.0 109.716 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.7 t -161.06 178.92 8.86 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.182 1.793 . . . . 0.0 107.169 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.1 mt -134.32 139.55 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -148.2 170.9 16.84 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -138.9 -177.91 15.84 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -58.56 -39.36 83.7 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 CA-C-N 119.069 1.435 . . . . 0.0 109.063 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -161.14 164.94 30.27 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 127.24 2.216 . . . . 0.0 106.374 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -133.61 152.64 51.93 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.072 2.149 . . . . 0.0 106.467 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' TRP . . . . . 0.4 ' CZ3' ' HB2' ' A' ' 340' ' ' TRP . 8.2 t90 -75.94 160.75 29.56 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 t 54.4 26.65 7.25 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 119.274 0.943 . . . . 0.0 112.238 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -58.28 114.4 2.39 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.128 0.971 . . . . 0.0 109.704 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.2 tt -97.25 -37.9 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.46 1.104 . . . . 0.0 110.888 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -98.79 -89.6 0.31 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.332 1.053 . . . . 0.0 108.759 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.3 t -153.12 -164.83 2.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.299 1.047 . . . . 0.0 111.004 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.3 m -132.53 133.4 43.7 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 130.873 3.669 . . . . 0.0 101.177 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -130.5 123.35 29.48 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 120.564 1.529 . . . . 0.0 110.85 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.3 m -52.51 140.9 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 126.444 1.897 . . . . 0.0 113.826 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.27 172.14 10.71 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.146 0.978 . . . . 0.0 109.047 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -163.67 -177.56 5.26 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.706 1.203 . . . . 0.0 109.204 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 64.74 -159.6 42.5 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.0 p -160.48 120.77 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.53 1.132 . . . . 0.0 108.728 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' A' ' 115' ' ' LEU . 5.8 t -153.23 -173.64 4.65 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.697 -0.627 . . . . 0.0 110.827 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 38.6 t -72.97 167.14 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 127.962 2.505 . . . . 0.0 109.285 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.55 129.64 17.63 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.0 123.52 10.1 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.418 2.079 . . . . 0.0 109.207 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.5 p -100.53 169.28 9.17 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -77.85 167.11 22.03 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -51.35 104.64 0.08 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 126.003 1.721 . . . . 0.0 110.249 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.52 8.21 44.69 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 117.97 -1.461 . . . . 0.0 116.556 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.59 124.25 10.35 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 121.569 2.685 . . . . 0.0 112.193 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.51 123.25 8.49 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.215 3.276 . . . . 0.0 113.576 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 20.0 m -62.37 159.06 16.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.578 1.151 . . . . 0.0 111.621 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -147.35 100.53 3.83 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.902 1.281 . . . . 0.0 111.172 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -69.97 -63.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.693 0 N-CA-C 107.274 -1.856 . . . . 0.0 107.274 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -160.66 -173.15 3.81 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.153 2.981 . . . . 0.0 106.702 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.6 120.46 56.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 126.811 2.044 . . . . 0.0 106.829 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -103.05 132.61 11.08 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.46 140.49 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.9 tt -81.35 140.42 34.77 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.3 m -126.9 154.28 44.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 122.903 0.481 . . . . 0.0 111.286 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -132.67 146.2 51.68 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.153 0.981 . . . . 0.0 108.579 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -139.85 148.62 20.19 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 82.6 mt -95.12 137.36 23.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -72.13 133.5 45.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.046 0.385 . . . . 0.0 110.296 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -79.29 -25.11 42.5 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.031 -0.985 . . . . 0.0 113.33 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ALA . . . . . 0.42 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -74.22 -12.69 60.64 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.531 1.06 . . . . 0.0 113.325 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 61.9 m -60.15 165.51 4.89 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.49 -41.23 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 CA-C-N 120.59 1.246 . . . . 0.0 110.58 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -122.71 168.55 12.07 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.717 1.607 . . . . 0.0 108.164 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -132.88 -26.73 1.73 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.199 1.399 . . . . 0.0 110.303 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -61.47 -40.1 93.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.32 -34.56 72.49 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.827 -1.171 . . . . 0.0 111.195 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.61 -45.43 37.46 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.134 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -36.54 83.96 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.784 0.72 . . . . 0.0 109.154 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -64.78 -46.11 83.46 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -60.84 -37.41 81.98 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 120.102 1.319 . . . . 0.0 108.175 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.3 mp -77.24 -0.05 23.82 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 117.63 -1.176 . . . . 0.0 114.019 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -137.58 2.31 2.44 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 120.867 1.667 . . . . 0.0 113.587 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.52 -55.94 3.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.949 1.249 . . . . 0.0 110.613 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -126.11 -29.25 3.06 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.784 1.634 . . . . 0.0 113.299 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -55.21 -35.1 64.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.486 1.039 . . . . 0.0 111.885 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.36 74.57 0.96 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.329 1.052 . . . . 0.0 108.41 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 22.9 p -137.11 163.39 30.92 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.19 -17.41 63.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.25 1.82 . . . . 0.0 112.628 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -116.07 -36.56 4.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.602 1.561 . . . . 0.0 110.927 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.57 -31.04 59.18 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-O 118.846 -0.974 . . . . 0.0 110.883 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 29.7 mt -73.34 -41.79 63.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 119.577 1.689 . . . . 0.0 106.631 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -56.13 -47.32 78.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.555 1.142 . . . . 0.0 110.667 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.75 -29.44 64.8 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' A' ' 20' ' ' LEU . 48.5 t -91.08 -34.32 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 C-N-CA 124.477 1.111 . . . . 0.0 110.119 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -62.13 -30.4 71.0 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.067 0.849 . . . . 0.0 110.158 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -61.92 -17.81 58.09 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.969 0.908 . . . . 0.0 111.216 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -122.4 -76.27 0.59 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -61.66 142.69 94.33 Favored Pre-proline 0 C--O 1.234 0.272 0 O-C-N 121.189 -0.944 . . . . 0.0 111.457 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.08 93.1 1.03 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 N-CA-C 106.415 -2.186 . . . . 0.0 106.415 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.3 mt -77.23 -19.58 56.43 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 117.234 -1.365 . . . . 0.0 111.16 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 55.12 -138.98 41.89 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -85.75 165.57 16.8 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.42 155.56 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 O-C-N 120.306 -1.496 . . . . 0.0 110.814 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.52 70.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.111 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.21 101.05 0.26 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.872 1.269 . . . . 0.0 111.089 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -65.37 -20.73 66.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.785 178.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.91 -21.62 62.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.011 0.924 . . . . 0.0 111.494 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -113.6 -11.13 13.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.977 1.262 . . . . 0.0 110.559 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -59.86 -41.78 92.23 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.451 1.1 . . . . 0.0 108.355 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.88 -17.02 61.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.917 1.287 . . . . 0.0 112.817 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -95.96 -52.61 3.98 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.444 ' HB3' HG21 ' A' ' 317' ' ' ILE . 8.5 mt -56.62 -38.71 72.45 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.479 -0.763 . . . . 0.0 110.906 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.59 -6.66 5.58 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.262 1.425 . . . . 0.0 114.121 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -63.23 -13.61 39.75 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.4 1.08 . . . . 0.0 111.439 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -123.66 139.54 32.39 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.27 1.028 . . . . 0.0 109.255 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.47 -20.28 48.26 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.908 2.405 . . . . 0.0 112.941 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -63.93 -24.65 67.81 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.737 0.699 . . . . 0.0 112.684 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' A' ' 311' ' ' LEU . 2.3 mp -96.09 -56.84 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.39 -51.77 10.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.318 1.047 . . . . 0.0 112.576 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.23 -42.76 91.8 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.616 -0.678 . . . . 0.0 112.334 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 14.5 m -66.57 -34.19 77.35 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -53.76 43.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -55.49 -36.14 66.33 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.494 0.718 . . . . 0.0 111.432 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -67.7 -31.05 70.74 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.796 0.839 . . . . 0.0 111.128 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -83.61 -34.06 25.18 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.595 -0.691 . . . . 0.0 109.667 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -65.64 -48.25 72.84 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 125.191 1.396 . . . . 0.0 110.303 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -2.49 21.86 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -108.89 177.09 20.27 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-O 122.561 1.089 . . . . 0.0 113.481 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.2 161.84 29.2 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 127.694 2.398 . . . . 0.0 109.596 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 32.4 mt -90.86 155.85 3.05 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 7.4 ptp -60.86 148.57 82.91 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.611 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.98 -179.65 4.84 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 124.099 3.2 . . . . 0.0 114.444 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -133.18 5.42 3.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.161 1.784 . . . . 0.0 112.277 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.6 pt -89.1 144.56 32.81 Favored Pre-proline 0 CA--C 1.537 0.452 0 O-C-N 121.233 -0.917 . . . . 0.0 109.287 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.01 -12.71 32.94 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.108 2.539 . . . . 0.0 114.398 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.57 -20.89 35.32 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.277 1.031 . . . . 0.0 111.792 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.0 mmm -62.06 -24.76 67.29 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.341 -0.849 . . . . 0.0 110.58 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 61.0 p -63.75 -28.16 69.69 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.768 -1.208 . . . . 0.0 110.05 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -90.45 -30.66 17.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.808 1.643 . . . . 0.0 111.266 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 343' ' ' VAL . 56.6 t80 -53.68 -60.77 2.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.391 1.077 . . . . 0.0 109.124 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 232' ' ' TRP . 66.9 m95 -56.85 -43.01 80.7 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.745 0.418 . . . . 0.0 111.215 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -60.85 -27.47 68.12 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.05 0.54 . . . . 0.0 111.952 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.404 ' HB3' HD11 ' A' ' 368' ' ' ILE . . . -81.12 -61.74 1.86 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.613 0.765 . . . . 0.0 110.538 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 339' ' ' PHE . 1.6 m -56.44 -25.84 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.364 0.666 . . . . 0.0 111.677 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -54.0 -56.8 14.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.967 0.907 . . . . 0.0 108.694 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' THR . . . . . 0.653 HG21 HH22 ' A' ' 367' ' ' ARG . 88.6 m -66.3 -38.35 87.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.186 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.04 77.05 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.47 -49.87 75.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 124.652 1.181 . . . . 0.0 109.024 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 32.7 mm -62.71 -38.55 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.148 0.886 . . . . 0.0 110.591 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -61.15 -41.91 97.6 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.122 -0.986 . . . . 0.0 110.774 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.35 -46.72 59.83 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 123.275 0.359 . . . . 0.0 110.328 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.93 98.34 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.703 1.201 . . . . 0.0 113.327 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 19.2 m -87.93 -1.32 57.91 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.659 0.783 . . . . 0.0 110.297 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 71.05 14.11 73.29 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-O 119.433 -0.649 . . . . 0.0 114.608 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -65.56 -26.97 68.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.541 1.171 . . . . 0.0 109.031 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -153.76 167.63 28.99 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.957 0.903 . . . . 0.0 109.65 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.6 m -72.26 156.14 39.44 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 39.6 t -54.95 -56.4 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.93 -51.47 40.78 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.641 2.376 . . . . 0.0 112.894 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -72.57 -32.69 66.23 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.86 71.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 24.6 mt -70.18 -43.35 70.97 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -51.76 -54.84 24.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.969 1.707 . . . . 0.0 108.178 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -52.31 -47.58 65.87 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.381 1.072 . . . . 0.0 109.317 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.92 -46.6 87.02 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 117.597 -1.192 . . . . 0.0 111.736 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.13 -39.78 72.75 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.406 1.003 . . . . 0.0 108.708 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 3.1 m -62.58 -25.08 67.89 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.184 0.993 . . . . 0.0 112.235 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.653 HH22 HG21 ' A' ' 345' ' ' THR . 93.2 mtt180 -83.07 -14.32 54.0 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.642 -1.287 . . . . 0.0 112.085 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.404 HD11 ' HB3' ' A' ' 342' ' ' ALA . 9.9 mt -105.85 -30.47 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.556 0.616 . . . . 0.0 109.426 -178.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 24.0 p -69.42 -37.87 77.63 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 27.6 tptt . . . . . 0 C--O 1.246 0.886 0 C-N-CA 126.371 1.868 . . . . 0.0 107.933 178.413 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.2 mt -140.44 167.63 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -79.16 103.78 9.33 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -83.66 175.31 9.8 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.163 0.985 . . . . 0.0 108.684 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.64 35.62 86.59 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.374 1.464 . . . . 0.0 115.651 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -147.11 167.69 23.48 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 119.246 1.523 . . . . 0.0 112.658 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.0 mt -150.08 145.6 26.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.519 2.728 . . . . 0.0 105.664 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.445 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 50.4 t -139.56 134.68 39.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.9 mt -125.6 136.21 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.079 1.352 . . . . 0.0 110.092 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -127.07 154.66 44.41 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.0 pt -145.21 163.46 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 123.597 0.759 . . . . 0.0 111.348 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -0.95 2.27 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.52 -76.01 0.22 Allowed Glycine 0 C--N 1.332 0.354 0 CA-C-N 120.098 1.317 . . . . 0.0 112.438 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -63.26 17.11 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 130.121 3.369 . . . . 0.0 115.219 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -84.9 165.79 17.36 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.733 1.213 . . . . 0.0 112.309 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.02 83.14 1.6 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 103.466 -3.854 . . . . 0.0 103.466 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -95.59 -20.7 18.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -58.73 -42.05 87.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.699 1.136 . . . . 0.0 110.934 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.96 -41.39 40.91 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.6 tp -59.76 -43.13 94.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.08 0.94 . . . . 0.0 111.434 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.15 -38.8 71.34 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.881 -1.057 . . . . 0.0 111.17 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -60.0 -35.51 75.19 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.121 0.873 . . . . 0.0 111.852 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.6 -42.97 90.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.91 -39.98 96.9 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -63.34 -51.31 66.5 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 118.542 1.171 . . . . 0.0 108.695 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -53.71 -57.65 10.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.689 1.195 . . . . 0.0 108.544 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -58.01 -45.17 87.28 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.879 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -66.31 -8.29 24.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.036 1.289 . . . . 0.0 111.25 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -109.08 -8.28 15.19 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 119.994 -1.691 . . . . 0.0 112.657 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -110.79 -38.26 5.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.898 1.279 . . . . 0.0 108.801 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.9 p -104.16 -32.71 9.02 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.016 0.926 . . . . 0.0 111.249 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.47 -12.09 69.38 Favored Glycine 0 C--N 1.342 0.904 0 O-C-N 121.452 -0.78 . . . . 0.0 111.787 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.2 128.79 24.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -60.09 138.76 57.81 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.972 0.509 . . . . 0.0 111.22 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.05 119.73 17.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.8 m -114.62 148.88 37.48 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -137.29 113.64 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -130.67 166.06 21.52 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.144 0.977 . . . . 0.0 108.621 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -127.27 57.16 21.98 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.52 0.728 . . . . 0.0 111.65 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.09 149.77 65.22 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 N-CA-C 107.71 -1.688 . . . . 0.0 107.71 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -95.97 -37.23 10.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 121.245 -0.91 . . . . 0.0 108.656 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' CE ' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -65.44 -3.84 4.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.117 1.367 . . . . 0.0 111.816 178.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.11 -31.63 13.84 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.296 1.038 . . . . 0.0 109.417 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -50.0 -29.87 9.49 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.289 2.236 . . . . 0.0 112.433 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -125.5 -20.62 4.7 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.433 1.015 . . . . 0.0 110.569 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -73.65 -49.96 23.36 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 116.384 -1.77 . . . . 0.0 111.548 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -45.87 -57.58 7.76 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 120.114 1.325 . . . . 0.0 109.879 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.09 -18.11 63.47 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 N-CA-C 115.896 1.46 . . . . 0.0 115.896 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -92.34 -46.34 7.74 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.959 1.708 . . . . 0.0 112.289 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 t -69.45 -39.37 78.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 O-C-N 121.261 -0.899 . . . . 0.0 108.665 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.45 -16.34 61.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.402 -0.812 . . . . 0.0 110.847 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.34 7.43 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.072 0.949 . . . . 0.0 110.912 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -130.73 -39.6 1.24 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.764 2.026 . . . . 0.0 106.414 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.56 6.77 12.76 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 124.564 1.078 . . . . 0.0 114.737 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.45 -0.52 54.69 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.036 1.418 . . . . 0.0 111.238 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.73 -175.0 30.61 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 126.972 2.225 . . . . 0.0 116.529 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -67.35 -178.76 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.377 3.385 . . . . 0.0 112.0 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 9.9 m-20 -115.81 -20.03 10.21 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.538 HD11 ' HB1' ' A' ' 276' ' ' ALA . 17.5 mt -141.68 143.62 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.14 144.08 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.832 1.653 . . . . 0.0 108.144 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -131.28 114.66 15.3 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.836 1.654 . . . . 0.0 110.358 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -156.04 172.84 17.72 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.997 0.817 . . . . 0.0 111.538 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.43 149.31 50.61 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -55.6 -31.75 62.51 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.09 -12.76 61.97 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -109.44 -0.65 18.83 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.971 1.26 . . . . 0.0 109.544 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -92.88 -11.52 33.3 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.292 1.837 . . . . 0.0 112.225 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.62 -10.39 86.26 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.638 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.12 -60.61 1.17 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.087 1.327 . . . . 0.0 111.007 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -43.91 -44.14 6.89 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.543 1.537 . . . . 0.0 114.692 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -70.56 -41.5 72.36 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.085 0.857 . . . . 0.0 110.946 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -36.31 70.58 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.12 0.968 . . . . 0.0 109.003 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 m -67.99 -44.74 75.92 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.358 1.063 . . . . 0.0 108.697 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.77 -2.24 8.01 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.978 1.751 . . . . 0.0 113.345 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.0 mp -68.79 -11.0 59.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.514 1.657 . . . . 0.0 114.461 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 71' ' ' ALA . 76.5 mt -108.85 129.36 55.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.324 0.966 . . . . 0.0 108.511 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.84 167.22 13.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.172 1.789 . . . . 0.0 110.701 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -69.1 101.5 1.45 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.471 1.108 . . . . 0.0 109.656 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 pp -76.28 165.56 3.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 124.491 1.116 . . . . 0.0 111.424 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.4 m 48.08 97.71 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 128.581 2.752 . . . . 0.0 114.908 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.31 -22.95 21.3 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.916 2.411 . . . . 0.0 114.135 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -133.95 151.91 51.66 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -60.98 -32.68 72.24 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.5 1.52 . . . . 0.0 112.719 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.9 -42.12 65.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 120.07 1.305 . . . . 0.0 112.303 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.69 -30.72 71.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.886 0.475 . . . . 0.0 110.894 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -69.13 -37.42 78.31 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.142 -0.974 . . . . 0.0 111.379 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.26 -19.13 65.82 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.342 0.519 . . . . 0.0 111.484 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -79.08 -2.46 40.59 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.3 mt -130.38 151.6 50.69 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.329 1.052 . . . . 0.0 109.206 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -72.26 151.12 92.19 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 119.589 -0.845 . . . . 0.0 109.985 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.47 -45.47 3.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.282 3.322 . . . . 0.0 113.704 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -60.01 -33.51 72.09 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.428 1.013 . . . . 0.0 110.094 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.503 HG22 ' CB ' ' A' ' 107' ' ' PRO . 3.8 m -68.86 -36.19 77.83 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.806 0.843 . . . . 0.0 109.342 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -65.67 -45.18 83.88 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.141 0.977 . . . . 0.0 110.032 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.31 -33.71 13.88 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.438 1.495 . . . . 0.0 112.39 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.84 -35.27 22.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.207 1.403 . . . . 0.0 111.267 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.39 6.36 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.419 1.888 . . . . 0.0 113.328 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -69.02 156.67 38.23 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -138.5 175.59 9.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -62.97 111.18 2.05 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.596 0.758 . . . . 0.0 110.06 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.98 -77.76 0.67 Allowed Glycine 0 CA--C 1.522 0.514 0 C-N-CA 124.804 1.192 . . . . 0.0 114.169 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 166.03 22.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.06 0.944 . . . . 0.0 110.778 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.71 170.01 8.44 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.746 1.218 . . . . 0.0 110.052 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.1 pt -138.17 -35.42 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.72 176.93 11.54 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.235 1.414 . . . . 0.0 108.61 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -131.76 150.41 76.16 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.526 0.731 . . . . 0.0 110.94 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.503 ' CB ' HG22 ' A' ' 93' ' ' THR . 72.4 Cg_endo -72.57 151.95 53.37 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.591 2.86 . . . . 0.0 109.639 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mm -128.79 -45.09 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 123.972 0.909 . . . . 0.0 111.125 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.41 157.78 44.71 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 123.141 0.577 . . . . 0.0 112.007 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.7 t -132.4 100.15 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -127.34 121.52 31.24 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.998 1.319 . . . . 0.0 107.754 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.88 71.48 1.4 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.955 1.302 . . . . 0.0 109.025 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.14 151.12 9.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.806 0.842 . . . . 0.0 111.399 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 p -179.2 155.37 0.71 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.676 1.19 . . . . 0.0 111.062 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.5 tp -153.91 136.27 14.95 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.193 1.797 . . . . 0.0 108.193 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.1 mp -103.22 125.6 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -143.41 163.28 33.51 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.788 1.235 . . . . 0.0 110.208 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -85.02 141.23 30.45 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.113 1.365 . . . . 0.0 111.801 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -79.42 2.09 23.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.366 1.467 . . . . 0.0 112.316 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -63.94 166.19 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 121.02 -1.05 . . . . 0.0 111.435 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.58 -1.47 13.65 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.92 0.888 . . . . 0.0 111.534 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.0 tp -128.15 67.21 74.33 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 128.624 2.769 . . . . 0.0 105.767 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.68 -24.47 6.15 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.763 2.976 . . . . 0.0 114.873 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 46.35 71.61 1.51 Allowed Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 127.024 2.13 . . . . 0.0 114.598 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.69 119.63 6.55 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.22 2.613 . . . . 0.0 107.99 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -81.53 162.98 19.27 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.901 1.734 . . . . 0.0 112.925 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -126.5 -9.14 6.28 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 t -168.26 154.49 7.27 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.401 ' CE2' HD13 ' A' ' 160' ' ' LEU . 6.2 m95 -69.31 -18.94 63.88 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.947 -0.471 . . . . 0.0 111.061 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -75.43 -18.8 59.81 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.916 0.78 . . . . 0.0 110.291 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -87.22 -26.39 23.54 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.906 0.882 . . . . 0.0 109.783 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.1 mm -51.46 -60.43 5.87 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.0 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.83 -25.57 23.48 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 CA-C-N 120.631 1.261 . . . . 0.0 110.981 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.18 96.81 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.584 0.754 . . . . 0.0 109.227 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.9 tp -79.67 -27.89 40.78 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.705 1.202 . . . . 0.0 110.637 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -57.02 -46.36 82.41 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.788 0.722 . . . . 0.0 110.496 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -69.52 -28.48 66.07 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -74.37 -44.62 51.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.1 mt -72.2 -34.68 68.56 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 119.167 -0.444 . . . . 0.0 109.824 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -66.12 -32.34 73.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.81 -15.87 63.28 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 119.082 -0.485 . . . . 0.0 112.166 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.69 5.95 6.15 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.879 1.272 . . . . 0.0 112.832 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.21 -101.98 0.16 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 118.97 0.805 . . . . 0.0 111.329 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -139.42 -176.23 4.46 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.091 1.357 . . . . 0.0 111.519 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.23 162.13 2.17 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.416 1.486 . . . . 0.0 114.185 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.27 -45.32 8.28 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.723 1.209 . . . . 0.0 111.466 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.6 tp -124.88 149.67 47.29 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.571 1.549 . . . . 0.0 107.289 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.0 ttm -154.33 103.08 2.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -121.96 158.98 27.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.525 1.057 . . . . 0.0 111.112 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.477 HD22 ' HB2' ' A' ' 210' ' ' TYR . 62.4 t-20 -69.14 98.15 0.98 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.98 -11.74 60.01 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.808 0.843 . . . . 0.0 110.883 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -78.88 -23.52 44.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.962 1.305 . . . . 0.0 113.683 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -95.38 132.01 28.59 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 119.976 1.262 . . . . 0.0 110.772 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.29 -22.8 39.46 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 121.897 1.731 . . . . 0.0 114.468 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -68.97 -14.89 63.31 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.263 1.392 . . . . 0.0 113.104 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -95.82 -25.56 15.98 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.486 1.039 . . . . 0.0 109.066 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 p -88.7 -28.51 20.52 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.838 -1.164 . . . . 0.0 110.516 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -51.69 79.02 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 120.069 -1.644 . . . . 0.0 113.239 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.0 -5.03 12.54 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.857 1.705 . . . . 0.0 111.651 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.401 HD13 ' CE2' ' A' ' 129' ' ' TRP . 15.1 tp -85.76 -62.33 1.55 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . 0.27 0.2 OUTLIER -70.52 -27.59 31.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.391 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.56 -25.09 36.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.721 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -49.46 -47.3 48.4 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.174 1.39 . . . . 0.0 113.023 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -66.29 -45.37 80.64 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.456 0.702 . . . . 0.0 111.291 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -176.43 -26.04 0.03 OUTLIER Glycine 0 C--N 1.338 0.653 0 CA-C-O 117.255 -1.858 . . . . 0.0 115.937 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -42.01 133.06 4.11 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.204 1.383 . . . . 0.0 112.876 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -139.01 122.81 17.62 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.35 -55.1 37.62 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.64 -0.662 . . . . 0.0 112.043 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -140.41 145.17 36.69 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -71.65 139.44 49.25 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 121.648 -0.658 . . . . 0.0 111.683 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -141.84 138.17 31.97 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.367 -2.456 . . . . 0.0 104.367 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -110.36 -120.33 0.28 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.455 1.102 . . . . 0.0 108.555 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -111.03 53.85 0.69 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 128.252 2.621 . . . . 0.0 108.011 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.02 9.29 34.71 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.694 -1.059 . . . . 0.0 113.568 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -118.47 125.17 49.35 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -116.96 133.79 55.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.716 2.006 . . . . 0.0 106.933 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -138.91 110.4 7.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.787 0.803 . . . . 0.0 111.641 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -2.73 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.09 1.356 . . . . 0.0 112.493 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -93.42 -0.59 56.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.06 1.344 . . . . 0.0 111.73 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -127.17 106.18 9.07 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.975 1.71 . . . . 0.0 107.247 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 96.9 t -122.76 122.9 67.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.995 2.118 . . . . 0.0 109.81 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -107.69 54.95 0.54 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.84 1.21 . . . . 0.0 114.555 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -93.9 -50.42 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 123.415 0.686 . . . . 0.0 109.287 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -81.83 63.39 6.06 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.504 1.522 . . . . 0.0 107.457 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -124.14 152.25 43.02 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.138 0.975 . . . . 0.0 109.77 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.24 -40.73 67.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.544 1.138 . . . . 0.0 112.638 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.18 -31.36 77.3 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.129 -0.982 . . . . 0.0 112.566 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.05 -48.13 54.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.791 0.796 . . . . 0.0 109.213 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -63.42 -35.41 80.33 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.747 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -55.01 -55.44 30.84 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.823 0.849 . . . . 0.0 112.023 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -69.52 -29.9 71.32 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.401 HD23 HG13 ' A' ' 357' ' ' VAL . 41.4 tp -67.87 -46.53 71.44 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.136 -1.214 . . . . 0.0 109.803 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -34.21 63.9 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.97 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -60.15 -58.76 7.12 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.065 1.302 . . . . 0.0 109.651 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.9 -48.69 77.62 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.336 1.055 . . . . 0.0 110.102 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.19 -28.04 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 123.634 0.774 . . . . 0.0 110.664 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.42 -37.17 86.59 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 119.509 1.05 . . . . 0.0 111.855 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.4 mt -71.95 -40.52 68.63 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.39 -41.46 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.151 0.98 . . . . 0.0 108.365 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -54.59 -41.12 69.53 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.496 1.119 . . . . 0.0 108.956 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -86.45 -1.84 57.93 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.396 1.879 . . . . 0.0 113.133 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.2 mptt 57.7 6.55 0.45 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.049 2.539 . . . . 0.0 114.842 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -76.72 -10.7 59.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.121 0.873 . . . . 0.0 111.802 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.9 tpt -95.24 150.99 19.63 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.377 1.071 . . . . 0.0 109.735 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -88.31 67.06 8.61 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.39 -19.67 3.72 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.665 1.986 . . . . 0.0 115.676 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -86.27 0.71 53.21 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.952 2.101 . . . . 0.0 111.811 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 42.7 m -70.12 131.24 43.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.684 1.129 . . . . 0.0 109.768 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -127.6 -178.63 4.55 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.906 1.682 . . . . 0.0 106.612 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' TYR . . . . . 0.477 ' HB2' HD22 ' A' ' 150' ' ' ASN . 40.3 t80 -56.03 -46.82 78.72 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.324 0.65 . . . . 0.0 112.52 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 68.4 m -56.28 -49.49 74.07 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.484 1.114 . . . . 0.0 110.519 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 53.4 mt -64.09 -43.87 97.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.605 0.762 . . . . 0.0 109.429 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.86 -53.71 52.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.982 0.913 . . . . 0.0 112.592 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -65.36 -33.66 76.49 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.783 -0.573 . . . . 0.0 110.144 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.9 -51.39 64.73 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.83 -33.98 73.86 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.59 0.632 . . . . 0.0 111.129 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -65.6 -45.58 82.65 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 177.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -60.63 -35.17 75.5 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -69.45 -16.45 63.48 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.979 -1.01 . . . . 0.0 111.759 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.0 13.86 65.66 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 119.591 1.087 . . . . 0.0 111.645 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -84.23 -43.27 15.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.099 0.95 . . . . 0.0 112.47 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 58.4 p -75.48 107.72 7.8 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.234 0.47 . . . . 0.0 111.66 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.91 -26.37 66.83 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -146.51 158.12 43.85 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.878 1.671 . . . . 0.0 110.127 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 5.9 t -149.5 154.0 38.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt -122.86 116.19 48.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -158.77 158.7 34.11 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.471 1.908 . . . . 0.0 108.949 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -66.03 -68.84 1.52 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.834 1.683 . . . . 0.0 114.723 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.7 109.17 2.39 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.338 2.692 . . . . 0.0 110.859 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -78.8 30.49 0.2 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.686 1.195 . . . . 0.0 111.083 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -51.73 138.31 23.69 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.433 1.093 . . . . 0.0 111.318 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -65.33 -14.8 61.63 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.029 1.332 . . . . 0.0 114.068 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.0 p -162.77 156.44 20.32 Favored 'General case' 0 C--O 1.241 0.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.42 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -148.28 -99.83 0.08 Allowed 'General case' 0 C--O 1.232 0.142 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.9 pt -68.98 -31.87 52.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 C-N-CA 124.284 1.034 . . . . 0.0 112.144 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -143.32 165.29 27.9 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 5.1 m -82.14 68.87 8.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 125.365 1.466 . . . . 0.0 109.052 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 70.0 m -78.4 86.6 4.45 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -61.86 70.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 127.471 2.309 . . . . 0.0 113.768 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 9.7 p -75.29 169.85 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 126.167 1.787 . . . . 0.0 109.328 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -103.03 166.03 10.68 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -114.17 156.3 24.5 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.775 0.83 . . . . 0.0 110.373 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 156.53 -166.86 33.42 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 125.6 1.572 . . . . 0.0 111.625 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 59.8 t -137.6 127.88 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.3 t -141.55 164.27 30.67 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 57.6 t -61.11 135.1 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -100.5 158.74 31.36 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.77 132.25 24.54 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 120.506 1.216 . . . . 0.0 109.383 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 25.4 p -116.57 172.83 6.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.086 1.354 . . . . 0.0 109.347 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -84.65 169.36 14.4 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.576 0.703 . . . . 0.0 110.249 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -62.13 117.99 6.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.59 11.91 57.93 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.63 145.18 18.08 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-N 121.351 2.575 . . . . 0.0 111.71 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.04 171.7 17.01 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 124.305 3.337 . . . . 0.0 111.289 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.6 p -93.12 137.01 32.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -129.27 74.84 80.76 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.468 1.907 . . . . 0.0 109.217 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.08 -83.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.706 2.271 . . . . 0.0 109.893 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.2 -179.08 6.49 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.806 2.042 . . . . 0.0 107.866 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.5 t -126.58 159.91 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -161.31 148.31 15.92 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 106.008 -2.837 . . . . 0.0 106.008 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.06 148.61 23.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 118.891 1.345 . . . . 0.0 112.083 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.0 tp -84.59 133.94 34.41 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.8 m -113.06 157.33 21.7 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.279 1.032 . . . . 0.0 111.595 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -135.5 138.5 43.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.476 1.11 . . . . 0.0 108.87 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.33 163.57 25.13 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 71.2 mt -109.57 142.66 21.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -74.18 116.08 14.41 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.51 -24.98 59.04 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.833 -0.604 . . . . 0.0 112.028 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -70.94 -9.46 57.9 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 118.195 -0.907 . . . . 0.0 113.302 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 6.9 t -62.56 144.24 95.89 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.4 -34.89 52.66 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.239 1.292 . . . . 0.0 109.887 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -141.73 109.53 5.74 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -14.53 63.02 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.691 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.6 -33.42 75.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.067 0.547 . . . . 0.0 111.05 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.38 -37.83 76.06 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.282 -0.886 . . . . 0.0 109.573 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.538 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -74.59 -45.94 41.92 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.777 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -34.41 78.06 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 118.862 -0.59 . . . . 0.0 110.114 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -73.29 -41.16 63.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.545 0.611 . . . . 0.0 109.593 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -58.35 -47.0 85.2 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.996 -1.065 . . . . 0.0 109.109 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.77 -45.57 81.99 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.528 -0.749 . . . . 0.0 111.571 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -77.01 -12.93 60.0 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -106.44 -17.62 14.22 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.727 1.603 . . . . 0.0 113.306 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -136.99 -51.11 0.66 Allowed 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 119.51 1.05 . . . . 0.0 111.484 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -5.69 20.05 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.97 31.03 6.97 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.013 -1.68 . . . . 0.0 111.523 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 70.7 p -116.31 163.66 15.68 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -40.79 95.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.206 1.403 . . . . 0.0 107.443 178.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.0 -48.68 73.08 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.976 1.71 . . . . 0.0 110.903 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -62.75 -50.47 63.8 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 58.1 mt -60.21 -44.64 94.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.125 0.57 . . . . 0.0 109.841 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -62.59 -42.87 99.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.848 0.459 . . . . 0.0 109.976 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.52 74.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.232 0.469 . . . . 0.0 110.407 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.7 t -73.6 -36.55 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.288 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -63.46 -31.09 72.15 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.815 1.646 . . . . 0.0 112.417 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -62.2 -45.85 91.54 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.467 -0.771 . . . . 0.0 112.156 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -65.1 -50.85 64.47 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.428 ' HE2' ' HD2' ' A' ' 298' ' ' PRO . 10.4 mmmm -138.24 146.64 52.46 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.428 ' HD2' ' HE2' ' A' ' 297' ' ' LYS . 36.7 Cg_endo -61.64 124.18 14.13 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.307 2.671 . . . . 0.0 109.985 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 29.1 mt -102.82 -13.64 16.91 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 67.89 -146.93 47.36 Favored Glycine 0 C--O 1.241 0.544 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.71 178.34 2.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 122.759 1.266 . . . . 0.0 110.08 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.3 m -131.69 152.17 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 O-C-N 120.934 -1.104 . . . . 0.0 109.087 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.12 -29.46 60.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.73 108.56 3.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.831 1.252 . . . . 0.0 108.883 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -55.47 -21.89 18.32 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.7 m -68.15 -49.59 60.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.538 1.063 . . . . 0.0 113.409 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -89.11 -9.31 51.57 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.886 0.874 . . . . 0.0 110.792 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.64 -47.22 80.22 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -60.6 -31.95 71.09 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.112 1.365 . . . . 0.0 113.914 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -81.0 -44.22 18.42 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.922 0.889 . . . . 0.0 109.612 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 20.9 mt -66.36 -33.6 76.09 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.59 -9.07 7.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.655 1.582 . . . . 0.0 112.794 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -63.92 -28.23 69.69 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.212 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -98.41 136.51 20.84 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.71 -21.82 71.0 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 123.695 2.93 . . . . 0.0 117.125 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -71.43 -30.02 65.56 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.507 1.048 . . . . 0.0 110.438 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.9 mp -79.07 -56.42 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -44.02 -60.76 1.71 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.113 1.365 . . . . 0.0 113.751 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.75 -44.38 90.53 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.947 0.794 . . . . 0.0 112.898 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 16.9 m -59.41 -35.55 74.2 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -44.38 52.67 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 121.611 -0.681 . . . . 0.0 109.274 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.94 -30.03 67.57 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.513 -0.742 . . . . 0.0 109.789 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -75.83 -31.33 59.32 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.46 -0.775 . . . . 0.0 109.529 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -74.63 -35.33 62.89 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 119.167 0.894 . . . . 0.0 109.643 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -65.06 -18.63 65.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.293 1.437 . . . . 0.0 112.146 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.49 0.61 9.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.572 1.549 . . . . 0.0 112.073 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -109.39 -167.0 20.3 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 127.165 2.317 . . . . 0.0 107.991 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -157.12 161.67 39.4 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 58.7 mt -107.12 123.46 62.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 127.777 2.431 . . . . 0.0 108.086 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 46.6 ttm 17.13 90.53 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 129.655 3.182 . . . . 0.0 114.323 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.79 -71.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.59 2.86 . . . . 0.0 113.307 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 92.68 14.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 130.472 3.509 . . . . 0.0 110.819 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.8 pt -57.42 143.83 73.16 Favored Pre-proline 0 CA--C 1.538 0.505 0 O-C-N 121.487 -0.758 . . . . 0.0 109.081 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.37 -21.13 47.74 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.487 1.458 . . . . 0.0 112.996 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -63.71 -22.23 66.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.299 1.04 . . . . 0.0 110.256 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 8.0 mtt -61.4 -29.38 69.89 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.225 0.92 . . . . 0.0 110.589 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 37.1 t -56.07 -43.0 77.53 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 118.53 0.605 . . . . 0.0 109.653 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.56 -41.27 47.05 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.17 0.588 . . . . 0.0 109.79 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -48.47 -46.65 38.32 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.472 1.109 . . . . 0.0 111.871 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -66.42 -54.0 29.21 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.004 -0.435 . . . . 0.0 110.918 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -60.33 -29.94 69.2 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.94 0.791 . . . . 0.0 112.406 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.98 -60.48 2.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.272 1.029 . . . . 0.0 111.073 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 22.5 t -69.2 -34.93 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 117.44 -1.266 . . . . 0.0 112.439 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.37 -28.98 60.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.485 1.493 . . . . 0.0 110.321 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 61.1 m -81.32 -51.69 8.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.389 1.076 . . . . 0.0 108.2 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -49.77 -45.91 50.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.533 1.06 . . . . 0.0 113.513 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 38.7 t -57.3 -52.66 53.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.061 0.944 . . . . 0.0 109.685 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.49 -38.58 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.212 0.605 . . . . 0.0 109.842 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -59.7 -48.67 80.75 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 118.825 0.738 . . . . 0.0 109.842 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.66 75.22 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.149 0.579 . . . . 0.0 110.775 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.95 80.94 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 10.9 m -89.34 -8.98 52.13 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.914 0.885 . . . . 0.0 110.812 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 73.34 15.28 78.95 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.154 -0.804 . . . . 0.0 112.547 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -64.52 -31.62 72.91 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.906 1.353 . . . . 0.0 109.233 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -148.31 156.12 42.14 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 14.2 t -73.2 162.61 29.21 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.401 HG13 HD23 ' A' ' 192' ' ' LEU . 54.1 t -52.45 -51.04 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 126.153 1.781 . . . . 0.0 109.536 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.14 -46.83 75.67 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.177 1.791 . . . . 0.0 112.711 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -75.61 -39.65 57.59 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.873 0.869 . . . . 0.0 111.744 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.42 -44.04 84.3 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.79 -43.51 83.76 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.854 0.862 . . . . 0.0 110.287 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -55.98 -59.28 5.12 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.58 -44.3 26.23 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.883 1.673 . . . . 0.0 110.914 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.45 -44.81 70.51 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.757 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -58.28 -37.07 74.27 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.028 1.285 . . . . 0.0 109.208 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 2.3 m -57.17 -40.63 77.69 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 123.429 0.692 . . . . 0.0 111.285 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -65.46 -18.37 65.27 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.53 -1.356 . . . . 0.0 114.136 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.2 mp -95.23 -41.77 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 20.6 p -71.91 -16.08 62.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.396 0.544 . . . . 0.0 111.831 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 39.4 tptt . . . . . 0 C--O 1.25 1.131 0 C-N-CA 127.032 2.133 . . . . 0.0 105.867 178.851 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.8 tptm . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 mt -58.41 135.96 22.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 O-C-N 125.596 1.81 . . . . 0.0 108.521 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -71.9 105.48 3.85 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 104.843 -2.281 . . . . 0.0 104.843 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -99.52 136.32 39.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.76 1.624 . . . . 0.0 109.216 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.1 25.1 17.79 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.874 0.75 . . . . 0.0 112.819 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.34 165.81 29.05 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.468 1.107 . . . . 0.0 109.482 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.6 mt -138.55 151.39 47.28 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.8 t -143.12 144.37 23.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 37' ' ' VAL . 10.2 mt -134.56 144.64 34.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 123.835 0.854 . . . . 0.0 109.231 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -134.84 132.85 39.1 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.309 1.444 . . . . 0.0 107.903 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -105.77 169.6 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -83.3 -39.56 20.65 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.0 -79.98 0.09 OUTLIER Glycine 0 C--N 1.339 0.71 0 CA-C-N 119.14 0.882 . . . . 0.0 112.271 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.99 -3.12 9.02 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -61.21 157.35 16.38 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 120.789 -1.194 . . . . 0.0 109.416 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.48 69.11 0.76 Allowed Glycine 0 CA--C 1.518 0.258 0 O-C-N 121.78 -0.575 . . . . 0.0 112.038 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -54.2 -19.97 6.07 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.904 1.681 . . . . 0.0 113.623 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -62.97 -58.17 8.25 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.456 1.48 . . . . 0.0 108.238 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.63 -36.76 79.94 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 123.382 0.515 . . . . 0.0 111.915 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.9 -32.06 73.35 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.923 -0.751 . . . . 0.0 110.578 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.01 -43.36 81.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.576 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -58.16 -41.93 84.89 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.647 0.779 . . . . 0.0 110.672 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.65 -50.86 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.53 -45.38 95.97 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 121.421 -0.799 . . . . 0.0 113.247 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -34.0 75.05 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.213 1.007 . . . . 0.0 110.831 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -66.13 -54.8 21.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -56.0 -42.43 76.4 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.332 0.969 . . . . 0.0 110.854 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.86 -27.41 69.15 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.214 -0.929 . . . . 0.0 110.085 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -84.66 -18.93 33.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.769 -1.207 . . . . 0.0 112.703 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -102.79 -16.25 16.01 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 124.219 0.949 . . . . 0.0 111.162 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.5 p -124.86 -31.95 3.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.23 61.36 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.232 -0.917 . . . . 0.0 112.903 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.4 129.83 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -66.04 148.55 51.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 123.835 0.854 . . . . 0.0 109.253 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 t -139.53 156.18 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.2 m -144.22 141.65 30.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.404 HG22 HD12 ' A' ' 9' ' ' ILE . 17.3 t -130.56 122.94 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -137.81 163.63 30.92 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.764 0.826 . . . . 0.0 110.469 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -121.66 57.9 8.05 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.782 1.233 . . . . 0.0 112.679 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.11 165.1 31.86 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.299 1.333 . . . . 0.0 111.658 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.86 -30.0 6.88 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -16.75 62.48 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.696 1.599 . . . . 0.0 114.063 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -46.27 -34.2 4.28 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.733 1.213 . . . . 0.0 114.213 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -57.61 -24.03 54.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.117 0.967 . . . . 0.0 113.451 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -128.2 -8.21 5.34 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.716 0.806 . . . . 0.0 112.1 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -84.47 -47.35 10.71 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.242 1.417 . . . . 0.0 107.369 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -46.18 -52.32 28.4 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 119.233 0.924 . . . . 0.0 112.656 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.81 -17.6 59.97 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.626 1.551 . . . . 0.0 114.386 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -85.45 -4.24 59.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.3 1.04 . . . . 0.0 111.896 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.7 -39.57 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.752 0.821 . . . . 0.0 110.214 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.49 73.0 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.85 -0.531 . . . . 0.0 110.345 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.12 10.15 1.03 Allowed 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.041 -1.037 . . . . 0.0 112.0 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.7 m -131.88 -0.99 3.78 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.779 1.172 . . . . 0.0 113.64 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.52 56.18 2.86 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -166.23 -176.93 3.88 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 128.824 2.85 . . . . 0.0 105.796 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.27 179.12 31.4 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.168 1.366 . . . . 0.0 114.196 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.07 167.18 16.66 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.456 2.104 . . . . 0.0 110.068 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.14 -21.72 18.32 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.0 mt -138.28 143.94 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 tt -130.51 135.91 59.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.317 1.847 . . . . 0.0 106.197 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.17 109.5 11.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.841 1.256 . . . . 0.0 110.117 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -154.94 169.38 24.18 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.46 152.6 37.92 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.809 0.814 . . . . 0.0 110.013 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -55.15 -30.02 58.96 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.801 1.24 . . . . 0.0 111.537 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.34 -12.54 9.47 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.196 1.798 . . . . 0.0 115.733 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -123.3 2.36 9.13 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.787 1.176 . . . . 0.0 109.909 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -85.24 -5.96 59.29 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.304 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.3 -17.22 79.65 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.889 1.222 . . . . 0.0 111.185 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.65 -66.69 1.1 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-O 118.513 -1.159 . . . . 0.0 113.266 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -44.19 -46.92 9.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.201 1.0 . . . . 0.0 113.22 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.58 -55.15 36.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.786 0.835 . . . . 0.0 110.081 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.36 -49.57 61.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.57 1.148 . . . . 0.0 109.314 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.4 m -58.63 -7.17 0.88 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.48 1.912 . . . . 0.0 112.953 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.77 17.59 72.43 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 125.712 1.625 . . . . 0.0 112.805 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.2 mt -85.86 -15.92 40.29 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.245 1.023 . . . . 0.0 113.507 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.9 mt -105.48 136.01 45.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.88 1.218 . . . . 0.0 111.65 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.51 164.37 25.96 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.62 1.168 . . . . 0.0 111.959 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.09 105.9 5.52 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.431 HG13 ' CA ' ' A' ' 105' ' ' ALA . 7.3 mm -67.42 152.46 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.39 1.076 . . . . 0.0 112.087 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.2 m 78.09 88.84 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 129.68 3.192 . . . . 0.0 110.058 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -72.44 -28.88 14.26 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.206 1.937 . . . . 0.0 110.755 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -141.58 147.0 36.96 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.221 1.408 . . . . 0.0 109.411 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -54.95 -34.25 63.1 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.805 1.642 . . . . 0.0 112.96 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.46 -35.04 60.08 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.119 0.968 . . . . 0.0 113.037 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -63.51 -28.05 69.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.434 0.561 . . . . 0.0 111.418 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -67.27 -33.08 74.56 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 120.972 -1.08 . . . . 0.0 111.534 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.0 -18.49 55.85 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.207 0.603 . . . . 0.0 111.481 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -74.72 -17.9 60.59 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.7 mt -123.03 155.76 36.21 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.398 0.679 . . . . 0.0 111.671 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -68.94 151.28 97.33 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 122.853 0.461 . . . . 0.0 111.175 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.5 -46.03 2.17 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.433 2.089 . . . . 0.0 112.509 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -54.77 -45.79 74.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.184 0.902 . . . . 0.0 111.68 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.59 -20.64 57.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.019 1.328 . . . . 0.0 112.607 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -72.62 -28.7 62.92 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.904 1.229 . . . . 0.0 109.903 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.92 -34.79 72.12 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.872 1.215 . . . . 0.0 110.902 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.74 -17.34 55.47 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.045 1.338 . . . . 0.0 114.475 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.8 m -127.49 4.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.014 1.326 . . . . 0.0 111.6 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -66.26 157.47 31.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.333 1.064 . . . . 0.0 108.871 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -150.43 -177.33 5.9 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -68.86 108.2 3.37 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.609 1.164 . . . . 0.0 111.969 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.57 -53.65 0.48 Allowed Glycine 0 N--CA 1.47 0.901 0 C-N-CA 128.273 2.844 . . . . 0.0 117.337 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 163.38 12.31 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.198 1.399 . . . . 0.0 107.986 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -97.15 159.55 14.85 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 pt -121.32 -25.25 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.755 -1.111 . . . . 0.0 113.287 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.431 ' CA ' HG13 ' A' ' 79' ' ' ILE . . . -159.43 176.96 11.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.275 1.03 . . . . 0.0 108.318 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.53 145.8 58.78 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 124.558 1.143 . . . . 0.0 108.917 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.76 150.98 51.05 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.467 2.111 . . . . 0.0 109.354 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.2 mm -127.82 -53.71 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.131 1.772 . . . . 0.0 110.56 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -124.78 147.24 48.8 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.587 0.755 . . . . 0.0 112.462 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.4 t -122.47 104.17 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.465 1.506 . . . . 0.0 107.464 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -119.67 172.43 7.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.51 -177.23 4.57 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -55.69 154.35 6.94 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.594 1.558 . . . . 0.0 112.104 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.4 m -138.15 174.44 10.56 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.634 0.774 . . . . 0.0 109.868 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.693 HD13 ' H ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -127.82 168.55 15.0 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.693 ' H ' HD13 ' A' ' 115' ' ' LEU . 4.2 mp -134.24 122.05 39.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -131.29 170.99 13.85 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.713 1.205 . . . . 0.0 109.893 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -61.43 132.31 53.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.69 1.196 . . . . 0.0 109.52 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -59.17 -2.97 0.32 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 116.231 1.938 . . . . 0.0 116.231 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -63.18 156.39 25.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 119.732 1.151 . . . . 0.0 109.875 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -73.02 -2.23 20.35 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.4 tp -145.96 70.54 13.46 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 118.874 0.761 . . . . 0.0 109.735 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -82.84 -3.82 11.24 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 124.323 3.349 . . . . 0.0 116.728 -178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 56.4 t30 32.48 80.46 0.25 Allowed Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 127.181 2.193 . . . . 0.0 114.465 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -64.31 156.59 59.02 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.065 1.843 . . . . 0.0 112.614 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.17 172.53 15.82 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.751 2.967 . . . . 0.0 109.905 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -118.8 -12.78 9.59 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.258 1.023 . . . . 0.0 112.426 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.3 t -167.11 162.72 15.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.777 1.231 . . . . 0.0 108.413 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -65.62 -24.86 67.15 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.537 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.5 -15.47 63.69 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.211 1.369 . . . . 0.0 112.926 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.51 -21.41 28.63 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.409 0.683 . . . . 0.0 110.08 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.73 -58.38 19.85 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-O 117.235 -1.364 . . . . 0.0 109.237 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.2 -26.98 49.05 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 CA-C-N 121.45 1.554 . . . . 0.0 111.751 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.92 67.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.728 0.811 . . . . 0.0 110.032 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 64.2 tp -75.81 -26.42 57.23 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.093 1.357 . . . . 0.0 110.999 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.89 -42.32 99.73 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.496 0.718 . . . . 0.0 110.126 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 7.2 ptmm? -72.4 -32.53 66.45 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.248 -0.908 . . . . 0.0 111.126 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -69.28 -44.79 71.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.666 0.387 . . . . 0.0 110.675 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.7 -30.54 36.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.147 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.21 -33.17 71.36 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 120.182 1.356 . . . . 0.0 109.095 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.99 -7.69 42.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.85 0.07 2.88 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.66 0.784 . . . . 0.0 111.895 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -162.84 -107.0 0.21 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.399 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -141.69 -173.33 3.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.323 1.449 . . . . 0.0 109.581 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.9 p -62.55 152.5 34.66 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.155 0.889 . . . . 0.0 113.024 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.44 -49.57 13.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.345 1.458 . . . . 0.0 114.228 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.9 tp -134.66 143.37 47.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.125 0.97 . . . . 0.0 110.887 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -137.06 138.21 40.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.255 1.422 . . . . 0.0 107.606 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -151.29 166.49 30.79 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.925 1.239 . . . . 0.0 111.941 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -70.17 91.13 0.69 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.405 1.882 . . . . 0.0 106.629 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.2 tt -87.47 -35.6 18.14 Favored 'General case' 0 CA--C 1.524 -0.052 0 C-N-CA 125.715 1.606 . . . . 0.0 112.566 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -64.2 -12.45 40.66 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -103.78 122.48 44.47 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 118.689 0.677 . . . . 0.0 109.992 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.86 -16.48 49.58 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 120.723 0.949 . . . . 0.0 110.639 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -47.66 -44.44 27.21 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 127.54 2.336 . . . . 0.0 111.671 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -98.84 -33.41 10.9 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 p -69.82 -27.35 64.8 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.352 1.433 . . . . 0.0 110.338 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -53.6 -60.61 6.69 Favored Pre-proline 0 C--N 1.343 0.308 0 C-N-CA 124.875 1.27 . . . . 0.0 113.392 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -57.28 -15.92 20.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.913 1.742 . . . . 0.0 114.537 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 8.6 tt -75.44 -66.57 0.75 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.2 pt -56.69 -34.62 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.217 1.007 . . . . 0.0 112.845 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.03 -26.23 64.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.028 -1.045 . . . . 0.0 112.86 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.43 86.88 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.498 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.07 -42.65 73.05 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.412 0.685 . . . . 0.0 111.439 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.83 -13.96 0.09 OUTLIER Glycine 0 CA--C 1.526 0.753 0 CA-C-O 117.959 -1.467 . . . . 0.0 113.025 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -49.4 133.12 25.57 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -138.02 144.97 41.3 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 119.719 1.76 . . . . 0.0 111.509 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.79 -59.49 2.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -141.65 171.42 14.08 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.901 2.08 . . . . 0.0 106.658 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -119.85 139.83 51.76 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 119.528 1.058 . . . . 0.0 112.643 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.17 105.73 12.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.698 1.199 . . . . 0.0 108.448 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -173.13 1.13 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.306 2.242 . . . . 0.0 109.098 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -51.31 -20.71 1.79 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.13 2.172 . . . . 0.0 115.012 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.94 3.09 0.04 OUTLIER Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.112 0.863 . . . . 0.0 113.693 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.44 151.55 48.68 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 119.531 1.666 . . . . 0.0 107.314 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -122.13 126.04 47.48 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 125.534 1.534 . . . . 0.0 108.203 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.79 150.81 52.12 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 122.512 1.149 . . . . 0.0 113.566 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.09 1.58 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.843 -1.98 . . . . 0.0 110.133 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -75.97 -35.7 59.55 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.2 97.16 10.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.82 121.09 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.44 1.896 . . . . 0.0 106.827 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -122.83 38.69 2.45 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 123.924 0.773 . . . . 0.0 114.862 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.72 -25.03 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.117 0.967 . . . . 0.0 111.17 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.84 17.22 19.98 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -66.19 164.2 16.2 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 121.596 -0.69 . . . . 0.0 110.995 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.9 65.27 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.9 -36.8 93.76 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.898 0.772 . . . . 0.0 111.651 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.58 -50.55 64.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.791 0.796 . . . . 0.0 109.24 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -63.82 -32.2 73.63 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 117.869 -1.063 . . . . 0.0 111.616 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.54 -51.25 70.66 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.244 0.929 . . . . 0.0 110.217 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.14 -28.95 69.36 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 29.9 tp -69.74 -55.96 8.49 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.605 1.203 . . . . 0.0 110.785 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.43 -26.47 53.69 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.6 0.76 . . . . 0.0 112.152 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -56.66 -42.1 78.38 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.126 -0.984 . . . . 0.0 108.953 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 19.6 tp -69.25 -48.95 60.4 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.835 1.254 . . . . 0.0 108.456 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 47.4 t -54.48 -34.05 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.517 1.527 . . . . 0.0 109.78 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.18 -42.56 88.75 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.553 1.541 . . . . 0.0 110.778 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.62 -40.25 84.67 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.245 -0.909 . . . . 0.0 108.564 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 89.4 mt -66.85 -36.93 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -60.33 -36.89 79.0 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.992 -1.693 . . . . 0.0 108.473 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -82.3 -2.11 51.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.288 1.435 . . . . 0.0 111.272 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? 56.46 9.56 0.56 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.707 2.403 . . . . 0.0 114.394 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -82.46 -14.68 54.66 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ttp -112.17 147.97 35.03 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.46 1.104 . . . . 0.0 110.074 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -85.58 103.57 14.53 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.897 1.279 . . . . 0.0 107.919 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -77.51 -21.62 52.45 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -91.67 0.12 57.52 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.5 m -60.88 131.48 50.82 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.526 1.13 . . . . 0.0 110.315 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.54 -173.51 2.75 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.785 1.234 . . . . 0.0 108.048 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -56.53 -45.81 80.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.074 0.949 . . . . 0.0 109.725 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.86 -49.68 75.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.948 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 46.3 mm -59.0 -48.75 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.621 1.101 . . . . 0.0 110.356 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.09 87.08 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -74.59 -57.42 3.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -50.81 -55.89 14.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.754 1.621 . . . . 0.0 112.241 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.42 76.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.139 0.881 . . . . 0.0 110.734 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.5 -38.8 90.79 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -63.1 -35.69 81.11 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.89 0.876 . . . . 0.0 109.708 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -72.78 -22.79 60.78 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.01 18.61 21.82 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 126.143 1.83 . . . . 0.0 112.68 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.88 -71.74 0.31 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.233 1.016 . . . . 0.0 113.648 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . 0.28 4.2 t -68.55 152.81 44.86 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.27 0.557 . . . . 0.0 112.365 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.83 31.42 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.612 0.765 . . . . 0.0 112.454 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -152.85 155.66 37.51 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.506 1.123 . . . . 0.0 108.234 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.5 t -147.78 159.05 44.24 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.85 122.61 54.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 119.408 1.004 . . . . 0.0 110.236 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -130.36 133.92 46.78 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.936 1.694 . . . . 0.0 109.761 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -92.85 -75.3 1.3 Allowed Glycine 0 CA--C 1.534 1.262 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.52 86.92 1.56 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.762 2.975 . . . . 0.0 110.635 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -53.54 94.91 0.01 OUTLIER 'General case' 0 C--O 1.238 0.487 0 C-N-CA 127.249 2.22 . . . . 0.0 111.38 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.49 172.26 13.27 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.43 1.492 . . . . 0.0 112.505 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -68.26 -176.42 0.74 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.487 1.915 . . . . 0.0 109.113 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 38.5 t -144.39 173.6 11.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -94.88 8.6 42.2 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.323 1.049 . . . . 0.0 110.348 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.4 tp -152.95 123.73 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 127.787 2.435 . . . . 0.0 105.517 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.48 85.98 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.609 1.163 . . . . 0.0 108.783 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 10.8 m -96.33 95.53 8.14 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 14.6 m -91.43 -3.88 56.19 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.145 0.578 . . . . 0.0 111.615 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -84.4 77.35 10.02 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.241 -1.537 . . . . 0.0 112.493 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.34 166.04 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -70.4 176.84 3.71 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.704 0.802 . . . . 0.0 109.949 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -117.01 99.92 7.4 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.774 0.829 . . . . 0.0 112.338 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 86.74 164.18 39.56 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 125.09 1.329 . . . . 0.0 114.24 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 13.6 p -87.61 143.06 12.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.7 t -111.03 172.35 6.93 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.299 0.64 . . . . 0.0 109.434 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.5 t -71.63 143.1 14.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pp -122.07 154.19 61.35 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.56 1.144 . . . . 0.0 109.326 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.94 141.41 30.0 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.71 2.273 . . . . 0.0 111.559 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.1 p -149.48 -172.23 4.09 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 127.793 2.437 . . . . 0.0 107.512 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -87.5 144.95 26.46 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -55.73 119.77 6.27 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.984 0.914 . . . . 0.0 110.389 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.01 -4.9 44.11 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.055 0.836 . . . . 0.0 114.321 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.57 87.14 32.56 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.927 1.863 . . . . 0.0 109.543 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.48 152.7 60.45 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.721 1.614 . . . . 0.0 110.661 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 19.5 m -72.2 134.81 45.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.65 0.78 . . . . 0.0 109.913 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 256' ' ' LYS . 0.2 OUTLIER -140.39 87.18 12.04 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.528 1.531 . . . . 0.0 108.01 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.15 -90.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.628 2.218 . . . . 0.0 109.35 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -145.88 167.97 21.96 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.517 2.327 . . . . 0.0 106.046 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 46.0 t -94.68 155.94 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -154.74 139.67 6.88 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 106.555 -2.618 . . . . 0.0 106.555 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.0 164.37 33.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.169 0.509 . . . . 0.0 109.947 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.68 173.19 10.83 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.608 0.763 . . . . 0.0 109.726 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -148.39 141.3 24.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.722 -1.236 . . . . 0.0 110.135 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.29 132.46 47.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.7 152.18 19.79 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.218 -0.768 . . . . 0.0 111.362 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.1 mt -89.83 135.63 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -71.35 120.29 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.424 1.09 . . . . 0.0 109.14 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.24 -20.66 62.21 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -75.88 -4.14 39.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.059 1.744 . . . . 0.0 114.924 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 33.1 m -71.7 167.49 30.4 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 124.894 1.278 . . . . 0.0 110.672 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -80.75 -43.45 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.196 1.264 . . . . 0.0 110.605 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -139.23 106.84 5.59 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.032 0.933 . . . . 0.0 109.379 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.422 ' HD2' ' H ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -61.93 -19.79 63.11 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.115 0.966 . . . . 0.0 112.045 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.11 -40.57 81.57 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 68.3 mt -57.62 -36.58 71.98 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.722 -0.612 . . . . 0.0 111.492 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.81 -45.45 28.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.976 0.511 . . . . 0.0 112.024 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -32.72 74.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.2 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -70.34 -56.45 6.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -52.52 -46.14 66.59 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.238 -0.914 . . . . 0.0 111.255 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 4.1 tt -66.81 -42.54 85.75 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.517 -1.23 . . . . 0.0 113.063 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.3 -15.74 39.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.51 1.504 . . . . 0.0 114.713 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -109.55 -17.58 13.71 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -131.29 -51.5 1.02 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 118.993 0.815 . . . . 0.0 111.471 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.86 -55.7 20.89 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.338 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.52 HD22 HD21 ' A' ' 304' ' ' LEU . 55.3 mt -88.34 77.26 8.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.74 0.816 . . . . 0.0 109.91 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 39.8 p -140.8 159.43 42.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.23 -38.04 89.15 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -81.87 -29.25 32.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.009 0.524 . . . . 0.0 112.227 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.04 -43.84 20.55 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.97 -39.83 90.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.31 -46.57 85.9 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -53.52 -46.78 70.25 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.736 0.698 . . . . 0.0 111.214 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.66 -37.79 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.19 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -72.01 -22.45 61.41 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.774 1.629 . . . . 0.0 113.584 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -69.29 -44.97 70.72 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.626 0.771 . . . . 0.0 109.01 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -71.76 -48.31 47.68 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -135.08 152.92 77.98 Favored Pre-proline 0 N--CA 1.461 0.082 0 C-N-CA 123.992 0.917 . . . . 0.0 109.909 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.9 125.57 10.01 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.086 1.857 . . . . 0.0 110.937 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 86.7 mt -99.89 -24.23 14.71 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.535 -0.745 . . . . 0.0 112.335 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 81.26 -155.02 35.66 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.22 168.93 14.72 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 12.7 m -121.68 162.2 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 O-C-N 120.641 -1.287 . . . . 0.0 110.991 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.33 -13.59 49.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.286 0.634 . . . . 0.0 110.434 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.52 HD21 HD22 ' A' ' 285' ' ' LEU . 4.1 mm? -76.31 112.5 12.86 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 127.239 2.216 . . . . 0.0 107.703 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -62.89 -36.51 83.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.071 0.462 . . . . 0.0 110.32 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -52.15 64.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.434 1.894 . . . . 0.0 111.172 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -84.84 -11.8 54.9 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.815 0.846 . . . . 0.0 112.224 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -60.49 -42.77 96.99 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -63.24 -9.89 13.38 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.43 1.492 . . . . 0.0 112.164 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -109.61 -36.8 5.86 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.051 0.94 . . . . 0.0 110.495 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 14.7 mt -74.27 -24.32 59.24 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.453 -1.405 . . . . 0.0 108.521 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.56 -8.05 17.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.495 1.118 . . . . 0.0 112.382 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -56.59 -37.76 71.07 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.03 133.31 24.32 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.39 -24.69 71.17 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.578 2.185 . . . . 0.0 113.332 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -62.57 -30.71 71.52 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.77 0.714 . . . . 0.0 109.851 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.9 mp -77.54 -61.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -44.13 -55.99 4.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.164 1.386 . . . . 0.0 114.342 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.18 -32.41 68.21 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.596 -0.69 . . . . 0.0 112.859 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 24.7 m -74.74 -36.54 62.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.687 0.795 . . . . 0.0 109.164 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.8 tpt -66.75 -43.15 84.92 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.219 1.007 . . . . 0.0 109.084 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -55.74 -41.01 73.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.595 0.758 . . . . 0.0 110.419 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -63.28 -26.85 68.97 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.728 -0.608 . . . . 0.0 112.324 -179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -76.68 -40.19 49.68 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -61.73 -45.37 94.24 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.249 0.619 . . . . 0.0 111.023 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -15.59 58.22 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.59 -165.09 37.23 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -142.31 134.15 27.08 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 63.7 mt -81.82 88.24 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 10.9 mtp 59.07 165.19 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 126.461 1.904 . . . . 0.0 113.363 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -80.5 -26.18 4.13 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.141 1.894 . . . . 0.0 115.595 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 66.96 34.52 5.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.687 1.995 . . . . 0.0 112.002 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.2 pt -132.33 156.48 80.04 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 123.845 0.858 . . . . 0.0 110.937 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.46 -25.99 24.74 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.002 2.468 . . . . 0.0 113.666 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -57.66 -16.91 12.11 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.227 0.921 . . . . 0.0 113.343 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -22.83 65.69 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.16 -0.963 . . . . 0.0 111.411 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.4 t -65.62 -54.72 23.74 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.56 -34.97 78.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.499 1.12 . . . . 0.0 111.302 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -50.34 -56.81 9.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.805 0.842 . . . . 0.0 111.658 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -65.98 -40.9 91.64 Favored 'General case' 0 CA--C 1.522 -0.118 0 O-C-N 121.247 -0.908 . . . . 0.0 111.404 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.57 -45.77 84.77 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.155 0.503 . . . . 0.0 110.518 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.39 -51.68 64.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.647 1.179 . . . . 0.0 111.581 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.84 -27.46 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.707 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -53.99 -50.1 67.35 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.352 1.433 . . . . 0.0 107.596 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.5 m -68.51 -44.43 74.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.051 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.86 -47.03 68.09 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.948 1.249 . . . . 0.0 113.768 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 24.2 t -56.08 -51.68 59.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 124.61 1.164 . . . . 0.0 109.113 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.03 -37.45 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -58.75 -46.06 88.29 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.177 -1.577 . . . . 0.0 110.947 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.35 -45.46 59.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.634 0.773 . . . . 0.0 110.48 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.14 -44.42 97.36 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.33 0.514 . . . . 0.0 111.623 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 59.8 m -75.04 -25.91 59.05 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.899 0.879 . . . . 0.0 109.313 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.86 32.77 44.01 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -85.14 -21.29 29.3 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.846 0.858 . . . . 0.0 110.62 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -147.42 151.42 36.43 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.6 m -58.65 152.21 19.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.991 0.916 . . . . 0.0 109.293 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 61.8 t -57.2 -44.77 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 118.988 0.813 . . . . 0.0 109.414 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -52.18 66.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.469 1.108 . . . . 0.0 110.009 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -63.87 -37.71 88.41 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.262 0.625 . . . . 0.0 111.838 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.93 92.48 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 38.2 mt -73.15 -38.85 66.1 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.597 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -57.88 -53.46 57.99 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 119.681 1.128 . . . . 0.0 109.807 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -29.93 70.76 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -70.99 -55.34 8.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 118.114 -0.946 . . . . 0.0 108.895 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -49.66 -38.57 33.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.178 1.391 . . . . 0.0 110.069 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 26.4 m -57.93 -45.64 86.27 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.008 0.523 . . . . 0.0 110.452 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -61.67 -8.63 4.81 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.147 2.179 . . . . 0.0 114.027 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 2.3 mp -104.17 -40.11 6.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.1 p -68.76 -25.43 64.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.402 0.547 . . . . 0.0 110.801 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? . . . . . 0 C--O 1.245 0.85 0 C-N-CA 127.135 2.174 . . . . 0.0 108.36 -179.089 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.2 mt -148.09 148.81 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 103.705 -2.702 . . . . 0.0 103.705 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -98.97 100.79 12.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -71.92 69.49 0.71 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.718 1.207 . . . . 0.0 113.786 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.57 30.95 0.02 OUTLIER Glycine 0 CA--C 1.526 0.731 0 O-C-N 121.352 -0.843 . . . . 0.0 114.017 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -143.5 172.06 13.3 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.253 1.027 . . . . 0.0 110.259 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.6 mt -150.81 140.13 21.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 127.682 2.393 . . . . 0.0 106.506 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.8 t -137.06 148.05 26.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.473 HD12 HG22 ' A' ' 37' ' ' VAL . 11.9 mt -130.43 142.4 43.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.606 1.562 . . . . 0.0 109.119 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -137.76 134.08 34.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.8 147.68 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -60.31 -35.57 75.89 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.27 168.72 11.45 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t0 48.66 30.25 2.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.107 1.363 . . . . 0.0 110.961 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.38 -14.58 16.21 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -177.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.66 30.57 4.56 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.909 1.719 . . . . 0.0 112.972 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -45.82 -46.21 15.39 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.66 1.184 . . . . 0.0 113.723 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -58.19 -41.37 83.79 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.445 1.02 . . . . 0.0 112.874 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.57 -42.18 41.25 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.8 tp -58.42 -39.21 79.16 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.928 1.291 . . . . 0.0 110.238 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.78 -46.7 64.25 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.729 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.36 -39.5 79.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.269 1.028 . . . . 0.0 111.573 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 t -59.95 -42.78 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.72 -39.57 96.77 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -62.47 -46.87 86.51 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 119.651 1.725 . . . . 0.0 109.012 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -59.65 -56.19 24.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -55.55 -47.07 76.96 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.628 0.649 . . . . 0.0 112.017 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.24 -28.85 69.99 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 121.103 -0.998 . . . . 0.0 110.794 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.64 -23.0 37.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.904 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -100.3 -11.05 20.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.409 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.3 p -127.34 -32.39 2.46 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.478 1.035 . . . . 0.0 113.693 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.2 -14.73 62.86 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 119.393 0.997 . . . . 0.0 112.818 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.6 mm -69.24 122.81 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.26 145.49 47.24 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 123.345 0.658 . . . . 0.0 110.13 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.8 t -133.0 136.38 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -128.96 138.54 52.03 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.473 HG22 HD12 ' A' ' 9' ' ' ILE . 24.8 t -133.94 128.55 53.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.7 1.2 . . . . 0.0 107.931 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -140.55 160.09 40.78 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.14 1.776 . . . . 0.0 107.184 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -122.26 59.03 10.89 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.094 0.958 . . . . 0.0 111.708 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.84 136.41 20.73 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.906 2.404 . . . . 0.0 109.32 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.31 -33.41 63.19 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.561 0.948 . . . . 0.0 113.561 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -99.27 24.23 8.24 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -178.403 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 pp -49.2 -29.3 5.41 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.266 -0.896 . . . . 0.0 112.287 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -57.69 -24.98 59.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.359 1.864 . . . . 0.0 114.518 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -110.05 -19.29 13.12 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.555 0.693 . . . . 0.0 111.023 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -81.08 -50.29 9.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.357 -0.84 . . . . 0.0 108.874 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -44.12 -55.98 8.58 Favored Pre-proline 0 CA--C 1.529 0.146 0 CA-C-O 117.334 -1.317 . . . . 0.0 111.937 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 30.6 Cg_endo -60.98 -28.51 86.4 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 120.813 1.326 . . . . 0.0 115.402 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -83.05 -32.87 26.62 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.401 1.455 . . . . 0.0 112.154 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 t -87.37 -40.52 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.221 0.464 . . . . 0.0 110.258 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.26 -32.28 73.87 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 120.483 -1.385 . . . . 0.0 110.034 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 48' ' ' PRO . . . -58.2 -20.03 38.2 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.107 1.363 . . . . 0.0 112.585 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.1 p -113.37 2.91 15.64 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.993 0.917 . . . . 0.0 112.897 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.49 12.54 83.64 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.071 0.851 . . . . 0.0 111.287 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -103.97 -10.27 18.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.544 1.138 . . . . 0.0 111.468 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.92 174.27 55.29 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.017 1.294 . . . . 0.0 115.333 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.71 172.0 7.59 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.41 3.406 . . . . 0.0 113.389 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -101.43 -20.19 15.25 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.39 127.12 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.707 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 tp -107.67 144.72 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 127.202 2.201 . . . . 0.0 106.846 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -131.97 107.74 8.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.744 1.218 . . . . 0.0 110.637 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -157.24 -175.82 5.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.065 0.946 . . . . 0.0 110.076 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.4 151.0 33.02 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -52.3 -33.41 42.18 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.553 1.541 . . . . 0.0 113.409 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.42 -18.08 48.53 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -103.31 -7.61 20.96 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.163 -1.585 . . . . 0.0 110.514 178.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -91.32 -28.69 17.58 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.755 -0.59 . . . . 0.0 112.388 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.04 14.08 1.26 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.905 1.241 . . . . 0.0 113.725 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.87 -59.9 0.25 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 129.394 3.378 . . . . 0.0 105.853 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -50.11 -51.75 40.52 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.024 0.93 . . . . 0.0 110.665 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.66 95.81 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.14 0.495 . . . . 0.0 111.135 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -65.24 -13.34 58.09 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.857 0.863 . . . . 0.0 112.44 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.4 m -106.52 -6.32 18.18 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.745 2.418 . . . . 0.0 112.473 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.42 16.49 39.97 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.1 mt -96.18 -15.01 22.32 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 73.5 mt -106.53 139.77 40.48 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.832 1.651 . . . . 0.0 110.755 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.56 -178.36 7.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -69.34 106.74 3.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.418 2.287 . . . . 0.0 106.373 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 79' ' ' ILE . 1.6 mm -80.4 148.7 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.417 HG22 HG22 ' A' ' 79' ' ' ILE . 3.9 t 38.96 80.37 0.28 Allowed Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 129.026 2.931 . . . . 0.0 111.499 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.82 -24.9 68.02 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 121.635 1.557 . . . . 0.0 111.848 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -123.62 142.59 50.9 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.267 1.427 . . . . 0.0 109.138 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -61.44 -27.51 68.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.205 2.202 . . . . 0.0 109.98 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.69 63.25 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.202 0.91 . . . . 0.0 112.905 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -76.62 -31.09 57.2 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.314 0.961 . . . . 0.0 108.925 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -67.05 -39.5 86.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.205 -0.935 . . . . 0.0 109.816 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -57.3 -28.4 63.0 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.502 1.121 . . . . 0.0 112.077 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -75.06 -18.24 60.34 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.4 mt -117.17 162.05 18.47 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.131 0.878 . . . . 0.0 110.782 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -75.0 148.65 84.69 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.783 0.833 . . . . 0.0 109.972 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.52 -42.51 3.58 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.596 2.198 . . . . 0.0 113.342 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -60.57 -40.01 90.12 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.55 0.614 . . . . 0.0 109.991 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.02 -28.34 70.03 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.73 -1.231 . . . . 0.0 109.98 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.402 ' CZ3' ' HB3' ' A' ' 106' ' ' TYR . 70.6 m95 -71.84 -33.3 68.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.214 0.915 . . . . 0.0 109.951 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.11 -38.73 73.84 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.262 0.937 . . . . 0.0 110.42 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.94 -7.47 3.85 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.79 8.21 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.222 1.409 . . . . 0.0 112.167 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -63.75 162.67 12.94 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.502 1.144 . . . . 0.0 111.182 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -145.71 -174.91 4.54 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.759 1.624 . . . . 0.0 108.408 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.68 105.15 0.61 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.304 1.442 . . . . 0.0 107.84 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.05 -78.06 0.29 Allowed Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.795 1.188 . . . . 0.0 113.637 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -178.86 7.21 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.614 1.566 . . . . 0.0 110.57 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.51 169.35 8.71 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.842 0.83 . . . . 0.0 111.403 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.5 pt -130.07 -22.41 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.082 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.426 ' CA ' HG13 ' A' ' 79' ' ' ILE . . . -155.71 167.86 29.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.877 0.871 . . . . 0.0 109.051 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.402 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -123.94 150.35 62.39 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.583 1.153 . . . . 0.0 109.383 179.112 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -72.74 144.45 39.33 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.764 2.309 . . . . 0.0 109.371 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -126.26 -46.82 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.877 0.871 . . . . 0.0 111.608 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.8 144.9 49.29 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.25 119.03 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -125.93 177.21 6.46 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.096 0.958 . . . . 0.0 111.265 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.523 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -135.0 -172.79 3.14 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.267 1.427 . . . . 0.0 109.065 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.432 ' N ' HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -135.03 172.76 12.56 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 127.844 2.458 . . . . 0.0 108.714 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.0 m -142.37 174.77 10.32 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.094 1.357 . . . . 0.0 110.975 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.3 tp -71.37 152.13 43.45 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 68.9 mt -107.49 107.44 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -131.48 164.7 25.19 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.62 1.568 . . . . 0.0 109.59 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -53.34 151.37 5.47 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.838 1.255 . . . . 0.0 111.841 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.16 -4.2 3.39 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -75.69 156.78 34.4 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 pp -73.89 -2.08 22.3 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.755 1.622 . . . . 0.0 113.338 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.7 tp -33.65 105.06 0.25 Allowed Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 127.514 2.326 . . . . 0.0 112.742 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -70.93 176.2 7.98 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.549 2.166 . . . . 0.0 109.266 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 38.1 t30 60.31 73.81 0.6 Allowed Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.394 1.477 . . . . 0.0 110.907 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.63 160.67 31.38 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.645 2.23 . . . . 0.0 111.711 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.74 148.53 65.42 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.12 2.547 . . . . 0.0 110.921 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -136.41 -8.8 1.95 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 117.401 -1.285 . . . . 0.0 112.449 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.6 t -147.1 144.63 29.18 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 121.714 2.052 . . . . 0.0 112.287 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -61.48 -19.99 62.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.627 1.171 . . . . 0.0 112.974 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -74.74 -15.86 60.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.615 1.098 . . . . 0.0 112.642 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -92.51 -26.92 17.72 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.987 0.812 . . . . 0.0 110.474 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.5 mm -48.69 -56.77 13.29 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 125.382 1.473 . . . . 0.0 110.951 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.69 -22.36 32.5 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 CA-C-N 120.487 1.209 . . . . 0.0 112.236 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.57 -36.7 63.07 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.1 tp -78.49 -28.55 46.4 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.861 1.264 . . . . 0.0 110.068 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.04 -50.21 71.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.71 0.687 . . . . 0.0 110.062 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.7 ptmm? -63.52 -31.85 73.13 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.044 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.59 -42.21 52.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.358 0.526 . . . . 0.0 109.697 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.8 mt -71.35 -31.41 67.33 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -67.42 -29.98 69.62 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.59 -3.53 18.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.128 0.571 . . . . 0.0 112.071 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.31 3.86 2.17 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.402 1.481 . . . . 0.0 111.478 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.87 -95.59 0.1 Allowed Glycine 0 CA--C 1.524 0.647 0 CA-C-N 120.077 1.308 . . . . 0.0 115.344 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -138.72 -171.6 3.11 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 125.341 1.456 . . . . 0.0 110.738 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.0 p -62.22 154.1 28.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.913 0.885 . . . . 0.0 110.599 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -76.85 -39.58 50.7 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.669 1.188 . . . . 0.0 110.805 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.2 tp -130.46 147.82 52.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.216 1.006 . . . . 0.0 112.5 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 25.4 mtp -150.75 127.84 11.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.642 2.377 . . . . 0.0 105.243 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -158.71 173.61 16.3 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -78.99 84.63 4.99 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.128 -0.982 . . . . 0.0 110.636 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 mp -71.61 -28.59 63.9 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.051 0.387 . . . . 0.0 109.986 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -61.42 -15.14 34.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -115.21 130.24 24.41 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 119.478 1.035 . . . . 0.0 110.605 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.04 -21.67 72.83 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.324 1.349 . . . . 0.0 112.394 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -54.4 -31.42 54.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.263 1.025 . . . . 0.0 113.461 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.12 -24.8 15.15 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.2 p -90.89 -15.93 29.04 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.33 0.968 . . . . 0.0 111.456 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -62.23 -35.3 19.6 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.08 -11.54 30.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 123.276 2.206 . . . . 0.0 113.98 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.7 tp -68.31 -67.05 0.49 Allowed 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.51 1.524 . . . . 0.0 111.621 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.696 HD13 ' H ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.28 -24.7 35.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.616 1.166 . . . . 0.0 113.295 -179.26 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.35 -16.15 63.29 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.865 -0.522 . . . . 0.0 111.035 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.85 -60.54 2.77 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.153 1.381 . . . . 0.0 109.568 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.76 -54.99 38.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.0 15.79 0.02 OUTLIER Glycine 0 C--N 1.337 0.629 0 CA-C-O 117.887 -1.507 . . . . 0.0 116.149 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.66 147.97 41.07 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 120.804 2.302 . . . . 0.0 109.639 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -151.9 128.24 10.59 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.89 -48.97 62.04 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -143.66 149.51 37.36 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -101.84 159.28 15.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.217 -0.927 . . . . 0.0 109.315 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -155.59 113.98 3.45 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 102.011 -3.329 . . . . 0.0 102.011 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -73.67 -168.59 0.59 Allowed 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.308 1.843 . . . . 0.0 108.429 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -57.13 -34.56 68.51 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.741 -1.224 . . . . 0.0 110.765 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -154.56 8.28 0.36 Allowed Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.284 -1.287 . . . . 0.0 114.558 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -112.49 130.46 55.99 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.366 2.083 . . . . 0.0 107.06 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.17 115.37 17.58 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.96 1.704 . . . . 0.0 109.368 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -132.56 111.78 11.52 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -10.45 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.869 0.867 . . . . 0.0 112.789 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -77.13 -28.78 54.42 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.821 0.848 . . . . 0.0 109.937 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -73.76 80.98 1.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.911 1.284 . . . . 0.0 110.619 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 63.7 t -108.19 141.77 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 127.591 2.357 . . . . 0.0 108.851 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -132.16 34.04 2.59 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.093 1.33 . . . . 0.0 115.092 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.17 -37.76 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 117.301 -1.333 . . . . 0.0 113.796 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.46 ' OD2' ' HE3' ' A' ' 362' ' ' LYS 0.293 21.4 t70 -108.8 34.91 3.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.53 1.514 . . . . 0.0 113.279 -178.613 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -79.14 151.69 31.18 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -47.75 -24.8 1.04 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.17 -19.74 68.88 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 120.145 1.339 . . . . 0.0 111.738 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.66 -45.07 47.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.809 0.844 . . . . 0.0 108.981 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -64.39 -54.56 30.92 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.71 -45.07 70.32 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.617 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -63.56 -30.43 77.58 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 118.814 -0.992 . . . . 0.0 112.128 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 46.0 tp -84.09 -40.46 18.27 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.206 1.402 . . . . 0.0 110.881 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.4 m -44.24 -54.49 5.66 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 127.763 2.425 . . . . 0.0 112.156 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.02 -44.41 91.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.778 0.717 . . . . 0.0 111.769 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.66 -46.05 91.39 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.636 -0.665 . . . . 0.0 109.38 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.78 -34.42 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.65 -43.32 99.12 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.531 1.06 . . . . 0.0 111.811 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 75.7 mt -65.12 -50.76 64.82 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.678 0.791 . . . . 0.0 109.103 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.48 -35.97 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.406 1.083 . . . . 0.0 110.572 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -58.61 -49.13 78.62 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.345 0.975 . . . . 0.0 108.545 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.88 4.27 17.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.843 1.257 . . . . 0.0 112.286 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 58.39 20.49 7.42 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.919 1.288 . . . . 0.0 112.292 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.79 9.63 6.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.366 1.466 . . . . 0.0 110.882 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.2 ttt -146.91 148.05 31.4 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 121.206 -0.934 . . . . 0.0 108.6 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -78.15 78.63 4.63 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.25 -13.08 61.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.861 1.665 . . . . 0.0 114.782 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -92.88 -8.2 44.03 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.58 0.752 . . . . 0.0 112.372 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.7 m -61.97 127.66 32.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 122.522 1.153 . . . . 0.0 110.065 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 29.5 p30 -119.16 -177.52 3.36 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.711 2.004 . . . . 0.0 106.683 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.44 -42.9 99.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.4 m -60.11 -45.59 92.46 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 118.522 -0.751 . . . . 0.0 109.56 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.93 -56.26 19.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -54.49 -59.44 4.69 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.942 1.697 . . . . 0.0 112.982 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -58.19 -44.58 88.11 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.845 0.748 . . . . 0.0 111.475 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.8 -45.65 91.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.434 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.82 95.25 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.411 1.084 . . . . 0.0 112.166 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -63.3 -38.59 91.75 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.098 0.559 . . . . 0.0 110.056 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -59.68 -46.07 90.16 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -68.46 -42.9 78.1 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.341 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.64 36.5 2.05 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.283 1.421 . . . . 0.0 109.596 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -78.22 -62.02 1.81 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.746 -0.856 . . . . 0.0 109.298 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.4 t -73.27 137.1 44.7 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.552 1.541 . . . . 0.0 108.075 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.05 -15.65 57.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.163 0.585 . . . . 0.0 112.53 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -159.29 168.4 26.53 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.919 1.688 . . . . 0.0 109.443 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -155.81 -179.56 8.24 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.452 1.501 . . . . 0.0 109.046 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.3 mt -144.3 109.08 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -138.89 173.55 11.45 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.886 2.075 . . . . 0.0 107.59 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -77.86 -90.24 0.33 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-O 118.989 -0.895 . . . . 0.0 113.383 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.11 169.96 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.091 2.527 . . . . 0.0 116.194 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -76.09 -13.97 60.2 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.358 1.063 . . . . 0.0 113.599 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -134.7 178.04 7.31 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.882 1.219 . . . . 0.0 112.115 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -134.06 -36.45 0.92 Allowed 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.489 0.715 . . . . 0.0 111.818 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.9 m -78.51 -65.23 1.01 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -154.8 160.45 41.28 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 129.447 3.099 . . . . 0.0 106.083 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 11.2 mt -91.35 115.29 30.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -134.12 89.53 2.58 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.711 0.804 . . . . 0.0 111.698 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 5.1 p -88.71 167.45 13.31 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 84.0 p -135.47 -45.64 0.68 Allowed 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.37 0.668 . . . . 0.0 110.957 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -145.48 169.64 17.96 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.65 0.78 . . . . 0.0 110.966 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 9.4 p -76.53 164.79 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.806 1.243 . . . . 0.0 109.809 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.85 178.83 8.18 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.521 1.129 . . . . 0.0 109.293 178.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -142.91 175.51 9.78 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.868 1.667 . . . . 0.0 109.151 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 85.76 111.95 0.77 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 106.541 -2.623 . . . . 0.0 106.541 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.78 138.91 53.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 117.134 0.467 . . . . 0.0 110.232 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 23.7 m -125.92 124.29 40.49 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.2 t -81.55 154.3 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.97 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 32.0 mt -67.21 149.69 98.31 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.46 153.7 77.03 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.277 1.985 . . . . 0.0 111.849 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 255' ' ' SER . 36.7 p -113.81 -165.38 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.265 1.426 . . . . 0.0 109.149 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -125.98 149.88 48.45 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -51.09 120.24 4.74 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.618 1.167 . . . . 0.0 109.616 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.61 -4.13 57.43 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 117.621 -1.655 . . . . 0.0 114.615 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.69 115.01 3.51 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 121.777 2.789 . . . . 0.0 115.191 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.29 147.07 28.84 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.709 2.939 . . . . 0.0 111.254 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.419 ' H ' HG22 ' A' ' 249' ' ' THR . 5.4 p -64.81 155.52 33.67 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -133.02 66.69 76.59 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.512 1.525 . . . . 0.0 108.599 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.15 179.68 6.27 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.426 2.751 . . . . 0.0 113.174 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -77.2 152.09 34.92 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.903 0.859 . . . . 0.0 112.155 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 82.7 t -110.74 158.83 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.04 1.736 . . . . 0.0 108.064 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -145.83 146.78 17.27 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.89 154.96 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 119.114 1.457 . . . . 0.0 111.829 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.37 117.46 11.03 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.4 m -104.49 144.98 30.93 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.561 1.144 . . . . 0.0 110.811 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.0 129.7 47.15 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.76 131.54 8.55 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 123.556 0.535 . . . . 0.0 111.891 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 85.5 mt -75.09 131.15 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -71.33 120.27 16.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.708 0.803 . . . . 0.0 109.143 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.47 -12.39 60.18 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.951 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.85 -6.67 59.48 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.164 0.893 . . . . 0.0 112.96 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.5 m -63.05 161.3 31.85 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.268 1.027 . . . . 0.0 108.681 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.88 -53.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 121.204 1.466 . . . . 0.0 109.417 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -132.75 104.32 6.56 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' LYS . . . . . 0.506 ' HD2' ' H ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -60.06 -19.04 51.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.318 -1.31 . . . . 0.0 113.389 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.34 -33.2 72.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.02 -36.52 83.85 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.882 -1.136 . . . . 0.0 110.993 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.31 -47.23 28.8 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 122.646 0.378 . . . . 0.0 110.565 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -35.73 78.44 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.206 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -70.37 -55.34 9.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.421 ' HE2' HD11 ' A' ' 9' ' ' ILE . 9.0 t80 -51.48 -46.89 63.3 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 120.225 1.375 . . . . 0.0 112.322 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.25 -23.72 66.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 116.944 -1.503 . . . . 0.0 112.294 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -108.63 -17.91 13.85 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.7 1.591 . . . . 0.0 113.606 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -80.47 -33.38 36.69 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.461 1.104 . . . . 0.0 108.816 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -133.66 -46.09 0.81 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.102 -0.952 . . . . 0.0 111.079 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . 0.256 0.1 OUTLIER -67.85 0.24 3.58 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 120.71 1.595 . . . . 0.0 114.831 -179.462 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 58.7 mt -130.17 40.47 3.53 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 119.524 -1.985 . . . . 0.0 108.863 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 63.9 p -117.5 156.42 28.05 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.24 -43.38 98.96 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -73.31 -33.04 64.95 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -75.44 -42.25 28.06 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.09 -44.47 76.16 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -54.83 -47.17 74.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.189 0.996 . . . . 0.0 109.52 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.24 -42.32 63.52 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 22.5 t -75.34 -36.52 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -61.54 -20.47 63.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.482 0.713 . . . . 0.0 110.97 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -67.85 -45.45 74.57 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 121.163 -0.961 . . . . 0.0 110.139 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.42 -39.77 58.51 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -146.35 156.72 49.75 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.245 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.32 114.08 3.67 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.761 1.641 . . . . 0.0 109.299 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.47 -32.47 37.11 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 119.37 -0.348 . . . . 0.0 110.074 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.57 -167.81 47.07 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -59.13 157.63 10.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.56 0.695 . . . . 0.0 109.932 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.8 156.27 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.723 0.773 . . . . 0.0 111.191 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.63 -35.12 67.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.67 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.38 103.6 0.32 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.729 1.211 . . . . 0.0 112.332 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -47.95 -33.4 7.69 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.587 1.555 . . . . 0.0 112.703 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.8 -49.93 68.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.469 1.108 . . . . 0.0 113.211 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -96.41 -10.58 27.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.242 0.928 . . . . 0.0 111.504 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.27 -46.71 87.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.331 1.452 . . . . 0.0 108.098 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -69.16 -22.58 63.92 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 119.074 -0.488 . . . . 0.0 112.046 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -78.94 -49.57 12.59 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 7.1 mt -62.69 -38.16 89.29 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.61 -2.41 2.39 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.531 1.132 . . . . 0.0 114.043 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -66.71 -35.79 80.97 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.445 1.02 . . . . 0.0 108.529 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.9 150.49 58.89 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 123.747 0.819 . . . . 0.0 109.643 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.14 -24.59 20.03 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.466 2.11 . . . . 0.0 115.23 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -48.0 77.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.385 0.993 . . . . 0.0 109.447 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.501 HD12 ' H ' ' A' ' 317' ' ' ILE . 4.9 mp -64.04 -55.77 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.5 -53.39 23.57 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 123.926 0.766 . . . . 0.0 111.967 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.44 -47.13 87.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.523 HG23 ' HB3' ' A' ' 112' ' ' ALA . 87.0 m -67.57 -29.71 69.14 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 7.8 tpt -71.91 -39.52 69.46 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 120.9 -1.125 . . . . 0.0 109.136 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -56.78 -26.81 58.54 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.62 0.768 . . . . 0.0 110.223 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -66.18 -36.86 84.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.263 0.625 . . . . 0.0 112.332 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -76.91 -35.25 57.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -64.81 -52.25 57.79 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.129 0.972 . . . . 0.0 109.99 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -10.34 59.42 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -86.54 -169.73 46.2 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -148.33 113.16 5.42 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.75 149.0 11.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.239 1.816 . . . . 0.0 110.81 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 34.9 mtp -62.26 149.92 85.96 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.738 1.215 . . . . 0.0 112.707 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -83.29 -179.42 4.31 Favored 'Trans proline' 0 C--N 1.348 0.534 1 C-N-CA 125.563 4.175 . . . . 0.0 112.576 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -134.23 38.53 3.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.88 1.272 . . . . 0.0 112.764 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.1 pt -114.05 152.09 45.47 Favored Pre-proline 0 N--CA 1.472 0.656 0 O-C-N 120.879 -1.138 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.98 -17.22 36.69 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.581 2.188 . . . . 0.0 113.969 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -56.23 -22.83 31.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.103 1.761 . . . . 0.0 112.024 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -32.51 65.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.849 1.26 . . . . 0.0 111.544 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -48.57 76.65 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.404 1.002 . . . . 0.0 109.208 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.5 87.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -58.87 -54.51 46.28 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.354 0.525 . . . . 0.0 110.393 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -61.29 -42.37 98.54 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.561 -0.712 . . . . 0.0 109.989 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -63.93 -23.04 67.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.069 0.948 . . . . 0.0 112.307 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -85.02 -57.73 2.98 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 120.955 -1.09 . . . . 0.0 110.639 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 347' ' ' VAL . 19.3 t -57.84 -38.74 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 118.068 -0.968 . . . . 0.0 111.946 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -52.15 -48.57 64.84 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.145 1.339 . . . . 0.0 111.365 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 8.5 m -66.4 -40.22 89.48 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.375 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.56 83.74 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.373 0.988 . . . . 0.0 111.413 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 343' ' ' VAL . 36.2 t -60.69 -55.38 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.784 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.8 mm -66.26 -33.38 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 123.575 0.547 . . . . 0.0 110.652 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -61.09 -46.02 92.34 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.425 -1.422 . . . . 0.0 108.8 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.9 -50.18 44.87 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.881 0.872 . . . . 0.0 109.729 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -57.08 -37.79 72.39 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 69.0 m -87.55 -7.13 57.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.548 0.739 . . . . 0.0 110.256 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.62 13.71 71.72 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 118.491 0.587 . . . . 0.0 111.78 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 -65.98 -28.61 69.02 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.311 1.056 . . . . 0.0 109.633 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -149.25 153.24 37.26 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 9.0 m -66.07 150.71 48.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.448 1.099 . . . . 0.0 108.671 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 18.8 t -52.52 -54.53 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.911 1.285 . . . . 0.0 108.339 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.38 -44.91 55.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.344 2.257 . . . . 0.0 112.597 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -82.6 -26.92 31.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.48 85.57 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 76.4 mt -68.87 -39.44 79.84 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.73 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.46 ' HE3' ' OD2' ' A' ' 184' ' ' ASP . 2.1 tppp? -58.33 -35.81 72.44 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.896 0.878 . . . . 0.0 110.545 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.22 -32.74 22.46 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.789 0.722 . . . . 0.0 110.98 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.17 -40.16 90.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.564 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.64 -37.9 76.95 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.878 0.763 . . . . 0.0 109.606 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 4.3 m -67.53 -19.58 65.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.209 1.404 . . . . 0.0 113.141 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -80.66 -11.94 59.56 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.141 -0.975 . . . . 0.0 110.874 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.11 -42.02 11.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.5 p -68.02 -13.75 62.43 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.451 0.569 . . . . 0.0 111.859 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 32.2 tptt . . . . . 0 C--O 1.245 0.828 0 C-N-CA 125.868 1.667 . . . . 0.0 107.087 179.278 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.8 tptm . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 120.904 0.383 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 68.8 mt -70.79 133.71 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.31 41.26 0.24 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.435 1.47 . . . . 0.0 114.21 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -65.51 133.05 50.41 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.52 22.02 72.97 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 126.915 2.198 . . . . 0.0 114.634 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -153.7 167.04 30.94 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 119.215 1.507 . . . . 0.0 110.279 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -137.09 158.39 44.55 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 127.583 2.353 . . . . 0.0 108.07 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.7 t -143.42 134.51 22.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 125.803 1.641 . . . . 0.0 107.21 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.72 141.7 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.172 1.389 . . . . 0.0 109.491 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -130.1 162.51 28.64 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -126.73 170.18 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 124.504 1.122 . . . . 0.0 108.74 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -74.31 -25.19 59.42 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.02 -30.53 3.19 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 120.138 1.335 . . . . 0.0 115.331 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -113.13 6.5 17.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.436 1.494 . . . . 0.0 113.335 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' A' ' 297' ' ' LYS . 34.0 mmtm -75.59 -168.14 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.447 1.499 . . . . 0.0 110.448 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.04 65.53 0.37 Allowed Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -52.53 -34.82 51.69 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.853 0.826 . . . . 0.0 112.528 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -58.18 -55.22 37.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.605 0.639 . . . . 0.0 110.251 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.63 -31.17 77.76 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HA ' HG22 ' A' ' 293' ' ' VAL . 53.6 tp -67.45 -35.53 79.4 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.214 -1.168 . . . . 0.0 110.333 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.39 -40.91 83.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 117.904 -1.046 . . . . 0.0 108.918 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -54.68 -45.02 73.84 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.451 1.1 . . . . 0.0 110.731 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 t -57.01 -47.14 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.63 -35.35 85.94 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.682 -1.065 . . . . 0.0 110.88 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm -64.26 -46.52 83.38 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.289 1.544 . . . . 0.0 108.696 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -57.74 11.26 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -55.64 -49.76 72.0 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 117.641 0.201 . . . . 0.0 111.418 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.16 -30.09 69.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.524 1.129 . . . . 0.0 111.545 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -25.39 45.09 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 117.726 -1.131 . . . . 0.0 110.759 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -100.68 -4.04 29.08 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.513 1.133 . . . . 0.0 111.767 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.2 p -132.52 -38.68 1.03 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.82 -18.36 56.06 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 121.201 -0.937 . . . . 0.0 112.779 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.2 mm -66.79 116.15 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 147.33 49.84 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.753 -0.592 . . . . 0.0 110.141 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.2 t -132.54 104.63 7.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 125.89 1.676 . . . . 0.0 109.154 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 m -84.7 141.77 30.34 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.92 115.95 19.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -125.65 167.67 14.78 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.21 0.604 . . . . 0.0 112.001 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -120.13 65.95 11.09 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.509 1.124 . . . . 0.0 112.945 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.7 161.61 36.46 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.14 1.893 . . . . 0.0 109.843 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -124.85 17.21 8.64 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.288 1.035 . . . . 0.0 110.648 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.98 8.23 2.5 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.844 1.658 . . . . 0.0 111.809 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.0 pt? -51.32 -26.78 8.1 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.249 1.42 . . . . 0.0 114.188 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.2 pm0 -61.07 -25.75 67.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.497 1.044 . . . . 0.0 111.437 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -115.5 -28.01 6.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -67.62 -44.25 78.49 Favored 'General case' 0 C--O 1.221 -0.447 0 O-C-N 119.813 -1.804 . . . . 0.0 109.687 179.226 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -52.98 -59.8 8.16 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 120.503 1.501 . . . . 0.0 109.343 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.34 -13.72 37.7 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 121.75 1.633 . . . . 0.0 114.213 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -90.07 -9.87 46.88 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.795 1.634 . . . . 0.0 111.69 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.2 -34.88 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 119.941 1.246 . . . . 0.0 112.036 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.96 -34.04 74.12 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.38 -14.76 30.19 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.611 1.164 . . . . 0.0 112.316 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.88 5.51 17.44 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.222 1.809 . . . . 0.0 110.509 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.6 30.28 76.13 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.37 7.43 7.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.736 1.214 . . . . 0.0 112.283 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.73 -171.51 43.68 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.139 1.828 . . . . 0.0 111.961 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.67 178.15 2.93 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.348 2.699 . . . . 0.0 111.27 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -104.2 -17.69 14.78 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.557 -0.714 . . . . 0.0 111.939 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.17 157.22 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.5 tp -143.9 142.68 24.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -131.2 107.38 8.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.817 1.247 . . . . 0.0 108.684 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -151.95 172.62 15.96 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.387 1.075 . . . . 0.0 108.579 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.27 162.46 28.43 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.827 1.194 . . . . 0.0 110.641 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -55.13 -26.34 37.74 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.77 1.628 . . . . 0.0 112.493 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -58.87 -64.77 0.82 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 118.015 -0.993 . . . . 0.0 112.462 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -62.5 -23.23 66.83 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 121.213 1.824 . . . . 0.0 109.918 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -72.78 -15.64 61.65 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.6 -0.687 . . . . 0.0 111.359 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.56 -21.5 60.43 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.23 1.395 . . . . 0.0 112.776 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.09 -33.89 2.09 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.477 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -53.65 -47.57 70.2 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.792 1.796 . . . . 0.0 114.241 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.07 -43.65 91.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.606 1.094 . . . . 0.0 110.417 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -56.61 -49.52 74.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.9 m -62.51 -3.25 1.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.952 1.701 . . . . 0.0 113.845 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.12 11.11 85.68 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 119.778 1.172 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -81.36 -21.32 39.17 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.026 1.413 . . . . 0.0 110.555 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.6 mt -111.44 140.98 45.59 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.356 0.98 . . . . 0.0 109.594 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.77 176.13 6.47 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.595 1.558 . . . . 0.0 110.469 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.54 144.36 49.6 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.576 1.15 . . . . 0.0 109.205 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.5 163.87 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.841 1.256 . . . . 0.0 109.665 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.2 m 65.39 81.8 0.21 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.767 1.627 . . . . 0.0 112.227 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.87 -65.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.964 1.776 . . . . 0.0 108.51 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.27 155.02 17.39 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.631 1.172 . . . . 0.0 110.07 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tptp -65.58 -28.51 69.2 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.74 1.216 . . . . 0.0 113.081 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.06 -36.65 60.86 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.288 0.949 . . . . 0.0 111.663 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -63.09 -28.11 69.85 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.861 -0.524 . . . . 0.0 111.084 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -73.75 -43.19 59.78 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.272 0.942 . . . . 0.0 110.176 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.19 -27.97 67.58 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.478 1.111 . . . . 0.0 112.476 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -66.03 -16.72 64.16 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.696 0.798 . . . . 0.0 111.559 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.1 mt -119.88 163.45 17.52 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.465 1.506 . . . . 0.0 109.13 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -69.86 147.79 96.2 Favored Pre-proline 0 C--O 1.235 0.292 0 O-C-N 121.403 -0.81 . . . . 0.0 110.245 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.89 -51.01 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.59 2.193 . . . . 0.0 113.083 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -55.2 -44.67 75.54 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.739 0.7 . . . . 0.0 109.944 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -27.47 57.13 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.23 1.012 . . . . 0.0 112.69 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -73.52 -33.28 64.68 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.651 1.114 . . . . 0.0 111.451 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -59.86 -37.02 78.1 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.225 0.61 . . . . 0.0 111.82 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.54 -3.31 4.31 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.994 -1.003 . . . . 0.0 113.002 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -132.19 11.89 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.369 1.468 . . . . 0.0 111.571 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.5 mtp-105 -76.26 156.36 33.56 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 121.038 -1.039 . . . . 0.0 109.404 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -131.13 177.78 7.2 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.846 1.658 . . . . 0.0 107.156 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -65.57 100.17 0.49 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.261 1.025 . . . . 0.0 109.298 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.61 -76.62 1.69 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.227 1.394 . . . . 0.0 110.701 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 166.69 20.51 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mt -100.34 160.13 14.58 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.769 1.627 . . . . 0.0 108.087 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.1 pt -133.52 -19.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.44 164.81 26.96 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.591 1.542 . . . . 0.0 108.165 178.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.2 137.51 22.53 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-O 118.747 -0.644 . . . . 0.0 110.443 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.49 129.44 18.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.777 2.318 . . . . 0.0 108.73 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 mm -121.2 -46.34 2.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.55 148.8 52.38 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 67.8 t -121.18 111.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -120.04 167.58 12.04 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.62 130.69 50.98 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.494 ' HB2' ' H ' ' A' ' 245' ' ' THR . 0.3 OUTLIER -88.6 168.92 12.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.634 1.574 . . . . 0.0 113.544 -178.607 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.8 m -144.48 115.98 8.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.03 1.732 . . . . 0.0 111.689 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.69 170.17 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 129.39 3.076 . . . . 0.0 117.209 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.2 mp -86.98 136.34 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.717 1.207 . . . . 0.0 108.655 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.435 ' CE1' HD22 ' A' ' 122' ' ' LEU . 6.2 p90 -147.14 167.19 24.76 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.421 1.888 . . . . 0.0 108.758 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -74.46 147.32 42.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.269 1.028 . . . . 0.0 111.351 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -66.93 28.2 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.894 2.878 . . . . 0.0 114.745 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -84.36 -163.06 0.74 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.686 1.194 . . . . 0.0 107.992 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -60.57 -20.7 61.23 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.435 HD22 ' CE1' ' A' ' 117' ' ' TYR . 51.2 tp 50.99 80.71 0.28 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.69 1.596 . . . . 0.0 109.168 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -75.66 74.92 4.17 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.884 3.056 . . . . 0.0 110.455 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m120 64.08 161.71 0.12 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 128.781 2.832 . . . . 0.0 111.571 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.88 163.23 38.24 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 121.546 1.498 . . . . 0.0 109.416 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.434 ' HG2' HG21 ' A' ' 246' ' ' VAL . 91.5 Cg_endo -72.11 157.89 53.28 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.042 1.161 . . . . 0.0 110.226 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -138.52 -19.06 1.08 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 116.437 -1.744 . . . . 0.0 114.159 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.76 136.38 32.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.716 1.598 . . . . 0.0 111.219 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -65.93 -26.09 67.43 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.167 -0.958 . . . . 0.0 110.89 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.32 -12.88 62.04 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.834 0.743 . . . . 0.0 112.748 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -92.45 -11.53 34.49 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.711 0.804 . . . . 0.0 111.171 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.58 -59.0 12.9 Favored Pre-proline 0 C--O 1.233 0.186 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.58 -23.31 49.86 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 CA-C-N 119.826 0.974 . . . . 0.0 110.978 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.89 89.76 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.738 0.699 . . . . 0.0 109.887 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.6 tp -80.79 -27.49 36.65 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -57.19 -47.58 80.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 124.292 1.037 . . . . 0.0 111.205 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -66.69 -28.44 68.45 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 122.994 0.518 . . . . 0.0 112.064 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -75.89 -42.4 49.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 56.9 mt -78.82 -32.84 46.38 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.722 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.85 -35.89 79.35 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.63 67.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.204 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -5.62 15.41 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.471 1.108 . . . . 0.0 112.414 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.69 -94.57 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 119.159 0.89 . . . . 0.0 113.556 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.484 ' HE2' ' OE2' ' A' ' 221' ' ' GLU . 27.9 mmtm -132.92 172.15 13.0 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.511 1.124 . . . . 0.0 110.849 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.56 162.73 3.63 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.424 1.49 . . . . 0.0 111.696 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.54 -55.99 4.14 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.8 tp -115.96 157.18 24.96 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.155 0.982 . . . . 0.0 110.818 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.3 mtp -148.7 114.17 5.6 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -140.5 174.01 10.93 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.799 0.84 . . . . 0.0 109.171 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.429 ' H ' HD22 ' A' ' 150' ' ' ASN . 1.2 p30 -69.42 76.05 0.39 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.864 2.065 . . . . 0.0 109.978 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.3 mt -73.07 -23.15 60.51 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -79.66 -1.73 39.56 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.655 0.782 . . . . 0.0 112.672 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -117.75 129.74 25.16 Favored Pre-proline 0 CA--C 1.529 0.147 0 C-N-CA 123.962 0.905 . . . . 0.0 112.878 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.11 -13.31 17.24 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.352 2.035 . . . . 0.0 112.286 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -59.04 -44.62 91.79 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.873 0.869 . . . . 0.0 110.4 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -91.92 -28.29 17.36 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.395 0.543 . . . . 0.0 111.42 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.5 p -80.16 -2.13 43.34 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 119.133 0.879 . . . . 0.0 110.47 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 32.8 t-105 -56.97 -66.3 1.29 Allowed Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 120.421 -1.424 . . . . 0.0 111.093 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.46 -20.39 60.96 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 CA-C-N 120.242 1.122 . . . . 0.0 112.899 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.82 -43.2 90.56 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-O 118.341 -0.838 . . . . 0.0 108.829 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 9.3 pt -93.01 -32.12 4.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.441 0.564 . . . . 0.0 111.663 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.86 -6.94 18.32 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.118 -0.988 . . . . 0.0 113.256 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -54.01 -46.21 71.72 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.903 1.281 . . . . 0.0 112.968 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -63.84 -50.4 69.0 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.521 0.601 . . . . 0.0 109.843 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.47 42.77 0.05 OUTLIER Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.329 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.03 154.6 24.63 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -159.91 121.99 3.32 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.33 -47.8 80.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -146.01 131.45 18.67 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -58.28 126.73 28.75 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -150.63 101.25 2.92 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.18 158.57 43.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 119.109 0.868 . . . . 0.0 108.888 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 47.9 27.33 1.13 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.156 1.783 . . . . 0.0 112.445 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 79.42 18.87 72.83 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.576 -1.125 . . . . 0.0 114.04 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -120.99 115.25 22.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.55 1.675 . . . . 0.0 107.372 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -106.08 121.24 43.73 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.287 1.435 . . . . 0.0 108.881 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -130.7 110.89 11.69 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 122.394 1.093 . . . . 0.0 111.094 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.1 OUTLIER -73.55 0.29 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 124.307 1.043 . . . . 0.0 109.367 177.088 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -84.19 -11.52 56.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.488 2.315 . . . . 0.0 111.623 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -127.4 105.69 8.69 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.67 140.4 49.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -124.52 29.8 4.89 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 117.871 -1.516 . . . . 0.0 116.188 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.38 -11.54 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.221 2.011 . . . . 0.0 113.693 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.14 10.25 10.0 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.472 1.033 . . . . 0.0 112.166 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.09 159.93 13.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.846 0.858 . . . . 0.0 110.055 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.79 -35.58 61.5 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.292 1.037 . . . . 0.0 110.862 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.85 -41.6 97.41 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 118.373 0.533 . . . . 0.0 112.366 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.07 64.98 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.16 0.98 . . . . 0.0 109.911 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -63.08 -37.79 88.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 118.566 -0.73 . . . . 0.0 110.671 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.23 71.9 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.646 0.778 . . . . 0.0 111.863 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.09 -28.03 24.22 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 192' ' ' LEU . 19.8 tp -74.92 -39.03 61.63 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.281 -1.717 . . . . 0.0 111.618 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.2 t -56.58 -33.61 66.37 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.923 0.489 . . . . 0.0 111.511 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -60.01 -54.62 43.9 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 119.389 0.995 . . . . 0.0 109.459 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 7.4 tt -56.38 -45.0 80.74 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.458 1.103 . . . . 0.0 110.233 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.31 -32.96 52.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.713 0.805 . . . . 0.0 109.893 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.589 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 19.1 t70 -63.72 -46.37 85.74 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.859 1.209 . . . . 0.0 112.726 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.62 -39.52 94.08 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.688 0.795 . . . . 0.0 109.76 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 75.5 mt -68.69 -40.29 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -52.67 -40.79 63.21 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.659 1.183 . . . . 0.0 109.7 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -90.99 0.87 57.43 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.121 1.768 . . . . 0.0 113.22 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.9 mptt 52.91 17.55 0.9 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 128.452 2.701 . . . . 0.0 114.972 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -82.27 -24.97 34.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.983 0.81 . . . . 0.0 109.315 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.0 tpt -77.94 163.38 26.04 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -82.52 51.19 1.8 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.68 -22.41 8.91 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 127.347 2.259 . . . . 0.0 115.905 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.99 8.63 43.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.506 1.522 . . . . 0.0 112.398 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 71.4 m -101.06 144.31 30.14 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.762 1.625 . . . . 0.0 111.158 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.78 -177.54 4.32 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.596 1.958 . . . . 0.0 108.85 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -48.48 -51.0 29.28 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.814 0.846 . . . . 0.0 112.884 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.26 -43.76 90.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.274 0.629 . . . . 0.0 111.142 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.09 -49.05 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.755 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.94 -47.53 86.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.5 1.12 . . . . 0.0 110.885 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.03 -42.68 80.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.138 0.575 . . . . 0.0 111.547 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.55 -48.18 35.03 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 122.023 -0.423 . . . . 0.0 110.146 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.25 -39.33 56.44 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.031 1.732 . . . . 0.0 111.775 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -53.79 -55.0 30.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.168 1.387 . . . . 0.0 109.079 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -62.13 -38.15 87.86 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.44 -17.67 64.72 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.627 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.62 11.9 76.35 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 119.117 0.871 . . . . 0.0 111.024 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.484 ' OE2' ' HE2' ' A' ' 144' ' ' LYS . 7.4 mm-40 -65.52 -60.63 2.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.544 1.137 . . . . 0.0 110.332 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.8 t -87.82 141.77 28.33 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.961 0.904 . . . . 0.0 109.444 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.19 -35.24 59.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -127.13 164.19 22.17 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.317 0.647 . . . . 0.0 109.545 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 52.4 m -151.13 155.29 38.61 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.763 0.825 . . . . 0.0 108.871 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt -133.73 126.93 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -143.81 178.5 7.78 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 130.208 3.403 . . . . 0.0 110.014 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.27 64.85 1.02 Allowed Glycine 0 CA--C 1.531 1.047 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.04 156.33 65.57 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.313 2.675 . . . . 0.0 110.773 178.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -89.0 112.72 23.71 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.55 62.44 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.147 2.179 . . . . 0.0 113.044 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -144.15 116.21 8.38 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.54 1.936 . . . . 0.0 105.988 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 28.0 m 63.58 -13.01 0.09 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.465 1.906 . . . . 0.0 115.193 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -68.31 172.99 5.21 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.376 1.47 . . . . 0.0 110.509 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.13 -14.76 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -72.95 157.38 37.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.407 1.458 . . . . 0.0 108.178 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 8.8 t -148.52 137.52 21.68 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.1 t -140.49 162.31 35.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.944 1.698 . . . . 0.0 107.818 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -80.77 0.22 35.72 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 9.1 p -147.13 151.84 13.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -155.35 64.93 0.62 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.614 0.643 . . . . 0.0 110.382 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -65.35 163.65 15.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.478 0.656 . . . . 0.0 111.439 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -117.29 83.46 0.34 Allowed Glycine 0 C--N 1.335 0.524 0 N-CA-C 106.694 -2.563 . . . . 0.0 106.694 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 1.3 m -134.55 91.21 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.709 2.404 . . . . 0.0 107.575 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.803 HG22 ' H ' ' A' ' 246' ' ' VAL . 1.1 m -142.24 -171.51 3.4 Favored 'General case' 0 C--O 1.217 -0.612 0 O-C-N 118.892 -2.38 . . . . 0.0 111.03 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.803 ' H ' HG22 ' A' ' 245' ' ' THR . 11.6 p -141.56 176.8 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 120.832 1.651 . . . . 0.0 109.618 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.442 ' H ' HG22 ' A' ' 246' ' ' VAL . 0.7 OUTLIER -131.7 59.79 47.45 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.788 1.235 . . . . 0.0 113.648 -178.319 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.555 ' HD3' HG13 ' A' ' 246' ' ' VAL . 65.3 Cg_endo -64.97 155.0 70.49 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.487 2.125 . . . . 0.0 108.798 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 61.6 p -97.45 179.76 4.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.356 1.062 . . . . 0.0 110.427 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -107.84 164.75 11.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -59.34 114.21 2.55 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.068 0.395 . . . . 0.0 110.201 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 69.92 15.29 71.5 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 118.364 -1.242 . . . . 0.0 113.965 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.46 117.9 3.23 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 120.639 2.22 . . . . 0.0 111.668 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.34 113.49 3.12 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.854 2.37 . . . . 0.0 111.165 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 31.6 t -57.82 157.03 7.97 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.215 1.006 . . . . 0.0 108.382 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -132.86 60.8 52.41 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 125.634 1.574 . . . . 0.0 112.792 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.88 164.59 31.06 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.542 1.495 . . . . 0.0 109.452 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -63.62 170.88 2.93 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.642 1.211 . . . . 0.0 112.966 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 77.0 t -106.21 157.11 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.149 1.78 . . . . 0.0 108.489 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -138.22 149.52 20.53 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 19.0 t -145.11 148.93 17.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.43 1.092 . . . . 0.0 109.56 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 263' ' ' SER . 1.1 tt -77.02 149.49 35.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.57 ' H ' HD23 ' A' ' 262' ' ' LEU . 19.3 m -126.38 154.2 43.91 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.814 0.846 . . . . 0.0 111.828 -178.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -136.93 134.48 36.81 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.471 1.108 . . . . 0.0 108.277 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -142.53 154.99 25.51 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 75.1 mt -93.55 136.37 25.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.974 1.309 . . . . 0.0 107.591 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -72.72 113.78 10.14 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.9 -20.07 66.25 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.184 -0.912 . . . . 0.0 113.429 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -73.74 -16.35 61.18 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.7 m -70.27 163.56 61.07 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 119.084 0.856 . . . . 0.0 110.514 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.69 -46.06 2.88 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.331 2.021 . . . . 0.0 115.327 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -137.42 114.7 10.93 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 119.078 0.854 . . . . 0.0 112.203 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -18.32 64.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.024 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -59.83 -40.36 88.19 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 98.9 mt -57.8 -41.22 81.72 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.496 -0.752 . . . . 0.0 111.093 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -77.91 -42.76 32.11 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -33.94 76.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.431 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -68.76 -52.57 29.05 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -55.33 -43.54 75.03 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.204 -0.935 . . . . 0.0 112.326 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -61.03 -51.23 70.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.486 1.114 . . . . 0.0 110.09 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -75.07 -17.81 60.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -105.79 -26.45 11.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.06 -1.448 . . . . 0.0 113.858 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -131.18 -37.41 1.26 Allowed 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 120.719 1.6 . . . . 0.0 113.609 -178.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 284' ' ' LEU . 1.7 tm? -62.0 -50.0 73.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 116.516 -2.073 . . . . 0.0 107.415 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 90.6 mt -82.91 52.5 2.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.586 1.954 . . . . 0.0 115.883 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 13.2 p -131.01 160.34 34.85 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -63.19 -47.01 84.41 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -70.44 -32.63 70.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.524 1.13 . . . . 0.0 111.074 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.87 -42.76 44.38 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 54.7 mt -70.37 -46.54 63.88 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -56.67 -43.55 80.54 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.491 0.716 . . . . 0.0 109.954 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.34 61.18 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 20' ' ' LEU . 5.0 t -88.27 -31.4 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 122.842 0.457 . . . . 0.0 109.886 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -71.62 -23.92 61.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.763 0.425 . . . . 0.0 111.251 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -59.71 -47.35 86.01 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.17 -59.62 4.51 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.106 0.962 . . . . 0.0 112.033 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -137.87 160.46 64.55 Favored Pre-proline 0 N--CA 1.463 0.211 0 O-C-N 121.389 -0.82 . . . . 0.0 112.293 -178.576 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -69.92 110.07 2.5 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.691 1.594 . . . . 0.0 108.164 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.41 -9.75 58.84 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 85.22 -166.58 40.52 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 119.709 1.141 . . . . 0.0 110.276 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -73.67 168.43 19.37 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.026 0.93 . . . . 0.0 110.765 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.16 153.9 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 123.61 0.764 . . . . 0.0 110.831 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.0 41.17 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.947 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 63.5 tp -65.75 100.46 0.54 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.52 1.928 . . . . 0.0 106.869 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -47.5 -37.72 12.5 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.353 1.061 . . . . 0.0 112.983 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.8 m -55.41 -60.48 3.35 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.693 0.797 . . . . 0.0 112.768 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -83.77 -9.97 58.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.822 1.249 . . . . 0.0 111.806 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -61.5 -42.62 99.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -67.47 -37.79 83.43 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 124.39 1.056 . . . . 0.0 111.272 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -65.16 -50.74 64.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.6 -38.62 89.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.86 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.64 -15.97 33.89 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.561 1.145 . . . . 0.0 113.662 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -60.25 -16.02 30.09 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.973 0.806 . . . . 0.0 111.605 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.3 135.26 19.68 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 119.335 0.97 . . . . 0.0 110.597 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.43 -34.46 94.63 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.288 2.659 . . . . 0.0 112.805 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.62 -33.47 75.07 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.029 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.9 mp -79.68 -54.26 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -43.96 -55.21 4.78 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.507 1.123 . . . . 0.0 112.211 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.22 -30.03 70.18 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 9.8 m -77.55 -32.54 53.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.765 0.826 . . . . 0.0 109.259 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.0 tpt -74.39 -41.84 60.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -49.64 -42.02 44.03 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 125.384 1.474 . . . . 0.0 111.288 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -59.27 -44.51 92.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.815 2.046 . . . . 0.0 110.368 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -75.87 -22.37 56.25 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.222 -0.299 . . . . 0.0 110.815 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -88.5 -14.06 38.72 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.492 1.117 . . . . 0.0 112.756 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.42 -3.2 25.76 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.159 1.384 . . . . 0.0 112.09 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -114.68 -178.64 18.89 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -135.9 141.99 44.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 90.7 mt -72.61 153.66 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.537 1.135 . . . . 0.0 110.097 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 31.8 mtp -62.67 162.98 17.1 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.023 0.929 . . . . 0.0 112.155 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -71.57 178.23 5.91 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.49 2.127 . . . . 0.0 112.399 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -134.19 16.58 3.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.43 1.892 . . . . 0.0 112.056 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.3 pt -116.91 153.72 49.47 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.709 1.204 . . . . 0.0 112.021 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.28 -5.42 17.13 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.771 2.981 . . . . 0.0 115.406 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -57.79 -19.24 26.96 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.768 -1.207 . . . . 0.0 111.884 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 2.2 mtp -61.85 -24.07 66.67 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.772 -0.58 . . . . 0.0 110.472 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 40.3 t -54.57 -53.56 52.9 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.073 1.349 . . . . 0.0 109.004 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.22 -43.71 90.6 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.824 0.449 . . . . 0.0 110.514 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -53.67 -54.09 42.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.816 0.846 . . . . 0.0 110.773 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -59.96 -50.0 75.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.133 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -55.38 -42.75 74.42 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.473 0.579 . . . . 0.0 111.217 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.411 ' HB1' ' HB1' ' A' ' 364' ' ' ALA . . . -62.32 -57.3 11.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.468 1.107 . . . . 0.0 111.979 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.5 t -63.58 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.109 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -50.87 -41.31 58.07 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.539 1.063 . . . . 0.0 110.041 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.0 m -79.94 -47.14 15.48 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.415 -0.803 . . . . 0.0 110.525 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.07 -44.74 64.46 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 36.4 t -60.51 -47.69 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.34 -36.18 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.45 0.568 . . . . 0.0 109.766 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -59.41 -49.88 76.12 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.438 1.017 . . . . 0.0 109.527 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.36 -43.49 73.48 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.081 0.552 . . . . 0.0 110.79 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.84 -29.03 70.43 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.778 0.831 . . . . 0.0 112.37 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 6.7 m -92.45 -10.31 38.39 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.651 0.78 . . . . 0.0 110.076 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 72.73 10.39 76.38 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.194 -0.781 . . . . 0.0 112.572 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -67.15 -29.41 69.11 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.935 1.367 . . . . 0.0 111.883 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -140.09 157.5 45.53 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.4 m -62.3 152.56 33.39 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.855 0.862 . . . . 0.0 109.214 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.8 -48.49 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.35 -49.52 72.03 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.976 1.71 . . . . 0.0 111.159 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -75.53 -30.79 59.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.31 -41.32 98.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 7.9 mp -73.21 -38.62 66.02 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.243 1.017 . . . . 0.0 109.518 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -57.29 13.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.579 1.081 . . . . 0.0 110.389 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -55.42 -36.32 66.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 122.386 1.089 . . . . 0.0 109.951 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.411 ' HB1' ' HB1' ' A' ' 342' ' ' ALA . . . -68.57 -46.99 67.97 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 117.537 -1.221 . . . . 0.0 111.236 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -52.72 -39.29 61.92 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.538 1.063 . . . . 0.0 109.655 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 4.4 m -63.77 -26.15 68.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 112.828 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -72.89 -18.92 61.37 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.448 -1.407 . . . . 0.0 111.028 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.9 mp -92.68 -38.46 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.214 1.006 . . . . 0.0 109.105 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 7.7 p -69.19 -15.67 63.45 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.373 0.988 . . . . 0.0 111.668 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 51.6 tttm . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.955 2.102 . . . . 0.0 110.309 179.155 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.422 ' H3 ' ' CG ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 117.445 -1.264 . . . . 0.0 113.401 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.6 mm 48.26 167.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 131.308 3.843 . . . . 0.0 115.604 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -132.37 116.7 17.18 Favored 'General case' 0 N--CA 1.45 -0.473 1 N-CA-C 97.888 -4.856 . . . . 0.0 97.888 177.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -77.03 171.16 15.24 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.764 0.711 . . . . 0.0 111.818 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.49 38.89 71.97 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.812 1.196 . . . . 0.0 115.78 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -145.77 173.5 12.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.864 0.832 . . . . 0.0 110.031 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.3 mt -142.13 154.49 44.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.951 2.101 . . . . 0.0 107.519 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.4 t -144.53 117.33 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.422 HD11 ' CE2' ' A' ' 279' ' ' PHE . 40.5 mt -99.4 126.52 52.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -112.93 140.37 47.8 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mp -129.79 148.84 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 C-N-CA 125.588 1.555 . . . . 0.0 109.846 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.76 -64.75 1.01 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.3 169.45 42.28 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.629 1.585 . . . . 0.0 109.149 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 52.45 3.17 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.22 3.008 . . . . 0.0 115.775 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.56 -28.85 68.13 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.763 1.625 . . . . 0.0 115.376 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.7 36.15 6.98 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -51.61 -34.23 36.53 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -59.47 -40.51 87.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.645 0.778 . . . . 0.0 112.087 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.59 -30.81 26.07 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -62.71 -38.01 88.73 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.603 1.161 . . . . 0.0 111.552 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.22 -46.3 62.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.66 0.784 . . . . 0.0 110.945 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -60.0 -35.5 75.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.844 -0.598 . . . . 0.0 112.438 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.2 t -62.32 -43.98 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.88 -40.89 93.67 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -63.39 -40.92 98.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.216 1.008 . . . . 0.0 109.52 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -63.64 -57.71 9.19 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -55.0 -43.61 73.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.637 0.653 . . . . 0.0 111.992 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.86 -28.19 69.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.448 1.022 . . . . 0.0 110.651 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.4 -23.04 35.11 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.058 -1.026 . . . . 0.0 112.272 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -99.83 -17.95 17.4 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.264 0.978 . . . . 0.0 111.979 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.3 p -122.76 -34.4 3.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.161 0.891 . . . . 0.0 113.184 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.38 -15.05 64.04 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.992 -0.893 . . . . 0.0 111.682 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.0 mm -66.86 120.15 13.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -61.79 146.4 49.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.9 t -135.51 143.49 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.7 m -125.12 143.06 51.12 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.74 119.01 23.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.41 163.23 25.32 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.128 0.971 . . . . 0.0 109.915 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -139.09 65.34 36.14 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.161 0.585 . . . . 0.0 111.262 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.86 173.09 14.06 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 125.054 3.836 . . . . 0.0 109.123 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -123.5 1.14 8.92 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.622 0.769 . . . . 0.0 111.828 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -119.29 6.84 11.19 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.172 0.989 . . . . 0.0 111.097 178.651 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -59.32 -20.71 56.76 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.709 -1.244 . . . . 0.0 112.072 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -60.58 -21.29 62.46 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.729 0.811 . . . . 0.0 112.499 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -122.63 -23.01 5.23 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.715 1.606 . . . . 0.0 111.026 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -78.07 -38.84 43.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.927 1.291 . . . . 0.0 110.693 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -52.02 -57.22 15.83 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 120.376 1.443 . . . . 0.0 110.094 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.82 -16.23 52.19 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.77 1.646 . . . . 0.0 114.385 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -84.54 -12.63 53.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.698 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.82 -40.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 120.154 1.343 . . . . 0.0 109.746 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.34 -43.09 53.84 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.803 1.241 . . . . 0.0 112.498 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.55 70.94 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.546 -0.721 . . . . 0.0 111.689 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 m -74.79 -5.89 45.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.204 1.402 . . . . 0.0 112.79 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.18 47.62 10.77 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.422 ' CG ' ' H3 ' ' A' ' 1' ' ' LYS . 13.6 m-20 -158.42 176.23 12.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 130.99 3.716 . . . . 0.0 104.111 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.6 -170.55 13.59 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.669 -1.269 . . . . 0.0 110.472 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -78.07 -177.16 3.66 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.637 2.892 . . . . 0.0 110.289 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.3 -20.16 13.36 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.573 -0.705 . . . . 0.0 111.972 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mt -137.92 151.84 25.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.546 0.689 . . . . 0.0 110.552 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.02 139.73 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.656 1.182 . . . . 0.0 109.106 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.82 114.43 17.23 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.984 1.314 . . . . 0.0 109.695 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -165.35 -166.01 0.94 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.295 0.952 . . . . 0.0 112.072 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.34 133.4 44.94 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.077 2.151 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -60.08 -29.47 68.58 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.579 1.952 . . . . 0.0 112.308 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.98 -37.6 78.84 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.844 0.747 . . . . 0.0 110.403 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -24.46 56.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -68.66 -30.84 69.62 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.79 -36.26 86.01 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.84 -52.54 14.42 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -56.16 -34.66 66.36 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.531 1.165 . . . . 0.0 111.057 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -45.67 83.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -40.78 88.09 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.1 m -63.66 -12.47 34.24 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.611 -0.68 . . . . 0.0 110.138 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.55 16.22 76.23 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.744 1.64 . . . . 0.0 112.215 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.1 mt -88.15 -10.25 50.58 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mt -96.14 140.9 30.18 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.778 0.717 . . . . 0.0 110.954 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.03 172.2 8.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.981 1.312 . . . . 0.0 112.152 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -78.11 90.18 4.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.453 1.501 . . . . 0.0 111.834 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.447 HD12 ' HB ' ' A' ' 80' ' ' THR . 2.4 pp -73.23 178.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.815 1.246 . . . . 0.0 111.444 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.447 ' HB ' HD12 ' A' ' 79' ' ' ILE 0.337 0.5 OUTLIER 57.77 74.42 0.65 Allowed Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 127.602 2.361 . . . . 0.0 106.363 -178.447 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.42 -24.49 64.1 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.72 2.28 . . . . 0.0 113.605 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -147.13 148.59 31.73 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.709 0.804 . . . . 0.0 109.805 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -55.64 -29.46 59.28 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.842 2.057 . . . . 0.0 112.977 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.25 -36.24 77.34 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.331 0.514 . . . . 0.0 110.102 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -58.6 -32.64 69.17 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.514 0.726 . . . . 0.0 111.595 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -64.27 -46.52 83.32 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.675 -0.64 . . . . 0.0 110.587 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -66.95 -19.15 65.67 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -74.26 -11.47 60.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.348 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mt -124.55 160.91 27.31 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.272 1.429 . . . . 0.0 110.545 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -72.07 150.27 92.4 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.96 -44.45 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.075 2.516 . . . . 0.0 114.416 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -58.19 -34.32 70.23 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.029 0.832 . . . . 0.0 111.782 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -29.82 71.08 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.049 -1.032 . . . . 0.0 111.024 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -73.72 -35.23 65.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.32 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.76 -31.55 64.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.231 0.923 . . . . 0.0 112.501 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.3 -29.75 67.67 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.58 2.64 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.559 1.144 . . . . 0.0 113.733 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -63.79 160.38 17.41 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 122.328 1.061 . . . . 0.0 110.163 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -143.92 175.0 10.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -70.6 110.16 5.29 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.456 0.702 . . . . 0.0 110.463 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.88 -78.29 0.77 Allowed Glycine 0 C--N 1.335 0.486 0 C-N-CA 125.862 1.696 . . . . 0.0 111.028 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.04 166.25 21.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.69 165.5 11.12 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 pt -128.51 -30.52 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.88 176.78 12.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 119.148 0.885 . . . . 0.0 108.62 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.56 145.92 58.95 Favored Pre-proline 0 C--O 1.238 0.473 0 O-C-N 123.083 0.239 . . . . 0.0 110.852 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -66.47 147.96 83.2 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.561 2.841 . . . . 0.0 107.847 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 mm -133.43 -52.44 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 124.043 0.937 . . . . 0.0 110.67 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -131.38 167.29 19.53 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.336 0.398 . . . . 0.0 111.297 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.5 t -135.31 141.15 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -137.07 165.6 25.65 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.679 1.592 . . . . 0.0 107.525 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.03 176.23 12.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.581 1.552 . . . . 0.0 107.838 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.57 166.61 6.57 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.742 0.817 . . . . 0.0 109.912 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.5 p -146.62 159.38 43.52 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.5 tp -76.8 146.05 38.09 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.7 mt -121.86 133.07 69.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -118.43 174.72 6.08 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.361 1.064 . . . . 0.0 109.878 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -73.27 -179.04 3.18 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.678 0.791 . . . . 0.0 112.847 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.93 -9.88 48.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.367 1.067 . . . . 0.0 113.214 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.82 -172.96 0.57 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.237 1.815 . . . . 0.0 108.317 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.96 1.29 8.64 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.208 1.003 . . . . 0.0 109.199 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -42.88 101.44 0.25 Allowed Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 129.796 3.239 . . . . 0.0 109.966 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.56 106.31 1.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.73 2.953 . . . . 0.0 111.437 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -155.61 75.4 5.11 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.9 116.65 4.73 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.877 3.051 . . . . 0.0 116.708 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -81.77 171.59 13.03 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.607 2.871 . . . . 0.0 110.164 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -136.75 -33.66 0.77 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.834 1.253 . . . . 0.0 111.804 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.2 162.62 33.79 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 117.974 0.352 . . . . 0.0 110.844 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.405 ' CE2' HD13 ' A' ' 160' ' ' LEU . 28.3 m95 -67.23 -18.23 65.15 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.999 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -64.51 -8.5 14.05 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.877 1.271 . . . . 0.0 113.4 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -107.08 -18.76 13.81 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.668 1.587 . . . . 0.0 110.996 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.6 mm -56.9 -58.18 19.36 Favored Pre-proline 0 C--N 1.333 -0.141 0 O-C-N 120.823 -1.173 . . . . 0.0 111.822 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -67.41 -25.61 41.74 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 120.501 1.215 . . . . 0.0 110.717 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.85 -41.16 83.34 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.631 1.173 . . . . 0.0 110.349 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.6 tp -82.46 -27.89 31.58 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.148 0.885 . . . . 0.0 109.759 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.71 -44.91 96.02 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 121.325 -0.86 . . . . 0.0 109.615 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -64.54 -28.42 69.63 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.558 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -75.11 -43.35 53.34 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 123.102 0.561 . . . . 0.0 110.658 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 54.2 mt -75.38 -29.96 60.0 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.465 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.14 -38.04 81.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.8 -22.16 66.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.704 1.202 . . . . 0.0 113.07 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.12 4.92 9.81 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 125.445 1.498 . . . . 0.0 112.358 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.92 -95.47 0.1 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 119.37 0.986 . . . . 0.0 113.634 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -142.1 178.21 7.69 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.84 1.256 . . . . 0.0 111.617 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.18 154.01 10.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.878 1.271 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.93 -63.54 1.34 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.954 1.302 . . . . 0.0 111.999 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 41.2 tp -97.43 138.08 35.42 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.323 1.049 . . . . 0.0 110.707 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.415 ' CE ' HG22 ' A' ' 212' ' ' ILE . 94.3 mtp -145.44 110.25 5.12 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -142.19 157.18 45.15 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -72.97 137.66 45.61 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.615 0.722 . . . . 0.0 110.744 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.8 mt -121.01 -9.51 9.21 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.807 1.643 . . . . 0.0 111.276 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -72.14 -22.26 61.34 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.625 0.77 . . . . 0.0 112.53 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -113.99 152.05 45.39 Favored Pre-proline 0 N--CA 1.468 0.425 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.46 -11.83 10.46 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.594 2.196 . . . . 0.0 114.791 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -60.57 -41.85 95.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 120.896 1.68 . . . . 0.0 111.986 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -76.42 -28.81 56.78 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 79.0 p -91.43 -9.4 44.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.474 0.71 . . . . 0.0 111.001 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -62.36 -61.13 8.19 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 121.173 -0.954 . . . . 0.0 111.84 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.19 -19.79 69.44 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 121.216 1.47 . . . . 0.0 112.625 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.405 HD13 ' CE2' ' A' ' 129' ' ' TRP . 47.1 tp -68.19 -61.6 1.78 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 15.8 pt -67.03 -27.33 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.254 0.479 . . . . 0.0 111.687 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.1 0.58 27.49 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.762 -1.211 . . . . 0.0 112.929 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.99 -52.34 66.19 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 119.408 1.004 . . . . 0.0 112.076 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -58.3 -58.43 8.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.744 0.817 . . . . 0.0 110.757 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -176.61 25.78 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.543 -1.143 . . . . 0.0 113.492 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.21 149.44 37.42 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -152.61 138.8 18.32 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.54 -64.79 0.92 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.86 126.64 32.68 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -69.8 148.97 48.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.992 0.517 . . . . 0.0 110.297 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -148.85 105.63 3.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -77.71 -166.41 0.77 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.85 1.26 . . . . 0.0 109.036 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -62.18 16.97 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.475 2.71 . . . . 0.0 113.403 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.22 -2.8 0.62 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.989 1.757 . . . . 0.0 113.761 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -112.25 120.38 41.56 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.462 1.631 . . . . 0.0 107.732 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -118.43 112.88 20.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -125.86 106.3 9.56 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -59.46 -6.82 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.313 1.445 . . . . 0.0 112.183 179.247 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -31.79 57.81 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.857 1.663 . . . . 0.0 110.723 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.86 101.34 12.22 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.0 t -120.8 135.87 59.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 125.694 1.598 . . . . 0.0 109.784 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -114.3 18.1 18.52 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.202 -0.776 . . . . 0.0 114.664 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 66.4 t -49.52 -40.99 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.133 1.773 . . . . 0.0 114.051 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.8 23.91 12.6 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -70.56 167.6 18.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.406 0.622 . . . . 0.0 111.022 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.61 60.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.714 1.205 . . . . 0.0 113.691 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.85 -35.3 65.77 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 118.617 0.644 . . . . 0.0 112.288 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -68.23 -51.63 43.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.677 0.791 . . . . 0.0 109.459 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -61.75 -36.59 81.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.374 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.92 -48.91 79.65 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.668 0.667 . . . . 0.0 109.98 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.75 -36.88 93.89 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 27.3 tp -72.16 -51.09 22.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.47 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 6.2 t -56.21 -32.99 64.92 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.623 1.101 . . . . 0.0 111.122 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -58.66 -59.44 5.39 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.464 1.029 . . . . 0.0 109.232 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.06 -45.55 94.28 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.317 0.647 . . . . 0.0 110.529 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.8 t -57.87 -32.03 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.369 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.02 -35.84 82.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.983 1.265 . . . . 0.0 111.1 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 25.1 mt -64.73 -36.19 83.5 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.25 -41.88 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.094 1.358 . . . . 0.0 109.182 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -52.55 -45.56 66.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.97 1.308 . . . . 0.0 108.917 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -88.24 2.76 51.58 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.148 1.779 . . . . 0.0 112.749 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.1 mptt 56.51 19.93 4.49 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.319 2.248 . . . . 0.0 112.934 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -31.45 65.07 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.429 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.0 tpt -89.19 -176.61 5.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.811 1.645 . . . . 0.0 111.514 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -125.63 73.14 1.31 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.576 1.55 . . . . 0.0 108.84 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.73 -18.77 56.53 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -79.81 -7.12 58.49 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.418 1.887 . . . . 0.0 112.564 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 51.9 m -72.19 120.81 18.31 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.303 1.049 . . . . 0.0 109.339 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -118.7 175.1 5.89 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -48.73 -41.23 31.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.507 0.723 . . . . 0.0 112.262 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.8 t -57.35 -51.96 67.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.562 1.945 . . . . 0.0 111.954 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.415 HG22 ' CE ' ' A' ' 148' ' ' MET . 16.5 mm -61.75 -47.71 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 124.406 1.082 . . . . 0.0 111.323 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.1 -45.84 66.11 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.969 -178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -56.94 -45.09 83.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.451 0.569 . . . . 0.0 111.023 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.86 -57.91 10.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.207 0.603 . . . . 0.0 109.97 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.35 -47.28 69.53 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.694 0.798 . . . . 0.0 110.826 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -59.03 -41.47 87.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.9 1.28 . . . . 0.0 111.622 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -61.03 -37.01 81.05 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.763 0.711 . . . . 0.0 110.413 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -74.48 -45.09 48.3 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 116.06 14.3 7.9 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.916 2.198 . . . . 0.0 109.755 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -70.29 21.34 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.763 3.225 . . . . 0.0 112.789 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.2 p -130.48 174.74 9.59 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.57 2.348 . . . . 0.0 109.345 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.09 -33.73 2.4 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.742 0.817 . . . . 0.0 112.106 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 7.8 ptt? -152.86 161.15 42.92 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.847 0.859 . . . . 0.0 109.05 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.0 t -151.83 173.07 15.22 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 14.4 mt -139.89 93.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -132.47 166.14 22.71 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.017 0.927 . . . . 0.0 109.188 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -125.52 171.78 17.45 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.111 0.862 . . . . 0.0 113.899 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.12 173.89 5.54 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 125.152 3.901 . . . . 0.0 112.881 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 14.3 t90 68.85 -12.45 0.38 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.762 2.425 . . . . 0.0 112.366 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.72 95.75 1.93 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -78.63 100.99 7.23 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 14.4 m -117.3 -42.84 2.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.318 1.047 . . . . 0.0 110.726 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -130.99 177.47 7.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.301 1.841 . . . . 0.0 108.212 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 60.6 mt -124.9 95.11 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 102.175 -3.269 . . . . 0.0 102.175 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -134.71 137.27 43.37 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.832 1.253 . . . . 0.0 107.618 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 24.3 m -83.09 104.99 13.7 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.455 1.102 . . . . 0.0 110.015 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 17.0 p -68.78 97.69 0.84 Allowed 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.648 1.179 . . . . 0.0 109.748 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -139.45 144.77 38.19 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.117 0.967 . . . . 0.0 108.83 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . 0.371 10.3 p 55.45 38.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 125.572 1.549 . . . . 0.0 110.165 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -76.99 74.4 3.57 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -94.03 167.54 11.53 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.748 0.819 . . . . 0.0 109.844 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 84.71 133.44 2.7 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -144.62 159.55 14.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.2 t -163.11 171.0 17.02 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.64 161.31 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.81 156.17 45.33 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 124.26 1.024 . . . . 0.0 109.185 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.78 125.97 10.38 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.527 2.152 . . . . 0.0 109.947 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 255' ' ' SER . 43.4 p -143.5 -151.44 0.36 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.44 141.8 39.77 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 177.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -53.0 125.83 18.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.415 1.886 . . . . 0.0 110.386 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 61.63 11.67 30.27 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.808 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -155.57 75.75 5.06 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.1 154.87 57.38 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.971 1.781 . . . . 0.0 114.112 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.404 ' H ' ' HB ' ' A' ' 249' ' ' THR . 33.8 m -65.01 140.88 58.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' A' ' 256' ' ' LYS . 0.1 OUTLIER -146.19 93.32 5.09 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 125.227 1.411 . . . . 0.0 109.053 -178.688 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.32 -63.01 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.327 2.018 . . . . 0.0 111.472 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -153.06 174.35 14.3 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.667 1.587 . . . . 0.0 108.366 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.9 113.99 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.12 132.8 9.3 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 105.398 -3.081 . . . . 0.0 105.398 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.48 156.77 42.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-N 117.852 0.826 . . . . 0.0 109.851 -178.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.7 139.97 30.01 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.017 0.927 . . . . 0.0 109.115 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.2 m -131.75 169.11 16.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.154 0.982 . . . . 0.0 112.138 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -134.69 140.42 45.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.865 1.266 . . . . 0.0 108.325 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.64 167.69 16.92 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.9 mt -117.48 135.59 57.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -75.07 115.28 14.53 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.82 -15.53 21.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.65 0.78 . . . . 0.0 113.012 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -66.29 -23.24 66.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.332 1.053 . . . . 0.0 111.663 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 11.2 m -60.42 154.81 52.08 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 126.187 1.795 . . . . 0.0 112.649 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.5 -47.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.347 2.032 . . . . 0.0 111.801 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.44 86.25 2.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.701 0.8 . . . . 0.0 109.477 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -52.84 -24.05 8.23 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.236 1.414 . . . . 0.0 112.332 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -59.37 -34.68 72.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.193 1.797 . . . . 0.0 110.15 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.24 -36.98 81.43 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 120.713 -1.242 . . . . 0.0 110.009 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.23 57.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.948 -0.549 . . . . 0.0 111.028 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -37.4 87.07 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.845 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -71.54 -51.24 24.57 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 124.024 0.828 . . . . 0.0 109.747 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.422 ' CE2' HD11 ' A' ' 9' ' ' ILE . 9.0 t80 -48.87 -52.91 21.75 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.913 0.485 . . . . 0.0 110.295 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.86 -55.23 31.96 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.321 0.248 . . . . 0.0 111.353 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.318 7.6 pt-20 -71.57 1.65 6.28 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -177.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -115.11 -21.0 10.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.229 -1.367 . . . . 0.0 111.226 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -132.5 -59.21 0.92 Allowed 'General case' 0 C--N 1.346 0.418 0 CA-C-N 119.998 1.272 . . . . 0.0 109.673 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.65 -42.48 62.11 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 44.0 mt -82.91 27.52 0.54 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 14.8 p -113.7 167.77 10.34 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.57 -38.51 90.35 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -71.41 -38.55 71.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.982 0.913 . . . . 0.0 111.604 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -69.08 -45.7 61.36 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.94 -46.41 81.72 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -57.1 -43.57 82.35 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.802 0.841 . . . . 0.0 110.291 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.2 -49.92 68.28 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.65 -36.33 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 119.375 -0.345 . . . . 0.0 110.24 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -63.75 -27.43 69.19 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.706 0.803 . . . . 0.0 111.656 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -67.44 -43.64 80.65 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.759 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -70.24 -56.44 6.76 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.878 0.763 . . . . 0.0 109.749 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -134.92 145.04 52.95 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.27 136.37 40.09 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.518 2.145 . . . . 0.0 112.252 -178.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 80.3 mt -78.48 -29.84 46.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 101.09 -78.39 0.4 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 105.9 -2.88 . . . . 0.0 105.9 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -149.35 171.09 17.09 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 131.577 3.951 . . . . 0.0 104.93 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 35.9 m -132.18 149.88 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 O-C-N 120.656 -1.277 . . . . 0.0 112.244 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.69 -21.33 55.52 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.623 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.93 105.26 1.94 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 126.287 1.835 . . . . 0.0 107.256 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -53.57 -27.63 27.47 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.9 m -73.11 -61.18 1.91 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 118.552 0.614 . . . . 0.0 111.246 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -67.36 -23.63 65.62 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.571 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -63.95 -21.41 66.47 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.206 0.912 . . . . 0.0 108.719 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -72.97 -37.51 67.05 Favored 'General case' 0 C--N 1.342 0.245 0 O-C-N 120.286 -1.509 . . . . 0.0 108.725 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -70.26 -46.91 63.42 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.185 0.994 . . . . 0.0 108.607 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.437 ' O ' HD13 ' A' ' 317' ' ' ILE . 23.1 mt -63.31 -40.71 98.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.17 -11.63 9.79 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.82 -11.48 27.47 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.488 1.04 . . . . 0.0 111.201 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.52 133.66 23.53 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -56.78 -23.85 52.38 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.133 2.555 . . . . 0.0 115.946 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.465 ' HG2' HD12 ' A' ' 317' ' ' ILE . 0.0 OUTLIER -62.66 -44.18 96.92 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.298 1.408 . . . . 0.0 110.802 179.546 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.465 HD12 ' HG2' ' A' ' 316' ' ' ARG . 4.8 mp -74.55 -46.38 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.55 -52.23 48.82 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.291 0.496 . . . . 0.0 110.112 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.85 -35.63 78.85 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.722 -0.611 . . . . 0.0 112.059 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.0 m -62.04 -39.25 91.71 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.58 -40.77 48.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.694 0.398 . . . . 0.0 110.55 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -53.05 -45.78 68.21 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.436 1.495 . . . . 0.0 109.784 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -41.35 94.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.76 -36.5 83.27 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.838 0.745 . . . . 0.0 111.414 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -63.66 -30.52 71.62 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.455 1.502 . . . . 0.0 110.622 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.28 10.11 41.72 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.176 0.99 . . . . 0.0 111.807 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -118.87 -179.59 16.83 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 115.086 0.794 . . . . 0.0 115.086 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.98 164.33 30.31 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.041 1.337 . . . . 0.0 110.596 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 31.4 mt -78.16 160.73 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 125.521 1.529 . . . . 0.0 108.128 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 46.3 ttp -66.33 139.99 96.54 Favored Pre-proline 0 CA--C 1.538 0.494 0 O-C-N 121.085 -1.01 . . . . 0.0 108.512 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.29 179.5 6.31 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.505 2.137 . . . . 0.0 112.482 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -138.77 10.09 2.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.794 1.638 . . . . 0.0 110.99 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.9 pt -82.3 154.59 69.33 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 120.341 -1.475 . . . . 0.0 111.213 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.46 -17.01 16.78 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.163 2.575 . . . . 0.0 113.497 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -57.45 -21.57 37.85 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.501 1.12 . . . . 0.0 112.506 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 73.8 mmm -57.83 -31.13 66.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.336 1.054 . . . . 0.0 111.154 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 22.4 t -57.3 -53.04 62.65 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.88 -29.64 65.79 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 118.401 -0.809 . . . . 0.0 112.101 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.57 ' O ' HG22 ' A' ' 343' ' ' VAL . 52.7 t80 -57.75 -58.53 7.97 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.573 0.624 . . . . 0.0 109.754 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -56.25 -44.01 79.25 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -59.09 -39.92 83.71 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.113 0.415 . . . . 0.0 110.942 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.38 -59.98 2.95 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.157 0.583 . . . . 0.0 111.675 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 339' ' ' PHE . 3.2 m -59.27 -36.73 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 118.944 -0.551 . . . . 0.0 111.901 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 56.9 ttp85 -56.75 -37.22 70.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.261 0.937 . . . . 0.0 109.774 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 54.0 m -79.93 -44.49 20.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.683 -0.675 . . . . 0.0 109.834 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.45 -46.05 69.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.384 0.993 . . . . 0.0 112.882 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 89.0 t -59.11 -52.78 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.8 mm -64.08 -35.51 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.845 0.748 . . . . 0.0 110.491 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -61.22 -45.83 92.96 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.623 -1.298 . . . . 0.0 110.537 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.57 -50.32 32.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.128 0.571 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.42 -35.54 77.84 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.461 1.504 . . . . 0.0 114.895 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 28.9 m -91.22 0.33 57.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.206 0.602 . . . . 0.0 109.87 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 71.13 12.87 72.5 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 119.379 -0.679 . . . . 0.0 113.534 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -64.54 -32.96 74.82 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.313 1.056 . . . . 0.0 108.469 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -147.3 163.65 35.72 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.3 m -66.45 155.94 36.13 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.272 1.029 . . . . 0.0 108.917 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.58 -52.64 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.776 0.83 . . . . 0.0 110.001 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.66 -50.8 71.02 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.486 1.115 . . . . 0.0 110.159 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -62.0 -42.06 98.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.52 94.27 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 122.025 -0.422 . . . . 0.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 46.6 mt -71.23 -42.89 68.3 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.341 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -54.63 -50.74 67.4 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.396 1.079 . . . . 0.0 108.838 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.7 -49.95 69.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.42 87.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.159 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -58.84 -38.18 78.12 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.27 0.941 . . . . 0.0 108.676 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.4 m -64.22 -47.16 80.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.913 0.885 . . . . 0.0 109.309 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 72.0 mtt-85 -57.89 -25.71 61.17 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.321 0.964 . . . . 0.0 113.212 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 70.1 mt -94.57 -19.26 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 126.925 2.09 . . . . 0.0 112.101 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 66.5 p -113.56 1.95 15.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.24 1.382 . . . . 0.0 114.459 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? . . . . . 0 C--O 1.248 1.013 0 C-N-CA 125.179 1.392 . . . . 0.0 109.134 179.5 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.3 tptt . . . . . 0 N--CA 1.467 0.411 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 57.5 mt -92.79 128.13 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.92 121.3 20.75 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.939 1.696 . . . . 0.0 107.409 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.82 165.44 14.13 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.727 0.694 . . . . 0.0 111.037 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.15 35.78 89.16 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.101 1.334 . . . . 0.0 114.768 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -143.51 169.58 17.44 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.809 1.304 . . . . 0.0 112.974 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.1 mt -151.98 141.24 21.41 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.207 3.003 . . . . 0.0 108.012 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.08 134.44 36.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 119.784 1.175 . . . . 0.0 108.78 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.2 mt -124.11 128.69 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 125.244 1.417 . . . . 0.0 108.752 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -114.61 138.99 49.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.38 159.98 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.924 0.783 . . . . 0.0 109.502 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -154.39 166.43 33.26 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.27 24.2 27.29 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-O 117.823 -1.543 . . . . 0.0 114.857 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.1 t70 68.97 24.1 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.427 1.491 . . . . 0.0 114.413 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -59.39 157.2 11.48 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.444 1.897 . . . . 0.0 112.591 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.15 67.32 3.63 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.794 1.664 . . . . 0.0 109.818 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -58.75 -33.74 70.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.839 0.819 . . . . 0.0 112.484 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -61.17 -45.69 93.6 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.525 0.602 . . . . 0.0 109.791 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.77 -37.59 94.53 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.7 tp -69.93 -35.98 74.97 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 121.634 -0.921 . . . . 0.0 110.977 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.49 -40.14 36.32 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 117.681 -1.152 . . . . 0.0 112.821 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.78 -37.62 74.03 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.843 1.257 . . . . 0.0 113.386 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 t -61.54 -52.12 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.67 76.65 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -64.37 -29.42 70.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 118.817 1.308 . . . . 0.0 109.83 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.12 -52.04 7.81 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -53.31 -48.21 68.61 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.017 0.371 . . . . 0.0 110.453 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -60.38 -39.15 86.24 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.728 -1.232 . . . . 0.0 110.802 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 29' ' ' LYS . 13.3 tppt? -67.19 -28.3 67.98 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.554 0.742 . . . . 0.0 111.476 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -98.34 -3.89 36.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.935 1.294 . . . . 0.0 112.434 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.3 p -135.8 -36.04 0.77 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.45 -15.97 61.32 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.281 1.42 . . . . 0.0 112.054 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.85 130.38 28.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -68.44 130.26 42.35 Favored 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 121.498 -0.751 . . . . 0.0 109.414 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 t -128.46 118.34 47.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 33.9 m -114.34 142.96 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.614 0.766 . . . . 0.0 110.903 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.0 t -120.18 131.19 73.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -137.05 169.04 18.44 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.28 1.032 . . . . 0.0 109.404 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -140.25 54.55 5.3 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.26 168.31 25.11 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.877 2.385 . . . . 0.0 110.509 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -124.76 -7.71 7.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.258 1.023 . . . . 0.0 111.142 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -95.14 2.52 55.08 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.39 1.876 . . . . 0.0 111.103 -179.305 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.638 HD22 ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -48.55 -34.09 10.81 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 124.193 0.997 . . . . 0.0 111.988 179.297 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.638 ' N ' HD22 ' A' ' 43' ' ' LEU . 11.7 pt-20 -46.7 -33.57 4.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.04 2.136 . . . . 0.0 111.93 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -120.04 -21.25 7.15 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 125.92 1.688 . . . . 0.0 111.067 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -46.68 21.51 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.383 -1.448 . . . . 0.0 110.879 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -49.66 -55.62 21.87 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.41 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.7 0.33 3.1 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.899 1.733 . . . . 0.0 114.962 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -109.72 -15.48 14.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.865 1.211 . . . . 0.0 112.548 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.41 -28.36 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.64 1.176 . . . . 0.0 110.215 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.48 -18.27 59.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.075 -1.016 . . . . 0.0 110.725 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.98 -20.27 62.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.137 0.975 . . . . 0.0 110.985 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.7 p -119.96 -2.47 10.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.563 1.545 . . . . 0.0 112.572 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.14 8.94 85.82 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.8 -14.05 59.47 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.362 -1.081 . . . . 0.0 109.947 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.37 -172.85 48.4 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.898 1.714 . . . . 0.0 115.104 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -64.95 -178.05 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.73 3.62 . . . . 0.0 112.507 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -116.31 -12.85 11.08 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.5 mt -140.87 150.61 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 tt -137.62 132.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.22 107.99 13.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.25 1.82 . . . . 0.0 108.235 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -151.46 -175.67 5.28 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.49 147.01 40.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.02 -1.05 . . . . 0.0 108.662 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -49.19 -45.44 44.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.237 1.415 . . . . 0.0 112.223 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -62.31 -4.73 1.94 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.683 1.993 . . . . 0.0 115.534 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -110.55 -4.25 15.57 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.215 0.916 . . . . 0.0 110.871 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -97.32 -18.98 18.83 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.42 -44.58 77.01 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 120.207 1.367 . . . . 0.0 112.217 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.75 -47.88 30.97 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.722 -1.043 . . . . 0.0 112.014 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -55.78 -39.12 70.82 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.985 1.393 . . . . 0.0 110.465 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -65.61 -47.34 76.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.706 -0.664 . . . . 0.0 109.429 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -37.14 80.18 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.529 0.604 . . . . 0.0 110.012 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.8 m -63.97 -13.74 48.52 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.13 -0.981 . . . . 0.0 110.686 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.34 10.94 67.51 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 126.168 1.842 . . . . 0.0 113.426 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.5 mt -83.68 -3.71 57.99 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.949 1.374 . . . . 0.0 114.203 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 71' ' ' ALA . 28.8 mt -109.0 137.57 46.7 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.048 1.294 . . . . 0.0 110.139 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.94 179.56 5.49 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.604 1.162 . . . . 0.0 111.812 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -92.19 92.04 8.03 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pp -69.28 169.35 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.991 0.916 . . . . 0.0 112.413 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.283 7.6 p 49.51 73.69 0.95 Allowed Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 127.459 2.304 . . . . 0.0 112.054 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.11 -22.68 46.96 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.628 2.219 . . . . 0.0 112.667 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -128.81 164.31 23.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.616 1.967 . . . . 0.0 108.895 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -85.52 -34.9 21.44 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.76 -21.59 19.79 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.456 1.48 . . . . 0.0 114.531 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -68.5 -30.18 68.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -64.69 -41.08 96.29 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 120.964 -1.085 . . . . 0.0 110.024 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.81 -16.46 63.11 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.556 1.542 . . . . 0.0 112.123 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -84.66 -2.56 57.69 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 120.896 -1.127 . . . . 0.0 110.967 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt -131.14 159.22 38.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.371 1.068 . . . . 0.0 110.493 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -77.68 152.43 80.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.452 0.701 . . . . 0.0 109.272 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.88 -42.56 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.719 2.946 . . . . 0.0 114.75 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -58.09 -44.31 87.53 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.668 1.122 . . . . 0.0 110.707 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.75 -28.33 69.51 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.102 1.361 . . . . 0.0 111.26 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -71.3 -42.63 68.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.24 0.616 . . . . 0.0 110.331 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.12 -28.23 51.15 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.903 0.881 . . . . 0.0 111.647 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.37 -23.73 65.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.07 1.348 . . . . 0.0 114.263 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.57 11.61 6.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.375 1.07 . . . . 0.0 112.368 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -72.25 147.72 46.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.288 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.477 ' CD1' ' HE3' ' A' ' 102' ' ' LYS . 51.2 t80 -131.84 178.69 6.57 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.935 1.294 . . . . 0.0 108.543 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -57.67 89.82 0.01 OUTLIER 'General case' 0 C--O 1.235 0.308 0 C-N-CA 127.711 2.404 . . . . 0.0 109.546 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.14 -77.93 1.13 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.477 ' HE3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -66.83 177.03 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.8 1.24 . . . . 0.0 109.395 179.272 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.7 mt -116.52 -179.54 3.71 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 110.893 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.9 pt -133.74 -29.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.5 177.64 9.3 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.969 0.804 . . . . 0.0 109.443 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.38 145.93 54.58 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 124.238 1.015 . . . . 0.0 108.733 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.37 145.73 54.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.925 2.417 . . . . 0.0 108.17 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.0 mm -129.0 -50.56 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 123.369 0.668 . . . . 0.0 109.963 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.25 157.39 44.49 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.932 0.396 . . . . 0.0 111.169 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.15 119.37 26.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.006 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -161.2 149.99 16.21 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.172 0.989 . . . . 0.0 109.313 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.4 81.64 1.67 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.696 1.198 . . . . 0.0 110.523 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.94 107.62 1.28 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.949 1.3 . . . . 0.0 109.447 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.1 p -149.0 131.29 15.56 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.492 1.117 . . . . 0.0 110.694 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.8 tp -136.13 170.2 16.39 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.645 1.178 . . . . 0.0 110.56 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 mt -135.55 140.16 45.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 126.288 1.835 . . . . 0.0 106.9 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -141.33 171.26 14.31 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.581 1.952 . . . . 0.0 107.404 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.69 157.48 9.3 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.234 0.54 . . . . 0.0 111.438 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -70.61 -6.91 40.23 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.024 0.93 . . . . 0.0 112.76 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -69.16 158.32 35.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.896 0.855 . . . . 0.0 110.378 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.96 9.78 0.86 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.05 2.14 . . . . 0.0 115.65 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.25 69.27 2.6 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.145 1.378 . . . . 0.0 113.717 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.01 89.29 1.25 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.676 2.917 . . . . 0.0 112.19 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -129.83 68.08 80.23 Favored Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -72.11 168.08 25.03 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.061 2.508 . . . . 0.0 113.014 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.7 171.25 13.58 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.75 2.967 . . . . 0.0 113.571 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -123.85 -17.13 6.42 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 117.192 -1.385 . . . . 0.0 112.776 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.65 143.93 31.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.84 1.655 . . . . 0.0 112.205 -178.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -65.24 -22.77 66.92 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.394 -0.816 . . . . 0.0 111.911 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -72.19 -12.78 61.33 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.371 0.668 . . . . 0.0 111.934 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -98.85 -19.02 17.61 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.094 1.758 . . . . 0.0 111.014 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.33 -52.62 70.04 Favored Pre-proline 0 N--CA 1.465 0.319 0 C-N-CA 124.6 1.16 . . . . 0.0 109.851 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -69.37 -24.76 31.12 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 120.248 1.124 . . . . 0.0 111.771 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.35 -54.23 27.01 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.08 -30.02 70.71 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.175 -0.953 . . . . 0.0 110.316 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -61.78 -45.18 95.0 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.616 1.166 . . . . 0.0 110.352 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -74.39 -25.48 59.5 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.523 -0.736 . . . . 0.0 111.688 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.58 -45.84 61.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.675 -0.679 . . . . 0.0 110.249 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . 0.259 6.2 mt -80.1 -24.18 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 117.876 -1.53 . . . . 0.0 110.799 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -66.96 -31.56 72.21 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.19 -11.89 60.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.56 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.67 0.77 8.16 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.516 1.527 . . . . 0.0 111.932 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 172.14 -91.05 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 119.467 1.031 . . . . 0.0 113.721 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.08 -175.83 4.38 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.802 0.841 . . . . 0.0 109.659 -178.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.7 p -74.34 166.2 23.88 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.37 -63.9 1.31 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.039 2.536 . . . . 0.0 112.268 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.4 tp -102.92 137.15 41.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.473 1.509 . . . . 0.0 107.941 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 65.6 mtp -148.34 103.07 3.4 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 128.373 2.669 . . . . 0.0 105.721 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -128.33 161.93 28.27 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -72.38 93.56 1.54 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.007 0.908 . . . . 0.0 112.114 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.5 mt -73.48 -8.81 57.46 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.631 1.572 . . . . 0.0 110.288 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -70.58 -19.12 62.88 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.403 1.481 . . . . 0.0 112.597 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -115.66 135.62 22.69 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.619 1.1 . . . . 0.0 111.896 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.05 -21.93 48.48 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.759 2.306 . . . . 0.0 112.961 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -59.96 -27.34 66.73 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.505 0.593 . . . . 0.0 112.237 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -86.85 -44.91 11.34 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.791 0.723 . . . . 0.0 111.307 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.5 p -76.99 -17.2 59.02 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -62.12 -60.85 8.95 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 117.844 -1.074 . . . . 0.0 113.073 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.451 ' HA ' ' HB3' ' A' ' 162' ' ' ALA . 30.5 Cg_endo -61.9 -23.53 76.05 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.318 1.863 . . . . 0.0 111.422 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.34 -57.59 10.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 22.6 pt -69.19 -25.25 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.028 0.442 . . . . 0.0 111.229 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 159' ' ' PRO . . . -67.56 -23.14 65.39 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 120.901 -1.124 . . . . 0.0 111.06 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.76 87.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -57.96 -58.9 6.37 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.92 5.1 0.03 OUTLIER Glycine 0 CA--C 1.522 0.523 0 CA-C-O 118.688 -1.062 . . . . 0.0 115.064 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.62 129.88 33.72 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.244 1.522 . . . . 0.0 109.329 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -138.46 149.24 45.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.821 1.31 . . . . 0.0 108.092 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.09 -66.62 0.74 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -140.19 173.22 11.73 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.266 1.427 . . . . 0.0 107.869 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -114.5 139.59 49.43 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -155.74 117.1 3.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.229 1.412 . . . . 0.0 107.792 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -160.32 163.33 33.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.898 1.279 . . . . 0.0 108.706 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 49.74 26.87 2.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.269 1.828 . . . . 0.0 112.961 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.83 9.25 87.26 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.265 -1.297 . . . . 0.0 113.469 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -115.06 118.94 34.8 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.93 1.865 . . . . 0.0 107.612 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.06 116.69 23.22 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.118 1.767 . . . . 0.0 109.451 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -130.3 104.09 7.08 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -64.6 -3.36 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 125.152 1.381 . . . . 0.0 112.341 178.889 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -72.89 -36.25 67.28 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.676 1.191 . . . . 0.0 111.015 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -89.78 72.31 7.64 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.94 0.896 . . . . 0.0 111.112 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.2 138.76 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 128.295 2.638 . . . . 0.0 111.446 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.83 15.16 10.44 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -1.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 120.116 1.958 . . . . 0.0 115.36 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -125.52 14.03 8.17 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.641 1.564 . . . . 0.0 111.639 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -71.09 158.4 36.53 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.941 -1.099 . . . . 0.0 108.456 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -48.69 -31.77 7.35 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.12 -37.59 42.51 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 119.504 1.047 . . . . 0.0 112.845 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.83 88.25 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -71.42 -35.5 70.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.415 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -56.65 -50.76 71.11 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.012 1.278 . . . . 0.0 111.209 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.83 -34.44 88.68 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.612 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 60.3 tp -70.05 -55.17 10.2 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.948 0.874 . . . . 0.0 110.476 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.432 ' HB ' HG11 ' A' ' 357' ' ' VAL . 2.0 t -55.2 -41.71 72.35 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.585 -1.198 . . . . 0.0 108.989 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -57.01 -54.05 51.1 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.707 1.14 . . . . 0.0 109.278 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.29 -44.58 88.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.801 0.841 . . . . 0.0 111.33 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 72.6 t -67.16 -31.2 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 121.431 -0.793 . . . . 0.0 109.783 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -39.91 82.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 O-C-N 121.283 -0.885 . . . . 0.0 109.141 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.54 -45.53 90.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 70.2 mt -59.37 -49.0 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -54.69 -37.96 66.44 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.979 0.912 . . . . 0.0 110.534 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -92.44 8.02 40.49 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 64.8 22.16 12.49 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.976 1.71 . . . . 0.0 113.256 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -85.94 -3.97 59.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.769 1.228 . . . . 0.0 110.669 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 77.4 mtp -143.64 167.33 22.51 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.504 1.922 . . . . 0.0 107.703 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -120.9 92.71 3.82 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.851 1.26 . . . . 0.0 109.728 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.99 -11.58 14.22 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.017 1.327 . . . . 0.0 114.38 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -89.1 -5.24 57.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.388 1.475 . . . . 0.0 111.762 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.7 m -69.96 131.1 43.87 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.74 0.816 . . . . 0.0 110.48 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.445 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 7.6 p30 -129.38 -177.5 4.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.704 2.002 . . . . 0.0 108.281 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -62.92 -26.66 68.91 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.6 m -91.4 -34.66 14.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.257 1.423 . . . . 0.0 109.562 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.445 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 33.1 mm -66.13 -49.12 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.39 -53.15 61.57 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.946 0.898 . . . . 0.0 109.039 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -60.16 -33.88 72.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.238 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.94 -54.28 23.52 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 119.309 0.959 . . . . 0.0 108.738 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.88 82.91 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.843 0.857 . . . . 0.0 109.865 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.96 -37.73 88.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.26 0.624 . . . . 0.0 110.244 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.06 -23.71 67.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.906 0.775 . . . . 0.0 109.786 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -87.84 -20.25 26.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.247 1.019 . . . . 0.0 109.658 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.36 12.65 72.6 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.514 1.531 . . . . 0.0 111.752 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -66.23 -45.85 79.21 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.911 0.855 . . . . 0.0 110.87 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 43.5 p -71.38 171.5 11.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.919 1.688 . . . . 0.0 109.069 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -129.38 -13.48 4.37 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -157.21 -179.63 8.38 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 121.745 -0.597 . . . . 0.0 110.653 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.3 t -164.53 174.29 11.07 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.475 1.51 . . . . 0.0 107.39 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.4 mt -148.19 109.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -148.68 164.59 33.89 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.327 1.051 . . . . 0.0 108.452 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.401 ' HA3' ' CH2' ' A' ' 230' ' ' TRP . . . 159.32 81.87 0.04 OUTLIER Glycine 0 CA--C 1.523 0.544 0 N-CA-C 107.927 -2.069 . . . . 0.0 107.927 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -76.03 46.89 1.84 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.746 3.631 . . . . 0.0 112.648 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.401 ' CH2' ' HA3' ' A' ' 228' ' ' GLY . 3.5 m-90 -74.12 51.97 0.43 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.511 1.524 . . . . 0.0 111.929 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.97 124.55 23.64 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.765 1.626 . . . . 0.0 108.524 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 64.1 t-105 46.75 43.6 13.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.451 1.5 . . . . 0.0 111.804 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 72.7 m 45.58 39.21 4.63 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.08 1.752 . . . . 0.0 113.192 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -60.76 146.27 46.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.8 pt -65.92 173.97 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.527 0.731 . . . . 0.0 109.479 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 80.4 6.54 1.58 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 128.117 2.567 . . . . 0.0 113.151 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 4.5 m -59.73 -30.8 69.08 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.554 -1.341 . . . . 0.0 110.809 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 10.7 p -81.18 5.86 15.63 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.022 1.329 . . . . 0.0 113.123 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -53.41 -29.95 37.67 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.943 1.247 . . . . 0.0 112.341 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 1.9 p -115.97 123.71 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 102.331 -3.211 . . . . 0.0 102.331 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -64.29 -49.4 71.97 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.301 0.64 . . . . 0.0 109.575 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -178.18 178.07 0.94 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 128.188 2.595 . . . . 0.0 107.081 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 148.01 142.51 3.67 Favored Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 107.564 -2.214 . . . . 0.0 107.564 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.88 130.43 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 118.248 1.024 . . . . 0.0 108.332 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.0 t -169.97 172.12 6.72 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.393 0.677 . . . . 0.0 109.681 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 14.9 p -67.88 160.16 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -131.61 155.89 80.84 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 118.506 0.594 . . . . 0.0 111.382 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.91 134.49 23.68 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.802 1.668 . . . . 0.0 109.924 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 65.1 p -129.78 176.58 7.91 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.883 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -88.73 140.25 29.63 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -52.89 131.76 36.11 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.519 -1.363 . . . . 0.0 110.871 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.38 -1.36 50.91 Favored Glycine 0 CA--C 1.519 0.285 0 CA-C-O 118.54 -1.144 . . . . 0.0 114.635 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.93 103.39 3.19 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 119.647 1.723 . . . . 0.0 111.842 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.17 170.23 15.0 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.345 2.696 . . . . 0.0 114.376 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 74.9 m -57.75 140.79 50.67 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.164 1.386 . . . . 0.0 110.648 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -140.25 73.95 30.56 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.478 1.111 . . . . 0.0 108.439 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.98 -95.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.578 3.518 . . . . 0.0 109.121 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -136.2 178.32 7.15 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 128.623 2.769 . . . . 0.0 107.631 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 324' ' ' ALA . 85.3 t -96.91 130.98 44.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.59 59.94 0.41 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 1.5 p -69.18 112.98 4.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 121.427 0.632 . . . . 0.0 109.301 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 8.8 tt -77.87 134.75 37.88 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.5 m -125.7 168.31 13.93 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.616 1.167 . . . . 0.0 110.712 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -137.05 140.99 42.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.03 147.59 19.27 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 69.8 mt -90.32 136.77 23.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -71.73 128.24 35.13 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.4 8.23 2.38 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -116.25 3.41 13.41 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.09 1.314 . . . . 0.0 112.48 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 62.7 m -63.5 160.51 42.23 Favored Pre-proline 0 C--O 1.237 0.447 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.8 -60.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 108.333 -1.449 . . . . 0.0 108.333 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -123.78 102.68 7.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -16.19 37.38 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.239 0.472 . . . . 0.0 110.595 178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.44 ' HA ' ' HG3' ' A' ' 277' ' ' LYS . 15.3 tt0 -57.17 -41.9 80.09 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 127.456 2.303 . . . . 0.0 108.469 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.02 -37.09 76.12 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.018 -1.051 . . . . 0.0 110.852 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.06 -46.82 40.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 122.094 -0.379 . . . . 0.0 109.994 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.44 ' HG3' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -62.15 -34.48 76.46 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.704 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.51 -55.24 10.76 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -52.55 -46.26 66.71 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.042 -1.036 . . . . 0.0 111.617 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -51.66 68.7 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 119.264 -0.398 . . . . 0.0 110.929 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -10.98 59.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -108.59 -27.73 9.7 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -138.11 -25.62 0.95 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 120.102 1.319 . . . . 0.0 114.04 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.51 -51.02 10.58 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.681 1.128 . . . . 0.0 110.859 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 88.7 mt -86.57 68.36 10.15 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.602 1.161 . . . . 0.0 110.819 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.8 p -135.21 162.62 32.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -75.75 5.0 6.82 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.395 0.617 . . . . 0.0 110.457 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -113.26 -42.82 3.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.091 2.156 . . . . 0.0 109.478 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.93 -37.11 87.64 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.18 1.371 . . . . 0.0 111.884 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.09 -36.06 61.74 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.556 1.178 . . . . 0.0 109.267 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -70.33 -39.26 74.83 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.807 0.843 . . . . 0.0 110.044 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -53.73 -38.31 64.22 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.16 0.891 . . . . 0.0 112.707 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 20.2 t -81.34 -35.47 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.148 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -63.35 -33.34 75.31 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.852 0.861 . . . . 0.0 111.356 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -61.33 -54.06 48.75 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.139 1.376 . . . . 0.0 108.784 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -42.42 99.14 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -152.42 141.76 14.43 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 124.873 1.269 . . . . 0.0 107.801 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.75 110.56 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.435 2.09 . . . . 0.0 109.031 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 12.5 mt -75.22 -22.25 58.07 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.27 -155.7 19.91 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.504 -1.839 . . . . 0.0 108.504 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.6 178.06 5.63 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.965 0.888 . . . . 0.0 109.398 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.74 150.55 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 C-N-CA 123.753 0.821 . . . . 0.0 109.198 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.24 -20.86 40.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.625 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.1 106.9 6.83 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.971 1.708 . . . . 0.0 110.165 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -56.42 -26.55 53.89 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.8 m -57.13 -54.79 42.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.635 1.107 . . . . 0.0 110.663 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -90.46 -17.96 26.21 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.517 0.727 . . . . 0.0 111.803 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -60.88 -39.77 90.47 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.895 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -66.58 -15.89 63.76 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.529 1.059 . . . . 0.0 113.033 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -95.73 -23.49 16.95 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.704 2.001 . . . . 0.0 110.323 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 32.4 mt -86.69 -44.4 11.85 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.76 -17.9 57.78 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.888 2.075 . . . . 0.0 112.03 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 314' ' ' ASP . 0.1 OUTLIER -69.81 -16.91 63.36 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.695 -0.628 . . . . 0.0 109.561 178.071 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.452 ' HB2' ' HE3' ' A' ' 313' ' ' LYS . 2.5 t70 -103.94 131.51 21.9 Favored Pre-proline 0 N--CA 1.438 -1.051 0 C-N-CA 125.91 1.684 . . . . 0.0 107.562 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.81 -23.63 67.86 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.497 2.131 . . . . 0.0 114.43 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 -60.39 -54.98 39.16 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.848 1.259 . . . . 0.0 111.009 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.4 mp -71.96 -49.37 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.92 -52.06 36.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 123.948 0.78 . . . . 0.0 111.903 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.22 -28.45 70.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.511 0.596 . . . . 0.0 112.566 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 24.0 m -76.61 -37.45 56.4 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.1 tpt -71.84 -33.1 68.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.715 1.206 . . . . 0.0 111.393 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -55.99 -35.37 66.7 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.691 0.796 . . . . 0.0 109.696 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -63.23 -36.85 85.03 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.968 0.907 . . . . 0.0 111.486 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.44 ' HA ' HG22 ' A' ' 259' ' ' VAL . . . -76.92 -35.14 57.56 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.967 0.907 . . . . 0.0 109.522 178.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -69.53 -18.11 63.64 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.502 1.121 . . . . 0.0 112.923 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.11 -18.83 9.94 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.367 1.067 . . . . 0.0 112.793 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -72.73 -167.14 10.33 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 125.184 1.373 . . . . 0.0 114.403 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -125.32 139.39 53.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.947 1.299 . . . . 0.0 108.375 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 50.1 mt -112.04 100.24 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 10.4 tmm? 32.35 89.01 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 128.161 2.584 . . . . 0.0 112.846 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.55 102.82 1.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.783 2.322 . . . . 0.0 109.713 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -83.0 4.21 26.97 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 48.6 pt -60.89 151.93 71.73 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.38 1.072 . . . . 0.0 111.263 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.61 -21.8 21.69 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.52 2.147 . . . . 0.0 113.771 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -68.78 -18.41 64.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.233 0.924 . . . . 0.0 111.67 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 64.3 mmm -61.85 -29.23 70.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.349 0.977 . . . . 0.0 109.867 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.1 m -63.7 -52.0 62.56 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.96 86.37 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.074 0.549 . . . . 0.0 110.105 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -56.93 -54.86 41.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.821 1.248 . . . . 0.0 109.86 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -60.56 -39.97 89.92 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.98 0.809 . . . . 0.0 110.599 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -68.09 -25.89 65.55 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.96 -59.17 2.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.814 1.246 . . . . 0.0 110.552 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.9 t -55.95 -38.97 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.655 0.782 . . . . 0.0 110.667 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.68 -46.59 74.11 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.177 1.353 . . . . 0.0 110.8 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 47.7 m -67.71 -46.4 72.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.627 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -56.48 -43.41 79.62 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.47 1.032 . . . . 0.0 112.652 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.72 -53.5 46.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 125.041 1.336 . . . . 0.0 109.14 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.77 -40.78 88.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 122.809 0.444 . . . . 0.0 109.833 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -56.08 -45.23 79.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 120.969 -1.082 . . . . 0.0 110.984 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.72 -46.94 34.23 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.24 0.616 . . . . 0.0 111.015 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -63.1 -42.07 99.51 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.138 0.975 . . . . 0.0 113.266 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 36.4 m -84.87 -5.29 59.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.396 0.678 . . . . 0.0 109.362 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.86 12.55 71.14 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 118.538 0.608 . . . . 0.0 113.711 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -65.56 -28.01 68.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.134 0.967 . . . . 0.0 109.707 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -142.98 156.96 44.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 9.0 m -66.71 148.73 51.52 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.432 HG11 ' HB ' ' A' ' 193' ' ' THR . 83.6 t -51.27 -57.24 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.436 1.094 . . . . 0.0 111.272 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -63.56 -39.93 95.67 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -70.06 -25.45 63.55 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.774 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.49 76.39 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.507 0.723 . . . . 0.0 109.309 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.56 -36.21 60.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 118.686 -0.674 . . . . 0.0 110.297 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -55.63 -54.67 41.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.205 1.402 . . . . 0.0 108.115 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -51.19 -61.35 2.29 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.873 2.469 . . . . 0.0 110.338 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.75 77.07 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 127.047 2.139 . . . . 0.0 114.092 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -59.62 -36.07 75.62 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 16.7 m -64.11 -38.8 92.37 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.307 0.575 . . . . 0.0 110.567 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -61.21 -24.04 66.05 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.074 -1.016 . . . . 0.0 111.787 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.8 mt -91.52 -29.94 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.793 1.237 . . . . 0.0 110.17 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 17.3 p -76.8 -20.96 55.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.299 0.954 . . . . 0.0 110.026 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? . . . . . 0 C--O 1.247 0.955 0 C-N-CA 126.156 1.782 . . . . 0.0 108.355 179.301 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -91.4 167.12 12.5 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.25 24.31 75.68 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 117.099 1.6 . . . . 0.0 117.099 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -148.24 157.92 43.78 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 121.145 2.472 . . . . 0.0 113.856 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.2 mt -144.95 152.19 39.8 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.346 2.258 . . . . 0.0 108.604 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -134.82 139.78 46.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 126.641 1.976 . . . . 0.0 106.97 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.2 mt -122.77 121.23 62.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.697 1.199 . . . . 0.0 108.99 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -115.95 137.08 52.44 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 mt -128.59 159.22 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -52.74 -20.35 3.1 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.17 155.13 30.22 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 104.846 -3.302 . . . . 0.0 104.846 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.89 0.57 0.38 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.261 1.424 . . . . 0.0 113.943 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -82.23 172.5 13.07 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.0 2.12 . . . . 0.0 111.885 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.61 51.01 2.97 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.062 1.791 . . . . 0.0 113.355 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -57.42 -35.98 70.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.76 1.224 . . . . 0.0 113.978 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -62.21 -38.51 89.41 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.871 0.76 . . . . 0.0 111.031 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.11 -35.72 57.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.8 tp -70.9 -32.46 69.41 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 123.119 0.568 . . . . 0.0 111.535 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.28 -48.64 71.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.298 0.639 . . . . 0.0 110.851 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -53.31 -38.47 63.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.42 HG11 ' HA ' ' A' ' 284' ' ' LEU . 21.4 t -57.33 -46.66 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.82 -29.42 72.61 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 124.539 1.066 . . . . 0.0 111.215 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -68.06 -43.77 77.87 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 118.851 1.326 . . . . 0.0 107.448 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -60.47 3.29 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -52.69 -54.17 37.33 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.984 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.18 -29.74 65.88 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.553 1.524 . . . . 0.0 112.292 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -28.39 58.74 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.601 -1.312 . . . . 0.0 109.83 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -91.63 -38.33 12.52 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.223 0.952 . . . . 0.0 112.05 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.5 p -102.62 -31.54 10.33 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.45 -17.35 54.69 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 121.106 -0.996 . . . . 0.0 112.206 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.3 mm -62.76 119.96 8.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.4 143.08 15.91 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 t -138.83 105.88 2.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 123.649 0.779 . . . . 0.0 109.128 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.5 m -96.96 153.45 17.89 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.82 127.28 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.88 154.79 51.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -122.58 57.29 9.22 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.08 1.752 . . . . 0.0 110.281 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.46 167.26 27.48 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.187 2.592 . . . . 0.0 112.299 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -121.71 1.78 10.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.221 1.008 . . . . 0.0 112.874 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 14.37 6.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.886 1.674 . . . . 0.0 112.117 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -58.33 -26.36 63.0 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 120.588 -1.32 . . . . 0.0 113.083 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -58.58 -27.51 64.68 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.845 1.202 . . . . 0.0 113.635 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -106.17 -24.55 12.3 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 123.66 0.784 . . . . 0.0 110.192 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.35 28.03 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.716 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -48.78 -60.06 5.23 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 117.629 -1.177 . . . . 0.0 109.403 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.28 -17.12 57.46 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.602 1.535 . . . . 0.0 114.004 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -89.03 -28.54 20.09 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.34 1.427 . . . . 0.0 111.753 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.8 -45.73 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 120.01 1.277 . . . . 0.0 109.651 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.26 -22.95 66.4 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 122.061 -0.399 . . . . 0.0 111.315 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.72 -24.31 67.61 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.23 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -103.23 4.86 37.16 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.59 1.556 . . . . 0.0 109.917 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.35 36.54 78.53 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.797 -1.189 . . . . 0.0 111.64 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -128.39 1.97 5.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.855 1.662 . . . . 0.0 112.915 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.41 -169.94 44.47 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.892 1.234 . . . . 0.0 113.693 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.36 162.24 34.41 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.189 1.926 . . . . 0.0 109.768 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -94.47 -19.2 20.77 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 124.545 1.138 . . . . 0.0 111.225 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -138.9 147.96 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tp -134.4 145.98 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.625 1.17 . . . . 0.0 108.622 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -130.55 108.94 10.3 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.714 1.606 . . . . 0.0 109.707 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -156.4 167.22 31.12 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 123.878 0.871 . . . . 0.0 109.975 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.76 155.33 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -57.29 -29.42 63.87 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -49.89 -59.06 4.21 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -66.09 -17.56 64.78 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.547 -0.721 . . . . 0.0 111.659 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -83.17 -5.11 59.0 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.497 -0.752 . . . . 0.0 110.3 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.4 -13.96 46.39 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.052 1.311 . . . . 0.0 113.591 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -125.06 -31.41 0.86 Allowed Glycine 0 CA--C 1.526 0.727 0 CA-C-N 118.827 1.314 . . . . 0.0 114.128 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -57.51 -41.74 81.41 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.017 1.408 . . . . 0.0 112.822 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.8 -40.72 79.42 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.58 1.082 . . . . 0.0 110.705 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -41.79 87.55 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.5 m -68.44 -8.12 37.85 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.079 0.952 . . . . 0.0 111.781 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.74 1.24 83.08 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 126.545 2.021 . . . . 0.0 113.016 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.38 -41.07 89.96 Favored 'General case' 0 C--N 1.338 0.067 0 CA-C-N 118.899 1.35 . . . . 0.0 113.232 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 mt -85.5 130.47 34.57 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.18 164.94 19.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.464 1.106 . . . . 0.0 112.082 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -73.8 131.34 41.44 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pp -113.99 -174.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.315 1.446 . . . . 0.0 109.191 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m 60.08 75.73 0.47 Allowed Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.502 1.121 . . . . 0.0 111.051 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.16 -23.64 15.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.021 2.481 . . . . 0.0 113.984 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -140.95 -162.67 1.4 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.518 1.927 . . . . 0.0 108.575 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -110.56 -19.92 12.74 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.793 1.237 . . . . 0.0 113.376 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.25 83.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.97 -1.081 . . . . 0.0 113.586 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -61.76 -28.28 69.33 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.862 1.265 . . . . 0.0 110.356 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -68.57 -44.51 74.29 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.294 0.952 . . . . 0.0 108.916 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.26 -21.53 66.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.228 0.467 . . . . 0.0 111.762 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -68.04 -12.04 60.08 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.526 0.603 . . . . 0.0 110.509 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -122.07 165.78 15.54 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.833 1.653 . . . . 0.0 111.211 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -77.1 155.69 82.33 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.31 -43.1 3.26 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.325 2.684 . . . . 0.0 114.295 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -57.2 -41.99 80.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.543 1.065 . . . . 0.0 112.354 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.96 -25.63 67.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.649 1.18 . . . . 0.0 111.051 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -76.26 -40.67 51.23 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -37.99 81.3 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.8 0.75 0.75 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.474 1.51 . . . . 0.0 114.002 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.04 3.91 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-N 120.487 1.494 . . . . 0.0 111.693 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.9 mtt-85 -63.08 170.46 2.79 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 123.3 1.524 . . . . 0.0 113.418 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -149.92 179.47 8.02 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 128.17 2.588 . . . . 0.0 105.868 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -68.21 99.9 0.96 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.79 -72.9 1.74 Allowed Glycine 0 CA--C 1.521 0.466 0 C-N-CA 125.012 1.291 . . . . 0.0 111.782 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 167.67 13.49 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 122.53 1.157 . . . . 0.0 112.374 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.14 154.1 22.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.266 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.3 pt -134.2 -15.08 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.9 172.55 13.84 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.084 1.311 . . . . 0.0 108.029 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.22 150.5 75.52 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 123.842 0.857 . . . . 0.0 110.829 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.94 144.63 53.67 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 124.336 3.358 . . . . 0.0 111.387 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.58 -55.53 3.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 126.105 1.762 . . . . 0.0 111.596 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.06 162.0 33.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.1 t -128.69 75.07 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 . . . . . 0 C--N 1.331 -0.229 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.73 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.5 mt . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.3 p90 . . . . . 0 CA--C 1.537 0.443 0 C-N-CA 126.553 1.941 . . . . 0.0 110.529 -179.847 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo . . . . . 0 N--CA 1.459 -0.559 0 CA-C-O 121.375 0.49 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -86.6 -26.04 24.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.913 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.9 t -170.96 161.13 6.88 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.953 1.252 . . . . 0.0 108.822 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -64.81 -29.22 70.18 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.61 -12.67 61.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.625 0.648 . . . . 0.0 112.485 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -90.38 -21.3 22.04 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.743 1.217 . . . . 0.0 109.951 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.43 -57.34 21.18 Favored Pre-proline 0 N--CA 1.456 -0.158 0 CA-C-O 117.441 -1.266 . . . . 0.0 110.762 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.75 -23.4 62.98 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 CA-C-N 120.769 1.31 . . . . 0.0 111.815 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.58 -39.83 57.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.488 0.715 . . . . 0.0 110.494 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.0 tp -79.39 -31.44 42.81 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.306 1.443 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.57 -46.84 80.53 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.617 1.167 . . . . 0.0 110.862 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -70.74 -29.42 65.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.35 0.66 . . . . 0.0 112.139 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -75.0 -41.43 59.52 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.56 -33.99 67.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -65.24 -32.91 74.82 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.22 -14.67 61.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 4.38 5.76 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.098 1.359 . . . . 0.0 111.879 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 174.08 -96.21 0.11 Allowed Glycine 0 CA--C 1.526 0.719 0 CA-C-N 119.748 1.158 . . . . 0.0 115.007 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -134.97 -173.54 3.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.145 0.973 . . . . 0.0 112.493 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.4 p -62.8 161.62 12.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.429 1.892 . . . . 0.0 112.055 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.82 -68.05 0.79 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.809 1.244 . . . . 0.0 109.375 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.4 tp -125.93 141.23 52.07 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.451 1.5 . . . . 0.0 110.577 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.6 mtp -139.43 149.1 43.65 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.739 1.616 . . . . 0.0 107.452 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -163.76 173.56 12.68 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.126 0.97 . . . . 0.0 109.766 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -75.36 80.73 2.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.207 1.803 . . . . 0.0 108.904 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mp -72.63 -16.23 61.72 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 121.031 -1.043 . . . . 0.0 110.12 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -70.05 -14.06 62.5 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -121.29 155.12 58.99 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 121.718 2.054 . . . . 0.0 114.845 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.0 -28.71 12.71 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.521 2.147 . . . . 0.0 115.619 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -56.13 -41.51 75.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -89.93 -25.31 21.0 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 119.252 -0.404 . . . . 0.0 111.387 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . 0.25 53.3 p -85.33 -13.39 49.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.011 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -61.54 -53.48 61.21 Favored Pre-proline 0 CA--C 1.532 0.258 0 O-C-N 120.605 -1.309 . . . . 0.0 111.159 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.18 -7.81 14.75 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 CA-C-N 120.574 1.241 . . . . 0.0 112.746 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.79 -67.84 0.63 Allowed 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 121.424 1.92 . . . . 0.0 107.979 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.41 -27.09 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 126.005 1.722 . . . . 0.0 115.014 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.74 -18.72 56.32 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.774 -0.579 . . . . 0.0 111.01 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.89 -47.1 75.97 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.13 -33.24 73.08 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 154.56 -9.79 0.41 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-O 117.188 -1.895 . . . . 0.0 116.756 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.02 149.28 38.47 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-N 120.242 2.021 . . . . 0.0 112.798 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -151.29 143.42 24.0 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.232 1.016 . . . . 0.0 109.285 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.46 -67.99 0.42 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.832 0.853 . . . . 0.0 112.126 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -139.0 143.53 38.52 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.476 1.11 . . . . 0.0 108.695 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -76.85 141.01 40.81 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.26 102.33 3.96 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -70.87 -174.12 0.89 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -67.02 34.43 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.449 1.899 . . . . 0.0 114.262 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 138.6 -3.51 2.93 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.47 1.986 . . . . 0.0 112.645 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.65 127.5 56.13 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.875 1.838 . . . . 0.0 106.68 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -120.82 152.2 38.67 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.894 0.746 . . . . 0.0 110.962 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.12 161.14 40.4 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 128.989 2.916 . . . . 0.0 106.093 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.73 -3.66 10.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.376 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -75.15 -30.7 60.84 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.281 0.632 . . . . 0.0 112.394 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.67 87.34 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.949 0.88 . . . . 0.0 110.606 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -105.91 110.48 31.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.756 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -81.23 28.67 2.93 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.029 1.776 . . . . 0.0 114.046 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 37.5 t -74.23 -57.13 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -80.11 57.6 2.74 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 122.183 0.992 . . . . 0.0 110.18 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -127.09 142.25 51.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -51.0 -34.56 29.73 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.417 1.087 . . . . 0.0 113.755 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.63 -38.66 96.78 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 119.474 1.034 . . . . 0.0 112.162 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.98 51.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 117.679 0.739 . . . . 0.0 109.397 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.457 ' HE3' ' OD2' ' A' ' 358' ' ' ASP . 2.6 ptmm? -62.44 -38.45 89.81 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -54.64 -53.3 56.54 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.823 1.249 . . . . 0.0 111.8 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -74.01 -29.81 62.19 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 13.0 tp -70.2 -37.23 75.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.727 1.264 . . . . 0.0 112.856 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 6.6 t -67.53 -19.1 65.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 117.397 -1.287 . . . . 0.0 110.97 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -65.65 -50.58 64.45 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.412 1.46 . . . . 0.0 107.84 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.9 tt -52.9 -49.91 64.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.273 1.429 . . . . 0.0 109.761 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.45 -27.68 42.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 124.401 1.08 . . . . 0.0 111.041 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.71 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 18.2 t0 -65.43 -31.73 72.98 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.933 1.242 . . . . 0.0 112.848 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.4 mt -76.46 -48.31 20.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 51.6 mt -59.75 -36.13 64.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.145 0.978 . . . . 0.0 109.488 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.71 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -52.18 -43.82 64.35 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.076 1.35 . . . . 0.0 110.666 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -90.77 -2.91 57.76 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.319 1.848 . . . . 0.0 112.189 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 59.22 9.8 1.49 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.887 2.475 . . . . 0.0 113.679 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -28.68 67.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.582 0.628 . . . . 0.0 109.934 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.7 tpt -90.88 154.37 19.53 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.402 0.681 . . . . 0.0 109.759 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -75.59 88.26 2.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.51 -8.08 55.82 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.28 1.032 . . . . 0.0 112.232 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -105.63 8.19 33.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.892 1.277 . . . . 0.0 113.882 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.8 m -87.12 127.61 35.13 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.524 -0.735 . . . . 0.0 109.494 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.25 -172.08 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.476 1.91 . . . . 0.0 107.412 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -51.67 60.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.893 1.277 . . . . 0.0 109.267 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -50.13 70.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.771 1.229 . . . . 0.0 111.428 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.86 -46.53 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.35 0.66 . . . . 0.0 111.506 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.38 79.05 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.463 1.105 . . . . 0.0 113.156 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -59.18 -54.77 43.15 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.084 1.353 . . . . 0.0 108.885 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.52 -55.79 25.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 124.393 1.058 . . . . 0.0 110.771 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.27 -35.39 64.96 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.719 0.69 . . . . 0.0 111.956 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -69.83 -43.04 72.79 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -58.25 -40.13 80.98 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -66.95 -21.18 65.98 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.337 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.28 12.47 63.15 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.297 0.951 . . . . 0.0 111.998 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -79.99 -49.71 11.44 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.483 1.142 . . . . 0.0 112.502 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.3 p -64.8 119.99 11.65 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.77 -17.33 62.94 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.361 0.528 . . . . 0.0 112.406 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -158.54 166.56 31.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.405 1.082 . . . . 0.0 109.151 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 2.0 t -159.06 170.81 21.21 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.453 -0.317 0 C-N-CA 126.064 1.746 . . . . 0.0 106.744 179.168 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.5 tt . . . . . 0 C--O 1.236 0.358 0 CA-C-O 117.73 -1.129 . . . . 0.0 108.041 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.74 156.29 65.95 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.938 2.425 . . . . 0.0 108.721 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.4 p -131.25 -173.22 3.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.15 0.98 . . . . 0.0 110.936 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -91.1 171.87 8.96 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -51.65 102.38 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.328 2.251 . . . . 0.0 110.09 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 63.85 23.63 67.59 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 117.603 -1.665 . . . . 0.0 114.726 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.8 128.41 4.74 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-N 121.291 2.546 . . . . 0.0 111.196 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.67 159.55 52.36 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.016 2.477 . . . . 0.0 111.473 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.6 m -92.3 162.88 14.1 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.553 ' HA ' ' HE2' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -150.51 91.68 4.08 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.198 1.399 . . . . 0.0 110.877 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.21 -77.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.197 2.598 . . . . 0.0 109.644 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 127.049 2.139 . . . . 0.0 106.876 179.369 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.209 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.9 165.47 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.172 0.989 . . . . 0.0 110.985 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.16 140.98 30.51 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.034 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.3 m -133.09 168.27 18.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.114 0.87 . . . . 0.0 111.356 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -139.6 147.57 41.29 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.296 1.439 . . . . 0.0 108.606 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.26 155.01 23.2 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.57 138.74 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -71.98 132.22 44.0 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.49 0.662 . . . . 0.0 109.892 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -73.67 -17.4 61.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -80.54 -18.88 47.08 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 116.954 -1.498 . . . . 0.0 114.953 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 40.8 m -55.06 154.26 10.55 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 119.577 1.08 . . . . 0.0 109.974 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -69.51 -54.64 0.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.84 1.693 . . . . 0.0 111.229 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -125.16 92.85 3.72 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.512 1.925 . . . . 0.0 110.444 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -55.62 -18.34 7.54 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.512 1.925 . . . . 0.0 112.199 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.85 -35.78 77.44 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.969 1.308 . . . . 0.0 109.807 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 95.9 mt -56.51 -44.41 80.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.989 0.813 . . . . 0.0 110.123 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.4 -48.52 60.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.175 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -38.04 81.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 123.5 0.5 . . . . 0.0 110.614 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -68.34 -53.47 23.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.491 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -49.14 -46.66 45.42 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 119.328 0.967 . . . . 0.0 111.434 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.46 -50.74 72.04 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.799 0.84 . . . . 0.0 111.105 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.262 4.8 pt-20 -95.59 26.96 3.64 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -135.31 -35.51 0.82 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 110.73 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -130.17 -39.19 1.37 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 119.454 1.025 . . . . 0.0 112.453 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.42 ' HA ' HG11 ' A' ' 23' ' ' VAL . 12.4 tp -62.67 -58.48 7.33 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 119.504 1.047 . . . . 0.0 110.331 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 40.0 mt -78.79 60.46 2.81 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.434 1.494 . . . . 0.0 113.059 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 43.7 p -133.98 162.31 32.41 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.21 -3.22 15.94 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.734 0.813 . . . . 0.0 111.629 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -109.28 -44.3 3.96 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.247 1.419 . . . . 0.0 109.691 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.29 -50.57 21.14 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 124.924 1.249 . . . . 0.0 110.304 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.53 -38.01 85.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.054 0.927 . . . . 0.0 109.414 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -63.05 -45.43 92.26 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 124.468 1.105 . . . . 0.0 108.521 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.78 82.66 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 123.808 0.843 . . . . 0.0 111.698 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.5 t -68.9 -38.55 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -67.55 -28.96 68.24 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.496 0.589 . . . . 0.0 111.405 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -68.12 -42.55 80.06 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.0 -32.71 73.28 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -160.03 147.06 12.41 Favored Pre-proline 0 N--CA 1.467 0.379 0 C-N-CA 125.341 1.456 . . . . 0.0 108.931 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.06 123.94 9.22 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.566 2.177 . . . . 0.0 108.681 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 32.7 mt -107.1 -4.36 18.98 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.463 1.505 . . . . 0.0 112.971 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 62.05 -153.17 42.37 Favored Glycine 0 C--N 1.335 0.498 0 CA-C-N 119.23 0.923 . . . . 0.0 111.391 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.65 159.03 7.05 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.965 0.906 . . . . 0.0 112.65 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 4.1 m -125.57 155.27 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 124.072 0.949 . . . . 0.0 109.797 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.67 -36.12 62.8 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.187 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.18 105.56 0.73 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.93 1.292 . . . . 0.0 110.43 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -53.71 -38.16 63.99 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.244 1.018 . . . . 0.0 112.547 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 21.4 m -56.1 -35.02 66.56 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.626 0.77 . . . . 0.0 112.937 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -109.28 -5.87 15.73 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.187 0.995 . . . . 0.0 110.942 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -60.94 -50.0 75.19 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -58.16 -33.35 69.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.457 1.103 . . . . 0.0 111.733 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -69.62 -49.21 56.07 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.7 0.8 . . . . 0.0 109.896 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 21.1 mt -68.82 -34.15 75.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.23 -5.3 6.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.618 1.567 . . . . 0.0 112.444 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -62.11 -21.05 64.68 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.31 0.959 . . . . 0.0 109.439 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.13 142.33 26.65 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 119.266 0.939 . . . . 0.0 109.171 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.82 -30.67 84.69 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.55 2.833 . . . . 0.0 115.038 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -58.08 -36.47 72.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.303 0.956 . . . . 0.0 110.148 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.5 mp -77.89 -61.02 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.83 -54.78 7.53 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.992 0.917 . . . . 0.0 113.222 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.94 86.04 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.252 -0.905 . . . . 0.0 112.513 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 55.6 m -68.5 -33.17 73.67 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.153 0.581 . . . . 0.0 109.482 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.0 tpt -69.27 -45.37 69.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -59.12 -35.47 73.52 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 122.709 0.404 . . . . 0.0 110.093 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -62.56 -27.63 69.31 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.713 -0.617 . . . . 0.0 111.186 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 CA-C-N 118.864 0.757 . . . . 0.0 108.977 178.121 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 CA--C 1.538 0.692 0 CA-C-O 121.818 0.674 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -129.19 24.42 5.57 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.249 1.82 . . . . 0.0 110.429 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 20.5 pt -86.04 153.08 56.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.857 1.263 . . . . 0.0 113.101 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -72.95 -21.63 20.71 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.446 2.097 . . . . 0.0 111.935 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.55 -21.99 41.9 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.36 1.864 . . . . 0.0 111.258 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 67.7 mtp -57.09 -35.1 69.0 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.814 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 10.2 t -60.04 -49.52 77.33 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.902 1.228 . . . . 0.0 109.295 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.92 92.4 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 122.544 0.338 . . . . 0.0 110.633 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -58.64 -53.58 56.8 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.514 1.126 . . . . 0.0 110.031 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -62.66 -41.69 99.2 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.142 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -65.79 -38.32 88.7 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.253 0.479 . . . . 0.0 110.849 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.78 -57.06 5.56 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.637 1.175 . . . . 0.0 113.054 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.24 -39.59 74.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 122.922 0.489 . . . . 0.0 110.261 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -53.43 28.09 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.768 0.827 . . . . 0.0 109.037 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 27.4 m -62.4 -39.66 93.98 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.441 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.75 99.68 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.008 1.276 . . . . 0.0 112.173 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.1 -48.69 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 24.4 mm -58.39 -40.48 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 118.481 0.582 . . . . 0.0 109.494 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -61.25 -44.61 96.97 Favored 'General case' 0 CA--C 1.522 -0.121 0 O-C-N 121.206 -0.933 . . . . 0.0 110.839 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.31 -43.93 69.31 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 118.25 0.477 . . . . 0.0 110.431 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.69 89.49 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.936 0.895 . . . . 0.0 111.977 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 46.6 m -83.88 -14.54 50.88 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.199 1.0 . . . . 0.0 109.587 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 74.36 17.05 79.68 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -66.9 -31.3 71.8 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.848 1.259 . . . . 0.0 110.363 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -147.73 159.67 43.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.8 m -66.64 150.14 49.48 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.3 t -57.27 -52.72 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . 0.457 ' OD2' ' HE3' ' A' ' 189' ' ' LYS . 0.8 OUTLIER -47.35 -49.98 23.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 129.411 3.084 . . . . 0.0 111.881 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.59 -35.62 58.02 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.16 77.6 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.202 -0.936 . . . . 0.0 109.66 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.1 mp -66.59 -49.44 66.35 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.552 1.941 . . . . 0.0 108.635 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -55.39 -49.73 71.55 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.464 1.105 . . . . 0.0 108.726 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -56.92 -53.1 61.77 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.977 1.311 . . . . 0.0 109.746 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.95 -47.81 83.76 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.544 1.138 . . . . 0.0 113.56 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -60.06 -37.61 80.37 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.0 m -64.19 -37.49 87.64 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -62.6 -17.17 59.65 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.447 -1.408 . . . . 0.0 112.374 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.3 mt -98.07 -20.58 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.369 1.068 . . . . 0.0 110.733 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 80.7 p -105.77 -12.19 15.98 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.807 -1.183 . . . . 0.0 112.412 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 46.3 pttt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 117.368 -1.301 . . . . 0.0 111.06 -178.77 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.48 168.2 9.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.72 1.608 . . . . 0.0 110.128 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.66 33.8 73.97 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.913 1.244 . . . . 0.0 115.072 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -145.36 172.86 12.57 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 118.372 1.086 . . . . 0.0 110.34 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.6 mt -150.56 144.77 25.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.944 2.098 . . . . 0.0 107.297 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.8 140.0 41.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.6 mt -125.12 133.0 70.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 C-N-CA 127.149 2.179 . . . . 0.0 106.558 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -122.72 136.76 54.97 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.7 mm -121.91 165.69 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.424 0.689 . . . . 0.0 110.279 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -77.98 -15.35 59.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 117.441 2.385 . . . . 0.0 117.441 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.29 -13.79 58.4 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 120.506 1.503 . . . . 0.0 116.347 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -116.92 -13.81 10.66 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.748 1.219 . . . . 0.0 111.222 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -83.81 167.87 16.68 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.845 -0.534 . . . . 0.0 110.383 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.3 72.64 2.3 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.359 1.457 . . . . 0.0 109.712 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -73.89 -28.87 61.77 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.55 -0.971 . . . . 0.0 111.664 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.12 -45.03 86.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.417 1.008 . . . . 0.0 109.2 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.43 94.88 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.8 tp -70.23 -32.56 70.49 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.638 -0.919 . . . . 0.0 110.442 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.14 80.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 117.773 -1.108 . . . . 0.0 109.41 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -59.89 -33.7 72.18 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.007 0.821 . . . . 0.0 111.456 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.4 t -68.48 -50.99 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.83 -41.9 99.68 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.232 -0.918 . . . . 0.0 114.228 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -29.69 69.37 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.42 -1.047 . . . . 0.0 110.341 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -71.03 -53.53 14.42 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -54.82 -46.55 74.58 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.699 0.227 . . . . 0.0 110.661 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.46 -28.72 70.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.92 0.888 . . . . 0.0 111.017 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 11.0 tppt? -74.0 -26.61 60.54 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.446 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.25 -35.25 10.41 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 124.113 0.883 . . . . 0.0 112.176 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.5 p -101.77 -27.8 12.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.494 1.043 . . . . 0.0 113.424 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.6 -15.65 53.68 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.181 -0.949 . . . . 0.0 111.718 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.8 mm -65.74 120.6 13.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -55.9 140.34 43.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.815 0.846 . . . . 0.0 112.203 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.1 102.43 5.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.9 m -91.63 139.79 30.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.71 117.73 45.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -123.38 158.14 31.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.743 0.817 . . . . 0.0 109.337 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -124.77 67.12 50.23 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.546 1.139 . . . . 0.0 108.813 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -73.7 175.29 10.93 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.094 1.862 . . . . 0.0 108.821 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.41 -18.28 6.78 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.373 0.669 . . . . 0.0 111.063 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.34 1.33 49.31 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.731 2.012 . . . . 0.0 112.897 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.92 -23.32 2.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.126 1.37 . . . . 0.0 114.196 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -55.14 -36.1 65.41 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.439 1.096 . . . . 0.0 111.275 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -118.53 -26.33 6.22 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.578 1.551 . . . . 0.0 110.092 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -67.98 -42.88 80.14 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 117.245 -1.36 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.54 -58.5 15.17 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 120.524 1.511 . . . . 0.0 109.776 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.41 -25.99 81.71 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 121.027 1.403 . . . . 0.0 113.67 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -75.03 -54.85 6.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.631 1.105 . . . . 0.0 112.165 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.57 -40.53 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.099 0.56 . . . . 0.0 110.634 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.75 -29.45 70.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.095 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 -17.17 17.83 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.497 1.044 . . . . 0.0 113.053 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.8 t -123.26 17.5 9.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.586 0.754 . . . . 0.0 112.108 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.05 7.44 66.8 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.16 -10.68 32.41 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.193 1.496 . . . . 0.0 111.776 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.32 -177.85 34.72 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.616 1.579 . . . . 0.0 116.212 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.11 176.9 3.44 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.427 2.751 . . . . 0.0 111.084 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -108.6 -21.15 12.83 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.4 mt -136.6 148.55 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.8 tt -133.12 135.62 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.27 1.428 . . . . 0.0 108.494 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -130.15 101.06 5.64 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.651 1.58 . . . . 0.0 109.306 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -151.66 178.42 9.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.312 0.96 . . . . 0.0 109.99 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.02 154.48 39.36 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -57.77 -27.49 63.12 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.512 0.725 . . . . 0.0 109.844 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.28 -58.79 5.56 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.517 1.127 . . . . 0.0 111.556 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -69.99 -14.48 62.72 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.619 -1.301 . . . . 0.0 111.276 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.18 11.96 8.87 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.369 -0.832 . . . . 0.0 109.512 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.41 0.43 77.79 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.114 -1.381 . . . . 0.0 112.983 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.9 -27.65 0.23 Allowed Glycine 0 CA--C 1.535 1.338 0 CA-C-N 120.351 2.075 . . . . 0.0 116.576 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -56.44 -44.08 80.1 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.945 1.872 . . . . 0.0 113.401 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.71 -41.18 99.02 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.3 -0.875 . . . . 0.0 110.076 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -29.89 59.21 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.961 1.304 . . . . 0.0 110.474 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.6 m -86.62 1.05 53.21 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.702 1.201 . . . . 0.0 112.388 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.94 16.77 80.48 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.886 1.708 . . . . 0.0 110.931 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.3 mt -83.49 -11.98 56.81 Favored 'General case' 0 CA--C 1.527 0.072 0 O-C-N 121.017 -1.284 . . . . 0.0 114.018 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.7 mt -114.15 142.54 46.1 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 119.7 1.136 . . . . 0.0 111.039 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.02 -161.57 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.508 1.923 . . . . 0.0 113.316 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.3 86.43 2.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.851 1.661 . . . . 0.0 110.152 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.26 174.22 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.973 1.309 . . . . 0.0 111.933 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.9 m 61.77 82.2 0.22 Allowed Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 126.119 1.768 . . . . 0.0 110.681 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.81 -28.93 7.47 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.416 2.077 . . . . 0.0 111.377 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -139.81 165.82 26.28 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.488 1.915 . . . . 0.0 109.277 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -63.29 -34.94 78.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.638 1.175 . . . . 0.0 110.985 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.46 -43.06 44.74 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.399 1.08 . . . . 0.0 112.371 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -60.0 -33.62 72.24 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.617 -0.677 . . . . 0.0 111.483 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -69.53 -44.29 71.29 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.479 -0.763 . . . . 0.0 109.576 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -62.2 -26.38 68.32 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.418 1.087 . . . . 0.0 112.536 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -71.35 -11.52 60.95 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.042 0.937 . . . . 0.0 111.062 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 mt -126.51 164.91 20.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.202 0.91 . . . . 0.0 110.539 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -75.26 149.92 84.86 Favored Pre-proline 0 CA--C 1.544 0.742 0 O-C-N 121.514 -0.741 . . . . 0.0 110.817 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.73 -46.75 1.12 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.514 2.809 . . . . 0.0 114.789 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -61.26 -33.93 74.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.968 1.258 . . . . 0.0 111.824 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -21.81 64.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.517 0.727 . . . . 0.0 110.716 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -70.84 -37.13 73.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.317 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.44 -28.11 64.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.476 1.035 . . . . 0.0 113.141 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.72 -23.35 67.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.444 0.698 . . . . 0.0 111.787 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.1 m -120.57 6.86 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.227 1.411 . . . . 0.0 112.284 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -72.66 170.25 14.89 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.806 0.813 . . . . 0.0 108.965 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -153.26 -174.52 4.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.487 1.115 . . . . 0.0 108.048 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -73.54 107.94 6.1 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.95 -77.68 0.53 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.719 1.628 . . . . 0.0 112.835 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 174.92 2.67 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.408 1.083 . . . . 0.0 111.928 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.75 156.22 27.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.99 1.316 . . . . 0.0 109.932 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.3 pt -126.04 -17.96 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.66 178.04 4.28 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.589 1.541 . . . . 0.0 109.291 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.62 148.39 69.83 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 124.27 1.028 . . . . 0.0 110.522 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.42 148.7 38.52 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.226 3.284 . . . . 0.0 109.265 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.3 mm -130.07 -53.01 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.982 1.313 . . . . 0.0 110.898 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -130.8 156.01 45.72 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.2 t -136.11 101.86 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.3 1.04 . . . . 0.0 110.551 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 . . . . . 0 N--CA 1.465 0.317 0 O-C-N 121.117 -0.989 . . . . 0.0 109.064 179.098 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.233 0.217 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.6 p90 . . . . . 0 C--O 1.238 0.48 0 C-N-CA 124.146 0.978 . . . . 0.0 109.359 179.271 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 N--CA 1.458 -0.589 0 N-CA-C 110.384 -0.66 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -104.64 -17.23 14.75 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.6 t -166.34 160.34 15.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.393 1.451 . . . . 0.0 108.481 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -70.1 -27.86 64.93 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 121.325 -0.859 . . . . 0.0 112.156 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -70.04 -16.11 63.11 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.138 0.881 . . . . 0.0 111.226 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -88.2 -23.98 23.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 110.544 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 40.2 mm -54.34 -58.84 12.06 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.58 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.77 -21.33 38.63 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 CA-C-N 120.429 1.189 . . . . 0.0 111.581 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.98 -36.92 64.58 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.975 1.31 . . . . 0.0 111.25 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 68.4 tp -88.23 -30.04 20.0 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.338 1.455 . . . . 0.0 110.712 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.45 -45.0 85.2 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -66.65 -33.14 74.99 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.572 0.749 . . . . 0.0 112.22 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -72.35 -44.45 62.59 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.7 mt -72.93 -33.27 65.84 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.672 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -34.75 77.26 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.62 -13.02 60.6 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 0.12 7.3 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 124.815 1.246 . . . . 0.0 111.903 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.53 -90.08 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 119.231 0.923 . . . . 0.0 114.961 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 176.22 8.88 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.146 0.978 . . . . 0.0 112.231 -177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.95 160.68 7.51 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.852 1.261 . . . . 0.0 112.811 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.89 -71.01 0.66 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.0 0.92 . . . . 0.0 109.043 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.3 tp -106.15 135.54 47.44 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.81 1.244 . . . . 0.0 109.45 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.6 ttm -147.46 104.85 3.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -126.97 163.07 24.5 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -77.89 144.92 36.53 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.6 mt -120.56 -9.82 9.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.724 0.81 . . . . 0.0 111.87 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -69.32 -16.58 63.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -113.56 124.04 32.0 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.652 1.581 . . . . 0.0 110.81 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.09 -14.06 42.68 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.347 2.031 . . . . 0.0 114.911 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -60.83 -27.93 68.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.826 1.194 . . . . 0.0 112.258 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -88.99 -36.71 15.69 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.184 0.994 . . . . 0.0 113.194 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -86.52 -21.68 26.8 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -51.65 -54.29 41.21 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -64.91 -19.32 64.0 Favored 'Trans proline' 0 C--N 1.348 0.513 0 CA-C-N 121.163 1.451 . . . . 0.0 113.883 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.58 -57.35 3.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.528 HG21 HD22 ' A' ' 192' ' ' LEU . 46.2 pt -63.04 -29.39 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 119.213 0.915 . . . . 0.0 112.131 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.66 -20.01 66.05 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.281 0.633 . . . . 0.0 111.914 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -43.16 -60.65 1.58 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.246 1.818 . . . . 0.0 113.065 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.69 -46.37 81.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.984 0.514 . . . . 0.0 111.977 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -175.52 -23.7 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.681 0 CA-C-O 116.99 -2.005 . . . . 0.0 114.497 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -37.09 123.46 0.95 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.387 1.946 . . . . 0.0 114.089 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -139.59 140.8 37.13 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.98 -59.11 2.86 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -135.8 149.67 49.19 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 125.294 1.438 . . . . 0.0 108.691 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.459 ' HE3' ' OD2' ' A' ' 180' ' ' ASP . 10.9 tppt? -76.75 145.14 38.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.886 0.85 . . . . 0.0 109.931 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -142.21 104.83 4.51 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -74.79 -171.08 1.2 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -51.25 -20.39 1.6 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.08 22.36 0.05 OUTLIER Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.92 1.724 . . . . 0.0 111.277 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -125.5 106.27 9.66 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 118.61 1.205 . . . . 0.0 107.822 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -97.14 137.08 36.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.86 147.64 28.96 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.176 1.39 . . . . 0.0 108.808 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.79 -0.31 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.944 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.06 -42.57 69.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.459 ' OD2' ' HE3' ' A' ' 170' ' ' LYS . 56.2 t0 -90.2 107.69 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.658 1.583 . . . . 0.0 109.622 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.3 t -118.37 157.73 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.25 2.22 . . . . 0.0 107.55 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -143.39 29.7 2.02 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 118.536 0.607 . . . . 0.0 114.508 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.04 -42.93 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 C-N-CA 125.049 1.34 . . . . 0.0 111.217 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -96.12 61.45 2.09 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -117.23 154.35 31.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.231 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -48.93 -38.31 22.46 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.4 -35.56 82.27 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 118.774 0.715 . . . . 0.0 112.703 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.6 -49.0 65.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.032 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.79 -42.52 99.1 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-O 118.856 -0.592 . . . . 0.0 109.446 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.25 95.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.12 0.968 . . . . 0.0 109.81 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.13 -26.41 71.49 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.859 -0.967 . . . . 0.0 112.383 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.528 HD22 HG21 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -85.43 -44.46 12.73 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.262 1.031 . . . . 0.0 111.77 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.4 t -55.01 -28.5 52.52 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.023 0.829 . . . . 0.0 111.86 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -60.21 -50.91 71.78 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.6 tp -59.82 -51.92 67.65 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.721 1.208 . . . . 0.0 109.832 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 56.2 t -55.55 -30.41 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 117.429 -1.272 . . . . 0.0 109.949 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.618 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 12.7 t0 -66.58 -44.52 82.03 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 120.431 1.469 . . . . 0.0 111.857 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.6 mt -66.66 -40.04 88.46 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 83.9 mt -66.01 -36.44 77.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.618 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -60.95 -46.82 89.18 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.116 1.367 . . . . 0.0 108.247 178.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -79.22 -2.32 40.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.157 0.983 . . . . 0.0 110.703 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt 55.38 1.56 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 130.126 3.37 . . . . 0.0 116.636 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -66.36 -26.94 67.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 11.1 ttt -81.64 141.39 33.71 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -79.57 77.91 6.14 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.0 -5.0 18.98 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.04 1.736 . . . . 0.0 114.176 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -94.67 -20.96 19.1 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 128.0 2.52 . . . . 0.0 111.457 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.2 m -58.14 137.2 57.17 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.061 0.945 . . . . 0.0 110.58 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -130.78 -178.82 4.97 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 127.481 2.312 . . . . 0.0 106.195 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -54.87 -44.79 74.36 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -46.74 88.6 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 123.694 0.798 . . . . 0.0 110.4 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.6 mt -67.37 -48.99 75.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.926 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.39 76.96 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.956 0.798 . . . . 0.0 110.485 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.03 -46.44 65.04 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.34 -55.19 34.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.008 0.923 . . . . 0.0 110.178 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.79 -49.93 61.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.818 2.047 . . . . 0.0 109.86 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -61.69 -38.15 86.76 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.853 -0.529 . . . . 0.0 110.524 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -63.87 -11.03 24.02 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.75 0.82 . . . . 0.0 112.167 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -111.6 -8.13 14.24 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.188 1.795 . . . . 0.0 112.128 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.01 27.79 25.1 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.457 1.027 . . . . 0.0 111.79 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -87.48 -0.35 56.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.289 1.045 . . . . 0.0 112.424 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.8 p -138.84 160.49 39.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.914 0.886 . . . . 0.0 109.274 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -117.24 -19.62 9.55 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.395 1.078 . . . . 0.0 109.544 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -159.2 164.91 34.68 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.952 0.901 . . . . 0.0 111.693 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.6 t -165.78 174.03 10.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.826 2.45 . . . . 0.0 106.975 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 41.6 mt . . . . . 0 C--O 1.236 0.376 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.716 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.2 149.73 64.53 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 60.6 p -124.28 167.49 14.26 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -73.54 153.5 40.24 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -64.82 135.0 55.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.68 -11.23 10.66 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 117.62 -1.655 . . . . 0.0 115.425 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.2 124.32 5.32 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 120.693 2.246 . . . . 0.0 113.591 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.48 146.22 34.69 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.146 2.564 . . . . 0.0 110.86 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.1 m -66.81 157.94 31.7 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -133.6 100.28 13.73 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.62 -175.76 2.74 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.73 2.287 . . . . 0.0 110.638 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 CA--C 1.541 0.616 0 C-N-CA 126.096 1.758 . . . . 0.0 108.878 178.137 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.466 0 N-CA-C 104.341 -3.504 . . . . 0.0 104.341 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 26.4 m -133.11 137.05 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 119.761 1.781 . . . . 0.0 111.213 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.49 138.32 57.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 m -124.37 148.41 47.55 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.864 0.866 . . . . 0.0 110.269 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.11 139.39 52.53 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 123.461 0.704 . . . . 0.0 109.449 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -137.16 164.16 25.31 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.59 1.09 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 61.9 mt -113.31 136.18 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -67.48 117.61 9.67 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.95 -22.23 64.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 118.475 -0.774 . . . . 0.0 112.642 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -74.62 -13.27 60.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 72.5 m -59.99 155.28 44.41 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 118.819 0.736 . . . . 0.0 109.597 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.92 -60.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.514 1.476 . . . . 0.0 110.117 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -108.9 88.43 2.72 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -54.7 -23.72 18.84 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.4 1.08 . . . . 0.0 111.169 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -64.82 -31.28 72.44 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.848 1.259 . . . . 0.0 112.235 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.76 -40.28 83.44 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.048 -1.033 . . . . 0.0 109.402 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.88 -42.94 63.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.53 -0.747 . . . . 0.0 111.407 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -34.92 79.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.718 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -70.84 -56.12 7.01 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -48.78 -49.09 40.3 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 119.18 0.9 . . . . 0.0 110.854 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.7 tt -62.31 -45.83 91.45 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.006 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -79.21 -18.54 52.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.744 -1.223 . . . . 0.0 114.148 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -90.34 -33.88 15.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 117.612 -1.185 . . . . 0.0 112.344 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -137.52 -23.24 1.1 Allowed 'General case' 0 C--N 1.347 0.457 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.01 -50.89 13.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.184 1.356 . . . . 0.0 109.09 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.47 67.27 9.28 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.63 1.572 . . . . 0.0 109.47 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.8 p -144.12 166.22 25.62 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -67.42 -41.36 84.96 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -73.42 -29.75 62.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.323 1.049 . . . . 0.0 111.092 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.79 -51.19 11.63 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.987 1.279 . . . . 0.0 110.036 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 27.8 mt -59.85 -45.28 92.92 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.64 -45.85 84.91 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.359 1.064 . . . . 0.0 109.793 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.56 -44.4 89.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.6 1.091 . . . . 0.0 112.292 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.6 t -72.59 -34.35 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.657 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -68.2 -38.02 81.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.233 1.413 . . . . 0.0 110.319 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -60.47 -43.9 96.44 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.44 1.496 . . . . 0.0 110.252 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.26 -43.88 69.62 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.482 0.313 . . . . 0.0 111.484 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -151.69 152.27 30.02 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 124.808 1.243 . . . . 0.0 108.389 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.11 137.13 73.53 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.771 2.981 . . . . 0.0 113.92 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 23.2 mt -124.0 -7.39 7.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.574 1.549 . . . . 0.0 112.958 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 65.26 -131.56 35.67 Favored Glycine 0 N--CA 1.464 0.559 0 C-N-CA 126.068 1.794 . . . . 0.0 112.186 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.62 177.41 8.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 17.9 m -135.44 153.67 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 O-C-N 120.626 -1.296 . . . . 0.0 110.434 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.27 -26.93 56.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.494 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.85 106.7 1.96 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -54.94 -31.87 60.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 57.8 m -68.59 -52.8 27.67 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.612 1.096 . . . . 0.0 111.064 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -72.14 -17.64 61.94 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.152 0.433 . . . . 0.0 110.664 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -61.7 -39.35 91.17 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -62.71 -39.83 95.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.708 0.685 . . . . 0.0 111.413 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -66.19 -49.99 65.42 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.683 1.193 . . . . 0.0 109.837 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.54 -34.45 74.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.679 -0.677 . . . . 0.0 110.135 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.13 -2.85 4.59 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.513 1.525 . . . . 0.0 112.469 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -58.13 -14.46 6.91 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.647 1.112 . . . . 0.0 110.387 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.95 145.5 52.2 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 124.914 1.286 . . . . 0.0 109.194 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.57 -17.56 43.22 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.692 2.261 . . . . 0.0 113.138 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -59.87 -48.52 81.34 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 317' ' ' ILE . 4.6 mp -68.33 -57.73 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.449 1.1 . . . . 0.0 108.255 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.6 -43.38 62.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.31 -35.73 81.14 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 120.402 1.456 . . . . 0.0 112.407 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 3.7 m -65.43 -37.25 86.37 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 7.2 tpt -61.55 -49.5 76.44 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -61.0 -27.95 68.69 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.71 1.204 . . . . 0.0 113.464 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -76.75 -42.77 39.74 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.487 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.554 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo . . . . . 0 CA--C 1.536 0.604 0 CA-C-O 122.114 0.797 . . . . 0.0 111.391 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -78.4 65.35 3.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.553 1.941 . . . . 0.0 108.905 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.8 pt -130.35 144.18 52.22 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 120.558 -1.339 . . . . 0.0 112.247 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.86 -15.29 37.31 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.341 2.694 . . . . 0.0 114.634 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -80.22 -18.28 49.96 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.462 -0.774 . . . . 0.0 110.864 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 59.6 mmm -70.22 -34.43 72.89 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.123 -0.986 . . . . 0.0 111.565 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.3 p -66.1 -42.31 89.42 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.338 -1.476 . . . . 0.0 108.522 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.61 -46.35 88.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -51.7 -51.46 55.86 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.841 1.656 . . . . 0.0 110.254 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -59.06 -36.2 74.65 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.024 -1.047 . . . . 0.0 113.18 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -76.26 -42.17 46.55 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.172 0.51 . . . . 0.0 109.835 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.8 72.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.442 1.497 . . . . 0.0 110.903 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 44.7 t -68.53 -46.25 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 117.223 -1.37 . . . . 0.0 111.483 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -55.76 -42.55 75.61 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 121.391 1.905 . . . . 0.0 108.832 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 20.0 m -65.0 -44.88 87.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.02 0.528 . . . . 0.0 109.751 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -56.91 -37.26 71.2 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.311 -0.868 . . . . 0.0 112.193 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 71.2 t -69.27 -58.79 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.2 mm -53.45 -46.62 59.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.86 0.864 . . . . 0.0 111.47 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -51.84 -49.68 62.38 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 121.924 -0.485 . . . . 0.0 110.842 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -77.95 -37.66 47.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.25 71.24 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.189 0.904 . . . . 0.0 110.69 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.3 m -94.74 -9.22 35.34 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.442 1.097 . . . . 0.0 110.593 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.51 14.79 82.11 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 118.843 0.747 . . . . 0.0 112.695 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -64.16 -40.06 95.34 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -147.75 154.64 40.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.1 m -61.77 155.14 23.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.826 1.25 . . . . 0.0 111.449 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.97 -53.02 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.201 1.0 . . . . 0.0 109.063 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.83 -50.12 61.49 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.844 2.057 . . . . 0.0 111.549 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -70.52 -42.51 71.15 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.951 1.301 . . . . 0.0 112.166 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.18 77.12 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.566 -0.709 . . . . 0.0 110.426 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.2 mp -72.69 -43.96 62.4 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.047 0.939 . . . . 0.0 109.243 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -54.45 -48.67 71.47 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.21 -34.3 74.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.304 1.042 . . . . 0.0 111.105 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.94 -48.36 66.14 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.825 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -52.16 -39.88 60.63 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.572 0.749 . . . . 0.0 109.746 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.4 m -62.46 -24.82 67.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.461 0.704 . . . . 0.0 112.184 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -81.5 -15.48 54.81 Favored 'General case' 0 C--O 1.226 -0.145 0 O-C-N 120.603 -1.311 . . . . 0.0 111.409 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.5 mt -98.16 -31.45 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.782 1.633 . . . . 0.0 110.398 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 3.2 p -81.55 -17.99 46.5 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.879 -0.513 . . . . 0.0 111.145 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt . . . . . 0 C--O 1.251 1.178 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 177.446 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.38 162.18 14.91 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.1 41.88 99.71 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.231 0.923 . . . . 0.0 115.037 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -149.18 169.22 21.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.33 1.052 . . . . 0.0 109.844 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.0 mt -146.19 135.85 23.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.616 1.567 . . . . 0.0 108.208 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.0 t -127.21 136.84 59.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.0 mt -135.71 142.11 40.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.888 1.275 . . . . 0.0 109.393 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -120.54 154.41 35.37 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.0 mm -116.52 147.29 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.913 2.085 . . . . 0.0 106.104 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.654 ' HB3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -152.4 118.07 5.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.502 1.121 . . . . 0.0 109.916 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.46 20.3 6.26 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.576 -1.125 . . . . 0.0 112.86 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 53.75 30.55 11.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.296 1.838 . . . . 0.0 111.155 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -58.35 172.11 0.51 Allowed 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 127.672 2.389 . . . . 0.0 114.194 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.85 50.85 1.2 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.676 2.084 . . . . 0.0 113.474 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -56.14 -30.4 62.11 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.475 1.11 . . . . 0.0 111.467 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -58.19 -30.6 66.56 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.233 1.013 . . . . 0.0 111.42 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.56 -33.96 17.78 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.6 tp -71.75 -31.18 66.39 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.257 1.423 . . . . 0.0 112.711 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.8 86.01 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.33 1.052 . . . . 0.0 109.889 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -58.89 -37.82 77.47 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.368 1.867 . . . . 0.0 110.287 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.469 HG13 ' HB3' ' A' ' 283' ' ' TYR . 95.0 t -70.09 -48.34 62.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.528 1.131 . . . . 0.0 109.2 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.2 -43.54 99.26 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.755 -0.591 . . . . 0.0 111.722 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -33.27 71.24 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 121.687 -0.89 . . . . 0.0 111.05 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -63.88 -53.02 57.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -56.7 -43.02 80.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.046 0.839 . . . . 0.0 110.774 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -13.42 58.61 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.698 1.199 . . . . 0.0 110.821 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.34 -14.94 17.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.619 -1.926 . . . . 0.0 111.86 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -105.79 -10.93 16.46 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.062 0.851 . . . . 0.0 109.95 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.0 p -130.45 -35.16 1.54 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.488 1.115 . . . . 0.0 112.346 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.64 -13.31 67.45 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.384 -0.823 . . . . 0.0 111.229 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.4 mm -64.3 130.92 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.74 145.55 54.54 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.646 1.179 . . . . 0.0 110.719 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.8 t -140.27 126.7 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.5 m -114.97 141.77 47.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.074 1.35 . . . . 0.0 108.257 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.25 121.31 45.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 126.022 1.729 . . . . 0.0 106.682 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -140.35 157.77 45.04 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.702 0.683 . . . . 0.0 109.651 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -126.38 71.03 71.06 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.407 1.083 . . . . 0.0 111.748 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.68 165.75 30.85 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.463 2.775 . . . . 0.0 111.526 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.56 5.24 15.42 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.774 1.63 . . . . 0.0 110.214 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.52 2.58 7.64 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.457 1.103 . . . . 0.0 113.481 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.654 HD21 ' HB3' ' A' ' 12' ' ' ASN . 2.1 pt? -52.62 -24.93 9.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.419 1.009 . . . . 0.0 113.677 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.48 -24.32 65.17 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.444 1.098 . . . . 0.0 112.284 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -120.53 -22.16 6.52 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.002 1.321 . . . . 0.0 110.175 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -47.59 26.05 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 117.575 -1.202 . . . . 0.0 109.407 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -48.25 -58.21 8.62 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 120.328 1.422 . . . . 0.0 111.157 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.03 -18.2 63.97 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 121.857 1.705 . . . . 0.0 114.187 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -92.87 -1.11 57.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.909 1.284 . . . . 0.0 112.927 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 t -128.13 -37.74 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 120.287 1.403 . . . . 0.0 110.268 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.83 77.62 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.864 -0.588 . . . . 0.0 111.996 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.05 73.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.413 0.551 . . . . 0.0 110.764 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -77.11 -43.73 33.09 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.847 -0.533 . . . . 0.0 110.809 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.92 19.2 4.89 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -114.82 3.53 14.66 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.261 1.031 . . . . 0.0 111.705 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.32 -170.07 26.84 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.805 1.669 . . . . 0.0 113.82 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.15 178.15 7.31 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.822 2.348 . . . . 0.0 111.916 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -99.99 -24.36 14.65 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 120.593 -1.317 . . . . 0.0 111.526 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.2 mt -140.08 156.37 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 124.832 1.253 . . . . 0.0 107.904 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 tt -142.9 147.27 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.398 1.479 . . . . 0.0 107.863 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -140.05 107.26 5.49 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.635 1.174 . . . . 0.0 110.187 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.402 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 41.5 t-105 -153.0 -165.88 2.3 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.838 1.199 . . . . 0.0 110.576 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 62' ' ' TRP . . . -73.44 147.81 43.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.061 1.344 . . . . 0.0 110.163 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -61.04 -27.38 68.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.239 0.542 . . . . 0.0 112.116 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -58.87 -31.43 68.56 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -104.33 -6.0 21.24 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.473 0.579 . . . . 0.0 109.796 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.16 -35.57 61.6 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.434 0.694 . . . . 0.0 111.267 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.89 -4.64 59.26 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.83 -60.78 1.4 Allowed Glycine 0 C--N 1.336 0.556 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -51.85 -43.47 63.22 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.082 0.953 . . . . 0.0 113.208 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.558 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -63.9 -46.34 85.31 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 119.211 0.914 . . . . 0.0 111.266 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -48.86 70.74 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.1 m -61.06 -14.39 23.4 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.532 1.533 . . . . 0.0 112.909 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.45 24.65 33.0 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 124.578 1.085 . . . . 0.0 112.548 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.23 6.97 44.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.3 1.05 . . . . 0.0 113.241 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 71' ' ' ALA . 98.6 mt -128.88 138.64 52.14 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 120.076 -1.64 . . . . 0.0 108.345 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.5 160.16 28.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.03 101.31 0.12 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.171 2.189 . . . . 0.0 106.459 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -67.0 152.7 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 122.086 0.946 . . . . 0.0 111.77 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.419 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 35.3 m 56.22 93.91 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 129.889 3.276 . . . . 0.0 115.574 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 80' ' ' THR . 34.9 Cg_endo -66.74 -41.66 10.43 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.805 1.67 . . . . 0.0 110.909 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -131.07 142.64 50.31 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.905 0.882 . . . . 0.0 112.912 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -44.76 -43.18 8.35 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 128.073 2.549 . . . . 0.0 116.994 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.01 -34.03 12.35 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.24 1.382 . . . . 0.0 114.698 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -64.55 -25.36 67.95 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.456 -0.778 . . . . 0.0 111.338 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -72.04 -44.88 62.66 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -61.85 -22.68 65.72 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.789 1.236 . . . . 0.0 112.261 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -75.4 -13.74 60.42 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.477 1.111 . . . . 0.0 112.25 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mt -124.38 154.51 40.27 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.159 0.891 . . . . 0.0 112.838 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -69.98 146.87 95.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.95 -41.39 7.74 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.173 2.582 . . . . 0.0 114.124 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -59.72 -37.21 78.29 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.138 0.881 . . . . 0.0 111.629 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -26.2 66.69 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.268 1.027 . . . . 0.0 111.56 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -73.74 -30.98 63.13 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 121.471 -0.768 . . . . 0.0 111.387 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.0 -29.33 65.19 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.208 0.913 . . . . 0.0 111.919 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.64 -16.91 63.5 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.524 1.129 . . . . 0.0 112.978 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 m -132.23 18.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.666 1.586 . . . . 0.0 112.167 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -70.65 165.54 22.67 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 122.275 1.036 . . . . 0.0 110.509 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -152.33 -177.02 5.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.419 1.488 . . . . 0.0 107.155 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -69.71 102.02 1.8 Allowed 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.21 -81.53 0.47 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.447 1.499 . . . . 0.0 112.323 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.91 170.26 4.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.393 0.596 . . . . 0.0 109.595 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.94 162.03 13.94 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.86 0.864 . . . . 0.0 109.432 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 37.7 pt -123.67 -14.58 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.182 0.993 . . . . 0.0 112.599 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.3 175.4 4.89 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.04 1.736 . . . . 0.0 107.977 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -134.3 148.29 67.14 Favored Pre-proline 0 C--O 1.242 0.684 0 C-N-CA 124.83 1.252 . . . . 0.0 111.58 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.02 143.7 26.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.301 2.668 . . . . 0.0 108.267 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.3 mm -134.42 -52.08 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 C-N-CA 125.128 1.371 . . . . 0.0 109.773 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.42 148.86 44.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.507 0.723 . . . . 0.0 111.008 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.1 t -137.82 110.37 7.04 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.116 0 C-N-CA 123.478 0.711 . . . . 0.0 110.106 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 . . . . . 0 C--O 1.238 0.45 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.054 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.1 mt . . . . . 0 C--O 1.238 0.466 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 35.9 p90 . . . . . 0 C--O 1.236 0.379 0 C-N-CA 124.342 1.057 . . . . 0.0 111.196 -178.587 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo . . . . . 0 C--O 1.238 0.498 0 N-CA-C 109.781 -0.892 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -132.27 -25.01 2.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.046 1.338 . . . . 0.0 112.091 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.6 t -147.75 152.58 37.98 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.569 1.077 . . . . 0.0 109.337 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -67.34 -15.85 63.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.28 -24.41 61.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.846 1.203 . . . . 0.0 112.329 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -86.41 -16.26 37.78 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 118.292 0.497 . . . . 0.0 110.691 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.66 -57.12 29.04 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 124.775 1.23 . . . . 0.0 107.988 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.25 -24.76 31.64 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 CA-C-N 120.804 1.323 . . . . 0.0 111.023 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.09 -52.7 38.67 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.18 -26.16 68.03 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.187 0.995 . . . . 0.0 109.838 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.37 -41.25 89.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.098 0.863 . . . . 0.0 111.25 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -75.67 -31.16 59.65 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.936 -0.477 . . . . 0.0 110.376 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -70.49 -46.75 63.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 42.2 mt -74.01 -32.44 63.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.766 -1.111 . . . . 0.0 110.294 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -67.88 -36.32 80.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 120.54 1.518 . . . . 0.0 108.707 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.69 -9.78 15.85 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.41 0.684 . . . . 0.0 112.796 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.56 11.27 2.29 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.321 1.449 . . . . 0.0 111.829 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.01 -111.95 0.32 Allowed Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -142.46 -170.25 3.15 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.488 1.915 . . . . 0.0 110.558 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 p -52.38 148.69 6.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.17 1.788 . . . . 0.0 112.802 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.09 -57.0 3.95 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.64 1.176 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.11 146.23 29.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.012 1.725 . . . . 0.0 107.604 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.7 ttm -145.88 105.76 4.0 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -138.23 163.47 31.66 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -72.18 91.81 1.31 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.273 1.429 . . . . 0.0 112.452 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -16.69 61.44 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.212 1.405 . . . . 0.0 109.188 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -75.37 -9.47 58.59 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.991 0.916 . . . . 0.0 112.358 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -119.47 123.34 28.74 Favored Pre-proline 0 C--N 1.34 0.19 0 C-N-CA 124.029 0.932 . . . . 0.0 108.728 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.01 -10.55 27.47 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.714 2.276 . . . . 0.0 115.749 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -61.07 -37.64 83.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -90.13 -23.5 21.34 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.335 0.516 . . . . 0.0 112.179 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.7 p -83.59 -25.87 30.51 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.146 0.43 . . . . 0.0 110.363 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -55.44 -55.87 35.27 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.204 -0.903 . . . . 0.0 112.608 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -62.66 -21.01 72.51 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.62 1.547 . . . . 0.0 112.071 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.2 tp -70.93 -59.48 2.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 25.3 pt -64.74 -30.8 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 117.573 -1.203 . . . . 0.0 113.793 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.68 -4.34 11.82 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 120.822 1.646 . . . . 0.0 113.883 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.35 -50.24 65.45 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.468 1.107 . . . . 0.0 113.801 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.97 -44.57 97.16 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 120.803 -1.186 . . . . 0.0 111.644 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 175.35 13.28 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.807 -0.996 . . . . 0.0 115.248 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.52 151.46 48.72 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 118.78 1.29 . . . . 0.0 111.624 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -164.25 151.34 11.69 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.31 -55.46 3.66 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -141.93 167.83 21.21 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.468 0.707 . . . . 0.0 112.038 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -101.12 155.23 18.12 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.936 0.874 . . . . 0.0 108.691 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -155.56 118.87 4.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.613 1.565 . . . . 0.0 107.574 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -92.58 67.72 4.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 33.6 47.6 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.391 2.276 . . . . 0.0 115.232 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.51 -18.91 1.67 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 126.157 1.837 . . . . 0.0 112.057 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -117.97 106.19 12.68 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.13 128.91 34.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -132.0 88.69 2.58 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-O 123.705 1.716 . . . . 0.0 109.512 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -5.2 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.306 1.443 . . . . 0.0 114.06 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -70.01 -40.39 75.29 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 120.11 1.323 . . . . 0.0 108.25 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -76.76 108.05 9.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.2 t -129.08 140.32 49.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -129.63 16.92 5.57 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 118.283 -1.287 . . . . 0.0 115.676 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.537 HG21 HD13 ' A' ' 368' ' ' ILE . 0.0 OUTLIER -62.13 -13.99 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.164 1.982 . . . . 0.0 115.341 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 365' ' ' GLN . 4.4 p-10 -119.12 10.15 12.0 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 120.841 -1.162 . . . . 0.0 111.083 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -65.38 155.75 34.4 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -49.08 -35.66 16.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.562 0.745 . . . . 0.0 112.198 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.27 -40.13 98.61 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 119.878 1.217 . . . . 0.0 114.055 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.91 -52.1 52.85 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.622 1.211 . . . . 0.0 109.189 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -63.0 -39.9 96.14 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 119.095 -0.479 . . . . 0.0 110.598 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.78 65.61 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.72 0.808 . . . . 0.0 111.92 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -94.14 -34.76 6.3 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 31.5 tp -70.72 -40.13 72.97 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.481 0.712 . . . . 0.0 111.269 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.4 t -50.55 -45.76 57.12 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 116.672 -1.633 . . . . 0.0 109.848 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -55.64 -56.75 16.71 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 120.547 1.521 . . . . 0.0 111.054 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 64.6 tp -56.04 -49.36 73.94 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.583 0.753 . . . . 0.0 110.934 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.07 -27.89 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.135 0.974 . . . . 0.0 110.895 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.12 -40.16 96.79 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.998 1.319 . . . . 0.0 110.135 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 9.7 mt -66.23 -45.52 80.38 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.28 -40.6 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.458 1.103 . . . . 0.0 108.891 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -56.62 -37.48 70.77 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.779 -1.2 . . . . 0.0 109.588 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -88.27 -4.17 58.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.767 1.627 . . . . 0.0 112.268 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 56.65 14.51 1.77 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.5 2.32 . . . . 0.0 113.758 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -83.42 -5.31 59.11 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.381 -0.825 . . . . 0.0 111.251 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.7 tpt -109.07 154.59 22.04 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.726 0.81 . . . . 0.0 111.382 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -76.18 71.09 2.89 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 108.767 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.3 -10.66 59.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.324 1.05 . . . . 0.0 112.003 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -85.85 -15.84 40.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 129.517 3.127 . . . . 0.0 115.086 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 12.4 m -67.16 127.76 33.82 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.03 1.332 . . . . 0.0 113.244 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -122.24 -178.37 3.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -62.47 -31.63 72.4 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.258 -0.901 . . . . 0.0 113.002 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 t -64.98 -48.8 72.7 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.223 1.009 . . . . 0.0 109.842 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 13.8 mm -61.39 -47.9 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.783 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.68 -52.74 59.34 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.428 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.96 -44.31 94.5 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.62 1.1 . . . . 0.0 110.164 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.81 -54.2 45.42 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.601 0.36 . . . . 0.0 110.35 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.9 79.36 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.655 0.661 . . . . 0.0 111.556 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.85 -44.72 92.29 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -59.22 -42.17 90.37 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -68.45 -27.72 66.42 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.219 -0.925 . . . . 0.0 111.717 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.68 63.48 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.57 1.557 . . . . 0.0 111.948 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.15 -60.85 2.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.442 1.497 . . . . 0.0 111.503 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.2 t -69.04 151.29 46.66 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.67 -26.92 13.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.305 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -130.29 158.66 39.19 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 3.1 t -173.23 -179.72 2.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.09 2.156 . . . . 0.0 108.424 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 63.4 mt . . . . . 0 C--O 1.235 0.321 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.335 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.65 152.77 79.99 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.324 2.016 . . . . 0.0 111.75 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 69.8 p -119.6 171.45 8.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.245 1.418 . . . . 0.0 111.033 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -84.81 158.97 20.51 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -59.11 122.94 15.04 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 120.82 -1.175 . . . . 0.0 109.762 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 71.01 7.74 63.04 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 117.712 -1.605 . . . . 0.0 114.215 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.38 127.02 6.08 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 121.269 2.535 . . . . 0.0 112.574 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.02 161.13 47.13 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.728 2.952 . . . . 0.0 113.693 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 89.4 p -83.24 139.3 33.19 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.829 0.852 . . . . 0.0 108.77 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -132.77 76.17 71.52 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.831 1.652 . . . . 0.0 107.967 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -77.01 -170.32 0.9 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.324 3.349 . . . . 0.0 112.139 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.47 0.546 0 C-N-CA 123.982 0.913 . . . . 0.0 110.869 179.535 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.533 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.37 127.18 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.83 158.7 35.04 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.1 m -131.05 140.66 50.11 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 120.917 -1.114 . . . . 0.0 110.551 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.4 128.2 40.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.967 1.707 . . . . 0.0 107.407 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.61 160.45 24.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 58.8 mt -95.16 130.11 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -77.51 133.34 38.58 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -82.46 -5.02 58.44 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -62.33 -31.05 71.62 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 49.7 m -78.5 157.15 77.79 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.156 1.782 . . . . 0.0 112.564 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.32 -59.64 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.028 3.152 . . . . 0.0 113.335 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -104.68 98.84 8.53 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -13.76 61.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.758 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.412 ' HA ' ' HG3' ' A' ' 277' ' ' LYS . 1.1 tt0 -59.81 -41.04 90.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.251 1.42 . . . . 0.0 109.926 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.75 -39.49 84.96 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.3 -44.44 62.71 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.942 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.412 ' HG3' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -67.89 -29.72 68.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.046 -179.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -79.46 -49.92 11.56 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.94 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -55.93 -45.38 78.77 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.889 1.677 . . . . 0.0 109.726 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.36 -30.03 70.89 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.102 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -99.26 -17.4 18.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 120.337 1.426 . . . . 0.0 114.55 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -84.11 -35.9 23.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.899 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.469 ' HB3' HG13 ' A' ' 23' ' ' VAL . 39.1 m-85 -139.23 -32.37 0.66 Allowed 'General case' 0 C--N 1.344 0.329 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -21.2 63.46 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.6 1.545 . . . . 0.0 112.002 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.432 ' CD2' HD21 ' A' ' 304' ' ' LEU . 57.6 mt -110.35 41.6 1.72 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.825 1.65 . . . . 0.0 109.837 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.0 p -128.47 160.08 33.43 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.4 -38.59 66.39 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -68.68 -43.79 75.36 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.33 -42.22 66.05 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.32 -43.04 92.25 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.636 1.174 . . . . 0.0 110.213 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.33 -43.53 90.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.68 -43.63 80.65 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.101 0.961 . . . . 0.0 112.323 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.7 t -71.3 -39.94 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.46 1.027 . . . . 0.0 108.341 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -62.26 -35.43 78.94 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.026 0.531 . . . . 0.0 111.215 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -60.91 -47.95 84.06 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 121.283 -0.885 . . . . 0.0 109.695 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -41.05 66.54 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -143.98 148.33 41.62 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.01 131.29 23.49 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.594 2.196 . . . . 0.0 111.809 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 24.6 mt -119.35 -17.8 8.72 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.723 0.809 . . . . 0.0 112.592 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 70.06 -150.75 49.33 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 119.629 1.104 . . . . 0.0 110.69 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -65.53 167.82 8.31 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.525 1.53 . . . . 0.0 112.206 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.03 165.43 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 124.05 1.881 . . . . 0.0 111.086 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.58 -23.11 29.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.055 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.432 HD21 ' CD2' ' A' ' 285' ' ' LEU . 4.0 mm? -74.02 107.71 6.38 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 125.177 1.391 . . . . 0.0 110.57 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -61.1 1.87 0.15 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.192 1.397 . . . . 0.0 114.676 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.7 m -95.97 -67.75 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -68.62 -22.33 64.43 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.86 0.755 . . . . 0.0 111.263 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -62.67 -32.16 73.18 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 118.955 0.798 . . . . 0.0 109.186 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.89 -34.11 77.61 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.005 1.275 . . . . 0.0 110.244 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -79.18 -42.31 26.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.771 1.228 . . . . 0.0 110.45 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 19.3 mt -68.15 -39.31 82.67 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.07 -7.85 10.04 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.78 1.232 . . . . 0.0 112.361 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -62.44 -30.27 71.12 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.188 -0.945 . . . . 0.0 108.677 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.6 142.06 25.34 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 124.238 1.015 . . . . 0.0 108.934 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.74 -25.2 46.52 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.524 2.15 . . . . 0.0 113.138 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -58.47 -49.8 76.03 Favored 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.44 HD12 ' H ' ' A' ' 317' ' ' ILE . 4.2 mp -69.01 -42.01 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.334 1.054 . . . . 0.0 109.05 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.66 -47.6 73.36 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.148 0.431 . . . . 0.0 110.166 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.24 91.63 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.641 -0.662 . . . . 0.0 111.503 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.6 m -61.88 -37.47 84.67 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 60.7 tpp -73.05 -42.31 63.25 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 118.584 0.629 . . . . 0.0 109.974 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -56.78 -38.96 73.21 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -57.9 -41.82 83.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.401 0.28 . . . . 0.0 110.399 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.36 0 O-C-N 121.861 -0.524 . . . . 0.0 111.125 178.718 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo . . . . . 0 N--CA 1.461 -0.428 0 N-CA-C 111.559 -0.208 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -129.58 73.96 1.56 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 pt -129.67 153.73 80.82 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.501 1.121 . . . . 0.0 111.225 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.41 -32.73 49.43 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.33 2.687 . . . . 0.0 113.453 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -63.26 -24.24 67.78 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.106 -0.996 . . . . 0.0 111.084 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 26.3 mmm -68.64 -26.36 65.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.239 0.927 . . . . 0.0 111.102 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.5 m -62.53 -48.82 77.86 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.72 -31.03 67.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.409 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.609 ' O ' HG23 ' A' ' 343' ' ' VAL . 30.8 t80 -55.92 -58.87 6.05 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.305 0.957 . . . . 0.0 109.909 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -60.55 -37.77 82.32 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.943 -0.473 . . . . 0.0 111.742 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -62.56 -44.33 96.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.403 0.681 . . . . 0.0 109.226 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.63 -50.99 67.16 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.056 1.342 . . . . 0.0 110.698 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 339' ' ' PHE . 2.1 t -59.19 -43.76 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.069 0.395 . . . . 0.0 110.236 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -53.65 -38.55 64.23 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.684 0.794 . . . . 0.0 110.833 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 5.7 m -82.4 -50.44 8.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.522 1.055 . . . . 0.0 110.067 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.84 63.46 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.37 -49.12 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 118.051 -0.975 . . . . 0.0 109.918 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.6 mm -65.31 -35.4 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 119.836 1.198 . . . . 0.0 109.67 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -64.73 -45.97 84.25 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.143 -0.973 . . . . 0.0 109.93 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.46 65.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.701 0.8 . . . . 0.0 111.003 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.91 -36.81 84.6 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 125.328 1.451 . . . . 0.0 113.497 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 42.4 m -92.22 -2.7 56.34 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.443 0.697 . . . . 0.0 110.707 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 76.32 13.01 83.76 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 115.532 0.973 . . . . 0.0 115.532 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -66.36 -30.78 71.24 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 119.06 1.43 . . . . 0.0 109.945 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.12 156.09 43.69 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.4 m -66.99 156.23 36.53 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.69 -51.66 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.14 -50.93 65.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.362 1.465 . . . . 0.0 111.621 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.41 -39.14 74.63 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.15 89.31 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 121.463 -0.773 . . . . 0.0 109.605 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.7 mp -72.13 -43.42 64.7 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.396 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.6 tptt -53.14 -55.07 26.97 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.122 1.369 . . . . 0.0 110.228 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -53.9 -49.16 69.21 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 127.99 2.516 . . . . 0.0 112.281 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.48 -50.11 74.88 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 125.668 1.587 . . . . 0.0 111.408 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 184' ' ' ASP . 1.3 tm0? -56.44 -33.09 65.53 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.485 1.039 . . . . 0.0 110.625 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 14.0 m -62.14 -37.01 83.55 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.806 0.73 . . . . 0.0 109.873 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -65.84 -20.39 66.22 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.154 -0.966 . . . . 0.0 112.244 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.537 HD13 HG21 ' A' ' 183' ' ' VAL . 5.7 mt -88.7 -29.21 5.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.274 1.03 . . . . 0.0 109.732 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.0 p -92.55 -7.74 46.37 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.672 -0.643 . . . . 0.0 110.709 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 25.5 tptt . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.312 1.445 . . . . 0.0 110.97 -178.55 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.655 0.74 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -92.02 99.36 12.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 145.76 19.86 0.14 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-O 119.239 -0.756 . . . . 0.0 114.958 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -141.11 172.2 13.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.55 1.175 . . . . 0.0 110.933 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.1 mt -153.53 147.03 24.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 128.521 2.728 . . . . 0.0 106.314 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.8 t -142.02 136.12 29.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.6 mt -124.02 137.79 55.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 126.348 1.859 . . . . 0.0 108.82 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -128.42 149.91 50.35 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.2 pt -136.25 168.08 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -158.91 150.95 21.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 128.121 2.569 . . . . 0.0 108.933 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.74 16.3 49.17 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-O 117.432 -1.76 . . . . 0.0 115.577 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 70.12 37.64 1.64 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.728 2.011 . . . . 0.0 110.675 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -57.61 157.05 7.48 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.299 1.047 . . . . 0.0 111.345 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.96 56.89 4.58 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.788 -0.642 . . . . 0.0 114.071 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -50.54 -39.45 49.17 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -66.51 -12.37 57.2 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.86 -45.53 1.49 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.6 tp -61.45 -37.87 85.15 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.466 0.706 . . . . 0.0 111.9 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.69 -41.76 64.16 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.705 0.802 . . . . 0.0 111.92 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -62.82 -33.15 74.62 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.3 t -65.18 -47.13 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.33 -35.77 92.5 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -62.88 -45.72 91.21 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.215 -0.898 . . . . 0.0 109.083 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -58.89 -54.94 41.48 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -52.36 -48.87 65.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.996 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -66.08 -32.51 74.01 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.858 1.208 . . . . 0.0 110.721 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 8.3 tppt? -68.93 -28.05 66.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 118.171 -0.919 . . . . 0.0 112.604 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.62 -0.43 20.23 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.255 0.972 . . . . 0.0 112.903 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.2 p -130.6 -38.79 1.3 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.61 1.096 . . . . 0.0 112.259 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.72 -10.91 66.57 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.832 -0.982 . . . . 0.0 113.74 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 40.0 mm -70.31 132.28 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 147.39 53.53 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.897 -0.502 . . . . 0.0 111.373 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 t -137.84 125.94 31.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.8 m -118.46 142.49 47.52 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.5 t -132.14 120.97 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -136.29 164.95 26.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.089 1.356 . . . . 0.0 110.245 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -122.4 58.22 10.14 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.126 1.37 . . . . 0.0 112.063 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.93 136.49 16.66 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.212 1.941 . . . . 0.0 110.611 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.12 -18.4 25.92 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.236 -0.915 . . . . 0.0 110.403 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.445 ' H ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -83.66 -2.11 55.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 128.12 2.568 . . . . 0.0 112.761 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.47 -31.6 10.28 Favored 'General case' 0 N--CA 1.461 0.085 0 C-N-CA 124.586 1.154 . . . . 0.0 113.459 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -52.6 -33.44 46.33 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.62 1.168 . . . . 0.0 113.561 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -119.14 -21.6 7.54 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 123.375 0.67 . . . . 0.0 110.967 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -72.55 -42.78 64.31 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 117.717 -1.135 . . . . 0.0 109.122 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -51.26 -60.51 5.58 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 117.558 -1.211 . . . . 0.0 109.96 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.52 -24.57 75.37 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.146 1.23 . . . . 0.0 113.142 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -69.4 -55.26 10.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.087 0.858 . . . . 0.0 111.337 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.412 HG12 ' C ' ' A' ' 55' ' ' ASP . 2.5 t -77.06 -37.47 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.696 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.07 90.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.782 -0.627 . . . . 0.0 109.31 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.0 -15.4 43.85 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 118.925 -0.56 . . . . 0.0 111.979 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.8 m -102.85 -9.23 20.09 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.036 1.734 . . . . 0.0 111.825 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.88 10.06 73.05 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.897 -1.127 . . . . 0.0 112.393 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.412 ' C ' HG12 ' A' ' 50' ' ' VAL . 1.4 m-20 -112.21 2.09 16.48 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.109 1.364 . . . . 0.0 112.582 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.45 176.9 34.23 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.958 -1.089 . . . . 0.0 114.848 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.23 -178.41 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.97 3.113 . . . . 0.0 110.818 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.56 -22.16 12.11 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 120.982 -1.074 . . . . 0.0 112.272 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mt -139.23 148.14 23.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.8 tp -129.35 144.45 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.974 1.71 . . . . 0.0 107.573 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -132.82 102.29 5.59 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.757 1.223 . . . . 0.0 108.808 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -153.13 171.39 18.52 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.053 0.842 . . . . 0.0 111.782 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.19 161.11 31.34 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.745 -1.222 . . . . 0.0 110.984 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -54.54 -32.14 57.72 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.794 1.638 . . . . 0.0 114.736 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.12 -58.15 8.84 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.622 1.169 . . . . 0.0 111.175 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -73.52 -9.39 58.63 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 121.156 -0.965 . . . . 0.0 111.592 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -93.75 12.1 26.83 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.218 1.807 . . . . 0.0 110.035 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 -9.9 56.61 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.815 -0.991 . . . . 0.0 112.006 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.56 -31.26 1.39 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.708 1.754 . . . . 0.0 116.211 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -53.02 -53.98 42.01 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.247 2.024 . . . . 0.0 111.863 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.21 89.75 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.427 -0.796 . . . . 0.0 109.412 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -40.86 76.91 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.804 0.842 . . . . 0.0 109.292 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 m -73.98 -38.01 64.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.694 0.797 . . . . 0.0 108.877 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.07 8.73 6.46 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.97 1.272 . . . . 0.0 114.549 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.8 mt -76.94 -8.01 56.6 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 mt -108.34 139.83 42.48 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.808 1.64 . . . . 0.0 111.857 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.32 175.12 8.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.625 0.77 . . . . 0.0 112.096 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -71.04 135.62 47.87 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.922 0.889 . . . . 0.0 109.326 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 pp -125.74 161.35 30.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 123.474 0.709 . . . . 0.0 110.805 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.9 m 50.87 82.58 0.24 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 127.122 2.169 . . . . 0.0 113.971 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.6 -21.68 25.32 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.349 2.7 . . . . 0.0 113.68 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -134.79 159.63 40.73 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.067 1.303 . . . . 0.0 113.106 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -70.78 -35.81 72.76 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.139 1.376 . . . . 0.0 113.021 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.73 -35.17 60.92 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.776 1.171 . . . . 0.0 112.213 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -65.58 -32.94 74.8 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 122.12 -0.363 . . . . 0.0 111.079 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -66.2 -43.19 87.5 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.607 -0.683 . . . . 0.0 109.54 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -60.0 -27.49 66.91 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.77 1.628 . . . . 0.0 112.938 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -72.17 -2.93 20.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.987 0.915 . . . . 0.0 111.627 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mt -132.81 156.36 47.26 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.185 1.394 . . . . 0.0 110.561 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -68.38 156.47 90.26 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.26 -50.89 0.86 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.187 3.258 . . . . 0.0 114.613 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -52.45 -36.51 54.77 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.374 0.988 . . . . 0.0 112.067 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -31.13 72.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.958 0.903 . . . . 0.0 111.28 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -75.75 -42.51 50.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.813 0.733 . . . . 0.0 110.599 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.491 ' HA ' ' HG3' ' A' ' 98' ' ' ARG . 4.0 m-20 -55.19 -36.08 65.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.086 0.403 . . . . 0.0 110.02 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.47 -2.51 4.72 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 m -133.06 15.96 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 120.146 1.339 . . . . 0.0 110.17 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 10.4 mmt180 -71.26 161.65 30.74 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 123.932 0.893 . . . . 0.0 110.832 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -152.05 179.29 8.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.616 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -63.43 97.77 0.14 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.692 1.197 . . . . 0.0 109.537 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.55 -80.96 1.0 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.443 1.496 . . . . 0.0 111.029 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 170.19 13.47 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.962 -0.728 . . . . 0.0 111.06 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.8 163.97 12.76 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.769 1.227 . . . . 0.0 109.385 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.6 pt -129.04 -34.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 116.752 -1.594 . . . . 0.0 114.03 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -143.83 -179.29 6.38 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.994 1.725 . . . . 0.0 109.165 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 264' ' ' ALA . 6.3 p90 -132.51 148.13 68.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.251 1.02 . . . . 0.0 111.303 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.66 151.88 32.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.676 2.918 . . . . 0.0 109.388 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -133.05 -55.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.695 1.198 . . . . 0.0 110.745 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.81 161.04 31.66 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.44 108.32 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 N--CA 1.466 0.359 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.253 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 p90 . . . . . 0 N--CA 1.451 -0.388 0 O-C-N 120.834 -1.166 . . . . 0.0 110.425 -177.965 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.456 -0.725 0 CA-C-O 123.428 1.345 . . . . 0.0 114.458 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -101.29 -33.12 10.17 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.944 2.898 . . . . 0.0 114.493 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 t -161.13 152.38 18.85 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.8 0.727 . . . . 0.0 110.47 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -64.96 -28.06 69.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.761 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -67.39 -17.27 64.66 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.886 0.766 . . . . 0.0 112.97 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -94.38 -18.6 21.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.962 0.905 . . . . 0.0 109.534 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.6 mm -52.5 -56.83 18.95 Favored Pre-proline 0 C--O 1.234 0.279 0 O-C-N 121.259 -0.901 . . . . 0.0 110.391 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.44 -29.77 44.83 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 CA-C-N 120.34 1.157 . . . . 0.0 111.608 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.25 -15.08 62.42 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.793 1.637 . . . . 0.0 112.474 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 36.6 tp -104.88 -24.57 12.85 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.798 1.639 . . . . 0.0 107.225 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.69 -49.21 69.39 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -65.51 -27.4 68.44 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.14 -42.77 30.74 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.5 mt -70.85 -33.27 70.47 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.31 68.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 123.615 0.572 . . . . 0.0 111.948 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.02 0.73 16.08 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.766 1.226 . . . . 0.0 112.982 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 179.59 -97.65 0.11 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 119.203 0.911 . . . . 0.0 113.134 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -140.55 -176.19 4.55 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.152 0.981 . . . . 0.0 111.165 -177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.3 p -52.99 166.46 0.22 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.343 1.857 . . . . 0.0 115.181 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -95.45 -69.47 0.75 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.137 1.375 . . . . 0.0 109.828 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.7 tp -121.32 152.5 38.88 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.73 2.012 . . . . 0.0 110.687 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 88.0 mtp -149.76 131.51 15.03 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.741 2.416 . . . . 0.0 105.399 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -148.58 164.58 33.82 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.8 1.24 . . . . 0.0 110.639 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.66 94.43 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.885 1.274 . . . . 0.0 113.828 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.4 mt -85.07 -19.5 31.83 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.668 -1.27 . . . . 0.0 110.342 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -77.13 -0.81 26.32 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.784 0.834 . . . . 0.0 112.85 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -125.24 122.43 25.19 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.903 0.881 . . . . 0.0 109.735 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.1 -15.09 32.19 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.417 1.411 . . . . 0.0 112.395 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -48.7 -42.19 34.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.921 1.288 . . . . 0.0 113.3 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -93.77 -33.72 13.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.8 0.727 . . . . 0.0 112.354 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 82.6 p -72.28 -28.56 63.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.018 0.826 . . . . 0.0 111.914 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -47.46 -63.33 1.49 Allowed Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.137 1.775 . . . . 0.0 112.458 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -66.4 -11.86 33.26 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.737 1.624 . . . . 0.0 114.482 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.2 tp -78.89 -55.61 5.02 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.6 pt -62.48 -34.14 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.539 0.609 . . . . 0.0 111.79 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.44 -12.42 60.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.677 -1.154 . . . . 0.0 112.206 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -48.4 -54.37 14.27 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.191 1.396 . . . . 0.0 112.396 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -53.14 -49.81 65.81 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.455 0.57 . . . . 0.0 111.447 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.81 1.54 0.03 OUTLIER Glycine 0 CA--C 1.523 0.537 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.645 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -54.83 144.5 30.89 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 119.408 1.604 . . . . 0.0 110.19 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.424 ' CE1' ' HA3' ' A' ' 182' ' ' GLY . 37.6 p90 -148.83 136.71 20.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 118.568 1.184 . . . . 0.0 108.924 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.54 -67.77 0.71 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 335' ' ' GLN . 62.0 m-85 -133.91 134.31 42.5 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -75.49 124.28 26.9 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -131.71 100.78 5.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -79.57 -173.72 3.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.421 1.488 . . . . 0.0 107.724 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -46.9 -27.59 1.3 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.822 1.649 . . . . 0.0 114.25 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.57 13.82 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 CA-C-O 118.535 -1.147 . . . . 0.0 113.848 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -122.67 132.34 54.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.684 1.742 . . . . 0.0 108.891 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.01 114.36 19.65 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -139.52 96.01 3.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 122.442 1.115 . . . . 0.0 110.428 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.59 -3.41 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 127.622 2.369 . . . . 0.0 114.789 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -76.87 -36.74 56.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.04 93.94 5.85 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.88 151.21 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 126.246 1.819 . . . . 0.0 107.623 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.424 ' HA3' ' CE1' ' A' ' 167' ' ' TYR . . . -148.69 31.99 1.22 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.68 1.133 . . . . 0.0 112.246 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.05 -24.04 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 121.712 -0.875 . . . . 0.0 111.48 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -112.86 18.52 18.11 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.314 1.445 . . . . 0.0 112.814 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -61.57 160.38 11.44 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.591 0.71 . . . . 0.0 109.161 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.68 -26.27 63.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.636 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -72.45 -33.38 61.3 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.132 -0.98 . . . . 0.0 112.447 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.38 43.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.182 0.993 . . . . 0.0 109.758 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -59.79 -34.56 73.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.497 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.66 -54.34 48.21 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.709 0.686 . . . . 0.0 110.562 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.92 -32.06 81.5 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.848 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.87 -44.52 63.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.234 1.017 . . . . 0.0 111.143 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 12.9 t -62.27 -29.1 70.17 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 117.427 -1.273 . . . . 0.0 110.233 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -57.49 -46.6 83.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 120.205 1.366 . . . . 0.0 108.922 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.35 -51.56 67.12 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.918 0.887 . . . . 0.0 109.683 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.67 -32.71 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.526 0.73 . . . . 0.0 110.66 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -32.23 73.68 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.974 0.91 . . . . 0.0 110.601 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.16 -45.26 57.66 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 50.5 mt -60.81 -39.79 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.173 0.989 . . . . 0.0 108.627 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -54.69 -35.79 63.98 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.049 0.94 . . . . 0.0 109.627 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -93.15 -1.97 55.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.736 2.015 . . . . 0.0 113.131 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 9.1 mptt 55.98 11.82 0.8 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.317 2.647 . . . . 0.0 115.503 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -79.91 -8.41 59.3 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.947 -1.095 . . . . 0.0 112.362 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.62 136.44 50.84 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.236 1.014 . . . . 0.0 109.766 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -76.87 79.28 3.45 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.49 77.46 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.18 -2.25 9.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.906 2.082 . . . . 0.0 114.554 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 43.4 m -63.04 126.95 29.04 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.611 1.164 . . . . 0.0 113.629 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.82 179.38 4.03 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.954 2.102 . . . . 0.0 107.097 177.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -57.05 -45.54 83.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -40.25 97.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.148 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 59.6 mt -68.4 -48.86 70.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.42 85.51 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.088 0.555 . . . . 0.0 111.907 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -77.26 -49.55 14.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.047 0.839 . . . . 0.0 111.718 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.69 -50.54 71.84 Favored 'General case' 0 C--N 1.337 0.054 0 CA-C-N 119.114 0.87 . . . . 0.0 110.737 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.34 -44.6 84.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.292 1.037 . . . . 0.0 109.761 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -60.76 -44.06 97.22 Favored 'General case' 0 CA--C 1.524 -0.053 0 C-N-CA 123.501 0.72 . . . . 0.0 109.243 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -55.78 -42.76 76.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.797 0.839 . . . . 0.0 110.05 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -74.51 -21.33 59.6 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.265 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.96 20.26 13.17 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.981 -0.899 . . . . 0.0 112.537 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -73.46 -31.71 63.94 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.513 1.656 . . . . 0.0 112.701 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.7 t -124.2 146.57 48.62 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.796 1.639 . . . . 0.0 106.743 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -106.5 -9.63 16.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.31 1.044 . . . . 0.0 112.241 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.67 153.7 41.89 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.2 t -164.84 157.53 16.43 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 0 C--O 1.234 0.261 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.625 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 CA--C 1.541 0.622 0 CA-C-O 119.587 -0.244 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.73 153.81 68.59 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.395 1.396 . . . . 0.0 109.062 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.5 p -125.64 163.97 21.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -83.41 139.55 32.91 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 135.39 52.16 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.745 -1.222 . . . . 0.0 109.573 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 71.59 -1.61 27.93 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.182 -1.343 . . . . 0.0 113.974 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.99 105.14 2.64 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 121.283 2.542 . . . . 0.0 111.67 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.15 144.29 56.79 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.754 1.636 . . . . 0.0 110.809 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.39 146.86 46.85 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.504 1.522 . . . . 0.0 108.019 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -140.26 92.01 9.65 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.169 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -81.97 -165.07 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 125.244 3.963 . . . . 0.0 112.082 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 124.741 1.216 . . . . 0.0 109.386 178.404 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.269 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.7 149.48 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 123.217 0.607 . . . . 0.0 110.34 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.9 tt -82.69 127.63 33.59 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.4 m -111.05 159.59 17.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.851 1.261 . . . . 0.0 107.871 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.43 ' HB3' ' CE1' ' A' ' 106' ' ' TYR . . . -139.07 151.49 46.78 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.427 0.691 . . . . 0.0 109.849 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -147.77 164.38 28.83 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 124.739 1.274 . . . . 0.0 113.128 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 45.7 mt -103.67 133.83 46.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.309 1.444 . . . . 0.0 108.366 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -69.91 118.82 13.24 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.04 -13.27 62.35 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.619 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -73.28 -26.49 61.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.45 1.023 . . . . 0.0 112.729 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 48.8 m -62.55 161.52 26.53 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.007 0.523 . . . . 0.0 110.782 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.3 -44.79 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.541 1.494 . . . . 0.0 114.892 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -133.92 100.62 4.8 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 119.61 1.096 . . . . 0.0 109.861 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -58.01 -20.73 40.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.247 1.019 . . . . 0.0 113.092 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -60.76 -32.09 71.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.426 0.69 . . . . 0.0 111.214 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.31 -27.89 67.69 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.42 -0.8 . . . . 0.0 110.802 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -85.22 -40.21 16.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.403 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.46 83.51 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 118.888 0.767 . . . . 0.0 110.189 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -71.29 -43.89 66.26 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.03 -49.66 77.03 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.122 -0.986 . . . . 0.0 109.28 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.3 mp -59.42 -50.6 73.32 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 118.19 -0.909 . . . . 0.0 112.712 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -76.17 -21.32 56.66 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -93.7 -23.83 18.08 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 117.06 -1.448 . . . . 0.0 112.075 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -137.17 -28.18 0.94 Allowed 'General case' 0 C--N 1.346 0.424 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 284' ' ' LEU . 1.2 tm? -83.5 -16.16 46.66 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.86 1.664 . . . . 0.0 112.442 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.552 HD22 HD21 ' A' ' 304' ' ' LEU . 67.6 mt -121.98 68.02 0.92 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.35 1.06 . . . . 0.0 109.702 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 65.6 p -139.44 154.84 47.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.959 1.704 . . . . 0.0 107.137 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.1 1.67 7.06 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.387 1.875 . . . . 0.0 112.246 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -113.21 -48.82 2.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.672 2.389 . . . . 0.0 111.058 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.52 -35.71 62.83 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.17 -42.88 99.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -60.39 -46.47 89.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 123.933 0.77 . . . . 0.0 109.545 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.84 -32.35 60.47 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 118.035 -0.984 . . . . 0.0 113.39 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 7.1 t -84.29 -24.57 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 120.406 1.457 . . . . 0.0 109.967 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -72.06 -23.85 61.43 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.285 0.948 . . . . 0.0 110.064 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -57.76 -49.9 75.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -64.67 -50.49 66.83 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 157.19 69.42 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 118.553 0.615 . . . . 0.0 112.296 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.89 101.18 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.776 2.317 . . . . 0.0 108.323 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 71.0 mt -81.27 -12.28 59.13 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 67.47 -154.04 52.93 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 120.168 1.349 . . . . 0.0 110.313 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.89 170.24 10.05 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.423 1.089 . . . . 0.0 112.639 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 18.7 m -133.64 155.84 40.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.45 1.5 . . . . 0.0 109.003 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.08 -24.37 59.48 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.659 -0.651 . . . . 0.0 109.378 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.552 HD21 HD22 ' A' ' 285' ' ' LEU . 4.4 mm? -66.48 102.61 0.91 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 127.57 2.348 . . . . 0.0 110.893 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -58.76 -24.13 61.19 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.2 p -64.69 -53.36 48.54 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 120.437 -1.414 . . . . 0.0 111.16 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -86.62 -19.68 28.97 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -62.12 -36.85 83.01 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.22 -10.44 23.42 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.127 0.876 . . . . 0.0 111.672 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -97.02 -45.31 6.63 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.424 1.49 . . . . 0.0 109.049 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 27.5 mt -67.51 -41.83 83.79 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.566 1.146 . . . . 0.0 109.043 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.55 0.87 0.42 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.633 1.973 . . . . 0.0 114.256 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -67.09 -18.44 65.32 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 120.244 1.384 . . . . 0.0 110.631 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -117.57 141.03 28.23 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.52 1.128 . . . . 0.0 109.486 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.97 -16.67 46.81 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.583 2.856 . . . . 0.0 116.462 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.44 -23.95 64.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 121.201 1.819 . . . . 0.0 109.581 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.2 mp -86.46 -65.43 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.01 -52.03 15.79 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.21 -22.17 66.84 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.699 -1.251 . . . . 0.0 114.088 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 41.0 m -85.11 -31.0 23.57 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.739 1.215 . . . . 0.0 108.069 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.8 tpt -71.26 -38.56 71.87 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.41 -29.93 68.1 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.539 1.136 . . . . 0.0 110.004 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -65.93 -42.56 89.93 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.278 0.631 . . . . 0.0 110.941 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.365 0 CA-C-N 118.148 0.431 . . . . 0.0 110.085 179.021 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 CA--C 1.54 0.804 0 CA-C-O 121.683 0.618 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.71 61.34 4.34 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.035 1.334 . . . . 0.0 108.526 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 44.8 pt -126.3 147.24 59.13 Favored Pre-proline 0 CA--C 1.535 0.387 0 O-C-N 121.093 -1.004 . . . . 0.0 111.288 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.36 -19.16 67.6 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.263 2.642 . . . . 0.0 114.354 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 169' ' ' PHE . 4.2 mp0 -66.95 -22.84 65.92 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.66 -0.65 . . . . 0.0 110.298 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 97.6 mmm -64.85 -27.6 68.98 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.757 0.708 . . . . 0.0 110.387 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 7.4 t -56.73 -52.22 65.83 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.561 1.144 . . . . 0.0 108.103 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.19 68.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.316 -0.849 . . . . 0.0 110.781 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -48.31 -57.7 5.63 Favored 'General case' 0 CA--C 1.524 -0.055 0 C-N-CA 123.788 0.835 . . . . 0.0 112.574 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -62.19 -50.04 73.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -61.34 -39.84 92.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.18 -57.65 6.33 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.428 1.091 . . . . 0.0 109.922 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.65 -42.97 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.816 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -53.66 -53.51 50.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.038 1.29 . . . . 0.0 108.419 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 18.8 m -60.22 -42.56 95.45 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.829 0.452 . . . . 0.0 110.833 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.11 94.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.244 0.929 . . . . 0.0 111.638 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.75 -49.81 83.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 123.7 0.8 . . . . 0.0 109.112 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.1 mm -65.84 -38.4 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.9 0.773 . . . . 0.0 109.034 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -57.77 -49.25 77.21 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.178 -0.951 . . . . 0.0 109.979 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.24 -50.58 60.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.814 0.845 . . . . 0.0 111.936 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.18 70.71 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.165 1.386 . . . . 0.0 114.235 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 49.4 m -97.71 3.12 50.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.641 0.777 . . . . 0.0 110.284 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.51 11.26 68.17 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 121.168 -0.958 . . . . 0.0 114.577 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 31.8 ttm-85 -68.13 -27.95 66.9 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 118.128 0.964 . . . . 0.0 110.014 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -149.55 156.13 41.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.8 m -71.11 155.84 40.3 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 80.0 t -52.57 -54.14 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.575 1.15 . . . . 0.0 109.346 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.71 -47.64 73.49 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.741 1.616 . . . . 0.0 112.127 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -71.6 -34.83 70.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.38 98.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 9.9 mt -72.11 -41.68 66.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.766 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -53.52 -46.18 70.01 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.724 0.81 . . . . 0.0 110.634 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.55 -48.06 83.13 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.567 1.547 . . . . 0.0 111.793 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.65 80.2 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.823 2.049 . . . . 0.0 111.959 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.68 -36.26 61.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.518 0.599 . . . . 0.0 110.898 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.83 -44.79 84.53 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.046 0.385 . . . . 0.0 111.322 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -61.02 -25.36 66.85 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.365 -0.835 . . . . 0.0 112.591 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 48.8 mt -90.46 -21.65 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.627 1.571 . . . . 0.0 113.683 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . 0.331 1.6 t -116.66 5.84 13.27 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.339 0.972 . . . . 0.0 111.731 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? . . . . . 0 C--O 1.247 0.939 0 C-N-CA 126.667 1.987 . . . . 0.0 110.312 178.593 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.78 -173.36 2.7 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.896 0.878 . . . . 0.0 109.463 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.1 27.22 68.56 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.429 -0.794 . . . . 0.0 114.184 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -144.68 168.08 21.02 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.596 1.198 . . . . 0.0 112.44 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.2 mt -151.65 149.12 28.77 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 129.516 3.127 . . . . 0.0 107.221 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -145.13 146.16 20.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 124.72 1.208 . . . . 0.0 108.627 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.1 mt -136.0 139.8 45.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 126.155 1.782 . . . . 0.0 107.958 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -123.91 155.07 38.78 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.2 mp -135.94 136.79 49.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 125.53 1.532 . . . . 0.0 109.799 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -78.4 -50.35 11.87 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.709 0.804 . . . . 0.0 108.872 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.52 177.85 39.28 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.258 1.408 . . . . 0.0 109.779 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 64.23 -1.23 0.74 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.402 2.281 . . . . 0.0 115.448 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -85.97 170.98 11.79 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.473 -1.392 . . . . 0.0 112.862 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.17 62.79 0.49 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 126.163 1.84 . . . . 0.0 109.872 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -55.68 -34.3 64.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.61 -0.709 . . . . 0.0 112.444 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -59.2 -36.76 75.96 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.854 0.752 . . . . 0.0 111.954 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.69 -39.21 10.81 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.61 -44.74 89.6 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.656 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.52 -49.38 26.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.854 0.721 . . . . 0.0 110.491 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -57.47 -31.76 66.29 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.4 -42.68 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.67 -40.96 90.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 123.729 0.681 . . . . 0.0 111.415 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -64.37 -42.41 96.2 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.79 1.295 . . . . 0.0 109.324 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -58.24 -59.66 4.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -59.28 -42.85 92.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.075 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -66.21 -27.76 68.23 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 120.776 1.625 . . . . 0.0 110.557 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.9 -28.88 55.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.421 -1.425 . . . . 0.0 110.37 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -84.39 -47.14 10.99 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.069 1.748 . . . . 0.0 111.928 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.3 p -100.39 -32.09 11.0 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.11 -12.76 68.77 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.904 -1.122 . . . . 0.0 111.36 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.9 mm -66.86 130.58 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 142.52 58.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 118.926 -0.559 . . . . 0.0 111.807 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -135.85 102.11 3.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.2 m -96.9 142.43 28.89 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.185 0.994 . . . . 0.0 108.8 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.95 129.84 58.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -137.39 164.55 28.35 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.43 1.092 . . . . 0.0 108.662 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -133.44 61.51 54.49 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.297 1.039 . . . . 0.0 109.821 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.404 ' HG2' ' HB3' ' A' ' 43' ' ' LEU . 87.4 Cg_endo -69.64 155.13 67.15 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.161 2.574 . . . . 0.0 111.64 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -100.61 -0.04 38.35 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.72 18.43 3.55 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.1 pt? -55.97 -23.95 35.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 117.829 -1.081 . . . . 0.0 113.625 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -59.7 -23.71 63.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.109 1.322 . . . . 0.0 112.491 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.38 -30.15 6.66 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.929 0.871 . . . . 0.0 109.407 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -70.43 -28.06 64.75 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.191 -0.943 . . . . 0.0 109.149 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -66.67 -60.61 6.18 Favored Pre-proline 0 CA--C 1.536 0.433 0 O-C-N 119.961 -1.712 . . . . 0.0 108.448 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.06 -25.72 80.53 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.277 1.985 . . . . 0.0 114.716 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.66 -0.63 18.59 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.278 1.031 . . . . 0.0 112.758 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.2 -36.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.85 74.19 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.73 -30.74 70.3 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.893 0.477 . . . . 0.0 110.903 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.0 m -81.43 -14.41 57.12 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.564 1.946 . . . . 0.0 110.919 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.81 56.57 2.32 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.41 -172.48 2.96 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.593 2.357 . . . . 0.0 106.382 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.72 -162.61 14.76 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 120.239 -1.538 . . . . 0.0 113.9 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.53 -179.05 3.36 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.001 3.134 . . . . 0.0 110.33 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -109.29 -24.37 11.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.409 -0.807 . . . . 0.0 112.135 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.9 mt -145.41 148.87 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 tp -132.78 141.34 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -128.97 107.32 9.52 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.875 1.67 . . . . 0.0 107.776 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -152.84 -150.71 0.35 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.945 1.248 . . . . 0.0 113.47 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.15 136.52 32.98 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.589 2.356 . . . . 0.0 110.152 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -48.66 -48.82 39.49 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.441 1.496 . . . . 0.0 112.489 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.45 -5.47 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 129.272 3.029 . . . . 0.0 113.972 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -108.84 -12.18 14.94 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.532 1.133 . . . . 0.0 109.633 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -94.34 -26.01 16.74 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 124.231 1.012 . . . . 0.0 112.304 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -49.97 -41.12 36.49 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.31 -55.79 16.79 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.949 0.785 . . . . 0.0 111.621 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -53.99 -42.48 69.08 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.55 1.14 . . . . 0.0 111.663 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.65 90.3 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 122.843 0.457 . . . . 0.0 111.086 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -44.65 96.72 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.2 m -66.87 -4.38 9.22 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.433 1.493 . . . . 0.0 113.319 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.99 6.66 88.72 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.375 0.988 . . . . 0.0 112.985 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.43 -22.87 64.58 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.6 mt -95.24 133.15 39.44 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.81 155.28 40.6 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -64.35 118.91 9.38 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.457 HG13 ' CA ' ' A' ' 105' ' ' ALA . 9.8 mm -71.58 165.33 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 122.351 1.072 . . . . 0.0 111.099 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.2 m 71.29 92.85 0.05 OUTLIER Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 129.031 2.932 . . . . 0.0 108.096 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.94 -34.54 10.49 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.463 1.442 . . . . 0.0 109.744 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.57 150.46 36.43 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.501 1.12 . . . . 0.0 109.128 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -57.27 -34.1 68.3 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.472 1.109 . . . . 0.0 112.041 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.24 -27.27 63.83 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.64 1.109 . . . . 0.0 111.898 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.31 -36.64 84.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.277 0.944 . . . . 0.0 109.008 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -59.29 -38.36 79.99 Favored 'General case' 0 C--N 1.343 0.284 0 O-C-N 121.044 -1.035 . . . . 0.0 112.707 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -65.67 -17.8 64.87 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.567 0.747 . . . . 0.0 111.6 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.14 -10.25 58.75 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.424 HD13 ' CE2' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -126.53 156.36 40.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.519 1.054 . . . . 0.0 111.962 -178.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -70.52 156.17 92.32 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.971 0.908 . . . . 0.0 110.705 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.16 -41.15 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.181 2.587 . . . . 0.0 113.821 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -63.81 -27.62 69.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.038 0.835 . . . . 0.0 110.87 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.05 -28.17 54.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.837 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.424 ' CE2' HD13 ' A' ' 89' ' ' LEU . 4.1 m95 -70.57 -39.21 74.04 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 118.717 0.69 . . . . 0.0 109.874 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.63 -27.57 68.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.36 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.57 -4.78 36.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.88 12.52 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.605 1.162 . . . . 0.0 111.773 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -65.74 165.27 13.0 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 122.449 1.119 . . . . 0.0 111.547 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -154.42 -171.04 3.72 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.09 1.756 . . . . 0.0 107.123 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -66.23 98.78 0.48 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.171 1.388 . . . . 0.0 109.047 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.49 -74.27 0.42 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.085 1.802 . . . . 0.0 113.433 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.52 166.62 22.31 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.766 0.827 . . . . 0.0 110.735 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mt -100.15 145.88 27.48 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.0 pt -110.19 -25.87 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.457 ' CA ' HG13 ' A' ' 79' ' ' ILE . . . -154.29 171.97 18.41 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.01 146.82 62.28 Favored Pre-proline 0 C--O 1.242 0.668 0 C-N-CA 123.529 0.732 . . . . 0.0 110.106 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.3 149.01 44.59 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.885 2.39 . . . . 0.0 110.09 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.5 mm -138.73 -52.06 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.835 2.054 . . . . 0.0 109.421 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.51 150.91 46.99 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.594 1.158 . . . . 0.0 112.671 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.3 t -126.12 118.36 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.436 1.894 . . . . 0.0 107.723 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 C--O 1.236 0.354 0 C-N-CA 124.371 1.068 . . . . 0.0 108.411 179.651 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.237 0.436 0 C-N-CA 126.559 1.944 . . . . 0.0 109.46 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.457 -0.619 0 CA-C-O 121.497 0.54 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -126.74 -31.88 2.64 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.827 0.851 . . . . 0.0 111.212 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.68 154.81 14.02 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.582 1.083 . . . . 0.0 109.783 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -61.79 -22.61 65.59 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 121.232 -0.917 . . . . 0.0 110.936 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -71.39 -12.41 61.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.567 1.076 . . . . 0.0 111.07 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -108.73 -17.02 14.05 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.973 2.509 . . . . 0.0 111.817 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.2 mm -58.66 -63.01 4.58 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 121.161 -0.962 . . . . 0.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.63 -18.76 37.45 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.773 1.649 . . . . 0.0 111.745 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.71 -49.61 57.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.514 1.126 . . . . 0.0 108.52 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.8 tp -72.1 -30.59 65.23 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.794 0.838 . . . . 0.0 109.781 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.38 -48.02 72.01 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.761 0.824 . . . . 0.0 111.645 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -70.17 -31.12 68.45 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.465 0.306 . . . . 0.0 111.069 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -67.83 -45.05 75.76 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.7 mt -71.32 -30.28 66.03 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.243 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -67.8 -34.51 76.89 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 119.79 1.177 . . . . 0.0 108.14 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.43 -7.69 27.21 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.323 1.049 . . . . 0.0 111.965 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 6.12 3.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.312 1.445 . . . . 0.0 111.614 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.0 -76.42 0.1 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.02 176.09 12.97 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.45 1.1 . . . . 0.0 110.175 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.65 165.1 8.66 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.902 0.858 . . . . 0.0 111.561 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -84.85 -70.09 0.6 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.289 1.436 . . . . 0.0 111.3 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.2 tp -103.22 157.72 16.81 Favored 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 125.893 1.677 . . . . 0.0 113.334 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 92.4 mtp -150.06 118.69 6.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.466 2.306 . . . . 0.0 106.093 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -142.13 155.23 45.32 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.803 0.729 . . . . 0.0 109.281 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -68.06 96.53 0.62 Allowed 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.338 -0.851 . . . . 0.0 111.79 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.51 -10.67 58.18 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.239 1.016 . . . . 0.0 110.806 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -75.79 -29.78 58.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.566 -0.73 . . . . 0.0 112.099 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -99.55 133.0 22.2 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 119.485 1.039 . . . . 0.0 109.491 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.41 -5.39 14.97 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.68 2.92 . . . . 0.0 113.719 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -66.84 -37.62 84.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.524 1.13 . . . . 0.0 110.506 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -75.74 -46.12 32.7 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 122.034 -0.416 . . . . 0.0 112.084 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.9 p -73.96 -17.2 61.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -53.68 -61.28 5.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.69 -3.8 10.98 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.324 2.016 . . . . 0.0 114.111 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.99 -59.24 2.28 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 30.5 pt -61.84 -49.41 84.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 116.977 -1.487 . . . . 0.0 111.708 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -49.36 -8.88 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.277 2.631 . . . . 0.0 115.236 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.75 85.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.399 1.08 . . . . 0.0 111.221 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -67.87 -50.13 58.14 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 177.8 11.96 0.02 OUTLIER Glycine 0 CA--C 1.534 1.265 0 O-C-N 121.251 -0.905 . . . . 0.0 115.154 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.77 131.35 10.43 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 125.869 1.699 . . . . 0.0 111.026 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -146.76 143.32 28.59 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.55 -45.73 13.21 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.23 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -148.69 126.94 12.15 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -76.01 145.88 39.9 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.859 0.754 . . . . 0.0 111.219 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -140.46 116.27 10.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -91.75 -174.81 3.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.347 1.059 . . . . 0.0 108.306 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -56.51 -9.22 0.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.513 1.925 . . . . 0.0 115.185 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -178.9 13.41 0.03 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.208 1.861 . . . . 0.0 112.85 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -132.52 106.2 7.7 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.955 1.378 . . . . 0.0 110.47 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -104.09 125.8 50.71 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.62 110.66 8.28 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -8.61 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.058 0.543 . . . . 0.0 112.446 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -77.53 -31.19 53.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.568 1.147 . . . . 0.0 110.544 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -84.18 87.71 7.18 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 74.7 t -104.57 152.82 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.884 1.674 . . . . 0.0 108.86 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -145.25 24.83 1.88 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.881 1.229 . . . . 0.0 113.766 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.09 -22.56 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 120.796 -1.414 . . . . 0.0 113.013 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -106.27 5.93 30.21 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.125 1.77 . . . . 0.0 111.807 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -59.82 157.13 12.82 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.584 -0.698 . . . . 0.0 110.38 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.92 -34.43 55.21 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.193 0.997 . . . . 0.0 110.755 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.99 -33.01 65.68 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.9 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.45 -49.87 61.74 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.579 1.69 . . . . 0.0 107.743 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -61.85 -41.05 97.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.068 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.1 -46.6 89.93 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.054 0.942 . . . . 0.0 110.216 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.72 -36.72 93.7 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 31.5 tp -75.02 -49.36 20.08 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.998 0.919 . . . . 0.0 113.164 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.7 t -52.95 -33.7 52.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.123 0.969 . . . . 0.0 112.993 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -58.93 -51.91 68.02 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.234 1.379 . . . . 0.0 109.466 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.0 tt -64.57 -46.38 83.02 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.308 1.043 . . . . 0.0 110.264 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.61 -34.45 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 123.751 0.82 . . . . 0.0 110.695 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.674 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.3 OUTLIER -63.57 -33.46 75.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.017 0.826 . . . . 0.0 111.876 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 13.8 mt -71.65 -43.92 65.23 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 44.6 mt -60.18 -41.47 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.674 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.7 OUTLIER -55.83 -30.48 61.48 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.995 -1.066 . . . . 0.0 110.346 178.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -93.3 -5.3 50.03 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.367 1.467 . . . . 0.0 112.093 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? 58.13 18.19 5.09 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.918 2.487 . . . . 0.0 113.891 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -91.2 -13.3 33.1 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 9.1 tpt -92.86 167.13 12.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.934 0.788 . . . . 0.0 111.496 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -76.25 42.69 0.27 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.906 2.882 . . . . 0.0 109.424 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.18 -33.41 75.42 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 126.059 1.744 . . . . 0.0 115.22 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.34 -9.22 57.9 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.487 1.115 . . . . 0.0 112.685 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.3 m -78.17 131.4 37.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.165 1.386 . . . . 0.0 111.036 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -119.04 179.39 4.18 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.411 1.884 . . . . 0.0 107.821 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -52.69 -46.69 67.4 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.816 0.846 . . . . 0.0 113.082 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 54.0 m -63.31 -36.94 85.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.571 0.749 . . . . 0.0 110.785 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 28.0 mm -68.64 -49.94 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 117.78 -1.105 . . . . 0.0 108.512 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.33 -47.82 82.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.999 1.272 . . . . 0.0 111.938 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -56.62 -48.62 77.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.843 0.457 . . . . 0.0 110.164 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.96 -52.39 56.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.55 0.74 . . . . 0.0 110.744 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.71 -43.12 68.76 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.841 1.657 . . . . 0.0 110.75 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -60.41 -39.5 87.58 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.23 -43.84 97.92 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -69.31 -12.09 61.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.915 1.286 . . . . 0.0 112.704 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.69 13.31 70.23 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 120.193 1.36 . . . . 0.0 111.613 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -74.51 -9.06 58.21 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 116.609 2.078 . . . . 0.0 116.609 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.03 157.04 47.96 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 120.345 1.43 . . . . 0.0 110.543 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.41 -35.12 14.56 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.217 1.007 . . . . 0.0 110.368 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -145.05 145.66 31.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.41 1.084 . . . . 0.0 110.369 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.06 155.48 47.02 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 78.2 mt . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.306 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.37 156.13 37.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.273 2.649 . . . . 0.0 110.782 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 255' ' ' SER . 75.3 p -99.48 176.11 5.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.682 1.193 . . . . 0.0 108.722 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -107.79 159.25 16.64 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -55.15 103.52 0.09 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.815 0.846 . . . . 0.0 111.936 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.58 -5.65 63.89 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-O 118.176 -1.347 . . . . 0.0 113.223 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.84 108.32 32.92 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 120.206 2.003 . . . . 0.0 110.48 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.17 131.79 31.72 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.643 1.562 . . . . 0.0 109.334 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.473 ' H ' HG22 ' A' ' 249' ' ' THR . 10.1 p -64.13 160.1 19.03 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.39 1.076 . . . . 0.0 109.928 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -132.75 71.68 78.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 118.348 0.522 . . . . 0.0 110.596 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.43 156.64 65.33 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.831 2.354 . . . . 0.0 111.46 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 . . . . . 0 C--O 1.238 0.48 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.41 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.828 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 11.4 m -144.69 157.15 14.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 118.561 1.181 . . . . 0.0 109.779 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.75 147.69 52.98 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.198 0.999 . . . . 0.0 108.322 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -133.01 127.31 33.85 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.606 1.094 . . . . 0.0 109.277 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -110.26 138.77 46.19 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.344 1.858 . . . . 0.0 106.959 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -145.5 141.06 9.46 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.221 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 67.4 mt -78.48 137.8 21.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -72.65 129.26 37.85 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.43 -15.93 60.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -67.19 -40.7 86.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.095 -0.955 . . . . 0.0 113.071 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.9 m -47.41 148.85 2.14 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 125.048 1.339 . . . . 0.0 113.78 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.96 -56.02 0.23 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.479 2.119 . . . . 0.0 112.479 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -113.7 102.4 10.22 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.176 1.353 . . . . 0.0 110.392 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.63 -16.82 63.45 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 122.024 -0.423 . . . . 0.0 111.794 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -64.62 -38.08 89.77 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.969 0.907 . . . . 0.0 110.017 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.74 -39.69 81.66 Favored 'General case' 0 N--CA 1.461 0.102 0 O-C-N 121.627 -0.67 . . . . 0.0 110.504 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.89 -44.8 68.99 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -32.53 72.31 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.314 -0.85 . . . . 0.0 111.348 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -74.26 -44.75 51.66 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -58.84 -39.31 80.9 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.57 -48.06 76.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.845 -0.597 . . . . 0.0 111.107 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -79.34 -18.61 52.17 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -107.07 -16.79 14.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.645 1.111 . . . . 0.0 113.932 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -136.82 -40.04 0.62 Allowed 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.235 0.925 . . . . 0.0 113.459 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.65 -36.98 65.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.262 0.937 . . . . 0.0 111.076 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.407 HD22 HD21 ' A' ' 304' ' ' LEU . 30.5 mt -107.65 63.45 0.62 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.36 1.464 . . . . 0.0 111.79 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 23.5 p -134.15 155.2 50.53 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.35 -37.8 88.68 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.93 -31.87 61.62 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -75.78 -45.81 16.02 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 65.2 mt -61.66 -43.17 99.36 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.805 0.842 . . . . 0.0 109.598 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -56.67 -41.51 77.41 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.882 0.738 . . . . 0.0 110.249 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.5 93.0 Favored 'General case' 0 C--N 1.343 0.292 0 O-C-N 121.246 -0.909 . . . . 0.0 112.463 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 4.5 t -67.14 -41.82 87.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -65.27 -27.72 68.84 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.705 0.764 . . . . 0.0 112.51 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -70.86 -35.49 72.41 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 117.232 -1.366 . . . . 0.0 109.707 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.61 -45.4 21.69 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.595 1.543 . . . . 0.0 111.791 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -138.33 152.3 71.15 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.757 1.223 . . . . 0.0 108.851 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.65 123.43 10.13 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.556 1.504 . . . . 0.0 109.641 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 20.8 mt -79.21 -30.05 43.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 119.016 -0.516 . . . . 0.0 109.703 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.4 -155.64 22.91 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 106.098 -2.801 . . . . 0.0 106.098 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -75.43 171.58 14.0 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.29 157.01 30.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 123.58 1.657 . . . . 0.0 114.163 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.76 -17.32 59.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.852 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.407 HD21 HD22 ' A' ' 285' ' ' LEU . 4.4 mm? -71.04 104.76 3.1 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 125.672 1.589 . . . . 0.0 109.146 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -57.48 -29.17 64.03 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 20.5 t -63.37 -66.58 0.52 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.686 1.994 . . . . 0.0 110.304 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.93 -17.5 60.55 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -63.96 -32.29 73.78 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -70.15 -11.35 60.83 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.34 -0.85 . . . . 0.0 111.19 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -98.18 -49.15 4.83 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.97 2.108 . . . . 0.0 108.991 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 64.6 mt -69.8 -31.23 69.02 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 121.865 -0.522 . . . . 0.0 110.143 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.17 -3.78 4.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.263 0.938 . . . . 0.0 112.207 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -64.07 -10.99 25.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.553 1.141 . . . . 0.0 110.88 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.23 144.13 35.62 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 126.162 1.785 . . . . 0.0 107.376 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.78 -24.89 46.48 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.344 2.696 . . . . 0.0 114.805 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 16.9 mmm-85 -62.45 -48.21 80.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.733 0.697 . . . . 0.0 109.151 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.1 mp -65.02 -50.48 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.45 -52.25 39.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 124.197 0.935 . . . . 0.0 109.736 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.8 -36.32 76.51 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.393 -0.817 . . . . 0.0 112.404 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 88.2 m -65.56 -38.52 89.81 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 49.7 tpp -76.51 -38.34 55.34 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.351 0.523 . . . . 0.0 109.818 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -58.23 -34.07 70.03 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 123.942 0.897 . . . . 0.0 109.096 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -61.8 -38.45 88.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.042 -0.411 . . . . 0.0 109.898 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.472 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo . . . . . 0 N--CA 1.454 -0.799 0 CA-C-O 122.142 0.809 . . . . 0.0 111.501 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -103.07 73.18 1.22 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.5 pt -138.55 146.23 49.93 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.734 0.813 . . . . 0.0 109.076 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.78 -18.43 53.02 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.676 2.917 . . . . 0.0 114.478 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -65.43 -17.7 64.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.522 1.129 . . . . 0.0 109.84 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 85.6 mmm -61.64 -32.5 72.66 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.313 0.645 . . . . 0.0 111.381 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 70.5 m -64.89 -45.24 86.8 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.403 1.001 . . . . 0.0 109.478 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.76 80.23 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -64.79 -51.44 62.21 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.395 1.478 . . . . 0.0 109.794 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -58.6 -45.94 88.08 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.45 1.023 . . . . 0.0 110.727 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -58.91 -47.21 85.79 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -56.19 -57.08 13.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.227 1.011 . . . . 0.0 113.052 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 23.5 t -62.41 -35.59 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.217 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -54.08 -50.07 67.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.73 1.605 . . . . 0.0 110.119 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 32.2 m -67.02 -40.88 87.34 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.743 -0.598 . . . . 0.0 110.516 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.77 98.99 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.578 1.081 . . . . 0.0 113.426 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.48 -46.99 95.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 33.1 mm -68.7 -37.12 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 118.544 0.611 . . . . 0.0 110.068 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -57.21 -46.94 82.44 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.245 -0.909 . . . . 0.0 108.942 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.27 -53.77 32.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.417 1.087 . . . . 0.0 110.789 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -57.61 -34.19 69.02 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.469 1.508 . . . . 0.0 114.372 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 52.1 m -97.39 0.48 47.89 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.1 0.56 . . . . 0.0 111.173 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 67.89 12.33 62.17 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.93 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -62.98 -31.49 72.63 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.557 1.179 . . . . 0.0 108.481 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -147.18 152.95 39.24 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 7.5 m -61.52 153.13 28.31 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.283 1.433 . . . . 0.0 108.674 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 11.1 t -58.81 -45.72 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 119.435 1.016 . . . . 0.0 108.386 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.26 -48.56 76.31 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.168 1.387 . . . . 0.0 111.28 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -68.42 -44.92 73.96 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.879 1.271 . . . . 0.0 111.988 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.24 -44.04 83.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.308 0.643 . . . . 0.0 110.58 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.3 mp -70.17 -39.97 74.98 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.555 0.742 . . . . 0.0 110.602 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -57.37 -47.55 81.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.1 -54.29 45.03 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.517 1.527 . . . . 0.0 108.206 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -54.33 -50.82 66.52 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.411 1.485 . . . . 0.0 112.902 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -54.71 -39.68 68.44 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 5.6 m -69.78 -22.98 63.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.162 0.585 . . . . 0.0 111.565 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -78.41 -4.74 49.81 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 120.139 -1.6 . . . . 0.0 112.135 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 5.2 mt -112.68 -29.19 2.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 124.063 0.945 . . . . 0.0 110.252 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 20.4 p -75.7 -23.95 56.2 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.595 1.089 . . . . 0.0 110.445 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 CA-C-O 117.444 -1.265 . . . . 0.0 108.989 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 . . . . . 0 CA--C 1.515 -0.368 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -74.27 115.45 13.79 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 126.411 1.884 . . . . 0.0 107.715 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.63 31.86 1.42 Allowed Glycine 0 CA--C 1.532 1.1 0 N-CA-C 115.284 0.873 . . . . 0.0 115.284 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.39 169.72 20.2 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.217 -1.167 . . . . 0.0 110.829 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.6 mt -150.7 148.92 29.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.573 2.749 . . . . 0.0 105.743 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.5 t -140.7 128.72 23.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.53 HD12 HG22 ' A' ' 37' ' ' VAL . 18.7 mt -108.4 137.4 40.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 125.169 1.388 . . . . 0.0 107.501 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -135.57 129.48 33.03 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.333 1.853 . . . . 0.0 106.364 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -149.05 163.94 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 126.533 1.933 . . . . 0.0 108.106 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -78.55 170.92 15.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.817 0.847 . . . . 0.0 111.727 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.14 -43.24 73.71 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 127.217 2.342 . . . . 0.0 117.006 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -68.51 -13.37 62.28 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.342 1.071 . . . . 0.0 112.631 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -70.63 160.23 32.95 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 123.563 1.649 . . . . 0.0 113.132 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.39 60.09 4.75 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 106.306 -2.718 . . . . 0.0 106.306 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -60.11 -46.69 88.76 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 124.448 1.099 . . . . 0.0 109.693 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -61.82 -49.61 75.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.3 94.79 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.6 tp -68.99 -34.68 75.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.142 0.977 . . . . 0.0 110.972 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.68 74.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.352 -0.833 . . . . 0.0 109.602 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -58.72 -34.35 71.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.381 1.072 . . . . 0.0 111.946 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 t -76.8 -45.12 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.455 1.502 . . . . 0.0 108.291 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.58 -46.83 93.48 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 124.104 0.859 . . . . 0.0 112.222 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -37.22 84.91 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 117.886 -1.054 . . . . 0.0 108.72 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -61.33 -54.27 46.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -53.73 -46.23 70.76 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.552 0.614 . . . . 0.0 110.668 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -65.34 -32.26 73.82 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.044 -1.035 . . . . 0.0 111.0 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -71.93 -28.52 63.53 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.986 0.914 . . . . 0.0 110.879 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -95.98 -16.05 21.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.667 1.187 . . . . 0.0 111.97 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -126.33 -27.87 3.15 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.25 -14.49 63.54 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 120.866 -1.146 . . . . 0.0 113.654 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 mm -70.67 130.58 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 120.078 1.939 . . . . 0.0 106.81 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.432 ' H ' ' HE2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -58.11 145.28 37.28 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.82 87.65 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.505 1.122 . . . . 0.0 109.215 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 m -78.35 136.44 37.69 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.53 HG22 HD12 ' A' ' 9' ' ' ILE . 25.5 t -130.26 119.88 47.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -133.34 164.17 27.69 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.016 1.326 . . . . 0.0 107.838 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -120.26 62.15 8.6 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.661 1.585 . . . . 0.0 110.8 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.18 152.13 81.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.915 1.743 . . . . 0.0 110.662 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -120.42 19.84 11.98 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.683 1.593 . . . . 0.0 109.628 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.45 12.64 0.73 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.292 2.237 . . . . 0.0 112.683 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.2 pt? -56.48 -27.93 58.36 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 120.315 -1.49 . . . . 0.0 112.921 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -59.07 -20.03 49.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.29 1.436 . . . . 0.0 113.532 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -120.36 -18.02 8.04 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.756 -0.59 . . . . 0.0 110.948 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -46.7 15.43 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.491 1.116 . . . . 0.0 110.917 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -46.32 -57.38 8.59 Favored Pre-proline 0 N--CA 1.468 0.444 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.628 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.15 -18.9 64.58 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.778 1.652 . . . . 0.0 114.592 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -89.07 -8.68 53.42 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 119.995 1.27 . . . . 0.0 112.987 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.1 -36.01 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 119.191 0.905 . . . . 0.0 111.105 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -28.18 67.99 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.044 -1.035 . . . . 0.0 109.848 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.75 -5.58 4.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.581 1.152 . . . . 0.0 113.248 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.0 t -131.33 7.57 4.58 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.742 2.017 . . . . 0.0 109.585 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.37 5.6 72.89 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 119.955 -1.716 . . . . 0.0 114.881 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.53 -2.48 57.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.216 1.008 . . . . 0.0 110.103 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.55 -172.28 48.38 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.401 1.953 . . . . 0.0 115.778 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -69.82 173.92 10.31 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.188 3.259 . . . . 0.0 111.907 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -108.36 -18.4 13.76 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -141.45 145.37 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.907 1.283 . . . . 0.0 107.664 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 tt -137.06 141.19 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.701 1.6 . . . . 0.0 107.408 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -130.32 113.36 14.28 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.086 1.355 . . . . 0.0 109.608 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -157.68 171.11 20.91 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.722 0.809 . . . . 0.0 109.257 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.42 162.21 25.96 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -52.25 -25.51 9.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.327 1.451 . . . . 0.0 112.2 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -50.22 -65.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.96 1.704 . . . . 0.0 113.64 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -69.55 -18.93 63.69 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 122.151 -0.343 . . . . 0.0 110.291 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -78.03 -20.96 51.46 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.65 -5.05 7.88 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 117.836 -1.535 . . . . 0.0 112.939 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.74 -17.91 0.55 Allowed Glycine 0 CA--C 1.535 1.331 0 CA-C-O 117.26 -1.855 . . . . 0.0 115.816 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -65.09 -33.89 77.11 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.027 2.414 . . . . 0.0 112.865 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.94 -36.39 75.25 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 119.411 1.005 . . . . 0.0 108.316 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -48.04 79.77 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.8 m -65.61 -5.39 8.14 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.128 1.771 . . . . 0.0 112.856 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.29 16.95 79.99 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 126.761 2.124 . . . . 0.0 113.048 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.5 mt -87.63 -18.11 30.35 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.5 mt -96.93 135.44 38.91 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.962 0.801 . . . . 0.0 109.21 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -81.68 161.32 23.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.274 1.029 . . . . 0.0 111.314 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -68.34 105.46 2.16 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.593 1.157 . . . . 0.0 108.058 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.83 163.67 2.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 118.753 0.706 . . . . 0.0 111.034 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.4 m 114.77 91.21 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.525 1 C-N-CA 132.668 4.387 . . . . 0.0 108.788 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.87 -54.51 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.436 2.091 . . . . 0.0 109.106 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -148.23 152.58 37.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.175 1.79 . . . . 0.0 106.83 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -62.31 -33.76 75.29 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 118.99 -0.529 . . . . 0.0 111.084 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.05 -28.5 52.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.371 0.987 . . . . 0.0 112.306 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -68.93 -30.61 69.1 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.652 0.66 . . . . 0.0 109.989 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -69.1 -41.64 77.18 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.584 1.084 . . . . 0.0 110.707 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.07 -28.37 69.03 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.969 0.908 . . . . 0.0 111.716 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -69.03 -7.71 38.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.85 0.86 . . . . 0.0 112.952 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -117.93 149.58 40.65 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.692 1.133 . . . . 0.0 113.417 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -63.54 150.64 89.76 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.582 0.753 . . . . 0.0 110.33 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.54 -43.63 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.657 2.238 . . . . 0.0 112.95 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -61.52 -42.08 98.28 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 121.809 -0.557 . . . . 0.0 110.973 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.69 -28.93 68.1 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -49.16 66.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.84 0.856 . . . . 0.0 109.592 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -16.72 51.43 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.9 -41.83 82.11 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.755 0.707 . . . . 0.0 109.964 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.5 m -86.08 -15.38 10.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.071 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -51.74 149.54 4.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.767 1.167 . . . . 0.0 113.612 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.5 -174.48 3.13 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 126.367 1.867 . . . . 0.0 107.381 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -63.32 100.74 0.26 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.313 0.645 . . . . 0.0 109.323 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.27 -83.04 0.25 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 124.83 1.205 . . . . 0.0 111.05 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.2 173.84 2.32 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.691 1.196 . . . . 0.0 111.661 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.4 mt -106.54 169.83 8.29 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.216 1.007 . . . . 0.0 111.358 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.7 pt -143.48 -28.18 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.03 1.732 . . . . 0.0 114.232 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.1 177.76 10.97 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.659 1.572 . . . . 0.0 111.167 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -122.16 145.65 44.62 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 125.057 1.343 . . . . 0.0 110.469 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.34 149.83 45.78 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.667 2.911 . . . . 0.0 108.171 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.463 HG13 ' HB2' ' A' ' 264' ' ' ALA . 29.8 mm -125.98 -44.99 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.109 1.364 . . . . 0.0 111.797 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.1 159.34 43.41 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.368 0.531 . . . . 0.0 110.992 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.4 t -122.45 116.01 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.657 1.183 . . . . 0.0 108.018 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 . . . . . 0 CA--C 1.519 -0.25 0 C-N-CA 125.255 1.422 . . . . 0.0 107.63 178.874 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 71.3 mt . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 . . . . . 0 C--O 1.241 0.644 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.39 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 N--CA 1.452 -0.954 0 N-CA-C 110.303 -0.691 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -134.98 -30.74 1.04 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.838 1.255 . . . . 0.0 112.731 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.457 ' HA ' ' H ' ' A' ' 249' ' ' THR . 14.9 t -158.96 157.73 31.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -65.43 -22.4 66.76 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.815 1.246 . . . . 0.0 112.426 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 4.1 mm-40 -69.85 -27.46 64.86 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.912 1.685 . . . . 0.0 110.469 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -89.61 -22.02 22.53 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.217 1.807 . . . . 0.0 111.983 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.6 mm -54.4 -56.02 31.11 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 117.889 -1.053 . . . . 0.0 110.355 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.85 -24.47 46.53 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 CA-C-N 120.398 1.178 . . . . 0.0 112.026 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.49 -55.4 10.35 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.5 tp -64.13 -27.23 68.94 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.529 -1.357 . . . . 0.0 110.244 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.44 -43.95 95.96 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 121.782 -0.574 . . . . 0.0 109.78 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -71.87 -27.45 62.87 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 119.116 -0.469 . . . . 0.0 111.182 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -70.69 -48.24 55.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.3 -33.46 73.21 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.501 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -67.96 -36.91 80.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.12 -27.05 69.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.863 0.756 . . . . 0.0 111.656 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.9 3.22 20.37 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.923 0.889 . . . . 0.0 112.673 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.41 -102.65 0.17 Allowed Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 118.825 0.739 . . . . 0.0 111.585 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -137.5 178.54 7.02 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.397 1.079 . . . . 0.0 110.693 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 p -54.99 157.6 3.18 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.923 1.689 . . . . 0.0 114.208 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.9 -69.14 0.73 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.644 1.578 . . . . 0.0 112.31 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.2 tp -99.2 132.64 44.37 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.029 1.332 . . . . 0.0 110.218 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.2 ttm -142.47 133.26 25.53 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -161.75 172.93 15.36 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.952 1.301 . . . . 0.0 108.954 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -69.77 92.31 0.67 Allowed 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 mt -77.12 -14.66 59.76 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.219 -0.926 . . . . 0.0 110.105 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -68.74 -31.87 71.23 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.051 -1.452 . . . . 0.0 114.742 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -104.05 154.96 37.78 Favored Pre-proline 0 C--N 1.343 0.316 0 CA-C-N 121.661 2.028 . . . . 0.0 114.147 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.16 -15.05 11.76 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.212 1.941 . . . . 0.0 114.158 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -61.04 -39.62 90.49 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.771 1.623 . . . . 0.0 111.805 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -82.28 -33.45 29.1 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -81.75 -15.84 53.0 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.242 0.928 . . . . 0.0 111.319 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -46.34 -58.21 7.02 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.04 -16.94 29.01 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.591 1.527 . . . . 0.0 115.086 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.7 tp -67.4 -62.22 1.53 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 120.262 1.392 . . . . 0.0 107.393 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 6.2 pt -68.63 -24.88 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.494 1.118 . . . . 0.0 112.649 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.62 -18.21 62.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.485 -0.759 . . . . 0.0 111.127 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -56.6 -53.84 52.95 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.655 1.182 . . . . 0.0 111.229 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -61.84 -58.19 8.92 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.26 22.37 0.03 OUTLIER Glycine 0 C--N 1.333 0.376 0 CA-C-O 118.611 -1.105 . . . . 0.0 115.126 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.29 134.11 13.36 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -137.51 140.77 41.34 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.859 1.83 . . . . 0.0 114.022 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.92 81.12 4.15 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.718 2.007 . . . . 0.0 106.992 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 67.22 164.75 0.21 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 127.166 2.186 . . . . 0.0 111.061 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -127.75 138.52 52.79 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.177 0.591 . . . . 0.0 109.51 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.58 119.66 25.19 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.604 1.962 . . . . 0.0 105.77 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -96.96 41.38 1.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.932 2.093 . . . . 0.0 111.521 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 55.33 81.21 0.12 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.743 1.217 . . . . 0.0 110.974 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 101.98 -18.62 51.82 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.728 -1.04 . . . . 0.0 113.301 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -117.54 122.75 44.52 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -131.55 115.99 16.85 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 125.733 1.613 . . . . 0.0 108.431 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -124.54 93.18 3.83 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.492 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -55.28 -7.33 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.524 1.929 . . . . 0.0 112.894 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -75.88 -30.89 59.01 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 120.898 -1.126 . . . . 0.0 109.422 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -81.9 67.84 8.05 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.121 0.968 . . . . 0.0 109.288 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 45.3 t -80.78 156.0 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.62 40.11 1.7 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-O 118.122 -1.377 . . . . 0.0 113.53 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.0 t -95.64 -27.64 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 120.029 1.914 . . . . 0.0 112.692 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -90.72 10.7 24.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.804 1.638 . . . . 0.0 109.995 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -60.31 152.2 25.69 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.808 -1.182 . . . . 0.0 109.311 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.73 -27.22 62.79 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.972 0.509 . . . . 0.0 111.7 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.98 -40.16 44.31 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 123.566 0.603 . . . . 0.0 112.286 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.1 -51.14 70.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -60.31 -42.83 96.38 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.561 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.41 -46.51 86.3 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.836 0.744 . . . . 0.0 110.943 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -72.62 -29.54 65.48 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 119.462 -0.632 . . . . 0.0 113.944 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 18.2 tp -80.21 -39.88 28.23 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.2 t -57.83 -34.16 69.39 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.85 0.75 . . . . 0.0 109.885 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -59.46 -48.12 82.86 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.58 0.627 . . . . 0.0 109.852 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.57 -45.53 88.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.362 0.665 . . . . 0.0 109.843 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.03 -29.4 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.148 0.579 . . . . 0.0 110.26 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -62.25 -39.25 92.24 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.085 -1.009 . . . . 0.0 112.387 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.5 mt -70.92 -43.47 68.16 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 55.4 mt -64.06 -39.84 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -52.27 -46.6 65.9 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.06 -1.025 . . . . 0.0 108.849 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -80.66 -0.98 40.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.093 2.157 . . . . 0.0 113.82 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.1 mptt 57.58 4.64 0.25 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.671 2.388 . . . . 0.0 115.424 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -71.57 -31.74 67.3 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.686 -0.634 . . . . 0.0 112.097 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.5 tpt -69.01 163.31 24.93 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 118.554 0.616 . . . . 0.0 109.97 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -91.34 52.18 2.05 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.51 -11.27 1.87 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.979 2.512 . . . . 0.0 115.606 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -102.81 0.23 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.679 0.791 . . . . 0.0 111.921 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 85.9 m -74.19 124.7 26.86 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.879 1.272 . . . . 0.0 110.908 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.61 177.31 4.88 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -53.14 -45.94 68.61 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.522 0.677 . . . . 0.0 112.268 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.5 m -63.88 -29.41 70.59 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.787 2.435 . . . . 0.0 112.577 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 77.0 mt -81.35 -49.11 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.77 72.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.09 -45.8 93.22 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.699 0.681 . . . . 0.0 111.205 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.15 -55.65 31.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.55 -38.15 77.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.548 0.739 . . . . 0.0 111.761 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -61.26 -46.55 89.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -64.69 -35.76 82.08 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -68.46 -18.93 64.52 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.951 -1.093 . . . . 0.0 111.735 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.88 16.89 66.69 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -86.81 -8.13 57.61 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 35.1 p -113.33 136.97 52.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.731 1.612 . . . . 0.0 106.71 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.07 -21.39 46.83 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.288 -0.883 . . . . 0.0 111.081 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -164.99 170.05 15.65 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.592 -0.692 . . . . 0.0 109.721 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 4.4 t -162.95 -178.44 6.09 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.486 1.914 . . . . 0.0 106.498 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 C--N 1.324 -0.523 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 178.829 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 C--O 1.239 0.527 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.19 150.36 87.67 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.114 1.876 . . . . 0.0 110.793 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.686 HG22 ' H ' ' A' ' 255' ' ' SER . 57.4 p -129.51 165.57 21.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.855 2.062 . . . . 0.0 110.234 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -85.29 159.86 19.96 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.136 0.88 . . . . 0.0 109.176 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -49.81 103.54 0.05 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.284 1.434 . . . . 0.0 113.287 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.17 1.52 90.49 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 117.225 -1.875 . . . . 0.0 115.279 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.26 122.19 11.54 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 121.39 2.595 . . . . 0.0 113.437 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.95 147.83 85.24 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.149 1.9 . . . . 0.0 111.374 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.686 ' H ' HG22 ' A' ' 249' ' ' THR . 48.0 t -64.13 152.41 40.63 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.804 1.241 . . . . 0.0 109.426 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -134.21 77.68 60.3 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.365 1.466 . . . . 0.0 107.693 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -82.62 -175.37 2.43 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.298 3.332 . . . . 0.0 111.437 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 123.621 0.768 . . . . 0.0 108.957 177.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.715 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 75.4 t -135.22 112.04 13.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.582 0.706 . . . . 0.0 109.448 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.91 126.82 28.89 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 12.5 m -117.32 164.56 14.64 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.215 1.006 . . . . 0.0 110.933 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.463 ' HB2' HG13 ' A' ' 108' ' ' ILE . . . -134.27 135.54 42.95 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.693 1.597 . . . . 0.0 107.495 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -127.42 166.54 20.11 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 62.6 mt -114.19 133.35 60.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.07 122.97 23.51 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -68.23 -15.07 63.43 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.197 -1.382 . . . . 0.0 114.641 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -76.63 -14.02 60.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.649 1.568 . . . . 0.0 114.373 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 36.5 m -61.98 154.24 69.48 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 123.838 0.855 . . . . 0.0 109.361 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.04 -58.5 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.967 1.778 . . . . 0.0 110.914 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -118.15 100.26 7.41 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.989 1.316 . . . . 0.0 108.254 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.408 ' HE2' ' HB1' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -59.0 -15.77 14.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.787 0.435 . . . . 0.0 112.139 178.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -59.97 -34.19 72.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.391 1.476 . . . . 0.0 110.105 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.9 mt -57.69 -44.03 85.55 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.58 -37.05 63.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.139 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -35.43 79.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.026 0.83 . . . . 0.0 109.651 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -69.97 -55.19 10.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.947 -0.549 . . . . 0.0 109.727 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -52.19 -46.51 65.6 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.049 0.841 . . . . 0.0 111.58 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.4 tt -64.63 -40.82 96.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -90.11 -3.9 57.64 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -105.96 -23.68 12.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.051 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -143.24 -36.72 0.37 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.901 1.228 . . . . 0.0 114.017 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.14 -32.7 71.26 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.105 1.321 . . . . 0.0 113.678 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.57 51.31 0.94 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.333 1.853 . . . . 0.0 110.242 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 47.7 p -120.55 163.13 18.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.26 -39.26 92.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -70.97 -41.91 70.4 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.269 0.628 . . . . 0.0 111.438 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.6 67.12 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 78.9 mt -67.62 -43.16 81.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.93 -44.5 94.3 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.2 -41.57 88.84 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.343 1.057 . . . . 0.0 113.606 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 92.9 t -76.84 -36.29 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -66.82 -36.41 82.3 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -66.96 -32.91 74.48 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.729 -0.607 . . . . 0.0 111.055 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.34 -50.49 15.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.517 1.127 . . . . 0.0 110.585 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -141.79 150.94 58.47 Favored Pre-proline 0 N--CA 1.47 0.535 0 O-C-N 121.045 -1.034 . . . . 0.0 109.299 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.01 115.77 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.202 2.602 . . . . 0.0 110.777 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 14.4 mt -84.0 -31.93 25.23 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.673 -0.642 . . . . 0.0 111.54 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 93.02 -146.91 18.34 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 106.343 -2.703 . . . . 0.0 106.343 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.66 173.28 11.5 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.01 153.34 38.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 123.193 1.473 . . . . 0.0 113.475 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.97 -30.92 62.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.914 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 58.7 tp -66.29 104.93 1.3 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.43 1.892 . . . . 0.0 107.968 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -56.66 -23.05 38.91 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.662 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 40.1 m -72.38 -61.73 1.69 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.909 0.777 . . . . 0.0 110.825 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -71.5 -19.19 62.23 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.102 0.864 . . . . 0.0 112.769 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -63.62 -31.37 72.51 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -67.95 -15.2 63.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.364 0.984 . . . . 0.0 111.264 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.46 ' HA ' ' HE3' ' A' ' 313' ' ' LYS . 29.3 mm-40 -94.71 -48.47 6.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.259 1.424 . . . . 0.0 108.264 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.453 ' HB3' HG21 ' A' ' 317' ' ' ILE . 7.2 mt -64.65 -41.25 96.25 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.36 -0.55 0.59 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 310' ' ' GLU . 90.6 mttt -67.58 -13.51 62.13 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.376 1.07 . . . . 0.0 111.835 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.0 151.21 68.6 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 119.756 1.162 . . . . 0.0 109.711 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.64 -23.8 63.28 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.095 2.53 . . . . 0.0 113.84 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -61.57 -27.99 69.02 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.661 0.664 . . . . 0.0 110.551 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 311' ' ' LEU . 4.2 mp -91.08 -52.32 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -48.09 -50.37 28.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.905 0.753 . . . . 0.0 110.679 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.25 -32.52 71.22 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 13.6 m -68.91 -41.04 78.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.492 1.042 . . . . 0.0 108.21 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.8 tpp -69.53 -41.57 75.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.843 -0.599 . . . . 0.0 109.457 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -53.35 -43.31 67.63 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -58.68 -46.66 86.75 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.36 1.064 . . . . 0.0 109.268 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 123.424 0.69 . . . . 0.0 111.433 178.531 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo . . . . . 0 N--CA 1.462 -0.339 0 N-CA-C 113.985 0.725 . . . . 0.0 113.985 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -116.4 76.25 1.01 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.607 1.563 . . . . 0.0 108.925 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.64 147.69 49.97 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.995 1.318 . . . . 0.0 110.922 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.46 -18.67 33.55 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.497 2.131 . . . . 0.0 111.799 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -72.49 -23.02 60.97 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 120.921 -1.112 . . . . 0.0 109.09 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -40.45 83.94 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.518 1.508 . . . . 0.0 109.42 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 p -69.0 -34.25 74.98 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.383 -0.823 . . . . 0.0 109.242 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -69.63 -42.64 74.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -53.84 -54.56 36.74 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 126.557 1.943 . . . . 0.0 109.849 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -60.89 -45.66 93.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.579 0.627 . . . . 0.0 110.084 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -63.15 -26.72 68.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.99 -60.87 2.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.702 1.201 . . . . 0.0 109.41 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -24.71 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.353 -0.842 . . . . 0.0 111.795 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 26.7 ttt-85 -56.71 -27.65 59.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.356 1.062 . . . . 0.0 110.788 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 1.5 m -97.79 -37.92 9.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.48 -48.3 66.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.874 0.761 . . . . 0.0 112.66 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.09 -56.88 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 37.4 mm -58.07 -36.5 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.289 0.635 . . . . 0.0 110.265 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -56.65 -48.99 76.35 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.843 -1.161 . . . . 0.0 110.094 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.42 -42.42 59.21 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.433 -0.318 . . . . 0.0 111.337 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -59.72 -37.14 78.09 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.468 0.707 . . . . 0.0 112.079 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.0 m -86.85 -7.72 57.96 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.148 0.979 . . . . 0.0 109.64 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 75.99 17.62 79.94 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 118.905 0.775 . . . . 0.0 113.018 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -73.3 -30.71 63.57 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.151 0.981 . . . . 0.0 110.699 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -150.75 166.45 30.42 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.032 0.833 . . . . 0.0 110.519 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.9 m -71.91 152.72 42.35 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.0 t -52.37 -56.19 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.455 1.102 . . . . 0.0 108.306 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.66 -44.73 77.5 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 124.777 1.231 . . . . 0.0 113.461 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -71.97 -36.49 69.85 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.649 0.659 . . . . 0.0 111.964 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.11 -35.25 80.14 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 10.7 tp -73.07 -42.48 63.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.949 1.699 . . . . 0.0 110.673 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -58.29 -52.86 63.82 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.461 1.504 . . . . 0.0 108.095 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -49.87 -56.73 9.35 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 126.283 1.833 . . . . 0.0 108.916 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.94 -48.61 80.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.934 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -57.39 -37.04 72.07 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.9 m -62.66 -43.97 97.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.407 0.683 . . . . 0.0 110.069 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 45.4 mtt-85 -57.97 -27.7 63.68 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.445 -0.784 . . . . 0.0 111.563 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.7 mt -86.12 -39.28 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.986 0.914 . . . . 0.0 110.459 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 22.4 p -70.17 -31.1 68.42 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.518 1.054 . . . . 0.0 112.434 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.541 1.537 . . . . 0.0 110.855 -178.787 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 123.353 1.549 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -71.94 107.24 4.58 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.129 1.772 . . . . 0.0 108.647 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.62 22.64 3.01 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 116.063 1.185 . . . . 0.0 116.063 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -136.43 170.91 15.27 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 119.218 1.509 . . . . 0.0 110.19 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.0 mt -148.38 152.87 37.76 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 128.695 2.798 . . . . 0.0 107.63 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.75 149.65 16.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.458 HG21 HD21 ' A' ' 20' ' ' LEU . 67.3 mt -128.82 120.69 52.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 126.893 2.077 . . . . 0.0 105.95 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -119.2 114.72 22.87 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.533 1.133 . . . . 0.0 109.124 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.7 mt -122.92 164.58 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.962 1.305 . . . . 0.0 108.074 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -84.11 4.43 30.35 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.89 175.68 49.29 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 59.51 22.42 10.99 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.234 1.017 . . . . 0.0 111.359 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -125.64 166.08 17.39 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 126.655 1.982 . . . . 0.0 108.041 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.34 47.21 2.63 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 119.062 -0.855 . . . . 0.0 114.791 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -50.83 -38.86 51.36 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.036 0.934 . . . . 0.0 113.08 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -58.57 -47.23 84.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.012 0.823 . . . . 0.0 110.303 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.96 -38.02 93.77 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.458 HD21 HG21 ' A' ' 9' ' ' ILE . 46.6 tp -68.37 -35.64 78.01 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.752 0.821 . . . . 0.0 111.164 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.26 -37.44 64.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.376 0.67 . . . . 0.0 110.23 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -67.33 -30.05 69.78 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.117 0.872 . . . . 0.0 111.963 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 t -69.26 -43.94 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.58 -41.17 94.21 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -60.21 -45.73 92.18 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -58.25 -55.04 40.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -52.19 -55.6 20.02 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 117.892 0.315 . . . . 0.0 110.927 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.93 -35.68 73.5 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.144 -0.973 . . . . 0.0 111.191 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -69.06 -28.34 66.44 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 120.931 -1.106 . . . . 0.0 111.285 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -98.53 -5.86 31.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.591 1.156 . . . . 0.0 111.519 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.1 p -134.96 -35.46 0.85 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.44 -11.5 63.28 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.356 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.9 mm -67.58 137.27 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -70.64 139.8 51.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 117.652 -1.166 . . . . 0.0 109.727 -179.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.0 t -135.18 121.12 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.5 m -114.14 145.15 42.04 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.831 2.052 . . . . 0.0 110.87 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.432 HG22 HD12 ' A' ' 9' ' ' ILE . 20.6 t -137.24 128.52 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.84 1.656 . . . . 0.0 107.319 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -140.55 160.64 39.57 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.639 0.776 . . . . 0.0 111.68 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -127.07 68.06 71.35 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.214 1.405 . . . . 0.0 112.559 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.83 168.72 20.54 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 124.812 3.675 . . . . 0.0 111.267 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -110.8 8.11 22.25 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.709 1.604 . . . . 0.0 110.758 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.67 11.79 4.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 43' ' ' LEU . 1.5 pt? -52.07 -30.74 27.22 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -63.7 -20.45 65.73 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.874 2.07 . . . . 0.0 113.438 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -117.82 -24.32 7.2 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 123.841 0.856 . . . . 0.0 109.498 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.412 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.2 mmpt? -74.76 -46.09 39.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.795 -1.097 . . . . 0.0 110.886 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -50.73 -57.44 13.42 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 120.296 1.407 . . . . 0.0 110.199 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.46 -0.19 5.54 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 121.767 1.644 . . . . 0.0 114.558 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -112.05 -0.15 15.77 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.753 1.221 . . . . 0.0 111.561 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 46' ' ' LYS . 6.4 t -130.59 -42.63 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.349 1.06 . . . . 0.0 108.657 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.33 73.73 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 120.995 -1.066 . . . . 0.0 108.759 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.01 -13.36 4.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.021 1.328 . . . . 0.0 113.266 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.2 p -118.95 -0.76 11.11 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.91 1.232 . . . . 0.0 111.445 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.31 15.15 64.91 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.33 0.967 . . . . 0.0 111.56 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -106.79 -6.01 18.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.649 1.224 . . . . 0.0 113.633 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.01 -173.56 32.34 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.896 1.236 . . . . 0.0 115.228 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -70.78 179.29 4.37 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 124.205 3.27 . . . . 0.0 111.435 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -105.57 -20.18 13.55 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 121.264 -0.898 . . . . 0.0 113.045 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 mt -140.92 149.85 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.5 tt -128.71 148.88 33.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 126.293 1.837 . . . . 0.0 106.695 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -138.87 99.3 3.75 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.752 1.221 . . . . 0.0 109.785 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -153.11 177.81 10.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.133 0.968 . . . . 0.0 111.667 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.52 134.33 53.16 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.781 1.632 . . . . 0.0 107.345 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -52.63 -27.84 18.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 129.01 2.924 . . . . 0.0 112.279 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.95 -26.4 65.95 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.427 0.691 . . . . 0.0 109.717 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -102.73 12.48 36.23 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 127.507 2.323 . . . . 0.0 110.852 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -108.02 -30.83 8.23 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.825 1.648 . . . . 0.0 111.227 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.8 -10.48 38.64 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.801 -1.0 . . . . 0.0 113.865 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.27 -47.59 3.26 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 119.928 1.864 . . . . 0.0 109.229 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -55.31 -46.74 76.26 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.709 1.604 . . . . 0.0 111.68 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.14 93.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.734 1.152 . . . . 0.0 109.673 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.91 1.09 4.81 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.972 1.709 . . . . 0.0 111.149 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -122.68 2.32 9.5 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.305 2.642 . . . . 0.0 109.511 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.62 -1.03 68.29 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 125.656 1.598 . . . . 0.0 112.401 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -69.04 -34.3 74.99 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.566 1.183 . . . . 0.0 112.848 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.5 mt -89.15 127.88 35.75 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.654 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -81.44 170.34 16.07 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.692 0.797 . . . . 0.0 112.602 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -60.11 117.31 4.97 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.508 ' HA ' HD13 ' A' ' 79' ' ' ILE . 1.4 mm -70.96 166.19 2.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 m -39.58 113.96 0.9 Allowed Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.265 1.826 . . . . 0.0 110.955 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.77 -53.32 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.434 2.756 . . . . 0.0 113.364 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -62.26 116.75 5.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.427 1.108 . . . . 0.0 111.731 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -54.33 -28.59 43.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.479 1.512 . . . . 0.0 111.971 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.82 -32.5 67.66 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.861 1.209 . . . . 0.0 112.786 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -68.98 -39.44 79.39 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -66.22 -37.73 86.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.722 1.209 . . . . 0.0 110.329 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.8 -13.4 59.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.311 1.845 . . . . 0.0 112.186 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -76.97 -9.65 58.84 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.757 -1.214 . . . . 0.0 110.591 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.9 mt -118.29 157.51 26.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.529 1.932 . . . . 0.0 108.614 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.404 ' CD1' ' HG2' ' A' ' 305' ' ' LYS . 48.9 m-85 -64.93 152.71 90.28 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 119.118 0.872 . . . . 0.0 109.497 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.53 -35.72 9.94 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.763 2.308 . . . . 0.0 114.531 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -64.18 -32.82 74.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.863 0.756 . . . . 0.0 110.902 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.77 -21.77 66.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.301 1.04 . . . . 0.0 110.401 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -77.43 -32.77 54.82 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.413 -0.804 . . . . 0.0 109.827 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.81 -4.03 3.97 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.493 1.517 . . . . 0.0 111.083 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.62 -7.0 22.16 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.032 2.133 . . . . 0.0 111.995 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.48 11.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.997 1.319 . . . . 0.0 113.179 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -69.32 169.44 12.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 122.43 1.109 . . . . 0.0 112.15 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -159.7 168.1 26.77 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 127.868 2.467 . . . . 0.0 105.469 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -60.95 108.02 0.8 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.876 1.67 . . . . 0.0 111.091 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.34 -83.39 0.87 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.62 1.105 . . . . 0.0 111.366 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.1 173.43 6.58 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.84 0.856 . . . . 0.0 111.788 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 103' ' ' LEU . 3.4 mm? -109.2 157.46 18.77 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.9 pt -119.53 -26.23 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.706 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.39 178.16 8.9 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.195 0.998 . . . . 0.0 109.177 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.473 ' CE2' HD12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -129.63 148.66 70.32 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.75 0.82 . . . . 0.0 109.864 178.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.71 142.24 43.26 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.569 2.846 . . . . 0.0 108.917 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.0 mm -129.9 -49.09 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 124.656 1.182 . . . . 0.0 111.422 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 262' ' ' LEU . . . -122.01 147.08 46.52 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.033 0.833 . . . . 0.0 109.614 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.24 104.82 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 N--CA 1.447 -0.612 0 N-CA-C 102.005 -3.331 . . . . 0.0 102.005 177.659 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 CA--C 1.53 0.197 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.0 p90 . . . . . 0 C--N 1.325 -0.494 0 C-N-CA 125.483 1.513 . . . . 0.0 108.127 -179.824 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.453 -0.853 0 N-CA-C 107.575 -1.74 . . . . 0.0 107.575 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -113.57 -10.07 13.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.047 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.7 t -153.86 157.35 39.16 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.15 1.341 . . . . 0.0 110.98 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -72.98 -24.73 60.81 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.675 -0.641 . . . . 0.0 111.261 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -70.92 -17.04 62.7 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.0 0.818 . . . . 0.0 109.956 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -86.99 -24.34 24.72 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 125.513 1.525 . . . . 0.0 110.243 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 33.7 mm -52.69 -58.97 9.88 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.894 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.77 -22.32 27.61 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 CA-C-N 120.253 1.126 . . . . 0.0 112.164 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.99 -31.05 62.8 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.271 1.428 . . . . 0.0 111.834 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.6 tp -91.89 -31.37 15.7 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.184 1.393 . . . . 0.0 110.134 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -58.57 -44.17 89.64 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.671 0.748 . . . . 0.0 110.675 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -65.17 -30.38 71.28 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.967 0.907 . . . . 0.0 112.316 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -77.43 -42.35 36.41 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 20.3 mt -72.58 -31.67 65.39 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.534 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.89 -34.88 79.14 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.81 -13.02 61.89 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.02 -5.4 8.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.052 0.941 . . . . 0.0 112.471 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -173.31 -89.46 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 118.868 0.758 . . . . 0.0 112.885 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.42 ' HE3' ' OE2' ' A' ' 221' ' ' GLU . 62.2 mttm -146.22 -177.45 5.62 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.515 1.526 . . . . 0.0 109.082 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 p -57.78 166.97 1.25 Allowed 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.839 0.856 . . . . 0.0 111.508 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.83 -76.51 0.46 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.5 tp -90.18 133.27 35.0 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.464 1.506 . . . . 0.0 110.207 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 53.9 ttm -139.82 107.17 5.53 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.84 160.85 37.3 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.364 1.465 . . . . 0.0 109.196 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -67.93 120.09 13.64 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.106 0.962 . . . . 0.0 110.994 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.3 mt -106.97 -9.76 16.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.659 1.984 . . . . 0.0 111.909 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -77.67 -17.61 57.52 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.337 -0.852 . . . . 0.0 111.733 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -109.57 147.44 36.08 Favored Pre-proline 0 N--CA 1.469 0.486 0 C-N-CA 124.467 1.107 . . . . 0.0 109.347 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -82.07 -18.26 7.6 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.832 2.354 . . . . 0.0 114.138 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -58.94 -37.6 77.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.445 1.021 . . . . 0.0 111.974 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -71.54 -43.67 66.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.794 0.838 . . . . 0.0 112.445 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.2 p -80.9 -14.18 58.24 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.071 0.549 . . . . 0.0 112.16 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -54.99 -57.3 20.23 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.657 -1.164 . . . . 0.0 113.509 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.5 -26.38 81.81 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 121.763 1.665 . . . . 0.0 113.332 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.82 -56.02 9.33 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.4 pt -67.6 -25.71 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.144 0.884 . . . . 0.0 111.685 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.77 -4.1 25.8 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.283 -0.886 . . . . 0.0 110.912 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.6 -54.49 42.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.698 0.799 . . . . 0.0 110.534 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -55.15 -61.23 2.46 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.105 0.479 . . . . 0.0 111.121 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.26 6.41 0.03 OUTLIER Glycine 0 CA--C 1.524 0.6 0 CA-C-O 118.47 -1.183 . . . . 0.0 115.261 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -53.37 133.08 42.76 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 118.277 1.038 . . . . 0.0 112.155 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -142.66 120.41 11.89 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.131 0.967 . . . . 0.0 110.681 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.7 85.57 5.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 335' ' ' GLN . 11.0 m-85 66.54 165.84 0.2 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.6 1.56 . . . . 0.0 108.445 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -132.54 159.25 40.01 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 120.819 -1.175 . . . . 0.0 109.258 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -149.09 104.62 3.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.284 -1.746 . . . . 0.0 106.284 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.1 -174.79 0.84 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -52.5 -35.79 53.82 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.061 -1.024 . . . . 0.0 110.986 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -145.29 6.89 1.54 Allowed Glycine 0 CA--C 1.533 1.212 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.756 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -122.43 121.48 36.73 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 120.999 2.4 . . . . 0.0 109.275 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.48 123.6 50.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -146.36 83.49 1.61 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -0.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -83.5 -25.76 30.8 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 119.67 -1.894 . . . . 0.0 107.774 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -96.0 103.78 15.68 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 127.727 2.411 . . . . 0.0 106.798 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.7 t -142.95 165.12 16.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -140.63 35.71 1.84 Allowed Glycine 0 CA--C 1.533 1.163 0 N-CA-C 115.025 0.77 . . . . 0.0 115.025 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.0 t -60.11 -17.04 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 119.436 1.618 . . . . 0.0 114.617 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.273 0.0 OUTLIER -117.86 20.49 13.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.554 1.541 . . . . 0.0 111.255 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -69.71 159.04 34.25 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 120.601 -1.312 . . . . 0.0 108.176 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.34 -30.18 62.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.549 0.74 . . . . 0.0 112.422 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.23 -41.11 94.95 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.511 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.1 -52.92 56.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.918 0.487 . . . . 0.0 109.938 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -62.64 -36.93 84.41 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 117.921 -1.038 . . . . 0.0 111.656 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.57 -49.71 76.45 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.24 0.927 . . . . 0.0 110.234 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.85 -15.12 75.91 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.308 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 44.0 tp -89.12 -50.21 6.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.195 0.998 . . . . 0.0 110.996 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.6 t -55.61 -38.63 69.71 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.824 -1.084 . . . . 0.0 111.856 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -54.6 -54.52 40.26 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.173 1.351 . . . . 0.0 111.028 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 9.9 tt -62.01 -49.73 74.9 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.687 1.195 . . . . 0.0 109.563 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.26 -29.23 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.105 0.962 . . . . 0.0 110.601 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.51 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.9 OUTLIER -67.35 -37.03 82.6 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 119.043 0.838 . . . . 0.0 111.476 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.57 -39.55 88.53 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 37.3 mt -61.95 -48.61 87.77 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.51 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -51.39 -40.18 58.73 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.731 1.612 . . . . 0.0 111.567 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -84.77 2.23 43.1 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.969 1.308 . . . . 0.0 112.745 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? 48.32 46.72 20.16 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.776 2.03 . . . . 0.0 111.396 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 -2.31 9.18 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.7 ttp -114.49 153.52 29.84 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.28 49.92 0.73 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.453 1.501 . . . . 0.0 110.671 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.63 -11.37 11.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.481 2.712 . . . . 0.0 115.046 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -91.72 -13.51 31.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.979 1.711 . . . . 0.0 110.815 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.7 m -61.31 162.14 8.14 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.524 1.929 . . . . 0.0 108.562 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.77 -174.19 4.55 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -56.17 -45.63 79.63 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.865 0.466 . . . . 0.0 111.001 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.3 m -64.39 -44.21 92.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.984 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 22.5 mm -62.34 -51.9 66.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -56.26 -59.09 5.45 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.516 1.126 . . . . 0.0 111.829 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -55.7 -40.67 72.72 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.345 0.658 . . . . 0.0 111.99 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.09 -53.82 39.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.09 -35.52 71.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.548 0.739 . . . . 0.0 111.317 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.05 -48.96 74.22 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.62 -27.75 68.88 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.075 0.55 . . . . 0.0 110.131 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -76.49 -10.97 59.79 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.719 -1.238 . . . . 0.0 111.431 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.87 24.7 73.53 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.42 ' OE2' ' HE3' ' A' ' 144' ' ' LYS . 5.4 mm-40 -93.68 -30.26 15.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 69.9 p -87.77 146.68 25.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.996 0.816 . . . . 0.0 110.386 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -85.26 -31.25 23.21 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -160.03 166.71 29.45 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.44 0.564 . . . . 0.0 112.396 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 6.3 t -147.39 161.99 39.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.081 1.352 . . . . 0.0 107.889 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.9 mt . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -179.644 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.237 0.409 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.69 146.89 80.43 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.6 1.533 . . . . 0.0 109.257 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 255' ' ' SER . 20.4 p -129.32 156.24 44.33 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.181 0.992 . . . . 0.0 108.822 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -81.33 155.26 26.09 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.103 -0.998 . . . . 0.0 108.896 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.71 119.98 7.06 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.145 -0.972 . . . . 0.0 112.523 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.39 5.52 63.33 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.667 1.603 . . . . 0.0 113.982 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -148.12 115.46 4.0 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 119.907 1.854 . . . . 0.0 114.379 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.86 141.98 15.48 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.17 2.58 . . . . 0.0 112.574 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.472 ' H ' HG22 ' A' ' 249' ' ' THR . 58.8 m -59.88 140.12 56.87 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 84.17 15.01 Favored Pre-proline 0 N--CA 1.466 0.329 0 O-C-N 121.802 -0.561 . . . . 0.0 109.929 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -77.05 -175.57 2.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.762 2.308 . . . . 0.0 110.259 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 . . . . . 0 C--O 1.236 0.38 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.792 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 106.355 -2.698 . . . . 0.0 106.355 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.49 176.55 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.196 0.998 . . . . 0.0 108.365 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 5.7 tt -106.42 151.62 24.68 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.7 m -140.49 169.5 17.54 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.571 0.623 . . . . 0.0 112.18 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -132.54 137.83 47.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.835 1.654 . . . . 0.0 107.082 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.35 134.97 7.46 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.092 0.87 . . . . 0.0 111.69 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 54.2 mt -75.44 136.72 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.298 1.049 . . . . 0.0 110.431 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -71.91 123.61 23.08 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.654 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -71.22 -28.64 64.34 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.69 -0.671 . . . . 0.0 112.166 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -69.37 -8.42 46.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 59.9 m -64.61 163.15 29.34 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.267 1.027 . . . . 0.0 108.285 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -74.16 -56.58 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.653 1.569 . . . . 0.0 110.421 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -128.86 102.47 6.55 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.507 ' HE2' ' HB1' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -57.82 -17.51 16.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -59.42 -31.58 69.4 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.553 0.741 . . . . 0.0 110.721 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 98.8 mt -60.36 -43.34 96.6 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.104 -0.998 . . . . 0.0 109.777 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.38 -43.22 41.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.739 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -34.79 75.95 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.675 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -73.41 -52.75 12.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -52.55 -50.98 61.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.059 0.845 . . . . 0.0 112.826 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.6 tt -62.35 -20.12 64.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -111.88 -8.9 14.08 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -97.3 -31.95 12.15 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.937 1.244 . . . . 0.0 112.336 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -133.18 -37.86 0.97 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.048 0.84 . . . . 0.0 113.115 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.5 -25.47 67.28 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 63.3 mt -112.11 50.53 0.85 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.598 1.159 . . . . 0.0 111.2 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 50.8 p -125.37 157.89 35.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -60.49 -44.19 96.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -65.0 -38.65 91.65 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.093 0.957 . . . . 0.0 111.883 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.57 -44.84 56.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 16.2 mt -65.35 -49.87 67.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.879 0.839 . . . . 0.0 108.852 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.18 -40.26 76.98 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.824 1.25 . . . . 0.0 111.719 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.26 74.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 118.99 0.814 . . . . 0.0 112.692 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 20.5 t -79.25 -37.95 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.203 0.601 . . . . 0.0 109.846 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -63.78 -30.43 71.53 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.607 0.718 . . . . 0.0 111.904 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -64.55 -37.18 86.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.395 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.87 -42.49 39.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.43 1.013 . . . . 0.0 111.673 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.518 ' HA ' ' HE2' ' A' ' 297' ' ' LYS . 8.2 mmpt? -145.52 148.1 35.79 Favored Pre-proline 0 N--CA 1.464 0.274 0 C-N-CA 123.716 0.806 . . . . 0.0 109.361 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.6 126.95 15.54 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.378 2.052 . . . . 0.0 108.778 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 70.2 mt -102.36 -9.9 19.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 77.38 -155.97 44.4 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.46 170.59 15.39 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 23.3 m -130.32 156.71 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 121.039 -1.038 . . . . 0.0 109.569 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.14 -28.71 42.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.147 0.979 . . . . 0.0 110.96 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.19 106.91 1.78 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.471 1.109 . . . . 0.0 108.624 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.404 ' HG2' ' CD1' ' A' ' 90' ' ' TYR . 18.0 mtmt -52.89 -40.8 63.78 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.391 0.676 . . . . 0.0 112.335 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 5.1 m -53.48 -29.84 37.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.076 1.75 . . . . 0.0 112.768 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -112.75 -12.26 13.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.629 0.649 . . . . 0.0 110.196 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -64.36 -42.19 96.32 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.9 -23.37 66.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.042 0.937 . . . . 0.0 112.493 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -90.35 -44.76 9.46 Favored 'General case' 0 N--CA 1.46 0.058 0 C-N-CA 124.417 1.087 . . . . 0.0 109.014 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 6.3 mt -62.86 -35.01 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.245 -0.91 . . . . 0.0 109.888 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.02 -6.54 6.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.259 1.424 . . . . 0.0 113.242 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -68.83 -14.65 63.16 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.26 1.024 . . . . 0.0 111.377 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.93 137.51 20.12 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -14.76 37.08 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.233 2.622 . . . . 0.0 110.762 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.55 -48.05 70.92 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.186 0.994 . . . . 0.0 108.608 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.9 mp -67.97 -52.63 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.58 -49.49 26.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.92 0.888 . . . . 0.0 112.349 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.02 -11.01 2.95 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 29.6 m -98.51 -40.21 8.36 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.3 tpt -69.45 -30.17 68.03 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.837 0.455 . . . . 0.0 111.676 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -62.11 -28.5 69.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.896 -0.573 . . . . 0.0 109.81 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -61.14 -46.34 90.94 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 124.892 1.277 . . . . 0.0 110.697 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.21 0 C-N-CA 122.681 0.392 . . . . 0.0 111.486 -179.414 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.458 -0.607 0 N-CA-C 110.636 -0.563 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -77.02 56.73 1.26 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.665 1.186 . . . . 0.0 111.486 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.81 147.86 49.53 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.46 1.104 . . . . 0.0 111.422 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.48 -28.89 38.15 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.144 2.563 . . . . 0.0 110.959 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 169' ' ' PHE . 21.8 mp0 -54.23 -29.04 45.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.154 0.982 . . . . 0.0 111.81 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 5.7 mmt -62.77 -35.63 80.45 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.717 1.144 . . . . 0.0 110.729 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 8.7 t -60.8 -46.2 91.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.93 -41.61 86.73 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.423 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -56.37 -53.81 52.99 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 125.142 1.377 . . . . 0.0 109.88 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -60.16 -52.57 64.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.451 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -57.21 -38.11 73.21 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.903 0.774 . . . . 0.0 111.646 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.3 -60.71 2.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.335 1.054 . . . . 0.0 111.793 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 18.2 t -62.59 -33.0 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.377 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -34.71 70.89 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 21.4 m -80.58 -43.96 19.75 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.43 -50.83 64.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.202 1.001 . . . . 0.0 112.773 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.0 -48.99 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 123.447 0.699 . . . . 0.0 109.335 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mm -65.86 -32.79 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.909 0.777 . . . . 0.0 110.019 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -62.21 -51.11 69.11 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.822 -1.174 . . . . 0.0 109.011 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.51 -48.07 76.52 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.451 0.701 . . . . 0.0 110.602 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.37 69.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.284 1.034 . . . . 0.0 113.153 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 16.4 m -92.22 -3.33 55.69 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.591 0.757 . . . . 0.0 110.148 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 68.7 16.23 69.73 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 118.955 0.798 . . . . 0.0 111.715 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -74.74 -28.89 60.97 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.495 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -147.23 158.54 43.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.836 0.744 . . . . 0.0 109.591 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.2 m -62.71 149.9 42.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.631 1.173 . . . . 0.0 108.782 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 42.1 t -60.17 -45.71 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.83 -51.23 70.9 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 123.78 0.832 . . . . 0.0 110.097 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -66.87 -27.86 67.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.42 -38.94 91.64 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 19.5 mt -78.92 -33.99 44.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.829 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -55.18 -47.5 75.11 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.34 1.056 . . . . 0.0 108.475 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -58.32 -55.94 28.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.09 1.756 . . . . 0.0 109.265 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -55.36 -50.56 69.36 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.435 1.494 . . . . 0.0 113.533 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -37.52 73.61 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 28.3 m -66.46 -48.63 69.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 117.563 -1.208 . . . . 0.0 109.166 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -58.65 -14.58 8.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.014 1.279 . . . . 0.0 113.761 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 35.7 mt -101.51 -26.2 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.755 1.622 . . . . 0.0 110.339 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 40.1 p -101.31 8.11 42.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.011 1.324 . . . . 0.0 110.678 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? . . . . . 0 C--O 1.254 1.311 0 C-N-CA 130.347 3.459 . . . . 0.0 104.54 178.34 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.58 128.35 31.88 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.73 6.57 21.09 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 126.66 2.076 . . . . 0.0 113.958 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.32 170.91 14.83 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.765 1.626 . . . . 0.0 108.502 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -145.88 147.35 31.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.464 2.306 . . . . 0.0 105.724 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.53 143.23 39.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.6 mt -128.8 127.36 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -115.2 105.77 13.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.1 mp -71.28 155.45 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.406 HD21 HD11 ' A' ' 43' ' ' LEU . 4.8 m-80 -122.63 108.0 12.6 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.827 0.851 . . . . 0.0 112.541 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.67 24.32 7.44 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 49.65 41.78 22.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.899 1.35 . . . . 0.0 110.085 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -63.36 -178.04 0.23 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.67 1.988 . . . . 0.0 113.286 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.51 51.86 2.64 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.27 1.891 . . . . 0.0 110.74 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -60.09 -20.7 59.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.571 1.548 . . . . 0.0 112.777 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -58.7 -44.55 90.37 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.543 1.065 . . . . 0.0 111.013 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.24 -31.38 78.95 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.0 tp -71.83 -38.35 70.17 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.002 0.921 . . . . 0.0 110.819 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.98 -42.75 65.85 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.965 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -58.43 -34.12 70.45 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.953 0.797 . . . . 0.0 111.39 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -68.68 -45.09 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.658 1.583 . . . . 0.0 106.981 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.83 -37.82 95.51 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -66.12 -42.86 88.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 117.848 -1.072 . . . . 0.0 108.522 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -57.62 -56.5 21.16 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -54.89 -48.83 72.49 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.325 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.93 -31.78 72.12 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.891 0.768 . . . . 0.0 111.103 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -73.26 -27.13 61.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.818 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -97.25 -36.26 10.48 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.823 0.849 . . . . 0.0 112.816 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.3 p -102.18 -27.73 12.71 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.397 0.999 . . . . 0.0 113.245 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.82 -15.73 56.72 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.623 -1.098 . . . . 0.0 112.581 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.8 mm -69.07 133.11 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' CA ' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.69 151.57 46.24 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.716 -0.615 . . . . 0.0 111.327 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.2 t -136.68 112.06 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.9 m -102.92 123.47 46.62 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.27 115.71 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 105.933 -1.876 . . . . 0.0 105.933 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -130.7 159.47 37.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.642 0.655 . . . . 0.0 109.7 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -125.23 63.39 42.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.57 1.148 . . . . 0.0 108.888 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.87 146.49 42.41 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.494 2.129 . . . . 0.0 111.807 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -101.06 24.22 9.68 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.87 0.868 . . . . 0.0 110.185 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.67 14.09 0.84 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.586 -0.696 . . . . 0.0 112.657 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.406 HD11 HD21 ' A' ' 12' ' ' ASN . 0.8 OUTLIER -56.18 -27.98 56.49 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.472 -1.393 . . . . 0.0 112.491 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.89 -25.3 56.63 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.91 1.284 . . . . 0.0 112.4 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.61 -25.26 7.93 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.222 1.009 . . . . 0.0 109.428 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -45.8 65.08 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 120.263 -1.523 . . . . 0.0 109.878 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -49.75 -59.2 7.24 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 117.598 -1.191 . . . . 0.0 110.06 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.58 -18.83 65.71 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.135 1.89 . . . . 0.0 114.559 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -89.73 1.13 56.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.313 1.445 . . . . 0.0 113.147 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 t -131.27 -41.21 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 119.481 1.037 . . . . 0.0 108.388 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.09 -30.56 71.09 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 122.038 -0.414 . . . . 0.0 110.629 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.28 95.19 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.65 -41.18 79.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.431 0.692 . . . . 0.0 110.43 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.39 19.9 1.47 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.131 -1.372 . . . . 0.0 114.324 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -134.96 -160.72 1.08 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.896 1.678 . . . . 0.0 107.038 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.78 -160.54 13.39 Favored Glycine 0 C--N 1.339 0.729 0 O-C-N 120.078 -1.639 . . . . 0.0 114.262 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.51 -179.66 5.03 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.08 2.52 . . . . 0.0 109.8 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -111.87 -23.56 10.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 121.564 -0.71 . . . . 0.0 112.418 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.1 mt -145.51 142.72 22.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.119 0.968 . . . . 0.0 108.851 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.2 tt -127.38 142.43 43.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.531 1.532 . . . . 0.0 107.412 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.64 116.85 22.35 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.69 1.196 . . . . 0.0 109.866 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -158.59 170.61 21.78 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.676 0.79 . . . . 0.0 109.371 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.58 153.64 40.97 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -58.19 -23.0 54.06 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.85 -54.63 42.29 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.853 -1.154 . . . . 0.0 111.731 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -63.7 -22.65 67.02 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 119.255 -0.402 . . . . 0.0 110.828 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -77.76 -2.75 37.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.724 0.41 . . . . 0.0 111.205 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.95 -9.13 75.3 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 120.852 -1.155 . . . . 0.0 110.871 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.97 -42.23 0.38 Allowed Glycine 0 CA--C 1.533 1.156 0 N-CA-C 117.938 1.935 . . . . 0.0 117.938 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -46.28 -44.79 16.84 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.874 2.337 . . . . 0.0 115.403 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.02 -41.49 82.07 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 119.585 1.084 . . . . 0.0 110.078 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -28.45 69.63 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.237 -0.915 . . . . 0.0 109.82 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.5 m -77.58 -2.96 38.36 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.013 1.325 . . . . 0.0 111.29 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.13 42.74 23.34 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.4 mt -126.81 -2.1 6.61 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.7 mt -121.69 135.75 54.95 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.98 1.718 . . . . 0.0 110.944 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -81.98 162.75 22.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.295 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -75.65 104.79 6.36 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 103.555 -2.758 . . . . 0.0 103.555 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.52 168.55 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.815 1.246 . . . . 0.0 112.982 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.5 m 57.02 91.36 0.08 OUTLIER Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 127.205 2.202 . . . . 0.0 115.049 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.36 -27.81 9.12 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.177 1.918 . . . . 0.0 112.563 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -124.99 137.69 54.24 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.856 1.207 . . . . 0.0 113.012 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -58.1 -22.97 53.02 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.778 2.431 . . . . 0.0 115.766 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.67 70.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 120.188 1.358 . . . . 0.0 111.699 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -59.33 -31.56 69.28 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.477 0.711 . . . . 0.0 110.881 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -65.36 -45.02 85.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.63 0.772 . . . . 0.0 110.302 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.22 -15.53 60.17 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.302 1.041 . . . . 0.0 112.815 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -84.39 -6.41 59.38 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.239 1.016 . . . . 0.0 111.043 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mt -126.7 159.44 33.68 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.882 1.673 . . . . 0.0 108.771 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -76.99 158.19 80.51 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 121.501 -0.749 . . . . 0.0 109.215 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.83 -47.56 1.84 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.636 2.89 . . . . 0.0 113.386 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -56.71 -30.49 63.54 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.765 0.711 . . . . 0.0 111.734 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -30.8 69.42 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.275 -0.891 . . . . 0.0 110.092 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -79.23 -40.75 29.88 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.096 0.958 . . . . 0.0 110.206 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -55.72 -21.88 20.85 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.673 1.189 . . . . 0.0 112.74 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.28 3.68 55.25 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.029 2.132 . . . . 0.0 113.997 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.18 0.53 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.48 1.112 . . . . 0.0 111.336 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -68.04 155.26 39.91 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.298 -0.877 . . . . 0.0 108.685 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -136.1 169.92 16.85 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -57.83 102.6 0.1 Allowed 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.442 0.697 . . . . 0.0 111.336 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.46 -81.68 0.95 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.521 1.058 . . . . 0.0 110.911 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.66 169.69 13.86 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.904 0.852 . . . . 0.0 110.816 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.9 mt -105.06 168.92 8.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.78 1.232 . . . . 0.0 108.502 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.6 pt -138.77 -25.88 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.17 173.25 16.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.874 1.215 . . . . 0.0 109.631 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.49 149.69 74.25 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 123.659 0.784 . . . . 0.0 109.217 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.72 141.78 38.33 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.182 2.588 . . . . 0.0 109.0 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -121.55 -51.1 3.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.431 0.692 . . . . 0.0 109.331 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.51 166.85 22.23 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.085 0.402 . . . . 0.0 111.282 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -136.67 123.64 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.579 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.4 p90 . . . . . 0 C--O 1.239 0.551 0 C-N-CA 124.605 1.162 . . . . 0.0 108.754 179.48 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 N--CA 1.45 -1.03 0 N-CA-C 109.185 -1.121 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -130.66 -38.31 1.32 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.843 0.857 . . . . 0.0 109.609 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.16 150.67 47.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.802 0.335 . . . . 0.0 110.89 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -64.29 -20.52 66.13 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.994 -1.003 . . . . 0.0 111.464 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.64 -11.55 60.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.785 1.175 . . . . 0.0 110.951 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -99.02 -28.56 13.35 Favored 'General case' 0 C--O 1.222 -0.364 0 O-C-N 120.929 -1.107 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.9 mm -52.04 -56.31 22.93 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 119.657 1.117 . . . . 0.0 111.256 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -71.13 -20.12 28.92 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 CA-C-N 120.976 1.384 . . . . 0.0 112.42 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.9 -36.46 56.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.926 1.29 . . . . 0.0 110.887 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.15 -30.52 16.65 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 126.517 1.927 . . . . 0.0 112.402 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.8 -45.79 85.57 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.402 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 9.5 ptmm? -64.1 -35.66 81.5 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.581 0.752 . . . . 0.0 111.768 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.52 -43.67 69.14 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.7 mt -73.33 -30.83 63.61 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.765 -0.635 . . . . 0.0 110.182 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -67.41 -39.64 85.53 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.68 -16.23 60.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 123.764 0.665 . . . . 0.0 112.727 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.45 4.25 8.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.629 1.171 . . . . 0.0 112.208 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.84 -99.93 0.13 Allowed Glycine 0 C--N 1.337 0.629 0 CA-C-N 118.746 0.703 . . . . 0.0 114.706 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -139.5 -176.09 4.42 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.659 2.384 . . . . 0.0 109.135 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.87 163.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.73 -52.32 5.38 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.486 1.514 . . . . 0.0 109.423 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.3 tp -137.68 150.78 47.62 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 127.621 2.369 . . . . 0.0 108.244 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -156.24 128.94 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -147.88 163.79 35.68 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -67.03 110.15 3.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.121 0.963 . . . . 0.0 108.41 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.15 -13.2 22.28 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -76.79 -15.13 59.83 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -99.72 130.73 25.96 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 119.805 1.184 . . . . 0.0 111.356 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.84 -14.05 35.29 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 121.594 1.529 . . . . 0.0 110.902 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -64.63 -42.17 95.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.609 1.964 . . . . 0.0 110.109 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -86.08 -30.36 22.65 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.358 0.663 . . . . 0.0 112.687 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.7 p -84.47 -7.51 59.26 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.09 0.859 . . . . 0.0 110.625 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -55.31 -57.94 17.72 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.546 -1.346 . . . . 0.0 112.521 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.33 -25.32 56.14 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.703 1.602 . . . . 0.0 112.95 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -66.18 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.045 1.338 . . . . 0.0 108.04 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 39.4 pt -64.82 -27.13 41.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 O-C-N 121.74 -0.6 . . . . 0.0 111.938 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.38 -16.88 61.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.947 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.0 -59.46 4.51 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.973 0.909 . . . . 0.0 113.161 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -62.33 -54.42 40.72 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.39 12.09 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 CA-C-O 118.553 -1.137 . . . . 0.0 114.51 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.57 133.97 41.53 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 119.842 1.821 . . . . 0.0 109.903 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.418 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 48.9 p90 -145.56 137.46 25.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.05 -48.68 12.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -144.46 141.11 29.36 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.046 0.939 . . . . 0.0 108.951 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.418 ' HE2' ' CE1' ' A' ' 167' ' ' TYR . 10.3 tppt? -91.2 153.06 20.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -159.38 102.35 1.57 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -138.3 160.37 39.66 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 56.77 11.74 0.99 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.209 1.803 . . . . 0.0 111.334 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.84 16.29 80.18 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -178.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -114.84 110.26 19.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 126.18 1.792 . . . . 0.0 108.928 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -81.12 143.62 32.27 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -145.32 76.05 1.46 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 119.833 1.197 . . . . 0.0 113.271 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.56 -6.94 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -41.38 80.82 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.963 1.705 . . . . 0.0 108.186 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -87.78 105.3 17.3 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.34 1.056 . . . . 0.0 108.849 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 81.1 t -127.49 98.62 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -76.0 18.0 3.49 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 117.272 1.669 . . . . 0.0 117.272 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.0 t -70.2 -20.18 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.531 2.165 . . . . 0.0 112.863 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.53 2.09 25.91 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.813 0.733 . . . . 0.0 111.854 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -66.29 165.49 13.88 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.541 1.136 . . . . 0.0 111.369 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.14 -41.39 71.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.403 1.081 . . . . 0.0 111.308 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.0 -27.96 73.53 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 120.995 -1.066 . . . . 0.0 113.394 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.91 -38.09 54.14 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.417 1.109 . . . . 0.0 110.11 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -73.55 -33.19 64.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.786 -0.571 . . . . 0.0 110.988 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -54.73 -48.64 72.28 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.478 1.111 . . . . 0.0 112.457 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -75.87 -19.08 79.2 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.95 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.9 tp -77.61 -53.12 7.96 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 122.95 0.5 . . . . 0.0 112.247 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.2 t -54.78 -32.94 60.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.417 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -53.06 -53.2 53.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.359 0.981 . . . . 0.0 110.697 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 27.4 tp -63.41 -48.78 76.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.723 0.409 . . . . 0.0 110.473 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.16 -31.61 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 123.998 0.919 . . . . 0.0 110.025 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -48.18 80.14 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.895 1.278 . . . . 0.0 110.53 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.24 -39.26 93.58 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.932 -0.48 . . . . 0.0 109.863 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 73.3 mt -67.4 -38.2 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.971 0.908 . . . . 0.0 108.753 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -57.71 -47.61 81.91 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.538 -1.351 . . . . 0.0 108.015 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -80.77 -0.13 37.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.29 1.436 . . . . 0.0 112.459 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp 56.26 6.39 0.25 Allowed 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 129.829 3.252 . . . . 0.0 116.729 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -71.45 -20.6 62.07 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.922 -0.711 . . . . 0.0 112.447 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.7 tpt -82.97 159.27 22.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.287 1.035 . . . . 0.0 112.485 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -95.94 76.09 3.12 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.34 -7.36 30.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.291 1.436 . . . . 0.0 113.598 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.61 -22.69 26.06 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 130.519 3.528 . . . . 0.0 112.179 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.6 m -58.84 127.79 33.95 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -128.62 -178.43 4.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.367 1.867 . . . . 0.0 107.513 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -59.34 -39.49 83.35 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -53.51 56.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.522 1.129 . . . . 0.0 109.121 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 60.5 mt -61.98 -55.93 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.831 1.252 . . . . 0.0 110.848 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.65 94.22 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.628 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.82 -45.27 82.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.294 1.407 . . . . 0.0 110.904 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.47 -55.43 27.65 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.485 1.114 . . . . 0.0 110.403 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.92 -38.7 76.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.397 1.079 . . . . 0.0 110.16 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -62.03 -30.65 71.11 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.456 0.571 . . . . 0.0 109.581 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.57 -35.84 65.52 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 120.923 -1.11 . . . . 0.0 109.443 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -77.01 -12.38 59.93 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.574 1.149 . . . . 0.0 113.622 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.1 16.53 59.18 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-N 120.683 1.583 . . . . 0.0 111.442 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -78.99 -9.4 59.52 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.031 1.732 . . . . 0.0 114.349 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -146.62 127.1 14.09 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.082 -1.011 . . . . 0.0 108.702 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.71 -24.77 66.29 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.322 -0.862 . . . . 0.0 111.575 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -140.92 166.64 24.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.567 1.147 . . . . 0.0 111.603 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.9 t -153.15 166.65 31.85 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.279 1.831 . . . . 0.0 107.179 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.5 mt . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 179.413 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.41 144.56 62.04 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.511 1.474 . . . . 0.0 109.211 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 254' ' ' PRO . 81.6 p -136.03 -161.63 1.18 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.915 0.886 . . . . 0.0 110.262 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.5 143.65 40.53 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -55.65 134.75 51.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.569 -0.707 . . . . 0.0 110.033 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 70.58 -7.81 4.75 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.42 98.47 4.26 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 119.293 1.547 . . . . 0.0 112.1 -178.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 249' ' ' THR . 37.8 Cg_endo -66.07 158.24 55.45 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.327 1.352 . . . . 0.0 110.788 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 80.7 p -83.07 142.53 31.22 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 120.893 -1.13 . . . . 0.0 110.116 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -142.5 118.15 6.77 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.832 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -75.76 -61.89 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.731 2.287 . . . . 0.0 110.904 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 . . . . . 0 C--O 1.24 0.591 0 C-N-CA 129.613 3.165 . . . . 0.0 105.953 179.678 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.123 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.82 122.4 62.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 117.604 0.702 . . . . 0.0 112.535 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.7 tt -77.77 128.04 33.39 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.4 m -114.97 163.42 15.61 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.28 0.632 . . . . 0.0 112.179 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -139.26 139.98 37.54 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.19 0.996 . . . . 0.0 109.27 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -129.44 153.94 20.14 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.035 1.778 . . . . 0.0 108.896 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 75.9 mt -104.41 137.97 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 125.139 1.376 . . . . 0.0 107.654 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -68.05 114.46 6.6 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -63.22 -24.71 68.0 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.334 -0.854 . . . . 0.0 110.946 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -69.84 -16.72 63.31 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 118.451 -0.785 . . . . 0.0 113.079 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 44.7 m -58.3 150.42 53.69 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 118.985 0.812 . . . . 0.0 109.781 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.83 -37.24 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.195 1.93 . . . . 0.0 112.221 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -135.81 89.03 2.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -57.31 -18.57 17.52 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.622 0.369 . . . . 0.0 111.084 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.85 -42.33 84.24 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.557 1.943 . . . . 0.0 108.409 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.08 -37.84 81.12 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.905 -1.122 . . . . 0.0 110.674 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.35 -45.53 38.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -35.33 77.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.473 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -71.71 -52.63 16.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.215 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -54.89 -47.99 73.61 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 120.657 1.572 . . . . 0.0 111.167 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.31 -45.73 91.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.772 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -83.42 -7.3 59.58 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -108.17 -24.32 11.59 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 116.92 -1.514 . . . . 0.0 114.603 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -139.65 -35.67 0.53 Allowed 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.457 1.026 . . . . 0.0 112.256 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -64.82 -44.76 88.83 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.397 1.453 . . . . 0.0 108.549 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 77.7 mt -96.86 53.97 1.26 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.358 1.863 . . . . 0.0 112.834 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.1 p -131.75 157.47 43.72 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.29 -38.49 89.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -69.44 -39.1 78.02 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.71 -0.619 . . . . 0.0 110.885 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.84 -32.26 61.34 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 121.769 -0.582 . . . . 0.0 112.122 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.9 mt -74.75 -44.17 51.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.31 -45.26 84.4 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.377 1.071 . . . . 0.0 108.541 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.69 -50.42 63.35 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.435 1.094 . . . . 0.0 112.289 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 65.4 t -72.94 -34.57 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.209 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -68.92 -32.91 72.87 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.452 0.569 . . . . 0.0 111.386 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -62.63 -35.18 78.76 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -67.17 -72.44 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.57 154.51 77.6 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 124.493 1.117 . . . . 0.0 111.581 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.44 108.1 2.54 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.44 2.093 . . . . 0.0 109.868 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.22 -30.51 70.45 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.03 -116.47 5.59 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 106.49 -2.644 . . . . 0.0 106.49 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -109.9 169.13 8.92 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.993 1.396 . . . . 0.0 108.328 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 18.6 m -131.74 153.1 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 O-C-N 121.377 -0.827 . . . . 0.0 110.977 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.11 -34.34 50.12 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.974 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 15.4 tp -69.34 102.19 1.69 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.303 1.041 . . . . 0.0 108.327 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -53.2 -28.44 26.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.608 1.563 . . . . 0.0 115.217 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -62.37 1.7 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.764 1.165 . . . . 0.0 111.483 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -78.96 -14.01 59.46 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 125.246 1.418 . . . . 0.0 112.691 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -58.88 -32.23 69.3 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.66 -30.87 71.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.711 1.204 . . . . 0.0 112.601 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -82.38 -39.46 22.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.641 1.176 . . . . 0.0 110.009 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.439 ' HB3' HG21 ' A' ' 317' ' ' ILE . 12.6 mt -69.14 -34.82 75.6 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.33 -6.96 1.72 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.089 1.756 . . . . 0.0 113.497 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -62.05 -33.06 73.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.797 0.726 . . . . 0.0 109.913 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.14 142.81 25.17 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.04 -13.2 37.54 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.149 1.899 . . . . 0.0 113.509 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.5 mtm-85 -64.5 -45.14 88.58 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.757 -1.215 . . . . 0.0 109.384 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.562 HD12 ' H ' ' A' ' 317' ' ' ILE . 4.3 mp -67.25 -57.68 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 124.596 1.158 . . . . 0.0 107.965 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.63 -54.97 18.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 124.176 0.923 . . . . 0.0 110.171 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.33 -30.8 71.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.694 -1.254 . . . . 0.0 113.171 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 16.7 m -66.5 -42.92 86.66 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.3 tpt -67.33 -51.42 52.63 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.807 1.643 . . . . 0.0 110.393 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -55.16 -33.05 62.61 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.217 1.007 . . . . 0.0 112.427 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -81.97 -38.34 25.3 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.813 0.845 . . . . 0.0 108.976 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.483 0 CA-C-N 118.714 0.688 . . . . 0.0 110.48 178.851 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 CA--C 1.539 0.765 0 N-CA-C 112.833 0.282 . . . . 0.0 112.833 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -148.65 46.35 1.03 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.976 0.91 . . . . 0.0 111.768 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.41 155.43 43.71 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.553 1.541 . . . . 0.0 113.063 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.39 -19.43 61.46 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.094 3.196 . . . . 0.0 115.448 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -56.35 -24.01 41.28 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.592 1.157 . . . . 0.0 111.574 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 87.4 mmm -59.28 -33.59 71.24 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.685 0.794 . . . . 0.0 111.504 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 13.1 t -58.68 -49.3 78.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.681 0.673 . . . . 0.0 110.315 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.86 82.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.751 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -56.09 -48.93 75.2 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.892 0.877 . . . . 0.0 110.035 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 21.6 m95 -56.95 -44.34 82.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.428 0.558 . . . . 0.0 111.349 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -66.93 -45.12 78.82 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.967 -0.458 . . . . 0.0 110.258 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -52.93 -56.19 17.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.136 1.774 . . . . 0.0 112.149 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 18.1 t -68.45 -40.2 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 117.616 -1.183 . . . . 0.0 109.561 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -52.28 -50.73 61.56 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.875 1.67 . . . . 0.0 109.023 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 2.1 m -67.45 -45.01 77.24 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.58 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.06 -42.1 68.89 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.878 1.217 . . . . 0.0 111.964 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 44.1 t -58.28 -57.38 11.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.354 1.062 . . . . 0.0 109.43 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.9 mm -67.09 -26.47 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 119.344 -0.36 . . . . 0.0 110.687 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -64.94 -51.39 62.12 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 119.85 -1.781 . . . . 0.0 109.088 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.52 -44.57 70.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.383 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.24 -29.02 70.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.4 m -85.71 -12.36 51.36 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.095 0.861 . . . . 0.0 109.571 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 73.33 8.73 75.99 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.416 -0.658 . . . . 0.0 111.676 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -66.78 -34.62 78.23 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.681 1.241 . . . . 0.0 108.915 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -138.99 155.86 47.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.0 t -76.11 166.47 23.43 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.8 t -55.73 -56.07 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.142 1.377 . . . . 0.0 109.901 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -51.75 -41.25 61.45 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.59 1.556 . . . . 0.0 113.478 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -77.28 -36.48 54.2 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.19 0.196 . . . . 0.0 111.099 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.61 -50.26 72.5 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.49 -0.756 . . . . 0.0 109.74 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.04 -39.18 89.96 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.108 -0.949 . . . . 0.0 111.157 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -57.55 -56.25 24.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.815 0.734 . . . . 0.0 110.395 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.95 -38.57 91.61 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 124.274 0.984 . . . . 0.0 111.012 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.59 92.61 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.682 -0.636 . . . . 0.0 110.452 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.38 -36.36 68.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.585 0.754 . . . . 0.0 109.792 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 5.8 m -59.69 -39.08 83.36 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.62 0.645 . . . . 0.0 110.398 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -65.75 -15.67 63.06 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.092 -1.005 . . . . 0.0 112.34 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 7.8 mt -102.56 -8.62 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.988 1.315 . . . . 0.0 109.974 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 19.7 p -113.36 -2.52 13.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.802 1.641 . . . . 0.0 111.874 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.106 0 C-N-CA 127.344 2.257 . . . . 0.0 106.544 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 122.216 1.007 . . . . 0.0 108.521 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -73.04 -176.03 1.97 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.812 2.445 . . . . 0.0 113.018 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.94 17.27 75.17 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.106 0.86 . . . . 0.0 111.963 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.47 163.36 36.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.173 1.389 . . . . 0.0 110.656 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.6 mt -148.99 150.28 32.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 129.237 3.015 . . . . 0.0 104.933 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.52 134.36 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.581 HD12 HG22 ' A' ' 37' ' ' VAL . 42.2 mt -114.43 123.55 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -121.45 118.93 30.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -145.81 154.78 13.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.37 1.068 . . . . 0.0 110.726 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -69.52 150.8 46.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.25 -26.79 37.48 Favored Glycine 0 N--CA 1.465 0.569 0 C-N-CA 126.161 1.839 . . . . 0.0 115.034 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.82 -19.77 63.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.605 0.703 . . . . 0.0 110.554 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -73.09 164.8 26.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 122.167 0.984 . . . . 0.0 109.962 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.69 63.5 4.35 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -68.51 -45.87 71.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.326 1.05 . . . . 0.0 110.959 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -38.63 80.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.92 -38.74 22.39 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.47 -34.95 78.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.204 1.002 . . . . 0.0 110.545 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HA ' HG21 ' A' ' 37' ' ' VAL . . . -56.93 -44.66 82.68 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.142 0.577 . . . . 0.0 109.567 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -56.11 -43.1 77.8 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.527 0.731 . . . . 0.0 111.635 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.1 -44.52 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.509 1.524 . . . . 0.0 107.362 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.73 -42.84 95.05 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.305 -0.872 . . . . 0.0 110.994 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -43.25 99.2 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.052 0.926 . . . . 0.0 108.724 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -62.74 -50.32 71.56 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.613 1.165 . . . . 0.0 108.942 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -56.77 -41.89 78.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.561 1.073 . . . . 0.0 110.272 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.93 -35.93 79.86 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.965 -1.084 . . . . 0.0 108.7 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -74.18 3.77 6.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.3 1.84 . . . . 0.0 111.263 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -125.4 -37.4 2.37 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.79 1.636 . . . . 0.0 112.604 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.0 p -112.29 -22.0 11.13 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.716 0.806 . . . . 0.0 113.013 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.44 53.01 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.063 -1.023 . . . . 0.0 112.954 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.77 133.06 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 119.145 1.473 . . . . 0.0 107.468 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HE2' ' N ' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -66.81 146.03 54.86 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.262 -0.899 . . . . 0.0 108.812 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.3 t -136.75 91.59 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.8 m -80.73 134.28 35.8 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.581 HG22 HD12 ' A' ' 9' ' ' ILE . 27.2 t -130.84 129.4 63.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -140.01 166.23 25.22 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -118.54 58.66 3.55 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 123.59 0.756 . . . . 0.0 111.606 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.32 159.97 51.64 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.18 1.253 . . . . 0.0 109.24 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -120.45 -23.08 6.23 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.375 0.67 . . . . 0.0 110.501 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.2 9.13 41.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.913 1.285 . . . . 0.0 110.543 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.3 pt? -56.86 -30.74 64.12 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 120.565 -1.334 . . . . 0.0 112.286 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.26 -23.81 64.4 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.22 1.373 . . . . 0.0 113.652 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -105.14 -28.03 11.24 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.164 0.438 . . . . 0.0 110.272 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -51.29 10.88 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 124.492 1.117 . . . . 0.0 110.647 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -41.92 -58.25 3.46 Favored Pre-proline 0 N--CA 1.457 -0.079 0 CA-C-O 116.321 -1.799 . . . . 0.0 109.883 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.99 1.37 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.27 1.98 . . . . 0.0 116.93 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.36 -52.86 2.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.802 1.183 . . . . 0.0 108.752 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.466 HG12 ' C ' ' A' ' 55' ' ' ASP . 2.3 t -63.17 -40.95 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.58 -31.04 59.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.378 -0.827 . . . . 0.0 111.144 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.15 -13.44 60.81 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.033 0.533 . . . . 0.0 111.011 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 m -93.33 -82.34 0.34 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 163.36 37.77 0.02 OUTLIER Glycine 0 CA--C 1.524 0.612 0 C-N-CA 125.598 1.57 . . . . 0.0 109.291 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.466 ' C ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -136.79 -3.32 2.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.812 1.645 . . . . 0.0 113.292 -176.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.9 176.27 21.66 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 116.933 1.533 . . . . 0.0 116.933 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.92 172.38 7.28 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.766 2.311 . . . . 0.0 109.584 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -107.92 -18.5 13.79 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -142.36 143.05 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.348 1.459 . . . . 0.0 108.726 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.8 tt -135.29 140.6 44.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 125.608 1.563 . . . . 0.0 108.277 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -132.45 116.32 16.64 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -154.73 179.29 9.21 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.72 0.691 . . . . 0.0 110.726 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.41 152.95 40.63 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -61.81 -25.62 67.61 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -61.52 -23.79 66.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -98.76 -4.9 32.39 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.797 -0.564 . . . . 0.0 110.78 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -92.46 20.87 5.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.004 1.322 . . . . 0.0 109.73 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.79 -14.03 51.16 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 120.667 -1.271 . . . . 0.0 111.391 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.65 -27.45 1.94 Allowed Glycine 0 C--N 1.344 0.982 0 CA-C-N 119.304 1.552 . . . . 0.0 116.498 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -53.75 -47.37 70.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.114 1.957 . . . . 0.0 111.763 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.21 -40.91 94.78 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -27.08 54.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.303 1.041 . . . . 0.0 112.223 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.0 m -96.88 3.07 52.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.353 1.461 . . . . 0.0 112.045 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.66 16.76 78.72 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.421 1.01 . . . . 0.0 112.267 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.7 mt -88.73 9.47 24.27 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.142 0.977 . . . . 0.0 113.425 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.0 mt -131.29 146.01 52.12 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 120.979 -1.076 . . . . 0.0 108.244 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.41 161.58 14.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -78.7 94.21 5.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.11 175.21 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 127.103 2.161 . . . . 0.0 112.212 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.455 HG21 HE21 ' A' ' 86' ' ' GLN . 89.4 m 66.64 95.88 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 126.777 2.031 . . . . 0.0 111.013 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.92 -48.24 1.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.339 1.359 . . . . 0.0 110.749 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.84 154.65 51.55 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.079 0.951 . . . . 0.0 110.509 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -49.34 -38.85 29.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.07 2.548 . . . . 0.0 111.768 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.98 -25.55 44.49 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.189 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -68.77 -28.64 66.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.718 1.145 . . . . 0.0 109.963 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.455 HE21 HG21 ' A' ' 80' ' ' THR . 39.9 mt-30 -64.05 -36.37 83.79 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 120.76 -1.212 . . . . 0.0 110.76 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.18 -15.3 61.02 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.065 0.946 . . . . 0.0 112.286 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -70.85 -20.92 62.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.717 1.207 . . . . 0.0 111.771 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.415 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 8.0 mt -122.93 161.16 24.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.799 1.64 . . . . 0.0 108.541 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -72.98 157.76 88.15 Favored Pre-proline 0 N--CA 1.476 0.847 0 CA-C-N 120.23 1.377 . . . . 0.0 108.91 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.9 -46.18 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.08 2.52 . . . . 0.0 114.168 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -60.1 -30.93 69.58 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.259 0.936 . . . . 0.0 111.34 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.11 -29.46 69.21 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.233 -0.917 . . . . 0.0 110.15 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.415 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 73.7 m95 -72.88 -30.29 63.84 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.966 0.803 . . . . 0.0 110.684 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -62.99 -16.5 59.92 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.45 -5.18 59.08 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.326 0.65 . . . . 0.0 112.506 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.5 m -133.3 27.82 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.882 1.273 . . . . 0.0 112.238 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.6 mtp85 -86.37 164.11 17.24 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.199 0.999 . . . . 0.0 110.878 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -149.95 175.5 11.62 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.174 1.39 . . . . 0.0 107.603 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -66.55 101.19 0.74 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.559 0.743 . . . . 0.0 112.157 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.84 -69.95 2.8 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.099 1.333 . . . . 0.0 111.974 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.86 162.04 27.95 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.141 0.47 . . . . 0.0 110.064 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.84 155.21 17.16 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.742 1.617 . . . . 0.0 108.557 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.1 pt -123.09 -32.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.72 -178.58 7.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 119.925 1.239 . . . . 0.0 109.912 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -133.36 147.53 65.3 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 124.668 1.187 . . . . 0.0 109.431 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.93 153.8 63.4 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.651 2.9 . . . . 0.0 109.665 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 264' ' ' ALA . 18.9 mm -125.84 -47.63 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 125.364 1.466 . . . . 0.0 110.979 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.26 165.7 26.7 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 117.877 0.308 . . . . 0.0 110.739 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.7 t -127.02 121.43 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 124.281 0.988 . . . . 0.0 109.399 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.88 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--O 1.242 0.68 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--O 1.237 0.396 0 C-N-CA 123.544 0.738 . . . . 0.0 109.484 179.154 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.457 -0.648 0 N-CA-C 112.748 0.249 . . . . 0.0 112.748 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.83 -12.03 3.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.068 0.547 . . . . 0.0 112.365 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.33 154.84 45.91 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.128 -0.983 . . . . 0.0 111.949 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -80.05 -22.92 41.79 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.23 -18.29 47.66 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.79 -5.13 21.5 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.264 1.025 . . . . 0.0 111.511 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.4 mm -61.05 -52.53 71.29 Favored Pre-proline 0 C--N 1.339 0.128 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.82 -23.75 54.92 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 CA-C-N 120.997 1.392 . . . . 0.0 111.503 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.43 -44.39 75.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.4 tp -80.43 -27.29 38.02 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.219 1.008 . . . . 0.0 111.928 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.9 -44.51 82.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 123.943 0.897 . . . . 0.0 110.736 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -68.41 -31.2 70.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.407 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -71.34 -46.78 59.7 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 61.0 mt -72.57 -31.48 65.28 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.402 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -71.17 -37.37 72.2 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.01 68.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.538 0.608 . . . . 0.0 111.89 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.68 6.15 16.75 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.978 0.911 . . . . 0.0 112.534 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 179.42 -104.46 0.18 Allowed Glycine 0 CA--C 1.524 0.626 0 CA-C-N 119.141 0.882 . . . . 0.0 112.792 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -136.91 178.08 7.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.134 2.174 . . . . 0.0 109.978 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.01 155.36 3.54 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.36 1.064 . . . . 0.0 113.674 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.07 -47.61 35.42 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.7 tp -125.48 155.55 40.35 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.192 1.397 . . . . 0.0 110.247 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.457 ' CG ' HG21 ' A' ' 208' ' ' THR . 45.1 ttm -150.68 130.5 13.25 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -159.91 168.93 24.6 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.865 1.666 . . . . 0.0 115.399 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.52 83.11 0.06 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 126.766 2.026 . . . . 0.0 112.095 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.5 mt -80.83 -20.87 41.47 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 125.842 1.657 . . . . 0.0 110.724 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.3 mm-40 -78.92 -6.53 56.41 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -112.62 129.92 23.93 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 119.163 0.892 . . . . 0.0 112.105 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.64 -13.73 24.69 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.156 1.904 . . . . 0.0 112.318 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -64.6 -40.09 94.88 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.854 1.662 . . . . 0.0 113.311 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.521 ' CZ ' HG21 ' A' ' 226' ' ' ILE . 30.5 t80 -95.13 -29.6 14.48 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.5 p -72.75 -28.43 62.62 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.336 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -56.6 -58.67 15.65 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -56.02 -16.36 16.26 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.586 2.191 . . . . 0.0 115.842 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 66.4 tp -82.11 -59.17 2.65 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.811 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.402 HG22 ' HA3' ' A' ' 191' ' ' GLY . 17.8 pt -68.21 -27.42 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 119.403 1.001 . . . . 0.0 111.768 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.25 -20.89 66.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.449 0.699 . . . . 0.0 110.917 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.61 -54.01 43.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.153 1.381 . . . . 0.0 112.244 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.21 -41.75 84.7 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.364 0.529 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 165.88 26.13 0.02 OUTLIER Glycine 0 C--N 1.34 0.778 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -88.92 131.95 10.98 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -147.27 151.44 36.64 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.115 1.457 . . . . 0.0 112.059 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.412 ' HB2' ' CE2' ' A' ' 339' ' ' PHE . . . -85.17 -63.01 1.4 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.775 1.23 . . . . 0.0 112.542 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -138.37 126.24 22.47 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.309 1.444 . . . . 0.0 108.832 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -73.38 129.37 37.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.425 1.011 . . . . 0.0 112.156 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.85 122.18 38.87 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.525 ' HG2' ' H ' ' A' ' 173' ' ' ASN . 14.9 tt0 -93.82 -163.57 1.07 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.987 1.315 . . . . 0.0 109.45 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.525 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 71.0 m-80 -56.77 -8.84 0.65 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.249 2.22 . . . . 0.0 115.731 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.36 11.62 0.02 OUTLIER Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.224 1.392 . . . . 0.0 113.861 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.6 156.7 40.5 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.808 2.443 . . . . 0.0 105.078 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -144.93 148.71 34.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -147.88 141.03 25.04 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.449 ' H ' HD13 ' A' ' 178' ' ' ILE . 0.1 OUTLIER -94.8 -8.67 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.664 1.186 . . . . 0.0 110.3 178.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -40.01 73.51 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -78.33 92.48 4.54 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.587 1.155 . . . . 0.0 111.009 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.9 t -115.96 150.29 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.885 1.674 . . . . 0.0 108.996 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -146.08 48.58 0.68 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.55 1.548 . . . . 0.0 111.629 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 80.3 t -81.3 -55.2 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 125.1 1.36 . . . . 0.0 107.937 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -87.51 67.22 9.31 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -113.03 155.95 23.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 126.317 1.847 . . . . 0.0 110.435 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.15 -39.05 66.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.992 1.317 . . . . 0.0 113.152 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.21 -45.96 76.08 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.08 -56.59 19.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 189' ' ' LYS . 10.7 ptpt -58.87 -34.49 71.69 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 117.438 -1.268 . . . . 0.0 112.768 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.05 -52.09 66.42 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.608 1.094 . . . . 0.0 109.286 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.402 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -68.3 -30.31 73.48 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.77 -53.72 20.12 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.332 1.066 . . . . 0.0 108.442 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.4 t -61.14 -33.66 73.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.327 0.651 . . . . 0.0 110.303 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.85 -55.07 34.38 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.6 tt -60.58 -47.89 84.22 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.445 1.498 . . . . 0.0 110.323 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 70.9 t -57.1 -36.23 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 118.18 -0.914 . . . . 0.0 109.75 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.457 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.3 OUTLIER -65.04 -35.51 81.39 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 120.033 1.288 . . . . 0.0 112.122 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.04 -41.23 99.46 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 85.7 mt -67.98 -42.76 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -57.83 -31.69 66.89 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.575 1.55 . . . . 0.0 109.841 178.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -88.69 -5.29 58.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.764 1.625 . . . . 0.0 111.246 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? 60.39 16.88 6.66 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.321 2.648 . . . . 0.0 113.755 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -86.3 -34.53 20.31 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.4 tpt -85.44 128.37 34.7 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -76.68 120.68 22.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -88.92 -3.12 58.83 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -95.72 -15.34 22.7 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.603 1.961 . . . . 0.0 115.144 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.457 HG21 ' CG ' ' A' ' 148' ' ' MET . 3.3 m -67.55 128.43 36.4 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.957 0.903 . . . . 0.0 112.197 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -126.95 172.32 10.55 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.761 2.024 . . . . 0.0 108.114 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -47.66 -39.81 18.17 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 57.8 m -63.14 -45.91 89.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.743 1.217 . . . . 0.0 110.45 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 58.1 mt -66.9 -48.47 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 117.063 -1.446 . . . . 0.0 110.868 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.76 91.06 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.798 1.635 . . . . 0.0 112.717 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.42 -35.32 80.58 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.047 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.26 -55.9 20.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.62 -43.14 75.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.939 2.495 . . . . 0.0 112.119 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -62.49 -45.68 91.91 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.986 1.266 . . . . 0.0 108.543 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -37.9 82.59 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 118.44 -0.791 . . . . 0.0 109.192 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -74.56 -23.08 58.71 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.089 1.313 . . . . 0.0 111.618 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.47 38.25 5.36 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.415 1.483 . . . . 0.0 111.081 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -93.74 -31.1 14.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.672 1.236 . . . . 0.0 113.764 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.5 t -115.15 152.01 33.35 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.612 1.165 . . . . 0.0 109.24 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -87.88 -27.95 21.88 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.781 0.832 . . . . 0.0 111.498 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -136.51 145.49 45.16 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.927 1.291 . . . . 0.0 108.224 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 23.0 m -149.4 149.72 31.28 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.666 1.186 . . . . 0.0 108.919 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.521 HG21 ' CZ ' ' A' ' 156' ' ' PHE . 27.6 mt . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 119.136 -0.459 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.24 143.56 39.82 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.431 1.421 . . . . 0.0 110.041 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 47.8 p -135.51 -145.0 0.21 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.834 2.054 . . . . 0.0 108.231 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -124.12 141.59 51.93 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 12.0 pttp -54.02 107.1 0.23 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.279 1.031 . . . . 0.0 109.049 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.76 84.43 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.772 1.177 . . . . 0.0 114.394 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.08 93.64 43.23 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.865 1.333 . . . . 0.0 108.936 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.4 144.17 25.55 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.976 2.451 . . . . 0.0 109.433 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 37.3 p -63.33 141.41 58.78 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 121.058 -1.026 . . . . 0.0 108.804 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -116.39 88.14 22.59 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.511 1.125 . . . . 0.0 110.398 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -82.16 168.08 15.42 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.382 2.055 . . . . 0.0 112.239 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 . . . . . 0 C--O 1.237 0.422 0 C-N-CA 124.621 1.168 . . . . 0.0 108.446 178.195 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.551 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.49 136.64 54.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 118.042 0.921 . . . . 0.0 112.092 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 tp -68.86 137.48 53.92 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.1 m -121.99 158.23 29.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.494 1.043 . . . . 0.0 113.568 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.427 ' HB2' HG13 ' A' ' 108' ' ' ILE . . . -135.33 141.2 45.57 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.194 1.798 . . . . 0.0 110.004 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.78 167.46 23.22 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.441 1.496 . . . . 0.0 110.196 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 56.2 mt -119.46 132.25 69.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.508 1.523 . . . . 0.0 107.363 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -74.1 130.5 39.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -76.2 -19.48 58.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 117.797 -1.097 . . . . 0.0 113.518 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -72.94 -7.74 52.46 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.574 1.079 . . . . 0.0 113.182 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 66.8 m -63.06 154.72 76.26 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -62.29 -53.69 1.79 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 121.877 1.718 . . . . 0.0 108.052 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -132.42 125.55 31.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.473 ' H ' ' HD2' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -74.39 -16.59 60.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.718 0.807 . . . . 0.0 111.406 178.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.48 ' HA ' ' HG3' ' A' ' 277' ' ' LYS . 3.9 tt0 -61.55 -33.78 74.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.707 0.803 . . . . 0.0 112.517 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 61.9 mt -59.3 -40.74 87.14 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.791 -0.568 . . . . 0.0 111.031 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.42 -43.63 48.88 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.771 0.429 . . . . 0.0 111.057 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.48 ' HG3' ' HA ' ' A' ' 274' ' ' GLU 0.261 0.0 OUTLIER -63.9 -32.95 74.65 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.768 -0.634 . . . . 0.0 111.331 -179.084 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -72.44 -48.07 44.01 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -51.47 -49.89 60.9 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.23 -54.42 47.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.4 -22.55 66.99 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -97.55 -24.6 15.48 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 117.817 -1.087 . . . . 0.0 113.55 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -138.66 -36.42 0.56 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.99 -25.29 62.63 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.468 1.031 . . . . 0.0 110.692 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 89.7 mt -105.57 24.97 11.34 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.445 1.498 . . . . 0.0 113.711 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 6.8 p -103.07 158.19 16.47 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.48 -42.81 99.75 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -71.41 -30.73 66.44 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.582 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.05 -48.89 14.34 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 63.8 mt -62.0 -43.86 97.94 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -62.23 -42.5 99.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.03 -35.14 68.93 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.823 0.738 . . . . 0.0 110.996 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 76.0 t -72.25 -42.01 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -60.01 -29.99 68.84 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.399 1.079 . . . . 0.0 112.705 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -52.56 -47.36 66.86 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 118.272 0.487 . . . . 0.0 110.708 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.91 -73.98 0.24 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -101.47 144.64 28.96 Favored Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 121.051 -1.031 . . . . 0.0 111.615 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.62 108.48 2.64 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.256 2.637 . . . . 0.0 111.556 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 66.8 mt -73.18 -31.47 64.23 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.967 0.907 . . . . 0.0 110.908 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 71.08 -103.71 1.28 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 108.244 -1.942 . . . . 0.0 108.244 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.02 168.44 10.27 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 10.8 m -140.17 153.12 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 120.869 -1.144 . . . . 0.0 110.97 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.06 -18.73 49.29 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.773 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 21.0 tp -81.36 111.83 18.08 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -56.6 -34.16 66.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 119.198 -0.429 . . . . 0.0 111.84 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -37.49 65.96 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.25 1.42 . . . . 0.0 112.186 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -101.43 -16.85 16.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.266 0.485 . . . . 0.0 109.742 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -63.76 -38.76 92.32 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.36 -23.4 62.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.138 0.881 . . . . 0.0 111.331 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -89.39 -51.37 5.59 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.614 1.166 . . . . 0.0 109.058 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 22.0 mt -61.43 -34.66 75.77 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.757 -0.59 . . . . 0.0 110.093 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.68 -3.0 5.58 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.392 1.477 . . . . 0.0 112.964 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -61.62 -28.81 69.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.386 1.448 . . . . 0.0 107.445 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -94.54 135.63 23.91 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.9 -11.99 33.27 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.483 2.122 . . . . 0.0 113.285 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -64.83 -46.29 82.54 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.56 -48.65 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 124.412 1.085 . . . . 0.0 108.531 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.77 -49.49 65.43 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 123.545 0.528 . . . . 0.0 110.684 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.8 84.77 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.775 -0.578 . . . . 0.0 111.823 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 21.0 m -61.46 -35.2 76.95 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.0 tpt -71.12 -48.07 54.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 122.857 0.463 . . . . 0.0 110.42 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -58.45 -30.63 67.09 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.54 1.136 . . . . 0.0 111.985 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -64.32 -28.74 69.92 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.2 -0.937 . . . . 0.0 110.335 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.313 0 CA-C-N 118.774 0.716 . . . . 0.0 109.979 178.106 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.451 -1.013 0 N-CA-C 108.487 -1.39 . . . . 0.0 108.487 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -101.14 29.84 4.46 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.423 2.289 . . . . 0.0 112.63 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.1 pt -130.24 154.45 81.41 Favored Pre-proline 0 N--CA 1.47 0.573 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.1 -14.15 31.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.135 3.223 . . . . 0.0 115.163 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -57.04 -16.27 6.85 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.449 1.499 . . . . 0.0 112.394 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -32.98 71.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.443 0.697 . . . . 0.0 110.141 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 37.4 p -60.85 -48.25 82.66 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 119.115 0.87 . . . . 0.0 111.405 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.54 94.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.608 0.763 . . . . 0.0 109.147 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 168' ' ' ALA . 14.8 t80 -52.98 -53.99 41.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.459 1.104 . . . . 0.0 111.692 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -62.63 -47.22 84.7 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.804 0.729 . . . . 0.0 110.42 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -60.59 -31.33 70.48 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.782 0.433 . . . . 0.0 111.654 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.426 ' HA ' HH11 ' A' ' 367' ' ' ARG . . . -69.74 -57.33 5.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.4 1.48 . . . . 0.0 110.617 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.89 -38.16 75.17 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.15 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -48.83 -56.15 9.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.263 0.938 . . . . 0.0 110.994 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -45.7 85.4 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.748 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.82 -41.88 71.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.3 -53.31 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.513 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 49.3 mm -62.76 -36.54 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.014 0.824 . . . . 0.0 110.064 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.32 -50.62 73.29 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.114 0.87 . . . . 0.0 109.599 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.49 -52.24 58.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.647 0.779 . . . . 0.0 111.152 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -59.26 -29.01 67.25 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.036 1.334 . . . . 0.0 114.115 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 7.7 m -93.26 -3.9 52.83 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.581 0.752 . . . . 0.0 110.95 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 69.02 23.35 76.07 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 35.4 mtt-85 -80.73 -33.22 35.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -150.45 148.03 28.25 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 10.8 t -71.55 166.6 21.49 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.592 0.71 . . . . 0.0 109.426 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.78 -44.65 99.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.174 1.79 . . . . 0.0 110.771 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -55.4 -47.06 76.47 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.158 0.583 . . . . 0.0 111.251 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -78.47 -38.02 42.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.113 0.565 . . . . 0.0 111.262 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.13 89.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.454 -0.779 . . . . 0.0 110.825 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.0 mt -77.25 -30.06 54.29 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.26 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -58.22 -49.2 77.91 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.349 1.431 . . . . 0.0 108.645 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -51.03 -54.53 23.81 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.737 2.015 . . . . 0.0 108.638 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.84 -49.77 76.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.605 1.562 . . . . 0.0 112.879 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -54.76 -37.15 65.62 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.11 1.364 . . . . 0.0 109.412 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 20.0 m -66.4 -37.96 86.42 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.127 0.571 . . . . 0.0 110.944 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.426 HH11 ' HA ' ' A' ' 342' ' ' ALA . 77.0 mtt180 -66.11 -31.02 71.63 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.247 -0.908 . . . . 0.0 109.912 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.0 mt -80.22 -38.26 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.762 0.825 . . . . 0.0 111.292 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.5 p -73.61 -12.98 60.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.468 1.031 . . . . 0.0 110.9 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 51.3 tttm . . . . . 0 C--O 1.251 1.139 0 C-N-CA 124.689 1.196 . . . . 0.0 109.01 178.842 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -62.33 123.87 19.38 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 131.18 3.792 . . . . 0.0 109.491 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.97 39.54 93.27 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.995 1.284 . . . . 0.0 112.634 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -146.08 -179.15 6.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.468 1.107 . . . . 0.0 108.392 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.1 mt -145.6 144.64 30.59 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 128.539 2.735 . . . . 0.0 106.864 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.0 t -145.37 129.88 12.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.727 1.611 . . . . 0.0 107.222 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.59 141.59 46.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.773 0.829 . . . . 0.0 109.391 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.513 ' HB3' HD22 ' A' ' 43' ' ' LEU . 33.4 m0 -120.42 164.87 15.71 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.313 1.045 . . . . 0.0 111.812 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 13' ' ' GLY . 3.6 mt -136.79 136.32 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.828 1.251 . . . . 0.0 111.545 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -117.66 12.01 13.87 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.963 1.705 . . . . 0.0 110.655 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 11' ' ' ILE . . . -161.74 59.18 0.29 Allowed Glycine 0 C--N 1.339 0.724 0 O-C-N 119.974 -1.704 . . . . 0.0 115.689 -177.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 33.23 48.93 0.18 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.552 1.941 . . . . 0.0 115.019 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 168.8 10.7 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.32 64.89 3.71 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -69.74 -23.57 63.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.079 -0.962 . . . . 0.0 112.757 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -64.72 -57.28 9.4 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-N 119.428 1.013 . . . . 0.0 108.856 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.98 -40.52 73.5 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.3 tp -68.19 -35.92 78.76 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.077 0.951 . . . . 0.0 112.034 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.47 97.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.169 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.38 -35.13 73.35 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.919 0.781 . . . . 0.0 110.096 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.69 -42.61 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.39 -38.77 95.3 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -63.45 -47.03 83.55 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.729 1.265 . . . . 0.0 107.909 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -58.76 -58.38 8.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -53.1 -45.11 68.09 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.909 1.232 . . . . 0.0 112.236 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.19 -23.33 66.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.434 1.494 . . . . 0.0 110.937 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -92.16 -17.28 25.13 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.277 -1.514 . . . . 0.0 112.437 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.73 -7.0 22.05 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 124.247 0.967 . . . . 0.0 109.551 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 59.1 p -133.47 -34.42 1.05 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.495 1.118 . . . . 0.0 113.823 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.64 -17.91 58.44 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.696 1.141 . . . . 0.0 112.808 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.9 128.01 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.33 145.79 52.89 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.8 t -138.44 83.25 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.3 m -73.62 151.25 40.9 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.3 t -139.81 118.52 11.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.541 1.537 . . . . 0.0 107.942 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -143.86 157.34 44.43 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.855 0.752 . . . . 0.0 111.247 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -117.95 54.82 1.91 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.37 1.468 . . . . 0.0 112.218 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.486 ' HG2' ' HB3' ' A' ' 43' ' ' LEU . 78.9 Cg_endo -69.42 123.89 10.67 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.83 2.353 . . . . 0.0 111.59 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -13.64 58.99 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 127.818 2.447 . . . . 0.0 114.398 -178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.454 ' H ' ' HE2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -121.24 21.1 11.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.245 1.418 . . . . 0.0 113.727 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 10' ' ' TRP . 0.6 OUTLIER -58.37 -23.35 56.7 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.16 -26.75 61.09 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -106.72 -20.57 13.31 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.205 0.526 . . . . 0.0 110.675 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -75.92 -56.42 4.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -40.01 -57.82 2.54 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-O 116.743 -1.599 . . . . 0.0 112.354 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.96 -44.29 25.67 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.803 1.669 . . . . 0.0 114.219 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.5 mm100 -64.01 -49.13 73.64 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.472 1.109 . . . . 0.0 112.337 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 t -72.08 -39.18 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.474 0.71 . . . . 0.0 110.366 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.62 -28.61 63.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 120.949 -1.094 . . . . 0.0 113.018 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.47 -14.32 27.92 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.165 0.893 . . . . 0.0 112.813 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.9 m -118.15 4.22 12.0 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.945 1.298 . . . . 0.0 111.081 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.52 0.43 88.12 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.279 0.942 . . . . 0.0 113.71 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.23 -10.61 58.47 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.643 -1.504 . . . . 0.0 113.277 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.92 -179.05 19.84 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.69 -177.78 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 125.222 3.948 . . . . 0.0 113.45 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.53 -25.88 13.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.262 0.554 . . . . 0.0 111.057 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 mt -146.27 154.63 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 tp -137.31 146.28 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -132.2 111.9 11.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.61 1.564 . . . . 0.0 108.02 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -156.99 -167.04 2.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.161 0.892 . . . . 0.0 112.271 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.01 143.62 50.72 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.127 0.971 . . . . 0.0 110.865 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -56.8 -41.62 78.08 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.775 1.23 . . . . 0.0 109.541 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -67.84 -5.37 16.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.436 2.294 . . . . 0.0 114.101 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -111.91 -10.18 13.99 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.891 0.876 . . . . 0.0 110.301 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -86.73 4.04 42.4 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.415 1.486 . . . . 0.0 110.254 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.24 -9.6 84.84 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.369 -1.457 . . . . 0.0 109.6 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.56 -70.59 1.16 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.542 1.544 . . . . 0.0 112.191 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -46.7 -47.56 20.41 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.707 1.603 . . . . 0.0 112.966 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.36 -45.06 94.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.379 1.071 . . . . 0.0 111.343 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.53 -46.66 83.58 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.3 m -65.61 -4.86 6.8 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.256 0.623 . . . . 0.0 112.289 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.87 13.32 83.54 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.837 1.684 . . . . 0.0 112.274 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.2 mt -73.87 -17.82 61.0 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.211 1.006 . . . . 0.0 111.67 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mt -95.22 136.41 35.59 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 121.136 -0.977 . . . . 0.0 111.167 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.98 170.42 16.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 123.954 0.784 . . . . 0.0 111.826 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -69.04 115.34 8.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.536 HD12 ' CD2' ' A' ' 106' ' ' TYR . 2.2 mm -72.14 158.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.23 0.538 . . . . 0.0 110.291 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.5 m 60.72 84.02 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.032 1.733 . . . . 0.0 109.786 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.06 -27.59 29.62 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.643 1.562 . . . . 0.0 111.158 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -136.34 144.87 44.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.153 1.381 . . . . 0.0 110.815 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -52.35 -37.96 57.5 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.484 1.914 . . . . 0.0 112.833 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.63 -37.63 68.44 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.375 0.989 . . . . 0.0 112.002 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -60.28 -25.72 65.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.427 0.691 . . . . 0.0 111.869 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -67.04 -48.16 69.18 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -19.5 61.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 125.413 1.485 . . . . 0.0 113.401 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.26 -15.21 62.88 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.497 -0.752 . . . . 0.0 110.888 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.9 mt -124.18 154.83 39.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.444 1.498 . . . . 0.0 108.519 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -67.59 152.52 96.19 Favored Pre-proline 0 CA--C 1.54 0.576 0 O-C-N 121.663 -0.648 . . . . 0.0 110.133 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.2 -36.27 7.45 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.109 2.539 . . . . 0.0 114.675 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -63.59 -43.18 97.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.437 0.562 . . . . 0.0 111.088 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -23.28 62.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.353 1.461 . . . . 0.0 111.667 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -70.45 -22.63 62.67 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.561 1.073 . . . . 0.0 110.621 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.61 -23.74 67.36 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.35 1.06 . . . . 0.0 111.189 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.36 -17.38 60.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.256 1.022 . . . . 0.0 113.424 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.67 14.94 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.46 168.78 4.28 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 122.723 1.249 . . . . 0.0 112.083 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -159.93 177.97 10.22 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 129.008 2.923 . . . . 0.0 105.168 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -64.12 99.01 0.24 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.492 1.117 . . . . 0.0 111.097 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.88 -84.88 0.47 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 124.588 1.09 . . . . 0.0 110.892 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 153.46 41.84 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.784 0.802 . . . . 0.0 109.968 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.6 mt -91.62 152.06 20.42 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.4 pt -111.77 -27.73 2.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.831 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.92 174.76 14.68 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.478 1.035 . . . . 0.0 108.771 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.536 ' CD2' HD12 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -125.7 150.5 68.62 Favored Pre-proline 0 C--O 1.239 0.517 0 C-N-CA 124.386 1.075 . . . . 0.0 110.209 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.83 141.68 41.45 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.266 2.644 . . . . 0.0 107.851 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.3 mm -126.44 -45.51 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.691 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.37 122.34 10.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -90.36 118.68 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.482 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 54.7 mt . . . . . 0 C--O 1.236 0.387 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 27.6 p90 . . . . . 0 N--CA 1.451 -0.38 0 C-N-CA 124.799 1.239 . . . . 0.0 110.576 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo . . . . . 0 N--CA 1.46 -0.486 0 N-CA-C 110.868 -0.474 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -118.13 -2.5 11.2 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.296 -0.877 . . . . 0.0 112.71 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -169.41 160.48 9.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.416 1.087 . . . . 0.0 108.443 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -67.88 -24.57 65.25 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.091 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -69.93 -13.92 62.47 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.228 0.922 . . . . 0.0 112.183 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -90.67 -21.67 21.54 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.337 1.055 . . . . 0.0 110.209 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.3 mm -55.76 -57.37 21.87 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-O 117.83 -1.081 . . . . 0.0 109.214 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.87 -20.4 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 120.983 1.387 . . . . 0.0 113.163 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.58 -40.45 66.6 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.249 1.02 . . . . 0.0 112.067 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 27.5 tp -94.85 -22.92 17.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.492 1.117 . . . . 0.0 112.077 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -61.28 -35.39 77.17 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.785 -1.197 . . . . 0.0 111.252 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -75.54 -33.94 60.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.885 1.274 . . . . 0.0 111.188 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -70.21 -45.5 66.47 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.43 -32.37 73.2 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.77 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -70.96 -28.95 64.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.597 0.635 . . . . 0.0 109.566 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.88 -26.6 63.32 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.404 0.547 . . . . 0.0 111.102 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.61 -1.21 16.94 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.122 0.969 . . . . 0.0 112.812 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.21 -98.72 0.12 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -142.18 178.74 7.34 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.623 1.169 . . . . 0.0 112.062 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.2 p -53.98 156.09 3.13 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.74 1.616 . . . . 0.0 113.088 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.74 -58.51 2.55 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.678 1.591 . . . . 0.0 109.959 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.51 142.69 47.35 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.484 0.714 . . . . 0.0 112.075 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 55.5 mtp -144.97 135.48 24.32 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 128.308 2.643 . . . . 0.0 105.749 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -156.19 168.63 26.69 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.069 1.748 . . . . 0.0 107.48 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.73 HD22 ' HB2' ' A' ' 210' ' ' TYR . 37.9 t-20 -75.93 126.26 30.66 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.9 mp -114.62 -8.14 12.72 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.607 0.639 . . . . 0.0 110.623 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -80.0 -10.28 59.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.307 2.243 . . . . 0.0 112.213 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -115.64 137.55 23.27 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 119.628 1.104 . . . . 0.0 108.206 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.59 -27.66 32.43 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.617 1.545 . . . . 0.0 112.14 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -65.95 -25.3 67.06 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 118.938 0.79 . . . . 0.0 112.015 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -85.58 -9.88 56.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.431 1.014 . . . . 0.0 112.286 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 13.1 p -112.58 -19.86 11.93 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.024 0.929 . . . . 0.0 110.343 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -54.84 41.31 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.01 -24.72 59.19 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.17 1.913 . . . . 0.0 113.515 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.7 tt -69.17 -65.38 0.72 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 37.0 pt -58.66 -28.94 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.981 0.913 . . . . 0.0 113.179 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.78 -22.15 63.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.752 0.821 . . . . 0.0 112.62 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -49.18 -57.12 7.25 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.904 2.081 . . . . 0.0 114.863 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -67.1 -49.2 65.79 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.293 0.371 . . . . 0.0 111.785 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.55 49.19 0.05 OUTLIER Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.517 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -116.76 133.27 10.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -147.51 143.7 28.02 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.91 -68.14 0.46 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -139.01 151.09 46.54 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.557 0.743 . . . . 0.0 111.474 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -74.51 128.77 36.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -151.46 104.46 3.07 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -155.87 155.03 32.2 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 55.03 20.87 3.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.328 1.451 . . . . 0.0 114.429 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.4 6.51 83.76 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 119.416 1.007 . . . . 0.0 113.082 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.65 117.65 32.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 125.703 1.601 . . . . 0.0 107.641 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -116.85 119.17 34.56 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.749 2.02 . . . . 0.0 106.14 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -135.72 110.61 8.77 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.519 0.728 . . . . 0.0 109.059 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.44 0.39 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.215 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -76.98 -19.61 57.1 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.971 -1.081 . . . . 0.0 110.712 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -102.83 96.49 6.87 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.628 1.971 . . . . 0.0 106.52 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 70.8 t -125.68 147.24 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.83 1.252 . . . . 0.0 110.612 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -127.99 22.26 5.43 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 118.333 -1.26 . . . . 0.0 115.574 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.26 -40.33 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.807 2.303 . . . . 0.0 111.907 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -90.47 19.5 5.22 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.496 0.718 . . . . 0.0 112.786 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -70.61 155.23 41.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 120.384 -1.447 . . . . 0.0 110.487 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.51 92.0 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.398 0.679 . . . . 0.0 109.482 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.58 95.78 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.56 -50.82 56.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 117.324 0.562 . . . . 0.0 110.197 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -63.1 -36.21 82.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.583 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.31 74.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.91 0.884 . . . . 0.0 112.187 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -84.85 -24.47 45.28 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 118.612 0.642 . . . . 0.0 112.229 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 52.3 tp -76.39 -49.55 16.47 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.181 0.993 . . . . 0.0 112.401 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.4 -31.99 56.21 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 118.606 0.639 . . . . 0.0 110.433 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -56.57 -44.08 80.65 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.555 1.542 . . . . 0.0 109.891 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -40.74 94.63 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.238 -0.914 . . . . 0.0 110.548 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 22.2 t -64.14 -38.55 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 C-N-CA 125.028 1.331 . . . . 0.0 109.347 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -59.92 -46.95 87.75 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.328 1.451 . . . . 0.0 110.792 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.3 mt -65.9 -37.8 87.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.03 0.832 . . . . 0.0 109.85 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 59.7 mt -67.46 -37.73 79.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -61.47 -41.72 97.68 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.25 -14.76 62.34 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.673 1.189 . . . . 0.0 111.715 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt 60.99 4.44 0.81 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.433 2.693 . . . . 0.0 112.77 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.79 -12.91 60.27 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.312 -0.243 . . . . 0.0 110.862 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 4.2 tpt -88.97 154.78 19.94 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.56 -0.712 . . . . 0.0 110.646 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -82.84 64.3 7.39 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.14 -14.49 4.07 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.59 -15.07 27.35 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.989 1.316 . . . . 0.0 112.761 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 57.4 m -66.71 137.59 56.79 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.094 0.958 . . . . 0.0 111.929 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -131.13 -176.73 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.49 1.916 . . . . 0.0 107.603 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.73 ' HB2' HD22 ' A' ' 150' ' ' ASN . 54.1 t80 -57.53 -45.56 84.9 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.31 -0.244 . . . . 0.0 111.294 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.68 -47.65 76.42 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.189 1.796 . . . . 0.0 111.029 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.89 -48.08 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.844 1.257 . . . . 0.0 110.57 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.16 83.28 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.814 0.734 . . . . 0.0 110.674 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.93 -52.1 40.08 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.27 -49.07 77.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.894 0.478 . . . . 0.0 111.612 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.62 -44.22 89.9 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -61.29 -40.66 94.96 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -58.97 -16.11 16.37 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.623 1.169 . . . . 0.0 113.513 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.0 -13.39 14.1 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.684 1.194 . . . . 0.0 111.387 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.49 18.82 58.07 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.832 1.206 . . . . 0.0 111.098 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -66.97 -12.23 59.14 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.818 1.247 . . . . 0.0 111.606 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 43.6 p -113.36 141.84 46.58 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.646 1.978 . . . . 0.0 109.681 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -82.57 -34.79 27.63 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.42 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 4.2 ptt? -146.3 164.24 32.99 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.784 2.034 . . . . 0.0 111.304 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.5 t -164.79 169.62 16.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.082 1.353 . . . . 0.0 107.687 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mt . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.71 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 C--O 1.239 0.501 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -71.36 134.46 24.72 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.927 1.751 . . . . 0.0 108.805 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.6 p -147.26 -172.49 4.02 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.466 1.506 . . . . 0.0 107.574 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.68 137.02 32.8 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -51.37 128.97 23.97 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.426 -0.796 . . . . 0.0 109.936 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.43 -10.5 6.35 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.863 1.105 . . . . 0.0 115.863 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.65 92.37 14.97 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 120.113 1.957 . . . . 0.0 107.943 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.55 161.96 43.75 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.489 2.126 . . . . 0.0 112.293 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 40.8 t -66.54 150.32 49.16 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.913 1.285 . . . . 0.0 108.763 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -139.22 89.19 12.51 Favored Pre-proline 0 N--CA 1.456 -0.171 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -80.94 -174.58 2.29 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.545 2.83 . . . . 0.0 110.476 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 125.121 1.369 . . . . 0.0 109.49 178.387 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.809 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.85 128.6 50.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.682 0.793 . . . . 0.0 110.409 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.5 tt -62.96 138.23 58.5 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.982 1.313 . . . . 0.0 107.646 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.6 m -118.76 144.23 46.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.826 0.822 . . . . 0.0 110.836 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -138.86 136.9 36.06 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -149.66 145.36 13.46 Favored Glycine 0 C--O 1.236 0.232 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 34.5 mt -69.32 134.52 30.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.229 1.012 . . . . 0.0 108.991 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -90.38 113.61 25.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.16 -14.41 37.13 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.958 1.303 . . . . 0.0 112.934 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.71 78.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.366 0.985 . . . . 0.0 111.88 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 48.7 m -62.13 164.86 9.66 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 123.101 0.25 . . . . 0.0 110.654 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -89.43 -26.17 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.797 2.331 . . . . 0.0 117.06 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -127.68 90.03 3.04 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.664 1.12 . . . . 0.0 110.537 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -62.99 -14.99 54.61 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.656 0.382 . . . . 0.0 111.907 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -66.03 -41.35 91.06 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 75.3 mt -57.0 -37.51 71.78 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.375 -0.828 . . . . 0.0 110.148 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.92 -48.04 60.09 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 122.041 -0.412 . . . . 0.0 110.789 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -31.44 71.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.981 -0.533 . . . . 0.0 111.152 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -75.86 -42.51 49.19 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.95 -46.04 90.69 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.952 1.251 . . . . 0.0 108.855 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.9 mp -63.65 -48.1 78.59 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 117.509 -1.234 . . . . 0.0 110.973 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -79.9 -20.55 45.56 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -97.79 -20.18 17.7 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.949 1.704 . . . . 0.0 113.019 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -138.6 -33.55 0.66 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-O 117.503 -1.237 . . . . 0.0 114.198 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.4 -57.1 4.09 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 121.167 1.803 . . . . 0.0 111.797 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.46 23.54 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 128.1 2.56 . . . . 0.0 114.137 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 77.2 p -98.65 160.99 13.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -65.08 -30.67 71.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -71.0 -47.43 58.87 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.353 1.061 . . . . 0.0 111.202 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -63.43 -47.34 88.3 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.12 -41.03 97.84 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.299 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -64.17 -43.27 95.64 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.434 0.561 . . . . 0.0 109.539 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.67 -43.5 85.07 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.587 0.631 . . . . 0.0 112.385 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 41.4 t -71.05 -38.45 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.718 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -68.54 -26.75 65.58 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.449 0.568 . . . . 0.0 111.797 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -66.43 -50.97 61.6 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.76 -52.12 65.54 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 119.085 -0.483 . . . . 0.0 112.23 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -140.6 147.42 48.99 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-N 119.04 0.836 . . . . 0.0 109.419 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.93 123.26 11.36 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.33 2.02 . . . . 0.0 111.06 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 28.5 mt -94.52 -6.91 42.69 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.728 1.211 . . . . 0.0 112.519 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 63.12 -141.92 46.91 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 107.018 -2.433 . . . . 0.0 107.018 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.1 176.45 9.66 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.95 157.11 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 120.683 -1.26 . . . . 0.0 112.941 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -82.4 -25.3 33.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.34 111.2 7.33 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -56.8 -33.56 66.81 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.8 m -54.67 -57.26 12.19 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.842 1.257 . . . . 0.0 110.35 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -81.03 -13.04 59.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.684 0.794 . . . . 0.0 112.414 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -63.73 -33.13 74.96 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -69.52 -17.33 63.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.379 0.672 . . . . 0.0 111.284 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.503 ' HA ' ' HE2' ' A' ' 313' ' ' LYS . 45.1 mm-40 -93.73 -46.15 7.36 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.471 1.508 . . . . 0.0 109.415 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 7.1 mt -69.15 -34.37 74.89 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.264 -0.897 . . . . 0.0 110.463 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.05 -15.97 48.59 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.503 ' HE2' ' HA ' ' A' ' 310' ' ' GLU . 54.2 mttm -54.3 -34.64 61.35 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 118.912 0.778 . . . . 0.0 110.699 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -93.22 136.01 24.95 Favored Pre-proline 0 N--CA 1.448 -0.549 0 C-N-CA 123.983 0.913 . . . . 0.0 110.35 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.98 -23.03 75.38 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.372 2.048 . . . . 0.0 114.472 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.72 -47.9 81.09 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 119.24 0.927 . . . . 0.0 109.752 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.2 mp -67.82 -59.2 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.079 1.352 . . . . 0.0 109.526 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.94 -46.52 64.76 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.61 -37.82 76.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 119.39 0.995 . . . . 0.0 112.597 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 88.6 m -68.68 -37.1 79.32 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.038 0.935 . . . . 0.0 108.97 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.6 tpt -66.04 -48.13 72.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.273 1.029 . . . . 0.0 109.883 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -58.82 -37.59 76.73 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.993 0.815 . . . . 0.0 110.412 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -69.39 -37.28 77.46 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.537 0 CA-C-N 118.959 0.799 . . . . 0.0 110.829 178.271 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.456 -0.7 0 CA-C-O 121.42 0.508 . . . . 0.0 113.24 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -81.53 73.79 8.55 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 6.1 pt -132.15 157.77 77.34 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 126.177 1.791 . . . . 0.0 109.935 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -71.15 -33.82 11.03 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.952 1.768 . . . . 0.0 111.76 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.77 -19.64 29.51 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 6.2 mmt -64.62 -29.73 70.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.656 0.662 . . . . 0.0 109.644 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 20.1 m -56.38 -53.49 56.75 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.001 0.92 . . . . 0.0 110.544 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.41 -39.75 64.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.644 -1.169 . . . . 0.0 110.549 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -48.39 -55.87 9.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.433 1.015 . . . . 0.0 112.147 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -60.31 -53.04 62.37 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.946 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -60.23 -42.65 95.67 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 118.705 0.684 . . . . 0.0 112.766 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -58.84 -56.68 19.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.132 1.373 . . . . 0.0 110.254 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 33.6 t -65.96 -38.78 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 118.47 -0.776 . . . . 0.0 110.023 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -54.11 -45.77 71.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.685 1.13 . . . . 0.0 108.18 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 28.0 m -70.13 -46.35 64.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.584 -0.722 . . . . 0.0 110.253 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -51.21 -45.04 61.75 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.189 0.904 . . . . 0.0 112.661 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.08 -57.96 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 125.126 1.37 . . . . 0.0 108.457 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 48.0 mm -60.57 -38.46 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.264 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -60.03 -48.14 82.96 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.669 1.122 . . . . 0.0 109.288 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.93 -49.14 60.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.858 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.51 -23.67 66.08 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.934 1.294 . . . . 0.0 113.319 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.3 m -94.79 -2.66 50.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.397 0.679 . . . . 0.0 109.945 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.41 12.63 69.86 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.753 0.706 . . . . 0.0 111.534 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -69.93 -36.04 75.01 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.02 0.928 . . . . 0.0 109.827 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -142.18 164.83 29.09 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 359' ' ' GLU . 15.4 t -81.37 159.96 24.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.07 -52.63 42.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 124.917 1.287 . . . . 0.0 109.843 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.47 -47.81 69.43 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 127.115 2.166 . . . . 0.0 111.42 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . 0.48 ' H ' HG23 ' A' ' 356' ' ' THR . 47.6 mm-40 -75.46 -33.26 60.85 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.733 0.697 . . . . 0.0 111.174 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.56 85.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.1 mp -68.35 -45.91 71.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.571 1.949 . . . . 0.0 110.445 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -55.52 -58.09 9.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.24 1.016 . . . . 0.0 108.536 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -53.3 -42.25 66.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.166 2.187 . . . . 0.0 112.084 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -68.66 -49.82 56.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.878 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -58.68 -32.25 68.95 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.21 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 6.6 m -63.38 -36.48 83.85 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.93 1.241 . . . . 0.0 110.62 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 12.2 mtt85 -65.84 -30.84 71.53 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.95 -1.094 . . . . 0.0 110.908 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 36.5 mt -82.58 -37.98 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.633 1.573 . . . . 0.0 111.15 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 65.9 p -78.29 -12.09 59.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.763 1.165 . . . . 0.0 112.921 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? . . . . . 0 C--O 1.254 1.294 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.025 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 . . . . . 0 C--O 1.232 0.137 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -81.18 -176.08 5.78 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.808 2.043 . . . . 0.0 109.342 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.33 29.48 73.29 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.129 -0.982 . . . . 0.0 114.759 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.99 162.12 37.69 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.252 1.021 . . . . 0.0 111.285 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.6 mt -152.53 147.4 26.16 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 130.095 3.358 . . . . 0.0 106.59 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.408 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 94.5 t -144.95 146.46 19.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.123 1.369 . . . . 0.0 108.639 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.462 HD12 HG22 ' A' ' 37' ' ' VAL . 20.5 mt -134.79 139.4 47.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -126.73 124.49 39.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 12' ' ' ASN . 1.5 mp -131.9 171.63 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.165 1.386 . . . . 0.0 108.327 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.441 ' H ' HG22 ' A' ' 11' ' ' ILE . 14.8 p-10 -103.94 157.28 17.21 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.403 1.481 . . . . 0.0 109.345 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.46 -22.15 60.98 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 125.608 1.575 . . . . 0.0 114.4 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -77.39 -3.11 38.52 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.522 1.661 . . . . 0.0 109.91 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.14 160.86 15.74 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 120.883 -1.136 . . . . 0.0 110.566 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.81 75.55 2.36 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.771 1.177 . . . . 0.0 110.238 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -74.38 -24.6 59.16 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -73.33 -43.1 61.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.744 1.611 . . . . 0.0 110.535 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.75 -30.66 73.18 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.3 tp -74.91 -40.69 60.73 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.804 1.242 . . . . 0.0 110.958 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.14 -46.97 54.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.115 0.566 . . . . 0.0 109.967 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -55.66 -32.85 63.58 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.8 t -64.89 -41.14 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.07 -38.47 73.57 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.021 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -59.36 -43.79 92.77 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.473 1.137 . . . . 0.0 108.325 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -60.22 -55.1 37.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.328 0.651 . . . . 0.0 109.803 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -58.4 -51.84 68.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.749 0.655 . . . . 0.0 111.989 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.43 -31.06 70.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.943 0.897 . . . . 0.0 110.74 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' CE ' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -68.41 -31.77 71.35 Favored 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 120.752 -1.218 . . . . 0.0 110.198 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.29 -47.12 9.69 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 123.629 0.581 . . . . 0.0 111.961 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -90.05 -32.3 16.79 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 -176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.52 -10.77 72.22 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 120.97 -1.081 . . . . 0.0 111.658 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.29 136.52 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HE2' ' N ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -66.63 134.7 52.83 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 117.785 -1.102 . . . . 0.0 109.359 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -134.31 78.46 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.66 155.55 29.44 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.462 HG22 HD12 ' A' ' 9' ' ' ILE . 94.4 t -141.54 127.91 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -136.53 161.43 35.89 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -123.34 68.13 37.98 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.106 0.963 . . . . 0.0 111.004 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -66.35 170.72 11.61 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.545 2.164 . . . . 0.0 111.114 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -122.97 -3.12 8.63 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.223 -0.923 . . . . 0.0 111.905 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -132.21 12.1 4.62 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.361 1.865 . . . . 0.0 112.785 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.94 -32.48 20.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.073 0.851 . . . . 0.0 112.315 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -52.54 -30.19 29.36 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.51 1.124 . . . . 0.0 112.259 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -116.9 -18.79 10.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.856 0.862 . . . . 0.0 112.206 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -41.38 31.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -51.41 -59.86 6.99 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.762 0.825 . . . . 0.0 109.834 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.47 -17.48 59.74 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 CA-C-N 121.245 1.48 . . . . 0.0 113.617 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -84.08 -5.48 59.24 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.667 1.121 . . . . 0.0 112.391 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.63 -38.85 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.031 0.932 . . . . 0.0 108.805 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.93 -32.54 70.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.213 1.005 . . . . 0.0 111.344 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.98 -31.61 68.91 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.741 0.7 . . . . 0.0 110.562 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.8 m -86.39 -15.97 38.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.598 1.159 . . . . 0.0 110.202 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.79 36.57 5.51 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.198 1.38 . . . . 0.0 110.381 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -132.16 173.71 10.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.691 1.196 . . . . 0.0 108.618 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.13 -160.21 14.77 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 126.497 1.998 . . . . 0.0 113.554 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.27 175.83 2.4 Favored 'Trans proline' 0 C--N 1.356 0.964 1 C-N-CA 125.861 4.374 . . . . 0.0 114.113 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 3.9 m-20 -106.96 -18.59 13.87 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.8 -1.187 . . . . 0.0 113.999 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.4 mt -148.22 135.15 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.33 1.052 . . . . 0.0 109.006 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.2 tt -115.19 142.06 29.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -129.95 107.57 9.46 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.45 1.5 . . . . 0.0 108.16 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.8 t-105 -156.13 -176.67 6.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.966 0.803 . . . . 0.0 111.553 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.35 138.14 51.16 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -46.37 -43.44 16.17 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 126.157 1.783 . . . . 0.0 113.619 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -55.53 -27.76 50.73 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -81.47 -18.66 44.44 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.764 0.711 . . . . 0.0 111.567 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -76.32 -13.51 60.14 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 118.465 -0.779 . . . . 0.0 112.833 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.13 -11.69 33.69 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.284 0.945 . . . . 0.0 113.544 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.95 -63.03 0.92 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -47.53 -56.37 7.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.043 1.737 . . . . 0.0 114.331 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.27 91.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.21 0.604 . . . . 0.0 111.758 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.31 -43.91 75.29 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.068 1.347 . . . . 0.0 109.717 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.5 m -74.87 -1.25 21.49 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.486 1.115 . . . . 0.0 113.347 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.77 18.15 64.22 Favored Glycine 0 C--N 1.337 0.626 0 O-C-N 120.805 -1.184 . . . . 0.0 113.602 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.6 mt -77.65 -32.91 53.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.687 1.244 . . . . 0.0 112.359 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.2 mt -91.45 142.1 28.03 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.476 -0.765 . . . . 0.0 111.706 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -78.88 172.24 14.05 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.857 1.263 . . . . 0.0 113.167 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -69.93 100.13 1.52 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.585 1.954 . . . . 0.0 108.911 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.514 HD12 ' CD2' ' A' ' 106' ' ' TYR . 9.9 mm -63.33 153.75 6.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.912 0.863 . . . . 0.0 110.107 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.9 m 60.86 77.44 0.37 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 127.376 2.27 . . . . 0.0 109.725 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 -26.17 21.53 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.274 1.316 . . . . 0.0 110.252 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -129.94 138.09 50.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.523 1.529 . . . . 0.0 110.754 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -57.49 -37.0 72.22 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.74 -24.42 56.9 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.308 1.413 . . . . 0.0 112.953 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.8 -28.23 68.85 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.693 0.679 . . . . 0.0 110.648 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -66.01 -43.96 86.17 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -64.95 -11.84 43.0 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.45 0.7 . . . . 0.0 111.894 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -87.19 -15.89 36.97 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 120.767 -1.208 . . . . 0.0 112.578 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.489 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 25.2 mt -124.17 163.12 22.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.475 1.034 . . . . 0.0 112.625 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -81.23 153.33 71.68 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 123.71 0.804 . . . . 0.0 112.03 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.05 -47.78 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 124.378 3.385 . . . . 0.0 114.216 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -54.05 -36.74 63.4 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.078 1.308 . . . . 0.0 111.937 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.435 HG22 ' CB ' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -73.5 -27.68 61.51 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.726 1.61 . . . . 0.0 110.634 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.489 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 12.9 m95 -69.5 -36.79 76.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.631 1.105 . . . . 0.0 109.999 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -63.2 -27.43 69.36 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.632 -0.667 . . . . 0.0 111.063 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.76 -4.16 22.43 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.291 1.437 . . . . 0.0 113.979 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.34 6.91 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 125.4 1.48 . . . . 0.0 111.206 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -71.6 170.67 12.92 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -149.14 -152.14 0.43 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -57.48 -11.76 2.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.536 1.934 . . . . 0.0 115.708 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.38 -85.14 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 105.563 -3.015 . . . . 0.0 105.563 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 162.08 16.98 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.425 0.69 . . . . 0.0 110.706 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.11 158.46 18.56 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.245 1.018 . . . . 0.0 109.614 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.0 pt -117.62 -24.5 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.651 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.418 ' CA ' HG13 ' A' ' 79' ' ' ILE . . . -156.81 -178.46 7.38 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.811 1.244 . . . . 0.0 110.051 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.514 ' CD2' HD12 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -136.82 149.52 67.1 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 123.895 0.878 . . . . 0.0 111.355 178.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.435 ' CB ' HG22 ' A' ' 93' ' ' THR . 96.3 Cg_endo -75.01 142.62 28.05 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.843 2.362 . . . . 0.0 109.891 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.3 mm -124.56 -52.76 2.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.698 1.599 . . . . 0.0 108.173 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.34 148.81 43.27 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.827 1.251 . . . . 0.0 109.824 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.5 t -130.51 95.67 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.095 0.958 . . . . 0.0 109.254 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 N--CA 1.472 0.652 0 C-N-CA 124.491 1.117 . . . . 0.0 109.277 178.638 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.442 ' HB ' HG23 ' A' ' 225' ' ' THR . 5.3 mp . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.9 p90 . . . . . 0 C--O 1.236 0.39 0 C-N-CA 123.96 0.904 . . . . 0.0 109.086 178.984 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.455 -0.745 0 N-CA-C 108.721 -1.3 . . . . 0.0 108.721 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -80.72 -25.55 38.01 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.045 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.6 t -154.67 162.69 41.02 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.413 1.006 . . . . 0.0 109.689 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -65.75 -25.79 67.44 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 123.864 0.866 . . . . 0.0 111.786 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -71.56 -19.27 62.17 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.923 1.238 . . . . 0.0 109.79 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -89.37 -22.88 22.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.368 1.067 . . . . 0.0 111.125 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 15.8 mm -54.73 -59.33 10.81 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.195 -0.907 . . . . 0.0 108.796 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -69.87 -25.02 28.5 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.222 1.281 . . . . 0.0 111.47 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.16 -50.36 70.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 64.0 tp -70.13 -31.74 69.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -59.09 -44.76 91.95 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 118.684 0.674 . . . . 0.0 111.305 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -30.12 61.37 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.551 0.614 . . . . 0.0 110.832 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -66.27 -50.89 62.17 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.1 mt -67.48 -33.01 74.24 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.562 -1.208 . . . . 0.0 110.287 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -68.87 -34.62 75.74 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.931 1.241 . . . . 0.0 108.971 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.38 -16.36 62.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.378 0.536 . . . . 0.0 112.018 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.24 7.5 6.5 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.173 1.389 . . . . 0.0 112.121 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 170.92 -94.52 0.1 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 115.737 1.055 . . . . 0.0 115.737 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.74 -178.88 5.44 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.38 1.072 . . . . 0.0 113.58 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.64 169.08 9.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.803 1.287 . . . . 0.0 112.612 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -93.26 -73.12 0.57 Allowed 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.066 1.746 . . . . 0.0 109.292 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.9 tp -103.42 130.4 50.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.261 1.024 . . . . 0.0 112.749 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 76.7 mtp -131.37 117.3 18.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -143.22 156.31 44.72 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.69 88.22 0.35 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.746 1.618 . . . . 0.0 109.577 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -18.04 63.38 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.067 1.347 . . . . 0.0 109.812 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -71.41 -13.14 61.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.536 0.734 . . . . 0.0 112.644 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -103.76 129.3 25.57 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 119.19 0.905 . . . . 0.0 109.739 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.92 -10.41 23.03 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.786 2.324 . . . . 0.0 113.248 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -65.44 -42.09 92.75 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.796 1.638 . . . . 0.0 112.758 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -79.52 -32.67 42.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.6 p -84.33 -11.68 55.93 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.274 0.63 . . . . 0.0 111.77 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -53.75 -58.86 11.33 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 117.625 -1.178 . . . . 0.0 112.044 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.53 -18.01 58.53 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.281 1.493 . . . . 0.0 114.055 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.0 tp -71.35 -63.77 1.05 Allowed 'General case' 0 C--N 1.34 0.193 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.4 pt -66.41 -36.03 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.26 -12.97 59.54 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.121 -0.943 . . . . 0.0 113.095 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -44.63 -55.95 4.78 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 125.513 1.525 . . . . 0.0 114.06 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.78 -34.68 74.86 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.53 19.73 0.02 OUTLIER Glycine 0 C--N 1.332 0.335 0 CA-C-O 118.294 -1.281 . . . . 0.0 116.068 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.13 144.1 34.21 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 119.402 1.601 . . . . 0.0 111.548 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.427 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 51.7 p90 -153.86 144.99 22.85 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.46 -49.56 12.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.499 ' CD2' HD11 ' A' ' 333' ' ' ILE . 65.7 m-85 -145.9 133.67 21.16 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.646 0.778 . . . . 0.0 109.658 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.427 ' HE2' ' CE1' ' A' ' 167' ' ' TYR . 14.5 tppt? -70.65 149.53 46.92 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.522 0.729 . . . . 0.0 110.037 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -143.32 113.06 7.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -156.07 170.03 23.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 55.96 26.96 10.49 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.603 1.161 . . . . 0.0 111.495 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 56.17 43.79 88.88 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -149.5 166.54 28.85 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 126.69 1.996 . . . . 0.0 108.198 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.19 127.65 54.96 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -126.7 87.78 2.72 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 123.117 1.437 . . . . 0.0 112.184 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.439 ' H ' HD13 ' A' ' 178' ' ' ILE . 0.2 OUTLIER -63.61 -8.92 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.403 178.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -74.54 -12.34 60.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.373 1.069 . . . . 0.0 108.987 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.412 ' OD2' ' HE3' ' A' ' 170' ' ' LYS . 61.7 t0 -118.94 93.57 4.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.244 1.417 . . . . 0.0 108.349 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 86.8 t -99.03 147.2 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -129.89 44.77 1.19 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-O 119.185 -0.786 . . . . 0.0 111.947 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.3 t -86.76 -63.42 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 124.958 1.303 . . . . 0.0 108.725 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -85.9 67.63 10.08 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 122.538 1.161 . . . . 0.0 110.029 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -121.48 159.34 26.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.93 -38.89 70.89 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -56.46 -46.66 87.24 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.702 0.683 . . . . 0.0 113.503 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.43 -52.6 60.84 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.891 0.476 . . . . 0.0 111.349 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -64.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 118.318 -0.849 . . . . 0.0 111.879 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.31 -51.91 39.44 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.73 -38.99 94.68 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.488 HD23 HG13 ' A' ' 357' ' ' VAL . 56.1 tp -70.61 -45.2 65.71 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 118.291 -0.862 . . . . 0.0 111.324 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.12 -37.92 67.51 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 117.313 -1.327 . . . . 0.0 110.736 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -52.17 -48.71 64.83 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.784 1.629 . . . . 0.0 111.344 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.7 tt -69.22 -48.01 63.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.114 0.566 . . . . 0.0 110.645 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.66 -35.15 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 121.38 -0.825 . . . . 0.0 111.41 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.01 -29.6 69.47 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.204 -0.935 . . . . 0.0 109.279 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.94 -42.3 60.74 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 65.8 mt -58.38 -47.9 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -52.18 -51.29 58.98 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.181 1.392 . . . . 0.0 109.73 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -78.47 0.9 24.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.158 0.983 . . . . 0.0 112.087 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt 60.78 12.06 3.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 128.109 2.564 . . . . 0.0 113.812 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.79 6.35 1.2 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 127.272 2.229 . . . . 0.0 111.806 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 14.3 ttt -147.49 143.8 28.11 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.108 1.322 . . . . 0.0 109.649 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -83.36 70.28 10.14 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -47.81 -40.31 20.75 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.492 2.717 . . . . 0.0 116.388 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -72.02 0.23 9.95 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.044 1.738 . . . . 0.0 114.113 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.8 m -65.37 123.18 18.93 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.008 -1.058 . . . . 0.0 110.512 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.1 -172.65 2.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.073 1.749 . . . . 0.0 108.241 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -60.2 -50.57 73.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.649 0.38 . . . . 0.0 110.91 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.1 m -60.89 -41.07 95.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.537 0.735 . . . . 0.0 111.132 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 41.4 mm -65.59 -49.33 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.879 -1.058 . . . . 0.0 108.556 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.16 -46.15 90.27 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.235 1.014 . . . . 0.0 111.707 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -62.78 -48.08 80.68 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.91 1.284 . . . . 0.0 108.888 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.53 87.81 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.94 99.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -62.22 -39.08 91.61 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -57.32 -20.2 27.06 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.558 1.543 . . . . 0.0 111.774 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.38 -13.14 12.9 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.889 -1.132 . . . . 0.0 112.095 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.44 28.31 40.26 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.213 1.387 . . . . 0.0 110.47 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.83 7.18 4.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.585 1.954 . . . . 0.0 113.372 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.06 160.49 43.28 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 120.683 -1.261 . . . . 0.0 108.905 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -106.34 -15.14 14.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.536 1.534 . . . . 0.0 113.606 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -159.88 153.46 22.57 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.889 1.276 . . . . 0.0 109.976 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.442 HG23 ' HB ' ' A' ' 116' ' ' ILE . 4.3 t -150.02 161.1 43.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.4 mt . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 -179.791 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 118.781 -0.628 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.59 159.43 53.61 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.572 1.515 . . . . 0.0 109.622 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 255' ' ' SER . 68.1 p -120.68 -176.4 3.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.369 1.068 . . . . 0.0 109.987 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -100.16 169.35 9.21 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.568 1.076 . . . . 0.0 109.762 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -66.86 126.31 28.66 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.24 3.41 57.02 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 117.848 -1.529 . . . . 0.0 115.327 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.32 137.19 9.2 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 121.706 2.753 . . . . 0.0 114.347 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.42 146.7 40.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.881 2.387 . . . . 0.0 108.568 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.516 ' H ' HG22 ' A' ' 249' ' ' THR . 10.4 p -72.62 173.46 8.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . 0.344 12.8 ptmt -133.32 71.87 75.99 Favored Pre-proline 0 C--O 1.238 0.495 0 O-C-N 120.857 -1.152 . . . . 0.0 112.843 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.88 166.18 30.31 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.704 3.603 . . . . 0.0 113.291 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 . . . . . 0 C--O 1.237 0.439 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.005 179.668 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.99 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 14.9 m -138.21 168.4 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 119.794 1.797 . . . . 0.0 110.979 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 15.6 tp -74.96 152.2 38.8 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.0 m -133.87 129.6 36.64 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 121.122 1.783 . . . . 0.0 111.885 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -116.01 132.87 56.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.1 134.15 6.74 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.101 0.864 . . . . 0.0 112.608 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 81.5 mt -74.58 145.93 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 117.67 0.735 . . . . 0.0 109.842 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -75.52 124.98 28.11 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.315 1.446 . . . . 0.0 109.028 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.12 -22.29 65.8 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.251 -0.906 . . . . 0.0 113.06 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -77.82 -10.61 59.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.696 1.199 . . . . 0.0 112.606 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 70.4 m -65.96 146.45 99.01 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.97 -38.64 3.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.663 1.575 . . . . 0.0 112.672 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -132.23 88.22 2.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.649 0.78 . . . . 0.0 109.419 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -54.7 -22.97 15.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.123 0.969 . . . . 0.0 112.011 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -61.87 -30.68 71.02 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.06 1.344 . . . . 0.0 111.27 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.34 -42.01 94.77 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 121.183 -0.948 . . . . 0.0 108.553 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.19 -40.29 68.0 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.79 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -37.68 86.68 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 118.585 0.63 . . . . 0.0 109.957 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -73.64 -41.01 63.33 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -57.84 -49.69 75.83 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.703 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.8 mp -64.32 -49.36 72.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 119.104 -0.475 . . . . 0.0 111.53 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -71.29 -15.68 62.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -105.7 -19.7 13.68 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.969 1.713 . . . . 0.0 113.961 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -137.52 -45.51 0.55 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 117.923 -1.037 . . . . 0.0 111.843 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -59.15 -55.83 29.9 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.059 1.299 . . . . 0.0 111.68 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.5 mt -84.12 63.41 7.64 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.624 2.37 . . . . 0.0 110.38 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 68.9 p -138.87 161.55 36.99 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.95 -21.72 66.88 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 122.839 0.456 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -96.37 -27.68 14.82 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.052 0.941 . . . . 0.0 110.79 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -80.51 -43.96 8.94 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.568 1.08 . . . . 0.0 112.116 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 35.7 mt -65.22 -40.7 94.44 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -58.13 -47.23 83.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.783 1.233 . . . . 0.0 109.425 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.43 74.52 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.464 1.029 . . . . 0.0 112.839 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 24.8 t -73.54 -35.72 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 118.912 -0.566 . . . . 0.0 109.924 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -68.94 -29.87 68.2 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.807 0.731 . . . . 0.0 110.775 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -64.12 -38.27 90.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -51.14 35.83 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 123.518 0.511 . . . . 0.0 110.21 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -147.79 150.61 36.68 Favored Pre-proline 0 C--N 1.344 0.356 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.693 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.57 115.1 2.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.709 2.939 . . . . 0.0 110.792 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 90.9 mt -91.57 -20.94 21.14 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.23 -158.41 24.65 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.25 175.64 4.48 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 35.8 m -127.71 146.9 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 120.043 -1.661 . . . . 0.0 110.329 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.29 -29.47 63.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.662 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 22.3 tp -68.52 106.31 2.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -52.23 -27.33 14.41 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.007 0.923 . . . . 0.0 112.405 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.4 m -61.64 -70.94 0.16 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.663 0.785 . . . . 0.0 111.042 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -66.98 -21.14 65.97 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.188 0.449 . . . . 0.0 111.39 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -65.08 -25.51 67.83 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.24 -18.21 61.84 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.153 -1.592 . . . . 0.0 110.009 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -89.04 -51.77 5.43 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.999 1.32 . . . . 0.0 107.527 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.471 ' HB3' HG21 ' A' ' 317' ' ' ILE . 47.7 mt -61.26 -41.52 97.05 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.59 3.32 1.9 Allowed 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.672 0.789 . . . . 0.0 112.563 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -59.66 -25.73 64.96 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.486 1.494 . . . . 0.0 109.219 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.91 147.56 37.48 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.52 -14.22 43.16 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.138 2.559 . . . . 0.0 114.585 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -62.1 -56.31 20.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.784 1.174 . . . . 0.0 108.975 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 317' ' ' ILE . 4.2 mp -62.85 -51.78 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 125.306 1.442 . . . . 0.0 108.616 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.49 -48.4 62.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 123.447 0.467 . . . . 0.0 110.56 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.22 -33.69 71.28 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 1.3 m -67.21 -41.62 85.46 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -38.79 66.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.084 0.554 . . . . 0.0 111.973 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -53.41 -39.02 64.0 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 124.626 1.17 . . . . 0.0 109.323 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.06 -30.87 68.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.273 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.539 0.772 0 N-CA-C 110.883 -0.468 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -61.02 0.31 0.24 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . 0.499 HD11 ' CD2' ' A' ' 169' ' ' PHE . 22.7 pt -69.5 150.13 96.98 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 120.549 1.522 . . . . 0.0 114.223 -178.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.97 -13.69 39.03 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.236 2.624 . . . . 0.0 114.396 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -71.34 -13.08 61.75 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.998 -1.064 . . . . 0.0 110.727 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 73.8 mmm -66.09 -28.7 69.02 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 121.373 -0.829 . . . . 0.0 111.759 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 29.9 t -55.35 -51.51 66.54 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.98 -39.1 87.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.954 0.901 . . . . 0.0 110.987 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -51.94 -54.76 25.82 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.923 0.889 . . . . 0.0 110.148 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -64.26 -45.65 87.19 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.643 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -53.71 -42.16 67.76 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.377 0.671 . . . . 0.0 110.725 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.0 -62.57 1.32 Allowed 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 125.601 1.56 . . . . 0.0 112.637 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.57 -36.8 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.977 0.911 . . . . 0.0 111.827 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.47 -49.4 45.64 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.75 1.159 . . . . 0.0 110.356 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 6.6 m -73.53 -42.63 61.49 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.14 57.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.822 1.192 . . . . 0.0 112.745 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.2 t -61.28 -56.1 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 32.3 mm -59.96 -37.2 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.24 0.616 . . . . 0.0 110.657 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -57.21 -47.59 80.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.337 0.972 . . . . 0.0 109.539 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.0 -47.95 55.91 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.566 0.747 . . . . 0.0 110.816 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.89 -24.67 66.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.978 0.911 . . . . 0.0 112.924 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 18.5 m -92.16 -8.51 45.39 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.669 1.188 . . . . 0.0 110.513 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 69.97 16.18 72.42 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.608 0.64 . . . . 0.0 111.76 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -76.62 -33.44 58.39 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 118.092 0.946 . . . . 0.0 110.019 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -143.52 148.95 36.76 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 8.9 t -65.98 156.99 32.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.488 HG13 HD23 ' A' ' 192' ' ' LEU . 64.6 t -56.88 -47.99 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 123.742 0.817 . . . . 0.0 109.786 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -52.39 -46.6 66.31 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.31 0.644 . . . . 0.0 111.036 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -69.48 -36.46 76.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 119.457 -0.306 . . . . 0.0 111.048 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.09 -45.03 90.49 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 8.1 mt -69.18 -41.31 77.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.345 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -56.58 -49.47 74.77 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.911 1.285 . . . . 0.0 109.307 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -51.94 -56.4 14.42 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.261 1.824 . . . . 0.0 108.786 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.78 -49.85 76.11 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.182 1.393 . . . . 0.0 113.403 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -55.3 -38.5 68.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.579 1.551 . . . . 0.0 109.196 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.7 m -65.75 -42.79 90.52 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.425 -0.797 . . . . 0.0 109.855 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -59.2 -26.59 64.96 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.272 0.942 . . . . 0.0 113.233 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.7 mt -79.51 -25.1 12.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.047 0.939 . . . . 0.0 109.531 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 43.9 p -93.39 -23.65 18.35 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.491 0.716 . . . . 0.0 112.271 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.445 1.498 . . . . 0.0 108.346 -178.55 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -75.57 82.12 2.59 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.2 2.2 . . . . 0.0 108.325 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.71 32.43 0.04 OUTLIER Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.21 -1.359 . . . . 0.0 115.312 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -145.8 166.63 25.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.34 1.57 . . . . 0.0 111.357 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 mt -146.41 145.8 30.38 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.781 2.032 . . . . 0.0 107.195 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.82 144.55 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.945 1.298 . . . . 0.0 108.363 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.1 mt -131.74 135.16 59.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 126.606 1.963 . . . . 0.0 108.243 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -126.05 111.82 15.15 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -140.88 148.11 22.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 C-N-CA 124.426 1.09 . . . . 0.0 109.035 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.31 177.56 11.22 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.196 -0.94 . . . . 0.0 110.384 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.13 55.4 7.93 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-O 118.734 -1.036 . . . . 0.0 110.98 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.3 34.52 20.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.728 1.211 . . . . 0.0 113.424 177.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 20.32 0.06 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 116.261 1.949 . . . . 0.0 116.261 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.11 44.18 98.48 Favored Glycine 0 CA--C 1.536 1.396 0 O-C-N 120.678 -1.264 . . . . 0.0 111.318 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -60.35 -40.2 89.84 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -68.34 -39.79 81.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.026 1.284 . . . . 0.0 108.721 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.06 -35.08 91.6 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.7 tp -71.43 -35.46 70.95 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.799 -0.824 . . . . 0.0 111.546 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.71 -43.1 68.72 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.052 0.842 . . . . 0.0 110.25 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -57.83 -21.46 42.5 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.127 1.371 . . . . 0.0 113.953 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 t -86.34 -47.81 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.23 -41.29 96.9 Favored Glycine 0 C--N 1.335 0.512 0 O-C-N 121.01 -1.056 . . . . 0.0 112.237 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -37.64 88.15 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 117.998 0.899 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -61.23 -53.34 58.14 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -58.96 -47.82 83.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.765 0.426 . . . . 0.0 111.804 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -15.75 53.75 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.789 1.636 . . . . 0.0 110.728 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -94.99 -0.19 54.06 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 120.296 -1.503 . . . . 0.0 113.438 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -115.33 -51.83 2.69 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.894 1.678 . . . . 0.0 107.58 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -93.75 -21.68 19.17 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.27 -18.12 19.75 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.674 -1.266 . . . . 0.0 113.905 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.6 mm -61.47 118.04 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.011 1.406 . . . . 0.0 107.616 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -56.57 145.2 29.0 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 124.869 1.268 . . . . 0.0 112.463 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.1 t -130.16 104.41 10.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.8 m -91.84 127.18 37.2 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.43 115.17 46.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.356 -2.091 . . . . 0.0 105.356 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -127.13 171.73 11.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.345 1.058 . . . . 0.0 110.275 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -138.08 68.16 48.66 Favored Pre-proline 0 N--CA 1.455 -0.199 0 C-N-CA 123.619 0.768 . . . . 0.0 112.894 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.29 139.95 19.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 N-CA-C 107.997 -1.578 . . . . 0.0 107.997 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.58 9.52 41.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.555 1.542 . . . . 0.0 108.978 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.36 2.66 10.28 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.514 1.926 . . . . 0.0 114.112 -177.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pp -53.53 -25.58 17.46 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 117.677 -1.154 . . . . 0.0 113.738 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -57.09 -23.4 46.66 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.988 1.315 . . . . 0.0 113.092 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -124.46 -24.02 4.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.801 0.84 . . . . 0.0 112.368 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -77.88 -48.58 16.07 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.27 1.428 . . . . 0.0 110.77 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -45.12 -56.86 8.23 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 117.85 -1.072 . . . . 0.0 111.376 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.56 -39.58 81.74 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 CA-C-N 120.577 1.242 . . . . 0.0 115.211 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -67.43 -46.58 72.73 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.583 1.083 . . . . 0.0 112.326 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 56' ' ' GLY . 22.2 t -68.96 -41.55 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.1 -32.38 71.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.189 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.7 -19.05 57.73 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.951 0.796 . . . . 0.0 110.459 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 m -99.82 -41.7 7.14 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.431 1.492 . . . . 0.0 107.599 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.401 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 117.61 9.14 10.4 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.274 1.416 . . . . 0.0 114.769 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -89.04 -8.53 53.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.374 1.087 . . . . 0.0 112.965 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.417 ' N ' HG12 ' A' ' 50' ' ' VAL . . . -70.83 171.26 45.3 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.442 1.02 . . . . 0.0 114.639 -177.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -64.09 167.79 13.6 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.219 2.613 . . . . 0.0 110.18 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.0 -19.36 22.47 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 126.16 1.784 . . . . 0.0 110.564 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.0 mt -124.24 148.02 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 123.817 0.847 . . . . 0.0 109.812 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.3 tt -141.04 136.64 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -133.37 107.96 8.41 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -154.58 170.87 20.47 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.493 1.042 . . . . 0.0 108.978 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.06 158.27 31.49 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.748 -0.595 . . . . 0.0 110.358 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -55.14 -32.89 62.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.101 0.96 . . . . 0.0 110.168 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.34 -11.11 0.46 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 129.062 2.945 . . . . 0.0 114.912 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -129.63 13.36 5.93 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.014 2.125 . . . . 0.0 109.431 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -115.73 26.48 9.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.655 1.982 . . . . 0.0 111.275 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.27 -19.89 15.21 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 120.467 -1.396 . . . . 0.0 111.894 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -107.05 -35.5 2.73 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 117.948 -1.473 . . . . 0.0 116.075 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -51.68 -45.33 63.42 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.593 2.196 . . . . 0.0 111.464 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.59 95.99 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -32.45 73.2 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.003 1.321 . . . . 0.0 109.592 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.7 m -80.57 -4.62 54.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.386 1.474 . . . . 0.0 110.129 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.54 18.04 76.49 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.912 1.244 . . . . 0.0 112.257 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.5 mt -88.46 -17.58 30.08 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.893 1.346 . . . . 0.0 113.756 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.2 mt -99.41 126.83 45.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.395 0.998 . . . . 0.0 111.277 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.56 164.73 26.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.435 1.094 . . . . 0.0 110.818 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -71.32 94.32 1.2 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.957 1.303 . . . . 0.0 109.17 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.1 pp -74.71 172.91 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 m 67.37 82.75 0.19 Allowed Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 126.141 1.776 . . . . 0.0 111.495 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.91 -34.64 8.36 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.712 1.608 . . . . 0.0 108.529 178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -147.0 155.72 42.47 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.926 0.869 . . . . 0.0 111.817 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -56.36 -33.86 66.09 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.783 2.433 . . . . 0.0 112.896 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.08 -26.75 66.43 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 120.191 1.36 . . . . 0.0 113.214 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -76.09 -26.32 56.33 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 120.25 1.386 . . . . 0.0 109.09 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -62.87 -46.82 86.08 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.229 1.012 . . . . 0.0 109.117 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.48 -14.1 62.02 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -14.73 61.43 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 120.861 -1.149 . . . . 0.0 109.916 178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mt -120.98 164.37 16.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.292 1.837 . . . . 0.0 107.758 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.86 150.45 81.41 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 121.059 -1.026 . . . . 0.0 111.719 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.06 -49.21 2.17 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.569 2.846 . . . . 0.0 112.118 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -57.79 -25.21 60.22 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.18 -20.33 41.43 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.809 -1.182 . . . . 0.0 110.574 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -72.92 -26.97 61.59 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -53.26 -41.94 65.98 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.91 1.684 . . . . 0.0 110.091 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.17 -6.43 4.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.923 1.289 . . . . 0.0 113.428 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.15 -0.18 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.104 1.361 . . . . 0.0 111.832 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 -63.16 148.98 46.46 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.089 1.313 . . . . 0.0 108.375 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.451 ' CE1' ' HE2' ' A' ' 102' ' ' LYS . 26.0 t80 -142.02 167.33 22.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -63.7 114.52 4.04 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.455 0.702 . . . . 0.0 110.801 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.9 -84.33 0.3 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 124.65 1.119 . . . . 0.0 111.34 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.451 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -72.83 166.03 23.73 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.21 0.604 . . . . 0.0 109.876 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.73 166.31 10.56 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.38 -40.17 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.96 174.01 11.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.649 0.659 . . . . 0.0 111.096 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -131.68 149.55 73.78 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 124.76 1.224 . . . . 0.0 110.419 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.27 145.62 30.78 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.198 2.599 . . . . 0.0 110.043 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -128.12 -53.66 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.261 1.425 . . . . 0.0 111.043 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.77 155.6 43.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.998 0.817 . . . . 0.0 112.45 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.5 t -130.95 110.1 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.059 0.544 . . . . 0.0 110.652 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 . . . . . 0 N--CA 1.474 0.729 0 CA-C-N 118.716 0.689 . . . . 0.0 112.746 177.717 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mm . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 44.1 p90 . . . . . 0 C--O 1.24 0.59 0 C-N-CA 126.653 1.981 . . . . 0.0 106.565 179.335 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo . . . . . 0 N--CA 1.454 -0.832 0 N-CA-C 110.137 -0.755 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -143.31 -31.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.715 1.206 . . . . 0.0 112.186 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.39 141.3 27.06 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -64.25 -16.1 61.38 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.039 -1.663 . . . . 0.0 113.203 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.84 -13.12 59.63 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.376 -0.827 . . . . 0.0 111.942 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -90.03 -14.01 34.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.326 0.65 . . . . 0.0 110.377 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.7 mm -53.39 -55.73 31.64 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 125.302 1.441 . . . . 0.0 110.424 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.98 -25.56 51.83 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 CA-C-N 120.693 1.283 . . . . 0.0 112.414 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.03 -60.52 2.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.61 -25.26 68.01 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.39 -0.819 . . . . 0.0 110.4 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.97 -47.81 76.29 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -67.67 -31.38 71.32 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 119.181 0.9 . . . . 0.0 110.997 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.06 -49.53 74.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 63.2 mt -76.68 -28.58 55.97 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.961 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -67.47 -34.25 76.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 119.785 1.175 . . . . 0.0 108.648 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.59 -15.19 62.49 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.16 5.62 5.87 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.918 1.287 . . . . 0.0 111.958 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.52 -97.76 0.12 Allowed Glycine 0 C--N 1.341 0.808 0 CA-C-N 119.686 1.13 . . . . 0.0 113.829 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -141.45 -162.1 1.33 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.941 1.297 . . . . 0.0 110.128 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.35 178.83 0.18 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.903 2.481 . . . . 0.0 115.766 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.96 -36.11 3.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.585 1.954 . . . . 0.0 111.069 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.2 tp -123.56 110.0 14.49 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.143 1.777 . . . . 0.0 108.343 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 49.0 ttm -121.2 106.77 11.83 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.407 1.083 . . . . 0.0 108.585 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -135.02 167.74 20.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.933 0.788 . . . . 0.0 110.722 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -67.0 89.0 0.16 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.722 1.609 . . . . 0.0 109.561 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.1 mt -81.91 -5.22 58.1 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.904 1.281 . . . . 0.0 111.602 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -85.57 -8.01 58.53 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -120.41 130.17 24.98 Favored Pre-proline 0 C--O 1.236 0.382 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.54 -15.96 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.884 1.723 . . . . 0.0 113.584 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -55.47 -36.22 66.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.593 0.757 . . . . 0.0 112.236 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -81.35 -37.76 27.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.572 0.749 . . . . 0.0 112.027 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.7 p -82.84 -10.96 58.6 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.878 0.763 . . . . 0.0 112.297 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -60.8 -59.49 13.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 O-C-N 120.912 -1.117 . . . . 0.0 113.507 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -68.04 -3.5 10.74 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 121.326 1.509 . . . . 0.0 114.585 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.0 tp -79.24 -66.67 0.84 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 8.2 pt -68.7 -25.43 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.59 -23.58 67.11 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.821 -1.175 . . . . 0.0 110.591 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -45.53 -60.04 2.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.937 2.095 . . . . 0.0 111.099 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -58.98 -57.3 13.67 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.31 5.19 0.03 OUTLIER Glycine 0 C--N 1.334 0.441 0 CA-C-O 116.991 -2.005 . . . . 0.0 117.713 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -61.35 134.34 48.14 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -141.64 121.91 13.93 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.54 -53.9 44.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.378 -0.201 . . . . 0.0 110.965 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -142.81 132.22 23.54 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -71.3 151.42 44.21 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -141.41 99.12 3.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -71.31 178.09 3.56 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -60.44 22.14 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.084 2.554 . . . . 0.0 116.747 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.57 -4.58 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 127.294 2.378 . . . . 0.0 111.866 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -113.8 107.88 16.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.613 1.706 . . . . 0.0 108.738 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.97 47.04 0.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.082 1.353 . . . . 0.0 109.58 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.88 92.64 1.27 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.25 1.42 . . . . 0.0 112.259 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -55.82 -1.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 130.303 3.441 . . . . 0.0 113.532 178.029 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -70.7 -33.93 71.4 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -82.72 100.89 10.52 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.1 t -116.48 102.34 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 126.56 1.944 . . . . 0.0 111.487 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -90.96 40.15 3.01 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 126.276 1.893 . . . . 0.0 113.842 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.94 -19.99 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.526 0.73 . . . . 0.0 111.063 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -108.34 51.04 0.75 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.976 1.369 . . . . 0.0 108.08 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -106.64 153.44 22.38 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.496 1.118 . . . . 0.0 109.913 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.56 -40.99 66.01 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.055 1.342 . . . . 0.0 111.729 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -59.67 -42.04 97.69 Favored Glycine 0 CA--C 1.523 0.588 0 O-C-N 121.474 -0.766 . . . . 0.0 112.656 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.22 -52.15 60.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -62.74 -32.73 73.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.241 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.1 -60.42 3.62 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.316 1.416 . . . . 0.0 110.065 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.65 -34.44 86.32 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 36.5 tp -70.48 -54.87 10.53 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.525 0.662 . . . . 0.0 110.1 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.62 -36.43 71.79 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.706 0.802 . . . . 0.0 109.616 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.86 -41.58 87.35 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.553 1.069 . . . . 0.0 109.595 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.5 tt -73.76 -45.54 51.14 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.248 -0.907 . . . . 0.0 109.671 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.61 -36.64 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.833 1.253 . . . . 0.0 110.037 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -58.28 -31.56 67.57 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.092 1.357 . . . . 0.0 111.138 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 49.5 mt -73.71 -40.94 63.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.52 -40.84 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -55.23 -37.67 67.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.122 0.969 . . . . 0.0 109.634 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -88.69 0.18 56.69 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.5 1.52 . . . . 0.0 112.37 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? 58.72 10.12 1.36 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 128.131 2.572 . . . . 0.0 114.759 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -42.9 89.83 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.8 tpt -92.64 142.32 27.5 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.88 1.272 . . . . 0.0 107.991 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -82.65 110.15 17.46 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.33 -8.04 54.87 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.906 0.882 . . . . 0.0 112.765 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -100.75 0.53 39.02 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.355 1.062 . . . . 0.0 112.807 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 93.6 m -63.93 130.04 42.48 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -129.8 -179.68 5.34 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.573 1.149 . . . . 0.0 108.696 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -55.12 -47.36 75.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.427 -0.32 . . . . 0.0 110.792 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.6 m -57.56 -45.58 85.0 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.408 1.483 . . . . 0.0 111.105 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 17.5 mm -64.19 -50.21 77.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.21 99.28 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.855 0.722 . . . . 0.0 111.927 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -59.23 -45.63 90.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.085 1.754 . . . . 0.0 110.574 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.15 -48.61 64.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.34 -51.46 68.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.023 0.929 . . . . 0.0 111.366 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -56.12 -39.37 72.13 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.669 0.788 . . . . 0.0 110.458 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -61.08 -25.01 66.66 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.998 -0.439 . . . . 0.0 112.117 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -94.5 -15.04 24.53 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.409 0.684 . . . . 0.0 111.138 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.04 11.94 58.2 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.311 1.434 . . . . 0.0 112.135 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -53.26 -70.08 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.672 2.389 . . . . 0.0 112.588 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.1 t -72.5 153.21 41.46 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -111.04 -18.59 13.0 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.022 0.529 . . . . 0.0 112.347 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -149.28 139.79 22.49 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.801 1.64 . . . . 0.0 108.669 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.7 t -160.29 -177.49 6.29 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 N--CA 1.45 -0.461 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 179.137 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.238 0.448 0 CA-C-O 119.262 -0.399 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.48 154.29 74.88 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 N-CA-C 107.745 -1.675 . . . . 0.0 107.745 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.0 p -115.28 179.0 4.09 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.926 0.891 . . . . 0.0 112.282 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -102.27 148.5 25.37 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 120.377 -1.452 . . . . 0.0 108.027 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.29 104.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.222 1.409 . . . . 0.0 110.592 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 95.61 -5.41 67.1 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.778 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.41 120.53 4.46 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 120.426 2.113 . . . . 0.0 112.578 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.07 159.28 33.91 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.968 3.112 . . . . 0.0 110.712 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 4.2 p -77.62 167.47 21.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.79 0.805 . . . . 0.0 110.131 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -147.33 78.17 10.33 Favored Pre-proline 0 N--CA 1.453 -0.305 0 C-N-CA 123.622 0.769 . . . . 0.0 110.344 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.05 172.31 16.2 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.86 1.707 . . . . 0.0 110.343 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 . . . . . 0 C--O 1.24 0.603 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.948 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.02 0 N-CA-C 105.502 -3.039 . . . . 0.0 105.502 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 8.4 m -143.91 147.56 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.11 159.23 24.75 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.5 m -133.09 144.52 50.03 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.899 0.772 . . . . 0.0 109.64 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.23 139.91 51.66 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 121.453 -0.779 . . . . 0.0 109.122 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.91 177.23 18.57 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.965 0.793 . . . . 0.0 113.076 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.3 mt -122.01 119.39 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 125.408 1.483 . . . . 0.0 107.229 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.98 123.02 21.08 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 120.499 -1.376 . . . . 0.0 107.945 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.51 -5.4 7.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.297 1.439 . . . . 0.0 112.739 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.401 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -67.2 -42.54 83.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 127.292 2.237 . . . . 0.0 113.671 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.8 m -57.39 152.49 32.52 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 123.98 0.912 . . . . 0.0 113.307 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.34 -51.45 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.772 2.315 . . . . 0.0 110.594 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -123.06 109.63 14.31 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.509 ' HD2' ' H ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -67.08 -24.29 65.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.71 -34.52 62.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.138 1.375 . . . . 0.0 111.56 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 78.2 mt -60.42 -36.17 77.53 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.327 -0.858 . . . . 0.0 110.146 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -81.25 -39.43 25.31 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.236 -0.887 . . . . 0.0 111.315 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.41 83.36 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.153 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -67.58 -49.4 63.35 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -56.41 -49.78 73.51 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.36 -0.838 . . . . 0.0 110.764 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.53 -21.94 66.62 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.81 -14.9 14.68 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -103.32 -24.27 13.52 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.986 0.812 . . . . 0.0 112.242 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -139.43 -32.18 0.66 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -67.07 -47.95 69.72 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.443 1.474 . . . . 0.0 112.847 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.05 73.13 5.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 71.4 p -138.72 153.98 48.53 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.88 -24.37 67.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -86.85 -43.67 12.29 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.175 1.79 . . . . 0.0 110.898 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -68.52 -44.93 70.2 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 54.1 mt -67.61 -34.74 77.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -62.15 -49.01 77.55 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.411 ' HA ' ' HE2' ' A' ' 295' ' ' LYS . . . -54.4 -42.84 70.9 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 119.595 1.089 . . . . 0.0 110.926 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.4 t -63.56 -41.18 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.804 1.242 . . . . 0.0 108.797 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -64.14 -38.92 92.79 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.126 1.371 . . . . 0.0 112.059 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 292' ' ' ALA . 21.9 mtmt -56.78 -54.7 43.32 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.246 -0.909 . . . . 0.0 108.755 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -55.18 -52.87 61.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.058 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.481 ' HA ' ' HE3' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -147.78 156.33 44.6 Favored Pre-proline 0 N--CA 1.473 0.715 0 O-C-N 120.799 -1.188 . . . . 0.0 111.799 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -61.34 130.9 33.81 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 N-CA-C 105.963 -2.36 . . . . 0.0 105.963 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -95.38 -15.78 22.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.342 -0.837 . . . . 0.0 112.882 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.36 -157.27 47.81 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.16 164.12 25.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 22.7 m -125.91 148.89 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 O-C-N 121.246 -0.909 . . . . 0.0 109.852 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.05 -22.47 58.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.675 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 62.7 tp -66.93 105.4 1.61 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.789 1.635 . . . . 0.0 109.365 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -61.41 -1.86 0.61 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.6 t -92.9 -66.64 0.91 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -63.51 -19.32 64.67 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.438 -0.789 . . . . 0.0 110.877 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -60.2 -35.5 75.55 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -68.22 -20.43 64.83 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.072 0.851 . . . . 0.0 111.687 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -88.12 -50.36 6.44 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.582 1.153 . . . . 0.0 108.403 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 48.7 mt -67.64 -35.32 78.69 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.012 0.525 . . . . 0.0 110.554 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.3 1.92 4.37 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.182 -0.949 . . . . 0.0 112.686 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -62.53 -20.88 65.08 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 120.111 1.323 . . . . 0.0 109.575 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -109.82 129.22 24.17 Favored Pre-proline 0 C--O 1.24 0.554 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.7 -8.41 9.21 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.378 2.719 . . . . 0.0 114.54 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -67.23 -54.48 20.58 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 119.68 1.127 . . . . 0.0 108.607 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.7 -49.55 83.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.45 -50.56 62.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 123.75 0.656 . . . . 0.0 109.947 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.81 -41.35 86.59 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.9 m -62.16 -37.76 86.46 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.8 tpt -68.2 -46.62 70.13 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.257 0.623 . . . . 0.0 110.596 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -60.68 -30.07 69.69 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.019 0.928 . . . . 0.0 113.111 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -74.82 -35.35 62.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.651 0 C-N-CA 123.777 0.831 . . . . 0.0 111.315 179.01 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 CA--C 1.538 0.721 0 N-CA-C 113.557 0.561 . . . . 0.0 113.557 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -84.22 70.4 10.56 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.657 1.583 . . . . 0.0 106.992 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 30.1 pt -124.08 152.09 66.47 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 124.396 1.078 . . . . 0.0 110.549 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -68.78 -30.94 26.4 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.09 2.526 . . . . 0.0 113.106 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -65.66 -17.19 64.42 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -61.43 -31.35 71.29 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.986 0.812 . . . . 0.0 109.563 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 4.6 t -57.57 -46.09 84.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.457 0.703 . . . . 0.0 110.712 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -79.6 -36.25 38.33 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.604 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.0 -52.35 63.42 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.786 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -58.26 -40.47 81.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.865 1.211 . . . . 0.0 111.1 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -65.64 -23.13 66.73 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.962 0.905 . . . . 0.0 111.46 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.3 -50.73 8.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.538 1.135 . . . . 0.0 110.272 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 11.2 t -60.7 -49.81 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.612 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.01 -54.33 13.28 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.637 0.653 . . . . 0.0 110.275 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.477 HG21 HH22 ' A' ' 367' ' ' ARG . 87.3 m -64.3 -43.18 95.54 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.296 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.27 -43.07 87.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.122 1.328 . . . . 0.0 111.519 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.82 -52.68 51.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 125.041 1.336 . . . . 0.0 108.897 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 30.1 mm -60.5 -43.18 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.151 0.58 . . . . 0.0 110.13 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -59.88 -47.36 86.06 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.738 0.699 . . . . 0.0 110.265 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.26 72.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.719 0.808 . . . . 0.0 110.679 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.66 -32.17 72.32 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.246 1.019 . . . . 0.0 111.97 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 14.1 m -85.15 -11.75 54.37 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.739 0.816 . . . . 0.0 109.723 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.74 10.04 66.75 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 123.667 0.651 . . . . 0.0 112.428 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -69.15 -34.48 75.04 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 118.158 0.979 . . . . 0.0 109.985 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -134.93 148.04 49.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 359' ' ' GLU . 11.9 t -68.34 156.24 38.15 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 26.0 t -58.14 -40.43 77.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 125.011 1.325 . . . . 0.0 110.086 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.06 -47.84 84.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.956 0.502 . . . . 0.0 109.738 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . 0.449 ' H ' HG23 ' A' ' 356' ' ' THR . 52.6 mm-40 -68.92 -37.82 79.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 122.147 -0.345 . . . . 0.0 111.21 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.4 -39.87 73.72 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.97 -41.3 59.84 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.567 1.147 . . . . 0.0 110.296 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -55.45 -50.16 70.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.493 0.717 . . . . 0.0 109.363 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -49.85 76.32 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 127.042 2.137 . . . . 0.0 111.1 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.21 -52.15 66.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.076 0.95 . . . . 0.0 112.209 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -52.84 -33.04 47.72 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.551 0.74 . . . . 0.0 110.482 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.3 m -64.22 -48.03 77.41 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.413 1.006 . . . . 0.0 109.451 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.477 HH22 HG21 ' A' ' 345' ' ' THR . 79.9 mtt180 -57.25 -23.35 47.54 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.3 mt -96.14 -10.41 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.025 1.33 . . . . 0.0 111.565 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 55.5 p -120.08 1.72 10.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.673 1.189 . . . . 0.0 112.491 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 36.1 tptt . . . . . 0 C--O 1.251 1.179 0 C-N-CA 127.665 2.386 . . . . 0.0 105.547 178.401 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -79.12 175.07 10.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.53 1.532 . . . . 0.0 109.384 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.95 22.71 77.68 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.427 1.013 . . . . 0.0 113.302 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -146.87 166.48 26.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.992 0.896 . . . . 0.0 112.664 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.2 mt -151.32 142.93 23.64 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.939 2.895 . . . . 0.0 106.681 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.26 126.61 49.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 mt -108.07 136.11 44.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 125.81 1.644 . . . . 0.0 108.146 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -127.76 130.6 49.02 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.035 1.734 . . . . 0.0 106.511 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 15' ' ' LYS . 11.8 pt -131.76 165.65 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 127.26 2.224 . . . . 0.0 110.383 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.497 ' HB3' HD21 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -151.35 165.57 33.66 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.367 1.067 . . . . 0.0 112.975 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.68 40.5 7.68 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-O 118.466 -1.185 . . . . 0.0 111.855 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 54.51 32.85 17.65 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.622 1.169 . . . . 0.0 108.213 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HB3' HD12 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -56.77 163.37 1.92 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.539 1.536 . . . . 0.0 113.372 -177.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.09 76.35 1.44 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -66.17 -39.52 89.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.611 1.164 . . . . 0.0 109.352 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -58.57 -59.76 4.87 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 125.875 1.67 . . . . 0.0 110.526 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.27 94.53 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.7 tp -62.94 -42.55 99.84 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 117.889 0.845 . . . . 0.0 108.944 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.63 73.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.863 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -62.39 -27.89 69.4 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.452 1.024 . . . . 0.0 110.443 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.9 t -79.31 -46.47 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.28 -39.07 97.24 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 121.257 -0.902 . . . . 0.0 113.069 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -37.62 68.35 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 117.776 -1.107 . . . . 0.0 109.1 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -58.42 -57.33 13.41 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.38 -48.03 80.13 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.937 -0.554 . . . . 0.0 110.384 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.48 -22.96 66.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.958 1.254 . . . . 0.0 112.61 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tppm? -85.74 -23.22 27.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 117.876 -1.059 . . . . 0.0 110.805 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -102.83 -22.59 13.86 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.925 0.765 . . . . 0.0 112.71 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -114.79 -35.95 4.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.468 1.107 . . . . 0.0 111.355 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.17 -18.74 56.95 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.121 0.867 . . . . 0.0 113.414 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.8 mm -60.45 125.63 16.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HA ' ' CE ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -63.77 127.93 33.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.107 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.7 t -123.2 104.91 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -93.97 139.14 31.3 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.3 t -130.67 118.46 42.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -128.84 158.99 37.18 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -116.85 60.64 2.38 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.664 1.186 . . . . 0.0 110.185 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.485 ' HG2' HD22 ' A' ' 43' ' ' LEU . 48.3 Cg_endo -62.09 160.41 30.34 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 121.867 1.711 . . . . 0.0 109.966 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -117.79 9.12 12.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.596 0.758 . . . . 0.0 111.709 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.17 17.69 2.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.073 1.749 . . . . 0.0 112.876 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 43' ' ' LEU . 1.3 pt? -56.11 -24.15 38.74 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.627 -1.295 . . . . 0.0 111.797 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.99 -24.95 57.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.203 1.401 . . . . 0.0 112.104 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -121.57 -22.27 5.94 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.219 1.008 . . . . 0.0 111.218 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -41.92 59.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 117.24 -1.362 . . . . 0.0 110.9 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -52.49 -58.71 10.73 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 120.642 1.565 . . . . 0.0 110.111 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.78 -17.3 54.28 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.501 1.467 . . . . 0.0 113.553 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -88.7 2.12 53.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.649 1.58 . . . . 0.0 113.638 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.3 -34.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.18 0.9 . . . . 0.0 109.61 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.77 66.12 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.708 -1.245 . . . . 0.0 110.011 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.73 -2.92 5.55 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.887 0.875 . . . . 0.0 112.368 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.2 p -126.33 -11.72 6.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.461 1.504 . . . . 0.0 110.256 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.412 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 84.6 15.76 67.61 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.277 0.942 . . . . 0.0 111.892 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -106.38 6.44 30.43 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.007 0.904 . . . . 0.0 110.684 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.41 -167.59 43.39 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 127.001 2.239 . . . . 0.0 116.371 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.92 -179.32 2.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.634 2.89 . . . . 0.0 110.136 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.95 -18.28 8.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.8 mt -135.44 143.84 35.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.428 1.091 . . . . 0.0 109.306 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tt -130.02 143.2 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 C-N-CA 125.014 1.326 . . . . 0.0 110.953 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -137.92 109.83 7.19 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.823 1.649 . . . . 0.0 107.609 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 29.2 t-105 -159.88 178.91 9.27 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.438 1.017 . . . . 0.0 108.981 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.36 153.55 43.42 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -60.16 -19.14 52.52 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.362 1.465 . . . . 0.0 111.658 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -53.07 -61.95 1.96 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.895 1.278 . . . . 0.0 111.322 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -68.15 -18.22 64.56 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.598 -0.689 . . . . 0.0 111.088 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -68.67 -30.43 69.11 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.483 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.8 -12.79 49.44 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.99 0.805 . . . . 0.0 112.296 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -104.58 -45.72 1.39 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -60.47 -52.04 66.9 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.554 -0.968 . . . . 0.0 111.322 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.62 84.22 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.692 0.678 . . . . 0.0 111.235 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.21 -47.31 69.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.776 1.23 . . . . 0.0 108.71 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -72.21 -6.89 46.09 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.43 9.85 80.91 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.781 1.181 . . . . 0.0 112.296 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 mt -73.21 -22.03 60.53 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.389 1.094 . . . . 0.0 111.156 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -103.87 140.28 37.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.12 -171.95 3.31 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -76.93 159.72 29.76 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.414 HD11 ' HB3' ' A' ' 103' ' ' LEU . 2.7 pp -137.73 172.04 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.727 1.211 . . . . 0.0 110.184 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.57 HG23 ' HB3' ' A' ' 85' ' ' PHE . 42.4 m 42.36 77.24 0.45 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.105 2.162 . . . . 0.0 114.552 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.88 -22.0 27.51 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.084 2.523 . . . . 0.0 115.291 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -120.16 135.24 55.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.22 1.373 . . . . 0.0 111.526 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -51.32 -39.11 56.26 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.781 2.032 . . . . 0.0 112.265 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.5 -27.18 62.31 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.57 ' HB3' HG23 ' A' ' 80' ' ' THR . 14.2 t80 -66.46 -37.11 84.41 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -64.54 -42.86 95.45 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 118.845 0.748 . . . . 0.0 109.284 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -57.0 -30.11 63.87 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.52 1.528 . . . . 0.0 112.718 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -75.4 -2.24 27.64 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mt -130.18 154.15 47.83 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 120.728 -1.232 . . . . 0.0 110.892 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -69.12 155.83 92.78 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 122.436 -0.165 . . . . 0.0 110.786 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.41 -45.68 2.46 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.906 3.07 . . . . 0.0 114.241 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -58.01 -38.62 76.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.565 1.075 . . . . 0.0 111.143 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -25.58 66.24 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.555 1.142 . . . . 0.0 110.722 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -77.94 -44.45 26.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.411 0.684 . . . . 0.0 110.119 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.71 -33.38 64.14 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.56 -7.4 4.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.4 1.48 . . . . 0.0 114.179 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.73 10.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.966 1.706 . . . . 0.0 111.887 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.9 mtp85 -70.28 160.48 32.12 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -132.7 -165.11 1.56 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -70.37 81.25 0.55 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.291 1.036 . . . . 0.0 109.401 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.35 -60.81 4.84 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.368 0.985 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -178.56 5.07 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.32 0.648 . . . . 0.0 109.881 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.414 ' HB3' HD11 ' A' ' 79' ' ' ILE . 34.5 mt -115.9 169.95 8.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.161 1.385 . . . . 0.0 109.248 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 pt -138.65 -28.88 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.79 175.32 13.0 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.456 1.026 . . . . 0.0 109.701 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -133.31 150.02 74.09 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.9 143.73 29.77 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.966 2.444 . . . . 0.0 110.888 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -131.53 -50.65 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.808 2.443 . . . . 0.0 111.546 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.71 131.51 52.55 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 110.396 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.65 95.99 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 122.605 1.193 . . . . 0.0 110.164 179.904 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 43.8 p90 . . . . . 0 C--O 1.235 0.299 0 O-C-N 120.777 -1.202 . . . . 0.0 110.952 178.772 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo . . . . . 0 N--CA 1.453 -0.864 0 N-CA-C 110.441 -0.638 . . . . 0.0 110.441 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.35 -31.6 2.77 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 124.441 1.096 . . . . 0.0 113.325 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.95 152.4 9.46 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.269 1.395 . . . . 0.0 109.832 -178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -56.1 -27.68 54.7 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.46 -16.52 24.35 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.283 0.947 . . . . 0.0 113.132 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -92.23 -14.22 29.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.062 0.847 . . . . 0.0 111.212 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 26.0 mm -59.65 -57.89 23.51 Favored Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -69.9 -25.54 27.86 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 CA-C-N 120.306 1.145 . . . . 0.0 110.967 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.64 71.65 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 118.67 0.668 . . . . 0.0 109.863 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 61.5 tp -88.84 -29.88 19.36 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.737 0.815 . . . . 0.0 109.585 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -59.08 -45.74 90.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.429 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 5.5 ptmm? -64.06 -32.19 73.65 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.534 0.334 . . . . 0.0 111.832 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -71.62 -43.04 66.87 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.203 0.601 . . . . 0.0 110.206 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.4 mt -75.8 -32.18 59.76 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -67.81 -33.33 74.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.609 -1.307 . . . . 0.0 108.498 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.1 -14.08 59.62 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 3.24 5.45 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.179 0.992 . . . . 0.0 112.127 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.65 -99.67 0.13 Allowed Glycine 0 CA--C 1.523 0.566 0 CA-C-N 119.267 0.94 . . . . 0.0 113.448 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -138.12 -177.75 4.97 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.433 1.493 . . . . 0.0 111.719 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.5 p -56.16 168.76 0.47 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.064 1.746 . . . . 0.0 113.817 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.89 -74.14 0.6 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.745 1.618 . . . . 0.0 110.183 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.8 tp -88.66 147.32 24.59 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.896 0.878 . . . . 0.0 110.701 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 11.3 mtp -149.0 113.97 5.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -138.1 172.3 13.12 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.978 2.111 . . . . 0.0 108.474 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.41 124.74 28.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.623 0.769 . . . . 0.0 112.86 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.3 mp -111.15 7.85 21.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.085 0.954 . . . . 0.0 111.166 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -97.57 -23.12 16.14 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -102.29 128.17 28.98 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.167 0.987 . . . . 0.0 108.913 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.67 -14.85 27.28 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.657 2.238 . . . . 0.0 114.32 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -59.01 -41.75 88.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.851 1.261 . . . . 0.0 113.397 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -79.83 -41.11 27.06 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.065 0.46 . . . . 0.0 111.767 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.4 p -69.93 -24.59 63.39 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.746 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -53.3 -63.02 2.75 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -61.69 -14.71 37.56 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.109 1.872 . . . . 0.0 115.076 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.4 tp -78.56 -63.83 1.32 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.8 pt -63.05 -32.61 56.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.825 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.421 ' HB1' ' HD3' ' A' ' 256' ' ' LYS . . . -68.81 -14.36 62.98 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.528 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -52.94 -45.37 67.64 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.927 1.239 . . . . 0.0 113.603 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.67 -43.82 98.13 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 172.33 43.15 0.04 OUTLIER Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.952 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -99.55 155.51 19.79 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -160.73 119.26 2.54 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 118.278 1.039 . . . . 0.0 109.019 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.95 84.31 7.48 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 70.05 105.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.754 2.421 . . . . 0.0 107.874 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -72.25 134.78 45.78 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.636 -0.665 . . . . 0.0 109.314 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -131.65 120.05 22.27 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 173' ' ' ASN . 5.6 tt0 -102.78 -159.15 0.71 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.584 1.154 . . . . 0.0 108.428 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.491 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 78.5 m-20 -66.84 78.63 0.12 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.66 1.984 . . . . 0.0 110.708 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.66 10.91 84.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.269 0.938 . . . . 0.0 112.597 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -112.15 103.46 11.63 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.34 113.24 18.58 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -131.07 100.7 5.31 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.93 -9.38 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -69.48 -29.34 66.98 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.891 -1.131 . . . . 0.0 108.324 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -75.29 75.29 2.41 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.606 1.563 . . . . 0.0 110.863 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.7 t -97.11 113.82 32.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 126.414 1.886 . . . . 0.0 108.737 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -109.32 96.1 0.94 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 45.8 t -138.38 -43.47 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 117.822 0.811 . . . . 0.0 109.579 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -108.84 77.04 1.05 Allowed 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -128.97 163.1 26.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.778 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -50.03 -41.52 47.62 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.2 1.4 . . . . 0.0 113.197 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.95 -43.41 95.99 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.581 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.6 -51.35 65.69 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.432 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -58.78 -36.64 74.76 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.135 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.23 -38.61 87.27 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.212 0.915 . . . . 0.0 110.386 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -82.43 -26.54 46.82 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.82 -0.55 . . . . 0.0 112.826 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.5 tp -76.29 -41.82 47.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.08 -1.247 . . . . 0.0 107.792 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 7.4 t -65.08 -27.62 68.9 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.987 0.812 . . . . 0.0 109.065 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -58.19 -52.06 67.13 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.96 -46.24 88.54 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.764 1.226 . . . . 0.0 110.144 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 42.7 t -60.58 -38.91 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 117.639 -1.172 . . . . 0.0 110.506 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.517 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 14.2 t0 -56.6 -50.11 72.96 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.213 1.405 . . . . 0.0 114.009 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.11 -38.7 91.54 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.548 0.689 . . . . 0.0 109.693 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.17 -31.8 51.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -63.76 -44.7 92.66 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 126.125 1.77 . . . . 0.0 107.887 178.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -71.97 -10.92 60.46 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.377 0.671 . . . . 0.0 109.424 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt 60.96 15.6 6.23 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 128.175 2.59 . . . . 0.0 112.513 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -83.08 -14.04 54.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.04 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.24 124.98 52.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.813 1.645 . . . . 0.0 110.028 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.65 84.66 0.29 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.745 2.018 . . . . 0.0 110.69 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -58.53 -16.53 15.88 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.549 1.94 . . . . 0.0 115.011 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.08 -7.08 54.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.252 1.821 . . . . 0.0 114.097 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.3 m -60.99 134.48 57.14 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 118.941 0.791 . . . . 0.0 110.408 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.0 -178.43 4.18 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.542 1.937 . . . . 0.0 107.08 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -57.89 -38.56 76.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.391 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -55.38 26.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.321 1.048 . . . . 0.0 110.456 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.22 -45.13 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 123.57 0.748 . . . . 0.0 110.38 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.45 -51.13 67.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.724 0.693 . . . . 0.0 110.816 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -63.35 -43.97 96.17 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.82 1.191 . . . . 0.0 110.313 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.09 -55.77 30.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.06 0.544 . . . . 0.0 109.548 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.84 -46.07 74.58 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.56 1.144 . . . . 0.0 110.425 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -58.42 -44.19 88.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.24 0.616 . . . . 0.0 109.429 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.46 -21.73 66.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.689 0.795 . . . . 0.0 112.203 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -91.97 -10.64 38.64 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.665 0.786 . . . . 0.0 110.008 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.82 18.44 70.2 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -80.78 0.72 33.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.947 1.299 . . . . 0.0 113.745 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 27.3 p -124.04 149.79 45.69 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.532 1.133 . . . . 0.0 108.184 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.3 -21.31 19.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.264 0.625 . . . . 0.0 111.469 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 14.0 ptt? -158.28 157.48 32.58 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.8 t -150.89 171.38 17.34 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 122.535 1.16 . . . . 0.0 109.792 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 5.9 mt . . . . . 0 N--CA 1.443 -0.824 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.262 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 CA--C 1.543 0.679 0 CA-C-O 118.869 -0.586 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.07 -84.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.834 3.023 . . . . 0.0 111.073 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . 0.292 0.5 OUTLIER 92.38 -164.69 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.483 3.113 . . . . 0.0 108.052 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.27 131.83 47.11 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.02 120.31 7.25 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.52 -0.738 . . . . 0.0 109.181 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.91 -7.12 56.83 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.511 -1.16 . . . . 0.0 113.928 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.39 102.65 14.03 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.317 2.059 . . . . 0.0 109.801 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.78 143.49 21.1 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.223 1.948 . . . . 0.0 113.606 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.2 m -68.66 159.56 31.87 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.148 0.979 . . . . 0.0 109.234 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.421 ' HD3' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -129.08 55.72 19.85 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.61 161.65 34.58 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 121.788 1.659 . . . . 0.0 111.406 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.233 0.236 0 CA-C-O 121.604 0.716 . . . . 0.0 111.142 179.587 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.633 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.43 172.22 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 119.403 1.601 . . . . 0.0 111.545 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 34.5 tp -84.41 156.52 21.77 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.055 -1.653 . . . . 0.0 107.569 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.7 m -131.76 137.17 48.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 120.481 1.492 . . . . 0.0 109.001 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -115.24 130.67 56.98 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.349 1.059 . . . . 0.0 109.513 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.14 170.59 21.73 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.308 1.432 . . . . 0.0 111.804 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 76.3 mt -119.19 134.72 61.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -68.09 122.54 18.48 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.61 -10.78 60.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.412 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -95.13 7.33 46.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.84 0.856 . . . . 0.0 112.459 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.5 m -69.33 157.49 89.25 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.418 1.087 . . . . 0.0 108.712 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.13 -50.82 2.55 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.906 1.737 . . . . 0.0 111.005 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -135.5 100.36 4.48 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -19.68 49.31 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.47 -0.769 . . . . 0.0 112.437 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -64.63 -32.9 74.76 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.049 0.386 . . . . 0.0 110.123 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.87 -38.63 79.23 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.379 -0.825 . . . . 0.0 108.897 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.66 -42.29 42.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 117.903 -1.046 . . . . 0.0 111.671 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -41.3 91.99 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.3 0.954 . . . . 0.0 108.788 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -66.94 -50.93 60.79 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 124.619 1.199 . . . . 0.0 109.434 -177.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -53.22 -51.69 61.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.194 -0.431 . . . . 0.0 110.335 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 2.2 mp -63.11 -48.04 80.22 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.332 6.7 pt-20 -78.74 -4.35 48.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -177.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -108.45 -19.45 13.45 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.311 1.414 . . . . 0.0 112.211 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -135.61 -53.3 0.77 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.789 1.177 . . . . 0.0 110.735 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 0.2 OUTLIER -48.61 -48.04 39.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.753 0.821 . . . . 0.0 112.515 -179.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.66 29.03 0.93 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.948 2.099 . . . . 0.0 114.505 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 19.4 p -116.29 165.18 13.47 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 120.411 1.459 . . . . 0.0 108.097 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.66 -44.06 85.41 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.46 -33.63 75.53 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.506 0.722 . . . . 0.0 112.787 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.53 -46.08 12.58 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 51.8 mt -62.52 -47.12 85.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -57.78 -44.49 86.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.678 1.191 . . . . 0.0 110.647 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.0 -46.78 71.84 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 117.93 0.332 . . . . 0.0 110.963 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.65 -40.32 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 117.047 -1.454 . . . . 0.0 109.723 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -63.15 -34.33 77.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.311 0.959 . . . . 0.0 112.754 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -63.49 -61.34 2.39 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.8 -48.33 80.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 117.219 -1.372 . . . . 0.0 112.387 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -137.7 150.47 68.13 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 121.509 1.959 . . . . 0.0 109.137 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.77 101.95 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.254 1.969 . . . . 0.0 114.21 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 7.8 mt -76.03 -32.86 59.55 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 123.608 0.763 . . . . 0.0 109.731 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 80.87 -115.64 4.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.95 160.8 14.01 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.206 1.003 . . . . 0.0 111.698 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.16 162.7 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 124.479 1.112 . . . . 0.0 110.179 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.36 -29.44 22.95 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 28.0 tp -65.07 104.07 0.83 Allowed 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.749 0.82 . . . . 0.0 111.166 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -49.53 -33.43 14.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.143 1.377 . . . . 0.0 112.482 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.3 t -62.53 -57.46 11.07 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.877 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -78.19 -20.72 51.33 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.923 1.238 . . . . 0.0 111.262 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -57.6 -43.13 84.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.25 -13.02 46.72 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.005 0.82 . . . . 0.0 113.207 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -94.12 -37.54 11.55 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 63.2 mt -74.95 -26.02 59.3 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.515 -1.366 . . . . 0.0 109.035 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.87 -1.63 7.7 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.544 1.538 . . . . 0.0 112.918 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -65.11 -19.45 65.99 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.807 0.843 . . . . 0.0 110.846 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -120.36 131.95 24.28 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 124.526 1.13 . . . . 0.0 108.189 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -59.84 -15.05 30.18 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.215 2.61 . . . . 0.0 116.368 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -66.5 -39.5 88.75 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 121.93 2.15 . . . . 0.0 108.602 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.7 mp -70.77 -46.38 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.43 -49.54 72.15 Favored 'General case' 0 C--O 1.222 -0.395 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.166 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.17 -37.55 77.62 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.085 -1.009 . . . . 0.0 112.101 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 55.1 m -61.06 -39.1 88.59 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -81.35 -37.23 28.63 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 123.585 0.754 . . . . 0.0 111.434 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -55.17 -37.35 66.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.134 0.973 . . . . 0.0 108.837 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -63.9 -38.54 91.48 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.471 0 C-N-CA 123.385 0.674 . . . . 0.0 110.171 178.168 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo . . . . . 0 N--CA 1.453 -0.888 0 N-CA-C 108.374 -1.433 . . . . 0.0 108.374 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -120.81 23.49 10.7 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.0 pt -137.8 141.37 32.66 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 118.953 0.797 . . . . 0.0 110.454 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.82 -9.94 27.3 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 124.001 3.134 . . . . 0.0 113.82 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -64.69 -24.05 67.45 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.417 1.087 . . . . 0.0 109.539 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 91.1 mmm -58.99 -22.39 60.47 Favored 'General case' 0 C--N 1.342 0.247 0 O-C-N 120.744 -1.222 . . . . 0.0 113.571 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 80.4 p -64.24 -33.11 75.06 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.369 1.44 . . . . 0.0 108.821 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.5 -41.97 65.35 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 121.247 -0.908 . . . . 0.0 108.894 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -49.96 -57.08 8.26 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.081 0.952 . . . . 0.0 109.584 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -64.02 -35.4 80.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -68.07 -37.43 81.24 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.158 0.583 . . . . 0.0 111.671 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.52 -55.16 6.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.868 2.067 . . . . 0.0 112.496 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 67.3 t -57.33 -33.55 43.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.378 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -54.63 -58.38 7.74 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.747 1.158 . . . . 0.0 108.859 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.4 m -61.38 -37.32 82.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.984 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.13 82.37 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 121.003 1.729 . . . . 0.0 111.403 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 75.2 t -58.82 -56.46 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.5 mm -61.21 -32.94 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.2 0.6 . . . . 0.0 111.803 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.44 -52.72 62.42 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.638 -1.288 . . . . 0.0 110.158 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.23 -43.68 64.04 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.217 0.607 . . . . 0.0 111.233 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -56.38 -41.6 76.51 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.306 1.042 . . . . 0.0 111.246 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.8 m -85.09 -17.48 37.22 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.443 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.5 28.48 47.7 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 123.583 0.611 . . . . 0.0 112.314 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -81.84 -27.63 33.46 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.735 -0.862 . . . . 0.0 109.976 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -142.7 151.52 41.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.6 m -58.95 153.82 16.63 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.014 0.926 . . . . 0.0 109.485 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 90.5 t -52.56 -56.26 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.224 1.009 . . . . 0.0 110.133 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.1 -49.06 74.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.213 1.405 . . . . 0.0 110.825 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -68.65 -25.57 64.89 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.93 83.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 74.9 mt -68.35 -43.5 77.35 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -50.54 -51.82 44.44 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.293 1.437 . . . . 0.0 109.536 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -54.42 -43.46 71.56 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.324 1.849 . . . . 0.0 110.757 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.437 ' O ' HD12 ' A' ' 368' ' ' ILE . . . -68.86 -50.75 47.15 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 118.725 -0.655 . . . . 0.0 109.488 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -52.01 -38.71 57.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.757 1.223 . . . . 0.0 108.773 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.2 m -59.68 -54.3 47.96 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.953 1.301 . . . . 0.0 108.283 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -58.56 -39.95 81.7 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.764 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.437 HD12 ' O ' ' A' ' 364' ' ' ALA . 1.6 mp -66.93 -41.55 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.074 0.852 . . . . 0.0 109.653 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 38.7 p -80.32 -11.66 59.69 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 36.3 tttm . . . . . 0 C--O 1.245 0.82 0 C-N-CA 126.036 1.734 . . . . 0.0 108.45 178.661 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.95 103.28 15.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.55 21.37 0.31 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.333 0.968 . . . . 0.0 114.344 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -143.56 155.55 44.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.721 1.76 . . . . 0.0 113.126 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.9 mt -137.72 151.37 48.14 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.101 1.76 . . . . 0.0 108.328 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 77.2 t -138.92 132.42 39.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 125.501 1.52 . . . . 0.0 108.431 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.7 mt -129.15 134.27 64.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.652 1.181 . . . . 0.0 108.116 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -118.68 157.22 27.87 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.957 1.303 . . . . 0.0 109.369 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.0 pt -144.97 165.63 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 125.631 1.572 . . . . 0.0 108.252 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -68.88 -33.29 73.55 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.014 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.19 -73.17 0.31 Allowed Glycine 0 C--N 1.342 0.876 0 C-N-CA 123.68 0.657 . . . . 0.0 113.37 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -70.85 26.9 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 129.424 3.089 . . . . 0.0 116.134 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -75.21 -45.79 38.1 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 125.123 1.369 . . . . 0.0 114.615 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.0 42.46 0.72 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 126.841 2.163 . . . . 0.0 111.96 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.525 ' CE1' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -56.68 -16.93 7.21 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -178.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -52.62 -45.14 66.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 121.826 2.103 . . . . 0.0 112.056 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.09 -40.22 35.32 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 121.435 0.464 . . . . 0.0 112.032 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.604 ' HA ' HG22 ' A' ' 293' ' ' VAL . 33.1 tp -64.77 -36.86 85.67 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.771 1.228 . . . . 0.0 114.242 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.37 64.55 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.675 0.79 . . . . 0.0 111.051 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -59.62 -33.99 72.21 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.96 -40.86 90.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.97 -34.99 83.37 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -68.58 -47.39 66.9 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 118.752 1.276 . . . . 0.0 108.322 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.05 -59.39 4.81 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.378 1.071 . . . . 0.0 109.101 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -56.5 -44.95 81.22 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.881 -0.581 . . . . 0.0 111.31 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -64.32 -16.38 62.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 120.395 1.452 . . . . 0.0 111.929 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -96.86 -16.36 20.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 117.295 -1.336 . . . . 0.0 112.708 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -106.54 -37.59 6.42 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 124.791 1.307 . . . . 0.0 110.434 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.3 p -101.15 -34.0 9.87 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.147 -0.97 . . . . 0.0 110.739 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.06 -11.79 67.37 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 121.146 -0.971 . . . . 0.0 113.396 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.0 132.9 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -67.51 150.03 49.39 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.161 -0.962 . . . . 0.0 109.677 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.9 t -140.49 97.78 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.585 1.554 . . . . 0.0 108.976 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.7 m -77.14 153.48 34.17 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.525 HG22 ' CE1' ' A' ' 17' ' ' TYR . 2.3 t -138.55 110.62 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 104.224 -2.509 . . . . 0.0 104.224 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -135.14 161.55 35.01 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -127.26 61.01 46.27 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.463 1.505 . . . . 0.0 113.969 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.46 143.24 38.23 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.424 1.416 . . . . 0.0 110.35 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -97.2 21.6 9.71 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.4 3.09 2.1 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.93 -22.75 5.96 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.005 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -48.84 -34.56 12.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.442 1.497 . . . . 0.0 112.096 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -122.32 -24.42 5.04 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.109 0.963 . . . . 0.0 111.937 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.78 -39.25 76.73 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.008 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -55.96 -59.53 11.39 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 119.988 1.267 . . . . 0.0 109.259 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.05 -29.4 89.16 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 CA-C-N 120.909 1.36 . . . . 0.0 113.916 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -77.23 0.49 21.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.101 1.319 . . . . 0.0 113.645 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.43 HG12 ' C ' ' A' ' 55' ' ' ASP . 3.7 t -131.73 -32.97 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.76 -26.65 60.76 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.837 -1.165 . . . . 0.0 110.053 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.86 -30.66 65.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.787 -0.571 . . . . 0.0 109.803 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 p -90.94 -16.45 28.06 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.351 1.06 . . . . 0.0 112.834 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 96.96 26.19 10.64 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-O 118.178 -1.346 . . . . 0.0 116.388 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.43 ' C ' HG12 ' A' ' 50' ' ' VAL . 57.2 m-20 -131.01 5.91 4.56 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.828 1.314 . . . . 0.0 110.084 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.1 -178.54 47.43 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.447 1.499 . . . . 0.0 114.941 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.34 169.78 9.0 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.416 2.077 . . . . 0.0 109.938 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -105.71 -16.8 14.58 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -139.38 145.66 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.45 144.8 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.691 1.196 . . . . 0.0 108.955 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -129.49 108.63 10.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.933 1.693 . . . . 0.0 110.429 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -152.41 -174.53 4.93 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.174 -0.954 . . . . 0.0 110.869 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.03 158.04 36.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.816 1.246 . . . . 0.0 108.558 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -63.8 -25.75 68.32 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.376 -0.203 . . . . 0.0 111.322 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.48 -62.01 2.2 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 126.027 1.731 . . . . 0.0 111.398 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -61.5 -19.88 62.57 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.492 0.717 . . . . 0.0 112.601 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -78.93 -20.75 48.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.789 -0.624 . . . . 0.0 111.896 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.56 -39.57 95.19 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.13 -50.5 5.79 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.765 1.174 . . . . 0.0 111.613 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -55.41 -42.66 74.4 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.422 1.111 . . . . 0.0 112.215 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.92 -43.13 79.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.639 0.654 . . . . 0.0 110.451 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.01 -50.8 68.13 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.487 1.115 . . . . 0.0 108.81 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 m -63.85 -5.11 3.85 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.319 1.848 . . . . 0.0 113.505 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.17 10.33 86.18 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.36 1.457 . . . . 0.0 113.392 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.7 mt -73.18 -18.95 61.21 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.305 1.053 . . . . 0.0 110.851 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.71 146.15 26.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.96 0.8 . . . . 0.0 109.949 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -93.1 -178.9 4.93 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.684 1.994 . . . . 0.0 110.321 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -72.43 128.61 36.14 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.623 1.569 . . . . 0.0 107.629 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.15 159.19 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.836 0.744 . . . . 0.0 110.67 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 m 47.27 75.03 0.71 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.468 2.307 . . . . 0.0 113.517 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -67.06 -45.13 4.25 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.0 1.8 . . . . 0.0 111.878 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -94.15 132.81 38.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.071 1.348 . . . . 0.0 112.019 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -65.13 -31.63 72.93 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.83 -36.41 64.97 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 121.081 1.764 . . . . 0.0 112.137 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -59.82 -30.78 69.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.783 0.719 . . . . 0.0 110.772 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -70.35 -29.83 66.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.99 -1.068 . . . . 0.0 112.124 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -78.39 -21.55 49.19 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.352 0.661 . . . . 0.0 111.47 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -69.44 -12.51 61.71 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.176 -0.953 . . . . 0.0 111.672 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.458 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 11.0 mt -120.61 164.04 17.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.127 1.771 . . . . 0.0 111.555 -177.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -66.2 160.65 63.15 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.73 -49.3 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.66 2.24 . . . . 0.0 112.491 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -51.78 -41.08 61.38 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.856 0.862 . . . . 0.0 113.229 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -28.12 65.54 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.495 -0.753 . . . . 0.0 111.177 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.458 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 73.9 m95 -78.03 -46.57 20.57 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -21.22 23.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.252 1.021 . . . . 0.0 112.507 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.15 -28.9 57.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.488 1.515 . . . . 0.0 111.085 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.71 0.64 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.531 1.532 . . . . 0.0 113.056 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -65.27 162.87 16.46 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.862 0.756 . . . . 0.0 109.515 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -145.51 176.84 9.3 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.283 1.833 . . . . 0.0 107.256 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -55.09 104.47 0.12 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.451 1.1 . . . . 0.0 109.186 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.16 -85.12 0.31 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 125.161 1.362 . . . . 0.0 111.317 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 170.09 4.29 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.711 1.604 . . . . 0.0 112.5 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -98.91 169.97 9.07 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.452 1.501 . . . . 0.0 108.531 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.7 pt -135.55 -37.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.37 172.34 14.58 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.914 1.686 . . . . 0.0 108.419 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.66 149.81 69.28 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.359 0.664 . . . . 0.0 111.352 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.22 140.84 38.1 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 124.645 3.563 . . . . 0.0 110.902 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.3 mm -121.04 -45.5 2.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 124.853 1.261 . . . . 0.0 112.808 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.43 161.53 37.82 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.891 0.876 . . . . 0.0 109.63 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.65 107.37 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 . . . . . 0 C--N 1.33 -0.243 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.871 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.155 0 C-N-CA 126.561 1.944 . . . . 0.0 106.703 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 N--CA 1.454 -0.809 0 N-CA-C 110.214 -0.725 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -100.37 -38.48 8.42 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.824 1.25 . . . . 0.0 112.677 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 t -157.22 157.17 33.84 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.585 1.084 . . . . 0.0 110.881 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -58.29 -30.42 66.62 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 118.334 -0.841 . . . . 0.0 113.12 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -66.36 -14.48 62.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.504 1.047 . . . . 0.0 112.052 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -101.63 -18.74 15.74 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.012 1.325 . . . . 0.0 111.239 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 26.1 mm -49.99 -56.24 18.94 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 120.736 1.607 . . . . 0.0 111.501 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.1 -20.07 25.54 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 CA-C-N 119.88 0.993 . . . . 0.0 112.557 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.65 -34.48 46.37 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 124.932 1.293 . . . . 0.0 111.453 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.8 -31.39 28.21 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.59 1.556 . . . . 0.0 108.55 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -59.43 -44.07 92.95 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.325 0.65 . . . . 0.0 109.625 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -65.51 -31.26 72.23 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 122.839 0.456 . . . . 0.0 111.319 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -69.79 -47.27 63.49 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 146' ' ' ALA . 26.7 mt -66.57 -32.85 74.46 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.627 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -70.68 -27.73 64.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.098 0.863 . . . . 0.0 110.076 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.84 -27.79 63.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 118.219 0.463 . . . . 0.0 110.481 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.1 -1.42 20.42 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.377 0.671 . . . . 0.0 112.569 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -177.22 -101.6 0.15 Allowed Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 118.989 0.813 . . . . 0.0 112.36 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -137.23 -179.5 5.76 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.942 2.097 . . . . 0.0 109.208 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 p -51.59 172.27 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.438 1.895 . . . . 0.0 115.569 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.459 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -106.19 -55.46 2.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.755 1.622 . . . . 0.0 112.343 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.4 tp -133.1 146.39 51.6 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.814 1.246 . . . . 0.0 110.844 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 90.2 mtp -146.1 127.99 15.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -149.27 166.84 27.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.17 136.73 33.08 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.57 -4.58 9.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.165 0.986 . . . . 0.0 108.912 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -65.56 -19.99 66.15 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 125.297 1.439 . . . . 0.0 110.823 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -127.8 143.14 46.55 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.094 0.958 . . . . 0.0 109.493 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -72.49 -12.75 27.36 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.095 3.197 . . . . 0.0 114.121 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -51.41 -45.76 62.67 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.276 0.944 . . . . 0.0 111.948 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.12 -37.71 19.93 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-O 119.157 -0.449 . . . . 0.0 112.128 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.0 p -72.93 -14.03 61.38 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.102 0.864 . . . . 0.0 111.448 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -53.84 -63.05 2.91 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.574 1.149 . . . . 0.0 111.866 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.14 -6.18 10.92 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.226 1.951 . . . . 0.0 114.325 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 28.2 tp -82.5 -62.88 1.49 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.448 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 12.5 pt -58.77 -42.2 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.35 2.61 3.65 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.59 -37.07 82.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -86.86 -48.52 8.11 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.43 1.014 . . . . 0.0 108.606 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.71 63.55 0.07 OUTLIER Glycine 0 C--N 1.336 0.553 0 CA-C-N 118.964 0.802 . . . . 0.0 113.632 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -117.18 140.42 15.82 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 105.835 -2.906 . . . . 0.0 105.835 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -151.36 151.32 31.58 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.298 1.549 . . . . 0.0 109.315 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.13 -65.21 1.0 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -136.71 150.35 48.4 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.624 0.77 . . . . 0.0 111.056 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -86.03 149.9 24.84 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -150.85 106.2 3.35 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.73 57.31 4.43 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.734 1.614 . . . . 0.0 112.276 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 49.99 16.39 0.23 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.092 2.157 . . . . 0.0 116.522 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.41 -15.34 0.06 OUTLIER Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.392 0.996 . . . . 0.0 112.282 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -117.67 130.54 56.41 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -126.7 131.17 51.44 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 124.944 1.402 . . . . 0.0 108.315 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.2 146.48 33.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.144 0.973 . . . . 0.0 109.955 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -0.71 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.827 1.651 . . . . 0.0 110.749 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -80.1 -37.4 33.8 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -81.93 100.71 9.81 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.22 150.65 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.419 1.487 . . . . 0.0 109.889 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.52 16.17 5.42 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.032 0.825 . . . . 0.0 115.149 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.0 t -54.83 -33.24 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.181 1.792 . . . . 0.0 115.01 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.61 14.48 12.69 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.27 0.628 . . . . 0.0 111.68 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -62.18 164.93 6.29 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.437 0.636 . . . . 0.0 110.1 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -50.95 -34.63 29.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.953 0.901 . . . . 0.0 112.093 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.21 -47.01 47.18 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.968 0.804 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -55.89 -48.78 74.99 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.969 -0.724 . . . . 0.0 109.415 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -67.04 -40.42 87.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 117.726 -1.131 . . . . 0.0 111.025 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.55 -49.64 76.68 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.133 0.879 . . . . 0.0 111.563 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -71.55 -27.93 70.34 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.319 -0.944 . . . . 0.0 112.057 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 14.2 tp -77.35 -34.14 55.22 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.773 1.287 . . . . 0.0 112.355 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.4 t -55.9 -45.31 78.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 117.452 -1.261 . . . . 0.0 108.805 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -52.39 -53.91 38.86 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.271 1.428 . . . . 0.0 111.237 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.6 tt -54.12 -48.39 70.81 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.122 0.969 . . . . 0.0 111.278 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 38.6 t -73.41 -21.95 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.39 0.676 . . . . 0.0 110.492 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.419 ' HA ' ' CE ' ' A' ' 200' ' ' LYS . 2.8 t70 -63.37 -36.85 85.1 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.768 1.227 . . . . 0.0 109.749 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.8 mt -71.9 -41.73 67.59 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 79.5 mt -63.09 -39.48 85.38 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.419 ' CE ' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -54.71 -34.27 62.18 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.817 1.247 . . . . 0.0 109.769 178.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -91.47 -9.93 42.73 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.693 1.197 . . . . 0.0 111.906 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 64.82 6.53 3.38 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 128.735 2.814 . . . . 0.0 113.387 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -67.54 -36.22 80.56 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.541 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 8.4 tpt -77.96 154.07 31.91 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -88.43 91.18 8.7 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.459 -0.775 . . . . 0.0 110.573 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.3 -28.93 70.05 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.376 -0.827 . . . . 0.0 112.49 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.11 -4.65 48.47 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.8 m -71.46 126.98 31.09 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.274 -1.516 . . . . 0.0 109.053 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.03 -178.08 3.86 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.863 1.665 . . . . 0.0 107.095 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -58.11 -37.74 75.12 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.093 0.557 . . . . 0.0 111.404 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 39.5 m -73.59 -40.1 64.12 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.54 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 19.4 mm -64.58 -50.99 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 120.839 1.654 . . . . 0.0 109.053 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -55.94 -44.06 78.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.854 0.752 . . . . 0.0 110.631 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -67.48 -40.69 85.26 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.555 0.742 . . . . 0.0 111.762 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.31 -56.51 8.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.699 0.8 . . . . 0.0 109.594 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.99 -39.44 66.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.415 1.486 . . . . 0.0 110.519 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -60.15 -45.93 91.39 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -64.06 -30.54 71.61 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.076 -0.488 . . . . 0.0 111.793 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -77.21 -11.38 59.82 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.969 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.97 19.82 49.34 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 125.174 1.369 . . . . 0.0 112.21 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.07 -48.76 19.58 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 118.385 1.093 . . . . 0.0 111.016 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -104.12 153.37 21.0 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -105.5 -25.38 12.34 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.676 0.79 . . . . 0.0 110.322 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -129.07 170.04 13.99 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.625 1.17 . . . . 0.0 109.716 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.7 t -161.06 178.92 8.86 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.182 1.793 . . . . 0.0 107.169 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.1 mt . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 179.457 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.239 0.528 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.0 123.52 10.1 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.418 2.079 . . . . 0.0 109.207 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.5 p -100.53 169.28 9.17 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -77.85 167.11 22.03 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -51.35 104.64 0.08 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 126.003 1.721 . . . . 0.0 110.249 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.52 8.21 44.69 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 117.97 -1.461 . . . . 0.0 116.556 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.59 124.25 10.35 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 121.569 2.685 . . . . 0.0 112.193 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.51 123.25 8.49 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.215 3.276 . . . . 0.0 113.576 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 20.0 m -62.37 159.06 16.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.578 1.151 . . . . 0.0 111.621 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -147.35 100.53 3.83 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.902 1.281 . . . . 0.0 111.172 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -69.97 -63.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.693 0 N-CA-C 107.274 -1.856 . . . . 0.0 107.274 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 . . . . . 0 CA--C 1.545 0.767 0 C-N-CA 129.153 2.981 . . . . 0.0 106.702 178.906 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.696 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.46 140.49 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.9 tt -81.35 140.42 34.77 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.3 m -126.9 154.28 44.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 122.903 0.481 . . . . 0.0 111.286 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -132.67 146.2 51.68 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.153 0.981 . . . . 0.0 108.579 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -139.85 148.62 20.19 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 82.6 mt -95.12 137.36 23.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -72.13 133.5 45.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.046 0.385 . . . . 0.0 110.296 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -79.29 -25.11 42.5 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.031 -0.985 . . . . 0.0 113.33 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . 0.42 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -74.22 -12.69 60.64 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.531 1.06 . . . . 0.0 113.325 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 61.9 m -60.15 165.51 4.89 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.49 -41.23 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 CA-C-N 120.59 1.246 . . . . 0.0 110.58 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -122.71 168.55 12.07 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.717 1.607 . . . . 0.0 108.164 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -132.88 -26.73 1.73 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.199 1.399 . . . . 0.0 110.303 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -61.47 -40.1 93.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.32 -34.56 72.49 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.827 -1.171 . . . . 0.0 111.195 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.61 -45.43 37.46 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.134 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -36.54 83.96 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.784 0.72 . . . . 0.0 109.154 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -64.78 -46.11 83.46 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -60.84 -37.41 81.98 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 120.102 1.319 . . . . 0.0 108.175 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.3 mp -77.24 -0.05 23.82 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 117.63 -1.176 . . . . 0.0 114.019 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -137.58 2.31 2.44 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 120.867 1.667 . . . . 0.0 113.587 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.52 -55.94 3.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.949 1.249 . . . . 0.0 110.613 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -126.11 -29.25 3.06 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.784 1.634 . . . . 0.0 113.299 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -55.21 -35.1 64.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.486 1.039 . . . . 0.0 111.885 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.36 74.57 0.96 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.329 1.052 . . . . 0.0 108.41 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 22.9 p -137.11 163.39 30.92 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.19 -17.41 63.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.25 1.82 . . . . 0.0 112.628 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -116.07 -36.56 4.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.602 1.561 . . . . 0.0 110.927 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.57 -31.04 59.18 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-O 118.846 -0.974 . . . . 0.0 110.883 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 29.7 mt -73.34 -41.79 63.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 119.577 1.689 . . . . 0.0 106.631 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -56.13 -47.32 78.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.555 1.142 . . . . 0.0 110.667 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.75 -29.44 64.8 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' A' ' 20' ' ' LEU . 48.5 t -91.08 -34.32 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 C-N-CA 124.477 1.111 . . . . 0.0 110.119 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -62.13 -30.4 71.0 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.067 0.849 . . . . 0.0 110.158 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -61.92 -17.81 58.09 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.969 0.908 . . . . 0.0 111.216 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -122.4 -76.27 0.59 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -61.66 142.69 94.33 Favored Pre-proline 0 C--O 1.234 0.272 0 O-C-N 121.189 -0.944 . . . . 0.0 111.457 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.08 93.1 1.03 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 N-CA-C 106.415 -2.186 . . . . 0.0 106.415 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.3 mt -77.23 -19.58 56.43 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 117.234 -1.365 . . . . 0.0 111.16 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 55.12 -138.98 41.89 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -85.75 165.57 16.8 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.42 155.56 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 O-C-N 120.306 -1.496 . . . . 0.0 110.814 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.52 70.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.111 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.21 101.05 0.26 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.872 1.269 . . . . 0.0 111.089 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -65.37 -20.73 66.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.785 178.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.91 -21.62 62.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.011 0.924 . . . . 0.0 111.494 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -113.6 -11.13 13.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.977 1.262 . . . . 0.0 110.559 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -59.86 -41.78 92.23 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.451 1.1 . . . . 0.0 108.355 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.88 -17.02 61.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.917 1.287 . . . . 0.0 112.817 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -95.96 -52.61 3.98 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.444 ' HB3' HG21 ' A' ' 317' ' ' ILE . 8.5 mt -56.62 -38.71 72.45 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.479 -0.763 . . . . 0.0 110.906 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.59 -6.66 5.58 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.262 1.425 . . . . 0.0 114.121 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -63.23 -13.61 39.75 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.4 1.08 . . . . 0.0 111.439 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -123.66 139.54 32.39 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.27 1.028 . . . . 0.0 109.255 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.47 -20.28 48.26 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.908 2.405 . . . . 0.0 112.941 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -63.93 -24.65 67.81 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.737 0.699 . . . . 0.0 112.684 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' A' ' 311' ' ' LEU . 2.3 mp -96.09 -56.84 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.39 -51.77 10.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.318 1.047 . . . . 0.0 112.576 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.23 -42.76 91.8 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.616 -0.678 . . . . 0.0 112.334 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 14.5 m -66.57 -34.19 77.35 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -53.76 43.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -55.49 -36.14 66.33 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.494 0.718 . . . . 0.0 111.432 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -67.7 -31.05 70.74 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.796 0.839 . . . . 0.0 111.128 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.368 0 O-C-N 121.595 -0.691 . . . . 0.0 109.667 178.038 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo . . . . . 0 CA--C 1.535 0.569 0 N-CA-C 114.444 0.902 . . . . 0.0 114.444 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -133.18 5.42 3.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.161 1.784 . . . . 0.0 112.277 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.6 pt -89.1 144.56 32.81 Favored Pre-proline 0 CA--C 1.537 0.452 0 O-C-N 121.233 -0.917 . . . . 0.0 109.287 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.01 -12.71 32.94 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.108 2.539 . . . . 0.0 114.398 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.57 -20.89 35.32 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.277 1.031 . . . . 0.0 111.792 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.0 mmm -62.06 -24.76 67.29 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.341 -0.849 . . . . 0.0 110.58 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 61.0 p -63.75 -28.16 69.69 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.768 -1.208 . . . . 0.0 110.05 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -90.45 -30.66 17.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.808 1.643 . . . . 0.0 111.266 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 343' ' ' VAL . 56.6 t80 -53.68 -60.77 2.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.391 1.077 . . . . 0.0 109.124 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -56.85 -43.01 80.7 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.745 0.418 . . . . 0.0 111.215 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -60.85 -27.47 68.12 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.05 0.54 . . . . 0.0 111.952 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.404 ' HB3' HD11 ' A' ' 368' ' ' ILE . . . -81.12 -61.74 1.86 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.613 0.765 . . . . 0.0 110.538 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 339' ' ' PHE . 1.6 m -56.44 -25.84 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.364 0.666 . . . . 0.0 111.677 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -54.0 -56.8 14.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.967 0.907 . . . . 0.0 108.694 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . 0.653 HG21 HH22 ' A' ' 367' ' ' ARG . 88.6 m -66.3 -38.35 87.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.186 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.04 77.05 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.47 -49.87 75.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 124.652 1.181 . . . . 0.0 109.024 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 32.7 mm -62.71 -38.55 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.148 0.886 . . . . 0.0 110.591 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -61.15 -41.91 97.6 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.122 -0.986 . . . . 0.0 110.774 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.35 -46.72 59.83 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 123.275 0.359 . . . . 0.0 110.328 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.93 98.34 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.703 1.201 . . . . 0.0 113.327 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 19.2 m -87.93 -1.32 57.91 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.659 0.783 . . . . 0.0 110.297 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 71.05 14.11 73.29 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-O 119.433 -0.649 . . . . 0.0 114.608 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -65.56 -26.97 68.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.541 1.171 . . . . 0.0 109.031 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -153.76 167.63 28.99 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.957 0.903 . . . . 0.0 109.65 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.6 m -72.26 156.14 39.44 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 39.6 t -54.95 -56.4 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.93 -51.47 40.78 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.641 2.376 . . . . 0.0 112.894 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -72.57 -32.69 66.23 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.86 71.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 24.6 mt -70.18 -43.35 70.97 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -51.76 -54.84 24.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.969 1.707 . . . . 0.0 108.178 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -52.31 -47.58 65.87 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.381 1.072 . . . . 0.0 109.317 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.92 -46.6 87.02 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 117.597 -1.192 . . . . 0.0 111.736 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.13 -39.78 72.75 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.406 1.003 . . . . 0.0 108.708 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 3.1 m -62.58 -25.08 67.89 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.184 0.993 . . . . 0.0 112.235 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.653 HH22 HG21 ' A' ' 345' ' ' THR . 93.2 mtt180 -83.07 -14.32 54.0 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.642 -1.287 . . . . 0.0 112.085 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.404 HD11 ' HB3' ' A' ' 342' ' ' ALA . 9.9 mt -105.85 -30.47 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.556 0.616 . . . . 0.0 109.426 -178.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 24.0 p -69.42 -37.87 77.63 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 27.6 tptt . . . . . 0 C--O 1.246 0.886 0 C-N-CA 126.371 1.868 . . . . 0.0 107.933 178.413 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -83.66 175.31 9.8 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.163 0.985 . . . . 0.0 108.684 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.64 35.62 86.59 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.374 1.464 . . . . 0.0 115.651 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -147.11 167.69 23.48 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 119.246 1.523 . . . . 0.0 112.658 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.0 mt -150.08 145.6 26.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.519 2.728 . . . . 0.0 105.664 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.445 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 50.4 t -139.56 134.68 39.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.9 mt -125.6 136.21 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.079 1.352 . . . . 0.0 110.092 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -127.07 154.66 44.41 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.0 pt -145.21 163.46 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 123.597 0.759 . . . . 0.0 111.348 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -0.95 2.27 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.52 -76.01 0.22 Allowed Glycine 0 C--N 1.332 0.354 0 CA-C-N 120.098 1.317 . . . . 0.0 112.438 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -63.26 17.11 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 130.121 3.369 . . . . 0.0 115.219 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -84.9 165.79 17.36 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.733 1.213 . . . . 0.0 112.309 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.02 83.14 1.6 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 103.466 -3.854 . . . . 0.0 103.466 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -95.59 -20.7 18.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -58.73 -42.05 87.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.699 1.136 . . . . 0.0 110.934 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.96 -41.39 40.91 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.6 tp -59.76 -43.13 94.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.08 0.94 . . . . 0.0 111.434 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.15 -38.8 71.34 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.881 -1.057 . . . . 0.0 111.17 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -60.0 -35.51 75.19 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.121 0.873 . . . . 0.0 111.852 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.6 -42.97 90.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.91 -39.98 96.9 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -63.34 -51.31 66.5 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 118.542 1.171 . . . . 0.0 108.695 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -53.71 -57.65 10.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.689 1.195 . . . . 0.0 108.544 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -58.01 -45.17 87.28 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.879 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -66.31 -8.29 24.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.036 1.289 . . . . 0.0 111.25 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -109.08 -8.28 15.19 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 119.994 -1.691 . . . . 0.0 112.657 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -110.79 -38.26 5.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.898 1.279 . . . . 0.0 108.801 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.9 p -104.16 -32.71 9.02 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.016 0.926 . . . . 0.0 111.249 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.47 -12.09 69.38 Favored Glycine 0 C--N 1.342 0.904 0 O-C-N 121.452 -0.78 . . . . 0.0 111.787 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.2 128.79 24.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -60.09 138.76 57.81 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.972 0.509 . . . . 0.0 111.22 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.05 119.73 17.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.8 m -114.62 148.88 37.48 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -137.29 113.64 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -130.67 166.06 21.52 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.144 0.977 . . . . 0.0 108.621 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -127.27 57.16 21.98 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.52 0.728 . . . . 0.0 111.65 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.09 149.77 65.22 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 N-CA-C 107.71 -1.688 . . . . 0.0 107.71 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -95.97 -37.23 10.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 121.245 -0.91 . . . . 0.0 108.656 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.404 ' CE ' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -65.44 -3.84 4.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.117 1.367 . . . . 0.0 111.816 178.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.11 -31.63 13.84 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.296 1.038 . . . . 0.0 109.417 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -50.0 -29.87 9.49 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.289 2.236 . . . . 0.0 112.433 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -125.5 -20.62 4.7 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.433 1.015 . . . . 0.0 110.569 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -73.65 -49.96 23.36 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 116.384 -1.77 . . . . 0.0 111.548 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -45.87 -57.58 7.76 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 120.114 1.325 . . . . 0.0 109.879 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.09 -18.11 63.47 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 N-CA-C 115.896 1.46 . . . . 0.0 115.896 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -92.34 -46.34 7.74 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.959 1.708 . . . . 0.0 112.289 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 t -69.45 -39.37 78.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 O-C-N 121.261 -0.899 . . . . 0.0 108.665 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.45 -16.34 61.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.402 -0.812 . . . . 0.0 110.847 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.34 7.43 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.072 0.949 . . . . 0.0 110.912 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -130.73 -39.6 1.24 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.764 2.026 . . . . 0.0 106.414 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.56 6.77 12.76 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 124.564 1.078 . . . . 0.0 114.737 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.45 -0.52 54.69 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.036 1.418 . . . . 0.0 111.238 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.73 -175.0 30.61 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 126.972 2.225 . . . . 0.0 116.529 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -67.35 -178.76 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.377 3.385 . . . . 0.0 112.0 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 9.9 m-20 -115.81 -20.03 10.21 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.538 HD11 ' HB1' ' A' ' 276' ' ' ALA . 17.5 mt -141.68 143.62 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.14 144.08 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.832 1.653 . . . . 0.0 108.144 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -131.28 114.66 15.3 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.836 1.654 . . . . 0.0 110.358 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -156.04 172.84 17.72 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.997 0.817 . . . . 0.0 111.538 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.43 149.31 50.61 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -55.6 -31.75 62.51 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.09 -12.76 61.97 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -109.44 -0.65 18.83 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.971 1.26 . . . . 0.0 109.544 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -92.88 -11.52 33.3 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.292 1.837 . . . . 0.0 112.225 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.62 -10.39 86.26 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.638 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.12 -60.61 1.17 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.087 1.327 . . . . 0.0 111.007 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -43.91 -44.14 6.89 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.543 1.537 . . . . 0.0 114.692 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -70.56 -41.5 72.36 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.085 0.857 . . . . 0.0 110.946 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -36.31 70.58 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.12 0.968 . . . . 0.0 109.003 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 m -67.99 -44.74 75.92 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.358 1.063 . . . . 0.0 108.697 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.77 -2.24 8.01 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.978 1.751 . . . . 0.0 113.345 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.0 mp -68.79 -11.0 59.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.514 1.657 . . . . 0.0 114.461 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 71' ' ' ALA . 76.5 mt -108.85 129.36 55.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.324 0.966 . . . . 0.0 108.511 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.84 167.22 13.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.172 1.789 . . . . 0.0 110.701 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -69.1 101.5 1.45 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.471 1.108 . . . . 0.0 109.656 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 pp -76.28 165.56 3.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 124.491 1.116 . . . . 0.0 111.424 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.4 m 48.08 97.71 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 128.581 2.752 . . . . 0.0 114.908 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.31 -22.95 21.3 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.916 2.411 . . . . 0.0 114.135 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -133.95 151.91 51.66 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -60.98 -32.68 72.24 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.5 1.52 . . . . 0.0 112.719 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.9 -42.12 65.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 120.07 1.305 . . . . 0.0 112.303 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.69 -30.72 71.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.886 0.475 . . . . 0.0 110.894 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -69.13 -37.42 78.31 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.142 -0.974 . . . . 0.0 111.379 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.26 -19.13 65.82 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.342 0.519 . . . . 0.0 111.484 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -79.08 -2.46 40.59 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.3 mt -130.38 151.6 50.69 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.329 1.052 . . . . 0.0 109.206 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -72.26 151.12 92.19 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 119.589 -0.845 . . . . 0.0 109.985 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.47 -45.47 3.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.282 3.322 . . . . 0.0 113.704 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -60.01 -33.51 72.09 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.428 1.013 . . . . 0.0 110.094 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.503 HG22 ' CB ' ' A' ' 107' ' ' PRO . 3.8 m -68.86 -36.19 77.83 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.806 0.843 . . . . 0.0 109.342 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -65.67 -45.18 83.88 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.141 0.977 . . . . 0.0 110.032 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.31 -33.71 13.88 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.438 1.495 . . . . 0.0 112.39 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.84 -35.27 22.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.207 1.403 . . . . 0.0 111.267 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.39 6.36 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.419 1.888 . . . . 0.0 113.328 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -69.02 156.67 38.23 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -138.5 175.59 9.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -62.97 111.18 2.05 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.596 0.758 . . . . 0.0 110.06 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.98 -77.76 0.67 Allowed Glycine 0 CA--C 1.522 0.514 0 C-N-CA 124.804 1.192 . . . . 0.0 114.169 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 166.03 22.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.06 0.944 . . . . 0.0 110.778 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.71 170.01 8.44 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.746 1.218 . . . . 0.0 110.052 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.1 pt -138.17 -35.42 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.72 176.93 11.54 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.235 1.414 . . . . 0.0 108.61 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -131.76 150.41 76.16 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.526 0.731 . . . . 0.0 110.94 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.503 ' CB ' HG22 ' A' ' 93' ' ' THR . 72.4 Cg_endo -72.57 151.95 53.37 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.591 2.86 . . . . 0.0 109.639 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mm -128.79 -45.09 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 123.972 0.909 . . . . 0.0 111.125 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.41 157.78 44.71 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 123.141 0.577 . . . . 0.0 112.007 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.7 t -132.4 100.15 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 C--O 1.237 0.428 0 C-N-CA 124.998 1.319 . . . . 0.0 107.754 178.789 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.2 p90 . . . . . 0 C--O 1.233 0.231 0 C-N-CA 124.788 1.235 . . . . 0.0 110.208 -178.56 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo . . . . . 0 N--CA 1.458 -0.609 0 N-CA-C 112.925 0.317 . . . . 0.0 112.925 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -126.5 -9.14 6.28 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 t -168.26 154.49 7.27 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.401 ' CE2' HD13 ' A' ' 160' ' ' LEU . 6.2 m95 -69.31 -18.94 63.88 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.947 -0.471 . . . . 0.0 111.061 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -75.43 -18.8 59.81 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.916 0.78 . . . . 0.0 110.291 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -87.22 -26.39 23.54 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.906 0.882 . . . . 0.0 109.783 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.1 mm -51.46 -60.43 5.87 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.0 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.83 -25.57 23.48 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 CA-C-N 120.631 1.261 . . . . 0.0 110.981 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.18 96.81 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.584 0.754 . . . . 0.0 109.227 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.9 tp -79.67 -27.89 40.78 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.705 1.202 . . . . 0.0 110.637 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -57.02 -46.36 82.41 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.788 0.722 . . . . 0.0 110.496 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -69.52 -28.48 66.07 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -74.37 -44.62 51.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.1 mt -72.2 -34.68 68.56 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 119.167 -0.444 . . . . 0.0 109.824 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -66.12 -32.34 73.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.81 -15.87 63.28 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 119.082 -0.485 . . . . 0.0 112.166 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.69 5.95 6.15 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.879 1.272 . . . . 0.0 112.832 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.21 -101.98 0.16 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 118.97 0.805 . . . . 0.0 111.329 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -139.42 -176.23 4.46 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.091 1.357 . . . . 0.0 111.519 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.23 162.13 2.17 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.416 1.486 . . . . 0.0 114.185 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.27 -45.32 8.28 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.723 1.209 . . . . 0.0 111.466 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.6 tp -124.88 149.67 47.29 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.571 1.549 . . . . 0.0 107.289 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.0 ttm -154.33 103.08 2.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -121.96 158.98 27.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.525 1.057 . . . . 0.0 111.112 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.477 HD22 ' HB2' ' A' ' 210' ' ' TYR . 62.4 t-20 -69.14 98.15 0.98 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.98 -11.74 60.01 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.808 0.843 . . . . 0.0 110.883 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -78.88 -23.52 44.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.962 1.305 . . . . 0.0 113.683 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -95.38 132.01 28.59 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 119.976 1.262 . . . . 0.0 110.772 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.29 -22.8 39.46 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 121.897 1.731 . . . . 0.0 114.468 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -68.97 -14.89 63.31 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.263 1.392 . . . . 0.0 113.104 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -95.82 -25.56 15.98 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.486 1.039 . . . . 0.0 109.066 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 p -88.7 -28.51 20.52 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.838 -1.164 . . . . 0.0 110.516 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -51.69 79.02 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 120.069 -1.644 . . . . 0.0 113.239 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.0 -5.03 12.54 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.857 1.705 . . . . 0.0 111.651 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.401 HD13 ' CE2' ' A' ' 129' ' ' TRP . 15.1 tp -85.76 -62.33 1.55 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . 0.27 0.2 OUTLIER -70.52 -27.59 31.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.56 -25.09 36.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.721 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -49.46 -47.3 48.4 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.174 1.39 . . . . 0.0 113.023 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -66.29 -45.37 80.64 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.456 0.702 . . . . 0.0 111.291 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -176.43 -26.04 0.03 OUTLIER Glycine 0 C--N 1.338 0.653 0 CA-C-O 117.255 -1.858 . . . . 0.0 115.937 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -42.01 133.06 4.11 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.204 1.383 . . . . 0.0 112.876 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -139.01 122.81 17.62 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.35 -55.1 37.62 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.64 -0.662 . . . . 0.0 112.043 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -140.41 145.17 36.69 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -71.65 139.44 49.25 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 121.648 -0.658 . . . . 0.0 111.683 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -141.84 138.17 31.97 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.367 -2.456 . . . . 0.0 104.367 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -110.36 -120.33 0.28 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.455 1.102 . . . . 0.0 108.555 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -111.03 53.85 0.69 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 128.252 2.621 . . . . 0.0 108.011 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.02 9.29 34.71 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.694 -1.059 . . . . 0.0 113.568 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -118.47 125.17 49.35 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -116.96 133.79 55.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.716 2.006 . . . . 0.0 106.933 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -138.91 110.4 7.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.787 0.803 . . . . 0.0 111.641 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -2.73 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.09 1.356 . . . . 0.0 112.493 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -93.42 -0.59 56.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.06 1.344 . . . . 0.0 111.73 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -127.17 106.18 9.07 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.975 1.71 . . . . 0.0 107.247 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 96.9 t -122.76 122.9 67.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.995 2.118 . . . . 0.0 109.81 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -107.69 54.95 0.54 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.84 1.21 . . . . 0.0 114.555 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -93.9 -50.42 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 123.415 0.686 . . . . 0.0 109.287 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -81.83 63.39 6.06 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.504 1.522 . . . . 0.0 107.457 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -124.14 152.25 43.02 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.138 0.975 . . . . 0.0 109.77 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.24 -40.73 67.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.544 1.138 . . . . 0.0 112.638 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.18 -31.36 77.3 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.129 -0.982 . . . . 0.0 112.566 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.05 -48.13 54.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.791 0.796 . . . . 0.0 109.213 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -63.42 -35.41 80.33 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.747 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -55.01 -55.44 30.84 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.823 0.849 . . . . 0.0 112.023 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -69.52 -29.9 71.32 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.401 HD23 HG13 ' A' ' 357' ' ' VAL . 41.4 tp -67.87 -46.53 71.44 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.136 -1.214 . . . . 0.0 109.803 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -34.21 63.9 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.97 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -60.15 -58.76 7.12 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.065 1.302 . . . . 0.0 109.651 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.9 -48.69 77.62 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.336 1.055 . . . . 0.0 110.102 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.19 -28.04 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 123.634 0.774 . . . . 0.0 110.664 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.42 -37.17 86.59 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 119.509 1.05 . . . . 0.0 111.855 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.4 mt -71.95 -40.52 68.63 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.39 -41.46 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.151 0.98 . . . . 0.0 108.365 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -54.59 -41.12 69.53 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.496 1.119 . . . . 0.0 108.956 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -86.45 -1.84 57.93 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.396 1.879 . . . . 0.0 113.133 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.2 mptt 57.7 6.55 0.45 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.049 2.539 . . . . 0.0 114.842 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -76.72 -10.7 59.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.121 0.873 . . . . 0.0 111.802 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.9 tpt -95.24 150.99 19.63 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.377 1.071 . . . . 0.0 109.735 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.31 67.06 8.61 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.39 -19.67 3.72 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.665 1.986 . . . . 0.0 115.676 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -86.27 0.71 53.21 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.952 2.101 . . . . 0.0 111.811 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 42.7 m -70.12 131.24 43.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.684 1.129 . . . . 0.0 109.768 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -127.6 -178.63 4.55 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.906 1.682 . . . . 0.0 106.612 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . 0.477 ' HB2' HD22 ' A' ' 150' ' ' ASN . 40.3 t80 -56.03 -46.82 78.72 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.324 0.65 . . . . 0.0 112.52 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 68.4 m -56.28 -49.49 74.07 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.484 1.114 . . . . 0.0 110.519 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 53.4 mt -64.09 -43.87 97.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.605 0.762 . . . . 0.0 109.429 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.86 -53.71 52.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.982 0.913 . . . . 0.0 112.592 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -65.36 -33.66 76.49 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.783 -0.573 . . . . 0.0 110.144 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.9 -51.39 64.73 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.83 -33.98 73.86 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.59 0.632 . . . . 0.0 111.129 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -65.6 -45.58 82.65 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 177.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -60.63 -35.17 75.5 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -69.45 -16.45 63.48 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.979 -1.01 . . . . 0.0 111.759 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.0 13.86 65.66 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 119.591 1.087 . . . . 0.0 111.645 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -84.23 -43.27 15.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.099 0.95 . . . . 0.0 112.47 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 58.4 p -75.48 107.72 7.8 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.234 0.47 . . . . 0.0 111.66 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.91 -26.37 66.83 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -146.51 158.12 43.85 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.878 1.671 . . . . 0.0 110.127 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 5.9 t -149.5 154.0 38.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--N 1.331 -0.212 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -179.2 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.77 132.25 24.54 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 120.506 1.216 . . . . 0.0 109.383 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 25.4 p -116.57 172.83 6.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.086 1.354 . . . . 0.0 109.347 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -84.65 169.36 14.4 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.576 0.703 . . . . 0.0 110.249 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -62.13 117.99 6.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.59 11.91 57.93 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.63 145.18 18.08 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-N 121.351 2.575 . . . . 0.0 111.71 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.04 171.7 17.01 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 124.305 3.337 . . . . 0.0 111.289 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.6 p -93.12 137.01 32.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -129.27 74.84 80.76 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.468 1.907 . . . . 0.0 109.217 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.08 -83.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.706 2.271 . . . . 0.0 109.893 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.439 0 C-N-CA 126.806 2.042 . . . . 0.0 107.866 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.455 0 N-CA-C 106.008 -2.837 . . . . 0.0 106.008 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.06 148.61 23.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 118.891 1.345 . . . . 0.0 112.083 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.0 tp -84.59 133.94 34.41 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.8 m -113.06 157.33 21.7 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.279 1.032 . . . . 0.0 111.595 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -135.5 138.5 43.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.476 1.11 . . . . 0.0 108.87 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.33 163.57 25.13 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 71.2 mt -109.57 142.66 21.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -74.18 116.08 14.41 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.51 -24.98 59.04 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.833 -0.604 . . . . 0.0 112.028 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -70.94 -9.46 57.9 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 118.195 -0.907 . . . . 0.0 113.302 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 6.9 t -62.56 144.24 95.89 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.4 -34.89 52.66 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.239 1.292 . . . . 0.0 109.887 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -141.73 109.53 5.74 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -14.53 63.02 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.691 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.6 -33.42 75.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.067 0.547 . . . . 0.0 111.05 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.38 -37.83 76.06 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.282 -0.886 . . . . 0.0 109.573 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.538 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -74.59 -45.94 41.92 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.777 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -34.41 78.06 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 118.862 -0.59 . . . . 0.0 110.114 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -73.29 -41.16 63.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.545 0.611 . . . . 0.0 109.593 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -58.35 -47.0 85.2 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.996 -1.065 . . . . 0.0 109.109 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.77 -45.57 81.99 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.528 -0.749 . . . . 0.0 111.571 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -77.01 -12.93 60.0 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -106.44 -17.62 14.22 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.727 1.603 . . . . 0.0 113.306 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -136.99 -51.11 0.66 Allowed 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 119.51 1.05 . . . . 0.0 111.484 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -5.69 20.05 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.97 31.03 6.97 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.013 -1.68 . . . . 0.0 111.523 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 70.7 p -116.31 163.66 15.68 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -40.79 95.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.206 1.403 . . . . 0.0 107.443 178.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.0 -48.68 73.08 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.976 1.71 . . . . 0.0 110.903 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -62.75 -50.47 63.8 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 58.1 mt -60.21 -44.64 94.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.125 0.57 . . . . 0.0 109.841 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -62.59 -42.87 99.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.848 0.459 . . . . 0.0 109.976 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.52 74.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.232 0.469 . . . . 0.0 110.407 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.7 t -73.6 -36.55 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.288 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -63.46 -31.09 72.15 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.815 1.646 . . . . 0.0 112.417 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -62.2 -45.85 91.54 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.467 -0.771 . . . . 0.0 112.156 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -65.1 -50.85 64.47 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.428 ' HE2' ' HD2' ' A' ' 298' ' ' PRO . 10.4 mmmm -138.24 146.64 52.46 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.428 ' HD2' ' HE2' ' A' ' 297' ' ' LYS . 36.7 Cg_endo -61.64 124.18 14.13 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.307 2.671 . . . . 0.0 109.985 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 29.1 mt -102.82 -13.64 16.91 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 67.89 -146.93 47.36 Favored Glycine 0 C--O 1.241 0.544 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.71 178.34 2.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 122.759 1.266 . . . . 0.0 110.08 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.3 m -131.69 152.17 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 O-C-N 120.934 -1.104 . . . . 0.0 109.087 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.12 -29.46 60.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.73 108.56 3.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.831 1.252 . . . . 0.0 108.883 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -55.47 -21.89 18.32 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.7 m -68.15 -49.59 60.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.538 1.063 . . . . 0.0 113.409 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -89.11 -9.31 51.57 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.886 0.874 . . . . 0.0 110.792 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.64 -47.22 80.22 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -60.6 -31.95 71.09 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.112 1.365 . . . . 0.0 113.914 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -81.0 -44.22 18.42 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.922 0.889 . . . . 0.0 109.612 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 20.9 mt -66.36 -33.6 76.09 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.59 -9.07 7.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.655 1.582 . . . . 0.0 112.794 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -63.92 -28.23 69.69 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.212 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -98.41 136.51 20.84 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.71 -21.82 71.0 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 123.695 2.93 . . . . 0.0 117.125 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -71.43 -30.02 65.56 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.507 1.048 . . . . 0.0 110.438 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.9 mp -79.07 -56.42 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -44.02 -60.76 1.71 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.113 1.365 . . . . 0.0 113.751 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.75 -44.38 90.53 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.947 0.794 . . . . 0.0 112.898 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 16.9 m -59.41 -35.55 74.2 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -44.38 52.67 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 121.611 -0.681 . . . . 0.0 109.274 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.94 -30.03 67.57 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.513 -0.742 . . . . 0.0 109.789 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -75.83 -31.33 59.32 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.46 -0.775 . . . . 0.0 109.529 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.334 0 CA-C-N 119.167 0.894 . . . . 0.0 109.643 177.63 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo . . . . . 0 N--CA 1.462 -0.378 0 N-CA-C 113.307 0.464 . . . . 0.0 113.307 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 92.68 14.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 130.472 3.509 . . . . 0.0 110.819 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.8 pt -57.42 143.83 73.16 Favored Pre-proline 0 CA--C 1.538 0.505 0 O-C-N 121.487 -0.758 . . . . 0.0 109.081 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.37 -21.13 47.74 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.487 1.458 . . . . 0.0 112.996 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -63.71 -22.23 66.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.299 1.04 . . . . 0.0 110.256 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 8.0 mtt -61.4 -29.38 69.89 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.225 0.92 . . . . 0.0 110.589 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 37.1 t -56.07 -43.0 77.53 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 118.53 0.605 . . . . 0.0 109.653 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.56 -41.27 47.05 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.17 0.588 . . . . 0.0 109.79 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -48.47 -46.65 38.32 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.472 1.109 . . . . 0.0 111.871 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -66.42 -54.0 29.21 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.004 -0.435 . . . . 0.0 110.918 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -60.33 -29.94 69.2 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.94 0.791 . . . . 0.0 112.406 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.98 -60.48 2.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.272 1.029 . . . . 0.0 111.073 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 22.5 t -69.2 -34.93 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 117.44 -1.266 . . . . 0.0 112.439 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.37 -28.98 60.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.485 1.493 . . . . 0.0 110.321 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 61.1 m -81.32 -51.69 8.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.389 1.076 . . . . 0.0 108.2 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -49.77 -45.91 50.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.533 1.06 . . . . 0.0 113.513 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 38.7 t -57.3 -52.66 53.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.061 0.944 . . . . 0.0 109.685 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.49 -38.58 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.212 0.605 . . . . 0.0 109.842 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -59.7 -48.67 80.75 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 118.825 0.738 . . . . 0.0 109.842 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.66 75.22 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.149 0.579 . . . . 0.0 110.775 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.95 80.94 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 10.9 m -89.34 -8.98 52.13 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.914 0.885 . . . . 0.0 110.812 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 73.34 15.28 78.95 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.154 -0.804 . . . . 0.0 112.547 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -64.52 -31.62 72.91 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.906 1.353 . . . . 0.0 109.233 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -148.31 156.12 42.14 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 14.2 t -73.2 162.61 29.21 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.401 HG13 HD23 ' A' ' 192' ' ' LEU . 54.1 t -52.45 -51.04 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 126.153 1.781 . . . . 0.0 109.536 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.14 -46.83 75.67 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.177 1.791 . . . . 0.0 112.711 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -75.61 -39.65 57.59 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.873 0.869 . . . . 0.0 111.744 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.42 -44.04 84.3 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.79 -43.51 83.76 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.854 0.862 . . . . 0.0 110.287 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -55.98 -59.28 5.12 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.58 -44.3 26.23 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.883 1.673 . . . . 0.0 110.914 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.45 -44.81 70.51 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.757 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -58.28 -37.07 74.27 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.028 1.285 . . . . 0.0 109.208 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 2.3 m -57.17 -40.63 77.69 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 123.429 0.692 . . . . 0.0 111.285 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -65.46 -18.37 65.27 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.53 -1.356 . . . . 0.0 114.136 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.2 mp -95.23 -41.77 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 20.6 p -71.91 -16.08 62.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.396 0.544 . . . . 0.0 111.831 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 39.4 tptt . . . . . 0 C--O 1.25 1.131 0 C-N-CA 127.032 2.133 . . . . 0.0 105.867 178.851 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 . . . . . 0 C--O 1.234 0.261 0 N-CA-C 104.843 -2.281 . . . . 0.0 104.843 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -99.52 136.32 39.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.76 1.624 . . . . 0.0 109.216 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.1 25.1 17.79 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.874 0.75 . . . . 0.0 112.819 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.34 165.81 29.05 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.468 1.107 . . . . 0.0 109.482 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.6 mt -138.55 151.39 47.28 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.8 t -143.12 144.37 23.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 37' ' ' VAL . 10.2 mt -134.56 144.64 34.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 123.835 0.854 . . . . 0.0 109.231 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -134.84 132.85 39.1 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.309 1.444 . . . . 0.0 107.903 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -105.77 169.6 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -83.3 -39.56 20.65 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.0 -79.98 0.09 OUTLIER Glycine 0 C--N 1.339 0.71 0 CA-C-N 119.14 0.882 . . . . 0.0 112.271 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.99 -3.12 9.02 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -61.21 157.35 16.38 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 120.789 -1.194 . . . . 0.0 109.416 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.48 69.11 0.76 Allowed Glycine 0 CA--C 1.518 0.258 0 O-C-N 121.78 -0.575 . . . . 0.0 112.038 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -54.2 -19.97 6.07 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.904 1.681 . . . . 0.0 113.623 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -62.97 -58.17 8.25 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.456 1.48 . . . . 0.0 108.238 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.63 -36.76 79.94 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 123.382 0.515 . . . . 0.0 111.915 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.9 -32.06 73.35 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.923 -0.751 . . . . 0.0 110.578 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.01 -43.36 81.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.576 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -58.16 -41.93 84.89 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.647 0.779 . . . . 0.0 110.672 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.65 -50.86 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.53 -45.38 95.97 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 121.421 -0.799 . . . . 0.0 113.247 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -34.0 75.05 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.213 1.007 . . . . 0.0 110.831 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -66.13 -54.8 21.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -56.0 -42.43 76.4 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.332 0.969 . . . . 0.0 110.854 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.86 -27.41 69.15 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.214 -0.929 . . . . 0.0 110.085 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -84.66 -18.93 33.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.769 -1.207 . . . . 0.0 112.703 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -102.79 -16.25 16.01 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 124.219 0.949 . . . . 0.0 111.162 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.5 p -124.86 -31.95 3.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.23 61.36 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.232 -0.917 . . . . 0.0 112.903 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.4 129.83 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -66.04 148.55 51.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 123.835 0.854 . . . . 0.0 109.253 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 t -139.53 156.18 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.2 m -144.22 141.65 30.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.404 HG22 HD12 ' A' ' 9' ' ' ILE . 17.3 t -130.56 122.94 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -137.81 163.63 30.92 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.764 0.826 . . . . 0.0 110.469 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -121.66 57.9 8.05 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.782 1.233 . . . . 0.0 112.679 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.11 165.1 31.86 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.299 1.333 . . . . 0.0 111.658 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.86 -30.0 6.88 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -16.75 62.48 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.696 1.599 . . . . 0.0 114.063 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -46.27 -34.2 4.28 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.733 1.213 . . . . 0.0 114.213 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -57.61 -24.03 54.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.117 0.967 . . . . 0.0 113.451 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -128.2 -8.21 5.34 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.716 0.806 . . . . 0.0 112.1 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -84.47 -47.35 10.71 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.242 1.417 . . . . 0.0 107.369 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -46.18 -52.32 28.4 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 119.233 0.924 . . . . 0.0 112.656 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.81 -17.6 59.97 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.626 1.551 . . . . 0.0 114.386 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -85.45 -4.24 59.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.3 1.04 . . . . 0.0 111.896 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.7 -39.57 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.752 0.821 . . . . 0.0 110.214 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.49 73.0 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.85 -0.531 . . . . 0.0 110.345 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.12 10.15 1.03 Allowed 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.041 -1.037 . . . . 0.0 112.0 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.7 m -131.88 -0.99 3.78 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.779 1.172 . . . . 0.0 113.64 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.52 56.18 2.86 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -166.23 -176.93 3.88 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 128.824 2.85 . . . . 0.0 105.796 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.27 179.12 31.4 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.168 1.366 . . . . 0.0 114.196 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.07 167.18 16.66 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.456 2.104 . . . . 0.0 110.068 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.14 -21.72 18.32 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.0 mt -138.28 143.94 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 tt -130.51 135.91 59.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.317 1.847 . . . . 0.0 106.197 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.17 109.5 11.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.841 1.256 . . . . 0.0 110.117 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -154.94 169.38 24.18 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.46 152.6 37.92 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.809 0.814 . . . . 0.0 110.013 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -55.15 -30.02 58.96 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.801 1.24 . . . . 0.0 111.537 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.34 -12.54 9.47 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.196 1.798 . . . . 0.0 115.733 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -123.3 2.36 9.13 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.787 1.176 . . . . 0.0 109.909 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -85.24 -5.96 59.29 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.304 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.3 -17.22 79.65 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.889 1.222 . . . . 0.0 111.185 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.65 -66.69 1.1 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-O 118.513 -1.159 . . . . 0.0 113.266 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -44.19 -46.92 9.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.201 1.0 . . . . 0.0 113.22 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.58 -55.15 36.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.786 0.835 . . . . 0.0 110.081 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.36 -49.57 61.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.57 1.148 . . . . 0.0 109.314 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.4 m -58.63 -7.17 0.88 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.48 1.912 . . . . 0.0 112.953 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.77 17.59 72.43 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 125.712 1.625 . . . . 0.0 112.805 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.2 mt -85.86 -15.92 40.29 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.245 1.023 . . . . 0.0 113.507 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.9 mt -105.48 136.01 45.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.88 1.218 . . . . 0.0 111.65 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.51 164.37 25.96 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.62 1.168 . . . . 0.0 111.959 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.09 105.9 5.52 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.431 HG13 ' CA ' ' A' ' 105' ' ' ALA . 7.3 mm -67.42 152.46 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.39 1.076 . . . . 0.0 112.087 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.2 m 78.09 88.84 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 129.68 3.192 . . . . 0.0 110.058 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -72.44 -28.88 14.26 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.206 1.937 . . . . 0.0 110.755 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -141.58 147.0 36.96 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.221 1.408 . . . . 0.0 109.411 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -54.95 -34.25 63.1 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.805 1.642 . . . . 0.0 112.96 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.46 -35.04 60.08 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.119 0.968 . . . . 0.0 113.037 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -63.51 -28.05 69.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.434 0.561 . . . . 0.0 111.418 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -67.27 -33.08 74.56 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 120.972 -1.08 . . . . 0.0 111.534 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.0 -18.49 55.85 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.207 0.603 . . . . 0.0 111.481 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -74.72 -17.9 60.59 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.7 mt -123.03 155.76 36.21 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.398 0.679 . . . . 0.0 111.671 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -68.94 151.28 97.33 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 122.853 0.461 . . . . 0.0 111.175 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.5 -46.03 2.17 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.433 2.089 . . . . 0.0 112.509 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -54.77 -45.79 74.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.184 0.902 . . . . 0.0 111.68 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.59 -20.64 57.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.019 1.328 . . . . 0.0 112.607 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -72.62 -28.7 62.92 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.904 1.229 . . . . 0.0 109.903 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.92 -34.79 72.12 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.872 1.215 . . . . 0.0 110.902 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.74 -17.34 55.47 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.045 1.338 . . . . 0.0 114.475 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.8 m -127.49 4.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.014 1.326 . . . . 0.0 111.6 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -66.26 157.47 31.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.333 1.064 . . . . 0.0 108.871 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -150.43 -177.33 5.9 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -68.86 108.2 3.37 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.609 1.164 . . . . 0.0 111.969 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.57 -53.65 0.48 Allowed Glycine 0 N--CA 1.47 0.901 0 C-N-CA 128.273 2.844 . . . . 0.0 117.337 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 163.38 12.31 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.198 1.399 . . . . 0.0 107.986 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -97.15 159.55 14.85 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 pt -121.32 -25.25 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.755 -1.111 . . . . 0.0 113.287 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.431 ' CA ' HG13 ' A' ' 79' ' ' ILE . . . -159.43 176.96 11.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.275 1.03 . . . . 0.0 108.318 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.53 145.8 58.78 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 124.558 1.143 . . . . 0.0 108.917 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.76 150.98 51.05 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.467 2.111 . . . . 0.0 109.354 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.2 mm -127.82 -53.71 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.131 1.772 . . . . 0.0 110.56 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -124.78 147.24 48.8 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.587 0.755 . . . . 0.0 112.462 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.4 t -122.47 104.17 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.465 1.506 . . . . 0.0 107.464 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.478 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.2 mp . . . . . 0 CA--C 1.52 -0.181 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 39.7 p90 . . . . . 0 C--O 1.236 0.39 0 C-N-CA 124.713 1.205 . . . . 0.0 109.893 -179.081 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo . . . . . 0 N--CA 1.457 -0.659 0 N-CA-C 109.905 -0.844 . . . . 0.0 109.905 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -118.8 -12.78 9.59 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.258 1.023 . . . . 0.0 112.426 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.3 t -167.11 162.72 15.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.777 1.231 . . . . 0.0 108.413 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -65.62 -24.86 67.15 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.537 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.5 -15.47 63.69 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.211 1.369 . . . . 0.0 112.926 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.51 -21.41 28.63 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.409 0.683 . . . . 0.0 110.08 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.73 -58.38 19.85 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-O 117.235 -1.364 . . . . 0.0 109.237 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.2 -26.98 49.05 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 CA-C-N 121.45 1.554 . . . . 0.0 111.751 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.92 67.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.728 0.811 . . . . 0.0 110.032 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 64.2 tp -75.81 -26.42 57.23 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.093 1.357 . . . . 0.0 110.999 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.89 -42.32 99.73 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.496 0.718 . . . . 0.0 110.126 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 7.2 ptmm? -72.4 -32.53 66.45 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.248 -0.908 . . . . 0.0 111.126 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -69.28 -44.79 71.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.666 0.387 . . . . 0.0 110.675 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.7 -30.54 36.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.147 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.21 -33.17 71.36 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 120.182 1.356 . . . . 0.0 109.095 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.99 -7.69 42.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.85 0.07 2.88 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.66 0.784 . . . . 0.0 111.895 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -162.84 -107.0 0.21 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.399 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -141.69 -173.33 3.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.323 1.449 . . . . 0.0 109.581 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.9 p -62.55 152.5 34.66 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.155 0.889 . . . . 0.0 113.024 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.44 -49.57 13.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.345 1.458 . . . . 0.0 114.228 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.9 tp -134.66 143.37 47.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.125 0.97 . . . . 0.0 110.887 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -137.06 138.21 40.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.255 1.422 . . . . 0.0 107.606 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -151.29 166.49 30.79 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.925 1.239 . . . . 0.0 111.941 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -70.17 91.13 0.69 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.405 1.882 . . . . 0.0 106.629 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.2 tt -87.47 -35.6 18.14 Favored 'General case' 0 CA--C 1.524 -0.052 0 C-N-CA 125.715 1.606 . . . . 0.0 112.566 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -64.2 -12.45 40.66 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -103.78 122.48 44.47 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 118.689 0.677 . . . . 0.0 109.992 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.86 -16.48 49.58 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 120.723 0.949 . . . . 0.0 110.639 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -47.66 -44.44 27.21 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 127.54 2.336 . . . . 0.0 111.671 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -98.84 -33.41 10.9 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 p -69.82 -27.35 64.8 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.352 1.433 . . . . 0.0 110.338 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -53.6 -60.61 6.69 Favored Pre-proline 0 C--N 1.343 0.308 0 C-N-CA 124.875 1.27 . . . . 0.0 113.392 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -57.28 -15.92 20.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.913 1.742 . . . . 0.0 114.537 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 8.6 tt -75.44 -66.57 0.75 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.2 pt -56.69 -34.62 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.217 1.007 . . . . 0.0 112.845 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.03 -26.23 64.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.028 -1.045 . . . . 0.0 112.86 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.43 86.88 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.498 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.07 -42.65 73.05 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.412 0.685 . . . . 0.0 111.439 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.83 -13.96 0.09 OUTLIER Glycine 0 CA--C 1.526 0.753 0 CA-C-O 117.959 -1.467 . . . . 0.0 113.025 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -49.4 133.12 25.57 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -138.02 144.97 41.3 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 119.719 1.76 . . . . 0.0 111.509 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.79 -59.49 2.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -141.65 171.42 14.08 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.901 2.08 . . . . 0.0 106.658 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -119.85 139.83 51.76 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 119.528 1.058 . . . . 0.0 112.643 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.17 105.73 12.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.698 1.199 . . . . 0.0 108.448 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -173.13 1.13 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.306 2.242 . . . . 0.0 109.098 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -51.31 -20.71 1.79 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.13 2.172 . . . . 0.0 115.012 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.94 3.09 0.04 OUTLIER Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.112 0.863 . . . . 0.0 113.693 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.44 151.55 48.68 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 119.531 1.666 . . . . 0.0 107.314 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -122.13 126.04 47.48 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 125.534 1.534 . . . . 0.0 108.203 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.79 150.81 52.12 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 122.512 1.149 . . . . 0.0 113.566 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.09 1.58 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.843 -1.98 . . . . 0.0 110.133 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -75.97 -35.7 59.55 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.2 97.16 10.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.82 121.09 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.44 1.896 . . . . 0.0 106.827 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -122.83 38.69 2.45 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 123.924 0.773 . . . . 0.0 114.862 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.72 -25.03 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.117 0.967 . . . . 0.0 111.17 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.84 17.22 19.98 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -66.19 164.2 16.2 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 121.596 -0.69 . . . . 0.0 110.995 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.9 65.27 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.9 -36.8 93.76 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.898 0.772 . . . . 0.0 111.651 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.58 -50.55 64.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.791 0.796 . . . . 0.0 109.24 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -63.82 -32.2 73.63 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 117.869 -1.063 . . . . 0.0 111.616 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.54 -51.25 70.66 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.244 0.929 . . . . 0.0 110.217 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.14 -28.95 69.36 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 29.9 tp -69.74 -55.96 8.49 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.605 1.203 . . . . 0.0 110.785 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.43 -26.47 53.69 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.6 0.76 . . . . 0.0 112.152 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -56.66 -42.1 78.38 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.126 -0.984 . . . . 0.0 108.953 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 19.6 tp -69.25 -48.95 60.4 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.835 1.254 . . . . 0.0 108.456 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 47.4 t -54.48 -34.05 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.517 1.527 . . . . 0.0 109.78 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.18 -42.56 88.75 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.553 1.541 . . . . 0.0 110.778 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.62 -40.25 84.67 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.245 -0.909 . . . . 0.0 108.564 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 89.4 mt -66.85 -36.93 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -60.33 -36.89 79.0 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.992 -1.693 . . . . 0.0 108.473 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -82.3 -2.11 51.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.288 1.435 . . . . 0.0 111.272 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? 56.46 9.56 0.56 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.707 2.403 . . . . 0.0 114.394 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -82.46 -14.68 54.66 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ttp -112.17 147.97 35.03 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.46 1.104 . . . . 0.0 110.074 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -85.58 103.57 14.53 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.897 1.279 . . . . 0.0 107.919 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -77.51 -21.62 52.45 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -91.67 0.12 57.52 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.5 m -60.88 131.48 50.82 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.526 1.13 . . . . 0.0 110.315 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.54 -173.51 2.75 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.785 1.234 . . . . 0.0 108.048 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -56.53 -45.81 80.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.074 0.949 . . . . 0.0 109.725 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.86 -49.68 75.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.948 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 46.3 mm -59.0 -48.75 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.621 1.101 . . . . 0.0 110.356 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.09 87.08 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -74.59 -57.42 3.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -50.81 -55.89 14.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.754 1.621 . . . . 0.0 112.241 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.42 76.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.139 0.881 . . . . 0.0 110.734 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.5 -38.8 90.79 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -63.1 -35.69 81.11 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.89 0.876 . . . . 0.0 109.708 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -72.78 -22.79 60.78 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.01 18.61 21.82 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 126.143 1.83 . . . . 0.0 112.68 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.88 -71.74 0.31 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.233 1.016 . . . . 0.0 113.648 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . 0.28 4.2 t -68.55 152.81 44.86 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.27 0.557 . . . . 0.0 112.365 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.83 31.42 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.612 0.765 . . . . 0.0 112.454 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -152.85 155.66 37.51 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.506 1.123 . . . . 0.0 108.234 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.5 t -147.78 159.05 44.24 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.5 mt . . . . . 0 C--O 1.238 0.461 0 CA-C-N 119.408 1.004 . . . . 0.0 110.236 -179.563 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pp . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.94 141.41 30.0 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.71 2.273 . . . . 0.0 111.559 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.1 p -149.48 -172.23 4.09 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 127.793 2.437 . . . . 0.0 107.512 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -87.5 144.95 26.46 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -55.73 119.77 6.27 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.984 0.914 . . . . 0.0 110.389 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.01 -4.9 44.11 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.055 0.836 . . . . 0.0 114.321 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.57 87.14 32.56 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.927 1.863 . . . . 0.0 109.543 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.48 152.7 60.45 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.721 1.614 . . . . 0.0 110.661 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 19.5 m -72.2 134.81 45.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.65 0.78 . . . . 0.0 109.913 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 256' ' ' LYS . 0.2 OUTLIER -140.39 87.18 12.04 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.528 1.531 . . . . 0.0 108.01 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.15 -90.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.628 2.218 . . . . 0.0 109.35 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.444 -0.725 0 C-N-CA 127.517 2.327 . . . . 0.0 106.046 179.729 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.867 0 N-CA-C 106.555 -2.618 . . . . 0.0 106.555 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.0 164.37 33.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.169 0.509 . . . . 0.0 109.947 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.68 173.19 10.83 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.608 0.763 . . . . 0.0 109.726 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -148.39 141.3 24.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.722 -1.236 . . . . 0.0 110.135 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.29 132.46 47.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.7 152.18 19.79 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.218 -0.768 . . . . 0.0 111.362 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.1 mt -89.83 135.63 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -71.35 120.29 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.424 1.09 . . . . 0.0 109.14 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.24 -20.66 62.21 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -75.88 -4.14 39.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.059 1.744 . . . . 0.0 114.924 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 33.1 m -71.7 167.49 30.4 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 124.894 1.278 . . . . 0.0 110.672 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -80.75 -43.45 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.196 1.264 . . . . 0.0 110.605 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -139.23 106.84 5.59 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.032 0.933 . . . . 0.0 109.379 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.422 ' HD2' ' H ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -61.93 -19.79 63.11 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.115 0.966 . . . . 0.0 112.045 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.11 -40.57 81.57 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 68.3 mt -57.62 -36.58 71.98 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.722 -0.612 . . . . 0.0 111.492 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.81 -45.45 28.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.976 0.511 . . . . 0.0 112.024 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -32.72 74.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.2 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -70.34 -56.45 6.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -52.52 -46.14 66.59 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.238 -0.914 . . . . 0.0 111.255 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 4.1 tt -66.81 -42.54 85.75 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.517 -1.23 . . . . 0.0 113.063 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.3 -15.74 39.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.51 1.504 . . . . 0.0 114.713 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -109.55 -17.58 13.71 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -131.29 -51.5 1.02 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 118.993 0.815 . . . . 0.0 111.471 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.86 -55.7 20.89 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.338 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.52 HD22 HD21 ' A' ' 304' ' ' LEU . 55.3 mt -88.34 77.26 8.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.74 0.816 . . . . 0.0 109.91 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 39.8 p -140.8 159.43 42.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.23 -38.04 89.15 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -81.87 -29.25 32.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.009 0.524 . . . . 0.0 112.227 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.04 -43.84 20.55 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.97 -39.83 90.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.31 -46.57 85.9 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -53.52 -46.78 70.25 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.736 0.698 . . . . 0.0 111.214 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.66 -37.79 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.19 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -72.01 -22.45 61.41 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.774 1.629 . . . . 0.0 113.584 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -69.29 -44.97 70.72 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.626 0.771 . . . . 0.0 109.01 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -71.76 -48.31 47.68 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -135.08 152.92 77.98 Favored Pre-proline 0 N--CA 1.461 0.082 0 C-N-CA 123.992 0.917 . . . . 0.0 109.909 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.9 125.57 10.01 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.086 1.857 . . . . 0.0 110.937 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 86.7 mt -99.89 -24.23 14.71 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.535 -0.745 . . . . 0.0 112.335 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 81.26 -155.02 35.66 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.22 168.93 14.72 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 12.7 m -121.68 162.2 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 O-C-N 120.641 -1.287 . . . . 0.0 110.991 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.33 -13.59 49.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.286 0.634 . . . . 0.0 110.434 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.52 HD21 HD22 ' A' ' 285' ' ' LEU . 4.1 mm? -76.31 112.5 12.86 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 127.239 2.216 . . . . 0.0 107.703 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -62.89 -36.51 83.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.071 0.462 . . . . 0.0 110.32 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -52.15 64.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.434 1.894 . . . . 0.0 111.172 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -84.84 -11.8 54.9 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.815 0.846 . . . . 0.0 112.224 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -60.49 -42.77 96.99 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -63.24 -9.89 13.38 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.43 1.492 . . . . 0.0 112.164 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -109.61 -36.8 5.86 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.051 0.94 . . . . 0.0 110.495 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 14.7 mt -74.27 -24.32 59.24 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.453 -1.405 . . . . 0.0 108.521 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.56 -8.05 17.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.495 1.118 . . . . 0.0 112.382 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -56.59 -37.76 71.07 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.03 133.31 24.32 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.39 -24.69 71.17 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.578 2.185 . . . . 0.0 113.332 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -62.57 -30.71 71.52 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.77 0.714 . . . . 0.0 109.851 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.9 mp -77.54 -61.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -44.13 -55.99 4.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.164 1.386 . . . . 0.0 114.342 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.18 -32.41 68.21 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.596 -0.69 . . . . 0.0 112.859 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 24.7 m -74.74 -36.54 62.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.687 0.795 . . . . 0.0 109.164 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.8 tpt -66.75 -43.15 84.92 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.219 1.007 . . . . 0.0 109.084 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -55.74 -41.01 73.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.595 0.758 . . . . 0.0 110.419 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -63.28 -26.85 68.97 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.728 -0.608 . . . . 0.0 112.324 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.485 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo . . . . . 0 CA--C 1.538 0.685 0 N-CA-C 115.595 1.344 . . . . 0.0 115.595 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 66.96 34.52 5.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.687 1.995 . . . . 0.0 112.002 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.2 pt -132.33 156.48 80.04 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 123.845 0.858 . . . . 0.0 110.937 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.46 -25.99 24.74 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.002 2.468 . . . . 0.0 113.666 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -57.66 -16.91 12.11 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.227 0.921 . . . . 0.0 113.343 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -22.83 65.69 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.16 -0.963 . . . . 0.0 111.411 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.4 t -65.62 -54.72 23.74 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.56 -34.97 78.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.499 1.12 . . . . 0.0 111.302 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -50.34 -56.81 9.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.805 0.842 . . . . 0.0 111.658 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -65.98 -40.9 91.64 Favored 'General case' 0 CA--C 1.522 -0.118 0 O-C-N 121.247 -0.908 . . . . 0.0 111.404 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.57 -45.77 84.77 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.155 0.503 . . . . 0.0 110.518 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.39 -51.68 64.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.647 1.179 . . . . 0.0 111.581 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.84 -27.46 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.707 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -53.99 -50.1 67.35 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.352 1.433 . . . . 0.0 107.596 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.5 m -68.51 -44.43 74.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.051 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.86 -47.03 68.09 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.948 1.249 . . . . 0.0 113.768 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 24.2 t -56.08 -51.68 59.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 124.61 1.164 . . . . 0.0 109.113 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.03 -37.45 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -58.75 -46.06 88.29 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.177 -1.577 . . . . 0.0 110.947 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.35 -45.46 59.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.634 0.773 . . . . 0.0 110.48 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.14 -44.42 97.36 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.33 0.514 . . . . 0.0 111.623 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 59.8 m -75.04 -25.91 59.05 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.899 0.879 . . . . 0.0 109.313 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.86 32.77 44.01 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -85.14 -21.29 29.3 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.846 0.858 . . . . 0.0 110.62 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -147.42 151.42 36.43 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.6 m -58.65 152.21 19.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.991 0.916 . . . . 0.0 109.293 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 61.8 t -57.2 -44.77 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 118.988 0.813 . . . . 0.0 109.414 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -52.18 66.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.469 1.108 . . . . 0.0 110.009 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -63.87 -37.71 88.41 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.262 0.625 . . . . 0.0 111.838 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.93 92.48 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 38.2 mt -73.15 -38.85 66.1 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.597 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -57.88 -53.46 57.99 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 119.681 1.128 . . . . 0.0 109.807 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -29.93 70.76 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -70.99 -55.34 8.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 118.114 -0.946 . . . . 0.0 108.895 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -49.66 -38.57 33.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.178 1.391 . . . . 0.0 110.069 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 26.4 m -57.93 -45.64 86.27 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.008 0.523 . . . . 0.0 110.452 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -61.67 -8.63 4.81 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.147 2.179 . . . . 0.0 114.027 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 2.3 mp -104.17 -40.11 6.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.1 p -68.76 -25.43 64.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.402 0.547 . . . . 0.0 110.801 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? . . . . . 0 C--O 1.245 0.85 0 C-N-CA 127.135 2.174 . . . . 0.0 108.36 -179.089 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -71.92 69.49 0.71 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.718 1.207 . . . . 0.0 113.786 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.57 30.95 0.02 OUTLIER Glycine 0 CA--C 1.526 0.731 0 O-C-N 121.352 -0.843 . . . . 0.0 114.017 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -143.5 172.06 13.3 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.253 1.027 . . . . 0.0 110.259 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.6 mt -150.81 140.13 21.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 127.682 2.393 . . . . 0.0 106.506 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.8 t -137.06 148.05 26.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.473 HD12 HG22 ' A' ' 37' ' ' VAL . 11.9 mt -130.43 142.4 43.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.606 1.562 . . . . 0.0 109.119 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -137.76 134.08 34.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.8 147.68 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -60.31 -35.57 75.89 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.27 168.72 11.45 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t0 48.66 30.25 2.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.107 1.363 . . . . 0.0 110.961 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.38 -14.58 16.21 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -177.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.66 30.57 4.56 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.909 1.719 . . . . 0.0 112.972 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -45.82 -46.21 15.39 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.66 1.184 . . . . 0.0 113.723 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -58.19 -41.37 83.79 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.445 1.02 . . . . 0.0 112.874 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.57 -42.18 41.25 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.8 tp -58.42 -39.21 79.16 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.928 1.291 . . . . 0.0 110.238 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.78 -46.7 64.25 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.729 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.36 -39.5 79.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.269 1.028 . . . . 0.0 111.573 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 t -59.95 -42.78 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.72 -39.57 96.77 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -62.47 -46.87 86.51 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 119.651 1.725 . . . . 0.0 109.012 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -59.65 -56.19 24.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -55.55 -47.07 76.96 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.628 0.649 . . . . 0.0 112.017 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.24 -28.85 69.99 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 121.103 -0.998 . . . . 0.0 110.794 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.64 -23.0 37.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.904 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -100.3 -11.05 20.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.409 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.3 p -127.34 -32.39 2.46 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.478 1.035 . . . . 0.0 113.693 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.2 -14.73 62.86 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 119.393 0.997 . . . . 0.0 112.818 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.6 mm -69.24 122.81 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.26 145.49 47.24 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 123.345 0.658 . . . . 0.0 110.13 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.8 t -133.0 136.38 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -128.96 138.54 52.03 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.473 HG22 HD12 ' A' ' 9' ' ' ILE . 24.8 t -133.94 128.55 53.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.7 1.2 . . . . 0.0 107.931 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -140.55 160.09 40.78 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.14 1.776 . . . . 0.0 107.184 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -122.26 59.03 10.89 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.094 0.958 . . . . 0.0 111.708 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.84 136.41 20.73 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.906 2.404 . . . . 0.0 109.32 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.31 -33.41 63.19 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.561 0.948 . . . . 0.0 113.561 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -99.27 24.23 8.24 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -178.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 pp -49.2 -29.3 5.41 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.266 -0.896 . . . . 0.0 112.287 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -57.69 -24.98 59.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.359 1.864 . . . . 0.0 114.518 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -110.05 -19.29 13.12 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.555 0.693 . . . . 0.0 111.023 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -81.08 -50.29 9.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.357 -0.84 . . . . 0.0 108.874 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -44.12 -55.98 8.58 Favored Pre-proline 0 CA--C 1.529 0.146 0 CA-C-O 117.334 -1.317 . . . . 0.0 111.937 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 30.6 Cg_endo -60.98 -28.51 86.4 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 120.813 1.326 . . . . 0.0 115.402 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -83.05 -32.87 26.62 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.401 1.455 . . . . 0.0 112.154 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 t -87.37 -40.52 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.221 0.464 . . . . 0.0 110.258 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.26 -32.28 73.87 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 120.483 -1.385 . . . . 0.0 110.034 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 48' ' ' PRO . . . -58.2 -20.03 38.2 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.107 1.363 . . . . 0.0 112.585 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.1 p -113.37 2.91 15.64 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.993 0.917 . . . . 0.0 112.897 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.49 12.54 83.64 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.071 0.851 . . . . 0.0 111.287 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -103.97 -10.27 18.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.544 1.138 . . . . 0.0 111.468 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.92 174.27 55.29 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.017 1.294 . . . . 0.0 115.333 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.71 172.0 7.59 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.41 3.406 . . . . 0.0 113.389 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -101.43 -20.19 15.25 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.39 127.12 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.707 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 tp -107.67 144.72 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 127.202 2.201 . . . . 0.0 106.846 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -131.97 107.74 8.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.744 1.218 . . . . 0.0 110.637 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -157.24 -175.82 5.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.065 0.946 . . . . 0.0 110.076 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.4 151.0 33.02 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -52.3 -33.41 42.18 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.553 1.541 . . . . 0.0 113.409 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.42 -18.08 48.53 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -103.31 -7.61 20.96 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.163 -1.585 . . . . 0.0 110.514 178.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -91.32 -28.69 17.58 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.755 -0.59 . . . . 0.0 112.388 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.04 14.08 1.26 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.905 1.241 . . . . 0.0 113.725 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.87 -59.9 0.25 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 129.394 3.378 . . . . 0.0 105.853 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -50.11 -51.75 40.52 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.024 0.93 . . . . 0.0 110.665 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.66 95.81 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.14 0.495 . . . . 0.0 111.135 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.24 -13.34 58.09 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.857 0.863 . . . . 0.0 112.44 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.4 m -106.52 -6.32 18.18 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.745 2.418 . . . . 0.0 112.473 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.42 16.49 39.97 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.1 mt -96.18 -15.01 22.32 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 73.5 mt -106.53 139.77 40.48 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.832 1.651 . . . . 0.0 110.755 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.56 -178.36 7.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -69.34 106.74 3.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.418 2.287 . . . . 0.0 106.373 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 79' ' ' ILE . 1.6 mm -80.4 148.7 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.417 HG22 HG22 ' A' ' 79' ' ' ILE . 3.9 t 38.96 80.37 0.28 Allowed Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 129.026 2.931 . . . . 0.0 111.499 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.82 -24.9 68.02 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 121.635 1.557 . . . . 0.0 111.848 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -123.62 142.59 50.9 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.267 1.427 . . . . 0.0 109.138 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -61.44 -27.51 68.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.205 2.202 . . . . 0.0 109.98 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.69 63.25 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.202 0.91 . . . . 0.0 112.905 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -76.62 -31.09 57.2 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.314 0.961 . . . . 0.0 108.925 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -67.05 -39.5 86.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.205 -0.935 . . . . 0.0 109.816 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -57.3 -28.4 63.0 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.502 1.121 . . . . 0.0 112.077 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -75.06 -18.24 60.34 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.4 mt -117.17 162.05 18.47 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.131 0.878 . . . . 0.0 110.782 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -75.0 148.65 84.69 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.783 0.833 . . . . 0.0 109.972 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.52 -42.51 3.58 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.596 2.198 . . . . 0.0 113.342 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -60.57 -40.01 90.12 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.55 0.614 . . . . 0.0 109.991 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.02 -28.34 70.03 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.73 -1.231 . . . . 0.0 109.98 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.402 ' CZ3' ' HB3' ' A' ' 106' ' ' TYR . 70.6 m95 -71.84 -33.3 68.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.214 0.915 . . . . 0.0 109.951 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.11 -38.73 73.84 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.262 0.937 . . . . 0.0 110.42 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.94 -7.47 3.85 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.79 8.21 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.222 1.409 . . . . 0.0 112.167 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -63.75 162.67 12.94 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.502 1.144 . . . . 0.0 111.182 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -145.71 -174.91 4.54 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.759 1.624 . . . . 0.0 108.408 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.68 105.15 0.61 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.304 1.442 . . . . 0.0 107.84 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.05 -78.06 0.29 Allowed Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.795 1.188 . . . . 0.0 113.637 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -178.86 7.21 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.614 1.566 . . . . 0.0 110.57 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.51 169.35 8.71 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.842 0.83 . . . . 0.0 111.403 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.5 pt -130.07 -22.41 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.082 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.426 ' CA ' HG13 ' A' ' 79' ' ' ILE . . . -155.71 167.86 29.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.877 0.871 . . . . 0.0 109.051 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.402 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -123.94 150.35 62.39 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.583 1.153 . . . . 0.0 109.383 179.112 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -72.74 144.45 39.33 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.764 2.309 . . . . 0.0 109.371 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -126.26 -46.82 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.877 0.871 . . . . 0.0 111.608 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.8 144.9 49.29 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.25 119.03 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 C--N 1.326 -0.43 0 C-N-CA 124.096 0.958 . . . . 0.0 111.265 -178.406 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 68.9 mt . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 30.1 p90 . . . . . 0 C--O 1.234 0.242 0 C-N-CA 125.62 1.568 . . . . 0.0 109.59 -179.081 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 N--CA 1.458 -0.607 0 N-CA-C 110.921 -0.453 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -136.41 -8.8 1.95 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 117.401 -1.285 . . . . 0.0 112.449 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.6 t -147.1 144.63 29.18 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 121.714 2.052 . . . . 0.0 112.287 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -61.48 -19.99 62.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.627 1.171 . . . . 0.0 112.974 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -74.74 -15.86 60.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.615 1.098 . . . . 0.0 112.642 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -92.51 -26.92 17.72 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.987 0.812 . . . . 0.0 110.474 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.5 mm -48.69 -56.77 13.29 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 125.382 1.473 . . . . 0.0 110.951 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.69 -22.36 32.5 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 CA-C-N 120.487 1.209 . . . . 0.0 112.236 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.57 -36.7 63.07 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.1 tp -78.49 -28.55 46.4 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.861 1.264 . . . . 0.0 110.068 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.04 -50.21 71.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.71 0.687 . . . . 0.0 110.062 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.7 ptmm? -63.52 -31.85 73.13 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.044 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.59 -42.21 52.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.358 0.526 . . . . 0.0 109.697 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.8 mt -71.35 -31.41 67.33 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -67.42 -29.98 69.62 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.59 -3.53 18.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.128 0.571 . . . . 0.0 112.071 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.31 3.86 2.17 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.402 1.481 . . . . 0.0 111.478 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.87 -95.59 0.1 Allowed Glycine 0 CA--C 1.524 0.647 0 CA-C-N 120.077 1.308 . . . . 0.0 115.344 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -138.72 -171.6 3.11 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 125.341 1.456 . . . . 0.0 110.738 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.0 p -62.22 154.1 28.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.913 0.885 . . . . 0.0 110.599 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -76.85 -39.58 50.7 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.669 1.188 . . . . 0.0 110.805 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.2 tp -130.46 147.82 52.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.216 1.006 . . . . 0.0 112.5 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 25.4 mtp -150.75 127.84 11.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.642 2.377 . . . . 0.0 105.243 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -158.71 173.61 16.3 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -78.99 84.63 4.99 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.128 -0.982 . . . . 0.0 110.636 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 mp -71.61 -28.59 63.9 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.051 0.387 . . . . 0.0 109.986 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -61.42 -15.14 34.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -115.21 130.24 24.41 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 119.478 1.035 . . . . 0.0 110.605 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.04 -21.67 72.83 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.324 1.349 . . . . 0.0 112.394 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -54.4 -31.42 54.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.263 1.025 . . . . 0.0 113.461 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.12 -24.8 15.15 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.2 p -90.89 -15.93 29.04 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.33 0.968 . . . . 0.0 111.456 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -62.23 -35.3 19.6 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.08 -11.54 30.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 123.276 2.206 . . . . 0.0 113.98 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.7 tp -68.31 -67.05 0.49 Allowed 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.51 1.524 . . . . 0.0 111.621 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.696 HD13 ' H ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.28 -24.7 35.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.616 1.166 . . . . 0.0 113.295 -179.26 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.35 -16.15 63.29 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.865 -0.522 . . . . 0.0 111.035 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.85 -60.54 2.77 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.153 1.381 . . . . 0.0 109.568 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.76 -54.99 38.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.0 15.79 0.02 OUTLIER Glycine 0 C--N 1.337 0.629 0 CA-C-O 117.887 -1.507 . . . . 0.0 116.149 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.66 147.97 41.07 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 120.804 2.302 . . . . 0.0 109.639 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -151.9 128.24 10.59 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.89 -48.97 62.04 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -143.66 149.51 37.36 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -101.84 159.28 15.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.217 -0.927 . . . . 0.0 109.315 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -155.59 113.98 3.45 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 102.011 -3.329 . . . . 0.0 102.011 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -73.67 -168.59 0.59 Allowed 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.308 1.843 . . . . 0.0 108.429 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -57.13 -34.56 68.51 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.741 -1.224 . . . . 0.0 110.765 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -154.56 8.28 0.36 Allowed Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.284 -1.287 . . . . 0.0 114.558 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -112.49 130.46 55.99 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.366 2.083 . . . . 0.0 107.06 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.17 115.37 17.58 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.96 1.704 . . . . 0.0 109.368 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -132.56 111.78 11.52 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -10.45 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.869 0.867 . . . . 0.0 112.789 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -77.13 -28.78 54.42 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.821 0.848 . . . . 0.0 109.937 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -73.76 80.98 1.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.911 1.284 . . . . 0.0 110.619 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 63.7 t -108.19 141.77 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 127.591 2.357 . . . . 0.0 108.851 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -132.16 34.04 2.59 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.093 1.33 . . . . 0.0 115.092 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.17 -37.76 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 117.301 -1.333 . . . . 0.0 113.796 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.46 ' OD2' ' HE3' ' A' ' 362' ' ' LYS 0.293 21.4 t70 -108.8 34.91 3.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.53 1.514 . . . . 0.0 113.279 -178.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -79.14 151.69 31.18 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -47.75 -24.8 1.04 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.17 -19.74 68.88 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 120.145 1.339 . . . . 0.0 111.738 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.66 -45.07 47.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.809 0.844 . . . . 0.0 108.981 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -64.39 -54.56 30.92 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.71 -45.07 70.32 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.617 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -63.56 -30.43 77.58 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 118.814 -0.992 . . . . 0.0 112.128 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 46.0 tp -84.09 -40.46 18.27 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.206 1.402 . . . . 0.0 110.881 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.4 m -44.24 -54.49 5.66 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 127.763 2.425 . . . . 0.0 112.156 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.02 -44.41 91.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.778 0.717 . . . . 0.0 111.769 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.66 -46.05 91.39 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.636 -0.665 . . . . 0.0 109.38 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.78 -34.42 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.65 -43.32 99.12 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.531 1.06 . . . . 0.0 111.811 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 75.7 mt -65.12 -50.76 64.82 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.678 0.791 . . . . 0.0 109.103 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.48 -35.97 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.406 1.083 . . . . 0.0 110.572 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -58.61 -49.13 78.62 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.345 0.975 . . . . 0.0 108.545 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.88 4.27 17.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.843 1.257 . . . . 0.0 112.286 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 58.39 20.49 7.42 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.919 1.288 . . . . 0.0 112.292 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.79 9.63 6.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.366 1.466 . . . . 0.0 110.882 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.2 ttt -146.91 148.05 31.4 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 121.206 -0.934 . . . . 0.0 108.6 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -78.15 78.63 4.63 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.25 -13.08 61.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.861 1.665 . . . . 0.0 114.782 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -92.88 -8.2 44.03 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.58 0.752 . . . . 0.0 112.372 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.7 m -61.97 127.66 32.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 122.522 1.153 . . . . 0.0 110.065 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 29.5 p30 -119.16 -177.52 3.36 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.711 2.004 . . . . 0.0 106.683 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.44 -42.9 99.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.4 m -60.11 -45.59 92.46 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 118.522 -0.751 . . . . 0.0 109.56 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.93 -56.26 19.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -54.49 -59.44 4.69 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.942 1.697 . . . . 0.0 112.982 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -58.19 -44.58 88.11 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.845 0.748 . . . . 0.0 111.475 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.8 -45.65 91.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.434 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.82 95.25 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.411 1.084 . . . . 0.0 112.166 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -63.3 -38.59 91.75 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.098 0.559 . . . . 0.0 110.056 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -59.68 -46.07 90.16 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -68.46 -42.9 78.1 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.341 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.64 36.5 2.05 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.283 1.421 . . . . 0.0 109.596 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -78.22 -62.02 1.81 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.746 -0.856 . . . . 0.0 109.298 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.4 t -73.27 137.1 44.7 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.552 1.541 . . . . 0.0 108.075 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.05 -15.65 57.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.163 0.585 . . . . 0.0 112.53 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -159.29 168.4 26.53 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.919 1.688 . . . . 0.0 109.443 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -155.81 -179.56 8.24 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.452 1.501 . . . . 0.0 109.046 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.3 mt . . . . . 0 C--O 1.236 0.384 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 178.868 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 32.0 mt . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.46 153.7 77.03 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.277 1.985 . . . . 0.0 111.849 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 255' ' ' SER . 36.7 p -113.81 -165.38 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.265 1.426 . . . . 0.0 109.149 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -125.98 149.88 48.45 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -51.09 120.24 4.74 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.618 1.167 . . . . 0.0 109.616 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.61 -4.13 57.43 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 117.621 -1.655 . . . . 0.0 114.615 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.69 115.01 3.51 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 121.777 2.789 . . . . 0.0 115.191 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.29 147.07 28.84 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.709 2.939 . . . . 0.0 111.254 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.419 ' H ' HG22 ' A' ' 249' ' ' THR . 5.4 p -64.81 155.52 33.67 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -133.02 66.69 76.59 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.512 1.525 . . . . 0.0 108.599 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.15 179.68 6.27 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.426 2.751 . . . . 0.0 113.174 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 . . . . . 0 C--O 1.234 0.288 0 CA-C-O 121.903 0.859 . . . . 0.0 112.155 -179.928 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.855 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.89 154.96 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 119.114 1.457 . . . . 0.0 111.829 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.37 117.46 11.03 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.4 m -104.49 144.98 30.93 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.561 1.144 . . . . 0.0 110.811 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.0 129.7 47.15 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.76 131.54 8.55 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 123.556 0.535 . . . . 0.0 111.891 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 85.5 mt -75.09 131.15 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -71.33 120.27 16.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.708 0.803 . . . . 0.0 109.143 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.47 -12.39 60.18 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.951 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.85 -6.67 59.48 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.164 0.893 . . . . 0.0 112.96 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.5 m -63.05 161.3 31.85 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.268 1.027 . . . . 0.0 108.681 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.88 -53.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 121.204 1.466 . . . . 0.0 109.417 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -132.75 104.32 6.56 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . 0.506 ' HD2' ' H ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -60.06 -19.04 51.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.318 -1.31 . . . . 0.0 113.389 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.34 -33.2 72.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.02 -36.52 83.85 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.882 -1.136 . . . . 0.0 110.993 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.31 -47.23 28.8 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 122.646 0.378 . . . . 0.0 110.565 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -35.73 78.44 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.206 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -70.37 -55.34 9.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.421 ' HE2' HD11 ' A' ' 9' ' ' ILE . 9.0 t80 -51.48 -46.89 63.3 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 120.225 1.375 . . . . 0.0 112.322 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.25 -23.72 66.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 116.944 -1.503 . . . . 0.0 112.294 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -108.63 -17.91 13.85 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.7 1.591 . . . . 0.0 113.606 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -80.47 -33.38 36.69 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.461 1.104 . . . . 0.0 108.816 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -133.66 -46.09 0.81 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.102 -0.952 . . . . 0.0 111.079 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . 0.256 0.1 OUTLIER -67.85 0.24 3.58 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 120.71 1.595 . . . . 0.0 114.831 -179.462 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 58.7 mt -130.17 40.47 3.53 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 119.524 -1.985 . . . . 0.0 108.863 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 63.9 p -117.5 156.42 28.05 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.24 -43.38 98.96 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -73.31 -33.04 64.95 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -75.44 -42.25 28.06 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.09 -44.47 76.16 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -54.83 -47.17 74.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.189 0.996 . . . . 0.0 109.52 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.24 -42.32 63.52 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 22.5 t -75.34 -36.52 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -61.54 -20.47 63.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.482 0.713 . . . . 0.0 110.97 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -67.85 -45.45 74.57 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 121.163 -0.961 . . . . 0.0 110.139 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.42 -39.77 58.51 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -146.35 156.72 49.75 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.245 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.32 114.08 3.67 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.761 1.641 . . . . 0.0 109.299 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.47 -32.47 37.11 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 119.37 -0.348 . . . . 0.0 110.074 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.57 -167.81 47.07 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -59.13 157.63 10.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.56 0.695 . . . . 0.0 109.932 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.8 156.27 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.723 0.773 . . . . 0.0 111.191 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.63 -35.12 67.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.67 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.38 103.6 0.32 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.729 1.211 . . . . 0.0 112.332 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -47.95 -33.4 7.69 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.587 1.555 . . . . 0.0 112.703 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.8 -49.93 68.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.469 1.108 . . . . 0.0 113.211 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -96.41 -10.58 27.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.242 0.928 . . . . 0.0 111.504 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.27 -46.71 87.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.331 1.452 . . . . 0.0 108.098 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -69.16 -22.58 63.92 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 119.074 -0.488 . . . . 0.0 112.046 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -78.94 -49.57 12.59 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 7.1 mt -62.69 -38.16 89.29 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.61 -2.41 2.39 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.531 1.132 . . . . 0.0 114.043 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -66.71 -35.79 80.97 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.445 1.02 . . . . 0.0 108.529 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.9 150.49 58.89 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 123.747 0.819 . . . . 0.0 109.643 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.14 -24.59 20.03 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.466 2.11 . . . . 0.0 115.23 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -48.0 77.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.385 0.993 . . . . 0.0 109.447 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.501 HD12 ' H ' ' A' ' 317' ' ' ILE . 4.9 mp -64.04 -55.77 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.5 -53.39 23.57 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 123.926 0.766 . . . . 0.0 111.967 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.44 -47.13 87.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 87.0 m -67.57 -29.71 69.14 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 7.8 tpt -71.91 -39.52 69.46 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 120.9 -1.125 . . . . 0.0 109.136 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -56.78 -26.81 58.54 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.62 0.768 . . . . 0.0 110.223 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -66.18 -36.86 84.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.263 0.625 . . . . 0.0 112.332 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.483 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo . . . . . 0 CA--C 1.534 0.482 0 N-CA-C 112.576 0.183 . . . . 0.0 112.576 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -134.23 38.53 3.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.88 1.272 . . . . 0.0 112.764 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.1 pt -114.05 152.09 45.47 Favored Pre-proline 0 N--CA 1.472 0.656 0 O-C-N 120.879 -1.138 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.98 -17.22 36.69 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.581 2.188 . . . . 0.0 113.969 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -56.23 -22.83 31.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.103 1.761 . . . . 0.0 112.024 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -32.51 65.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.849 1.26 . . . . 0.0 111.544 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -48.57 76.65 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.404 1.002 . . . . 0.0 109.208 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.5 87.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -58.87 -54.51 46.28 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.354 0.525 . . . . 0.0 110.393 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -61.29 -42.37 98.54 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.561 -0.712 . . . . 0.0 109.989 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -63.93 -23.04 67.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.069 0.948 . . . . 0.0 112.307 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -85.02 -57.73 2.98 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 120.955 -1.09 . . . . 0.0 110.639 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 347' ' ' VAL . 19.3 t -57.84 -38.74 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 118.068 -0.968 . . . . 0.0 111.946 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -52.15 -48.57 64.84 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.145 1.339 . . . . 0.0 111.365 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 8.5 m -66.4 -40.22 89.48 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.375 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.56 83.74 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.373 0.988 . . . . 0.0 111.413 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 343' ' ' VAL . 36.2 t -60.69 -55.38 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.784 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.8 mm -66.26 -33.38 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 123.575 0.547 . . . . 0.0 110.652 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -61.09 -46.02 92.34 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.425 -1.422 . . . . 0.0 108.8 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.9 -50.18 44.87 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.881 0.872 . . . . 0.0 109.729 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -57.08 -37.79 72.39 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 69.0 m -87.55 -7.13 57.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.548 0.739 . . . . 0.0 110.256 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.62 13.71 71.72 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 118.491 0.587 . . . . 0.0 111.78 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 -65.98 -28.61 69.02 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.311 1.056 . . . . 0.0 109.633 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -149.25 153.24 37.26 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 9.0 m -66.07 150.71 48.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.448 1.099 . . . . 0.0 108.671 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 18.8 t -52.52 -54.53 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.911 1.285 . . . . 0.0 108.339 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.38 -44.91 55.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.344 2.257 . . . . 0.0 112.597 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -82.6 -26.92 31.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.48 85.57 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 76.4 mt -68.87 -39.44 79.84 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.73 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.46 ' HE3' ' OD2' ' A' ' 184' ' ' ASP . 2.1 tppp? -58.33 -35.81 72.44 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.896 0.878 . . . . 0.0 110.545 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.22 -32.74 22.46 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.789 0.722 . . . . 0.0 110.98 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.17 -40.16 90.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.564 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.64 -37.9 76.95 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.878 0.763 . . . . 0.0 109.606 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 4.3 m -67.53 -19.58 65.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.209 1.404 . . . . 0.0 113.141 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -80.66 -11.94 59.56 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.141 -0.975 . . . . 0.0 110.874 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.11 -42.02 11.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.5 p -68.02 -13.75 62.43 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.451 0.569 . . . . 0.0 111.859 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 32.2 tptt . . . . . 0 C--O 1.245 0.828 0 C-N-CA 125.868 1.667 . . . . 0.0 107.087 179.278 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 . . . . . 0 N--CA 1.471 0.587 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -65.51 133.05 50.41 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.52 22.02 72.97 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 126.915 2.198 . . . . 0.0 114.634 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -153.7 167.04 30.94 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 119.215 1.507 . . . . 0.0 110.279 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -137.09 158.39 44.55 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 127.583 2.353 . . . . 0.0 108.07 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.7 t -143.42 134.51 22.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 125.803 1.641 . . . . 0.0 107.21 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.72 141.7 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.172 1.389 . . . . 0.0 109.491 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -130.1 162.51 28.64 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -126.73 170.18 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 124.504 1.122 . . . . 0.0 108.74 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -74.31 -25.19 59.42 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.02 -30.53 3.19 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 120.138 1.335 . . . . 0.0 115.331 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -113.13 6.5 17.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.436 1.494 . . . . 0.0 113.335 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' A' ' 297' ' ' LYS . 34.0 mmtm -75.59 -168.14 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.447 1.499 . . . . 0.0 110.448 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.04 65.53 0.37 Allowed Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -52.53 -34.82 51.69 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.853 0.826 . . . . 0.0 112.528 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -58.18 -55.22 37.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.605 0.639 . . . . 0.0 110.251 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.63 -31.17 77.76 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HA ' HG22 ' A' ' 293' ' ' VAL . 53.6 tp -67.45 -35.53 79.4 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.214 -1.168 . . . . 0.0 110.333 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.39 -40.91 83.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 117.904 -1.046 . . . . 0.0 108.918 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -54.68 -45.02 73.84 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.451 1.1 . . . . 0.0 110.731 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 t -57.01 -47.14 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.63 -35.35 85.94 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.682 -1.065 . . . . 0.0 110.88 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm -64.26 -46.52 83.38 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.289 1.544 . . . . 0.0 108.696 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -57.74 11.26 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -55.64 -49.76 72.0 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 117.641 0.201 . . . . 0.0 111.418 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.16 -30.09 69.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.524 1.129 . . . . 0.0 111.545 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -25.39 45.09 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 117.726 -1.131 . . . . 0.0 110.759 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -100.68 -4.04 29.08 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.513 1.133 . . . . 0.0 111.767 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.2 p -132.52 -38.68 1.03 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.82 -18.36 56.06 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 121.201 -0.937 . . . . 0.0 112.779 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.2 mm -66.79 116.15 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 147.33 49.84 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.753 -0.592 . . . . 0.0 110.141 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.2 t -132.54 104.63 7.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 125.89 1.676 . . . . 0.0 109.154 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 m -84.7 141.77 30.34 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.92 115.95 19.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -125.65 167.67 14.78 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.21 0.604 . . . . 0.0 112.001 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -120.13 65.95 11.09 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.509 1.124 . . . . 0.0 112.945 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.7 161.61 36.46 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.14 1.893 . . . . 0.0 109.843 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -124.85 17.21 8.64 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.288 1.035 . . . . 0.0 110.648 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.98 8.23 2.5 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.844 1.658 . . . . 0.0 111.809 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.0 pt? -51.32 -26.78 8.1 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.249 1.42 . . . . 0.0 114.188 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.2 pm0 -61.07 -25.75 67.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.497 1.044 . . . . 0.0 111.437 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -115.5 -28.01 6.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -67.62 -44.25 78.49 Favored 'General case' 0 C--O 1.221 -0.447 0 O-C-N 119.813 -1.804 . . . . 0.0 109.687 179.226 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -52.98 -59.8 8.16 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 120.503 1.501 . . . . 0.0 109.343 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.34 -13.72 37.7 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 121.75 1.633 . . . . 0.0 114.213 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -90.07 -9.87 46.88 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.795 1.634 . . . . 0.0 111.69 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.2 -34.88 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 119.941 1.246 . . . . 0.0 112.036 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.96 -34.04 74.12 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.38 -14.76 30.19 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.611 1.164 . . . . 0.0 112.316 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.88 5.51 17.44 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.222 1.809 . . . . 0.0 110.509 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.6 30.28 76.13 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.37 7.43 7.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.736 1.214 . . . . 0.0 112.283 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.73 -171.51 43.68 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.139 1.828 . . . . 0.0 111.961 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.67 178.15 2.93 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.348 2.699 . . . . 0.0 111.27 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -104.2 -17.69 14.78 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.557 -0.714 . . . . 0.0 111.939 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.17 157.22 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.5 tp -143.9 142.68 24.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -131.2 107.38 8.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.817 1.247 . . . . 0.0 108.684 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -151.95 172.62 15.96 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.387 1.075 . . . . 0.0 108.579 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.27 162.46 28.43 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.827 1.194 . . . . 0.0 110.641 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -55.13 -26.34 37.74 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.77 1.628 . . . . 0.0 112.493 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -58.87 -64.77 0.82 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 118.015 -0.993 . . . . 0.0 112.462 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -62.5 -23.23 66.83 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 121.213 1.824 . . . . 0.0 109.918 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -72.78 -15.64 61.65 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.6 -0.687 . . . . 0.0 111.359 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.56 -21.5 60.43 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.23 1.395 . . . . 0.0 112.776 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.09 -33.89 2.09 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.477 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -53.65 -47.57 70.2 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.792 1.796 . . . . 0.0 114.241 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.07 -43.65 91.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.606 1.094 . . . . 0.0 110.417 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -56.61 -49.52 74.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.9 m -62.51 -3.25 1.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.952 1.701 . . . . 0.0 113.845 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.12 11.11 85.68 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 119.778 1.172 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -81.36 -21.32 39.17 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.026 1.413 . . . . 0.0 110.555 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.6 mt -111.44 140.98 45.59 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.356 0.98 . . . . 0.0 109.594 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.77 176.13 6.47 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.595 1.558 . . . . 0.0 110.469 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.54 144.36 49.6 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.576 1.15 . . . . 0.0 109.205 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.5 163.87 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.841 1.256 . . . . 0.0 109.665 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.2 m 65.39 81.8 0.21 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.767 1.627 . . . . 0.0 112.227 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.87 -65.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.964 1.776 . . . . 0.0 108.51 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.27 155.02 17.39 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.631 1.172 . . . . 0.0 110.07 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tptp -65.58 -28.51 69.2 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.74 1.216 . . . . 0.0 113.081 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.06 -36.65 60.86 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.288 0.949 . . . . 0.0 111.663 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -63.09 -28.11 69.85 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.861 -0.524 . . . . 0.0 111.084 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -73.75 -43.19 59.78 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.272 0.942 . . . . 0.0 110.176 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.19 -27.97 67.58 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.478 1.111 . . . . 0.0 112.476 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -66.03 -16.72 64.16 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.696 0.798 . . . . 0.0 111.559 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.1 mt -119.88 163.45 17.52 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.465 1.506 . . . . 0.0 109.13 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -69.86 147.79 96.2 Favored Pre-proline 0 C--O 1.235 0.292 0 O-C-N 121.403 -0.81 . . . . 0.0 110.245 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.89 -51.01 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.59 2.193 . . . . 0.0 113.083 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -55.2 -44.67 75.54 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.739 0.7 . . . . 0.0 109.944 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -27.47 57.13 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.23 1.012 . . . . 0.0 112.69 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -73.52 -33.28 64.68 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.651 1.114 . . . . 0.0 111.451 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -59.86 -37.02 78.1 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.225 0.61 . . . . 0.0 111.82 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.54 -3.31 4.31 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.994 -1.003 . . . . 0.0 113.002 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -132.19 11.89 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.369 1.468 . . . . 0.0 111.571 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.5 mtp-105 -76.26 156.36 33.56 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 121.038 -1.039 . . . . 0.0 109.404 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -131.13 177.78 7.2 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.846 1.658 . . . . 0.0 107.156 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -65.57 100.17 0.49 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.261 1.025 . . . . 0.0 109.298 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.61 -76.62 1.69 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.227 1.394 . . . . 0.0 110.701 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 166.69 20.51 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mt -100.34 160.13 14.58 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.769 1.627 . . . . 0.0 108.087 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.1 pt -133.52 -19.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.44 164.81 26.96 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.591 1.542 . . . . 0.0 108.165 178.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.2 137.51 22.53 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-O 118.747 -0.644 . . . . 0.0 110.443 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.49 129.44 18.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.777 2.318 . . . . 0.0 108.73 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 mm -121.2 -46.34 2.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.55 148.8 52.38 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 67.8 t -121.18 111.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.212 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.2 p90 . . . . . 0 C--O 1.237 0.432 0 C-N-CA 126.421 1.888 . . . . 0.0 108.758 179.745 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo . . . . . 0 N--CA 1.452 -0.925 0 N-CA-C 110.226 -0.721 . . . . 0.0 110.226 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -138.52 -19.06 1.08 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 116.437 -1.744 . . . . 0.0 114.159 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.76 136.38 32.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.716 1.598 . . . . 0.0 111.219 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -65.93 -26.09 67.43 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.167 -0.958 . . . . 0.0 110.89 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.32 -12.88 62.04 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.834 0.743 . . . . 0.0 112.748 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -92.45 -11.53 34.49 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.711 0.804 . . . . 0.0 111.171 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.58 -59.0 12.9 Favored Pre-proline 0 C--O 1.233 0.186 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.58 -23.31 49.86 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 CA-C-N 119.826 0.974 . . . . 0.0 110.978 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.89 89.76 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.738 0.699 . . . . 0.0 109.887 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.6 tp -80.79 -27.49 36.65 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -57.19 -47.58 80.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 124.292 1.037 . . . . 0.0 111.205 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -66.69 -28.44 68.45 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 122.994 0.518 . . . . 0.0 112.064 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -75.89 -42.4 49.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 56.9 mt -78.82 -32.84 46.38 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.722 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.85 -35.89 79.35 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.63 67.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.204 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -5.62 15.41 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.471 1.108 . . . . 0.0 112.414 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.69 -94.57 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 119.159 0.89 . . . . 0.0 113.556 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.484 ' HE2' ' OE2' ' A' ' 221' ' ' GLU . 27.9 mmtm -132.92 172.15 13.0 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.511 1.124 . . . . 0.0 110.849 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.56 162.73 3.63 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.424 1.49 . . . . 0.0 111.696 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.54 -55.99 4.14 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.8 tp -115.96 157.18 24.96 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.155 0.982 . . . . 0.0 110.818 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.3 mtp -148.7 114.17 5.6 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -140.5 174.01 10.93 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.799 0.84 . . . . 0.0 109.171 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.429 ' H ' HD22 ' A' ' 150' ' ' ASN . 1.2 p30 -69.42 76.05 0.39 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.864 2.065 . . . . 0.0 109.978 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.3 mt -73.07 -23.15 60.51 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -79.66 -1.73 39.56 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.655 0.782 . . . . 0.0 112.672 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -117.75 129.74 25.16 Favored Pre-proline 0 CA--C 1.529 0.147 0 C-N-CA 123.962 0.905 . . . . 0.0 112.878 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.11 -13.31 17.24 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.352 2.035 . . . . 0.0 112.286 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -59.04 -44.62 91.79 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.873 0.869 . . . . 0.0 110.4 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -91.92 -28.29 17.36 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.395 0.543 . . . . 0.0 111.42 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.5 p -80.16 -2.13 43.34 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 119.133 0.879 . . . . 0.0 110.47 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 32.8 t-105 -56.97 -66.3 1.29 Allowed Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 120.421 -1.424 . . . . 0.0 111.093 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.46 -20.39 60.96 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 CA-C-N 120.242 1.122 . . . . 0.0 112.899 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.82 -43.2 90.56 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-O 118.341 -0.838 . . . . 0.0 108.829 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 9.3 pt -93.01 -32.12 4.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.441 0.564 . . . . 0.0 111.663 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.86 -6.94 18.32 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.118 -0.988 . . . . 0.0 113.256 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -54.01 -46.21 71.72 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.903 1.281 . . . . 0.0 112.968 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -63.84 -50.4 69.0 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.521 0.601 . . . . 0.0 109.843 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.47 42.77 0.05 OUTLIER Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.329 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.03 154.6 24.63 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -159.91 121.99 3.32 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.33 -47.8 80.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -146.01 131.45 18.67 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -58.28 126.73 28.75 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -150.63 101.25 2.92 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.18 158.57 43.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 119.109 0.868 . . . . 0.0 108.888 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 47.9 27.33 1.13 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.156 1.783 . . . . 0.0 112.445 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 79.42 18.87 72.83 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.576 -1.125 . . . . 0.0 114.04 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -120.99 115.25 22.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.55 1.675 . . . . 0.0 107.372 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -106.08 121.24 43.73 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.287 1.435 . . . . 0.0 108.881 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -130.7 110.89 11.69 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 122.394 1.093 . . . . 0.0 111.094 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.1 OUTLIER -73.55 0.29 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 124.307 1.043 . . . . 0.0 109.367 177.088 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -84.19 -11.52 56.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.488 2.315 . . . . 0.0 111.623 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -127.4 105.69 8.69 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.67 140.4 49.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -124.52 29.8 4.89 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 117.871 -1.516 . . . . 0.0 116.188 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.38 -11.54 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.221 2.011 . . . . 0.0 113.693 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.14 10.25 10.0 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.472 1.033 . . . . 0.0 112.166 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.09 159.93 13.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.846 0.858 . . . . 0.0 110.055 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.79 -35.58 61.5 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.292 1.037 . . . . 0.0 110.862 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.85 -41.6 97.41 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 118.373 0.533 . . . . 0.0 112.366 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.07 64.98 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.16 0.98 . . . . 0.0 109.911 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -63.08 -37.79 88.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 118.566 -0.73 . . . . 0.0 110.671 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.23 71.9 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.646 0.778 . . . . 0.0 111.863 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.09 -28.03 24.22 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 192' ' ' LEU . 19.8 tp -74.92 -39.03 61.63 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.281 -1.717 . . . . 0.0 111.618 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.2 t -56.58 -33.61 66.37 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.923 0.489 . . . . 0.0 111.511 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -60.01 -54.62 43.9 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 119.389 0.995 . . . . 0.0 109.459 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 7.4 tt -56.38 -45.0 80.74 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.458 1.103 . . . . 0.0 110.233 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.31 -32.96 52.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.713 0.805 . . . . 0.0 109.893 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.589 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 19.1 t70 -63.72 -46.37 85.74 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.859 1.209 . . . . 0.0 112.726 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.62 -39.52 94.08 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.688 0.795 . . . . 0.0 109.76 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 75.5 mt -68.69 -40.29 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -52.67 -40.79 63.21 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.659 1.183 . . . . 0.0 109.7 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -90.99 0.87 57.43 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.121 1.768 . . . . 0.0 113.22 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.9 mptt 52.91 17.55 0.9 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 128.452 2.701 . . . . 0.0 114.972 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -82.27 -24.97 34.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.983 0.81 . . . . 0.0 109.315 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.0 tpt -77.94 163.38 26.04 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -82.52 51.19 1.8 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.68 -22.41 8.91 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 127.347 2.259 . . . . 0.0 115.905 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.99 8.63 43.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.506 1.522 . . . . 0.0 112.398 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 71.4 m -101.06 144.31 30.14 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.762 1.625 . . . . 0.0 111.158 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.78 -177.54 4.32 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.596 1.958 . . . . 0.0 108.85 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -48.48 -51.0 29.28 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.814 0.846 . . . . 0.0 112.884 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.26 -43.76 90.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.274 0.629 . . . . 0.0 111.142 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.09 -49.05 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.755 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.94 -47.53 86.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.5 1.12 . . . . 0.0 110.885 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.03 -42.68 80.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.138 0.575 . . . . 0.0 111.547 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.55 -48.18 35.03 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 122.023 -0.423 . . . . 0.0 110.146 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.25 -39.33 56.44 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.031 1.732 . . . . 0.0 111.775 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -53.79 -55.0 30.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.168 1.387 . . . . 0.0 109.079 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -62.13 -38.15 87.86 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.44 -17.67 64.72 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.627 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.62 11.9 76.35 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 119.117 0.871 . . . . 0.0 111.024 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.484 ' OE2' ' HE2' ' A' ' 144' ' ' LYS . 7.4 mm-40 -65.52 -60.63 2.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.544 1.137 . . . . 0.0 110.332 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.8 t -87.82 141.77 28.33 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.961 0.904 . . . . 0.0 109.444 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.19 -35.24 59.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -127.13 164.19 22.17 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.317 0.647 . . . . 0.0 109.545 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 52.4 m -151.13 155.29 38.61 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.763 0.825 . . . . 0.0 108.871 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 178.684 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -64.97 155.0 70.49 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.487 2.125 . . . . 0.0 108.798 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 61.6 p -97.45 179.76 4.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.356 1.062 . . . . 0.0 110.427 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -107.84 164.75 11.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -59.34 114.21 2.55 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.068 0.395 . . . . 0.0 110.201 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 69.92 15.29 71.5 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 118.364 -1.242 . . . . 0.0 113.965 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.46 117.9 3.23 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 120.639 2.22 . . . . 0.0 111.668 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.34 113.49 3.12 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.854 2.37 . . . . 0.0 111.165 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 31.6 t -57.82 157.03 7.97 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.215 1.006 . . . . 0.0 108.382 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -132.86 60.8 52.41 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 125.634 1.574 . . . . 0.0 112.792 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.88 164.59 31.06 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.542 1.495 . . . . 0.0 109.452 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 . . . . . 0 C--O 1.237 0.444 0 CA-C-O 122.642 1.211 . . . . 0.0 112.966 -179.327 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.552 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 19.0 t -145.11 148.93 17.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.43 1.092 . . . . 0.0 109.56 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 263' ' ' SER . 1.1 tt -77.02 149.49 35.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.57 ' H ' HD23 ' A' ' 262' ' ' LEU . 19.3 m -126.38 154.2 43.91 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.814 0.846 . . . . 0.0 111.828 -178.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -136.93 134.48 36.81 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.471 1.108 . . . . 0.0 108.277 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -142.53 154.99 25.51 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 75.1 mt -93.55 136.37 25.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.974 1.309 . . . . 0.0 107.591 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -72.72 113.78 10.14 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.9 -20.07 66.25 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.184 -0.912 . . . . 0.0 113.429 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -73.74 -16.35 61.18 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.7 m -70.27 163.56 61.07 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 119.084 0.856 . . . . 0.0 110.514 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.69 -46.06 2.88 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.331 2.021 . . . . 0.0 115.327 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -137.42 114.7 10.93 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 119.078 0.854 . . . . 0.0 112.203 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -18.32 64.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.024 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -59.83 -40.36 88.19 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 98.9 mt -57.8 -41.22 81.72 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.496 -0.752 . . . . 0.0 111.093 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -77.91 -42.76 32.11 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -33.94 76.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.431 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -68.76 -52.57 29.05 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -55.33 -43.54 75.03 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.204 -0.935 . . . . 0.0 112.326 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -61.03 -51.23 70.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.486 1.114 . . . . 0.0 110.09 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -75.07 -17.81 60.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -105.79 -26.45 11.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.06 -1.448 . . . . 0.0 113.858 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -131.18 -37.41 1.26 Allowed 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 120.719 1.6 . . . . 0.0 113.609 -178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 284' ' ' LEU . 1.7 tm? -62.0 -50.0 73.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 116.516 -2.073 . . . . 0.0 107.415 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 90.6 mt -82.91 52.5 2.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.586 1.954 . . . . 0.0 115.883 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 13.2 p -131.01 160.34 34.85 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -63.19 -47.01 84.41 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -70.44 -32.63 70.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.524 1.13 . . . . 0.0 111.074 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.87 -42.76 44.38 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 54.7 mt -70.37 -46.54 63.88 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -56.67 -43.55 80.54 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.491 0.716 . . . . 0.0 109.954 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.34 61.18 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 20' ' ' LEU . 5.0 t -88.27 -31.4 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 122.842 0.457 . . . . 0.0 109.886 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -71.62 -23.92 61.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.763 0.425 . . . . 0.0 111.251 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -59.71 -47.35 86.01 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.17 -59.62 4.51 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.106 0.962 . . . . 0.0 112.033 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -137.87 160.46 64.55 Favored Pre-proline 0 N--CA 1.463 0.211 0 O-C-N 121.389 -0.82 . . . . 0.0 112.293 -178.576 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -69.92 110.07 2.5 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.691 1.594 . . . . 0.0 108.164 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.41 -9.75 58.84 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 85.22 -166.58 40.52 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 119.709 1.141 . . . . 0.0 110.276 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -73.67 168.43 19.37 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.026 0.93 . . . . 0.0 110.765 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.16 153.9 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 123.61 0.764 . . . . 0.0 110.831 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.0 41.17 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.947 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 63.5 tp -65.75 100.46 0.54 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.52 1.928 . . . . 0.0 106.869 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -47.5 -37.72 12.5 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.353 1.061 . . . . 0.0 112.983 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.8 m -55.41 -60.48 3.35 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.693 0.797 . . . . 0.0 112.768 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -83.77 -9.97 58.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.822 1.249 . . . . 0.0 111.806 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -61.5 -42.62 99.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -67.47 -37.79 83.43 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 124.39 1.056 . . . . 0.0 111.272 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -65.16 -50.74 64.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.6 -38.62 89.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.86 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.64 -15.97 33.89 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.561 1.145 . . . . 0.0 113.662 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -60.25 -16.02 30.09 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.973 0.806 . . . . 0.0 111.605 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.3 135.26 19.68 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 119.335 0.97 . . . . 0.0 110.597 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.43 -34.46 94.63 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.288 2.659 . . . . 0.0 112.805 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.62 -33.47 75.07 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.029 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.9 mp -79.68 -54.26 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -43.96 -55.21 4.78 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.507 1.123 . . . . 0.0 112.211 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.22 -30.03 70.18 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 9.8 m -77.55 -32.54 53.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.765 0.826 . . . . 0.0 109.259 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.0 tpt -74.39 -41.84 60.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -49.64 -42.02 44.03 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 125.384 1.474 . . . . 0.0 111.288 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -59.27 -44.51 92.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.815 2.046 . . . . 0.0 110.368 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.519 0 O-C-N 122.222 -0.299 . . . . 0.0 110.815 178.184 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo . . . . . 0 N--CA 1.455 -0.792 0 CA-C-O 122.725 1.052 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -134.19 16.58 3.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.43 1.892 . . . . 0.0 112.056 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.3 pt -116.91 153.72 49.47 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.709 1.204 . . . . 0.0 112.021 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.28 -5.42 17.13 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.771 2.981 . . . . 0.0 115.406 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -57.79 -19.24 26.96 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.768 -1.207 . . . . 0.0 111.884 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 2.2 mtp -61.85 -24.07 66.67 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.772 -0.58 . . . . 0.0 110.472 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 40.3 t -54.57 -53.56 52.9 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.073 1.349 . . . . 0.0 109.004 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.22 -43.71 90.6 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.824 0.449 . . . . 0.0 110.514 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -53.67 -54.09 42.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.816 0.846 . . . . 0.0 110.773 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -59.96 -50.0 75.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.133 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -55.38 -42.75 74.42 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.473 0.579 . . . . 0.0 111.217 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.411 ' HB1' ' HB1' ' A' ' 364' ' ' ALA . . . -62.32 -57.3 11.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.468 1.107 . . . . 0.0 111.979 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.5 t -63.58 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.109 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -50.87 -41.31 58.07 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.539 1.063 . . . . 0.0 110.041 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.0 m -79.94 -47.14 15.48 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.415 -0.803 . . . . 0.0 110.525 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.07 -44.74 64.46 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 36.4 t -60.51 -47.69 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.34 -36.18 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.45 0.568 . . . . 0.0 109.766 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -59.41 -49.88 76.12 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.438 1.017 . . . . 0.0 109.527 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.36 -43.49 73.48 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.081 0.552 . . . . 0.0 110.79 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.84 -29.03 70.43 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.778 0.831 . . . . 0.0 112.37 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 6.7 m -92.45 -10.31 38.39 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.651 0.78 . . . . 0.0 110.076 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 72.73 10.39 76.38 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.194 -0.781 . . . . 0.0 112.572 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -67.15 -29.41 69.11 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.935 1.367 . . . . 0.0 111.883 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.427 HE21 ' HA ' ' A' ' 360' ' ' ALA . 19.7 tt0 -140.09 157.5 45.53 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.4 m -62.3 152.56 33.39 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.855 0.862 . . . . 0.0 109.214 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.8 -48.49 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.35 -49.52 72.03 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.976 1.71 . . . . 0.0 111.159 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -75.53 -30.79 59.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.427 ' HA ' HE21 ' A' ' 355' ' ' GLN . . . -63.31 -41.32 98.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 7.9 mp -73.21 -38.62 66.02 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.243 1.017 . . . . 0.0 109.518 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -57.29 13.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.579 1.081 . . . . 0.0 110.389 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -55.42 -36.32 66.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 122.386 1.089 . . . . 0.0 109.951 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.411 ' HB1' ' HB1' ' A' ' 342' ' ' ALA . . . -68.57 -46.99 67.97 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 117.537 -1.221 . . . . 0.0 111.236 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -52.72 -39.29 61.92 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.538 1.063 . . . . 0.0 109.655 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 4.4 m -63.77 -26.15 68.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 112.828 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -72.89 -18.92 61.37 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.448 -1.407 . . . . 0.0 111.028 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.9 mp -92.68 -38.46 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.214 1.006 . . . . 0.0 109.105 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 7.7 p -69.19 -15.67 63.45 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.373 0.988 . . . . 0.0 111.668 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 51.6 tttm . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.955 2.102 . . . . 0.0 110.309 179.155 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 . . . . . 0 N--CA 1.45 -0.473 1 N-CA-C 97.888 -4.856 . . . . 0.0 97.888 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -77.03 171.16 15.24 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.764 0.711 . . . . 0.0 111.818 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.49 38.89 71.97 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.812 1.196 . . . . 0.0 115.78 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -145.77 173.5 12.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.864 0.832 . . . . 0.0 110.031 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.3 mt -142.13 154.49 44.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.951 2.101 . . . . 0.0 107.519 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.4 t -144.53 117.33 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.422 HD11 ' CE2' ' A' ' 279' ' ' PHE . 40.5 mt -99.4 126.52 52.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -112.93 140.37 47.8 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mp -129.79 148.84 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 C-N-CA 125.588 1.555 . . . . 0.0 109.846 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.76 -64.75 1.01 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.3 169.45 42.28 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.629 1.585 . . . . 0.0 109.149 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 52.45 3.17 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.22 3.008 . . . . 0.0 115.775 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.56 -28.85 68.13 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.763 1.625 . . . . 0.0 115.376 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.7 36.15 6.98 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -51.61 -34.23 36.53 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.47 -40.51 87.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.645 0.778 . . . . 0.0 112.087 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.59 -30.81 26.07 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -62.71 -38.01 88.73 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.603 1.161 . . . . 0.0 111.552 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.22 -46.3 62.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.66 0.784 . . . . 0.0 110.945 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -60.0 -35.5 75.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.844 -0.598 . . . . 0.0 112.438 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.2 t -62.32 -43.98 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.88 -40.89 93.67 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -63.39 -40.92 98.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.216 1.008 . . . . 0.0 109.52 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -63.64 -57.71 9.19 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -55.0 -43.61 73.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.637 0.653 . . . . 0.0 111.992 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.86 -28.19 69.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.448 1.022 . . . . 0.0 110.651 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.4 -23.04 35.11 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.058 -1.026 . . . . 0.0 112.272 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -99.83 -17.95 17.4 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.264 0.978 . . . . 0.0 111.979 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.3 p -122.76 -34.4 3.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.161 0.891 . . . . 0.0 113.184 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.38 -15.05 64.04 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.992 -0.893 . . . . 0.0 111.682 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.0 mm -66.86 120.15 13.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -61.79 146.4 49.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.9 t -135.51 143.49 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.7 m -125.12 143.06 51.12 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.74 119.01 23.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.41 163.23 25.32 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.128 0.971 . . . . 0.0 109.915 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -139.09 65.34 36.14 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.161 0.585 . . . . 0.0 111.262 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.86 173.09 14.06 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 125.054 3.836 . . . . 0.0 109.123 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -123.5 1.14 8.92 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.622 0.769 . . . . 0.0 111.828 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -119.29 6.84 11.19 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.172 0.989 . . . . 0.0 111.097 178.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -59.32 -20.71 56.76 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.709 -1.244 . . . . 0.0 112.072 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -60.58 -21.29 62.46 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.729 0.811 . . . . 0.0 112.499 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -122.63 -23.01 5.23 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.715 1.606 . . . . 0.0 111.026 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -78.07 -38.84 43.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.927 1.291 . . . . 0.0 110.693 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -52.02 -57.22 15.83 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 120.376 1.443 . . . . 0.0 110.094 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.82 -16.23 52.19 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.77 1.646 . . . . 0.0 114.385 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -84.54 -12.63 53.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.698 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.82 -40.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 120.154 1.343 . . . . 0.0 109.746 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.34 -43.09 53.84 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.803 1.241 . . . . 0.0 112.498 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.55 70.94 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.546 -0.721 . . . . 0.0 111.689 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 m -74.79 -5.89 45.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.204 1.402 . . . . 0.0 112.79 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.18 47.62 10.77 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -158.42 176.23 12.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 130.99 3.716 . . . . 0.0 104.111 178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.6 -170.55 13.59 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.669 -1.269 . . . . 0.0 110.472 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -78.07 -177.16 3.66 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.637 2.892 . . . . 0.0 110.289 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.3 -20.16 13.36 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.573 -0.705 . . . . 0.0 111.972 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mt -137.92 151.84 25.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.546 0.689 . . . . 0.0 110.552 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.02 139.73 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.656 1.182 . . . . 0.0 109.106 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.82 114.43 17.23 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.984 1.314 . . . . 0.0 109.695 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -165.35 -166.01 0.94 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.295 0.952 . . . . 0.0 112.072 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.34 133.4 44.94 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.077 2.151 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -60.08 -29.47 68.58 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.579 1.952 . . . . 0.0 112.308 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.98 -37.6 78.84 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.844 0.747 . . . . 0.0 110.403 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -24.46 56.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -68.66 -30.84 69.62 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.79 -36.26 86.01 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.84 -52.54 14.42 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -56.16 -34.66 66.36 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.531 1.165 . . . . 0.0 111.057 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -45.67 83.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -40.78 88.09 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.1 m -63.66 -12.47 34.24 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.611 -0.68 . . . . 0.0 110.138 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.55 16.22 76.23 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.744 1.64 . . . . 0.0 112.215 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.1 mt -88.15 -10.25 50.58 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mt -96.14 140.9 30.18 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.778 0.717 . . . . 0.0 110.954 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.03 172.2 8.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.981 1.312 . . . . 0.0 112.152 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -78.11 90.18 4.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.453 1.501 . . . . 0.0 111.834 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.447 HD12 ' HB ' ' A' ' 80' ' ' THR . 2.4 pp -73.23 178.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.815 1.246 . . . . 0.0 111.444 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.447 ' HB ' HD12 ' A' ' 79' ' ' ILE 0.337 0.5 OUTLIER 57.77 74.42 0.65 Allowed Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 127.602 2.361 . . . . 0.0 106.363 -178.447 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.42 -24.49 64.1 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.72 2.28 . . . . 0.0 113.605 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -147.13 148.59 31.73 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.709 0.804 . . . . 0.0 109.805 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -55.64 -29.46 59.28 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.842 2.057 . . . . 0.0 112.977 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.25 -36.24 77.34 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.331 0.514 . . . . 0.0 110.102 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -58.6 -32.64 69.17 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.514 0.726 . . . . 0.0 111.595 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -64.27 -46.52 83.32 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.675 -0.64 . . . . 0.0 110.587 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -66.95 -19.15 65.67 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -74.26 -11.47 60.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.348 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mt -124.55 160.91 27.31 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.272 1.429 . . . . 0.0 110.545 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -72.07 150.27 92.4 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.96 -44.45 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.075 2.516 . . . . 0.0 114.416 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -58.19 -34.32 70.23 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.029 0.832 . . . . 0.0 111.782 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -29.82 71.08 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.049 -1.032 . . . . 0.0 111.024 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -73.72 -35.23 65.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.32 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.76 -31.55 64.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.231 0.923 . . . . 0.0 112.501 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.3 -29.75 67.67 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.58 2.64 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.559 1.144 . . . . 0.0 113.733 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -63.79 160.38 17.41 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 122.328 1.061 . . . . 0.0 110.163 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -143.92 175.0 10.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -70.6 110.16 5.29 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.456 0.702 . . . . 0.0 110.463 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.88 -78.29 0.77 Allowed Glycine 0 C--N 1.335 0.486 0 C-N-CA 125.862 1.696 . . . . 0.0 111.028 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.04 166.25 21.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.69 165.5 11.12 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 pt -128.51 -30.52 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.88 176.78 12.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 119.148 0.885 . . . . 0.0 108.62 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.56 145.92 58.95 Favored Pre-proline 0 C--O 1.238 0.473 0 O-C-N 123.083 0.239 . . . . 0.0 110.852 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -66.47 147.96 83.2 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.561 2.841 . . . . 0.0 107.847 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 mm -133.43 -52.44 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 124.043 0.937 . . . . 0.0 110.67 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -131.38 167.29 19.53 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.336 0.398 . . . . 0.0 111.297 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.5 t -135.31 141.15 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 C--N 1.328 -0.366 0 C-N-CA 125.679 1.592 . . . . 0.0 107.525 177.664 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.7 mt . . . . . 0 C--O 1.236 0.394 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 30.6 p90 . . . . . 0 C--O 1.239 0.543 0 C-N-CA 124.361 1.064 . . . . 0.0 109.878 179.952 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 N-CA-C 110.164 -0.745 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -136.75 -33.66 0.77 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.834 1.253 . . . . 0.0 111.804 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.2 162.62 33.79 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 117.974 0.352 . . . . 0.0 110.844 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.405 ' CE2' HD13 ' A' ' 160' ' ' LEU . 28.3 m95 -67.23 -18.23 65.15 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.999 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -64.51 -8.5 14.05 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.877 1.271 . . . . 0.0 113.4 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -107.08 -18.76 13.81 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.668 1.587 . . . . 0.0 110.996 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.6 mm -56.9 -58.18 19.36 Favored Pre-proline 0 C--N 1.333 -0.141 0 O-C-N 120.823 -1.173 . . . . 0.0 111.822 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -67.41 -25.61 41.74 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 120.501 1.215 . . . . 0.0 110.717 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.85 -41.16 83.34 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.631 1.173 . . . . 0.0 110.349 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.6 tp -82.46 -27.89 31.58 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.148 0.885 . . . . 0.0 109.759 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.71 -44.91 96.02 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 121.325 -0.86 . . . . 0.0 109.615 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -64.54 -28.42 69.63 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.558 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -75.11 -43.35 53.34 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 123.102 0.561 . . . . 0.0 110.658 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 54.2 mt -75.38 -29.96 60.0 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.465 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.14 -38.04 81.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.8 -22.16 66.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.704 1.202 . . . . 0.0 113.07 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.12 4.92 9.81 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 125.445 1.498 . . . . 0.0 112.358 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.92 -95.47 0.1 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 119.37 0.986 . . . . 0.0 113.634 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -142.1 178.21 7.69 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.84 1.256 . . . . 0.0 111.617 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.18 154.01 10.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.878 1.271 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.93 -63.54 1.34 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.954 1.302 . . . . 0.0 111.999 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 41.2 tp -97.43 138.08 35.42 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.323 1.049 . . . . 0.0 110.707 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.415 ' CE ' HG22 ' A' ' 212' ' ' ILE . 94.3 mtp -145.44 110.25 5.12 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -142.19 157.18 45.15 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -72.97 137.66 45.61 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.615 0.722 . . . . 0.0 110.744 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.8 mt -121.01 -9.51 9.21 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.807 1.643 . . . . 0.0 111.276 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -72.14 -22.26 61.34 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.625 0.77 . . . . 0.0 112.53 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -113.99 152.05 45.39 Favored Pre-proline 0 N--CA 1.468 0.425 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.46 -11.83 10.46 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.594 2.196 . . . . 0.0 114.791 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -60.57 -41.85 95.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 120.896 1.68 . . . . 0.0 111.986 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -76.42 -28.81 56.78 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 79.0 p -91.43 -9.4 44.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.474 0.71 . . . . 0.0 111.001 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -62.36 -61.13 8.19 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 121.173 -0.954 . . . . 0.0 111.84 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.19 -19.79 69.44 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 121.216 1.47 . . . . 0.0 112.625 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.405 HD13 ' CE2' ' A' ' 129' ' ' TRP . 47.1 tp -68.19 -61.6 1.78 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 15.8 pt -67.03 -27.33 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.254 0.479 . . . . 0.0 111.687 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.1 0.58 27.49 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.762 -1.211 . . . . 0.0 112.929 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.99 -52.34 66.19 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 119.408 1.004 . . . . 0.0 112.076 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -58.3 -58.43 8.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.744 0.817 . . . . 0.0 110.757 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -176.61 25.78 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.543 -1.143 . . . . 0.0 113.492 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.21 149.44 37.42 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -152.61 138.8 18.32 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.54 -64.79 0.92 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.86 126.64 32.68 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -69.8 148.97 48.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.992 0.517 . . . . 0.0 110.297 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -148.85 105.63 3.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -77.71 -166.41 0.77 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.85 1.26 . . . . 0.0 109.036 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -62.18 16.97 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.475 2.71 . . . . 0.0 113.403 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.22 -2.8 0.62 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.989 1.757 . . . . 0.0 113.761 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -112.25 120.38 41.56 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.462 1.631 . . . . 0.0 107.732 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -118.43 112.88 20.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -125.86 106.3 9.56 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -59.46 -6.82 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.313 1.445 . . . . 0.0 112.183 179.247 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -31.79 57.81 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.857 1.663 . . . . 0.0 110.723 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.86 101.34 12.22 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.0 t -120.8 135.87 59.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 125.694 1.598 . . . . 0.0 109.784 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -114.3 18.1 18.52 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.202 -0.776 . . . . 0.0 114.664 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 66.4 t -49.52 -40.99 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.133 1.773 . . . . 0.0 114.051 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.8 23.91 12.6 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -70.56 167.6 18.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.406 0.622 . . . . 0.0 111.022 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.61 60.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.714 1.205 . . . . 0.0 113.691 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.85 -35.3 65.77 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 118.617 0.644 . . . . 0.0 112.288 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -68.23 -51.63 43.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.677 0.791 . . . . 0.0 109.459 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -61.75 -36.59 81.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.374 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.92 -48.91 79.65 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.668 0.667 . . . . 0.0 109.98 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.75 -36.88 93.89 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 27.3 tp -72.16 -51.09 22.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.47 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 6.2 t -56.21 -32.99 64.92 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.623 1.101 . . . . 0.0 111.122 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -58.66 -59.44 5.39 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.464 1.029 . . . . 0.0 109.232 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.06 -45.55 94.28 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.317 0.647 . . . . 0.0 110.529 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.8 t -57.87 -32.03 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.369 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.02 -35.84 82.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.983 1.265 . . . . 0.0 111.1 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 25.1 mt -64.73 -36.19 83.5 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.25 -41.88 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.094 1.358 . . . . 0.0 109.182 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -52.55 -45.56 66.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.97 1.308 . . . . 0.0 108.917 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -88.24 2.76 51.58 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.148 1.779 . . . . 0.0 112.749 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.1 mptt 56.51 19.93 4.49 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.319 2.248 . . . . 0.0 112.934 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -31.45 65.07 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.429 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.0 tpt -89.19 -176.61 5.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.811 1.645 . . . . 0.0 111.514 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -125.63 73.14 1.31 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.576 1.55 . . . . 0.0 108.84 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.73 -18.77 56.53 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -79.81 -7.12 58.49 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.418 1.887 . . . . 0.0 112.564 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 51.9 m -72.19 120.81 18.31 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.303 1.049 . . . . 0.0 109.339 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -118.7 175.1 5.89 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -48.73 -41.23 31.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.507 0.723 . . . . 0.0 112.262 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.8 t -57.35 -51.96 67.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.562 1.945 . . . . 0.0 111.954 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.415 HG22 ' CE ' ' A' ' 148' ' ' MET . 16.5 mm -61.75 -47.71 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 124.406 1.082 . . . . 0.0 111.323 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.1 -45.84 66.11 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.969 -178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -56.94 -45.09 83.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.451 0.569 . . . . 0.0 111.023 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.86 -57.91 10.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.207 0.603 . . . . 0.0 109.97 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.35 -47.28 69.53 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.694 0.798 . . . . 0.0 110.826 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -59.03 -41.47 87.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.9 1.28 . . . . 0.0 111.622 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -61.03 -37.01 81.05 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.763 0.711 . . . . 0.0 110.413 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -74.48 -45.09 48.3 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 116.06 14.3 7.9 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.916 2.198 . . . . 0.0 109.755 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -70.29 21.34 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.763 3.225 . . . . 0.0 112.789 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.2 p -130.48 174.74 9.59 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.57 2.348 . . . . 0.0 109.345 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.09 -33.73 2.4 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.742 0.817 . . . . 0.0 112.106 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 7.8 ptt? -152.86 161.15 42.92 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.847 0.859 . . . . 0.0 109.05 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.0 t -151.83 173.07 15.22 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 14.4 mt . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.296 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.537 0.461 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.78 125.97 10.38 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.527 2.152 . . . . 0.0 109.947 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 255' ' ' SER . 43.4 p -143.5 -151.44 0.36 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.44 141.8 39.77 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 177.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -53.0 125.83 18.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.415 1.886 . . . . 0.0 110.386 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 61.63 11.67 30.27 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.808 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.57 75.75 5.06 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.1 154.87 57.38 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.971 1.781 . . . . 0.0 114.112 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.404 ' H ' ' HB ' ' A' ' 249' ' ' THR . 33.8 m -65.01 140.88 58.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' A' ' 256' ' ' LYS . 0.1 OUTLIER -146.19 93.32 5.09 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 125.227 1.411 . . . . 0.0 109.053 -178.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.32 -63.01 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.327 2.018 . . . . 0.0 111.472 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 . . . . . 0 C--O 1.232 0.162 0 C-N-CA 125.667 1.587 . . . . 0.0 108.366 179.812 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.365 0 N-CA-C 105.398 -3.081 . . . . 0.0 105.398 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.48 156.77 42.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-N 117.852 0.826 . . . . 0.0 109.851 -178.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.7 139.97 30.01 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.017 0.927 . . . . 0.0 109.115 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.2 m -131.75 169.11 16.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.154 0.982 . . . . 0.0 112.138 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -134.69 140.42 45.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.865 1.266 . . . . 0.0 108.325 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.64 167.69 16.92 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.9 mt -117.48 135.59 57.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.07 115.28 14.53 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.82 -15.53 21.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.65 0.78 . . . . 0.0 113.012 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -66.29 -23.24 66.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.332 1.053 . . . . 0.0 111.663 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 11.2 m -60.42 154.81 52.08 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 126.187 1.795 . . . . 0.0 112.649 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.5 -47.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.347 2.032 . . . . 0.0 111.801 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.44 86.25 2.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.701 0.8 . . . . 0.0 109.477 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -52.84 -24.05 8.23 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.236 1.414 . . . . 0.0 112.332 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -59.37 -34.68 72.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.193 1.797 . . . . 0.0 110.15 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.24 -36.98 81.43 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 120.713 -1.242 . . . . 0.0 110.009 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.23 57.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.948 -0.549 . . . . 0.0 111.028 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -37.4 87.07 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.845 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -71.54 -51.24 24.57 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 124.024 0.828 . . . . 0.0 109.747 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.422 ' CE2' HD11 ' A' ' 9' ' ' ILE . 9.0 t80 -48.87 -52.91 21.75 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.913 0.485 . . . . 0.0 110.295 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.86 -55.23 31.96 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.321 0.248 . . . . 0.0 111.353 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.318 7.6 pt-20 -71.57 1.65 6.28 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -177.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -115.11 -21.0 10.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.229 -1.367 . . . . 0.0 111.226 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -132.5 -59.21 0.92 Allowed 'General case' 0 C--N 1.346 0.418 0 CA-C-N 119.998 1.272 . . . . 0.0 109.673 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.65 -42.48 62.11 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 44.0 mt -82.91 27.52 0.54 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 14.8 p -113.7 167.77 10.34 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.57 -38.51 90.35 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -71.41 -38.55 71.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.982 0.913 . . . . 0.0 111.604 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -69.08 -45.7 61.36 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.94 -46.41 81.72 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -57.1 -43.57 82.35 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.802 0.841 . . . . 0.0 110.291 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.2 -49.92 68.28 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.65 -36.33 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 119.375 -0.345 . . . . 0.0 110.24 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -63.75 -27.43 69.19 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.706 0.803 . . . . 0.0 111.656 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -67.44 -43.64 80.65 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.759 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -70.24 -56.44 6.76 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.878 0.763 . . . . 0.0 109.749 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -134.92 145.04 52.95 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.27 136.37 40.09 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.518 2.145 . . . . 0.0 112.252 -178.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 80.3 mt -78.48 -29.84 46.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 101.09 -78.39 0.4 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 105.9 -2.88 . . . . 0.0 105.9 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -149.35 171.09 17.09 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 131.577 3.951 . . . . 0.0 104.93 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 35.9 m -132.18 149.88 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 O-C-N 120.656 -1.277 . . . . 0.0 112.244 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.69 -21.33 55.52 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.623 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.93 105.26 1.94 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 126.287 1.835 . . . . 0.0 107.256 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -53.57 -27.63 27.47 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.9 m -73.11 -61.18 1.91 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 118.552 0.614 . . . . 0.0 111.246 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -67.36 -23.63 65.62 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.571 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -63.95 -21.41 66.47 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.206 0.912 . . . . 0.0 108.719 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -72.97 -37.51 67.05 Favored 'General case' 0 C--N 1.342 0.245 0 O-C-N 120.286 -1.509 . . . . 0.0 108.725 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -70.26 -46.91 63.42 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.185 0.994 . . . . 0.0 108.607 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.437 ' O ' HD13 ' A' ' 317' ' ' ILE . 23.1 mt -63.31 -40.71 98.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.17 -11.63 9.79 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.82 -11.48 27.47 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.488 1.04 . . . . 0.0 111.201 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.52 133.66 23.53 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -56.78 -23.85 52.38 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.133 2.555 . . . . 0.0 115.946 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.465 ' HG2' HD12 ' A' ' 317' ' ' ILE . 0.0 OUTLIER -62.66 -44.18 96.92 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.298 1.408 . . . . 0.0 110.802 179.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.465 HD12 ' HG2' ' A' ' 316' ' ' ARG . 4.8 mp -74.55 -46.38 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.55 -52.23 48.82 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.291 0.496 . . . . 0.0 110.112 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.85 -35.63 78.85 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.722 -0.611 . . . . 0.0 112.059 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.0 m -62.04 -39.25 91.71 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.58 -40.77 48.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.694 0.398 . . . . 0.0 110.55 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -53.05 -45.78 68.21 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.436 1.495 . . . . 0.0 109.784 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -41.35 94.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.551 0 CA-C-N 118.838 0.745 . . . . 0.0 111.414 178.901 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.537 0.663 0 CA-C-O 122.007 0.753 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -138.77 10.09 2.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.794 1.638 . . . . 0.0 110.99 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.9 pt -82.3 154.59 69.33 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 120.341 -1.475 . . . . 0.0 111.213 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.46 -17.01 16.78 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.163 2.575 . . . . 0.0 113.497 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -57.45 -21.57 37.85 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.501 1.12 . . . . 0.0 112.506 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 73.8 mmm -57.83 -31.13 66.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.336 1.054 . . . . 0.0 111.154 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 22.4 t -57.3 -53.04 62.65 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.88 -29.64 65.79 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 118.401 -0.809 . . . . 0.0 112.101 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.57 ' O ' HG22 ' A' ' 343' ' ' VAL . 52.7 t80 -57.75 -58.53 7.97 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.573 0.624 . . . . 0.0 109.754 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -56.25 -44.01 79.25 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -59.09 -39.92 83.71 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.113 0.415 . . . . 0.0 110.942 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.38 -59.98 2.95 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.157 0.583 . . . . 0.0 111.675 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 339' ' ' PHE . 3.2 m -59.27 -36.73 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 118.944 -0.551 . . . . 0.0 111.901 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 56.9 ttp85 -56.75 -37.22 70.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.261 0.937 . . . . 0.0 109.774 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 54.0 m -79.93 -44.49 20.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.683 -0.675 . . . . 0.0 109.834 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.45 -46.05 69.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.384 0.993 . . . . 0.0 112.882 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 89.0 t -59.11 -52.78 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.8 mm -64.08 -35.51 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.845 0.748 . . . . 0.0 110.491 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -61.22 -45.83 92.96 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.623 -1.298 . . . . 0.0 110.537 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.57 -50.32 32.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.128 0.571 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.42 -35.54 77.84 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.461 1.504 . . . . 0.0 114.895 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 28.9 m -91.22 0.33 57.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.206 0.602 . . . . 0.0 109.87 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 71.13 12.87 72.5 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 119.379 -0.679 . . . . 0.0 113.534 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -64.54 -32.96 74.82 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.313 1.056 . . . . 0.0 108.469 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -147.3 163.65 35.72 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.3 m -66.45 155.94 36.13 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.272 1.029 . . . . 0.0 108.917 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.58 -52.64 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.776 0.83 . . . . 0.0 110.001 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.66 -50.8 71.02 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.486 1.115 . . . . 0.0 110.159 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -62.0 -42.06 98.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.52 94.27 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 122.025 -0.422 . . . . 0.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 46.6 mt -71.23 -42.89 68.3 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.341 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -54.63 -50.74 67.4 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.396 1.079 . . . . 0.0 108.838 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.7 -49.95 69.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.42 87.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.159 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -58.84 -38.18 78.12 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.27 0.941 . . . . 0.0 108.676 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.4 m -64.22 -47.16 80.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.913 0.885 . . . . 0.0 109.309 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 72.0 mtt-85 -57.89 -25.71 61.17 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.321 0.964 . . . . 0.0 113.212 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 70.1 mt -94.57 -19.26 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 126.925 2.09 . . . . 0.0 112.101 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 66.5 p -113.56 1.95 15.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.24 1.382 . . . . 0.0 114.459 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? . . . . . 0 C--O 1.248 1.013 0 C-N-CA 125.179 1.392 . . . . 0.0 109.134 179.5 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.82 165.44 14.13 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.727 0.694 . . . . 0.0 111.037 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.15 35.78 89.16 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.101 1.334 . . . . 0.0 114.768 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -143.51 169.58 17.44 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.809 1.304 . . . . 0.0 112.974 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.1 mt -151.98 141.24 21.41 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.207 3.003 . . . . 0.0 108.012 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.08 134.44 36.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 119.784 1.175 . . . . 0.0 108.78 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.2 mt -124.11 128.69 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 125.244 1.417 . . . . 0.0 108.752 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -114.61 138.99 49.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.38 159.98 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.924 0.783 . . . . 0.0 109.502 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -154.39 166.43 33.26 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.27 24.2 27.29 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-O 117.823 -1.543 . . . . 0.0 114.857 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.1 t70 68.97 24.1 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.427 1.491 . . . . 0.0 114.413 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -59.39 157.2 11.48 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.444 1.897 . . . . 0.0 112.591 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.15 67.32 3.63 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.794 1.664 . . . . 0.0 109.818 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -58.75 -33.74 70.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.839 0.819 . . . . 0.0 112.484 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -61.17 -45.69 93.6 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.525 0.602 . . . . 0.0 109.791 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.77 -37.59 94.53 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.7 tp -69.93 -35.98 74.97 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 121.634 -0.921 . . . . 0.0 110.977 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.49 -40.14 36.32 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 117.681 -1.152 . . . . 0.0 112.821 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.78 -37.62 74.03 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.843 1.257 . . . . 0.0 113.386 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 t -61.54 -52.12 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.67 76.65 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -64.37 -29.42 70.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 118.817 1.308 . . . . 0.0 109.83 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.12 -52.04 7.81 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -53.31 -48.21 68.61 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.017 0.371 . . . . 0.0 110.453 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -60.38 -39.15 86.24 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.728 -1.232 . . . . 0.0 110.802 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 29' ' ' LYS . 13.3 tppt? -67.19 -28.3 67.98 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.554 0.742 . . . . 0.0 111.476 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -98.34 -3.89 36.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.935 1.294 . . . . 0.0 112.434 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.3 p -135.8 -36.04 0.77 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.45 -15.97 61.32 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.281 1.42 . . . . 0.0 112.054 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.85 130.38 28.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -68.44 130.26 42.35 Favored 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 121.498 -0.751 . . . . 0.0 109.414 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 t -128.46 118.34 47.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 33.9 m -114.34 142.96 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.614 0.766 . . . . 0.0 110.903 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.0 t -120.18 131.19 73.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -137.05 169.04 18.44 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.28 1.032 . . . . 0.0 109.404 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -140.25 54.55 5.3 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.26 168.31 25.11 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.877 2.385 . . . . 0.0 110.509 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -124.76 -7.71 7.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.258 1.023 . . . . 0.0 111.142 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -95.14 2.52 55.08 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.39 1.876 . . . . 0.0 111.103 -179.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.638 HD22 ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -48.55 -34.09 10.81 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 124.193 0.997 . . . . 0.0 111.988 179.297 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.638 ' N ' HD22 ' A' ' 43' ' ' LEU . 11.7 pt-20 -46.7 -33.57 4.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.04 2.136 . . . . 0.0 111.93 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -120.04 -21.25 7.15 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 125.92 1.688 . . . . 0.0 111.067 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -46.68 21.51 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.383 -1.448 . . . . 0.0 110.879 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -49.66 -55.62 21.87 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.41 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.7 0.33 3.1 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.899 1.733 . . . . 0.0 114.962 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -109.72 -15.48 14.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.865 1.211 . . . . 0.0 112.548 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.41 -28.36 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.64 1.176 . . . . 0.0 110.215 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.48 -18.27 59.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.075 -1.016 . . . . 0.0 110.725 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.98 -20.27 62.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.137 0.975 . . . . 0.0 110.985 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.7 p -119.96 -2.47 10.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.563 1.545 . . . . 0.0 112.572 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.14 8.94 85.82 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.8 -14.05 59.47 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.362 -1.081 . . . . 0.0 109.947 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.37 -172.85 48.4 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.898 1.714 . . . . 0.0 115.104 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -64.95 -178.05 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.73 3.62 . . . . 0.0 112.507 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -116.31 -12.85 11.08 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.5 mt -140.87 150.61 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 tt -137.62 132.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.22 107.99 13.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.25 1.82 . . . . 0.0 108.235 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -151.46 -175.67 5.28 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.49 147.01 40.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.02 -1.05 . . . . 0.0 108.662 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -49.19 -45.44 44.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.237 1.415 . . . . 0.0 112.223 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -62.31 -4.73 1.94 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.683 1.993 . . . . 0.0 115.534 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -110.55 -4.25 15.57 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.215 0.916 . . . . 0.0 110.871 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -97.32 -18.98 18.83 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.42 -44.58 77.01 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 120.207 1.367 . . . . 0.0 112.217 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.75 -47.88 30.97 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.722 -1.043 . . . . 0.0 112.014 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -55.78 -39.12 70.82 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.985 1.393 . . . . 0.0 110.465 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -65.61 -47.34 76.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.706 -0.664 . . . . 0.0 109.429 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -37.14 80.18 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.529 0.604 . . . . 0.0 110.012 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.8 m -63.97 -13.74 48.52 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.13 -0.981 . . . . 0.0 110.686 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.34 10.94 67.51 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 126.168 1.842 . . . . 0.0 113.426 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.5 mt -83.68 -3.71 57.99 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.949 1.374 . . . . 0.0 114.203 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 71' ' ' ALA . 28.8 mt -109.0 137.57 46.7 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.048 1.294 . . . . 0.0 110.139 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.94 179.56 5.49 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.604 1.162 . . . . 0.0 111.812 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -92.19 92.04 8.03 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pp -69.28 169.35 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.991 0.916 . . . . 0.0 112.413 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.283 7.6 p 49.51 73.69 0.95 Allowed Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 127.459 2.304 . . . . 0.0 112.054 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.11 -22.68 46.96 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.628 2.219 . . . . 0.0 112.667 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -128.81 164.31 23.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.616 1.967 . . . . 0.0 108.895 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -85.52 -34.9 21.44 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.76 -21.59 19.79 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.456 1.48 . . . . 0.0 114.531 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -68.5 -30.18 68.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -64.69 -41.08 96.29 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 120.964 -1.085 . . . . 0.0 110.024 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.81 -16.46 63.11 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.556 1.542 . . . . 0.0 112.123 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -84.66 -2.56 57.69 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 120.896 -1.127 . . . . 0.0 110.967 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt -131.14 159.22 38.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.371 1.068 . . . . 0.0 110.493 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -77.68 152.43 80.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.452 0.701 . . . . 0.0 109.272 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.88 -42.56 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.719 2.946 . . . . 0.0 114.75 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -58.09 -44.31 87.53 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.668 1.122 . . . . 0.0 110.707 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.75 -28.33 69.51 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.102 1.361 . . . . 0.0 111.26 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -71.3 -42.63 68.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.24 0.616 . . . . 0.0 110.331 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.12 -28.23 51.15 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.903 0.881 . . . . 0.0 111.647 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.37 -23.73 65.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.07 1.348 . . . . 0.0 114.263 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.57 11.61 6.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.375 1.07 . . . . 0.0 112.368 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -72.25 147.72 46.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.288 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.477 ' CD1' ' HE3' ' A' ' 102' ' ' LYS . 51.2 t80 -131.84 178.69 6.57 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.935 1.294 . . . . 0.0 108.543 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -57.67 89.82 0.01 OUTLIER 'General case' 0 C--O 1.235 0.308 0 C-N-CA 127.711 2.404 . . . . 0.0 109.546 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.14 -77.93 1.13 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.477 ' HE3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -66.83 177.03 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.8 1.24 . . . . 0.0 109.395 179.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.7 mt -116.52 -179.54 3.71 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 110.893 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.9 pt -133.74 -29.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.5 177.64 9.3 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.969 0.804 . . . . 0.0 109.443 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.38 145.93 54.58 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 124.238 1.015 . . . . 0.0 108.733 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.37 145.73 54.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.925 2.417 . . . . 0.0 108.17 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.0 mm -129.0 -50.56 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 123.369 0.668 . . . . 0.0 109.963 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.25 157.39 44.49 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.932 0.396 . . . . 0.0 111.169 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.15 119.37 26.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.006 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 . . . . . 0 CA--C 1.536 0.407 0 C-N-CA 124.172 0.989 . . . . 0.0 109.313 178.459 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 mt . . . . . 0 CA--C 1.532 0.28 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.2 p90 . . . . . 0 C--O 1.239 0.509 0 C-N-CA 126.581 1.952 . . . . 0.0 107.404 179.666 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.458 -0.573 0 CA-C-O 121.711 0.63 . . . . 0.0 113.571 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -123.85 -17.13 6.42 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 117.192 -1.385 . . . . 0.0 112.776 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.65 143.93 31.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.84 1.655 . . . . 0.0 112.205 -178.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -65.24 -22.77 66.92 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.394 -0.816 . . . . 0.0 111.911 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -72.19 -12.78 61.33 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.371 0.668 . . . . 0.0 111.934 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -98.85 -19.02 17.61 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.094 1.758 . . . . 0.0 111.014 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.33 -52.62 70.04 Favored Pre-proline 0 N--CA 1.465 0.319 0 C-N-CA 124.6 1.16 . . . . 0.0 109.851 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -69.37 -24.76 31.12 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 120.248 1.124 . . . . 0.0 111.771 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.35 -54.23 27.01 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.08 -30.02 70.71 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.175 -0.953 . . . . 0.0 110.316 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -61.78 -45.18 95.0 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.616 1.166 . . . . 0.0 110.352 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -74.39 -25.48 59.5 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.523 -0.736 . . . . 0.0 111.688 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.58 -45.84 61.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.675 -0.679 . . . . 0.0 110.249 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . 0.259 6.2 mt -80.1 -24.18 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 117.876 -1.53 . . . . 0.0 110.799 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -66.96 -31.56 72.21 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.19 -11.89 60.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.56 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.67 0.77 8.16 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.516 1.527 . . . . 0.0 111.932 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 172.14 -91.05 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 119.467 1.031 . . . . 0.0 113.721 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.08 -175.83 4.38 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.802 0.841 . . . . 0.0 109.659 -178.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.7 p -74.34 166.2 23.88 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.37 -63.9 1.31 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.039 2.536 . . . . 0.0 112.268 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.4 tp -102.92 137.15 41.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.473 1.509 . . . . 0.0 107.941 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 65.6 mtp -148.34 103.07 3.4 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 128.373 2.669 . . . . 0.0 105.721 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -128.33 161.93 28.27 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -72.38 93.56 1.54 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.007 0.908 . . . . 0.0 112.114 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.5 mt -73.48 -8.81 57.46 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.631 1.572 . . . . 0.0 110.288 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -70.58 -19.12 62.88 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.403 1.481 . . . . 0.0 112.597 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -115.66 135.62 22.69 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.619 1.1 . . . . 0.0 111.896 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.05 -21.93 48.48 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.759 2.306 . . . . 0.0 112.961 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -59.96 -27.34 66.73 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.505 0.593 . . . . 0.0 112.237 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -86.85 -44.91 11.34 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.791 0.723 . . . . 0.0 111.307 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.5 p -76.99 -17.2 59.02 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -62.12 -60.85 8.95 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 117.844 -1.074 . . . . 0.0 113.073 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.451 ' HA ' ' HB3' ' A' ' 162' ' ' ALA . 30.5 Cg_endo -61.9 -23.53 76.05 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.318 1.863 . . . . 0.0 111.422 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.34 -57.59 10.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 22.6 pt -69.19 -25.25 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.028 0.442 . . . . 0.0 111.229 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 159' ' ' PRO . . . -67.56 -23.14 65.39 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 120.901 -1.124 . . . . 0.0 111.06 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.76 87.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -57.96 -58.9 6.37 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.92 5.1 0.03 OUTLIER Glycine 0 CA--C 1.522 0.523 0 CA-C-O 118.688 -1.062 . . . . 0.0 115.064 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.62 129.88 33.72 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.244 1.522 . . . . 0.0 109.329 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -138.46 149.24 45.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.821 1.31 . . . . 0.0 108.092 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.09 -66.62 0.74 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -140.19 173.22 11.73 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.266 1.427 . . . . 0.0 107.869 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -114.5 139.59 49.43 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -155.74 117.1 3.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.229 1.412 . . . . 0.0 107.792 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -160.32 163.33 33.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.898 1.279 . . . . 0.0 108.706 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 49.74 26.87 2.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.269 1.828 . . . . 0.0 112.961 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.83 9.25 87.26 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.265 -1.297 . . . . 0.0 113.469 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -115.06 118.94 34.8 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.93 1.865 . . . . 0.0 107.612 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.06 116.69 23.22 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.118 1.767 . . . . 0.0 109.451 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -130.3 104.09 7.08 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -64.6 -3.36 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 125.152 1.381 . . . . 0.0 112.341 178.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -72.89 -36.25 67.28 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.676 1.191 . . . . 0.0 111.015 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -89.78 72.31 7.64 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.94 0.896 . . . . 0.0 111.112 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.2 138.76 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 128.295 2.638 . . . . 0.0 111.446 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.83 15.16 10.44 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -1.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 120.116 1.958 . . . . 0.0 115.36 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -125.52 14.03 8.17 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.641 1.564 . . . . 0.0 111.639 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -71.09 158.4 36.53 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.941 -1.099 . . . . 0.0 108.456 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -48.69 -31.77 7.35 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.12 -37.59 42.51 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 119.504 1.047 . . . . 0.0 112.845 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.83 88.25 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -71.42 -35.5 70.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.415 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -56.65 -50.76 71.11 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.012 1.278 . . . . 0.0 111.209 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.83 -34.44 88.68 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.612 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 60.3 tp -70.05 -55.17 10.2 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.948 0.874 . . . . 0.0 110.476 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.432 ' HB ' HG11 ' A' ' 357' ' ' VAL . 2.0 t -55.2 -41.71 72.35 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.585 -1.198 . . . . 0.0 108.989 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -57.01 -54.05 51.1 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.707 1.14 . . . . 0.0 109.278 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.29 -44.58 88.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.801 0.841 . . . . 0.0 111.33 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 72.6 t -67.16 -31.2 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 121.431 -0.793 . . . . 0.0 109.783 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -39.91 82.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 O-C-N 121.283 -0.885 . . . . 0.0 109.141 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.54 -45.53 90.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 70.2 mt -59.37 -49.0 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -54.69 -37.96 66.44 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.979 0.912 . . . . 0.0 110.534 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -92.44 8.02 40.49 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 64.8 22.16 12.49 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.976 1.71 . . . . 0.0 113.256 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -85.94 -3.97 59.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.769 1.228 . . . . 0.0 110.669 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 77.4 mtp -143.64 167.33 22.51 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.504 1.922 . . . . 0.0 107.703 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -120.9 92.71 3.82 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.851 1.26 . . . . 0.0 109.728 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.99 -11.58 14.22 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.017 1.327 . . . . 0.0 114.38 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -89.1 -5.24 57.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.388 1.475 . . . . 0.0 111.762 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.7 m -69.96 131.1 43.87 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.74 0.816 . . . . 0.0 110.48 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.445 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 7.6 p30 -129.38 -177.5 4.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.704 2.002 . . . . 0.0 108.281 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -62.92 -26.66 68.91 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.6 m -91.4 -34.66 14.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.257 1.423 . . . . 0.0 109.562 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.445 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 33.1 mm -66.13 -49.12 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.39 -53.15 61.57 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.946 0.898 . . . . 0.0 109.039 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -60.16 -33.88 72.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.238 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.94 -54.28 23.52 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 119.309 0.959 . . . . 0.0 108.738 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.88 82.91 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.843 0.857 . . . . 0.0 109.865 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.96 -37.73 88.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.26 0.624 . . . . 0.0 110.244 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.06 -23.71 67.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.906 0.775 . . . . 0.0 109.786 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -87.84 -20.25 26.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.247 1.019 . . . . 0.0 109.658 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.36 12.65 72.6 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.514 1.531 . . . . 0.0 111.752 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -66.23 -45.85 79.21 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.911 0.855 . . . . 0.0 110.87 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 43.5 p -71.38 171.5 11.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.919 1.688 . . . . 0.0 109.069 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -129.38 -13.48 4.37 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -157.21 -179.63 8.38 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 121.745 -0.597 . . . . 0.0 110.653 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.3 t -164.53 174.29 11.07 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.475 1.51 . . . . 0.0 107.39 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.4 mt . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.859 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--O 1.237 0.408 0 CA-C-O 118.878 -0.582 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.91 134.49 23.68 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.802 1.668 . . . . 0.0 109.924 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 65.1 p -129.78 176.58 7.91 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.883 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -88.73 140.25 29.63 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -52.89 131.76 36.11 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.519 -1.363 . . . . 0.0 110.871 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.38 -1.36 50.91 Favored Glycine 0 CA--C 1.519 0.285 0 CA-C-O 118.54 -1.144 . . . . 0.0 114.635 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.93 103.39 3.19 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 119.647 1.723 . . . . 0.0 111.842 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.17 170.23 15.0 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.345 2.696 . . . . 0.0 114.376 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 74.9 m -57.75 140.79 50.67 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.164 1.386 . . . . 0.0 110.648 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -140.25 73.95 30.56 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.478 1.111 . . . . 0.0 108.439 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.98 -95.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.578 3.518 . . . . 0.0 109.121 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 . . . . . 0 C--O 1.236 0.343 0 C-N-CA 128.623 2.769 . . . . 0.0 107.631 179.095 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.413 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 1.5 p -69.18 112.98 4.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 121.427 0.632 . . . . 0.0 109.301 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 8.8 tt -77.87 134.75 37.88 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.5 m -125.7 168.31 13.93 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.616 1.167 . . . . 0.0 110.712 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -137.05 140.99 42.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.03 147.59 19.27 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 69.8 mt -90.32 136.77 23.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -71.73 128.24 35.13 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.4 8.23 2.38 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -116.25 3.41 13.41 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.09 1.314 . . . . 0.0 112.48 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 62.7 m -63.5 160.51 42.23 Favored Pre-proline 0 C--O 1.237 0.447 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.8 -60.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 108.333 -1.449 . . . . 0.0 108.333 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -123.78 102.68 7.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -16.19 37.38 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.239 0.472 . . . . 0.0 110.595 178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.44 ' HA ' ' HG3' ' A' ' 277' ' ' LYS . 15.3 tt0 -57.17 -41.9 80.09 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 127.456 2.303 . . . . 0.0 108.469 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.02 -37.09 76.12 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.018 -1.051 . . . . 0.0 110.852 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.06 -46.82 40.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 122.094 -0.379 . . . . 0.0 109.994 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.44 ' HG3' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -62.15 -34.48 76.46 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.704 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.51 -55.24 10.76 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -52.55 -46.26 66.71 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.042 -1.036 . . . . 0.0 111.617 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -51.66 68.7 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 119.264 -0.398 . . . . 0.0 110.929 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -10.98 59.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -108.59 -27.73 9.7 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -138.11 -25.62 0.95 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 120.102 1.319 . . . . 0.0 114.04 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.51 -51.02 10.58 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.681 1.128 . . . . 0.0 110.859 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 88.7 mt -86.57 68.36 10.15 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.602 1.161 . . . . 0.0 110.819 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.8 p -135.21 162.62 32.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -75.75 5.0 6.82 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.395 0.617 . . . . 0.0 110.457 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -113.26 -42.82 3.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.091 2.156 . . . . 0.0 109.478 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.93 -37.11 87.64 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.18 1.371 . . . . 0.0 111.884 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.09 -36.06 61.74 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.556 1.178 . . . . 0.0 109.267 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -70.33 -39.26 74.83 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.807 0.843 . . . . 0.0 110.044 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -53.73 -38.31 64.22 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.16 0.891 . . . . 0.0 112.707 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 20.2 t -81.34 -35.47 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.148 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -63.35 -33.34 75.31 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.852 0.861 . . . . 0.0 111.356 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -61.33 -54.06 48.75 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.139 1.376 . . . . 0.0 108.784 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -42.42 99.14 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -152.42 141.76 14.43 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 124.873 1.269 . . . . 0.0 107.801 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.75 110.56 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.435 2.09 . . . . 0.0 109.031 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 12.5 mt -75.22 -22.25 58.07 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.27 -155.7 19.91 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.504 -1.839 . . . . 0.0 108.504 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.6 178.06 5.63 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.965 0.888 . . . . 0.0 109.398 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.74 150.55 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 C-N-CA 123.753 0.821 . . . . 0.0 109.198 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.24 -20.86 40.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.625 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.1 106.9 6.83 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.971 1.708 . . . . 0.0 110.165 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -56.42 -26.55 53.89 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.8 m -57.13 -54.79 42.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.635 1.107 . . . . 0.0 110.663 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -90.46 -17.96 26.21 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.517 0.727 . . . . 0.0 111.803 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -60.88 -39.77 90.47 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.895 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -66.58 -15.89 63.76 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.529 1.059 . . . . 0.0 113.033 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -95.73 -23.49 16.95 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.704 2.001 . . . . 0.0 110.323 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 32.4 mt -86.69 -44.4 11.85 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.76 -17.9 57.78 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.888 2.075 . . . . 0.0 112.03 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 314' ' ' ASP . 0.1 OUTLIER -69.81 -16.91 63.36 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.695 -0.628 . . . . 0.0 109.561 178.071 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.452 ' HB2' ' HE3' ' A' ' 313' ' ' LYS . 2.5 t70 -103.94 131.51 21.9 Favored Pre-proline 0 N--CA 1.438 -1.051 0 C-N-CA 125.91 1.684 . . . . 0.0 107.562 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.81 -23.63 67.86 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.497 2.131 . . . . 0.0 114.43 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 -60.39 -54.98 39.16 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.848 1.259 . . . . 0.0 111.009 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.4 mp -71.96 -49.37 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.92 -52.06 36.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 123.948 0.78 . . . . 0.0 111.903 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.22 -28.45 70.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.511 0.596 . . . . 0.0 112.566 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 24.0 m -76.61 -37.45 56.4 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.1 tpt -71.84 -33.1 68.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.715 1.206 . . . . 0.0 111.393 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -55.99 -35.37 66.7 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.691 0.796 . . . . 0.0 109.696 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -63.23 -36.85 85.03 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.968 0.907 . . . . 0.0 111.486 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.376 0 C-N-CA 123.967 0.907 . . . . 0.0 109.522 178.74 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.453 -0.873 0 N-CA-C 109.713 -0.918 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -83.0 4.21 26.97 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 48.6 pt -60.89 151.93 71.73 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.38 1.072 . . . . 0.0 111.263 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.61 -21.8 21.69 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.52 2.147 . . . . 0.0 113.771 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -68.78 -18.41 64.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.233 0.924 . . . . 0.0 111.67 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 64.3 mmm -61.85 -29.23 70.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.349 0.977 . . . . 0.0 109.867 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.1 m -63.7 -52.0 62.56 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.96 86.37 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.074 0.549 . . . . 0.0 110.105 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -56.93 -54.86 41.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.821 1.248 . . . . 0.0 109.86 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -60.56 -39.97 89.92 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.98 0.809 . . . . 0.0 110.599 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -68.09 -25.89 65.55 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.96 -59.17 2.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.814 1.246 . . . . 0.0 110.552 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.9 t -55.95 -38.97 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.655 0.782 . . . . 0.0 110.667 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.68 -46.59 74.11 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.177 1.353 . . . . 0.0 110.8 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 47.7 m -67.71 -46.4 72.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.627 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -56.48 -43.41 79.62 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.47 1.032 . . . . 0.0 112.652 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.72 -53.5 46.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 125.041 1.336 . . . . 0.0 109.14 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.77 -40.78 88.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 122.809 0.444 . . . . 0.0 109.833 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -56.08 -45.23 79.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 120.969 -1.082 . . . . 0.0 110.984 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.72 -46.94 34.23 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.24 0.616 . . . . 0.0 111.015 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -63.1 -42.07 99.51 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.138 0.975 . . . . 0.0 113.266 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 36.4 m -84.87 -5.29 59.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.396 0.678 . . . . 0.0 109.362 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.86 12.55 71.14 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 118.538 0.608 . . . . 0.0 113.711 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -65.56 -28.01 68.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.134 0.967 . . . . 0.0 109.707 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -142.98 156.96 44.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 9.0 m -66.71 148.73 51.52 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.432 HG11 ' HB ' ' A' ' 193' ' ' THR . 83.6 t -51.27 -57.24 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.436 1.094 . . . . 0.0 111.272 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -63.56 -39.93 95.67 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -70.06 -25.45 63.55 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.774 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.49 76.39 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.507 0.723 . . . . 0.0 109.309 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.56 -36.21 60.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 118.686 -0.674 . . . . 0.0 110.297 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -55.63 -54.67 41.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.205 1.402 . . . . 0.0 108.115 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -51.19 -61.35 2.29 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.873 2.469 . . . . 0.0 110.338 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.75 77.07 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 127.047 2.139 . . . . 0.0 114.092 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -59.62 -36.07 75.62 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 16.7 m -64.11 -38.8 92.37 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.307 0.575 . . . . 0.0 110.567 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -61.21 -24.04 66.05 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.074 -1.016 . . . . 0.0 111.787 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.8 mt -91.52 -29.94 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.793 1.237 . . . . 0.0 110.17 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 17.3 p -76.8 -20.96 55.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.299 0.954 . . . . 0.0 110.026 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? . . . . . 0 C--O 1.247 0.955 0 C-N-CA 126.156 1.782 . . . . 0.0 108.355 179.301 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.413 ' H ' HD12 ' A' ' 2' ' ' ILE . 3.1 mp -82.42 165.16 2.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 125.307 1.629 . . . . 0.0 109.764 -179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -72.49 119.54 16.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -91.4 167.12 12.5 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.25 24.31 75.68 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 117.099 1.6 . . . . 0.0 117.099 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -148.24 157.92 43.78 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 121.145 2.472 . . . . 0.0 113.856 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.2 mt -144.95 152.19 39.8 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 127.346 2.258 . . . . 0.0 108.604 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -134.82 139.78 46.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 126.641 1.976 . . . . 0.0 106.97 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.2 mt -122.77 121.23 62.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.697 1.199 . . . . 0.0 108.99 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -115.95 137.08 52.44 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 mt -128.59 159.22 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -52.74 -20.35 3.1 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 118.222 2.675 . . . . 0.0 118.222 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.17 155.13 30.22 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 104.846 -3.302 . . . . 0.0 104.846 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.89 0.57 0.38 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.261 1.424 . . . . 0.0 113.943 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -82.23 172.5 13.07 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 127.0 2.12 . . . . 0.0 111.885 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.61 51.01 2.97 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.062 1.791 . . . . 0.0 113.355 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -57.42 -35.98 70.77 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.76 1.224 . . . . 0.0 113.978 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -62.21 -38.51 89.41 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.871 0.76 . . . . 0.0 111.031 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.11 -35.72 57.16 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.8 tp -70.9 -32.46 69.41 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 123.119 0.568 . . . . 0.0 111.535 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.28 -48.64 71.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.298 0.639 . . . . 0.0 110.851 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -53.31 -38.47 63.2 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.42 HG11 ' HA ' ' A' ' 284' ' ' LEU . 21.4 t -57.33 -46.66 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.82 -29.42 72.61 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 124.539 1.066 . . . . 0.0 111.215 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -68.06 -43.77 77.87 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 118.851 1.326 . . . . 0.0 107.448 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -60.47 3.29 Favored 'General case' 0 C--O 1.224 -0.269 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -52.69 -54.17 37.33 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.984 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -58.18 -29.74 65.88 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.553 1.524 . . . . 0.0 112.292 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 -28.39 58.74 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 120.601 -1.312 . . . . 0.0 109.83 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -91.63 -38.33 12.52 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.223 0.952 . . . . 0.0 112.05 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 51.5 p -102.62 -31.54 10.33 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.45 -17.35 54.69 Favored Glycine 0 CA--C 1.529 0.931 0 O-C-N 121.106 -0.996 . . . . 0.0 112.206 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.3 mm -62.76 119.96 8.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.4 143.08 15.91 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -177.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.8 t -138.83 105.88 2.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 123.649 0.779 . . . . 0.0 109.128 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.5 m -96.96 153.45 17.89 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 25.0 t -141.82 127.28 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 104.693 -2.336 . . . . 0.0 104.693 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -134.88 154.79 51.52 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -122.58 57.29 9.22 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.08 1.752 . . . . 0.0 110.281 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.46 167.26 27.48 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.187 2.592 . . . . 0.0 112.299 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -121.71 1.78 10.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.221 1.008 . . . . 0.0 112.874 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 14.37 6.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.886 1.674 . . . . 0.0 112.117 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -58.33 -26.36 63.0 Favored 'General case' 0 C--O 1.222 -0.383 0 O-C-N 120.588 -1.32 . . . . 0.0 113.083 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 pm0 -58.58 -27.51 64.68 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.845 1.202 . . . . 0.0 113.635 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -106.17 -24.55 12.3 Favored 'General case' 0 CA--C 1.527 0.063 0 C-N-CA 123.66 0.784 . . . . 0.0 110.192 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -45.35 28.03 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 118.136 -0.935 . . . . 0.0 109.716 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -48.78 -60.06 5.23 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 117.629 -1.177 . . . . 0.0 109.403 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.28 -17.12 57.46 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.602 1.535 . . . . 0.0 114.004 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.9 mm-40 -89.03 -28.54 20.09 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.34 1.427 . . . . 0.0 111.753 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.8 -45.73 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 120.01 1.277 . . . . 0.0 109.651 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.26 -22.95 66.4 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 122.061 -0.399 . . . . 0.0 111.315 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.72 -24.31 67.61 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.23 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.4 m -103.23 4.86 37.16 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.59 1.556 . . . . 0.0 109.917 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.35 36.54 78.53 Favored Glycine 0 CA--C 1.526 0.762 0 O-C-N 120.797 -1.189 . . . . 0.0 111.64 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -128.39 1.97 5.67 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.855 1.662 . . . . 0.0 112.915 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.41 -169.94 44.47 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.892 1.234 . . . . 0.0 113.693 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.36 162.24 34.41 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.189 1.926 . . . . 0.0 109.768 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -94.47 -19.2 20.77 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 124.545 1.138 . . . . 0.0 111.225 -177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -138.9 147.96 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.4 tp -134.4 145.98 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 124.625 1.17 . . . . 0.0 108.622 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -130.55 108.94 10.3 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.714 1.606 . . . . 0.0 109.707 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -156.4 167.22 31.12 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 123.878 0.871 . . . . 0.0 109.975 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.76 155.33 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -57.29 -29.42 63.87 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -49.89 -59.06 4.21 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.143 0.977 . . . . 0.0 111.561 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -66.09 -17.56 64.78 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 121.547 -0.721 . . . . 0.0 111.659 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -83.17 -5.11 59.0 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.497 -0.752 . . . . 0.0 110.3 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.4 -13.96 46.39 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.052 1.311 . . . . 0.0 113.591 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -125.06 -31.41 0.86 Allowed Glycine 0 CA--C 1.526 0.727 0 CA-C-N 118.827 1.314 . . . . 0.0 114.128 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -57.51 -41.74 81.41 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.017 1.408 . . . . 0.0 112.822 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.8 -40.72 79.42 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 119.58 1.082 . . . . 0.0 110.705 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -41.79 87.55 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.5 m -68.44 -8.12 37.85 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.079 0.952 . . . . 0.0 111.781 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.74 1.24 83.08 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 126.545 2.021 . . . . 0.0 113.016 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.38 -41.07 89.96 Favored 'General case' 0 C--N 1.338 0.067 0 CA-C-N 118.899 1.35 . . . . 0.0 113.232 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.8 mt -85.5 130.47 34.57 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.18 164.94 19.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.464 1.106 . . . . 0.0 112.082 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -73.8 131.34 41.44 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pp -113.99 -174.41 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.315 1.446 . . . . 0.0 109.191 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m 60.08 75.73 0.47 Allowed Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.502 1.121 . . . . 0.0 111.051 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.16 -23.64 15.54 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.021 2.481 . . . . 0.0 113.984 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -140.95 -162.67 1.4 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.518 1.927 . . . . 0.0 108.575 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -110.56 -19.92 12.74 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.793 1.237 . . . . 0.0 113.376 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.84 -47.25 83.2 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.97 -1.081 . . . . 0.0 113.586 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -61.76 -28.28 69.33 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.862 1.265 . . . . 0.0 110.356 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -68.57 -44.51 74.29 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.294 0.952 . . . . 0.0 108.916 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -65.26 -21.53 66.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.228 0.467 . . . . 0.0 111.762 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -68.04 -12.04 60.08 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.526 0.603 . . . . 0.0 110.509 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -122.07 165.78 15.54 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.833 1.653 . . . . 0.0 111.211 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -77.1 155.69 82.33 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -69.31 -43.1 3.26 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.325 2.684 . . . . 0.0 114.295 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -57.2 -41.99 80.4 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.543 1.065 . . . . 0.0 112.354 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.96 -25.63 67.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.649 1.18 . . . . 0.0 111.051 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 37.0 m95 -76.26 -40.67 51.23 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.0 -37.99 81.3 Favored 'General case' 0 C--O 1.227 -0.1 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.8 0.75 0.75 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.474 1.51 . . . . 0.0 114.002 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.04 3.91 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-N 120.487 1.494 . . . . 0.0 111.693 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.9 mtt-85 -63.08 170.46 2.79 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-O 123.3 1.524 . . . . 0.0 113.418 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -149.92 179.47 8.02 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 128.17 2.588 . . . . 0.0 105.868 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -68.21 99.9 0.96 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.79 -72.9 1.74 Allowed Glycine 0 CA--C 1.521 0.466 0 C-N-CA 125.012 1.291 . . . . 0.0 111.782 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.06 167.67 13.49 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 122.53 1.157 . . . . 0.0 112.374 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.14 154.1 22.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.266 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 33.3 pt -134.2 -15.08 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -163.9 172.55 13.84 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.084 1.311 . . . . 0.0 108.029 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.22 150.5 75.52 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 123.842 0.857 . . . . 0.0 110.829 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -69.94 144.63 53.67 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 124.336 3.358 . . . . 0.0 111.387 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 30.3 mm -121.58 -55.53 3.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 126.105 1.762 . . . . 0.0 111.596 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.06 162.0 33.71 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.1 t -128.69 75.07 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 113.566 0.951 . . . . 0.0 113.566 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -128.99 101.96 6.29 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -102.67 71.82 1.2 Allowed 'General case' 0 C--O 1.24 0.561 0 C-N-CA 126.681 1.992 . . . . 0.0 109.011 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -160.1 121.46 3.14 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 m -160.95 154.16 21.56 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.583 1.553 . . . . 0.0 108.104 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.0 tp -158.48 137.48 11.39 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.676 1.59 . . . . 0.0 108.033 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 22.5 mt -93.52 156.08 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 125.404 1.482 . . . . 0.0 110.204 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -142.72 173.82 11.2 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.553 1.941 . . . . 0.0 110.529 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -58.04 171.79 0.49 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.712 1.205 . . . . 0.0 111.913 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -61.09 -17.68 53.88 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.301 -0.874 . . . . 0.0 112.629 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -90.1 127.64 36.13 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.391 1.476 . . . . 0.0 110.086 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.47 36.16 0.1 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.531 1.932 . . . . 0.0 113.304 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.87 108.2 17.42 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.17 95.3 1.03 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 123.371 2.714 . . . . 0.0 112.31 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -140.75 74.35 27.1 Favored Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -78.58 150.91 25.02 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.835 2.357 . . . . 0.0 112.126 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -65.82 148.25 86.23 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.968 2.445 . . . . 0.0 111.584 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -86.6 -26.04 24.63 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.913 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 13.9 t -170.96 161.13 6.88 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.953 1.252 . . . . 0.0 108.822 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 36.8 m95 -64.81 -29.22 70.18 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.61 -12.67 61.71 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.625 0.648 . . . . 0.0 112.485 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -90.38 -21.3 22.04 Favored 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.743 1.217 . . . . 0.0 109.951 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 39.3 mm -55.43 -57.34 21.18 Favored Pre-proline 0 N--CA 1.456 -0.158 0 CA-C-O 117.441 -1.266 . . . . 0.0 110.762 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.75 -23.4 62.98 Favored 'Trans proline' 0 N--CA 1.447 -1.218 0 CA-C-N 120.769 1.31 . . . . 0.0 111.815 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.58 -39.83 57.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.488 0.715 . . . . 0.0 110.494 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.0 tp -79.39 -31.44 42.81 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 125.306 1.443 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.57 -46.84 80.53 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.617 1.167 . . . . 0.0 110.862 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.5 ptmm? -70.74 -29.42 65.66 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.35 0.66 . . . . 0.0 112.139 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -75.0 -41.43 59.52 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.56 -33.99 67.18 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -65.24 -32.91 74.82 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.22 -14.67 61.22 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 4.38 5.76 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 125.098 1.359 . . . . 0.0 111.879 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 174.08 -96.21 0.11 Allowed Glycine 0 CA--C 1.526 0.719 0 CA-C-N 119.748 1.158 . . . . 0.0 115.007 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -134.97 -173.54 3.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.145 0.973 . . . . 0.0 112.493 -177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 13.4 p -62.8 161.62 12.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.429 1.892 . . . . 0.0 112.055 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.82 -68.05 0.79 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.809 1.244 . . . . 0.0 109.375 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.4 tp -125.93 141.23 52.07 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 125.451 1.5 . . . . 0.0 110.577 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.6 mtp -139.43 149.1 43.65 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.739 1.616 . . . . 0.0 107.452 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -163.76 173.56 12.68 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.126 0.97 . . . . 0.0 109.766 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -75.36 80.73 2.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.207 1.803 . . . . 0.0 108.904 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 mp -72.63 -16.23 61.72 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 121.031 -1.043 . . . . 0.0 110.12 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -70.05 -14.06 62.5 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -121.29 155.12 58.99 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 121.718 2.054 . . . . 0.0 114.845 -178.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.0 -28.71 12.71 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.521 2.147 . . . . 0.0 115.619 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -56.13 -41.51 75.45 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 113.483 0.919 . . . . 0.0 113.483 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -89.93 -25.31 21.0 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 119.252 -0.404 . . . . 0.0 111.387 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . 0.25 53.3 p -85.33 -13.39 49.75 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.011 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -61.54 -53.48 61.21 Favored Pre-proline 0 CA--C 1.532 0.258 0 O-C-N 120.605 -1.309 . . . . 0.0 111.159 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -64.18 -7.81 14.75 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 CA-C-N 120.574 1.241 . . . . 0.0 112.746 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.79 -67.84 0.63 Allowed 'General case' 0 CA--C 1.523 -0.069 0 CA-C-N 121.424 1.92 . . . . 0.0 107.979 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.41 -27.09 40.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 C-N-CA 126.005 1.722 . . . . 0.0 115.014 -177.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.74 -18.72 56.32 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.774 -0.579 . . . . 0.0 111.01 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.89 -47.1 75.97 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.13 -33.24 73.08 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 154.56 -9.79 0.41 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-O 117.188 -1.895 . . . . 0.0 116.756 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.02 149.28 38.47 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-N 120.242 2.021 . . . . 0.0 112.798 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -151.29 143.42 24.0 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.232 1.016 . . . . 0.0 109.285 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -67.46 -67.99 0.42 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.832 0.853 . . . . 0.0 112.126 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -139.0 143.53 38.52 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.476 1.11 . . . . 0.0 108.695 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -76.85 141.01 40.81 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.26 102.33 3.96 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -70.87 -174.12 0.89 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -67.02 34.43 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.449 1.899 . . . . 0.0 114.262 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 138.6 -3.51 2.93 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.47 1.986 . . . . 0.0 112.645 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.65 127.5 56.13 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.875 1.838 . . . . 0.0 106.68 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -120.82 152.2 38.67 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 123.894 0.746 . . . . 0.0 110.962 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -156.12 161.14 40.4 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 128.989 2.916 . . . . 0.0 106.093 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.73 -3.66 10.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.376 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -75.15 -30.7 60.84 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.281 0.632 . . . . 0.0 112.394 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -90.67 87.34 6.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.949 0.88 . . . . 0.0 110.606 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.9 t -105.91 110.48 31.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.756 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -81.23 28.67 2.93 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 126.029 1.776 . . . . 0.0 114.046 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 37.5 t -74.23 -57.13 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -80.11 57.6 2.74 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 122.183 0.992 . . . . 0.0 110.18 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -127.09 142.25 51.57 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -51.0 -34.56 29.73 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.417 1.087 . . . . 0.0 113.755 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.63 -38.66 96.78 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 119.474 1.034 . . . . 0.0 112.162 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.03 -53.98 51.4 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 117.679 0.739 . . . . 0.0 109.397 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.457 ' HE3' ' OD2' ' A' ' 358' ' ' ASP . 2.6 ptmm? -62.44 -38.45 89.81 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -54.64 -53.3 56.54 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.823 1.249 . . . . 0.0 111.8 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -74.01 -29.81 62.19 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 110.644 -0.983 . . . . 0.0 110.644 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 13.0 tp -70.2 -37.23 75.03 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.727 1.264 . . . . 0.0 112.856 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 6.6 t -67.53 -19.1 65.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 117.397 -1.287 . . . . 0.0 110.97 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -65.65 -50.58 64.45 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 120.412 1.46 . . . . 0.0 107.84 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.9 tt -52.9 -49.91 64.96 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.273 1.429 . . . . 0.0 109.761 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.45 -27.68 42.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 C-N-CA 124.401 1.08 . . . . 0.0 111.041 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.71 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 18.2 t0 -65.43 -31.73 72.98 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.933 1.242 . . . . 0.0 112.848 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.4 mt -76.46 -48.31 20.04 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 51.6 mt -59.75 -36.13 64.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.145 0.978 . . . . 0.0 109.488 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.71 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -52.18 -43.82 64.35 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.076 1.35 . . . . 0.0 110.666 179.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -90.77 -2.91 57.76 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.319 1.848 . . . . 0.0 112.189 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 59.22 9.8 1.49 Allowed 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.887 2.475 . . . . 0.0 113.679 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.66 -28.68 67.09 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.582 0.628 . . . . 0.0 109.934 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.7 tpt -90.88 154.37 19.53 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.402 0.681 . . . . 0.0 109.759 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -75.59 88.26 2.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -75.51 -8.08 55.82 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.28 1.032 . . . . 0.0 112.232 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -105.63 8.19 33.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.892 1.277 . . . . 0.0 113.882 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 72.8 m -87.12 127.61 35.13 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.524 -0.735 . . . . 0.0 109.494 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -124.25 -172.08 2.47 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.476 1.91 . . . . 0.0 107.412 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -52.83 -51.67 60.01 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.893 1.277 . . . . 0.0 109.267 178.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -50.13 70.32 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.771 1.229 . . . . 0.0 111.428 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.86 -46.53 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.35 0.66 . . . . 0.0 111.506 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.38 79.05 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.463 1.105 . . . . 0.0 113.156 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -59.18 -54.77 43.15 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.084 1.353 . . . . 0.0 108.885 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -54.52 -55.79 25.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 124.393 1.058 . . . . 0.0 110.771 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.27 -35.39 64.96 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.719 0.69 . . . . 0.0 111.956 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -69.83 -43.04 72.79 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -58.25 -40.13 80.98 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -66.95 -21.18 65.98 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.337 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.28 12.47 63.15 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 124.297 0.951 . . . . 0.0 111.998 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -79.99 -49.71 11.44 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.483 1.142 . . . . 0.0 112.502 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.3 p -64.8 119.99 11.65 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -63.77 -17.33 62.94 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.361 0.528 . . . . 0.0 112.406 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.6 ptt? -158.54 166.56 31.84 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.405 1.082 . . . . 0.0 109.151 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 2.0 t -159.06 170.81 21.21 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 62.0 mt -132.07 150.44 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 126.064 1.746 . . . . 0.0 106.744 179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -153.22 177.27 11.03 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.261 1.424 . . . . 0.0 108.242 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 147.59 -82.75 0.19 Allowed Glycine 0 CA--C 1.523 0.545 0 CA-C-O 117.977 -1.457 . . . . 0.0 114.846 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.56 161.65 44.23 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.964 2.443 . . . . 0.0 113.401 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 5.3 m0 -115.25 105.78 13.28 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.318 1.447 . . . . 0.0 110.458 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.79 -60.64 1.93 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.844 1.258 . . . . 0.0 108.937 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 51.4 m0 -67.53 159.09 30.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.664 0.786 . . . . 0.0 109.295 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 17.7 t -70.8 -8.95 56.19 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.895 -0.503 . . . . 0.0 112.036 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 15.5 t30 -155.31 157.33 37.02 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.272 1.429 . . . . 0.0 109.574 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 57.7 mt -112.58 141.4 28.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -119.82 -7.14 10.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.439 1.096 . . . . 0.0 112.767 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.07 119.87 9.27 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.196 1.398 . . . . 0.0 107.337 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 9.6 t -121.35 128.29 52.12 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.888 0.851 . . . . 0.0 110.376 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 21.2 mtmm -93.75 164.13 13.26 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.067 1.347 . . . . 0.0 107.798 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.46 162.65 32.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -160.33 136.99 8.95 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.796 -0.565 . . . . 0.0 110.255 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -92.61 155.29 17.86 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 54.51 -160.76 4.79 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.98 0.8 . . . . 0.0 113.422 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 7.6 p -118.85 163.67 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 125.018 1.327 . . . . 0.0 109.007 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 27.2 m -144.86 157.11 44.27 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.5 HG22 ' H ' ' A' ' 247' ' ' LEU . 14.5 p -73.58 -179.53 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.5 ' H ' HG22 ' A' ' 246' ' ' VAL . 1.5 tt -139.8 127.27 12.81 Favored Pre-proline 0 C--O 1.236 0.358 0 O-C-N 120.017 -1.677 . . . . 0.0 108.041 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.74 156.29 65.95 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.938 2.425 . . . . 0.0 108.721 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 67.4 p -131.25 -173.22 3.05 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 124.15 0.98 . . . . 0.0 110.936 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -91.1 171.87 8.96 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -51.65 102.38 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 127.328 2.251 . . . . 0.0 110.09 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 63.85 23.63 67.59 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 117.603 -1.665 . . . . 0.0 114.726 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.8 128.41 4.74 Favored Pre-proline 0 N--CA 1.466 0.348 0 CA-C-N 121.291 2.546 . . . . 0.0 111.196 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.67 159.55 52.36 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.016 2.477 . . . . 0.0 111.473 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.6 m -92.3 162.88 14.1 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.553 ' HA ' ' HE2' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -150.51 91.68 4.08 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.198 1.399 . . . . 0.0 110.877 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.21 -77.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.197 2.598 . . . . 0.0 109.644 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -154.81 164.31 39.0 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.049 2.139 . . . . 0.0 106.876 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 40.2 t -86.19 95.16 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -101.85 106.82 3.07 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 105.623 -2.991 . . . . 0.0 105.623 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.9 165.47 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.172 0.989 . . . . 0.0 110.985 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.16 140.98 30.51 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.034 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.3 m -133.09 168.27 18.81 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.114 0.87 . . . . 0.0 111.356 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -139.6 147.57 41.29 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 125.296 1.439 . . . . 0.0 108.606 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.26 155.01 23.2 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 73.2 mt -101.57 138.74 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -71.98 132.22 44.0 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.49 0.662 . . . . 0.0 109.892 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -73.67 -17.4 61.15 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -80.54 -18.88 47.08 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 116.954 -1.498 . . . . 0.0 114.953 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 40.8 m -55.06 154.26 10.55 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 119.577 1.08 . . . . 0.0 109.974 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -69.51 -54.64 0.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.84 1.693 . . . . 0.0 111.229 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -125.16 92.85 3.72 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.512 1.925 . . . . 0.0 110.444 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -55.62 -18.34 7.54 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 126.512 1.925 . . . . 0.0 112.199 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.85 -35.78 77.44 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 124.969 1.308 . . . . 0.0 109.807 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 95.9 mt -56.51 -44.41 80.7 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.989 0.813 . . . . 0.0 110.123 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.4 -48.52 60.82 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.175 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -38.04 81.94 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 123.5 0.5 . . . . 0.0 110.614 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -68.34 -53.47 23.94 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.491 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -49.14 -46.66 45.42 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 119.328 0.967 . . . . 0.0 111.434 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.46 -50.74 72.04 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.799 0.84 . . . . 0.0 111.105 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.262 4.8 pt-20 -95.59 26.96 3.64 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -135.31 -35.51 0.82 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.397 1.079 . . . . 0.0 110.73 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -130.17 -39.19 1.37 Allowed 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 119.454 1.025 . . . . 0.0 112.453 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.42 ' HA ' HG11 ' A' ' 23' ' ' VAL . 12.4 tp -62.67 -58.48 7.33 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 119.504 1.047 . . . . 0.0 110.331 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 40.0 mt -78.79 60.46 2.81 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.434 1.494 . . . . 0.0 113.059 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 43.7 p -133.98 162.31 32.41 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -70.21 -3.22 15.94 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.734 0.813 . . . . 0.0 111.629 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -109.28 -44.3 3.96 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.247 1.419 . . . . 0.0 109.691 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.29 -50.57 21.14 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 124.924 1.249 . . . . 0.0 110.304 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 95.1 mt -61.53 -38.01 85.87 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.054 0.927 . . . . 0.0 109.414 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -63.05 -45.43 92.26 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 124.468 1.105 . . . . 0.0 108.521 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.97 -45.78 82.66 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 123.808 0.843 . . . . 0.0 111.698 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.5 t -68.9 -38.55 78.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 30.7 t30 -67.55 -28.96 68.24 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.496 0.589 . . . . 0.0 111.405 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -68.12 -42.55 80.06 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -68.0 -32.71 73.28 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -160.03 147.06 12.41 Favored Pre-proline 0 N--CA 1.467 0.379 0 C-N-CA 125.341 1.456 . . . . 0.0 108.931 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.06 123.94 9.22 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.566 2.177 . . . . 0.0 108.681 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 32.7 mt -107.1 -4.36 18.98 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.463 1.505 . . . . 0.0 112.971 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 62.05 -153.17 42.37 Favored Glycine 0 C--N 1.335 0.498 0 CA-C-N 119.23 0.923 . . . . 0.0 111.391 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -58.65 159.03 7.05 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.965 0.906 . . . . 0.0 112.65 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 4.1 m -125.57 155.27 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 C-N-CA 124.072 0.949 . . . . 0.0 109.797 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.67 -36.12 62.8 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.187 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.18 105.56 0.73 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.93 1.292 . . . . 0.0 110.43 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -53.71 -38.16 63.99 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.244 1.018 . . . . 0.0 112.547 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 21.4 m -56.1 -35.02 66.56 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.626 0.77 . . . . 0.0 112.937 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -109.28 -5.87 15.73 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.187 0.995 . . . . 0.0 110.942 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -60.94 -50.0 75.19 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -58.16 -33.35 69.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.457 1.103 . . . . 0.0 111.733 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -69.62 -49.21 56.07 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.7 0.8 . . . . 0.0 109.896 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 21.1 mt -68.82 -34.15 75.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.23 -5.3 6.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.618 1.567 . . . . 0.0 112.444 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -62.11 -21.05 64.68 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.31 0.959 . . . . 0.0 109.439 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.13 142.33 26.65 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 119.266 0.939 . . . . 0.0 109.171 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -61.82 -30.67 84.69 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.55 2.833 . . . . 0.0 115.038 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -58.08 -36.47 72.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.303 0.956 . . . . 0.0 110.148 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.5 mp -77.89 -61.02 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.83 -54.78 7.53 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.992 0.917 . . . . 0.0 113.222 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.94 86.04 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.252 -0.905 . . . . 0.0 112.513 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 55.6 m -68.5 -33.17 73.67 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.153 0.581 . . . . 0.0 109.482 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 10.0 tpt -69.27 -45.37 69.83 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -59.12 -35.47 73.52 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 122.709 0.404 . . . . 0.0 110.093 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -62.56 -27.63 69.31 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 121.713 -0.617 . . . . 0.0 111.186 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -84.2 -34.65 23.9 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.864 0.757 . . . . 0.0 108.977 178.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -63.25 -47.46 82.32 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.463 1.105 . . . . 0.0 110.164 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -3.04 49.42 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.044 0.937 . . . . 0.0 113.005 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -89.42 174.28 41.46 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 124.723 1.154 . . . . 0.0 112.673 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.65 153.36 33.45 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.296 2.239 . . . . 0.0 110.583 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 98.9 mt -104.41 138.24 29.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 38.8 ttp -62.16 123.86 79.86 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.0 -178.04 3.89 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.055 2.503 . . . . 0.0 112.906 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -129.19 24.42 5.57 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.249 1.82 . . . . 0.0 110.429 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 20.5 pt -86.04 153.08 56.93 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 124.857 1.263 . . . . 0.0 113.101 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -72.95 -21.63 20.71 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.446 2.097 . . . . 0.0 111.935 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.55 -21.99 41.9 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.36 1.864 . . . . 0.0 111.258 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 67.7 mtp -57.09 -35.1 69.0 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 118.873 -0.584 . . . . 0.0 109.814 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 10.2 t -60.04 -49.52 77.33 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.902 1.228 . . . . 0.0 109.295 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -59.27 -44.92 92.4 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 122.544 0.338 . . . . 0.0 110.633 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -58.64 -53.58 56.8 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.514 1.126 . . . . 0.0 110.031 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -62.66 -41.69 99.2 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.142 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -65.79 -38.32 88.7 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.253 0.479 . . . . 0.0 110.849 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.78 -57.06 5.56 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.637 1.175 . . . . 0.0 113.054 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 44.3 t -58.24 -39.59 74.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 122.922 0.489 . . . . 0.0 110.261 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.21 -53.43 28.09 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.768 0.827 . . . . 0.0 109.037 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 27.4 m -62.4 -39.66 93.98 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.441 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.75 99.68 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 120.008 1.276 . . . . 0.0 112.173 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.1 -48.69 84.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 24.4 mm -58.39 -40.48 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 118.481 0.582 . . . . 0.0 109.494 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -61.25 -44.61 96.97 Favored 'General case' 0 CA--C 1.522 -0.121 0 O-C-N 121.206 -0.933 . . . . 0.0 110.839 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.31 -43.93 69.31 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 118.25 0.477 . . . . 0.0 110.431 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.69 89.49 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.936 0.895 . . . . 0.0 111.977 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 46.6 m -83.88 -14.54 50.88 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.199 1.0 . . . . 0.0 109.587 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 74.36 17.05 79.68 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -66.9 -31.3 71.8 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 124.848 1.259 . . . . 0.0 110.363 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -147.73 159.67 43.55 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.8 m -66.64 150.14 49.48 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 3.3 t -57.27 -52.72 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . 0.457 ' OD2' ' HE3' ' A' ' 189' ' ' LYS . 0.8 OUTLIER -47.35 -49.98 23.11 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 129.411 3.084 . . . . 0.0 111.881 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -76.59 -35.62 58.02 Favored 'General case' 0 CA--C 1.522 -0.104 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.16 77.6 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 121.202 -0.936 . . . . 0.0 109.66 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.1 mp -66.59 -49.44 66.35 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.552 1.941 . . . . 0.0 108.635 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -55.39 -49.73 71.55 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.464 1.105 . . . . 0.0 108.726 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -56.92 -53.1 61.77 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.977 1.311 . . . . 0.0 109.746 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.95 -47.81 83.76 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.544 1.138 . . . . 0.0 113.56 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -60.06 -37.61 80.37 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.0 m -64.19 -37.49 87.64 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 64.1 mtt85 -62.6 -17.17 59.65 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.447 -1.408 . . . . 0.0 112.374 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.3 mt -98.07 -20.58 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.369 1.068 . . . . 0.0 110.733 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 80.7 p -105.77 -12.19 15.98 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 120.807 -1.183 . . . . 0.0 112.412 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 46.3 pttt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 117.368 -1.301 . . . . 0.0 111.06 -178.77 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.7 tptp . . . . . 0 N--CA 1.479 0.995 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.8 mt -141.37 149.17 20.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 178.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -69.34 111.79 5.47 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.48 168.2 9.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.72 1.608 . . . . 0.0 110.128 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.66 33.8 73.97 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 124.913 1.244 . . . . 0.0 115.072 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -145.36 172.86 12.57 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 118.372 1.086 . . . . 0.0 110.34 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 73.6 mt -150.56 144.77 25.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.944 2.098 . . . . 0.0 107.297 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.8 140.0 41.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.6 mt -125.12 133.0 70.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 C-N-CA 127.149 2.179 . . . . 0.0 106.558 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 39.1 m0 -122.72 136.76 54.97 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.7 mm -121.91 165.69 17.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 123.424 0.689 . . . . 0.0 110.279 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -77.98 -15.35 59.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 117.441 2.385 . . . . 0.0 117.441 -178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.29 -13.79 58.4 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-N 120.506 1.503 . . . . 0.0 116.347 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -116.92 -13.81 10.66 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.748 1.219 . . . . 0.0 111.222 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -83.81 167.87 16.68 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.845 -0.534 . . . . 0.0 110.383 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.3 72.64 2.3 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.359 1.457 . . . . 0.0 109.712 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -73.89 -28.87 61.77 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 121.55 -0.971 . . . . 0.0 111.664 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -65.12 -45.03 86.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.417 1.008 . . . . 0.0 109.2 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.51 -38.43 94.88 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.8 tp -70.23 -32.56 70.49 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 121.638 -0.919 . . . . 0.0 110.442 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.14 80.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 117.773 -1.108 . . . . 0.0 109.41 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -59.89 -33.7 72.18 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.007 0.821 . . . . 0.0 111.456 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.4 t -68.48 -50.99 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.83 -41.9 99.68 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.232 -0.918 . . . . 0.0 114.228 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.26 -29.69 69.37 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 121.42 -1.047 . . . . 0.0 110.341 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -71.03 -53.53 14.42 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -54.82 -46.55 74.58 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 117.699 0.227 . . . . 0.0 110.661 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -62.46 -28.72 70.01 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.92 0.888 . . . . 0.0 111.017 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 11.0 tppt? -74.0 -26.61 60.54 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 118.107 -0.949 . . . . 0.0 111.446 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.25 -35.25 10.41 Favored 'General case' 0 C--N 1.33 -0.267 0 O-C-N 124.113 0.883 . . . . 0.0 112.176 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.5 p -101.77 -27.8 12.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 119.494 1.043 . . . . 0.0 113.424 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.6 -15.65 53.68 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.181 -0.949 . . . . 0.0 111.718 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.8 mm -65.74 120.6 13.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tptm -55.9 140.34 43.05 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.815 0.846 . . . . 0.0 112.203 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.7 t -132.1 102.43 5.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.9 m -91.63 139.79 30.35 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.5 t -128.71 117.73 45.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -123.38 158.14 31.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.743 0.817 . . . . 0.0 109.337 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -124.77 67.12 50.23 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.546 1.139 . . . . 0.0 108.813 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -73.7 175.29 10.93 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.094 1.862 . . . . 0.0 108.821 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.41 -18.28 6.78 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.373 0.669 . . . . 0.0 111.063 179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.34 1.33 49.31 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.731 2.012 . . . . 0.0 112.897 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.92 -23.32 2.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.126 1.37 . . . . 0.0 114.196 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -55.14 -36.1 65.41 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.439 1.096 . . . . 0.0 111.275 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -118.53 -26.33 6.22 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 125.578 1.551 . . . . 0.0 110.092 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -67.98 -42.88 80.14 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 117.245 -1.36 . . . . 0.0 109.288 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -55.54 -58.5 15.17 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-N 120.524 1.511 . . . . 0.0 109.776 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -60.41 -25.99 81.71 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 121.027 1.403 . . . . 0.0 113.67 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -75.03 -54.85 6.45 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 119.631 1.105 . . . . 0.0 112.165 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.57 -40.53 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.099 0.56 . . . . 0.0 110.634 -177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.75 -29.45 70.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.095 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 -17.17 17.83 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.497 1.044 . . . . 0.0 113.053 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.8 t -123.26 17.5 9.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.586 0.754 . . . . 0.0 112.108 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.05 7.44 66.8 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.16 -10.68 32.41 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.193 1.496 . . . . 0.0 111.776 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.32 -177.85 34.72 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.616 1.579 . . . . 0.0 116.212 -177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.11 176.9 3.44 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.427 2.751 . . . . 0.0 111.084 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -108.6 -21.15 12.83 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.4 mt -136.6 148.55 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.8 tt -133.12 135.62 56.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 125.27 1.428 . . . . 0.0 108.494 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -130.15 101.06 5.64 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.651 1.58 . . . . 0.0 109.306 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -151.66 178.42 9.36 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.312 0.96 . . . . 0.0 109.99 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.02 154.48 39.36 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -57.77 -27.49 63.12 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.512 0.725 . . . . 0.0 109.844 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.28 -58.79 5.56 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.517 1.127 . . . . 0.0 111.556 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -69.99 -14.48 62.72 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.619 -1.301 . . . . 0.0 111.276 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -85.18 11.96 8.87 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.369 -0.832 . . . . 0.0 109.512 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.41 0.43 77.79 Favored Glycine 0 CA--C 1.533 1.158 0 CA-C-O 118.114 -1.381 . . . . 0.0 112.983 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -139.9 -27.65 0.23 Allowed Glycine 0 CA--C 1.535 1.338 0 CA-C-N 120.351 2.075 . . . . 0.0 116.576 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -56.44 -44.08 80.1 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.945 1.872 . . . . 0.0 113.401 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.71 -41.18 99.02 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.3 -0.875 . . . . 0.0 110.076 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.34 -29.89 59.21 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.961 1.304 . . . . 0.0 110.474 178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.6 m -86.62 1.05 53.21 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.702 1.201 . . . . 0.0 112.388 178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.94 16.77 80.48 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.886 1.708 . . . . 0.0 110.931 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.3 mt -83.49 -11.98 56.81 Favored 'General case' 0 CA--C 1.527 0.072 0 O-C-N 121.017 -1.284 . . . . 0.0 114.018 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.7 mt -114.15 142.54 46.1 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 119.7 1.136 . . . . 0.0 111.039 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.02 -161.57 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.508 1.923 . . . . 0.0 113.316 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.3 86.43 2.56 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.851 1.661 . . . . 0.0 110.152 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -65.26 174.22 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.973 1.309 . . . . 0.0 111.933 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.9 m 61.77 82.2 0.22 Allowed Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 126.119 1.768 . . . . 0.0 110.681 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.81 -28.93 7.47 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.416 2.077 . . . . 0.0 111.377 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -139.81 165.82 26.28 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 126.488 1.915 . . . . 0.0 109.277 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? -63.29 -34.94 78.78 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.638 1.175 . . . . 0.0 110.985 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.46 -43.06 44.74 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.399 1.08 . . . . 0.0 112.371 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -60.0 -33.62 72.24 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.617 -0.677 . . . . 0.0 111.483 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -69.53 -44.29 71.29 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 121.479 -0.763 . . . . 0.0 109.576 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -62.2 -26.38 68.32 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.418 1.087 . . . . 0.0 112.536 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -71.35 -11.52 60.95 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 124.042 0.937 . . . . 0.0 111.062 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.1 mt -126.51 164.91 20.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 119.202 0.91 . . . . 0.0 110.539 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -75.26 149.92 84.86 Favored Pre-proline 0 CA--C 1.544 0.742 0 O-C-N 121.514 -0.741 . . . . 0.0 110.817 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.73 -46.75 1.12 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.514 2.809 . . . . 0.0 114.789 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -61.26 -33.93 74.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 119.968 1.258 . . . . 0.0 111.824 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.71 -21.81 64.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.517 0.727 . . . . 0.0 110.716 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -70.84 -37.13 73.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 118.623 -0.703 . . . . 0.0 110.317 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.44 -28.11 64.98 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.476 1.035 . . . . 0.0 113.141 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.72 -23.35 67.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.444 0.698 . . . . 0.0 111.787 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.1 m -120.57 6.86 6.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 125.227 1.411 . . . . 0.0 112.284 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.5 mtp180 -72.66 170.25 14.89 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 121.806 0.813 . . . . 0.0 108.965 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -153.26 -174.52 4.97 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.487 1.115 . . . . 0.0 108.048 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -73.54 107.94 6.1 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.95 -77.68 0.53 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.719 1.628 . . . . 0.0 112.835 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 174.92 2.67 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.408 1.083 . . . . 0.0 111.928 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.75 156.22 27.57 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.99 1.316 . . . . 0.0 109.932 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.3 pt -126.04 -17.96 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.66 178.04 4.28 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.589 1.541 . . . . 0.0 109.291 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.62 148.39 69.83 Favored Pre-proline 0 C--O 1.24 0.58 0 C-N-CA 124.27 1.028 . . . . 0.0 110.522 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.42 148.7 38.52 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 124.226 3.284 . . . . 0.0 109.265 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.3 mm -130.07 -53.01 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 124.982 1.313 . . . . 0.0 110.898 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -130.8 156.01 45.72 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.2 t -136.11 101.86 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.3 1.04 . . . . 0.0 110.551 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -144.2 113.88 7.16 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.117 -0.989 . . . . 0.0 109.064 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.411 ' H ' ' CG2' ' A' ' 320' ' ' THR . . . -133.01 89.32 2.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.911 1.284 . . . . 0.0 112.192 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 245' ' ' THR . 0.0 OUTLIER -166.2 162.05 17.27 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.952 2.101 . . . . 0.0 111.027 178.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.8 m -179.57 127.03 0.09 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.999 2.52 . . . . 0.0 111.202 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.6 tp -120.09 155.23 33.39 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.394 1.877 . . . . 0.0 108.516 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 88.7 mt -128.11 90.64 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -107.49 171.3 7.46 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.146 0.978 . . . . 0.0 109.359 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -54.97 166.32 0.53 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -99.78 1.04 42.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.416 1.487 . . . . 0.0 111.619 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -74.01 173.61 9.77 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 128.142 2.577 . . . . 0.0 110.175 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -93.39 19.22 8.55 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 35.0 tp -112.36 70.24 1.05 Allowed Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.956 1.303 . . . . 0.0 112.449 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.64 94.59 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.81 3.007 . . . . 0.0 110.984 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -128.52 72.97 80.71 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -73.44 159.16 47.02 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.088 3.192 . . . . 0.0 113.875 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.37 152.6 44.33 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.886 3.057 . . . . 0.0 110.384 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -104.64 -17.23 14.75 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 4.6 t -166.34 160.34 15.66 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.393 1.451 . . . . 0.0 108.481 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 26.5 m95 -70.1 -27.86 64.93 Favored 'General case' 0 C--O 1.226 -0.163 0 O-C-N 121.325 -0.859 . . . . 0.0 112.156 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -70.04 -16.11 63.11 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.138 0.881 . . . . 0.0 111.226 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -88.2 -23.98 23.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.579 1.152 . . . . 0.0 110.544 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 40.2 mm -54.34 -58.84 12.06 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.58 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.77 -21.33 38.63 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 CA-C-N 120.429 1.189 . . . . 0.0 111.581 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.98 -36.92 64.58 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.975 1.31 . . . . 0.0 111.25 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 68.4 tp -88.23 -30.04 20.0 Favored 'General case' 0 C--N 1.334 -0.1 0 C-N-CA 125.338 1.455 . . . . 0.0 110.712 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.45 -45.0 85.2 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -66.65 -33.14 74.99 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 123.572 0.749 . . . . 0.0 112.22 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -72.35 -44.45 62.59 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 36.7 mt -72.93 -33.27 65.84 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.672 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.89 -34.75 77.26 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.62 -13.02 60.6 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.9 0.12 7.3 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 124.815 1.246 . . . . 0.0 111.903 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.53 -90.08 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 119.231 0.923 . . . . 0.0 114.961 -178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 176.22 8.88 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.146 0.978 . . . . 0.0 112.231 -177.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.95 160.68 7.51 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.852 1.261 . . . . 0.0 112.811 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.89 -71.01 0.66 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.0 0.92 . . . . 0.0 109.043 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.3 tp -106.15 135.54 47.44 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.81 1.244 . . . . 0.0 109.45 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 29.6 ttm -147.46 104.85 3.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -126.97 163.07 24.5 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -77.89 144.92 36.53 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 32.6 mt -120.56 -9.82 9.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.724 0.81 . . . . 0.0 111.87 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -69.32 -16.58 63.58 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -113.56 124.04 32.0 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 125.652 1.581 . . . . 0.0 110.81 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -66.09 -14.06 42.68 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.347 2.031 . . . . 0.0 114.911 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.451 ' CE2' ' HA3' ' A' ' 228' ' ' GLY . 82.0 t80 -60.83 -27.93 68.42 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.826 1.194 . . . . 0.0 112.258 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -88.99 -36.71 15.69 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.184 0.994 . . . . 0.0 113.194 -178.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -86.52 -21.68 26.8 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -51.65 -54.29 41.21 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -64.91 -19.32 64.0 Favored 'Trans proline' 0 C--N 1.348 0.513 0 CA-C-N 121.163 1.451 . . . . 0.0 113.883 -178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.4 tp -79.58 -57.35 3.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.528 HG21 HD22 ' A' ' 192' ' ' LEU . 46.2 pt -63.04 -29.39 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 119.213 0.915 . . . . 0.0 112.131 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.66 -20.01 66.05 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.281 0.633 . . . . 0.0 111.914 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -43.16 -60.65 1.58 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 126.246 1.818 . . . . 0.0 113.065 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -56.69 -46.37 81.22 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 122.984 0.514 . . . . 0.0 111.977 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -175.52 -23.7 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.681 0 CA-C-O 116.99 -2.005 . . . . 0.0 114.497 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -37.09 123.46 0.95 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.387 1.946 . . . . 0.0 114.089 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -139.59 140.8 37.13 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -72.98 -59.11 2.86 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -135.8 149.67 49.19 Favored 'General case' 0 C--O 1.243 0.76 0 C-N-CA 125.294 1.438 . . . . 0.0 108.691 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.459 ' HE3' ' OD2' ' A' ' 180' ' ' ASP . 10.9 tppt? -76.75 145.14 38.77 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.886 0.85 . . . . 0.0 109.931 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -142.21 104.83 4.51 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -74.79 -171.08 1.2 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -51.25 -20.39 1.6 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.08 22.36 0.05 OUTLIER Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.92 1.724 . . . . 0.0 111.277 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -125.5 106.27 9.66 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 118.61 1.205 . . . . 0.0 107.822 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -97.14 137.08 36.73 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.86 147.64 28.96 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.176 1.39 . . . . 0.0 108.808 179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.79 -0.31 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 114.851 -1.068 . . . . 0.0 110.944 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.06 -42.57 69.26 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.459 ' OD2' ' HE3' ' A' ' 170' ' ' LYS . 56.2 t0 -90.2 107.69 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 125.658 1.583 . . . . 0.0 109.622 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 72.3 t -118.37 157.73 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 127.25 2.22 . . . . 0.0 107.55 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -143.39 29.7 2.02 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 118.536 0.607 . . . . 0.0 114.508 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 47.0 t -77.04 -42.93 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 C-N-CA 125.049 1.34 . . . . 0.0 111.217 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -96.12 61.45 2.09 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -117.23 154.35 31.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.231 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -48.93 -38.31 22.46 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.4 -35.56 82.27 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 118.774 0.715 . . . . 0.0 112.703 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.6 -49.0 65.21 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 118.997 -0.525 . . . . 0.0 110.032 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.79 -42.52 99.1 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-O 118.856 -0.592 . . . . 0.0 109.446 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.99 -45.25 95.56 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.12 0.968 . . . . 0.0 109.81 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.13 -26.41 71.49 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.859 -0.967 . . . . 0.0 112.383 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.528 HD22 HG21 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -85.43 -44.46 12.73 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 118.262 1.031 . . . . 0.0 111.77 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.4 t -55.01 -28.5 52.52 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.023 0.829 . . . . 0.0 111.86 -179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -60.21 -50.91 71.78 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 13.6 tp -59.82 -51.92 67.65 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.721 1.208 . . . . 0.0 109.832 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 56.2 t -55.55 -30.41 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 117.429 -1.272 . . . . 0.0 109.949 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.618 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 12.7 t0 -66.58 -44.52 82.03 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 120.431 1.469 . . . . 0.0 111.857 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.6 mt -66.66 -40.04 88.46 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 83.9 mt -66.01 -36.44 77.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.618 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -60.95 -46.82 89.18 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.116 1.367 . . . . 0.0 108.247 178.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -79.22 -2.32 40.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.157 0.983 . . . . 0.0 110.703 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 12.9 mmtt 55.38 1.56 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 130.126 3.37 . . . . 0.0 116.636 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -66.36 -26.94 67.51 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 11.1 ttt -81.64 141.39 33.71 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -79.57 77.91 6.14 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -69.0 -5.0 18.98 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.04 1.736 . . . . 0.0 114.176 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -94.67 -20.96 19.1 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 128.0 2.52 . . . . 0.0 111.457 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.2 m -58.14 137.2 57.17 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 124.061 0.945 . . . . 0.0 110.58 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -130.78 -178.82 4.97 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 127.481 2.312 . . . . 0.0 106.195 178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -54.87 -44.79 74.36 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.11 -46.74 88.6 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 123.694 0.798 . . . . 0.0 110.4 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 90.6 mt -67.37 -48.99 75.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.926 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.39 76.96 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.956 0.798 . . . . 0.0 110.485 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -70.03 -46.44 65.04 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -55.34 -55.19 34.42 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.008 0.923 . . . . 0.0 110.178 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.79 -49.93 61.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.818 2.047 . . . . 0.0 109.86 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -61.69 -38.15 86.76 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.853 -0.529 . . . . 0.0 110.524 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -63.87 -11.03 24.02 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.75 0.82 . . . . 0.0 112.167 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.1 mmtt -111.6 -8.13 14.24 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.188 1.795 . . . . 0.0 112.128 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.01 27.79 25.1 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 124.457 1.027 . . . . 0.0 111.79 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -87.48 -0.35 56.69 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.289 1.045 . . . . 0.0 112.424 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 36.8 p -138.84 160.49 39.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.914 0.886 . . . . 0.0 109.274 -178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -117.24 -19.62 9.55 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.395 1.078 . . . . 0.0 109.544 177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.3 ptt? -159.2 164.91 34.68 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.952 0.901 . . . . 0.0 111.693 -178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.6 t -165.78 174.03 10.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.826 2.45 . . . . 0.0 106.975 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 41.6 mt -147.76 121.27 1.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -108.97 154.68 21.82 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.003 1.721 . . . . 0.0 106.855 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 155' ' ' TYR . . . -62.4 174.64 7.71 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 123.935 0.779 . . . . 0.0 113.456 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -67.77 166.97 22.53 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 123.216 2.611 . . . . 0.0 112.727 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -74.82 62.01 1.06 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.728 1.611 . . . . 0.0 110.13 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.36 -171.81 2.92 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.59 1.156 . . . . 0.0 110.953 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -61.08 120.9 11.17 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.841 1.256 . . . . 0.0 108.686 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.7 t -148.3 172.6 14.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.696 1.198 . . . . 0.0 109.878 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -89.62 -2.81 58.42 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.85 1.66 . . . . 0.0 112.069 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 7.4 tp -145.82 153.71 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.199 1.4 . . . . 0.0 107.936 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.92 156.08 39.22 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.957 1.303 . . . . 0.0 109.992 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.7 135.32 38.8 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.504 1.522 . . . . 0.0 108.972 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 28.2 t -74.69 158.67 33.19 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.844 1.257 . . . . 0.0 110.883 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 7.7 ptpt -124.79 7.6 8.13 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.095 1.758 . . . . 0.0 110.712 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . 0.256 10.4 t -64.2 -11.07 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 O-C-N 121.252 -0.905 . . . . 0.0 111.94 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -126.67 147.67 49.91 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 120.487 1.494 . . . . 0.0 110.245 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -148.98 112.6 5.06 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 102.63 -3.1 . . . . 0.0 102.63 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 163.72 70.32 0.02 OUTLIER Glycine 0 CA--C 1.521 0.442 0 CA-C-N 119.316 0.962 . . . . 0.0 111.941 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.404 HG23 HD21 ' A' ' 113' ' ' LEU . 11.0 p -35.02 117.18 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 128.179 2.591 . . . . 0.0 112.786 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.453 ' O ' HD23 ' A' ' 113' ' ' LEU . 13.6 t -162.24 176.94 10.08 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.859 -0.526 . . . . 0.0 110.149 179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.679 HG12 ' H ' ' A' ' 247' ' ' LEU . 4.5 t -81.84 -169.29 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.48 1.912 . . . . 0.0 107.018 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.679 ' H ' HG12 ' A' ' 246' ' ' VAL . 0.3 OUTLIER -142.05 163.32 40.83 Favored Pre-proline 0 CA--C 1.537 0.449 0 O-C-N 119.597 -1.94 . . . . 0.0 107.191 178.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -70.2 149.73 64.53 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 60.6 p -124.28 167.49 14.26 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -73.54 153.5 40.24 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -64.82 135.0 55.28 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 75.68 -11.23 10.66 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 117.62 -1.655 . . . . 0.0 115.425 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.2 124.32 5.32 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 120.693 2.246 . . . . 0.0 113.591 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.48 146.22 34.69 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.146 2.564 . . . . 0.0 110.86 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 14.1 m -66.81 157.94 31.7 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -133.6 100.28 13.73 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.62 -175.76 2.74 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 122.73 2.287 . . . . 0.0 110.638 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -82.57 176.24 9.54 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.096 1.758 . . . . 0.0 108.878 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 24.0 t -90.8 149.03 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.16 -0.962 . . . . 0.0 108.713 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -162.7 110.84 0.45 Allowed Glycine 0 CA--C 1.521 0.466 0 N-CA-C 104.341 -3.504 . . . . 0.0 104.341 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 26.4 m -133.11 137.05 54.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 119.761 1.781 . . . . 0.0 111.213 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.49 138.32 57.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 24.8 m -124.37 148.41 47.55 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.864 0.866 . . . . 0.0 110.269 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.11 139.39 52.53 Favored 'General case' 0 C--N 1.334 -0.076 0 C-N-CA 123.461 0.704 . . . . 0.0 109.449 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -137.16 164.16 25.31 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.59 1.09 . . . . 0.0 110.786 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 61.9 mt -113.31 136.18 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -67.48 117.61 9.67 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -68.95 -22.23 64.14 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 118.475 -0.774 . . . . 0.0 112.642 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -74.62 -13.27 60.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 72.5 m -59.99 155.28 44.41 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 118.819 0.736 . . . . 0.0 109.597 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.92 -60.61 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.514 1.476 . . . . 0.0 110.117 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -108.9 88.43 2.72 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 7.9 mtpt -54.7 -23.72 18.84 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.4 1.08 . . . . 0.0 111.169 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -64.82 -31.28 72.44 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.848 1.259 . . . . 0.0 112.235 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.76 -40.28 83.44 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 121.048 -1.033 . . . . 0.0 109.402 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.88 -42.94 63.12 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 118.53 -0.747 . . . . 0.0 111.407 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.46 -34.92 79.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.718 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -70.84 -56.12 7.01 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -48.78 -49.09 40.3 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 119.18 0.9 . . . . 0.0 110.854 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.7 tt -62.31 -45.83 91.45 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.006 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -79.21 -18.54 52.74 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.744 -1.223 . . . . 0.0 114.148 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -90.34 -33.88 15.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 117.612 -1.185 . . . . 0.0 112.344 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -137.52 -23.24 1.1 Allowed 'General case' 0 C--N 1.347 0.457 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -76.01 -50.89 13.58 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 120.184 1.356 . . . . 0.0 109.09 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 91.6 mt -83.47 67.27 9.28 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 125.63 1.572 . . . . 0.0 109.47 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 69.8 p -144.12 166.22 25.62 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -67.42 -41.36 84.96 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -73.42 -29.75 62.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.323 1.049 . . . . 0.0 111.092 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.79 -51.19 11.63 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 124.987 1.279 . . . . 0.0 110.036 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 27.8 mt -59.85 -45.28 92.92 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -57.64 -45.85 84.91 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.359 1.064 . . . . 0.0 109.793 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.56 -44.4 89.7 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 119.6 1.091 . . . . 0.0 112.292 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 16.6 t -72.59 -34.35 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.657 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -68.2 -38.02 81.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.233 1.413 . . . . 0.0 110.319 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -60.47 -43.9 96.44 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.44 1.496 . . . . 0.0 110.252 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.26 -43.88 69.62 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 122.482 0.313 . . . . 0.0 111.484 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -151.69 152.27 30.02 Favored Pre-proline 0 N--CA 1.465 0.321 0 C-N-CA 124.808 1.243 . . . . 0.0 108.389 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -60.11 137.13 73.53 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.771 2.981 . . . . 0.0 113.92 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 23.2 mt -124.0 -7.39 7.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.574 1.549 . . . . 0.0 112.958 178.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 65.26 -131.56 35.67 Favored Glycine 0 N--CA 1.464 0.559 0 C-N-CA 126.068 1.794 . . . . 0.0 112.186 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.62 177.41 8.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 17.9 m -135.44 153.67 33.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 O-C-N 120.626 -1.296 . . . . 0.0 110.434 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.27 -26.93 56.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.494 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.85 106.7 1.96 Allowed 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -54.94 -31.87 60.82 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 57.8 m -68.59 -52.8 27.67 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 119.612 1.096 . . . . 0.0 111.064 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -72.14 -17.64 61.94 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.152 0.433 . . . . 0.0 110.664 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -61.7 -39.35 91.17 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -62.71 -39.83 95.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.708 0.685 . . . . 0.0 111.413 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -66.19 -49.99 65.42 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.683 1.193 . . . . 0.0 109.837 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 64.9 mt -69.54 -34.45 74.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.679 -0.677 . . . . 0.0 110.135 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.13 -2.85 4.59 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.513 1.525 . . . . 0.0 112.469 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -58.13 -14.46 6.91 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.647 1.112 . . . . 0.0 110.387 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.95 145.5 52.2 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 124.914 1.286 . . . . 0.0 109.194 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.57 -17.56 43.22 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.692 2.261 . . . . 0.0 113.138 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 79.3 mmt-85 -59.87 -48.52 81.34 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.446 HD12 ' H ' ' A' ' 317' ' ' ILE . 4.6 mp -68.33 -57.73 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.449 1.1 . . . . 0.0 108.255 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.6 -43.38 62.48 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.31 -35.73 81.14 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 120.402 1.456 . . . . 0.0 112.407 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.411 ' CG2' ' H ' ' A' ' 112' ' ' ALA . 3.7 m -65.43 -37.25 86.37 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 7.2 tpt -61.55 -49.5 76.44 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -61.0 -27.95 68.69 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 124.71 1.204 . . . . 0.0 113.464 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -76.75 -42.77 39.74 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -67.16 -32.07 72.91 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -62.1 -49.38 76.16 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.601 0.637 . . . . 0.0 110.189 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -5.72 59.1 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.591 1.156 . . . . 0.0 113.92 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -82.17 178.91 53.41 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-O 122.991 1.329 . . . . 0.0 113.6 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -110.45 128.11 55.44 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 128.903 2.881 . . . . 0.0 107.793 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 11.4 mt -92.4 94.77 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 N-CA-C 104.173 -2.528 . . . . 0.0 104.173 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 12.3 ptp 38.58 83.96 0.19 Allowed Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 127.776 2.431 . . . . 0.0 111.88 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -66.44 85.71 0.27 Allowed 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.679 2.919 . . . . 0.0 111.391 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -78.4 65.35 3.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.553 1.941 . . . . 0.0 108.905 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.8 pt -130.35 144.18 52.22 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 120.558 -1.339 . . . . 0.0 112.247 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.86 -15.29 37.31 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.341 2.694 . . . . 0.0 114.634 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -80.22 -18.28 49.96 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.462 -0.774 . . . . 0.0 110.864 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 59.6 mmm -70.22 -34.43 72.89 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.123 -0.986 . . . . 0.0 111.565 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 15.3 p -66.1 -42.31 89.42 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 120.338 -1.476 . . . . 0.0 108.522 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -62.61 -46.35 88.66 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -51.7 -51.46 55.86 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.841 1.656 . . . . 0.0 110.254 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -59.06 -36.2 74.65 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.024 -1.047 . . . . 0.0 113.18 -179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -76.26 -42.17 46.55 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 121.172 0.51 . . . . 0.0 109.835 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -58.95 -50.8 72.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.442 1.497 . . . . 0.0 110.903 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 44.7 t -68.53 -46.25 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 117.223 -1.37 . . . . 0.0 111.483 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 20.3 ptp180 -55.76 -42.55 75.61 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 121.391 1.905 . . . . 0.0 108.832 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 20.0 m -65.0 -44.88 87.8 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.02 0.528 . . . . 0.0 109.751 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -56.91 -37.26 71.2 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.311 -0.868 . . . . 0.0 112.193 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 71.2 t -69.27 -58.79 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 26.2 mm -53.45 -46.62 59.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.86 0.864 . . . . 0.0 111.47 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -51.84 -49.68 62.38 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 121.924 -0.485 . . . . 0.0 110.842 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -77.95 -37.66 47.07 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.66 -30.25 71.24 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.189 0.904 . . . . 0.0 110.69 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.3 m -94.74 -9.22 35.34 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.442 1.097 . . . . 0.0 110.593 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.51 14.79 82.11 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 118.843 0.747 . . . . 0.0 112.695 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -64.16 -40.06 95.34 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -147.75 154.64 40.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.1 m -61.77 155.14 23.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.826 1.25 . . . . 0.0 111.449 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.97 -53.02 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.201 1.0 . . . . 0.0 109.063 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.83 -50.12 61.49 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.844 2.057 . . . . 0.0 111.549 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -70.52 -42.51 71.15 Favored 'General case' 0 C--O 1.226 -0.135 0 C-N-CA 124.951 1.301 . . . . 0.0 112.166 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -58.5 -38.18 77.12 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 121.566 -0.709 . . . . 0.0 110.426 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 4.2 mp -72.69 -43.96 62.4 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 124.047 0.939 . . . . 0.0 109.243 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -54.45 -48.67 71.47 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.21 -34.3 74.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.304 1.042 . . . . 0.0 111.105 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.94 -48.36 66.14 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 118.084 -0.96 . . . . 0.0 112.825 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -52.16 -39.88 60.63 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.572 0.749 . . . . 0.0 109.746 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.4 m -62.46 -24.82 67.65 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.461 0.704 . . . . 0.0 112.184 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 40.1 mtt-85 -81.5 -15.48 54.81 Favored 'General case' 0 C--O 1.226 -0.145 0 O-C-N 120.603 -1.311 . . . . 0.0 111.409 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 21.5 mt -98.16 -31.45 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 125.782 1.633 . . . . 0.0 110.398 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 3.2 p -81.55 -17.99 46.5 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.879 -0.513 . . . . 0.0 111.145 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt . . . . . 0 C--O 1.251 1.178 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 177.446 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.1 mm -62.26 138.83 21.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 O-C-N 125.175 1.547 . . . . 0.0 108.762 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -95.28 137.28 34.55 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 105.559 -2.015 . . . . 0.0 105.559 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.38 162.18 14.91 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.1 41.88 99.71 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 119.231 0.923 . . . . 0.0 115.037 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -149.18 169.22 21.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.33 1.052 . . . . 0.0 109.844 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 80.0 mt -146.19 135.85 23.21 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.616 1.567 . . . . 0.0 108.208 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.0 t -127.21 136.84 59.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 13.0 mt -135.71 142.11 40.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 124.888 1.275 . . . . 0.0 109.393 -178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 26.9 m0 -120.54 154.41 35.37 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.0 mm -116.52 147.29 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 126.913 2.085 . . . . 0.0 106.104 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.654 ' HB3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -152.4 118.07 5.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.502 1.121 . . . . 0.0 109.916 179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 113.46 20.3 6.26 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 118.576 -1.125 . . . . 0.0 112.86 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 53.75 30.55 11.38 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.296 1.838 . . . . 0.0 111.155 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -58.35 172.11 0.51 Allowed 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 127.672 2.389 . . . . 0.0 114.194 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -71.85 50.85 1.2 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 126.676 2.084 . . . . 0.0 113.474 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -56.14 -30.4 62.11 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.475 1.11 . . . . 0.0 111.467 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -58.19 -30.6 66.56 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.233 1.013 . . . . 0.0 111.42 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.56 -33.96 17.78 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.6 tp -71.75 -31.18 66.39 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.257 1.423 . . . . 0.0 112.711 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.8 86.01 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.33 1.052 . . . . 0.0 109.889 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -58.89 -37.82 77.47 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.368 1.867 . . . . 0.0 110.287 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.469 HG13 ' HB3' ' A' ' 283' ' ' TYR . 95.0 t -70.09 -48.34 62.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.528 1.131 . . . . 0.0 109.2 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.2 -43.54 99.26 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 121.755 -0.591 . . . . 0.0 111.722 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -33.27 71.24 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 121.687 -0.89 . . . . 0.0 111.05 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -63.88 -53.02 57.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -56.7 -43.02 80.12 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.046 0.839 . . . . 0.0 110.774 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.39 -13.42 58.61 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.698 1.199 . . . . 0.0 110.821 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.34 -14.94 17.4 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 119.619 -1.926 . . . . 0.0 111.86 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -105.79 -10.93 16.46 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 124.062 0.851 . . . . 0.0 109.95 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.0 p -130.45 -35.16 1.54 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.488 1.115 . . . . 0.0 112.346 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.64 -13.31 67.45 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 121.384 -0.823 . . . . 0.0 111.229 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.4 mm -64.3 130.92 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -62.74 145.55 54.54 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.646 1.179 . . . . 0.0 110.719 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.8 t -140.27 126.7 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.5 m -114.97 141.77 47.52 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.074 1.35 . . . . 0.0 108.257 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.25 121.31 45.81 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 126.022 1.729 . . . . 0.0 106.682 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -140.35 157.77 45.04 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.702 0.683 . . . . 0.0 109.651 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -126.38 71.03 71.06 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.407 1.083 . . . . 0.0 111.748 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.68 165.75 30.85 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.463 2.775 . . . . 0.0 111.526 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -114.56 5.24 15.42 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.774 1.63 . . . . 0.0 110.214 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.52 2.58 7.64 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.457 1.103 . . . . 0.0 113.481 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.654 HD21 ' HB3' ' A' ' 12' ' ' ASN . 2.1 pt? -52.62 -24.93 9.32 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 119.419 1.009 . . . . 0.0 113.677 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -60.48 -24.32 65.17 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.444 1.098 . . . . 0.0 112.284 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -120.53 -22.16 6.52 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.002 1.321 . . . . 0.0 110.175 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -47.59 26.05 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 117.575 -1.202 . . . . 0.0 109.407 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -48.25 -58.21 8.62 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 120.328 1.422 . . . . 0.0 111.157 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.03 -18.2 63.97 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 121.857 1.705 . . . . 0.0 114.187 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -92.87 -1.11 57.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.909 1.284 . . . . 0.0 112.927 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.3 t -128.13 -37.74 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.539 0 CA-C-N 120.287 1.403 . . . . 0.0 110.268 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.48 -34.83 77.62 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 118.864 -0.588 . . . . 0.0 111.996 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.05 73.34 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.413 0.551 . . . . 0.0 110.764 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.7 m -77.11 -43.73 33.09 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 121.847 -0.533 . . . . 0.0 110.809 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.92 19.2 4.89 Favored Glycine 0 CA--C 1.535 1.329 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -114.82 3.53 14.66 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.261 1.031 . . . . 0.0 111.705 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.32 -170.07 26.84 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.805 1.669 . . . . 0.0 113.82 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.15 178.15 7.31 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.822 2.348 . . . . 0.0 111.916 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -99.99 -24.36 14.65 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 120.593 -1.317 . . . . 0.0 111.526 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.2 mt -140.08 156.37 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 124.832 1.253 . . . . 0.0 107.904 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.0 tt -142.9 147.27 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.398 1.479 . . . . 0.0 107.863 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -140.05 107.26 5.49 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.635 1.174 . . . . 0.0 110.187 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.402 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 41.5 t-105 -153.0 -165.88 2.3 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.838 1.199 . . . . 0.0 110.576 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.402 ' N ' ' CG ' ' A' ' 62' ' ' TRP . . . -73.44 147.81 43.83 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.061 1.344 . . . . 0.0 110.163 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -61.04 -27.38 68.29 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.239 0.542 . . . . 0.0 112.116 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -58.87 -31.43 68.56 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 115.81 1.781 . . . . 0.0 115.81 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -104.33 -6.0 21.24 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.473 0.579 . . . . 0.0 109.796 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -75.16 -35.57 61.6 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 123.434 0.694 . . . . 0.0 111.267 -178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.89 -4.64 59.26 Favored Glycine 0 CA--C 1.534 1.235 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -89.83 -60.78 1.4 Allowed Glycine 0 C--N 1.336 0.556 0 N-CA-C 107.861 -2.096 . . . . 0.0 107.861 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -51.85 -43.47 63.22 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.082 0.953 . . . . 0.0 113.208 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.558 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -63.9 -46.34 85.31 Favored 'General case' 0 C--O 1.225 -0.194 0 CA-C-N 119.211 0.914 . . . . 0.0 111.266 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.27 -48.86 70.74 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.1 m -61.06 -14.39 23.4 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.532 1.533 . . . . 0.0 112.909 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.45 24.65 33.0 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 124.578 1.085 . . . . 0.0 112.548 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.23 6.97 44.77 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.3 1.05 . . . . 0.0 113.241 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.558 HD12 ' HB2' ' A' ' 71' ' ' ALA . 98.6 mt -128.88 138.64 52.14 Favored 'General case' 0 CA--C 1.51 -0.586 0 O-C-N 120.076 -1.64 . . . . 0.0 108.345 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.5 160.16 28.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -60.03 101.31 0.12 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 127.171 2.189 . . . . 0.0 106.459 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 3.5 mm -67.0 152.7 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 122.086 0.946 . . . . 0.0 111.77 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.419 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 35.3 m 56.22 93.91 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.427 0 C-N-CA 129.889 3.276 . . . . 0.0 115.574 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 80' ' ' THR . 34.9 Cg_endo -66.74 -41.66 10.43 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 121.805 1.67 . . . . 0.0 110.909 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -131.07 142.64 50.31 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.905 0.882 . . . . 0.0 112.912 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 7.3 tppt? -44.76 -43.18 8.35 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 128.073 2.549 . . . . 0.0 116.994 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.01 -34.03 12.35 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 120.24 1.382 . . . . 0.0 114.698 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -64.55 -25.36 67.95 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.456 -0.778 . . . . 0.0 111.338 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -72.04 -44.88 62.66 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -61.85 -22.68 65.72 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.789 1.236 . . . . 0.0 112.261 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -75.4 -13.74 60.42 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.477 1.111 . . . . 0.0 112.25 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mt -124.38 154.51 40.27 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 119.159 0.891 . . . . 0.0 112.838 -177.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -69.98 146.87 95.58 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.95 -41.39 7.74 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.173 2.582 . . . . 0.0 114.124 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -59.72 -37.21 78.29 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 119.138 0.881 . . . . 0.0 111.629 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.98 -26.2 66.69 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.268 1.027 . . . . 0.0 111.56 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 35.5 m95 -73.74 -30.98 63.13 Favored 'General case' 0 C--N 1.34 0.171 0 O-C-N 121.471 -0.768 . . . . 0.0 111.387 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.0 -29.33 65.19 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.208 0.913 . . . . 0.0 111.919 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -64.64 -16.91 63.5 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.524 1.129 . . . . 0.0 112.978 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.8 m -132.23 18.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.666 1.586 . . . . 0.0 112.167 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -70.65 165.54 22.67 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 122.275 1.036 . . . . 0.0 110.509 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -152.33 -177.02 5.94 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.419 1.488 . . . . 0.0 107.155 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -69.71 102.02 1.8 Allowed 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.21 -81.53 0.47 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.447 1.499 . . . . 0.0 112.323 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.91 170.26 4.46 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 117.393 0.596 . . . . 0.0 109.595 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -105.94 162.03 13.94 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.86 0.864 . . . . 0.0 109.432 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 37.7 pt -123.67 -14.58 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 124.182 0.993 . . . . 0.0 112.599 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -170.3 175.4 4.89 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.04 1.736 . . . . 0.0 107.977 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -134.3 148.29 67.14 Favored Pre-proline 0 C--O 1.242 0.684 0 C-N-CA 124.83 1.252 . . . . 0.0 111.58 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -76.02 143.7 26.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.301 2.668 . . . . 0.0 108.267 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.3 mm -134.42 -52.08 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 C-N-CA 125.128 1.371 . . . . 0.0 109.773 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -122.42 148.86 44.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 123.507 0.723 . . . . 0.0 111.008 -178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.1 t -137.82 110.37 7.04 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.116 0 C-N-CA 123.478 0.711 . . . . 0.0 110.106 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -146.83 138.55 24.43 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -125.43 85.09 2.35 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.315 1.846 . . . . 0.0 111.759 -177.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.3 pp -171.92 167.24 6.25 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.896 1.278 . . . . 0.0 111.17 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.1 t 177.59 160.59 0.48 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 128.544 2.737 . . . . 0.0 106.289 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.7 tp -161.26 139.52 9.56 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 27.1 mt -122.41 138.69 51.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -149.33 -179.58 7.17 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.342 1.057 . . . . 0.0 111.196 -178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -60.81 167.93 2.56 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.749 2.02 . . . . 0.0 111.813 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.36 3.62 2.18 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -179.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -77.97 168.09 20.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.866 1.666 . . . . 0.0 110.482 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -75.6 -11.18 59.96 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.594 -1.316 . . . . 0.0 111.907 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.6 tp 45.22 71.61 1.48 Allowed Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 128.111 2.565 . . . . 0.0 110.326 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -73.47 -17.3 23.84 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.146 2.564 . . . . 0.0 112.442 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -124.58 68.63 52.2 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 124.624 1.17 . . . . 0.0 108.614 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.31 159.11 47.56 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.959 2.439 . . . . 0.0 111.737 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.98 162.02 44.11 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.699 2.266 . . . . 0.0 109.781 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -132.27 -25.01 2.02 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.046 1.338 . . . . 0.0 112.091 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.6 t -147.75 152.58 37.98 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 119.569 1.077 . . . . 0.0 109.337 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 46.1 m95 -67.34 -15.85 63.92 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -72.28 -24.41 61.34 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 119.846 1.203 . . . . 0.0 112.329 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -86.41 -16.26 37.78 Favored 'General case' 0 C--O 1.223 -0.309 0 CA-C-N 118.292 0.497 . . . . 0.0 110.691 -178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.8 mm -58.66 -57.12 29.04 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 124.775 1.23 . . . . 0.0 107.988 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.25 -24.76 31.64 Favored 'Trans proline' 0 N--CA 1.446 -1.318 0 CA-C-N 120.804 1.323 . . . . 0.0 111.023 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.09 -52.7 38.67 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 58.8 tp -65.18 -26.16 68.03 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.187 0.995 . . . . 0.0 109.838 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -66.37 -41.25 89.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.098 0.863 . . . . 0.0 111.25 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -75.67 -31.16 59.65 Favored 'General case' 0 C--O 1.232 0.134 0 O-C-N 121.936 -0.477 . . . . 0.0 110.376 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -70.49 -46.75 63.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 42.2 mt -74.01 -32.44 63.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 117.766 -1.111 . . . . 0.0 110.294 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -67.88 -36.32 80.05 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 120.54 1.518 . . . . 0.0 108.707 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.69 -9.78 15.85 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.41 0.684 . . . . 0.0 112.796 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.56 11.27 2.29 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.321 1.449 . . . . 0.0 111.829 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.01 -111.95 0.32 Allowed Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -142.46 -170.25 3.15 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.488 1.915 . . . . 0.0 110.558 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.3 p -52.38 148.69 6.42 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.17 1.788 . . . . 0.0 112.802 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.09 -57.0 3.95 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.64 1.176 . . . . 0.0 110.068 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.11 146.23 29.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.012 1.725 . . . . 0.0 107.604 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.7 ttm -145.88 105.76 4.0 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -138.23 163.47 31.66 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -72.18 91.81 1.31 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.273 1.429 . . . . 0.0 112.452 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.13 -16.69 61.44 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.212 1.405 . . . . 0.0 109.188 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -75.37 -9.47 58.59 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.991 0.916 . . . . 0.0 112.358 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -119.47 123.34 28.74 Favored Pre-proline 0 C--N 1.34 0.19 0 C-N-CA 124.029 0.932 . . . . 0.0 108.728 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.01 -10.55 27.47 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.714 2.276 . . . . 0.0 115.749 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -61.07 -37.64 83.39 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -90.13 -23.5 21.34 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.335 0.516 . . . . 0.0 112.179 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 58.7 p -83.59 -25.87 30.51 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.146 0.43 . . . . 0.0 110.363 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 25.0 t-105 -55.44 -55.87 35.27 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 118.204 -0.903 . . . . 0.0 112.608 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -62.66 -21.01 72.51 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 121.62 1.547 . . . . 0.0 112.071 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 9.2 tp -70.93 -59.48 2.77 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 177.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 25.3 pt -64.74 -30.8 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 117.573 -1.203 . . . . 0.0 113.793 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.68 -4.34 11.82 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 120.822 1.646 . . . . 0.0 113.883 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.35 -50.24 65.45 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.468 1.107 . . . . 0.0 113.801 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.97 -44.57 97.16 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 120.803 -1.186 . . . . 0.0 111.644 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 175.35 13.28 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.807 -0.996 . . . . 0.0 115.248 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.52 151.46 48.72 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 118.78 1.29 . . . . 0.0 111.624 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -164.25 151.34 11.69 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.31 -55.46 3.66 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -141.93 167.83 21.21 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.468 0.707 . . . . 0.0 112.038 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -101.12 155.23 18.12 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.936 0.874 . . . . 0.0 108.691 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -155.56 118.87 4.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.613 1.565 . . . . 0.0 107.574 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -92.58 67.72 4.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 33.6 47.6 0.16 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.391 2.276 . . . . 0.0 115.232 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 146.51 -18.91 1.67 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 126.157 1.837 . . . . 0.0 112.057 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -117.97 106.19 12.68 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -84.13 128.91 34.86 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -132.0 88.69 2.58 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-O 123.705 1.716 . . . . 0.0 109.512 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.74 -5.2 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.306 1.443 . . . . 0.0 114.06 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -70.01 -40.39 75.29 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 120.11 1.323 . . . . 0.0 108.25 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -76.76 108.05 9.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.2 t -129.08 140.32 49.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -129.63 16.92 5.57 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-O 118.283 -1.287 . . . . 0.0 115.676 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.537 HG21 HD13 ' A' ' 368' ' ' ILE . 0.0 OUTLIER -62.13 -13.99 11.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 120.164 1.982 . . . . 0.0 115.341 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 365' ' ' GLN . 4.4 p-10 -119.12 10.15 12.0 Favored 'General case' 0 C--O 1.234 0.244 0 O-C-N 120.841 -1.162 . . . . 0.0 111.083 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 -65.38 155.75 34.4 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -49.08 -35.66 16.55 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.562 0.745 . . . . 0.0 112.198 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -62.27 -40.13 98.61 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 119.878 1.217 . . . . 0.0 114.055 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.91 -52.1 52.85 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 118.622 1.211 . . . . 0.0 109.189 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -63.0 -39.9 96.14 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 119.095 -0.479 . . . . 0.0 110.598 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.78 65.61 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.72 0.808 . . . . 0.0 111.92 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -94.14 -34.76 6.3 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 31.5 tp -70.72 -40.13 72.97 Favored 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.481 0.712 . . . . 0.0 111.269 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 9.4 t -50.55 -45.76 57.12 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 116.672 -1.633 . . . . 0.0 109.848 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -55.64 -56.75 16.71 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 120.547 1.521 . . . . 0.0 111.054 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 64.6 tp -56.04 -49.36 73.94 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.583 0.753 . . . . 0.0 110.934 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 76.1 t -65.07 -27.89 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.135 0.974 . . . . 0.0 110.895 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.12 -40.16 96.79 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.998 1.319 . . . . 0.0 110.135 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 9.7 mt -66.23 -45.52 80.38 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.28 -40.6 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.458 1.103 . . . . 0.0 108.891 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -56.62 -37.48 70.77 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.779 -1.2 . . . . 0.0 109.588 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -88.27 -4.17 58.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.767 1.627 . . . . 0.0 112.268 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.8 mptt 56.65 14.51 1.77 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.5 2.32 . . . . 0.0 113.758 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -83.42 -5.31 59.11 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.381 -0.825 . . . . 0.0 111.251 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.7 tpt -109.07 154.59 22.04 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.726 0.81 . . . . 0.0 111.382 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -76.18 71.09 2.89 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.632 1.573 . . . . 0.0 108.767 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -73.3 -10.66 59.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.324 1.05 . . . . 0.0 112.003 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -85.85 -15.84 40.58 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 129.517 3.127 . . . . 0.0 115.086 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 12.4 m -67.16 127.76 33.82 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.03 1.332 . . . . 0.0 113.244 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -122.24 -178.37 3.86 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 176.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -62.47 -31.63 72.4 Favored 'General case' 0 C--N 1.332 -0.186 0 O-C-N 121.258 -0.901 . . . . 0.0 113.002 -178.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.8 t -64.98 -48.8 72.7 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 124.223 1.009 . . . . 0.0 109.842 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 13.8 mm -61.39 -47.9 91.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.783 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.68 -52.74 59.34 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.428 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -59.96 -44.31 94.5 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.62 1.1 . . . . 0.0 110.164 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.81 -54.2 45.42 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.601 0.36 . . . . 0.0 110.35 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.47 -36.9 79.36 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.655 0.661 . . . . 0.0 111.556 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -63.85 -44.72 92.29 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -59.22 -42.17 90.37 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -68.45 -27.72 66.42 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 121.219 -0.925 . . . . 0.0 111.717 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.68 63.48 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.57 1.557 . . . . 0.0 111.948 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.15 -60.85 2.57 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.442 1.497 . . . . 0.0 111.503 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.2 t -69.04 151.29 46.66 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -99.67 -26.92 13.91 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 118.91 -0.567 . . . . 0.0 110.305 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -130.29 158.66 39.19 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 3.1 t -173.23 -179.72 2.01 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.09 2.156 . . . . 0.0 108.424 178.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 63.4 mt -149.11 131.32 5.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -137.63 166.89 22.84 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 77.86 75.1 0.97 Allowed Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.11 -72.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.846 3.03 . . . . 0.0 110.044 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -69.26 -17.12 63.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.197 0.599 . . . . 0.0 111.996 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 74.94 -1.34 3.11 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 128.542 2.737 . . . . 0.0 113.567 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -70.69 167.25 19.07 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 119.232 0.924 . . . . 0.0 109.654 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 70.5 m -65.48 109.26 2.26 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -146.3 162.77 37.4 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 126.387 1.875 . . . . 0.0 106.896 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 20.9 mt -133.86 -49.82 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 4.4 t70 59.06 29.63 19.24 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.995 1.318 . . . . 0.0 111.546 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 30.9 m 69.8 -6.95 0.97 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 125.814 1.646 . . . . 0.0 111.697 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 11.7 m -80.03 173.4 12.63 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.721 1.609 . . . . 0.0 110.61 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 26.0 mmtp -138.92 119.5 13.98 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.8 172.29 12.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 123.404 0.682 . . . . 0.0 109.894 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -119.23 141.84 48.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.411 1.085 . . . . 0.0 109.458 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -71.15 160.81 32.2 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 174.67 144.88 5.08 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 123.778 0.704 . . . . 0.0 112.089 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.7 m -135.35 119.31 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 126.01 1.724 . . . . 0.0 107.918 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.4 t -157.93 176.84 12.03 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.959 1.304 . . . . 0.0 107.581 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 44.0 t -66.09 125.2 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -101.77 153.41 37.96 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.65 152.77 79.99 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.324 2.016 . . . . 0.0 111.75 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 69.8 p -119.6 171.45 8.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.245 1.418 . . . . 0.0 111.033 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -84.81 158.97 20.51 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 50.6 pttt -59.11 122.94 15.04 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 120.82 -1.175 . . . . 0.0 109.762 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 71.01 7.74 63.04 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-O 117.712 -1.605 . . . . 0.0 114.215 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.38 127.02 6.08 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 121.269 2.535 . . . . 0.0 112.574 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.02 161.13 47.13 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.728 2.952 . . . . 0.0 113.693 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 89.4 p -83.24 139.3 33.19 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.829 0.852 . . . . 0.0 108.77 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -132.77 76.17 71.52 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 125.831 1.652 . . . . 0.0 107.967 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -77.01 -170.32 0.9 Allowed 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 124.324 3.349 . . . . 0.0 112.139 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -54.03 155.73 3.36 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.982 0.913 . . . . 0.0 110.869 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 33.5 t -94.38 106.24 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.107 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -98.87 147.5 18.52 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.37 127.18 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.83 158.7 35.04 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.1 m -131.05 140.66 50.11 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 120.917 -1.114 . . . . 0.0 110.551 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.4 128.2 40.89 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.967 1.707 . . . . 0.0 107.407 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.61 160.45 24.81 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 58.8 mt -95.16 130.11 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -77.51 133.34 38.58 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -82.46 -5.02 58.44 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -62.33 -31.05 71.62 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 -178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 49.7 m -78.5 157.15 77.79 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.156 1.782 . . . . 0.0 112.564 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -69.32 -59.64 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 124.028 3.152 . . . . 0.0 113.335 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 -104.68 98.84 8.53 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -13.76 61.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.758 177.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.412 ' HA ' ' HG3' ' A' ' 277' ' ' LYS . 1.1 tt0 -59.81 -41.04 90.36 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.251 1.42 . . . . 0.0 109.926 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 80.8 mt -59.75 -39.49 84.96 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.3 -44.44 62.71 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.942 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.412 ' HG3' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -67.89 -29.72 68.89 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.056 -0.973 . . . . 0.0 111.046 -179.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -79.46 -49.92 11.56 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.94 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -55.93 -45.38 78.77 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.889 1.677 . . . . 0.0 109.726 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.36 -30.03 70.89 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.102 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -99.26 -17.4 18.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 120.337 1.426 . . . . 0.0 114.55 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -84.11 -35.9 23.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.899 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.469 ' HB3' HG13 ' A' ' 23' ' ' VAL . 39.1 m-85 -139.23 -32.37 0.66 Allowed 'General case' 0 C--N 1.344 0.329 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.76 -21.2 63.46 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.6 1.545 . . . . 0.0 112.002 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.432 ' CD2' HD21 ' A' ' 304' ' ' LEU . 57.6 mt -110.35 41.6 1.72 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.825 1.65 . . . . 0.0 109.837 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.0 p -128.47 160.08 33.43 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.4 -38.59 66.39 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -68.68 -43.79 75.36 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.33 -42.22 66.05 Favored Glycine 0 C--N 1.336 0.532 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.32 -43.04 92.25 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.636 1.174 . . . . 0.0 110.213 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.33 -43.53 90.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -56.68 -43.63 80.65 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.101 0.961 . . . . 0.0 112.323 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.7 t -71.3 -39.94 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 119.46 1.027 . . . . 0.0 108.341 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -62.26 -35.43 78.94 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.026 0.531 . . . . 0.0 111.215 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -60.91 -47.95 84.06 Favored 'General case' 0 CA--C 1.519 -0.226 0 O-C-N 121.283 -0.885 . . . . 0.0 109.695 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -41.05 66.54 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -143.98 148.33 41.62 Favored Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.01 131.29 23.49 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.594 2.196 . . . . 0.0 111.809 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 24.6 mt -119.35 -17.8 8.72 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 123.723 0.809 . . . . 0.0 112.592 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 70.06 -150.75 49.33 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 119.629 1.104 . . . . 0.0 110.69 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -65.53 167.82 8.31 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.525 1.53 . . . . 0.0 112.206 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.03 165.43 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 124.05 1.881 . . . . 0.0 111.086 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -84.58 -23.11 29.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.055 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.432 HD21 ' CD2' ' A' ' 285' ' ' LEU . 4.0 mm? -74.02 107.71 6.38 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 125.177 1.391 . . . . 0.0 110.57 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -61.1 1.87 0.15 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.192 1.397 . . . . 0.0 114.676 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.7 m -95.97 -67.75 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -68.62 -22.33 64.43 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-N 118.86 0.755 . . . . 0.0 111.263 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -62.67 -32.16 73.18 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 118.955 0.798 . . . . 0.0 109.186 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.89 -34.11 77.61 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.005 1.275 . . . . 0.0 110.244 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -79.18 -42.31 26.37 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.771 1.228 . . . . 0.0 110.45 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 19.3 mt -68.15 -39.31 82.67 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.07 -7.85 10.04 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.78 1.232 . . . . 0.0 112.361 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -62.44 -30.27 71.12 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.188 -0.945 . . . . 0.0 108.677 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.6 142.06 25.34 Favored Pre-proline 0 C--O 1.235 0.327 0 C-N-CA 124.238 1.015 . . . . 0.0 108.934 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.74 -25.2 46.52 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.524 2.15 . . . . 0.0 113.138 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 90.3 mtm-85 -58.47 -49.8 76.03 Favored 'General case' 0 C--O 1.228 -0.05 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.44 HD12 ' H ' ' A' ' 317' ' ' ILE . 4.2 mp -69.01 -42.01 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.334 1.054 . . . . 0.0 109.05 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.66 -47.6 73.36 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 118.148 0.431 . . . . 0.0 110.166 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.02 -39.24 91.63 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.641 -0.662 . . . . 0.0 111.503 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.6 m -61.88 -37.47 84.67 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 60.7 tpp -73.05 -42.31 63.25 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 118.584 0.629 . . . . 0.0 109.974 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -56.78 -38.96 73.21 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -57.9 -41.82 83.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.401 0.28 . . . . 0.0 110.399 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.13 -32.17 72.27 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.861 -0.524 . . . . 0.0 111.125 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -78.56 -15.81 58.14 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.588 -0.695 . . . . 0.0 112.505 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 -10.69 9.69 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -99.08 -162.89 29.71 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 125.311 1.434 . . . . 0.0 111.22 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -141.6 122.13 14.17 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.645 0.778 . . . . 0.0 112.996 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 87.3 mt -78.89 105.48 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 1.5 mpt? 35.4 75.84 0.47 Allowed Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 125.231 1.412 . . . . 0.0 113.665 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.12 138.88 37.69 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 124.012 3.141 . . . . 0.0 111.559 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -129.58 73.96 1.56 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 10.1 pt -129.67 153.73 80.82 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.501 1.121 . . . . 0.0 111.225 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.41 -32.73 49.43 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.33 2.687 . . . . 0.0 113.453 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -63.26 -24.24 67.78 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.106 -0.996 . . . . 0.0 111.084 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 26.3 mmm -68.64 -26.36 65.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.239 0.927 . . . . 0.0 111.102 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.5 m -62.53 -48.82 77.86 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.72 -31.03 67.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 117.828 -1.082 . . . . 0.0 111.409 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.609 ' O ' HG23 ' A' ' 343' ' ' VAL . 30.8 t80 -55.92 -58.87 6.05 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 119.305 0.957 . . . . 0.0 109.909 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -60.55 -37.77 82.32 Favored 'General case' 0 C--O 1.236 0.354 0 O-C-N 121.943 -0.473 . . . . 0.0 111.742 -178.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -62.56 -44.33 96.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.403 0.681 . . . . 0.0 109.226 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.63 -50.99 67.16 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.056 1.342 . . . . 0.0 110.698 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 339' ' ' PHE . 2.1 t -59.19 -43.76 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 118.069 0.395 . . . . 0.0 110.236 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -53.65 -38.55 64.23 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.684 0.794 . . . . 0.0 110.833 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 5.7 m -82.4 -50.44 8.89 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 119.522 1.055 . . . . 0.0 110.067 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -51.75 -44.84 63.46 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.37 -49.12 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 118.051 -0.975 . . . . 0.0 109.918 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 27.6 mm -65.31 -35.4 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 119.836 1.198 . . . . 0.0 109.67 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 -64.73 -45.97 84.25 Favored 'General case' 0 N--CA 1.456 -0.157 0 O-C-N 121.143 -0.973 . . . . 0.0 109.93 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.46 65.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.701 0.8 . . . . 0.0 111.003 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.91 -36.81 84.6 Favored 'General case' 0 N--CA 1.461 0.077 0 C-N-CA 125.328 1.451 . . . . 0.0 113.497 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 42.4 m -92.22 -2.7 56.34 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.443 0.697 . . . . 0.0 110.707 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 76.32 13.01 83.76 Favored Glycine 0 C--N 1.34 0.757 0 N-CA-C 115.532 0.973 . . . . 0.0 115.532 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -66.36 -30.78 71.24 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-N 119.06 1.43 . . . . 0.0 109.945 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -145.12 156.09 43.69 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.4 m -66.99 156.23 36.53 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 96.5 t -56.69 -51.66 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.14 -50.93 65.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.362 1.465 . . . . 0.0 111.621 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.41 -39.14 74.63 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.26 -40.15 89.31 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 121.463 -0.773 . . . . 0.0 109.605 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.7 mp -72.13 -43.42 64.7 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.396 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 26.6 tptt -53.14 -55.07 26.97 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.122 1.369 . . . . 0.0 110.228 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -53.9 -49.16 69.21 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 127.99 2.516 . . . . 0.0 112.281 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.48 -50.11 74.88 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 125.668 1.587 . . . . 0.0 111.408 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 184' ' ' ASP . 1.3 tm0? -56.44 -33.09 65.53 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.485 1.039 . . . . 0.0 110.625 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 14.0 m -62.14 -37.01 83.55 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.806 0.73 . . . . 0.0 109.873 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -65.84 -20.39 66.22 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.154 -0.966 . . . . 0.0 112.244 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.537 HD13 HG21 ' A' ' 183' ' ' VAL . 5.7 mt -88.7 -29.21 5.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.274 1.03 . . . . 0.0 109.732 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.0 p -92.55 -7.74 46.37 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.672 -0.643 . . . . 0.0 110.709 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 25.5 tptt . . . . . 0 C--O 1.255 1.345 0 C-N-CA 125.312 1.445 . . . . 0.0 110.97 -178.55 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 27.6 tptp . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.9 mt -127.15 151.46 34.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -68.88 89.93 0.42 Allowed 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 129.74 3.216 . . . . 0.0 110.637 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -92.02 99.36 12.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 145.76 19.86 0.14 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-O 119.239 -0.756 . . . . 0.0 114.958 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -141.11 172.2 13.01 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 118.55 1.175 . . . . 0.0 110.933 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.1 mt -153.53 147.03 24.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 128.521 2.728 . . . . 0.0 106.314 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.8 t -142.02 136.12 29.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.6 mt -124.02 137.79 55.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 126.348 1.859 . . . . 0.0 108.82 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -128.42 149.91 50.35 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.2 pt -136.25 168.08 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -158.91 150.95 21.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 128.121 2.569 . . . . 0.0 108.933 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.74 16.3 49.17 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-O 117.432 -1.76 . . . . 0.0 115.577 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 70.12 37.64 1.64 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.728 2.011 . . . . 0.0 110.675 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -57.61 157.05 7.48 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.299 1.047 . . . . 0.0 111.345 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.96 56.89 4.58 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.788 -0.642 . . . . 0.0 114.071 -178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -50.54 -39.45 49.17 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -66.51 -12.37 57.2 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.86 -45.53 1.49 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.6 tp -61.45 -37.87 85.15 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.466 0.706 . . . . 0.0 111.9 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.69 -41.76 64.16 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.705 0.802 . . . . 0.0 111.92 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -62.82 -33.15 74.62 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.3 t -65.18 -47.13 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.33 -35.77 92.5 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -62.88 -45.72 91.21 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 118.215 -0.898 . . . . 0.0 109.083 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -58.89 -54.94 41.48 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -52.36 -48.87 65.3 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.996 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -66.08 -32.51 74.01 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.858 1.208 . . . . 0.0 110.721 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 8.3 tppt? -68.93 -28.05 66.31 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 118.171 -0.919 . . . . 0.0 112.604 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.62 -0.43 20.23 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 124.255 0.972 . . . . 0.0 112.903 -177.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 46.2 p -130.6 -38.79 1.3 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.61 1.096 . . . . 0.0 112.259 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.72 -10.91 66.57 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.832 -0.982 . . . . 0.0 113.74 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 40.0 mm -70.31 132.28 33.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 147.39 53.53 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.897 -0.502 . . . . 0.0 111.373 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.8 t -137.84 125.94 31.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 177.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.8 m -118.46 142.49 47.52 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.5 t -132.14 120.97 45.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -136.29 164.95 26.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.089 1.356 . . . . 0.0 110.245 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -122.4 58.22 10.14 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.126 1.37 . . . . 0.0 112.063 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.93 136.49 16.66 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.212 1.941 . . . . 0.0 110.611 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.12 -18.4 25.92 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.236 -0.915 . . . . 0.0 110.403 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.445 ' H ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -83.66 -2.11 55.45 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 128.12 2.568 . . . . 0.0 112.761 -179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -49.47 -31.6 10.28 Favored 'General case' 0 N--CA 1.461 0.085 0 C-N-CA 124.586 1.154 . . . . 0.0 113.459 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -52.6 -33.44 46.33 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.62 1.168 . . . . 0.0 113.561 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -119.14 -21.6 7.54 Favored 'General case' 0 N--CA 1.461 0.105 0 C-N-CA 123.375 0.67 . . . . 0.0 110.967 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -72.55 -42.78 64.31 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 117.717 -1.135 . . . . 0.0 109.122 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -51.26 -60.51 5.58 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-O 117.558 -1.211 . . . . 0.0 109.96 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.52 -24.57 75.37 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.146 1.23 . . . . 0.0 113.142 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -69.4 -55.26 10.86 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 119.087 0.858 . . . . 0.0 111.337 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.412 HG12 ' C ' ' A' ' 55' ' ' ASP . 2.5 t -77.06 -37.47 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.843 0.857 . . . . 0.0 111.696 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.07 90.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 118.782 -0.627 . . . . 0.0 109.31 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.0 -15.4 43.85 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 118.925 -0.56 . . . . 0.0 111.979 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.8 m -102.85 -9.23 20.09 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.036 1.734 . . . . 0.0 111.825 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.88 10.06 73.05 Favored Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.897 -1.127 . . . . 0.0 112.393 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.412 ' C ' HG12 ' A' ' 50' ' ' VAL . 1.4 m-20 -112.21 2.09 16.48 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.109 1.364 . . . . 0.0 112.582 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.45 176.9 34.23 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.958 -1.089 . . . . 0.0 114.848 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.23 -178.41 0.83 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.97 3.113 . . . . 0.0 110.818 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.56 -22.16 12.11 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 120.982 -1.074 . . . . 0.0 112.272 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.0 mt -139.23 148.14 23.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.8 tp -129.35 144.45 38.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.974 1.71 . . . . 0.0 107.573 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -132.82 102.29 5.59 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.757 1.223 . . . . 0.0 108.808 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.6 t-105 -153.13 171.39 18.52 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.053 0.842 . . . . 0.0 111.782 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.19 161.11 31.34 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.745 -1.222 . . . . 0.0 110.984 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -54.54 -32.14 57.72 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.794 1.638 . . . . 0.0 114.736 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -55.12 -58.15 8.84 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.622 1.169 . . . . 0.0 111.175 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -73.52 -9.39 58.63 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 121.156 -0.965 . . . . 0.0 111.592 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -93.75 12.1 26.83 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.218 1.807 . . . . 0.0 110.035 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 -9.9 56.61 Favored Glycine 0 CA--C 1.534 1.272 0 CA-C-O 118.815 -0.991 . . . . 0.0 112.006 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.56 -31.26 1.39 Allowed Glycine 0 CA--C 1.533 1.158 0 CA-C-N 119.708 1.754 . . . . 0.0 116.211 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -53.02 -53.98 42.01 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.247 2.024 . . . . 0.0 111.863 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.21 89.75 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.427 -0.796 . . . . 0.0 109.412 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.86 -40.86 76.91 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.804 0.842 . . . . 0.0 109.292 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 m -73.98 -38.01 64.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.694 0.797 . . . . 0.0 108.877 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.07 8.73 6.46 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.97 1.272 . . . . 0.0 114.549 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.8 mt -76.94 -8.01 56.6 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 mt -108.34 139.83 42.48 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.808 1.64 . . . . 0.0 111.857 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.32 175.12 8.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.625 0.77 . . . . 0.0 112.096 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -71.04 135.62 47.87 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.922 0.889 . . . . 0.0 109.326 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 pp -125.74 161.35 30.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 123.474 0.709 . . . . 0.0 110.805 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.9 m 50.87 82.58 0.24 Allowed Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 127.122 2.169 . . . . 0.0 113.971 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.6 -21.68 25.32 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.349 2.7 . . . . 0.0 113.68 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -134.79 159.63 40.73 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.067 1.303 . . . . 0.0 113.106 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -70.78 -35.81 72.76 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.139 1.376 . . . . 0.0 113.021 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.73 -35.17 60.92 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.776 1.171 . . . . 0.0 112.213 -178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -65.58 -32.94 74.8 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 122.12 -0.363 . . . . 0.0 111.079 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -66.2 -43.19 87.5 Favored 'General case' 0 C--N 1.341 0.207 0 O-C-N 121.607 -0.683 . . . . 0.0 109.54 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -60.0 -27.49 66.91 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.77 1.628 . . . . 0.0 112.938 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -72.17 -2.93 20.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.987 0.915 . . . . 0.0 111.627 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.8 mt -132.81 156.36 47.26 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.185 1.394 . . . . 0.0 110.561 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -68.38 156.47 90.26 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -67.26 -50.89 0.86 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.187 3.258 . . . . 0.0 114.613 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -52.45 -36.51 54.77 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.374 0.988 . . . . 0.0 112.067 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -31.13 72.21 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.958 0.903 . . . . 0.0 111.28 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 33.9 m95 -75.75 -42.51 50.27 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 118.813 0.733 . . . . 0.0 110.599 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.491 ' HA ' ' HG3' ' A' ' 98' ' ' ARG . 4.0 m-20 -55.19 -36.08 65.53 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.086 0.403 . . . . 0.0 110.02 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.47 -2.51 4.72 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.5 m -133.06 15.96 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 120.146 1.339 . . . . 0.0 110.17 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.491 ' HG3' ' HA ' ' A' ' 95' ' ' ASP . 10.4 mmt180 -71.26 161.65 30.74 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 123.932 0.893 . . . . 0.0 110.832 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -152.05 179.29 8.61 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.309 -1.314 . . . . 0.0 108.616 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -63.43 97.77 0.14 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.692 1.197 . . . . 0.0 109.537 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.55 -80.96 1.0 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 125.443 1.496 . . . . 0.0 111.029 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 170.19 13.47 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.962 -0.728 . . . . 0.0 111.06 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 mt -96.8 163.97 12.76 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.769 1.227 . . . . 0.0 109.385 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.6 pt -129.04 -34.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 116.752 -1.594 . . . . 0.0 114.03 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -143.83 -179.29 6.38 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.994 1.725 . . . . 0.0 109.165 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.43 ' CE1' ' HB3' ' A' ' 264' ' ' ALA . 6.3 p90 -132.51 148.13 68.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 124.251 1.02 . . . . 0.0 111.303 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.66 151.88 32.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.676 2.918 . . . . 0.0 109.388 178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 22.2 mm -133.05 -55.21 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.695 1.198 . . . . 0.0 110.745 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -129.81 161.04 31.66 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.44 108.32 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -155.02 146.2 22.8 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.15 85.93 1.09 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.093 1.757 . . . . 0.0 107.066 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -170.85 160.22 6.67 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.881 1.673 . . . . 0.0 111.228 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.6 p -179.6 158.41 0.82 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.089 1.756 . . . . 0.0 110.285 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.7 tp -153.78 149.23 27.22 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.0 mp -124.13 164.86 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -152.93 -177.61 6.39 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 120.834 -1.166 . . . . 0.0 110.425 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -64.55 164.36 11.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.148 1.379 . . . . 0.0 110.974 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . 0.25 0.0 OUTLIER -65.51 -15.54 62.78 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 120.835 -1.166 . . . . 0.0 112.455 178.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -69.87 176.96 3.34 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 130.02 3.328 . . . . 0.0 110.258 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 23.5 mt -78.58 -22.68 46.75 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.963 1.305 . . . . 0.0 110.539 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.82 162.33 0.11 Allowed Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 128.999 2.92 . . . . 0.0 113.92 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -73.12 -82.08 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.888 2.392 . . . . 0.0 109.362 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -153.3 150.35 23.5 Favored Pre-proline 0 C--O 1.236 0.35 0 C-N-CA 127.137 2.175 . . . . 0.0 107.079 179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.24 161.12 45.97 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.653 2.236 . . . . 0.0 110.862 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.0 159.51 53.69 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.876 2.384 . . . . 0.0 114.458 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 44.3 mttm -101.29 -33.12 10.17 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.944 2.898 . . . . 0.0 114.493 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.2 t -161.13 152.38 18.85 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.8 0.727 . . . . 0.0 110.47 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -64.96 -28.06 69.27 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.761 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -67.39 -17.27 64.66 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.886 0.766 . . . . 0.0 112.97 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -94.38 -18.6 21.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.962 0.905 . . . . 0.0 109.534 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.6 mm -52.5 -56.83 18.95 Favored Pre-proline 0 C--O 1.234 0.279 0 O-C-N 121.259 -0.901 . . . . 0.0 110.391 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.44 -29.77 44.83 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 CA-C-N 120.34 1.157 . . . . 0.0 111.608 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.25 -15.08 62.42 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 125.793 1.637 . . . . 0.0 112.474 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 36.6 tp -104.88 -24.57 12.85 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.798 1.639 . . . . 0.0 107.225 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -65.69 -49.21 69.39 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -65.51 -27.4 68.44 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.14 -42.77 30.74 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 87.5 mt -70.85 -33.27 70.47 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.1 tppp? -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.95 -26.31 68.13 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 123.615 0.572 . . . . 0.0 111.948 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.02 0.73 16.08 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 124.766 1.226 . . . . 0.0 112.982 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 179.59 -97.65 0.11 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 119.203 0.911 . . . . 0.0 113.134 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -140.55 -176.19 4.55 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.152 0.981 . . . . 0.0 111.165 -177.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.3 p -52.99 166.46 0.22 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.343 1.857 . . . . 0.0 115.181 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -95.45 -69.47 0.75 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.137 1.375 . . . . 0.0 109.828 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 47.7 tp -121.32 152.5 38.88 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.73 2.012 . . . . 0.0 110.687 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 88.0 mtp -149.76 131.51 15.03 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.741 2.416 . . . . 0.0 105.399 177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -148.58 164.58 33.82 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.8 1.24 . . . . 0.0 110.639 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.66 94.43 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.885 1.274 . . . . 0.0 113.828 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 38.4 mt -85.07 -19.5 31.83 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.668 -1.27 . . . . 0.0 110.342 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -77.13 -0.81 26.32 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.784 0.834 . . . . 0.0 112.85 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -125.24 122.43 25.19 Favored Pre-proline 0 C--O 1.235 0.323 0 C-N-CA 123.903 0.881 . . . . 0.0 109.735 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.1 -15.09 32.19 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 121.417 1.411 . . . . 0.0 112.395 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -48.7 -42.19 34.19 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.921 1.288 . . . . 0.0 113.3 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -93.77 -33.72 13.48 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 118.8 0.727 . . . . 0.0 112.354 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 82.6 p -72.28 -28.56 63.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.018 0.826 . . . . 0.0 111.914 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -47.46 -63.33 1.49 Allowed Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.137 1.775 . . . . 0.0 112.458 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -66.4 -11.86 33.26 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.737 1.624 . . . . 0.0 114.482 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.2 tp -78.89 -55.61 5.02 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 26.6 pt -62.48 -34.14 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.539 0.609 . . . . 0.0 111.79 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.44 -12.42 60.23 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 117.677 -1.154 . . . . 0.0 112.206 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -48.4 -54.37 14.27 Favored 'General case' 0 C--N 1.343 0.318 0 C-N-CA 125.191 1.396 . . . . 0.0 112.396 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -53.14 -49.81 65.81 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.455 0.57 . . . . 0.0 111.447 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 176.81 1.54 0.03 OUTLIER Glycine 0 CA--C 1.523 0.537 0 CA-C-O 117.341 -1.81 . . . . 0.0 115.645 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -54.83 144.5 30.89 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 119.408 1.604 . . . . 0.0 110.19 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.424 ' CE1' ' HA3' ' A' ' 182' ' ' GLY . 37.6 p90 -148.83 136.71 20.69 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 118.568 1.184 . . . . 0.0 108.924 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.54 -67.77 0.71 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 335' ' ' GLN . 62.0 m-85 -133.91 134.31 42.5 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -75.49 124.28 26.9 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -131.71 100.78 5.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -79.57 -173.72 3.91 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.421 1.488 . . . . 0.0 107.724 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -46.9 -27.59 1.3 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.822 1.649 . . . . 0.0 114.25 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.57 13.82 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 CA-C-O 118.535 -1.147 . . . . 0.0 113.848 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -122.67 132.34 54.22 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 119.684 1.742 . . . . 0.0 108.891 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.01 114.36 19.65 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -139.52 96.01 3.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 122.442 1.115 . . . . 0.0 110.428 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -56.59 -3.41 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 127.622 2.369 . . . . 0.0 114.789 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -76.87 -36.74 56.54 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -80.04 93.94 5.85 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 62.1 t -119.88 151.21 22.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 126.246 1.819 . . . . 0.0 107.623 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.424 ' HA3' ' CE1' ' A' ' 167' ' ' TYR . . . -148.69 31.99 1.22 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 124.68 1.133 . . . . 0.0 112.246 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.2 t -62.05 -24.04 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 O-C-N 121.712 -0.875 . . . . 0.0 111.48 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -112.86 18.52 18.11 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.314 1.445 . . . . 0.0 112.814 -178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -61.57 160.38 11.44 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.591 0.71 . . . . 0.0 109.161 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -58.68 -26.27 63.67 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.636 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -72.45 -33.38 61.3 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 121.132 -0.98 . . . . 0.0 112.447 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -69.85 -50.38 43.24 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.182 0.993 . . . . 0.0 109.758 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -59.79 -34.56 73.19 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 117.924 -1.036 . . . . 0.0 111.497 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.66 -54.34 48.21 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.709 0.686 . . . . 0.0 110.562 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.92 -32.06 81.5 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 120.784 -0.722 . . . . 0.0 111.848 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 28.8 tp -71.87 -44.52 63.64 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.234 1.017 . . . . 0.0 111.143 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 12.9 t -62.27 -29.1 70.17 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 117.427 -1.273 . . . . 0.0 110.233 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -57.49 -46.6 83.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 120.205 1.366 . . . . 0.0 108.922 178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.35 -51.56 67.12 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.918 0.887 . . . . 0.0 109.683 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 87.4 t -57.67 -32.71 43.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 123.526 0.73 . . . . 0.0 110.66 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.83 -32.23 73.68 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 123.974 0.91 . . . . 0.0 110.601 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.2 mt -73.16 -45.26 57.66 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 50.5 mt -60.81 -39.79 82.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.173 0.989 . . . . 0.0 108.627 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 31.7 mtpt -54.69 -35.79 63.98 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.049 0.94 . . . . 0.0 109.627 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -93.15 -1.97 55.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.736 2.015 . . . . 0.0 113.131 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 9.1 mptt 55.98 11.82 0.8 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.317 2.647 . . . . 0.0 115.503 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -79.91 -8.41 59.3 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 120.947 -1.095 . . . . 0.0 112.362 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.62 136.44 50.84 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.236 1.014 . . . . 0.0 109.766 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -76.87 79.28 3.45 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.49 77.46 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.18 -2.25 9.95 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.906 2.082 . . . . 0.0 114.554 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 43.4 m -63.04 126.95 29.04 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.611 1.164 . . . . 0.0 113.629 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.82 179.38 4.03 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 126.954 2.102 . . . . 0.0 107.097 177.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -57.05 -45.54 83.13 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.94 -40.25 97.07 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 118.986 -0.531 . . . . 0.0 111.148 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 59.6 mt -68.4 -48.86 70.87 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.54 -41.42 85.51 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.088 0.555 . . . . 0.0 111.907 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -77.26 -49.55 14.8 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 119.047 0.839 . . . . 0.0 111.718 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -56.69 -50.54 71.84 Favored 'General case' 0 C--N 1.337 0.054 0 CA-C-N 119.114 0.87 . . . . 0.0 110.737 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.34 -44.6 84.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.292 1.037 . . . . 0.0 109.761 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -60.76 -44.06 97.22 Favored 'General case' 0 CA--C 1.524 -0.053 0 C-N-CA 123.501 0.72 . . . . 0.0 109.243 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -55.78 -42.76 76.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.797 0.839 . . . . 0.0 110.05 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -74.51 -21.33 59.6 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 119.002 -0.523 . . . . 0.0 112.265 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 101.96 20.26 13.17 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 118.981 -0.899 . . . . 0.0 112.537 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -73.46 -31.71 63.94 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.513 1.656 . . . . 0.0 112.701 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.7 t -124.2 146.57 48.62 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.796 1.639 . . . . 0.0 106.743 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -106.5 -9.63 16.57 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.31 1.044 . . . . 0.0 112.241 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.67 153.7 41.89 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.2 t -164.84 157.53 16.43 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.8 mt -142.59 155.59 18.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -156.47 151.11 25.78 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.623 0.725 . . . . 0.0 109.819 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -159.9 -67.39 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 128.567 2.984 . . . . 0.0 107.709 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -70.6 179.68 3.97 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.24 2.627 . . . . 0.0 112.935 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -113.83 130.18 56.5 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 103.661 -2.718 . . . . 0.0 103.661 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.15 -177.9 6.81 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 122.482 1.134 . . . . 0.0 112.969 -178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -120.28 10.55 11.32 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.994 2.117 . . . . 0.0 111.22 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 15.9 m -114.45 112.27 22.74 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.266 1.827 . . . . 0.0 108.483 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -65.59 121.72 15.58 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 8.2 tp -149.71 143.63 17.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.427 1.091 . . . . 0.0 109.076 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.89 114.62 26.26 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 10.2 t -85.98 169.65 13.03 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.761 1.624 . . . . 0.0 108.883 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 61.1 p -148.61 19.88 1.04 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 123.252 0.621 . . . . 0.0 112.122 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 15.9 tptp -139.21 162.74 34.23 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 124.557 1.143 . . . . 0.0 108.031 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 14.1 m -143.24 139.05 26.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.189 1.796 . . . . 0.0 107.448 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -122.52 147.5 46.29 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -151.08 -174.77 4.91 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 124.664 1.186 . . . . 0.0 108.373 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 67.47 -175.76 25.06 Favored Glycine 0 CA--C 1.53 1.0 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.6 m -114.44 144.7 21.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 O-C-N 121.96 -0.73 . . . . 0.0 109.174 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 95.2 m -149.27 134.34 18.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.53 153.28 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.266 1.426 . . . . 0.0 109.462 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.4 pp -121.4 160.42 45.97 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.095 0.958 . . . . 0.0 111.085 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.73 153.81 68.59 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 121.395 1.396 . . . . 0.0 109.062 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.5 p -125.64 163.97 21.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -83.41 139.55 32.91 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 135.39 52.16 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 120.745 -1.222 . . . . 0.0 109.573 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 71.59 -1.61 27.93 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.182 -1.343 . . . . 0.0 113.974 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.99 105.14 2.64 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 121.283 2.542 . . . . 0.0 111.67 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.15 144.29 56.79 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 121.754 1.636 . . . . 0.0 110.809 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.39 146.86 46.85 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.504 1.522 . . . . 0.0 108.019 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -140.26 92.01 9.65 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 118.762 -0.637 . . . . 0.0 112.169 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -81.97 -165.07 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 125.244 3.963 . . . . 0.0 112.082 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -69.05 174.45 4.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.741 1.216 . . . . 0.0 109.386 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 12.9 t -97.86 150.68 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 O-C-N 121.465 -0.772 . . . . 0.0 108.973 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -165.8 58.34 0.24 Allowed Glycine 0 C--N 1.334 0.465 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.4 m -61.7 149.48 8.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 C-N-CA 123.217 0.607 . . . . 0.0 110.34 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.9 tt -82.69 127.63 33.59 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.4 m -111.05 159.59 17.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.851 1.261 . . . . 0.0 107.871 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.43 ' HB3' ' CE1' ' A' ' 106' ' ' TYR . . . -139.07 151.49 46.78 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.427 0.691 . . . . 0.0 109.849 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -147.77 164.38 28.83 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 124.739 1.274 . . . . 0.0 113.128 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 45.7 mt -103.67 133.83 46.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.309 1.444 . . . . 0.0 108.366 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -69.91 118.82 13.24 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -69.04 -13.27 62.35 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.172 -0.918 . . . . 0.0 112.619 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -73.28 -26.49 61.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.45 1.023 . . . . 0.0 112.729 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 48.8 m -62.55 161.52 26.53 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.007 0.523 . . . . 0.0 110.782 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.3 -44.79 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.541 1.494 . . . . 0.0 114.892 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -133.92 100.62 4.8 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 119.61 1.096 . . . . 0.0 109.861 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -58.01 -20.73 40.77 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.247 1.019 . . . . 0.0 113.092 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -60.76 -32.09 71.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.426 0.69 . . . . 0.0 111.214 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.31 -27.89 67.69 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.42 -0.8 . . . . 0.0 110.802 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -85.22 -40.21 16.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 118.588 -0.72 . . . . 0.0 111.403 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.46 83.51 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 118.888 0.767 . . . . 0.0 110.189 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -71.29 -43.89 66.26 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -59.03 -49.66 77.03 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 121.122 -0.986 . . . . 0.0 109.28 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.3 mp -59.42 -50.6 73.32 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 118.19 -0.909 . . . . 0.0 112.712 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -76.17 -21.32 56.66 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -93.7 -23.83 18.08 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 117.06 -1.448 . . . . 0.0 112.075 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -137.17 -28.18 0.94 Allowed 'General case' 0 C--N 1.346 0.424 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 284' ' ' LEU . 1.2 tm? -83.5 -16.16 46.66 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.86 1.664 . . . . 0.0 112.442 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.552 HD22 HD21 ' A' ' 304' ' ' LEU . 67.6 mt -121.98 68.02 0.92 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.35 1.06 . . . . 0.0 109.702 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 65.6 p -139.44 154.84 47.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 125.959 1.704 . . . . 0.0 107.137 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.1 1.67 7.06 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 126.387 1.875 . . . . 0.0 112.246 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -113.21 -48.82 2.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 127.672 2.389 . . . . 0.0 111.058 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.52 -35.71 62.83 Favored Glycine 0 C--N 1.338 0.679 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.3 mt -62.17 -42.88 99.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -60.39 -46.47 89.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 123.933 0.77 . . . . 0.0 109.545 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.84 -32.35 60.47 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 118.035 -0.984 . . . . 0.0 113.39 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 7.1 t -84.29 -24.57 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-N 120.406 1.457 . . . . 0.0 109.967 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -72.06 -23.85 61.43 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.285 0.948 . . . . 0.0 110.064 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -57.76 -49.9 75.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -64.67 -50.49 66.83 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 157.19 69.42 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 118.553 0.615 . . . . 0.0 112.296 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.89 101.18 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.776 2.317 . . . . 0.0 108.323 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 71.0 mt -81.27 -12.28 59.13 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.069 1.507 . . . . 0.0 115.069 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 67.47 -154.04 52.93 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 120.168 1.349 . . . . 0.0 110.313 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.89 170.24 10.05 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.423 1.089 . . . . 0.0 112.639 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 18.7 m -133.64 155.84 40.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 125.45 1.5 . . . . 0.0 109.003 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.08 -24.37 59.48 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.659 -0.651 . . . . 0.0 109.378 178.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.552 HD21 HD22 ' A' ' 285' ' ' LEU . 4.4 mm? -66.48 102.61 0.91 Allowed 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 127.57 2.348 . . . . 0.0 110.893 -179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -58.76 -24.13 61.19 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.2 p -64.69 -53.36 48.54 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 120.437 -1.414 . . . . 0.0 111.16 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -86.62 -19.68 28.97 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -62.12 -36.85 83.01 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -64.22 -10.44 23.42 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.127 0.876 . . . . 0.0 111.672 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -97.02 -45.31 6.63 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.424 1.49 . . . . 0.0 109.049 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 27.5 mt -67.51 -41.83 83.79 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.566 1.146 . . . . 0.0 109.043 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.55 0.87 0.42 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.633 1.973 . . . . 0.0 114.256 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -67.09 -18.44 65.32 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 120.244 1.384 . . . . 0.0 110.631 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -117.57 141.03 28.23 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.52 1.128 . . . . 0.0 109.486 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -60.97 -16.67 46.81 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.583 2.856 . . . . 0.0 116.462 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.44 -23.95 64.67 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 121.201 1.819 . . . . 0.0 109.581 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.2 mp -86.46 -65.43 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.01 -52.03 15.79 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.21 -22.17 66.84 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.699 -1.251 . . . . 0.0 114.088 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 41.0 m -85.11 -31.0 23.57 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.739 1.215 . . . . 0.0 108.069 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.8 tpt -71.26 -38.56 71.87 Favored 'General case' 0 C--N 1.342 0.254 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.41 -29.93 68.1 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.539 1.136 . . . . 0.0 110.004 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -65.93 -42.56 89.93 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.278 0.631 . . . . 0.0 110.941 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -68.4 -33.43 74.23 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.148 0.431 . . . . 0.0 110.085 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -63.41 -48.98 75.57 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.381 0.673 . . . . 0.0 110.791 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.53 -25.71 26.64 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.67 175.08 17.47 Favored Glycine 0 N--CA 1.437 -1.247 0 C-N-CA 124.913 1.245 . . . . 0.0 113.121 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -118.72 119.57 34.82 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 126.196 1.798 . . . . 0.0 109.171 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 42.3 mt -83.94 94.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 31.5 ttp 48.09 82.11 0.24 Allowed Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 126.552 1.941 . . . . 0.0 111.684 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.48 78.14 0.93 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.102 2.535 . . . . 0.0 111.456 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.71 61.34 4.34 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.035 1.334 . . . . 0.0 108.526 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 44.8 pt -126.3 147.24 59.13 Favored Pre-proline 0 CA--C 1.535 0.387 0 O-C-N 121.093 -1.004 . . . . 0.0 111.288 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -63.36 -19.16 67.6 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.263 2.642 . . . . 0.0 114.354 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 169' ' ' PHE . 4.2 mp0 -66.95 -22.84 65.92 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.66 -0.65 . . . . 0.0 110.298 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 97.6 mmm -64.85 -27.6 68.98 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.757 0.708 . . . . 0.0 110.387 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 7.4 t -56.73 -52.22 65.83 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.561 1.144 . . . . 0.0 108.103 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.19 68.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.316 -0.849 . . . . 0.0 110.781 179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -48.31 -57.7 5.63 Favored 'General case' 0 CA--C 1.524 -0.055 0 C-N-CA 123.788 0.835 . . . . 0.0 112.574 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -62.19 -50.04 73.4 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -61.34 -39.84 92.05 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.18 -57.65 6.33 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.428 1.091 . . . . 0.0 109.922 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 91.6 t -58.65 -42.97 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.816 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -53.66 -53.51 50.99 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 120.038 1.29 . . . . 0.0 108.419 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 18.8 m -60.22 -42.56 95.45 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.829 0.452 . . . . 0.0 110.833 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.11 94.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.244 0.929 . . . . 0.0 111.638 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 77.3 t -60.75 -49.81 83.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 123.7 0.8 . . . . 0.0 109.112 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.1 mm -65.84 -38.4 82.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 118.9 0.773 . . . . 0.0 109.034 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -57.77 -49.25 77.21 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.178 -0.951 . . . . 0.0 109.979 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.24 -50.58 60.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.814 0.845 . . . . 0.0 111.936 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.18 70.71 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.165 1.386 . . . . 0.0 114.235 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 49.4 m -97.71 3.12 50.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.641 0.777 . . . . 0.0 110.284 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.51 11.26 68.17 Favored Glycine 0 C--N 1.341 0.856 0 O-C-N 121.168 -0.958 . . . . 0.0 114.577 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 31.8 ttm-85 -68.13 -27.95 66.9 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 118.128 0.964 . . . . 0.0 110.014 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -149.55 156.13 41.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.8 m -71.11 155.84 40.3 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 80.0 t -52.57 -54.14 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.575 1.15 . . . . 0.0 109.346 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.71 -47.64 73.49 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.741 1.616 . . . . 0.0 112.127 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -71.6 -34.83 70.22 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.38 98.96 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 9.9 mt -72.11 -41.68 66.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.288 -0.565 . . . . 0.0 110.766 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -53.52 -46.18 70.01 Favored 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.724 0.81 . . . . 0.0 110.634 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -59.55 -48.06 83.13 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.567 1.547 . . . . 0.0 111.793 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.65 80.2 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 126.823 2.049 . . . . 0.0 111.959 -178.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -53.68 -36.26 61.97 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.518 0.599 . . . . 0.0 110.898 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -65.83 -44.79 84.53 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.046 0.385 . . . . 0.0 111.322 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 32.5 mtt180 -61.02 -25.36 66.85 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 121.365 -0.835 . . . . 0.0 112.591 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 48.8 mt -90.46 -21.65 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 125.627 1.571 . . . . 0.0 113.683 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . 0.331 1.6 t -116.66 5.84 13.27 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 119.339 0.972 . . . . 0.0 111.731 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.5 tmtm? . . . . . 0 C--O 1.247 0.939 0 C-N-CA 126.667 1.987 . . . . 0.0 110.312 178.593 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.4 tppm? . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.6 mt -71.67 154.26 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 O-C-N 124.762 1.289 . . . . 0.0 108.302 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -68.39 121.6 16.65 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 125.781 1.632 . . . . 0.0 107.779 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.78 -173.36 2.7 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.896 0.878 . . . . 0.0 109.463 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.1 27.22 68.56 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 121.429 -0.794 . . . . 0.0 114.184 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -144.68 168.08 21.02 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.596 1.198 . . . . 0.0 112.44 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.2 mt -151.65 149.12 28.77 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 129.516 3.127 . . . . 0.0 107.221 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -145.13 146.16 20.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 124.72 1.208 . . . . 0.0 108.627 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.1 mt -136.0 139.8 45.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 126.155 1.782 . . . . 0.0 107.958 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -123.91 155.07 38.78 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.2 mp -135.94 136.79 49.57 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 125.53 1.532 . . . . 0.0 109.799 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -78.4 -50.35 11.87 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.709 0.804 . . . . 0.0 108.872 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 167.52 177.85 39.28 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.258 1.408 . . . . 0.0 109.779 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 64.23 -1.23 0.74 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.402 2.281 . . . . 0.0 115.448 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -85.97 170.98 11.79 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.473 -1.392 . . . . 0.0 112.862 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.17 62.79 0.49 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 126.163 1.84 . . . . 0.0 109.872 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -55.68 -34.3 64.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.61 -0.709 . . . . 0.0 112.444 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -59.2 -36.76 75.96 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.854 0.752 . . . . 0.0 111.954 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -82.69 -39.21 10.81 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 52.7 tp -64.61 -44.74 89.6 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 118.621 -0.704 . . . . 0.0 112.656 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.52 -49.38 26.24 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.854 0.721 . . . . 0.0 110.491 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -57.47 -31.76 66.29 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.2 t -63.4 -42.68 97.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.67 -40.96 90.21 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 123.729 0.681 . . . . 0.0 111.415 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -64.37 -42.41 96.2 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.79 1.295 . . . . 0.0 109.324 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.2 tppt? -58.24 -59.66 4.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -59.28 -42.85 92.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 118.457 -0.782 . . . . 0.0 112.075 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.9 tt0 -66.21 -27.76 68.23 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 120.776 1.625 . . . . 0.0 110.557 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.9 -28.88 55.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.421 -1.425 . . . . 0.0 110.37 178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -84.39 -47.14 10.99 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 126.069 1.748 . . . . 0.0 111.928 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.3 p -100.39 -32.09 11.0 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.11 -12.76 68.77 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 120.904 -1.122 . . . . 0.0 111.36 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 42.9 mm -66.86 130.58 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 105.513 -2.032 . . . . 0.0 105.513 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.82 142.52 58.18 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 118.926 -0.559 . . . . 0.0 111.807 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -135.85 102.11 3.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.2 m -96.9 142.43 28.89 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.185 0.994 . . . . 0.0 108.8 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.95 129.84 58.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -137.39 164.55 28.35 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.43 1.092 . . . . 0.0 108.662 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -133.44 61.51 54.49 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.297 1.039 . . . . 0.0 109.821 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.404 ' HG2' ' HB3' ' A' ' 43' ' ' LEU . 87.4 Cg_endo -69.64 155.13 67.15 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.161 2.574 . . . . 0.0 111.64 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -100.61 -0.04 38.35 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.72 18.43 3.55 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.443 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.1 pt? -55.97 -23.95 35.52 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 117.829 -1.081 . . . . 0.0 113.625 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 pm0 -59.7 -23.71 63.36 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 120.109 1.322 . . . . 0.0 112.491 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -114.38 -30.15 6.66 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.929 0.871 . . . . 0.0 109.407 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -70.43 -28.06 64.75 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 121.191 -0.943 . . . . 0.0 109.149 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -66.67 -60.61 6.18 Favored Pre-proline 0 CA--C 1.536 0.433 0 O-C-N 119.961 -1.712 . . . . 0.0 108.448 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -60.06 -25.72 80.53 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.277 1.985 . . . . 0.0 114.716 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -74.66 -0.63 18.59 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.278 1.031 . . . . 0.0 112.758 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.2 -36.28 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.24 -33.85 74.19 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.73 -30.74 70.3 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 122.893 0.477 . . . . 0.0 110.903 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.0 m -81.43 -14.41 57.12 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.564 1.946 . . . . 0.0 110.919 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.81 56.57 2.32 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.41 -172.48 2.96 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.593 2.357 . . . . 0.0 106.382 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.72 -162.61 14.76 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 120.239 -1.538 . . . . 0.0 113.9 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.53 -179.05 3.36 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.001 3.134 . . . . 0.0 110.33 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -109.29 -24.37 11.12 Favored 'General case' 0 CA--C 1.513 -0.457 0 O-C-N 121.409 -0.807 . . . . 0.0 112.135 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.9 mt -145.41 148.87 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 tp -132.78 141.34 45.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -128.97 107.32 9.52 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 125.875 1.67 . . . . 0.0 107.776 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -152.84 -150.71 0.35 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.945 1.248 . . . . 0.0 113.47 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.15 136.52 32.98 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.589 2.356 . . . . 0.0 110.152 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -48.66 -48.82 39.49 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.441 1.496 . . . . 0.0 112.489 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.45 -5.47 3.74 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 129.272 3.029 . . . . 0.0 113.972 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -108.84 -12.18 14.94 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.532 1.133 . . . . 0.0 109.633 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -94.34 -26.01 16.74 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 124.231 1.012 . . . . 0.0 112.304 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -49.97 -41.12 36.49 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.31 -55.79 16.79 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 123.949 0.785 . . . . 0.0 111.621 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -53.99 -42.48 69.08 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.55 1.14 . . . . 0.0 111.663 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.65 90.3 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 122.843 0.457 . . . . 0.0 111.086 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.48 -44.65 96.72 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.2 m -66.87 -4.38 9.22 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.433 1.493 . . . . 0.0 113.319 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.99 6.66 88.72 Favored Glycine 0 CA--C 1.523 0.55 0 C-N-CA 124.375 0.988 . . . . 0.0 112.985 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.9 mt -68.43 -22.87 64.58 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -178.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.6 mt -95.24 133.15 39.44 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.81 155.28 40.6 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -64.35 118.91 9.38 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.457 HG13 ' CA ' ' A' ' 105' ' ' ALA . 9.8 mm -71.58 165.33 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 122.351 1.072 . . . . 0.0 111.099 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 27.2 m 71.29 92.85 0.05 OUTLIER Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 129.031 2.932 . . . . 0.0 108.096 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.94 -34.54 10.49 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.463 1.442 . . . . 0.0 109.744 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -145.57 150.46 36.43 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.501 1.12 . . . . 0.0 109.128 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -57.27 -34.1 68.3 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 124.472 1.109 . . . . 0.0 112.041 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -58.24 -27.27 63.83 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 119.64 1.109 . . . . 0.0 111.898 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.31 -36.64 84.69 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.277 0.944 . . . . 0.0 109.008 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -59.29 -38.36 79.99 Favored 'General case' 0 C--N 1.343 0.284 0 O-C-N 121.044 -1.035 . . . . 0.0 112.707 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -65.67 -17.8 64.87 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.567 0.747 . . . . 0.0 111.6 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.14 -10.25 58.75 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.424 HD13 ' CE2' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -126.53 156.36 40.92 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.519 1.054 . . . . 0.0 111.962 -178.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -70.52 156.17 92.32 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.971 0.908 . . . . 0.0 110.705 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.16 -41.15 1.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.181 2.587 . . . . 0.0 113.821 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -63.81 -27.62 69.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.038 0.835 . . . . 0.0 110.87 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.05 -28.17 54.69 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.837 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.424 ' CE2' HD13 ' A' ' 89' ' ' LEU . 4.1 m95 -70.57 -39.21 74.04 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 118.717 0.69 . . . . 0.0 109.874 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.63 -27.57 68.76 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.36 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.57 -4.78 36.16 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.88 12.52 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.605 1.162 . . . . 0.0 111.773 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.4 mtp85 -65.74 165.27 13.0 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-O 122.449 1.119 . . . . 0.0 111.547 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 40.4 t80 -154.42 -171.04 3.72 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 126.09 1.756 . . . . 0.0 107.123 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -66.23 98.78 0.48 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.171 1.388 . . . . 0.0 109.047 179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.49 -74.27 0.42 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 126.085 1.802 . . . . 0.0 113.433 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.52 166.62 22.31 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.766 0.827 . . . . 0.0 110.735 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.6 mt -100.15 145.88 27.48 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.0 pt -110.19 -25.87 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.457 ' CA ' HG13 ' A' ' 79' ' ' ILE . . . -154.29 171.97 18.41 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.01 146.82 62.28 Favored Pre-proline 0 C--O 1.242 0.668 0 C-N-CA 123.529 0.732 . . . . 0.0 110.106 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.3 149.01 44.59 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.885 2.39 . . . . 0.0 110.09 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 31.5 mm -138.73 -52.06 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 126.835 2.054 . . . . 0.0 109.421 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.51 150.91 46.99 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.594 1.158 . . . . 0.0 112.671 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 99.3 t -126.12 118.36 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 126.436 1.894 . . . . 0.0 107.723 -179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -125.21 141.57 52.01 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.371 1.068 . . . . 0.0 108.411 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.37 106.58 4.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mp -67.91 176.99 2.31 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.522 1.529 . . . . 0.0 109.845 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 29.9 p -84.33 -175.8 5.96 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.686 1.194 . . . . 0.0 109.389 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.463 ' HB2' HG22 ' A' ' 245' ' ' THR . 0.9 OUTLIER -95.98 156.74 16.21 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 176.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.2 mp -88.28 98.39 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.64 171.55 7.67 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.559 1.944 . . . . 0.0 109.46 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -68.26 161.24 27.68 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -65.36 -19.8 66.11 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 115.5 1.667 . . . . 0.0 115.5 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -58.47 142.77 47.77 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 119.993 1.269 . . . . 0.0 110.079 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.7 pt? -70.54 4.69 2.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.918 1.287 . . . . 0.0 112.558 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.3 tp -121.86 64.3 17.35 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 126.25 1.82 . . . . 0.0 106.554 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.26 -3.19 13.42 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.517 2.145 . . . . 0.0 114.216 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 21.91 82.77 0.12 Allowed Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 129.416 3.086 . . . . 0.0 112.953 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.16 160.86 42.8 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.379 2.719 . . . . 0.0 116.584 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.43 170.8 16.52 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 124.221 3.281 . . . . 0.0 111.101 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -126.74 -31.88 2.64 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 123.827 0.851 . . . . 0.0 111.212 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.68 154.81 14.02 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 119.582 1.083 . . . . 0.0 109.783 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 76.0 m95 -61.79 -22.61 65.59 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 121.232 -0.917 . . . . 0.0 110.936 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -71.39 -12.41 61.4 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 119.567 1.076 . . . . 0.0 111.07 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -108.73 -17.02 14.05 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.973 2.509 . . . . 0.0 111.817 -178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.2 mm -58.66 -63.01 4.58 Favored Pre-proline 0 N--CA 1.466 0.357 0 O-C-N 121.161 -0.962 . . . . 0.0 110.974 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.63 -18.76 37.45 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 121.773 1.649 . . . . 0.0 111.745 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.71 -49.61 57.5 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.514 1.126 . . . . 0.0 108.52 178.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.8 tp -72.1 -30.59 65.23 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.794 0.838 . . . . 0.0 109.781 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.38 -48.02 72.01 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.761 0.824 . . . . 0.0 111.645 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 ptmm? -70.17 -31.12 68.45 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 122.465 0.306 . . . . 0.0 111.069 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -67.83 -45.05 75.76 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.7 mt -71.32 -30.28 66.03 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 118.512 -0.756 . . . . 0.0 110.243 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -67.8 -34.51 76.89 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 119.79 1.177 . . . . 0.0 108.14 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.43 -7.69 27.21 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.323 1.049 . . . . 0.0 111.965 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 6.12 3.72 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.312 1.445 . . . . 0.0 111.614 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 171.0 -76.42 0.1 OUTLIER Glycine 0 C--N 1.34 0.79 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.02 176.09 12.97 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.45 1.1 . . . . 0.0 110.175 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.65 165.1 8.66 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.902 0.858 . . . . 0.0 111.561 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -84.85 -70.09 0.6 Allowed 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 125.289 1.436 . . . . 0.0 111.3 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 58.2 tp -103.22 157.72 16.81 Favored 'General case' 0 CA--C 1.527 0.067 0 C-N-CA 125.893 1.677 . . . . 0.0 113.334 -177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 92.4 mtp -150.06 118.69 6.54 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.466 2.306 . . . . 0.0 106.093 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -142.13 155.23 45.32 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.803 0.729 . . . . 0.0 109.281 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -68.06 96.53 0.62 Allowed 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 121.338 -0.851 . . . . 0.0 111.79 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.51 -10.67 58.18 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.239 1.016 . . . . 0.0 110.806 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -75.79 -29.78 58.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 118.566 -0.73 . . . . 0.0 112.099 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -99.55 133.0 22.2 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 119.485 1.039 . . . . 0.0 109.491 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.41 -5.39 14.97 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.68 2.92 . . . . 0.0 113.719 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -66.84 -37.62 84.83 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.524 1.13 . . . . 0.0 110.506 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -75.74 -46.12 32.7 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 122.034 -0.416 . . . . 0.0 112.084 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 63.9 p -73.96 -17.2 61.04 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -53.68 -61.28 5.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.69 -3.8 10.98 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.324 2.016 . . . . 0.0 114.111 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.99 -59.24 2.28 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 105.283 -2.118 . . . . 0.0 105.283 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 30.5 pt -61.84 -49.41 84.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 116.977 -1.487 . . . . 0.0 111.708 -178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -49.36 -8.88 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 128.277 2.631 . . . . 0.0 115.236 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.75 85.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.399 1.08 . . . . 0.0 111.221 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -67.87 -50.13 58.14 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 177.8 11.96 0.02 OUTLIER Glycine 0 CA--C 1.534 1.265 0 O-C-N 121.251 -0.905 . . . . 0.0 115.154 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -85.77 131.35 10.43 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 125.869 1.699 . . . . 0.0 111.026 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -146.76 143.32 28.59 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 177.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.55 -45.73 13.21 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 119.187 -0.435 . . . . 0.0 110.23 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -148.69 126.94 12.15 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -76.01 145.88 39.9 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.859 0.754 . . . . 0.0 111.219 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -140.46 116.27 10.3 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -91.75 -174.81 3.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 124.347 1.059 . . . . 0.0 108.306 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -56.51 -9.22 0.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.513 1.925 . . . . 0.0 115.185 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -178.9 13.41 0.03 OUTLIER Glycine 0 CA--C 1.533 1.169 0 C-N-CA 126.208 1.861 . . . . 0.0 112.85 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -132.52 106.2 7.7 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.955 1.378 . . . . 0.0 110.47 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -104.09 125.8 50.71 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -136.62 110.66 8.28 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.74 -8.61 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.058 0.543 . . . . 0.0 112.446 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -77.53 -31.19 53.21 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.568 1.147 . . . . 0.0 110.544 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -84.18 87.71 7.18 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 74.7 t -104.57 152.82 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 125.884 1.674 . . . . 0.0 108.86 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -145.25 24.83 1.88 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.881 1.229 . . . . 0.0 113.766 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 25.6 t -65.09 -22.56 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 120.796 -1.414 . . . . 0.0 113.013 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -106.27 5.93 30.21 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.125 1.77 . . . . 0.0 111.807 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -59.82 157.13 12.82 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 121.584 -0.698 . . . . 0.0 110.38 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.92 -34.43 55.21 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.193 0.997 . . . . 0.0 110.755 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.99 -33.01 65.68 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-O 119.243 -0.754 . . . . 0.0 112.9 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.45 -49.87 61.74 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.579 1.69 . . . . 0.0 107.743 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -61.85 -41.05 97.35 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.068 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.1 -46.6 89.93 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.054 0.942 . . . . 0.0 110.216 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.72 -36.72 93.7 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 31.5 tp -75.02 -49.36 20.08 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.998 0.919 . . . . 0.0 113.164 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 5.7 t -52.95 -33.7 52.27 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.123 0.969 . . . . 0.0 112.993 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -58.93 -51.91 68.02 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 120.234 1.379 . . . . 0.0 109.466 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.0 tt -64.57 -46.38 83.02 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.308 1.043 . . . . 0.0 110.264 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 58.5 t -56.61 -34.45 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 C-N-CA 123.751 0.82 . . . . 0.0 110.695 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.674 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.3 OUTLIER -63.57 -33.46 75.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.017 0.826 . . . . 0.0 111.876 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 13.8 mt -71.65 -43.92 65.23 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 44.6 mt -60.18 -41.47 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.674 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.7 OUTLIER -55.83 -30.48 61.48 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 120.995 -1.066 . . . . 0.0 110.346 178.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -93.3 -5.3 50.03 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.367 1.467 . . . . 0.0 112.093 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? 58.13 18.19 5.09 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.918 2.487 . . . . 0.0 113.891 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -91.2 -13.3 33.1 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 114.209 1.189 . . . . 0.0 114.209 -179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 9.1 tpt -92.86 167.13 12.05 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 118.934 0.788 . . . . 0.0 111.496 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -76.25 42.69 0.27 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.906 2.882 . . . . 0.0 109.424 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.18 -33.41 75.42 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 126.059 1.744 . . . . 0.0 115.22 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.34 -9.22 57.9 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.487 1.115 . . . . 0.0 112.685 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 24.3 m -78.17 131.4 37.18 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.165 1.386 . . . . 0.0 111.036 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -119.04 179.39 4.18 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 126.411 1.884 . . . . 0.0 107.821 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -52.69 -46.69 67.4 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 123.816 0.846 . . . . 0.0 113.082 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 54.0 m -63.31 -36.94 85.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 123.571 0.749 . . . . 0.0 110.785 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 28.0 mm -68.64 -49.94 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 117.78 -1.105 . . . . 0.0 108.512 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.33 -47.82 82.54 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.999 1.272 . . . . 0.0 111.938 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -56.62 -48.62 77.08 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.843 0.457 . . . . 0.0 110.164 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.96 -52.39 56.52 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.55 0.74 . . . . 0.0 110.744 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.71 -43.12 68.76 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.841 1.657 . . . . 0.0 110.75 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -60.41 -39.5 87.58 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -62.23 -43.84 97.92 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -69.31 -12.09 61.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.915 1.286 . . . . 0.0 112.704 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.69 13.31 70.23 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 120.193 1.36 . . . . 0.0 111.613 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -74.51 -9.06 58.21 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 116.609 2.078 . . . . 0.0 116.609 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.03 157.04 47.96 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 120.345 1.43 . . . . 0.0 110.543 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -91.41 -35.12 14.56 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.217 1.007 . . . . 0.0 110.368 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 10.2 ptt? -145.05 145.66 31.55 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.41 1.084 . . . . 0.0 110.369 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.06 155.48 47.02 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 106.965 -1.495 . . . . 0.0 106.965 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 78.2 mt -128.1 92.41 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -121.24 -110.57 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -158.97 -88.14 0.07 OUTLIER Glycine 0 CA--C 1.523 0.538 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -71.8 139.1 32.91 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.166 1.91 . . . . 0.0 111.023 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 71.5 t90 -93.22 -6.26 48.09 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.283 1.033 . . . . 0.0 111.181 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -52.9 164.13 0.42 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.342 1.857 . . . . 0.0 112.252 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -99.95 -27.82 13.4 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 14.8 m -73.9 -45.62 49.56 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 120.124 1.329 . . . . 0.0 111.557 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 68.5 m-20 57.86 1.11 0.13 Allowed 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 116.251 1.945 . . . . 0.0 116.251 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 27.6 pt -67.55 -10.61 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.677 1.991 . . . . 0.0 111.563 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.27 168.03 3.71 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.746 1.619 . . . . 0.0 112.324 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.3 t -127.15 9.82 6.81 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.32 1.048 . . . . 0.0 111.105 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 8.4 p -118.44 158.53 25.15 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.55 1.54 . . . . 0.0 109.842 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -146.39 73.4 1.32 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 31.5 m -104.38 163.64 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 123.821 0.848 . . . . 0.0 110.736 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 60.6 t30 46.61 42.41 11.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.886 2.074 . . . . 0.0 110.408 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -90.31 166.66 13.19 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 127.003 2.121 . . . . 0.0 111.267 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 165.88 174.62 35.56 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.178 -1.969 . . . . 0.0 108.178 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 19.1 m -151.76 167.57 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 124.949 1.3 . . . . 0.0 109.806 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.463 HG22 ' HB2' ' A' ' 115' ' ' LEU . 1.2 t -74.58 169.95 16.75 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.0 t -53.8 116.15 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.184 0.994 . . . . 0.0 109.384 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.0 mp -69.69 145.91 95.3 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.37 156.13 37.4 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.273 2.649 . . . . 0.0 110.782 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 255' ' ' SER . 75.3 p -99.48 176.11 5.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.682 1.193 . . . . 0.0 108.722 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -107.79 159.25 16.64 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 13.9 ptpt -55.15 103.52 0.09 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.815 0.846 . . . . 0.0 111.936 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 80.58 -5.65 63.89 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-O 118.176 -1.347 . . . . 0.0 113.223 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.84 108.32 32.92 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 120.206 2.003 . . . . 0.0 110.48 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.17 131.79 31.72 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.643 1.562 . . . . 0.0 109.334 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.473 ' H ' HG22 ' A' ' 249' ' ' THR . 10.1 p -64.13 160.1 19.03 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.39 1.076 . . . . 0.0 109.928 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 2.0 mmmp? -132.75 71.68 78.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 118.348 0.522 . . . . 0.0 110.596 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.43 156.64 65.33 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.831 2.354 . . . . 0.0 111.46 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -74.23 160.98 30.4 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 69.4 t -129.21 133.35 65.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 C-N-CA 124.13 0.972 . . . . 0.0 110.856 -177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.06 141.84 17.27 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 11.4 m -144.69 157.15 14.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 118.561 1.181 . . . . 0.0 109.779 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.3 tt -65.75 147.69 52.98 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.198 0.999 . . . . 0.0 108.322 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 1.4 m -133.01 127.31 33.85 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 119.606 1.094 . . . . 0.0 109.277 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -110.26 138.77 46.19 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.344 1.858 . . . . 0.0 106.959 179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -145.5 141.06 9.46 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.221 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 67.4 mt -78.48 137.8 21.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -72.65 129.26 37.85 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.43 -15.93 60.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -67.19 -40.7 86.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 118.095 -0.955 . . . . 0.0 113.071 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.9 m -47.41 148.85 2.14 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 125.048 1.339 . . . . 0.0 113.78 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.96 -56.02 0.23 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.479 2.119 . . . . 0.0 112.479 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -113.7 102.4 10.22 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.176 1.353 . . . . 0.0 110.392 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.63 -16.82 63.45 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 122.024 -0.423 . . . . 0.0 111.794 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -64.62 -38.08 89.77 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.969 0.907 . . . . 0.0 110.017 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.74 -39.69 81.66 Favored 'General case' 0 N--CA 1.461 0.102 0 O-C-N 121.627 -0.67 . . . . 0.0 110.504 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.89 -44.8 68.99 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -32.53 72.31 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 118.314 -0.85 . . . . 0.0 111.348 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -74.26 -44.75 51.66 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -58.84 -39.31 80.9 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.57 -48.06 76.42 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 118.845 -0.597 . . . . 0.0 111.107 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -79.34 -18.61 52.17 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -107.07 -16.79 14.34 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.645 1.111 . . . . 0.0 113.932 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -136.82 -40.04 0.62 Allowed 'General case' 0 C--N 1.341 0.236 0 CA-C-N 119.235 0.925 . . . . 0.0 113.459 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -73.65 -36.98 65.45 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.262 0.937 . . . . 0.0 111.076 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.407 HD22 HD21 ' A' ' 304' ' ' LEU . 30.5 mt -107.65 63.45 0.62 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.36 1.464 . . . . 0.0 111.79 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 23.5 p -134.15 155.2 50.53 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.35 -37.8 88.68 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.244 -0.651 . . . . 0.0 109.244 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -74.93 -31.87 61.62 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -75.78 -45.81 16.02 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 65.2 mt -61.66 -43.17 99.36 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.805 0.842 . . . . 0.0 109.598 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -56.67 -41.51 77.41 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.882 0.738 . . . . 0.0 110.249 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.5 93.0 Favored 'General case' 0 C--N 1.343 0.292 0 O-C-N 121.246 -0.909 . . . . 0.0 112.463 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 4.5 t -67.14 -41.82 87.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -65.27 -27.72 68.84 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.705 0.764 . . . . 0.0 112.51 -178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -70.86 -35.49 72.41 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 117.232 -1.366 . . . . 0.0 109.707 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.61 -45.4 21.69 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.595 1.543 . . . . 0.0 111.791 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -138.33 152.3 71.15 Favored Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 124.757 1.223 . . . . 0.0 108.851 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.65 123.43 10.13 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.556 1.504 . . . . 0.0 109.641 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 20.8 mt -79.21 -30.05 43.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 119.016 -0.516 . . . . 0.0 109.703 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.4 -155.64 22.91 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 106.098 -2.801 . . . . 0.0 106.098 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -75.43 171.58 14.0 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.8 m -138.29 157.01 30.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 123.58 1.657 . . . . 0.0 114.163 -178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.76 -17.32 59.13 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.852 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.407 HD21 HD22 ' A' ' 285' ' ' LEU . 4.4 mm? -71.04 104.76 3.1 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 125.672 1.589 . . . . 0.0 109.146 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -57.48 -29.17 64.03 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 20.5 t -63.37 -66.58 0.52 Allowed 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.686 1.994 . . . . 0.0 110.304 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -74.93 -17.5 60.55 Favored 'General case' 0 C--O 1.227 -0.111 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -63.96 -32.29 73.78 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -70.15 -11.35 60.83 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.34 -0.85 . . . . 0.0 111.19 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -98.18 -49.15 4.83 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.97 2.108 . . . . 0.0 108.991 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 64.6 mt -69.8 -31.23 69.02 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 121.865 -0.522 . . . . 0.0 110.143 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.17 -3.78 4.25 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.263 0.938 . . . . 0.0 112.207 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -64.07 -10.99 25.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.553 1.141 . . . . 0.0 110.88 178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.23 144.13 35.62 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 126.162 1.785 . . . . 0.0 107.376 178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.78 -24.89 46.48 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.344 2.696 . . . . 0.0 114.805 -177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 16.9 mmm-85 -62.45 -48.21 80.66 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.733 0.697 . . . . 0.0 109.151 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.1 mp -65.02 -50.48 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.45 -52.25 39.61 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 124.197 0.935 . . . . 0.0 109.736 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.8 -36.32 76.51 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.393 -0.817 . . . . 0.0 112.404 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 88.2 m -65.56 -38.52 89.81 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 49.7 tpp -76.51 -38.34 55.34 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.351 0.523 . . . . 0.0 109.818 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -58.23 -34.07 70.03 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 123.942 0.897 . . . . 0.0 109.096 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -61.8 -38.45 88.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.042 -0.411 . . . . 0.0 109.898 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.25 -35.67 66.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -64.34 -49.84 70.13 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 123.792 0.837 . . . . 0.0 111.345 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -4.38 42.45 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.418 1.087 . . . . 0.0 113.402 -179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -107.21 -156.6 20.41 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 125.403 1.478 . . . . 0.0 110.645 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -158.94 179.34 9.17 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.609 1.964 . . . . 0.0 108.525 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 27.3 mm -112.43 132.71 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 123.343 0.657 . . . . 0.0 110.089 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 22.4 ptp -63.77 135.83 96.46 Favored Pre-proline 0 CA--C 1.54 0.586 0 O-C-N 124.825 1.328 . . . . 0.0 107.507 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.51 144.8 51.03 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.844 1.696 . . . . 0.0 111.501 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -103.07 73.18 1.22 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.5 pt -138.55 146.23 49.93 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.734 0.813 . . . . 0.0 109.076 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.78 -18.43 53.02 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.676 2.917 . . . . 0.0 114.478 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -65.43 -17.7 64.74 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.522 1.129 . . . . 0.0 109.84 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 85.6 mmm -61.64 -32.5 72.66 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.313 0.645 . . . . 0.0 111.381 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 70.5 m -64.89 -45.24 86.8 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 119.403 1.001 . . . . 0.0 109.478 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.76 80.23 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -64.79 -51.44 62.21 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.395 1.478 . . . . 0.0 109.794 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.8 m95 -58.6 -45.94 88.08 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.45 1.023 . . . . 0.0 110.727 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -58.91 -47.21 85.79 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -56.19 -57.08 13.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.227 1.011 . . . . 0.0 113.052 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 23.5 t -62.41 -35.59 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-O 118.142 -0.932 . . . . 0.0 111.217 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 7.4 tmm_? -54.08 -50.07 67.63 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.73 1.605 . . . . 0.0 110.119 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 32.2 m -67.02 -40.88 87.34 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.743 -0.598 . . . . 0.0 110.516 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.46 -41.77 98.99 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.578 1.081 . . . . 0.0 113.426 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 79.5 t -62.48 -46.99 95.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 33.1 mm -68.7 -37.12 77.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 118.544 0.611 . . . . 0.0 110.068 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -57.21 -46.94 82.44 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 121.245 -0.909 . . . . 0.0 108.942 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.27 -53.77 32.81 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.417 1.087 . . . . 0.0 110.789 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -57.61 -34.19 69.02 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.469 1.508 . . . . 0.0 114.372 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 52.1 m -97.39 0.48 47.89 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.1 0.56 . . . . 0.0 111.173 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 67.89 12.33 62.17 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-O 119.232 -0.76 . . . . 0.0 112.93 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -62.98 -31.49 72.63 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.557 1.179 . . . . 0.0 108.481 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -147.18 152.95 39.24 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 7.5 m -61.52 153.13 28.31 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.283 1.433 . . . . 0.0 108.674 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 11.1 t -58.81 -45.72 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 119.435 1.016 . . . . 0.0 108.386 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.26 -48.56 76.31 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 125.168 1.387 . . . . 0.0 111.28 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -68.42 -44.92 73.96 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.879 1.271 . . . . 0.0 111.988 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.24 -44.04 83.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.308 0.643 . . . . 0.0 110.58 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.3 mp -70.17 -39.97 74.98 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.555 0.742 . . . . 0.0 110.602 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -57.37 -47.55 81.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.1 -54.29 45.03 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.517 1.527 . . . . 0.0 108.206 178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -54.33 -50.82 66.52 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 125.411 1.485 . . . . 0.0 112.902 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -54.71 -39.68 68.44 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 5.6 m -69.78 -22.98 63.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.162 0.585 . . . . 0.0 111.565 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 83.3 mtt-85 -78.41 -4.74 49.81 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 120.139 -1.6 . . . . 0.0 112.135 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 5.2 mt -112.68 -29.19 2.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 124.063 0.945 . . . . 0.0 110.252 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 20.4 p -75.7 -23.95 56.2 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.595 1.089 . . . . 0.0 110.445 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.265 0 CA-C-O 117.444 -1.265 . . . . 0.0 108.989 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.441 ' CG2' ' HD3' ' A' ' 271' ' ' PRO . 4.1 mp -80.58 131.71 33.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 102.617 -3.105 . . . . 0.0 102.617 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -72.3 104.97 3.88 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -74.27 115.45 13.79 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 126.411 1.884 . . . . 0.0 107.715 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.63 31.86 1.42 Allowed Glycine 0 CA--C 1.532 1.1 0 N-CA-C 115.284 0.873 . . . . 0.0 115.284 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.39 169.72 20.2 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.217 -1.167 . . . . 0.0 110.829 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 25.6 mt -150.7 148.92 29.17 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.573 2.749 . . . . 0.0 105.743 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.5 t -140.7 128.72 23.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.53 HD12 HG22 ' A' ' 37' ' ' VAL . 18.7 mt -108.4 137.4 40.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 125.169 1.388 . . . . 0.0 107.501 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -135.57 129.48 33.03 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.333 1.853 . . . . 0.0 106.364 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -149.05 163.94 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 126.533 1.933 . . . . 0.0 108.106 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -78.55 170.92 15.89 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.817 0.847 . . . . 0.0 111.727 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.14 -43.24 73.71 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 127.217 2.342 . . . . 0.0 117.006 -177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -68.51 -13.37 62.28 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.342 1.071 . . . . 0.0 112.631 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -70.63 160.23 32.95 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-O 123.563 1.649 . . . . 0.0 113.132 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.39 60.09 4.75 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 106.306 -2.718 . . . . 0.0 106.306 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 41.9 p90 -60.11 -46.69 88.76 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 124.448 1.099 . . . . 0.0 109.693 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -61.82 -49.61 75.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.3 94.79 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.6 tp -68.99 -34.68 75.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.142 0.977 . . . . 0.0 110.972 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.72 -41.68 74.19 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 118.352 -0.833 . . . . 0.0 109.602 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -58.72 -34.35 71.24 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.381 1.072 . . . . 0.0 111.946 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.7 t -76.8 -45.12 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.455 1.502 . . . . 0.0 108.291 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -61.58 -46.83 93.48 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 124.104 0.859 . . . . 0.0 112.222 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -37.22 84.91 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 117.886 -1.054 . . . . 0.0 108.72 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -61.33 -54.27 46.0 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -53.73 -46.23 70.76 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 118.552 0.614 . . . . 0.0 110.668 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -65.34 -32.26 73.82 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.044 -1.035 . . . . 0.0 111.0 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -71.93 -28.52 63.53 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.986 0.914 . . . . 0.0 110.879 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -95.98 -16.05 21.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.667 1.187 . . . . 0.0 111.97 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -126.33 -27.87 3.15 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.25 -14.49 63.54 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 120.866 -1.146 . . . . 0.0 113.654 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 mm -70.67 130.58 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 120.078 1.939 . . . . 0.0 106.81 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.432 ' H ' ' HE2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -58.11 145.28 37.28 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.8 t -139.82 87.65 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.505 1.122 . . . . 0.0 109.215 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 m -78.35 136.44 37.69 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.53 HG22 HD12 ' A' ' 9' ' ' ILE . 25.5 t -130.26 119.88 47.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -133.34 164.17 27.69 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.016 1.326 . . . . 0.0 107.838 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -120.26 62.15 8.6 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 125.661 1.585 . . . . 0.0 110.8 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -63.18 152.13 81.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 121.915 1.743 . . . . 0.0 110.662 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -120.42 19.84 11.98 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.683 1.593 . . . . 0.0 109.628 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.45 12.64 0.73 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.292 2.237 . . . . 0.0 112.683 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.2 pt? -56.48 -27.93 58.36 Favored 'General case' 0 N--CA 1.463 0.2 0 O-C-N 120.315 -1.49 . . . . 0.0 112.921 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -59.07 -20.03 49.63 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.29 1.436 . . . . 0.0 113.532 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -120.36 -18.02 8.04 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.756 -0.59 . . . . 0.0 110.948 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -46.7 15.43 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.491 1.116 . . . . 0.0 110.917 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -46.32 -57.38 8.59 Favored Pre-proline 0 N--CA 1.468 0.444 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.628 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.15 -18.9 64.58 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.778 1.652 . . . . 0.0 114.592 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -89.07 -8.68 53.42 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 119.995 1.27 . . . . 0.0 112.987 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.9 t -127.1 -36.01 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 119.191 0.905 . . . . 0.0 111.105 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.05 -28.18 67.99 Favored 'General case' 0 C--O 1.224 -0.288 0 O-C-N 121.044 -1.035 . . . . 0.0 109.848 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.75 -5.58 4.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.581 1.152 . . . . 0.0 113.248 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.0 t -131.33 7.57 4.58 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.742 2.017 . . . . 0.0 109.585 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.37 5.6 72.89 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 119.955 -1.716 . . . . 0.0 114.881 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.53 -2.48 57.16 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 118.216 1.008 . . . . 0.0 110.103 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.55 -172.28 48.38 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 126.401 1.953 . . . . 0.0 115.778 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -69.82 173.92 10.31 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 124.188 3.259 . . . . 0.0 111.907 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -108.36 -18.4 13.76 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -141.45 145.37 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.907 1.283 . . . . 0.0 107.664 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 tt -137.06 141.19 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.701 1.6 . . . . 0.0 107.408 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -130.32 113.36 14.28 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.086 1.355 . . . . 0.0 109.608 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -157.68 171.11 20.91 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.722 0.809 . . . . 0.0 109.257 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.42 162.21 25.96 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -52.25 -25.51 9.54 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.327 1.451 . . . . 0.0 112.2 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -50.22 -65.7 0.52 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 125.96 1.704 . . . . 0.0 113.64 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -69.55 -18.93 63.69 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 122.151 -0.343 . . . . 0.0 110.291 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -78.03 -20.96 51.46 Favored 'General case' 0 N--CA 1.461 0.108 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.65 -5.05 7.88 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 117.836 -1.535 . . . . 0.0 112.939 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -138.74 -17.91 0.55 Allowed Glycine 0 CA--C 1.535 1.331 0 CA-C-O 117.26 -1.855 . . . . 0.0 115.816 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -65.09 -33.89 77.11 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.027 2.414 . . . . 0.0 112.865 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.94 -36.39 75.25 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-N 119.411 1.005 . . . . 0.0 108.316 178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -48.04 79.77 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.8 m -65.61 -5.39 8.14 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.128 1.771 . . . . 0.0 112.856 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.29 16.95 79.99 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 126.761 2.124 . . . . 0.0 113.048 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.5 mt -87.63 -18.11 30.35 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.5 mt -96.93 135.44 38.91 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.962 0.801 . . . . 0.0 109.21 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -81.68 161.32 23.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.274 1.029 . . . . 0.0 111.314 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -68.34 105.46 2.16 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.593 1.157 . . . . 0.0 108.058 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.83 163.67 2.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 118.753 0.706 . . . . 0.0 111.034 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 25.4 m 114.77 91.21 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.525 1 C-N-CA 132.668 4.387 . . . . 0.0 108.788 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.87 -54.51 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.436 2.091 . . . . 0.0 109.106 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -148.23 152.58 37.43 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.175 1.79 . . . . 0.0 106.83 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -62.31 -33.76 75.29 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 118.99 -0.529 . . . . 0.0 111.084 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.05 -28.5 52.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.371 0.987 . . . . 0.0 112.306 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -68.93 -30.61 69.1 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.652 0.66 . . . . 0.0 109.989 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -69.1 -41.64 77.18 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.584 1.084 . . . . 0.0 110.707 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.07 -28.37 69.03 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.969 0.908 . . . . 0.0 111.716 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -69.03 -7.71 38.19 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.85 0.86 . . . . 0.0 112.952 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -117.93 149.58 40.65 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.692 1.133 . . . . 0.0 113.417 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -63.54 150.64 89.76 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 123.582 0.753 . . . . 0.0 110.33 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.54 -43.63 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.657 2.238 . . . . 0.0 112.95 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -61.52 -42.08 98.28 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 121.809 -0.557 . . . . 0.0 110.973 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.69 -28.93 68.1 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -66.81 -49.16 66.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 123.84 0.856 . . . . 0.0 109.592 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.7 -16.72 51.43 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.9 -41.83 82.11 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.755 0.707 . . . . 0.0 109.964 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 32.5 m -86.08 -15.38 10.25 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.071 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -51.74 149.54 4.61 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.767 1.167 . . . . 0.0 113.612 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.5 -174.48 3.13 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 126.367 1.867 . . . . 0.0 107.381 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -63.32 100.74 0.26 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.313 0.645 . . . . 0.0 109.323 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.27 -83.04 0.25 Allowed Glycine 0 CA--C 1.524 0.623 0 C-N-CA 124.83 1.205 . . . . 0.0 111.05 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.2 173.84 2.32 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.691 1.196 . . . . 0.0 111.661 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.4 mt -106.54 169.83 8.29 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.216 1.007 . . . . 0.0 111.358 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 19.7 pt -143.48 -28.18 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.03 1.732 . . . . 0.0 114.232 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.1 177.76 10.97 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 120.659 1.572 . . . . 0.0 111.167 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -122.16 145.65 44.62 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 125.057 1.343 . . . . 0.0 110.469 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.34 149.83 45.78 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.667 2.911 . . . . 0.0 108.171 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.463 HG13 ' HB2' ' A' ' 264' ' ' ALA . 29.8 mm -125.98 -44.99 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 125.109 1.364 . . . . 0.0 111.797 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -146.1 159.34 43.41 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 118.368 0.531 . . . . 0.0 110.992 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.4 t -122.45 116.01 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.657 1.183 . . . . 0.0 108.018 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -144.98 148.79 34.17 Favored 'General case' 0 CA--C 1.519 -0.25 0 C-N-CA 125.255 1.422 . . . . 0.0 107.63 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -84.98 176.39 8.47 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 68.2 mt -61.37 162.31 8.04 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.939 0.876 . . . . 0.0 110.568 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.6 p -137.43 161.03 37.42 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.934 0.893 . . . . 0.0 111.996 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.8 tp -73.43 154.77 39.85 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.743 1.217 . . . . 0.0 110.033 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 71.3 mt -124.33 101.28 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.472 ' CE2' HG21 ' A' ' 245' ' ' THR . 28.8 m-85 -78.28 174.14 11.54 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -82.77 -172.74 4.26 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.487 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.1 ptpt -74.29 1.57 11.21 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.31 1.844 . . . . 0.0 111.335 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -98.36 144.18 28.03 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.722 2.009 . . . . 0.0 110.707 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.1 pp -81.05 5.36 16.77 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 32.1 tp -36.82 109.59 0.44 Allowed Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 125.191 1.396 . . . . 0.0 110.823 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.84 -169.12 0.36 Allowed 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.773 2.982 . . . . 0.0 110.956 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.7 t30 64.9 69.87 0.64 Allowed Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 126.019 1.728 . . . . 0.0 110.602 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -68.94 167.07 24.39 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.284 2.656 . . . . 0.0 110.846 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.02 168.87 23.73 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.959 1.773 . . . . 0.0 110.303 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -134.98 -30.74 1.04 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.838 1.255 . . . . 0.0 112.731 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.457 ' HA ' ' H ' ' A' ' 249' ' ' THR . 14.9 t -158.96 157.73 31.9 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 45.0 m95 -65.43 -22.4 66.76 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 124.815 1.246 . . . . 0.0 112.426 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 4.1 mm-40 -69.85 -27.46 64.86 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.912 1.685 . . . . 0.0 110.469 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -89.61 -22.02 22.53 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.217 1.807 . . . . 0.0 111.983 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.6 mm -54.4 -56.02 31.11 Favored Pre-proline 0 N--CA 1.453 -0.276 0 CA-C-O 117.889 -1.053 . . . . 0.0 110.355 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.85 -24.47 46.53 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 CA-C-N 120.398 1.178 . . . . 0.0 112.026 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.49 -55.4 10.35 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 63.5 tp -64.13 -27.23 68.94 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.529 -1.357 . . . . 0.0 110.244 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.44 -43.95 95.96 Favored 'General case' 0 N--CA 1.457 -0.077 0 O-C-N 121.782 -0.574 . . . . 0.0 109.78 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -71.87 -27.45 62.87 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 119.116 -0.469 . . . . 0.0 111.182 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -70.69 -48.24 55.72 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 41.0 mt -69.3 -33.46 73.21 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 119.295 -0.383 . . . . 0.0 110.501 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -67.96 -36.91 80.86 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.12 -27.05 69.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.863 0.756 . . . . 0.0 111.656 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.9 3.22 20.37 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.923 0.889 . . . . 0.0 112.673 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.41 -102.65 0.17 Allowed Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 118.825 0.739 . . . . 0.0 111.585 -178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.0 mtmt -137.5 178.54 7.02 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.397 1.079 . . . . 0.0 110.693 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.1 p -54.99 157.6 3.18 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.923 1.689 . . . . 0.0 114.208 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.9 -69.14 0.73 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.644 1.578 . . . . 0.0 112.31 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.2 tp -99.2 132.64 44.37 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.029 1.332 . . . . 0.0 110.218 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.2 ttm -142.47 133.26 25.53 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -161.75 172.93 15.36 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.952 1.301 . . . . 0.0 108.954 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -69.77 92.31 0.67 Allowed 'General case' 0 C--O 1.227 -0.129 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.0 mt -77.12 -14.66 59.76 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 121.219 -0.926 . . . . 0.0 110.105 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -68.74 -31.87 71.23 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.051 -1.452 . . . . 0.0 114.742 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -104.05 154.96 37.78 Favored Pre-proline 0 C--N 1.343 0.316 0 CA-C-N 121.661 2.028 . . . . 0.0 114.147 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.16 -15.05 11.76 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.212 1.941 . . . . 0.0 114.158 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -61.04 -39.62 90.49 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.771 1.623 . . . . 0.0 111.805 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -82.28 -33.45 29.1 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.0 p -81.75 -15.84 53.0 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.242 0.928 . . . . 0.0 111.319 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -46.34 -58.21 7.02 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -58.04 -16.94 29.01 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 121.591 1.527 . . . . 0.0 115.086 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.7 tp -67.4 -62.22 1.53 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 120.262 1.392 . . . . 0.0 107.393 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 6.2 pt -68.63 -24.88 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.494 1.118 . . . . 0.0 112.649 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.62 -18.21 62.22 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.485 -0.759 . . . . 0.0 111.127 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -56.6 -53.84 52.95 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 124.655 1.182 . . . . 0.0 111.229 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -61.84 -58.19 8.92 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.26 22.37 0.03 OUTLIER Glycine 0 C--N 1.333 0.376 0 CA-C-O 118.611 -1.105 . . . . 0.0 115.126 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.29 134.11 13.36 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -137.51 140.77 41.34 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.859 1.83 . . . . 0.0 114.022 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.92 81.12 4.15 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.718 2.007 . . . . 0.0 106.992 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 67.22 164.75 0.21 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 127.166 2.186 . . . . 0.0 111.061 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -127.75 138.52 52.79 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.177 0.591 . . . . 0.0 109.51 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.58 119.66 25.19 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.604 1.962 . . . . 0.0 105.77 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -96.96 41.38 1.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.932 2.093 . . . . 0.0 111.521 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 55.33 81.21 0.12 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.743 1.217 . . . . 0.0 110.974 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 101.98 -18.62 51.82 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-O 118.728 -1.04 . . . . 0.0 113.301 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -117.54 122.75 44.52 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.82 -1.919 . . . . 0.0 105.82 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -131.55 115.99 16.85 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 125.733 1.613 . . . . 0.0 108.431 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -124.54 93.18 3.83 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.492 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -55.28 -7.33 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.524 1.929 . . . . 0.0 112.894 179.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -75.88 -30.89 59.01 Favored 'General case' 0 C--N 1.34 0.188 0 O-C-N 120.898 -1.126 . . . . 0.0 109.422 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -81.9 67.84 8.05 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.121 0.968 . . . . 0.0 109.288 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 45.3 t -80.78 156.0 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.62 40.11 1.7 Allowed Glycine 0 CA--C 1.526 0.776 0 CA-C-O 118.122 -1.377 . . . . 0.0 113.53 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 5.0 t -95.64 -27.64 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 120.029 1.914 . . . . 0.0 112.692 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -90.72 10.7 24.85 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 120.804 1.638 . . . . 0.0 109.995 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 44.9 m-20 -60.31 152.2 25.69 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 120.808 -1.182 . . . . 0.0 109.311 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.73 -27.22 62.79 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.972 0.509 . . . . 0.0 111.7 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -73.98 -40.16 44.31 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 123.566 0.603 . . . . 0.0 112.286 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.1 -51.14 70.37 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -60.31 -42.83 96.38 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.561 178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.41 -46.51 86.3 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 118.836 0.744 . . . . 0.0 110.943 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -72.62 -29.54 65.48 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-O 119.462 -0.632 . . . . 0.0 113.944 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 18.2 tp -80.21 -39.88 28.23 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.2 t -57.83 -34.16 69.39 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.85 0.75 . . . . 0.0 109.885 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -59.46 -48.12 82.86 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.58 0.627 . . . . 0.0 109.852 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 5.9 tt -58.57 -45.53 88.84 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.362 0.665 . . . . 0.0 109.843 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.03 -29.4 47.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.148 0.579 . . . . 0.0 110.26 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -62.25 -39.25 92.24 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 121.085 -1.009 . . . . 0.0 112.387 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.5 mt -70.92 -43.47 68.16 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 55.4 mt -64.06 -39.84 86.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -52.27 -46.6 65.9 Favored 'General case' 0 C--N 1.342 0.269 0 O-C-N 121.06 -1.025 . . . . 0.0 108.849 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -80.66 -0.98 40.51 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.093 2.157 . . . . 0.0 113.82 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.1 mptt 57.58 4.64 0.25 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.671 2.388 . . . . 0.0 115.424 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -71.57 -31.74 67.3 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.686 -0.634 . . . . 0.0 112.097 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.5 tpt -69.01 163.31 24.93 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 118.554 0.616 . . . . 0.0 109.97 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -91.34 52.18 2.05 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.51 -11.27 1.87 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.979 2.512 . . . . 0.0 115.606 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -102.81 0.23 32.39 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.679 0.791 . . . . 0.0 111.921 -178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 85.9 m -74.19 124.7 26.86 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.879 1.272 . . . . 0.0 110.908 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.61 177.31 4.88 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -53.14 -45.94 68.61 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 121.522 0.677 . . . . 0.0 112.268 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 3.5 m -63.88 -29.41 70.59 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.787 2.435 . . . . 0.0 112.577 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 77.0 mt -81.35 -49.11 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.06 -50.77 72.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.737 0.643 . . . . 0.0 112.737 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.09 -45.8 93.22 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 118.699 0.681 . . . . 0.0 111.205 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.15 -55.65 31.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.55 -38.15 77.21 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.548 0.739 . . . . 0.0 111.761 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -61.26 -46.55 89.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -64.69 -35.76 82.08 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt -68.46 -18.93 64.52 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.951 -1.093 . . . . 0.0 111.735 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 83.88 16.89 66.69 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 110.564 -1.015 . . . . 0.0 110.564 -178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -86.81 -8.13 57.61 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 35.1 p -113.33 136.97 52.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.731 1.612 . . . . 0.0 106.71 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.07 -21.39 46.83 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 121.288 -0.883 . . . . 0.0 111.081 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -164.99 170.05 15.65 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 121.592 -0.692 . . . . 0.0 109.721 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 4.4 t -162.95 -178.44 6.09 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.486 1.914 . . . . 0.0 106.498 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.43 154.32 39.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -153.29 151.23 29.78 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.495 -0.753 . . . . 0.0 108.985 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -102.94 -179.98 26.34 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.897 1.237 . . . . 0.0 111.107 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -61.0 -49.27 8.5 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 123.768 2.979 . . . . 0.0 110.693 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -133.84 133.27 41.38 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.041 2.136 . . . . 0.0 105.763 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -112.19 109.75 19.61 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -61.48 130.09 44.32 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.3 t -167.67 168.51 12.55 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.301 1.84 . . . . 0.0 106.644 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -139.24 29.45 2.22 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.219 1.408 . . . . 0.0 108.282 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 12.5 tt -158.45 150.42 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 128.429 2.691 . . . . 0.0 105.688 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 32.57 55.3 0.38 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 129.514 3.126 . . . . 0.0 113.075 179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.6 p -69.32 87.13 0.43 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.442 1.497 . . . . 0.0 109.829 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 19.9 m -127.42 167.67 15.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.971 1.708 . . . . 0.0 108.232 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -155.85 162.88 40.38 Favored 'General case' 0 N--CA 1.463 0.218 0 O-C-N 121.007 -1.058 . . . . 0.0 110.056 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.65 149.49 32.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 123.405 0.682 . . . . 0.0 109.64 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -72.89 158.26 35.86 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.341 0.656 . . . . 0.0 109.458 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -140.27 170.4 15.9 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.837 1.255 . . . . 0.0 110.199 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -125.51 177.53 16.96 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.131 1.824 . . . . 0.0 109.528 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 14.4 p -100.63 110.4 27.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 O-C-N 121.352 -1.087 . . . . 0.0 111.529 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.472 HG21 ' CE2' ' A' ' 117' ' ' TYR . 5.0 t -142.32 173.81 11.19 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 123.871 0.868 . . . . 0.0 108.814 179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.91 162.13 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 127.21 2.204 . . . . 0.0 110.519 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pp -143.77 152.14 55.07 Favored Pre-proline 0 C--O 1.239 0.527 0 C-N-CA 125.033 1.333 . . . . 0.0 108.105 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -65.19 150.36 87.67 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.114 1.876 . . . . 0.0 110.793 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.686 HG22 ' H ' ' A' ' 255' ' ' SER . 57.4 p -129.51 165.57 21.39 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.855 2.062 . . . . 0.0 110.234 -178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -85.29 159.86 19.96 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.136 0.88 . . . . 0.0 109.176 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -49.81 103.54 0.05 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.284 1.434 . . . . 0.0 113.287 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 83.17 1.52 90.49 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 117.225 -1.875 . . . . 0.0 115.279 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.26 122.19 11.54 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 121.39 2.595 . . . . 0.0 113.437 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -65.95 147.83 85.24 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.149 1.9 . . . . 0.0 111.374 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.686 ' H ' HG22 ' A' ' 249' ' ' THR . 48.0 t -64.13 152.41 40.63 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.804 1.241 . . . . 0.0 109.426 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.442 ' HD3' ' HE3' ' A' ' 326' ' ' LYS . 69.9 mttt -134.21 77.68 60.3 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.365 1.466 . . . . 0.0 107.693 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -82.62 -175.37 2.43 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.298 3.332 . . . . 0.0 111.437 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -66.86 166.65 12.94 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.621 0.768 . . . . 0.0 108.957 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 26.5 t -96.22 164.47 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -147.49 150.99 23.3 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 107.446 -2.262 . . . . 0.0 107.446 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 75.4 t -135.22 112.04 13.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-O 121.582 0.706 . . . . 0.0 109.448 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 44.1 tp -63.91 126.82 28.89 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 12.5 m -117.32 164.56 14.64 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 124.215 1.006 . . . . 0.0 110.933 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.463 ' HB2' HG13 ' A' ' 108' ' ' ILE . . . -134.27 135.54 42.95 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.693 1.597 . . . . 0.0 107.495 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -127.42 166.54 20.11 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 62.6 mt -114.19 133.35 60.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -74.07 122.97 23.51 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -68.23 -15.07 63.43 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.197 -1.382 . . . . 0.0 114.641 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -76.63 -14.02 60.01 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.649 1.568 . . . . 0.0 114.373 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 36.5 m -61.98 154.24 69.48 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 123.838 0.855 . . . . 0.0 109.361 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.441 ' HD3' ' CG2' ' A' ' 2' ' ' ILE . 52.2 Cg_endo -68.04 -58.5 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.967 1.778 . . . . 0.0 110.914 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -118.15 100.26 7.41 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.989 1.316 . . . . 0.0 108.254 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.408 ' HE2' ' HB1' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -59.0 -15.77 14.78 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 122.787 0.435 . . . . 0.0 112.139 178.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -59.97 -34.19 72.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.391 1.476 . . . . 0.0 110.105 178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.9 mt -57.69 -44.03 85.55 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.58 -37.05 63.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.139 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -35.43 79.08 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 119.026 0.83 . . . . 0.0 109.651 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -69.97 -55.19 10.27 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 118.947 -0.549 . . . . 0.0 109.727 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -52.19 -46.51 65.6 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 119.049 0.841 . . . . 0.0 111.58 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.4 tt -64.63 -40.82 96.14 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -90.11 -3.9 57.64 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -105.96 -23.68 12.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.051 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -143.24 -36.72 0.37 Allowed 'General case' 0 C--N 1.344 0.349 0 CA-C-N 119.901 1.228 . . . . 0.0 114.017 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.14 -32.7 71.26 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 120.105 1.321 . . . . 0.0 113.678 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 77.6 mt -115.57 51.31 0.94 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.333 1.853 . . . . 0.0 110.242 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 47.7 p -120.55 163.13 18.45 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.26 -39.26 92.28 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -70.97 -41.91 70.4 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.269 0.628 . . . . 0.0 111.438 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.6 67.12 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 112.003 -0.439 . . . . 0.0 112.003 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 78.9 mt -67.62 -43.16 81.1 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.93 -44.5 94.3 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -59.2 -41.57 88.84 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.343 1.057 . . . . 0.0 113.606 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 92.9 t -76.84 -36.29 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -66.82 -36.41 82.3 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -66.96 -32.91 74.48 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.729 -0.607 . . . . 0.0 111.055 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.34 -50.49 15.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.517 1.127 . . . . 0.0 110.585 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 51.5 mmtt -141.79 150.94 58.47 Favored Pre-proline 0 N--CA 1.47 0.535 0 O-C-N 121.045 -1.034 . . . . 0.0 109.299 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.01 115.77 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.202 2.602 . . . . 0.0 110.777 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 14.4 mt -84.0 -31.93 25.23 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.673 -0.642 . . . . 0.0 111.54 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 93.02 -146.91 18.34 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 106.343 -2.703 . . . . 0.0 106.343 -177.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -83.66 173.28 11.5 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.01 153.34 38.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 123.193 1.473 . . . . 0.0 113.475 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.97 -30.92 62.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.914 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 58.7 tp -66.29 104.93 1.3 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.43 1.892 . . . . 0.0 107.968 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 9.5 mtmt -56.66 -23.05 38.91 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.662 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 40.1 m -72.38 -61.73 1.69 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.909 0.777 . . . . 0.0 110.825 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -71.5 -19.19 62.23 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.102 0.864 . . . . 0.0 112.769 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -63.62 -31.37 72.51 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -67.95 -15.2 63.5 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.364 0.984 . . . . 0.0 111.264 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.46 ' HA ' ' HE3' ' A' ' 313' ' ' LYS . 29.3 mm-40 -94.71 -48.47 6.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.259 1.424 . . . . 0.0 108.264 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.453 ' HB3' HG21 ' A' ' 317' ' ' ILE . 7.2 mt -64.65 -41.25 96.25 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.36 -0.55 0.59 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.46 ' HE3' ' HA ' ' A' ' 310' ' ' GLU . 90.6 mttt -67.58 -13.51 62.13 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.376 1.07 . . . . 0.0 111.835 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.0 151.21 68.6 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 119.756 1.162 . . . . 0.0 109.711 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.64 -23.8 63.28 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.095 2.53 . . . . 0.0 113.84 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 51.6 ttt85 -61.57 -27.99 69.02 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.661 0.664 . . . . 0.0 110.551 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 311' ' ' LEU . 4.2 mp -91.08 -52.32 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -48.09 -50.37 28.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.905 0.753 . . . . 0.0 110.679 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.25 -32.52 71.22 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 13.6 m -68.91 -41.04 78.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.492 1.042 . . . . 0.0 108.21 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 26.8 tpp -69.53 -41.57 75.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.843 -0.599 . . . . 0.0 109.457 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -53.35 -43.31 67.63 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -58.68 -46.66 86.75 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.36 1.064 . . . . 0.0 109.268 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.41 -25.33 67.97 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.424 0.69 . . . . 0.0 111.433 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -82.03 -26.45 33.78 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.824 0.738 . . . . 0.0 111.422 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.442 ' HE3' ' HD3' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -103.79 -8.25 19.94 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -179.465 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -86.4 -147.75 11.19 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 125.327 1.441 . . . . 0.0 112.396 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -145.94 130.3 17.69 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 126.264 1.826 . . . . 0.0 106.483 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 67.3 mt -104.91 97.49 5.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 127.001 2.12 . . . . 0.0 107.27 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 35.54 73.99 0.6 Allowed Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 126.824 2.05 . . . . 0.0 111.454 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -64.75 130.0 25.02 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.904 3.069 . . . . 0.0 113.985 -178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -116.4 76.25 1.01 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.607 1.563 . . . . 0.0 108.925 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 18.0 pt -140.64 147.69 49.97 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 124.995 1.318 . . . . 0.0 110.922 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.46 -18.67 33.55 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.497 2.131 . . . . 0.0 111.799 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -72.49 -23.02 60.97 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 120.921 -1.112 . . . . 0.0 109.09 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -40.45 83.94 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-N 120.518 1.508 . . . . 0.0 109.42 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 1.1 p -69.0 -34.25 74.98 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.383 -0.823 . . . . 0.0 109.242 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -69.63 -42.64 74.04 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -53.84 -54.56 36.74 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 126.557 1.943 . . . . 0.0 109.849 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -60.89 -45.66 93.73 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.579 0.627 . . . . 0.0 110.084 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -63.15 -26.72 68.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -73.99 -60.87 2.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.702 1.201 . . . . 0.0 109.41 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -24.71 34.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 O-C-N 121.353 -0.842 . . . . 0.0 111.795 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 26.7 ttt-85 -56.71 -27.65 59.46 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.356 1.062 . . . . 0.0 110.788 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 1.5 m -97.79 -37.92 9.67 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.48 -48.3 66.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 118.874 0.761 . . . . 0.0 112.66 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.09 -56.88 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 37.4 mm -58.07 -36.5 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 123.289 0.635 . . . . 0.0 110.265 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -56.65 -48.99 76.35 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.843 -1.161 . . . . 0.0 110.094 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.42 -42.42 59.21 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 119.433 -0.318 . . . . 0.0 111.337 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -59.72 -37.14 78.09 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.468 0.707 . . . . 0.0 112.079 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 21.0 m -86.85 -7.72 57.96 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.148 0.979 . . . . 0.0 109.64 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 75.99 17.62 79.94 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 118.905 0.775 . . . . 0.0 113.018 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -73.3 -30.71 63.57 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.151 0.981 . . . . 0.0 110.699 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -150.75 166.45 30.42 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.032 0.833 . . . . 0.0 110.519 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.9 m -71.91 152.72 42.35 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.0 t -52.37 -56.19 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.455 1.102 . . . . 0.0 108.306 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.66 -44.73 77.5 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 124.777 1.231 . . . . 0.0 113.461 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -71.97 -36.49 69.85 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 118.649 0.659 . . . . 0.0 111.964 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.11 -35.25 80.14 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 10.7 tp -73.07 -42.48 63.0 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.949 1.699 . . . . 0.0 110.673 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -58.29 -52.86 63.82 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 125.461 1.504 . . . . 0.0 108.095 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -49.87 -56.73 9.35 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 126.283 1.833 . . . . 0.0 108.916 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.94 -48.61 80.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.934 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 12.7 tm0? -57.39 -37.04 72.07 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.9 m -62.66 -43.97 97.44 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.407 0.683 . . . . 0.0 110.069 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 45.4 mtt-85 -57.97 -27.7 63.68 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.445 -0.784 . . . . 0.0 111.563 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 13.7 mt -86.12 -39.28 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 123.986 0.914 . . . . 0.0 110.459 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 22.4 p -70.17 -31.1 68.42 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 119.518 1.054 . . . . 0.0 112.434 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? . . . . . 0 C--O 1.251 1.142 0 C-N-CA 125.541 1.537 . . . . 0.0 110.855 -178.787 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 26.4 tptt . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 44.2 mt -126.92 154.52 37.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -77.87 88.04 4.08 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 123.353 1.549 . . . . 0.0 111.277 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -71.94 107.24 4.58 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 126.129 1.772 . . . . 0.0 108.647 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 120.62 22.64 3.01 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 116.063 1.185 . . . . 0.0 116.063 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -136.43 170.91 15.27 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 119.218 1.509 . . . . 0.0 110.19 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 35.0 mt -148.38 152.87 37.76 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 128.695 2.798 . . . . 0.0 107.63 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.75 149.65 16.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.458 HG21 HD21 ' A' ' 20' ' ' LEU . 67.3 mt -128.82 120.69 52.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 126.893 2.077 . . . . 0.0 105.95 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -119.2 114.72 22.87 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.533 1.133 . . . . 0.0 109.124 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.7 mt -122.92 164.58 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 124.962 1.305 . . . . 0.0 108.074 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -84.11 4.43 30.35 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.89 175.68 49.29 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 107.398 -2.281 . . . . 0.0 107.398 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 59.51 22.42 10.99 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 118.234 1.017 . . . . 0.0 111.359 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -125.64 166.08 17.39 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 126.655 1.982 . . . . 0.0 108.041 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.34 47.21 2.63 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-O 119.062 -0.855 . . . . 0.0 114.791 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -50.83 -38.86 51.36 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.036 0.934 . . . . 0.0 113.08 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -58.57 -47.23 84.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.012 0.823 . . . . 0.0 110.303 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.96 -38.02 93.77 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.458 HD21 HG21 ' A' ' 9' ' ' ILE . 46.6 tp -68.37 -35.64 78.01 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.752 0.821 . . . . 0.0 111.164 179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.26 -37.44 64.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.376 0.67 . . . . 0.0 110.23 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -67.33 -30.05 69.78 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.117 0.872 . . . . 0.0 111.963 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.6 t -69.26 -43.94 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.58 -41.17 94.21 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -60.21 -45.73 92.18 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -58.25 -55.04 40.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -52.19 -55.6 20.02 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 117.892 0.315 . . . . 0.0 110.927 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -58.93 -35.68 73.5 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.144 -0.973 . . . . 0.0 111.191 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -69.06 -28.34 66.44 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 120.931 -1.106 . . . . 0.0 111.285 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -98.53 -5.86 31.31 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.591 1.156 . . . . 0.0 111.519 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.1 p -134.96 -35.46 0.85 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.44 -11.5 63.28 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.356 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.9 mm -67.58 137.27 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 106.32 -1.734 . . . . 0.0 106.32 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -70.64 139.8 51.41 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 117.652 -1.166 . . . . 0.0 109.727 -179.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.0 t -135.18 121.12 31.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 26.5 m -114.14 145.15 42.04 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.831 2.052 . . . . 0.0 110.87 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.432 HG22 HD12 ' A' ' 9' ' ' ILE . 20.6 t -137.24 128.52 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.84 1.656 . . . . 0.0 107.319 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -140.55 160.64 39.57 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.639 0.776 . . . . 0.0 111.68 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -127.07 68.06 71.35 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.214 1.405 . . . . 0.0 112.559 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -78.83 168.72 20.54 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 124.812 3.675 . . . . 0.0 111.267 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -110.8 8.11 22.25 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.709 1.604 . . . . 0.0 110.758 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.67 11.79 4.05 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 43' ' ' LEU . 1.5 pt? -52.07 -30.74 27.22 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -63.7 -20.45 65.73 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.874 2.07 . . . . 0.0 113.438 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -117.82 -24.32 7.2 Favored 'General case' 0 C--O 1.224 -0.288 0 C-N-CA 123.841 0.856 . . . . 0.0 109.498 178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.412 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.2 mmpt? -74.76 -46.09 39.56 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.795 -1.097 . . . . 0.0 110.886 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -50.73 -57.44 13.42 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 120.296 1.407 . . . . 0.0 110.199 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -68.46 -0.19 5.54 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 121.767 1.644 . . . . 0.0 114.558 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -112.05 -0.15 15.77 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.753 1.221 . . . . 0.0 111.561 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 46' ' ' LYS . 6.4 t -130.59 -42.63 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.349 1.06 . . . . 0.0 108.657 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.38 -32.33 73.73 Favored 'General case' 0 C--O 1.224 -0.269 0 O-C-N 120.995 -1.066 . . . . 0.0 108.759 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.01 -13.36 4.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.021 1.328 . . . . 0.0 113.266 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 82.2 p -118.95 -0.76 11.11 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.91 1.232 . . . . 0.0 111.445 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.31 15.15 64.91 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.33 0.967 . . . . 0.0 111.56 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -106.79 -6.01 18.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.649 1.224 . . . . 0.0 113.633 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.01 -173.56 32.34 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.896 1.236 . . . . 0.0 115.228 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -70.78 179.29 4.37 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 124.205 3.27 . . . . 0.0 111.435 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -105.57 -20.18 13.55 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 121.264 -0.898 . . . . 0.0 113.045 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.8 mt -140.92 149.85 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.5 tt -128.71 148.88 33.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 126.293 1.837 . . . . 0.0 106.695 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -138.87 99.3 3.75 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.752 1.221 . . . . 0.0 109.785 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -153.11 177.81 10.4 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 122.133 0.968 . . . . 0.0 111.667 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.52 134.33 53.16 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.781 1.632 . . . . 0.0 107.345 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -52.63 -27.84 18.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 129.01 2.924 . . . . 0.0 112.279 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -59.95 -26.4 65.95 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.427 0.691 . . . . 0.0 109.717 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.1 tpm_? -102.73 12.48 36.23 Favored 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 127.507 2.323 . . . . 0.0 110.852 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -108.02 -30.83 8.23 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.825 1.648 . . . . 0.0 111.227 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.8 -10.48 38.64 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 118.801 -1.0 . . . . 0.0 113.865 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.27 -47.59 3.26 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-N 119.928 1.864 . . . . 0.0 109.229 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -55.31 -46.74 76.26 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.709 1.604 . . . . 0.0 111.68 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.14 93.4 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.734 1.152 . . . . 0.0 109.673 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -69.91 1.09 4.81 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.972 1.709 . . . . 0.0 111.149 178.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -122.68 2.32 9.5 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.305 2.642 . . . . 0.0 109.511 177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.62 -1.03 68.29 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 125.656 1.598 . . . . 0.0 112.401 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.3 mt -69.04 -34.3 74.99 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.566 1.183 . . . . 0.0 112.848 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.5 mt -89.15 127.88 35.75 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.654 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -81.44 170.34 16.07 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.692 0.797 . . . . 0.0 112.602 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -60.11 117.31 4.97 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.508 ' HA ' HD13 ' A' ' 79' ' ' ILE . 1.4 mm -70.96 166.19 2.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 m -39.58 113.96 0.9 Allowed Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 126.265 1.826 . . . . 0.0 110.955 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.77 -53.32 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.434 2.756 . . . . 0.0 113.364 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -62.26 116.75 5.28 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.427 1.108 . . . . 0.0 111.731 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -54.33 -28.59 43.56 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.479 1.512 . . . . 0.0 111.971 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.82 -32.5 67.66 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.861 1.209 . . . . 0.0 112.786 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -68.98 -39.44 79.39 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -66.22 -37.73 86.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.722 1.209 . . . . 0.0 110.329 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -65.8 -13.4 59.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.311 1.845 . . . . 0.0 112.186 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -76.97 -9.65 58.84 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 120.757 -1.214 . . . . 0.0 110.591 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.9 mt -118.29 157.51 26.92 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.529 1.932 . . . . 0.0 108.614 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.404 ' CD1' ' HG2' ' A' ' 305' ' ' LYS . 48.9 m-85 -64.93 152.71 90.28 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 119.118 0.872 . . . . 0.0 109.497 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -70.53 -35.72 9.94 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.763 2.308 . . . . 0.0 114.531 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -64.18 -32.82 74.54 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.863 0.756 . . . . 0.0 110.902 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.77 -21.77 66.05 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.301 1.04 . . . . 0.0 110.401 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -77.43 -32.77 54.82 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 121.413 -0.804 . . . . 0.0 109.827 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.81 -4.03 3.97 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.493 1.517 . . . . 0.0 111.083 178.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -102.62 -7.0 22.16 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.032 2.133 . . . . 0.0 111.995 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.48 11.53 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.997 1.319 . . . . 0.0 113.179 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -69.32 169.44 12.24 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 122.43 1.109 . . . . 0.0 112.15 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -159.7 168.1 26.77 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 127.868 2.467 . . . . 0.0 105.469 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -60.95 108.02 0.8 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.876 1.67 . . . . 0.0 111.091 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.34 -83.39 0.87 Allowed Glycine 0 CA--C 1.523 0.58 0 C-N-CA 124.62 1.105 . . . . 0.0 111.366 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.1 173.43 6.58 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.84 0.856 . . . . 0.0 111.788 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 103' ' ' LEU . 3.4 mm? -109.2 157.46 18.77 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.9 pt -119.53 -26.23 2.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.706 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.39 178.16 8.9 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 124.195 0.998 . . . . 0.0 109.177 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.473 ' CE2' HD12 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -129.63 148.66 70.32 Favored Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.75 0.82 . . . . 0.0 109.864 178.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.71 142.24 43.26 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.569 2.846 . . . . 0.0 108.917 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.0 mm -129.9 -49.09 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 124.656 1.182 . . . . 0.0 111.422 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 262' ' ' LEU . . . -122.01 147.08 46.52 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.033 0.833 . . . . 0.0 109.614 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.24 104.82 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -157.34 130.49 7.75 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 102.005 -3.331 . . . . 0.0 102.005 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.79 69.5 0.74 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 127.057 2.143 . . . . 0.0 106.889 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 pp -164.46 154.38 14.13 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.809 0.844 . . . . 0.0 111.001 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.7 m 179.91 156.81 0.64 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 130.418 3.487 . . . . 0.0 106.895 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 tp -149.5 160.64 43.3 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.52 140.61 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -141.9 -177.35 5.16 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.483 1.513 . . . . 0.0 108.127 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -60.29 147.51 40.07 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.718 -0.614 . . . . 0.0 110.547 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -64.68 -9.91 23.26 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.072 0.949 . . . . 0.0 112.281 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -62.28 -177.89 0.15 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.611 1.164 . . . . 0.0 111.821 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.11 20.38 19.09 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.248 1.819 . . . . 0.0 113.255 -177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -119.78 72.07 15.71 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.79 89.79 0.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.08 2.52 . . . . 0.0 110.338 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -113.01 73.03 1.54 Allowed Pre-proline 0 CA--C 1.533 0.293 0 C-N-CA 123.781 0.832 . . . . 0.0 109.006 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -74.99 156.55 43.05 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.711 1.607 . . . . 0.0 111.639 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.13 167.26 27.81 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.942 2.428 . . . . 0.0 107.575 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -113.57 -10.07 13.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.047 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 9.7 t -153.86 157.35 39.16 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 120.15 1.341 . . . . 0.0 110.98 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 50.5 m95 -72.98 -24.73 60.81 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.675 -0.641 . . . . 0.0 111.261 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -70.92 -17.04 62.7 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 119.0 0.818 . . . . 0.0 109.956 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -86.99 -24.34 24.72 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 125.513 1.525 . . . . 0.0 110.243 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 33.7 mm -52.69 -58.97 9.88 Favored Pre-proline 0 N--CA 1.453 -0.314 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.894 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.77 -22.32 27.61 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 CA-C-N 120.253 1.126 . . . . 0.0 112.164 -179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -73.99 -31.05 62.8 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.271 1.428 . . . . 0.0 111.834 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.6 tp -91.89 -31.37 15.7 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.184 1.393 . . . . 0.0 110.134 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -58.57 -44.17 89.64 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 121.671 0.748 . . . . 0.0 110.675 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.6 ptmm? -65.17 -30.38 71.28 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 123.967 0.907 . . . . 0.0 112.316 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -77.43 -42.35 36.41 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 20.3 mt -72.58 -31.67 65.39 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.534 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -65.89 -34.88 79.14 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.81 -13.02 61.89 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.02 -5.4 8.46 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.052 0.941 . . . . 0.0 112.471 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -173.31 -89.46 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 118.868 0.758 . . . . 0.0 112.885 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.42 ' HE3' ' OE2' ' A' ' 221' ' ' GLU . 62.2 mttm -146.22 -177.45 5.62 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.515 1.526 . . . . 0.0 109.082 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 p -57.78 166.97 1.25 Allowed 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.839 0.856 . . . . 0.0 111.508 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.83 -76.51 0.46 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.5 tp -90.18 133.27 35.0 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.464 1.506 . . . . 0.0 110.207 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 53.9 ttm -139.82 107.17 5.53 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.7 p90 -135.84 160.85 37.3 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.364 1.465 . . . . 0.0 109.196 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -67.93 120.09 13.64 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.106 0.962 . . . . 0.0 110.994 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 13.3 mt -106.97 -9.76 16.16 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.659 1.984 . . . . 0.0 111.909 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 67.1 mm-40 -77.67 -17.61 57.52 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.337 -0.852 . . . . 0.0 111.733 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -109.57 147.44 36.08 Favored Pre-proline 0 N--CA 1.469 0.486 0 C-N-CA 124.467 1.107 . . . . 0.0 109.347 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -82.07 -18.26 7.6 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.832 2.354 . . . . 0.0 114.138 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -58.94 -37.6 77.07 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.445 1.021 . . . . 0.0 111.974 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -71.54 -43.67 66.0 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.794 0.838 . . . . 0.0 112.445 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.2 p -80.9 -14.18 58.24 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.071 0.549 . . . . 0.0 112.16 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 38.9 t-105 -54.99 -57.3 20.23 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.657 -1.164 . . . . 0.0 113.509 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.5 -26.38 81.81 Favored 'Trans proline' 0 C--N 1.351 0.679 0 CA-C-N 121.763 1.665 . . . . 0.0 113.332 -179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.82 -56.02 9.33 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.4 pt -67.6 -25.71 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 119.144 0.884 . . . . 0.0 111.685 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.77 -4.1 25.8 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.283 -0.886 . . . . 0.0 110.912 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.6 -54.49 42.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.698 0.799 . . . . 0.0 110.534 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -55.15 -61.23 2.46 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.105 0.479 . . . . 0.0 111.121 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.26 6.41 0.03 OUTLIER Glycine 0 CA--C 1.524 0.6 0 CA-C-O 118.47 -1.183 . . . . 0.0 115.261 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -53.37 133.08 42.76 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 118.277 1.038 . . . . 0.0 112.155 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -142.66 120.41 11.89 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 122.131 0.967 . . . . 0.0 110.681 178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -91.7 85.57 5.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 335' ' ' GLN . 11.0 m-85 66.54 165.84 0.2 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.6 1.56 . . . . 0.0 108.445 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -132.54 159.25 40.01 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 120.819 -1.175 . . . . 0.0 109.258 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -149.09 104.62 3.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.284 -1.746 . . . . 0.0 106.284 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.1 -174.79 0.84 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -52.5 -35.79 53.82 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.061 -1.024 . . . . 0.0 110.986 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -145.29 6.89 1.54 Allowed Glycine 0 CA--C 1.533 1.212 0 CA-C-O 117.799 -1.556 . . . . 0.0 115.756 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -122.43 121.48 36.73 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 120.999 2.4 . . . . 0.0 109.275 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.48 123.6 50.4 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -146.36 83.49 1.61 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.75 -0.55 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -83.5 -25.76 30.8 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 119.67 -1.894 . . . . 0.0 107.774 177.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -96.0 103.78 15.68 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 127.727 2.411 . . . . 0.0 106.798 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 1.7 t -142.95 165.12 16.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -140.63 35.71 1.84 Allowed Glycine 0 CA--C 1.533 1.163 0 N-CA-C 115.025 0.77 . . . . 0.0 115.025 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.0 t -60.11 -17.04 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 119.436 1.618 . . . . 0.0 114.617 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . 0.273 0.0 OUTLIER -117.86 20.49 13.33 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.554 1.541 . . . . 0.0 111.255 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -69.71 159.04 34.25 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 120.601 -1.312 . . . . 0.0 108.176 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.34 -30.18 62.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.549 0.74 . . . . 0.0 112.422 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.23 -41.11 94.95 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.511 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.1 -52.92 56.95 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 122.918 0.487 . . . . 0.0 109.938 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -62.64 -36.93 84.41 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 117.921 -1.038 . . . . 0.0 111.656 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.57 -49.71 76.45 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 119.24 0.927 . . . . 0.0 110.234 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.85 -15.12 75.91 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.308 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 44.0 tp -89.12 -50.21 6.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 118.195 0.998 . . . . 0.0 110.996 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.6 t -55.61 -38.63 69.71 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 117.824 -1.084 . . . . 0.0 111.856 -178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -54.6 -54.52 40.26 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 120.173 1.351 . . . . 0.0 111.028 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 9.9 tt -62.01 -49.73 74.9 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.687 1.195 . . . . 0.0 109.563 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.26 -29.23 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 124.105 0.962 . . . . 0.0 110.601 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.51 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.9 OUTLIER -67.35 -37.03 82.6 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 119.043 0.838 . . . . 0.0 111.476 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 15.8 mt -66.57 -39.55 88.53 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 37.3 mt -61.95 -48.61 87.77 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.51 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -51.39 -40.18 58.73 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.731 1.612 . . . . 0.0 111.567 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -84.77 2.23 43.1 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.969 1.308 . . . . 0.0 112.745 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? 48.32 46.72 20.16 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.776 2.03 . . . . 0.0 111.396 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.08 -2.31 9.18 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 6.7 ttp -114.49 153.52 29.84 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -77.28 49.92 0.73 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.453 1.501 . . . . 0.0 110.671 -178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.63 -11.37 11.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.481 2.712 . . . . 0.0 115.046 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -91.72 -13.51 31.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.979 1.711 . . . . 0.0 110.815 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.7 m -61.31 162.14 8.14 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.524 1.929 . . . . 0.0 108.562 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.77 -174.19 4.55 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -56.17 -45.63 79.63 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 122.865 0.466 . . . . 0.0 111.001 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 29.3 m -64.39 -44.21 92.03 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.984 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 22.5 mm -62.34 -51.9 66.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -56.26 -59.09 5.45 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.516 1.126 . . . . 0.0 111.829 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -55.7 -40.67 72.72 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.345 0.658 . . . . 0.0 111.99 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.09 -53.82 39.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.09 -35.52 71.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.548 0.739 . . . . 0.0 111.317 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -64.05 -48.96 74.22 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -61.62 -27.75 68.88 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.075 0.55 . . . . 0.0 110.131 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 23.2 mmtt -76.49 -10.97 59.79 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.719 -1.238 . . . . 0.0 111.431 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 73.87 24.7 73.53 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.42 ' OE2' ' HE3' ' A' ' 144' ' ' LYS . 5.4 mm-40 -93.68 -30.26 15.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 69.9 p -87.77 146.68 25.53 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 118.996 0.816 . . . . 0.0 110.386 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -85.26 -31.25 23.21 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -160.03 166.71 29.45 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 118.44 0.564 . . . . 0.0 112.396 -178.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 6.3 t -147.39 161.99 39.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.081 1.352 . . . . 0.0 107.889 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.9 mt -131.78 122.38 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -142.06 -178.64 5.8 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.945 1.698 . . . . 0.0 108.527 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -170.44 -169.57 33.71 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.649 -0.657 . . . . 0.0 112.532 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -63.06 -178.68 0.45 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.228 3.285 . . . . 0.0 112.724 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -141.05 139.28 34.07 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.924 1.29 . . . . 0.0 108.351 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -112.43 149.74 32.13 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.337 1.455 . . . . 0.0 110.659 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 47.1 m95 50.5 21.1 0.79 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.561 1.944 . . . . 0.0 114.069 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 35.4 t -119.47 162.4 18.93 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.06 1.744 . . . . 0.0 109.431 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -61.61 153.94 26.43 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.5 -0.75 . . . . 0.0 111.664 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.62 -6.21 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -137.81 104.69 5.36 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.547 1.939 . . . . 0.0 106.648 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 16.6 p -136.26 -73.96 0.44 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 9.1 p -157.55 149.45 22.24 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.843 1.257 . . . . 0.0 110.355 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.65 150.96 5.02 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.076 1.351 . . . . 0.0 110.64 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m -144.92 0.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.5 1.12 . . . . 0.0 112.784 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -47.62 131.59 14.26 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.762 1.225 . . . . 0.0 112.83 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -158.67 130.74 6.73 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.592 1.557 . . . . 0.0 107.177 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 68.72 174.16 9.08 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 121.57 0.539 . . . . 0.0 111.993 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 85.2 t -145.67 128.79 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.5 t -155.44 169.42 24.29 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 33.7 t -68.82 122.0 19.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 124.442 1.097 . . . . 0.0 111.196 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -79.33 154.87 76.94 Favored Pre-proline 0 C--O 1.237 0.409 0 C-N-CA 123.383 0.673 . . . . 0.0 109.348 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.69 146.89 80.43 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.6 1.533 . . . . 0.0 109.257 178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 255' ' ' SER . 20.4 p -129.32 156.24 44.33 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.181 0.992 . . . . 0.0 108.822 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -81.33 155.26 26.09 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.103 -0.998 . . . . 0.0 108.896 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.71 119.98 7.06 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 121.145 -0.972 . . . . 0.0 112.523 -178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.39 5.52 63.33 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.667 1.603 . . . . 0.0 113.982 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -148.12 115.46 4.0 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 119.907 1.854 . . . . 0.0 114.379 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.86 141.98 15.48 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.17 2.58 . . . . 0.0 112.574 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.472 ' H ' HG22 ' A' ' 249' ' ' THR . 58.8 m -59.88 140.12 56.87 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 84.17 15.01 Favored Pre-proline 0 N--CA 1.466 0.329 0 O-C-N 121.802 -0.561 . . . . 0.0 109.929 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -77.05 -175.57 2.72 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.762 2.308 . . . . 0.0 110.259 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -67.55 162.45 23.34 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.59 130.2 36.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -140.18 159.04 26.07 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 106.355 -2.698 . . . . 0.0 106.355 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 16.0 m -141.49 176.55 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.196 0.998 . . . . 0.0 108.365 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 5.7 tt -106.42 151.62 24.68 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.7 m -140.49 169.5 17.54 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.571 0.623 . . . . 0.0 112.18 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -132.54 137.83 47.27 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.835 1.654 . . . . 0.0 107.082 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.35 134.97 7.46 Favored Glycine 0 CA--C 1.532 1.096 0 O-C-N 124.092 0.87 . . . . 0.0 111.69 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 54.2 mt -75.44 136.72 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.298 1.049 . . . . 0.0 110.431 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -71.91 123.61 23.08 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.654 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -71.22 -28.64 64.34 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.69 -0.671 . . . . 0.0 112.166 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -69.37 -8.42 46.23 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 59.9 m -64.61 163.15 29.34 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.267 1.027 . . . . 0.0 108.285 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -74.16 -56.58 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.653 1.569 . . . . 0.0 110.421 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -128.86 102.47 6.55 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.507 ' HE2' ' HB1' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -57.82 -17.51 16.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -59.42 -31.58 69.4 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 123.553 0.741 . . . . 0.0 110.721 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 98.8 mt -60.36 -43.34 96.6 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 121.104 -0.998 . . . . 0.0 109.777 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.38 -43.22 41.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.739 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -34.79 75.95 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 118.848 -0.596 . . . . 0.0 110.675 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -73.41 -52.75 12.65 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -52.55 -50.98 61.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.059 0.845 . . . . 0.0 112.826 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.6 tt -62.35 -20.12 64.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -111.88 -8.9 14.08 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -97.3 -31.95 12.15 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 119.937 1.244 . . . . 0.0 112.336 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -133.18 -37.86 0.97 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.048 0.84 . . . . 0.0 113.115 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.5 -25.47 67.28 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 63.3 mt -112.11 50.53 0.85 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.598 1.159 . . . . 0.0 111.2 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 50.8 p -125.37 157.89 35.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -60.49 -44.19 96.22 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -65.0 -38.65 91.65 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.093 0.957 . . . . 0.0 111.883 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.57 -44.84 56.6 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 16.2 mt -65.35 -49.87 67.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.879 0.839 . . . . 0.0 108.852 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -57.18 -40.26 76.98 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.824 1.25 . . . . 0.0 111.719 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -58.09 -37.26 74.16 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 118.99 0.814 . . . . 0.0 112.692 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 20.5 t -79.25 -37.95 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.203 0.601 . . . . 0.0 109.846 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -63.78 -30.43 71.53 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.607 0.718 . . . . 0.0 111.904 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -64.55 -37.18 86.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.395 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.87 -42.49 39.78 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.43 1.013 . . . . 0.0 111.673 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.518 ' HA ' ' HE2' ' A' ' 297' ' ' LYS . 8.2 mmpt? -145.52 148.1 35.79 Favored Pre-proline 0 N--CA 1.464 0.274 0 C-N-CA 123.716 0.806 . . . . 0.0 109.361 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.6 126.95 15.54 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.378 2.052 . . . . 0.0 108.778 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 70.2 mt -102.36 -9.9 19.93 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 77.38 -155.97 44.4 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.46 170.59 15.39 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 23.3 m -130.32 156.71 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 121.039 -1.038 . . . . 0.0 109.569 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.14 -28.71 42.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.147 0.979 . . . . 0.0 110.96 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 33.4 tp -66.19 106.91 1.78 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 124.471 1.109 . . . . 0.0 108.624 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.404 ' HG2' ' CD1' ' A' ' 90' ' ' TYR . 18.0 mtmt -52.89 -40.8 63.78 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 123.391 0.676 . . . . 0.0 112.335 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 5.1 m -53.48 -29.84 37.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 126.076 1.75 . . . . 0.0 112.768 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -112.75 -12.26 13.38 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.629 0.649 . . . . 0.0 110.196 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -64.36 -42.19 96.32 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.9 -23.37 66.28 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.042 0.937 . . . . 0.0 112.493 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 55.9 mm-40 -90.35 -44.76 9.46 Favored 'General case' 0 N--CA 1.46 0.058 0 C-N-CA 124.417 1.087 . . . . 0.0 109.014 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 6.3 mt -62.86 -35.01 78.57 Favored 'General case' 0 C--N 1.331 -0.201 0 O-C-N 121.245 -0.91 . . . . 0.0 109.888 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.02 -6.54 6.44 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.259 1.424 . . . . 0.0 113.242 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -68.83 -14.65 63.16 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.26 1.024 . . . . 0.0 111.377 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.93 137.51 20.12 Favored Pre-proline 0 C--O 1.237 0.403 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.6 -14.76 37.08 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.233 2.622 . . . . 0.0 110.762 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 27.7 tpt180 -66.55 -48.05 70.92 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 124.186 0.994 . . . . 0.0 108.608 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.9 mp -67.97 -52.63 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.58 -49.49 26.56 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.92 0.888 . . . . 0.0 112.349 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.02 -11.01 2.95 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 29.6 m -98.51 -40.21 8.36 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.3 tpt -69.45 -30.17 68.03 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.837 0.455 . . . . 0.0 111.676 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -62.11 -28.5 69.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.896 -0.573 . . . . 0.0 109.81 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -61.14 -46.34 90.94 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 124.892 1.277 . . . . 0.0 110.697 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -55.79 -41.15 73.69 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.681 0.392 . . . . 0.0 111.486 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -71.38 -18.98 62.33 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.846 1.658 . . . . 0.0 113.344 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.33 1.43 15.14 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.75 0.82 . . . . 0.0 111.493 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -112.81 -165.84 16.69 Favored Glycine 0 CA--C 1.523 0.582 0 C-N-CA 124.712 1.148 . . . . 0.0 112.485 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -134.27 136.95 43.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.672 1.589 . . . . 0.0 112.588 -178.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 49.7 mt -104.54 86.57 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 103.776 -2.675 . . . . 0.0 103.776 178.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 2.5 mpt? 54.02 84.17 0.21 Allowed Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.897 1.279 . . . . 0.0 111.51 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.29 104.62 1.1 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.864 3.042 . . . . 0.0 110.636 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -77.02 56.73 1.26 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.665 1.186 . . . . 0.0 111.486 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.81 147.86 49.53 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.46 1.104 . . . . 0.0 111.422 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.48 -28.89 38.15 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.144 2.563 . . . . 0.0 110.959 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 169' ' ' PHE . 21.8 mp0 -54.23 -29.04 45.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.154 0.982 . . . . 0.0 111.81 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 5.7 mmt -62.77 -35.63 80.45 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.717 1.144 . . . . 0.0 110.729 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 8.7 t -60.8 -46.2 91.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.93 -41.61 86.73 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.423 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -56.37 -53.81 52.99 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 125.142 1.377 . . . . 0.0 109.88 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -60.16 -52.57 64.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.451 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -57.21 -38.11 73.21 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.903 0.774 . . . . 0.0 111.646 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.3 -60.71 2.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 124.335 1.054 . . . . 0.0 111.793 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 18.2 t -62.59 -33.0 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.377 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -34.71 70.89 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 21.4 m -80.58 -43.96 19.75 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.43 -50.83 64.4 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.202 1.001 . . . . 0.0 112.773 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.0 -48.99 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 123.447 0.699 . . . . 0.0 109.335 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mm -65.86 -32.79 59.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 118.909 0.777 . . . . 0.0 110.019 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -62.21 -51.11 69.11 Favored 'General case' 0 N--CA 1.466 0.349 0 O-C-N 120.822 -1.174 . . . . 0.0 109.011 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.51 -48.07 76.52 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.451 0.701 . . . . 0.0 110.602 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.37 69.62 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.284 1.034 . . . . 0.0 113.153 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 16.4 m -92.22 -3.33 55.69 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.591 0.757 . . . . 0.0 110.148 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 68.7 16.23 69.73 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 118.955 0.798 . . . . 0.0 111.715 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -74.74 -28.89 60.97 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.495 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -147.23 158.54 43.99 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 118.836 0.744 . . . . 0.0 109.591 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 4.2 m -62.71 149.9 42.55 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.631 1.173 . . . . 0.0 108.782 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 42.1 t -60.17 -45.71 95.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.83 -51.23 70.9 Favored 'General case' 0 C--N 1.334 -0.068 0 C-N-CA 123.78 0.832 . . . . 0.0 110.097 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -66.87 -27.86 67.86 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -177.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -62.42 -38.94 91.64 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 19.5 mt -78.92 -33.99 44.98 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 118.697 -0.668 . . . . 0.0 109.829 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -55.18 -47.5 75.11 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.34 1.056 . . . . 0.0 108.475 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -58.32 -55.94 28.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.09 1.756 . . . . 0.0 109.265 178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -55.36 -50.56 69.36 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 125.435 1.494 . . . . 0.0 113.533 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -57.69 -37.52 73.61 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 28.3 m -66.46 -48.63 69.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 117.563 -1.208 . . . . 0.0 109.166 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -58.65 -14.58 8.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.014 1.279 . . . . 0.0 113.761 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 35.7 mt -101.51 -26.2 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.755 1.622 . . . . 0.0 110.339 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 40.1 p -101.31 8.11 42.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.011 1.324 . . . . 0.0 110.678 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? . . . . . 0 C--O 1.254 1.311 0 C-N-CA 130.347 3.459 . . . . 0.0 104.54 178.34 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.5 mt -68.36 173.67 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -66.12 32.3 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.746 2.419 . . . . 0.0 114.558 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.58 128.35 31.88 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.73 6.57 21.09 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 126.66 2.076 . . . . 0.0 113.958 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.32 170.91 14.83 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 125.765 1.626 . . . . 0.0 108.502 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 84.5 mt -145.88 147.35 31.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.464 2.306 . . . . 0.0 105.724 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.1 t -133.53 143.23 39.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 42.6 mt -128.8 127.36 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -115.2 105.77 13.29 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.1 mp -71.28 155.45 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.406 HD21 HD11 ' A' ' 43' ' ' LEU . 4.8 m-80 -122.63 108.0 12.6 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.827 0.851 . . . . 0.0 112.541 -177.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.67 24.32 7.44 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 177.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 49.65 41.78 22.26 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.899 1.35 . . . . 0.0 110.085 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -63.36 -178.04 0.23 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.67 1.988 . . . . 0.0 113.286 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.51 51.86 2.64 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.27 1.891 . . . . 0.0 110.74 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -60.09 -20.7 59.44 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.571 1.548 . . . . 0.0 112.777 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -58.7 -44.55 90.37 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 119.543 1.065 . . . . 0.0 111.013 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.24 -31.38 78.95 Favored Glycine 0 CA--C 1.533 1.211 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.0 tp -71.83 -38.35 70.17 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.002 0.921 . . . . 0.0 110.819 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.98 -42.75 65.85 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.965 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -58.43 -34.12 70.45 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.953 0.797 . . . . 0.0 111.39 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.9 t -68.68 -45.09 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 125.658 1.583 . . . . 0.0 106.981 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.83 -37.82 95.51 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -66.12 -42.86 88.61 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 117.848 -1.072 . . . . 0.0 108.522 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -57.62 -56.5 21.16 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -54.89 -48.83 72.49 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 119.396 -0.335 . . . . 0.0 111.325 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.93 -31.78 72.12 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.891 0.768 . . . . 0.0 111.103 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -73.26 -27.13 61.4 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.818 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -97.25 -36.26 10.48 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.823 0.849 . . . . 0.0 112.816 -178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.3 p -102.18 -27.73 12.71 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.397 0.999 . . . . 0.0 113.245 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.82 -15.73 56.72 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 118.623 -1.098 . . . . 0.0 112.581 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.8 mm -69.07 133.11 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' CA ' ' HE3' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -65.69 151.57 46.24 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 121.716 -0.615 . . . . 0.0 111.327 -179.137 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.2 t -136.68 112.06 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 59.9 m -102.92 123.47 46.62 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.27 115.71 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 105.933 -1.876 . . . . 0.0 105.933 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -130.7 159.47 37.16 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.642 0.655 . . . . 0.0 109.7 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -125.23 63.39 42.18 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 124.57 1.148 . . . . 0.0 108.888 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -72.87 146.49 42.41 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.494 2.129 . . . . 0.0 111.807 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -101.06 24.22 9.68 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.87 0.868 . . . . 0.0 110.185 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.67 14.09 0.84 Allowed 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.586 -0.696 . . . . 0.0 112.657 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.406 HD11 HD21 ' A' ' 12' ' ' ASN . 0.8 OUTLIER -56.18 -27.98 56.49 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 120.472 -1.393 . . . . 0.0 112.491 -179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.89 -25.3 56.63 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.91 1.284 . . . . 0.0 112.4 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.61 -25.26 7.93 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 124.222 1.009 . . . . 0.0 109.428 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -45.8 65.08 Favored 'General case' 0 C--O 1.221 -0.433 0 O-C-N 120.263 -1.523 . . . . 0.0 109.878 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -49.75 -59.2 7.24 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 117.598 -1.191 . . . . 0.0 110.06 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.58 -18.83 65.71 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.135 1.89 . . . . 0.0 114.559 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -89.73 1.13 56.46 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.313 1.445 . . . . 0.0 113.147 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 t -131.27 -41.21 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-N 119.481 1.037 . . . . 0.0 108.388 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.09 -30.56 71.09 Favored 'General case' 0 C--N 1.339 0.15 0 O-C-N 122.038 -0.414 . . . . 0.0 110.629 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.28 95.19 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.65 -41.18 79.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.431 0.692 . . . . 0.0 110.43 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 129.39 19.9 1.47 Allowed Glycine 0 CA--C 1.531 1.045 0 CA-C-O 118.131 -1.372 . . . . 0.0 114.324 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -134.96 -160.72 1.08 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.896 1.678 . . . . 0.0 107.038 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.78 -160.54 13.39 Favored Glycine 0 C--N 1.339 0.729 0 O-C-N 120.078 -1.639 . . . . 0.0 114.262 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.51 -179.66 5.03 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.08 2.52 . . . . 0.0 109.8 179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -111.87 -23.56 10.49 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 121.564 -0.71 . . . . 0.0 112.418 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.1 mt -145.51 142.72 22.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.119 0.968 . . . . 0.0 108.851 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 16.2 tt -127.38 142.43 43.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 125.531 1.532 . . . . 0.0 107.412 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.64 116.85 22.35 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.69 1.196 . . . . 0.0 109.866 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 6.5 t-105 -158.59 170.61 21.78 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.676 0.79 . . . . 0.0 109.371 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.58 153.64 40.97 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -58.19 -23.0 54.06 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -55.85 -54.63 42.29 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.853 -1.154 . . . . 0.0 111.731 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -63.7 -22.65 67.02 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 119.255 -0.402 . . . . 0.0 110.828 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -77.76 -2.75 37.85 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.724 0.41 . . . . 0.0 111.205 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.95 -9.13 75.3 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 120.852 -1.155 . . . . 0.0 110.871 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.97 -42.23 0.38 Allowed Glycine 0 CA--C 1.533 1.156 0 N-CA-C 117.938 1.935 . . . . 0.0 117.938 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -46.28 -44.79 16.84 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 120.874 2.337 . . . . 0.0 115.403 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.02 -41.49 82.07 Favored 'General case' 0 N--CA 1.457 -0.111 0 CA-C-N 119.585 1.084 . . . . 0.0 110.078 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -28.45 69.63 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.237 -0.915 . . . . 0.0 109.82 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.5 m -77.58 -2.96 38.36 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.013 1.325 . . . . 0.0 111.29 178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.13 42.74 23.34 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.4 mt -126.81 -2.1 6.61 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.7 mt -121.69 135.75 54.95 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.98 1.718 . . . . 0.0 110.944 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -81.98 162.75 22.54 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.295 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -75.65 104.79 6.36 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 103.555 -2.758 . . . . 0.0 103.555 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -83.52 168.55 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 124.815 1.246 . . . . 0.0 112.982 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.5 m 57.02 91.36 0.08 OUTLIER Pre-proline 0 CA--C 1.532 0.276 0 C-N-CA 127.205 2.202 . . . . 0.0 115.049 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.36 -27.81 9.12 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.177 1.918 . . . . 0.0 112.563 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -124.99 137.69 54.24 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.856 1.207 . . . . 0.0 113.012 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -58.1 -22.97 53.02 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.778 2.431 . . . . 0.0 115.766 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.53 -29.67 70.33 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 120.188 1.358 . . . . 0.0 111.699 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -59.33 -31.56 69.28 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.477 0.711 . . . . 0.0 110.881 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 15.9 mp0 -65.36 -45.02 85.76 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.63 0.772 . . . . 0.0 110.302 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -64.22 -15.53 60.17 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.302 1.041 . . . . 0.0 112.815 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -84.39 -6.41 59.38 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.239 1.016 . . . . 0.0 111.043 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mt -126.7 159.44 33.68 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.882 1.673 . . . . 0.0 108.771 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -76.99 158.19 80.51 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 121.501 -0.749 . . . . 0.0 109.215 178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.83 -47.56 1.84 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.636 2.89 . . . . 0.0 113.386 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -56.71 -30.49 63.54 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.765 0.711 . . . . 0.0 111.734 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.84 -30.8 69.42 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.275 -0.891 . . . . 0.0 110.092 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -79.23 -40.75 29.88 Favored 'General case' 0 CA--C 1.522 -0.12 0 C-N-CA 124.096 0.958 . . . . 0.0 110.206 178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -55.72 -21.88 20.85 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.673 1.189 . . . . 0.0 112.74 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -93.28 3.68 55.25 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 127.029 2.132 . . . . 0.0 113.997 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.18 0.53 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.48 1.112 . . . . 0.0 111.336 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -68.04 155.26 39.91 Favored 'General case' 0 C--N 1.341 0.227 0 O-C-N 121.298 -0.877 . . . . 0.0 108.685 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -136.1 169.92 16.85 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -57.83 102.6 0.1 Allowed 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.442 0.697 . . . . 0.0 111.336 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.46 -81.68 0.95 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.521 1.058 . . . . 0.0 110.911 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.66 169.69 13.86 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.904 0.852 . . . . 0.0 110.816 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 61.9 mt -105.06 168.92 8.74 Favored 'General case' 0 CA--C 1.515 -0.369 0 C-N-CA 124.78 1.232 . . . . 0.0 108.502 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.6 pt -138.77 -25.88 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -159.17 173.25 16.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 119.874 1.215 . . . . 0.0 109.631 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -131.49 149.69 74.25 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 123.659 0.784 . . . . 0.0 109.217 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.72 141.78 38.33 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.182 2.588 . . . . 0.0 109.0 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.3 mm -121.55 -51.1 3.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 123.431 0.692 . . . . 0.0 109.331 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -135.51 166.85 22.23 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.085 0.402 . . . . 0.0 111.282 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -136.67 123.64 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -118.43 175.1 5.87 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -160.31 162.35 33.52 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.844 0.857 . . . . 0.0 110.461 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.08 133.69 55.62 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 125.953 1.701 . . . . 0.0 108.878 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 71.6 m -131.77 169.27 16.44 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 126.285 1.834 . . . . 0.0 109.996 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.4 tp -92.44 149.71 21.23 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.635 0.774 . . . . 0.0 111.527 -179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.99 131.5 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 126.312 1.845 . . . . 0.0 106.269 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -135.2 177.66 7.64 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.605 1.162 . . . . 0.0 108.754 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -82.62 174.87 10.63 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -79.17 -1.18 34.98 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.161 1.384 . . . . 0.0 112.849 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -65.74 164.86 13.75 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.98 0.895 . . . . 0.0 111.722 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -75.02 -10.44 59.48 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.01 0.745 . . . . 0.0 113.01 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.8 tp -115.71 91.72 31.16 Favored Pre-proline 0 C--O 1.236 0.367 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.15 -29.0 18.13 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.664 2.242 . . . . 0.0 112.607 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 42.26 62.73 7.58 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 127.237 2.215 . . . . 0.0 111.248 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -73.5 124.75 9.59 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.278 2.652 . . . . 0.0 111.227 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -78.96 174.9 11.58 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.471 2.114 . . . . 0.0 109.185 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.2 mtpp -130.66 -38.31 1.32 Allowed 'General case' 0 CA--C 1.51 -0.568 0 C-N-CA 123.843 0.857 . . . . 0.0 109.609 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.16 150.67 47.01 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.802 0.335 . . . . 0.0 110.89 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -64.29 -20.52 66.13 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-O 117.994 -1.003 . . . . 0.0 111.464 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.64 -11.55 60.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 119.785 1.175 . . . . 0.0 110.951 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -99.02 -28.56 13.35 Favored 'General case' 0 C--O 1.222 -0.364 0 O-C-N 120.929 -1.107 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.9 mm -52.04 -56.31 22.93 Favored Pre-proline 0 CA--C 1.533 0.315 0 CA-C-N 119.657 1.117 . . . . 0.0 111.256 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -71.13 -20.12 28.92 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 CA-C-N 120.976 1.384 . . . . 0.0 112.42 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.9 -36.46 56.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.926 1.29 . . . . 0.0 110.887 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 60.2 tp -91.15 -30.52 16.65 Favored 'General case' 0 C--N 1.334 -0.097 0 C-N-CA 126.517 1.927 . . . . 0.0 112.402 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -57.8 -45.79 85.57 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.402 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 9.5 ptmm? -64.1 -35.66 81.5 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.581 0.752 . . . . 0.0 111.768 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -70.52 -43.67 69.14 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 77.7 mt -73.33 -30.83 63.61 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 118.765 -0.635 . . . . 0.0 110.182 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.8 mmtt -67.41 -39.64 85.53 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.68 -16.23 60.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 123.764 0.665 . . . . 0.0 112.727 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.45 4.25 8.36 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.629 1.171 . . . . 0.0 112.208 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.84 -99.93 0.13 Allowed Glycine 0 C--N 1.337 0.629 0 CA-C-N 118.746 0.703 . . . . 0.0 114.706 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -139.5 -176.09 4.42 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.659 2.384 . . . . 0.0 109.135 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.87 163.74 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.73 -52.32 5.38 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.486 1.514 . . . . 0.0 109.423 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.3 tp -137.68 150.78 47.62 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 127.621 2.369 . . . . 0.0 108.244 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -156.24 128.94 7.79 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -147.88 163.79 35.68 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -67.03 110.15 3.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 122.121 0.963 . . . . 0.0 108.41 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.2 mt -97.15 -13.2 22.28 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.1 mm-40 -76.79 -15.13 59.83 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -99.72 130.73 25.96 Favored Pre-proline 0 C--O 1.236 0.352 0 CA-C-N 119.805 1.184 . . . . 0.0 111.356 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.84 -14.05 35.29 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 121.594 1.529 . . . . 0.0 110.902 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -64.63 -42.17 95.67 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.609 1.964 . . . . 0.0 110.109 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -86.08 -30.36 22.65 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.358 0.663 . . . . 0.0 112.687 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.7 p -84.47 -7.51 59.26 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 119.09 0.859 . . . . 0.0 110.625 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -55.31 -57.94 17.72 Favored Pre-proline 0 CA--C 1.539 0.527 0 O-C-N 120.546 -1.346 . . . . 0.0 112.521 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.33 -25.32 56.14 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.703 1.602 . . . . 0.0 112.95 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -66.18 0.58 Allowed 'General case' 0 C--N 1.34 0.195 0 C-N-CA 125.045 1.338 . . . . 0.0 108.04 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 39.4 pt -64.82 -27.13 41.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 O-C-N 121.74 -0.6 . . . . 0.0 111.938 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.38 -16.88 61.33 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 118.302 -0.856 . . . . 0.0 112.947 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.0 -59.46 4.51 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.973 0.909 . . . . 0.0 113.161 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -62.33 -54.42 40.72 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -177.39 12.09 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 CA-C-O 118.553 -1.137 . . . . 0.0 114.51 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -63.57 133.97 41.53 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 119.842 1.821 . . . . 0.0 109.903 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.418 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 48.9 p90 -145.56 137.46 25.38 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.05 -48.68 12.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -144.46 141.11 29.36 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.046 0.939 . . . . 0.0 108.951 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.418 ' HE2' ' CE1' ' A' ' 167' ' ' TYR . 10.3 tppt? -91.2 153.06 20.28 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -159.38 102.35 1.57 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -138.3 160.37 39.66 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 56.77 11.74 0.99 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.209 1.803 . . . . 0.0 111.334 -178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.84 16.29 80.18 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -178.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -114.84 110.26 19.41 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 126.18 1.792 . . . . 0.0 108.928 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -81.12 143.62 32.27 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -145.32 76.05 1.46 Allowed 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 119.833 1.197 . . . . 0.0 113.271 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -50.56 -6.94 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 N-CA-C 116.518 2.044 . . . . 0.0 116.518 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.34 -41.38 80.82 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 125.963 1.705 . . . . 0.0 108.186 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -87.78 105.3 17.3 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.34 1.056 . . . . 0.0 108.849 -178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 81.1 t -127.49 98.62 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -76.0 18.0 3.49 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 117.272 1.669 . . . . 0.0 117.272 -177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.0 t -70.2 -20.18 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 120.531 2.165 . . . . 0.0 112.863 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.53 2.09 25.91 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.813 0.733 . . . . 0.0 111.854 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -66.29 165.49 13.88 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.541 1.136 . . . . 0.0 111.369 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.14 -41.39 71.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.403 1.081 . . . . 0.0 111.308 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.0 -27.96 73.53 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 120.995 -1.066 . . . . 0.0 113.394 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -76.91 -38.09 54.14 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.417 1.109 . . . . 0.0 110.11 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -73.55 -33.19 64.58 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 121.786 -0.571 . . . . 0.0 110.988 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -54.73 -48.64 72.28 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.478 1.111 . . . . 0.0 112.457 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -75.87 -19.08 79.2 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.95 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 21.9 tp -77.61 -53.12 7.96 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 122.95 0.5 . . . . 0.0 112.247 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 3.2 t -54.78 -32.94 60.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.417 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -53.06 -53.2 53.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.359 0.981 . . . . 0.0 110.697 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 27.4 tp -63.41 -48.78 76.4 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.723 0.409 . . . . 0.0 110.473 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.16 -31.61 32.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 123.998 0.919 . . . . 0.0 110.025 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -48.18 80.14 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 124.895 1.278 . . . . 0.0 110.53 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.8 mt -64.24 -39.26 93.58 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.932 -0.48 . . . . 0.0 109.863 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 73.3 mt -67.4 -38.2 80.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.971 0.908 . . . . 0.0 108.753 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 30.6 mtpt -57.71 -47.61 81.91 Favored 'General case' 0 C--O 1.237 0.415 0 O-C-N 120.538 -1.351 . . . . 0.0 108.015 178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -80.77 -0.13 37.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.29 1.436 . . . . 0.0 112.459 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp 56.26 6.39 0.25 Allowed 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 129.829 3.252 . . . . 0.0 116.729 176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 31.0 p80 -71.45 -20.6 62.07 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.922 -0.711 . . . . 0.0 112.447 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.7 tpt -82.97 159.27 22.27 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.287 1.035 . . . . 0.0 112.485 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -95.94 76.09 3.12 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.34 -7.36 30.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.291 1.436 . . . . 0.0 113.598 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.61 -22.69 26.06 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 130.519 3.528 . . . . 0.0 112.179 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 2.6 m -58.84 127.79 33.95 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 32.7 p30 -128.62 -178.43 4.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.367 1.867 . . . . 0.0 107.513 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -59.34 -39.49 83.35 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.14 -53.51 56.88 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.522 1.129 . . . . 0.0 109.121 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 60.5 mt -61.98 -55.93 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.831 1.252 . . . . 0.0 110.848 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.65 94.22 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.628 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -65.82 -45.27 82.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.294 1.407 . . . . 0.0 110.904 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.47 -55.43 27.65 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.485 1.114 . . . . 0.0 110.403 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.92 -38.7 76.39 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.397 1.079 . . . . 0.0 110.16 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -62.03 -30.65 71.11 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.456 0.571 . . . . 0.0 109.581 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.57 -35.84 65.52 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 120.923 -1.11 . . . . 0.0 109.443 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 28.4 mmtt -77.01 -12.38 59.93 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.574 1.149 . . . . 0.0 113.622 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.1 16.53 59.18 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-N 120.683 1.583 . . . . 0.0 111.442 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -78.99 -9.4 59.52 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.031 1.732 . . . . 0.0 114.349 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -146.62 127.1 14.09 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.082 -1.011 . . . . 0.0 108.702 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.71 -24.77 66.29 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 121.322 -0.862 . . . . 0.0 111.575 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -140.92 166.64 24.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.567 1.147 . . . . 0.0 111.603 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.9 t -153.15 166.65 31.85 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.279 1.831 . . . . 0.0 107.179 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.5 mt -123.79 120.97 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -150.98 175.26 12.24 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.422 1.489 . . . . 0.0 107.075 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 166.96 76.83 0.03 OUTLIER Glycine 0 CA--C 1.522 0.495 0 CA-C-O 118.222 -1.321 . . . . 0.0 110.048 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -75.97 68.07 6.59 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 124.036 3.157 . . . . 0.0 110.635 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 37.4 t90 -63.83 -42.41 97.63 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.171 1.388 . . . . 0.0 109.161 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.58 -171.26 3.14 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -107.19 -10.76 15.76 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 120.724 -1.235 . . . . 0.0 113.076 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 50.9 m -72.73 1.34 8.63 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -121.02 163.27 18.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.993 1.317 . . . . 0.0 107.576 178.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 18.5 tt -127.31 135.71 62.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.659 1.184 . . . . 0.0 109.684 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -158.7 178.04 10.54 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 128.36 2.664 . . . . 0.0 106.088 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 70.5 p -75.4 -30.83 60.23 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.883 -1.136 . . . . 0.0 109.738 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 31.0 m 53.26 21.67 2.37 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.742 1.617 . . . . 0.0 112.661 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -77.32 108.64 10.59 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.246 1.418 . . . . 0.0 109.787 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.7 m -57.38 134.46 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -150.32 171.37 17.1 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.373 -0.829 . . . . 0.0 112.113 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -85.15 147.72 26.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.608 1.163 . . . . 0.0 109.822 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 87.0 99.5 0.83 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 114.95 0.74 . . . . 0.0 114.95 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.8 p -133.15 167.65 26.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 126.466 1.906 . . . . 0.0 106.913 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.7 t -155.17 177.81 10.91 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 121.138 -0.976 . . . . 0.0 110.577 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.7 t -76.17 151.44 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 C-N-CA 126.7 2.0 . . . . 0.0 109.181 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.5 pp -100.04 157.06 34.55 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 124.489 1.116 . . . . 0.0 108.699 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.41 144.56 62.04 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.511 1.474 . . . . 0.0 109.211 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 254' ' ' PRO . 81.6 p -136.03 -161.63 1.18 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.915 0.886 . . . . 0.0 110.262 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.5 143.65 40.53 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -55.65 134.75 51.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 121.569 -0.707 . . . . 0.0 110.033 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 70.58 -7.81 4.75 Favored Glycine 0 CA--C 1.532 1.147 0 N-CA-C 115.417 0.927 . . . . 0.0 115.417 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.42 98.47 4.26 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 119.293 1.547 . . . . 0.0 112.1 -178.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.446 ' HA ' ' HB ' ' A' ' 249' ' ' THR . 37.8 Cg_endo -66.07 158.24 55.45 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.327 1.352 . . . . 0.0 110.788 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 80.7 p -83.07 142.53 31.22 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 120.893 -1.13 . . . . 0.0 110.116 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.4 tmtm? -142.5 118.15 6.77 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 117.727 -1.13 . . . . 0.0 108.832 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -75.76 -61.89 0.03 OUTLIER 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.731 2.287 . . . . 0.0 110.904 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -159.11 164.31 35.4 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 129.613 3.165 . . . . 0.0 105.953 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.53 167.66 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -151.91 116.3 0.75 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.82 122.4 62.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 117.604 0.702 . . . . 0.0 112.535 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.7 tt -77.77 128.04 33.39 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 103.23 -2.878 . . . . 0.0 103.23 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.4 m -114.97 163.42 15.61 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 123.28 0.632 . . . . 0.0 112.179 -178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -139.26 139.98 37.54 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.19 0.996 . . . . 0.0 109.27 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -129.44 153.94 20.14 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 126.035 1.778 . . . . 0.0 108.896 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 75.9 mt -104.41 137.97 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 125.139 1.376 . . . . 0.0 107.654 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -68.05 114.46 6.6 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -63.22 -24.71 68.0 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.334 -0.854 . . . . 0.0 110.946 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -69.84 -16.72 63.31 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 118.451 -0.785 . . . . 0.0 113.079 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 44.7 m -58.3 150.42 53.69 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 118.985 0.812 . . . . 0.0 109.781 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -74.83 -37.24 2.24 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.195 1.93 . . . . 0.0 112.221 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -135.81 89.03 2.45 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -57.31 -18.57 17.52 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 122.622 0.369 . . . . 0.0 111.084 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -57.85 -42.33 84.24 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 126.557 1.943 . . . . 0.0 108.409 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.08 -37.84 81.12 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 120.905 -1.122 . . . . 0.0 110.674 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.35 -45.53 38.83 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.62 -35.33 77.58 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.473 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -71.71 -52.63 16.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.215 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -54.89 -47.99 73.61 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 120.657 1.572 . . . . 0.0 111.167 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.1 tt -62.31 -45.73 91.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.772 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -83.42 -7.3 59.58 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.595 1.332 . . . . 0.0 114.595 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -108.17 -24.32 11.59 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 116.92 -1.514 . . . . 0.0 114.603 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -139.65 -35.67 0.53 Allowed 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 119.457 1.026 . . . . 0.0 112.256 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -64.82 -44.76 88.83 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 120.397 1.453 . . . . 0.0 108.549 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 77.7 mt -96.86 53.97 1.26 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.358 1.863 . . . . 0.0 112.834 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.1 p -131.75 157.47 43.72 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 176.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.29 -38.49 89.55 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -69.44 -39.1 78.02 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.71 -0.619 . . . . 0.0 110.885 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.84 -32.26 61.34 Favored Glycine 0 C--N 1.335 0.507 0 O-C-N 121.769 -0.582 . . . . 0.0 112.122 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 43.9 mt -74.75 -44.17 51.15 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -57.31 -45.26 84.4 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.377 1.071 . . . . 0.0 108.541 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.69 -50.42 63.35 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.435 1.094 . . . . 0.0 112.289 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 65.4 t -72.94 -34.57 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.209 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -68.92 -32.91 72.87 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 118.452 0.569 . . . . 0.0 111.386 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -62.63 -35.18 78.76 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -67.17 -72.44 0.17 Allowed 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.57 154.51 77.6 Favored Pre-proline 0 C--O 1.232 0.173 0 C-N-CA 124.493 1.117 . . . . 0.0 111.581 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.44 108.1 2.54 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.44 2.093 . . . . 0.0 109.868 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 81.4 mt -67.22 -30.51 70.45 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.03 -116.47 5.59 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 106.49 -2.644 . . . . 0.0 106.49 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -109.9 169.13 8.92 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.993 1.396 . . . . 0.0 108.328 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 18.6 m -131.74 153.1 38.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 O-C-N 121.377 -0.827 . . . . 0.0 110.977 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -78.11 -34.34 50.12 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.974 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 15.4 tp -69.34 102.19 1.69 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 124.303 1.041 . . . . 0.0 108.327 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.2 mtmp? -53.2 -28.44 26.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.608 1.563 . . . . 0.0 115.217 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.25 -62.37 1.7 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.764 1.165 . . . . 0.0 111.483 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -78.96 -14.01 59.46 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 125.246 1.418 . . . . 0.0 112.691 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -58.88 -32.23 69.3 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -61.66 -30.87 71.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.711 1.204 . . . . 0.0 112.601 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -82.38 -39.46 22.68 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 124.641 1.176 . . . . 0.0 110.009 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.439 ' HB3' HG21 ' A' ' 317' ' ' ILE . 12.6 mt -69.14 -34.82 75.6 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.33 -6.96 1.72 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.089 1.756 . . . . 0.0 113.497 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -62.05 -33.06 73.68 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.797 0.726 . . . . 0.0 109.913 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.14 142.81 25.17 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.04 -13.2 37.54 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 122.149 1.899 . . . . 0.0 113.509 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.5 mtm-85 -64.5 -45.14 88.58 Favored 'General case' 0 N--CA 1.465 0.312 0 O-C-N 120.757 -1.215 . . . . 0.0 109.384 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.562 HD12 ' H ' ' A' ' 317' ' ' ILE . 4.3 mp -67.25 -57.68 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 C-N-CA 124.596 1.158 . . . . 0.0 107.965 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -50.63 -54.97 18.57 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 124.176 0.923 . . . . 0.0 110.171 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -62.33 -30.8 71.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.694 -1.254 . . . . 0.0 113.171 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 16.7 m -66.5 -42.92 86.66 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.3 tpt -67.33 -51.42 52.63 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.807 1.643 . . . . 0.0 110.393 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -55.16 -33.05 62.61 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.217 1.007 . . . . 0.0 112.427 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -81.97 -38.34 25.3 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 123.813 0.845 . . . . 0.0 108.976 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.71 -36.18 82.88 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.714 0.688 . . . . 0.0 110.48 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -63.78 -51.14 66.14 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.268 1.027 . . . . 0.0 110.778 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.3 -20.97 54.26 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -64.55 176.99 9.95 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 125.257 1.408 . . . . 0.0 115.085 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.96 133.76 49.2 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.674 1.99 . . . . 0.0 109.26 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 93.7 mt -71.83 136.31 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 37.0 tpp -56.27 112.83 4.87 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.867 1.267 . . . . 0.0 110.53 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.52 178.5 7.29 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.425 3.417 . . . . 0.0 112.833 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -148.65 46.35 1.03 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.976 0.91 . . . . 0.0 111.768 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.6 pt -112.41 155.43 43.71 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.553 1.541 . . . . 0.0 113.063 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.39 -19.43 61.46 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.094 3.196 . . . . 0.0 115.448 -178.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -56.35 -24.01 41.28 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.592 1.157 . . . . 0.0 111.574 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 87.4 mmm -59.28 -33.59 71.24 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.685 0.794 . . . . 0.0 111.504 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 13.1 t -58.68 -49.3 78.07 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.681 0.673 . . . . 0.0 110.315 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -67.88 -37.86 82.3 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 118.46 -0.781 . . . . 0.0 109.751 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -56.09 -48.93 75.2 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.892 0.877 . . . . 0.0 110.035 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 21.6 m95 -56.95 -44.34 82.48 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 118.428 0.558 . . . . 0.0 111.349 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -66.93 -45.12 78.82 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.967 -0.458 . . . . 0.0 110.258 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -52.93 -56.19 17.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.136 1.774 . . . . 0.0 112.149 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 18.1 t -68.45 -40.2 81.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 117.616 -1.183 . . . . 0.0 109.561 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -52.28 -50.73 61.56 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.875 1.67 . . . . 0.0 109.023 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 2.1 m -67.45 -45.01 77.24 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.58 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.06 -42.1 68.89 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 119.878 1.217 . . . . 0.0 111.964 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 44.1 t -58.28 -57.38 11.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 C-N-CA 124.354 1.062 . . . . 0.0 109.43 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.9 mm -67.09 -26.47 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-O 119.344 -0.36 . . . . 0.0 110.687 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -64.94 -51.39 62.12 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 119.85 -1.781 . . . . 0.0 109.088 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.52 -44.57 70.75 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.383 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.24 -29.02 70.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.4 m -85.71 -12.36 51.36 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.095 0.861 . . . . 0.0 109.571 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 73.33 8.73 75.99 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.416 -0.658 . . . . 0.0 111.676 -178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -66.78 -34.62 78.23 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 118.681 1.241 . . . . 0.0 108.915 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -138.99 155.86 47.67 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.0 t -76.11 166.47 23.43 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.8 t -55.73 -56.07 14.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.142 1.377 . . . . 0.0 109.901 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -51.75 -41.25 61.45 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 125.59 1.556 . . . . 0.0 113.478 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -77.28 -36.48 54.2 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.19 0.196 . . . . 0.0 111.099 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.61 -50.26 72.5 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.49 -0.756 . . . . 0.0 109.74 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.04 -39.18 89.96 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 118.108 -0.949 . . . . 0.0 111.157 177.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -57.55 -56.25 24.33 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.815 0.734 . . . . 0.0 110.395 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.95 -38.57 91.61 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 124.274 0.984 . . . . 0.0 111.012 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -60.18 -45.59 92.61 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 121.682 -0.636 . . . . 0.0 110.452 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -56.38 -36.36 68.78 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.585 0.754 . . . . 0.0 109.792 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 5.8 m -59.69 -39.08 83.36 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 118.62 0.645 . . . . 0.0 110.398 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -65.75 -15.67 63.06 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.092 -1.005 . . . . 0.0 112.34 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 7.8 mt -102.56 -8.62 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 124.988 1.315 . . . . 0.0 109.974 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 19.7 p -113.36 -2.52 13.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.802 1.641 . . . . 0.0 111.874 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.106 0 C-N-CA 127.344 2.257 . . . . 0.0 106.544 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.3 mm -89.43 146.4 6.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.652 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -101.62 106.78 17.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 122.216 1.007 . . . . 0.0 108.521 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -73.04 -176.03 1.97 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.812 2.445 . . . . 0.0 113.018 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.94 17.27 75.17 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 124.106 0.86 . . . . 0.0 111.963 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.47 163.36 36.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.173 1.389 . . . . 0.0 110.656 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.6 mt -148.99 150.28 32.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 129.237 3.015 . . . . 0.0 104.933 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.52 134.36 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.581 HD12 HG22 ' A' ' 37' ' ' VAL . 42.2 mt -114.43 123.55 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -121.45 118.93 30.61 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -145.81 154.78 13.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.37 1.068 . . . . 0.0 110.726 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -69.52 150.8 46.75 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.25 -26.79 37.48 Favored Glycine 0 N--CA 1.465 0.569 0 C-N-CA 126.161 1.839 . . . . 0.0 115.034 -178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -69.82 -19.77 63.46 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 117.605 0.703 . . . . 0.0 110.554 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mmtm -73.09 164.8 26.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-O 122.167 0.984 . . . . 0.0 109.962 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.69 63.5 4.35 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -68.51 -45.87 71.12 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.326 1.05 . . . . 0.0 110.959 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -38.63 80.96 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -78.92 -38.74 22.39 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.4 tp -63.47 -34.95 78.9 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 118.204 1.002 . . . . 0.0 110.545 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HA ' HG21 ' A' ' 37' ' ' VAL . . . -56.93 -44.66 82.68 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 123.142 0.577 . . . . 0.0 109.567 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -56.11 -43.1 77.8 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.527 0.731 . . . . 0.0 111.635 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 30.7 t -62.1 -44.52 99.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 125.509 1.524 . . . . 0.0 107.362 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.73 -42.84 95.05 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.305 -0.872 . . . . 0.0 110.994 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.55 -43.25 99.2 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.052 0.926 . . . . 0.0 108.724 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -62.74 -50.32 71.56 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 124.613 1.165 . . . . 0.0 108.942 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -56.77 -41.89 78.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.561 1.073 . . . . 0.0 110.272 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -61.93 -35.93 79.86 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.965 -1.084 . . . . 0.0 108.7 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -74.18 3.77 6.64 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.3 1.84 . . . . 0.0 111.263 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -125.4 -37.4 2.37 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.79 1.636 . . . . 0.0 112.604 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.0 p -112.29 -22.0 11.13 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.716 0.806 . . . . 0.0 113.013 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.87 -17.44 53.01 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 121.063 -1.023 . . . . 0.0 112.954 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.77 133.06 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 119.145 1.473 . . . . 0.0 107.468 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HE2' ' N ' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -66.81 146.03 54.86 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.262 -0.899 . . . . 0.0 108.812 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 36.3 t -136.75 91.59 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.179 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 85.8 m -80.73 134.28 35.8 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.581 HG22 HD12 ' A' ' 9' ' ' ILE . 27.2 t -130.84 129.4 63.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -140.01 166.23 25.22 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -118.54 58.66 3.55 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 123.59 0.756 . . . . 0.0 111.606 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -69.32 159.97 51.64 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.18 1.253 . . . . 0.0 109.24 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -120.45 -23.08 6.23 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.375 0.67 . . . . 0.0 110.501 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.2 9.13 41.98 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.913 1.285 . . . . 0.0 110.543 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.3 pt? -56.86 -30.74 64.12 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 120.565 -1.334 . . . . 0.0 112.286 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -60.26 -23.81 64.4 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.22 1.373 . . . . 0.0 113.652 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -105.14 -28.03 11.24 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.164 0.438 . . . . 0.0 110.272 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -51.29 10.88 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 124.492 1.117 . . . . 0.0 110.647 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -41.92 -58.25 3.46 Favored Pre-proline 0 N--CA 1.457 -0.079 0 CA-C-O 116.321 -1.799 . . . . 0.0 109.883 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.99 1.37 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.27 1.98 . . . . 0.0 116.93 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.36 -52.86 2.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 119.802 1.183 . . . . 0.0 108.752 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.466 HG12 ' C ' ' A' ' 55' ' ' ASP . 2.3 t -63.17 -40.95 91.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.58 -31.04 59.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 121.378 -0.827 . . . . 0.0 111.144 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.15 -13.44 60.81 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.033 0.533 . . . . 0.0 111.011 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 24.7 m -93.33 -82.34 0.34 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 103.014 -2.958 . . . . 0.0 103.014 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 163.36 37.77 0.02 OUTLIER Glycine 0 CA--C 1.524 0.612 0 C-N-CA 125.598 1.57 . . . . 0.0 109.291 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.466 ' C ' HG12 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -136.79 -3.32 2.06 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.812 1.645 . . . . 0.0 113.292 -176.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.9 176.27 21.66 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 116.933 1.533 . . . . 0.0 116.933 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -64.92 172.38 7.28 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 122.766 2.311 . . . . 0.0 109.584 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -107.92 -18.5 13.79 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -142.36 143.05 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 C-N-CA 125.348 1.459 . . . . 0.0 108.726 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.8 tt -135.29 140.6 44.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 125.608 1.563 . . . . 0.0 108.277 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -132.45 116.32 16.64 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -154.73 179.29 9.21 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.72 0.691 . . . . 0.0 110.726 -179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.41 152.95 40.63 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -61.81 -25.62 67.61 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -61.52 -23.79 66.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -98.76 -4.9 32.39 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.797 -0.564 . . . . 0.0 110.78 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -92.46 20.87 5.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.004 1.322 . . . . 0.0 109.73 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -94.79 -14.03 51.16 Favored Glycine 0 CA--C 1.534 1.222 0 O-C-N 120.667 -1.271 . . . . 0.0 111.391 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -120.65 -27.45 1.94 Allowed Glycine 0 C--N 1.344 0.982 0 CA-C-N 119.304 1.552 . . . . 0.0 116.498 -178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -53.75 -47.37 70.72 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 120.114 1.957 . . . . 0.0 111.763 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.21 -40.91 94.78 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.29 -27.08 54.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.303 1.041 . . . . 0.0 112.223 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.0 m -96.88 3.07 52.34 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.353 1.461 . . . . 0.0 112.045 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.66 16.76 78.72 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.421 1.01 . . . . 0.0 112.267 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.7 mt -88.73 9.47 24.27 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.142 0.977 . . . . 0.0 113.425 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.0 mt -131.29 146.01 52.12 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 120.979 -1.076 . . . . 0.0 108.244 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.41 161.58 14.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -78.7 94.21 5.05 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.11 175.21 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 127.103 2.161 . . . . 0.0 112.212 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.455 HG21 HE21 ' A' ' 86' ' ' GLN . 89.4 m 66.64 95.88 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.513 0 C-N-CA 126.777 2.031 . . . . 0.0 111.013 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.92 -48.24 1.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.339 1.359 . . . . 0.0 110.749 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -134.84 154.65 51.55 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.079 0.951 . . . . 0.0 110.509 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -49.34 -38.85 29.46 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.07 2.548 . . . . 0.0 111.768 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.98 -25.55 44.49 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.189 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -68.77 -28.64 66.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.718 1.145 . . . . 0.0 109.963 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.455 HE21 HG21 ' A' ' 80' ' ' THR . 39.9 mt-30 -64.05 -36.37 83.79 Favored 'General case' 0 C--N 1.341 0.206 0 O-C-N 120.76 -1.212 . . . . 0.0 110.76 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.18 -15.3 61.02 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.065 0.946 . . . . 0.0 112.286 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -70.85 -20.92 62.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.717 1.207 . . . . 0.0 111.771 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.415 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 8.0 mt -122.93 161.16 24.71 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.799 1.64 . . . . 0.0 108.541 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -72.98 157.76 88.15 Favored Pre-proline 0 N--CA 1.476 0.847 0 CA-C-N 120.23 1.377 . . . . 0.0 108.91 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.9 -46.18 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.08 2.52 . . . . 0.0 114.168 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -60.1 -30.93 69.58 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.259 0.936 . . . . 0.0 111.34 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.11 -29.46 69.21 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.233 -0.917 . . . . 0.0 110.15 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.415 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 73.7 m95 -72.88 -30.29 63.84 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 118.966 0.803 . . . . 0.0 110.684 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -62.99 -16.5 59.92 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -83.45 -5.18 59.08 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.326 0.65 . . . . 0.0 112.506 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 9.5 m -133.3 27.82 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.882 1.273 . . . . 0.0 112.238 -178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 63.6 mtp85 -86.37 164.11 17.24 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.199 0.999 . . . . 0.0 110.878 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -149.95 175.5 11.62 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 125.174 1.39 . . . . 0.0 107.603 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -66.55 101.19 0.74 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.559 0.743 . . . . 0.0 112.157 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.84 -69.95 2.8 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.099 1.333 . . . . 0.0 111.974 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.86 162.04 27.95 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 117.141 0.47 . . . . 0.0 110.064 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.84 155.21 17.16 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.742 1.617 . . . . 0.0 108.557 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 27.1 pt -123.09 -32.37 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 116.037 1.865 . . . . 0.0 116.037 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -155.72 -178.58 7.39 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 119.925 1.239 . . . . 0.0 109.912 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -133.36 147.53 65.3 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 124.668 1.187 . . . . 0.0 109.431 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.93 153.8 63.4 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.651 2.9 . . . . 0.0 109.665 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.427 HG13 ' HB2' ' A' ' 264' ' ' ALA . 18.9 mm -125.84 -47.63 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 C-N-CA 125.364 1.466 . . . . 0.0 110.979 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.26 165.7 26.7 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-N 117.877 0.308 . . . . 0.0 110.739 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 98.7 t -127.02 121.43 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 124.281 0.988 . . . . 0.0 109.399 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -108.44 122.29 46.71 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -159.37 176.57 11.98 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.341 1.457 . . . . 0.0 110.298 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mp -95.93 -164.57 1.17 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.697 1.999 . . . . 0.0 111.133 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.3 p -167.21 171.5 10.76 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.668 1.987 . . . . 0.0 110.27 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.499 HD23 HG23 ' A' ' 245' ' ' THR . 49.5 tp -109.54 146.91 33.86 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 120.251 1.387 . . . . 0.0 107.821 178.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.4 mt -122.3 151.61 26.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -152.29 162.21 41.48 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.544 0.738 . . . . 0.0 109.484 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -50.75 140.46 14.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.861 1.264 . . . . 0.0 109.239 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.479 ' H ' ' HD3' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -59.91 -11.27 5.21 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.304 1.442 . . . . 0.0 114.046 -178.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -74.05 170.78 14.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 120.729 1.604 . . . . 0.0 110.35 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 pp -93.08 8.31 40.55 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.28 1.032 . . . . 0.0 112.844 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -34.88 107.68 0.32 Allowed Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 128.198 2.599 . . . . 0.0 110.462 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.35 -173.96 1.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.364 3.376 . . . . 0.0 115.93 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 47.7 67.35 4.57 Favored Pre-proline 0 CA--C 1.534 0.346 0 C-N-CA 128.027 2.531 . . . . 0.0 110.897 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.26 158.87 37.76 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 121.956 1.77 . . . . 0.0 111.749 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.52 153.06 74.5 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.959 3.106 . . . . 0.0 112.748 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.83 -12.03 3.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.068 0.547 . . . . 0.0 112.365 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.33 154.84 45.91 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.128 -0.983 . . . . 0.0 111.949 -178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 35.8 m95 -80.05 -22.92 41.79 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -60.23 -18.29 47.66 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.79 -5.13 21.5 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.264 1.025 . . . . 0.0 111.511 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 19.4 mm -61.05 -52.53 71.29 Favored Pre-proline 0 C--N 1.339 0.128 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.82 -23.75 54.92 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 CA-C-N 120.997 1.392 . . . . 0.0 111.503 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.43 -44.39 75.05 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 57.4 tp -80.43 -27.29 38.02 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.219 1.008 . . . . 0.0 111.928 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.9 -44.51 82.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 C-N-CA 123.943 0.897 . . . . 0.0 110.736 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.6 ptmm? -68.41 -31.2 70.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.407 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -71.34 -46.78 59.7 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 61.0 mt -72.57 -31.48 65.28 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 118.172 -0.918 . . . . 0.0 111.402 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -71.17 -37.37 72.2 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.66 -26.01 68.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.538 0.608 . . . . 0.0 111.89 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.68 6.15 16.75 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.978 0.911 . . . . 0.0 112.534 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 179.42 -104.46 0.18 Allowed Glycine 0 CA--C 1.524 0.626 0 CA-C-N 119.141 0.882 . . . . 0.0 112.792 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -136.91 178.08 7.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 127.134 2.174 . . . . 0.0 109.978 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.01 155.36 3.54 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.36 1.064 . . . . 0.0 113.674 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -74.07 -47.61 35.42 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 40.7 tp -125.48 155.55 40.35 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.192 1.397 . . . . 0.0 110.247 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.457 ' CG ' HG21 ' A' ' 208' ' ' THR . 45.1 ttm -150.68 130.5 13.25 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -159.91 168.93 24.6 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.865 1.666 . . . . 0.0 115.399 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.52 83.11 0.06 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 126.766 2.026 . . . . 0.0 112.095 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.5 mt -80.83 -20.87 41.47 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 125.842 1.657 . . . . 0.0 110.724 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.3 mm-40 -78.92 -6.53 56.41 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -112.62 129.92 23.93 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 119.163 0.892 . . . . 0.0 112.105 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -73.64 -13.73 24.69 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.156 1.904 . . . . 0.0 112.318 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -64.6 -40.09 94.88 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.854 1.662 . . . . 0.0 113.311 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.521 ' CZ ' HG21 ' A' ' 226' ' ' ILE . 30.5 t80 -95.13 -29.6 14.48 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 80.5 p -72.75 -28.43 62.62 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.336 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 44.5 t-105 -56.6 -58.67 15.65 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 115.054 1.502 . . . . 0.0 115.054 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -56.02 -16.36 16.26 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.586 2.191 . . . . 0.0 115.842 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 66.4 tp -82.11 -59.17 2.65 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.811 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.402 HG22 ' HA3' ' A' ' 191' ' ' GLY . 17.8 pt -68.21 -27.42 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 119.403 1.001 . . . . 0.0 111.768 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.25 -20.89 66.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 123.449 0.699 . . . . 0.0 110.917 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -53.61 -54.01 43.72 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 125.153 1.381 . . . . 0.0 112.244 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.21 -41.75 84.7 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.364 0.529 . . . . 0.0 111.224 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 165.88 26.13 0.02 OUTLIER Glycine 0 C--N 1.34 0.778 0 N-CA-C 116.422 1.329 . . . . 0.0 116.422 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -88.92 131.95 10.98 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -147.27 151.44 36.64 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 119.115 1.457 . . . . 0.0 112.059 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.412 ' HB2' ' CE2' ' A' ' 339' ' ' PHE . . . -85.17 -63.01 1.4 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.775 1.23 . . . . 0.0 112.542 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -138.37 126.24 22.47 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.309 1.444 . . . . 0.0 108.832 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -73.38 129.37 37.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.425 1.011 . . . . 0.0 112.156 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -121.85 122.18 38.87 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.525 ' HG2' ' H ' ' A' ' 173' ' ' ASN . 14.9 tt0 -93.82 -163.57 1.07 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.987 1.315 . . . . 0.0 109.45 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.525 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 71.0 m-80 -56.77 -8.84 0.65 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.249 2.22 . . . . 0.0 115.731 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.36 11.62 0.02 OUTLIER Glycine 0 CA--C 1.53 0.984 0 C-N-CA 125.224 1.392 . . . . 0.0 113.861 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.6 156.7 40.5 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.808 2.443 . . . . 0.0 105.078 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -144.93 148.71 34.15 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -147.88 141.03 25.04 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.449 ' H ' HD13 ' A' ' 178' ' ' ILE . 0.1 OUTLIER -94.8 -8.67 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 124.664 1.186 . . . . 0.0 110.3 178.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.59 -40.01 73.51 Favored 'General case' 0 C--O 1.231 0.121 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -78.33 92.48 4.54 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.587 1.155 . . . . 0.0 111.009 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 59.9 t -115.96 150.29 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 125.885 1.674 . . . . 0.0 108.996 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -146.08 48.58 0.68 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.55 1.548 . . . . 0.0 111.629 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 80.3 t -81.3 -55.2 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.327 0 C-N-CA 125.1 1.36 . . . . 0.0 107.937 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -87.51 67.22 9.31 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -113.03 155.95 23.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 126.317 1.847 . . . . 0.0 110.435 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.15 -39.05 66.17 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.992 1.317 . . . . 0.0 113.152 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.21 -45.96 76.08 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.08 -56.59 19.79 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.406 ' HB3' ' HE2' ' A' ' 189' ' ' LYS . 10.7 ptpt -58.87 -34.49 71.69 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 117.438 -1.268 . . . . 0.0 112.768 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.05 -52.09 66.42 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.608 1.094 . . . . 0.0 109.286 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.402 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -68.3 -30.31 73.48 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 111.494 -0.643 . . . . 0.0 111.494 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.77 -53.72 20.12 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.332 1.066 . . . . 0.0 108.442 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.4 t -61.14 -33.66 73.76 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.327 0.651 . . . . 0.0 110.303 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.85 -55.07 34.38 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.6 tt -60.58 -47.89 84.22 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.445 1.498 . . . . 0.0 110.323 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 70.9 t -57.1 -36.23 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-O 118.18 -0.914 . . . . 0.0 109.75 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.457 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 0.3 OUTLIER -65.04 -35.51 81.39 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 120.033 1.288 . . . . 0.0 112.122 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 13.1 mt -63.04 -41.23 99.46 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 85.7 mt -67.98 -42.76 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.457 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -57.83 -31.69 66.89 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.575 1.55 . . . . 0.0 109.841 178.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 18.1 m-80 -88.69 -5.29 58.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.764 1.625 . . . . 0.0 111.246 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? 60.39 16.88 6.66 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 128.321 2.648 . . . . 0.0 113.755 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -86.3 -34.53 20.31 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 7.4 tpt -85.44 128.37 34.7 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -76.68 120.68 22.19 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -88.92 -3.12 58.83 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -95.72 -15.34 22.7 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.603 1.961 . . . . 0.0 115.144 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.457 HG21 ' CG ' ' A' ' 148' ' ' MET . 3.3 m -67.55 128.43 36.4 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.957 0.903 . . . . 0.0 112.197 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -126.95 172.32 10.55 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.761 2.024 . . . . 0.0 108.114 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -47.66 -39.81 18.17 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 57.8 m -63.14 -45.91 89.69 Favored 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.743 1.217 . . . . 0.0 110.45 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 58.1 mt -66.9 -48.47 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 117.063 -1.446 . . . . 0.0 110.868 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -59.65 -45.76 91.06 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 120.798 1.635 . . . . 0.0 112.717 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -65.42 -35.32 80.58 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.047 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.26 -55.9 20.97 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.62 -43.14 75.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.939 2.495 . . . . 0.0 112.119 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -62.49 -45.68 91.91 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 119.986 1.266 . . . . 0.0 108.543 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -37.9 82.59 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 118.44 -0.791 . . . . 0.0 109.192 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 37.6 mmtt -74.56 -23.08 58.71 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 120.089 1.313 . . . . 0.0 111.618 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.47 38.25 5.36 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.415 1.483 . . . . 0.0 111.081 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -93.74 -31.1 14.55 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.672 1.236 . . . . 0.0 113.764 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.5 t -115.15 152.01 33.35 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 124.612 1.165 . . . . 0.0 109.24 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -87.88 -27.95 21.88 Favored 'General case' 0 CA--C 1.527 0.076 0 C-N-CA 123.781 0.832 . . . . 0.0 111.498 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -136.51 145.49 45.16 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.927 1.291 . . . . 0.0 108.224 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 23.0 m -149.4 149.72 31.28 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.666 1.186 . . . . 0.0 108.919 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.521 HG21 ' CZ ' ' A' ' 156' ' ' PHE . 27.6 mt -124.68 127.17 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.84 157.78 45.43 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.223 1.409 . . . . 0.0 107.313 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -101.95 -163.52 26.81 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-O 119.124 -0.82 . . . . 0.0 113.391 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -72.74 73.56 2.93 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.95 3.1 . . . . 0.0 108.457 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -67.73 -63.5 1.05 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.854 0.861 . . . . 0.0 110.806 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -159.36 -90.96 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.085 0.954 . . . . 0.0 109.586 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -121.32 176.83 5.44 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.802 1.241 . . . . 0.0 112.4 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.4 m -63.58 172.23 2.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.369 1.868 . . . . 0.0 111.613 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -132.73 -35.25 1.11 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.8 mt -132.54 71.26 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 120.074 1.307 . . . . 0.0 108.1 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -71.23 -17.17 62.51 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.202 1.801 . . . . 0.0 112.815 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 6.7 m -85.15 -59.92 2.19 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.917 0.781 . . . . 0.0 111.805 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.403 ' O ' ' HE3' ' A' ' 239' ' ' LYS . 3.8 m -71.2 73.66 0.67 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.713 1.205 . . . . 0.0 110.508 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.417 ' HA ' ' HE3' ' A' ' 239' ' ' LYS . 0.0 OUTLIER -124.28 97.29 5.26 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 125.309 1.444 . . . . 0.0 110.762 -178.157 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.92 17.28 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 126.048 1.739 . . . . 0.0 109.527 178.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -103.11 173.06 6.47 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.976 2.51 . . . . 0.0 109.376 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -81.3 173.22 12.7 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -55.62 -37.66 68.69 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 123.97 0.795 . . . . 0.0 113.738 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 12.6 p -143.25 169.48 11.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 124.97 1.308 . . . . 0.0 107.962 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.499 HG23 HD23 ' A' ' 115' ' ' LEU . 7.9 t -132.98 151.42 52.07 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.22 144.6 14.43 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 124.469 1.108 . . . . 0.0 110.417 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -116.0 154.96 48.45 Favored Pre-proline 0 CA--C 1.528 0.128 0 C-N-CA 124.866 1.266 . . . . 0.0 111.049 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -72.24 143.56 39.82 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.431 1.421 . . . . 0.0 110.041 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 47.8 p -135.51 -145.0 0.21 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.834 2.054 . . . . 0.0 108.231 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -124.12 141.59 51.93 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 12.0 pttp -54.02 107.1 0.23 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.279 1.031 . . . . 0.0 109.049 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.9 -5.76 84.43 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 124.772 1.177 . . . . 0.0 114.394 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.08 93.64 43.23 Favored Pre-proline 0 CA--C 1.545 0.766 0 CA-C-N 118.865 1.333 . . . . 0.0 108.936 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.4 144.17 25.55 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.976 2.451 . . . . 0.0 109.433 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 37.3 p -63.33 141.41 58.78 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 121.058 -1.026 . . . . 0.0 108.804 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -116.39 88.14 22.59 Favored Pre-proline 0 C--O 1.236 0.376 0 C-N-CA 124.511 1.125 . . . . 0.0 110.398 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -82.16 168.08 15.42 Favored 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.382 2.055 . . . . 0.0 112.239 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -95.83 164.7 12.63 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.621 1.168 . . . . 0.0 108.446 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 19.9 t -141.3 127.04 19.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -126.07 122.07 4.33 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 21.9 m -117.49 136.64 54.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 118.042 0.921 . . . . 0.0 112.092 -178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 tp -68.86 137.48 53.92 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 23.1 m -121.99 158.23 29.58 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.494 1.043 . . . . 0.0 113.568 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.427 ' HB2' HG13 ' A' ' 108' ' ' ILE . . . -135.33 141.2 45.57 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 126.194 1.798 . . . . 0.0 110.004 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.78 167.46 23.22 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.441 1.496 . . . . 0.0 110.196 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 56.2 mt -119.46 132.25 69.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.508 1.523 . . . . 0.0 107.363 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -74.1 130.5 39.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -76.2 -19.48 58.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 117.797 -1.097 . . . . 0.0 113.518 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -72.94 -7.74 52.46 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.574 1.079 . . . . 0.0 113.182 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 66.8 m -63.06 154.72 76.26 Favored Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -62.29 -53.69 1.79 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 121.877 1.718 . . . . 0.0 108.052 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -132.42 125.55 31.04 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.473 ' H ' ' HD2' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -74.39 -16.59 60.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.718 0.807 . . . . 0.0 111.406 178.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.48 ' HA ' ' HG3' ' A' ' 277' ' ' LYS . 3.9 tt0 -61.55 -33.78 74.43 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 123.707 0.803 . . . . 0.0 112.517 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 61.9 mt -59.3 -40.74 87.14 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.791 -0.568 . . . . 0.0 111.031 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.42 -43.63 48.88 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.771 0.429 . . . . 0.0 111.057 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.48 ' HG3' ' HA ' ' A' ' 274' ' ' GLU 0.261 0.0 OUTLIER -63.9 -32.95 74.65 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 118.768 -0.634 . . . . 0.0 111.331 -179.084 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -72.44 -48.07 44.01 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -51.47 -49.89 60.9 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.23 -54.42 47.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -64.4 -22.55 66.99 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 -97.55 -24.6 15.48 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 117.817 -1.087 . . . . 0.0 113.55 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -138.66 -36.42 0.56 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -70.99 -25.29 62.63 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.468 1.031 . . . . 0.0 110.692 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 89.7 mt -105.57 24.97 11.34 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.445 1.498 . . . . 0.0 113.711 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 6.8 p -103.07 158.19 16.47 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -62.48 -42.81 99.75 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -71.41 -30.73 66.44 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.582 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.05 -48.89 14.34 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 63.8 mt -62.0 -43.86 97.94 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -62.23 -42.5 99.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.03 -35.14 68.93 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.823 0.738 . . . . 0.0 110.996 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 76.0 t -72.25 -42.01 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -60.01 -29.99 68.84 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.399 1.079 . . . . 0.0 112.705 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -52.56 -47.36 66.86 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 118.272 0.487 . . . . 0.0 110.708 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.91 -73.98 0.24 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -101.47 144.64 28.96 Favored Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 121.051 -1.031 . . . . 0.0 111.615 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -73.62 108.48 2.64 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.256 2.637 . . . . 0.0 111.556 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 66.8 mt -73.18 -31.47 64.23 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.967 0.907 . . . . 0.0 110.908 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 71.08 -103.71 1.28 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 108.244 -1.942 . . . . 0.0 108.244 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.02 168.44 10.27 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 10.8 m -140.17 153.12 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 120.869 -1.144 . . . . 0.0 110.97 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.06 -18.73 49.29 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 118.449 -0.786 . . . . 0.0 112.773 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 21.0 tp -81.36 111.83 18.08 Favored 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -56.6 -34.16 66.93 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 119.198 -0.429 . . . . 0.0 111.84 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.73 -37.49 65.96 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.25 1.42 . . . . 0.0 112.186 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -101.43 -16.85 16.72 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.266 0.485 . . . . 0.0 109.742 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -63.76 -38.76 92.32 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -59.36 -23.4 62.51 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.138 0.881 . . . . 0.0 111.331 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -89.39 -51.37 5.59 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.614 1.166 . . . . 0.0 109.058 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 22.0 mt -61.43 -34.66 75.77 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.757 -0.59 . . . . 0.0 110.093 179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -66.68 -3.0 5.58 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.392 1.477 . . . . 0.0 112.964 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -61.62 -28.81 69.63 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.386 1.448 . . . . 0.0 107.445 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -94.54 135.63 23.91 Favored Pre-proline 0 CA--C 1.54 0.562 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -68.9 -11.99 33.27 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.483 2.122 . . . . 0.0 113.285 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -64.83 -46.29 82.54 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.5 mp -68.56 -48.65 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 C-N-CA 124.412 1.085 . . . . 0.0 108.531 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.77 -49.49 65.43 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 123.545 0.528 . . . . 0.0 110.684 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.8 84.77 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.775 -0.578 . . . . 0.0 111.823 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 21.0 m -61.46 -35.2 76.95 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 5.0 tpt -71.12 -48.07 54.36 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 122.857 0.463 . . . . 0.0 110.42 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -58.45 -30.63 67.09 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 124.54 1.136 . . . . 0.0 111.985 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -64.32 -28.74 69.92 Favored 'General case' 0 C--N 1.332 -0.18 0 O-C-N 121.2 -0.937 . . . . 0.0 110.335 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -79.63 -28.17 40.92 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.774 0.716 . . . . 0.0 109.979 178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -71.6 -15.92 62.27 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.275 1.43 . . . . 0.0 109.348 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.13 -7.4 7.12 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -107.4 -168.59 21.97 Favored Glycine 0 N--CA 1.467 0.721 0 CA-C-N 119.413 1.006 . . . . 0.0 110.88 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -136.55 155.02 50.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.425 1.113 . . . . 0.0 110.216 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 16.6 mt -59.69 133.28 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 127.042 2.137 . . . . 0.0 111.818 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 82.9 mtp -58.32 162.03 6.67 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 126.491 1.916 . . . . 0.0 111.12 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.42 160.22 28.97 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.925 1.75 . . . . 0.0 108.487 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -101.14 29.84 4.46 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.423 2.289 . . . . 0.0 112.63 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.1 pt -130.24 154.45 81.41 Favored Pre-proline 0 N--CA 1.47 0.573 0 N-CA-C 114.603 1.335 . . . . 0.0 114.603 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.1 -14.15 31.71 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.135 3.223 . . . . 0.0 115.163 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -57.04 -16.27 6.85 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.449 1.499 . . . . 0.0 112.394 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -32.98 71.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.443 0.697 . . . . 0.0 110.141 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 37.4 p -60.85 -48.25 82.66 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 119.115 0.87 . . . . 0.0 111.405 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -64.31 -43.54 94.37 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.608 0.763 . . . . 0.0 109.147 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.412 ' CE2' ' HB2' ' A' ' 168' ' ' ALA . 14.8 t80 -52.98 -53.99 41.72 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.459 1.104 . . . . 0.0 111.692 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 69.6 m95 -62.63 -47.22 84.7 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.804 0.729 . . . . 0.0 110.42 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -60.59 -31.33 70.48 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.782 0.433 . . . . 0.0 111.654 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.426 ' HA ' HH11 ' A' ' 367' ' ' ARG . . . -69.74 -57.33 5.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.4 1.48 . . . . 0.0 110.617 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 43.8 t -59.89 -38.16 75.17 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.15 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -48.83 -56.15 9.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 119.263 0.938 . . . . 0.0 110.994 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.72 -45.7 85.4 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.748 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -54.82 -41.88 71.21 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.3 -53.31 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-O 118.606 -0.711 . . . . 0.0 109.513 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 49.3 mm -62.76 -36.54 75.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 119.014 0.824 . . . . 0.0 110.064 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.32 -50.62 73.29 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.114 0.87 . . . . 0.0 109.599 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -64.49 -52.24 58.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.647 0.779 . . . . 0.0 111.152 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -59.26 -29.01 67.25 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.036 1.334 . . . . 0.0 114.115 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 7.7 m -93.26 -3.9 52.83 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.581 0.752 . . . . 0.0 110.95 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 69.02 23.35 76.07 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 35.4 mtt-85 -80.73 -33.22 35.33 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -150.45 148.03 28.25 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 10.8 t -71.55 166.6 21.49 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.592 0.71 . . . . 0.0 109.426 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 99.3 t -61.78 -44.65 99.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 126.174 1.79 . . . . 0.0 110.771 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -55.4 -47.06 76.47 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.158 0.583 . . . . 0.0 111.251 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -78.47 -38.02 42.0 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.113 0.565 . . . . 0.0 111.262 -178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.13 89.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.454 -0.779 . . . . 0.0 110.825 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.0 mt -77.25 -30.06 54.29 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-O 117.71 -1.138 . . . . 0.0 110.26 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -58.22 -49.2 77.91 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 120.349 1.431 . . . . 0.0 108.645 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -51.03 -54.53 23.81 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.737 2.015 . . . . 0.0 108.638 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.84 -49.77 76.41 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.605 1.562 . . . . 0.0 112.879 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -54.76 -37.15 65.62 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.11 1.364 . . . . 0.0 109.412 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 20.0 m -66.4 -37.96 86.42 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.127 0.571 . . . . 0.0 110.944 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.426 HH11 ' HA ' ' A' ' 342' ' ' ALA . 77.0 mtt180 -66.11 -31.02 71.63 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.247 -0.908 . . . . 0.0 109.912 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.0 mt -80.22 -38.26 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.762 0.825 . . . . 0.0 111.292 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.5 p -73.61 -12.98 60.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.468 1.031 . . . . 0.0 110.9 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 51.3 tttm . . . . . 0 C--O 1.251 1.139 0 C-N-CA 124.689 1.196 . . . . 0.0 109.01 178.842 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.8 mt -131.18 152.16 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -83.71 66.87 9.25 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -62.33 123.87 19.38 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 131.18 3.792 . . . . 0.0 109.491 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.97 39.54 93.27 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.995 1.284 . . . . 0.0 112.634 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -146.08 -179.15 6.52 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.468 1.107 . . . . 0.0 108.392 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.1 mt -145.6 144.64 30.59 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 128.539 2.735 . . . . 0.0 106.864 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 93.0 t -145.37 129.88 12.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.727 1.611 . . . . 0.0 107.222 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.59 141.59 46.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.773 0.829 . . . . 0.0 109.391 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.513 ' HB3' HD22 ' A' ' 43' ' ' LEU . 33.4 m0 -120.42 164.87 15.71 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.313 1.045 . . . . 0.0 111.812 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 13' ' ' GLY . 3.6 mt -136.79 136.32 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.828 1.251 . . . . 0.0 111.545 -178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -117.66 12.01 13.87 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.963 1.705 . . . . 0.0 110.655 179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 11' ' ' ILE . . . -161.74 59.18 0.29 Allowed Glycine 0 C--N 1.339 0.724 0 O-C-N 119.974 -1.704 . . . . 0.0 115.689 -177.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 33.23 48.93 0.18 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 126.552 1.941 . . . . 0.0 115.019 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.74 168.8 10.7 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.32 64.89 3.71 Favored Glycine 0 CA--C 1.52 0.388 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -69.74 -23.57 63.41 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 118.079 -0.962 . . . . 0.0 112.757 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -64.72 -57.28 9.4 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-N 119.428 1.013 . . . . 0.0 108.856 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.98 -40.52 73.5 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 34.3 tp -68.19 -35.92 78.76 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.077 0.951 . . . . 0.0 112.034 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.85 -41.47 97.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 117.576 -1.202 . . . . 0.0 109.169 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -59.38 -35.13 73.35 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.919 0.781 . . . . 0.0 110.096 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.69 -42.61 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.39 -38.77 95.3 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.8 mtmm -63.45 -47.03 83.55 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 118.729 1.265 . . . . 0.0 107.909 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -58.76 -58.38 8.87 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -53.1 -45.11 68.09 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.909 1.232 . . . . 0.0 112.236 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.19 -23.33 66.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.434 1.494 . . . . 0.0 110.937 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -92.16 -17.28 25.13 Favored 'General case' 0 N--CA 1.446 -0.667 0 O-C-N 120.277 -1.514 . . . . 0.0 112.437 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -102.73 -7.0 22.05 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 124.247 0.967 . . . . 0.0 109.551 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 59.1 p -133.47 -34.42 1.05 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.495 1.118 . . . . 0.0 113.823 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.64 -17.91 58.44 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.696 1.141 . . . . 0.0 112.808 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.9 128.01 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.33 145.79 52.89 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.8 t -138.44 83.25 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.3 m -73.62 151.25 40.9 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 71.3 t -139.81 118.52 11.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 125.541 1.537 . . . . 0.0 107.942 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -143.86 157.34 44.43 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 118.855 0.752 . . . . 0.0 111.247 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -117.95 54.82 1.91 Allowed Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.37 1.468 . . . . 0.0 112.218 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.486 ' HG2' ' HB3' ' A' ' 43' ' ' LEU . 78.9 Cg_endo -69.42 123.89 10.67 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.83 2.353 . . . . 0.0 111.59 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -13.64 58.99 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 127.818 2.447 . . . . 0.0 114.398 -178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.454 ' H ' ' HE2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -121.24 21.1 11.26 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.245 1.418 . . . . 0.0 113.727 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 10' ' ' TRP . 0.6 OUTLIER -58.37 -23.35 56.7 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.16 -26.75 61.09 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -106.72 -20.57 13.31 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.205 0.526 . . . . 0.0 110.675 -178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -75.92 -56.42 4.69 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -40.01 -57.82 2.54 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-O 116.743 -1.599 . . . . 0.0 112.354 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.96 -44.29 25.67 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.803 1.669 . . . . 0.0 114.219 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.5 mm100 -64.01 -49.13 73.64 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 124.472 1.109 . . . . 0.0 112.337 -178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 t -72.08 -39.18 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 123.474 0.71 . . . . 0.0 110.366 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.62 -28.61 63.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 120.949 -1.094 . . . . 0.0 113.018 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.47 -14.32 27.92 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 119.165 0.893 . . . . 0.0 112.813 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.9 m -118.15 4.22 12.0 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.945 1.298 . . . . 0.0 111.081 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.52 0.43 88.12 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.279 0.942 . . . . 0.0 113.71 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -83.23 -10.61 58.47 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.643 -1.504 . . . . 0.0 113.277 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -68.92 -179.05 19.84 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.69 -177.78 0.61 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 125.222 3.948 . . . . 0.0 113.45 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.53 -25.88 13.75 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.262 0.554 . . . . 0.0 111.057 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 mt -146.27 154.63 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 tp -137.31 146.28 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -132.2 111.9 11.81 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.61 1.564 . . . . 0.0 108.02 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -156.99 -167.04 2.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.161 0.892 . . . . 0.0 112.271 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.01 143.62 50.72 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 124.127 0.971 . . . . 0.0 110.865 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -56.8 -41.62 78.08 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.775 1.23 . . . . 0.0 109.541 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -67.84 -5.37 16.25 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 127.436 2.294 . . . . 0.0 114.101 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -111.91 -10.18 13.99 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 123.891 0.876 . . . . 0.0 110.301 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -86.73 4.04 42.4 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.415 1.486 . . . . 0.0 110.254 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.24 -9.6 84.84 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 120.369 -1.457 . . . . 0.0 109.6 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.56 -70.59 1.16 Allowed Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.542 1.544 . . . . 0.0 112.191 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -46.7 -47.56 20.41 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.707 1.603 . . . . 0.0 112.966 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.36 -45.06 94.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.379 1.071 . . . . 0.0 111.343 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.53 -46.66 83.58 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.3 m -65.61 -4.86 6.8 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.256 0.623 . . . . 0.0 112.289 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.87 13.32 83.54 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 125.837 1.684 . . . . 0.0 112.274 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.2 mt -73.87 -17.82 61.0 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.211 1.006 . . . . 0.0 111.67 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.5 mt -95.22 136.41 35.59 Favored 'General case' 0 CA--C 1.514 -0.411 0 O-C-N 121.136 -0.977 . . . . 0.0 111.167 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.98 170.42 16.03 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 123.954 0.784 . . . . 0.0 111.826 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -69.04 115.34 8.22 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.536 HD12 ' CD2' ' A' ' 106' ' ' TYR . 2.2 mm -72.14 158.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.23 0.538 . . . . 0.0 110.291 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.5 m 60.72 84.02 0.2 Allowed Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 126.032 1.733 . . . . 0.0 109.786 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.06 -27.59 29.62 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 121.643 1.562 . . . . 0.0 111.158 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -136.34 144.87 44.87 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.153 1.381 . . . . 0.0 110.815 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -52.35 -37.96 57.5 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 126.484 1.914 . . . . 0.0 112.833 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.63 -37.63 68.44 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.375 0.989 . . . . 0.0 112.002 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -60.28 -25.72 65.94 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.427 0.691 . . . . 0.0 111.869 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -67.04 -48.16 69.18 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.73 -19.5 61.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 125.413 1.485 . . . . 0.0 113.401 -178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.26 -15.21 62.88 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.497 -0.752 . . . . 0.0 110.888 179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.9 mt -124.18 154.83 39.53 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.444 1.498 . . . . 0.0 108.519 -179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -67.59 152.52 96.19 Favored Pre-proline 0 CA--C 1.54 0.576 0 O-C-N 121.663 -0.648 . . . . 0.0 110.133 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.2 -36.27 7.45 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.109 2.539 . . . . 0.0 114.675 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -63.59 -43.18 97.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.437 0.562 . . . . 0.0 111.088 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -23.28 62.88 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.353 1.461 . . . . 0.0 111.667 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -70.45 -22.63 62.67 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 119.561 1.073 . . . . 0.0 110.621 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.61 -23.74 67.36 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.35 1.06 . . . . 0.0 111.189 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.36 -17.38 60.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.256 1.022 . . . . 0.0 113.424 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.67 14.94 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.46 168.78 4.28 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 122.723 1.249 . . . . 0.0 112.083 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -159.93 177.97 10.22 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 129.008 2.923 . . . . 0.0 105.168 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -64.12 99.01 0.24 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.492 1.117 . . . . 0.0 111.097 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.88 -84.88 0.47 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 124.588 1.09 . . . . 0.0 110.892 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 153.46 41.84 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.784 0.802 . . . . 0.0 109.968 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.6 mt -91.62 152.06 20.42 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 22.4 pt -111.77 -27.73 2.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.831 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.92 174.76 14.68 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 119.478 1.035 . . . . 0.0 108.771 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.536 ' CD2' HD12 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -125.7 150.5 68.62 Favored Pre-proline 0 C--O 1.239 0.517 0 C-N-CA 124.386 1.075 . . . . 0.0 110.209 179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.83 141.68 41.45 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.266 2.644 . . . . 0.0 107.851 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.3 mm -126.44 -45.51 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.484 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.691 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -147.37 122.34 10.05 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -90.36 118.68 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -141.98 107.09 4.95 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.99 170.43 16.26 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 25.9 tp -43.21 134.14 3.77 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 126.212 1.805 . . . . 0.0 113.592 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 70.8 m -126.64 149.83 49.28 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.089 1.756 . . . . 0.0 109.374 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD23 HG23 ' A' ' 245' ' ' THR . 51.7 tp -76.83 149.19 36.21 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 54.7 mt -123.87 139.01 51.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 224' ' ' MET . 27.6 p90 -143.43 173.11 11.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.799 1.239 . . . . 0.0 110.576 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -59.29 166.1 2.38 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.938 1.295 . . . . 0.0 110.103 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -54.01 -26.74 27.84 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.093 1.357 . . . . 0.0 113.757 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -65.08 164.59 12.66 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.344 0.657 . . . . 0.0 110.16 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.9 pp -74.08 -8.46 56.22 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 121.548 -0.72 . . . . 0.0 111.993 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.4 tp 52.52 79.91 0.32 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.524 1.93 . . . . 0.0 109.961 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.42 2.78 5.34 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.487 2.792 . . . . 0.0 113.286 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -140.21 69.22 34.11 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 124.938 1.295 . . . . 0.0 111.059 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.12 159.68 37.06 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 122.449 2.099 . . . . 0.0 110.215 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.45 158.02 25.6 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.761 2.307 . . . . 0.0 110.868 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 3.3 mtpt -118.13 -2.5 11.2 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 121.296 -0.877 . . . . 0.0 112.71 179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -169.41 160.48 9.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.416 1.087 . . . . 0.0 108.443 -178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -67.88 -24.57 65.25 Favored 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 118.964 -0.541 . . . . 0.0 111.091 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -69.93 -13.92 62.47 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 119.228 0.922 . . . . 0.0 112.183 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -90.67 -21.67 21.54 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.337 1.055 . . . . 0.0 110.209 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 50.3 mm -55.76 -57.37 21.87 Favored Pre-proline 0 N--CA 1.454 -0.264 0 CA-C-O 117.83 -1.081 . . . . 0.0 109.214 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.87 -20.4 45.46 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 CA-C-N 120.983 1.387 . . . . 0.0 113.163 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.58 -40.45 66.6 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.249 1.02 . . . . 0.0 112.067 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 27.5 tp -94.85 -22.92 17.71 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.492 1.117 . . . . 0.0 112.077 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -61.28 -35.39 77.17 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 120.785 -1.197 . . . . 0.0 111.252 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -75.54 -33.94 60.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.885 1.274 . . . . 0.0 111.188 178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -70.21 -45.5 66.47 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 28.0 mt -67.43 -32.37 73.2 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.77 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -70.96 -28.95 64.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.597 0.635 . . . . 0.0 109.566 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.88 -26.6 63.32 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 118.404 0.547 . . . . 0.0 111.102 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.61 -1.21 16.94 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.122 0.969 . . . . 0.0 112.812 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -179.21 -98.72 0.12 Allowed Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -142.18 178.74 7.34 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.623 1.169 . . . . 0.0 112.062 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.2 p -53.98 156.09 3.13 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.74 1.616 . . . . 0.0 113.088 -178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -87.74 -58.51 2.55 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.678 1.591 . . . . 0.0 109.959 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.51 142.69 47.35 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.484 0.714 . . . . 0.0 112.075 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 55.5 mtp -144.97 135.48 24.32 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 128.308 2.643 . . . . 0.0 105.749 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -156.19 168.63 26.69 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.069 1.748 . . . . 0.0 107.48 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.73 HD22 ' HB2' ' A' ' 210' ' ' TYR . 37.9 t-20 -75.93 126.26 30.66 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.9 mp -114.62 -8.14 12.72 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.607 0.639 . . . . 0.0 110.623 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -80.0 -10.28 59.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.307 2.243 . . . . 0.0 112.213 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -115.64 137.55 23.27 Favored Pre-proline 0 C--O 1.237 0.43 0 CA-C-N 119.628 1.104 . . . . 0.0 108.206 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.59 -27.66 32.43 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 121.617 1.545 . . . . 0.0 112.14 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -65.95 -25.3 67.06 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 118.938 0.79 . . . . 0.0 112.015 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -85.58 -9.88 56.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.431 1.014 . . . . 0.0 112.286 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 13.1 p -112.58 -19.86 11.93 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.024 0.929 . . . . 0.0 110.343 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -54.84 41.31 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.01 -24.72 59.19 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.17 1.913 . . . . 0.0 113.515 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.7 tt -69.17 -65.38 0.72 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 37.0 pt -58.66 -28.94 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 123.981 0.913 . . . . 0.0 113.179 -178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.78 -22.15 63.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.752 0.821 . . . . 0.0 112.62 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -49.18 -57.12 7.25 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.904 2.081 . . . . 0.0 114.863 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -67.1 -49.2 65.79 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.293 0.371 . . . . 0.0 111.785 -177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.55 49.19 0.05 OUTLIER Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.517 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -116.76 133.27 10.59 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -147.51 143.7 28.02 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -70.91 -68.14 0.46 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -139.01 151.09 46.54 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.557 0.743 . . . . 0.0 111.474 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -74.51 128.77 36.37 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -151.46 104.46 3.07 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -155.87 155.03 32.2 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 55.03 20.87 3.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.328 1.451 . . . . 0.0 114.429 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.4 6.51 83.76 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-N 119.416 1.007 . . . . 0.0 113.082 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.65 117.65 32.86 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 125.703 1.601 . . . . 0.0 107.641 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -116.85 119.17 34.56 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.749 2.02 . . . . 0.0 106.14 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -135.72 110.61 8.77 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.519 0.728 . . . . 0.0 109.059 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.44 0.39 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.215 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -76.98 -19.61 57.1 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 120.971 -1.081 . . . . 0.0 110.712 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -102.83 96.49 6.87 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 126.628 1.971 . . . . 0.0 106.52 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 70.8 t -125.68 147.24 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.83 1.252 . . . . 0.0 110.612 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -127.99 22.26 5.43 Favored Glycine 0 CA--C 1.535 1.324 0 CA-C-O 118.333 -1.26 . . . . 0.0 115.574 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.26 -40.33 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.807 2.303 . . . . 0.0 111.907 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -90.47 19.5 5.22 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.496 0.718 . . . . 0.0 112.786 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -70.61 155.23 41.0 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 120.384 -1.447 . . . . 0.0 110.487 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.51 92.0 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.398 0.679 . . . . 0.0 109.482 179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -61.03 -38.58 95.78 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.657 -0.577 . . . . 0.0 111.657 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -67.56 -50.82 56.65 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 117.324 0.562 . . . . 0.0 110.197 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -63.1 -36.21 82.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 118.377 -0.82 . . . . 0.0 111.583 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.31 74.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.91 0.884 . . . . 0.0 112.187 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -84.85 -24.47 45.28 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 118.612 0.642 . . . . 0.0 112.229 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 52.3 tp -76.39 -49.55 16.47 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.181 0.993 . . . . 0.0 112.401 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.4 -31.99 56.21 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 118.606 0.639 . . . . 0.0 110.433 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -56.57 -44.08 80.65 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.555 1.542 . . . . 0.0 109.891 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.19 -40.74 94.63 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 121.238 -0.914 . . . . 0.0 110.548 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 22.2 t -64.14 -38.55 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.095 0 C-N-CA 125.028 1.331 . . . . 0.0 109.347 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -59.92 -46.95 87.75 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.328 1.451 . . . . 0.0 110.792 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.3 mt -65.9 -37.8 87.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.03 0.832 . . . . 0.0 109.85 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 59.7 mt -67.46 -37.73 79.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -61.47 -41.72 97.68 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.25 -14.76 62.34 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.673 1.189 . . . . 0.0 111.715 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt 60.99 4.44 0.81 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 128.433 2.693 . . . . 0.0 112.77 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.79 -12.91 60.27 Favored 'General case' 0 C--N 1.333 -0.138 0 O-C-N 122.312 -0.243 . . . . 0.0 110.862 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 4.2 tpt -88.97 154.78 19.94 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.56 -0.712 . . . . 0.0 110.646 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -82.84 64.3 7.39 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -57.14 -14.49 4.07 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -92.59 -15.07 27.35 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.989 1.316 . . . . 0.0 112.761 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 57.4 m -66.71 137.59 56.79 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.094 0.958 . . . . 0.0 111.929 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -131.13 -176.73 4.11 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.49 1.916 . . . . 0.0 107.603 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.73 ' HB2' HD22 ' A' ' 150' ' ' ASN . 54.1 t80 -57.53 -45.56 84.9 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 122.31 -0.244 . . . . 0.0 111.294 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.68 -47.65 76.42 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.189 1.796 . . . . 0.0 111.029 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 63.0 mt -71.89 -48.08 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 124.844 1.257 . . . . 0.0 110.57 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.77 -37.16 83.28 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.814 0.734 . . . . 0.0 110.674 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.93 -52.1 40.08 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -57.27 -49.07 77.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.894 0.478 . . . . 0.0 111.612 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -58.62 -44.22 89.9 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -61.29 -40.66 94.96 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -58.97 -16.11 16.37 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.623 1.169 . . . . 0.0 113.513 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.0 -13.39 14.1 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.684 1.194 . . . . 0.0 111.387 177.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.49 18.82 58.07 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.832 1.206 . . . . 0.0 111.098 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -66.97 -12.23 59.14 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.818 1.247 . . . . 0.0 111.606 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 43.6 p -113.36 141.84 46.58 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.646 1.978 . . . . 0.0 109.681 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -82.57 -34.79 27.63 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.42 ' HA ' ' HA ' ' A' ' 117' ' ' TYR . 4.2 ptt? -146.3 164.24 32.99 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 126.784 2.034 . . . . 0.0 111.304 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.5 t -164.79 169.62 16.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.082 1.353 . . . . 0.0 107.687 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mt -133.96 114.21 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -139.73 145.86 38.83 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 127.392 2.277 . . . . 0.0 105.215 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -68.86 165.37 48.44 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.787 0.708 . . . . 0.0 112.785 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -71.93 108.42 2.44 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.42 2.747 . . . . 0.0 109.152 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 86.4 m95 42.33 57.07 3.49 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.973 2.509 . . . . 0.0 113.845 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -89.0 -157.87 0.47 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -55.5 92.82 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.63 1.572 . . . . 0.0 111.48 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 19.3 m -108.78 91.2 3.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.436 1.494 . . . . 0.0 106.99 -179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -61.88 -9.87 7.9 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.879 0.872 . . . . 0.0 112.725 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 17.2 tt -150.21 128.59 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -78.88 132.52 36.82 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 22.0 p -121.67 125.59 47.01 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.173 0.511 . . . . 0.0 109.92 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.8 p -71.4 75.77 0.76 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.201 1.8 . . . . 0.0 108.353 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -71.64 -40.58 69.62 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 124.448 1.099 . . . . 0.0 109.798 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 3.0 t 48.78 31.9 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 125.871 1.668 . . . . 0.0 111.502 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -151.09 140.52 21.47 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.808 1.643 . . . . 0.0 109.037 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -163.92 144.99 8.73 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 127.795 2.438 . . . . 0.0 105.873 176.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -176.63 178.03 47.97 Favored Glycine 0 C--O 1.241 0.574 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.705 HG11 ' HG3' ' A' ' 316' ' ' ARG . 4.7 p -117.52 111.99 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.166 1.387 . . . . 0.0 108.228 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.494 HG23 HD23 ' A' ' 115' ' ' LEU . 14.1 t -133.18 165.24 25.24 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 2.4 p -64.4 108.02 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.835 0 C-N-CA 124.903 1.281 . . . . 0.0 110.223 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -86.08 151.09 53.86 Favored Pre-proline 0 C--O 1.239 0.501 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -71.36 134.46 24.72 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.927 1.751 . . . . 0.0 108.805 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.6 p -147.26 -172.49 4.02 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.466 1.506 . . . . 0.0 107.574 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -86.68 137.02 32.8 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 9.5 pttp -51.37 128.97 23.97 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.426 -0.796 . . . . 0.0 109.936 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 73.43 -10.5 6.35 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.863 1.105 . . . . 0.0 115.863 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.65 92.37 14.97 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 120.113 1.957 . . . . 0.0 107.943 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -71.55 161.96 43.75 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 122.489 2.126 . . . . 0.0 112.293 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 40.8 t -66.54 150.32 49.16 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.913 1.285 . . . . 0.0 108.763 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 3.1 mptt -139.22 89.19 12.51 Favored Pre-proline 0 N--CA 1.456 -0.171 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -80.94 -174.58 2.29 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.545 2.83 . . . . 0.0 110.476 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -63.47 -178.86 0.3 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.121 1.369 . . . . 0.0 109.49 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 48.3 t -115.98 85.75 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 O-C-N 121.068 -1.02 . . . . 0.0 108.43 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -76.56 136.77 19.85 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.85 128.6 50.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.682 0.793 . . . . 0.0 110.409 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.5 tt -62.96 138.23 58.5 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.982 1.313 . . . . 0.0 107.646 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 34.6 m -118.76 144.23 46.41 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.826 0.822 . . . . 0.0 110.836 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -138.86 136.9 36.06 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -149.66 145.36 13.46 Favored Glycine 0 C--O 1.236 0.232 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 34.5 mt -69.32 134.52 30.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 124.229 1.012 . . . . 0.0 108.991 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -90.38 113.61 25.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.16 -14.41 37.13 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.958 1.303 . . . . 0.0 112.934 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.71 78.18 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 119.366 0.985 . . . . 0.0 111.88 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 48.7 m -62.13 164.86 9.66 Favored Pre-proline 0 CA--C 1.546 0.826 0 O-C-N 123.101 0.25 . . . . 0.0 110.654 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -89.43 -26.17 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.797 2.331 . . . . 0.0 117.06 -175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -127.68 90.03 3.04 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-N 119.664 1.12 . . . . 0.0 110.537 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -62.99 -14.99 54.61 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 122.656 0.382 . . . . 0.0 111.907 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -66.03 -41.35 91.06 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 75.3 mt -57.0 -37.51 71.78 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 121.375 -0.828 . . . . 0.0 110.148 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.92 -48.04 60.09 Favored 'General case' 0 N--CA 1.444 -0.734 0 O-C-N 122.041 -0.412 . . . . 0.0 110.789 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -31.44 71.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 118.981 -0.533 . . . . 0.0 111.152 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -75.86 -42.51 49.19 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -59.95 -46.04 90.69 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 119.952 1.251 . . . . 0.0 108.855 178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.9 mp -63.65 -48.1 78.59 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 117.509 -1.234 . . . . 0.0 110.973 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -79.9 -20.55 45.56 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -97.79 -20.18 17.7 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.949 1.704 . . . . 0.0 113.019 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -138.6 -33.55 0.66 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-O 117.503 -1.237 . . . . 0.0 114.198 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.4 -57.1 4.09 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 121.167 1.803 . . . . 0.0 111.797 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.46 23.54 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 128.1 2.56 . . . . 0.0 114.137 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 77.2 p -98.65 160.99 13.9 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -65.08 -30.67 71.64 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -71.0 -47.43 58.87 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.353 1.061 . . . . 0.0 111.202 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -63.43 -47.34 88.3 Favored Glycine 0 C--N 1.334 0.437 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.8 mt -62.12 -41.03 97.84 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 118.607 -0.711 . . . . 0.0 110.299 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -64.17 -43.27 95.64 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.434 0.561 . . . . 0.0 109.539 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.67 -43.5 85.07 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.587 0.631 . . . . 0.0 112.385 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 41.4 t -71.05 -38.45 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.718 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -68.54 -26.75 65.58 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.449 0.568 . . . . 0.0 111.797 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -66.43 -50.97 61.6 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.76 -52.12 65.54 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 119.085 -0.483 . . . . 0.0 112.23 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -140.6 147.42 48.99 Favored Pre-proline 0 N--CA 1.469 0.52 0 CA-C-N 119.04 0.836 . . . . 0.0 109.419 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.93 123.26 11.36 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.33 2.02 . . . . 0.0 111.06 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 28.5 mt -94.52 -6.91 42.69 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.728 1.211 . . . . 0.0 112.519 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 63.12 -141.92 46.91 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 107.018 -2.433 . . . . 0.0 107.018 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -79.1 176.45 9.66 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.95 157.11 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 120.683 -1.26 . . . . 0.0 112.941 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -82.4 -25.3 33.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 18.4 tp -72.34 111.2 7.33 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -56.8 -33.56 66.81 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.8 m -54.67 -57.26 12.19 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.842 1.257 . . . . 0.0 110.35 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -81.03 -13.04 59.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.684 0.794 . . . . 0.0 112.414 -179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -63.73 -33.13 74.96 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -69.52 -17.33 63.58 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.379 0.672 . . . . 0.0 111.284 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.503 ' HA ' ' HE2' ' A' ' 313' ' ' LYS . 45.1 mm-40 -93.73 -46.15 7.36 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.471 1.508 . . . . 0.0 109.415 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 7.1 mt -69.15 -34.37 74.89 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.264 -0.897 . . . . 0.0 110.463 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.05 -15.97 48.59 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.406 1.262 . . . . 0.0 114.406 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.503 ' HE2' ' HA ' ' A' ' 310' ' ' GLU . 54.2 mttm -54.3 -34.64 61.35 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 118.912 0.778 . . . . 0.0 110.699 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -93.22 136.01 24.95 Favored Pre-proline 0 N--CA 1.448 -0.549 0 C-N-CA 123.983 0.913 . . . . 0.0 110.35 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo -61.98 -23.03 75.38 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.372 2.048 . . . . 0.0 114.472 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.705 ' HG3' HG11 ' A' ' 244' ' ' VAL . 0.2 OUTLIER -57.72 -47.9 81.09 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 119.24 0.927 . . . . 0.0 109.752 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.2 mp -67.82 -59.2 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 125.079 1.352 . . . . 0.0 109.526 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.94 -46.52 64.76 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.61 -37.82 76.68 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 119.39 0.995 . . . . 0.0 112.597 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 88.6 m -68.68 -37.1 79.32 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.038 0.935 . . . . 0.0 108.97 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.6 tpt -66.04 -48.13 72.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.273 1.029 . . . . 0.0 109.883 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -58.82 -37.59 76.73 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.993 0.815 . . . . 0.0 110.412 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -69.39 -37.28 77.46 Favored 'General case' 0 C--O 1.224 -0.287 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.59 -34.12 73.75 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.959 0.799 . . . . 0.0 110.829 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -72.68 -28.57 62.78 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.76 -19.29 16.8 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.647 -0.658 . . . . 0.0 112.536 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -83.54 177.3 52.62 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -105.38 127.19 52.84 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.621 1.568 . . . . 0.0 111.952 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 45.9 mt -94.45 132.38 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 8.6 tpt 5.18 86.56 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.594 0 C-N-CA 129.102 2.961 . . . . 0.0 112.068 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -66.76 87.66 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.36 2.707 . . . . 0.0 113.24 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -81.53 73.79 8.55 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 6.1 pt -132.15 157.77 77.34 Favored Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 126.177 1.791 . . . . 0.0 109.935 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -71.15 -33.82 11.03 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 121.952 1.768 . . . . 0.0 111.76 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.77 -19.64 29.51 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 6.2 mmt -64.62 -29.73 70.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.656 0.662 . . . . 0.0 109.644 178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 20.1 m -56.38 -53.49 56.75 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.001 0.92 . . . . 0.0 110.544 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.41 -39.75 64.8 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 117.644 -1.169 . . . . 0.0 110.549 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -48.39 -55.87 9.67 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.433 1.015 . . . . 0.0 112.147 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -60.31 -53.04 62.37 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 119.119 -0.467 . . . . 0.0 111.946 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -60.23 -42.65 95.67 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 118.705 0.684 . . . . 0.0 112.766 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -58.84 -56.68 19.04 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.132 1.373 . . . . 0.0 110.254 -178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 33.6 t -65.96 -38.78 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-O 118.47 -0.776 . . . . 0.0 110.023 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -54.11 -45.77 71.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.685 1.13 . . . . 0.0 108.18 179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 28.0 m -70.13 -46.35 64.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.584 -0.722 . . . . 0.0 110.253 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -51.21 -45.04 61.75 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.189 0.904 . . . . 0.0 112.661 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 24.2 t -58.08 -57.96 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 125.126 1.37 . . . . 0.0 108.457 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 48.0 mm -60.57 -38.46 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 118.502 -0.761 . . . . 0.0 111.264 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -60.03 -48.14 82.96 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.669 1.122 . . . . 0.0 109.288 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -68.93 -49.14 60.67 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 119.259 -0.4 . . . . 0.0 111.858 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.51 -23.67 66.08 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.934 1.294 . . . . 0.0 113.319 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 17.3 m -94.79 -2.66 50.49 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.397 0.679 . . . . 0.0 109.945 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.41 12.63 69.86 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 118.753 0.706 . . . . 0.0 111.534 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -69.93 -36.04 75.01 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.02 0.928 . . . . 0.0 109.827 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -142.18 164.83 29.09 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 359' ' ' GLU . 15.4 t -81.37 159.96 24.23 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.07 -52.63 42.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 C-N-CA 124.917 1.287 . . . . 0.0 109.843 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -53.47 -47.81 69.43 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 127.115 2.166 . . . . 0.0 111.42 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.48 ' H ' HG23 ' A' ' 356' ' ' THR . 47.6 mm-40 -75.46 -33.26 60.85 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 118.733 0.697 . . . . 0.0 111.174 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.56 85.4 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 1.1 mp -68.35 -45.91 71.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.571 1.949 . . . . 0.0 110.445 178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 13.4 tppt? -55.52 -58.09 9.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.24 1.016 . . . . 0.0 108.536 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -53.3 -42.25 66.44 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 127.166 2.187 . . . . 0.0 112.084 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -68.66 -49.82 56.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.864 -1.062 . . . . 0.0 111.878 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -58.68 -32.25 68.95 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.21 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 6.6 m -63.38 -36.48 83.85 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.93 1.241 . . . . 0.0 110.62 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 12.2 mtt85 -65.84 -30.84 71.53 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.95 -1.094 . . . . 0.0 110.908 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 36.5 mt -82.58 -37.98 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.633 1.573 . . . . 0.0 111.15 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 65.9 p -78.29 -12.09 59.98 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.763 1.165 . . . . 0.0 112.921 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 12.1 tmtt? . . . . . 0 C--O 1.254 1.294 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.025 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 29.9 tttm . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 14.5 mt -117.29 159.7 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -91.29 112.74 24.77 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.9 mp0 -81.18 -176.08 5.78 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 126.808 2.043 . . . . 0.0 109.342 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.33 29.48 73.29 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 121.129 -0.982 . . . . 0.0 114.759 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.99 162.12 37.69 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.252 1.021 . . . . 0.0 111.285 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 68.6 mt -152.53 147.4 26.16 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 130.095 3.358 . . . . 0.0 106.59 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.408 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 94.5 t -144.95 146.46 19.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 125.123 1.369 . . . . 0.0 108.639 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.462 HD12 HG22 ' A' ' 37' ' ' VAL . 20.5 mt -134.79 139.4 47.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 178.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -126.73 124.49 39.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 12' ' ' ASN . 1.5 mp -131.9 171.63 17.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.165 1.386 . . . . 0.0 108.327 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.441 ' H ' HG22 ' A' ' 11' ' ' ILE . 14.8 p-10 -103.94 157.28 17.21 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 125.403 1.481 . . . . 0.0 109.345 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -61.46 -22.15 60.98 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 125.608 1.575 . . . . 0.0 114.4 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -77.39 -3.11 38.52 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.522 1.661 . . . . 0.0 109.91 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.14 160.86 15.74 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 120.883 -1.136 . . . . 0.0 110.566 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.81 75.55 2.36 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 124.771 1.177 . . . . 0.0 110.238 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -74.38 -24.6 59.16 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -73.33 -43.1 61.46 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 120.744 1.611 . . . . 0.0 110.535 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.75 -30.66 73.18 Favored Glycine 0 CA--C 1.535 1.314 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.3 tp -74.91 -40.69 60.73 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.804 1.242 . . . . 0.0 110.958 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.14 -46.97 54.41 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.115 0.566 . . . . 0.0 109.967 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -55.66 -32.85 63.58 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.8 t -64.89 -41.14 91.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.07 -38.47 73.57 Favored Glycine 0 C--N 1.337 0.628 0 CA-C-O 118.838 -0.979 . . . . 0.0 111.021 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -59.36 -43.79 92.77 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 118.473 1.137 . . . . 0.0 108.325 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -60.22 -55.1 37.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.328 0.651 . . . . 0.0 109.803 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -58.4 -51.84 68.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 123.749 0.655 . . . . 0.0 111.989 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -61.43 -31.06 70.99 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.943 0.897 . . . . 0.0 110.74 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' CE ' ' HA ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -68.41 -31.77 71.35 Favored 'General case' 0 N--CA 1.436 -1.157 0 O-C-N 120.752 -1.218 . . . . 0.0 110.198 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -86.29 -47.12 9.69 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 123.629 0.581 . . . . 0.0 111.961 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.0 p -90.05 -32.3 16.79 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 -176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 89.52 -10.77 72.22 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 120.97 -1.081 . . . . 0.0 111.658 -179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.29 136.52 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 105.273 -2.121 . . . . 0.0 105.273 178.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HE2' ' N ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -66.63 134.7 52.83 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-O 117.785 -1.102 . . . . 0.0 109.359 -179.758 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.0 t -134.31 78.46 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.66 155.55 29.44 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.462 HG22 HD12 ' A' ' 9' ' ' ILE . 94.4 t -141.54 127.91 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -136.53 161.43 35.89 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -123.34 68.13 37.98 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 124.106 0.963 . . . . 0.0 111.004 -179.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -66.35 170.72 11.61 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.545 2.164 . . . . 0.0 111.114 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -122.97 -3.12 8.63 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.223 -0.923 . . . . 0.0 111.905 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -132.21 12.1 4.62 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 126.361 1.865 . . . . 0.0 112.785 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -50.94 -32.48 20.94 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.073 0.851 . . . . 0.0 112.315 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -52.54 -30.19 29.36 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.51 1.124 . . . . 0.0 112.259 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -116.9 -18.79 10.07 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.856 0.862 . . . . 0.0 112.206 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -41.38 31.89 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -51.41 -59.86 6.99 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.762 0.825 . . . . 0.0 109.834 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.47 -17.48 59.74 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 CA-C-N 121.245 1.48 . . . . 0.0 113.617 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -84.08 -5.48 59.24 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.667 1.121 . . . . 0.0 112.391 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.63 -38.85 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 124.031 0.932 . . . . 0.0 108.805 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.93 -32.54 70.88 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.213 1.005 . . . . 0.0 111.344 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.98 -31.61 68.91 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.741 0.7 . . . . 0.0 110.562 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.8 m -86.39 -15.97 38.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.598 1.159 . . . . 0.0 110.202 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.79 36.57 5.51 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 125.198 1.38 . . . . 0.0 110.381 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -132.16 173.71 10.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.691 1.196 . . . . 0.0 108.618 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.13 -160.21 14.77 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 126.497 1.998 . . . . 0.0 113.554 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -63.27 175.83 2.4 Favored 'Trans proline' 0 C--N 1.356 0.964 1 C-N-CA 125.861 4.374 . . . . 0.0 114.113 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 3.9 m-20 -106.96 -18.59 13.87 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 120.8 -1.187 . . . . 0.0 113.999 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.4 mt -148.22 135.15 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.33 1.052 . . . . 0.0 109.006 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.2 tt -115.19 142.06 29.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -129.95 107.57 9.46 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 125.45 1.5 . . . . 0.0 108.16 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.8 t-105 -156.13 -176.67 6.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 118.966 0.803 . . . . 0.0 111.553 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.35 138.14 51.16 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -46.37 -43.44 16.17 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 126.157 1.783 . . . . 0.0 113.619 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -55.53 -27.76 50.73 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -81.47 -18.66 44.44 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.764 0.711 . . . . 0.0 111.567 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -76.32 -13.51 60.14 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 118.465 -0.779 . . . . 0.0 112.833 -177.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -62.13 -11.69 33.69 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.284 0.945 . . . . 0.0 113.544 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.95 -63.03 0.92 Allowed Glycine 0 CA--C 1.522 0.505 0 N-CA-C 105.997 -2.841 . . . . 0.0 105.997 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -47.53 -56.37 7.23 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 126.043 1.737 . . . . 0.0 114.331 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.27 91.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.21 0.604 . . . . 0.0 111.758 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.31 -43.91 75.29 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.068 1.347 . . . . 0.0 109.717 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.5 m -74.87 -1.25 21.49 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.486 1.115 . . . . 0.0 113.347 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.77 18.15 64.22 Favored Glycine 0 C--N 1.337 0.626 0 O-C-N 120.805 -1.184 . . . . 0.0 113.602 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.6 mt -77.65 -32.91 53.59 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.687 1.244 . . . . 0.0 112.359 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.2 mt -91.45 142.1 28.03 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.476 -0.765 . . . . 0.0 111.706 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -78.88 172.24 14.05 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.857 1.263 . . . . 0.0 113.167 -179.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -69.93 100.13 1.52 Allowed 'General case' 0 C--O 1.234 0.241 0 C-N-CA 126.585 1.954 . . . . 0.0 108.911 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.514 HD12 ' CD2' ' A' ' 106' ' ' TYR . 9.9 mm -63.33 153.75 6.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.912 0.863 . . . . 0.0 110.107 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.9 m 60.86 77.44 0.37 Allowed Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 127.376 2.27 . . . . 0.0 109.725 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.16 -26.17 21.53 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.274 1.316 . . . . 0.0 110.252 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -129.94 138.09 50.7 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.523 1.529 . . . . 0.0 110.754 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -57.49 -37.0 72.22 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.74 -24.42 56.9 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 120.308 1.413 . . . . 0.0 112.953 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -65.8 -28.23 68.85 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.693 0.679 . . . . 0.0 110.648 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -66.01 -43.96 86.17 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -64.95 -11.84 43.0 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.45 0.7 . . . . 0.0 111.894 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.8 mtpt -87.19 -15.89 36.97 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 120.767 -1.208 . . . . 0.0 112.578 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.489 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 25.2 mt -124.17 163.12 22.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 119.475 1.034 . . . . 0.0 112.625 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -81.23 153.33 71.68 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 123.71 0.804 . . . . 0.0 112.03 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.05 -47.78 1.04 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 124.378 3.385 . . . . 0.0 114.216 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -54.05 -36.74 63.4 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 120.078 1.308 . . . . 0.0 111.937 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.435 HG22 ' CB ' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -73.5 -27.68 61.51 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.726 1.61 . . . . 0.0 110.634 179.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.489 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 12.9 m95 -69.5 -36.79 76.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.631 1.105 . . . . 0.0 109.999 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -63.2 -27.43 69.36 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.632 -0.667 . . . . 0.0 111.063 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.76 -4.16 22.43 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.291 1.437 . . . . 0.0 113.979 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.4 m -132.34 6.91 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 125.4 1.48 . . . . 0.0 111.206 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -71.6 170.67 12.92 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -149.14 -152.14 0.43 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -57.48 -11.76 2.18 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.536 1.934 . . . . 0.0 115.708 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.38 -85.14 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 105.563 -3.015 . . . . 0.0 105.563 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 162.08 16.98 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.425 0.69 . . . . 0.0 110.706 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.11 158.46 18.56 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.245 1.018 . . . . 0.0 109.614 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 20.0 pt -117.62 -24.5 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.651 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.418 ' CA ' HG13 ' A' ' 79' ' ' ILE . . . -156.81 -178.46 7.38 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.811 1.244 . . . . 0.0 110.051 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.514 ' CD2' HD12 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -136.82 149.52 67.1 Favored Pre-proline 0 C--O 1.24 0.584 0 C-N-CA 123.895 0.878 . . . . 0.0 111.355 178.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.435 ' CB ' HG22 ' A' ' 93' ' ' THR . 96.3 Cg_endo -75.01 142.62 28.05 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.843 2.362 . . . . 0.0 109.891 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.3 mm -124.56 -52.76 2.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 125.698 1.599 . . . . 0.0 108.173 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -120.34 148.81 43.27 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.827 1.251 . . . . 0.0 109.824 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 34.5 t -130.51 95.67 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.095 0.958 . . . . 0.0 109.254 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -94.71 164.46 12.94 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.491 1.117 . . . . 0.0 109.277 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.43 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -159.19 172.59 17.79 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.745 2.418 . . . . 0.0 106.721 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 26.3 mt -124.21 -170.22 2.1 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.695 1.198 . . . . 0.0 110.022 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.51 140.42 44.76 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.063 0.945 . . . . 0.0 109.847 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.7 168.82 7.13 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.074 0.949 . . . . 0.0 111.611 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.442 ' HB ' HG23 ' A' ' 225' ' ' THR . 5.3 mp -93.47 138.98 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 124.233 1.013 . . . . 0.0 109.202 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -155.79 155.53 33.18 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 123.96 0.904 . . . . 0.0 109.086 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -47.42 124.27 6.65 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.598 1.959 . . . . 0.0 109.061 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -65.89 9.69 0.13 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.096 1.358 . . . . 0.0 114.318 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -65.93 158.62 27.59 Favored 'General case' 0 C--O 1.237 0.444 0 O-C-N 120.805 -1.185 . . . . 0.0 110.461 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 121' ' ' LEU . 1.2 pt? -82.57 21.66 0.95 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.551 1.14 . . . . 0.0 110.695 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 5.8 tt -119.49 78.18 20.17 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 125.395 1.478 . . . . 0.0 108.99 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -74.93 115.27 4.24 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.599 2.199 . . . . 0.0 109.989 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -146.45 85.94 7.09 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -77.38 163.54 29.83 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.371 2.714 . . . . 0.0 114.571 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -77.32 124.06 6.94 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 124.129 3.219 . . . . 0.0 108.721 178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -80.72 -25.55 38.01 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.045 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 5.6 t -154.67 162.69 41.02 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 119.413 1.006 . . . . 0.0 109.689 -178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -65.75 -25.79 67.44 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 123.864 0.866 . . . . 0.0 111.786 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -71.56 -19.27 62.17 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.923 1.238 . . . . 0.0 109.79 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -89.37 -22.88 22.37 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.368 1.067 . . . . 0.0 111.125 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 15.8 mm -54.73 -59.33 10.81 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-O 118.195 -0.907 . . . . 0.0 108.796 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -69.87 -25.02 28.5 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 121.222 1.281 . . . . 0.0 111.47 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.16 -50.36 70.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 64.0 tp -70.13 -31.74 69.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -59.09 -44.76 91.95 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 118.684 0.674 . . . . 0.0 111.305 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -30.12 61.37 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-N 118.551 0.614 . . . . 0.0 110.832 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -66.27 -50.89 62.17 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 66.1 mt -67.48 -33.01 74.24 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.562 -1.208 . . . . 0.0 110.287 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -68.87 -34.62 75.74 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 119.931 1.241 . . . . 0.0 108.971 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.38 -16.36 62.16 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.378 0.536 . . . . 0.0 112.018 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.24 7.5 6.5 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 125.173 1.389 . . . . 0.0 112.121 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 170.92 -94.52 0.1 Allowed Glycine 0 CA--C 1.523 0.547 0 N-CA-C 115.737 1.055 . . . . 0.0 115.737 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.74 -178.88 5.44 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.38 1.072 . . . . 0.0 113.58 -176.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.64 169.08 9.99 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 122.803 1.287 . . . . 0.0 112.612 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -93.26 -73.12 0.57 Allowed 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 126.066 1.746 . . . . 0.0 109.292 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 50.9 tp -103.42 130.4 50.74 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 124.261 1.024 . . . . 0.0 112.749 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 76.7 mtp -131.37 117.3 18.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -143.22 156.31 44.72 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.69 88.22 0.35 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.746 1.618 . . . . 0.0 109.577 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -18.04 63.38 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.067 1.347 . . . . 0.0 109.812 -178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -71.41 -13.14 61.75 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 123.536 0.734 . . . . 0.0 112.644 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -103.76 129.3 25.57 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 119.19 0.905 . . . . 0.0 109.739 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.92 -10.41 23.03 Favored 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.786 2.324 . . . . 0.0 113.248 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -65.44 -42.09 92.75 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.796 1.638 . . . . 0.0 112.758 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -79.52 -32.67 42.34 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 21.6 p -84.33 -11.68 55.93 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 123.274 0.63 . . . . 0.0 111.77 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 49.3 t-105 -53.75 -58.86 11.33 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-O 117.625 -1.178 . . . . 0.0 112.044 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -65.53 -18.01 58.53 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 CA-C-N 121.281 1.493 . . . . 0.0 114.055 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.0 tp -71.35 -63.77 1.05 Allowed 'General case' 0 C--N 1.34 0.193 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.4 pt -66.41 -36.03 76.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.26 -12.97 59.54 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.121 -0.943 . . . . 0.0 113.095 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -44.63 -55.95 4.78 Favored 'General case' 0 CA--C 1.523 -0.096 0 C-N-CA 125.513 1.525 . . . . 0.0 114.06 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -60.78 -34.68 74.86 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.53 19.73 0.02 OUTLIER Glycine 0 C--N 1.332 0.335 0 CA-C-O 118.294 -1.281 . . . . 0.0 116.068 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -73.13 144.1 34.21 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-N 119.402 1.601 . . . . 0.0 111.548 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.427 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 51.7 p90 -153.86 144.99 22.85 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.46 -49.56 12.12 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.499 ' CD2' HD11 ' A' ' 333' ' ' ILE . 65.7 m-85 -145.9 133.67 21.16 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.646 0.778 . . . . 0.0 109.658 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.427 ' HE2' ' CE1' ' A' ' 167' ' ' TYR . 14.5 tppt? -70.65 149.53 46.92 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.522 0.729 . . . . 0.0 110.037 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -143.32 113.06 7.02 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -156.07 170.03 23.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 55.96 26.96 10.49 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.603 1.161 . . . . 0.0 111.495 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 56.17 43.79 88.88 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -149.5 166.54 28.85 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 126.69 1.996 . . . . 0.0 108.198 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.19 127.65 54.96 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.133 -1.802 . . . . 0.0 106.133 178.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -126.7 87.78 2.72 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 123.117 1.437 . . . . 0.0 112.184 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.439 ' H ' HD13 ' A' ' 178' ' ' ILE . 0.2 OUTLIER -63.61 -8.92 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.403 178.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -74.54 -12.34 60.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.373 1.069 . . . . 0.0 108.987 177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.412 ' OD2' ' HE3' ' A' ' 170' ' ' LYS . 61.7 t0 -118.94 93.57 4.14 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.244 1.417 . . . . 0.0 108.349 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 86.8 t -99.03 147.2 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -129.89 44.77 1.19 Allowed Glycine 0 CA--C 1.524 0.629 0 CA-C-O 119.185 -0.786 . . . . 0.0 111.947 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 70.3 t -86.76 -63.42 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 C-N-CA 124.958 1.303 . . . . 0.0 108.725 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -85.9 67.63 10.08 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 122.538 1.161 . . . . 0.0 110.029 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -121.48 159.34 26.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -55.93 -38.89 70.89 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -56.46 -46.66 87.24 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-N 118.702 0.683 . . . . 0.0 113.503 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.43 -52.6 60.84 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.891 0.476 . . . . 0.0 111.349 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -64.72 -31.02 72.06 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 118.318 -0.849 . . . . 0.0 111.879 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.31 -51.91 39.44 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -59.73 -38.99 94.68 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.488 HD23 HG13 ' A' ' 357' ' ' VAL . 56.1 tp -70.61 -45.2 65.71 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 118.291 -0.862 . . . . 0.0 111.324 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.12 -37.92 67.51 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 117.313 -1.327 . . . . 0.0 110.736 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -52.17 -48.71 64.83 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.784 1.629 . . . . 0.0 111.344 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.7 tt -69.22 -48.01 63.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.114 0.566 . . . . 0.0 110.645 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 85.6 t -60.66 -35.15 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 121.38 -0.825 . . . . 0.0 111.41 -179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -67.01 -29.6 69.47 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.204 -0.935 . . . . 0.0 109.279 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.94 -42.3 60.74 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 65.8 mt -58.38 -47.9 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -52.18 -51.29 58.98 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 125.181 1.392 . . . . 0.0 109.73 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -78.47 0.9 24.11 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.158 0.983 . . . . 0.0 112.087 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt 60.78 12.06 3.55 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 128.109 2.564 . . . . 0.0 113.812 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.79 6.35 1.2 Allowed 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 127.272 2.229 . . . . 0.0 111.806 178.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 14.3 ttt -147.49 143.8 28.11 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.108 1.322 . . . . 0.0 109.649 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -83.36 70.28 10.14 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -47.81 -40.31 20.75 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 128.492 2.717 . . . . 0.0 116.388 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -72.02 0.23 9.95 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.044 1.738 . . . . 0.0 114.113 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 82.8 m -65.37 123.18 18.93 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.008 -1.058 . . . . 0.0 110.512 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.1 -172.65 2.3 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.073 1.749 . . . . 0.0 108.241 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -60.2 -50.57 73.14 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.649 0.38 . . . . 0.0 110.91 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.1 m -60.89 -41.07 95.33 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.537 0.735 . . . . 0.0 111.132 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 41.4 mm -65.59 -49.33 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.879 -1.058 . . . . 0.0 108.556 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -62.16 -46.15 90.27 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.235 1.014 . . . . 0.0 111.707 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -62.78 -48.08 80.68 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.91 1.284 . . . . 0.0 108.888 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.53 87.81 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.02 -42.94 99.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -62.22 -39.08 91.61 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -57.32 -20.2 27.06 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.558 1.543 . . . . 0.0 111.774 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.38 -13.14 12.9 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 120.889 -1.132 . . . . 0.0 112.095 178.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.44 28.31 40.26 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.213 1.387 . . . . 0.0 110.47 -179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -75.83 7.18 4.13 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.585 1.954 . . . . 0.0 113.372 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.06 160.49 43.28 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 120.683 -1.261 . . . . 0.0 108.905 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -106.34 -15.14 14.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.536 1.534 . . . . 0.0 113.606 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 6.8 ptt? -159.88 153.46 22.57 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.889 1.276 . . . . 0.0 109.976 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.442 HG23 ' HB ' ' A' ' 116' ' ' ILE . 4.3 t -150.02 161.1 43.0 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 97.4 mt -132.23 106.94 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -156.7 -175.01 5.2 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.954 1.702 . . . . 0.0 107.451 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -75.85 172.21 54.17 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 123.689 0.661 . . . . 0.0 113.846 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -67.19 179.79 2.2 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 125.123 3.882 . . . . 0.0 112.553 179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.443 ' CE3' ' HE3' ' A' ' 239' ' ' LYS . 26.3 t90 63.51 23.59 13.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.355 1.862 . . . . 0.0 113.358 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.39 160.63 30.06 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.495 -1.378 . . . . 0.0 108.597 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -65.47 -15.08 62.28 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 122.664 1.221 . . . . 0.0 110.365 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 4.1 m -61.71 -24.57 66.87 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.014 1.325 . . . . 0.0 110.847 179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 41.8 p30 -125.47 175.12 7.73 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.742 1.617 . . . . 0.0 109.183 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 16.9 mm -110.1 -19.45 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -71.55 152.62 42.81 Favored 'General case' 0 C--N 1.339 0.138 0 O-C-N 120.746 -1.221 . . . . 0.0 108.993 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 66.6 p -120.53 87.58 2.78 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.842 0.857 . . . . 0.0 109.444 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 93.8 p -126.57 156.87 40.17 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 120.689 -1.257 . . . . 0.0 110.527 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . 0.443 ' HE3' ' CE3' ' A' ' 230' ' ' TRP . 8.1 mptt -134.94 134.2 40.34 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 179.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.5 p -176.16 167.77 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 128.823 2.849 . . . . 0.0 104.852 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -140.43 28.83 2.0 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.752 0.705 . . . . 0.0 112.615 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -145.51 150.34 36.28 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.999 1.272 . . . . 0.0 111.383 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 73.76 131.77 0.2 Allowed Glycine 0 C--N 1.337 0.618 0 C-N-CA 126.285 1.898 . . . . 0.0 114.746 178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.1 m -140.13 -175.48 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 124.969 1.308 . . . . 0.0 109.276 179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.5 t -98.82 -175.22 2.99 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 125.794 1.638 . . . . 0.0 107.942 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 14.5 p -50.8 149.45 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.097 1.359 . . . . 0.0 109.057 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -145.77 155.97 52.18 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 124.387 1.075 . . . . 0.0 110.487 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.59 159.43 53.61 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.572 1.515 . . . . 0.0 109.622 178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 255' ' ' SER . 68.1 p -120.68 -176.4 3.23 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.369 1.068 . . . . 0.0 109.987 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -100.16 169.35 9.21 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.568 1.076 . . . . 0.0 109.762 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -66.86 126.31 28.66 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 72.24 3.41 57.02 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 117.848 -1.529 . . . . 0.0 115.327 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.32 137.19 9.2 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 121.706 2.753 . . . . 0.0 114.347 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -73.42 146.7 40.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.881 2.387 . . . . 0.0 108.568 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.516 ' H ' HG22 ' A' ' 249' ' ' THR . 10.4 p -72.62 173.46 8.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . 0.344 12.8 ptmt -133.32 71.87 75.99 Favored Pre-proline 0 C--O 1.238 0.495 0 O-C-N 120.857 -1.152 . . . . 0.0 112.843 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.88 166.18 30.31 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.704 3.603 . . . . 0.0 113.291 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -85.88 161.78 18.91 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.005 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 77.5 t -145.01 162.04 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 128.942 2.897 . . . . 0.0 107.198 -179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -156.71 146.95 14.7 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 14.9 m -138.21 168.4 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 119.794 1.797 . . . . 0.0 110.979 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 15.6 tp -74.96 152.2 38.8 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.0 m -133.87 129.6 36.64 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 121.122 1.783 . . . . 0.0 111.885 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -116.01 132.87 56.53 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -138.1 134.15 6.74 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.101 0.864 . . . . 0.0 112.608 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 81.5 mt -74.58 145.93 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-N 117.67 0.735 . . . . 0.0 109.842 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -75.52 124.98 28.11 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.315 1.446 . . . . 0.0 109.028 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -67.12 -22.29 65.8 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.251 -0.906 . . . . 0.0 113.06 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -77.82 -10.61 59.64 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.696 1.199 . . . . 0.0 112.606 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 70.4 m -65.96 146.45 99.01 Favored Pre-proline 0 C--O 1.239 0.536 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.97 -38.64 3.82 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.663 1.575 . . . . 0.0 112.672 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -132.23 88.22 2.52 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.649 0.78 . . . . 0.0 109.419 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -54.7 -22.97 15.5 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.123 0.969 . . . . 0.0 112.011 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -61.87 -30.68 71.02 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.06 1.344 . . . . 0.0 111.27 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.34 -42.01 94.77 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 121.183 -0.948 . . . . 0.0 108.553 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -72.19 -40.29 68.0 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 118.535 -0.745 . . . . 0.0 110.79 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.39 -37.68 86.68 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 118.585 0.63 . . . . 0.0 109.957 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -73.64 -41.01 63.33 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -57.84 -49.69 75.83 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 121.218 -0.926 . . . . 0.0 109.703 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.8 mp -64.32 -49.36 72.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 119.104 -0.475 . . . . 0.0 111.53 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -71.29 -15.68 62.43 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -105.7 -19.7 13.68 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.969 1.713 . . . . 0.0 113.961 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -137.52 -45.51 0.55 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 117.923 -1.037 . . . . 0.0 111.843 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -59.15 -55.83 29.9 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 120.059 1.299 . . . . 0.0 111.68 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 92.5 mt -84.12 63.41 7.64 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 127.624 2.37 . . . . 0.0 110.38 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 68.9 p -138.87 161.55 36.99 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.95 -21.72 66.88 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 122.839 0.456 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -96.37 -27.68 14.82 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.052 0.941 . . . . 0.0 110.79 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -80.51 -43.96 8.94 Favored Glycine 0 C--N 1.337 0.636 0 C-N-CA 124.568 1.08 . . . . 0.0 112.116 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 35.7 mt -65.22 -40.7 94.44 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -58.13 -47.23 83.95 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 124.783 1.233 . . . . 0.0 109.425 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.43 74.52 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.464 1.029 . . . . 0.0 112.839 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 24.8 t -73.54 -35.72 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 118.912 -0.566 . . . . 0.0 109.924 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -68.94 -29.87 68.2 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.807 0.731 . . . . 0.0 110.775 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -64.12 -38.27 90.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.87 -51.14 35.83 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 123.518 0.511 . . . . 0.0 110.21 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -147.79 150.61 36.68 Favored Pre-proline 0 C--N 1.344 0.356 0 CA-C-O 118.551 -0.738 . . . . 0.0 111.693 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.57 115.1 2.84 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.709 2.939 . . . . 0.0 110.792 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 90.9 mt -91.57 -20.94 21.14 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 92.23 -158.41 24.65 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 107.063 -2.415 . . . . 0.0 107.063 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.25 175.64 4.48 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 177.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 35.8 m -127.71 146.9 32.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 120.043 -1.661 . . . . 0.0 110.329 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.29 -29.47 63.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.662 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 22.3 tp -68.52 106.31 2.52 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -52.23 -27.33 14.41 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.007 0.923 . . . . 0.0 112.405 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.4 m -61.64 -70.94 0.16 Allowed 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.663 0.785 . . . . 0.0 111.042 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -66.98 -21.14 65.97 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.188 0.449 . . . . 0.0 111.39 -179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -65.08 -25.51 67.83 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -72.24 -18.21 61.84 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.153 -1.592 . . . . 0.0 110.009 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -89.04 -51.77 5.43 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.999 1.32 . . . . 0.0 107.527 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.471 ' HB3' HG21 ' A' ' 317' ' ' ILE . 47.7 mt -61.26 -41.52 97.05 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.59 3.32 1.9 Allowed 'General case' 0 C--O 1.237 0.395 0 C-N-CA 123.672 0.789 . . . . 0.0 112.563 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -59.66 -25.73 64.96 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.486 1.494 . . . . 0.0 109.219 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.91 147.56 37.48 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.52 -14.22 43.16 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.138 2.559 . . . . 0.0 114.585 -178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -62.1 -56.31 20.13 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.784 1.174 . . . . 0.0 108.975 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.488 ' H ' HD12 ' A' ' 317' ' ' ILE . 4.2 mp -62.85 -51.78 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 125.306 1.442 . . . . 0.0 108.616 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.49 -48.4 62.9 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 123.447 0.467 . . . . 0.0 110.56 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.22 -33.69 71.28 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.43 HG23 ' HB3' ' A' ' 112' ' ' ALA . 1.3 m -67.21 -41.62 85.46 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.01 -38.79 66.46 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.084 0.554 . . . . 0.0 111.973 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -53.41 -39.02 64.0 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 124.626 1.17 . . . . 0.0 109.323 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -70.06 -30.87 68.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -75.38 -38.41 60.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -61.16 -45.73 93.45 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.84 1.256 . . . . 0.0 110.206 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.95 6.47 39.28 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.52 1.128 . . . . 0.0 112.378 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -101.54 -179.82 28.18 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 126.006 1.765 . . . . 0.0 111.016 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -142.98 165.45 27.32 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.743 2.417 . . . . 0.0 105.382 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.33 154.08 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 O-C-N 120.087 -1.633 . . . . 0.0 111.162 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 40.5 ttp -70.9 125.62 92.03 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 124.505 1.122 . . . . 0.0 108.376 178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.85 100.85 0.86 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.271 2.647 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -61.02 0.31 0.24 Allowed 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.499 HD11 ' CD2' ' A' ' 169' ' ' PHE . 22.7 pt -69.5 150.13 96.98 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 120.549 1.522 . . . . 0.0 114.223 -178.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -67.97 -13.69 39.03 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.236 2.624 . . . . 0.0 114.396 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -71.34 -13.08 61.75 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.998 -1.064 . . . . 0.0 110.727 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 73.8 mmm -66.09 -28.7 69.02 Favored 'General case' 0 C--N 1.342 0.272 0 O-C-N 121.373 -0.829 . . . . 0.0 111.759 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 29.9 t -55.35 -51.51 66.54 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -66.98 -39.1 87.1 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.954 0.901 . . . . 0.0 110.987 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -51.94 -54.76 25.82 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.923 0.889 . . . . 0.0 110.148 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -64.26 -45.65 87.19 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.643 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -53.71 -42.16 67.76 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.377 0.671 . . . . 0.0 110.725 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -69.0 -62.57 1.32 Allowed 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 125.601 1.56 . . . . 0.0 112.637 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.57 -36.8 55.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.977 0.911 . . . . 0.0 111.827 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.47 -49.4 45.64 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.75 1.159 . . . . 0.0 110.356 179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 6.6 m -73.53 -42.63 61.49 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 118.119 -0.943 . . . . 0.0 110.924 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.27 -38.14 57.45 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 119.822 1.192 . . . . 0.0 112.745 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 70.2 t -61.28 -56.1 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 32.3 mm -59.96 -37.2 71.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.24 0.616 . . . . 0.0 110.657 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 48.6 m-20 -57.21 -47.59 80.93 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.337 0.972 . . . . 0.0 109.539 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.0 -47.95 55.91 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.566 0.747 . . . . 0.0 110.816 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.89 -24.67 66.14 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.978 0.911 . . . . 0.0 112.924 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 18.5 m -92.16 -8.51 45.39 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.669 1.188 . . . . 0.0 110.513 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 69.97 16.18 72.42 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 118.608 0.64 . . . . 0.0 111.76 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -76.62 -33.44 58.39 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 118.092 0.946 . . . . 0.0 110.019 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -143.52 148.95 36.76 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 8.9 t -65.98 156.99 32.0 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.488 HG13 HD23 ' A' ' 192' ' ' LEU . 64.6 t -56.88 -47.99 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 123.742 0.817 . . . . 0.0 109.786 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -52.39 -46.6 66.31 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 123.31 0.644 . . . . 0.0 111.036 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -69.48 -36.46 76.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 119.457 -0.306 . . . . 0.0 111.048 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.09 -45.03 90.49 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 8.1 mt -69.18 -41.31 77.36 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 118.308 -0.853 . . . . 0.0 109.345 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -56.58 -49.47 74.77 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 124.911 1.285 . . . . 0.0 109.307 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -51.94 -56.4 14.42 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.261 1.824 . . . . 0.0 108.786 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -59.78 -49.85 76.11 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.182 1.393 . . . . 0.0 113.403 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -55.3 -38.5 68.73 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.579 1.551 . . . . 0.0 109.196 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 18.7 m -65.75 -42.79 90.52 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 118.425 -0.797 . . . . 0.0 109.855 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -59.2 -26.59 64.96 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 119.272 0.942 . . . . 0.0 113.233 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 19.7 mt -79.51 -25.1 12.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.047 0.939 . . . . 0.0 109.531 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 43.9 p -93.39 -23.65 18.35 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.491 0.716 . . . . 0.0 112.271 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.445 1.498 . . . . 0.0 108.346 -178.55 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 62.9 mttt . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 103.856 -2.646 . . . . 0.0 103.856 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 55.8 mt -85.38 179.06 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.903 0 N-CA-C 101.14 -3.652 . . . . 0.0 101.14 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.53 75.35 1.46 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -75.57 82.12 2.59 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 127.2 2.2 . . . . 0.0 108.325 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.71 32.43 0.04 OUTLIER Glycine 0 CA--C 1.532 1.12 0 CA-C-N 114.21 -1.359 . . . . 0.0 115.312 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -145.8 166.63 25.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.34 1.57 . . . . 0.0 111.357 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.6 mt -146.41 145.8 30.38 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 126.781 2.032 . . . . 0.0 107.195 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.82 144.55 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.945 1.298 . . . . 0.0 108.363 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.1 mt -131.74 135.16 59.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 C-N-CA 126.606 1.963 . . . . 0.0 108.243 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 33.0 m0 -126.05 111.82 15.15 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.9 pt -140.88 148.11 22.05 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.325 0 C-N-CA 124.426 1.09 . . . . 0.0 109.035 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.31 177.56 11.22 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 121.196 -0.94 . . . . 0.0 110.384 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 71.13 55.4 7.93 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-O 118.734 -1.036 . . . . 0.0 110.98 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 54.3 34.52 20.72 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.728 1.211 . . . . 0.0 113.424 177.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 20.32 0.06 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 116.261 1.949 . . . . 0.0 116.261 -178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.11 44.18 98.48 Favored Glycine 0 CA--C 1.536 1.396 0 O-C-N 120.678 -1.264 . . . . 0.0 111.318 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -60.35 -40.2 89.84 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -68.34 -39.79 81.78 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 120.026 1.284 . . . . 0.0 108.721 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.06 -35.08 91.6 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 41.7 tp -71.43 -35.46 70.95 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.799 -0.824 . . . . 0.0 111.546 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.71 -43.1 68.72 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.052 0.842 . . . . 0.0 110.25 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -57.83 -21.46 42.5 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.127 1.371 . . . . 0.0 113.953 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 t -86.34 -47.81 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.23 -41.29 96.9 Favored Glycine 0 C--N 1.335 0.512 0 O-C-N 121.01 -1.056 . . . . 0.0 112.237 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -37.64 88.15 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 117.998 0.899 . . . . 0.0 109.897 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -61.23 -53.34 58.14 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -58.96 -47.82 83.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 122.765 0.426 . . . . 0.0 111.804 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.67 -15.75 53.75 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.789 1.636 . . . . 0.0 110.728 178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -94.99 -0.19 54.06 Favored 'General case' 0 N--CA 1.444 -0.754 0 O-C-N 120.296 -1.503 . . . . 0.0 113.438 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -115.33 -51.83 2.69 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 125.894 1.678 . . . . 0.0 107.58 178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 73.2 p -93.75 -21.68 19.17 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.3 1.592 . . . . 0.0 115.3 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.27 -18.12 19.75 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.674 -1.266 . . . . 0.0 113.905 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.6 mm -61.47 118.04 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 119.011 1.406 . . . . 0.0 107.616 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -56.57 145.2 29.0 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 124.869 1.268 . . . . 0.0 112.463 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.1 t -130.16 104.41 10.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.8 m -91.84 127.18 37.2 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 t -119.43 115.17 46.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 105.356 -2.091 . . . . 0.0 105.356 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -127.13 171.73 11.15 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.345 1.058 . . . . 0.0 110.275 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -138.08 68.16 48.66 Favored Pre-proline 0 N--CA 1.455 -0.199 0 C-N-CA 123.619 0.768 . . . . 0.0 112.894 -179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -77.29 139.95 19.13 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 N-CA-C 107.997 -1.578 . . . . 0.0 107.997 178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -96.58 9.52 41.26 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 125.555 1.542 . . . . 0.0 108.978 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.36 2.66 10.28 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.514 1.926 . . . . 0.0 114.112 -177.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pp -53.53 -25.58 17.46 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 117.677 -1.154 . . . . 0.0 113.738 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -57.09 -23.4 46.66 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.988 1.315 . . . . 0.0 113.092 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -124.46 -24.02 4.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.801 0.84 . . . . 0.0 112.368 178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -77.88 -48.58 16.07 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 125.27 1.428 . . . . 0.0 110.77 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -45.12 -56.86 8.23 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 117.85 -1.072 . . . . 0.0 111.376 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.56 -39.58 81.74 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 CA-C-N 120.577 1.242 . . . . 0.0 115.211 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -67.43 -46.58 72.73 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.583 1.083 . . . . 0.0 112.326 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.417 HG12 ' N ' ' A' ' 56' ' ' GLY . 22.2 t -68.96 -41.55 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.1 -32.38 71.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.153 -0.927 . . . . 0.0 112.189 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.7 -19.05 57.73 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.951 0.796 . . . . 0.0 110.459 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 m -99.82 -41.7 7.14 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.431 1.492 . . . . 0.0 107.599 178.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.401 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 117.61 9.14 10.4 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.274 1.416 . . . . 0.0 114.769 178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -89.04 -8.53 53.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.374 1.087 . . . . 0.0 112.965 -177.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.417 ' N ' HG12 ' A' ' 50' ' ' VAL . . . -70.83 171.26 45.3 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 124.442 1.02 . . . . 0.0 114.639 -177.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -64.09 167.79 13.6 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.219 2.613 . . . . 0.0 110.18 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.0 -19.36 22.47 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 126.16 1.784 . . . . 0.0 110.564 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.0 mt -124.24 148.02 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 C-N-CA 123.817 0.847 . . . . 0.0 109.812 -178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.3 tt -141.04 136.64 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -133.37 107.96 8.41 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -154.58 170.87 20.47 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.493 1.042 . . . . 0.0 108.978 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.06 158.27 31.49 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.748 -0.595 . . . . 0.0 110.358 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -55.14 -32.89 62.46 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.101 0.96 . . . . 0.0 110.168 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.34 -11.11 0.46 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 129.062 2.945 . . . . 0.0 114.912 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -129.63 13.36 5.93 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.014 2.125 . . . . 0.0 109.431 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -115.73 26.48 9.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.655 1.982 . . . . 0.0 111.275 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.27 -19.89 15.21 Favored Glycine 0 CA--C 1.534 1.224 0 O-C-N 120.467 -1.396 . . . . 0.0 111.894 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -107.05 -35.5 2.73 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 117.948 -1.473 . . . . 0.0 116.075 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -51.68 -45.33 63.42 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.593 2.196 . . . . 0.0 111.464 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.75 -43.59 95.99 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -32.45 73.2 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.003 1.321 . . . . 0.0 109.592 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.7 m -80.57 -4.62 54.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.386 1.474 . . . . 0.0 110.129 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.54 18.04 76.49 Favored Glycine 0 C--N 1.34 0.78 0 C-N-CA 124.912 1.244 . . . . 0.0 112.257 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 84.5 mt -88.46 -17.58 30.08 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.893 1.346 . . . . 0.0 113.756 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.2 mt -99.41 126.83 45.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 119.395 0.998 . . . . 0.0 111.277 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.56 164.73 26.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.435 1.094 . . . . 0.0 110.818 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -71.32 94.32 1.2 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.957 1.303 . . . . 0.0 109.17 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.1 pp -74.71 172.91 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 m 67.37 82.75 0.19 Allowed Pre-proline 0 C--O 1.238 0.449 0 C-N-CA 126.141 1.776 . . . . 0.0 111.495 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.91 -34.64 8.36 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 121.712 1.608 . . . . 0.0 108.529 178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -147.0 155.72 42.47 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.926 0.869 . . . . 0.0 111.817 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -56.36 -33.86 66.09 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 127.783 2.433 . . . . 0.0 112.896 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.08 -26.75 66.43 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 120.191 1.36 . . . . 0.0 113.214 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -76.09 -26.32 56.33 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 120.25 1.386 . . . . 0.0 109.09 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -62.87 -46.82 86.08 Favored 'General case' 0 C--N 1.341 0.217 0 C-N-CA 124.229 1.012 . . . . 0.0 109.117 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.48 -14.1 62.02 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.14 -14.73 61.43 Favored 'General case' 0 C--O 1.232 0.184 0 O-C-N 120.861 -1.149 . . . . 0.0 109.916 178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.6 mt -120.98 164.37 16.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.292 1.837 . . . . 0.0 107.758 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.86 150.45 81.41 Favored Pre-proline 0 CA--C 1.534 0.351 0 O-C-N 121.059 -1.026 . . . . 0.0 111.719 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.06 -49.21 2.17 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 123.569 2.846 . . . . 0.0 112.118 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -57.79 -25.21 60.22 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.18 -20.33 41.43 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.809 -1.182 . . . . 0.0 110.574 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 72.0 m95 -72.92 -26.97 61.59 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -53.26 -41.94 65.98 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.91 1.684 . . . . 0.0 110.091 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.17 -6.43 4.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.923 1.289 . . . . 0.0 113.428 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.15 -0.18 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 125.104 1.361 . . . . 0.0 111.832 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 -63.16 148.98 46.46 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.089 1.313 . . . . 0.0 108.375 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.451 ' CE1' ' HE2' ' A' ' 102' ' ' LYS . 26.0 t80 -142.02 167.33 22.38 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -63.7 114.52 4.04 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.455 0.702 . . . . 0.0 110.801 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.9 -84.33 0.3 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 124.65 1.119 . . . . 0.0 111.34 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.451 ' HE2' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -72.83 166.03 23.73 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.21 0.604 . . . . 0.0 109.876 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.73 166.31 10.56 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.38 -40.17 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.96 174.01 11.38 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 118.649 0.659 . . . . 0.0 111.096 -179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -131.68 149.55 73.78 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 124.76 1.224 . . . . 0.0 110.419 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.27 145.62 30.78 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.198 2.599 . . . . 0.0 110.043 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.0 mm -128.12 -53.66 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 125.261 1.425 . . . . 0.0 111.043 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -127.77 155.6 43.78 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.998 0.817 . . . . 0.0 112.45 -178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.5 t -130.95 110.1 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 123.059 0.544 . . . . 0.0 110.652 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -143.47 126.15 16.01 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.716 0.689 . . . . 0.0 112.746 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.63 84.72 0.97 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.807 2.043 . . . . 0.0 108.126 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -153.91 138.32 16.73 Favored 'General case' 0 N--CA 1.466 0.341 0 O-C-N 120.568 -1.333 . . . . 0.0 107.437 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.8 p -176.07 125.33 0.2 Allowed 'General case' 0 C--O 1.237 0.42 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.8 tp -140.28 158.7 43.62 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 118.74 0.7 . . . . 0.0 109.483 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 2.9 mm -125.56 137.09 58.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -161.49 164.79 29.46 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 126.653 1.981 . . . . 0.0 106.565 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -64.89 134.51 54.17 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 122.878 0.471 . . . . 0.0 111.061 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -83.39 -12.53 56.38 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 121.821 -0.55 . . . . 0.0 112.317 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.24 174.85 0.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.749 2.42 . . . . 0.0 111.273 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.12 -11.68 9.66 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.762 1.225 . . . . 0.0 111.671 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 tt -115.87 70.35 3.64 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.847 2.459 . . . . 0.0 107.64 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -81.71 5.22 6.44 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 123.39 2.727 . . . . 0.0 114.811 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.3 t30 23.32 76.33 0.24 Allowed Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 128.754 2.822 . . . . 0.0 112.521 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.6 111.09 2.25 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.706 2.271 . . . . 0.0 110.747 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -82.0 173.69 10.81 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.518 2.145 . . . . 0.0 110.137 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -143.31 -31.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.715 1.206 . . . . 0.0 112.186 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.39 141.3 27.06 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -176.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 30.1 m95 -64.25 -16.1 61.38 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.039 -1.663 . . . . 0.0 113.203 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -79.84 -13.12 59.63 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.376 -0.827 . . . . 0.0 111.942 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -90.03 -14.01 34.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.326 0.65 . . . . 0.0 110.377 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.7 mm -53.39 -55.73 31.64 Favored Pre-proline 0 N--CA 1.454 -0.233 0 C-N-CA 125.302 1.441 . . . . 0.0 110.424 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -65.98 -25.56 51.83 Favored 'Trans proline' 0 N--CA 1.447 -1.213 0 CA-C-N 120.693 1.283 . . . . 0.0 112.414 -178.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -72.03 -60.52 2.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.61 -25.26 68.01 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.39 -0.819 . . . . 0.0 110.4 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.97 -47.81 76.29 Favored 'General case' 0 C--O 1.222 -0.355 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? -67.67 -31.38 71.32 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-N 119.181 0.9 . . . . 0.0 110.997 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -63.06 -49.53 74.2 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 63.2 mt -76.68 -28.58 55.97 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 118.931 -0.557 . . . . 0.0 110.961 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -67.47 -34.25 76.8 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 119.785 1.175 . . . . 0.0 108.648 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.59 -15.19 62.49 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.16 5.62 5.87 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.918 1.287 . . . . 0.0 111.958 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.52 -97.76 0.12 Allowed Glycine 0 C--N 1.341 0.808 0 CA-C-N 119.686 1.13 . . . . 0.0 113.829 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -141.45 -162.1 1.33 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.941 1.297 . . . . 0.0 110.128 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.35 178.83 0.18 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.903 2.481 . . . . 0.0 115.766 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -116.96 -36.11 3.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.585 1.954 . . . . 0.0 111.069 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.2 tp -123.56 110.0 14.49 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 126.143 1.777 . . . . 0.0 108.343 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 49.0 ttm -121.2 106.77 11.83 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 124.407 1.083 . . . . 0.0 108.585 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -135.02 167.74 20.39 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.933 0.788 . . . . 0.0 110.722 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -67.0 89.0 0.16 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.722 1.609 . . . . 0.0 109.561 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 18.1 mt -81.91 -5.22 58.1 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.904 1.281 . . . . 0.0 111.602 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -85.57 -8.01 58.53 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -120.41 130.17 24.98 Favored Pre-proline 0 C--O 1.236 0.382 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.54 -15.96 42.16 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.884 1.723 . . . . 0.0 113.584 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -55.47 -36.22 66.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.593 0.757 . . . . 0.0 112.236 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -81.35 -37.76 27.76 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.572 0.749 . . . . 0.0 112.027 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.7 p -82.84 -10.96 58.6 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.878 0.763 . . . . 0.0 112.297 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -60.8 -59.49 13.69 Favored Pre-proline 0 CA--C 1.539 0.538 0 O-C-N 120.912 -1.117 . . . . 0.0 113.507 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -68.04 -3.5 10.74 Favored 'Trans proline' 0 C--N 1.349 0.569 0 CA-C-N 121.326 1.509 . . . . 0.0 114.585 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.0 tp -79.24 -66.67 0.84 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 8.2 pt -68.7 -25.43 30.63 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 -178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.59 -23.58 67.11 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.821 -1.175 . . . . 0.0 110.591 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -45.53 -60.04 2.4 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.937 2.095 . . . . 0.0 111.099 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -58.98 -57.3 13.67 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -173.31 5.19 0.03 OUTLIER Glycine 0 C--N 1.334 0.441 0 CA-C-O 116.991 -2.005 . . . . 0.0 117.713 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -61.35 134.34 48.14 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 108.169 -1.972 . . . . 0.0 108.169 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -141.64 121.91 13.93 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.54 -53.9 44.61 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.378 -0.201 . . . . 0.0 110.965 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -142.81 132.22 23.54 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 10.9 tppt? -71.3 151.42 44.21 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -141.41 99.12 3.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -71.31 178.09 3.56 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -60.44 22.14 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.084 2.554 . . . . 0.0 116.747 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 156.57 -4.58 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 127.294 2.378 . . . . 0.0 111.866 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -113.8 107.88 16.33 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.613 1.706 . . . . 0.0 108.738 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.97 47.04 0.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 125.082 1.353 . . . . 0.0 109.58 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.88 92.64 1.27 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.25 1.42 . . . . 0.0 112.259 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -55.82 -1.21 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 130.303 3.441 . . . . 0.0 113.532 178.029 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -70.7 -33.93 71.4 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -82.72 100.89 10.52 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 90.1 t -116.48 102.34 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 126.56 1.944 . . . . 0.0 111.487 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -90.96 40.15 3.01 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 126.276 1.893 . . . . 0.0 113.842 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.5 t -88.94 -19.99 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 123.526 0.73 . . . . 0.0 111.063 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -108.34 51.04 0.75 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 122.976 1.369 . . . . 0.0 108.08 178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -106.64 153.44 22.38 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.496 1.118 . . . . 0.0 109.913 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.56 -40.99 66.01 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.055 1.342 . . . . 0.0 111.729 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -59.67 -42.04 97.69 Favored Glycine 0 CA--C 1.523 0.588 0 O-C-N 121.474 -0.766 . . . . 0.0 112.656 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.22 -52.15 60.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -62.74 -32.73 73.91 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.241 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.1 -60.42 3.62 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.316 1.416 . . . . 0.0 110.065 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -60.65 -34.44 86.32 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 36.5 tp -70.48 -54.87 10.53 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 117.525 0.662 . . . . 0.0 110.1 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.62 -36.43 71.79 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.706 0.802 . . . . 0.0 109.616 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -58.86 -41.58 87.35 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.553 1.069 . . . . 0.0 109.595 178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 10.5 tt -73.76 -45.54 51.14 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.248 -0.907 . . . . 0.0 109.671 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.5 t -56.61 -36.64 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.833 1.253 . . . . 0.0 110.037 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -58.28 -31.56 67.57 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.092 1.357 . . . . 0.0 111.138 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 49.5 mt -73.71 -40.94 63.22 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 2.3 mp -67.52 -40.84 85.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -55.23 -37.67 67.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.122 0.969 . . . . 0.0 109.634 179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -88.69 0.18 56.69 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.5 1.52 . . . . 0.0 112.37 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? 58.72 10.12 1.36 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 128.131 2.572 . . . . 0.0 114.759 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.86 -42.9 89.83 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 1.8 tpt -92.64 142.32 27.5 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.88 1.272 . . . . 0.0 107.991 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -82.65 110.15 17.46 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -74.33 -8.04 54.87 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.906 0.882 . . . . 0.0 112.765 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -100.75 0.53 39.02 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.355 1.062 . . . . 0.0 112.807 -178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 93.6 m -63.93 130.04 42.48 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -129.8 -179.68 5.34 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 124.573 1.149 . . . . 0.0 108.696 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -55.12 -47.36 75.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 119.427 -0.32 . . . . 0.0 110.792 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 70.6 m -57.56 -45.58 85.0 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 125.408 1.483 . . . . 0.0 111.105 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 17.5 mm -64.19 -50.21 77.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.21 99.28 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.855 0.722 . . . . 0.0 111.927 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -59.23 -45.63 90.64 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.085 1.754 . . . . 0.0 110.574 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.15 -48.61 64.88 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -56.34 -51.46 68.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.023 0.929 . . . . 0.0 111.366 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -56.12 -39.37 72.13 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.669 0.788 . . . . 0.0 110.458 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -61.08 -25.01 66.66 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.998 -0.439 . . . . 0.0 112.117 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 12.4 mmtt -94.5 -15.04 24.53 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.409 0.684 . . . . 0.0 111.138 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 93.04 11.94 58.2 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.311 1.434 . . . . 0.0 112.135 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -53.26 -70.08 0.1 Allowed 'General case' 0 C--O 1.237 0.4 0 C-N-CA 127.672 2.389 . . . . 0.0 112.588 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 2.1 t -72.5 153.21 41.46 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -111.04 -18.59 13.0 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.022 0.529 . . . . 0.0 112.347 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -149.28 139.79 22.49 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.801 1.64 . . . . 0.0 108.669 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.7 t -160.29 -177.49 6.29 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 58.5 mt -137.42 138.39 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 105.374 -2.084 . . . . 0.0 105.374 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -131.31 167.05 19.9 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.194 1.398 . . . . 0.0 107.885 178.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 157.62 -165.18 33.41 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -71.87 -177.66 2.69 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 124.873 3.715 . . . . 0.0 111.75 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -119.04 -8.76 10.15 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.159 0.984 . . . . 0.0 111.295 178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -147.8 -65.15 0.26 Allowed 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.945 1.298 . . . . 0.0 109.919 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -128.12 145.09 51.12 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.612 1.165 . . . . 0.0 109.122 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 8.2 p -69.26 1.59 3.63 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.967 1.707 . . . . 0.0 115.157 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -75.1 69.69 2.01 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.134 1.374 . . . . 0.0 109.719 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 44.5 pt -132.64 147.39 31.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 C-N-CA 126.107 1.763 . . . . 0.0 106.428 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -82.75 -159.17 0.31 Allowed 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.873 1.269 . . . . 0.0 110.253 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 32.4 p 46.94 38.3 6.01 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.952 2.101 . . . . 0.0 113.055 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 15.7 p -51.4 112.65 0.78 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 127.06 2.144 . . . . 0.0 109.081 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -72.87 42.26 0.1 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.839 1.656 . . . . 0.0 112.753 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 23.5 m -53.28 -23.0 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 125.641 1.576 . . . . 0.0 113.791 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -74.91 -16.19 60.67 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.838 0.855 . . . . 0.0 112.275 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -65.96 -179.69 0.77 Allowed 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.281 1.032 . . . . 0.0 111.55 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -62.64 173.04 9.4 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 123.774 0.702 . . . . 0.0 111.542 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 11.3 t -142.58 98.65 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . 0.251 9.7 t -137.02 -162.54 1.3 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.67 135.75 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.404 1.082 . . . . 0.0 109.244 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -67.47 148.47 98.65 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 123.85 0.86 . . . . 0.0 110.659 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -66.48 154.29 74.88 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 N-CA-C 107.745 -1.675 . . . . 0.0 107.745 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 3.0 p -115.28 179.0 4.09 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.926 0.891 . . . . 0.0 112.282 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -102.27 148.5 25.37 Favored 'General case' 0 N--CA 1.455 -0.188 0 O-C-N 120.377 -1.452 . . . . 0.0 108.027 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.29 104.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.222 1.409 . . . . 0.0 110.592 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 95.61 -5.41 67.1 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.778 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.41 120.53 4.46 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 120.426 2.113 . . . . 0.0 112.578 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -77.07 159.28 33.91 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.968 3.112 . . . . 0.0 110.712 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 4.2 p -77.62 167.47 21.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.79 0.805 . . . . 0.0 110.131 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.427 ' HE2' ' HE3' ' A' ' 326' ' ' LYS . 13.2 ptpt -147.33 78.17 10.33 Favored Pre-proline 0 N--CA 1.453 -0.305 0 C-N-CA 123.622 0.769 . . . . 0.0 110.344 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.05 172.31 16.2 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.86 1.707 . . . . 0.0 110.343 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -65.21 152.38 43.8 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.8 144.69 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -132.83 139.28 10.81 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 105.502 -3.039 . . . . 0.0 105.502 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 8.4 m -143.91 147.56 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.11 159.23 24.75 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.5 m -133.09 144.52 50.03 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.899 0.772 . . . . 0.0 109.64 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.23 139.91 51.66 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 121.453 -0.779 . . . . 0.0 109.122 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.91 177.23 18.57 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.965 0.793 . . . . 0.0 113.076 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.3 mt -122.01 119.39 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.121 0 C-N-CA 125.408 1.483 . . . . 0.0 107.229 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -70.98 123.02 21.08 Favored 'General case' 0 N--CA 1.463 0.221 0 O-C-N 120.499 -1.376 . . . . 0.0 107.945 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -65.51 -5.4 7.84 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.297 1.439 . . . . 0.0 112.739 179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.401 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -67.2 -42.54 83.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 127.292 2.237 . . . . 0.0 113.671 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 9.8 m -57.39 152.49 32.52 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 123.98 0.912 . . . . 0.0 113.307 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.34 -51.45 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.772 2.315 . . . . 0.0 110.594 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -123.06 109.63 14.31 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.509 ' HD2' ' H ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -67.08 -24.29 65.94 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -54.71 -34.52 62.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 125.138 1.375 . . . . 0.0 111.56 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 78.2 mt -60.42 -36.17 77.53 Favored 'General case' 0 CA--C 1.528 0.097 0 O-C-N 121.327 -0.858 . . . . 0.0 110.146 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -81.25 -39.43 25.31 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 118.236 -0.887 . . . . 0.0 111.315 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -36.41 83.36 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 118.604 -0.712 . . . . 0.0 110.153 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -67.58 -49.4 63.35 Favored 'General case' 0 C--O 1.224 -0.238 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -56.41 -49.78 73.51 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.36 -0.838 . . . . 0.0 110.764 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.53 -21.94 66.62 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -107.81 -14.9 14.68 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -103.32 -24.27 13.52 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 118.986 0.812 . . . . 0.0 112.242 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -139.43 -32.18 0.66 Allowed 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -67.07 -47.95 69.72 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 120.443 1.474 . . . . 0.0 112.847 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.05 73.13 5.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 71.4 p -138.72 153.98 48.53 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.88 -24.37 67.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -86.85 -43.67 12.29 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.175 1.79 . . . . 0.0 110.898 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -68.52 -44.93 70.2 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 54.1 mt -67.61 -34.74 77.62 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -62.15 -49.01 77.55 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.411 ' HA ' ' HE2' ' A' ' 295' ' ' LYS . . . -54.4 -42.84 70.9 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 119.595 1.089 . . . . 0.0 110.926 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 8.4 t -63.56 -41.18 91.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 124.804 1.242 . . . . 0.0 108.797 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -64.14 -38.92 92.79 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.126 1.371 . . . . 0.0 112.059 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.411 ' HE2' ' HA ' ' A' ' 292' ' ' ALA . 21.9 mtmt -56.78 -54.7 43.32 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.246 -0.909 . . . . 0.0 108.755 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -55.18 -52.87 61.95 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.058 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.481 ' HA ' ' HE3' ' A' ' 297' ' ' LYS . 0.0 OUTLIER -147.78 156.33 44.6 Favored Pre-proline 0 N--CA 1.473 0.715 0 O-C-N 120.799 -1.188 . . . . 0.0 111.799 179.62 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -61.34 130.9 33.81 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 N-CA-C 105.963 -2.36 . . . . 0.0 105.963 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -95.38 -15.78 22.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 118.342 -0.837 . . . . 0.0 112.882 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 76.36 -157.27 47.81 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -78.16 164.12 25.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 22.7 m -125.91 148.89 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 O-C-N 121.246 -0.909 . . . . 0.0 109.852 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.05 -22.47 58.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.675 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 62.7 tp -66.93 105.4 1.61 Allowed 'General case' 0 C--N 1.34 0.176 0 C-N-CA 125.789 1.635 . . . . 0.0 109.365 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.8 mtmt -61.41 -1.86 0.61 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.6 t -92.9 -66.64 0.91 Allowed 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -63.51 -19.32 64.67 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.438 -0.789 . . . . 0.0 110.877 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -60.2 -35.5 75.55 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -68.22 -20.43 64.83 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.072 0.851 . . . . 0.0 111.687 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -88.12 -50.36 6.44 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.582 1.153 . . . . 0.0 108.403 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 48.7 mt -67.64 -35.32 78.69 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.012 0.525 . . . . 0.0 110.554 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -70.3 1.92 4.37 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 121.182 -0.949 . . . . 0.0 112.686 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -62.53 -20.88 65.08 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 120.111 1.323 . . . . 0.0 109.575 178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -109.82 129.22 24.17 Favored Pre-proline 0 C--O 1.24 0.554 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.7 -8.41 9.21 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.378 2.719 . . . . 0.0 114.54 -178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -67.23 -54.48 20.58 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 119.68 1.127 . . . . 0.0 108.607 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.7 mp -61.7 -49.55 83.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.45 -50.56 62.39 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 123.75 0.656 . . . . 0.0 109.947 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.81 -41.35 86.59 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 97.9 m -62.16 -37.76 86.46 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 4.8 tpt -68.2 -46.62 70.13 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.257 0.623 . . . . 0.0 110.596 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -60.68 -30.07 69.69 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.019 0.928 . . . . 0.0 113.111 -178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -74.82 -35.35 62.45 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -69.19 -36.38 77.24 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 123.777 0.831 . . . . 0.0 111.315 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -65.96 -41.22 91.5 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.564 1.145 . . . . 0.0 111.856 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.427 ' HE3' ' HE2' ' A' ' 256' ' ' LYS . 0.0 OUTLIER -95.95 -3.18 45.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 116.676 -1.63 . . . . 0.0 115.117 -177.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -109.52 170.34 14.33 Favored Glycine 0 CA--C 1.527 0.827 0 CA-C-N 120.173 1.351 . . . . 0.0 114.975 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.26 129.04 34.91 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.709 0.803 . . . . 0.0 109.38 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 35.0 mt -98.13 121.43 48.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 45.9 mtm 24.32 76.57 0.25 Allowed Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 127.438 2.295 . . . . 0.0 112.178 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.66 80.27 0.47 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.8 3.0 . . . . 0.0 113.557 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -84.22 70.4 10.56 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.657 1.583 . . . . 0.0 106.992 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 30.1 pt -124.08 152.09 66.47 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 124.396 1.078 . . . . 0.0 110.549 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -68.78 -30.94 26.4 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.09 2.526 . . . . 0.0 113.106 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -65.66 -17.19 64.42 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -61.43 -31.35 71.29 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.986 0.812 . . . . 0.0 109.563 178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 4.6 t -57.57 -46.09 84.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 123.457 0.703 . . . . 0.0 110.712 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -79.6 -36.25 38.33 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.604 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -55.0 -52.35 63.42 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-O 118.489 -0.767 . . . . 0.0 110.786 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 29.9 m95 -58.26 -40.47 81.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.865 1.211 . . . . 0.0 111.1 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -65.64 -23.13 66.73 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.962 0.905 . . . . 0.0 111.46 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -83.3 -50.73 8.09 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.538 1.135 . . . . 0.0 110.272 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 11.2 t -60.7 -49.81 83.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.612 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.01 -54.33 13.28 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.637 0.653 . . . . 0.0 110.275 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.477 HG21 HH22 ' A' ' 367' ' ' ARG . 87.3 m -64.3 -43.18 95.54 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.296 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.27 -43.07 87.79 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 120.122 1.328 . . . . 0.0 111.519 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.82 -52.68 51.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 125.041 1.336 . . . . 0.0 108.897 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 30.1 mm -60.5 -43.18 93.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.151 0.58 . . . . 0.0 110.13 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 48.7 m-20 -59.88 -47.36 86.06 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 118.738 0.699 . . . . 0.0 110.265 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -66.75 -47.26 72.8 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.719 0.808 . . . . 0.0 110.679 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.66 -32.17 72.32 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.246 1.019 . . . . 0.0 111.97 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 14.1 m -85.15 -11.75 54.37 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.739 0.816 . . . . 0.0 109.723 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.74 10.04 66.75 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 123.667 0.651 . . . . 0.0 112.428 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -69.15 -34.48 75.04 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 118.158 0.979 . . . . 0.0 109.985 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -134.93 148.04 49.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 359' ' ' GLU . 11.9 t -68.34 156.24 38.15 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 26.0 t -58.14 -40.43 77.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 125.011 1.325 . . . . 0.0 110.086 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.06 -47.84 84.49 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.956 0.502 . . . . 0.0 109.738 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . 0.449 ' H ' HG23 ' A' ' 356' ' ' THR . 52.6 mm-40 -68.92 -37.82 79.17 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 122.147 -0.345 . . . . 0.0 111.21 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -56.4 -39.87 73.72 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.97 -41.3 59.84 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 124.567 1.147 . . . . 0.0 110.296 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -55.45 -50.16 70.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.493 0.717 . . . . 0.0 109.363 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.98 -49.85 76.32 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 127.042 2.137 . . . . 0.0 111.1 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -57.21 -52.15 66.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.076 0.95 . . . . 0.0 112.209 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -52.84 -33.04 47.72 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.551 0.74 . . . . 0.0 110.482 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.3 m -64.22 -48.03 77.41 Favored 'General case' 0 C--N 1.344 0.341 0 CA-C-N 119.413 1.006 . . . . 0.0 109.451 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.477 HH22 HG21 ' A' ' 345' ' ' THR . 79.9 mtt180 -57.25 -23.35 47.54 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -178.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 22.3 mt -96.14 -10.41 8.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 125.025 1.33 . . . . 0.0 111.565 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 55.5 p -120.08 1.72 10.89 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.673 1.189 . . . . 0.0 112.491 -179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 36.1 tptt . . . . . 0 C--O 1.251 1.179 0 C-N-CA 127.665 2.386 . . . . 0.0 105.547 178.401 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 43.4 tttm . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.8 mm -91.13 142.38 13.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -108.33 112.69 25.28 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -79.12 175.07 10.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.53 1.532 . . . . 0.0 109.384 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.95 22.71 77.68 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 124.427 1.013 . . . . 0.0 113.302 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -146.87 166.48 26.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.992 0.896 . . . . 0.0 112.664 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.2 mt -151.32 142.93 23.64 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 128.939 2.895 . . . . 0.0 106.681 179.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.26 126.61 49.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 11.6 mt -108.07 136.11 44.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 125.81 1.644 . . . . 0.0 108.146 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -127.76 130.6 49.02 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 126.035 1.734 . . . . 0.0 106.511 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 15' ' ' LYS . 11.8 pt -131.76 165.65 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 127.26 2.224 . . . . 0.0 110.383 -178.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.497 ' HB3' HD21 ' A' ' 43' ' ' LEU . 0.1 OUTLIER -151.35 165.57 33.66 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.367 1.067 . . . . 0.0 112.975 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.68 40.5 7.68 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-O 118.466 -1.185 . . . . 0.0 111.855 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 54.51 32.85 17.65 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.622 1.169 . . . . 0.0 108.213 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.408 ' HB3' HD12 ' A' ' 11' ' ' ILE . 0.3 OUTLIER -56.77 163.37 1.92 Allowed 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.539 1.536 . . . . 0.0 113.372 -177.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.09 76.35 1.44 Allowed Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -66.17 -39.52 89.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.611 1.164 . . . . 0.0 109.352 179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -58.57 -59.76 4.87 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 125.875 1.67 . . . . 0.0 110.526 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.27 94.53 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 19.7 tp -62.94 -42.55 99.84 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 117.889 0.845 . . . . 0.0 108.944 178.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.63 73.43 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 117.713 -1.137 . . . . 0.0 109.863 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -62.39 -27.89 69.4 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.452 1.024 . . . . 0.0 110.443 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.9 t -79.31 -46.47 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.28 -39.07 97.24 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 121.257 -0.902 . . . . 0.0 113.069 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -37.62 68.35 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-O 117.776 -1.107 . . . . 0.0 109.1 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -58.42 -57.33 13.41 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -57.38 -48.03 80.13 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 118.937 -0.554 . . . . 0.0 110.384 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -62.48 -22.96 66.65 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 119.958 1.254 . . . . 0.0 112.61 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.8 tppm? -85.74 -23.22 27.41 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 117.876 -1.059 . . . . 0.0 110.805 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -102.83 -22.59 13.86 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 123.925 0.765 . . . . 0.0 112.71 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 p -114.79 -35.95 4.66 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.468 1.107 . . . . 0.0 111.355 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.17 -18.74 56.95 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.121 0.867 . . . . 0.0 113.414 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.8 mm -60.45 125.63 16.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HA ' ' CE ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -63.77 127.93 33.58 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.107 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 90.7 t -123.2 104.91 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -93.97 139.14 31.3 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.3 t -130.67 118.46 42.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -128.84 158.99 37.18 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -116.85 60.64 2.38 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.664 1.186 . . . . 0.0 110.185 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.485 ' HG2' HD22 ' A' ' 43' ' ' LEU . 48.3 Cg_endo -62.09 160.41 30.34 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 121.867 1.711 . . . . 0.0 109.966 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -117.79 9.12 12.87 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.596 0.758 . . . . 0.0 111.709 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.17 17.69 2.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 126.073 1.749 . . . . 0.0 112.876 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 43' ' ' LEU . 1.3 pt? -56.11 -24.15 38.74 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 120.627 -1.295 . . . . 0.0 111.797 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.99 -24.95 57.27 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.203 1.401 . . . . 0.0 112.104 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -121.57 -22.27 5.94 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 124.219 1.008 . . . . 0.0 111.218 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -41.92 59.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 117.24 -1.362 . . . . 0.0 110.9 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -52.49 -58.71 10.73 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 120.642 1.565 . . . . 0.0 110.111 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.78 -17.3 54.28 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 121.501 1.467 . . . . 0.0 113.553 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -88.7 2.12 53.9 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.649 1.58 . . . . 0.0 113.638 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 t -138.3 -34.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 119.18 0.9 . . . . 0.0 109.61 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.77 66.12 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.708 -1.245 . . . . 0.0 110.011 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.73 -2.92 5.55 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.887 0.875 . . . . 0.0 112.368 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.2 p -126.33 -11.72 6.3 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.461 1.504 . . . . 0.0 110.256 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.412 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 84.6 15.76 67.61 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 124.277 0.942 . . . . 0.0 111.892 -178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -106.38 6.44 30.43 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.007 0.904 . . . . 0.0 110.684 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.41 -167.59 43.39 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 127.001 2.239 . . . . 0.0 116.371 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.92 -179.32 2.9 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.634 2.89 . . . . 0.0 110.136 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -118.95 -18.28 8.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 36.8 mt -135.44 143.84 35.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.428 1.091 . . . . 0.0 109.306 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tt -130.02 143.2 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 C-N-CA 125.014 1.326 . . . . 0.0 110.953 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -137.92 109.83 7.19 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.823 1.649 . . . . 0.0 107.609 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 29.2 t-105 -159.88 178.91 9.27 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.438 1.017 . . . . 0.0 108.981 178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.36 153.55 43.42 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -60.16 -19.14 52.52 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.362 1.465 . . . . 0.0 111.658 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -53.07 -61.95 1.96 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.895 1.278 . . . . 0.0 111.322 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.8 mmt85 -68.15 -18.22 64.56 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 121.598 -0.689 . . . . 0.0 111.088 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -68.67 -30.43 69.11 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.483 -179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.8 -12.79 49.44 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.99 0.805 . . . . 0.0 112.296 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -104.58 -45.72 1.39 Allowed Glycine 0 CA--C 1.522 0.475 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -60.47 -52.04 66.9 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.554 -0.968 . . . . 0.0 111.322 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.62 84.22 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 118.692 0.678 . . . . 0.0 111.235 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -53.21 -47.31 69.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.776 1.23 . . . . 0.0 108.71 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -72.21 -6.89 46.09 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 84.43 9.85 80.91 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.781 1.181 . . . . 0.0 112.296 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.6 mt -73.21 -22.03 60.53 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 118.389 1.094 . . . . 0.0 111.156 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.9 mt -103.87 140.28 37.88 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.12 -171.95 3.31 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -76.93 159.72 29.76 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.414 HD11 ' HB3' ' A' ' 103' ' ' LEU . 2.7 pp -137.73 172.04 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 124.727 1.211 . . . . 0.0 110.184 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.57 HG23 ' HB3' ' A' ' 85' ' ' PHE . 42.4 m 42.36 77.24 0.45 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 127.105 2.162 . . . . 0.0 114.552 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.88 -22.0 27.51 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.084 2.523 . . . . 0.0 115.291 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -120.16 135.24 55.04 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 120.22 1.373 . . . . 0.0 111.526 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -51.32 -39.11 56.26 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.781 2.032 . . . . 0.0 112.265 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.5 -27.18 62.31 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.57 ' HB3' HG23 ' A' ' 80' ' ' THR . 14.2 t80 -66.46 -37.11 84.41 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -64.54 -42.86 95.45 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-N 118.845 0.748 . . . . 0.0 109.284 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -57.0 -30.11 63.87 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 125.52 1.528 . . . . 0.0 112.718 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mtpt -75.4 -2.24 27.64 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mt -130.18 154.15 47.83 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 120.728 -1.232 . . . . 0.0 110.892 -177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -69.12 155.83 92.78 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 122.436 -0.165 . . . . 0.0 110.786 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.41 -45.68 2.46 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.906 3.07 . . . . 0.0 114.241 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -58.01 -38.62 76.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.565 1.075 . . . . 0.0 111.143 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -25.58 66.24 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.555 1.142 . . . . 0.0 110.722 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -77.94 -44.45 26.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.411 0.684 . . . . 0.0 110.119 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.71 -33.38 64.14 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.56 -7.4 4.61 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.4 1.48 . . . . 0.0 114.179 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.73 10.85 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.966 1.706 . . . . 0.0 111.887 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.9 mtp85 -70.28 160.48 32.12 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -132.7 -165.11 1.56 Allowed 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -70.37 81.25 0.55 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.291 1.036 . . . . 0.0 109.401 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.35 -60.81 4.84 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.368 0.985 . . . . 0.0 110.857 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -178.56 5.07 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.32 0.648 . . . . 0.0 109.881 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.414 ' HB3' HD11 ' A' ' 79' ' ' ILE . 34.5 mt -115.9 169.95 8.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 125.161 1.385 . . . . 0.0 109.248 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 pt -138.65 -28.88 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -152.79 175.32 13.0 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.456 1.026 . . . . 0.0 109.701 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -133.31 150.02 74.09 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.9 143.73 29.77 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.966 2.444 . . . . 0.0 110.888 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.6 mm -131.53 -50.65 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 127.808 2.443 . . . . 0.0 111.546 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -125.71 131.51 52.55 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 110.396 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -100.65 95.99 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -72.29 162.15 29.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.605 1.193 . . . . 0.0 110.164 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.408 ' CB ' HG23 ' A' ' 320' ' ' THR . . . -156.38 168.84 26.11 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.134 1.374 . . . . 0.0 109.291 178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.0 141.13 56.33 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.5 m -118.92 172.68 7.37 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.896 1.278 . . . . 0.0 112.162 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -144.44 147.4 33.29 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.919 1.288 . . . . 0.0 108.923 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.7 mp -138.26 121.02 19.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.821 1.248 . . . . 0.0 108.775 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -145.94 127.63 15.23 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 120.777 -1.202 . . . . 0.0 110.952 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -94.94 49.43 1.23 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.45 ' HE3' HD21 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -57.88 -60.32 3.89 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -177.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -167.39 -177.12 3.49 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 121' ' ' LEU . 1.1 pt? -93.22 -14.06 27.54 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 118.181 0.446 . . . . 0.0 110.729 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -81.21 157.56 70.67 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 124.595 1.158 . . . . 0.0 108.818 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.01 82.19 2.56 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.502 2.801 . . . . 0.0 110.576 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -126.62 79.19 71.85 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.259 1.424 . . . . 0.0 108.271 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.21 161.88 31.83 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.264 2.643 . . . . 0.0 114.079 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.16 159.79 40.37 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.516 2.811 . . . . 0.0 110.441 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.35 -31.6 2.77 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 124.441 1.096 . . . . 0.0 113.325 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.95 152.4 9.46 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 120.269 1.395 . . . . 0.0 109.832 -178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -56.1 -27.68 54.7 Favored 'General case' 0 C--O 1.225 -0.198 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.46 -16.52 24.35 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.283 0.947 . . . . 0.0 113.132 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -92.23 -14.22 29.3 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.062 0.847 . . . . 0.0 111.212 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 26.0 mm -59.65 -57.89 23.51 Favored Pre-proline 0 CA--C 1.529 0.141 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -69.9 -25.54 27.86 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 CA-C-N 120.306 1.145 . . . . 0.0 110.967 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.84 -30.64 71.65 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 118.67 0.668 . . . . 0.0 109.863 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.45 HD21 ' HE3' ' A' ' 119' ' ' LYS . 61.5 tp -88.84 -29.88 19.36 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.737 0.815 . . . . 0.0 109.585 178.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -59.08 -45.74 90.05 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.429 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 5.5 ptmm? -64.06 -32.19 73.65 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.534 0.334 . . . . 0.0 111.832 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -71.62 -43.04 66.87 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 123.203 0.601 . . . . 0.0 110.206 -179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 76.4 mt -75.8 -32.18 59.76 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -67.81 -33.33 74.6 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 120.609 -1.307 . . . . 0.0 108.498 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.1 -14.08 59.62 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 3.24 5.45 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.179 0.992 . . . . 0.0 112.127 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 178.65 -99.67 0.13 Allowed Glycine 0 CA--C 1.523 0.566 0 CA-C-N 119.267 0.94 . . . . 0.0 113.448 -178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -138.12 -177.75 4.97 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.433 1.493 . . . . 0.0 111.719 -177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.5 p -56.16 168.76 0.47 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.064 1.746 . . . . 0.0 113.817 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.89 -74.14 0.6 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.745 1.618 . . . . 0.0 110.183 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 48.8 tp -88.66 147.32 24.59 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.896 0.878 . . . . 0.0 110.701 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 11.3 mtp -149.0 113.97 5.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -138.1 172.3 13.12 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.978 2.111 . . . . 0.0 108.474 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.41 124.74 28.01 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.623 0.769 . . . . 0.0 112.86 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.3 mp -111.15 7.85 21.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.085 0.954 . . . . 0.0 111.166 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -97.57 -23.12 16.14 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -102.29 128.17 28.98 Favored Pre-proline 0 CA--C 1.536 0.426 0 C-N-CA 124.167 0.987 . . . . 0.0 108.913 -178.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.67 -14.85 27.28 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.657 2.238 . . . . 0.0 114.32 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -59.01 -41.75 88.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.851 1.261 . . . . 0.0 113.397 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -79.83 -41.11 27.06 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.065 0.46 . . . . 0.0 111.767 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 38.4 p -69.93 -24.59 63.39 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.746 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -53.3 -63.02 2.75 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -61.69 -14.71 37.56 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.109 1.872 . . . . 0.0 115.076 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 10.4 tp -78.56 -63.83 1.32 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 3.8 pt -63.05 -32.61 56.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.825 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.421 ' HB1' ' HD3' ' A' ' 256' ' ' LYS . . . -68.81 -14.36 62.98 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 118.469 -0.777 . . . . 0.0 112.528 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -52.94 -45.37 67.64 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 119.927 1.239 . . . . 0.0 113.603 -178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -61.67 -43.82 98.13 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 172.33 43.15 0.04 OUTLIER Glycine 0 C--N 1.332 0.321 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.952 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -99.55 155.51 19.79 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 107.205 -2.358 . . . . 0.0 107.205 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -160.73 119.26 2.54 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 118.278 1.039 . . . . 0.0 109.019 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.95 84.31 7.48 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 70.05 105.3 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.754 2.421 . . . . 0.0 107.874 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -72.25 134.78 45.78 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.636 -0.665 . . . . 0.0 109.314 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -131.65 120.05 22.27 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 173' ' ' ASN . 5.6 tt0 -102.78 -159.15 0.71 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.584 1.154 . . . . 0.0 108.428 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.491 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 78.5 m-20 -66.84 78.63 0.12 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.66 1.984 . . . . 0.0 110.708 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.66 10.91 84.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.269 0.938 . . . . 0.0 112.597 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -112.15 103.46 11.63 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.34 113.24 18.58 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -131.07 100.7 5.31 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.93 -9.38 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -69.48 -29.34 66.98 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.891 -1.131 . . . . 0.0 108.324 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -75.29 75.29 2.41 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.606 1.563 . . . . 0.0 110.863 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 75.7 t -97.11 113.82 32.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 126.414 1.886 . . . . 0.0 108.737 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -109.32 96.1 0.94 Allowed Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 107.109 -2.396 . . . . 0.0 107.109 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 45.8 t -138.38 -43.47 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 117.822 0.811 . . . . 0.0 109.579 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -108.84 77.04 1.05 Allowed 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -128.97 163.1 26.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.778 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -50.03 -41.52 47.62 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.2 1.4 . . . . 0.0 113.197 -178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.95 -43.41 95.99 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.581 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -63.6 -51.35 65.69 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 119.29 -0.386 . . . . 0.0 110.432 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 7.1 ptpt -58.78 -36.64 74.76 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.135 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.23 -38.61 87.27 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.212 0.915 . . . . 0.0 110.386 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -82.43 -26.54 46.82 Favored Glycine 0 CA--C 1.527 0.843 0 O-C-N 121.82 -0.55 . . . . 0.0 112.826 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 49.5 tp -76.29 -41.82 47.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 121.08 -1.247 . . . . 0.0 107.792 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 7.4 t -65.08 -27.62 68.9 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.987 0.812 . . . . 0.0 109.065 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -58.19 -52.06 67.13 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 4.1 tt -58.96 -46.24 88.54 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.764 1.226 . . . . 0.0 110.144 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 42.7 t -60.58 -38.91 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 117.639 -1.172 . . . . 0.0 110.506 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.517 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 14.2 t0 -56.6 -50.11 72.96 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.213 1.405 . . . . 0.0 114.009 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 9.6 mt -65.11 -38.7 91.54 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.548 0.689 . . . . 0.0 109.693 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.17 -31.8 51.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.0 OUTLIER -63.76 -44.7 92.66 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 126.125 1.77 . . . . 0.0 107.887 178.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -71.97 -10.92 60.46 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.377 0.671 . . . . 0.0 109.424 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt 60.96 15.6 6.23 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 128.175 2.59 . . . . 0.0 112.513 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -83.08 -14.04 54.53 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.399 -1.273 . . . . 0.0 112.04 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.24 124.98 52.76 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.813 1.645 . . . . 0.0 110.028 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.65 84.66 0.29 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.745 2.018 . . . . 0.0 110.69 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -58.53 -16.53 15.88 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.549 1.94 . . . . 0.0 115.011 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.08 -7.08 54.67 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.252 1.821 . . . . 0.0 114.097 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.3 m -60.99 134.48 57.14 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 118.941 0.791 . . . . 0.0 110.408 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.0 -178.43 4.18 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.542 1.937 . . . . 0.0 107.08 177.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -57.89 -38.56 76.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.391 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.86 -55.38 26.7 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.321 1.048 . . . . 0.0 110.456 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.22 -45.13 93.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 123.57 0.748 . . . . 0.0 110.38 -178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.45 -51.13 67.0 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.724 0.693 . . . . 0.0 110.816 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -63.35 -43.97 96.17 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 119.82 1.191 . . . . 0.0 110.313 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -58.09 -55.77 30.67 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.06 0.544 . . . . 0.0 109.548 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -54.84 -46.07 74.58 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.56 1.144 . . . . 0.0 110.425 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -58.42 -44.19 88.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 123.24 0.616 . . . . 0.0 109.429 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.46 -21.73 66.75 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.689 0.795 . . . . 0.0 112.203 179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt -91.97 -10.64 38.64 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.665 0.786 . . . . 0.0 110.008 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 80.82 18.44 70.2 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -80.78 0.72 33.52 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.947 1.299 . . . . 0.0 113.745 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 27.3 p -124.04 149.79 45.69 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.532 1.133 . . . . 0.0 108.184 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -94.3 -21.31 19.08 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.264 0.625 . . . . 0.0 111.469 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 14.0 ptt? -158.28 157.48 32.58 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.8 t -150.89 171.38 17.34 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 122.535 1.16 . . . . 0.0 109.792 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 5.9 mt -141.65 140.0 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 22.4 m-20 -153.1 139.2 18.27 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 173.14 -52.88 0.16 Allowed Glycine 0 CA--C 1.53 0.978 0 CA-C-O 117.782 -1.566 . . . . 0.0 112.54 -178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -78.19 73.08 5.94 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 CA-C-N 120.902 2.351 . . . . 0.0 108.241 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -77.42 128.97 35.15 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 126.02 1.728 . . . . 0.0 106.561 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.42 -178.6 0.39 Allowed 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 127.542 2.337 . . . . 0.0 110.26 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 16.8 p-90 -147.66 145.29 28.87 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 120.71 -1.243 . . . . 0.0 109.372 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 65.83 143.74 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.899 2.08 . . . . 0.0 109.523 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.7 m120 64.4 10.64 5.87 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.374 1.07 . . . . 0.0 111.892 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 17.9 tt -161.23 154.58 3.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.568 0 C-N-CA 129.316 3.047 . . . . 0.0 105.891 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -80.42 154.06 27.88 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.929 -0.482 . . . . 0.0 110.349 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 49.4 m -88.94 56.84 3.88 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 1.4 p -81.61 172.31 13.6 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.229 2.212 . . . . 0.0 111.305 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -164.94 171.98 13.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.548 1.139 . . . . 0.0 111.499 179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 t -97.16 168.79 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.887 1.275 . . . . 0.0 109.641 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -142.6 92.54 2.42 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 125.741 1.616 . . . . 0.0 108.372 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -139.96 167.5 21.98 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.886 2.074 . . . . 0.0 108.493 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -67.07 129.59 29.44 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 121.177 -0.952 . . . . 0.0 111.843 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 29.6 m -63.63 149.59 10.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 118.006 0.903 . . . . 0.0 109.921 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.8 t -147.72 -178.05 6.05 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.115 0.966 . . . . 0.0 109.396 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 14.2 p -93.11 137.18 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 124.522 1.129 . . . . 0.0 109.677 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 4.4 pp -84.06 157.65 62.58 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.144 0.978 . . . . 0.0 111.692 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.07 -84.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 123.834 3.023 . . . . 0.0 111.073 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . 0.292 0.5 OUTLIER 92.38 -164.69 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.483 3.113 . . . . 0.0 108.052 -179.233 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.27 131.83 47.11 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.02 120.31 7.25 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 121.52 -0.738 . . . . 0.0 109.181 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 79.91 -7.12 56.83 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.511 -1.16 . . . . 0.0 113.928 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.39 102.65 14.03 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 120.317 2.059 . . . . 0.0 109.801 -179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.78 143.49 21.1 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.223 1.948 . . . . 0.0 113.606 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 3.2 m -68.66 159.56 31.87 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.148 0.979 . . . . 0.0 109.234 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.421 ' HD3' ' HB1' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -129.08 55.72 19.85 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -179.267 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.61 161.65 34.58 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 121.788 1.659 . . . . 0.0 111.406 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -75.02 172.21 12.73 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.604 0.716 . . . . 0.0 111.142 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 13.6 t -114.39 155.26 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -172.12 148.41 10.78 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 23.3 m -136.43 172.22 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 119.403 1.601 . . . . 0.0 111.545 -178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 34.5 tp -84.41 156.52 21.77 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 120.055 -1.653 . . . . 0.0 107.569 178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 20.7 m -131.76 137.17 48.08 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 120.481 1.492 . . . . 0.0 109.001 178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -115.24 130.67 56.98 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.349 1.059 . . . . 0.0 109.513 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.14 170.59 21.73 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 125.308 1.432 . . . . 0.0 111.804 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 76.3 mt -119.19 134.72 61.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -68.09 122.54 18.48 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.61 -10.78 60.29 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.412 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -95.13 7.33 46.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.84 0.856 . . . . 0.0 112.459 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.5 m -69.33 157.49 89.25 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.418 1.087 . . . . 0.0 108.712 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.13 -50.82 2.55 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.906 1.737 . . . . 0.0 111.005 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -135.5 100.36 4.48 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -19.68 49.31 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.47 -0.769 . . . . 0.0 112.437 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -64.63 -32.9 74.76 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 118.049 0.386 . . . . 0.0 110.123 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 90.6 mt -58.87 -38.63 79.23 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.379 -0.825 . . . . 0.0 108.897 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.66 -42.29 42.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 117.903 -1.046 . . . . 0.0 111.671 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -41.3 91.99 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 119.3 0.954 . . . . 0.0 108.788 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -66.94 -50.93 60.79 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 124.619 1.199 . . . . 0.0 109.434 -177.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -53.22 -51.69 61.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 119.194 -0.431 . . . . 0.0 110.335 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 284' ' ' LEU . 2.2 mp -63.11 -48.04 80.22 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.332 6.7 pt-20 -78.74 -4.35 48.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -177.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -108.45 -19.45 13.45 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.311 1.414 . . . . 0.0 112.211 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -135.61 -53.3 0.77 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 119.789 1.177 . . . . 0.0 110.735 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 280' ' ' LEU . 0.2 OUTLIER -48.61 -48.04 39.59 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.753 0.821 . . . . 0.0 112.515 -179.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.66 29.03 0.93 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.948 2.099 . . . . 0.0 114.505 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 19.4 p -116.29 165.18 13.47 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 120.411 1.459 . . . . 0.0 108.097 178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.66 -44.06 85.41 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.46 -33.63 75.53 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.506 0.722 . . . . 0.0 112.787 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.53 -46.08 12.58 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 51.8 mt -62.52 -47.12 85.31 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -57.78 -44.49 86.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.678 1.191 . . . . 0.0 110.647 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.0 -46.78 71.84 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 117.93 0.332 . . . . 0.0 110.963 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.4 t -67.65 -40.32 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 117.047 -1.454 . . . . 0.0 109.723 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -63.15 -34.33 77.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.311 0.959 . . . . 0.0 112.754 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 17.8 mtmt -63.49 -61.34 2.39 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.8 -48.33 80.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 117.219 -1.372 . . . . 0.0 112.387 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -137.7 150.47 68.13 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-N 121.509 1.959 . . . . 0.0 109.137 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.77 101.95 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.254 1.969 . . . . 0.0 114.21 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 7.8 mt -76.03 -32.86 59.55 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 123.608 0.763 . . . . 0.0 109.731 178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 80.87 -115.64 4.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 107.225 -2.35 . . . . 0.0 107.225 -178.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -98.95 160.8 14.01 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 118.206 1.003 . . . . 0.0 111.698 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.16 162.7 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 124.479 1.112 . . . . 0.0 110.179 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -86.36 -29.44 22.95 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 28.0 tp -65.07 104.07 0.83 Allowed 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 123.749 0.82 . . . . 0.0 111.166 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 20.0 mtmt -49.53 -33.43 14.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.143 1.377 . . . . 0.0 112.482 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 3.3 t -62.53 -57.46 11.07 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 118.697 -0.668 . . . . 0.0 111.877 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -78.19 -20.72 51.33 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 119.923 1.238 . . . . 0.0 111.262 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -57.6 -43.13 84.46 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.25 -13.02 46.72 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.005 0.82 . . . . 0.0 113.207 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -94.12 -37.54 11.55 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 63.2 mt -74.95 -26.02 59.3 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.515 -1.366 . . . . 0.0 109.035 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -68.87 -1.63 7.7 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.544 1.538 . . . . 0.0 112.918 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -65.11 -19.45 65.99 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.807 0.843 . . . . 0.0 110.846 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -120.36 131.95 24.28 Favored Pre-proline 0 C--O 1.237 0.435 0 C-N-CA 124.526 1.13 . . . . 0.0 108.189 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -59.84 -15.05 30.18 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.215 2.61 . . . . 0.0 116.368 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -66.5 -39.5 88.75 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 121.93 2.15 . . . . 0.0 108.602 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.7 mp -70.77 -46.38 69.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -55.43 -49.54 72.15 Favored 'General case' 0 C--O 1.222 -0.395 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.166 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.17 -37.55 77.62 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.085 -1.009 . . . . 0.0 112.101 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.408 HG23 ' CB ' ' A' ' 112' ' ' ALA . 55.1 m -61.06 -39.1 88.59 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -81.35 -37.23 28.63 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 123.585 0.754 . . . . 0.0 111.434 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -55.17 -37.35 66.91 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.134 0.973 . . . . 0.0 108.837 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -63.9 -38.54 91.48 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -73.53 -33.67 64.85 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.385 0.674 . . . . 0.0 110.171 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -68.12 -48.15 66.21 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.049 1.34 . . . . 0.0 110.294 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -27.38 45.99 Favored 'General case' 0 C--N 1.333 -0.11 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -86.59 -172.32 48.38 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 124.581 1.086 . . . . 0.0 114.531 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.4 135.85 37.33 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.935 1.694 . . . . 0.0 107.082 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 85.7 mt -76.56 111.6 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 10.9 ptp 52.61 161.31 0.05 OUTLIER Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 130.972 3.709 . . . . 0.0 115.833 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.7 160.73 40.62 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 N-CA-C 108.374 -1.433 . . . . 0.0 108.374 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -120.81 23.49 10.7 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.0 pt -137.8 141.37 32.66 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 118.953 0.797 . . . . 0.0 110.454 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.82 -9.94 27.3 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 124.001 3.134 . . . . 0.0 113.82 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -64.69 -24.05 67.45 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.417 1.087 . . . . 0.0 109.539 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 91.1 mmm -58.99 -22.39 60.47 Favored 'General case' 0 C--N 1.342 0.247 0 O-C-N 120.744 -1.222 . . . . 0.0 113.571 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 80.4 p -64.24 -33.11 75.06 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.369 1.44 . . . . 0.0 108.821 178.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.5 -41.97 65.35 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 121.247 -0.908 . . . . 0.0 108.894 178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -49.96 -57.08 8.26 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.081 0.952 . . . . 0.0 109.584 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 50.8 m95 -64.02 -35.4 80.6 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -68.07 -37.43 81.24 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.158 0.583 . . . . 0.0 111.671 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -74.52 -55.16 6.24 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 126.868 2.067 . . . . 0.0 112.496 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 67.3 t -57.33 -33.55 43.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.378 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 61.4 ttp85 -54.63 -58.38 7.74 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 119.747 1.158 . . . . 0.0 108.859 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.4 m -61.38 -37.32 82.99 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.984 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.82 -48.13 82.37 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 121.003 1.729 . . . . 0.0 111.403 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 75.2 t -58.82 -56.46 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 39.5 mm -61.21 -32.94 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.2 0.6 . . . . 0.0 111.803 -178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -62.44 -52.72 62.42 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.638 -1.288 . . . . 0.0 110.158 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.23 -43.68 64.04 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.217 0.607 . . . . 0.0 111.233 -178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -56.38 -41.6 76.51 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.306 1.042 . . . . 0.0 111.246 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 41.8 m -85.09 -17.48 37.22 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.193 -0.432 . . . . 0.0 110.443 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.5 28.48 47.7 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 123.583 0.611 . . . . 0.0 112.314 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -81.84 -27.63 33.46 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.735 -0.862 . . . . 0.0 109.976 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -142.7 151.52 41.42 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 5.6 m -58.95 153.82 16.63 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.014 0.926 . . . . 0.0 109.485 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 90.5 t -52.56 -56.26 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.224 1.009 . . . . 0.0 110.133 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.1 -49.06 74.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.213 1.405 . . . . 0.0 110.825 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -68.65 -25.57 64.89 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.58 -41.93 83.34 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 74.9 mt -68.35 -43.5 77.35 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -50.54 -51.82 44.44 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 125.293 1.437 . . . . 0.0 109.536 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -54.42 -43.46 71.56 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.324 1.849 . . . . 0.0 110.757 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.437 ' O ' HD12 ' A' ' 368' ' ' ILE . . . -68.86 -50.75 47.15 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 118.725 -0.655 . . . . 0.0 109.488 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -52.01 -38.71 57.79 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.757 1.223 . . . . 0.0 108.773 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 19.2 m -59.68 -54.3 47.96 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.953 1.301 . . . . 0.0 108.283 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 54.9 mtt-85 -58.56 -39.95 81.7 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-O 118.747 -0.644 . . . . 0.0 111.764 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.437 HD12 ' O ' ' A' ' 364' ' ' ALA . 1.6 mp -66.93 -41.55 87.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 119.074 0.852 . . . . 0.0 109.653 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 38.7 p -80.32 -11.66 59.69 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 36.3 tttm . . . . . 0 C--O 1.245 0.82 0 C-N-CA 126.036 1.734 . . . . 0.0 108.45 178.661 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.403 HG13 ' H ' ' A' ' 2' ' ' ILE . 1.3 mt -63.47 146.46 12.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 112.454 -2.157 . . . . 0.0 109.266 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -112.42 130.54 55.94 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -98.95 103.28 15.22 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.55 21.37 0.31 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.333 0.968 . . . . 0.0 114.344 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -143.56 155.55 44.33 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 119.721 1.76 . . . . 0.0 113.126 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.9 mt -137.72 151.37 48.14 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 126.101 1.76 . . . . 0.0 108.328 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 77.2 t -138.92 132.42 39.66 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 125.501 1.52 . . . . 0.0 108.431 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.7 mt -129.15 134.27 64.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 124.652 1.181 . . . . 0.0 108.116 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -118.68 157.22 27.87 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.957 1.303 . . . . 0.0 109.369 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.0 pt -144.97 165.63 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 C-N-CA 125.631 1.572 . . . . 0.0 108.252 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -68.88 -33.29 73.55 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 118.727 -0.654 . . . . 0.0 111.014 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.19 -73.17 0.31 Allowed Glycine 0 C--N 1.342 0.876 0 C-N-CA 123.68 0.657 . . . . 0.0 113.37 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -70.85 26.9 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 129.424 3.089 . . . . 0.0 116.134 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -75.21 -45.79 38.1 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 125.123 1.369 . . . . 0.0 114.615 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.0 42.46 0.72 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 126.841 2.163 . . . . 0.0 111.96 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.525 ' CE1' HG22 ' A' ' 37' ' ' VAL . 0.1 OUTLIER -56.68 -16.93 7.21 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -178.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -52.62 -45.14 66.47 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 121.826 2.103 . . . . 0.0 112.056 -179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.09 -40.22 35.32 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 121.435 0.464 . . . . 0.0 112.032 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.604 ' HA ' HG22 ' A' ' 293' ' ' VAL . 33.1 tp -64.77 -36.86 85.67 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.771 1.228 . . . . 0.0 114.242 -178.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.37 64.55 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.675 0.79 . . . . 0.0 111.051 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -59.62 -33.99 72.21 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.96 -40.86 90.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.97 -34.99 83.37 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.5 mtpt -68.58 -47.39 66.9 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 118.752 1.276 . . . . 0.0 108.322 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -55.05 -59.39 4.81 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.378 1.071 . . . . 0.0 109.101 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -56.5 -44.95 81.22 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-O 118.881 -0.581 . . . . 0.0 111.31 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -64.32 -16.38 62.09 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 120.395 1.452 . . . . 0.0 111.929 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -96.86 -16.36 20.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 117.295 -1.336 . . . . 0.0 112.708 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -106.54 -37.59 6.42 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 124.791 1.307 . . . . 0.0 110.434 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.3 p -101.15 -34.0 9.87 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.147 -0.97 . . . . 0.0 110.739 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.06 -11.79 67.37 Favored Glycine 0 C--N 1.34 0.775 0 O-C-N 121.146 -0.971 . . . . 0.0 113.396 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 36.4 mm -70.0 132.9 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.52 ' HA ' ' HE3' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -67.51 150.03 49.39 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.161 -0.962 . . . . 0.0 109.677 179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.9 t -140.49 97.78 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 125.585 1.554 . . . . 0.0 108.976 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 24.7 m -77.14 153.48 34.17 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 178.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.525 HG22 ' CE1' ' A' ' 17' ' ' TYR . 2.3 t -138.55 110.62 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 104.224 -2.509 . . . . 0.0 104.224 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -135.14 161.55 35.01 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -127.26 61.01 46.27 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 125.463 1.505 . . . . 0.0 113.969 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.46 143.24 38.23 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 121.424 1.416 . . . . 0.0 110.35 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -97.2 21.6 9.71 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.4 3.09 2.1 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 -176.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.93 -22.75 5.96 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 117.837 -1.078 . . . . 0.0 113.005 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -48.84 -34.56 12.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.442 1.497 . . . . 0.0 112.096 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -122.32 -24.42 5.04 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 124.109 0.963 . . . . 0.0 111.937 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.78 -39.25 76.73 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 118.018 -0.991 . . . . 0.0 110.008 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -55.96 -59.53 11.39 Favored Pre-proline 0 CA--C 1.529 0.158 0 CA-C-N 119.988 1.267 . . . . 0.0 109.259 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.05 -29.4 89.16 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 CA-C-N 120.909 1.36 . . . . 0.0 113.916 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -77.23 0.49 21.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 120.101 1.319 . . . . 0.0 113.645 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.43 HG12 ' C ' ' A' ' 55' ' ' ASP . 3.7 t -131.73 -32.97 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.76 -26.65 60.76 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 120.837 -1.165 . . . . 0.0 110.053 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.86 -30.66 65.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.787 -0.571 . . . . 0.0 109.803 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.4 p -90.94 -16.45 28.06 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.351 1.06 . . . . 0.0 112.834 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' HA2' ' HB1' ' A' ' 269' ' ' ALA . . . 96.96 26.19 10.64 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-O 118.178 -1.346 . . . . 0.0 116.388 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.43 ' C ' HG12 ' A' ' 50' ' ' VAL . 57.2 m-20 -131.01 5.91 4.56 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 118.828 1.314 . . . . 0.0 110.084 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.1 -178.54 47.43 Favored Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.447 1.499 . . . . 0.0 114.941 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.34 169.78 9.0 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.416 2.077 . . . . 0.0 109.938 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -105.71 -16.8 14.58 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.8 mt -139.38 145.66 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.45 144.8 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.691 1.196 . . . . 0.0 108.955 178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -129.49 108.63 10.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.933 1.693 . . . . 0.0 110.429 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 5.3 t-105 -152.41 -174.53 4.93 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 121.174 -0.954 . . . . 0.0 110.869 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.03 158.04 36.7 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.816 1.246 . . . . 0.0 108.558 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -63.8 -25.75 68.32 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 122.376 -0.203 . . . . 0.0 111.322 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.48 -62.01 2.2 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 126.027 1.731 . . . . 0.0 111.398 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -61.5 -19.88 62.57 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 123.492 0.717 . . . . 0.0 112.601 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -78.93 -20.75 48.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.789 -0.624 . . . . 0.0 111.896 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -59.56 -39.57 95.19 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.13 -50.5 5.79 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.765 1.174 . . . . 0.0 111.613 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -55.41 -42.66 74.4 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 118.422 1.111 . . . . 0.0 112.215 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.92 -43.13 79.92 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 118.639 0.654 . . . . 0.0 110.451 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.01 -50.8 68.13 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.487 1.115 . . . . 0.0 108.81 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 m -63.85 -5.11 3.85 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.319 1.848 . . . . 0.0 113.505 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.17 10.33 86.18 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 125.36 1.457 . . . . 0.0 113.392 178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.7 mt -73.18 -18.95 61.21 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.305 1.053 . . . . 0.0 110.851 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.71 146.15 26.17 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 118.96 0.8 . . . . 0.0 109.949 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -93.1 -178.9 4.93 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 126.684 1.994 . . . . 0.0 110.321 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -72.43 128.61 36.14 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.623 1.569 . . . . 0.0 107.629 178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.15 159.19 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 118.836 0.744 . . . . 0.0 110.67 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.9 m 47.27 75.03 0.71 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 127.468 2.307 . . . . 0.0 113.517 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -67.06 -45.13 4.25 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.0 1.8 . . . . 0.0 111.878 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -94.15 132.81 38.3 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.071 1.348 . . . . 0.0 112.019 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -65.13 -31.63 72.93 Favored 'General case' 0 N--CA 1.462 0.128 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -178.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.83 -36.41 64.97 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 121.081 1.764 . . . . 0.0 112.137 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -59.82 -30.78 69.16 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.783 0.719 . . . . 0.0 110.772 179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -70.35 -29.83 66.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 120.99 -1.068 . . . . 0.0 112.124 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -78.39 -21.55 49.19 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.352 0.661 . . . . 0.0 111.47 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -69.44 -12.51 61.71 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 121.176 -0.953 . . . . 0.0 111.672 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.458 HD12 ' CZ2' ' A' ' 94' ' ' TRP . 11.0 mt -120.61 164.04 17.1 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.127 1.771 . . . . 0.0 111.555 -177.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -66.2 160.65 63.15 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -73.73 -49.3 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.66 2.24 . . . . 0.0 112.491 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -51.78 -41.08 61.38 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 123.856 0.862 . . . . 0.0 113.229 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -28.12 65.54 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.495 -0.753 . . . . 0.0 111.177 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.458 ' CZ2' HD12 ' A' ' 89' ' ' LEU . 73.9 m95 -78.03 -46.57 20.57 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.41 -21.22 23.71 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.252 1.021 . . . . 0.0 112.507 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.15 -28.9 57.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.488 1.515 . . . . 0.0 111.085 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 33.3 m -111.71 0.64 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 125.531 1.532 . . . . 0.0 113.056 -178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -65.27 162.87 16.46 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 118.862 0.756 . . . . 0.0 109.515 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -145.51 176.84 9.3 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.283 1.833 . . . . 0.0 107.256 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -55.09 104.47 0.12 Allowed 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.451 1.1 . . . . 0.0 109.186 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.16 -85.12 0.31 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 125.161 1.362 . . . . 0.0 111.317 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.54 170.09 4.29 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.711 1.604 . . . . 0.0 112.5 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.9 mt -98.91 169.97 9.07 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.452 1.501 . . . . 0.0 108.531 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 17.7 pt -135.55 -37.05 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.37 172.34 14.58 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.914 1.686 . . . . 0.0 108.419 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.66 149.81 69.28 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 123.359 0.664 . . . . 0.0 111.352 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.22 140.84 38.1 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 124.645 3.563 . . . . 0.0 110.902 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.3 mm -121.04 -45.5 2.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 124.853 1.261 . . . . 0.0 112.808 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.43 161.53 37.82 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.891 0.876 . . . . 0.0 109.63 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.65 107.37 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -152.77 135.72 15.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.03 74.52 1.49 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.813 0.845 . . . . 0.0 109.237 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.3 pp -161.9 158.84 25.95 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 124.66 1.184 . . . . 0.0 110.277 178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.9 p 156.65 153.6 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.519 1 C-N-CA 131.947 4.099 . . . . 0.0 110.798 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 245' ' ' THR . 36.6 tp -147.1 157.25 43.54 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 176.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 73.9 mt -114.22 128.73 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 120.396 -1.44 . . . . 0.0 110.142 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -152.81 143.79 23.0 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 126.561 1.944 . . . . 0.0 106.703 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -63.72 159.36 19.38 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.183 1.393 . . . . 0.0 113.94 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.71 14.2 0.11 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.603 1.961 . . . . 0.0 113.306 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.85 159.22 35.0 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.159 1.384 . . . . 0.0 112.746 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -78.26 9.37 3.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.459 1.104 . . . . 0.0 113.902 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -109.5 79.24 1.27 Allowed Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 119.753 1.161 . . . . 0.0 111.587 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.07 129.74 10.74 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 122.512 2.141 . . . . 0.0 108.612 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -131.95 58.35 36.71 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 125.154 1.382 . . . . 0.0 109.624 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -57.8 112.46 1.15 Allowed 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.811 3.007 . . . . 0.0 112.263 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.15 144.86 27.04 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.741 2.294 . . . . 0.0 110.214 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -100.37 -38.48 8.42 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.824 1.25 . . . . 0.0 112.677 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.8 t -157.22 157.17 33.84 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.585 1.084 . . . . 0.0 110.881 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -58.29 -30.42 66.62 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 118.334 -0.841 . . . . 0.0 113.12 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -66.36 -14.48 62.16 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.504 1.047 . . . . 0.0 112.052 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -101.63 -18.74 15.74 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 125.012 1.325 . . . . 0.0 111.239 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 26.1 mm -49.99 -56.24 18.94 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 120.736 1.607 . . . . 0.0 111.501 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.1 -20.07 25.54 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 CA-C-N 119.88 0.993 . . . . 0.0 112.557 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.65 -34.48 46.37 Favored 'General case' 0 C--O 1.223 -0.338 0 C-N-CA 124.932 1.293 . . . . 0.0 111.453 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.5 tp -82.8 -31.39 28.21 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.59 1.556 . . . . 0.0 108.55 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -59.43 -44.07 92.95 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.325 0.65 . . . . 0.0 109.625 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -65.51 -31.26 72.23 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 122.839 0.456 . . . . 0.0 111.319 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -69.79 -47.27 63.49 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 146' ' ' ALA . 26.7 mt -66.57 -32.85 74.46 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.627 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -70.68 -27.73 64.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.098 0.863 . . . . 0.0 110.076 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.84 -27.79 63.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 118.219 0.463 . . . . 0.0 110.481 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.1 -1.42 20.42 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.377 0.671 . . . . 0.0 112.569 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -177.22 -101.6 0.15 Allowed Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 118.989 0.813 . . . . 0.0 112.36 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -137.23 -179.5 5.76 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.942 2.097 . . . . 0.0 109.208 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.3 p -51.59 172.27 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.438 1.895 . . . . 0.0 115.569 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.459 ' HB2' HD12 ' A' ' 139' ' ' LEU . . . -106.19 -55.46 2.32 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.755 1.622 . . . . 0.0 112.343 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 60.4 tp -133.1 146.39 51.6 Favored 'General case' 0 CA--C 1.521 -0.164 0 C-N-CA 124.814 1.246 . . . . 0.0 110.844 -178.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 90.2 mtp -146.1 127.99 15.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -149.27 166.84 27.73 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.17 136.73 33.08 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -120.57 -4.58 9.8 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.165 0.986 . . . . 0.0 108.912 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -65.56 -19.99 66.15 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 125.297 1.439 . . . . 0.0 110.823 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -127.8 143.14 46.55 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.094 0.958 . . . . 0.0 109.493 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -72.49 -12.75 27.36 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 124.095 3.197 . . . . 0.0 114.121 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -51.41 -45.76 62.67 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.276 0.944 . . . . 0.0 111.948 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -85.12 -37.71 19.93 Favored 'General case' 0 C--O 1.231 0.079 0 CA-C-O 119.157 -0.449 . . . . 0.0 112.128 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.0 p -72.93 -14.03 61.38 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.102 0.864 . . . . 0.0 111.448 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -53.84 -63.05 2.91 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.574 1.149 . . . . 0.0 111.866 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.14 -6.18 10.92 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.226 1.951 . . . . 0.0 114.325 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 28.2 tp -82.5 -62.88 1.49 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 177.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.448 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 12.5 pt -58.77 -42.2 84.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.35 2.61 3.65 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.59 -37.07 82.55 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 -177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -86.86 -48.52 8.11 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.43 1.014 . . . . 0.0 108.606 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 179.71 63.55 0.07 OUTLIER Glycine 0 C--N 1.336 0.553 0 CA-C-N 118.964 0.802 . . . . 0.0 113.632 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -117.18 140.42 15.82 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 105.835 -2.906 . . . . 0.0 105.835 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -151.36 151.32 31.58 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.298 1.549 . . . . 0.0 109.315 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.13 -65.21 1.0 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -136.71 150.35 48.4 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.624 0.77 . . . . 0.0 111.056 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -86.03 149.9 24.84 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 36.6 t80 -150.85 106.2 3.35 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -86.73 57.31 4.43 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.734 1.614 . . . . 0.0 112.276 -178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 49.99 16.39 0.23 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 127.092 2.157 . . . . 0.0 116.522 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.41 -15.34 0.06 OUTLIER Glycine 0 CA--C 1.523 0.566 0 C-N-CA 124.392 0.996 . . . . 0.0 112.282 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -117.67 130.54 56.41 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -126.7 131.17 51.44 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 124.944 1.402 . . . . 0.0 108.315 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -143.2 146.48 33.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.144 0.973 . . . . 0.0 109.955 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.05 -0.71 10.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 125.827 1.651 . . . . 0.0 110.749 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -80.1 -37.4 33.8 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -81.93 100.71 9.81 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.22 150.65 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 125.419 1.487 . . . . 0.0 109.889 -178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -130.52 16.17 5.42 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.032 0.825 . . . . 0.0 115.149 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.0 t -54.83 -33.24 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.181 1.792 . . . . 0.0 115.01 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.61 14.48 12.69 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.27 0.628 . . . . 0.0 111.68 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -62.18 164.93 6.29 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.437 0.636 . . . . 0.0 110.1 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -50.95 -34.63 29.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.953 0.901 . . . . 0.0 112.093 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.21 -47.01 47.18 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 118.968 0.804 . . . . 0.0 112.521 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -55.89 -48.78 74.99 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.969 -0.724 . . . . 0.0 109.415 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -67.04 -40.42 87.16 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 117.726 -1.131 . . . . 0.0 111.025 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -58.55 -49.64 76.68 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.133 0.879 . . . . 0.0 111.563 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -71.55 -27.93 70.34 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.319 -0.944 . . . . 0.0 112.057 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 14.2 tp -77.35 -34.14 55.22 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.773 1.287 . . . . 0.0 112.355 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 2.4 t -55.9 -45.31 78.67 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 117.452 -1.261 . . . . 0.0 108.805 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -52.39 -53.91 38.86 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.271 1.428 . . . . 0.0 111.237 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.6 tt -54.12 -48.39 70.81 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.122 0.969 . . . . 0.0 111.278 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 38.6 t -73.41 -21.95 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 123.39 0.676 . . . . 0.0 110.492 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.419 ' HA ' ' CE ' ' A' ' 200' ' ' LYS . 2.8 t70 -63.37 -36.85 85.1 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.768 1.227 . . . . 0.0 109.749 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.8 mt -71.9 -41.73 67.59 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 79.5 mt -63.09 -39.48 85.38 Favored 'Isoleucine or valine' 0 C--N 1.343 0.309 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.419 ' CE ' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -54.71 -34.27 62.18 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.817 1.247 . . . . 0.0 109.769 178.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -91.47 -9.93 42.73 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.693 1.197 . . . . 0.0 111.906 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 64.82 6.53 3.38 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 128.735 2.814 . . . . 0.0 113.387 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -67.54 -36.22 80.56 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.541 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 8.4 tpt -77.96 154.07 31.91 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -88.43 91.18 8.7 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 121.459 -0.775 . . . . 0.0 110.573 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.3 -28.93 70.05 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 121.376 -0.827 . . . . 0.0 112.49 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.11 -4.65 48.47 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.8 m -71.46 126.98 31.09 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 120.274 -1.516 . . . . 0.0 109.053 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.03 -178.08 3.86 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.863 1.665 . . . . 0.0 107.095 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -58.11 -37.74 75.12 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.093 0.557 . . . . 0.0 111.404 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 39.5 m -73.59 -40.1 64.12 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.54 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 19.4 mm -64.58 -50.99 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 120.839 1.654 . . . . 0.0 109.053 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -55.94 -44.06 78.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.854 0.752 . . . . 0.0 110.631 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -67.48 -40.69 85.26 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.555 0.742 . . . . 0.0 111.762 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.31 -56.51 8.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.699 0.8 . . . . 0.0 109.594 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.99 -39.44 66.05 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.415 1.486 . . . . 0.0 110.519 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -60.15 -45.93 91.39 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -64.06 -30.54 71.61 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.076 -0.488 . . . . 0.0 111.793 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -77.21 -11.38 59.82 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.963 -0.541 . . . . 0.0 110.969 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.97 19.82 49.34 Favored Glycine 0 C--N 1.337 0.628 0 C-N-CA 125.174 1.369 . . . . 0.0 112.21 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -76.07 -48.76 19.58 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 118.385 1.093 . . . . 0.0 111.016 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -104.12 153.37 21.0 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -105.5 -25.38 12.34 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.676 0.79 . . . . 0.0 110.322 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -129.07 170.04 13.99 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 124.625 1.17 . . . . 0.0 109.716 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.7 t -161.06 178.92 8.86 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 126.182 1.793 . . . . 0.0 107.169 179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 42.1 mt -134.32 139.55 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -148.2 170.9 16.84 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -138.9 -177.91 15.84 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -58.56 -39.36 83.7 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 CA-C-N 119.069 1.435 . . . . 0.0 109.063 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -161.14 164.94 30.27 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 127.24 2.216 . . . . 0.0 106.374 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -133.61 152.64 51.93 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.072 2.149 . . . . 0.0 106.467 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . 0.4 ' CZ3' ' HB2' ' A' ' 340' ' ' TRP . 8.2 t90 -75.94 160.75 29.56 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 t 54.4 26.65 7.25 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 119.274 0.943 . . . . 0.0 112.238 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -58.28 114.4 2.39 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.128 0.971 . . . . 0.0 109.704 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 10.2 tt -97.25 -37.9 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.46 1.104 . . . . 0.0 110.888 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -98.79 -89.6 0.31 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.332 1.053 . . . . 0.0 108.759 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 3.3 t -153.12 -164.83 2.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.299 1.047 . . . . 0.0 111.004 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 2.3 m -132.53 133.4 43.7 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 130.873 3.669 . . . . 0.0 101.177 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -130.5 123.35 29.48 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 120.564 1.529 . . . . 0.0 110.85 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.3 m -52.51 140.9 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 126.444 1.897 . . . . 0.0 113.826 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.27 172.14 10.71 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.146 0.978 . . . . 0.0 109.047 178.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -163.67 -177.56 5.26 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.706 1.203 . . . . 0.0 109.204 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 64.74 -159.6 42.5 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.0 p -160.48 120.77 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.53 1.132 . . . . 0.0 108.728 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' A' ' 115' ' ' LEU . 5.8 t -153.23 -173.64 4.65 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.697 -0.627 . . . . 0.0 110.827 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 38.6 t -72.97 167.14 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 127.962 2.505 . . . . 0.0 109.285 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.55 129.64 17.63 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.0 123.52 10.1 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.418 2.079 . . . . 0.0 109.207 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 21.5 p -100.53 169.28 9.17 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -77.85 167.11 22.03 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -51.35 104.64 0.08 Allowed 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 126.003 1.721 . . . . 0.0 110.249 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.52 8.21 44.69 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 117.97 -1.461 . . . . 0.0 116.556 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.59 124.25 10.35 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-N 121.569 2.685 . . . . 0.0 112.193 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -73.51 123.25 8.49 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 124.215 3.276 . . . . 0.0 113.576 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 20.0 m -62.37 159.06 16.05 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.578 1.151 . . . . 0.0 111.621 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -147.35 100.53 3.83 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.902 1.281 . . . . 0.0 111.172 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -69.97 -63.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.693 0 N-CA-C 107.274 -1.856 . . . . 0.0 107.274 177.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -160.66 -173.15 3.81 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 129.153 2.981 . . . . 0.0 106.702 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.6 120.46 56.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 126.811 2.044 . . . . 0.0 106.829 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -103.05 132.61 11.08 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 19.7 m -140.46 140.49 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.9 tt -81.35 140.42 34.77 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 3.3 m -126.9 154.28 44.66 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 122.903 0.481 . . . . 0.0 111.286 -178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -132.67 146.2 51.68 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.153 0.981 . . . . 0.0 108.579 177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -139.85 148.62 20.19 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 82.6 mt -95.12 137.36 23.6 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -72.13 133.5 45.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 118.046 0.385 . . . . 0.0 110.296 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -79.29 -25.11 42.5 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.031 -0.985 . . . . 0.0 113.33 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . 0.42 ' HB1' ' HA2' ' A' ' 54' ' ' GLY . . . -74.22 -12.69 60.64 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.531 1.06 . . . . 0.0 113.325 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 61.9 m -60.15 165.51 4.89 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 177.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.49 -41.23 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 CA-C-N 120.59 1.246 . . . . 0.0 110.58 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -122.71 168.55 12.07 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.717 1.607 . . . . 0.0 108.164 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -132.88 -26.73 1.73 Allowed 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 125.199 1.399 . . . . 0.0 110.303 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -61.47 -40.1 93.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 53.6 mt -59.32 -34.56 72.49 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.827 -1.171 . . . . 0.0 111.195 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.61 -45.43 37.46 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.134 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -36.54 83.96 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 118.784 0.72 . . . . 0.0 109.154 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -64.78 -46.11 83.46 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -60.84 -37.41 81.98 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 120.102 1.319 . . . . 0.0 108.175 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 7.3 mp -77.24 -0.05 23.82 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 117.63 -1.176 . . . . 0.0 114.019 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -137.58 2.31 2.44 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 120.867 1.667 . . . . 0.0 113.587 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -90.52 -55.94 3.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 119.949 1.249 . . . . 0.0 110.613 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -126.11 -29.25 3.06 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.784 1.634 . . . . 0.0 113.299 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -55.21 -35.1 64.51 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 119.486 1.039 . . . . 0.0 111.885 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.36 74.57 0.96 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.329 1.052 . . . . 0.0 108.41 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 22.9 p -137.11 163.39 30.92 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -64.19 -17.41 63.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 126.25 1.82 . . . . 0.0 112.628 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -116.07 -36.56 4.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.602 1.561 . . . . 0.0 110.927 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -74.57 -31.04 59.18 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-O 118.846 -0.974 . . . . 0.0 110.883 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 29.7 mt -73.34 -41.79 63.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 119.577 1.689 . . . . 0.0 106.631 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -56.13 -47.32 78.38 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.555 1.142 . . . . 0.0 110.667 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -57.75 -29.44 64.8 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.604 HG22 ' HA ' ' A' ' 20' ' ' LEU . 48.5 t -91.08 -34.32 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 C-N-CA 124.477 1.111 . . . . 0.0 110.119 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -62.13 -30.4 71.0 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.067 0.849 . . . . 0.0 110.158 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -61.92 -17.81 58.09 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.969 0.908 . . . . 0.0 111.216 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -122.4 -76.27 0.59 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -61.66 142.69 94.33 Favored Pre-proline 0 C--O 1.234 0.272 0 O-C-N 121.189 -0.944 . . . . 0.0 111.457 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.08 93.1 1.03 Allowed 'Trans proline' 0 N--CA 1.446 -1.289 0 N-CA-C 106.415 -2.186 . . . . 0.0 106.415 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 16.3 mt -77.23 -19.58 56.43 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-O 117.234 -1.365 . . . . 0.0 111.16 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 55.12 -138.98 41.89 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 107.163 -2.375 . . . . 0.0 107.163 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -85.75 165.57 16.8 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.42 155.56 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 O-C-N 120.306 -1.496 . . . . 0.0 110.814 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.52 70.24 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.111 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.21 101.05 0.26 Allowed 'General case' 0 C--N 1.344 0.335 0 C-N-CA 124.872 1.269 . . . . 0.0 111.089 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 13.8 mtmt -65.37 -20.73 66.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.552 -0.459 . . . . 0.0 109.785 178.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.91 -21.62 62.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.011 0.924 . . . . 0.0 111.494 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -113.6 -11.13 13.05 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.977 1.262 . . . . 0.0 110.559 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -59.86 -41.78 92.23 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.451 1.1 . . . . 0.0 108.355 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -62.88 -17.02 61.04 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.917 1.287 . . . . 0.0 112.817 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -95.96 -52.61 3.98 Favored 'General case' 0 C--O 1.226 -0.152 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.444 ' HB3' HG21 ' A' ' 317' ' ' ILE . 8.5 mt -56.62 -38.71 72.45 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.479 -0.763 . . . . 0.0 110.906 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.59 -6.66 5.58 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.262 1.425 . . . . 0.0 114.121 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -63.23 -13.61 39.75 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.4 1.08 . . . . 0.0 111.439 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -123.66 139.54 32.39 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.27 1.028 . . . . 0.0 109.255 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.47 -20.28 48.26 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.908 2.405 . . . . 0.0 112.941 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 -63.93 -24.65 67.81 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 118.737 0.699 . . . . 0.0 112.684 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' A' ' 311' ' ' LEU . 2.3 mp -96.09 -56.84 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -45.39 -51.77 10.86 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.318 1.047 . . . . 0.0 112.576 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.23 -42.76 91.8 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.616 -0.678 . . . . 0.0 112.334 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 14.5 m -66.57 -34.19 77.35 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -53.76 43.59 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -55.49 -36.14 66.33 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.494 0.718 . . . . 0.0 111.432 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -67.7 -31.05 70.74 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.796 0.839 . . . . 0.0 111.128 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -83.61 -34.06 25.18 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.595 -0.691 . . . . 0.0 109.667 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -65.64 -48.25 72.84 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 125.191 1.396 . . . . 0.0 110.303 -178.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.18 -2.49 21.86 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -108.89 177.09 20.27 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-O 122.561 1.089 . . . . 0.0 113.481 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.2 161.84 29.2 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 127.694 2.398 . . . . 0.0 109.596 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 32.4 mt -90.86 155.85 3.05 Favored 'Isoleucine or valine' 0 C--O 1.245 0.826 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 7.4 ptp -60.86 148.57 82.91 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.611 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.98 -179.65 4.84 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 124.099 3.2 . . . . 0.0 114.444 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -133.18 5.42 3.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.161 1.784 . . . . 0.0 112.277 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 36.6 pt -89.1 144.56 32.81 Favored Pre-proline 0 CA--C 1.537 0.452 0 O-C-N 121.233 -0.917 . . . . 0.0 109.287 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.01 -12.71 32.94 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.108 2.539 . . . . 0.0 114.398 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -57.57 -20.89 35.32 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.277 1.031 . . . . 0.0 111.792 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 92.0 mmm -62.06 -24.76 67.29 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.341 -0.849 . . . . 0.0 110.58 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 61.0 p -63.75 -28.16 69.69 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.768 -1.208 . . . . 0.0 110.05 178.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -90.45 -30.66 17.2 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.808 1.643 . . . . 0.0 111.266 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 343' ' ' VAL . 56.6 t80 -53.68 -60.77 2.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.391 1.077 . . . . 0.0 109.124 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.4 ' HB2' ' CZ3' ' A' ' 232' ' ' TRP . 66.9 m95 -56.85 -43.01 80.7 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.745 0.418 . . . . 0.0 111.215 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -60.85 -27.47 68.12 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.05 0.54 . . . . 0.0 111.952 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.404 ' HB3' HD11 ' A' ' 368' ' ' ILE . . . -81.12 -61.74 1.86 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.613 0.765 . . . . 0.0 110.538 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 339' ' ' PHE . 1.6 m -56.44 -25.84 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.364 0.666 . . . . 0.0 111.677 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -54.0 -56.8 14.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.967 0.907 . . . . 0.0 108.694 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . 0.653 HG21 HH22 ' A' ' 367' ' ' ARG . 88.6 m -66.3 -38.35 87.54 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 118.341 -0.838 . . . . 0.0 110.186 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.04 77.05 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.47 -49.87 75.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 124.652 1.181 . . . . 0.0 109.024 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 32.7 mm -62.71 -38.55 81.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.148 0.886 . . . . 0.0 110.591 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.0 m-20 -61.15 -41.91 97.6 Favored 'General case' 0 CA--C 1.516 -0.346 0 O-C-N 121.122 -0.986 . . . . 0.0 110.774 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.35 -46.72 59.83 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 123.275 0.359 . . . . 0.0 110.328 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.93 98.34 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.703 1.201 . . . . 0.0 113.327 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 19.2 m -87.93 -1.32 57.91 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.659 0.783 . . . . 0.0 110.297 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 71.05 14.11 73.29 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-O 119.433 -0.649 . . . . 0.0 114.608 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -65.56 -26.97 68.11 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 118.541 1.171 . . . . 0.0 109.031 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -153.76 167.63 28.99 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.957 0.903 . . . . 0.0 109.65 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 6.6 m -72.26 156.14 39.44 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 39.6 t -54.95 -56.4 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.93 -51.47 40.78 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 127.641 2.376 . . . . 0.0 112.894 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -72.57 -32.69 66.23 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.86 71.65 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 24.6 mt -70.18 -43.35 70.97 Favored 'General case' 0 C--N 1.344 0.349 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -51.76 -54.84 24.11 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 125.969 1.707 . . . . 0.0 108.178 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -52.31 -47.58 65.87 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.381 1.072 . . . . 0.0 109.317 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.92 -46.6 87.02 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 117.597 -1.192 . . . . 0.0 111.736 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.13 -39.78 72.75 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.406 1.003 . . . . 0.0 108.708 178.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 3.1 m -62.58 -25.08 67.89 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.184 0.993 . . . . 0.0 112.235 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.653 HH22 HG21 ' A' ' 345' ' ' THR . 93.2 mtt180 -83.07 -14.32 54.0 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.642 -1.287 . . . . 0.0 112.085 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.404 HD11 ' HB3' ' A' ' 342' ' ' ALA . 9.9 mt -105.85 -30.47 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 118.556 0.616 . . . . 0.0 109.426 -178.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 24.0 p -69.42 -37.87 77.63 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 27.6 tptt . . . . . 0 C--O 1.246 0.886 0 C-N-CA 126.371 1.868 . . . . 0.0 107.933 178.413 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.2 mt -140.44 167.63 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 105.255 -2.128 . . . . 0.0 105.255 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -79.16 103.78 9.33 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -83.66 175.31 9.8 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.163 0.985 . . . . 0.0 108.684 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 59.64 35.62 86.59 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.374 1.464 . . . . 0.0 115.651 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -147.11 167.69 23.48 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 119.246 1.523 . . . . 0.0 112.658 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.0 mt -150.08 145.6 26.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.519 2.728 . . . . 0.0 105.664 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.445 ' H ' ' HB2' ' A' ' 58' ' ' ASP . 50.4 t -139.56 134.68 39.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.9 mt -125.6 136.21 61.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.079 1.352 . . . . 0.0 110.092 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -127.07 154.66 44.41 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 177.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 5.0 pt -145.21 163.46 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 123.597 0.759 . . . . 0.0 111.348 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.57 -0.95 2.27 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.52 -76.01 0.22 Allowed Glycine 0 C--N 1.332 0.354 0 CA-C-N 120.098 1.317 . . . . 0.0 112.438 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -63.26 17.11 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 130.121 3.369 . . . . 0.0 115.219 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -84.9 165.79 17.36 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.733 1.213 . . . . 0.0 112.309 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.02 83.14 1.6 Allowed Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 103.466 -3.854 . . . . 0.0 103.466 177.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -95.59 -20.7 18.76 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -58.73 -42.05 87.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.699 1.136 . . . . 0.0 110.934 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.96 -41.39 40.91 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.6 tp -59.76 -43.13 94.46 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 118.08 0.94 . . . . 0.0 111.434 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.15 -38.8 71.34 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.881 -1.057 . . . . 0.0 111.17 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -60.0 -35.51 75.19 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.121 0.873 . . . . 0.0 111.852 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.6 -42.97 90.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.91 -39.98 96.9 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.2 mtpt -63.34 -51.31 66.5 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 118.542 1.171 . . . . 0.0 108.695 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -53.71 -57.65 10.05 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.689 1.195 . . . . 0.0 108.544 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -58.01 -45.17 87.28 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.096 -0.478 . . . . 0.0 111.879 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -66.31 -8.29 24.14 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.036 1.289 . . . . 0.0 111.25 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -109.08 -8.28 15.19 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 119.994 -1.691 . . . . 0.0 112.657 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -110.79 -38.26 5.19 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.898 1.279 . . . . 0.0 108.801 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.9 p -104.16 -32.71 9.02 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 124.016 0.926 . . . . 0.0 111.249 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.47 -12.09 69.38 Favored Glycine 0 C--N 1.342 0.904 0 O-C-N 121.452 -0.78 . . . . 0.0 111.787 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 50.0 mm -62.2 128.79 24.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 104.841 -2.281 . . . . 0.0 104.841 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -60.09 138.76 57.81 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.972 0.509 . . . . 0.0 111.22 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.05 119.73 17.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.8 m -114.62 148.88 37.48 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -137.29 113.64 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -130.67 166.06 21.52 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.144 0.977 . . . . 0.0 108.621 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -127.27 57.16 21.98 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.52 0.728 . . . . 0.0 111.65 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.09 149.77 65.22 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 N-CA-C 107.71 -1.688 . . . . 0.0 107.71 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -95.97 -37.23 10.76 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 121.245 -0.91 . . . . 0.0 108.656 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.404 ' CE ' ' H ' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -65.44 -3.84 4.87 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.117 1.367 . . . . 0.0 111.816 178.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.11 -31.63 13.84 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.296 1.038 . . . . 0.0 109.417 178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -50.0 -29.87 9.49 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.289 2.236 . . . . 0.0 112.433 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -125.5 -20.62 4.7 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.433 1.015 . . . . 0.0 110.569 177.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -73.65 -49.96 23.36 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 116.384 -1.77 . . . . 0.0 111.548 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -45.87 -57.58 7.76 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 120.114 1.325 . . . . 0.0 109.879 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.09 -18.11 63.47 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 N-CA-C 115.896 1.46 . . . . 0.0 115.896 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -92.34 -46.34 7.74 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 120.959 1.708 . . . . 0.0 112.289 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 4.0 t -69.45 -39.37 78.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 O-C-N 121.261 -0.899 . . . . 0.0 108.665 -178.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.45 -16.34 61.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 121.402 -0.812 . . . . 0.0 110.847 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.34 7.43 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.072 0.949 . . . . 0.0 110.912 177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -130.73 -39.6 1.24 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.764 2.026 . . . . 0.0 106.414 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.56 6.77 12.76 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 124.564 1.078 . . . . 0.0 114.737 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.45 -0.52 54.69 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.036 1.418 . . . . 0.0 111.238 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.73 -175.0 30.61 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 126.972 2.225 . . . . 0.0 116.529 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -67.35 -178.76 1.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 124.377 3.385 . . . . 0.0 112.0 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 8' ' ' VAL . 9.9 m-20 -115.81 -20.03 10.21 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.538 HD11 ' HB1' ' A' ' 276' ' ' ALA . 17.5 mt -141.68 143.62 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.14 144.08 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 125.832 1.653 . . . . 0.0 108.144 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -131.28 114.66 15.3 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.836 1.654 . . . . 0.0 110.358 -179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -156.04 172.84 17.72 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.997 0.817 . . . . 0.0 111.538 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.43 149.31 50.61 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -55.6 -31.75 62.51 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.09 -12.76 61.97 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -109.44 -0.65 18.83 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.971 1.26 . . . . 0.0 109.544 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -92.88 -11.52 33.3 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.292 1.837 . . . . 0.0 112.225 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.62 -10.39 86.26 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.638 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.12 -60.61 1.17 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.087 1.327 . . . . 0.0 111.007 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -43.91 -44.14 6.89 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.543 1.537 . . . . 0.0 114.692 -178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -70.56 -41.5 72.36 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.085 0.857 . . . . 0.0 110.946 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -36.31 70.58 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.12 0.968 . . . . 0.0 109.003 178.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.4 m -67.99 -44.74 75.92 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.358 1.063 . . . . 0.0 108.697 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.77 -2.24 8.01 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.978 1.751 . . . . 0.0 113.345 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.0 mp -68.79 -11.0 59.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.514 1.657 . . . . 0.0 114.461 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 71' ' ' ALA . 76.5 mt -108.85 129.36 55.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.324 0.966 . . . . 0.0 108.511 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.84 167.22 13.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 126.172 1.789 . . . . 0.0 110.701 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -69.1 101.5 1.45 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.471 1.108 . . . . 0.0 109.656 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.8 pp -76.28 165.56 3.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 C-N-CA 124.491 1.116 . . . . 0.0 111.424 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.4 m 48.08 97.71 0.04 OUTLIER Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 128.581 2.752 . . . . 0.0 114.908 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.31 -22.95 21.3 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.916 2.411 . . . . 0.0 114.135 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -133.95 151.91 51.66 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -60.98 -32.68 72.24 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.5 1.52 . . . . 0.0 112.719 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.9 -42.12 65.02 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 120.07 1.305 . . . . 0.0 112.303 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -64.69 -30.72 71.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.886 0.475 . . . . 0.0 110.894 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -69.13 -37.42 78.31 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.142 -0.974 . . . . 0.0 111.379 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.26 -19.13 65.82 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.342 0.519 . . . . 0.0 111.484 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 mtpt -79.08 -2.46 40.59 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.3 mt -130.38 151.6 50.69 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.329 1.052 . . . . 0.0 109.206 -178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -72.26 151.12 92.19 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 119.589 -0.845 . . . . 0.0 109.985 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.47 -45.47 3.54 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.282 3.322 . . . . 0.0 113.704 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -60.01 -33.51 72.09 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.428 1.013 . . . . 0.0 110.094 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.503 HG22 ' CB ' ' A' ' 107' ' ' PRO . 3.8 m -68.86 -36.19 77.83 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.806 0.843 . . . . 0.0 109.342 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -65.67 -45.18 83.88 Favored 'General case' 0 C--N 1.34 0.183 0 C-N-CA 124.141 0.977 . . . . 0.0 110.032 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.31 -33.71 13.88 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.438 1.495 . . . . 0.0 112.39 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.84 -35.27 22.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.207 1.403 . . . . 0.0 111.267 178.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.39 6.36 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 126.419 1.888 . . . . 0.0 113.328 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.2 mtp180 -69.02 156.67 38.23 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -138.5 175.59 9.43 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -62.97 111.18 2.05 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.596 0.758 . . . . 0.0 110.06 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.98 -77.76 0.67 Allowed Glycine 0 CA--C 1.522 0.514 0 C-N-CA 124.804 1.192 . . . . 0.0 114.169 178.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.47 166.03 22.41 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.06 0.944 . . . . 0.0 110.778 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.71 170.01 8.44 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.746 1.218 . . . . 0.0 110.052 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.1 pt -138.17 -35.42 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -153.72 176.93 11.54 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.235 1.414 . . . . 0.0 108.61 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -131.76 150.41 76.16 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.526 0.731 . . . . 0.0 110.94 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.503 ' CB ' HG22 ' A' ' 93' ' ' THR . 72.4 Cg_endo -72.57 151.95 53.37 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.591 2.86 . . . . 0.0 109.639 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mm -128.79 -45.09 0.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 123.972 0.909 . . . . 0.0 111.125 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.41 157.78 44.71 Favored 'General case' 0 CA--C 1.515 -0.395 0 C-N-CA 123.141 0.577 . . . . 0.0 112.007 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.7 t -132.4 100.15 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -127.34 121.52 31.24 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.998 1.319 . . . . 0.0 107.754 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.88 71.48 1.4 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.955 1.302 . . . . 0.0 109.025 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.14 151.12 9.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.806 0.842 . . . . 0.0 111.399 -179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.7 p -179.2 155.37 0.71 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.676 1.19 . . . . 0.0 111.062 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.5 tp -153.91 136.27 14.95 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.193 1.797 . . . . 0.0 108.193 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 4.1 mp -103.22 125.6 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -143.41 163.28 33.51 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.788 1.235 . . . . 0.0 110.208 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -85.02 141.23 30.45 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.113 1.365 . . . . 0.0 111.801 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -79.42 2.09 23.07 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.366 1.467 . . . . 0.0 112.316 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -63.94 166.19 7.79 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 121.02 -1.05 . . . . 0.0 111.435 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.58 -1.47 13.65 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.92 0.888 . . . . 0.0 111.534 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 56.0 tp -128.15 67.21 74.33 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 128.624 2.769 . . . . 0.0 105.767 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.68 -24.47 6.15 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 123.763 2.976 . . . . 0.0 114.873 -178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 46.35 71.61 1.51 Allowed Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 127.024 2.13 . . . . 0.0 114.598 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.69 119.63 6.55 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.22 2.613 . . . . 0.0 107.99 178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -81.53 162.98 19.27 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.901 1.734 . . . . 0.0 112.925 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -126.5 -9.14 6.28 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.7 t -168.26 154.49 7.27 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.401 ' CE2' HD13 ' A' ' 160' ' ' LEU . 6.2 m95 -69.31 -18.94 63.88 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.947 -0.471 . . . . 0.0 111.061 178.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -75.43 -18.8 59.81 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.916 0.78 . . . . 0.0 110.291 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -87.22 -26.39 23.54 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.906 0.882 . . . . 0.0 109.783 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.1 mm -51.46 -60.43 5.87 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.0 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -70.83 -25.57 23.48 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 CA-C-N 120.631 1.261 . . . . 0.0 110.981 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.18 96.81 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.584 0.754 . . . . 0.0 109.227 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.9 tp -79.67 -27.89 40.78 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.705 1.202 . . . . 0.0 110.637 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -57.02 -46.36 82.41 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.788 0.722 . . . . 0.0 110.496 -179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.5 ptmm? -69.52 -28.48 66.07 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -74.37 -44.62 51.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 58.1 mt -72.2 -34.68 68.56 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 119.167 -0.444 . . . . 0.0 109.824 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -66.12 -32.34 73.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.81 -15.87 63.28 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 119.082 -0.485 . . . . 0.0 112.166 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.69 5.95 6.15 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 124.879 1.272 . . . . 0.0 112.832 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.21 -101.98 0.16 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 118.97 0.805 . . . . 0.0 111.329 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -139.42 -176.23 4.46 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.091 1.357 . . . . 0.0 111.519 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.23 162.13 2.17 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.416 1.486 . . . . 0.0 114.185 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -92.27 -45.32 8.28 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.723 1.209 . . . . 0.0 111.466 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.6 tp -124.88 149.67 47.29 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.571 1.549 . . . . 0.0 107.289 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.0 ttm -154.33 103.08 2.49 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -121.96 158.98 27.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.525 1.057 . . . . 0.0 111.112 179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.477 HD22 ' HB2' ' A' ' 210' ' ' TYR . 62.4 t-20 -69.14 98.15 0.98 Allowed 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 tt -78.98 -11.74 60.01 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.808 0.843 . . . . 0.0 110.883 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -78.88 -23.52 44.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 124.962 1.305 . . . . 0.0 113.683 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -95.38 132.01 28.59 Favored Pre-proline 0 N--CA 1.471 0.615 0 CA-C-N 119.976 1.262 . . . . 0.0 110.772 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.29 -22.8 39.46 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 121.897 1.731 . . . . 0.0 114.468 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -68.97 -14.89 63.31 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 120.263 1.392 . . . . 0.0 113.104 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -95.82 -25.56 15.98 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.486 1.039 . . . . 0.0 109.066 177.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 p -88.7 -28.51 20.52 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.838 -1.164 . . . . 0.0 110.516 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -51.69 79.02 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 120.069 -1.644 . . . . 0.0 113.239 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.0 -5.03 12.54 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.857 1.705 . . . . 0.0 111.651 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.401 HD13 ' CE2' ' A' ' 129' ' ' TRP . 15.1 tp -85.76 -62.33 1.55 Allowed 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . 0.27 0.2 OUTLIER -70.52 -27.59 31.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 -177.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -55.56 -25.09 36.14 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 118.499 -0.763 . . . . 0.0 111.721 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -49.46 -47.3 48.4 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.174 1.39 . . . . 0.0 113.023 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -66.29 -45.37 80.64 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.456 0.702 . . . . 0.0 111.291 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -176.43 -26.04 0.03 OUTLIER Glycine 0 C--N 1.338 0.653 0 CA-C-O 117.255 -1.858 . . . . 0.0 115.937 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -42.01 133.06 4.11 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.204 1.383 . . . . 0.0 112.876 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -139.01 122.81 17.62 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.35 -55.1 37.62 Favored 'General case' 0 N--CA 1.456 -0.133 0 O-C-N 121.64 -0.662 . . . . 0.0 112.043 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -140.41 145.17 36.69 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -71.65 139.44 49.25 Favored 'General case' 0 CA--C 1.513 -0.454 0 O-C-N 121.648 -0.658 . . . . 0.0 111.683 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -141.84 138.17 31.97 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.367 -2.456 . . . . 0.0 104.367 177.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -110.36 -120.33 0.28 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.455 1.102 . . . . 0.0 108.555 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -111.03 53.85 0.69 Allowed 'General case' 0 C--O 1.238 0.465 0 C-N-CA 128.252 2.621 . . . . 0.0 108.011 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 105.02 9.29 34.71 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.694 -1.059 . . . . 0.0 113.568 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -118.47 125.17 49.35 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -116.96 133.79 55.57 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.716 2.006 . . . . 0.0 106.933 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -138.91 110.4 7.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.787 0.803 . . . . 0.0 111.641 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -2.73 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.09 1.356 . . . . 0.0 112.493 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -93.42 -0.59 56.44 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.06 1.344 . . . . 0.0 111.73 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -127.17 106.18 9.07 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.975 1.71 . . . . 0.0 107.247 -179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 96.9 t -122.76 122.9 67.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.995 2.118 . . . . 0.0 109.81 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -107.69 54.95 0.54 Allowed Glycine 0 CA--C 1.529 0.936 0 C-N-CA 124.84 1.21 . . . . 0.0 114.555 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 91.9 t -93.9 -50.42 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 123.415 0.686 . . . . 0.0 109.287 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -81.83 63.39 6.06 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 125.504 1.522 . . . . 0.0 107.457 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -124.14 152.25 43.02 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 124.138 0.975 . . . . 0.0 109.77 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.24 -40.73 67.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.544 1.138 . . . . 0.0 112.638 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.18 -31.36 77.3 Favored Glycine 0 CA--C 1.528 0.897 0 O-C-N 121.129 -0.982 . . . . 0.0 112.566 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -71.05 -48.13 54.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 117.791 0.796 . . . . 0.0 109.213 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -63.42 -35.41 80.33 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.747 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -55.01 -55.44 30.84 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.823 0.849 . . . . 0.0 112.023 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -69.52 -29.9 71.32 Favored Glycine 0 CA--C 1.532 1.135 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.401 HD23 HG13 ' A' ' 357' ' ' VAL . 41.4 tp -67.87 -46.53 71.44 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.136 -1.214 . . . . 0.0 109.803 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.28 -34.21 63.9 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.845 -1.074 . . . . 0.0 110.97 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -60.15 -58.76 7.12 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.065 1.302 . . . . 0.0 109.651 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.9 -48.69 77.62 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.336 1.055 . . . . 0.0 110.102 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.19 -28.04 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 C-N-CA 123.634 0.774 . . . . 0.0 110.664 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -64.42 -37.17 86.59 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 119.509 1.05 . . . . 0.0 111.855 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 8.4 mt -71.95 -40.52 68.63 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 53.0 mt -66.39 -41.46 88.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 124.151 0.98 . . . . 0.0 108.365 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -54.59 -41.12 69.53 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.496 1.119 . . . . 0.0 108.956 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -86.45 -1.84 57.93 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.396 1.879 . . . . 0.0 113.133 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.2 mptt 57.7 6.55 0.45 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 128.049 2.539 . . . . 0.0 114.842 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -76.72 -10.7 59.57 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.121 0.873 . . . . 0.0 111.802 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.9 tpt -95.24 150.99 19.63 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 124.377 1.071 . . . . 0.0 109.735 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.31 67.06 8.61 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.39 -19.67 3.72 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.665 1.986 . . . . 0.0 115.676 -178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -86.27 0.71 53.21 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.952 2.101 . . . . 0.0 111.811 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 42.7 m -70.12 131.24 43.98 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.684 1.129 . . . . 0.0 109.768 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -127.6 -178.63 4.55 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 125.906 1.682 . . . . 0.0 106.612 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . 0.477 ' HB2' HD22 ' A' ' 150' ' ' ASN . 40.3 t80 -56.03 -46.82 78.72 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.324 0.65 . . . . 0.0 112.52 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 68.4 m -56.28 -49.49 74.07 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 124.484 1.114 . . . . 0.0 110.519 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 53.4 mt -64.09 -43.87 97.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 123.605 0.762 . . . . 0.0 109.429 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.86 -53.71 52.11 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.982 0.913 . . . . 0.0 112.592 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -65.36 -33.66 76.49 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.783 -0.573 . . . . 0.0 110.144 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.9 -51.39 64.73 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.83 -33.98 73.86 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.59 0.632 . . . . 0.0 111.129 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -65.6 -45.58 82.65 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 177.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -60.63 -35.17 75.5 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 21.1 mmtt -69.45 -16.45 63.48 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.979 -1.01 . . . . 0.0 111.759 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.0 13.86 65.66 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 119.591 1.087 . . . . 0.0 111.645 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -84.23 -43.27 15.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.099 0.95 . . . . 0.0 112.47 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 58.4 p -75.48 107.72 7.8 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.234 0.47 . . . . 0.0 111.66 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.91 -26.37 66.83 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -146.51 158.12 43.85 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.878 1.671 . . . . 0.0 110.127 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 5.9 t -149.5 154.0 38.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt -122.86 116.19 48.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -158.77 158.7 34.11 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 126.471 1.908 . . . . 0.0 108.949 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -66.03 -68.84 1.52 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.834 1.683 . . . . 0.0 114.723 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.7 109.17 2.39 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.338 2.692 . . . . 0.0 110.859 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -78.8 30.49 0.2 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.686 1.195 . . . . 0.0 111.083 178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -51.73 138.31 23.69 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.433 1.093 . . . . 0.0 111.318 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 48.4 t90 -65.33 -14.8 61.63 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.029 1.332 . . . . 0.0 114.068 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 2.0 p -162.77 156.44 20.32 Favored 'General case' 0 C--O 1.241 0.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.42 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -148.28 -99.83 0.08 Allowed 'General case' 0 C--O 1.232 0.142 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 45.9 pt -68.98 -31.87 52.21 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 C-N-CA 124.284 1.034 . . . . 0.0 112.144 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -143.32 165.29 27.9 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 5.1 m -82.14 68.87 8.71 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 125.365 1.466 . . . . 0.0 109.052 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 70.0 m -78.4 86.6 4.45 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -61.86 70.47 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 127.471 2.309 . . . . 0.0 113.768 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 9.7 p -75.29 169.85 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 126.167 1.787 . . . . 0.0 109.328 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -103.03 166.03 10.68 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -114.17 156.3 24.5 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 123.775 0.83 . . . . 0.0 110.373 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 156.53 -166.86 33.42 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 125.6 1.572 . . . . 0.0 111.625 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 59.8 t -137.6 127.88 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.3 t -141.55 164.27 30.67 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 57.6 t -61.11 135.1 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -100.5 158.74 31.36 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.77 132.25 24.54 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 CA-C-N 120.506 1.216 . . . . 0.0 109.383 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 25.4 p -116.57 172.83 6.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.086 1.354 . . . . 0.0 109.347 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -84.65 169.36 14.4 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.576 0.703 . . . . 0.0 110.249 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -62.13 117.99 6.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 66.59 11.91 57.93 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 116.602 1.401 . . . . 0.0 116.602 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.63 145.18 18.08 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-N 121.351 2.575 . . . . 0.0 111.71 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.04 171.7 17.01 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 124.305 3.337 . . . . 0.0 111.289 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 41.6 p -93.12 137.01 32.86 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 1.9 ptmt -129.27 74.84 80.76 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 126.468 1.907 . . . . 0.0 109.217 -177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.08 -83.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.147 0 C-N-CA 122.706 2.271 . . . . 0.0 109.893 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.2 -179.08 6.49 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.806 2.042 . . . . 0.0 107.866 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 11.5 t -126.58 159.91 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -161.31 148.31 15.92 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 106.008 -2.837 . . . . 0.0 106.008 179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 32.7 m -139.06 148.61 23.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 118.891 1.345 . . . . 0.0 112.083 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.0 tp -84.59 133.94 34.41 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 8.8 m -113.06 157.33 21.7 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.279 1.032 . . . . 0.0 111.595 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -135.5 138.5 43.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 124.476 1.11 . . . . 0.0 108.87 178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.33 163.57 25.13 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 71.2 mt -109.57 142.66 21.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -74.18 116.08 14.41 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 178.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -57.51 -24.98 59.04 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 118.833 -0.604 . . . . 0.0 112.028 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -70.94 -9.46 57.9 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 118.195 -0.907 . . . . 0.0 113.302 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 6.9 t -62.56 144.24 95.89 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.4 -34.89 52.66 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.239 1.292 . . . . 0.0 109.887 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -141.73 109.53 5.74 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -14.53 63.02 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.691 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.6 -33.42 75.56 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.067 0.547 . . . . 0.0 111.05 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 94.8 mt -58.38 -37.83 76.06 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.282 -0.886 . . . . 0.0 109.573 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.538 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -74.59 -45.94 41.92 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 118.832 -0.604 . . . . 0.0 111.777 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -34.41 78.06 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 118.862 -0.59 . . . . 0.0 110.114 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -73.29 -41.16 63.92 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 118.545 0.611 . . . . 0.0 109.593 -178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -58.35 -47.0 85.2 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 120.996 -1.065 . . . . 0.0 109.109 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 8.1 mp -65.77 -45.57 81.99 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.528 -0.749 . . . . 0.0 111.571 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -77.01 -12.93 60.0 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -106.44 -17.62 14.22 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 120.727 1.603 . . . . 0.0 113.306 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -136.99 -51.11 0.66 Allowed 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 119.51 1.05 . . . . 0.0 111.484 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.31 -5.69 20.05 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 58.1 mt -115.97 31.03 6.97 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 120.013 -1.68 . . . . 0.0 111.523 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 70.7 p -116.31 163.66 15.68 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.49 -40.79 95.84 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 125.206 1.403 . . . . 0.0 107.443 178.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.0 -48.68 73.08 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.976 1.71 . . . . 0.0 110.903 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -62.75 -50.47 63.8 Favored Glycine 0 CA--C 1.518 0.264 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 58.1 mt -60.21 -44.64 94.99 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.125 0.57 . . . . 0.0 109.841 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -62.59 -42.87 99.83 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.848 0.459 . . . . 0.0 109.976 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -55.31 -43.52 74.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.232 0.469 . . . . 0.0 110.407 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 17.7 t -73.6 -36.55 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.288 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -63.46 -31.09 72.15 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.815 1.646 . . . . 0.0 112.417 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -62.2 -45.85 91.54 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.467 -0.771 . . . . 0.0 112.156 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -65.1 -50.85 64.47 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.428 ' HE2' ' HD2' ' A' ' 298' ' ' PRO . 10.4 mmmm -138.24 146.64 52.46 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.428 ' HD2' ' HE2' ' A' ' 297' ' ' LYS . 36.7 Cg_endo -61.64 124.18 14.13 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.307 2.671 . . . . 0.0 109.985 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 29.1 mt -102.82 -13.64 16.91 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 67.89 -146.93 47.36 Favored Glycine 0 C--O 1.241 0.544 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -68.71 178.34 2.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 122.759 1.266 . . . . 0.0 110.08 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.3 m -131.69 152.17 36.6 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 O-C-N 120.934 -1.104 . . . . 0.0 109.087 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.12 -29.46 60.57 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 46.6 tp -68.73 108.56 3.45 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.831 1.252 . . . . 0.0 108.883 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -55.47 -21.89 18.32 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 1.7 m -68.15 -49.59 60.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.538 1.063 . . . . 0.0 113.409 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -89.11 -9.31 51.57 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.886 0.874 . . . . 0.0 110.792 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.64 -47.22 80.22 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -60.6 -31.95 71.09 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.112 1.365 . . . . 0.0 113.914 -178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -81.0 -44.22 18.42 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.922 0.889 . . . . 0.0 109.612 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 20.9 mt -66.36 -33.6 76.09 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.59 -9.07 7.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.655 1.582 . . . . 0.0 112.794 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -63.92 -28.23 69.69 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.212 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -98.41 136.51 20.84 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -60.71 -21.82 71.0 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 123.695 2.93 . . . . 0.0 117.125 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -71.43 -30.02 65.56 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.507 1.048 . . . . 0.0 110.438 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.9 mp -79.07 -56.42 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -44.02 -60.76 1.71 Allowed 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.113 1.365 . . . . 0.0 113.751 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.75 -44.38 90.53 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.947 0.794 . . . . 0.0 112.898 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 16.9 m -59.41 -35.55 74.2 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -44.38 52.67 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 121.611 -0.681 . . . . 0.0 109.274 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.94 -30.03 67.57 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.513 -0.742 . . . . 0.0 109.789 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -75.83 -31.33 59.32 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.46 -0.775 . . . . 0.0 109.529 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -74.63 -35.33 62.89 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 119.167 0.894 . . . . 0.0 109.643 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -65.06 -18.63 65.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.293 1.437 . . . . 0.0 112.146 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.49 0.61 9.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.572 1.549 . . . . 0.0 112.073 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -109.39 -167.0 20.3 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 127.165 2.317 . . . . 0.0 107.991 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -157.12 161.67 39.4 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 58.7 mt -107.12 123.46 62.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 127.777 2.431 . . . . 0.0 108.086 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 46.6 ttm 17.13 90.53 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 129.655 3.182 . . . . 0.0 114.323 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.79 -71.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.59 2.86 . . . . 0.0 113.307 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 92.68 14.87 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 130.472 3.509 . . . . 0.0 110.819 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.8 pt -57.42 143.83 73.16 Favored Pre-proline 0 CA--C 1.538 0.505 0 O-C-N 121.487 -0.758 . . . . 0.0 109.081 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.37 -21.13 47.74 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 121.487 1.458 . . . . 0.0 112.996 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -63.71 -22.23 66.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.299 1.04 . . . . 0.0 110.256 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 8.0 mtt -61.4 -29.38 69.89 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-N 119.225 0.92 . . . . 0.0 110.589 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 37.1 t -56.07 -43.0 77.53 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 118.53 0.605 . . . . 0.0 109.653 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.56 -41.27 47.05 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.17 0.588 . . . . 0.0 109.79 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -48.47 -46.65 38.32 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.472 1.109 . . . . 0.0 111.871 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 48.8 m95 -66.42 -54.0 29.21 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.004 -0.435 . . . . 0.0 110.918 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -60.33 -29.94 69.2 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.94 0.791 . . . . 0.0 112.406 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.98 -60.48 2.47 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 124.272 1.029 . . . . 0.0 111.073 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 22.5 t -69.2 -34.93 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 CA-C-O 117.44 -1.266 . . . . 0.0 112.439 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -56.37 -28.98 60.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 120.485 1.493 . . . . 0.0 110.321 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 61.1 m -81.32 -51.69 8.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.389 1.076 . . . . 0.0 108.2 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -49.77 -45.91 50.16 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.533 1.06 . . . . 0.0 113.513 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 38.7 t -57.3 -52.66 53.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 124.061 0.944 . . . . 0.0 109.685 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 42.9 mm -64.49 -38.58 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 123.212 0.605 . . . . 0.0 109.842 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -59.7 -48.67 80.75 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 118.825 0.738 . . . . 0.0 109.842 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -67.49 -45.66 75.22 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.149 0.579 . . . . 0.0 110.775 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.47 -35.95 80.94 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 10.9 m -89.34 -8.98 52.13 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.914 0.885 . . . . 0.0 110.812 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 73.34 15.28 78.95 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.154 -0.804 . . . . 0.0 112.547 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -64.52 -31.62 72.91 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 118.906 1.353 . . . . 0.0 109.233 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -148.31 156.12 42.14 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 14.2 t -73.2 162.61 29.21 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.401 HG13 HD23 ' A' ' 192' ' ' LEU . 54.1 t -52.45 -51.04 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 126.153 1.781 . . . . 0.0 109.536 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.14 -46.83 75.67 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 126.177 1.791 . . . . 0.0 112.711 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -75.61 -39.65 57.59 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 123.873 0.869 . . . . 0.0 111.744 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -57.42 -44.04 84.3 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 2.6 mp -66.79 -43.51 83.76 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.854 0.862 . . . . 0.0 110.287 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -55.98 -59.28 5.12 Favored 'General case' 0 CA--C 1.52 -0.191 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.58 -44.3 26.23 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.883 1.673 . . . . 0.0 110.914 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -69.45 -44.81 70.51 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 118.149 -0.929 . . . . 0.0 111.757 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -58.28 -37.07 74.27 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.028 1.285 . . . . 0.0 109.208 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 2.3 m -57.17 -40.63 77.69 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 123.429 0.692 . . . . 0.0 111.285 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -65.46 -18.37 65.27 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 120.53 -1.356 . . . . 0.0 114.136 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.2 mp -95.23 -41.77 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 20.6 p -71.91 -16.08 62.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.396 0.544 . . . . 0.0 111.831 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 39.4 tptt . . . . . 0 C--O 1.25 1.131 0 C-N-CA 127.032 2.133 . . . . 0.0 105.867 178.851 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.8 tptm . . . . . 0 N--CA 1.471 0.607 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 mt -58.41 135.96 22.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 O-C-N 125.596 1.81 . . . . 0.0 108.521 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -71.9 105.48 3.85 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 104.843 -2.281 . . . . 0.0 104.843 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -99.52 136.32 39.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.76 1.624 . . . . 0.0 109.216 -178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.1 25.1 17.79 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 123.874 0.75 . . . . 0.0 112.819 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -147.34 165.81 29.05 Favored 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 124.468 1.107 . . . . 0.0 109.482 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.6 mt -138.55 151.39 47.28 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.8 t -143.12 144.37 23.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 37' ' ' VAL . 10.2 mt -134.56 144.64 34.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 123.835 0.854 . . . . 0.0 109.231 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -134.84 132.85 39.1 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.309 1.444 . . . . 0.0 107.903 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -105.77 169.6 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -83.3 -39.56 20.65 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 170.0 -79.98 0.09 OUTLIER Glycine 0 C--N 1.339 0.71 0 CA-C-N 119.14 0.882 . . . . 0.0 112.271 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.99 -3.12 9.02 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.0 mttp -61.21 157.35 16.38 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 120.789 -1.194 . . . . 0.0 109.416 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.48 69.11 0.76 Allowed Glycine 0 CA--C 1.518 0.258 0 O-C-N 121.78 -0.575 . . . . 0.0 112.038 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -54.2 -19.97 6.07 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.904 1.681 . . . . 0.0 113.623 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -62.97 -58.17 8.25 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.456 1.48 . . . . 0.0 108.238 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -57.63 -36.76 79.94 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 123.382 0.515 . . . . 0.0 111.915 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.9 -32.06 73.35 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.923 -0.751 . . . . 0.0 110.578 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.01 -43.36 81.72 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.576 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -58.16 -41.93 84.89 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 123.647 0.779 . . . . 0.0 110.672 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.65 -50.86 78.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.53 -45.38 95.97 Favored Glycine 0 CA--C 1.527 0.841 0 O-C-N 121.421 -0.799 . . . . 0.0 113.247 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -34.0 75.05 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.213 1.007 . . . . 0.0 110.831 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -66.13 -54.8 21.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -56.0 -42.43 76.4 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.332 0.969 . . . . 0.0 110.854 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.86 -27.41 69.15 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 121.214 -0.929 . . . . 0.0 110.085 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -84.66 -18.93 33.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.769 -1.207 . . . . 0.0 112.703 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -102.79 -16.25 16.01 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 124.219 0.949 . . . . 0.0 111.162 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 61.5 p -124.86 -31.95 3.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.23 61.36 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.232 -0.917 . . . . 0.0 112.903 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 49.1 mm -63.4 129.83 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -66.04 148.55 51.63 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 123.835 0.854 . . . . 0.0 109.253 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.8 t -139.53 156.18 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.2 m -144.22 141.65 30.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 176.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.404 HG22 HD12 ' A' ' 9' ' ' ILE . 17.3 t -130.56 122.94 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -137.81 163.63 30.92 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.764 0.826 . . . . 0.0 110.469 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -121.66 57.9 8.05 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 124.782 1.233 . . . . 0.0 112.679 -178.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -75.11 165.1 31.86 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.299 1.333 . . . . 0.0 111.658 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -113.86 -30.0 6.88 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.28 -16.75 62.48 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.696 1.599 . . . . 0.0 114.063 -179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -46.27 -34.2 4.28 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.733 1.213 . . . . 0.0 114.213 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -57.61 -24.03 54.22 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.117 0.967 . . . . 0.0 113.451 -178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -128.2 -8.21 5.34 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.716 0.806 . . . . 0.0 112.1 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -84.47 -47.35 10.71 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 125.242 1.417 . . . . 0.0 107.369 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -46.18 -52.32 28.4 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 119.233 0.924 . . . . 0.0 112.656 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.81 -17.6 59.97 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.626 1.551 . . . . 0.0 114.386 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.0 mm100 -85.45 -4.24 59.1 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.3 1.04 . . . . 0.0 111.896 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.7 -39.57 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 123.752 0.821 . . . . 0.0 110.214 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.03 -32.49 73.0 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.85 -0.531 . . . . 0.0 110.345 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.12 10.15 1.03 Allowed 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.041 -1.037 . . . . 0.0 112.0 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.7 m -131.88 -0.99 3.78 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.779 1.172 . . . . 0.0 113.64 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.52 56.18 2.86 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -166.23 -176.93 3.88 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 128.824 2.85 . . . . 0.0 105.796 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.27 179.12 31.4 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.168 1.366 . . . . 0.0 114.196 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.07 167.18 16.66 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.456 2.104 . . . . 0.0 110.068 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -95.14 -21.72 18.32 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.0 mt -138.28 143.94 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.9 tt -130.51 135.91 59.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 126.317 1.847 . . . . 0.0 106.197 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.17 109.5 11.56 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.841 1.256 . . . . 0.0 110.117 -177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -154.94 169.38 24.18 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.46 152.6 37.92 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.809 0.814 . . . . 0.0 110.013 178.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -55.15 -30.02 58.96 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.801 1.24 . . . . 0.0 111.537 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -60.34 -12.54 9.47 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.196 1.798 . . . . 0.0 115.733 -179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -123.3 2.36 9.13 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.787 1.176 . . . . 0.0 109.909 177.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -85.24 -5.96 59.29 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 119.006 -0.521 . . . . 0.0 110.304 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.3 -17.22 79.65 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.889 1.222 . . . . 0.0 111.185 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -92.65 -66.69 1.1 Allowed Glycine 0 C--N 1.338 0.685 0 CA-C-O 118.513 -1.159 . . . . 0.0 113.266 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -44.19 -46.92 9.1 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.201 1.0 . . . . 0.0 113.22 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.58 -55.15 36.87 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.786 0.835 . . . . 0.0 110.081 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.36 -49.57 61.19 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.57 1.148 . . . . 0.0 109.314 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.4 m -58.63 -7.17 0.88 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.48 1.912 . . . . 0.0 112.953 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.77 17.59 72.43 Favored Glycine 0 C--N 1.337 0.592 0 C-N-CA 125.712 1.625 . . . . 0.0 112.805 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.2 mt -85.86 -15.92 40.29 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.245 1.023 . . . . 0.0 113.507 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.9 mt -105.48 136.01 45.82 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.88 1.218 . . . . 0.0 111.65 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.51 164.37 25.96 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.62 1.168 . . . . 0.0 111.959 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -74.09 105.9 5.52 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.431 HG13 ' CA ' ' A' ' 105' ' ' ALA . 7.3 mm -67.42 152.46 9.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.39 1.076 . . . . 0.0 112.087 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.2 m 78.09 88.84 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 129.68 3.192 . . . . 0.0 110.058 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -72.44 -28.88 14.26 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.206 1.937 . . . . 0.0 110.755 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -141.58 147.0 36.96 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.221 1.408 . . . . 0.0 109.411 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -54.95 -34.25 63.1 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.805 1.642 . . . . 0.0 112.96 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.46 -35.04 60.08 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 124.119 0.968 . . . . 0.0 113.037 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -63.51 -28.05 69.69 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.434 0.561 . . . . 0.0 111.418 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -67.27 -33.08 74.56 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 120.972 -1.08 . . . . 0.0 111.534 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.0 -18.49 55.85 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.207 0.603 . . . . 0.0 111.481 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -74.72 -17.9 60.59 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.7 mt -123.03 155.76 36.21 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.398 0.679 . . . . 0.0 111.671 -177.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -68.94 151.28 97.33 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 122.853 0.461 . . . . 0.0 111.175 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.5 -46.03 2.17 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.433 2.089 . . . . 0.0 112.509 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -54.77 -45.79 74.28 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.184 0.902 . . . . 0.0 111.68 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.59 -20.64 57.19 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.019 1.328 . . . . 0.0 112.607 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 48.9 m95 -72.62 -28.7 62.92 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 119.904 1.229 . . . . 0.0 109.903 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -58.92 -34.79 72.12 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.872 1.215 . . . . 0.0 110.902 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.74 -17.34 55.47 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.045 1.338 . . . . 0.0 114.475 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.8 m -127.49 4.38 3.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 125.014 1.326 . . . . 0.0 111.6 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -66.26 157.47 31.45 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.333 1.064 . . . . 0.0 108.871 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -150.43 -177.33 5.9 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -68.86 108.2 3.37 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.609 1.164 . . . . 0.0 111.969 -178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.57 -53.65 0.48 Allowed Glycine 0 N--CA 1.47 0.901 0 C-N-CA 128.273 2.844 . . . . 0.0 117.337 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.0 163.38 12.31 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.198 1.399 . . . . 0.0 107.986 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -97.15 159.55 14.85 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.2 pt -121.32 -25.25 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.755 -1.111 . . . . 0.0 113.287 -177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.431 ' CA ' HG13 ' A' ' 79' ' ' ILE . . . -159.43 176.96 11.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.275 1.03 . . . . 0.0 108.318 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.53 145.8 58.78 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 124.558 1.143 . . . . 0.0 108.917 178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.76 150.98 51.05 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.467 2.111 . . . . 0.0 109.354 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.2 mm -127.82 -53.71 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 126.131 1.772 . . . . 0.0 110.56 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -124.78 147.24 48.8 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.587 0.755 . . . . 0.0 112.462 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.4 t -122.47 104.17 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.465 1.506 . . . . 0.0 107.464 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -119.67 172.43 7.68 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -135.51 -177.23 4.57 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -55.69 154.35 6.94 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.594 1.558 . . . . 0.0 112.104 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.4 m -138.15 174.44 10.56 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.634 0.774 . . . . 0.0 109.868 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.693 HD13 ' H ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -127.82 168.55 15.0 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.693 ' H ' HD13 ' A' ' 115' ' ' LEU . 4.2 mp -134.24 122.05 39.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -131.29 170.99 13.85 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.713 1.205 . . . . 0.0 109.893 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -61.43 132.31 53.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.69 1.196 . . . . 0.0 109.52 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -59.17 -2.97 0.32 Allowed 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 116.231 1.938 . . . . 0.0 116.231 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -63.18 156.39 25.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 119.732 1.151 . . . . 0.0 109.875 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -73.02 -2.23 20.35 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.4 tp -145.96 70.54 13.46 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 118.874 0.761 . . . . 0.0 109.735 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -82.84 -3.82 11.24 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 124.323 3.349 . . . . 0.0 116.728 -178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 56.4 t30 32.48 80.46 0.25 Allowed Pre-proline 0 N--CA 1.475 0.788 0 C-N-CA 127.181 2.193 . . . . 0.0 114.465 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -64.31 156.59 59.02 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.065 1.843 . . . . 0.0 112.614 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.17 172.53 15.82 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.751 2.967 . . . . 0.0 109.905 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -118.8 -12.78 9.59 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.258 1.023 . . . . 0.0 112.426 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 3.3 t -167.11 162.72 15.49 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.777 1.231 . . . . 0.0 108.413 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -65.62 -24.86 67.15 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.537 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.5 -15.47 63.69 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 120.211 1.369 . . . . 0.0 112.926 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -85.51 -21.41 28.63 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 123.409 0.683 . . . . 0.0 110.08 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 41.5 mm -59.73 -58.38 19.85 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-O 117.235 -1.364 . . . . 0.0 109.237 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.2 -26.98 49.05 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 CA-C-N 121.45 1.554 . . . . 0.0 111.751 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.03 -47.92 67.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.728 0.811 . . . . 0.0 110.032 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 64.2 tp -75.81 -26.42 57.23 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.093 1.357 . . . . 0.0 110.999 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.89 -42.32 99.73 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 123.496 0.718 . . . . 0.0 110.126 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.413 ' HB2' ' HE2' ' A' ' 137' ' ' LYS . 7.2 ptmm? -72.4 -32.53 66.45 Favored 'General case' 0 C--N 1.331 -0.204 0 O-C-N 121.248 -0.908 . . . . 0.0 111.126 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -69.28 -44.79 71.11 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.666 0.387 . . . . 0.0 110.675 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.7 -30.54 36.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 118.434 -0.793 . . . . 0.0 110.147 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.21 -33.17 71.36 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 120.182 1.356 . . . . 0.0 109.095 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.99 -7.69 42.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.85 0.07 2.88 Favored 'General case' 0 CA--C 1.522 -0.118 0 C-N-CA 123.66 0.784 . . . . 0.0 111.895 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -162.84 -107.0 0.21 Allowed Glycine 0 CA--C 1.521 0.409 0 CA-C-O 118.44 -1.2 . . . . 0.0 112.399 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.9 mptt -141.69 -173.33 3.75 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.323 1.449 . . . . 0.0 109.581 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 66.9 p -62.55 152.5 34.66 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.155 0.889 . . . . 0.0 113.024 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.44 -49.57 13.23 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.345 1.458 . . . . 0.0 114.228 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.9 tp -134.66 143.37 47.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.125 0.97 . . . . 0.0 110.887 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -137.06 138.21 40.17 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.255 1.422 . . . . 0.0 107.606 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -151.29 166.49 30.79 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 119.925 1.239 . . . . 0.0 111.941 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -70.17 91.13 0.69 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.405 1.882 . . . . 0.0 106.629 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 9.2 tt -87.47 -35.6 18.14 Favored 'General case' 0 CA--C 1.524 -0.052 0 C-N-CA 125.715 1.606 . . . . 0.0 112.566 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -64.2 -12.45 40.66 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -103.78 122.48 44.47 Favored Pre-proline 0 N--CA 1.451 -0.38 0 CA-C-N 118.689 0.677 . . . . 0.0 109.992 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -61.86 -16.48 49.58 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 120.723 0.949 . . . . 0.0 110.639 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -47.66 -44.44 27.21 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 127.54 2.336 . . . . 0.0 111.671 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -98.84 -33.41 10.9 Favored 'General case' 0 C--N 1.342 0.246 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 p -69.82 -27.35 64.8 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.352 1.433 . . . . 0.0 110.338 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -53.6 -60.61 6.69 Favored Pre-proline 0 C--N 1.343 0.308 0 C-N-CA 124.875 1.27 . . . . 0.0 113.392 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -57.28 -15.92 20.51 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 121.913 1.742 . . . . 0.0 114.537 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 8.6 tt -75.44 -66.57 0.75 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.2 pt -56.69 -34.62 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.217 1.007 . . . . 0.0 112.845 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.03 -26.23 64.88 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 121.028 -1.045 . . . . 0.0 112.86 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.01 -45.43 86.88 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 118.559 -0.734 . . . . 0.0 112.498 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.07 -42.65 73.05 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.412 0.685 . . . . 0.0 111.439 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 164.83 -13.96 0.09 OUTLIER Glycine 0 CA--C 1.526 0.753 0 CA-C-O 117.959 -1.467 . . . . 0.0 113.025 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -49.4 133.12 25.57 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -138.02 144.97 41.3 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 119.719 1.76 . . . . 0.0 111.509 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.79 -59.49 2.7 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -141.65 171.42 14.08 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 126.901 2.08 . . . . 0.0 106.658 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -119.85 139.83 51.76 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 119.528 1.058 . . . . 0.0 112.643 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.17 105.73 12.56 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.698 1.199 . . . . 0.0 108.448 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -173.13 1.13 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.306 2.242 . . . . 0.0 109.098 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 17.0 m-80 -51.31 -20.71 1.79 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 127.13 2.172 . . . . 0.0 115.012 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.94 3.09 0.04 OUTLIER Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.112 0.863 . . . . 0.0 113.693 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -127.44 151.55 48.68 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 119.531 1.666 . . . . 0.0 107.314 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -122.13 126.04 47.48 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 125.534 1.534 . . . . 0.0 108.203 -178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.79 150.81 52.12 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 122.512 1.149 . . . . 0.0 113.566 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.09 1.58 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-N 112.843 -1.98 . . . . 0.0 110.133 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -75.97 -35.7 59.55 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 177.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.2 97.16 10.85 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 105.247 -2.131 . . . . 0.0 105.247 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 35.4 t -131.82 121.09 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 C-N-CA 126.44 1.896 . . . . 0.0 106.827 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -122.83 38.69 2.45 Favored Glycine 0 C--N 1.338 0.661 0 C-N-CA 123.924 0.773 . . . . 0.0 114.862 -178.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.72 -25.03 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.117 0.967 . . . . 0.0 111.17 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.84 17.22 19.98 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -66.19 164.2 16.2 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 121.596 -0.69 . . . . 0.0 110.995 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.89 -38.9 65.27 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -63.9 -36.8 93.76 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 118.898 0.772 . . . . 0.0 111.651 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -65.58 -50.55 64.72 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 117.791 0.796 . . . . 0.0 109.24 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -63.82 -32.2 73.63 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 117.869 -1.063 . . . . 0.0 111.616 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -59.54 -51.25 70.66 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.244 0.929 . . . . 0.0 110.217 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -71.14 -28.95 69.36 Favored Glycine 0 CA--C 1.533 1.181 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 29.9 tp -69.74 -55.96 8.49 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.605 1.203 . . . . 0.0 110.785 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.43 -26.47 53.69 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.6 0.76 . . . . 0.0 112.152 -179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -56.66 -42.1 78.38 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.126 -0.984 . . . . 0.0 108.953 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 19.6 tp -69.25 -48.95 60.4 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.835 1.254 . . . . 0.0 108.456 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 47.4 t -54.48 -34.05 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 125.517 1.527 . . . . 0.0 109.78 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.18 -42.56 88.75 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.553 1.541 . . . . 0.0 110.778 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 18.2 mt -67.62 -40.25 84.67 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 121.245 -0.909 . . . . 0.0 108.564 179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 89.4 mt -66.85 -36.93 78.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -60.33 -36.89 79.0 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.992 -1.693 . . . . 0.0 108.473 178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -82.3 -2.11 51.66 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.288 1.435 . . . . 0.0 111.272 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? 56.46 9.56 0.56 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.707 2.403 . . . . 0.0 114.394 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -82.46 -14.68 54.66 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ttp -112.17 147.97 35.03 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.46 1.104 . . . . 0.0 110.074 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -85.58 103.57 14.53 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.897 1.279 . . . . 0.0 107.919 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -77.51 -21.62 52.45 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -91.67 0.12 57.52 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.5 m -60.88 131.48 50.82 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.526 1.13 . . . . 0.0 110.315 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.54 -173.51 2.75 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.785 1.234 . . . . 0.0 108.048 178.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -56.53 -45.81 80.95 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.074 0.949 . . . . 0.0 109.725 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.86 -49.68 75.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.948 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 46.3 mm -59.0 -48.75 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 119.621 1.101 . . . . 0.0 110.356 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.09 87.08 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -74.59 -57.42 3.94 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -50.81 -55.89 14.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.754 1.621 . . . . 0.0 112.241 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.42 76.49 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.139 0.881 . . . . 0.0 110.734 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.5 -38.8 90.79 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -63.1 -35.69 81.11 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.89 0.876 . . . . 0.0 109.708 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -72.78 -22.79 60.78 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 100.01 18.61 21.82 Favored Glycine 0 C--N 1.339 0.735 0 C-N-CA 126.143 1.83 . . . . 0.0 112.68 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.88 -71.74 0.31 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.233 1.016 . . . . 0.0 113.648 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . 0.28 4.2 t -68.55 152.81 44.86 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.27 0.557 . . . . 0.0 112.365 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -83.74 -23.83 31.42 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 123.612 0.765 . . . . 0.0 112.454 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -152.85 155.66 37.51 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.506 1.123 . . . . 0.0 108.234 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 7.5 t -147.78 159.05 44.24 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 3.5 mt -129.85 122.61 54.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 119.408 1.004 . . . . 0.0 110.236 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -130.36 133.92 46.78 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.936 1.694 . . . . 0.0 109.761 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -92.85 -75.3 1.3 Allowed Glycine 0 CA--C 1.534 1.262 0 N-CA-C 107.816 -2.114 . . . . 0.0 107.816 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -77.52 86.92 1.56 Allowed 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.762 2.975 . . . . 0.0 110.635 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 30.4 m0 -53.54 94.91 0.01 OUTLIER 'General case' 0 C--O 1.238 0.487 0 C-N-CA 127.249 2.22 . . . . 0.0 111.38 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.49 172.26 13.27 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.43 1.492 . . . . 0.0 112.505 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -68.26 -176.42 0.74 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 126.487 1.915 . . . . 0.0 109.113 178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 38.5 t -144.39 173.6 11.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 -94.88 8.6 42.2 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.323 1.049 . . . . 0.0 110.348 178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.4 tp -152.95 123.73 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 127.787 2.435 . . . . 0.0 105.517 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.48 85.98 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.609 1.163 . . . . 0.0 108.783 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 10.8 m -96.33 95.53 8.14 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 14.6 m -91.43 -3.88 56.19 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.145 0.578 . . . . 0.0 111.615 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -84.4 77.35 10.02 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.241 -1.537 . . . . 0.0 112.493 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.34 166.04 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -70.4 176.84 3.71 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.704 0.802 . . . . 0.0 109.949 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -117.01 99.92 7.4 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.774 0.829 . . . . 0.0 112.338 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 86.74 164.18 39.56 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 125.09 1.329 . . . . 0.0 114.24 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 13.6 p -87.61 143.06 12.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.7 t -111.03 172.35 6.93 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.299 0.64 . . . . 0.0 109.434 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.5 t -71.63 143.1 14.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.2 pp -122.07 154.19 61.35 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.56 1.144 . . . . 0.0 109.326 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.94 141.41 30.0 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.71 2.273 . . . . 0.0 111.559 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 70.1 p -149.48 -172.23 4.09 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 127.793 2.437 . . . . 0.0 107.512 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -87.5 144.95 26.46 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 22.8 pttt -55.73 119.77 6.27 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.984 0.914 . . . . 0.0 110.389 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 76.01 -4.9 44.11 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 124.055 0.836 . . . . 0.0 114.321 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.57 87.14 32.56 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 119.927 1.863 . . . . 0.0 109.543 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -71.48 152.7 60.45 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.721 1.614 . . . . 0.0 110.661 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 19.5 m -72.2 134.81 45.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.65 0.78 . . . . 0.0 109.913 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 256' ' ' LYS . 0.2 OUTLIER -140.39 87.18 12.04 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.528 1.531 . . . . 0.0 108.01 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.15 -90.43 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.628 2.218 . . . . 0.0 109.35 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -145.88 167.97 21.96 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.517 2.327 . . . . 0.0 106.046 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 46.0 t -94.68 155.94 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 102.96 -2.978 . . . . 0.0 102.96 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -154.74 139.67 6.88 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 106.555 -2.618 . . . . 0.0 106.555 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.0 164.37 33.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.169 0.509 . . . . 0.0 109.947 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.68 173.19 10.83 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.608 0.763 . . . . 0.0 109.726 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 15.1 m -148.39 141.3 24.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.722 -1.236 . . . . 0.0 110.135 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.29 132.46 47.17 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.7 152.18 19.79 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-O 119.218 -0.768 . . . . 0.0 111.362 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.1 mt -89.83 135.63 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -71.35 120.29 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.424 1.09 . . . . 0.0 109.14 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -71.24 -20.66 62.21 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -75.88 -4.14 39.2 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.059 1.744 . . . . 0.0 114.924 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 33.1 m -71.7 167.49 30.4 Favored Pre-proline 0 C--O 1.239 0.519 0 C-N-CA 124.894 1.278 . . . . 0.0 110.672 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -80.75 -43.45 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 121.196 1.264 . . . . 0.0 110.605 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -139.23 106.84 5.59 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.032 0.933 . . . . 0.0 109.379 -179.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.422 ' HD2' ' H ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -61.93 -19.79 63.11 Favored 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 124.115 0.966 . . . . 0.0 112.045 179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -58.11 -40.57 81.57 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 68.3 mt -57.62 -36.58 71.98 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 121.722 -0.612 . . . . 0.0 111.492 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -76.81 -45.45 28.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.976 0.511 . . . . 0.0 112.024 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.07 -32.72 74.57 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 118.563 -0.732 . . . . 0.0 111.2 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -70.34 -56.45 6.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -52.52 -46.14 66.59 Favored 'General case' 0 C--O 1.237 0.407 0 O-C-N 121.238 -0.914 . . . . 0.0 111.255 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 4.1 tt -66.81 -42.54 85.75 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.517 -1.23 . . . . 0.0 113.063 -179.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -86.3 -15.74 39.7 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 120.51 1.504 . . . . 0.0 114.713 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 -109.55 -17.58 13.71 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -176.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -131.29 -51.5 1.02 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 118.993 0.815 . . . . 0.0 111.471 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.86 -55.7 20.89 Favored 'General case' 0 C--O 1.23 0.078 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.338 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.52 HD22 HD21 ' A' ' 304' ' ' LEU . 55.3 mt -88.34 77.26 8.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.74 0.816 . . . . 0.0 109.91 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 39.8 p -140.8 159.43 42.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.23 -38.04 89.15 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -81.87 -29.25 32.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.009 0.524 . . . . 0.0 112.227 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -76.04 -43.84 20.55 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.97 -39.83 90.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -58.31 -46.57 85.9 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -53.52 -46.78 70.25 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.736 0.698 . . . . 0.0 111.214 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.66 -37.79 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.19 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -72.01 -22.45 61.41 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.774 1.629 . . . . 0.0 113.584 -179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.7 mtpt -69.29 -44.97 70.72 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 123.626 0.771 . . . . 0.0 109.01 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -71.76 -48.31 47.68 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -135.08 152.92 77.98 Favored Pre-proline 0 N--CA 1.461 0.082 0 C-N-CA 123.992 0.917 . . . . 0.0 109.909 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -73.9 125.57 10.01 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.086 1.857 . . . . 0.0 110.937 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 86.7 mt -99.89 -24.23 14.71 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.535 -0.745 . . . . 0.0 112.335 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 81.26 -155.02 35.66 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -70.22 168.93 14.72 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 12.7 m -121.68 162.2 21.21 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 O-C-N 120.641 -1.287 . . . . 0.0 110.991 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -85.33 -13.59 49.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.286 0.634 . . . . 0.0 110.434 178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.52 HD21 HD22 ' A' ' 285' ' ' LEU . 4.1 mm? -76.31 112.5 12.86 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 127.239 2.216 . . . . 0.0 107.703 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -62.89 -36.51 83.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.071 0.462 . . . . 0.0 110.32 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.54 -52.15 64.68 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.434 1.894 . . . . 0.0 111.172 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -84.84 -11.8 54.9 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.815 0.846 . . . . 0.0 112.224 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -60.49 -42.77 96.99 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -63.24 -9.89 13.38 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.43 1.492 . . . . 0.0 112.164 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -109.61 -36.8 5.86 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.051 0.94 . . . . 0.0 110.495 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 14.7 mt -74.27 -24.32 59.24 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 120.453 -1.405 . . . . 0.0 108.521 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.56 -8.05 17.84 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.495 1.118 . . . . 0.0 112.382 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 28.7 mttm -56.59 -37.76 71.07 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.03 133.31 24.32 Favored Pre-proline 0 C--O 1.236 0.352 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.39 -24.69 71.17 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.578 2.185 . . . . 0.0 113.332 -177.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 5.9 tpp180 -62.57 -30.71 71.52 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.77 0.714 . . . . 0.0 109.851 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 3.9 mp -77.54 -61.53 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -44.13 -55.99 4.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.164 1.386 . . . . 0.0 114.342 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -58.18 -32.41 68.21 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.596 -0.69 . . . . 0.0 112.859 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 24.7 m -74.74 -36.54 62.63 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.687 0.795 . . . . 0.0 109.164 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 2.8 tpt -66.75 -43.15 84.92 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.219 1.007 . . . . 0.0 109.084 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -55.74 -41.01 73.31 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.595 0.758 . . . . 0.0 110.419 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -63.28 -26.85 68.97 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.728 -0.608 . . . . 0.0 112.324 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -76.68 -40.19 49.68 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -61.73 -45.37 94.24 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.249 0.619 . . . . 0.0 111.023 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -15.59 58.22 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -93.59 -165.09 37.23 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -142.31 134.15 27.08 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 63.7 mt -81.82 88.24 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.124 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 10.9 mtp 59.07 165.19 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 126.461 1.904 . . . . 0.0 113.363 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -80.5 -26.18 4.13 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.141 1.894 . . . . 0.0 115.595 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 66.96 34.52 5.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.687 1.995 . . . . 0.0 112.002 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 37.2 pt -132.33 156.48 80.04 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 123.845 0.858 . . . . 0.0 110.937 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.46 -25.99 24.74 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.002 2.468 . . . . 0.0 113.666 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -57.66 -16.91 12.11 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.227 0.921 . . . . 0.0 113.343 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.22 -22.83 65.69 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.16 -0.963 . . . . 0.0 111.411 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 3.4 t -65.62 -54.72 23.74 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.56 -34.97 78.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.499 1.12 . . . . 0.0 111.302 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -50.34 -56.81 9.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.805 0.842 . . . . 0.0 111.658 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 36.7 m95 -65.98 -40.9 91.64 Favored 'General case' 0 CA--C 1.522 -0.118 0 O-C-N 121.247 -0.908 . . . . 0.0 111.404 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -57.57 -45.77 84.77 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.155 0.503 . . . . 0.0 110.518 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.39 -51.68 64.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.647 1.179 . . . . 0.0 111.581 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.84 -27.46 30.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.707 -178.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -53.99 -50.1 67.35 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.352 1.433 . . . . 0.0 107.596 177.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 10.5 m -68.51 -44.43 74.66 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.051 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.86 -47.03 68.09 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.948 1.249 . . . . 0.0 113.768 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 24.2 t -56.08 -51.68 59.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 124.61 1.164 . . . . 0.0 109.113 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.03 -37.45 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -58.75 -46.06 88.29 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 120.177 -1.577 . . . . 0.0 110.947 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.35 -45.46 59.78 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.634 0.773 . . . . 0.0 110.48 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.14 -44.42 97.36 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.33 0.514 . . . . 0.0 111.623 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 59.8 m -75.04 -25.91 59.05 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.899 0.879 . . . . 0.0 109.313 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.86 32.77 44.01 Favored Glycine 0 N--CA 1.44 -1.05 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -85.14 -21.29 29.3 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.846 0.858 . . . . 0.0 110.62 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -147.42 151.42 36.43 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.6 m -58.65 152.21 19.12 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.991 0.916 . . . . 0.0 109.293 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 61.8 t -57.2 -44.77 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 118.988 0.813 . . . . 0.0 109.414 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -52.18 66.86 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.469 1.108 . . . . 0.0 110.009 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -63.87 -37.71 88.41 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 123.262 0.625 . . . . 0.0 111.838 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.93 92.48 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 38.2 mt -73.15 -38.85 66.1 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.597 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -57.88 -53.46 57.99 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 119.681 1.128 . . . . 0.0 109.807 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -29.93 70.76 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -70.99 -55.34 8.52 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 118.114 -0.946 . . . . 0.0 108.895 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -49.66 -38.57 33.13 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.178 1.391 . . . . 0.0 110.069 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 26.4 m -57.93 -45.64 86.27 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.008 0.523 . . . . 0.0 110.452 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -61.67 -8.63 4.81 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.147 2.179 . . . . 0.0 114.027 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 2.3 mp -104.17 -40.11 6.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.1 p -68.76 -25.43 64.73 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.402 0.547 . . . . 0.0 110.801 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? . . . . . 0 C--O 1.245 0.85 0 C-N-CA 127.135 2.174 . . . . 0.0 108.36 -179.089 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.2 mt -148.09 148.81 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 103.705 -2.702 . . . . 0.0 103.705 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -98.97 100.79 12.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -71.92 69.49 0.71 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.718 1.207 . . . . 0.0 113.786 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.57 30.95 0.02 OUTLIER Glycine 0 CA--C 1.526 0.731 0 O-C-N 121.352 -0.843 . . . . 0.0 114.017 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -143.5 172.06 13.3 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.253 1.027 . . . . 0.0 110.259 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 63.6 mt -150.81 140.13 21.34 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 127.682 2.393 . . . . 0.0 106.506 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.8 t -137.06 148.05 26.63 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.473 HD12 HG22 ' A' ' 37' ' ' VAL . 11.9 mt -130.43 142.4 43.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.606 1.562 . . . . 0.0 109.119 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -137.76 134.08 34.86 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.8 147.68 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -60.31 -35.57 75.89 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.27 168.72 11.45 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t0 48.66 30.25 2.48 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.107 1.363 . . . . 0.0 110.961 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.38 -14.58 16.21 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 117.139 2.274 . . . . 0.0 117.139 -177.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.66 30.57 4.56 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 125.909 1.719 . . . . 0.0 112.972 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -45.82 -46.21 15.39 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.66 1.184 . . . . 0.0 113.723 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -58.19 -41.37 83.79 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 119.445 1.02 . . . . 0.0 112.874 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.57 -42.18 41.25 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.8 tp -58.42 -39.21 79.16 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 124.928 1.291 . . . . 0.0 110.238 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.78 -46.7 64.25 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 118.409 -0.805 . . . . 0.0 109.729 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.36 -39.5 79.72 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.269 1.028 . . . . 0.0 111.573 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.5 t -59.95 -42.78 90.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.72 -39.57 96.77 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -62.47 -46.87 86.51 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 119.651 1.725 . . . . 0.0 109.012 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -59.65 -56.19 24.97 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -55.55 -47.07 76.96 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 118.628 0.649 . . . . 0.0 112.017 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.24 -28.85 69.99 Favored 'General case' 0 N--CA 1.463 0.177 0 O-C-N 121.103 -0.998 . . . . 0.0 110.794 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.64 -23.0 37.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.904 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -100.3 -11.05 20.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.409 -178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 72.3 p -127.34 -32.39 2.46 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.478 1.035 . . . . 0.0 113.693 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.2 -14.73 62.86 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-N 119.393 0.997 . . . . 0.0 112.818 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.6 mm -69.24 122.81 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.26 145.49 47.24 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 123.345 0.658 . . . . 0.0 110.13 -179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.8 t -133.0 136.38 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.5 m -128.96 138.54 52.03 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.473 HG22 HD12 ' A' ' 9' ' ' ILE . 24.8 t -133.94 128.55 53.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.7 1.2 . . . . 0.0 107.931 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -140.55 160.09 40.78 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.14 1.776 . . . . 0.0 107.184 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -122.26 59.03 10.89 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.094 0.958 . . . . 0.0 111.708 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.84 136.41 20.73 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.906 2.404 . . . . 0.0 109.32 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.31 -33.41 63.19 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.561 0.948 . . . . 0.0 113.561 -178.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.258 0.0 OUTLIER -99.27 24.23 8.24 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -178.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 pp -49.2 -29.3 5.41 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.266 -0.896 . . . . 0.0 112.287 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -57.69 -24.98 59.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.359 1.864 . . . . 0.0 114.518 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -110.05 -19.29 13.12 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.555 0.693 . . . . 0.0 111.023 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -81.08 -50.29 9.83 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 121.357 -0.84 . . . . 0.0 108.874 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -44.12 -55.98 8.58 Favored Pre-proline 0 CA--C 1.529 0.146 0 CA-C-O 117.334 -1.317 . . . . 0.0 111.937 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' ALA . 30.6 Cg_endo -60.98 -28.51 86.4 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 CA-C-N 120.813 1.326 . . . . 0.0 115.402 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -83.05 -32.87 26.62 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 120.401 1.455 . . . . 0.0 112.154 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.4 t -87.37 -40.52 13.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-N 118.221 0.464 . . . . 0.0 110.258 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.26 -32.28 73.87 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 120.483 -1.385 . . . . 0.0 110.034 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 48' ' ' PRO . . . -58.2 -20.03 38.2 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.107 1.363 . . . . 0.0 112.585 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.1 p -113.37 2.91 15.64 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.993 0.917 . . . . 0.0 112.897 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.49 12.54 83.64 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 119.071 0.851 . . . . 0.0 111.287 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -103.97 -10.27 18.23 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.544 1.138 . . . . 0.0 111.468 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.92 174.27 55.29 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.017 1.294 . . . . 0.0 115.333 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.71 172.0 7.59 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.41 3.406 . . . . 0.0 113.389 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -101.43 -20.19 15.25 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.0 mt -140.39 127.12 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.707 -177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 tp -107.67 144.72 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 127.202 2.201 . . . . 0.0 106.846 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -131.97 107.74 8.89 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.744 1.218 . . . . 0.0 110.637 -179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -157.24 -175.82 5.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.065 0.946 . . . . 0.0 110.076 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.4 151.0 33.02 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -52.3 -33.41 42.18 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.553 1.541 . . . . 0.0 113.409 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -60.42 -18.08 48.53 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.3 mmt180 -103.31 -7.61 20.96 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 120.163 -1.585 . . . . 0.0 110.514 178.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -91.32 -28.69 17.58 Favored 'General case' 0 C--O 1.235 0.319 0 O-C-N 121.755 -0.59 . . . . 0.0 112.388 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.04 14.08 1.26 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.905 1.241 . . . . 0.0 113.725 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.87 -59.9 0.25 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 129.394 3.378 . . . . 0.0 105.853 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -50.11 -51.75 40.52 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.024 0.93 . . . . 0.0 110.665 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.66 95.81 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.14 0.495 . . . . 0.0 111.135 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.24 -13.34 58.09 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.857 0.863 . . . . 0.0 112.44 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.4 m -106.52 -6.32 18.18 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.745 2.418 . . . . 0.0 112.473 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.42 16.49 39.97 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 116.601 1.4 . . . . 0.0 116.601 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.1 mt -96.18 -15.01 22.32 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 73.5 mt -106.53 139.77 40.48 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 120.832 1.651 . . . . 0.0 110.755 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.56 -178.36 7.01 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -69.34 106.74 3.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.418 2.287 . . . . 0.0 106.373 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 79' ' ' ILE . 1.6 mm -80.4 148.7 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.417 HG22 HG22 ' A' ' 79' ' ' ILE . 3.9 t 38.96 80.37 0.28 Allowed Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 129.026 2.931 . . . . 0.0 111.499 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -63.82 -24.9 68.02 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 121.635 1.557 . . . . 0.0 111.848 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -123.62 142.59 50.9 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 125.267 1.427 . . . . 0.0 109.138 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -61.44 -27.51 68.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.205 2.202 . . . . 0.0 109.98 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.69 63.25 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.202 0.91 . . . . 0.0 112.905 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -76.62 -31.09 57.2 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 119.314 0.961 . . . . 0.0 108.925 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -67.05 -39.5 86.92 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.205 -0.935 . . . . 0.0 109.816 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -57.3 -28.4 63.0 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.502 1.121 . . . . 0.0 112.077 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.6 mtpt -75.06 -18.24 60.34 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.4 mt -117.17 162.05 18.47 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.131 0.878 . . . . 0.0 110.782 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -75.0 148.65 84.69 Favored Pre-proline 0 CA--C 1.535 0.376 0 C-N-CA 123.783 0.833 . . . . 0.0 109.972 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.52 -42.51 3.58 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.596 2.198 . . . . 0.0 113.342 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -60.57 -40.01 90.12 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 118.55 0.614 . . . . 0.0 109.991 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.02 -28.34 70.03 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 120.73 -1.231 . . . . 0.0 109.98 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.402 ' CZ3' ' HB3' ' A' ' 106' ' ' TYR . 70.6 m95 -71.84 -33.3 68.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.214 0.915 . . . . 0.0 109.951 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.11 -38.73 73.84 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.262 0.937 . . . . 0.0 110.42 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.94 -7.47 3.85 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.79 8.21 2.0 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 125.222 1.409 . . . . 0.0 112.167 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.7 mtp180 -63.75 162.67 12.94 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 122.502 1.144 . . . . 0.0 111.182 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -145.71 -174.91 4.54 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 125.759 1.624 . . . . 0.0 108.408 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -62.68 105.15 0.61 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.304 1.442 . . . . 0.0 107.84 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.05 -78.06 0.29 Allowed Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.795 1.188 . . . . 0.0 113.637 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.35 -178.86 7.21 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.614 1.566 . . . . 0.0 110.57 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.51 169.35 8.71 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.842 0.83 . . . . 0.0 111.403 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 11.5 pt -130.07 -22.41 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.082 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.426 ' CA ' HG13 ' A' ' 79' ' ' ILE . . . -155.71 167.86 29.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.877 0.871 . . . . 0.0 109.051 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.402 ' HB3' ' CZ3' ' A' ' 94' ' ' TRP . 0.1 OUTLIER -123.94 150.35 62.39 Favored Pre-proline 0 C--O 1.236 0.378 0 C-N-CA 124.583 1.153 . . . . 0.0 109.383 179.112 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -72.74 144.45 39.33 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.764 2.309 . . . . 0.0 109.371 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.6 mm -126.26 -46.82 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.877 0.871 . . . . 0.0 111.608 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.8 144.9 49.29 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.1 t -106.25 119.03 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -125.93 177.21 6.46 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.096 0.958 . . . . 0.0 111.265 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.523 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -135.0 -172.79 3.14 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.267 1.427 . . . . 0.0 109.065 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.432 ' N ' HD13 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -135.03 172.76 12.56 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 127.844 2.458 . . . . 0.0 108.714 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 26.0 m -142.37 174.77 10.32 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.094 1.357 . . . . 0.0 110.975 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.3 tp -71.37 152.13 43.45 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 68.9 mt -107.49 107.44 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -131.48 164.7 25.19 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.62 1.568 . . . . 0.0 109.59 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -53.34 151.37 5.47 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.838 1.255 . . . . 0.0 111.841 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.16 -4.2 3.39 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 116.482 2.03 . . . . 0.0 116.482 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -75.69 156.78 34.4 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 -178.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 pp -73.89 -2.08 22.3 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.755 1.622 . . . . 0.0 113.338 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.7 tp -33.65 105.06 0.25 Allowed Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 127.514 2.326 . . . . 0.0 112.742 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -70.93 176.2 7.98 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.549 2.166 . . . . 0.0 109.266 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 38.1 t30 60.31 73.81 0.6 Allowed Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 125.394 1.477 . . . . 0.0 110.907 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.63 160.67 31.38 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.645 2.23 . . . . 0.0 111.711 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.74 148.53 65.42 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.12 2.547 . . . . 0.0 110.921 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -136.41 -8.8 1.95 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 117.401 -1.285 . . . . 0.0 112.449 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 10.6 t -147.1 144.63 29.18 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 121.714 2.052 . . . . 0.0 112.287 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -61.48 -19.99 62.66 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.627 1.171 . . . . 0.0 112.974 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -74.74 -15.86 60.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.615 1.098 . . . . 0.0 112.642 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -92.51 -26.92 17.72 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.987 0.812 . . . . 0.0 110.474 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.5 mm -48.69 -56.77 13.29 Favored Pre-proline 0 CA--C 1.531 0.228 0 C-N-CA 125.382 1.473 . . . . 0.0 110.951 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.69 -22.36 32.5 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 CA-C-N 120.487 1.209 . . . . 0.0 112.236 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -74.57 -36.7 63.07 Favored 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 65.1 tp -78.49 -28.55 46.4 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.861 1.264 . . . . 0.0 110.068 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.04 -50.21 71.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.71 0.687 . . . . 0.0 110.062 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.7 ptmm? -63.52 -31.85 73.13 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.044 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.59 -42.21 52.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 118.358 0.526 . . . . 0.0 109.697 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 69.8 mt -71.35 -31.41 67.33 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -67.42 -29.98 69.62 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.59 -3.53 18.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.128 0.571 . . . . 0.0 112.071 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.31 3.86 2.17 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.402 1.481 . . . . 0.0 111.478 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 175.87 -95.59 0.1 Allowed Glycine 0 CA--C 1.524 0.647 0 CA-C-N 120.077 1.308 . . . . 0.0 115.344 -179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -138.72 -171.6 3.11 Favored 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 125.341 1.456 . . . . 0.0 110.738 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.0 p -62.22 154.1 28.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.913 0.885 . . . . 0.0 110.599 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -76.85 -39.58 50.7 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.669 1.188 . . . . 0.0 110.805 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 63.2 tp -130.46 147.82 52.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.216 1.006 . . . . 0.0 112.5 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 25.4 mtp -150.75 127.84 11.17 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 127.642 2.377 . . . . 0.0 105.243 178.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.4 p90 -158.71 173.61 16.3 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -78.99 84.63 4.99 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.128 -0.982 . . . . 0.0 110.636 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 mp -71.61 -28.59 63.9 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 118.051 0.387 . . . . 0.0 109.986 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -61.42 -15.14 34.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -115.21 130.24 24.41 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 119.478 1.035 . . . . 0.0 110.605 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.04 -21.67 72.83 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 121.324 1.349 . . . . 0.0 112.394 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -54.4 -31.42 54.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.263 1.025 . . . . 0.0 113.461 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -98.12 -24.8 15.15 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.2 p -90.89 -15.93 29.04 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 119.33 0.968 . . . . 0.0 111.456 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -62.23 -35.3 19.6 Favored Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.08 -11.54 30.61 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 123.276 2.206 . . . . 0.0 113.98 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.7 tp -68.31 -67.05 0.49 Allowed 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.51 1.524 . . . . 0.0 111.621 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.696 HD13 ' H ' ' A' ' 161' ' ' ILE . 0.2 OUTLIER -62.28 -24.7 35.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 124.616 1.166 . . . . 0.0 113.295 -179.26 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.35 -16.15 63.29 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 121.865 -0.522 . . . . 0.0 111.035 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -65.85 -60.54 2.77 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.153 1.381 . . . . 0.0 109.568 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -60.76 -54.99 38.45 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.0 15.79 0.02 OUTLIER Glycine 0 C--N 1.337 0.629 0 CA-C-O 117.887 -1.507 . . . . 0.0 116.149 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -72.66 147.97 41.07 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 120.804 2.302 . . . . 0.0 109.639 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -151.9 128.24 10.59 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -68.89 -48.97 62.04 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -143.66 149.51 37.36 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -101.84 159.28 15.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.217 -0.927 . . . . 0.0 109.315 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -155.59 113.98 3.45 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 102.011 -3.329 . . . . 0.0 102.011 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -73.67 -168.59 0.59 Allowed 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 126.308 1.843 . . . . 0.0 108.429 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -57.13 -34.56 68.51 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 120.741 -1.224 . . . . 0.0 110.765 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -154.56 8.28 0.36 Allowed Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.284 -1.287 . . . . 0.0 114.558 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -112.49 130.46 55.99 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.366 2.083 . . . . 0.0 107.06 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.17 115.37 17.58 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.96 1.704 . . . . 0.0 109.368 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -132.56 111.78 11.52 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.02 -10.45 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.869 0.867 . . . . 0.0 112.789 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -77.13 -28.78 54.42 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.821 0.848 . . . . 0.0 109.937 178.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -73.76 80.98 1.58 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.911 1.284 . . . . 0.0 110.619 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 63.7 t -108.19 141.77 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 127.591 2.357 . . . . 0.0 108.851 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -132.16 34.04 2.59 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.093 1.33 . . . . 0.0 115.092 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 53.2 t -59.17 -37.76 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 117.301 -1.333 . . . . 0.0 113.796 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.46 ' OD2' ' HE3' ' A' ' 362' ' ' LYS 0.293 21.4 t70 -108.8 34.91 3.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.53 1.514 . . . . 0.0 113.279 -178.613 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -79.14 151.69 31.18 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -47.75 -24.8 1.04 Allowed 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 118.05 2.611 . . . . 0.0 118.05 -177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -80.17 -19.74 68.88 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 120.145 1.339 . . . . 0.0 111.738 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -74.66 -45.07 47.05 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.809 0.844 . . . . 0.0 108.981 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -64.39 -54.56 30.92 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -53.71 -45.07 70.32 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.617 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -63.56 -30.43 77.58 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 118.814 -0.992 . . . . 0.0 112.128 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 46.0 tp -84.09 -40.46 18.27 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.206 1.402 . . . . 0.0 110.881 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.4 m -44.24 -54.49 5.66 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 127.763 2.425 . . . . 0.0 112.156 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -59.02 -44.41 91.73 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 118.778 0.717 . . . . 0.0 111.769 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.66 -46.05 91.39 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.636 -0.665 . . . . 0.0 109.38 179.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.78 -34.42 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -62.65 -43.32 99.12 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.531 1.06 . . . . 0.0 111.811 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 75.7 mt -65.12 -50.76 64.82 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.678 0.791 . . . . 0.0 109.103 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.48 -35.97 74.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 124.406 1.083 . . . . 0.0 110.572 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -58.61 -49.13 78.62 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 119.345 0.975 . . . . 0.0 108.545 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.88 4.27 17.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.843 1.257 . . . . 0.0 112.286 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 58.39 20.49 7.42 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.919 1.288 . . . . 0.0 112.292 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -80.79 9.63 6.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.366 1.466 . . . . 0.0 110.882 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 13.2 ttt -146.91 148.05 31.4 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 121.206 -0.934 . . . . 0.0 108.6 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -78.15 78.63 4.63 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.25 -13.08 61.98 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.861 1.665 . . . . 0.0 114.782 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -92.88 -8.2 44.03 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.58 0.752 . . . . 0.0 112.372 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.7 m -61.97 127.66 32.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 122.522 1.153 . . . . 0.0 110.065 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 29.5 p30 -119.16 -177.52 3.36 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.711 2.004 . . . . 0.0 106.683 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -62.44 -42.9 99.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 31.4 m -60.11 -45.59 92.46 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 118.522 -0.751 . . . . 0.0 109.56 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 47.8 mm -60.93 -56.26 19.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.253 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -54.49 -59.44 4.69 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.942 1.697 . . . . 0.0 112.982 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -58.19 -44.58 88.11 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.845 0.748 . . . . 0.0 111.475 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.8 -45.65 91.66 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.434 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.82 95.25 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.411 1.084 . . . . 0.0 112.166 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -63.3 -38.59 91.75 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.098 0.559 . . . . 0.0 110.056 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -59.68 -46.07 90.16 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -68.46 -42.9 78.1 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.341 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.64 36.5 2.05 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.283 1.421 . . . . 0.0 109.596 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -78.22 -62.02 1.81 Allowed 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.746 -0.856 . . . . 0.0 109.298 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 13.4 t -73.27 137.1 44.7 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.552 1.541 . . . . 0.0 108.075 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.05 -15.65 57.91 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.163 0.585 . . . . 0.0 112.53 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 12.7 ptt? -159.29 168.4 26.53 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.919 1.688 . . . . 0.0 109.443 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -155.81 -179.56 8.24 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.452 1.501 . . . . 0.0 109.046 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.3 mt -144.3 109.08 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -138.89 173.55 11.45 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.886 2.075 . . . . 0.0 107.59 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -77.86 -90.24 0.33 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-O 118.989 -0.895 . . . . 0.0 113.383 -178.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.11 169.96 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 123.091 2.527 . . . . 0.0 116.194 -177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 3.5 m-90 -76.09 -13.97 60.2 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.358 1.063 . . . . 0.0 113.599 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -134.7 178.04 7.31 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.882 1.219 . . . . 0.0 112.115 -178.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 7.3 t90 -134.06 -36.45 0.92 Allowed 'General case' 0 N--CA 1.457 -0.087 0 C-N-CA 123.489 0.715 . . . . 0.0 111.818 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 6.9 m -78.51 -65.23 1.01 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -154.8 160.45 41.28 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 129.447 3.099 . . . . 0.0 106.083 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 11.2 mt -91.35 115.29 30.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -134.12 89.53 2.58 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.711 0.804 . . . . 0.0 111.698 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 5.1 p -88.71 167.45 13.31 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 84.0 p -135.47 -45.64 0.68 Allowed 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 123.37 0.668 . . . . 0.0 110.957 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -145.48 169.64 17.96 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.65 0.78 . . . . 0.0 110.966 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 9.4 p -76.53 164.79 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 124.806 1.243 . . . . 0.0 109.809 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.85 178.83 8.18 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.521 1.129 . . . . 0.0 109.293 178.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -142.91 175.51 9.78 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.868 1.667 . . . . 0.0 109.151 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 85.76 111.95 0.77 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 106.541 -2.623 . . . . 0.0 106.541 -179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.78 138.91 53.34 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-N 117.134 0.467 . . . . 0.0 110.232 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 23.7 m -125.92 124.29 40.49 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.2 t -81.55 154.3 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.97 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 32.0 mt -67.21 149.69 98.31 Favored Pre-proline 0 CA--C 1.54 0.596 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -66.46 153.7 77.03 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.277 1.985 . . . . 0.0 111.849 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 255' ' ' SER . 36.7 p -113.81 -165.38 1.0 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.265 1.426 . . . . 0.0 109.149 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -125.98 149.88 48.45 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -51.09 120.24 4.74 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 124.618 1.167 . . . . 0.0 109.616 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 77.61 -4.13 57.43 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 117.621 -1.655 . . . . 0.0 114.615 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.69 115.01 3.51 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-N 121.777 2.789 . . . . 0.0 115.191 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.29 147.07 28.84 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.709 2.939 . . . . 0.0 111.254 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.419 ' H ' HG22 ' A' ' 249' ' ' THR . 5.4 p -64.81 155.52 33.67 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -133.02 66.69 76.59 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.512 1.525 . . . . 0.0 108.599 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -78.15 179.68 6.27 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.426 2.751 . . . . 0.0 113.174 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -77.2 152.09 34.92 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.903 0.859 . . . . 0.0 112.155 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 82.7 t -110.74 158.83 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 126.04 1.736 . . . . 0.0 108.064 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -145.83 146.78 17.27 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.114 -1.994 . . . . 0.0 108.114 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 10.5 m -131.89 154.96 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 119.114 1.457 . . . . 0.0 111.829 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -69.37 117.46 11.03 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 7.4 m -104.49 144.98 30.93 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.561 1.144 . . . . 0.0 110.811 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.0 129.7 47.15 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.76 131.54 8.55 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 123.556 0.535 . . . . 0.0 111.891 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 85.5 mt -75.09 131.15 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -71.33 120.27 16.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.708 0.803 . . . . 0.0 109.143 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -67.47 -12.39 60.18 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 118.426 -0.797 . . . . 0.0 112.951 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.85 -6.67 59.48 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 119.164 0.893 . . . . 0.0 112.96 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.5 m -63.05 161.3 31.85 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.268 1.027 . . . . 0.0 108.681 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -77.88 -53.34 0.06 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.971 0 CA-C-N 121.204 1.466 . . . . 0.0 109.417 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -132.75 104.32 6.56 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . 0.506 ' HD2' ' H ' ' A' ' 273' ' ' LYS . 0.0 OUTLIER -60.06 -19.04 51.02 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.318 -1.31 . . . . 0.0 113.389 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -60.34 -33.2 72.06 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.02 -36.52 83.85 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.882 -1.136 . . . . 0.0 110.993 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.31 -47.23 28.8 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 122.646 0.378 . . . . 0.0 110.565 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.46 -35.73 78.44 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.206 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -70.37 -55.34 9.35 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.421 ' HE2' HD11 ' A' ' 9' ' ' ILE . 9.0 t80 -51.48 -46.89 63.3 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 120.225 1.375 . . . . 0.0 112.322 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.8 tt -62.25 -23.72 66.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 116.944 -1.503 . . . . 0.0 112.294 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -108.63 -17.91 13.85 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 120.7 1.591 . . . . 0.0 113.606 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -80.47 -33.38 36.69 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 124.461 1.104 . . . . 0.0 108.816 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -133.66 -46.09 0.81 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.102 -0.952 . . . . 0.0 111.079 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . 0.256 0.1 OUTLIER -67.85 0.24 3.58 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 120.71 1.595 . . . . 0.0 114.831 -179.462 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 58.7 mt -130.17 40.47 3.53 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 119.524 -1.985 . . . . 0.0 108.863 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 63.9 p -117.5 156.42 28.05 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.24 -43.38 98.96 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -73.31 -33.04 64.95 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -75.44 -42.25 28.06 Favored Glycine 0 C--N 1.334 0.418 0 N-CA-C 110.606 -0.998 . . . . 0.0 110.606 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 47.9 mt -68.09 -44.47 76.16 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -54.83 -47.17 74.47 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.189 0.996 . . . . 0.0 109.52 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.24 -42.32 63.52 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 113.679 0.992 . . . . 0.0 113.679 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 22.5 t -75.34 -36.52 36.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -61.54 -20.47 63.28 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.482 0.713 . . . . 0.0 110.97 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -67.85 -45.45 74.57 Favored 'General case' 0 C--N 1.345 0.407 0 O-C-N 121.163 -0.961 . . . . 0.0 110.139 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.42 -39.77 58.51 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 8.8 mmpt? -146.35 156.72 49.75 Favored Pre-proline 0 N--CA 1.464 0.239 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.245 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.32 114.08 3.67 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.761 1.641 . . . . 0.0 109.299 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 13.6 mt -80.47 -32.47 37.11 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 119.37 -0.348 . . . . 0.0 110.074 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 82.57 -167.81 47.07 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -59.13 157.63 10.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.56 0.695 . . . . 0.0 109.932 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 16.3 m -122.8 156.27 28.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.723 0.773 . . . . 0.0 111.191 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.63 -35.12 67.74 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.67 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.38 103.6 0.32 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.729 1.211 . . . . 0.0 112.332 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -47.95 -33.4 7.69 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.587 1.555 . . . . 0.0 112.703 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.8 -49.93 68.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.469 1.108 . . . . 0.0 113.211 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -96.41 -10.58 27.28 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.242 0.928 . . . . 0.0 111.504 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -59.27 -46.71 87.79 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.331 1.452 . . . . 0.0 108.098 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -69.16 -22.58 63.92 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 119.074 -0.488 . . . . 0.0 112.046 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -78.94 -49.57 12.59 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 7.1 mt -62.69 -38.16 89.29 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.61 -2.41 2.39 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.531 1.132 . . . . 0.0 114.043 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -66.71 -35.79 80.97 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 119.445 1.02 . . . . 0.0 108.529 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.9 150.49 58.89 Favored Pre-proline 0 CA--C 1.535 0.4 0 C-N-CA 123.747 0.819 . . . . 0.0 109.643 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.14 -24.59 20.03 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.466 2.11 . . . . 0.0 115.23 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -48.0 77.18 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 119.385 0.993 . . . . 0.0 109.447 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.501 HD12 ' H ' ' A' ' 317' ' ' ILE . 4.9 mp -64.04 -55.77 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.5 -53.39 23.57 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 123.926 0.766 . . . . 0.0 111.967 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.44 -47.13 87.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.523 HG23 ' HB3' ' A' ' 112' ' ' ALA . 87.0 m -67.57 -29.71 69.14 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 7.8 tpt -71.91 -39.52 69.46 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 120.9 -1.125 . . . . 0.0 109.136 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -56.78 -26.81 58.54 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.62 0.768 . . . . 0.0 110.223 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -66.18 -36.86 84.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.263 0.625 . . . . 0.0 112.332 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -76.91 -35.25 57.5 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -64.81 -52.25 57.79 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.129 0.972 . . . . 0.0 109.99 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.77 -10.34 59.42 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -86.54 -169.73 46.2 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -148.33 113.16 5.42 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 96.8 mt -64.75 149.0 11.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.239 1.816 . . . . 0.0 110.81 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 34.9 mtp -62.26 149.92 85.96 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.738 1.215 . . . . 0.0 112.707 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -83.29 -179.42 4.31 Favored 'Trans proline' 0 C--N 1.348 0.534 1 C-N-CA 125.563 4.175 . . . . 0.0 112.576 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -134.23 38.53 3.13 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.88 1.272 . . . . 0.0 112.764 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 24.1 pt -114.05 152.09 45.47 Favored Pre-proline 0 N--CA 1.472 0.656 0 O-C-N 120.879 -1.138 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.98 -17.22 36.69 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.581 2.188 . . . . 0.0 113.969 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -56.23 -22.83 31.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.103 1.761 . . . . 0.0 112.024 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -32.51 65.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.849 1.26 . . . . 0.0 111.544 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.67 -48.57 76.65 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.404 1.002 . . . . 0.0 109.208 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -63.5 -37.5 87.54 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -58.87 -54.51 46.28 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.354 0.525 . . . . 0.0 110.393 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 54.4 m95 -61.29 -42.37 98.54 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.561 -0.712 . . . . 0.0 109.989 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -63.93 -23.04 67.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.069 0.948 . . . . 0.0 112.307 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -85.02 -57.73 2.98 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 120.955 -1.09 . . . . 0.0 110.639 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.496 ' O ' HG23 ' A' ' 347' ' ' VAL . 19.3 t -57.84 -38.74 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 118.068 -0.968 . . . . 0.0 111.946 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -52.15 -48.57 64.84 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 120.145 1.339 . . . . 0.0 111.365 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 8.5 m -66.4 -40.22 89.48 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.375 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -58.64 -40.56 83.74 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.373 0.988 . . . . 0.0 111.413 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 343' ' ' VAL . 36.2 t -60.69 -55.38 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.784 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 36.8 mm -66.26 -33.38 63.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 O-C-N 123.575 0.547 . . . . 0.0 110.652 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 25.8 m-20 -61.09 -46.02 92.34 Favored 'General case' 0 N--CA 1.465 0.311 0 O-C-N 120.425 -1.422 . . . . 0.0 108.8 178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.9 -50.18 44.87 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.881 0.872 . . . . 0.0 109.729 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -57.08 -37.79 72.39 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 69.0 m -87.55 -7.13 57.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 123.548 0.739 . . . . 0.0 110.256 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.62 13.71 71.72 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-N 118.491 0.587 . . . . 0.0 111.78 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 -65.98 -28.61 69.02 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 118.311 1.056 . . . . 0.0 109.633 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -149.25 153.24 37.26 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 9.0 m -66.07 150.71 48.29 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.448 1.099 . . . . 0.0 108.671 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 18.8 t -52.52 -54.53 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.911 1.285 . . . . 0.0 108.339 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -50.38 -44.91 55.01 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.344 2.257 . . . . 0.0 112.597 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -82.6 -26.92 31.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -64.95 -45.48 85.57 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 76.4 mt -68.87 -39.44 79.84 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 118.806 -0.616 . . . . 0.0 109.73 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.46 ' HE3' ' OD2' ' A' ' 184' ' ' ASP . 2.1 tppp? -58.33 -35.81 72.44 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.896 0.878 . . . . 0.0 110.545 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.22 -32.74 22.46 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.789 0.722 . . . . 0.0 110.98 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.17 -40.16 90.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 118.902 -0.57 . . . . 0.0 110.564 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.64 -37.9 76.95 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 118.878 0.763 . . . . 0.0 109.606 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 4.3 m -67.53 -19.58 65.31 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.209 1.404 . . . . 0.0 113.141 -179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -80.66 -11.94 59.56 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.141 -0.975 . . . . 0.0 110.874 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.11 -42.02 11.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.5 p -68.02 -13.75 62.43 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.451 0.569 . . . . 0.0 111.859 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 32.2 tptt . . . . . 0 C--O 1.245 0.828 0 C-N-CA 125.868 1.667 . . . . 0.0 107.087 179.278 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.8 tptm . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 120.904 0.383 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 68.8 mt -70.79 133.71 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 103.756 -2.683 . . . . 0.0 103.756 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -76.31 41.26 0.24 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 120.435 1.47 . . . . 0.0 114.21 -179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -65.51 133.05 50.41 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.52 22.02 72.97 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 126.915 2.198 . . . . 0.0 114.634 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.2 ptpt -153.7 167.04 30.94 Favored 'General case' 0 CA--C 1.527 0.068 0 CA-C-N 119.215 1.507 . . . . 0.0 110.279 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.7 mt -137.09 158.39 44.55 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 127.583 2.353 . . . . 0.0 108.07 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 94.7 t -143.42 134.51 22.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 125.803 1.641 . . . . 0.0 107.21 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.2 mt -130.72 141.7 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.172 1.389 . . . . 0.0 109.491 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -130.1 162.51 28.64 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -126.73 170.18 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 124.504 1.122 . . . . 0.0 108.74 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -74.31 -25.19 59.42 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -177.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.02 -30.53 3.19 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-N 120.138 1.335 . . . . 0.0 115.331 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -113.13 6.5 17.57 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.436 1.494 . . . . 0.0 113.335 -178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.455 ' HA ' ' HE2' ' A' ' 297' ' ' LYS . 34.0 mmtm -75.59 -168.14 0.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.447 1.499 . . . . 0.0 110.448 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.04 65.53 0.37 Allowed Glycine 0 C--N 1.333 0.409 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -52.53 -34.82 51.69 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 117.853 0.826 . . . . 0.0 112.528 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -58.18 -55.22 37.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.605 0.639 . . . . 0.0 110.251 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.63 -31.17 77.76 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.497 ' HA ' HG22 ' A' ' 293' ' ' VAL . 53.6 tp -67.45 -35.53 79.4 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 121.214 -1.168 . . . . 0.0 110.333 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.39 -40.91 83.64 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 117.904 -1.046 . . . . 0.0 108.918 179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -54.68 -45.02 73.84 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.451 1.1 . . . . 0.0 110.731 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 t -57.01 -47.14 84.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.63 -35.35 85.94 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.682 -1.065 . . . . 0.0 110.88 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 mtmm -64.26 -46.52 83.38 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 119.289 1.544 . . . . 0.0 108.696 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.12 -57.74 11.26 Favored 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -55.64 -49.76 72.0 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 117.641 0.201 . . . . 0.0 111.418 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -60.16 -30.09 69.1 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.524 1.129 . . . . 0.0 111.545 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.62 -25.39 45.09 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 117.726 -1.131 . . . . 0.0 110.759 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -100.68 -4.04 29.08 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.513 1.133 . . . . 0.0 111.767 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.2 p -132.52 -38.68 1.03 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.82 -18.36 56.06 Favored Glycine 0 CA--C 1.528 0.851 0 O-C-N 121.201 -0.937 . . . . 0.0 112.779 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 32.2 mm -66.79 116.15 5.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.68 147.33 49.84 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.753 -0.592 . . . . 0.0 110.141 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.2 t -132.54 104.63 7.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 C-N-CA 125.89 1.676 . . . . 0.0 109.154 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.9 m -84.7 141.77 30.34 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.92 115.95 19.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -125.65 167.67 14.78 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.21 0.604 . . . . 0.0 112.001 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -120.13 65.95 11.09 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.509 1.124 . . . . 0.0 112.945 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -75.7 161.61 36.46 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.14 1.893 . . . . 0.0 109.843 178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -124.85 17.21 8.64 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.288 1.035 . . . . 0.0 110.648 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.98 8.23 2.5 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.844 1.658 . . . . 0.0 111.809 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.0 pt? -51.32 -26.78 8.1 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 125.249 1.42 . . . . 0.0 114.188 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.2 pm0 -61.07 -25.75 67.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.497 1.044 . . . . 0.0 111.437 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -115.5 -28.01 6.97 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -67.62 -44.25 78.49 Favored 'General case' 0 C--O 1.221 -0.447 0 O-C-N 119.813 -1.804 . . . . 0.0 109.687 179.226 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -52.98 -59.8 8.16 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 120.503 1.501 . . . . 0.0 109.343 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.34 -13.72 37.7 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 121.75 1.633 . . . . 0.0 114.213 179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -90.07 -9.87 46.88 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.795 1.634 . . . . 0.0 111.69 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.4 t -131.2 -34.88 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 119.941 1.246 . . . . 0.0 112.036 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.96 -34.04 74.12 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.38 -14.76 30.19 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.611 1.164 . . . . 0.0 112.316 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.88 5.51 17.44 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.222 1.809 . . . . 0.0 110.509 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.6 30.28 76.13 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -126.37 7.43 7.05 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.736 1.214 . . . . 0.0 112.283 -178.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -90.73 -171.51 43.68 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.139 1.828 . . . . 0.0 111.961 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -66.67 178.15 2.93 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.348 2.699 . . . . 0.0 111.27 179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -104.2 -17.69 14.78 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.557 -0.714 . . . . 0.0 111.939 -178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.17 157.22 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.5 tp -143.9 142.68 24.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -131.2 107.38 8.96 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.817 1.247 . . . . 0.0 108.684 -179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 -151.95 172.62 15.96 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.387 1.075 . . . . 0.0 108.579 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -70.27 162.46 28.43 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 119.827 1.194 . . . . 0.0 110.641 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -55.13 -26.34 37.74 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.77 1.628 . . . . 0.0 112.493 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -58.87 -64.77 0.82 Allowed 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 118.015 -0.993 . . . . 0.0 112.462 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -62.5 -23.23 66.83 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 121.213 1.824 . . . . 0.0 109.918 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -72.78 -15.64 61.65 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.6 -0.687 . . . . 0.0 111.359 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.56 -21.5 60.43 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.23 1.395 . . . . 0.0 112.776 179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.09 -33.89 2.09 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 118.422 -1.21 . . . . 0.0 112.477 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -53.65 -47.57 70.2 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.792 1.796 . . . . 0.0 114.241 -179.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.07 -43.65 91.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.606 1.094 . . . . 0.0 110.417 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -56.61 -49.52 74.71 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.9 m -62.51 -3.25 1.34 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.952 1.701 . . . . 0.0 113.845 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.12 11.11 85.68 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 119.778 1.172 . . . . 0.0 110.854 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 65.5 mt -81.36 -21.32 39.17 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.026 1.413 . . . . 0.0 110.555 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.6 mt -111.44 140.98 45.59 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 119.356 0.98 . . . . 0.0 109.594 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -93.77 176.13 6.47 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.595 1.558 . . . . 0.0 110.469 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -71.54 144.36 49.6 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.576 1.15 . . . . 0.0 109.205 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.5 163.87 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.841 1.256 . . . . 0.0 109.665 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 31.2 m 65.39 81.8 0.21 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.767 1.627 . . . . 0.0 112.227 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.87 -65.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.964 1.776 . . . . 0.0 108.51 178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.27 155.02 17.39 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.631 1.172 . . . . 0.0 110.07 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.6 tptp -65.58 -28.51 69.2 Favored 'General case' 0 N--CA 1.46 0.065 0 C-N-CA 124.74 1.216 . . . . 0.0 113.081 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.06 -36.65 60.86 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.288 0.949 . . . . 0.0 111.663 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -63.09 -28.11 69.85 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 121.861 -0.524 . . . . 0.0 111.084 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -73.75 -43.19 59.78 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 119.272 0.942 . . . . 0.0 110.176 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -60.19 -27.97 67.58 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 124.478 1.111 . . . . 0.0 112.476 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -66.03 -16.72 64.16 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.696 0.798 . . . . 0.0 111.559 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.1 mt -119.88 163.45 17.52 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 125.465 1.506 . . . . 0.0 109.13 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -69.86 147.79 96.2 Favored Pre-proline 0 C--O 1.235 0.292 0 O-C-N 121.403 -0.81 . . . . 0.0 110.245 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.89 -51.01 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.59 2.193 . . . . 0.0 113.083 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -55.2 -44.67 75.54 Favored 'General case' 0 CA--C 1.527 0.074 0 CA-C-N 118.739 0.7 . . . . 0.0 109.944 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -56.48 -27.47 57.13 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.23 1.012 . . . . 0.0 112.69 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -73.52 -33.28 64.68 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 119.651 1.114 . . . . 0.0 111.451 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -59.86 -37.02 78.1 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.225 0.61 . . . . 0.0 111.82 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.54 -3.31 4.31 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 117.994 -1.003 . . . . 0.0 113.002 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 16.0 m -132.19 11.89 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.369 1.468 . . . . 0.0 111.571 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 12.5 mtp-105 -76.26 156.36 33.56 Favored 'General case' 0 CA--C 1.52 -0.192 0 O-C-N 121.038 -1.039 . . . . 0.0 109.404 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -131.13 177.78 7.2 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 125.846 1.658 . . . . 0.0 107.156 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -65.57 100.17 0.49 Allowed 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.261 1.025 . . . . 0.0 109.298 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.61 -76.62 1.69 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.227 1.394 . . . . 0.0 110.701 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.83 166.69 20.51 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mt -100.34 160.13 14.58 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.769 1.627 . . . . 0.0 108.087 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.1 pt -133.52 -19.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.44 164.81 26.96 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 120.591 1.542 . . . . 0.0 108.165 178.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.2 137.51 22.53 Favored Pre-proline 0 N--CA 1.467 0.413 0 CA-C-O 118.747 -0.644 . . . . 0.0 110.443 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.49 129.44 18.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.777 2.318 . . . . 0.0 108.73 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 49.8 mm -121.2 -46.34 2.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.55 148.8 52.38 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 67.8 t -121.18 111.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -120.04 167.58 12.04 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.62 130.69 50.98 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.494 ' HB2' ' H ' ' A' ' 245' ' ' THR . 0.3 OUTLIER -88.6 168.92 12.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.634 1.574 . . . . 0.0 113.544 -178.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.8 m -144.48 115.98 8.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.03 1.732 . . . . 0.0 111.689 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.69 170.17 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 129.39 3.076 . . . . 0.0 117.209 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 5.2 mp -86.98 136.34 23.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.717 1.207 . . . . 0.0 108.655 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.435 ' CE1' HD22 ' A' ' 122' ' ' LEU . 6.2 p90 -147.14 167.19 24.76 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.421 1.888 . . . . 0.0 108.758 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -74.46 147.32 42.07 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.269 1.028 . . . . 0.0 111.351 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -66.93 28.2 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.894 2.878 . . . . 0.0 114.745 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -84.36 -163.06 0.74 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.686 1.194 . . . . 0.0 107.992 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -60.57 -20.7 61.23 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.435 HD22 ' CE1' ' A' ' 117' ' ' TYR . 51.2 tp 50.99 80.71 0.28 Allowed Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 125.69 1.596 . . . . 0.0 109.168 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -75.66 74.92 4.17 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.884 3.056 . . . . 0.0 110.455 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 3.8 m120 64.08 161.71 0.12 Allowed Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 128.781 2.832 . . . . 0.0 111.571 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.88 163.23 38.24 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 121.546 1.498 . . . . 0.0 109.416 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.434 ' HG2' HG21 ' A' ' 246' ' ' VAL . 91.5 Cg_endo -72.11 157.89 53.28 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.042 1.161 . . . . 0.0 110.226 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -138.52 -19.06 1.08 Allowed 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 116.437 -1.744 . . . . 0.0 114.159 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.76 136.38 32.46 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 120.716 1.598 . . . . 0.0 111.219 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 33.3 m95 -65.93 -26.09 67.43 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.167 -0.958 . . . . 0.0 110.89 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -69.32 -12.88 62.04 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.834 0.743 . . . . 0.0 112.748 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -92.45 -11.53 34.49 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.711 0.804 . . . . 0.0 111.171 -178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 25.2 mm -63.58 -59.0 12.9 Favored Pre-proline 0 C--O 1.233 0.186 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.58 -23.31 49.86 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 CA-C-N 119.826 0.974 . . . . 0.0 110.978 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.89 89.76 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 118.738 0.699 . . . . 0.0 109.887 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 62.6 tp -80.79 -27.49 36.65 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -57.19 -47.58 80.89 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 124.292 1.037 . . . . 0.0 111.205 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.2 ptmm? -66.69 -28.44 68.45 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 122.994 0.518 . . . . 0.0 112.064 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -75.89 -42.4 49.29 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 56.9 mt -78.82 -32.84 46.38 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.722 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.85 -35.89 79.35 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.63 67.72 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.204 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 -5.62 15.41 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.471 1.108 . . . . 0.0 112.414 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.69 -94.57 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 119.159 0.89 . . . . 0.0 113.556 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.484 ' HE2' ' OE2' ' A' ' 221' ' ' GLU . 27.9 mmtm -132.92 172.15 13.0 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.511 1.124 . . . . 0.0 110.849 -177.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.56 162.73 3.63 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.424 1.49 . . . . 0.0 111.696 -179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.54 -55.99 4.14 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 65.8 tp -115.96 157.18 24.96 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 124.155 0.982 . . . . 0.0 110.818 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 45.3 mtp -148.7 114.17 5.6 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -140.5 174.01 10.93 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 123.799 0.84 . . . . 0.0 109.171 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.429 ' H ' HD22 ' A' ' 150' ' ' ASN . 1.2 p30 -69.42 76.05 0.39 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.864 2.065 . . . . 0.0 109.978 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 15.3 mt -73.07 -23.15 60.51 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -79.66 -1.73 39.56 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 123.655 0.782 . . . . 0.0 112.672 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -117.75 129.74 25.16 Favored Pre-proline 0 CA--C 1.529 0.147 0 C-N-CA 123.962 0.905 . . . . 0.0 112.878 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.11 -13.31 17.24 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.352 2.035 . . . . 0.0 112.286 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -59.04 -44.62 91.79 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.873 0.869 . . . . 0.0 110.4 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -91.92 -28.29 17.36 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.395 0.543 . . . . 0.0 111.42 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.5 p -80.16 -2.13 43.34 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 119.133 0.879 . . . . 0.0 110.47 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 32.8 t-105 -56.97 -66.3 1.29 Allowed Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 120.421 -1.424 . . . . 0.0 111.093 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.46 -20.39 60.96 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 CA-C-N 120.242 1.122 . . . . 0.0 112.899 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.82 -43.2 90.56 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-O 118.341 -0.838 . . . . 0.0 108.829 179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 9.3 pt -93.01 -32.12 4.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 118.441 0.564 . . . . 0.0 111.663 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.86 -6.94 18.32 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.118 -0.988 . . . . 0.0 113.256 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -54.01 -46.21 71.72 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.903 1.281 . . . . 0.0 112.968 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -63.84 -50.4 69.0 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.521 0.601 . . . . 0.0 109.843 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 174.47 42.77 0.05 OUTLIER Glycine 0 C--N 1.335 0.501 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.329 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -89.03 154.6 24.63 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 21.5 p90 -159.91 121.99 3.32 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -63.33 -47.8 80.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -146.01 131.45 18.67 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -58.28 126.73 28.75 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -150.63 101.25 2.92 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.18 158.57 43.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 119.109 0.868 . . . . 0.0 108.888 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 47.9 27.33 1.13 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.156 1.783 . . . . 0.0 112.445 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 79.42 18.87 72.83 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 118.576 -1.125 . . . . 0.0 114.04 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -120.99 115.25 22.82 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.55 1.675 . . . . 0.0 107.372 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -106.08 121.24 43.73 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.287 1.435 . . . . 0.0 108.881 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -130.7 110.89 11.69 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 122.394 1.093 . . . . 0.0 111.094 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.467 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.1 OUTLIER -73.55 0.29 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 C-N-CA 124.307 1.043 . . . . 0.0 109.367 177.088 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -84.19 -11.52 56.4 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 127.488 2.315 . . . . 0.0 111.623 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -127.4 105.69 8.69 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.67 140.4 49.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -124.52 29.8 4.89 Favored Glycine 0 C--N 1.338 0.652 0 CA-C-O 117.871 -1.516 . . . . 0.0 116.188 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.38 -11.54 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 120.221 2.011 . . . . 0.0 113.693 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.14 10.25 10.0 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.472 1.033 . . . . 0.0 112.166 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.09 159.93 13.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 123.846 0.858 . . . . 0.0 110.055 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -53.79 -35.58 61.5 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.292 1.037 . . . . 0.0 110.862 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.85 -41.6 97.41 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-N 118.373 0.533 . . . . 0.0 112.366 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -64.45 -51.07 64.98 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.16 0.98 . . . . 0.0 109.911 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -63.08 -37.79 88.62 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 118.566 -0.73 . . . . 0.0 110.671 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.23 71.9 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.646 0.778 . . . . 0.0 111.863 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -88.09 -28.03 24.22 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 192' ' ' LEU . 19.8 tp -74.92 -39.03 61.63 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 120.281 -1.717 . . . . 0.0 111.618 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 4.2 t -56.58 -33.61 66.37 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.923 0.489 . . . . 0.0 111.511 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -60.01 -54.62 43.9 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 119.389 0.995 . . . . 0.0 109.459 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 7.4 tt -56.38 -45.0 80.74 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.458 1.103 . . . . 0.0 110.233 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.31 -32.96 52.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 123.713 0.805 . . . . 0.0 109.893 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.589 ' HA ' ' HE3' ' A' ' 200' ' ' LYS . 19.1 t70 -63.72 -46.37 85.74 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.859 1.209 . . . . 0.0 112.726 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 16.0 mt -62.62 -39.52 94.08 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.688 0.795 . . . . 0.0 109.76 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 75.5 mt -68.69 -40.29 81.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 197' ' ' ASP . 0.1 OUTLIER -52.67 -40.79 63.21 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.659 1.183 . . . . 0.0 109.7 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -90.99 0.87 57.43 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.121 1.768 . . . . 0.0 113.22 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 7.9 mptt 52.91 17.55 0.9 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 128.452 2.701 . . . . 0.0 114.972 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -82.27 -24.97 34.47 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 118.983 0.81 . . . . 0.0 109.315 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.0 tpt -77.94 163.38 26.04 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -82.52 51.19 1.8 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -53.68 -22.41 8.91 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 127.347 2.259 . . . . 0.0 115.905 -177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -99.99 8.63 43.88 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.506 1.522 . . . . 0.0 112.398 -177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 71.4 m -101.06 144.31 30.14 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.762 1.625 . . . . 0.0 111.158 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.78 -177.54 4.32 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.596 1.958 . . . . 0.0 108.85 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -48.48 -51.0 29.28 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.814 0.846 . . . . 0.0 112.884 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.26 -43.76 90.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 123.274 0.629 . . . . 0.0 111.142 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 20.4 mm -59.09 -49.05 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 118.9 -0.571 . . . . 0.0 109.755 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -60.94 -47.53 86.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.5 1.12 . . . . 0.0 110.885 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -57.03 -42.68 80.87 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.138 0.575 . . . . 0.0 111.547 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.55 -48.18 35.03 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 122.023 -0.423 . . . . 0.0 110.146 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.25 -39.33 56.44 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.031 1.732 . . . . 0.0 111.775 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -53.79 -55.0 30.4 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.168 1.387 . . . . 0.0 109.079 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -62.13 -38.15 87.86 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 31.8 mmtt -65.44 -17.67 64.72 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.627 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.62 11.9 76.35 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 119.117 0.871 . . . . 0.0 111.024 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.484 ' OE2' ' HE2' ' A' ' 144' ' ' LYS . 7.4 mm-40 -65.52 -60.63 2.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.544 1.137 . . . . 0.0 110.332 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 14.8 t -87.82 141.77 28.33 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.961 0.904 . . . . 0.0 109.444 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.19 -35.24 59.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -127.13 164.19 22.17 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.317 0.647 . . . . 0.0 109.545 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 52.4 m -151.13 155.29 38.61 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.763 0.825 . . . . 0.0 108.871 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.0 mt -133.73 126.93 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 104.654 -2.35 . . . . 0.0 104.654 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -143.81 178.5 7.78 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 130.208 3.403 . . . . 0.0 110.014 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.27 64.85 1.02 Allowed Glycine 0 CA--C 1.531 1.047 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.04 156.33 65.57 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.313 2.675 . . . . 0.0 110.773 178.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -89.0 112.72 23.71 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 103.314 -2.847 . . . . 0.0 103.314 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -65.55 62.44 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.147 2.179 . . . . 0.0 113.044 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -144.15 116.21 8.38 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.54 1.936 . . . . 0.0 105.988 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 28.0 m 63.58 -13.01 0.09 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.465 1.906 . . . . 0.0 115.193 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -68.31 172.99 5.21 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.376 1.47 . . . . 0.0 110.509 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 1.7 pp -130.13 -14.76 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -72.95 157.38 37.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.407 1.458 . . . . 0.0 108.178 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 8.8 t -148.52 137.52 21.68 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 3.1 t -140.49 162.31 35.64 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 125.944 1.698 . . . . 0.0 107.818 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -80.77 0.22 35.72 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 9.1 p -147.13 151.84 13.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -155.35 64.93 0.62 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.614 0.643 . . . . 0.0 110.382 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -65.35 163.65 15.14 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.478 0.656 . . . . 0.0 111.439 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -117.29 83.46 0.34 Allowed Glycine 0 C--N 1.335 0.524 0 N-CA-C 106.694 -2.563 . . . . 0.0 106.694 179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 1.3 m -134.55 91.21 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 127.709 2.404 . . . . 0.0 107.575 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.803 HG22 ' H ' ' A' ' 246' ' ' VAL . 1.1 m -142.24 -171.51 3.4 Favored 'General case' 0 C--O 1.217 -0.612 0 O-C-N 118.892 -2.38 . . . . 0.0 111.03 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.803 ' H ' HG22 ' A' ' 245' ' ' THR . 11.6 p -141.56 176.8 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 120.832 1.651 . . . . 0.0 109.618 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.442 ' H ' HG22 ' A' ' 246' ' ' VAL . 0.7 OUTLIER -131.7 59.79 47.45 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.788 1.235 . . . . 0.0 113.648 -178.319 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.555 ' HD3' HG13 ' A' ' 246' ' ' VAL . 65.3 Cg_endo -64.97 155.0 70.49 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.487 2.125 . . . . 0.0 108.798 178.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 61.6 p -97.45 179.76 4.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.356 1.062 . . . . 0.0 110.427 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -107.84 164.75 11.99 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -59.34 114.21 2.55 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 118.068 0.395 . . . . 0.0 110.201 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 69.92 15.29 71.5 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-O 118.364 -1.242 . . . . 0.0 113.965 179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.46 117.9 3.23 Favored Pre-proline 0 C--O 1.238 0.471 0 CA-C-N 120.639 2.22 . . . . 0.0 111.668 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -68.34 113.49 3.12 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.854 2.37 . . . . 0.0 111.165 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 31.6 t -57.82 157.03 7.97 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.215 1.006 . . . . 0.0 108.382 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 16.7 mtmm -132.86 60.8 52.41 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 125.634 1.574 . . . . 0.0 112.792 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.88 164.59 31.06 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 121.542 1.495 . . . . 0.0 109.452 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -63.62 170.88 2.93 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.642 1.211 . . . . 0.0 112.966 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 77.0 t -106.21 157.11 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 126.149 1.78 . . . . 0.0 108.489 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -138.22 149.52 20.53 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 108.205 -1.958 . . . . 0.0 108.205 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 19.0 t -145.11 148.93 17.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 124.43 1.092 . . . . 0.0 109.56 -178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.57 HD23 ' H ' ' A' ' 263' ' ' SER . 1.1 tt -77.02 149.49 35.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.57 ' H ' HD23 ' A' ' 262' ' ' LEU . 19.3 m -126.38 154.2 43.91 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.814 0.846 . . . . 0.0 111.828 -178.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -136.93 134.48 36.81 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.471 1.108 . . . . 0.0 108.277 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -142.53 154.99 25.51 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 75.1 mt -93.55 136.37 25.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.974 1.309 . . . . 0.0 107.591 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -72.72 113.78 10.14 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.9 -20.07 66.25 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 118.184 -0.912 . . . . 0.0 113.429 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -73.74 -16.35 61.18 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 32.7 m -70.27 163.56 61.07 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 119.084 0.856 . . . . 0.0 110.514 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.69 -46.06 2.88 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.331 2.021 . . . . 0.0 115.327 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -137.42 114.7 10.93 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-N 119.078 0.854 . . . . 0.0 112.203 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.91 -18.32 64.1 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 118.656 -0.688 . . . . 0.0 112.024 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -59.83 -40.36 88.19 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 98.9 mt -57.8 -41.22 81.72 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 121.496 -0.752 . . . . 0.0 111.093 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -77.91 -42.76 32.11 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -33.94 76.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.396 -0.811 . . . . 0.0 110.431 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -68.76 -52.57 29.05 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -55.33 -43.54 75.03 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.204 -0.935 . . . . 0.0 112.326 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -61.03 -51.23 70.11 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.486 1.114 . . . . 0.0 110.09 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -75.07 -17.81 60.4 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -105.79 -26.45 11.76 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.06 -1.448 . . . . 0.0 113.858 -178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -131.18 -37.41 1.26 Allowed 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 120.719 1.6 . . . . 0.0 113.609 -178.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.419 HD13 ' O ' ' A' ' 284' ' ' LEU . 1.7 tm? -62.0 -50.0 73.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 116.516 -2.073 . . . . 0.0 107.415 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 90.6 mt -82.91 52.5 2.17 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.586 1.954 . . . . 0.0 115.883 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 13.2 p -131.01 160.34 34.85 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -63.19 -47.01 84.41 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -70.44 -32.63 70.28 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.524 1.13 . . . . 0.0 111.074 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.87 -42.76 44.38 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 54.7 mt -70.37 -46.54 63.88 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -56.67 -43.55 80.54 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.491 0.716 . . . . 0.0 109.954 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -52.98 -37.34 61.18 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 20' ' ' LEU . 5.0 t -88.27 -31.4 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 122.842 0.457 . . . . 0.0 109.886 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -71.62 -23.92 61.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 122.763 0.425 . . . . 0.0 111.251 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -59.71 -47.35 86.01 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 178.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.17 -59.62 4.51 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.106 0.962 . . . . 0.0 112.033 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.455 ' HE2' ' HA ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -137.87 160.46 64.55 Favored Pre-proline 0 N--CA 1.463 0.211 0 O-C-N 121.389 -0.82 . . . . 0.0 112.293 -178.576 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -69.92 110.07 2.5 Favored 'Trans proline' 0 N--CA 1.45 -1.061 0 C-N-CA 121.691 1.594 . . . . 0.0 108.164 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.41 -9.75 58.84 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 85.22 -166.58 40.52 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 119.709 1.141 . . . . 0.0 110.276 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -73.67 168.43 19.37 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.026 0.93 . . . . 0.0 110.765 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.5 m -131.16 153.9 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 123.61 0.764 . . . . 0.0 110.831 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.0 41.17 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.947 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 63.5 tp -65.75 100.46 0.54 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 126.52 1.928 . . . . 0.0 106.869 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 35.7 mtmt -47.5 -37.72 12.5 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.353 1.061 . . . . 0.0 112.983 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 4.8 m -55.41 -60.48 3.35 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 123.693 0.797 . . . . 0.0 112.768 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -83.77 -9.97 58.43 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.822 1.249 . . . . 0.0 111.806 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -61.5 -42.62 99.08 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 67.4 mt-10 -67.47 -37.79 83.43 Favored 'General case' 0 C--O 1.224 -0.241 0 O-C-N 124.39 1.056 . . . . 0.0 111.272 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -65.16 -50.74 64.81 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.6 -38.62 89.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.86 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.64 -15.97 33.89 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.561 1.145 . . . . 0.0 113.662 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -60.25 -16.02 30.09 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.973 0.806 . . . . 0.0 111.605 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.3 135.26 19.68 Favored Pre-proline 0 N--CA 1.451 -0.382 0 CA-C-N 119.335 0.97 . . . . 0.0 110.597 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -56.43 -34.46 94.63 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 123.288 2.659 . . . . 0.0 112.805 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.62 -33.47 75.07 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.029 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 2.9 mp -79.68 -54.26 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -43.96 -55.21 4.78 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.507 1.123 . . . . 0.0 112.211 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.22 -30.03 70.18 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 9.8 m -77.55 -32.54 53.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.765 0.826 . . . . 0.0 109.259 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 11.0 tpt -74.39 -41.84 60.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -49.64 -42.02 44.03 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 125.384 1.474 . . . . 0.0 111.288 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -59.27 -44.51 92.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.815 2.046 . . . . 0.0 110.368 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -75.87 -22.37 56.25 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.222 -0.299 . . . . 0.0 110.815 178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -88.5 -14.06 38.72 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.492 1.117 . . . . 0.0 112.756 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.42 -3.2 25.76 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.159 1.384 . . . . 0.0 112.09 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -114.68 -178.64 18.89 Favored Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -135.9 141.99 44.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 90.7 mt -72.61 153.66 7.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.537 1.135 . . . . 0.0 110.097 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 31.8 mtp -62.67 162.98 17.1 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.023 0.929 . . . . 0.0 112.155 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -71.57 178.23 5.91 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.49 2.127 . . . . 0.0 112.399 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -134.19 16.58 3.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.43 1.892 . . . . 0.0 112.056 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.3 pt -116.91 153.72 49.47 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.709 1.204 . . . . 0.0 112.021 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.28 -5.42 17.13 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 123.771 2.981 . . . . 0.0 115.406 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -57.79 -19.24 26.96 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.768 -1.207 . . . . 0.0 111.884 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 2.2 mtp -61.85 -24.07 66.67 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.772 -0.58 . . . . 0.0 110.472 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 40.3 t -54.57 -53.56 52.9 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.073 1.349 . . . . 0.0 109.004 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -65.22 -43.71 90.6 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.824 0.449 . . . . 0.0 110.514 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -53.67 -54.09 42.76 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.816 0.846 . . . . 0.0 110.773 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -59.96 -50.0 75.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 118.66 -0.686 . . . . 0.0 111.133 -179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -55.38 -42.75 74.42 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.473 0.579 . . . . 0.0 111.217 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.411 ' HB1' ' HB1' ' A' ' 364' ' ' ALA . . . -62.32 -57.3 11.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.468 1.107 . . . . 0.0 111.979 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.5 t -63.58 -40.6 89.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.514 -0.755 . . . . 0.0 111.109 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -50.87 -41.31 58.07 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 119.539 1.063 . . . . 0.0 110.041 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 7.0 m -79.94 -47.14 15.48 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.415 -0.803 . . . . 0.0 110.525 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -52.07 -44.74 64.46 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 36.4 t -60.51 -47.69 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.34 -36.18 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.45 0.568 . . . . 0.0 109.766 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -59.41 -49.88 76.12 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.438 1.017 . . . . 0.0 109.527 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -69.36 -43.49 73.48 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.081 0.552 . . . . 0.0 110.79 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.84 -29.03 70.43 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.778 0.831 . . . . 0.0 112.37 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 6.7 m -92.45 -10.31 38.39 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.651 0.78 . . . . 0.0 110.076 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 72.73 10.39 76.38 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-O 119.194 -0.781 . . . . 0.0 112.572 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -67.15 -29.41 69.11 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 118.935 1.367 . . . . 0.0 111.883 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.427 HE21 ' HA ' ' A' ' 360' ' ' ALA . 19.7 tt0 -140.09 157.5 45.53 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 3.4 m -62.3 152.56 33.39 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 123.855 0.862 . . . . 0.0 109.214 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 47.3 t -57.8 -48.49 83.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.35 -49.52 72.03 Favored 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 125.976 1.71 . . . . 0.0 111.159 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -75.53 -30.79 59.88 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.427 ' HA ' HE21 ' A' ' 355' ' ' GLN . . . -63.31 -41.32 98.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 7.9 mp -73.21 -38.62 66.02 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.243 1.017 . . . . 0.0 109.518 178.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -57.29 13.7 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.579 1.081 . . . . 0.0 110.389 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -55.42 -36.32 66.34 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 122.386 1.089 . . . . 0.0 109.951 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.411 ' HB1' ' HB1' ' A' ' 342' ' ' ALA . . . -68.57 -46.99 67.97 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 117.537 -1.221 . . . . 0.0 111.236 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -52.72 -39.29 61.92 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.538 1.063 . . . . 0.0 109.655 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 4.4 m -63.77 -26.15 68.51 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.255 1.022 . . . . 0.0 112.828 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 36.9 mtt85 -72.89 -18.92 61.37 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.448 -1.407 . . . . 0.0 111.028 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 4.9 mp -92.68 -38.46 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.214 1.006 . . . . 0.0 109.105 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 7.7 p -69.19 -15.67 63.45 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.373 0.988 . . . . 0.0 111.668 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 51.6 tttm . . . . . 0 C--O 1.254 1.313 0 C-N-CA 126.955 2.102 . . . . 0.0 110.309 179.155 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.422 ' H3 ' ' CG ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 117.445 -1.264 . . . . 0.0 113.401 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.6 mm 48.26 167.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 131.308 3.843 . . . . 0.0 115.604 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -132.37 116.7 17.18 Favored 'General case' 0 N--CA 1.45 -0.473 1 N-CA-C 97.888 -4.856 . . . . 0.0 97.888 177.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -77.03 171.16 15.24 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.764 0.711 . . . . 0.0 111.818 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.49 38.89 71.97 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.812 1.196 . . . . 0.0 115.78 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.6 ptpt -145.77 173.5 12.05 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.864 0.832 . . . . 0.0 110.031 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.3 mt -142.13 154.49 44.92 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 126.951 2.101 . . . . 0.0 107.519 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 86.4 t -144.53 117.33 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.422 HD11 ' CE2' ' A' ' 279' ' ' PHE . 40.5 mt -99.4 126.52 52.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 10.5 m0 -112.93 140.37 47.8 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mp -129.79 148.84 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 C-N-CA 125.588 1.555 . . . . 0.0 109.846 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -99.76 -64.75 1.01 Allowed 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -175.3 169.45 42.28 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.629 1.585 . . . . 0.0 109.149 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 52.45 3.17 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 129.22 3.008 . . . . 0.0 115.775 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.56 -28.85 68.13 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 125.763 1.625 . . . . 0.0 115.376 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.7 36.15 6.98 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -51.61 -34.23 36.53 Favored 'General case' 0 C--N 1.343 0.286 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -178.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -59.47 -40.51 87.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 123.645 0.778 . . . . 0.0 112.087 -178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.59 -30.81 26.07 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -62.71 -38.01 88.73 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.603 1.161 . . . . 0.0 111.552 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.22 -46.3 62.21 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 123.66 0.784 . . . . 0.0 110.945 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -60.0 -35.5 75.17 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.844 -0.598 . . . . 0.0 112.438 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.2 t -62.32 -43.98 98.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.88 -40.89 93.67 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -63.39 -40.92 98.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.216 1.008 . . . . 0.0 109.52 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -63.64 -57.71 9.19 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -55.0 -43.61 73.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.637 0.653 . . . . 0.0 111.992 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -64.86 -28.19 69.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.448 1.022 . . . . 0.0 110.651 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -82.4 -23.04 35.11 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 121.058 -1.026 . . . . 0.0 112.272 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -99.83 -17.95 17.4 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.264 0.978 . . . . 0.0 111.979 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 44.3 p -122.76 -34.4 3.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.161 0.891 . . . . 0.0 113.184 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.38 -15.05 64.04 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.992 -0.893 . . . . 0.0 111.682 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.0 mm -66.86 120.15 13.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -61.79 146.4 49.59 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 22.9 t -135.51 143.49 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.7 m -125.12 143.06 51.12 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.74 119.01 23.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.41 163.23 25.32 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.128 0.971 . . . . 0.0 109.915 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -139.09 65.34 36.14 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.161 0.585 . . . . 0.0 111.262 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.86 173.09 14.06 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 125.054 3.836 . . . . 0.0 109.123 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -123.5 1.14 8.92 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 123.622 0.769 . . . . 0.0 111.828 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . 0.269 0.0 OUTLIER -119.29 6.84 11.19 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.172 0.989 . . . . 0.0 111.097 178.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -59.32 -20.71 56.76 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 120.709 -1.244 . . . . 0.0 112.072 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -60.58 -21.29 62.46 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.729 0.811 . . . . 0.0 112.499 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -122.63 -23.01 5.23 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.715 1.606 . . . . 0.0 111.026 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -78.07 -38.84 43.44 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.927 1.291 . . . . 0.0 110.693 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -52.02 -57.22 15.83 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 120.376 1.443 . . . . 0.0 110.094 178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.82 -16.23 52.19 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 121.77 1.646 . . . . 0.0 114.385 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -84.54 -12.63 53.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 117.998 -1.001 . . . . 0.0 111.698 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.82 -40.26 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 120.154 1.343 . . . . 0.0 109.746 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.34 -43.09 53.84 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.803 1.241 . . . . 0.0 112.498 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.55 70.94 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.546 -0.721 . . . . 0.0 111.689 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.3 m -74.79 -5.89 45.91 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.204 1.402 . . . . 0.0 112.79 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.18 47.62 10.77 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.422 ' CG ' ' H3 ' ' A' ' 1' ' ' LYS . 13.6 m-20 -158.42 176.23 12.71 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 130.99 3.716 . . . . 0.0 104.111 178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 117.6 -170.55 13.59 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 120.669 -1.269 . . . . 0.0 110.472 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -78.07 -177.16 3.66 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 123.637 2.892 . . . . 0.0 110.289 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -107.3 -20.16 13.36 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.573 -0.705 . . . . 0.0 111.972 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 mt -137.92 151.84 25.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.546 0.689 . . . . 0.0 110.552 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.7 tt -140.02 139.73 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 124.656 1.182 . . . . 0.0 109.106 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -127.82 114.43 17.23 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.984 1.314 . . . . 0.0 109.695 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 13.8 t-105 -165.35 -166.01 0.94 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.295 0.952 . . . . 0.0 112.072 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -72.34 133.4 44.94 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.077 2.151 . . . . 0.0 109.682 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.8 p-80 -60.08 -29.47 68.58 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.579 1.952 . . . . 0.0 112.308 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.98 -37.6 78.84 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.844 0.747 . . . . 0.0 110.403 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -24.46 56.87 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -68.66 -30.84 69.62 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.79 -36.26 86.01 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -70.84 -52.54 14.42 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -56.16 -34.66 66.36 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 118.531 1.165 . . . . 0.0 111.057 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.4 -45.67 83.03 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -40.78 88.09 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.1 m -63.66 -12.47 34.24 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.611 -0.68 . . . . 0.0 110.138 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.55 16.22 76.23 Favored Glycine 0 C--N 1.339 0.724 0 C-N-CA 125.744 1.64 . . . . 0.0 112.215 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.1 mt -88.15 -10.25 50.58 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.6 mt -96.14 140.9 30.18 Favored 'General case' 0 C--N 1.343 0.321 0 CA-C-N 118.778 0.717 . . . . 0.0 110.954 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.03 172.2 8.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.981 1.312 . . . . 0.0 112.152 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -78.11 90.18 4.24 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.453 1.501 . . . . 0.0 111.834 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.447 HD12 ' HB ' ' A' ' 80' ' ' THR . 2.4 pp -73.23 178.74 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.815 1.246 . . . . 0.0 111.444 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.447 ' HB ' HD12 ' A' ' 79' ' ' ILE 0.337 0.5 OUTLIER 57.77 74.42 0.65 Allowed Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 127.602 2.361 . . . . 0.0 106.363 -178.447 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -64.42 -24.49 64.1 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.72 2.28 . . . . 0.0 113.605 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -147.13 148.59 31.73 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.709 0.804 . . . . 0.0 109.805 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.9 tppt? -55.64 -29.46 59.28 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.842 2.057 . . . . 0.0 112.977 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -60.25 -36.24 77.34 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.331 0.514 . . . . 0.0 110.102 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -58.6 -32.64 69.17 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.514 0.726 . . . . 0.0 111.595 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -64.27 -46.52 83.32 Favored 'General case' 0 CA--C 1.529 0.136 0 O-C-N 121.675 -0.64 . . . . 0.0 110.587 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 47.3 m-20 -66.95 -19.15 65.67 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -74.26 -11.47 60.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 118.734 -0.651 . . . . 0.0 112.348 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mt -124.55 160.91 27.31 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 125.272 1.429 . . . . 0.0 110.545 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -72.07 150.27 92.4 Favored Pre-proline 0 C--O 1.239 0.546 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.96 -44.45 12.89 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 123.075 2.516 . . . . 0.0 114.416 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -58.19 -34.32 70.23 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.029 0.832 . . . . 0.0 111.782 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -29.82 71.08 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.049 -1.032 . . . . 0.0 111.024 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -73.72 -35.23 65.06 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.602 -0.713 . . . . 0.0 110.32 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.76 -31.55 64.71 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.231 0.923 . . . . 0.0 112.501 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.3 -29.75 67.67 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.8 m -102.58 2.64 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.559 1.144 . . . . 0.0 113.733 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -63.79 160.38 17.41 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 122.328 1.061 . . . . 0.0 110.163 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -143.92 175.0 10.35 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -70.6 110.16 5.29 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 123.456 0.702 . . . . 0.0 110.463 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.88 -78.29 0.77 Allowed Glycine 0 C--N 1.335 0.486 0 C-N-CA 125.862 1.696 . . . . 0.0 111.028 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.04 166.25 21.76 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.69 165.5 11.12 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 23.9 pt -128.51 -30.52 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -154.88 176.78 12.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 119.148 0.885 . . . . 0.0 108.62 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.56 145.92 58.95 Favored Pre-proline 0 C--O 1.238 0.473 0 O-C-N 123.083 0.239 . . . . 0.0 110.852 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -66.47 147.96 83.2 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.561 2.841 . . . . 0.0 107.847 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 mm -133.43 -52.44 0.67 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 124.043 0.937 . . . . 0.0 110.67 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -131.38 167.29 19.53 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 123.336 0.398 . . . . 0.0 111.297 -178.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 80.5 t -135.31 141.15 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -137.07 165.6 25.65 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.679 1.592 . . . . 0.0 107.525 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.03 176.23 12.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.581 1.552 . . . . 0.0 107.838 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.57 166.61 6.57 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.742 0.817 . . . . 0.0 109.912 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 82.5 p -146.62 159.38 43.52 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 52.5 tp -76.8 146.05 38.09 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 42.7 mt -121.86 133.07 69.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -118.43 174.72 6.08 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.361 1.064 . . . . 0.0 109.878 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -73.27 -179.04 3.18 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.678 0.791 . . . . 0.0 112.847 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.93 -9.88 48.74 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.367 1.067 . . . . 0.0 113.214 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.82 -172.96 0.57 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.237 1.815 . . . . 0.0 108.317 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.3 pp -123.96 1.29 8.64 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.208 1.003 . . . . 0.0 109.199 176.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -42.88 101.44 0.25 Allowed Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 129.796 3.239 . . . . 0.0 109.966 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.56 106.31 1.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.73 2.953 . . . . 0.0 111.437 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -155.61 75.4 5.11 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -73.9 116.65 4.73 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.877 3.051 . . . . 0.0 116.708 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -81.77 171.59 13.03 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.607 2.871 . . . . 0.0 110.164 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -136.75 -33.66 0.77 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.834 1.253 . . . . 0.0 111.804 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.2 162.62 33.79 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 117.974 0.352 . . . . 0.0 110.844 -177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.405 ' CE2' HD13 ' A' ' 160' ' ' LEU . 28.3 m95 -67.23 -18.23 65.15 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 119.205 -0.426 . . . . 0.0 111.999 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -64.51 -8.5 14.05 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.877 1.271 . . . . 0.0 113.4 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -107.08 -18.76 13.81 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.668 1.587 . . . . 0.0 110.996 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.6 mm -56.9 -58.18 19.36 Favored Pre-proline 0 C--N 1.333 -0.141 0 O-C-N 120.823 -1.173 . . . . 0.0 111.822 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -67.41 -25.61 41.74 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 CA-C-N 120.501 1.215 . . . . 0.0 110.717 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.85 -41.16 83.34 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.631 1.173 . . . . 0.0 110.349 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 66.6 tp -82.46 -27.89 31.58 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.148 0.885 . . . . 0.0 109.759 178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -61.71 -44.91 96.02 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 121.325 -0.86 . . . . 0.0 109.615 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.8 ptmm? -64.54 -28.42 69.63 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 119.268 -0.396 . . . . 0.0 111.558 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -75.11 -43.35 53.34 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 123.102 0.561 . . . . 0.0 110.658 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 54.2 mt -75.38 -29.96 60.0 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.465 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.14 -38.04 81.73 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.8 -22.16 66.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.704 1.202 . . . . 0.0 113.07 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.12 4.92 9.81 Favored 'General case' 0 CA--C 1.526 0.054 0 C-N-CA 125.445 1.498 . . . . 0.0 112.358 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 177.92 -95.47 0.1 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 119.37 0.986 . . . . 0.0 113.634 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -142.1 178.21 7.69 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.84 1.256 . . . . 0.0 111.617 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.18 154.01 10.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.878 1.271 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.93 -63.54 1.34 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.954 1.302 . . . . 0.0 111.999 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 41.2 tp -97.43 138.08 35.42 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.323 1.049 . . . . 0.0 110.707 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.415 ' CE ' HG22 ' A' ' 212' ' ' ILE . 94.3 mtp -145.44 110.25 5.12 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -142.19 157.18 45.15 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -72.97 137.66 45.61 Favored 'General case' 0 N--CA 1.457 -0.085 0 CA-C-O 121.615 0.722 . . . . 0.0 110.744 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 27.8 mt -121.01 -9.51 9.21 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.807 1.643 . . . . 0.0 111.276 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -72.14 -22.26 61.34 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.625 0.77 . . . . 0.0 112.53 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -113.99 152.05 45.39 Favored Pre-proline 0 N--CA 1.468 0.425 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.46 -11.83 10.46 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.594 2.196 . . . . 0.0 114.791 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -60.57 -41.85 95.45 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 120.896 1.68 . . . . 0.0 111.986 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -76.42 -28.81 56.78 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 79.0 p -91.43 -9.4 44.77 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.474 0.71 . . . . 0.0 111.001 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -62.36 -61.13 8.19 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 121.173 -0.954 . . . . 0.0 111.84 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.19 -19.79 69.44 Favored 'Trans proline' 0 C--N 1.351 0.698 0 CA-C-N 121.216 1.47 . . . . 0.0 112.625 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.405 HD13 ' CE2' ' A' ' 129' ' ' TRP . 47.1 tp -68.19 -61.6 1.78 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 15.8 pt -67.03 -27.33 39.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 118.254 0.479 . . . . 0.0 111.687 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -79.1 0.58 27.49 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.762 -1.211 . . . . 0.0 112.929 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.99 -52.34 66.19 Favored 'General case' 0 N--CA 1.458 -0.067 0 CA-C-N 119.408 1.004 . . . . 0.0 112.076 -178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -58.3 -58.43 8.53 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.744 0.817 . . . . 0.0 110.757 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -176.61 25.78 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 118.543 -1.143 . . . . 0.0 113.492 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.21 149.44 37.42 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -152.61 138.8 18.32 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -73.54 -64.79 0.92 Allowed 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.86 126.64 32.68 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -69.8 148.97 48.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.992 0.517 . . . . 0.0 110.297 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -148.85 105.63 3.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -77.71 -166.41 0.77 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.85 1.26 . . . . 0.0 109.036 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -62.18 16.97 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.475 2.71 . . . . 0.0 113.403 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 149.22 -2.8 0.62 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.989 1.757 . . . . 0.0 113.761 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -112.25 120.38 41.56 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.462 1.631 . . . . 0.0 107.732 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -118.43 112.88 20.55 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -125.86 106.3 9.56 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.436 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -59.46 -6.82 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.313 1.445 . . . . 0.0 112.183 179.247 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.55 -31.79 57.81 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.857 1.663 . . . . 0.0 110.723 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.86 101.34 12.22 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 97.0 t -120.8 135.87 59.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 125.694 1.598 . . . . 0.0 109.784 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -114.3 18.1 18.52 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 119.202 -0.776 . . . . 0.0 114.664 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 66.4 t -49.52 -40.99 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 126.133 1.773 . . . . 0.0 114.051 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.8 23.91 12.6 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 29.2 m-20 -70.56 167.6 18.12 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.406 0.622 . . . . 0.0 111.022 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.61 60.04 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.714 1.205 . . . . 0.0 113.691 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.85 -35.3 65.77 Favored Glycine 0 CA--C 1.524 0.599 0 CA-C-N 118.617 0.644 . . . . 0.0 112.288 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -68.23 -51.63 43.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.677 0.791 . . . . 0.0 109.459 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -61.75 -36.59 81.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.374 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -60.92 -48.91 79.65 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 118.668 0.667 . . . . 0.0 109.98 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -63.75 -36.88 93.89 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 27.3 tp -72.16 -51.09 22.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.47 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 6.2 t -56.21 -32.99 64.92 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.623 1.101 . . . . 0.0 111.122 -179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -58.66 -59.44 5.39 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.464 1.029 . . . . 0.0 109.232 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.06 -45.55 94.28 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 123.317 0.647 . . . . 0.0 110.529 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 73.8 t -57.87 -32.03 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.122 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.369 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.02 -35.84 82.47 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.983 1.265 . . . . 0.0 111.1 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 25.1 mt -64.73 -36.19 83.5 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.25 -41.88 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.094 1.358 . . . . 0.0 109.182 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -52.55 -45.56 66.41 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.97 1.308 . . . . 0.0 108.917 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -88.24 2.76 51.58 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.148 1.779 . . . . 0.0 112.749 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 8.1 mptt 56.51 19.93 4.49 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 127.319 2.248 . . . . 0.0 112.934 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -72.67 -31.45 65.07 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 121.207 -0.933 . . . . 0.0 109.429 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 3.0 tpt -89.19 -176.61 5.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.811 1.645 . . . . 0.0 111.514 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -125.63 73.14 1.31 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.576 1.55 . . . . 0.0 108.84 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.73 -18.77 56.53 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -79.81 -7.12 58.49 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.418 1.887 . . . . 0.0 112.564 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 51.9 m -72.19 120.81 18.31 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 122.303 1.049 . . . . 0.0 109.339 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -118.7 175.1 5.89 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 105.684 -1.969 . . . . 0.0 105.684 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -48.73 -41.23 31.29 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.507 0.723 . . . . 0.0 112.262 -178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 5.8 t -57.35 -51.96 67.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.562 1.945 . . . . 0.0 111.954 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.415 HG22 ' CE ' ' A' ' 148' ' ' MET . 16.5 mm -61.75 -47.71 92.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 124.406 1.082 . . . . 0.0 111.323 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -70.1 -45.84 66.11 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.969 -178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -56.94 -45.09 83.02 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 118.451 0.569 . . . . 0.0 111.023 -178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.86 -57.91 10.65 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.207 0.603 . . . . 0.0 109.97 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -53.35 -47.28 69.53 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.694 0.798 . . . . 0.0 110.826 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -59.03 -41.47 87.86 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.9 1.28 . . . . 0.0 111.622 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -61.03 -37.01 81.05 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.763 0.711 . . . . 0.0 110.413 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -74.48 -45.09 48.3 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 116.06 14.3 7.9 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.916 2.198 . . . . 0.0 109.755 -178.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -70.29 21.34 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 129.763 3.225 . . . . 0.0 112.789 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 3.2 p -130.48 174.74 9.59 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 127.57 2.348 . . . . 0.0 109.345 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -127.09 -33.73 2.4 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 123.742 0.817 . . . . 0.0 112.106 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 7.8 ptt? -152.86 161.15 42.92 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.847 0.859 . . . . 0.0 109.05 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.0 t -151.83 173.07 15.22 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 14.4 mt -139.89 93.12 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -132.47 166.14 22.71 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.017 0.927 . . . . 0.0 109.188 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -125.52 171.78 17.45 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.111 0.862 . . . . 0.0 113.899 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.12 173.89 5.54 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 125.152 3.901 . . . . 0.0 112.881 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 14.3 t90 68.85 -12.45 0.38 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.762 2.425 . . . . 0.0 112.366 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.72 95.75 1.93 Allowed 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 61.4 t90 -78.63 100.99 7.23 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 14.4 m -117.3 -42.84 2.87 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.318 1.047 . . . . 0.0 110.726 179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -130.99 177.47 7.42 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.301 1.841 . . . . 0.0 108.212 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 60.6 mt -124.9 95.11 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 102.175 -3.269 . . . . 0.0 102.175 178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -134.71 137.27 43.37 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.832 1.253 . . . . 0.0 107.618 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 24.3 m -83.09 104.99 13.7 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.455 1.102 . . . . 0.0 110.015 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 17.0 p -68.78 97.69 0.84 Allowed 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.648 1.179 . . . . 0.0 109.748 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -139.45 144.77 38.19 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.117 0.967 . . . . 0.0 108.83 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . 0.371 10.3 p 55.45 38.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 125.572 1.549 . . . . 0.0 110.165 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -76.99 74.4 3.57 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -94.03 167.54 11.53 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.748 0.819 . . . . 0.0 109.844 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 84.71 133.44 2.7 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 27.0 m -144.62 159.55 14.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.2 t -163.11 171.0 17.02 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.64 161.31 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 178.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.81 156.17 45.33 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 124.26 1.024 . . . . 0.0 109.185 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.78 125.97 10.38 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.527 2.152 . . . . 0.0 109.947 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 255' ' ' SER . 43.4 p -143.5 -151.44 0.36 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -108.44 141.8 39.77 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 177.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -53.0 125.83 18.5 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.415 1.886 . . . . 0.0 110.386 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 61.63 11.67 30.27 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.039 -0.867 . . . . 0.0 114.808 178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.57 75.75 5.06 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -72.1 154.87 57.38 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 121.971 1.781 . . . . 0.0 114.112 -178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.404 ' H ' ' HB ' ' A' ' 249' ' ' THR . 33.8 m -65.01 140.88 58.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' A' ' 256' ' ' LYS . 0.1 OUTLIER -146.19 93.32 5.09 Favored Pre-proline 0 N--CA 1.451 -0.382 0 C-N-CA 125.227 1.411 . . . . 0.0 109.053 -178.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.32 -63.01 0.11 Allowed 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.327 2.018 . . . . 0.0 111.472 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -153.06 174.35 14.3 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 125.667 1.587 . . . . 0.0 108.366 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.9 113.99 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -121.12 132.8 9.3 Favored Glycine 0 CA--C 1.52 0.365 0 N-CA-C 105.398 -3.081 . . . . 0.0 105.398 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 22.3 m -132.48 156.77 42.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-N 117.852 0.826 . . . . 0.0 109.851 -178.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.3 tt -92.7 139.97 30.01 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.017 0.927 . . . . 0.0 109.115 178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 6.2 m -131.75 169.11 16.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.154 0.982 . . . . 0.0 112.138 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -134.69 140.42 45.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.865 1.266 . . . . 0.0 108.325 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.64 167.69 16.92 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 92.9 mt -117.48 135.59 57.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.07 115.28 14.53 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -59.82 -15.53 21.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.65 0.78 . . . . 0.0 113.012 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -66.29 -23.24 66.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.332 1.053 . . . . 0.0 111.663 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 11.2 m -60.42 154.81 52.08 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 126.187 1.795 . . . . 0.0 112.649 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.5 -47.63 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.347 2.032 . . . . 0.0 111.801 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -128.44 86.25 2.43 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.701 0.8 . . . . 0.0 109.477 -178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -52.84 -24.05 8.23 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.236 1.414 . . . . 0.0 112.332 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -59.37 -34.68 72.71 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.193 1.797 . . . . 0.0 110.15 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 93.8 mt -61.24 -36.98 81.43 Favored 'General case' 0 CA--C 1.528 0.108 0 O-C-N 120.713 -1.242 . . . . 0.0 110.009 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.23 57.45 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.948 -0.549 . . . . 0.0 111.028 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -37.4 87.07 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.845 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -71.54 -51.24 24.57 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 124.024 0.828 . . . . 0.0 109.747 -179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.422 ' CE2' HD11 ' A' ' 9' ' ' ILE . 9.0 t80 -48.87 -52.91 21.75 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.913 0.485 . . . . 0.0 110.295 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.86 -55.23 31.96 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 122.321 0.248 . . . . 0.0 111.353 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . 0.318 7.6 pt-20 -71.57 1.65 6.28 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -177.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -115.11 -21.0 10.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 117.229 -1.367 . . . . 0.0 111.226 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -132.5 -59.21 0.92 Allowed 'General case' 0 C--N 1.346 0.418 0 CA-C-N 119.998 1.272 . . . . 0.0 109.673 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.65 -42.48 62.11 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 44.0 mt -82.91 27.52 0.54 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 -178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 14.8 p -113.7 167.77 10.34 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 177.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.57 -38.51 90.35 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -71.41 -38.55 71.41 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.982 0.913 . . . . 0.0 111.604 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -69.08 -45.7 61.36 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 64.8 mt -64.94 -46.41 81.72 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -57.1 -43.57 82.35 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.802 0.841 . . . . 0.0 110.291 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -54.2 -49.92 68.28 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.65 -36.33 59.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 119.375 -0.345 . . . . 0.0 110.24 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -63.75 -27.43 69.19 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 123.706 0.803 . . . . 0.0 111.656 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -67.44 -43.64 80.65 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.759 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -70.24 -56.44 6.76 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.878 0.763 . . . . 0.0 109.749 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -134.92 145.04 52.95 Favored Pre-proline 0 C--O 1.233 0.211 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.27 136.37 40.09 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.518 2.145 . . . . 0.0 112.252 -178.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 80.3 mt -78.48 -29.84 46.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 101.09 -78.39 0.4 Allowed Glycine 0 C--N 1.338 0.682 0 N-CA-C 105.9 -2.88 . . . . 0.0 105.9 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -149.35 171.09 17.09 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 131.577 3.951 . . . . 0.0 104.93 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 35.9 m -132.18 149.88 32.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 O-C-N 120.656 -1.277 . . . . 0.0 112.244 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.69 -21.33 55.52 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.623 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.93 105.26 1.94 Allowed 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 126.287 1.835 . . . . 0.0 107.256 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -53.57 -27.63 27.47 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 8.9 m -73.11 -61.18 1.91 Allowed 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 118.552 0.614 . . . . 0.0 111.246 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -67.36 -23.63 65.62 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 118.74 -0.648 . . . . 0.0 112.571 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -63.95 -21.41 66.47 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.206 0.912 . . . . 0.0 108.719 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -72.97 -37.51 67.05 Favored 'General case' 0 C--N 1.342 0.245 0 O-C-N 120.286 -1.509 . . . . 0.0 108.725 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -70.26 -46.91 63.42 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.185 0.994 . . . . 0.0 108.607 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.437 ' O ' HD13 ' A' ' 317' ' ' ILE . 23.1 mt -63.31 -40.71 98.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.17 -11.63 9.79 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -63.82 -11.48 27.47 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.488 1.04 . . . . 0.0 111.201 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.52 133.66 23.53 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -56.78 -23.85 52.38 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.133 2.555 . . . . 0.0 115.946 -177.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.465 ' HG2' HD12 ' A' ' 317' ' ' ILE . 0.0 OUTLIER -62.66 -44.18 96.92 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 120.298 1.408 . . . . 0.0 110.802 179.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.465 HD12 ' HG2' ' A' ' 316' ' ' ARG . 4.8 mp -74.55 -46.38 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.55 -52.23 48.82 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.291 0.496 . . . . 0.0 110.112 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -61.85 -35.63 78.85 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.722 -0.611 . . . . 0.0 112.059 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 89.0 m -62.04 -39.25 91.71 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.58 -40.77 48.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.694 0.398 . . . . 0.0 110.55 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -53.05 -45.78 68.21 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.436 1.495 . . . . 0.0 109.784 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.3 -41.35 94.18 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.76 -36.5 83.27 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.838 0.745 . . . . 0.0 111.414 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 14.2 mm-40 -63.66 -30.52 71.62 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.455 1.502 . . . . 0.0 110.622 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.28 10.11 41.72 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.176 0.99 . . . . 0.0 111.807 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -118.87 -179.59 16.83 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 115.086 0.794 . . . . 0.0 115.086 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -139.98 164.33 30.31 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.041 1.337 . . . . 0.0 110.596 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 31.4 mt -78.16 160.73 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 125.521 1.529 . . . . 0.0 108.128 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 46.3 ttp -66.33 139.99 96.54 Favored Pre-proline 0 CA--C 1.538 0.494 0 O-C-N 121.085 -1.01 . . . . 0.0 108.512 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.29 179.5 6.31 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.505 2.137 . . . . 0.0 112.482 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -138.77 10.09 2.64 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.794 1.638 . . . . 0.0 110.99 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 41.9 pt -82.3 154.59 69.33 Favored Pre-proline 0 CA--C 1.538 0.488 0 O-C-N 120.341 -1.475 . . . . 0.0 111.213 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -76.46 -17.01 16.78 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.163 2.575 . . . . 0.0 113.497 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -57.45 -21.57 37.85 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.501 1.12 . . . . 0.0 112.506 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 73.8 mmm -57.83 -31.13 66.32 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.336 1.054 . . . . 0.0 111.154 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 22.4 t -57.3 -53.04 62.65 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.88 -29.64 65.79 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 118.401 -0.809 . . . . 0.0 112.101 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.57 ' O ' HG22 ' A' ' 343' ' ' VAL . 52.7 t80 -57.75 -58.53 7.97 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.573 0.624 . . . . 0.0 109.754 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -56.25 -44.01 79.25 Favored 'General case' 0 CA--C 1.522 -0.098 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -59.09 -39.92 83.71 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.113 0.415 . . . . 0.0 110.942 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.38 -59.98 2.95 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.157 0.583 . . . . 0.0 111.675 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 339' ' ' PHE . 3.2 m -59.27 -36.73 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 118.944 -0.551 . . . . 0.0 111.901 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 56.9 ttp85 -56.75 -37.22 70.74 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.261 0.937 . . . . 0.0 109.774 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 54.0 m -79.93 -44.49 20.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 118.683 -0.675 . . . . 0.0 109.834 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -53.45 -46.05 69.71 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 119.384 0.993 . . . . 0.0 112.882 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 89.0 t -59.11 -52.78 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 50.8 mm -64.08 -35.51 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.845 0.748 . . . . 0.0 110.491 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -61.22 -45.83 92.96 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.623 -1.298 . . . . 0.0 110.537 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.57 -50.32 32.23 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.128 0.571 . . . . 0.0 111.378 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -61.42 -35.54 77.84 Favored 'General case' 0 C--O 1.231 0.101 0 C-N-CA 125.461 1.504 . . . . 0.0 114.895 -178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 28.9 m -91.22 0.33 57.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.206 0.602 . . . . 0.0 109.87 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 71.13 12.87 72.5 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 119.379 -0.679 . . . . 0.0 113.534 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -64.54 -32.96 74.82 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.313 1.056 . . . . 0.0 108.469 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -147.3 163.65 35.72 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 2.3 m -66.45 155.94 36.13 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.272 1.029 . . . . 0.0 108.917 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 74.9 t -56.58 -52.64 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 123.776 0.83 . . . . 0.0 110.001 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.66 -50.8 71.02 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.486 1.115 . . . . 0.0 110.159 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -62.0 -42.06 98.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -59.76 -43.52 94.27 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 122.025 -0.422 . . . . 0.0 110.248 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 46.6 mt -71.23 -42.89 68.3 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.341 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -54.63 -50.74 67.4 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 124.396 1.079 . . . . 0.0 108.838 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.7 -49.95 69.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -58.89 -46.42 87.88 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-O 117.937 -1.03 . . . . 0.0 112.159 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -58.84 -38.18 78.12 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 119.27 0.941 . . . . 0.0 108.676 178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.4 m -64.22 -47.16 80.78 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.913 0.885 . . . . 0.0 109.309 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 72.0 mtt-85 -57.89 -25.71 61.17 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.321 0.964 . . . . 0.0 113.212 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 70.1 mt -94.57 -19.26 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 126.925 2.09 . . . . 0.0 112.101 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 66.5 p -113.56 1.95 15.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.24 1.382 . . . . 0.0 114.459 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? . . . . . 0 C--O 1.248 1.013 0 C-N-CA 125.179 1.392 . . . . 0.0 109.134 179.5 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 11.3 tptt . . . . . 0 N--CA 1.467 0.411 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 57.5 mt -92.79 128.13 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.92 121.3 20.75 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.939 1.696 . . . . 0.0 107.409 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.82 165.44 14.13 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.727 0.694 . . . . 0.0 111.037 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 67.15 35.78 89.16 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 125.101 1.334 . . . . 0.0 114.768 178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -143.51 169.58 17.44 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 118.809 1.304 . . . . 0.0 112.974 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.1 mt -151.98 141.24 21.41 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 129.207 3.003 . . . . 0.0 108.012 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.9 t -140.08 134.44 36.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 CA-C-N 119.784 1.175 . . . . 0.0 108.78 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 6.2 mt -124.11 128.69 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 125.244 1.417 . . . . 0.0 108.752 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -114.61 138.99 49.99 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.38 159.98 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 118.924 0.783 . . . . 0.0 109.502 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -154.39 166.43 33.26 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.27 24.2 27.29 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-O 117.823 -1.543 . . . . 0.0 114.857 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.1 t70 68.97 24.1 6.4 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.427 1.491 . . . . 0.0 114.413 178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -59.39 157.2 11.48 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.444 1.897 . . . . 0.0 112.591 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.15 67.32 3.63 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 125.794 1.664 . . . . 0.0 109.818 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -58.75 -33.74 70.61 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.839 0.819 . . . . 0.0 112.484 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -61.17 -45.69 93.6 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.525 0.602 . . . . 0.0 109.791 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.77 -37.59 94.53 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 46.7 tp -69.93 -35.98 74.97 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 121.634 -0.921 . . . . 0.0 110.977 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.49 -40.14 36.32 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 117.681 -1.152 . . . . 0.0 112.821 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.78 -37.62 74.03 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 124.843 1.257 . . . . 0.0 113.386 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 t -61.54 -52.12 64.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.66 -33.67 76.65 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -64.37 -29.42 70.49 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 118.817 1.308 . . . . 0.0 109.83 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.12 -52.04 7.81 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -53.31 -48.21 68.61 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.017 0.371 . . . . 0.0 110.453 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -60.38 -39.15 86.24 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.728 -1.232 . . . . 0.0 110.802 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 29' ' ' LYS . 13.3 tppt? -67.19 -28.3 67.98 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 123.554 0.742 . . . . 0.0 111.476 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -98.34 -3.89 36.13 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.935 1.294 . . . . 0.0 112.434 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 75.3 p -135.8 -36.04 0.77 Allowed 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.45 -15.97 61.32 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.281 1.42 . . . . 0.0 112.054 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.85 130.38 28.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -68.44 130.26 42.35 Favored 'General case' 0 CA--C 1.511 -0.545 0 O-C-N 121.498 -0.751 . . . . 0.0 109.414 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 t -128.46 118.34 47.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 33.9 m -114.34 142.96 45.65 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 123.614 0.766 . . . . 0.0 110.903 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.0 t -120.18 131.19 73.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -137.05 169.04 18.44 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.28 1.032 . . . . 0.0 109.404 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -140.25 54.55 5.3 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.26 168.31 25.11 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.877 2.385 . . . . 0.0 110.509 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -124.76 -7.71 7.33 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.258 1.023 . . . . 0.0 111.142 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.408 ' H ' ' HD2' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -95.14 2.52 55.08 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.39 1.876 . . . . 0.0 111.103 -179.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.638 HD22 ' N ' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -48.55 -34.09 10.81 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 124.193 0.997 . . . . 0.0 111.988 179.297 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.638 ' N ' HD22 ' A' ' 43' ' ' LEU . 11.7 pt-20 -46.7 -33.57 4.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.04 2.136 . . . . 0.0 111.93 178.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -120.04 -21.25 7.15 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 125.92 1.688 . . . . 0.0 111.067 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -46.68 21.51 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 120.383 -1.448 . . . . 0.0 110.879 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -49.66 -55.62 21.87 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.41 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.7 0.33 3.1 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.899 1.733 . . . . 0.0 114.962 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -109.72 -15.48 14.13 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 119.865 1.211 . . . . 0.0 112.548 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 t -115.41 -28.36 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.64 1.176 . . . . 0.0 110.215 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.48 -18.27 59.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.075 -1.016 . . . . 0.0 110.725 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.98 -20.27 62.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.137 0.975 . . . . 0.0 110.985 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 38.7 p -119.96 -2.47 10.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.563 1.545 . . . . 0.0 112.572 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.14 8.94 85.82 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 -178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -78.8 -14.05 59.47 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.362 -1.081 . . . . 0.0 109.947 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.37 -172.85 48.4 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.898 1.714 . . . . 0.0 115.104 -178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -64.95 -178.05 0.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 124.73 3.62 . . . . 0.0 112.507 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -116.31 -12.85 11.08 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.5 mt -140.87 150.61 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 tt -137.62 132.64 45.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.659 -1.978 . . . . 0.0 105.659 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -121.22 107.99 13.22 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.25 1.82 . . . . 0.0 108.235 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -151.46 -175.67 5.28 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.49 147.01 40.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 121.02 -1.05 . . . . 0.0 108.662 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -49.19 -45.44 44.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.237 1.415 . . . . 0.0 112.223 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -62.31 -4.73 1.94 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.683 1.993 . . . . 0.0 115.534 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -110.55 -4.25 15.57 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 119.215 0.916 . . . . 0.0 110.871 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -97.32 -18.98 18.83 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -177.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.42 -44.58 77.01 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 120.207 1.367 . . . . 0.0 112.217 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.75 -47.88 30.97 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-O 118.722 -1.043 . . . . 0.0 112.014 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -55.78 -39.12 70.82 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.985 1.393 . . . . 0.0 110.465 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB2' HD12 ' A' ' 76' ' ' LEU . . . -65.61 -47.34 76.0 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 118.706 -0.664 . . . . 0.0 109.429 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -37.14 80.18 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.529 0.604 . . . . 0.0 110.012 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.8 m -63.97 -13.74 48.52 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.13 -0.981 . . . . 0.0 110.686 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 88.34 10.94 67.51 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 126.168 1.842 . . . . 0.0 113.426 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.5 mt -83.68 -3.71 57.99 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.949 1.374 . . . . 0.0 114.203 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 71' ' ' ALA . 28.8 mt -109.0 137.57 46.7 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 120.048 1.294 . . . . 0.0 110.139 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.94 179.56 5.49 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.604 1.162 . . . . 0.0 111.812 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -92.19 92.04 8.03 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.4 pp -69.28 169.35 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 C-N-CA 123.991 0.916 . . . . 0.0 112.413 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.283 7.6 p 49.51 73.69 0.95 Allowed Pre-proline 0 CA--C 1.535 0.386 0 C-N-CA 127.459 2.304 . . . . 0.0 112.054 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.11 -22.68 46.96 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.628 2.219 . . . . 0.0 112.667 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -128.81 164.31 23.33 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.616 1.967 . . . . 0.0 108.895 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -85.52 -34.9 21.44 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 -177.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.76 -21.59 19.79 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 120.456 1.48 . . . . 0.0 114.531 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -68.5 -30.18 68.95 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -64.69 -41.08 96.29 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 120.964 -1.085 . . . . 0.0 110.024 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.81 -16.46 63.11 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.556 1.542 . . . . 0.0 112.123 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -84.66 -2.56 57.69 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 120.896 -1.127 . . . . 0.0 110.967 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.8 mt -131.14 159.22 38.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.371 1.068 . . . . 0.0 110.493 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -77.68 152.43 80.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.452 0.701 . . . . 0.0 109.272 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.88 -42.56 3.18 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.719 2.946 . . . . 0.0 114.75 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -58.09 -44.31 87.53 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.668 1.122 . . . . 0.0 110.707 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.75 -28.33 69.51 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.102 1.361 . . . . 0.0 111.26 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -71.3 -42.63 68.42 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.24 0.616 . . . . 0.0 110.331 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -55.12 -28.23 51.15 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.903 0.881 . . . . 0.0 111.647 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.37 -23.73 65.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.07 1.348 . . . . 0.0 114.263 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.6 m -120.57 11.61 6.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.375 1.07 . . . . 0.0 112.368 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 mtp85 -72.25 147.72 46.18 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.288 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.477 ' CD1' ' HE3' ' A' ' 102' ' ' LYS . 51.2 t80 -131.84 178.69 6.57 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.935 1.294 . . . . 0.0 108.543 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.9 m-20 -57.67 89.82 0.01 OUTLIER 'General case' 0 C--O 1.235 0.308 0 C-N-CA 127.711 2.404 . . . . 0.0 109.546 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.14 -77.93 1.13 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.477 ' HE3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -66.83 177.03 1.79 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.8 1.24 . . . . 0.0 109.395 179.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.7 mt -116.52 -179.54 3.71 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 123.523 0.729 . . . . 0.0 110.893 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.9 pt -133.74 -29.54 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -162.5 177.64 9.3 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.969 0.804 . . . . 0.0 109.443 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -126.38 145.93 54.58 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 124.238 1.015 . . . . 0.0 108.733 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.37 145.73 54.45 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.925 2.417 . . . . 0.0 108.17 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.0 mm -129.0 -50.56 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 123.369 0.668 . . . . 0.0 109.963 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.25 157.39 44.49 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 120.932 0.396 . . . . 0.0 111.169 -178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 23.6 t -135.15 119.37 26.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.006 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -161.2 149.99 16.21 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.172 0.989 . . . . 0.0 109.313 178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.4 81.64 1.67 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.696 1.198 . . . . 0.0 110.523 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.94 107.62 1.28 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.949 1.3 . . . . 0.0 109.447 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.1 p -149.0 131.29 15.56 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.492 1.117 . . . . 0.0 110.694 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.8 tp -136.13 170.2 16.39 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.645 1.178 . . . . 0.0 110.56 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 14.5 mt -135.55 140.16 45.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 126.288 1.835 . . . . 0.0 106.9 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -141.33 171.26 14.31 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 126.581 1.952 . . . . 0.0 107.404 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -58.69 157.48 9.3 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.234 0.54 . . . . 0.0 111.438 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -70.61 -6.91 40.23 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 124.024 0.93 . . . . 0.0 112.76 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -69.16 158.32 35.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.896 0.855 . . . . 0.0 110.378 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.96 9.78 0.86 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.05 2.14 . . . . 0.0 115.65 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.25 69.27 2.6 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 125.145 1.378 . . . . 0.0 113.717 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -76.01 89.29 1.25 Allowed 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.676 2.917 . . . . 0.0 112.19 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -129.83 68.08 80.23 Favored Pre-proline 0 N--CA 1.466 0.365 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -72.11 168.08 25.03 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.061 2.508 . . . . 0.0 113.014 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.7 171.25 13.58 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.75 2.967 . . . . 0.0 113.571 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -123.85 -17.13 6.42 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 117.192 -1.385 . . . . 0.0 112.776 179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.65 143.93 31.0 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 120.84 1.655 . . . . 0.0 112.205 -178.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -65.24 -22.77 66.92 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.394 -0.816 . . . . 0.0 111.911 179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -72.19 -12.78 61.33 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.371 0.668 . . . . 0.0 111.934 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -98.85 -19.02 17.61 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.094 1.758 . . . . 0.0 111.014 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.33 -52.62 70.04 Favored Pre-proline 0 N--CA 1.465 0.319 0 C-N-CA 124.6 1.16 . . . . 0.0 109.851 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -69.37 -24.76 31.12 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 CA-C-N 120.248 1.124 . . . . 0.0 111.771 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.35 -54.23 27.01 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 59.7 tp -62.08 -30.02 70.71 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.175 -0.953 . . . . 0.0 110.316 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -61.78 -45.18 95.0 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.616 1.166 . . . . 0.0 110.352 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 3.6 ptmm? -74.39 -25.48 59.5 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.523 -0.736 . . . . 0.0 111.688 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.58 -45.84 61.06 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.675 -0.679 . . . . 0.0 110.249 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . 0.259 6.2 mt -80.1 -24.18 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 117.876 -1.53 . . . . 0.0 110.799 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -66.96 -31.56 72.21 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.19 -11.89 60.02 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 119.21 -0.424 . . . . 0.0 111.56 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.67 0.77 8.16 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 125.516 1.527 . . . . 0.0 111.932 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 172.14 -91.05 0.09 OUTLIER Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 119.467 1.031 . . . . 0.0 113.721 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.08 -175.83 4.38 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.802 0.841 . . . . 0.0 109.659 -178.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.7 p -74.34 166.2 23.88 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -79.37 -63.9 1.31 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 128.039 2.536 . . . . 0.0 112.268 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.4 tp -102.92 137.15 41.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.473 1.509 . . . . 0.0 107.941 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 65.6 mtp -148.34 103.07 3.4 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 128.373 2.669 . . . . 0.0 105.721 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -128.33 161.93 28.27 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -72.38 93.56 1.54 Allowed 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 122.007 0.908 . . . . 0.0 112.114 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 31.5 mt -73.48 -8.81 57.46 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.631 1.572 . . . . 0.0 110.288 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -70.58 -19.12 62.88 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.403 1.481 . . . . 0.0 112.597 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -115.66 135.62 22.69 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 119.619 1.1 . . . . 0.0 111.896 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.05 -21.93 48.48 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.759 2.306 . . . . 0.0 112.961 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -59.96 -27.34 66.73 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.505 0.593 . . . . 0.0 112.237 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -86.85 -44.91 11.34 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 118.791 0.723 . . . . 0.0 111.307 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.5 p -76.99 -17.2 59.02 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -62.12 -60.85 8.95 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 117.844 -1.074 . . . . 0.0 113.073 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.451 ' HA ' ' HB3' ' A' ' 162' ' ' ALA . 30.5 Cg_endo -61.9 -23.53 76.05 Favored 'Trans proline' 0 C--N 1.351 0.695 0 CA-C-N 122.318 1.863 . . . . 0.0 111.422 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.34 -57.59 10.78 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 22.6 pt -69.19 -25.25 29.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.028 0.442 . . . . 0.0 111.229 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 159' ' ' PRO . . . -67.56 -23.14 65.39 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 120.901 -1.124 . . . . 0.0 111.06 178.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.76 87.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -57.96 -58.9 6.37 Favored 'General case' 0 C--N 1.344 0.33 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 171.92 5.1 0.03 OUTLIER Glycine 0 CA--C 1.522 0.523 0 CA-C-O 118.688 -1.062 . . . . 0.0 115.064 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.62 129.88 33.72 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.244 1.522 . . . . 0.0 109.329 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -138.46 149.24 45.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 118.821 1.31 . . . . 0.0 108.092 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -75.09 -66.62 0.74 Allowed 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -140.19 173.22 11.73 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.266 1.427 . . . . 0.0 107.869 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -114.5 139.59 49.43 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -155.74 117.1 3.93 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.229 1.412 . . . . 0.0 107.792 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -160.32 163.33 33.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 124.898 1.279 . . . . 0.0 108.706 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 49.74 26.87 2.01 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.269 1.828 . . . . 0.0 112.961 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 78.83 9.25 87.26 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.265 -1.297 . . . . 0.0 113.469 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -115.06 118.94 34.8 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.93 1.865 . . . . 0.0 107.612 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.06 116.69 23.22 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.118 1.767 . . . . 0.0 109.451 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -130.3 104.09 7.08 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.491 HD13 ' H ' ' A' ' 178' ' ' ILE . 0.2 OUTLIER -64.6 -3.36 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 125.152 1.381 . . . . 0.0 112.341 178.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 tppt? -72.89 -36.25 67.28 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.676 1.191 . . . . 0.0 111.015 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -89.78 72.31 7.64 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.94 0.896 . . . . 0.0 111.112 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.2 138.76 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 128.295 2.638 . . . . 0.0 111.446 -178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -119.83 15.16 10.44 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 117.673 1.829 . . . . 0.0 117.673 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -65.51 -1.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 120.116 1.958 . . . . 0.0 115.36 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -125.52 14.03 8.17 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 120.641 1.564 . . . . 0.0 111.639 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -71.09 158.4 36.53 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 120.941 -1.099 . . . . 0.0 108.456 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -48.69 -31.77 7.35 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.12 -37.59 42.51 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 119.504 1.047 . . . . 0.0 112.845 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -60.07 -46.83 88.25 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 ptpm? -71.42 -35.5 70.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.415 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -56.65 -50.76 71.11 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 120.012 1.278 . . . . 0.0 111.209 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -65.83 -34.44 88.68 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 120.939 -0.648 . . . . 0.0 111.612 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 60.3 tp -70.05 -55.17 10.2 Favored 'General case' 0 C--N 1.339 0.141 0 CA-C-N 117.948 0.874 . . . . 0.0 110.476 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.432 ' HB ' HG11 ' A' ' 357' ' ' VAL . 2.0 t -55.2 -41.71 72.35 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.585 -1.198 . . . . 0.0 108.989 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -57.01 -54.05 51.1 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.707 1.14 . . . . 0.0 109.278 178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.29 -44.58 88.55 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.801 0.841 . . . . 0.0 111.33 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 72.6 t -67.16 -31.2 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 O-C-N 121.431 -0.793 . . . . 0.0 109.783 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.19 -39.91 82.37 Favored 'General case' 0 CA--C 1.52 -0.185 0 O-C-N 121.283 -0.885 . . . . 0.0 109.141 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.1 mt -63.54 -45.53 90.15 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 70.2 mt -59.37 -49.0 85.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -54.69 -37.96 66.44 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.979 0.912 . . . . 0.0 110.534 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -92.44 8.02 40.49 Favored 'General case' 0 C--O 1.226 -0.172 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? 64.8 22.16 12.49 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.976 1.71 . . . . 0.0 113.256 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -85.94 -3.97 59.05 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.769 1.228 . . . . 0.0 110.669 178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 77.4 mtp -143.64 167.33 22.51 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 126.504 1.922 . . . . 0.0 107.703 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -120.9 92.71 3.82 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 124.851 1.26 . . . . 0.0 109.728 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.99 -11.58 14.22 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.017 1.327 . . . . 0.0 114.38 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -89.1 -5.24 57.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.388 1.475 . . . . 0.0 111.762 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 23.7 m -69.96 131.1 43.87 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.74 0.816 . . . . 0.0 110.48 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.445 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 7.6 p30 -129.38 -177.5 4.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.704 2.002 . . . . 0.0 108.281 178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -62.92 -26.66 68.91 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.6 m -91.4 -34.66 14.77 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.257 1.423 . . . . 0.0 109.562 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.445 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 33.1 mm -66.13 -49.12 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -58.39 -53.15 61.57 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.946 0.898 . . . . 0.0 109.039 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -60.16 -33.88 72.8 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 118.699 -0.667 . . . . 0.0 112.238 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.94 -54.28 23.52 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 119.309 0.959 . . . . 0.0 108.738 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.88 82.91 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.843 0.857 . . . . 0.0 109.865 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.96 -37.73 88.62 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.26 0.624 . . . . 0.0 110.244 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -63.06 -23.71 67.57 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.906 0.775 . . . . 0.0 109.786 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -87.84 -20.25 26.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.247 1.019 . . . . 0.0 109.658 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.36 12.65 72.6 Favored Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.514 1.531 . . . . 0.0 111.752 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -66.23 -45.85 79.21 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 117.911 0.855 . . . . 0.0 110.87 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 43.5 p -71.38 171.5 11.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.919 1.688 . . . . 0.0 109.069 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -129.38 -13.48 4.37 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.827 1.417 . . . . 0.0 114.827 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -157.21 -179.63 8.38 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 121.745 -0.597 . . . . 0.0 110.653 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.3 t -164.53 174.29 11.07 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.475 1.51 . . . . 0.0 107.39 178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.4 mt -148.19 109.19 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 105.205 -2.146 . . . . 0.0 105.205 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -148.68 164.59 33.89 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.327 1.051 . . . . 0.0 108.452 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.401 ' HA3' ' CH2' ' A' ' 230' ' ' TRP . . . 159.32 81.87 0.04 OUTLIER Glycine 0 CA--C 1.523 0.544 0 N-CA-C 107.927 -2.069 . . . . 0.0 107.927 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -76.03 46.89 1.84 Allowed 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.746 3.631 . . . . 0.0 112.648 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.401 ' CH2' ' HA3' ' A' ' 228' ' ' GLY . 3.5 m-90 -74.12 51.97 0.43 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.511 1.524 . . . . 0.0 111.929 179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -135.97 124.55 23.64 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.765 1.626 . . . . 0.0 108.524 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 64.1 t-105 46.75 43.6 13.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.451 1.5 . . . . 0.0 111.804 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 72.7 m 45.58 39.21 4.63 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.08 1.752 . . . . 0.0 113.192 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -60.76 146.27 46.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 29.8 pt -65.92 173.97 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.527 0.731 . . . . 0.0 109.479 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 80.4 6.54 1.58 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 128.117 2.567 . . . . 0.0 113.151 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 4.5 m -59.73 -30.8 69.08 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.554 -1.341 . . . . 0.0 110.809 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 10.7 p -81.18 5.86 15.63 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.022 1.329 . . . . 0.0 113.123 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -53.41 -29.95 37.67 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.943 1.247 . . . . 0.0 112.341 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 1.9 p -115.97 123.71 71.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 102.331 -3.211 . . . . 0.0 102.331 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -64.29 -49.4 71.97 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.301 0.64 . . . . 0.0 109.575 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -178.18 178.07 0.94 Allowed 'General case' 0 C--O 1.235 0.292 0 C-N-CA 128.188 2.595 . . . . 0.0 107.081 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . 148.01 142.51 3.67 Favored Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 107.564 -2.214 . . . . 0.0 107.564 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 8.4 p -142.88 130.43 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 118.248 1.024 . . . . 0.0 108.332 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 9.0 t -169.97 172.12 6.72 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.393 0.677 . . . . 0.0 109.681 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 14.9 p -67.88 160.16 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 176.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -131.61 155.89 80.84 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 118.506 0.594 . . . . 0.0 111.382 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.91 134.49 23.68 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.802 1.668 . . . . 0.0 109.924 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 65.1 p -129.78 176.58 7.91 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.883 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -88.73 140.25 29.63 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 103.049 -2.945 . . . . 0.0 103.049 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -52.89 131.76 36.11 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.519 -1.363 . . . . 0.0 110.871 -178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 74.38 -1.36 50.91 Favored Glycine 0 CA--C 1.519 0.285 0 CA-C-O 118.54 -1.144 . . . . 0.0 114.635 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.93 103.39 3.19 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 119.647 1.723 . . . . 0.0 111.842 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.17 170.23 15.0 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.345 2.696 . . . . 0.0 114.376 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 74.9 m -57.75 140.79 50.67 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.164 1.386 . . . . 0.0 110.648 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -140.25 73.95 30.56 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.478 1.111 . . . . 0.0 108.439 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.98 -95.58 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.578 3.518 . . . . 0.0 109.121 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -136.2 178.32 7.15 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 128.623 2.769 . . . . 0.0 107.631 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 324' ' ' ALA . 85.3 t -96.91 130.98 44.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -105.59 59.94 0.41 Allowed Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 1.5 p -69.18 112.98 4.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-O 121.427 0.632 . . . . 0.0 109.301 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 8.8 tt -77.87 134.75 37.88 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 19.5 m -125.7 168.31 13.93 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.616 1.167 . . . . 0.0 110.712 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -137.05 140.99 42.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -136.03 147.59 19.27 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 69.8 mt -90.32 136.77 23.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -71.73 128.24 35.13 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -74.4 8.23 2.38 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -116.25 3.41 13.41 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.09 1.314 . . . . 0.0 112.48 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 62.7 m -63.5 160.51 42.23 Favored Pre-proline 0 C--O 1.237 0.447 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -67.8 -60.18 0.09 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 108.333 -1.449 . . . . 0.0 108.333 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -123.78 102.68 7.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -16.19 37.38 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.239 0.472 . . . . 0.0 110.595 178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.44 ' HA ' ' HG3' ' A' ' 277' ' ' LYS . 15.3 tt0 -57.17 -41.9 80.09 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 127.456 2.303 . . . . 0.0 108.469 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.02 -37.09 76.12 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.018 -1.051 . . . . 0.0 110.852 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -74.06 -46.82 40.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 122.094 -0.379 . . . . 0.0 109.994 -178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.44 ' HG3' ' HA ' ' A' ' 274' ' ' GLU . 0.0 OUTLIER -62.15 -34.48 76.46 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.704 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -69.51 -55.24 10.76 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -52.55 -46.26 66.71 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.042 -1.036 . . . . 0.0 111.617 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -51.66 68.7 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-O 119.264 -0.398 . . . . 0.0 110.929 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.54 -10.98 59.93 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -108.59 -27.73 9.7 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -138.11 -25.62 0.95 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 120.102 1.319 . . . . 0.0 114.04 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.51 -51.02 10.58 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.681 1.128 . . . . 0.0 110.859 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 88.7 mt -86.57 68.36 10.15 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.602 1.161 . . . . 0.0 110.819 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 45.8 p -135.21 162.62 32.02 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -75.75 5.0 6.82 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.395 0.617 . . . . 0.0 110.457 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -113.26 -42.82 3.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.091 2.156 . . . . 0.0 109.478 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -67.93 -37.11 87.64 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 125.18 1.371 . . . . 0.0 111.884 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 78.5 mt -75.09 -36.06 61.74 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.556 1.178 . . . . 0.0 109.267 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -70.33 -39.26 74.83 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.807 0.843 . . . . 0.0 110.044 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -53.73 -38.31 64.22 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.16 0.891 . . . . 0.0 112.707 -178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 20.2 t -81.34 -35.47 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 118.672 -0.68 . . . . 0.0 110.148 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -63.35 -33.34 75.31 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.852 0.861 . . . . 0.0 111.356 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -61.33 -54.06 48.75 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.139 1.376 . . . . 0.0 108.784 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.26 -42.42 99.14 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -152.42 141.76 14.43 Favored Pre-proline 0 N--CA 1.468 0.461 0 C-N-CA 124.873 1.269 . . . . 0.0 107.801 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.75 110.56 2.15 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.435 2.09 . . . . 0.0 109.031 -179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 12.5 mt -75.22 -22.25 58.07 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.27 -155.7 19.91 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 108.504 -1.839 . . . . 0.0 108.504 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -74.6 178.06 5.63 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.965 0.888 . . . . 0.0 109.398 179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.74 150.55 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 C-N-CA 123.753 0.821 . . . . 0.0 109.198 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -81.24 -20.86 40.11 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.625 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.1 106.9 6.83 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.971 1.708 . . . . 0.0 110.165 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 3.2 mtmp? -56.42 -26.55 53.89 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 2.8 m -57.13 -54.79 42.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.635 1.107 . . . . 0.0 110.663 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -90.46 -17.96 26.21 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.517 0.727 . . . . 0.0 111.803 -178.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -60.88 -39.77 90.47 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-O 118.103 -0.951 . . . . 0.0 108.895 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -66.58 -15.89 63.76 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.529 1.059 . . . . 0.0 113.033 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -95.73 -23.49 16.95 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.704 2.001 . . . . 0.0 110.323 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . . . . . . . . . 32.4 mt -86.69 -44.4 11.85 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.76 -17.9 57.78 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 126.888 2.075 . . . . 0.0 112.03 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 314' ' ' ASP . 0.1 OUTLIER -69.81 -16.91 63.36 Favored 'General case' 0 N--CA 1.462 0.166 0 O-C-N 121.695 -0.628 . . . . 0.0 109.561 178.071 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.452 ' HB2' ' HE3' ' A' ' 313' ' ' LYS . 2.5 t70 -103.94 131.51 21.9 Favored Pre-proline 0 N--CA 1.438 -1.051 0 C-N-CA 125.91 1.684 . . . . 0.0 107.562 -178.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -58.81 -23.63 67.86 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.497 2.131 . . . . 0.0 114.43 -177.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 11.2 mmt85 -60.39 -54.98 39.16 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.848 1.259 . . . . 0.0 111.009 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 4.4 mp -71.96 -49.37 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -49.92 -52.06 36.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 123.948 0.78 . . . . 0.0 111.903 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.22 -28.45 70.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.511 0.596 . . . . 0.0 112.566 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 24.0 m -76.61 -37.45 56.4 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 1.1 tpt -71.84 -33.1 68.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.715 1.206 . . . . 0.0 111.393 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -55.99 -35.37 66.7 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.691 0.796 . . . . 0.0 109.696 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -63.23 -36.85 85.03 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.968 0.907 . . . . 0.0 111.486 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.44 ' HA ' HG22 ' A' ' 259' ' ' VAL . . . -76.92 -35.14 57.56 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.967 0.907 . . . . 0.0 109.522 178.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -69.53 -18.11 63.64 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.502 1.121 . . . . 0.0 112.923 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.11 -18.83 9.94 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.367 1.067 . . . . 0.0 112.793 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -72.73 -167.14 10.33 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 125.184 1.373 . . . . 0.0 114.403 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -125.32 139.39 53.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.947 1.299 . . . . 0.0 108.375 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 50.1 mt -112.04 100.24 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 10.4 tmm? 32.35 89.01 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 128.161 2.584 . . . . 0.0 112.846 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.55 102.82 1.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.783 2.322 . . . . 0.0 109.713 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -83.0 4.21 26.97 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 48.6 pt -60.89 151.93 71.73 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.38 1.072 . . . . 0.0 111.263 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.61 -21.8 21.69 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.52 2.147 . . . . 0.0 113.771 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -68.78 -18.41 64.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.233 0.924 . . . . 0.0 111.67 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 64.3 mmm -61.85 -29.23 70.04 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.349 0.977 . . . . 0.0 109.867 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.1 m -63.7 -52.0 62.56 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -61.83 -37.96 86.37 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 123.074 0.549 . . . . 0.0 110.105 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -56.93 -54.86 41.74 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.821 1.248 . . . . 0.0 109.86 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 46.2 m95 -60.56 -39.97 89.92 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 118.98 0.809 . . . . 0.0 110.599 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -68.09 -25.89 65.55 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -81.96 -59.17 2.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.814 1.246 . . . . 0.0 110.552 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.9 t -55.95 -38.97 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 123.655 0.782 . . . . 0.0 110.667 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.68 -46.59 74.11 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.177 1.353 . . . . 0.0 110.8 179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 47.7 m -67.71 -46.4 72.35 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 118.304 -0.855 . . . . 0.0 109.627 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -56.48 -43.41 79.62 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 119.47 1.032 . . . . 0.0 112.652 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.72 -53.5 46.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 125.041 1.336 . . . . 0.0 109.14 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.77 -40.78 88.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 122.809 0.444 . . . . 0.0 109.833 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -56.08 -45.23 79.43 Favored 'General case' 0 CA--C 1.52 -0.205 0 O-C-N 120.969 -1.082 . . . . 0.0 110.984 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.72 -46.94 34.23 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 123.24 0.616 . . . . 0.0 111.015 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -63.1 -42.07 99.51 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.138 0.975 . . . . 0.0 113.266 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 36.4 m -84.87 -5.29 59.34 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.396 0.678 . . . . 0.0 109.362 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 70.86 12.55 71.14 Favored Glycine 0 C--N 1.343 0.937 0 CA-C-N 118.538 0.608 . . . . 0.0 113.711 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -65.56 -28.01 68.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.134 0.967 . . . . 0.0 109.707 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -142.98 156.96 44.96 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 9.0 m -66.71 148.73 51.52 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.432 HG11 ' HB ' ' A' ' 193' ' ' THR . 83.6 t -51.27 -57.24 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.436 1.094 . . . . 0.0 111.272 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -63.56 -39.93 95.67 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -70.06 -25.45 63.55 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.774 -178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.39 -41.49 76.39 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.507 0.723 . . . . 0.0 109.309 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.56 -36.21 60.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 118.686 -0.674 . . . . 0.0 110.297 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -55.63 -54.67 41.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.205 1.402 . . . . 0.0 108.115 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -51.19 -61.35 2.29 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 127.873 2.469 . . . . 0.0 110.338 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.75 77.07 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 127.047 2.139 . . . . 0.0 114.092 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -59.62 -36.07 75.62 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 16.7 m -64.11 -38.8 92.37 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.307 0.575 . . . . 0.0 110.567 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -61.21 -24.04 66.05 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.074 -1.016 . . . . 0.0 111.787 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 17.8 mt -91.52 -29.94 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.793 1.237 . . . . 0.0 110.17 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 17.3 p -76.8 -20.96 55.79 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.299 0.954 . . . . 0.0 110.026 178.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 5.4 tmmm? . . . . . 0 C--O 1.247 0.955 0 C-N-CA 126.156 1.782 . . . . 0.0 108.355 179.301 . . . . . . . . 0 0 . 1 stop_ save_